PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Yehuda-Shnaidman, E; Kalderon, B; Azazmeh, N; Bar-Tana, J				Yehuda-Shnaidman, Einav; Kalderon, Bella; Azazmeh, Narmen; Bar-Tana, Jacob			Gating of the mitochondrial permeability transition pore by thyroid hormone	FASEB JOURNAL			English	Article						Bcl2; IP3 receptor; PP2B; calcium; mitochondrial uncoupling; Jurkat; rat liver	INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; INTRACELLULAR CALCIUM MOBILIZATION; HYPOTHYROID RATS RESTORES; CYTOCHROME-C RELEASE; APOPTOTIC CELL-DEATH; ENDOPLASMIC-RETICULUM; PHYSIOLOGICAL SIGNIFICANCE; TRISPHOSPHATE RECEPTOR; LIVER-MITOCHONDRIA; OUTER-MEMBRANE	The calorigenic-thermogenic activity of thyroid hormone (T3) has long been ascribed to uncoupling of mitochondrial oxidative phosphorylation. However, the mode of action of T3 in promoting mitochondrial proton leak is still unresolved. Mitochondrial uncoupling by T3 is reported here to be transduced in vivo in rats and in cultured Jurkat cells by gating of the mitochondrial permeability transition pore (PTP). T3-induced PTP gating is shown here to be abrogated in inositol 1,4,5-trisphosphate (IP3) receptor 1 (IP(3)R1)(-/-) cells, indicating that the endoplasmic reticulum IP(3)R1 may serve as upstream target for the mitochondrial activity of T3. IP(3)R1 gating by T3 is due to its increased expression and truncation into channel-only peptides, resulting in IP3-independent Ca2+ efflux. Increased cytosolic Ca2+ results in activation of protein phosphatase 2B, dephosphorylation and depletion of mitochondrial Bcl2 (S70), and increase in mitochondrial free Bax leading to low-conductance PTP gating. The T3 transduction pathway integrates genomic and nongenomic activities of T3 in regulating mitochondrial energetics and may offer novel targets for thyromimetics designed to modulate energy expenditure.-Yehuda-Shnaidman, E., Kalderon, B., Azazmeh, N., Bar-Tana, J. Gating of the mitochondrial permeability transition pore by thyroid hormone. FASEB J. 24, 93-104 ( 2010). www.fasebj.org	[Yehuda-Shnaidman, Einav; Kalderon, Bella; Azazmeh, Narmen; Bar-Tana, Jacob] Hebrew Univ Jerusalem, Sch Med, Dept Human Nutr & Metab, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Bar-Tana, J (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Human Nutr & Metab, IL-91120 Jerusalem, Israel.	bartanaj@cc.huji.ac.il			Israeli Science Foundation	Israeli Science Foundation(Israel Science Foundation)	The kind generosity of Dr. A. R. Marks ( Columbia University, New York, NY, USA; IP3R <SUP>-/-</SUP> Jurkat cells) and Dr. A. Gross (Weizmann Institute of Science, Rehovot, Israel; rabbit anti-rat Bax antibody) is deeply acknowledged. We thank Dr. S. Collins for her support and V. Wong for excellent technical assistance. This work was supported by the Israeli Science Foundation.	Adachi M, 2004, AM J PHYSIOL-GASTR L, V287, pG695, DOI 10.1152/ajpgi.00415.2003; Assefa Z, 2004, J BIOL CHEM, V279, P43227, DOI 10.1074/jbc.M403872200; Belzacq AS, 2003, CANCER RES, V63, P541; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Brenner C, 2000, ONCOGENE, V19, P329, DOI 10.1038/sj.onc.1203298; Brustovetsky N, 2000, J NEUROSCI, V20, P103, DOI 10.1523/JNEUROSCI.20-01-00103.2000; CAMERON AM, 1995, P NATL ACAD SCI USA, V92, P1784, DOI 10.1073/pnas.92.5.1784; Chavez E, 1998, BBA-MOL BASIS DIS, V1407, P243, DOI 10.1016/S0925-4439(98)00048-9; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Crompton M, 2000, CURR OPIN CELL BIOL, V12, P414, DOI 10.1016/S0955-0674(00)00110-1; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; D'Arezzo S, 2004, ENDOCRINOLOGY, V145, P5694, DOI 10.1210/en.2004-0890; DENG X, 2000, J NATL CANC I MONOGR, V28, P30; Deng XM, 2004, P NATL ACAD SCI USA, V101, P153, DOI 10.1073/pnas.2533920100; Doran E, 2000, BIOCHEM J, V348, P343, DOI 10.1042/0264-6021:3480343; Erin N, 2003, NEUROSCIENCE, V117, P541, DOI 10.1016/S0306-4522(02)00933-8; EVERTS ME, 1986, AM J PHYSIOL, V251, pE258, DOI 10.1152/ajpendo.1986.251.3.E258; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Grundler W, 2001, CYTOMETRY, V44, P45, DOI 10.1002/1097-0320(20010501)44:1<45::AID-CYTO1081>3.3.CO;2-P; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hajnoczky G, 2002, CELL CALCIUM, V32, P363, DOI 10.1016/S0143416002001872; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Harper ME, 2008, ANNU REV NUTR, V28, P13, DOI 10.1146/annurev.nutr.28.061807.155357; Harper ME, 2008, THYROID, V18, P145, DOI 10.1089/thy.2007.0250; HARPER ME, 1993, J BIOL CHEM, V268, P14850; Hausenloy D, 2004, CIRCULATION, V109, P1714, DOI 10.1161/01.CIR.0000126294.81407.7D; Hermesh O, 2000, BBA-BIOENERGETICS, V1457, P166, DOI 10.1016/S0005-2728(00)00097-9; HUMMERICH H, 1989, BIOCHEM J, V258, P363, DOI 10.1042/bj2580363; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P468, DOI 10.1016/0003-9861(79)90373-4; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Ishizuya-Oka A, 2007, DEV DYNAM, V236, P3358, DOI 10.1002/dvdy.21291; JAYARAMAN T, 1995, P NATL ACAD SCI USA, V92, P6007, DOI 10.1073/pnas.92.13.6007; Jayaraman T, 2000, J BIOL CHEM, V275, P6417, DOI 10.1074/jbc.275.9.6417; Jorns A, 2002, DIABETOLOGIA, V45, P851, DOI 10.1007/s00125-002-0842-5; Joseph SK, 2007, APOPTOSIS, V12, P951, DOI 10.1007/s10495-007-0719-7; KALDERON B, 1995, ENDOCRINOLOGY, V136, P3552, DOI 10.1210/en.136.8.3552; Koshkin V, 2008, J BIOL CHEM, V283, P7936, DOI 10.1074/jbc.M705652200; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Mihara S, 1999, J CLIN ENDOCR METAB, V84, P1378, DOI 10.1210/jc.84.4.1378; Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200; Moro L, 2004, ENDOCRINOLOGY, V145, P5121, DOI 10.1210/en.2004-0909; Nakayama T, 2004, BIOCHEM J, V377, P299, DOI 10.1042/BJ20030599; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Novgorodov SA, 1996, J BIOENERG BIOMEMBR, V28, P139, DOI 10.1007/BF02110644; Ozawa T, 2006, INT J MOL MED, V18, P187; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Rolfe DFS, 1997, BIOSCIENCE REP, V17, P9, DOI 10.1023/A:1027327015957; Ruvolo PP, 2001, LEUKEMIA, V15, P515, DOI 10.1038/sj.leu.2402090; Sharpe JC, 2004, BBA-MOL CELL RES, V1644, P107, DOI 10.1016/j.bbamcr.2003.10.016; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; Shibasaki F, 1997, NATURE, V386, P728, DOI 10.1038/386728a0; Short KR, 2001, AM J PHYSIOL-ENDOC M, V280, pE761, DOI 10.1152/ajpendo.2001.280.5.E761; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; Smith MA, 1996, BRAIN RES, V717, P99, DOI 10.1016/0006-8993(95)01473-X; Szewczyk A, 2002, PHARMACOL REV, V54, P101, DOI 10.1124/pr.54.1.101; Szlufcik K, 2006, BIOL CELL, V98, P1, DOI 10.1042/BC20050031; Thrower EC, 2001, TRENDS PHARMACOL SCI, V22, P580, DOI 10.1016/S0165-6147(00)01809-5; TIMERMAN AP, 1993, J BIOL CHEM, V268, P22992; Upadhyay G, 2004, HEPATOLOGY, V39, P1120, DOI 10.1002/hep.20085; Vacca RA, 2003, ENDOCRINOLOGY, V144, P3783, DOI 10.1210/en.2003-0310; Verbert L, 2008, BIOL CELL, V100, P39, DOI 10.1042/BC20070086; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wojcikiewicz RJH, 1996, J BIOL CHEM, V271, P16652, DOI 10.1074/jbc.271.28.16652; Yamauchi M, 2008, MOL ENDOCRINOL, V22, P893, DOI 10.1210/me.2007-0249; Yehuda-Shnaidman E, 2005, ENDOCRINOLOGY, V146, P2462, DOI 10.1210/en.2004-1161; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	69	25	25	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					93	104		10.1096/fj.09-133538	http://dx.doi.org/10.1096/fj.09-133538			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19723706				2022-12-25	WOS:000273233600012
J	Chang, YC; Tien, SC; Tien, HF; Zhang, H; Bokoch, GM; Chang, ZF				Chang, Y-C; Tien, S-C; Tien, H-F; Zhang, H.; Bokoch, G. M.; Chang, Z-F			p210(Bcr-Abl) desensitizes Cdc42 GTPase signaling for SDF-1 alpha-directed migration in chronic myeloid leukemia cells	ONCOGENE			English	Article						chronic myeloid leukemia (CML); p210(Bcr-Abl); Cdc42, chemotaxis; stromal-derived factor-1 alpha (SDF-1 alpha)	CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE PHOSPHORYLATION; CHEMOTACTIC RESPONSE; BCR-ABL; PHILADELPHIA-CHROMOSOME; PROTOONCOGENE VAV; STRUCTURAL BASIS; ACTIVATION; INDUCTION; BCR/ABL	Chronic myeloid leukemia (CML) is a lethal hematological disorder caused by the p210(Bcr-Abl) oncogene. Previous studies have suggested that p210(Bcr-Abl) transformation contributes to homing and retention defects, typical of immature myeloid cells in CML, by attenuating chemotactic response to stromal-derived factor-1 alpha (SDF-1 alpha). As Rho family GTPases are key regulators of the cytoskeleton and have been previously found to interact with p210(Bcr-Abl), this study aimed to determine whether p210(Bcr-Abl) signaling affects SDF-1 alpha chemotaxis through Rho GTPase signaling. We found that SDF-1 alpha stimulated Cdc42 GTPase activation in myeloid progenitor 32D, but not in p210(BcrAbl)-transformed (32Dp210) cells. In fact, the basal level of active Cdc42 was elevated in 32Dp210 cells and mononuclear cells isolated from bone marrow of CML patients. Inhibition of p210(Bcr-Abl) kinase activity decreased basal Cdc42 activity and restored SDF-1 alpha-induced Cdc42 and migration responses. Transduction of active Tat-Cdc42V12 abolished this reconstituted chemotactic response. As Cdc42 is particularly important in cytoskeletal remodeling and directional sensing, these results suggest that sustained activation of Cdc42 GTPase through p210(Bcr-Abl) tyrosine kinase signaling in CML cells contributes to defects in SDF-1 alpha-chemotactic response due to desensitization of the actin polarization signal required for directional migration. Oncogene (2009) 28, 4105-4115; doi:10.1038/onc.2009.260; published online 31 August 2009	[Chang, Y-C; Tien, S-C; Chang, Z-F] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei, Taiwan; [Tien, H-F] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Zhang, H.; Bokoch, G. M.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Zhang, H.; Bokoch, G. M.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	National Taiwan University; National Taiwan University; National Taiwan University Hospital; Scripps Research Institute; Scripps Research Institute	Chang, ZF (corresponding author), Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, 1 Sect,1 Jen Ai Rd, Taipei, Taiwan.	zfchang@ntu.edu.tw		TIEN, HWEI-FANG/0000-0002-1384-5593	National Science Council, Taiwan [NSC 96-3112-B-002-006, NSC 97-3112-B-002-026]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	We are grateful to Dr RB Arlinghaus (Department of Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA) for providing 32Dp210 and WEHI cells. We thank the staff of the Second Core Lab, Department of Medical Research, National Taiwan University Hospital for technical support during this study. This study is supported by grant NSC 96-3112-B-002-006 and NSC 97-3112-B-002-026 from the National Science Council, Taiwan.	Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Bassermann F, 2002, J BIOL CHEM, V277, P12437, DOI 10.1074/jbc.M112397200; Burger JA, 2007, BRIT J HAEMATOL, V137, P288, DOI 10.1111/j.1365-2141.2007.06590.x; Chang YC, 2006, CELL DEATH DIFFER, V13, P2023, DOI 10.1038/sj.cdd.4401901; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Daubon T, 2008, ONCOGENE, V27, P2673, DOI 10.1038/sj.onc.1210933; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Geay JF, 2005, CANCER RES, V65, P2676, DOI 10.1158/0008-5472.CAN-04-2152; Genth H, 1996, BIOCHEM BIOPH RES CO, V229, P370, DOI 10.1006/bbrc.1996.1812; Gottig S, 2006, EUR J IMMUNOL, V36, P180, DOI 10.1002/eji.200525607; Haddad E, 2001, BLOOD, V97, P33, DOI 10.1182/blood.V97.1.33; Harnois T, 2003, ONCOGENE, V22, P6445, DOI 10.1038/sj.onc.1206626; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; MATSUGUCHI T, 1995, EMBO J, V14, P257, DOI 10.1002/j.1460-2075.1995.tb06999.x; Miletic AV, 2003, CURR OPIN IMMUNOL, V15, P261, DOI 10.1016/S0952-7915(03)00054-2; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Niggli V, 2003, INT J BIOCHEM CELL B, V35, P1619, DOI 10.1016/S1357-2725(03)00144-4; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ramaraj P, 2004, CANCER RES, V64, P5322, DOI 10.1158/0008-5472.CAN-03-3656; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; ROWLEY JD, 1990, CANCER, V65, P2178, DOI 10.1002/1097-0142(19900515)65:10<2178::AID-CNCR2820651004>3.0.CO;2-#; Salesse S, 2002, ONCOGENE, V21, P8547, DOI 10.1038/sj.onc.1206082; Salgia R, 1999, BLOOD, V94, P4233; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Stofega Mary, 2006, V332, P269; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Vicente-Manzanares M, 2005, BLOOD, V105, P3026, DOI 10.1182/blood-2004-07-2925; Volinsky N, 2006, BIOCHEM J, V397, P213, DOI 10.1042/BJ20051655; Wertheim JA, 2002, ONCOGENE, V21, P8612, DOI 10.1038/sj.onc.1206089; Wilkinson B, 2006, J BIOL CHEM, V281, P20842, DOI 10.1074/jbc.M600627200	36	16	16	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	NOV 19	2009	28	46					4105	4115		10.1038/onc.2009.260	http://dx.doi.org/10.1038/onc.2009.260			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	530AE	19718053				2022-12-25	WOS:000272560500006
J	Gruhne, B; Sompallae, R; Masucci, MG				Gruhne, B.; Sompallae, R.; Masucci, M. G.			Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints	ONCOGENE			English	Article						Epstein-Barr virus; genomic instability; DNA repair; mitotic spindle checkpoint	NUCLEAR ANTIGEN 3C; BURKITTS-LYMPHOMA CELLS; HUMAN EPITHELIAL-CELLS; NASOPHARYNGEAL CARCINOMA; MEMBRANE ANTIGEN; GENE-EXPRESSION; DOWN-REGULATION; TRANSCRIPTION; PATHWAY; LINES	Epstein-Barr virus (EBV) has been implicated in the pathogenesis of human malignancies, but its contribution to tumorigenesis is not well understood. EBV carriage is associated with increased genomic instability in Burkitt's lymphoma, suggesting that viral products may induce this tumor phenotype. Using a panel of transfected sublines of the B-lymphoma line BJAB expressing the viral genes associated with latent infection, we show that the EBV nuclear antigens, EBNA-1 and EBNA-3C, and the latent membrane protein 1, LMP-1, independently promote genomic instability, as detected by nonclonal chromosomal aberrations, DNA breaks and phosphorylation of histone H2AX. EBNA-1 promotes the generation of DNA damage by inducing reactive oxygen species (ROS), whereas DNA repair is inhibited in LMP-1-expressing cells through downregulation of the DNA damage-sensing kinase, ataxia telangiectasia mutated (ATM), reduction of phosphorylation of its downstream targets Chk2 and inactivation of the G(2) checkpoint. EBNA-3C enhances the propagation of damaged DNA through inactivation of the mitotic spindle checkpoint and transcriptional downregulation of BubR1. Thus, multiple cellular functions involved in the maintenance of genome integrity seem to be independently targeted by EBV, pointing to the induction of genomic instability as a critical event in viral oncogenesis. Oncogene (2009) 28, 3997-4008; doi:10.1038/onc.2009.258; published online 31 August 2009	[Gruhne, B.; Sompallae, R.; Masucci, M. G.] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Masucci, MG (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Berzelius Vag 35, S-17177 Stockholm, Sweden.	maria.masucci@ki.se	Masucci, Maria/AAC-6666-2019	Masucci, Maria/0000-0002-5541-2809	Swedish Cancer Society; Swedish Medical Research Council; Karolinska Institutet, Stockholm, Sweden; INCA [LSHC-CT-2005-018704]	Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Karolinska Institutet, Stockholm, Sweden; INCA(Institut National du Cancer (INCA) France)	We thank L Rymo, M Rowe and J Middledorp for the kind gift of transfected cell lines and antibodies and also many colleagues for helpful discussions. This study was supported by grants awarded by the Swedish Cancer Society, the Swedish Medical Research Council and Karolinska Institutet, Stockholm, Sweden and by the European Community Integrated Project on Infection and Cancer, INCA, Project No. LSHC-CT-2005-018704.	AMAN P, 1990, INT J CANCER, V45, P77, DOI 10.1002/ijc.2910450115; Bolt J, 2005, ORAL ONCOL, V41, P1013, DOI 10.1016/j.oraloncology.2005.06.003; Bose S, 2007, J PATHOL, V213, P329, DOI 10.1002/path.2232; Bose S, 2009, J PATHOL, V217, P345, DOI 10.1002/path.2487; Chandel NS, 2001, J BIOL CHEM, V276, P42728, DOI 10.1074/jbc.M103074200; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chen YR, 2008, J VIROL, V82, P8124, DOI 10.1128/JVI.00430-08; Choudhuri T, 2007, J VIROL, V81, P6718, DOI 10.1128/JVI.00053-07; CUOMO L, 1990, EUR J IMMUNOL, V20, P2293, DOI 10.1002/eji.1830201019; Eclache V, 2004, CANCER GENET CYTOGEN, V152, P72, DOI 10.1016/j.cancergencyto.2003.10.010; Erickson KD, 2000, J VIROL, V74, P1057, DOI 10.1128/JVI.74.2.1057-1060.2000; Floettmann JE, 1996, VIROLOGY, V223, P29, DOI 10.1006/viro.1996.0452; Greene LM, 2008, MOL PHARMACOL, V73, P419, DOI 10.1124/mol.107.039024; Gruhne B, 2009, P NATL ACAD SCI USA, V106, P2313, DOI 10.1073/pnas.0810619106; HUDSON GS, 1985, J VIROL, V53, P528, DOI 10.1128/JVI.53.2.528-535.1985; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Kamranvar SA, 2007, ONCOGENE, V26, P5115, DOI 10.1038/sj.onc.1210324; Kang MS, 2001, P NATL ACAD SCI USA, V98, P15233, DOI 10.1073/pnas.211556598; Kelly G, 2002, NAT MED, V8, P1098, DOI 10.1038/nm758; Kelly GL, 2006, P NATL ACAD SCI USA, V103, P14935, DOI 10.1073/pnas.0509988103; KLEIN G, 1986, AIDS RES HUM RETROV, V2, pS167; Knight JS, 2005, P NATL ACAD SCI USA, V102, P18562, DOI 10.1073/pnas.0503886102; Knight JS, 2004, J VIROL, V78, P1981, DOI 10.1128/JVI.78.4.1981-1991.2004; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Kulwichit W, 1998, P NATL ACAD SCI USA, V95, P11963, DOI 10.1073/pnas.95.20.11963; Leao M, 2007, J VIROL, V81, P248, DOI 10.1128/JVI.01096-06; Liu MT, 2005, ONCOGENE, V24, P2635, DOI 10.1038/sj.onc.1208319; Liu MT, 2004, ONCOGENE, V23, P2531, DOI 10.1038/sj.onc.1207375; MARSHALL D, 1995, J VIROL, V69, P3624, DOI 10.1128/JVI.69.6.3624-3630.1995; MCINTOSH JR, 1991, COLD SH Q B, V56, P613; MENEZES J, 1975, BIOMEDICINE, V22, P276; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Pan SH, 2009, CARCINOGENESIS, V30, P366, DOI 10.1093/carcin/bgn291; Parish Christopher R, 2009, Curr Protoc Immunol, VChapter 4, DOI 10.1002/0471142735.im0409s84; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Ranjan D, 1998, AM SURGEON, V64, P47; Rao CV, 2005, P NATL ACAD SCI USA, V102, P4365, DOI 10.1073/pnas.0407822102; Raptis S, 2006, EXP SUPPL, V96, P303; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; ROWE DT, 1986, EMBO J, V5, P2599, DOI 10.1002/j.1460-2075.1986.tb04540.x; Saha A, 2009, J VIROL, V83, P4652, DOI 10.1128/JVI.02408-08; SCHAEFER BC, 1995, P NATL ACAD SCI USA, V92, P10565, DOI 10.1073/pnas.92.23.10565; Shea LM, 1996, J IMMUNOL, V157, P3902; Sivachandran N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000170; STOLLMANN B, 1985, BRIT J HAEMATOL, V60, P183, DOI 10.1111/j.1365-2141.1985.tb07399.x; Taylor AMR, 1996, BLOOD, V87, P423, DOI 10.1182/blood.V87.2.423.bloodjournal872423; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; WANG F, 1990, J VIROL, V64, P2309, DOI 10.1128/JVI.64.5.2309-2318.1990; Winberg G, 2000, MOL CELL BIOL, V20, P8526, DOI 10.1128/MCB.20.22.8526-8535.2000; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; YOUNG LS, 1988, J GEN VIROL, V69, P1051, DOI 10.1099/0022-1317-69-5-1051	54	103	109	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 12	2009	28	45					3997	4008		10.1038/onc.2009.258	http://dx.doi.org/10.1038/onc.2009.258			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	530AC	19718051				2022-12-25	WOS:000272560300005
J	Ahn, SY; Eraly, SA; Tsigelny, I; Nigam, SK				Ahn, Sun-Young; Eraly, Satish A.; Tsigelny, Igor; Nigam, Sanjay K.			Interaction of Organic Cations with Organic Anion Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASOLATERAL MEMBRANE; FAMILY; SYSTEMS; IDENTIFICATION; LOCALIZATION; SUBSTANCES; VERAPAMIL; SLC22A8; KIDNEY; OAT3	Studies of the organic anion transporters (Oats) have focused mainly on their interactions with organic anionic substrates. However, as suggested when Oat1 was originally identified as NKT (Lopez-Nieto, C. E., You, G., Bush, K. T., Barros, E. J., Beier, D. R., and Nigam, S. K. (1997) J. Biol. Chem. 272, 6471-6478), since the Oats share close homology with organic cation transporters (Octs), it is possible that Oats interact with cations as well. We now show that mouse Oat1 (mOat1) and mOat3 and, to a lesser degree, mOat6 bind a number of "prototypical" Oct substrates, including 1-methyl-4-phenylpyridinium. In addition to oocyte expression assays, we have tested binding of organic cations to Oat1 and Oat3 in ex vivo assays by analyzing interactions in kidney organ cultures deficient in Oat1 and Oat3. We also demonstrate that mOat3 transports organic cations such as 1-methyl-4-phenylpyridinium and cimetidine. A pharmacophore based on the binding affinities of the tested organic cations for Oat3 was generated. Using this pharmacophore, we screened a chemical library and were able to identify novel cationic compounds that bound to Oat1 and Oat3. These compounds bound Oat3 with an affinity higher than the highest affinity compounds in the original set of prototypical Oct substrates. Thus, whereas Oat1, Oat3, and Oat6 appear to function largely in organic anion transport, they also bind and transport some organic cations. These findings could be of clinical significance, since drugs and metabolites that under normal physiological conditions do not bind to the Oats may undergo changes in charge and become Oat substrates during pathologic conditions wherein significant variations in body fluid pH occur.	[Ahn, Sun-Young; Nigam, Sanjay K.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Eraly, Satish A.; Nigam, Sanjay K.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Tsigelny, Igor] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Tsigelny, Igor] Univ Calif San Diego, Sch Med, San Diego Supercomp Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Nigam, SK (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, 9500 Gilman Dr, La Jolla, CA 92093 USA.	snigam@ucsd.edu		Ahn, Sun-Young/0000-0001-5571-6901	National Institutes of Health [AI057695, DK079784, NS062156, DK064839, DK075486]; Coplon award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK064839, R03DK075486, R01DK079784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coplon award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI057695, DK079784, and NS062156 (to S. K. N.) and DK064839 and DK075486. This work was also supported by a Coplon award (to S. A. E.).	Ahn SY, 2009, MOL PHARMACOL, V76, P481, DOI 10.1124/mol.109.056564; Barnum D, 1996, J CHEM INF COMP SCI, V36, P563, DOI 10.1021/ci950273r; Clement OO, 2000, IUL BIOTECH, V2, P69; DANTZLER WH, 1984, AM J PHYSIOL, V246, pF188, DOI 10.1152/ajprenal.1984.246.2.F188; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; JENSEN RE, 1988, J PHARMACOL EXP THER, V244, P543; Kaler G, 2007, J BIOL CHEM, V282, P23841, DOI 10.1074/jbc.M703467200; Kaler G, 2006, BIOCHEM BIOPH RES CO, V351, P872, DOI 10.1016/j.bbrc.2006.10.136; Karbach U, 2000, AM J PHYSIOL-RENAL, V279, pF679, DOI 10.1152/ajprenal.2000.279.4.F679; Koepsell H, 2004, REV PHYSIOL BIOCH P, V150, P36, DOI 10.1007/s10254-003-0017-x; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Monte JC, 2004, BIOCHEM BIOPH RES CO, V323, P429, DOI 10.1016/j.bbrc.2004.08.112; Motohashi H, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134866; RUSSELL MAH, 1980, BMJ-BRIT MED J, V280, P972, DOI 10.1136/bmj.280.6219.972; SOKOL PP, 1989, J PHARMACOL EXP THER, V251, P937; Sugawara-Yokoo M, 2000, HISTOCHEM CELL BIOL, V114, P175; Sweet DH, 2003, AM J PHYSIOL-RENAL, V284, pF763, DOI 10.1152/ajprenal.00405.2002; Sweet DH, 2002, J BIOL CHEM, V277, P26934, DOI 10.1074/jbc.M203803200; Sweet DH, 1997, J BIOL CHEM, V272, P30088, DOI 10.1074/jbc.272.48.30088; Truong DM, 2008, J BIOL CHEM, V283, P8654, DOI 10.1074/jbc.M708615200; ULLRICH KJ, 1993, PFLUG ARCH EUR J PHY, V425, P300, DOI 10.1007/BF00374180; ULLRICH KJ, 1993, PFLUG ARCH EUR J PHY, V425, P280, DOI 10.1007/BF00374179; Vallon V, 2008, J AM SOC NEPHROL, V19, P1732, DOI 10.1681/ASN.2008020180; Vallon V, 2008, AM J PHYSIOL-RENAL, V294, pF867, DOI 10.1152/ajprenal.00528.2007; Wright SH, 2005, TOXICOL APPL PHARM, V204, P309, DOI 10.1016/j.taap.2004.10.021; Wu W, 2009, PHYSIOL GENOMICS, V38, P116, DOI 10.1152/physiolgenomics.90309.2008	26	50	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31422	31430		10.1074/jbc.M109.024489	http://dx.doi.org/10.1074/jbc.M109.024489			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19737926	Green Published, hybrid			2022-12-25	WOS:000271378400067
J	Belogus, T; Haviv, H; Karlish, SJD				Belogus, Talya; Haviv, Haim; Karlish, Steven J. D.			Neutralization of the Charge on Asp(369) of Na+,K+-ATPase Triggers E-1 <-> E-2 Conformational Changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; TRANSPORT ADENOSINE-TRIPHOSPHATASE; FE2+-CATALYZED OXIDATIVE CLEAVAGE; SITE-DIRECTED MUTAGENESIS; SODIUM-POTASSIUM PUMP; PICHIA-PASTORIS; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT; ION-TRANSPORT; CALCIUM-PUMP	This work investigates the role of charge of the phosphorylated aspartate, Asp369, of Na+,K+-ATPase on E-1 <-> E-2 conformational changes. Wild type (porcine alpha(1)/His(10)-beta(1)), D369N/D369A/D369E, and T212A mutants were expressed in Pichia pastoris, labeled with fluorescein 5'-isothiocyanate (FITC), and purified. Conformational changes of wild type and mutant proteins were analyzed using fluorescein fluorescence (Karlish, S. J. (1980) J. Bioenerg. Biomembr. 12, 111-136). One central finding is that the D369N/D369A mutants are strongly stabilized in E2 compared with wild type and D369E or T212A mutants. Stabilization of E-2(Rb) is detected by a reduced K0.5Rb for the Rb+-induced E-1 <-> E-2(2Rb) transition. The mechanism involves a greatly reduced rate of E-2(2Rb) -> E1Na with no effect on E-1 -> E-2(2Rb). Lowering the pH from 7.5 to 5.5 strongly stabilizes wild type in E-2 but affects the D369N mutant only weakly. Thus, this "Bohr" effect of pH on E-1 <-> E-2 is due largely to protonation of Asp369. Two novel effects of phosphate and vanadate were observed with the D369N/D369A mutants as follows. (a) E-1 -> E-2 center dot P is induced by phosphate without Mg2+ ions by contrast with wild type, which requires Mg2+. (b) Both phosphate and vanadate induce rapid E-1 -> E-2 transitions compared with slow rates for the wild type. With reference to crystal structures of Ca2+-ATPase and Na+,K+-ATPase, negatively charged Asp369 favors disengagement of the A domain from N and P domains (E-1), whereas the neutral D369N/D369A mutants favor association of the A domain (TGES sequence) with P and N domains (E-2). Changes in charge interactions of Asp369 may play an important role in triggering E1P(3Na) <-> E2P and E-2(2K) -> E1Na transitions in native Na+,K+-ATPase.	[Belogus, Talya; Haviv, Haim; Karlish, Steven J. D.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	Steven.Karlish@weizmann.ac.il			Israel Science Foundation [538/04]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Grant 538/04 from the Israel Science Foundation.	BUHLER R, 1991, J MEMBRANE BIOL, V121, P141, DOI 10.1007/BF01870529; Clarke RJ, 2003, ANN NY ACAD SCI, V986, P159, DOI 10.1111/j.1749-6632.2003.tb07154.x; Cohen E, 2005, J BIOL CHEM, V280, P16610, DOI 10.1074/jbc.M414290200; DUPONT Y, 1976, BIOCHEM BIOPH RES CO, V71, P544, DOI 10.1016/0006-291X(76)90821-4; DUPONT Y, 1978, NATURE, V273, P396, DOI 10.1038/273396a0; FARLEY RA, 1984, J BIOL CHEM, V259, P9532; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; GLYNN IM, 1990, ANNU REV BIOCHEM, V59, P171, DOI 10.1146/annurev.bi.59.070190.001131; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; HEGYVARY C, 1981, J BIOL CHEM, V256, P6296; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jacobsen MD, 2002, BIOCHEMISTRY-US, V41, P1451, DOI 10.1021/bi015891h; Jorgensen PL, 1998, BBA-BIOENERGETICS, V1365, P65, DOI 10.1016/S0005-2728(98)00043-7; JORGENSEN PL, 1975, BIOCHIM BIOPHYS ACTA, V401, P399, DOI 10.1016/0005-2736(75)90239-4; KAPAKOS JG, 1986, J BIOL CHEM, V261, P2090; KAPAKOS JG, 1986, J BIOL CHEM, V261, P2084; KAPLAN JH, 1982, ANN NY ACAD SCI, V402, P292, DOI 10.1111/j.1749-6632.1982.tb25750.x; Karlish SJD, 2003, ANN NY ACAD SCI, V986, P39, DOI 10.1111/j.1749-6632.2003.tb07137.x; KARLISH SJD, 1980, J BIOENERG BIOMEMBR, V12, P111, DOI 10.1007/BF00744678; KARLISH SJD, 1978, BIOCHIM BIOPHYS ACTA, V525, P252, DOI 10.1016/0005-2744(78)90219-X; KARLISH SJD, 1978, BIOCHIM BIOPHYS ACTA, V527, P115, DOI 10.1016/0005-2744(78)90261-9; KARLISH SJD, 1979, NATURE, V282, P333, DOI 10.1038/282333a0; KUNTZWEILER TA, 1995, J BIOL CHEM, V270, P16206, DOI 10.1074/jbc.270.27.16206; Lifshitz Y, 2007, BIOCHEMISTRY-US, V46, P14937, DOI 10.1021/bi701812c; Lifshitz Y, 2006, J BIOL CHEM, V281, P15790, DOI 10.1074/jbc.M601993200; Marchand A, 2008, J BIOL CHEM, V283, P14867, DOI 10.1074/jbc.M710165200; McIntosh DB, 1999, J BIOL CHEM, V274, P25227, DOI 10.1074/jbc.274.36.25227; MCINTOSH DB, 1992, J BIOL CHEM, V267, P22328; MINTZ E, 1995, J BIOL CHEM, V270, P27160, DOI 10.1074/jbc.270.45.27160; Montigny C, 2008, BIOCHEMISTRY-US, V47, P12159, DOI 10.1021/bi8006498; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; OHTSUBO M, 1990, BIOCHIM BIOPHYS ACTA, V1021, P157, DOI 10.1016/0005-2736(90)90028-M; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; ORLOWSKI S, 1993, FEBS LETT, V328, P296, DOI 10.1016/0014-5793(93)80947-S; Pedersen PA, 1996, BIOCHEMISTRY-US, V35, P16085, DOI 10.1021/bi961614c; Pedersen PA, 2000, J BIOL CHEM, V275, P37588, DOI 10.1074/jbc.M005610200; PICK U, 1980, BIOCHIM BIOPHYS ACTA, V626, P255, DOI 10.1016/0005-2795(80)90216-0; PICK U, 1982, J BIOL CHEM, V257, P6120; POST RL, 1972, J BIOL CHEM, V247, P6530; RABON EC, 1990, J BIOL CHEM, V265, P19594; REPHAELI A, 1986, J BIOL CHEM, V261, P6248; SCOFANO HM, 1979, J BIOL CHEM, V254, P227; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SKOU JC, 1980, BIOCHIM BIOPHYS ACTA, V601, P386, DOI 10.1016/0005-2736(80)90543-X; SKOU JC, 1981, BIOCHIM BIOPHYS ACTA, V647, P232, DOI 10.1016/0005-2736(81)90251-0; SMIRNOVA IN, 1993, J BIOL CHEM, V268, P16120; STEINBERG M, 1989, J BIOL CHEM, V264, P2726; STEKHOVEN FMAHS, 1986, BIOCHIM BIOPHYS ACTA, V861, P259, DOI 10.1016/0005-2736(86)90428-1; Strugatsky D, 2003, J BIOL CHEM, V278, P46064, DOI 10.1074/jbc.M308303200; STURMER W, 1991, J MEMBRANE BIOL, V121, P163, DOI 10.1007/BF01870530; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008	53	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31038	31051		10.1074/jbc.M109.050054	http://dx.doi.org/10.1074/jbc.M109.050054			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19726667	hybrid, Green Published			2022-12-25	WOS:000271378400033
J	Roostaee, A; Cote, S; Roucou, X				Roostaee, Alireza; Cote, Sebastien; Roucou, Xavier			Aggregation and Amyloid Fibril Formation Induced by Chemical Dimerization of Recombinant Prion Protein in Physiological-like Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; PHYSICAL-PROPERTIES; SCRAPIE; CONVERSION; PRPSC; MECHANISM; DISEASE; DOMAIN; HETERODIMERIZATION; CONFORMATION	Prion diseases are caused by the conversion of a cellular protein (PrPC) into a misfolded, aggregated isoform (PrPRes). Misfolding of recombinant PrPC in the absence of PrPRes template, cellular factors, denaturing agents, or at neutral pH has not been achieved. A number of studies indicate that dimerization of PrPC may be a key step in the aggregation process. In an effort to understand the molecular event that may activate misfolding of PrPC in more relevant physiological conditions, we tested if enforced dimerization of PrPC may induce a conformational change reminiscent of the conversion of PrPC to PrPRes. We used a well described inducible dimerization strategy whereby a chimeric PrPC composed of a modified FK506-binding protein (Fv) fused with PrPC and termed Fv-PrP is incubated in the presence of a monomeric FK506 or dimerizing AP20187 ligand. Addition of AP20187 but not FK506 to recombinant Fv-PrP (rFv-PrP) in physiological-like conditions resulted in a rapid conformational change characterized by an increase in beta-sheet structure and simultaneous aggregation of the protein. Aggregates were partially resistant to proteinase K and induced the conversion of soluble rFv-PrP in serial seeding experiments. As judged from thioflavin T binding and electron microscopy, aggregates converted to amyloid fibers. Aggregates were toxic to cultured cells, whereas soluble rFv-PrP and amyloid fibers were harmless. This study strongly supports the proposition that dimerization of PrPC is a key pathological primary event in the conversion of PrPC and may initiate the pathogenesis of prion diseases.	[Roostaee, Alireza; Cote, Sebastien; Roucou, Xavier] Univ Sherbrooke, Fac Med, Dept Biochem, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Roucou, X (corresponding author), Univ Sherbrooke, Fac Med, Dept Biochem, 3001 12th Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	xavier.roucou@usherbrooke.ca			Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from Canadian Institutes for Health Research (to X. R.).	Abalos GC, 2008, J BIOL CHEM, V283, P34021, DOI 10.1074/jbc.M804475200; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Baskakov IV, 2007, FEBS J, V274, P576, DOI 10.1111/j.1742-4658.2007.05630.x; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2001, J BIOL CHEM, V276, P19687, DOI 10.1074/jbc.C100180200; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; BENDHEIM PE, 1986, P NATL ACAD SCI USA, V83, P2214, DOI 10.1073/pnas.83.7.2214; Bocharova OV, 2006, J BIOL CHEM, V281, P2373, DOI 10.1074/jbc.M510840200; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Cobb NJ, 2008, J BIOL CHEM, V283, P34704, DOI 10.1074/jbc.M806701200; Cordeiro Y, 2005, BIOPHYS J, V89, P2667, DOI 10.1529/biophysj.105.067603; Daugherty DL, 1998, J BIOL CHEM, V273, P33961, DOI 10.1074/jbc.273.51.33961; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; GODT RE, 1988, AM J PHYSIOL, V254, pC591, DOI 10.1152/ajpcell.1988.254.5.C591; Goggin K, 2007, J NEUROCHEM, V102, P1195, DOI 10.1111/j.1471-4159.2007.04611.x; GOMEZ J, 1995, PROTEINS, V22, P404, DOI 10.1002/prot.340220410; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Ho JGS, 2005, J BIOL CHEM, V280, P31999, DOI 10.1074/jbc.M504403200; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Lavigne P, 1998, J MOL BIOL, V281, P165, DOI 10.1006/jmbi.1998.1914; LAVIGNE P, 1995, J MOL BIOL, V254, P505, DOI 10.1006/jmbi.1995.0634; Leffers KW, 2005, BIOL CHEM, V386, P569, DOI 10.1515/BC.2005.067; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; LU S, 1991, J BIOL CHEM, V266, P10054; Luhrs TT, 2006, J MOL BIOL, V357, P833, DOI 10.1016/j.jmb.2006.01.016; May BCH, 2004, TRENDS BIOCHEM SCI, V29, P162, DOI 10.1016/j.tibs.2004.02.008; Meier P, 2003, CELL, V113, P49, DOI 10.1016/S0092-8674(03)00201-0; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PRIOLA SA, 1995, J BIOL CHEM, V270, P3299, DOI 10.1074/jbc.270.7.3299; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rezaei H, 2005, J MOL BIOL, V347, P665, DOI 10.1016/j.jmb.2005.01.043; Roostaee A, 2008, BIOCHEM J, V412, P553, DOI 10.1042/BJ20071264; Simoneau S, 2007, PLOS PATHOG, V3, P1175, DOI 10.1371/journal.ppat.0030125; SKLAVIADIS TK, 1989, J VIROL, V63, P1212, DOI 10.1128/JVI.63.3.1212-1222.1989; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Supattapone S, 2004, J MOL MED, V82, P348, DOI 10.1007/s00109-004-0534-3; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; Tompa P, 2002, BIOPHYS J, V82, P1711, DOI 10.1016/S0006-3495(02)75523-9; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	54	23	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30907	30916		10.1074/jbc.M109.057950	http://dx.doi.org/10.1074/jbc.M109.057950			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19710507	Green Published, hybrid			2022-12-25	WOS:000271378400019
J	Nishiyama, Y; Planque, S; Mitsuda, Y; Nitti, G; Taguchi, H; Jin, L; Symersky, J; Boivin, S; Sienczyk, M; Salas, M; Hanson, CV; Paul, S				Nishiyama, Yasuhiro; Planque, Stephanie; Mitsuda, Yukie; Nitti, Giovanni; Taguchi, Hiroaki; Jin, Lei; Symersky, Jindrich; Boivin, Stephane; Sienczyk, Marcin; Salas, Maria; Hanson, Carl V.; Paul, Sudhir			Toward Effective HIV Vaccination INDUCTION OF BINARY EPITOPE REACTIVE ANTIBODIES WITH BROAD HIV NEUTRALIZING ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SUPERANTIGEN-BINDING-SITE; HUMAN MONOCLONAL-ANTIBODY; B-CELL SUPERANTIGEN; VASOACTIVE-INTESTINAL-PEPTIDE; GP120 ENVELOPE GLYCOPROTEIN; TYPE-1 GP120; LIGHT-CHAIN; PROTEOLYTIC ANTIBODIES; SYNTHETIC PEPTIDES	We describe murine monoclonal antibodies (mAbs) raised by immunization with an electrophilic gp120 analog (E-gp120) expressing the rare ability to neutralize genetically heterologous human immunodeficiency virus (HIV) strains. Unlike gp120, E-gp120 formed covalent oligomers. The reactivity of gp120 and E-gp120 with mAbs to reference neutralizing epitopes was markedly different, indicating their divergent structures. Epitope mapping with synthetic peptides and electrophilic peptide analogs indicated binary recognition of two distinct gp120 regions by anti-E-gp120 mAbs, the 421-433 and 288-306 peptide regions. Univalent Fab and single chain Fv fragments expressed the ability to recognize both peptides. X-ray crystallography of an anti-E-gp120 Fab fragment revealed two neighboring cavities, the typical antigen-binding cavity formed by the complementarity determining regions (CDRs) and another cavity dominated by antibody heavy chain variable (V-H) domain framework (FR) residues. Substitution of the FR cavity V-H Lys-19 residue by an Ala residue resulted in attenuated binding of the 421-433 region peptide probe. The CDRs and V-H FR replacement/silent mutation ratios exceeded the ratio for a random mutation process, suggesting adaptive development of both putative binding sites. All mAbs studied were derived from V(H)1 family genes, suggesting biased recruitment of the V gene germ line repertoire by E-gp120. The conserved 421-433 region of gp120 is essential for HIV binding to host CD4 receptors. This region is recognized weakly by the FR of antibodies produced without exposure to HIV, but it usually fails to induce adaptive synthesis of neutralizing antibodies. We present models accounting for improved CD4-binding site recognition and broad HIV neutralizing activity of the mAbs, long sought goals in HIV vaccine development.	[Nishiyama, Yasuhiro; Planque, Stephanie; Mitsuda, Yukie; Nitti, Giovanni; Taguchi, Hiroaki; Jin, Lei; Symersky, Jindrich; Boivin, Stephane; Sienczyk, Marcin; Paul, Sudhir] Univ Texas Houston, Sch Med, Chem Immunol Res Ctr, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Salas, Maria; Hanson, Carl V.] Calif Dept Publ Hlth, Viral & Rickettsial Dis Lab, Ctr Infect Dis, Richmond, CA 94804 USA	University of Texas System; University of Texas Health Science Center Houston; California Department of Public Health	Paul, S (corresponding author), 6431 Fannin, Houston, TX 77030 USA.	Sudhir.Paul@uth.tmc.edu	Sienczyk, Marcin/I-3869-2012; Boivin, Stephane/K-4018-2012	Boivin, Stephane/0000-0003-1460-326X	National Institutes of Health [AI058684, AG025304, AI82515, AI62455, AI31268, AI058865]; Texas Higher Education Coordinating Board; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI062455, R01AI031268, R15AI082515, R01AI058865, R21AI031268, R21AI058684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025304] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Higher Education Coordinating Board; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AI058684, AG025304, AI82515, AI62455, AI31268, and AI058865. This work was also supported by the Texas Higher Education Coordinating Board.	Bangale Y, 2003, FASEB J, V17, P628, DOI 10.1096/fj.02-0475com; Bangale Y, 2002, PEPTIDES, V23, P2251, DOI 10.1016/S0196-9781(02)00265-6; BERBERIAN L, 1991, BLOOD, V78, P175; BERBERIAN L, 1994, J ACQ IMMUN DEF SYND, V7, P641; BERBERIAN L, 1993, SCIENCE, V261, P1588, DOI 10.1126/science.7690497; Berisha HI, 2002, PULM PHARMACOL THER, V15, P121, DOI 10.1006/pupt.2001.0337; BERMAS BL, 1994, AIDS RES HUM RETROV, V10, P1071, DOI 10.1089/aid.1994.10.1071; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bose B, 2005, IMMUNOLOGY, V116, P172, DOI 10.1111/j.1365-2567.2005.02208.x; Brezski RJ, 2008, ADV EXP MED BIOL, V640, P12, DOI 10.1007/978-0-387-09789-3_2; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Bures R, 2000, AIDS RES HUM RETROV, V16, P2019, DOI 10.1089/088922200750054756; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; CHANG B, 1994, IMMUNOL TODAY, V15, P367, DOI 10.1016/0167-5699(94)90175-9; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Chuenchitra T, 2003, AIDS RES HUM RETROV, V19, P293, DOI 10.1089/088922203764969492; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; FOSTER MH, 1991, J IMMUNOL, V147, P1504; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; GEONNOTTI AR, 2009, 16 C RETR OPP INF MO; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; GOODGLICK L, 1995, J IMMUNOL, V155, P5151; Goodyear CS, 2007, J IMMUNOL, V178, P2636, DOI 10.4049/jimmunol.178.5.2636; Goodyear CS, 2003, J EXP MED, V197, P1125, DOI 10.1084/jem.20020552; GORNY MK, 1991, P NATL ACAD SCI USA, V88, P3238, DOI 10.1073/pnas.88.8.3238; Gorse GJ, 1999, AIDS RES HUM RETROV, V15, P115, DOI 10.1089/088922299311547; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Herrera C, 2003, J VIROL, V77, P1084, DOI 10.1128/JVI.77.2.1084-1091.2003; Hifumi E, 2008, J BIOL CHEM, V283, P899, DOI 10.1074/jbc.M705674200; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Juompan L, 1998, FASEB J, V12, P1473, DOI 10.1096/fasebj.12.14.1473; Karle S, 2004, AIDS, V18, P329, DOI 10.1097/00002030-200401230-00026; Karle S, 2003, VACCINE, V21, P1213, DOI 10.1016/S0264-410X(02)00504-2; Karray S, 1997, P NATL ACAD SCI USA, V94, P1356, DOI 10.1073/pnas.94.4.1356; Karray S, 1998, J IMMUNOL, V161, P6681; KERR JA, 1995, CRC HDB CHEM PHYS, P51; KOMISAR JL, 1989, J IMMUNOL, V143, P340; Koning FA, 2003, J INFECT DIS, V188, P864, DOI 10.1086/377105; Krakauer T, 2002, CLIN DIAGN LAB IMMUN, V9, P126, DOI 10.1128/CDLI.9.1.126-131.2002; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Lacroix-Desmazes S, 2006, J IMMUNOL, V177, P1355, DOI 10.4049/jimmunol.177.2.1355; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; MATTHEWS TJ, 1986, P NATL ACAD SCI USA, V83, P9709, DOI 10.1073/pnas.83.24.9709; Mitsuda Y, 2004, BIOTECHNOL BIOENG, V86, P217, DOI 10.1002/bit.20031; MONTEFIORI DC, 1992, J CLIN IMMUNOL, V12, P429, DOI 10.1007/BF00918855; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; MOORE JP, 1994, J VIROL, V68, P469, DOI 10.1128/JVI.68.1.469-484.1994; Moore JP, 2001, J VIROL, V75, P5721, DOI 10.1128/JVI.75.13.5721-5729.2001; MORROW WJW, 1992, IMMUNOLOGY, V75, P557; Neshat MN, 2000, INT IMMUNOL, V12, P305, DOI 10.1093/intimm/12.3.305; NEURATH AR, 1990, J GEN VIROL, V71, P85, DOI 10.1099/0022-1317-71-1-85; Nishiyama Y, 2005, J MOL RECOGNIT, V18, P295, DOI 10.1002/jmr.734; Nishiyama Y, 2004, J BIOL CHEM, V279, P7877, DOI 10.1074/jbc.M310950200; Nishiyama Y, 2002, ARCH BIOCHEM BIOPHYS, V402, P281, DOI 10.1016/S0003-9861(02)00087-5; Nishiyama Y, 2007, J BIOL CHEM, V282, P31250, DOI 10.1074/jbc.M706471200; Nishiyama Y, 2007, MOL IMMUNOL, V44, P2707, DOI 10.1016/j.molimm.2006.12.005; Nishiyama Y, 2006, J MOL RECOGNIT, V19, P423, DOI 10.1002/jmr.795; OLSHEVSKY U, 1990, J VIROL, V64, P5701, DOI 10.1128/JVI.64.12.5701-5707.1990; PALKER TJ, 1989, J IMMUNOL, V142, P3612; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; Paul S, 2003, J BIOL CHEM, V278, P20429, DOI 10.1074/jbc.M300870200; Paul S, 2001, J BIOL CHEM, V276, P28314, DOI 10.1074/jbc.M102530200; Planque S, 2004, J BIOL CHEM, V279, P14024, DOI 10.1074/jbc.M312152200; Planque S, 2003, J BIOL CHEM, V278, P20436, DOI 10.1074/jbc.M301468200; PLANQUE S, 2008, AIDS 2008 17 INT AID; Planque S, 2007, AIDS RES HUM RETROV, V23, P1541, DOI 10.1089/aid.2007.0081; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Saphire EO, 2007, J MOL BIOL, V369, P696, DOI 10.1016/j.jmb.2007.01.060; SATTENTAU QJ, 1995, J EXP MED, V182, P185, DOI 10.1084/jem.182.1.185; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Taguchi H, 2002, BIOORG MED CHEM LETT, V12, P3167, DOI 10.1016/S0960-894X(02)00640-6; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; WEISS RA, 1986, NATURE, V324, P572, DOI 10.1038/324572a0; WILSON IA, 1991, CIBA F SYMP, V159, P13; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Xiang SH, 2002, AIDS RES HUM RETROV, V18, P1207, DOI 10.1089/08892220260387959; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zolla-Pazner S, 2004, AIDS RES HUM RETROV, V20, P1254, DOI 10.1089/aid.2004.20.1254	88	14	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30627	30642		10.1074/jbc.M109.032185	http://dx.doi.org/10.1074/jbc.M109.032185			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726674	hybrid, Green Published			2022-12-25	WOS:000271090000065
J	Pastor, MM; Proft, M; Pascual-Ahuir, A				Pastor, Mar Martinez; Proft, Markus; Pascual-Ahuir, Amparo			Mitochondrial Function Is an Inducible Determinant of Osmotic Stress Adaptation in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; SNF1 PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; GLUCOSE REPRESSION; OXIDATIVE-STRESS; HIGH-OSMOLARITY; TRANSCRIPTIONAL RESPONSE; ENA1 GENE; SUBCELLULAR-LOCALIZATION; ION HOMEOSTASIS	Hyperosmotic stress triggers a great variety of adaptive responses in eukaryotic cells that affect many different physiological functions. Here we investigate the role of the mitochondria during osmostress adaptation in budding yeast. Mitochondrial function is generally required for proper salt and osmotic stress adaptation because mutants with defects in many different mitochondrial components show hypersensitivity to increased NaCl and KCl concentrations. Mitochondrial protein abundance rapidly increases upon osmoshock in a selective manner, because it affects Calvin cycle enzymes (Sdh2 and Cit1) and components of the electron transport chain (Cox6) but not the ATP synthase complex (Atp5). Transcription of the SDH2, CIT1, and COX6 genes is severalfold induced within the first minutes of osmotic shock, dependent to various degree on the Hog1 and Snf1 protein kinases. Mitochondrial succinate dehydrogenase enzyme activity is stimulated upon osmostress in a Snf1-dependent manner. The osmosensitivity of mitochondrial mutants is not caused by impaired stress-activated transcription or by a general depletion of the cellular ATP pool during osmostress. We finally show that the growth defect of mitochondrial mutants in high salt medium can be partially rescued by supplementation of glutathione. Additionally, mitochondrial defects cause the hyperaccumulation of reactive oxygen species during salt stress. Our results indicate that the antioxidant function of the mitochondria might play an important role in adaptation to hyperosmotic stress.	[Pastor, Mar Martinez; Proft, Markus; Pascual-Ahuir, Amparo] Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, CSIC, Valencia 46022, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Proft, M (corresponding author), Univ Politecn Valencia, Inst Biol Mol & Celular Plantas, CSIC, Ingn Fausto Elio S-N, Valencia 46022, Spain.	mproft@ibmcp.upv.es	Pascual-ahuir, Amparo/K-1338-2014; Proft, Markus/K-2323-2014	Proft, Markus/0000-0002-6788-5830; PASCUAL-AHUIR, AMPARO/0000-0001-6173-1526	Ministerio de Educacion y Ciencia [BFU2005-0174]; Ministerio de Ciencia e Innovacion [BFU2008-00271]; Generalitat de Valencia [ACOMP07-198]	Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Valencia	This work was supported by Ministerio de Educacion y Ciencia Grant BFU2005-0174, Ministerio de Ciencia e Innovacion Grant BFU2008-00271, and Generalitat de Valencia Grant ACOMP07-198.	Alepuz PM, 1997, MOL MICROBIOL, V26, P91, DOI 10.1046/j.1365-2958.1997.5531917.x; AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barros MH, 2004, J BIOL CHEM, V279, P49883, DOI 10.1074/jbc.M408918200; Bilsland-Marchesan E, 2000, MOL CELL BIOL, V20, P3887, DOI 10.1128/MCB.20.11.3887-3895.2000; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Clotet J, 2007, METHOD ENZYMOL, V428, P63, DOI 10.1016/S0076-6879(07)28004-8; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; de Nadal E, 2002, EMBO REP, V3, P735, DOI 10.1093/embo-reports/kvf158; DEFONTAINE A, 1991, NUCLEIC ACIDS RES, V19, P185, DOI 10.1093/nar/19.1.185; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; DIECKMANN CL, 1994, INT REV CYTOL, V152, P145, DOI 10.1016/S0074-7696(08)62556-5; Escote X, 2004, NAT CELL BIOL, V6, P997, DOI 10.1038/ncb1174; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; Ganster RW, 1998, GENETICS, V150, P31; GAXIOLA R, 1992, EMBO J, V11, P3157, DOI 10.1002/j.1460-2075.1992.tb05392.x; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Grant CM, 1997, FEBS LETT, V410, P219, DOI 10.1016/S0014-5793(97)00592-9; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; HARO R, 1991, FEBS LETT, V291, P189, DOI 10.1016/0014-5793(91)81280-L; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Hohmann S, 2002, INT REV CYTOL, V215, P149; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hong SP, 2007, J BIOL CHEM, V282, P16838, DOI 10.1074/jbc.M700146200; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jia YK, 1997, MOL CELL BIOL, V17, P1110, DOI 10.1128/MCB.17.3.1110; Koziol S, 2005, FREE RADICAL RES, V39, P365, DOI 10.1080/10715760500045855; Krantz M, 2004, EUKARYOT CELL, V3, P1381, DOI 10.1128/EC.3.6.1381-1390.2004; LI F, 1989, J CHROMATOGR, V461, P353, DOI 10.1016/S0021-9673(00)94302-4; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; MUELLER DM, 1986, J BIOL CHEM, V261, P1756; NAKAI T, 1995, MOL CELL BIOL, V15, P4441; Norbeck J, 1998, FEMS MICROBIOL LETT, V158, P121, DOI 10.1016/S0378-1097(97)00511-9; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; Pandey G, 2007, APPL MICROBIOL BIOT, V75, P415, DOI 10.1007/s00253-007-0837-8; Pascual-Ahuir M, 2001, MOL CELL BIOL, V21, P16, DOI 10.1128/MCB.21.1.16-25.2001; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Perrone GG, 2008, BBA-MOL CELL RES, V1783, P1354, DOI 10.1016/j.bbamcr.2008.01.023; PINKHAM JL, 1985, MOL CELL BIOL, V5, P3410, DOI 10.1128/MCB.5.12.3410; Platara M, 2006, J BIOL CHEM, V281, P36632, DOI 10.1074/jbc.M606483200; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Proft M, 1999, MOL CELL BIOL, V19, P537; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Rep M, 2001, MOL MICROBIOL, V40, P1067, DOI 10.1046/j.1365-2958.2001.02384.x; Sanz P, 2003, BIOCHEM SOC T, V31, P178; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Sedensky MM, 2006, EXP GERONTOL, V41, P237, DOI 10.1016/j.exger.2006.01.004; Sekito T, 2000, MOL BIOL CELL, V11, P2103, DOI 10.1091/mbc.11.6.2103; Teige M, 2001, P NATL ACAD SCI USA, V98, P5625, DOI 10.1073/pnas.091610798; Thorpe GW, 2004, P NATL ACAD SCI USA, V101, P6564, DOI 10.1073/pnas.0305888101; TRAWICK JD, 1989, J BIOL CHEM, V264, P7005; Tsujimoto Y, 2000, J BACTERIOL, V182, P5121, DOI 10.1128/JB.182.18.5121-5126.2000; ULERY TL, 1994, MOL CELL BIOL, V14, P1160, DOI 10.1128/MCB.14.2.1160; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WRIGHT RM, 1990, MOL CELL BIOL, V10, P1297, DOI 10.1128/MCB.10.3.1297; Yale J, 2001, J BIOL CHEM, V276, P15996, DOI 10.1074/jbc.M008209200; Ye T, 2008, MICROBIOL-SGM, V154, P2814, DOI 10.1099/mic.0.2008/020149-0; Ye T, 2006, EUKARYOT CELL, V5, P1611, DOI 10.1128/EC.00215-06; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Zuin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002842	69	57	58	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30307	30317		10.1074/jbc.M109.050682	http://dx.doi.org/10.1074/jbc.M109.050682			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19720830	hybrid, Green Published			2022-12-25	WOS:000271090000034
J	Takazawa, T; Yamauchi, T; Tsuchida, A; Takata, M; Hada, Y; Iwabu, M; Okada-Iwabu, M; Ueki, K; Kadowaki, T				Takazawa, Takeshi; Yamauchi, Toshimasa; Tsuchida, Atsushi; Takata, Makoto; Hada, Yusuke; Iwabu, Masato; Okada-Iwabu, Miki; Ueki, Kohjiro; Kadowaki, Takashi			Peroxisome Proliferator-activated Receptor gamma Agonist Rosiglitazone Increases Expression of Very Low Density Lipoprotein Receptor Gene in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; PPAR-GAMMA; APOLIPOPROTEIN-E; VLDL RECEPTOR; ADIPONECTIN RECEPTORS; DEFICIENT MICE; OBESITY; DIFFERENTIATION; ADIPOGENESIS	Apolipoprotein E (apoE) and its receptor, very low density lipoprotein receptor (VLDLR), are involved in fat accumulation in adipocytes. Here, we investigated the effect of a peroxisome proliferator-activated receptor (PPAR) gamma agonist, rosiglitazone, on regulation of VLDLR expression both in white adipose tissue (WAT) of obese mice and in cultured adipocytes. Furthermore, to determine whether rosiglitazone directly regulates transcription of the VLDLR gene, we carried out luciferase assay with a reporter gene containing mouse VLDLR promoter region, electrophoretic mobility shift assay, and chromatin immunoprecipitation assay. Four-day treatment with rosiglitazone increased the expression of VLDLR in WAT of ob/ob mice. Moreover, rosiglitazone increased the expression of VLDLR in cultured adipocytes. The PPAR-responsive element (PPRE)-directed mutagenesis analyses revealed that the PPRE motif in the VLDLR promoter region plays a significant role in transcriptional activation of the VLDLR gene in adipocytes. In addition, electrophoretic mobility shift assay and chromatin immunoprecipitation assay demonstrated that endogenous PPAR gamma directly binds to this functional PPRE motif in the VLDLR promoter region. We also investigated the effects of rosiglitazone on insulin sensitivity and lipid accumulation in both ob/ob mice and apoE-deficient ob/ob mice. Rosiglitazone ameliorated insulin sensitivity in both ob/ob mice and apoE-deficient ob/ob mice, possibly through decreasing the expression of monocyte chemoattractant protein-1 (MCP-1), increasing the expression of superoxide dismutase 1 (SOD1) in WAT, and increasing plasma adiponectin concentration. In ob/ob mice, body weight and WAT weight were significantly higher in the mice treated with rosiglitazone than those treated with vehicle. However, in apoE-deficient ob/ob mice, no significant difference in body weight or WAT weight was observed between the vehicle-treated group and the rosiglitazone-treated group. Moreover, rosiglitazone did not increase body weight and WAT weight in VLDLR-deficient mice. These findings indicate that rosiglitazone directly increases VLDLR expression, thereby enhancing apoE-VLDLR-dependent lipid accumulation in adipocytes.	[Takazawa, Takeshi; Yamauchi, Toshimasa; Hada, Yusuke; Iwabu, Masato; Okada-Iwabu, Miki; Ueki, Kohjiro; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Metab Dis, Bunkyo Ku, Tokyo 1138655, Japan; [Yamauchi, Toshimasa] Univ Tokyo, Century Med & Res Ctr 22, Dept Integrated Mol Sci Metab Dis, Tokyo 1138655, Japan; [Tsuchida, Atsushi; Takata, Makoto] Dainippon Sumitomo Pharma Co Ltd, Pharmacol Res Labs, Osaka 5540022, Japan; [Kadowaki, Takashi] Natl Inst Hlth & Nutr, Tokyo 1628636, Japan	University of Tokyo; University of Tokyo; Dainippon Sumitomo Pharmaceutical Company; National Institute of Health & Nutrition - Japan	Kadowaki, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Metab Dis, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kadowaki-3im@h.u-tokyo.ac.jp			Organization for Pharmaceutical Safety and Research of Japan; Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labor and Welfare	Organization for Pharmaceutical Safety and Research of Japan; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a grant from the Program for Promotion of Fundamental Studies in Health Sciences of the Organization for Pharmaceutical Safety and Research of Japan (to T. K.), a grant-in aid for the Development of Innovative Technology from the Ministry of Education, Culture, Sports, Science and Technology (to T. K.), and health science research grants (Research on Human Genome and Gene Therapy) from the Ministry of Health, Labor and Welfare (to T. K.).	Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268; BRESLOW JL, 1985, ANNU REV BIOCHEM, V54, P699, DOI 10.1146/annurev.biochem.54.1.699; Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Chiba T, 2003, ARTERIOSCL THROM VAS, V23, P1423, DOI 10.1161/01.ATV.0000085040.58340.36; de Souza CJ, 2001, DIABETES, V50, P1863, DOI 10.2337/diabetes.50.8.1863; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; GAFVELS ME, 1994, ENDOCRINOLOGY, V135, P387, DOI 10.1210/en.135.1.387; Gao JH, 2007, DIABETES, V56, P24, DOI 10.2337/db06-0144; Goudriaan JR, 2004, J LIPID RES, V45, P1475, DOI 10.1194/jlr.M400009-JLR200; Goudriaan JR, 2001, ARTERIOSCL THROM VAS, V21, P1488, DOI 10.1161/hq0901.095147; HUSSAIN MM, 1991, J BIOL CHEM, V266, P13936; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; KRAFT HG, 1989, J CLIN INVEST, V83, P137, DOI 10.1172/JCI113849; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lowell BB, 1999, CELL, V99, P239, DOI 10.1016/S0092-8674(00)81654-2; Moore GBT, 2001, BIOCHEM BIOPH RES CO, V286, P735, DOI 10.1006/bbrc.2001.5460; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; SAKAI J, 1994, J BIOL CHEM, V269, P2173; Sato O, 2002, J BIOL CHEM, V277, P15703, DOI 10.1074/jbc.M110158200; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; TAKAHASHI S, 1995, J BIOL CHEM, V270, P15747, DOI 10.1074/jbc.270.26.15747; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Way JM, 2001, ENDOCRINOLOGY, V142, P1269, DOI 10.1210/en.142.3.1269; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yagyu H, 2002, J BIOL CHEM, V277, P10037, DOI 10.1074/jbc.M109966200; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, J CLIN INVEST, V108, P1001, DOI 10.1172/JCI12864; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; ZECHNER R, 1991, J BIOL CHEM, V266, P10583; Zenimaru Y, 2008, BIOCHEM BIOPH RES CO, V368, P716, DOI 10.1016/j.bbrc.2008.01.154	37	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30049	30057		10.1074/jbc.M109.047993	http://dx.doi.org/10.1074/jbc.M109.047993			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19706614	Green Published, hybrid			2022-12-25	WOS:000271090000007
J	Ruprecht, J; Yankovskaya, V; Maklashina, E; Iwata, S; Cecchini, G				Ruprecht, Jonathan; Yankovskaya, Victoria; Maklashina, Elena; Iwata, So; Cecchini, Gary			Structure of Escherichia coli Succinate: Quinone Oxidoreductase with an Occupied and Empty Quinone-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX-II SUCCINATE; FUMARATE REDUCTASE; UBIQUINONE OXIDOREDUCTASE; STRUCTURE VALIDATION; CRYSTALLIZATION; LIGAND; DEHYDROGENASE; REFINEMENT; MECHANISM; REPLACEMENT	Three new structures of Escherichia coli succinate-quinone oxidoreductase (SQR) have been solved. One with the specific quinone-binding site (Q-site) inhibitor carboxin present has been solved at 2.4 angstrom resolution and reveals how carboxin inhibits the Q-site. The other new structures are with the Q-site inhibitor pentachlorophenol and with an empty Q-site. These structures reveal important details unresolved in earlier structures. Comparison of the new SQR structures shows how subtle rearrangements of the quinone-binding site accommodate the different inhibitors. The position of conserved water molecules near the quinone binding pocket leads to a reassessment of possible water-mediated proton uptake networks that complete reduction of ubiquinone. The dicarboxylate-binding site in the soluble domain of SQR is highly similar to that seen in high resolution structures of avian SQR (PDB 2H88) and soluble flavocytochrome c (PDB 1QJD) showing mechanistically significant structural features conserved across prokaryotic and eukaryotic SQRs.	Univ London Imperial Coll Sci Technol & Med, Mol Biosci Div, Membrane Prot Crystallog Grp, London SW7 2AZ, England; [Yankovskaya, Victoria; Maklashina, Elena; Cecchini, Gary] Vet Adm Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA; [Maklashina, Elena; Cecchini, Gary] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	Imperial College London; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco		s.iwata@imperial.ac.uk; Gary.Cecchini@ucsf.edu		Ruprecht, Jonathan/0000-0002-1838-7245	National Institutes of Health [GM61606]; Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Division; Human Receptor Crystallography Project, ERATO, Japan Science and Technology Agency [B17935]; Biotechnology and Biological Sciences Research Council [BB/C505116/1, B17935] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061606] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Division(US Department of Veterans Affairs); Human Receptor Crystallography Project, ERATO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM61606. This work was also supported by the Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Division (to G. C.). The work in the UK was supported primarily by the Biotechnology and Biological Sciences Research Council (#B17935) with important contributions from the Human Receptor Crystallography Project, ERATO, Japan Science and Technology Agency.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2005, CCP4 NEWSL, V42; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bamford V, 1999, NAT STRUCT BIOL, V6, P1104; BELIKOVA YO, 1988, BIOCHIM BIOPHYS ACTA, V936, P1, DOI 10.1016/0005-2728(88)90245-9; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; Cheng VWT, 2008, BIOCHEMISTRY-US, V47, P9107, DOI 10.1021/bi801008e; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Evrard GX, 2007, ACTA CRYSTALLOGR D, V63, P108, DOI 10.1107/S0907444906023389; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; Horsefield R, 2004, CURR PROTEIN PEPT SC, V5, P107, DOI 10.2174/1389203043486847; Horsefield R, 2003, ACTA CRYSTALLOGR D, V59, P600, DOI 10.1107/S0907444903002075; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; Huang LS, 2006, BBA-BIOENERGETICS, V1757, P1073, DOI 10.1016/j.bbabio.2006.06.015; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; Huang LS, 2005, ACTA CRYSTALLOGR D, V61, P380, DOI 10.1107/S0907444905000181; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jormakka M, 2008, NAT STRUCT MOL BIOL, V15, P730, DOI 10.1038/nsmb.1434; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; KUHLBRANDT W, 1988, Q REV BIOPHYS, V21, P429, DOI 10.1017/S0033583500004625; Lamzin V. S., 2001, INT TABLES CRYSTALLO, VF, P720; Lancaster CRD, 2002, BBA-BIOENERGETICS, V1553, P1, DOI 10.1016/S0005-2728(01)00240-7; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Leys D, 1999, NAT STRUCT BIOL, V6, P1113; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; Maklashina E, 2006, J BIOL CHEM, V281, P11357, DOI 10.1074/jbc.M512544200; Maklashina E, 1999, ARCH BIOCHEM BIOPHYS, V369, P223, DOI 10.1006/abbi.1999.1359; Maklashina E, 2001, J BIOL CHEM, V276, P18968, DOI 10.1074/jbc.M011270200; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MICHEL H, 1983, TRENDS BIOCHEM SCI, V8, P56, DOI 10.1016/0968-0004(83)90390-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Taylor P, 1999, NAT STRUCT BIOL, V6, P1108; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tornroth S, 2002, BBA-BIOENERGETICS, V1553, P171, DOI 10.1016/S0005-2728(01)00236-5; Vibat CRT, 1998, BIOCHEMISTRY-US, V37, P4148, DOI 10.1021/bi9716635; Wiener MC, 2004, METHODS, V34, P364, DOI 10.1016/j.ymeth.2004.03.025; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605	51	67	71	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29836	29846		10.1074/jbc.M109.010058	http://dx.doi.org/10.1074/jbc.M109.010058			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19710024	hybrid, Green Published			2022-12-25	WOS:000270896800064
J	Umetsu, Y; Aizawa, T; Muto, K; Yamamoto, H; Kamiya, M; Kumaki, Y; Mizuguchi, M; Demura, M; Hayakawa, Y; Kawano, K				Umetsu, Yoshitaka; Aizawa, Tomoyasu; Muto, Kaori; Yamamoto, Hiroko; Kamiya, Masakatsu; Kumaki, Yasuhiro; Mizuguchi, Mineyuki; Demura, Makoto; Hayakawa, Yoichi; Kawano, Keiichi			C-terminal Elongation of Growth-blocking Peptide Enhances Its Biological Activity and Micelle Binding Affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMATOCYTE-SPREADING PEPTIDE; RECEPTOR-BINDING; DOPAMINE LEVELS; TMV RNA; INSECT; NMR; CYTOKINE; SYSTEM; RESIDUES; IDENTIFICATION	Growth-blocking peptide (GBP) is a hormone-like peptide that suppresses the growth of the host armyworm. Although the 23-amino acid GBP (1-23 GBP) is expressed in nonparasitized armyworm plasma, the parasitization by wasp produces the 28-amino acid GBP (1-28 GBP) through an elongation of the C-terminal amino acid sequence. In this study, we characterized the GBP variants, which consist of various lengths of the C-terminal region, by comparing their biological activities and three-dimensional structures. The results of an injection study indicate that 1-28 GBP most strongly suppresses larval growth. NMR analysis shows that these peptides have basically the same tertiary structures and that the extension of the C-terminal region is disordered. However, the C-terminal region of 1-28 GBP undergoes a conformational transition from a random coiled state to an alpha-helical state in the presence of dodecylphosphocholine micelles. This suggests that binding of the C-terminal region would affect larval growth activity.	[Kumaki, Yasuhiro; Demura, Makoto; Kawano, Keiichi] Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Aizawa, Tomoyasu; Kamiya, Masakatsu; Kumaki, Yasuhiro; Demura, Makoto; Kawano, Keiichi] Hokkaido Univ, Grad Sch Life Sci, Div Mol Life Sci, Sapporo, Hokkaido 0600810, Japan; [Muto, Kaori; Mizuguchi, Mineyuki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan; [Hayakawa, Yoichi] Saga Univ, Dept Appl Biol Sci, Saga 8408502, Japan	Hokkaido University; Hokkaido University; University of Toyama; Saga University	Kawano, K (corresponding author), Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Kita Ku, Kita 10,Nishi 8, Sapporo, Hokkaido 0600810, Japan.	kawano@sci.hokudai.ac.jp	Demura, Makoto/F-5272-2011; Aizawa, Tomoyasu/F-5278-2011; Kamiya, Masakatsu/F-5274-2011	Demura, Makoto/0000-0003-0912-9284; Aizawa, Tomoyasu/0000-0001-9134-7576; 	KAKENHI [19770123]; Program for the Promotion of Basic Research Activities for Innovative Biosciences	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program for the Promotion of Basic Research Activities for Innovative Biosciences	This work was supported in part by KAKENHI Grant 19770123 and the Program for the Promotion of Basic Research Activities for Innovative Biosciences.	Aizawa T, 2001, J BIOL CHEM, V276, P31813, DOI 10.1074/jbc.M105251200; Aizawa T, 1999, J BIOL CHEM, V274, P1887, DOI 10.1074/jbc.274.4.1887; BEIER H, 1984, EMBO J, V3, P351, DOI 10.1002/j.1460-2075.1984.tb01810.x; BEIER H, 1984, EMBO J, V3, P1091, DOI 10.1002/j.1460-2075.1984.tb01934.x; Besenicar M, 2006, CHEM PHYS LIPIDS, V141, P169, DOI 10.1016/j.chemphyslip.2006.02.010; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clark KD, 2004, J BIOL CHEM, V279, P33246, DOI 10.1074/jbc.M401157200; Clark KD, 1997, J BIOL CHEM, V272, P23440, DOI 10.1074/jbc.272.37.23440; Clark KD, 2001, J BIOL CHEM, V276, P37431, DOI 10.1074/jbc.M105235200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Goddard T., 2001, SPARKY; Gololobov G, 1998, J PHARMACOL EXP THER, V285, P753; HAARER BK, 1993, MOL CELL BIOL, V13, P7864, DOI 10.1128/MCB.13.12.7864; Hayakawa Y, 1998, BIOCHEM BIOPH RES CO, V250, P194, DOI 10.1006/bbrc.1998.8959; HAYAKAWA Y, 1995, J INSECT PHYSIOL, V41, P1, DOI 10.1016/0022-1910(94)00077-T; HAYAKAWA Y, 1990, J BIOL CHEM, V265, P10813; HAYAKAWA Y, 1991, J BIOL CHEM, V266, P7982; HAYAKAWA Y, 1995, FEBS LETT, V376, P185, DOI 10.1016/0014-5793(95)01273-7; HAYAKAWA Y, 1993, INSECT BIOCHEM MOLEC, V23, P225, DOI 10.1016/0965-1748(93)90003-B; Hayakawa Y, 1998, J INSECT PHYSIOL, V44, P859, DOI 10.1016/S0022-1910(98)00017-1; Hayakawa Y, 1998, EUR J BIOCHEM, V253, P810, DOI 10.1046/j.1432-1327.1998.2530810.x; KAISER ET, 1983, P NATL ACAD SCI USA, V80, P1137, DOI 10.1073/pnas.80.4.1137; KAISER ET, 1984, SCIENCE, V223, P249, DOI 10.1126/science.6322295; KAY LE, 1989, J MAGN RESON, V84, P72, DOI 10.1016/0022-2364(89)90006-1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lerch M, 2005, BIOCHEMISTRY-US, V44, P9255, DOI 10.1021/bi0501232; Lerch M, 2004, J MOL BIOL, V339, P1153, DOI 10.1016/j.jmb.2004.04.032; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; MACURA S, 1981, J MAGN RESON, V43, P259, DOI 10.1016/0022-2364(81)90037-8; Matsumoto Y, 2003, J BIOL CHEM, V278, P38579, DOI 10.1074/jbc.M305986200; Mozsolits H, 2001, BBA-BIOMEMBRANES, V1512, P64, DOI 10.1016/S0005-2736(01)00303-0; Noguchi H, 1996, INSECT BIOCHEM MOLEC, V26, P659, DOI 10.1016/S0965-1748(96)00016-1; NOGUCHI H, 1995, INSECT BIOCHEM MOLEC, V25, P197, DOI 10.1016/0965-1748(94)00054-L; Ohnishi A, 1995, INSECT BIOCHEM MOLEC, V25, P1121, DOI 10.1016/0965-1748(95)00054-2; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; SARGENT DF, 1986, P NATL ACAD SCI USA, V83, P5774, DOI 10.1073/pnas.83.16.5774; SCHWYZER R, 1995, J MOL RECOGNIT, V8, P3, DOI 10.1002/jmr.300080103; Sekiya T, 1990, Tanpakushitsu Kakusan Koso, V35, P2977; SKINNER WS, 1991, J BIOL CHEM, V266, P12873; Strand MR, 2000, J INSECT PHYSIOL, V46, P817, DOI 10.1016/S0022-1910(99)00171-7; Tada M, 2003, J BIOL CHEM, V278, P10778, DOI 10.1074/jbc.M211251200; WAGNER G, 1982, J MOL BIOL, V160, P343, DOI 10.1016/0022-2836(82)90180-2; Yoshida M, 2004, J BIOL CHEM, V279, P51331, DOI 10.1074/jbc.M409382200	48	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29625	29634		10.1074/jbc.M109.011148	http://dx.doi.org/10.1074/jbc.M109.011148			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19710009	Green Published, hybrid			2022-12-25	WOS:000270896800044
J	Sakai, S; Sugawara, T; Matsubara, K; Hirata, T				Sakai, Shota; Sugawara, Tatsuya; Matsubara, Kiminori; Hirata, Takashi			Inhibitory Effect of Carotenoids on the Degranulation of Mast Cells via Suppression of Antigen-induced Aggregation of High Affinity IgE Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; INFLAMMATORY GENE-EXPRESSION; BROWN-ALGAE FUCOXANTHIN; HUMAN INTESTINAL-CELLS; KAPPA-B ACTIVATION; MEMBRANE DOMAINS; IN-VITRO; CANCER CELLS; LIPID RAFTS; BETA	Carotenoids have been demonstrated to possess antioxidative and anti-inflammatory effects. However, there is no report that the effects of carotenoids on degranulation of mast cell is critical for type I allergy. In this study, we focused on the effect of carotenoids on antigen-induced degranulation of mast cells. Fucoxanthin, astaxanthin, zeaxanthin, and beta-carotene significantly inhibited the antigen-induced release of beta-hexosaminidase in rat basophilic leukemia 2H3 cells and mouse bone marrow-derived mast cells. Those carotenoids also inhibited antigen-induced aggregation of the high affinity IgE receptor (Fc epsilon RI), which is the most upstream of the degranulating signals of mast cells. Furthermore, carotenoids inhibited Fc epsilon RI-mediated intracellular signaling, such as phosphorylation of Lyn kinase and Fyn kinase. It suggests that the inhibitory effect of carotenoids on the degranulation of mast cells were mainly due to suppressing the aggregation of Fc epsilon RI followed by intracellular signaling. In addition, those carotenoids inhibited antigen-induced translocation of Fc epsilon RI to lipid rafts, which are known as platforms of the aggregation of Fc epsilon RI. We assume that carotenoids may modulate the function of lipid rafts and inhibit the translocation of Fc epsilon RI to lipid rafts. This is the first report that focused on the aggregation of Fc epsilon RI to investigate the mechanism of the inhibitory effects on the degranulation of mast cells and evaluated the functional activity of carotenoids associated with lipid rafts.	[Sakai, Shota; Sugawara, Tatsuya; Hirata, Takashi] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto 6068502, Japan; [Matsubara, Kiminori] Hiroshima Univ, Grad Sch Educ, Dept Human Life Sci Educ, Higashihiroshima 7398524, Japan	Kyoto University; Hiroshima University	Sugawara, T (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto 6068502, Japan.	sugawara@kais.kyoto-u.ac.jp	MATSUBARA, Kiminori/N-9804-2019	Sugawara, Tatsuya/0000-0002-1203-5521	Mishima Kaiun Memorial Foundation; Iijima Memorial Foundation for the Promotion of Food Science and Technology	Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Iijima Memorial Foundation for the Promotion of Food Science and Technology(Iijima Memorial Foundation for the Promotion of Food Science and Technology)	This work was supported in part by the Mishima Kaiun Memorial Foundation and the Iijima Memorial Foundation for the Promotion of Food Science and Technology.	Asai K, 2000, J HISTOCHEM CYTOCHEM, V48, P1705, DOI 10.1177/002215540004801213; Bai SK, 2005, EXP MOL MED, V37, P323, DOI 10.1038/emm.2005.42; Cho SH, 2004, J ALLERGY CLIN IMMUN, V114, P1085, DOI 10.1016/j.jaci.2004.07.035; Draber P, 2002, MOL IMMUNOL, V38, P1247, DOI 10.1016/S0161-5890(02)00071-8; Field KA, 1997, J BIOL CHEM, V272, P4276, DOI 10.1074/jbc.272.7.4276; Gehlhar K, 2005, INT ARCH ALLERGY IMM, V136, P311, DOI 10.1159/000083976; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gomez G, 2005, J IMMUNOL, V175, P7602, DOI 10.4049/jimmunol.175.11.7602; Holowka D, 2005, BBA-MOL CELL RES, V1746, P252, DOI 10.1016/j.bbamcr.2005.06.007; HULTNER L, 1989, J IMMUNOL, V142, P3440; Iwaki S, 2005, J BIOL CHEM, V280, P40261, DOI 10.1074/jbc.M506063200; Kotake-Nara E, 2001, J NUTR, V131, P3303, DOI 10.1093/jn/131.12.3303; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; Kurkinen K, 2001, NEUROCHEM RES, V26, P1139, DOI 10.1023/A:1012322906824; Lee SJ, 2003, MOL CELLS, V16, P97; Leitges M, 2002, MOL CELL BIOL, V22, P3970, DOI 10.1128/MCB.22.12.3970-3980.2002; Maeda-Yamamoto M, 2004, J IMMUNOL, V172, P4486, DOI 10.4049/jimmunol.172.7.4486; Nechushtan H, 2000, BLOOD, V95, P1752, DOI 10.1182/blood.V95.5.1752.005k18_1752_1757; Ohgami K, 2003, INVEST OPHTH VIS SCI, V44, P2694, DOI 10.1167/iovs.02-0822; Okabe T, 1996, BIOCHEM BIOPH RES CO, V223, P245, DOI 10.1006/bbrc.1996.0879; OZAWA K, 1993, J BIOL CHEM, V268, P2280; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; RAIZMAN MB, 1990, J IMMUNOL, V145, P1463; Sato Y, 2004, BIOL PHARM BULL, V27, P978, DOI 10.1248/bpb.27.978; Shiratori K, 2005, EXP EYE RES, V81, P422, DOI 10.1016/j.exer.2005.03.002; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Socaciu C, 2000, SPECTROCHIM ACTA A, V56, P2799, DOI 10.1016/S1386-1425(00)00375-9; Sugawara T, 2002, J NUTR, V132, P946, DOI 10.1093/jn/132.5.946; Sugawara T, 2001, J NUTR, V131, P2921, DOI 10.1093/jn/131.11.2921; Sugawara T, 2006, J AGR FOOD CHEM, V54, P9805, DOI 10.1021/jf062204q; Sugawara T, 2007, BIOSCI BIOTECH BIOCH, V71, P1069, DOI 10.1271/bbb.60597; Suzukawa M, 2005, INT IMMUNOL, V17, P1249, DOI 10.1093/intimm/dxh301; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Tkaczyk C, 2004, BLOOD, V104, P207, DOI 10.1182/blood-2003-08-2769; VANDEVEN M, 1984, BIOPHYS J, V45, P1203, DOI 10.1016/S0006-3495(84)84269-1; Wisniewska A, 2006, ACTA BIOCHIM POL, V53, P475; Wisniewska A, 2006, FREE RADICAL BIO MED, V40, P1820, DOI 10.1016/j.freeradbiomed.2006.01.016; Xu K, 1998, J CELL SCI, V111, P2385; Yamashita T, 2001, J BIOCHEM-TOKYO, V129, P861, DOI 10.1093/oxfordjournals.jbchem.a002930	39	71	76	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28172	28179		10.1074/jbc.M109.001099	http://dx.doi.org/10.1074/jbc.M109.001099			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19700409	hybrid, Green Published			2022-12-25	WOS:000270676300044
J	van Hal, SJ; Foo, H; Blyth, CC; McPhie, K; Armstrong, P; Sintchenko, V; Dwyer, DE				van Hal, Sebastiaan J.; Foo, Hong; Blyth, Christopher C.; McPhie, Kenneth; Armstrong, Paul; Sintchenko, Vitali; Dwyer, Dominic E.			Influenza Outbreak during Sydney World Youth Day 2008: The Utility of Laboratory Testing and Case Definitions on Mass Gathering Outbreak Containment	PLOS ONE			English	Article								Background: Influenza causes annual epidemics and often results in extensive outbreaks in closed communities. To minimize transmission, a range of interventions have been suggested. For these to be effective, an accurate and timely diagnosis of influenza is required. This is confirmed by a positive laboratory test result in an individual whose symptoms are consistent with a predefined clinical case definition. However, the utility of these clinical case definitions and laboratory testing in mass gathering outbreaks remains unknown. Methods and Results: An influenza outbreak was identified during World Youth Day 2008 in Sydney. From the data collected on pilgrims presenting to a single clinic, a Markov model was developed and validated against the actual epidemic curve. Simulations were performed to examine the utility of different clinical case definitions and laboratory testing strategies for containment of influenza outbreaks. Clinical case definitions were found to have the greatest impact on averting further cases with no added benefit when combined with any laboratory test. Although nucleic acid testing (NAT) demonstrated higher utility than indirect immunofluorescence antigen or on-site point-of-care testing, this effect was lost when laboratory NAT turnaround times was included. The main benefit of laboratory confirmation was limited to identification of true influenza cases amenable to interventions such as antiviral therapy. Conclusions: Continuous re-evaluation of case definitions and laboratory testing strategies are essential for effective management of influenza outbreaks during mass gatherings.			van Hal, SJ (corresponding author), Westmead Hosp, Ctr Infect Dis & Microbiol, Inst Clin Pathol & Med Res, Sydney, NSW, Australia.	vanhal@gotalk.net.au	Blyth, Christopher/ABG-8231-2020; Ali, Mohammad/E-2365-2017	Blyth, Christopher/0000-0003-2017-0683; Ali, Mohammad/0000-0003-1410-388X; Sintchenko, Vitali/0000-0002-9261-3650; van Hal, Sebastiaan/0000-0001-5852-4155				Bellei N, 2003, J VIROL METHODS, V109, P85, DOI 10.1016/S0166-0934(03)00050-8; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Brotherton JML, 2003, EPIDEMIOL INFECT, V130, P263, DOI 10.1017/S0950268802008166; *CDC, 2009, OV INFL SURV US; Ellis JS, 1997, J CLIN MICROBIOL, V35, P2076, DOI 10.1128/JCM.35.8.2076-2082.1997; Ellis JS, 2002, REV MED VIROL, V12, P375, DOI 10.1002/rmv.370; ELVEBACK LR, 1976, AM J EPIDEMIOL, V103, P152, DOI 10.1093/oxfordjournals.aje.a112213; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fizzell J, 2008, MED J AUSTRALIA, V189, P633, DOI 10.5694/j.1326-5377.2008.tb02222.x; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; GLEZEN WP, 1978, NEW ENGL J MED, V298, P587, DOI 10.1056/NEJM197803162981103; Govaert TME, 1998, FAM PRACT, V15, P16, DOI 10.1093/fampra/15.1.16; Grassly NC, 2008, NAT REV MICROBIOL, V6, P477, DOI 10.1038/nrmicro1845; Gundlapalli AV, 2006, EMERG INFECT DIS, V12, P144, DOI 10.3201/eid1201.050645; Halloran ME, 2002, VACCINE, V20, P3254; Herrmann B, 2001, J CLIN MICROBIOL, V39, P134, DOI 10.1128/JCM.39.1.134-138.2001; Hui DS, 2008, THORAX, V63, P690, DOI 10.1136/thx.2007.090951; Laurel VL, 2001, CLIN INFECT DIS, V32, P1639, DOI 10.1086/320513; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; McVernon J, 2007, INFLUENZA OTHER RESP, V1, P43, DOI 10.1111/j.1750-2659.2007.00008.x; Mitchell R, 2006, Can Commun Dis Rep, V32, P257; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; *NEW S WAL DEP HLT, 2006, NSW HLTH INT INFL PA; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Ohmit SE, 2006, CLIN INFECT DIS, V43, P564, DOI 10.1086/506352; Pachucki Constance T, 2005, Curr Infect Dis Rep, V7, P187, DOI 10.1007/s11908-005-0033-x; Peltola V, 2005, CLIN INFECT DIS, V41, P1198, DOI 10.1086/444508; Petric M, 2006, J INFECT DIS, V194, pS98, DOI 10.1086/507554; Playford EG, 2002, PATHOLOGY, V34, P115, DOI 10.1080/003130201201117909; Rashid H, 2008, LANCET INFECT DIS, V8, P526, DOI 10.1016/S1473-3099(08)70186-5; Rodriguez WJ, 2002, PEDIATR INFECT DIS J, V21, P193, DOI 10.1097/00006454-200203000-00006; Rothberg MB, 2003, J GEN INTERN MED, V18, P808, DOI 10.1046/j.1525-1497.2003.20822.x; Rothberg MB, 2003, ANN INTERN MED, V139, P321, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00007; Schweiger B, 2000, J CLIN MICROBIOL, V38, P1552, DOI 10.1128/JCM.38.4.1552-1558.2000; Siddiqui MR, 2008, EMERG INFECT DIS, V14, P267, DOI 10.3201/eid1402.070478; Thursky K, 2003, J CLIN VIROL, V27, P170, DOI 10.1016/S1386-6532(02)00172-5; Vynnycky E, 2007, INT J EPIDEMIOL, V36, P881, DOI 10.1093/ije/dym071; World Health Organization (WHO), 2005, WHO GLOB INFL PREP P; Zambon M, 2001, ARCH INTERN MED, V161, P2116, DOI 10.1001/archinte.161.17.2116; 2008, AUSTR HLTH MANAGEMEN	41	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6620	10.1371/journal.pone.0006620	http://dx.doi.org/10.1371/journal.pone.0006620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19727401	Green Published, Green Submitted, gold			2022-12-25	WOS:000269522900002
J	Nishiura, H; Klinkenberg, D; Roberts, M; Heesterbeek, JAP				Nishiura, Hiroshi; Klinkenberg, Don; Roberts, Mick; Heesterbeek, Johan A. P.			Early Epidemiological Assessment of the Virulence of Emerging Infectious Diseases: A Case Study of an Influenza Pandemic	PLOS ONE			English	Article							ACUTE-RESPIRATORY-SYNDROME; CASE-FATALITY RATIO	Background: The case fatality ratio (CFR), the ratio of deaths from an infectious disease to the number of cases, provides an assessment of virulence. Calculation of the ratio of the cumulative number of deaths to cases during the course of an epidemic tends to result in a biased CFR. The present study develops a simple method to obtain an unbiased estimate of confirmed CFR (cCFR), using only the confirmed cases as the denominator, at an early stage of epidemic, even when there have been only a few deaths. Methodology/Principal Findings: Our method adjusts the biased cCFR by a factor of underestimation which is informed by the time from symptom onset to death. We first examine the approach by analyzing an outbreak of severe acute respiratory syndrome in Hong Kong (2003) with known unbiased cCFR estimate, and then investigate published epidemiological datasets of novel swine-origin influenza A (H1N1) virus infection in the USA and Canada (2009). Because observation of a few deaths alone does not permit estimating the distribution of the time from onset to death, the uncertainty is addressed by means of sensitivity analysis. The maximum likelihood estimate of the unbiased cCFR for influenza may lie in the range of 0.16-4.48% within the assumed parameter space for a factor of underestimation. The estimates for influenza suggest that the virulence is comparable to the early estimate in Mexico. Even when there have been no deaths, our model permits estimating a conservative upper bound of the cCFR. Conclusions: Although one has to keep in mind that the cCFR for an entire population is vulnerable to its variations among sub-populations and underdiagnosis, our method is useful for assessing virulence at the early stage of an epidemic and for informing policy makers and the public.			Nishiura, H (corresponding author), Univ Utrecht, Utrecht, Netherlands.	h.nishiura@uu.nl	Nishiura, Hiroshi/D-1426-2011; Roberts, Mick/Q-7277-2019	Roberts, Mick/0000-0003-2693-5093; Klinkenberg, Don/0000-0002-9449-6873; Heesterbeek, Hans/0000-0001-8537-6418; Nishiura, Hiroshi/0000-0003-0941-8537				Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P453; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; Butler D, 2009, NATURE, V458, P1082, DOI 10.1038/4581082a; Butler D, 2009, NATURE, V459, P14, DOI 10.1038/459014a; Cameron AR, 1998, PREV VET MED, V34, P1, DOI 10.1016/S0167-5877(97)00081-0; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Wit E, 2008, VACCINE, V26, pD54, DOI 10.1016/j.vaccine.2008.07.072; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Fineberg HV, 2009, SCIENCE, V324, P987, DOI 10.1126/science.1176297; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Galvani AP, 2003, EMERG INFECT DIS, V9, P991; Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840; Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230; Jewell NP, 2007, STAT MED, V26, P1982, DOI 10.1002/sim.2691; Lipsitch M, 2009, NEW ENGL J MED, V361, P112, DOI 10.1056/NEJMp0904380; Ma JL, 2008, B MATH BIOL, V70, P118, DOI 10.1007/s11538-007-9243-8; Nicholson KG, 1998, TXB INFLUENZA, P219; Nishiura H, 2009, EUROSURVEILLANCE, V14; Nishiura H, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-20; *PUBL HLTH AG CAN, 2009, H1N1 FLU VIR HUM SWI; *TIME, 2009, MEX MYST WHY IS SWIN; Venette RC, 2002, ANNU REV ENTOMOL, V47, P143, DOI 10.1146/annurev.ento.47.091201.145147; WHO, 2009, EP PAND AL RESP EPR	25	74	76	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6852	10.1371/journal.pone.0006852	http://dx.doi.org/10.1371/journal.pone.0006852			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718434	Green Published, gold, Green Submitted			2022-12-25	WOS:000269415900021
J	Haque, U; Ahmed, SM; Hossain, S; Huda, M; Hossain, A; Alam, MS; Mondal, D; Khan, WA; Khalequzzaman, M; Haque, R				Haque, Ubydul; Ahmed, Syed Masud; Hossain, Shahed; Huda, Mamun; Hossain, Awlad; Alam, Mohammad Shafiul; Mondal, Dinesh; Khan, Wasif Ali; Khalequzzaman, Mohammod; Haque, Rashidul			Malaria Prevalence in Endemic Districts of Bangladesh	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; FOREST MALARIA	Background: Following the 1971 ban of DDT in Bangladesh, malaria cases have increased steadily. Malaria persists as a major health problem in the thirteen south-eastern and north-eastern districts of Bangladesh. At present the national malaria control program, largely supported by the Global Fund for AIDS, Tuberculosis and Malaria (GFATM), provides interventions including advocacy at community level, Insecticide Treated Net (ITN) distribution, introduction of Rapid Diagnostic Tests (RDT) and combination therapy with Coartem. It is imperative, therefore, that baseline data on malaria prevalence and other malaria indicators are collected to assess the effectiveness of the interventions and rationalize the prevention and control efforts. The objective of this study was to obtain this baseline on the prevalence of malaria and bed net use in the thirteen malaria endemic districts of Bangladesh. Methods and Principal Findings: In 2007, BRAC and ICDDR, B carried out a malaria prevalence survey in thirteen malaria endemic districts of Bangladesh. A multi-stage cluster sampling technique was used and 9750 blood samples were collected. Rapid Diagnostic Tests (RDT) were used for the diagnosis of malaria. The weighted average malaria prevalence in the thirteen endemic districts was 3.97%. In five south-eastern districts weighted average malaria prevalence rate was 6.00% and in the eight north-eastern districts weighted average malaria prevalence rate was (0.40%). The highest malaria prevalence was observed in Khagrachari district. The majority of the cases (90.18%) were P. falciparum infections. Malaria morbidity rates in five south-eastern districts was 2.94%. In eight north-eastern districts, morbidity was 0.07%. Conclusion and Significance: Bangladesh has hypoendemic malaria with P. falciparum the dominant parasite species. The malaria situation in the five north-eastern districts of Bangladesh in particular warrants urgent attention. Detailed maps of the baseline malaria prevalence and summaries of the data collected are provided along with the survey results in full, in a supplemental information			Haque, U (corresponding author), Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.	rhaque@icddrb.org	Hossain, Shahed/HDN-7819-2022; Alam, Mohammad Shafiul/C-2285-2011; Ahmed, Syed/GSN-7305-2022; Huda, M Mamun/AAA-2152-2020; Ahmed, Syed Masud/AGQ-4786-2022	Alam, Mohammad Shafiul/0000-0001-8330-5499; Huda, M Mamun/0000-0003-1069-3472; Ahmed, Syed Masud/0000-0001-5032-7181				Bangali AM, 2000, MEKONG MALARIA FORUM, V6, P16; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; *DIR GEN HLTH SERV, 1997, MAL PAR DIS CONTR MA; Eisele TP, 2007, EMERG INFECT DIS, V13, P1494, DOI 10.3201/eid1310.070567; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Faiz MA, 2002, AM J TROP MED HYG, V67, P396, DOI 10.4269/ajtmh.2002.67.396; GEOFFREY P, 2006, BR MED B, V7576, P29; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Kaya S, 2002, INT GEOSC REM SENS S; KHAN AH, 2001, BANGLADESH POPULATIO; Larson CP, 2006, INT J EPIDEMIOL, V35, P1430, DOI 10.1093/ije/dyl167; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Noor AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002081; Sanh NH, 2008, AM J TROP MED HYG, V79, P652, DOI 10.4269/ajtmh.2008.79.652; Sharma VP, 1996, INDIAN J MED RES, V103, P26; Singh N, 2002, J INFECTION, V45, P165, DOI 10.1053/jinf.2002.1055; Sintasath DM, 2005, AM J TROP MED HYG, V72, P682, DOI 10.4269/ajtmh.2005.72.682; WIJEYARATNE PM, 2004, 130 USAID; World Health Organization, 1999, WKLY EPIDEMIOL REC, V74, P265; World Health Organization, US MAL RAP DIAGN TES	21	51	53	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6737	10.1371/journal.pone.0006737	http://dx.doi.org/10.1371/journal.pone.0006737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707580	Green Submitted, Green Published, gold			2022-12-25	WOS:000269278400005
J	Green, CE; Liu, T; Montel, V; Hsiao, G; Lester, RD; Subramaniam, S; Gonias, SL; Klemke, RL				Green, Chad E.; Liu, Tiffany; Montel, Valerie; Hsiao, Gene; Lester, Robin D.; Subramaniam, Shankar; Gonias, Steven L.; Klemke, Richard L.			Chemoattractant Signaling between Tumor Cells and Macrophages Regulates Cancer Cell Migration, Metastasis and Neovascularization	PLOS ONE			English	Article								Tumor-associated macrophages are known to influence cancer progression by modulation of immune function, angiogenesis, and cell metastasis, however, little is known about the chemokine signaling networks that regulate this process. Utilizing CT26 colon cancer cells and RAW 264.7 macrophages as a model cellular system, we demonstrate that treatment of CT26 cells with RAW 264.7 conditioned medium induces cell migration, invasion and metastasis. Inflammatory gene microarray analysis indicated CT26-stimulated RAW 264.7 macrophages upregulate SDF-1 alpha and VEGF, and that these cytokines contribute to CT26 migration in vitro. RAW 264.7 macrophages also showed a robust chemotactic response towards CT26-derived chemokines. In particular, microarray analysis and functional testing revealed CSF-1 as the major chemoattractant for RAW 264.7 macrophages. Interestingly, in the chick CAM model of cancer progression, RAW 264.7 macrophages localized specifically to the tumor periphery where they were found to increase CT26 tumor growth, microvascular density, vascular disruption, and lung metastasis, suggesting these cells home to actively invading areas of the tumor, but not the hypoxic core of the tumor mass. In support of these findings, hypoxic conditions down regulated CSF-1 production in several tumor cell lines and decreased RAW 264.7 macrophage migration in vitro. Together our findings suggest a model where normoxic tumor cells release CSF-1 to recruit macrophages to the tumor periphery where they secrete motility and angiogenic factors that facilitate tumor cell invasion and metastasis.			Green, CE (corresponding author), Novocell Inc, San Diego, CA USA.	rklemke@ucsd.edu			NCI NIH HHS [R01 CA094900, R01 CA097022, R01CA097022, R01CA94900] Funding Source: Medline; NIGMS NIH HHS [R01GM068487, R01GM078005, R01 GM078005, R01 GM068487] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA094900, R01CA097022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068487, R01GM078005] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Burke B, 2002, J PATHOL, V196, P204, DOI 10.1002/path.1029; Cho SY, 2000, J CELL BIOL, V149, P223, DOI 10.1083/jcb.149.1.223; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Deryugina EI, 2008, HISTOCHEM CELL BIOL, V130, P1119, DOI 10.1007/s00418-008-0536-2; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Hagemann T, 2004, CARCINOGENESIS, V25, P1543, DOI 10.1093/carcin/bgh146; Hagemann T, 2006, J IMMUNOL, V176, P5023, DOI 10.4049/jimmunol.176.8.5023; Hsiao A, 2005, NUCLEIC ACIDS RES, V33, pW627, DOI 10.1093/nar/gki443; Hsiao A, 2004, BIOINFORMATICS, V20, P3108, DOI 10.1093/bioinformatics/bth371; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Kluger HM, 2005, CANCER RES, V65, P5578, DOI 10.1158/0008-5472.CAN-05-0108; Kryczek I, 2007, AM J PHYSIOL-CELL PH, V292, pC987, DOI 10.1152/ajpcell.00406.2006; Leek RD, 2002, J MAMMARY GLAND BIOL, V7, P177, DOI 10.1023/A:1020304003704; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Lester RD, 2007, J CELL BIOL, V178, P425, DOI 10.1083/jcb.200701092; LEWIS CE, 1995, J LEUKOCYTE BIOL, V57, P747, DOI 10.1002/jlb.57.5.747; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lewis JS, 2000, J PATHOL, V192, P150, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH687>3.0.CO;2-G; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lin EY, 2007, MOL ONCOL, V1, P288, DOI 10.1016/j.molonc.2007.10.003; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Montel V, 2005, AM J PATHOL, V166, P1565, DOI 10.1016/S0002-9440(10)62372-3; Murdoch C, 2005, INT J CANCER, V117, P701, DOI 10.1002/ijc.21422; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Ohno S, 2004, ANTICANCER RES, V24, P3335; OSULLIVAN C, 1993, LANCET, V342, P148, DOI 10.1016/0140-6736(93)91348-P; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; PUSZTAI L, 1994, BRIT J CANCER, V70, P289, DOI 10.1038/bjc.1994.294; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Stoletov K, 2007, P NATL ACAD SCI USA, V104, P17406, DOI 10.1073/pnas.0703446104; Sutton A, 2007, MOL CANCER RES, V5, P21, DOI 10.1158/1541-7786.MCR-06-0103; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; YAMASHIRO S, 1994, AM J PATHOL, V145, P856	42	110	120	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6713	10.1371/journal.pone.0006713	http://dx.doi.org/10.1371/journal.pone.0006713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696929	Green Published, Green Submitted, gold			2022-12-25	WOS:000269267600005
J	Lakshmana, MK; Chung, JY; Wickramarachchi, S; Tak, E; Bianchi, E; Koo, EH; Kang, DE				Lakshmana, Madepalli K.; Chung, John Y.; Wickramarachchi, Supul; Tak, Eileen; Bianchi, Elisabetta; Koo, Edward H.; Kang, David E.			A fragment of the scaffolding protein RanBP9 is increased in Alzheimer's disease brains and strongly potentiates amyloid-beta peptide generation	FASEB JOURNAL			English	Article						APP; BACE1; LRP; LisH	PRECURSOR PROTEIN; CYTOPLASMIC DOMAIN; NUCLEAR-PROTEIN; RECEPTOR; PATHWAY; COMPLEX; LRP; IDENTIFICATION; DIMERIZATION; CONTRIBUTES	Increasing biochemical and genetic evidence indicates that the amyloid-beta ( A beta)peptide derived from amyloid precursor protein (APP) plays a central role in Alzheimer's disease ( AD) pathogenesis. We previously reported that RanBP9 promotes A beta generation by scaffolding APP/BACE1/LRP complexes together. Interestingly, the RanBP9-Delta 1/N60 ( residues 1-392) deletion mutant interacted much more strongly with APP/BACE1/LRP than full-length RanBP9. In this study, we found that RanBP9-N60, a processed form of RanBP9 virtually identical to the RanBP9-Delta 1/N60 mutant, was strongly increased in AD brains compared with controls. To evaluate the potential pathogenic consequences of this phenotype, we studied the differential biological properties of full-length RanBP9 vs. RanBP9-Delta 1/N60 in HEK293T and Neuro-2A cells. The RanBP9-Delta 1/N60 fragment, which lacks a nuclear localization signal, displayed enhanced cytoplasmic vs. nuclear localization and >3-fold enhanced stability than full-length RanBP9. Importantly, RanBP9-Delta 1/N60, which contains the LisH dimerization domain, retained the capacity to form self-interacting multimeric complexes and increased A beta generation by similar to 5-fold over vector controls, more potent than the similar to 3-fold increase seen by full-length RanBP9. Taken together, these data indicate that RanBP9-N60 may further drive the amyloid cascade in AD and that the proteolytic processing of RanBP9 may be an attractive therapeutic target.-Lakshmana, M. K., Chung, J. Y., Wickramarachchi, S., Tak, E., Bianchi, E., Koo, E. H., Kang, D. E. A fragment of the scaffolding protein RanBP9 is increased in Alzheimer's disease brains and strongly potentiates amyloid beta peptide generation. FASEB J. 24,119-127 ( 2010). www.fasebj.org	[Lakshmana, Madepalli K.; Chung, John Y.; Wickramarachchi, Supul; Tak, Eileen; Koo, Edward H.; Kang, David E.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Bianchi, Elisabetta] Inst Pasteur, Dept Immunol, Immunoregulat Lab, F-75724 Paris, France; [Kang, David E.] Seoul Natl Univ, Coll Med, World Class Univ Neurocyt Program, Seoul, South Korea	University of California System; University of California San Diego; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Seoul National University (SNU)	Kang, DE (corresponding author), Univ Calif San Diego, Dept Neurosci, Leichtag Biomed Res 3A17,9500 Gilman Dr, La Jolla, CA 92093 USA.	dekang@ucsd.edu	Kang, David E./E-5234-2012	Kang, David E./0000-0002-7132-821X	American Health Assistance Foundation [A2007-05]; Alzheimer's Association [NIRG-07-60584]; National Institute of Aging [AG 005131-24S1]; Korea Science and Engineering Foundation; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	American Health Assistance Foundation(BrightFocus Foundation); Alzheimer's Association(Alzheimer's Association); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the American Health Assistance Foundation (A2007-05 to D. E. K.), the Alzheimer's Association (NIRG-07-60584, M. K. L.), the National Institute of Aging (AG 005131-24S1 to D. E. K.), and a World Class University grant from the Korea Science and Engineering Foundation ( to D. E. K.).	Bourne KZ, 2007, J NEUROSCI RES, V85, P1194, DOI 10.1002/jnr.21252; Bowman AL, 2008, MOL BIOL CELL, V19, P3782, DOI 10.1091/mbc.E08-03-0237; Dansereau DA, 2008, J CELL BIOL, V182, P963, DOI 10.1083/jcb.200711046; De Strooper B, 2000, J CELL SCI, V113, P1857; Denti S, 2004, J BIOL CHEM, V279, P13027, DOI 10.1074/jbc.M313515200; DESTROOPER B, 1995, J BIOL CHEM, V270, P4058, DOI 10.1074/jbc.270.8.4058; Gerlitz G, 2005, CELL CYCLE, V4, P1632, DOI 10.4161/cc.4.11.2151; Harper JA, 2003, CLIN GENET, V64, P461, DOI 10.1046/j.1399-0004.2003.00194.x; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kobayashi N, 2007, GENE, V396, P236, DOI 10.1016/j.gene.2007.02.032; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Lakshmana MK, 2008, J CELL MOL MED, V12, P2665, DOI 10.1111/j.1582-4934.2008.00320.x; Mateja A, 2006, J MOL BIOL, V357, P621, DOI 10.1016/j.jmb.2006.01.002; Nishitani H, 2001, GENE, V272, P25, DOI 10.1016/S0378-1119(01)00553-4; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Poirier MB, 2006, J MOL ENDOCRINOL, V36, P313, DOI 10.1677/jme.1.01891; Rao MA, 2002, J BIOL CHEM, V277, P48020, DOI 10.1074/jbc.M209741200; Repetto E, 2007, J BIOL CHEM, V282, P31504, DOI 10.1074/jbc.M704273200; Seebahn A, 2008, FEBS LETT, V582, P2453, DOI 10.1016/j.febslet.2008.06.010; Takeda T, 2003, AM J PHYSIOL-CELL PH, V284, pC1105, DOI 10.1152/ajpcell.00514.2002; Tamagno E, 2002, NEUROBIOL DIS, V10, P279, DOI 10.1006/nbdi.2002.0515; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Togashi H, 2006, J NEUROSCI, V26, P4961, DOI 10.1523/JNEUROSCI.0704-06.2006; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Umeda M, 2003, GENE, V303, P47, DOI 10.1016/S0378-1119(02)01153-8; Valiyaveettil M, 2008, J CELL BIOL, V182, P727, DOI 10.1083/jcb.200801133; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; Yoon IS, 2007, FASEB J, V21, P2742, DOI 10.1096/fj.07-8114com; Yoon IS, 2005, J BIOL CHEM, V280, P20140, DOI 10.1074/jbc.M413729200; Zou YL, 2003, J BIOL CHEM, V278, P49573, DOI 10.1074/jbc.M307556200	32	52	53	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					119	127		10.1096/fj.09-136457	http://dx.doi.org/10.1096/fj.09-136457			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19729516	Green Published			2022-12-25	WOS:000273233600014
J	Luo, W; Gangwal, K; Sankar, S; Boucher, KM; Thomas, D; Lessnick, SL				Luo, W.; Gangwal, K.; Sankar, S.; Boucher, K. M.; Thomas, D.; Lessnick, S. L.			GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance	ONCOGENE			English	Article						Ewing's sarcoma; EWS/FLI; GSTM4; transformation	GLUTATHIONE-S-TRANSFERASE; CELL-DEATH; GENE; GROWTH; TRANSLOCATION; REPRESSION; PHENOTYPE; FUSION; FAMILY; NKX2.2	Ewing's sarcoma is a malignant bone-associated tumor of children and young adults. Most cases of Ewing's sarcoma express the EWS/FLI fusion protein. EWS/FLI functions as an aberrant ETS-type transcription factor and serves as the master regulator of Ewing's sarcoma-transformed phenotype. We recently showed that EWS/FLI regulates one of its key targets, NR0B1, through a GGAA-microsatellite in its promoter. Whether other critical EWS/FLI targets are also regulated by GGAA-microsatellites was unknown. In this study, we combined transcriptional analysis, whole genome localization data, and RNA interference knockdown to identify glutathione S-transferase M4 (GSTM4) as a critical EWS/FLI target gene in Ewing's sarcoma. We found that EWS/FLI directly binds the GSTM4 promoter, and regulates GSTM4 expression through a GGAA-microsatellite in its promoter. Reduction of GSTM4 levels caused a loss of oncogenic transformation. Furthermore, reduction of GSTM4 resulted in an increased sensitivity of Ewing's sarcoma cells to chemotherapeutic agents, suggesting a role for this protein in drug resistance. Consistent with this hypothesis, patients with Ewing's sarcoma whose tumors had higher levels of GSTM4 expression had worse outcomes than those with lower expression levels. These data show that GSTM4 contributes to the cancerous behavior of Ewing's sarcoma and define a wider role for GGAA-microsatellites in EWS/FLI function than previously appreciated. These data also suggest a novel therapeutic resistance mechanism, in which the central oncogenic abnormality directly regulates a resistance gene. Oncogene (2009) 28, 4126-4132; doi:10.1038/onc.2009.262; published online 31 August 2009	[Luo, W.; Gangwal, K.; Sankar, S.; Lessnick, S. L.] Univ Utah, Ctr Childrens Canc Res, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Luo, W.; Gangwal, K.; Sankar, S.; Boucher, K. M.; Lessnick, S. L.] Univ Utah, Sch Med, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Thomas, D.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Lessnick, S. L.] Univ Utah, Sch Med, Div Pediat Hematol Oncol, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah	Lessnick, SL (corresponding author), Univ Utah, Ctr Childrens Canc Res, Huntsman Canc Inst, 2000 Circle Hope,Room 4242, Salt Lake City, UT 84112 USA.	stephen.lessnick@hci.utah.edu	SANKAR, SAVITA/R-6821-2017	Boucher, Kenneth/0000-0003-2833-0127	Shriver Sarcoma Initiative; Sunbeam Foundation; Huntsman Cancer Institute/Huntsman Cancer Foundation; Alex's Lemonade Stand Foundation; NIH [P30 CA042014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER	Shriver Sarcoma Initiative; Sunbeam Foundation; Huntsman Cancer Institute/Huntsman Cancer Foundation; Alex's Lemonade Stand Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Andrea Bild and Matt Topham for critical reading of the manuscript; Nikko Ronquillo, Mohan Kaadige and Kym Zumbrennen for technical assistance; and Elizabeth Leibold and members of the Lessnick laboratory for helpful discussions. This work was supported by funds awarded to SLL from the Terri Anna Perine Sarcoma Fund, the Liddy Shriver Sarcoma Initiative, the Sunbeam Foundation and Huntsman Cancer Institute/Huntsman Cancer Foundation, and by a grant to WL from the Alex's Lemonade Stand Foundation. We also acknowledge the NIH support to the Huntsman Cancer Institute (P30 CA042014).	ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Camp RL, 2008, J CLIN ONCOL, V26, P5630, DOI 10.1200/JCO.2008.17.3567; COMSTOCK KE, 1993, J BIOL CHEM, V268, P16958; COMSTOCK KE, 1994, ARCH BIOCHEM BIOPHYS, V311, P487, DOI 10.1006/abbi.1994.1266; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; DuBois SG, 2009, PEDIATR BLOOD CANCER, V52, P324, DOI 10.1002/pbc.21822; Gangwal K, 2008, CELL CYCLE, V7, P3127, DOI 10.4161/cc.7.20.6892; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hancock JD, 2008, CELL CYCLE, V7, P250, DOI 10.4161/cc.7.2.5229; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Hu-Lieskovan S, 2005, CANCER RES, V65, P8984, DOI 10.1158/0008-5472.CAN-05-0565; Kinsey M, 2006, MOL CANCER RES, V4, P851, DOI 10.1158/1541-7786.MCR-06-0090; Lessnick SL, 2002, CANCER CELL, V1, P393, DOI 10.1016/S1535-6108(02)00056-9; Liloglou T, 2002, LUNG CANCER-J IASLC, V37, P143, DOI 10.1016/S0169-5002(02)00078-8; Magwere T, 2008, EUR J CANCER, V44, P2276, DOI 10.1016/j.ejca.2008.06.008; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Myatt SS, 2008, ONCOGENE, V27, P985, DOI 10.1038/sj.onc.1210705; Owen LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001965; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Stegmaier K, 2007, PLOS MED, V4, P702, DOI 10.1371/journal.pmed.0040122; Tirado OM, 2006, CANCER RES, V66, P9937, DOI 10.1158/0008-5472.CAN-06-0927	24	52	57	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 19	2009	28	46					4126	4132		10.1038/onc.2009.262	http://dx.doi.org/10.1038/onc.2009.262			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	530AE	19718047				2022-12-25	WOS:000272560500008
J	Vomund, AN; Majerus, EM				Vomund, Anthony N.; Majerus, Elaine M.			ADAMTS13 Bound to Endothelial Cells Exhibits Enhanced Cleavage of von Willebrand Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC STELLATE CELLS; WEIBEL-PALADE BODIES; FLUID SHEAR-STRESS; VONWILLEBRAND-FACTOR; BLOOD-COAGULATION; FACTOR MULTIMERS; BINDING-SITE; PROTEIN-C; FACTOR-XA; RECEPTOR	ADAMTS13 is a plasma metalloprotease that cleaves ultralarge von Willebrand factor multimers to generate less thrombogenic fragments. Although this cleavage can occur at the surface of endothelial cells, it is currently unknown whether this process involves binding of the ADAMTS13 to the endothelial cell plasma membrane. Using different assay systems, we present evidence that ADAMTS13 binds to endothelial cells in a specific, reversible, and time-dependent manner with a K-d of 58 nM. This binding requires the COOH-terminal thrombospondin type 1 repeats of the protease. Binding is inhibited in the presence of heparin and by trypsin treatment of the cells. ADAMTS13 that was prebound to endothelial cells exhibited increased proteolysis of VWF as compared with ADAMTS13 present only in solution. These data support the notion that cleavage of VWF occurs mainly at the endothelial cell surface.	[Vomund, Anthony N.; Majerus, Elaine M.] Washington Univ, Sch Med, Div Hematol, Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Majerus, EM (corresponding author), Washington Univ, Sch Med, Div Hematol, Dept Internal Med, 660 S Euclid Ave,Box 8125, St Louis, MO 63110 USA.	emajerus@dom.wustl.edu			American Heart Association [0475035N]; Edward Mallinckrodt Jr. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016634, R01HL016634] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Edward Mallinckrodt Jr. Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was also supported by American Heart Association Fellow to Faculty Transition Award 0475035N and by the Edward Mallinckrodt Jr. Foundation.	AHMAD SS, 1989, J BIOL CHEM, V264, P20012; ASCH AS, 1992, BIOCHEM BIOPH RES CO, V182, P1208, DOI 10.1016/0006-291X(92)91860-S; Bono F, 1997, J CELL PHYSIOL, V172, P36, DOI 10.1002/(SICI)1097-4652(199707)172:1<36::AID-JCP4>3.0.CO;2-E; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; CRAMER EM, 1985, BLOOD, V66, P710; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DEBOER HC, 1992, J BIOL CHEM, V267, P2264; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; ESMON CT, 1989, J BIOL CHEM, V264, P4743; FOWLER WE, 1985, J CLIN INVEST, V76, P1491, DOI 10.1172/JCI112129; FUKUDOME K, 1994, J BIOL CHEM, V269, P26486; Hartigan N, 2003, J BIOL CHEM, V278, P18045, DOI 10.1074/jbc.M211448200; Huang J, 2009, BLOOD, V113, P1589, DOI 10.1182/blood-2008-05-158584; Hurskainen TL, 1999, J BIOL CHEM, V274, P25555, DOI 10.1074/jbc.274.36.25555; JAFFE EA, 1974, P NATL ACAD SCI USA, V71, P1906, DOI 10.1073/pnas.71.5.1906; Kristiansen M, 1999, J BIOL CHEM, V274, P20540, DOI 10.1074/jbc.274.29.20540; Liu L, 2005, J THROMB HAEMOST, V3, P2536, DOI 10.1111/j.1538-7836.2005.01561.x; Majerus EM, 2005, J BIOL CHEM, V280, P21773, DOI 10.1074/jbc.M502529200; MILETICH JP, 1978, J BIOL CHEM, V253, P6908; NACHMAN R, 1977, J CLIN INVEST, V60, P914, DOI 10.1172/JCI108846; NEMERSON Y, 1992, SEMIN HEMATOL, V29, P170; Niiya M, 2006, J THROMB HAEMOST, V4, P1063, DOI 10.1111/j.1538-7836.2006.01893.x; Padilla A, 2004, BLOOD, V103, P2150, DOI 10.1182/blood-2003-08-2956; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; SHANG D, 2005, BLOOD, V106, P2562; Shim K, 2008, BLOOD, V111, P651, DOI 10.1182/blood-2007-05-093021; Soejima K, 2003, BLOOD, V102, P3232, DOI 10.1182/blood-2003-03-0908; Tao ZY, 2005, BLOOD, V106, P4139, DOI 10.1182/blood-2005-05-2029; TSAI HM, 1994, BLOOD, V83, P2171; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; WAGNER DD, 1982, J CELL BIOL, V95, P355, DOI 10.1083/jcb.95.1.355; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; WEIGEL PH, 1981, J BIOL CHEM, V256, P2615; Zhang P, 2007, BLOOD, V110, P1887, DOI 10.1182/blood-2007-04-083329; Zhang WR, 2004, BLOOD, V104, p39A; Zheng XL, 2003, J BIOL CHEM, V278, P30136, DOI 10.1074/jbc.M305331200; Zhou WH, 2005, LAB INVEST, V85, P780, DOI 10.1038/labinvest.3700275	38	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30925	30932		10.1074/jbc.M109.000927	http://dx.doi.org/10.1074/jbc.M109.000927			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19729451	Green Published, hybrid			2022-12-25	WOS:000271378400021
J	Fuson, KL; Zheng, MZ; Craxton, M; Pataer, A; Ramesh, R; Chada, S; Sutton, RB				Fuson, Kerry L.; Zheng, Mingzhong; Craxton, Molly; Pataer, Abujiang; Ramesh, Rajagopal; Chada, Sunil; Sutton, R. Bryan			Structural Mapping of Post-translational Modifications in Human Interleukin-24 ROLE OF N-LINKED GLYCOSYLATION AND DISULFIDE BONDS IN SECRETION AND ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-ASSOCIATED GENE-7; MELANOMA-DIFFERENTIATION; IL-20 RECEPTOR; CRYSTAL-STRUCTURE; BYSTANDER ACTIVITY; ANTITUMOR-ACTIVITY; CANCER; MDA-7/IL-24; PROTEIN; CELLS	Human interleukin-24 (IL-24) is unique among the IL-10 superfamily as there is considerable evidence that it possesses multiple anti-cancer properties, including direct tumor cell cytotoxicity, helper T cell (TH1) immune stimulation, and anti-angiogenic activities. The primary sequence of human IL-24 differs from homologous cytokines, because it possesses three consensus N-linked glycosylation sites and the potential for a single disulfide bond. To address the significance of these modifications in human IL-24, we analyzed the relationship between post-translational modifications and the cytokine activity of the human IL-24 protein. In contrast to related interleukins, we identified a relationship between net glycosylation, protein solubility, and cytokine activity. In addition, abrogation of the two cysteine residues by mutagenesis dramatically altered the ability of IL-24 to secrete from host cells and resulted in the concomitant loss of IL-24 activity. We conclude that, unlike other IL-10 family members, human IL-24 must be glycosylated to maintain solubility and bioavailability. Further, a single, unique disulfide bond is required for secretion and activity. These structure-function relationships show that, although IL-24 is a member of the IL-19 subfamily of IL-10-like cytokines by sequence similarity, its surface properties and its distinctive disulfide arrangement make it unique. These observations could explain the novel biological activities measured of this cytokine. Understanding the structural basis of IL-24 activity will be important in the interpretation of the function of this cytokine and in the development of scale-up strategies for biophysical and clinical applications.	[Fuson, Kerry L.; Sutton, R. Bryan] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; [Zheng, Mingzhong] Introgen Therapeut Inc, Dept Clin Res & Dev, Introgen Res Inst, Houston, TX 77030 USA; [Craxton, Molly] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Pataer, Abujiang; Ramesh, Rajagopal] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Chada, Sunil] Intrexon Corp, Blacksburg, VA 24060 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; MRC Laboratory Molecular Biology; University of Texas System; UTMD Anderson Cancer Center	Sutton, RB (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, 3601 4th St,Mailstop 6551, Lubbock, TX 79430 USA.	roger.b.sutton@ttuhsc.edu			Melanoma Research Foundation; University of Texas M. D. Anderson SPORE in Melanoma developmental award [CA093459]; NATIONAL CANCER INSTITUTE [P50CA093459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008280] Funding Source: NIH RePORTER	Melanoma Research Foundation; University of Texas M. D. Anderson SPORE in Melanoma developmental award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Melanoma Research Foundation and a University of Texas M. D. Anderson SPORE in Melanoma developmental award (CA093459).	BEINTEMA JJ, 1986, J MOL EVOL, V24, P118, DOI 10.1007/BF02099959; Caudell EG, 2002, J IMMUNOL, V168, P6041, DOI 10.4049/jimmunol.168.12.6041; Chada S, 2005, MOL THER, V11, P724, DOI 10.1016/j.ymthe.2004.12.021; Chada S, 2004, MOL THER, V10, P1085, DOI 10.1016/j.ymthe.2004.08.020; Chang CS, 2003, J BIOL CHEM, V278, P3308, DOI 10.1074/jbc.M208602200; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Gopalan B, 2008, CANCER GENE THER, V15, P1, DOI 10.1038/sj.cgt.7701095; Inoue S, 2006, CURR GENE THER, V6, P73, DOI 10.2174/156652306775515574; Jiang HP, 1995, ONCOGENE, V11, P2477; Jones BC, 2002, P NATL ACAD SCI USA, V99, P9404, DOI 10.1073/pnas.152147499; Kreis S, 2008, J CELL MOL MED, V12, P2505, DOI 10.1111/j.1582-4934.2008.00372.x; Kreis S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001300; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Mumm JB, 2006, J INTERF CYTOK RES, V26, P877, DOI 10.1089/jir.2006.26.877; Nagem RAP, 2002, STRUCTURE, V10, P1051, DOI 10.1016/S0969-2126(02)00797-9; Neto MDO, 2008, BIOPHYS J, V94, P1754, DOI 10.1529/biophysj.107.112664; NG DTW, 1990, MOL CELL BIOL, V10, P1989, DOI 10.1128/MCB.10.5.1989; Poindexter NJ, 2005, J LEUKOCYTE BIOL, V78, P745, DOI 10.1189/jlb.0205116; Ramesh R, 2003, CANCER RES, V63, P5105; ROBERTS PC, 1993, J VIROL, V67, P3048, DOI 10.1128/JVI.67.6.3048-3060.1993; Runkel L, 1998, PHARM RES-DORDR, V15, P641, DOI 10.1023/A:1011974512425; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sauane M, 2004, ONCOGENE, V23, P7679, DOI 10.1038/sj.onc.1207958; Sauane M, 2006, CANCER RES, V66, P11869, DOI 10.1158/0008-5472.CAN-06-1887; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Tong AW, 2005, MOL THER, V11, P160, DOI 10.1016/j.ymthe.2004.09.021; Wang M, 2002, J BIOL CHEM, V277, P7341, DOI 10.1074/jbc.M106043200; WINDSOR WT, 1993, BIOCHEMISTRY-US, V32, P8807, DOI 10.1021/bi00085a011; Wong Emily Sw, 2006, Immunome Res, V2, P4, DOI 10.1186/1745-7580-2-4; Xu T, 2005, ACTA CRYSTALLOGR D, V61, P942, DOI 10.1107/S0907444905009601; Zdanov A, 2004, CURR PHARM DESIGN, V10, P3873, DOI 10.2174/1381612043382602; Zdanov A, 2006, VITAM HORM, V74, P61, DOI 10.1016/S0083-6729(06)74003-1; Zheng MZ, 2007, CANCER IMMUNOL IMMUN, V56, P205, DOI 10.1007/s00262-006-0175-1	36	27	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30526	30533		10.1074/jbc.M109.036061	http://dx.doi.org/10.1074/jbc.M109.036061			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19734147	hybrid, Green Published			2022-12-25	WOS:000271090000055
J	Shin, SY; Song, H; Kim, CG; Choi, YK; Lee, KS; Lee, SJ; Lee, HJ; Lim, Y; Lee, YH				Shin, Soon Young; Song, Haengseok; Kim, Chang Gun; Choi, Yang-Kyu; Lee, Kyoung Sun; Lee, Seung-Jae; Lee, He-Jin; Lim, Yoongho; Lee, Young Han			Egr-1 Is Necessary for Fibroblast Growth Factor-2-induced Transcriptional Activation of the Glial Cell Line-derived Neurotrophic Factor in Murine Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMEDIATE-EARLY GENE; MICE LACKING GDNF; SIGNAL-REGULATED KINASE; CULTURED RAT ASTROCYTES; C6 GLIOBLASTOMA CELLS; SERUM RESPONSE FACTOR; NGFI-A; PROMOTER ACTIVITY; FACTOR EXPRESSION; NERVOUS-SYSTEM	Glial cell line-derived neurotrophic factor (Gdnf) promotes neurite outgrowth and survival of neuronal cells, but its transcriptional regulation is poorly understood. Here, we sought to investigate the mechanism underlying fibroblast growth factor-2 (FGF2) induction of Gdnf expression in astrocytes. We found that FGF2 stimulation of rat astrocytes induced expression of Egr-1 at a high level. Sequence analysis of the rat Gdnf gene identified three overlapping Egr-1-binding sites between positions -185 and -163 of the rat Gdnf promoter. Transfection studies using a series of deleted Gdnf promoters revealed that these Egr-1-binding sites are required for maximal activation of the Gdnf promoter by FGF2. Chromatin immunoprecipitation analysis indicated that Egr-1 binds to the Gdnf promoter. Furthermore, the induction of Gdnf expression by FGF2 is strongly attenuated both in C6 glioma cells stably expressing Egr-1-specific small interfering RNA and in primary cultured astrocytes from the Egr-1 knock-out mouse. Additionally, we found that stimulation of the ERK and JNK pathways by FGF2 is functionally linked to Gdnf expression through the induction of Egr-1. These data demonstrate that FGF2-induced Gdnf expression is mediated by the induction of Egr-1 through activation of the ERK and JNK/Elk-1 signaling pathways.	[Lee, Young Han] Konkuk Univ, Dept Biomed Sci & Technol, IBST, Res Ctr Transcript Control,BMIC, Seoul 143701, South Korea; [Shin, Soon Young; Lee, Seung-Jae; Lee, Young Han] Konkuk Univ Hosp, Dept Biomed Sci & Technol, IBST, Seoul 143729, South Korea; [Choi, Yang-Kyu; Lee, Kyoung Sun] Konkuk Univ, Dept Lab Anim Sci, Coll Vet Med, BMIC, Seoul 143701, South Korea; [Lee, He-Jin] Konkuk Univ, Dept Anat, Sch Med, BMIC, Seoul 143701, South Korea; [Lim, Yoongho] Konkuk Univ, Div Biosci & Biotechnol, BMIC, Seoul 143701, South Korea; [Song, Haengseok] Cheil Gen Hosp, Lab Reprod Biol & Infertil, Seoul 100380, South Korea; [Song, Haengseok] Kwandong Univ, Womens Healthcare Ctr, Coll Med, Seoul 100380, South Korea	Konkuk University; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University; Konkuk University Medical Center; Konkuk University; Catholic Kwandong University	Lee, YH (corresponding author), Konkuk Univ, Dept Biomed Sci & Technol, IBST, Res Ctr Transcript Control,BMIC, 1 Hwang Dong, Seoul 143701, South Korea.	yhlee58@konkuk.ac.kr		Lee, Seung-Jae/0000-0002-5155-5335; Song, Haengseok/0000-0002-5027-7310	National Research Foundation of Korea [20090084181]; Ministry of Education, Science and Technology, Republic of Korea	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Disease Network Research Program Grant 20090084181 from the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology, Republic of Korea.	Bayatti N, 2001, J NEUROCHEM, V78, P972, DOI 10.1046/j.1471-4159.2001.00464.x; Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2; Biesiada E, 1996, J BIOL CHEM, V271, P18576, DOI 10.1074/jbc.271.31.18576; Bozon B, 2002, HIPPOCAMPUS, V12, P570, DOI 10.1002/hipo.10100; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Cen XB, 2006, J NEUROSCI, V26, P3335, DOI 10.1523/JNEUROSCI.5010-05.2006; Choi BH, 2008, CANCER RES, V68, P1369, DOI 10.1158/0008-5472.CAN-07-5222; Chung EY, 2007, NEUROSCI LETT, V422, P43, DOI 10.1016/j.neulet.2007.05.057; Cohen DM, 1996, P NATL ACAD SCI USA, V93, P11242, DOI 10.1073/pnas.93.20.11242; Darlington Cynthia L, 2005, Curr Opin Investig Drugs, V6, P700; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Gentilella A, 2008, ONCOGENE, V27, P5011, DOI 10.1038/onc.2008.142; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; HIPSKIND RA, 1994, MOL CELL BIOL, V14, P6219, DOI 10.1128/MCB.14.9.6219; Hisaoka K, 2008, BRAIN RES, V1196, P53, DOI 10.1016/j.brainres.2007.12.019; Hisaoka K, 2007, J PHARMACOL EXP THER, V321, P148, DOI 10.1124/jpet.106.116558; Jin Y, 2000, MOL PHARMACOL, V57, P984; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kim CG, 2007, CELL SIGNAL, V19, P1290, DOI 10.1016/j.cellsig.2007.01.008; Kitagawa H, 1998, STROKE, V29, P1417, DOI 10.1161/01.STR.29.7.1417; Koyama Y, 2004, BIOCHEM PHARMACOL, V68, P275, DOI 10.1016/j.bcp.2004.03.023; Koyama Y, 2003, BIOCHEM BIOPH RES CO, V303, P1101, DOI 10.1016/S0006-291X(03)00491-1; Ledda F, 2007, NAT NEUROSCI, V10, P293, DOI 10.1038/nn1855; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Lee SL, 1996, MOL CELL BIOL, V16, P4566; Lim CP, 1998, ONCOGENE, V16, P2915, DOI 10.1038/sj.onc.1201834; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Ling Y, 1997, EMBO J, V16, P2431, DOI 10.1093/emboj/16.9.2431; MACK K, 1990, MOL BRAIN RES, V8, P177, DOI 10.1016/0169-328X(90)90062-I; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Pozas E, 2005, NEURON, V45, P701, DOI 10.1016/j.neuron.2005.01.043; RUSSO MW, 1993, MOL CELL BIOL, V13, P6858, DOI 10.1128/MCB.13.11.6858; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Santiago FS, 1999, AM J PATHOL, V154, P937, DOI 10.1016/S0002-9440(10)65341-2; SCHLINGENSIEPEN KH, 1991, NEUROSCI LETT, V122, P67, DOI 10.1016/0304-3940(91)90195-Y; Schratt G, 2001, MOL CELL BIOL, V21, P2933, DOI 10.1128/MCB.21.8.2933-2943.2001; Shin SY, 2006, EMBO J, V25, P1093, DOI 10.1038/sj.emboj.7600987; Shin SY, 2001, J BIOL CHEM, V276, P7797, DOI 10.1074/jbc.M009465200; STROMBERG I, 1993, EXP NEUROL, V124, P401, DOI 10.1006/exnr.1993.1214; SuterCrazzolara C, 1996, MOL BRAIN RES, V41, P175, DOI 10.1016/0169-328X(96)00089-7; Tanaka M, 2000, MOL BRAIN RES, V85, P91, DOI 10.1016/S0169-328X(00)00250-3; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Tsai JC, 2000, AM J PHYSIOL-CELL PH, V279, pC1414, DOI 10.1152/ajpcell.2000.279.5.C1414; Tsuchioka M, 2008, J NEUROCHEM, V106, P244, DOI 10.1111/j.1471-4159.2008.05357.x; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; Verity AN, 1998, J NEUROCHEM, V70, P531; Watson DK, 1997, ONCOGENE, V14, P213, DOI 10.1038/sj.onc.1200839; Woodbury D, 1998, BRAIN RES, V803, P95, DOI 10.1016/S0006-8993(98)00627-1; Yamagata K, 2003, GLIA, V41, P199, DOI 10.1002/glia.10180; Yamagata K, 2007, NEUROSCI RES, V59, P467, DOI 10.1016/j.neures.2007.08.016; Yang SH, 2006, BIOCHEM SOC SYMP, V73, P121, DOI 10.1042/bss0730121; Yang SH, 2005, EMBO J, V24, P2161, DOI 10.1038/sj.emboj.7600690	54	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30583	30593		10.1074/jbc.M109.010678	http://dx.doi.org/10.1074/jbc.M109.010678			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19721135	Green Published, hybrid			2022-12-25	WOS:000271090000061
J	Carlile, CM; Pickart, CM; Matunis, MJ; Cohen, RE				Carlile, Candice M.; Pickart, Cecile M.; Matunis, Michael J.; Cohen, Robert E.			Synthesis of Free and Proliferating Cell Nuclear Antigen-bound Polyubiquitin Chains by the RING E3 Ubiquitin Ligase Rad5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLE REPETITIVE SEQUENCES; TRANSLESION DNA-SYNTHESIS; SACCHAROMYCES-CEREVISIAE; CONJUGATING ENZYME; POSTREPLICATION REPAIR; REPLICATION FORK; DAMAGED DNA; IN-VITRO; PROTEIN; COMPLEX	In replicating yeast, lysine 63-linked polyubiquitin (polyUb) chains are extended from the ubiquitin moiety of monoubiquitinated proliferating cell nuclear antigen (monoUb-PCNA) by the E2-E3 complex of (Ubc13-Mms2)-Rad5. This promotes error-free bypass of DNA damage lesions. The unusual ability of Ubc13-Mms2 to synthesize unanchored Lys(63)-linked polyUb chains in vitro allowed us to resolve the individual roles that it and Rad5 play in the catalysis and specificity of PCNA polyubiquitination. We found that Rad5 stimulates the synthesis of free polyUb chains by Ubc13-Mms2 in part by enhancing the reactivity of the Ubc13 similar to Ub thiolester bond. Polyubiquitination of monoUb-PCNA was further enhanced by interactions between the N-terminal domain of Rad5 and PCNA. Thus, Rad5 acts both to align monoUb-PCNA with Ub-charged Ubc13 and to stimulate Ub transfer onto Lys(63) of a Ub acceptor. We also found that Rad5 interacts with PCNA independently of the number of monoubiquitinated subunits in the trimer and that it binds to both unmodified and monoUb-PCNA with similar affinities. These findings indicate that Rad5-mediated recognition of monoUb-PCNA in vivo is likely to depend upon interactions with additional factors at stalled replication forks.	[Cohen, Robert E.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Carlile, Candice M.; Pickart, Cecile M.; Matunis, Michael J.; Cohen, Robert E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Colorado State University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Cohen, RE (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, 141 MRB,1870 Campus Delivery, Ft Collins, CO 80523 USA.	bob.cohen@colostate.edu		Matunis, Michael/0000-0002-9350-6611	National Institutes of Health [R01GM060372]; American Heart Association [0715305U]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060372] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01GM060372 (to C. M. P. and M. J. M.). This work was also supported by American Heart Association Predoctoral Grant 0715305U (to C. M. C.).	Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833; Chen S, 2005, NUCLEIC ACIDS RES, V33, P5878, DOI 10.1093/nar/gki902; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Gangavarapu V, 2006, MOL CELL BIOL, V26, P7783, DOI 10.1128/MCB.01260-06; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; HAAS AL, 1985, J BIOL CHEM, V260, P2464; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; Haracska L, 2006, P NATL ACAD SCI USA, V103, P6477, DOI 10.1073/pnas.0510924103; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Iyer LM, 2006, CELL CYCLE, V5, P775, DOI 10.4161/cc.5.7.2629; JOHNSON RE, 1992, MOL CELL BIOL, V12, P3807, DOI 10.1128/MCB.12.9.3807; JOHNSON RE, 1994, J BIOL CHEM, V269, P28259; McKenna S, 2001, J BIOL CHEM, V276, P40120, DOI 10.1074/jbc.M102858200; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Plosky BS, 2006, EMBO J, V25, P2847, DOI 10.1038/sj.emboj.7601178; Scaglione KM, 2007, MOL CELL BIOL, V27, P5860, DOI 10.1128/MCB.01555-06; Torres-Ramos CA, 2002, MOL CELL BIOL, V22, P2419, DOI 10.1128/MCB.22.7.2419-2426.2002; TorresRamos CA, 1996, P NATL ACAD SCI USA, V93, P9676, DOI 10.1073/pnas.93.18.9676; TSURIMOTO T, 1989, MOL CELL BIOL, V9, P3839, DOI 10.1128/MCB.9.9.3839; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Ulrich HD, 2003, J BIOL CHEM, V278, P7051, DOI 10.1074/jbc.M212195200; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Yin LM, 2000, BIOCHEMISTRY-US, V39, P10001, DOI 10.1021/bi0007019; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	41	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29326	29334		10.1074/jbc.M109.043885	http://dx.doi.org/10.1074/jbc.M109.043885			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19706603	hybrid, Green Published			2022-12-25	WOS:000270896800012
J	Lu, X; Kang, YB				Lu, Xin; Kang, Yibin			Chemokine (C-C Motif) Ligand 2 Engages CCR2(+) Stromal Cells of Monocytic Origin to Promote Breast Cancer Metastasis to Lung and Bone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF-LIKE LIGANDS; CHEMOATTRACTANT PROTEIN-1; MACROPHAGE RECRUITMENT; FUNCTIONAL EXPRESSION; PARATHYROID-HORMONE; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; TUMOR PROGRESSION; MOUSE MACROPHAGE; IN-VIVO	Metastatic spread of cancer to distant vital organs, including lung and bone, is the overwhelming cause of breast cancer mortality and morbidity. Effective treatment of systemic metastasis relies on the identification and functional characterization of metastasis mediators to multiple organs. Overexpression of the chemokine (C-C motif) ligand 2 (CCL2) is frequently associated with advanced tumor stage and metastatic relapse in breast cancer. However, the functional mechanism of CCL2 in promoting organ-specific metastasis of breast cancer has not been rigorously investigated. Here, we used organ-specific metastatic sub-lines of the MDA-MB-231 human breast cancer cell line to demonstrate that overexpression of CCL2 promotes breast cancer metastasis to both lung and bone. Conversely, blocking CCL2 function with a neutralizing antibody reduced lung and bone metastases. The enhancement of lung and bone metastases by CCL2 was associated with increased macrophage infiltration and osteoclast differentiation, respectively. By performing functional assays with primary cells isolated from the wild type, CCL2 and CCR2 knock-out mice, we showed that tumor cell-derived CCL2 depends on its receptor CCR2 (chemokine, CC motif, receptor 2) expressed on stromal cells to exert its function in promoting macrophage recruitment and osteoclast differentiation. Overall, these data demonstrated that CCL2-expressing breast tumor cells engage CCR2(+) stromal cells of monocytic origin, including macrophages and preosteoclasts, to facilitate colonization in lung and bone. Therefore, CCL2 and CCR2 are promising therapeutic targets for simultaneously inhibiting lung and bone metastasis of breast cancer.	[Lu, Xin; Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Kang, Yibin] Canc Inst New Jersey, Breast Canc Program, New Brunswick, NJ 08903 USA; [Kang, Yibin] Princeton Univ, Champalimaud Metastasis Program, Princeton, NJ 08544 USA	Princeton University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Princeton University	Kang, YB (corresponding author), Princeton Univ, Dept Mol Biol, WA Rd,LTL 255, Princeton, NJ 08544 USA.	ykang@princeton.edu	lu, xuemin/A-8741-2011	Kang, Yibin/0000-0002-1626-6730	National Institutes of Health [R01CA134519]; Department of Defense Era of Hope Scholar Award [BC051647]; American Cancer Society Research Scholar Award [MGO-110765]; NATIONAL CANCER INSTITUTE [R01CA134519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Era of Hope Scholar Award(United States Department of Defense); American Cancer Society Research Scholar Award(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA134519 (to Y. K.). This work was also supported by Department of Defense Era of Hope Scholar Award BC051647 and American Cancer Society Research Scholar Award RSG MGO-110765.	Aubin JE, 2000, OSTEOPOROSIS INT, V11, P905, DOI 10.1007/s001980070028; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Cai Z, 2009, NEOPLASIA, V11, P228, DOI 10.1593/neo.81282; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; Chvatchko Y, 2000, J EXP MED, V191, P1755, DOI 10.1084/jem.191.10.1755; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Guise Theresa A, 2005, Clin Breast Cancer, V5 Suppl, pS46, DOI 10.3816/CBC.2005.s.004; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karnoub Antoine E, 2006, Breast Dis, V26, P75; Kim MS, 2005, J BIOL CHEM, V280, P16163, DOI 10.1074/jbc.M412713200; Kinder M, 2008, EXP CELL RES, V314, P173, DOI 10.1016/j.yexcr.2007.09.021; Kos CH, 2003, J CLIN INVEST, V111, P1021, DOI 10.1172/JCI200317416; Kuroda T, 2005, CLIN CANCER RES, V11, P7629, DOI 10.1158/1078-0432.CCR-05-0798; Lebrecht A, 2004, TUMOR BIOL, V25, P14, DOI 10.1159/000077718; Leek RD, 1996, CANCER RES, V56, P4625; LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1; Li X, 2007, J BIOL CHEM, V282, P33098, DOI 10.1074/jbc.M611781200; Li X, 2009, CANCER RES, V69, P1685, DOI 10.1158/0008-5472.CAN-08-2164; Loberg RD, 2007, CANCER RES, V67, P9417, DOI 10.1158/0008-5472.CAN-07-1286; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Lu X, 2007, J MAMMARY GLAND BIOL, V12, P153, DOI 10.1007/s10911-007-9047-3; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Lu X, 2009, P NATL ACAD SCI USA, V106, P9385, DOI 10.1073/pnas.0900108106; Lu Y, 2007, INT J CANCER, V121, P724, DOI 10.1002/ijc.22704; Lu Y, 2007, CANCER RES, V67, P3646, DOI 10.1158/0008-5472.CAN-06-1210; Lu Y, 2006, PROSTATE, V66, P1311, DOI 10.1002/pros.20464; Lu Y, 2009, CLIN EXP METASTAS, V26, P161, DOI 10.1007/s10585-008-9226-7; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; Mestdagt M, 2006, INT J CANCER, V118, P35, DOI 10.1002/ijc.21291; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nam JS, 2006, CANCER RES, V66, P7176, DOI 10.1158/0008-5472.CAN-06-0825; POWER CA, 1995, J BIOL CHEM, V270, P19495, DOI 10.1074/jbc.270.33.19495; Rollins BJ, 2006, EUR J CANCER, V42, P760, DOI 10.1016/j.ejca.2006.01.002; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Saji H, 2001, CANCER, V92, P1085, DOI 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; SCHLAPPACK OK, 1988, KLIN WOCHENSCHR, V66, P790, DOI 10.1007/BF01726581; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Visscher DW, 1995, PATHOL RES PRACT, V191, P1133, DOI 10.1016/S0344-0338(11)80658-8; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Zhu J, 2007, J BIOL CHEM, V282, P26656, DOI 10.1074/jbc.M705064200	57	192	200	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29087	29096		10.1074/jbc.M109.035899	http://dx.doi.org/10.1074/jbc.M109.035899			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19720836	Green Published, hybrid			2022-12-25	WOS:000270678900065
J	Rizk, ML; Liao, JC				Rizk, Matthew L.; Liao, James C.			Ensemble Modeling for Aromatic Production in Escherichia coli	PLOS ONE			English	Article								Ensemble Modeling (EM) is a recently developed method for metabolic modeling, particularly for utilizing the effect of enzyme tuning data on the production of a specific compound to refine the model. This approach is used here to investigate the production of aromatic products in Escherichia coli. Instead of using dynamic metabolite data to fit a model, the EM approach uses phenotypic data (effects of enzyme overexpression or knockouts on the steady state production rate) to screen possible models. These data are routinely generated during strain design. An ensemble of models is constructed that all reach the same steady state and are based on the same mechanistic framework at the elementary reaction level. The behavior of the models spans the kinetics allowable by thermodynamics. Then by using existing data from the literature for the overexpression of genes coding for transketolase (Tkt), transaldolase (Tal), and phosphoenolpyruvate synthase (Pps) to screen the ensemble, we arrive at a set of models that properly describes the known enzyme overexpression phenotypes. This subset of models becomes more predictive as additional data are used to refine the models. The final ensemble of models demonstrates the characteristic of the cell that Tkt is the first rate controlling step, and correctly predicts that only after Tkt is overexpressed does an increase in Pps increase the production rate of aromatics. This work demonstrates that EM is able to capture the result of enzyme overexpression on aromatic producing bacteria by successfully utilizing routinely generated enzyme tuning data to guide model learning.			Rizk, ML (corresponding author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90024 USA.	liaoj@seas.ucla.edu		Liao, James/0000-0002-4580-7276	NIGMS NIH HHS [01GM076143, R01 GM076143] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076143] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; ANTONIEWICZ MR, 2006, METAB ENG A IN PRESS; Baez JL, 2001, BIOTECHNOL BIOENG, V73, P530, DOI 10.1002/bit.1088; Berry A, 1996, TRENDS BIOTECHNOL, V14, P250, DOI 10.1016/0167-7799(96)10033-0; Bongaerts J, 2001, METAB ENG, V3, P289, DOI 10.1006/mben.2001.0196; CHAO YP, 1993, J BACTERIOL, V175, P6939, DOI 10.1128/jb.175.21.6939-6944.1993; CONTADOR CA, 2009, METAB ENG; Cook P. F., 2007, ENZYME KINETICS MECH; Cornish-Bowden A., 1979, FUNDAMENTALS ENZYME, DOI 10.1016/C2013-0-04130-8; DRATHS KM, 1992, J AM CHEM SOC, V114, P3956, DOI 10.1021/ja00036a050; Farmer WR, 2001, BIOTECHNOL PROGR, V17, P57, DOI 10.1021/bp000137t; Flores N, 1996, NAT BIOTECHNOL, V14, P620, DOI 10.1038/nbt0596-620; Goldberg RN, 2004, BIOINFORMATICS, V20, P2874, DOI 10.1093/bioinformatics/bth314; Gosset G, 1996, J IND MICROBIOL, V17, P47, DOI 10.1007/BF01570148; Heijnen JJ, 2004, METAB ENG, V6, P391, DOI 10.1016/j.ymben.2004.07.002; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Henry CS, 2006, BIOPHYS J, V90, P1453, DOI 10.1529/biophysj.105.071720; Ikeda Masato, 2003, Adv Biochem Eng Biotechnol, V79, P1; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; KELL DB, 1986, FEMS MICROBIOL LETT, V39, P305, DOI 10.1016/0378-1097(86)90020-0; Kholodenko BN, 1998, BIOTECHNOL BIOENG, V59, P239, DOI 10.1002/(SICI)1097-0290(19980720)59:2&lt;239::AID-BIT11&gt;3.0.CO;2-9; LIAO JC, 1993, BIOTECHNOL PROGR, V9, P221, DOI 10.1021/bp00021a001; Lu JL, 1997, BIOTECHNOL BIOENG, V53, P132, DOI 10.1002/(SICI)1097-0290(19970120)53:2<132::AID-BIT2>3.0.CO;2-P; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; PATNAIK R, 1994, APPL ENVIRON MICROB, V60, P3903, DOI 10.1128/AEM.60.11.3903-3908.1994; PATNAIK R, 1995, BIOTECHNOL BIOENG, V46, P361, DOI 10.1002/bit.260460409; Rizk ML, 2009, J TAIWAN INST CHEM E, V40, P595, DOI 10.1016/j.jtice.2009.05.003; Schellenberger J, 2009, J BIOL CHEM, V284, P5457, DOI 10.1074/jbc.R800048200; Sriram G, 2004, PLANT PHYSIOL, V136, P3043, DOI 10.1104/pp.104.050625; Sriram G, 2004, METAB ENG, V6, P116, DOI 10.1016/j.ymben.2004.02.003; Tran LM, 2008, BIOPHYS J, V95, P5606, DOI 10.1529/biophysj.108.135442; Visser D, 2002, METAB ENG, V4, P114, DOI 10.1006/mben.2001.0216; Wang LQ, 2006, METAB ENG, V8, P142, DOI 10.1016/j.ymben.2005.11.002; Wang LQ, 2004, BIOPHYS J, V87, P3750, DOI 10.1529/biophysj.104.048090; Yang TH, 2005, COMPUT BIOL CHEM, V29, P121, DOI 10.1016/j.compbiolchem.2005.02.005; Yang TH, 2004, METAB ENG, V6, P256, DOI 10.1016/j.ymben.2004.02.002	37	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2009	4	9							e6903	10.1371/journal.pone.0006903	http://dx.doi.org/10.1371/journal.pone.0006903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZF	19730732	gold, Green Published, Green Submitted			2022-12-25	WOS:000269622100008
J	Klinghoffer, RA; Frazier, J; Annis, J; Berndt, JD; Roberts, BS; Arthur, WT; Lacson, R; Zhang, XD; Ferrer, M; Moon, RT; Cleary, MA				Klinghoffer, Richard A.; Frazier, Jason; Annis, James; Berndt, Jason D.; Roberts, Brian S.; Arthur, William T.; Lacson, Raul; Zhang, Xiaohua Douglas; Ferrer, Marc; Moon, Randall T.; Cleary, Michele A.			A Lentivirus-Mediated Genetic Screen Identifies Dihydrofolate Reductase (DHFR) as a Modulator of beta-Catenin/GSK3 Signaling	PLOS ONE			English	Article							BETA-CATENIN; HIT SELECTION; MELANOMA; PATHWAY; QUALITY; TUMORS; CELLS	The multi-protein beta-catenin destruction complex tightly regulates beta-catenin protein levels by shuttling beta-catenin to the proteasome. Glycogen synthase kinase 3 beta (GSK3 beta), a key serine/threonine kinase in the destruction complex, is responsible for several phosphorylation events that mark beta-catenin for ubiquitination and subsequent degradation. Because modulation of both beta-catenin and GSK3 beta activity may have important implications for treating disease, a complete understanding of the mechanisms that regulate the beta-catenin/GSK3 beta interaction is warranted. We screened an arrayed lentivirus library expressing small hairpin RNAs (shRNAs) targeting 5,201 human druggable genes for silencing events that activate a beta-catenin pathway reporter (BAR) in synergy with 6-bromoindirubin-3'oxime (BIO), a specific inhibitor of GSK3 beta. Top screen hits included shRNAs targeting dihydrofolate reductase (DHFR), the target of the anti-inflammatory compound methotrexate. Exposure of cells to BIO plus methotrexate resulted in potent synergistic activation of BAR activity, reduction of beta-catenin phosphorylation at GSK3-specific sites, and accumulation of nuclear beta-catenin. Furthermore, the observed synergy correlated with inhibitory phosphorylation of GSK3 beta and was neutralized upon inhibition of phosphatidyl inositol 3-kinase (PI3K). Linking these observations to inflammation, we also observed synergistic inhibition of lipopolysaccharide (LPS)-induced production of pro-inflammatory cytokines (TNF alpha, IL-6, and IL-12), and increased production of the anti-inflammatory cytokine IL-10 in peripheral blood mononuclear cells exposed to GSK3 inhibitors and methotrexate. Our data establish DHFR as a novel modulator of beta-catenin and GSK3 signaling and raise several implications for clinical use of combined methotrexate and GSK3 inhibitors as treatment for inflammatory disease.			Klinghoffer, RA (corresponding author), Rosetta Inpharmat LLC, Seattle, WA USA.	richard_klinghoffer@merck.com	Moon, Randall T/B-1743-2014; Moon, Randall/M-5605-2019	Moon, Randall T/0000-0002-9352-1408; Moon, Randall/0000-0002-9352-1408; Zhang, Xiaohua Douglas/0000-0002-2486-7931				Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bachmann IM, 2005, CLIN CANCER RES, V11, P8606, DOI 10.1158/1078-0432.CCR-05-0011; Bartz SR, 2006, MOL CELL BIOL, V26, P9377, DOI 10.1128/MCB.01229-06; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Buchbinder R, 2008, ARTHRIT RHEUM-ARTHR, V59, P794, DOI 10.1002/art.23716; Carter M, 2005, P NATL ACAD SCI USA, V102, P12843, DOI 10.1073/pnas.0501963102; CHEN MJ, 1984, J BIOL CHEM, V259, P3933; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CRONSTEIN BN, 1992, INFLAMMATION, V16, P411, DOI 10.1007/BF00918968; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Jaszewski R, 2004, CANCER LETT, V206, P27, DOI 10.1016/j.canlet.2003.10.027; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Klinghoffer RA, 2008, ASSAY DRUG DEV TECHN, V6, P105, DOI 10.1089/adt.2007.106; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu ZH, 2007, J NUTR, V137, P2701, DOI 10.1093/jn/137.12.2701; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Orth AP, 2004, EXPERT OPIN THER TAR, V8, P587, DOI 10.1517/14728222.8.6.587; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Strimmer K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-303; Yamada Y, 2005, P NATL ACAD SCI USA, V102, P13580, DOI 10.1073/pnas.0506612102; Zhang XHD, 2006, PHARMACOGENOMICS, V7, P299, DOI 10.2217/14622416.7.3.299; Zhang XHD, 2008, J BIOMOL SCREEN, V13, P378, DOI 10.1177/1087057108317145; Zhang XHD, 2008, J BIOMOL SCREEN, V13, P363, DOI 10.1177/1087057108317062; Zhang XD, 2007, J BIOMOL SCREEN, V12, P645, DOI 10.1177/1087057107300645; Zhang XD, 2007, J BIOMOL SCREEN, V12, P497, DOI 10.1177/1087057107300646; Zhang XHD, 2009, BIOINFORMATICS, V25, P841, DOI 10.1093/bioinformatics/btp082	33	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6892	10.1371/journal.pone.0006892	http://dx.doi.org/10.1371/journal.pone.0006892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19727391	gold, Green Published, Green Submitted			2022-12-25	WOS:000269522900021
J	Lamba, S; Felicioni, L; Buttitta, F; Bleeker, FE; Malatesta, S; Corbo, V; Scarpa, A; Rodolfo, M; Knowles, M; Frattini, M; Marchetti, A; Bardelli, A				Lamba, Simona; Felicioni, Lara; Buttitta, Fiamma; Bleeker, Fonnet E.; Malatesta, Sara; Corbo, Vincenzo; Scarpa, Aldo; Rodolfo, Monica; Knowles, Margaret; Frattini, Milo; Marchetti, Antonio; Bardelli, Alberto			Mutational Profile of GNAQ(Q209) in Human Tumors	PLOS ONE			English	Article								Background: Frequent somatic mutations have recently been identified in the ras-like domain of the heterotrimeric G protein alpha-subunit (GNAQ) in blue naevi 83%, malignant blue naevi (50%) and ocular melanoma of the uvea (46%). The mutations exclusively affect codon 209 and result in GNAQ constitutive activation which, in turn, acts as a dominant oncogene. Methodology: To assess if the mutations are present in other tumor types we performed a systematic mutational profile of the GNAQ exon 5 in a panel of 922 neoplasms, including glioblastoma, gastrointestinal stromal tumors (GIST), acute myeloid leukemia (AML), blue naevi, skin melanoma, bladder, breast, colorectal, lung, ovarian, pancreas, and thyroid carcinomas. Principal Findings: We detected the previously reported mutations in 6/13 (46%) blue naevi. Changes affecting Q209 were not found in any of the other tumors. Our data indicate that the occurrence of GNAQ mutations display a unique pattern being present in a subset of melanocytic tumors but not in malignancies of glial, epithelial and stromal origin analyzed in this study.			Lamba, S (corresponding author), Univ Torino, Med Sch Candiolo TO, Sch Med, Inst Canc Res & Treatment,Lab Mol Genet, Turin, Italy.	a.bardelli@unito.it	rodolfo, monica/H-2671-2012; scarpa, aldo/K-6832-2016; BARDELLI, Alberto/J-9721-2018; Corbo, Vincenzo/J-7754-2016	rodolfo, monica/0000-0002-9196-0298; scarpa, aldo/0000-0003-1678-739X; Lamba, Simona Elena/0000-0003-3207-1594; BARDELLI, Alberto/0000-0003-1647-5070; Corbo, Vincenzo/0000-0002-6340-8009; Knowles, Margaret/0000-0002-9363-8657	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Balakrishnan A, 2007, CANCER RES, V67, P3545, DOI 10.1158/0008-5472.CAN-07-0065; Bleeker FE, 2008, ONCOGENE, V27, P5648, DOI 10.1038/onc.2008.170; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; KATHERINE L, 2005, BIOCH CELL BIOL, V83, P1; Radhika V, 2001, ONCOGENE, V20, P1607, DOI 10.1038/sj.onc.1204274; Saldanha G, 2004, INT J CANCER, V111, P705, DOI 10.1002/ijc.20325; SHIN MK, 1999, NATURE DEV BIOL, P162; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586	9	56	57	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6833	10.1371/journal.pone.0006833	http://dx.doi.org/10.1371/journal.pone.0006833			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718445	gold, Green Submitted, Green Published			2022-12-25	WOS:000269415900006
J	Dao, T; Korontsvit, T; Zakhaleva, V; Haro, K; Packin, J; Scheinberg, DA				Dao, Tao; Korontsvit, Tatyana; Zakhaleva, Victoria; Haro, Kurtis; Packin, Jonathan; Scheinberg, David A.			Identification of a Human Cyclin D1-Derived Peptide that Induces Human Cytotoxic CD4 T Cells	PLOS ONE			English	Article							METASTATIC MELANOMA; ANTITUMOR IMMUNITY; TUMOR REJECTION; CANCER-PATIENTS; D1; LYMPHOCYTES; EXPRESSION; HELP; IMMUNOTHERAPY; LOCALIZATION	Cyclin D1 is over-expressed in various human tumors and therefore can be a potential oncogenic target antigen. However, only a limited number of T cell epitopes has been characterized. We aimed at identifying human cyclin D1-derived peptides that include both CD4 and CD8 T cell epitopes and to test if such multi-epitope peptides could yield improved cytotoxic CD8 T cell responses as well as cytotoxic CD4 T cells. Five HLA-DR. B1-binding peptides containing multiple overlapping CD4 epitopes and HLA-A0201-restricted CD8 T cell epitopes were predicted by computer algorithms. Immunogenicity of the synthetic peptides was assessed by stimulating T cells from healthy donors in vitro and the epitope recognition was measured by IFN-gamma ELISPOT and (51)Chromium release assays. A HLA-DR.B1 peptide, designed "DR-1'', in which a HLA-A0201-binding epitopes (D1-1) was imbedded, induced CD3 T cell responses against both DR-1 and D1-1 peptides in IFN-gamma ELISPOT assay. This suggested processing of the shorter D1-1 epitope from the DR-1 sequence. However, only DR-1-stimulated CD4 or CD3 T cells possessed cytotoxicity against peptide-pulsed autologous DCs and a cancer cell line, that expresses a high level of cyclin D1. Monoclonal antibody to HLA-DR abrogated the epitope-specific responses of both CD3 and CD4 T cells, demonstrating class II-mediated killing. Our studies suggest a possible role of CD4 T cells in anti-tumor immunity as cytotoxic effectors against HLA-DR expressing cancers and provide a rationale for designing peptide vaccines that include CD4 epitopes.			Dao, T (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10021 USA.	d-scheinberg@ski.mskcc.org			NCI NIH HHS [R01 CA55349, R01 CA055349, P01 CA023766, P01 CA23766] Funding Source: Medline; NIGMS NIH HHS [T32 GM073546] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA055349, P01CA023766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073546] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Algarra I, 2004, CANCER IMMUNOL IMMUN, V53, P904, DOI 10.1007/s00262-004-0517-9; Amoscato AA, 1998, J IMMUNOL, V161, P4023; Asemissen AM, 2006, CLIN CANCER RES, V12, P7476, DOI 10.1158/1078-0432.CCR-06-1337; Bijker MS, 2007, J IMMUNOL, V179, P5033, DOI 10.4049/jimmunol.179.8.5033; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Colombo MP, 2007, NAT REV CANCER, V7, P880, DOI 10.1038/nrc2250; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; Dengjel J, 2004, EUR J IMMUNOL, V34, P3644, DOI 10.1002/eji.200425510; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; FALO LD, 1992, P NATL ACAD SCI USA, V89, P8347, DOI 10.1073/pnas.89.17.8347; Gautschi O, 2007, LUNG CANCER, V55, P1, DOI 10.1016/j.lungcan.2006.09.024; Gladden AB, 2006, ONCOGENE, V25, P998, DOI 10.1038/sj.onc.1209147; Gladden AB, 2005, J CELL BIOCHEM, V96, P906, DOI 10.1002/jcb.20613; Gomez-Nunez M, 2006, LEUKEMIA RES, V30, P1293, DOI 10.1016/j.leukres.2006.02.010; Hegde NR, 2005, J EXP MED, V202, P1109, DOI 10.1084/jem.20050162; Heller KN, 2006, J EXP MED, V203, P805, DOI 10.1084/jem.20060215; Hosokawa Y, 1997, CANCER LETT, V113, P123, DOI 10.1016/S0304-3835(97)04605-3; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Kondo E, 2008, CLIN CANCER RES, V14, P6574, DOI 10.1158/1078-0432.CCR-08-0825; Lu FM, 2003, CANCER RES, V63, P7056; Marzec M, 2006, BLOOD, V108, P1744, DOI 10.1182/blood-2006-04-016634; Marzo AL, 2000, J IMMUNOL, V165, P6047, DOI 10.4049/jimmunol.165.11.6047; May RJ, 2007, CLIN CANCER RES, V13, P4547, DOI 10.1158/1078-0432.CCR-07-0708; Melief CJM, 2008, NAT REV CANCER, V8, P351, DOI 10.1038/nrc2373; Nishikawa H, 2008, BLOOD, V111, P1404, DOI 10.1182/blood-2007-09-113761; Nishikawa H, 2006, J IMMUNOL, V176, P6340, DOI 10.4049/jimmunol.176.10.6340; Onizuka S, 1999, CANCER RES, V59, P3128; Perez-Diez A, 2007, BLOOD, V109, P5346, DOI 10.1182/blood-2006-10-051318; Pinilla-Ibarz J, 2005, HAEMATOLOGICA, V90, P1324; Renno T, 2003, CELL MOL LIFE SCI, V60, P1296, DOI 10.1007/s00018-003-2185-x; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rosenberg SA, 2004, P NATL ACAD SCI USA, V101, P14639, DOI 10.1073/pnas.0405730101; Sadovnikova E, 1998, EUR J IMMUNOL, V28, P193, DOI 10.1002/(SICI)1521-4141(199801)28:01<193::AID-IMMU193>3.3.CO;2-B; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Schuurhuis DH, 2000, J EXP MED, V192, P145, DOI 10.1084/jem.192.1.145; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Slansky JE, 2000, IMMUNITY, V13, P529, DOI 10.1016/S1074-7613(00)00052-2; Solomon DA, 2003, J BIOL CHEM, V278, P30339, DOI 10.1074/jbc.M303969200; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; van der Burg SH, 2006, ADV DRUG DELIVER REV, V58, P916, DOI 10.1016/j.addr.2005.11.003; van Leeuwen EMM, 2006, BLOOD, V108, P3121, DOI 10.1182/blood-2006-03-006809; Wilson EB, 2008, J IMMUNOL, V181, P7445, DOI 10.4049/jimmunol.181.11.7445	45	14	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6730	10.1371/journal.pone.0006730	http://dx.doi.org/10.1371/journal.pone.0006730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707583	gold, Green Published, Green Submitted			2022-12-25	WOS:000269278400003
J	Homsi, DSF; Gupta, V; Stormo, GD				Homsi, Dana S. F.; Gupta, Vineet; Stormo, Gary D.			Modeling the Quantitative Specificity of DNA-Binding Proteins from Example Binding Sites	PLOS ONE			English	Article							REGULATORY ELEMENTS; INFORMATION-CONTENT; IDENTIFICATION; REPRESSOR; SEQUENCE; REPRESENTATION; MICROARRAYS; MOTIFS; ENERGY; CODE	Background: The binding of transcription factors to their respective DNA sites is a key component of every regulatory network. Predictions of transcription factor binding sites are usually based on models for transcription factor specificity. These models, in turn, are often based on examples of known binding sites. Methodology/Principal Findings: Collections of binding sites are obtained in simulation experiments where the true model for the transcription factor is known and various sampling procedures are employed. We compare the accuracies of three different and commonly used methods for predicting the specificity of the transcription factor based on example binding sites. Different methods for constructing the models can lead to significant differences in the accuracy of the predictions and we show that commonly used methods can be positively misleading, even at large sample sizes and using noise-free data. Methods that minimize the number of predicted binding sequences are often significantly more accurate than the other methods tested. Conclusions/Significance: Different methods for generating motifs from example binding sites can have significantly different numbers of false positive and false negative predictions. For many different sampling procedures models based on quadratic programming are the most accurate.			Homsi, DSF (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	stormo@genetics.wustl.edu	Stormo, Gary D/C-5367-2013	Stormo, Gary D/0000-0001-6896-1850	NHGRI NIH HHS [R01 HG000249, HG00249] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000249] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BARASH Y, 2003, P 7 ANN INT C RES CO, P28; Benos PV, 2002, BIOESSAYS, V24, P466, DOI 10.1002/bies.10073; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Bulyk ML, 2004, GENOME BIOL, V5; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chang LW, 2006, GENOME RES, V16, P405, DOI 10.1101/gr.4303406; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Ellrott K, 2002, BIOINFORMATICS, V18, pS100, DOI 10.1093/bioinformatics/18.suppl_2.S100; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Fields DS, 1997, J MOL BIOL, V271, P178, DOI 10.1006/jmbi.1997.1171; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; GuhaThakurta D, 2004, GENOME RES, V14, P2457, DOI 10.1101/gr.2961104; GuhaThakurta D, 2006, NUCLEIC ACIDS RES, V34, P3585, DOI 10.1093/nar/gkl372; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim Jan T, 2004, J Bioinform Comput Biol, V2, P289, DOI 10.1142/S0219720004000569; King OD, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng117; Lee MLT, 2002, BIOMETRICS, V58, P981, DOI 10.1111/j.0006-341X.2002.00981.x; Linnell J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh042; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Man TK, 2001, NUCLEIC ACIDS RES, V29, P2471, DOI 10.1093/nar/29.12.2471; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; SARAI A, 1989, P NATL ACAD SCI USA, V86, P6513, DOI 10.1073/pnas.86.17.6513; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; Stormo GD, 2007, BIOESSAYS, V29, P717, DOI 10.1002/bies.20617; Stormo GD, 1998, TRENDS BIOCHEM SCI, V23, P109, DOI 10.1016/S0968-0004(98)01187-6; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; STORMO GD, 1986, NUCLEIC ACIDS RES, V14, P6661, DOI 10.1093/nar/14.16.6661; TAKEDA Y, 1989, P NATL ACAD SCI USA, V86, P439, DOI 10.1073/pnas.86.2.439; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Wang XH, 2008, NUCLEIC ACIDS RES, V36, P4863, DOI 10.1093/nar/gkn477; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wasserman WW, 1998, J MOL BIOL, V278, P167, DOI 10.1006/jmbi.1998.1700; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; ZHANG MQ, 1993, COMPUT APPL BIOSCI, V9, P499; Zhao GY, 2007, GENOME RES, V17, P348, DOI 10.1101/gr.5989907; Zhou Q, 2004, BIOINFORMATICS, V20, P909, DOI 10.1093/bioinformatics/bth006	41	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6736	10.1371/journal.pone.0006736	http://dx.doi.org/10.1371/journal.pone.0006736			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707584	Green Published, Green Submitted, gold			2022-12-25	WOS:000269278400004
J	Sun, W; Roland, KL; Branger, CG; Kuang, XY; Curtiss, R				Sun, Wei; Roland, Kenneth L.; Branger, Christine G.; Kuang, Xiaoying; Curtiss, Roy, III			The Role of relA and spoT in Yersinia pestis KIM5(+) Pathogenicity	PLOS ONE			English	Article								The ppGpp molecule is part of a highly conserved regulatory system for mediating the growth response to various environmental conditions. This mechanism may represent a common strategy whereby pathogens such as Yersinia pestis, the causative agent of plague, regulate the virulence gene programs required for invasion, survival and persistence within host cells to match the capacity for growth. The products of the relA and spoT genes carry out ppGpp synthesis. To investigate the role of ppGpp on growth, protein synthesis, gene expression and virulence, we constructed a Delta relA Delta spoT Y. pestis mutant. The mutant was no longer able to synthesize ppGpp in response to amino acid or carbon starvation, as expected. We also found that it exhibited several novel phenotypes, including a reduced growth rate and autoaggregation at 26 degrees C. In addition, there was a reduction in the level of secretion of key virulence proteins and the mutant was>1,000-fold less virulent than its wild-type parent strain. Mice vaccinated subcutaneously (s.c.) with 2.5x10(4) CFU of the Delta relA Delta spoT mutant developed high anti-Y. pestis serum IgG titers, were completely protected against s.c. challenge with 1.5x10(5) CFU of virulent Y. pestis and partially protected (60% survival) against pulmonary challenge with 2.0x10(4) CFU of virulent Y. pestis. Our results indicate that ppGpp represents an important virulence determinant in Y. pestis and the Delta relA Delta spoT mutant strain is a promising vaccine candidate to provide protection against plague.			Sun, W (corresponding author), Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA.	rcurtiss@asu.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057885] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI057885, AI057885] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Bashaw J, 2007, CLIN VACCINE IMMUNOL, V14, P605, DOI 10.1128/CVI.00398-06; Battesti A, 2006, MOL MICROBIOL, V62, P1048, DOI 10.1111/j.1365-2958.2006.05442.x; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brockmann-Gretza O, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-230; Brubaker R R, 1972, Curr Top Microbiol Immunol, V57, P111; BRUBAKER RR, 1965, SCIENCE, V149, P422, DOI 10.1126/science.149.3682.422; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; Brubaker RR, 2003, INFECT IMMUN, V71, P3673, DOI 10.1128/IAI.71.7.3673-3681.2003; Brumell JH, 2004, CURR OPIN MICROBIOL, V7, P78, DOI 10.1016/j.mib.2003.12.005; Bubeck SS, 2007, CLIN VACCINE IMMUNOL, V14, P1235, DOI 10.1128/CVI.00137-07; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; CHARNETZKY WT, 1982, J BACTERIOL, V149, P1089, DOI 10.1128/JB.149.3.1089-1095.1982; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Chromy BA, 2005, J BACTERIOL, V187, P8172, DOI 10.1128/JB.187.23.8172-8180.2005; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cowan C, 2000, INFECT IMMUN, V68, P4523, DOI 10.1128/IAI.68.8.4523-4530.2000; Curtiss III R, 2006, US patent, Patent No. [2006/0140975 A1, 20060140975]; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Erickson DL, 2004, INFECT IMMUN, V72, P5638, DOI 10.1128/IAI.72.10.5638-5645.2004; FERBER DM, 1981, INFECT IMMUN, V31, P839, DOI 10.1128/IAI.31.2.839-841.1981; Gentry DR, 1996, MOL MICROBIOL, V19, P1373, DOI 10.1111/j.1365-2958.1996.tb02480.x; GEORGE JR, 1980, J CLIN MICROBIOL, V11, P286, DOI 10.1128/JCM.11.3.286-291.1980; Gong SM, 2001, INFECT IMMUN, V69, P2829, DOI 10.1128/IAI.67.5.2829-2837.2001; Gor DO, 2003, NAT IMMUNOL, V4, P503, DOI 10.1038/ni0603-503; Griffin KF, 1998, VACCINE, V16, P517, DOI 10.1016/S0264-410X(97)80005-9; Hales LM, 1999, J BACTERIOL, V181, P4879, DOI 10.1128/JB.181.16.4879-4889.1999; HALL PJ, 1974, INFECT IMMUN, V9, P1105, DOI 10.1128/IAI.9.6.1105-1113.1974; Hammer BK, 1999, MOL MICROBIOL, V33, P721, DOI 10.1046/j.1365-2958.1999.01519.x; Haralalka S, 2003, J BACTERIOL, V185, P4672, DOI 10.1128/JB.185.16.4672-4682.2003; HIGUCHI K, 1959, J BACTERIOL, V77, P317, DOI 10.1128/JB.77.3.317-321.1959; Hinnebusch J, 2000, INT J MED MICROBIOL, V290, P483, DOI 10.1016/S1438-4221(00)80070-3; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Kong W, 2008, P NATL ACAD SCI USA, V105, P9361, DOI 10.1073/pnas.0803801105; Kummer LW, 2008, VACCINE, V26, P6901, DOI 10.1016/j.vaccine.2008.09.063; Lahteenmaki K, 2001, FEBS LETT, V504, P69, DOI 10.1016/S0014-5793(01)02775-2; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Loessner H, 2007, CELL MICROBIOL, V9, P1529, DOI 10.1111/j.1462-5822.2007.00890.x; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; MEHIGH RJ, 1989, MICROB PATHOGENESIS, V6, P203, DOI 10.1016/0882-4010(89)90070-3; METZGER S, 1988, J BIOL CHEM, V263, P15699; MICHIELS T, 1990, INFECT IMMUN, V58, P2840, DOI 10.1128/IAI.58.9.2840-2849.1990; Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P585; MOTIN VL, 1994, INFECT IMMUN, V62, P4192, DOI 10.1128/IAI.62.10.4192-4201.1994; NAKAJIMA R, 1993, INFECT IMMUN, V61, P23, DOI 10.1128/IAI.61.1.23-31.1993; Nedialkov YA, 1997, INFECT IMMUN, V65, P1196, DOI 10.1128/IAI.65.4.1196-1203.1997; Olsson J, 2004, J BACTERIOL, V186, P4110, DOI 10.1128/JB.186.13.4110-4123.2004; Overheim KA, 2005, INFECT IMMUN, V73, P5152, DOI 10.1128/IAI.73.8.5152-5159.2005; Parent MA, 2005, INFECT IMMUN, V73, P7304, DOI 10.1128/IAI.73.11.7304-7310.2005; Parent MA, 2006, INFECT IMMUN, V74, P3381, DOI 10.1128/IAI.00185-06; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; Perry RD, 1998, INFECT IMMUN, V66, P4611, DOI 10.1128/IAI.66.10.4611-4623.1998; PERSSON C, 1995, MOL MICROBIOL, V18, P135, DOI 10.1111/j.1365-2958.1995.mmi_18010135.x; Pizarro-Cerda J, 2004, MOL MICROBIOL, V52, P1827, DOI 10.1111/j.1365-2958.2004.04122.x; PORTNOY DA, 1984, INFECT IMMUN, V43, P108, DOI 10.1128/IAI.43.1.108-114.1984; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Primm TP, 2000, J BACTERIOL, V182, P4889, DOI 10.1128/JB.182.17.4889-4898.2000; REED LJ, 1938, AM J HYG, V27; SARUBBI E, 1989, J BIOL CHEM, V264, P15074; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; SHEEHAN KCF, 1989, J IMMUNOL, V142, P3884; Smiley ST, 2008, EXPERT REV VACCINES, V7, P209, DOI 10.1586/14760584.7.2.209; SODEINDE OA, 1988, INFECT IMMUN, V56, P2749, DOI 10.1128/IAI.56.10.2749-2752.1988; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Song MY, 2004, J BIOL CHEM, V279, P34183, DOI 10.1074/jbc.M313491200; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; STRALEY SC, 1986, INFECT IMMUN, V51, P445, DOI 10.1128/IAI.51.2.445-454.1986; Sun W, 2008, APPL ENVIRON MICROB, V74, P4241, DOI 10.1128/AEM.00940-08; Suomalainen M, 2007, ADV EXP MED BIOL, V603, P268; Swanson MS, 1996, INFECT IMMUN, V64, P2585, DOI 10.1128/IAI.64.7.2585-2594.1996; Taylor CA, 2002, J BACTERIOL, V184, P621, DOI 10.1128/JB.184.3.621-628.2002; Tedin K, 2001, J BACTERIOL, V183, P6184, DOI 10.1128/JB.183.21.6184-6196.2001; Thompson A, 2006, J BIOL CHEM, V281, P30112, DOI 10.1074/jbc.M605616200; UNE T, 1984, INFECT IMMUN, V43, P895, DOI 10.1128/IAI.43.3.895-900.1984; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Williamson ED, 2007, MICROB PATHOGENESIS, V42, P11, DOI 10.1016/j.micpath.2006.09.003; Wolf YI, 1999, GENOME RES, V9, P689; XIAO H, 1991, J BIOL CHEM, V266, P5980; ZAHORCHAK RJ, 1982, INFECT IMMUN, V38, P953, DOI 10.1128/IAI.38.3.953-959.1982; Zusman T, 2002, J BACTERIOL, V184, P67, DOI 10.1128/JB.184.1.67-75.2002; PITT AN MOD CORR PRO	85	38	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2009	4	8							e6720	10.1371/journal.pone.0006720	http://dx.doi.org/10.1371/journal.pone.0006720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JF	19701461	Green Published, gold, Green Submitted			2022-12-25	WOS:000269268300005
J	Metsuyanim, S; Harari-Steinberg, O; Buzhor, E; Omer, D; Pode-Shakked, N; Ben-Hur, H; Halperin, R; Schneider, D; Dekel, B				Metsuyanim, Sally; Harari-Steinberg, Orit; Buzhor, Ella; Omer, Dorit; Pode-Shakked, Naomi; Ben-Hur, Herzl; Halperin, Reuvit; Schneider, David; Dekel, Benjamin			Expression of Stem Cell Markers in the Human Fetal Kidney	PLOS ONE			English	Article								In the human fetal kidney (HFK) self-renewing stem cells residing in the metanephric mesenchyme (MM)/blastema are induced to form all cell types of the nephron till 34(th) week of gestation. Definition of useful markers is crucial for the identification of HFK stem cells. Because wilms' tumor, a pediatric renal cancer, initiates from retention of renal stem cells, we hypothesized that surface antigens previously up-regulated in microarrays of both HFK and blastema-enriched stem-like wilms' tumor xenografts (NCAM, ACVRIIB, DLK1/PREF, GPR39, FZD7, FZD2, NTRK2) are likely to be relevant markers. Comprehensive profiling of these putative and of additional stem cell markers (CD34, CD133, c-Kit, CD90, CD105, CD24) in mid-gestation HFK was performed using immunostaining and FACS in conjunction with EpCAM, an epithelial surface marker that is absent from the MM and increases along nephron differentiation and hence can be separated into negative, dim or bright fractions. No marker was specifically localized to the MM. Nevertheless, FZD7 and NTRK2 were preferentially localized to the MM and emerging tubules (<10% of HFK cells) and were mostly present within the EpCAM(neg) and EpCAM(dim) fractions, indicating putative stem/progenitor markers. In contrast, single markers such as CD24 and CD133 as well as double-positive CD24(+)CD133(+) cells comprise >50% of HFK cells and predominantly co-express EpCAM(bright), indicating they are mostly markers of differentiation. Furthermore, localization of NCAM exclusively in the MM and in its nephron progenitor derivatives but also in stroma and the expression pattern of significantly elevated renal stem/progenitor genes Six2, Wt1, Cited1, and Sall1 in NCAM(+)EpCAM(-) and to a lesser extent in NCAM(+)EpCAM(+) fractions confirmed regional identity of cells and assisted us in pinpointing the presence of subpopulations that are putative MM-derived progenitor cells (NCAM(+)EpCAM(+)FZD7(+)), MM stem cells (NCAM(+)EpCAM(-)FZD7(+)) or both (NCAM(+)FZD7(+)). These results and concepts provide a framework for developing cell selection strategies for human renal cell-based therapies.			Metsuyanim, S (corresponding author), Chaim Sheba Med Ctr, Dept Pediat, IL-52621 Tel Hashomer, Israel.	benjamin.dekel@gmail.com						Bard JBL, 2001, J ANAT, V199, P385, DOI 10.1046/j.1469-7580.2001.19940385.x; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Brodbeck S, 2004, PEDIATR NEPHROL, V19, P249, DOI 10.1007/s00467-003-1374-z; Challen GA, 2004, J AM SOC NEPHROL, V15, P2344, DOI 10.1097/01.ASN.0000136779.17837.8F; Cho EA, 2003, KIDNEY NORMAL DEV CO, P195; Cicero SA, 2009, P NATL ACAD SCI USA, V106, P6685, DOI 10.1073/pnas.0901596106; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Dekel B, 2006, CANCER RES, V66, P6040, DOI 10.1158/0008-5472.CAN-05-4528; Dekel B, 1997, TRANSPLANTATION, V64, P1550, DOI 10.1097/00007890-199712150-00008; Dekel B, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134977; Dekel B, 2003, NAT MED, V9, P53, DOI 10.1038/nm812; DEKEL B, 2006, APPL TISSUE ENG TREA, P212; Dekel B, 2006, STEM CELLS, V24, P1185, DOI 10.1634/stemcells.2005-0265; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; DURBEEJ M, 1993, DEVELOPMENT, V119, P977; Esquela AF, 2003, DEV BIOL, V257, P356, DOI 10.1016/S0012-1606(03)00100-3; Kim SS, 2007, STEM CELLS, V25, P1393, DOI 10.1634/stemcells.2006-0183; Kim SS, 2007, TRANSPLANTATION, V83, P1249, DOI 10.1097/01.tp.0000261712.93299.a6; KLEIN G, 1988, DEVELOPMENT, V102, P749; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Lazzeri E, 2007, J AM SOC NEPHROL, V18, P3128, DOI 10.1681/ASN.2007020210; Loo D, 2008, METHOD CELL BIOL, V86, P241, DOI 10.1016/S0091-679X(08)00010-1; Metsuyanim S, 2008, STEM CELLS, V26, P1808, DOI 10.1634/stemcells.2007-0322; Nishinakamura R, 2003, SEMIN CELL DEV BIOL, V14, P241, DOI 10.1016/S1084-9521(03)00027-2; Oh SP, 1997, GENE DEV, V11, P1812, DOI 10.1101/gad.11.14.1812; Pode-Shakked N., 2008, J CELL MOL MED; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; Rosenblum ND, 2008, SEMIN FETAL NEONAT M, V13, P125, DOI 10.1016/j.siny.2007.10.005; ROTH J, 1988, AM J PATHOL, V133, P596; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; Schmidt-Ott KM, 2008, KIDNEY INT, V74, P1004, DOI 10.1038/ki.2008.322; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Sugiyama T, 2007, P NATL ACAD SCI USA, V104, P175, DOI 10.1073/pnas.0609490104; Trzpis M, 2008, TRANSGENIC RES, V17, P229, DOI 10.1007/s11248-007-9141-8; Trzpis M, 2007, NEPHRON EXP NEPHROL, V107, pE119, DOI 10.1159/000111039; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Woolf AS, 2001, PEDIATR RES, V49, P8, DOI 10.1203/00006450-200101000-00006; XU ASL, 2000, PRINCIPLES TISSUE EN, P559	43	94	98	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6709	10.1371/journal.pone.0006709	http://dx.doi.org/10.1371/journal.pone.0006709			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696931	Green Submitted, gold, Green Published			2022-12-25	WOS:000269267600001
J	Held-Kuznetsov, V; Rotem, S; Assaraf, YG; Mor, A				Held-Kuznetsov, Viktoria; Rotem, Shahar; Assaraf, Yehuda G.; Mor, Amram			Host-defense peptide mimicry for novel antitumor agents	FASEB JOURNAL			English	Article						antimicrobial peptide; peptide-mimetic; drug design; monotherapy; combination therapy; multidrug resistance	ACYL-LYSINE OLIGOMERS; KILLS CANCER-CELLS; ANTIMICROBIAL PEPTIDES; MULTIDRUG-RESISTANCE; FOLATE HOMEOSTASIS; CARCINOMA CELLS; TUMOR-GROWTH; IN-VITRO; LINES; DEATH	Although evidence is accumulating for promising anticancer properties of host-defense peptides (HDPs), their potential therapeutic use suffers from limitations inherent to peptide pharmaceuticals, including poor bioavailability and potential toxicity. Therefore, we tested the hypothesis that HDP mimics might generate improved anticancer derivatives. Oligomers of acyl-lysyl (OAKs) varying with respect to charge, hydrophobicity, and backbone length were screened against prostate adenocarcinoma cell line TRAMP-C2 using the XTT assay. A promising 11-mer sequence, designated alpha(12)-3 beta(12), was further characterized in terms of selectivity (using human primary fibroblasts and malignant cells), mechanism of action and its relation to multidrug resistance (using 7 ABC multidrug efflux transporters), and antitumor efficacy (as assessed in C57BL/6J mice bearing TRAMP-C2 tumors). The OAK exerted rapid and selective cytotoxicity against malignant cells, apparently via an intracellular multitarget mode of action, thereby overcoming major modalities of chemoresistance. Both systemic and local administrations of alpha(12)-3 beta(12) to tumor-bearing mice significantly inhibited tumor progression and were associated with an improved toxicity profile when compared to doxorubicin. Moreover, a combination of alpha(12)-3 beta(12) with doxorubicin can lead to tumor eradication. Collectively, the current findings establish the potential of an HDP-mimetic approach for developing simplified yet robust antitumor agents that bear a key advantage of overcoming MDR phenomena. Held-Kuznetsov, V., Rotem, S., Assaraf, Y. G., Mor, A. Host-defense peptide mimicry for novel antitumor agents. FASEB J. 23, 4299-4307 (2009). www.fasebj.org	[Held-Kuznetsov, Viktoria; Rotem, Shahar; Mor, Amram] Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel; [Assaraf, Yehuda G.] Technion Israel Inst Technol, Fred Wyszkowski Canc Res Lab, Fac Biol, IL-32000 Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology	Mor, A (corresponding author), Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel.	amor@tx.technion.ac.il			Israel Science Foundation [283/08]; Fred Wyszkowski Cancer Research Fund	Israel Science Foundation(Israel Science Foundation); Fred Wyszkowski Cancer Research Fund	This research was supported by the Israel Science Foundation (grant 283/08 to A. M.) and by the Fred Wyszkowski Cancer Research Fund (research grant to Y. G. A.). The assistance of Mrs. Abigail Morgenstern and Dr. Mark Tendler in animal experiments is gratefully acknowledged. The OAK sequences described here have been submitted as part of a U. S. patent application.	Assaraf YG, 2006, DRUG RESIST UPDATE, V9, P227, DOI 10.1016/j.drup.2006.09.001; AZACHIRICA P, 1994, EUR J BIOCHEM, V224, P257; Borgnia MJ, 1996, J BIOL CHEM, V271, P3163, DOI 10.1074/jbc.271.6.3163; Bram EE, 2007, BIOCHEM PHARMACOL, V74, P41, DOI 10.1016/j.bcp.2007.03.028; Bullard KM, 2003, INT J CANCER, V107, P739, DOI 10.1002/ijc.11475; Chan SC, 1998, ANTICANCER RES, V18, P4467; Chang CC, 2006, CANCER CHEMOTH PHARM, V58, P640, DOI 10.1007/s00280-006-0214-9; Chen HM, 1997, BBA-GEN SUBJECTS, V1336, P171, DOI 10.1016/S0304-4165(97)00024-X; Chen JG, 2005, CANCER RES, V65, P4614, DOI 10.1158/0008-5472.CAN-04-2253; Chongsiriwatana NP, 2008, P NATL ACAD SCI USA, V105, P2794, DOI 10.1073/pnas.0708254105; Chuang CM, 2009, HUM GENE THER, V20, P303, DOI 10.1089/hum.2008.124; CRUCIANI RA, 1991, P NATL ACAD SCI USA, V88, P3792, DOI 10.1073/pnas.88.9.3792; CRUCIANI RA, 1992, EUR J PHARM-MOLEC PH, V226, P287, DOI 10.1016/0922-4106(92)90045-W; Eliassen LT, 2006, INT J CANCER, V119, P493, DOI 10.1002/ijc.21886; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Epand RF, 2008, J MOL BIOL, V379, P38, DOI 10.1016/j.jmb.2008.03.047; Epand RM, 2008, J AM CHEM SOC, V130, P14346, DOI 10.1021/ja8062327; Foster BA, 1997, CANCER RES, V57, P3325; Fotin-Mleczek M, 2005, CURR PHARM DESIGN, V11, P3613, DOI 10.2174/138161205774580778; Gademann K, 2001, HELV CHIM ACTA, V84, P2924, DOI 10.1002/1522-2675(20011017)84:10<2924::AID-HLCA2924>3.3.CO;2-5; Galluzzi L, 2006, ONCOGENE, V25, P4812, DOI 10.1038/sj.onc.1209598; Ghavami S, 2008, J CELL MOL MED, V12, P1005, DOI 10.1111/j.1582-4934.2008.00129.x; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Heerdt BG, 2003, CANCER RES, V63, P6311; Heerdt BG, 2005, CANCER RES, V65, P9861, DOI 10.1158/0008-5472.CAN-05-2444; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hooijberg JH, 2003, BIOCHEM PHARMACOL, V65, P765, DOI 10.1016/S0006-2952(02)01615-5; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Kanome T, 2007, ONCOGENE, V26, P5991, DOI 10.1038/sj.onc.1210423; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Krugliak M, 2000, ANTIMICROB AGENTS CH, V44, P2442, DOI 10.1128/AAC.44.9.2442-2451.2000; LINCKE CR, 1990, CANCER RES, V50, P1779; Liu SJ, 2008, HEPATOLOGY, V47, P1964, DOI 10.1002/hep.22240; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Mader JS, 2005, MOL CANCER THER, V4, P612, DOI 10.1158/1535-7163.MCT-04-0077; Makovitzki A, 2009, CANCER RES, V69, P3458, DOI 10.1158/0008-5472.CAN-08-3021; Mowery BP, 2007, J AM CHEM SOC, V129, P15474, DOI 10.1021/ja077288d; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; OHSAKI Y, 1992, CANCER RES, V52, P3534; Papo N, 2004, CANCER RES, V64, P5779, DOI 10.1158/0008-5472.CAN-04-1438; Papo N, 2003, J BIOL CHEM, V278, P21018, DOI 10.1074/jbc.M211204200; Radzishevsky I, 2007, ANTIMICROB AGENTS CH, V51, P1753, DOI 10.1128/AAC.01288-06; Radzishevsky IS, 2008, CHEM BIOL, V15, P354, DOI 10.1016/j.chembiol.2008.03.006; Radzishevsky IS, 2007, NAT BIOTECHNOL, V25, P657, DOI 10.1038/nbt1309; Risso A, 2002, MOL CELL BIOL, V22, P1926, DOI 10.1128/MCB.22.6.1926-1935.2002; Rotem S, 2008, FASEB J, V22, P2652, DOI 10.1096/fj.07-105015; Rotem S, 2009, BBA-BIOMEMBRANES, V1788, P1582, DOI 10.1016/j.bbamem.2008.10.020; SHARMA SV, 1992, ONCOGENE, V7, P193; Shaw JE, 2008, J STRUCT BIOL, V162, P121, DOI 10.1016/j.jsb.2007.11.003; SOBALLE PW, 1995, INT J CANCER, V60, P280; Takeshima K, 2003, J BIOL CHEM, V278, P1310, DOI 10.1074/jbc.M208762200; Tew GN, 2002, P NATL ACAD SCI USA, V99, P5110, DOI 10.1073/pnas.082046199; Tyagi AK, 2002, CLIN CANCER RES, V8, P3512; UTSUGI T, 1991, CANCER RES, V51, P3062; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wang C, 2009, J BIOL CHEM, V284, P3804, DOI 10.1074/jbc.M807191200; Wielinga PR, 2002, MOL PHARMACOL, V62, P1321, DOI 10.1124/mol.62.6.1321; Xu N, 2008, MOL CANCER THER, V7, P1588, DOI 10.1158/1535-7163.MCT-08-0010; Yang N, 2002, J PEPT RES, V60, P187, DOI 10.1034/j.1399-3011.2002.21008.x; YOGEESWARAN G, 1981, SCIENCE, V212, P1514, DOI 10.1126/science.7233237; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	62	15	16	2	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4299	4307		10.1096/fj.09-136358	http://dx.doi.org/10.1096/fj.09-136358			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19706728				2022-12-25	WOS:000272193700024
J	Campbell, ZT; Baldwin, TO				Campbell, Zachary T.; Baldwin, Thomas O.			Two Lysine Residues in the Bacterial Luciferase Mobile Loop Stabilize Reaction Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; VIBRIO-HARVEYI; REDUCED FLAVIN; BIOLUMINESCENCE REACTION; NUCLEOTIDE-SEQUENCE; UNSTRUCTURED LOOP; CRYSTAL-STRUCTURE; LUX REGULON; MECHANISM; SUBUNIT	Bacterial luciferase catalyzes the reaction of FMNH2, O-2, and a long chain aliphatic aldehyde, yielding FMN, carboxylic acid, and blue-green light. The most conserved contiguous region of the primary sequence corresponds to a crystallographically disordered loop adjacent to the active center (Fisher, A. J., Raushel, F. M., Baldwin, T. O., and Rayment, I. (1995) Biochemistry 34, 6581-6586; Fisher, A. J., Thompson, T. B., Thoden, J. B., Baldwin, T. O., and Rayment, I. (1996) J. Biol. Chem. 271, 2195621968). Deletion of the mobile loop does not alter the chemistry of the reaction but decreases the total quantum yield of bioluminescence by 2 orders of magnitude (Sparks, J. M., and Baldwin, T. O. (2001) Biochemistry 40, 15436-15443). In this study, we attempt to localize the loss of activity observed in the loop deletion mutant to individual residues in the mobile loop. Using alanine mutagenesis, the effects of substitution at 15 of the 29 mobile loop residues were examined. Nine of the point mutants had reduced activity in vivo. Two mutations, K283A and K286A, resulted in a loss in quantum yield comparable with that of the loop deletion mutant. The bioluminescence emission spectrum of both mutants was normal, and both yielded the carboxylic acid chemical product at the same efficiency as the wild-type enzyme. Substitution of Lys(283) with alanine resulted in destabilization of intermediate II, whereas mutation of Lys(286) had an increase in exposure of reaction intermediates to a dynamic quencher. Based on a model of the enzyme-reduced flavin complex, the two critical lysine residues are adjacent to the quininoidal edge of the isoalloxazine.	[Baldwin, Thomas O.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Campbell, Zachary T.] Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA	University of California System; University of California Riverside; University of Arizona	Baldwin, TO (corresponding author), Coll Nat & Agr Sci, 900 Univ Ave,302 Coll Bldg N, Riverside, CA 92521 USA.	thomas.baldwin@ucr.edu		Campbell, Zachary/0000-0002-3768-6996				ABUSOUD HM, 1993, J BIOL CHEM, V268, P7699; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BALDWIN TO, 1989, J BIOLUM CHEMILUM, V4, P326, DOI 10.1002/bio.1170040145; BALDWIN TO, 1992, CHEM BIOCH FLAVOENZY, P467; BALNY C, 1975, BIOCHEMISTRY-US, V14, P4719, DOI 10.1021/bi00692a024; BANNER DW, 1975, NATURE, V255, P609, DOI 10.1038/255609a0; Campbell ZT, 2009, BIOCHEMISTRY-US, V48, P6085, DOI 10.1021/bi900003t; Campbell ZT, 2009, J BIOL CHEM, V284, P8322, DOI 10.1074/jbc.M808977200; CHEN LH, 1989, BIOCHEMISTRY-US, V28, P2684, DOI 10.1021/bi00432a048; CLINE TW, 1974, J BIOL CHEM, V249, P4668; CLINE TW, 1972, BIOCHEMISTRY-US, V11, P3359, DOI 10.1021/bi00768a008; COHN DH, 1985, J BIOL CHEM, V260, P6139; DEVINE JH, 1989, P NATL ACAD SCI USA, V86, P5688, DOI 10.1073/pnas.86.15.5688; EBERHARD A, 1972, BIOCHEM BIOPH RES CO, V47, P348, DOI 10.1016/0006-291X(72)90719-X; FARBER GK, 1990, TRENDS BIOCHEM SCI, V15, P228, DOI 10.1016/0968-0004(90)90035-A; Fisher AJ, 1996, J BIOL CHEM, V271, P21956, DOI 10.1074/jbc.271.36.21956; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P6581, DOI 10.1021/bi00020a002; Francisco WA, 1998, BIOCHEMISTRY-US, V37, P2596, DOI 10.1021/bi972266x; FRIEDLAND J, 1967, P NATL ACAD SCI USA, V58, P2336, DOI 10.1073/pnas.58.6.2336; GIBSON QH, 1962, BIOCHEM J, V83, P368, DOI 10.1042/bj0830368; Gordon S, 1998, METH MOL B, V101, P235, DOI 10.1385/0-89603-471-2:235; HASTINGS JW, 1969, BIOCHEMISTRY-US, V8, P4681, DOI 10.1021/bi00840a004; HASTINGS JW, 1973, P NATL ACAD SCI USA, V70, P3468, DOI 10.1073/pnas.70.12.3468; Hastings JW., 1978, METHOD ENZYMOL, V57, P135; HOLZMAN TF, 1980, P NATL ACAD SCI-BIOL, V77, P6363, DOI 10.1073/pnas.77.11.6363; Hosseinkhani S, 2005, BIOCHEM J, V385, P575, DOI 10.1042/BJ20040863; Huang SQ, 1998, BIOCHEMISTRY-US, V37, P8614, DOI 10.1021/bi985039j; Jeffers CE, 2003, BIOCHEMISTRY-US, V42, P529, DOI 10.1021/bi026877n; KASHA M, 1952, J CHEM PHYS, V20, P71, DOI 10.1063/1.1700199; LAKOWICZ JR, 2008, J BIOMED OPT, V13, P215; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lei BF, 1998, BIOCHEMISTRY-US, V37, P14623, DOI 10.1021/bi981841+; Lin LYC, 2004, BIOCHEMISTRY-US, V43, P3183, DOI 10.1021/bi030227h; Lin LYC, 2002, BIOCHEMISTRY-US, V41, P9938, DOI 10.1021/bi020295o; Lin LYC, 2001, PROTEIN SCI, V10, P1563, DOI 10.1110/ps.7201; LIU Y, 1995, J BACTERIOL, V177, P2080, DOI 10.1128/jb.177.8.2080-2086.1995; Low JC, 2002, BIOCHEMISTRY-US, V41, P1724, DOI 10.1021/bi011958p; MCELROY WD, 1953, SCIENCE, V118, P385, DOI 10.1126/science.118.3066.385; MEIGHEN EA, 1980, J BIOL CHEM, V255, P1181; MITCHELL GW, 1971, ANAL BIOCHEM, V39, P243, DOI 10.1016/0003-2697(71)90481-7; Moore C, 1999, ARCH BIOCHEM BIOPHYS, V370, P45, DOI 10.1006/abbi.1999.1379; NICOLI MZ, 1974, J BIOL CHEM, V249, P2385; RAUSHEL FM, 1989, BIOCHEM BIOPH RES CO, V164, P1137, DOI 10.1016/0006-291X(89)91787-7; SAMPSON NS, 1992, BIOCHEMISTRY-US, V31, P8488, DOI 10.1021/bi00151a015; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SINCLAIR JF, 1993, BIOCHEMISTRY-US, V32, P5036, DOI 10.1021/bi00070a010; SIROKMAN G, 1995, BIOCHEMISTRY-US, V34, P13074, DOI 10.1021/bi00040a019; Sparks JM, 2001, BIOCHEMISTRY-US, V40, P15436, DOI 10.1021/bi0111855; Sterner R, 2004, SCIENCE, V304, P1916, DOI 10.1126/science.1100482; Sullivan SM, 2008, P NATL ACAD SCI USA, V105, P13829, DOI 10.1073/pnas.0805364105; TU S, 1975, BIOCHEMISTRY-US, V14, P4310, DOI 10.1021/bi00690a027; Tu SC, 2001, ANTIOXID REDOX SIGN, V3, P881, DOI 10.1089/15230860152665046; TU SC, 1982, J BIOL CHEM, V257, P3719; TU SC, 1979, BIOCHEMISTRY-US, V18, P5940, DOI 10.1021/bi00593a028; Tu SC, 2000, J NUTR, V130, p331S, DOI 10.1093/jn/130.2.331S; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	57	17	17	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32827	32834		10.1074/jbc.M109.031716	http://dx.doi.org/10.1074/jbc.M109.031716			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19710008	Green Published, hybrid			2022-12-25	WOS:000272028400067
J	Wang, H; Hu, LP; Dalen, K; Dorward, H; Marcinkiewicz, A; Russell, D; Gong, DW; Londos, C; Yamaguchi, T; Holm, C; Rizzo, MA; Brasaemle, D; Sztalryd, C				Wang, Hong; Hu, Liping; Dalen, Knut; Dorward, Heidi; Marcinkiewicz, Amy; Russell, Deanna; Gong, Dawei; Londos, Constantine; Yamaguchi, Tomohiro; Holm, Cecilia; Rizzo, Mark A.; Brasaemle, Dawn; Sztalryd, Carole			Activation of Hormone-sensitive Lipase Requires Two Steps, Protein Phosphorylation and Binding to the PAT-1 Domain of Lipid Droplet Coat Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; FLUORESCENCE POLARIZATION MICROSCOPY; A-MEDIATED LIPOLYSIS; PERILIPIN-A; ENDOPLASMIC-RETICULUM; STIMULATED LIPOLYSIS; ADIPOCYTE LIPOLYSIS; 3T3-L1 ADIPOCYTES; STORAGE DROPLET; ALPHA-SYNUCLEIN	Lipolysis is an important metabolic pathway controlling energy homeostasis through degradation of triglycerides stored in lipid droplets and release of fatty acids. Lipid droplets of mammalian cells are coated with one or more members of the PAT protein family, which serve important functions in regulating lipolysis. In this study, we investigate the mechanisms by which PAT family members, perilipin A, adipose differentiation-related protein (ADFP), and LSDP5, control lipolysis catalyzed by hormone-sensitive lipase (HSL), a major lipase in adipocytes and several non-adipose cells. We applied fluorescence microscopic tools to analyze proteins in situ in cultured Chinese hamster ovary cells using fluorescence recovery after photo-bleaching and anisotropy Forster resonance energy transfer. Fluorescence recovery after photobleaching data show that ADFP and LSDP5 exchange between lipid droplet and cytoplasmic pools, whereas perilipin A does not. Differences in protein mobility do not correlate with PAT protein-mediated control of lipolysis catalyzed by HSL or endogenous lipases. Forster resonance energy transfer and co-immunoprecipitation experiments reveal that each of the three PAT proteins bind HSL through interaction of the lipase with amino acids within the highly conserved amino-terminal PAT-1 domain. ADFP and LSDP5 bind HSL under basal conditions, whereas phosphorylation of serine residues within three amino-terminal protein kinase A consensus sequences of perilipin A is required for HSL binding and maximal lipolysis. Finally, protein kinase A-mediated phosphorylation of HSL increases lipolysis in cells expressing ADFP or LSDP5; in contrast, phosphorylation of perilipin A exerts the major control over HSL-mediated lipolysis when perilipin is the main lipid droplet protein.	[Wang, Hong; Hu, Liping; Gong, Dawei; Sztalryd, Carole] Univ Maryland, Sch Med, Dept Med, Div Endocrinol, Baltimore, MD 21201 USA; [Wang, Hong; Hu, Liping; Sztalryd, Carole] Univ Maryland, Sch Med, Baltimore Vet Affairs Hlth Care Ctr, Geriatr Res Educ & Clin Ctr, Baltimore, MD 21201 USA; [Dalen, Knut; Dorward, Heidi; Londos, Constantine; Rizzo, Mark A.] NIDDK, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA; [Marcinkiewicz, Amy; Russell, Deanna; Brasaemle, Dawn] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; [Holm, Cecilia] Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden; [Rizzo, Mark A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Yamaguchi, Tomohiro] Hyogo Med Univ, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan	University System of Maryland; University of Maryland Baltimore; Geriatric Research Education & Clinical Center; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Rutgers State University New Brunswick; Lund University; University System of Maryland; University of Maryland Baltimore; University of Hyogo	Sztalryd, C (corresponding author), Univ Maryland, Sch Med, Dept Med, Div Endocrinol, Rm 445,Howard Hall,660 W Redwood St, Baltimore, MD 21201 USA.	csztalry@grecc.umaryland.edu	Gong, Dawei/AAB-4283-2020; Dalen, Knut Tomas/C-4719-2016	Dalen, Knut Tomas/0000-0002-0270-5982; Russell, Deanna/0000-0002-9650-2309; Brasaemle, Dawn/0000-0002-8553-8285	National Institutes of Health [RO1 DK075017, RO1 DK054797]; NIDDK Intramural Research Programs; American Diabetes Association [1-05-CD-17]; Geriatric Research, Education, and Clinical Center, Baltimore Veterans Affairs Health Care Center; Clinical Nutrition Research Unit of Maryland [DK072488]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK Intramural Research Programs; American Diabetes Association(American Diabetes Association); Geriatric Research, Education, and Clinical Center, Baltimore Veterans Affairs Health Care Center; Clinical Nutrition Research Unit of Maryland; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK075017 (to C. S.) and RO1 DK054797 (to D. L. B.) and NIDDK Intramural Research Programs. This work was also supported by Career Development Award 1-05-CD-17 from the American Diabetes Association (to C. S.), the Geriatric Research, Education, and Clinical Center, Baltimore Veterans Affairs Health Care Center, and the Clinical Nutrition Research Unit of Maryland Grant DK072488.	BECKER TC, 1994, METHOD CELL BIOL, V43, P161; BELFRAGE P, 1977, FEBS LETT, V75, P259, DOI 10.1016/0014-5793(77)80099-9; Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Brasaemle DL, 1997, J BIOL CHEM, V272, P9378; Bussell R, 2005, PROTEIN SCI, V14, P862, DOI 10.1110/ps.041255905; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Contreras JA, 1998, PROTEIN EXPRES PURIF, V12, P93, DOI 10.1006/prep.1997.0821; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Garcia A, 2003, J BIOL CHEM, V278, P625, DOI 10.1074/jbc.M206602200; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Krintel C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003756; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Osterlund T, 1996, BIOCHEM J, V319, P411, DOI 10.1042/bj3190411; Ozeki S, 2005, J CELL SCI, V118, P2601, DOI 10.1242/jcs.02401; Piston DW, 2008, METHOD CELL BIOL, V85, P415, DOI 10.1016/S0091-679X(08)85018-2; Prats C, 2006, J LIPID RES, V47, P2392, DOI 10.1194/jlr.M600247-JLR200; Rizzo MA, 2005, BIOPHYS J, V88, pL14, DOI 10.1529/biophysj.104.055442; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; SHEN WJ, 2009, J LIPID RES IN PRESS; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; Su CL, 2003, J BIOL CHEM, V278, P43615, DOI 10.1074/jbc.M301809200; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Sztalryd C, 2006, J BIOL CHEM, V281, P34341, DOI 10.1074/jbc.M602497200; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tansey JT, 2003, J BIOL CHEM, V278, P8401, DOI 10.1074/jbc.M211005200; Wu CC, 2000, ELECTROPHORESIS, V21, P3470, DOI 10.1002/1522-2683(20001001)21:16<3470::AID-ELPS3470>3.3.CO;2-7; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	44	122	126	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32116	32125		10.1074/jbc.M109.006726	http://dx.doi.org/10.1074/jbc.M109.006726			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19717842	Green Published, hybrid			2022-12-25	WOS:000271572700066
J	Khoo, KH; Mayer, S; Fersht, AR				Khoo, Kian Hoe; Mayer, Sebastian; Fersht, Alan R.			Effects of Stability on the Biological Function of p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR P53; COOPERATIVE DNA-BINDING; CORE DOMAIN; CANCER MUTATIONS; MUTANT P53; THERMODYNAMIC STABILITY; PROTEASOMAL DEGRADATION; ENHANCED STABILITY; STRUCTURAL BASIS; IN-VITRO	The core domain of the tumor suppressor p53 has low thermodynamic stability, and many oncogenic mutations cause it to denature rapidly at body temperature. We made a series of core domain mutants that are significantly less or more stable than wild type to investigate effects of stability on the transcriptional activity and levels of native full-length p53 in H1299 mammalian cells. The levels of transcriptionally inactive native protein with inactivating mutations in the N-terminal transactivation domain correlated strongly with stability. The levels of transcriptionally active proteins, however, depended on both their stability and the transcriptional activity that leads to the feedback loop of proteolytic degradation via transcription of E3 ligases. A very highly stabilized quadruple mutant and an even more stable hexamutant were more active than wild-type p53 in terms of Bax transcription and apoptotic activity, and reached higher levels than wild type in cells. The increased activity did not result from increased overall stability but was due to a single known suppressor mutation, N239Y. It is possible that the low intrinsic stability of p53 is a means of keeping its level low in the cell by spontaneous denaturation, by a route additional to that of proteolytic degradation via E3 ligase pathways. Denatured p53 does accumulate in cells, and there are pathways for the proteolysis of denatured proteins.	[Khoo, Kian Hoe; Mayer, Sebastian; Fersht, Alan R.] MRC, Ctr Prot Engn, Cambridge CB2 2QH, England	University of Cambridge	Fersht, AR (corresponding author), MRC, Ctr Prot Engn, Hills Rd, Cambridge CB2 2QH, England.	arf25@cam.ac.uk	Fersht, Alan R/B-2189-2008		Medical Research Council; Cancer Research UK; EC; Medical Research Council [MC_U105474168] Funding Source: researchfish; MRC [MC_U105474168] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); EC(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Medical Research Council and Cancer Research UK and EC FP6 funding.	Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Asher G, 2005, CELL CYCLE, V4, P1015, DOI 10.4161/cc.4.8.1900; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Brachmann RK, 1998, EMBO J, V17, P1847, DOI 10.1093/emboj/17.7.1847; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; Candau R, 1997, ONCOGENE, V15, P807, DOI 10.1038/sj.onc.1201244; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Friedler A, 2003, J BIOL CHEM, V278, P24108, DOI 10.1074/jbc.M302458200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Issaeva N, 2003, P NATL ACAD SCI USA, V100, P13303, DOI 10.1073/pnas.1835733100; Joerger AC, 2004, J BIOL CHEM, V279, P1291, DOI 10.1074/jbc.M309732200; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; Khoo KH, 2009, PROTEIN ENG DES SEL, V22, P421, DOI 10.1093/protein/gzp018; Klein C, 2001, J BIOL CHEM, V276, P37390, DOI 10.1074/jbc.M103801200; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levrero M, 2000, J CELL SCI, V113, P1661; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; MARINE JC, 2009, CELL DEATH IN PRESS; MAYER S, 2006, THESIS U CAMBRIDGE; Mayer S, 2007, J MOL BIOL, V372, P268, DOI 10.1016/j.jmb.2007.06.044; Menendez D, 2006, MOL CELL BIOL, V26, P2297, DOI 10.1128/MCB.26.6.2297-2308.2006; Nikolova PV, 2000, EMBO J, V19, P370, DOI 10.1093/emboj/19.3.370; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Patel S, 2008, BIOCHEMISTRY-US, V47, P3235, DOI 10.1021/bi7023207; Tang KS, 1999, J MOL BIOL, V285, P1869, DOI 10.1006/jmbi.1998.2420; Tidow H, 2007, P NATL ACAD SCI USA, V104, P12324, DOI 10.1073/pnas.0705069104; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Venot C, 1999, ONCOGENE, V18, P2405, DOI 10.1038/sj.onc.1202539; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103; ZHANG W, 1994, EMBO J, V13, P2535, DOI 10.1002/j.1460-2075.1994.tb06543.x; Zhu JH, 1998, J BIOL CHEM, V273, P13030, DOI 10.1074/jbc.273.21.13030	44	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30974	30980		10.1074/jbc.M109.033183	http://dx.doi.org/10.1074/jbc.M109.033183			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19700401	hybrid, Green Published			2022-12-25	WOS:000271378400027
J	van Tetering, G; van Diest, P; Verlaan, I; van der Wall, E; Kopan, R; Vooijs, M				van Tetering, Geert; van Diest, Paul; Verlaan, Ingrid; van der Wall, Elsken; Kopan, Raphael; Vooijs, Marc			Metalloprotease ADAM10 Is Required for Notch1 Site 2 Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; GAMMA-SECRETASE INHIBITORS; ACUTE LYMPHOBLASTIC-LEUKEMIA; PROTEOLYTIC ACTIVATION; THYMOCYTE DEVELOPMENT; SIGNAL-TRANSDUCTION; REGULATORY REGION; DROSOPHILA NOTCH; MAMMALIAN NOTCH; LIGAND	Notch signaling is controlled by ligand binding, which unfolds a negative control region to induce proteolytic cleavage of the receptor. First, a membrane-proximal cleavage is executed by a metalloprotease, removing the extracellular domain. This allows gamma-secretase to execute a second cleavage within the Notch transmembrane domain, which releases the intracellular domain to enter the nucleus. Here we show that the ADAM10 metalloprotease Kuzbanian, but not ADAM17/tumor necrosis factor alpha-converting enzyme, plays an essential role in executing ligand-induced extracellular cleavage at site 2 (S2) in cells and localizes this step to the plasma membrane. Importantly, genetic or pharmacological inhibition of metalloproteases still allowed extracellular cleavage of Notch, indicating the presence of unknown proteases with the ability to cleave at S2. Gain of function mutations identified in human cancers and in model organisms that map to the negative control region alleviate the requirement for ligand binding for extracellular cleavage to occur. Because cancer-causing Notch1 mutations also depend on (rate-limiting) S2 proteolysis, the identity of these alternative proteases has important implications for understanding Notch activation in normal and cancer cells.	Univ Med Ctr Utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands; [van der Wall, Elsken] Univ Med Ctr Utrecht, Dept Internal Med & Dermatol, NL-3584 CX Utrecht, Netherlands; [Kopan, Raphael] Washington Univ, Dept Mol Biol & Pharmacol, Sch Med, St Louis, MO 63110 USA	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Washington University (WUSTL)		m.vooijs@umcutrecht.nl	Kopan, Raphael/AFG-3275-2022; Kopan, Raphael/AAF-1357-2022; Vooijs, Marc/K-3522-2019	Kopan, Raphael/0000-0002-0350-2730	National Institutes of Health [GM55479]; Dutch Cancer Society [KWF UU2006-3623]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013956, R01AG013956] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Cancer Society(KWF Kankerbestrijding); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant GM55479 (to R. K.) and by Dutch Cancer Society Grant KWF UU2006-3623 (to M. V. and G. v. T.).	Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; DE SB, 1999, NATURE, V398, P518; Delwig A, 2008, CELL MOL LIFE SCI, V65, P2232, DOI 10.1007/s00018-008-8127-x; Dontje W, 2006, BLOOD, V107, P2446, DOI 10.1182/blood-2005-05-2090; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Girard L, 1996, GENE DEV, V10, P1930, DOI 10.1101/gad.10.15.1930; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Gordon WR, 2009, BLOOD, V113, P4381, DOI 10.1182/blood-2008-08-174748; GREENWALD I, 1990, NATURE, V346, P197, DOI 10.1038/346197a0; Groot AJ, 2008, CELL ONCOL, V30, P397, DOI 10.3233/CLO-2008-0442; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Jarriault S, 2005, DEV BIOL, V287, P1, DOI 10.1016/j.ydbio.2005.08.014; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Karlstrom H, 2002, J BIOL CHEM, V277, P6763, DOI 10.1074/jbc.C100649200; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Li K, 2008, J BIOL CHEM, V283, P8046, DOI 10.1074/jbc.M800170200; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Luty WH, 2007, J IMMUNOL, V179, P819, DOI 10.4049/jimmunol.179.2.819; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; Manilay JO, 2005, J IMMUNOL, V174, P6732, DOI 10.4049/jimmunol.174.11.6732; Merlos-Suarez A, 1998, J BIOL CHEM, V273, P24955, DOI 10.1074/jbc.273.38.24955; Merlos-Suarez A, 2001, J BIOL CHEM, V276, P48510, DOI 10.1074/jbc.M103488200; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Mishra-Gorur K, 2002, J CELL BIOL, V159, P313, DOI 10.1083/jcb.200203117; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Real PJ, 2009, NAT MED, V15, P50, DOI 10.1038/nm.1900; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sanchez-Irizarry C, 2004, MOL CELL BIOL, V24, P9265, DOI 10.1128/MCB.24.21.9265-9273.2004; Sapir A, 2005, DEVELOPMENT, V132, P123, DOI 10.1242/dev.01546; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Sotillos S, 1997, DEVELOPMENT, V124, P4769; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Tagami S, 2008, MOL CELL BIOL, V28, P165, DOI 10.1128/MCB.00863-07; Tian L, 2008, INT IMMUNOL, V20, P1181, DOI 10.1093/intimm/dxn076; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Vooijs M, 2004, J BIOL CHEM, V279, P50864, DOI 10.1074/jbc.M409430200; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wilson A, 2006, FEBS LETT, V580, P2860, DOI 10.1016/j.febslet.2006.03.024	57	193	197	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31018	31027		10.1074/jbc.M109.006775	http://dx.doi.org/10.1074/jbc.M109.006775			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19726682	Green Published, hybrid			2022-12-25	WOS:000271378400031
J	Li, XF; Yan, PJ; Shao, ZM				Li, X-F; Yan, P-J; Shao, Z-M			Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer	ONCOGENE			English	Article						microRNA; breast cancer; metastasis; uPA; mouse xenograft model	MICRORNA TARGETS; MESSENGER-RNA; CELL-MIGRATION; METASTASIS; CARCINOMA; PROGNOSIS; RECEPTOR; SYSTEM; GROWTH; DEMETHYLATION	Emerging evidence suggests the potential involvement of altered regulation of miRNAs in the pathogenesis of cancers, and these miRNAs are thought to be functional as tumor suppressors or oncogenes. Using miRNA arrays, we identified an miRNA differentially expressed between the MDA-MB-231 cell line and its highly metastatic variant. A bioinformatics search revealed a potential target site for miR-193b within the 3'UTR of uPA. Ectopic expression of miR-193b repressed the expression of sensor constructs harboring the 3'UTR of uPA in breast cancer cell lines. Anti-miR-193b treatment led to an increase of uPA protein and increased cell invasion in MDA-MB-231 cells. In contrast, overexpression of miR-193b significantly reduced uPA protein amounts and inhibited cell invasion in MDA-MB-231 and MDA-MB-435 cells. In an immunodeficient mouse model, miR-193b significantly inhibited the growth and dissemination of xenograft tumors. Immunohistochemical staining and real-time PCR assays showed that miR-193b was a negative regulator of the uPA gene in primary breast tumors. Our research reveals that miR-193b is closely associated with clinical metastasis and identifies miR-193b potentially targets uPA transcripts. Perturbation of the miRNA-mRNA pairing may have important roles in the initiation and development of breast cancer. Oncogene (2009) 28, 3937-3948; doi:10.1038/onc.2009.245; published online 24 August 2009	[Li, X-F; Yan, P-J; Shao, Z-M] Fudan Univ, Breast Canc Inst, Dept Breast Surg, Canc Hosp,Canc Inst,Shanghai Med Coll,Inst Biomed, Shanghai 200032, Peoples R China	Fudan University	Shao, ZM (corresponding author), Fudan Univ, Breast Canc Inst, Dept Breast Surg, Canc Hosp,Canc Inst,Shanghai Med Coll,Inst Biomed, 270 Dongan Rd, Shanghai 200032, Peoples R China.	zhimingshao@yahoo.com			National Basic Research Program of China [2006CB910501]; National Natural Science Foundation of China [30371580, 30572109]; Shanghai Science and Technology Committee [03J14019, 06DJ14004, 06DZ19504]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This research was supported in part by grants from the National Basic Research Program of China (2006CB910501), National Natural Science Foundation of China (30371580, 30572109) and Shanghai Science and Technology Committee (03J14019, 06DJ14004, 06DZ19504).	ACHBAROU A, 1994, CANCER RES, V54, P2372; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Biermann JC, 2008, INT J MOL MED, V21, P251; BLASI F, 1993, BIOESSAYS, V15, P105, DOI 10.1002/bies.950150206; BUSSO N, 1994, J CELL BIOL, V126, P259, DOI 10.1083/jcb.126.1.259; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Castello R, 2007, THROMB RES, V120, P753, DOI 10.1016/j.thromres.2006.12.016; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chapman HA, 1997, CURR OPIN CELL BIOL, V9, P714, DOI 10.1016/S0955-0674(97)80126-3; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Foekens JA, 2000, CANCER RES, V60, P636; Frandsen TL, 2001, CANCER RES, V61, P532; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; HolstHansen C, 1996, CLIN EXP METASTAS, V14, P297; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnsen M, 1998, CURR OPIN CELL BIOL, V10, P667, DOI 10.1016/S0955-0674(98)80044-6; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li DQ, 2006, PROTEOMICS, V6, P3352, DOI 10.1002/pmic.200500617; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; McSherry EA, 2007, CELL MOL LIFE SCI, V64, P3201, DOI 10.1007/s00018-007-7388-0; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; NANBU R, 1994, MOL CELL BIOL, V14, P4920, DOI 10.1128/MCB.14.7.4920; Pakneshan P, 2004, J BIOL CHEM, V279, P31735, DOI 10.1074/jbc.M401669200; Pakneshan P, 2004, CLIN CANCER RES, V10, P3035, DOI 10.1158/1078-0432.CCR-03-0545; Pulukuri SMK, 2007, CANCER RES, V67, P6637, DOI 10.1158/0008-5472.CAN-07-0751; Rabbani SA, 1998, INT J ONCOL, V12, P911; Rabbani SA, 2007, CANCER METAST REV, V26, P663, DOI 10.1007/s10555-007-9085-8; Sidenius N, 2003, CANCER METAST REV, V22, P205, DOI 10.1023/A:1023099415940; Sliva D, 2002, J BIOL CHEM, V277, P3150, DOI 10.1074/jbc.M109579200; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tetu B, 1998, HUM PATHOL, V29, P979, DOI 10.1016/S0046-8177(98)90204-0; Tetu B, 2001, CANCER, V92, P2957, DOI 10.1002/1097-0142(20011201)92:11<2957::AID-CNCR10112>3.0.CO;2-6; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488	42	142	152	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2009	28	44					3937	3948		10.1038/onc.2009.245	http://dx.doi.org/10.1038/onc.2009.245			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	515LJ	19701247				2022-12-25	WOS:000271471900008
J	Mikels, A; Minami, Y; Nusse, R				Mikels, Amanda; Minami, Yasuhiro; Nusse, Roel			Ror2 Receptor Requires Tyrosine Kinase Activity to Mediate Wnt5A Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRACHYDACTYLY TYPE-B; RECESSIVE ROBINOW-SYNDROME; MOUSE DEVELOPMENT; INSULIN-RECEPTOR; ENDOPLASMIC-RETICULUM; CELL POLARITY; PATHWAY; EXPRESSION; DISEASE; PHOSPHORYLATION	The Wnts include a large family of secreted proteins that serve as important signals during embryonic development and adult homeostasis. In the most well understood Wnt signaling pathway, Wnt binding to Frizzled and low density lipoprotein receptor-related protein induces beta-catenin protein stabilization and entry into the nucleus, resulting in changes in target gene transcription. Emerging evidence suggests that Wnt5a can inhibit Wnt/beta-catenin signaling through interaction with the receptor Ror2. The Ror2 protein belongs to the receptor tyrosine kinase superfamily and contains several recognizable structural motifs. However, limited information is available regarding which specific domains are required for the inhibitory signaling activity of Wnt5a. Through mutation and deletion analysis, we have analyzed which specific domains and residues, including those necessary for tyrosine kinase activity, mediate the Wnt5a signal. To determine whether Ror2 can inhibit canonical Wnt signaling in vivo, we examined the effect of Ror2 loss on the expression of the Wnt reporter Axin2(LacZ), finding increased reporter activity in Ror2 null mice, demonstrating that Ror2 can also inhibit Wnt/beta-catenin signaling in the context of intact tissues.	[Nusse, Roel] Stanford Univ, Beckman Ctr, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Mikels, Amanda; Nusse, Roel] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Minami, Yasuhiro] Kobe Univ, Fac Med Sci, Dept Physiol & Cell Biol, Chuo Ku, Kobe, Hyogo 6500017, Japan	Stanford University; Howard Hughes Medical Institute; Stanford University; Kobe University	Nusse, R (corresponding author), Stanford Univ, Beckman Ctr, Sch Med, Dept Dev Biol, 279 Campus Dr, Stanford, CA 94305 USA.	rnusse@stanford.edu			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the Howard Hughes Medical Institute.	Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Afzal AR, 2003, HUM MUTAT, V22, P1, DOI 10.1002/humu.10233; Akbarzadeh S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001873; Al-Shawi R, 2001, DEV GENES EVOL, V211, P161, DOI 10.1007/s004270100140; Ali BR, 2007, HUM GENET, V122, P389, DOI 10.1007/s00439-007-0409-0; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; Forrester WC, 2004, GENETICS, V168, P1951, DOI 10.1534/genetics.104.031781; Forrester WC, 2002, CELL MOL LIFE SCI, V59, P83, DOI 10.1007/s00018-002-8407-9; Fox S, 2006, FRONT BIOSCI-LANDMRK, V11, P2106, DOI 10.2741/1953; Green JL, 2008, CELL, V134, P646, DOI 10.1016/j.cell.2008.06.026; Hendrickx M, 2008, DEV GROWTH DIFFER, V50, P229, DOI [10.1111/j.1440-169x.2008.01016.x, 10.1111/j.1440-169X.2008.01016.x]; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kani S, 2004, J BIOL CHEM, V279, P50102, DOI 10.1074/jbc.M409039200; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kim C, 2003, DEV BIOL, V264, P376, DOI 10.1016/j.ydbio.2003.09.007; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Liu Y, 2008, J CELL BIOCHEM, V105, P497, DOI 10.1002/jcb.21848; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Loscertales M, 2008, DEVELOPMENT, V135, P1365, DOI 10.1242/dev.010504; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Malanchi I, 2009, CURR OPIN ONCOL, V21, P41, DOI 10.1097/CCO.0b013e32831d1faf; Matsuda T, 2001, MECH DEVELOP, V105, P153, DOI 10.1016/S0925-4773(01)00383-5; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Nomi M, 2001, MOL CELL BIOL, V21, P8329, DOI 10.1128/MCB.21.24.8329-8335.2001; Oishi I, 1999, GENES CELLS, V4, P41, DOI 10.1046/j.1365-2443.1999.00234.x; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; Polakis P, 2000, GENE DEV, V14, P1837; Saiga H, 2008, J IMMUNOL, V181, P8521, DOI 10.4049/jimmunol.181.12.8521; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SCHWARZER W, 2009, HUM MOL GENET; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; TORNQVIST HE, 1988, J BIOL CHEM, V263, P350; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; VIHINEN M, 1994, P NATL ACAD SCI USA, V91, P12803, DOI 10.1073/pnas.91.26.12803; WILDEN PA, 1990, P NATL ACAD SCI USA, V87, P3358, DOI 10.1073/pnas.87.9.3358; WILDEN PA, 1992, J BIOL CHEM, V267, P16660; Winkel A, 2008, CELL SIGNAL, V20, P2134, DOI 10.1016/j.cellsig.2008.08.009; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yamamoto H, 2007, GENES CELLS, V12, P1215, DOI 10.1111/j.1365-2443.2007.01128.x; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786	51	125	129	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30167	30176		10.1074/jbc.M109.041715	http://dx.doi.org/10.1074/jbc.M109.041715			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19720827	Green Published, hybrid			2022-12-25	WOS:000271090000020
J	Burgoyne, JR; Eaton, P				Burgoyne, Joseph R.; Eaton, Philip			Transnitrosylating Nitric Oxide Species Directly Activate Type I Protein Kinase A, Providing a Novel Adenylate Cyclase-independent Cross-talk to beta-Adrenergic-like Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-NITROSYLATION; VENTRICULAR FIBERS; FROG-HEART; CYCLIC-GMP; PEROXYNITRITE; CARDIOMYOCYTES; DISULFIDE; MECHANISM; TRANSPORT; DONORS	The transnitrosylating nitric oxide (NO) donor nitrocysteine (CysNO) induced a disulfide bond between the two regulatory RI subunits of protein kinase A (PKA). The conventional NO donor S-nitroso-N-acetylpenicillamine failed to do this, consistent with our observation that it also did not promote protein S-nitrosylation. This disulfide oxidation event activated PKA and induced vasorelaxation independently of the classical beta-adrenergic or NO signaling pathway. Activation of PKA had also been anticipated to exert a positive inotropic effect on the myocardium but did not. The lack of positive inotropy was explained by CysNO concomitantly activating protein kinase G (PKG) I alpha. PKG was found to exert a partial negative inotropic influence regardless of whether PKA was activated by classical beta-receptor stimulation or by disulfide bond formation. This work demonstrates that NO molecules that can induce S-nitrosylation directly activate type I PKA, providing a novel cross-talk to beta-adrenergic-like signaling without receptor or adenylate cyclase stimulation. However, the expected positive inotropic consequences of PKA activation by this novel mechanism are countermanded by the simultaneous dual activation of PKGI alpha, which is also activated by CysNO.	[Burgoyne, Joseph R.; Eaton, Philip] Kings Coll London, St Thomas Hosp, Rayne Inst, Div Cardiovasc, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Eaton, P (corresponding author), Kings Coll London, St Thomas Hosp, Rayne Inst, Div Cardiovasc, London SE1 7EH, England.	philip.eaton@kcl.ac.uk	Eaton, Philip/I-5444-2015	Eaton, Philip/0000-0003-0748-2367; Burgoyne, Joseph/0000-0001-7325-7382	Wellcome Trust [085483/Z/08/Z]; Medical Research Council [G0700320]; MRC [G0600785, G0700320] Funding Source: UKRI; Medical Research Council [G0600785] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Sir Henry Wellcome postdoctoral fellowship from The Wellcome Trust (Sponsor Reference 085483/Z/08/Z; to J. R. B.) and the Medical Research Council (Sponsor Reference G0700320).	Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Angelone T, 2008, ACTA PHYSIOL, V193, P229, DOI 10.1111/j.1748-1716.2008.01838.x; Asada K, 2009, J BIOL CHEM, V284, P6014, DOI 10.1074/jbc.M807158200; Banky P, 1998, J BIOL CHEM, V273, P35048, DOI 10.1074/jbc.273.52.35048; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Brennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200; Brennan JP, 2006, MOL CELL PROTEOMICS, V5, P215, DOI 10.1074/mcp.M500212-MCP200; Brennan JP, 2004, J BIOL CHEM, V279, P41352, DOI 10.1074/jbc.M403827200; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Chesnais JM, 1999, J PHYSIOL-LONDON, V518, P449, DOI 10.1111/j.1469-7793.1999.0449p.x; Chesnais JM, 1999, J PHYSIOL-LONDON, V521, P375, DOI 10.1111/j.1469-7793.1999.00375.x; Eaton P, 2006, FREE RADICAL BIO MED, V40, P1889, DOI 10.1016/j.freeradbiomed.2005.12.037; Ebihara Y, 1996, CARDIOVASC RES, V32, P622, DOI 10.1016/S0008-6363(96)00117-4; Gow AJ, 2002, J BIOL CHEM, V277, P9637, DOI 10.1074/jbc.C100746200; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hess DT, 2001, NAT CELL BIOL, V3, pE46, DOI 10.1038/35055152; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Kohr MJ, 2008, CARDIOVASC RES, V77, P353, DOI 10.1093/cvr/cvm018; Moncada S, 2006, BRIT J PHARMACOL, V147, pS193, DOI 10.1038/sj.bjp.0706458; Paolocci N, 2000, AM J PHYSIOL-HEART C, V279, pH1982, DOI 10.1152/ajpheart.2000.279.4.H1982; Paolocci N, 2007, PHARMACOL THERAPEUT, V113, P442, DOI 10.1016/j.pharmthera.2006.11.002; Sandirasegarane L, 1999, J MOL CELL CARDIOL, V31, P799, DOI 10.1006/jmcc.1998.0919; Schipke JD, 2001, Z KARDIOL, V90, P319, DOI 10.1007/s003920170161; Schnell JR, 2005, PROTEIN SCI, V14, P2421, DOI 10.1110/ps.051528905; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Tocchetti CG, 2007, CIRC RES, V100, P96, DOI 10.1161/01.RES.0000253904.53601.c9; Vigil D, 2004, BIOCHEMISTRY-US, V43, P5629, DOI 10.1021/bi0499157; Viste K, 2005, J BIOL CHEM, V280, P13279, DOI 10.1074/jbc.M413065200; WHEATLEY RM, 1994, AM J PHYSIOL, V266, pH291, DOI 10.1152/ajpheart.1994.266.1.H291; Wright DH, 2001, AM J PHYSIOL-REG I, V281, pR1343, DOI 10.1152/ajpregu.2001.281.5.R1343; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Yang L, 2007, CIRC RES, V101, P465, DOI 10.1161/CIRCRESAHA.107.156976; Zhang YH, 2005, FREE RADICAL BIO MED, V38, P831, DOI 10.1016/j.freeradbiomed.2004.12.016; Zhang YH, 2004, P NATL ACAD SCI USA, V101, P7891, DOI 10.1073/pnas.0401167101	37	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29260	29268		10.1074/jbc.M109.046722	http://dx.doi.org/10.1074/jbc.M109.046722			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19726669	Green Published, hybrid			2022-12-25	WOS:000270896800005
J	Tillgren, V; Onnerfjord, P; Haglund, L; Heinegard, D				Tillgren, Viveka; Onnerfjord, Patrik; Haglund, Lisbet; Heinegard, Dick			The Tyrosine Sulfate-rich Domains of the LRR Proteins Fibromodulin and Osteoadherin Bind Motifs of Basic Clusters in a Variety of Heparin-binding Proteins, Including Bioactive Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN TYPE-I; OLIGOMERIC MATRIX PROTEIN; ARTICULAR-CARTILAGE; BASEMENT-MEMBRANE; CELL-ADHESION; PRELP BINDS; PROTEOGLYCAN; DECORIN; REGION; THROMBOSPONDIN	The small leucine-rich repeat proteins, fibromodulin and osteoadherin, have N-terminal extensions with a variable number of O-sulfated tyrosine residues. This modification combined with a number of aspartic and glutamic acid residues results in a highly negatively charged domain of less than 30 amino acids. We hypothesized that this domain shares functional properties with heparin regarding binding to proteins and polypeptides containing clusters of basic amino acids. Two other family members, PRELP and chondroadherin, have distinctly different clusters of basic amino acids in their N and C termini, respectively, and PRELP is known to bind to heparin via this domain. Another heparin-binding protein is the cytokine Oncostatin M, with a different cluster of basic amino acids in its C terminus. We used polypeptides representing these basic domains in solid phase assays and demonstrate interactions with the negatively charged N-terminal domain of fibromodulin and full-length osteoadherin. The tyrosine sulfate domains also bound heparin-binding proteins such as basic fibroblast growth factor-2, thrombospondin I, MMP13, the NC4 domain of collagen IX, and interleukin-10. Fibronectin with large heparin-binding domains did not bind, neither did CILP containing a heparin-binding thrombospondin type I motif without clustered basic amino acids. Affinity depends on the number and position of the sulfated tyrosine residues shown by different binding properties of 10-kDa fragments subfractionated by ion-exchange chromatography. These interactions may sequester growth factors, cytokines, and matrix metalloproteinases in the extracellular matrix as well as contribute to its organization.	[Tillgren, Viveka; Onnerfjord, Patrik; Haglund, Lisbet; Heinegard, Dick] Lund Univ, Sect Rheumatol Mol Skeletal Biol, Dept Clin Sci, SE-22184 Lund, Sweden	Lund University	Heinegard, D (corresponding author), Lund Univ, Sect Rheumatol Mol Skeletal Biol, Dept Clin Sci, BMC Plan C12, SE-22184 Lund, Sweden.	dick.heinegard@med.lu.se	Onnerfjord, Patrik/R-3131-2019; Haglund, Lisbet/N-3095-2013	Onnerfjord, Patrik/0000-0002-2345-2937; Haglund, Lisbet/0000-0002-1288-2149	Swedish Research Council; Osterlund Foundation; Magnus Bergvall Foundation; IngaBritt and Arne Lundbergs Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Osterlund Foundation; Magnus Bergvall Foundation; IngaBritt and Arne Lundbergs Research Foundation	This work was supported by The Swedish Research Council, King Gustaf V's 80-year jubilee fund, the Osterlund Foundation, the Kock Foundation, the Magnus Bergvall Foundation, and Anamar Medical. Mass spectrometers were purchased through grants from the IngaBritt and Arne Lundbergs Research Foundation.	Bengtsson E, 2002, J BIOL CHEM, V277, P15061, DOI 10.1074/jbc.M108285200; Bengtsson E, 2000, J BIOL CHEM, V275, P40695, DOI 10.1074/jbc.M007917200; BLOCHBERGER TC, 1992, J BIOL CHEM, V267, P347; Chen RL, 2001, J BIOL CHEM, V276, P7507, DOI 10.1074/jbc.M008283200; DIXIT VM, 1984, J BIOL CHEM, V259, P100; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Ganu V, 1998, ARTHRITIS RHEUM, V41, P2143, DOI 10.1002/1529-0131(199812)41:12<2143::AID-ART9>3.0.CO;2-P; GomisRuth FX, 1996, J MOL BIOL, V264, P556, DOI 10.1006/jmbi.1996.0661; GUO NH, 1992, P NATL ACAD SCI USA, V89, P3040, DOI 10.1073/pnas.89.7.3040; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P4494, DOI 10.1073/pnas.77.8.4494; Heathfield TF, 2004, J BIOL CHEM, V279, P6286, DOI 10.1074/jbc.M307765200; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; HEDBOM E, 1993, J BIOL CHEM, V268, P27307; HEDLUND H, 1994, MATRIX BIOL, V14, P227, DOI 10.1016/0945-053X(94)90186-4; HEINEGARD D, 1986, J BIOL CHEM, V261, P3866; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Kalamajski S, 2007, J BIOL CHEM, V282, P26740, DOI 10.1074/jbc.M704026200; Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lorenzo P, 1998, J BIOL CHEM, V273, P23463, DOI 10.1074/jbc.273.36.23463; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; Lorenzo P, 1998, J BIOL CHEM, V273, P23469, DOI 10.1074/jbc.273.36.23469; Mansson B, 2001, J BIOL CHEM, V276, P32883, DOI 10.1074/jbc.M101680200; Mostafavi-Pour Z, 2001, MATRIX BIOL, V20, P63, DOI 10.1016/S0945-053X(00)00131-1; Onnerfjord P, 2004, J BIOL CHEM, V279, P26, DOI 10.1074/jbc.M308689200; Pihlajamaa T, 2004, J BIOL CHEM, V279, P24265, DOI 10.1074/jbc.M402865200; RAPRAEGER A, 1985, J BIOL CHEM, V260, P1046; SCOTT JE, 1981, BIOCHEM J, V197, P213, DOI 10.1042/bj1970213; SVENSSON L, 1995, J BIOL CHEM, V270, P20712, DOI 10.1074/jbc.270.35.20712; TSEN G, 1995, J BIOL CHEM, V270, P3392, DOI 10.1074/jbc.270.7.3392; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200	33	38	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28543	28553		10.1074/jbc.M109.047076	http://dx.doi.org/10.1074/jbc.M109.047076			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19700767	Green Published, hybrid			2022-12-25	WOS:000270678900008
J	Rosenberg, E; Ben-Shmuel, A; Shalev, O; Sinay, R; Cowman, A; Pollack, Y				Rosenberg, Elli; Ben-Shmuel, Amir; Shalev, Oshrit; Sinay, Rosa; Cowman, Alan; Pollack, Yaakov			Differential, Positional-Dependent Transcriptional Response of Antigenic Variation (var) Genes to Biological Stress in Plasmodium falciparum	PLOS ONE			English	Article							MALARIA PARASITE; VIRULENCE GENES; EXPRESSION; SEQUENCE; REGIONS	1% of the genes of the human malaria causing agent Plasmodium falciparum belong to the heterogeneous var gene family which encodes P. falciparum erythrocyte membrane protein 1 (PFEMP1). This protein mediates part of the pathogenesis of the disease by causing adherence of infected erythrocytes (IE) to the host endothelium. At any given time, only one copy of the family is expressed on the IE surface. The cues which regulate the allelic exclusion of these genes are not known. We show the existence of a differential expression pattern of these genes upon exposure to biological stress in relation to their positional placement on the chromosome expression of centrally located var genes is induced while sub-telomeric copies of the family are repressed - this phenomenon orchestrated by the histone deacetylase pfsir2. Moreover, stress was found to cause a switch in the pattern of the expressed var genes thus acting as a regulatory cue. By using pharmacological compounds which putatively affect pfsir2 activity, distinct changes of var gene expression patterns were achieved which may have therapeutic ramifications. As disease severity is partly associated with expression of particular var gene subtypes, manipulation of the IE environment may serve as a mechanism to direct transcription towards less virulent genes.	[Rosenberg, Elli; Ben-Shmuel, Amir; Shalev, Oshrit; Sinay, Rosa; Pollack, Yaakov] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel; [Cowman, Alan] Walter & Eliza Hall Inst Med Res, Dept Infect & Immun, Melbourne, Vic 3050, Australia	Ben Gurion University; Walter & Eliza Hall Institute	Rosenberg, E (corresponding author), Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, IL-84105 Beer Sheva, Israel.	polak@bgu.ac.il	Cowman, Alan F/C-7642-2013	Cowman, Alan F/0000-0001-5145-9004	Ben-Gurion University Research Fund [89331501]; Toman Fund [31020513]	Ben-Gurion University Research Fund; Toman Fund	This study was partially supported by the Ben-Gurion University Research Fund (number 89331501) and the Toman Fund (number 31020513). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; Calderwood MS, 2003, J BIOL CHEM, V278, P34125, DOI 10.1074/jbc.M213065200; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Deitsch KW, 1996, MOL BIOCHEM PARASIT, V76, P1, DOI 10.1016/0166-6851(95)02575-8; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Dyer M, 2000, PARASITOL TODAY, V16, P102, DOI 10.1016/S0169-4758(99)01608-7; Dzikowski R, 2006, PLOS PATHOG, V2, P184, DOI 10.1371/journal.ppat.0020022; Eason DD, 2004, SEMIN IMMUNOL, V16, P215, DOI 10.1016/j.smim.2004.08.001; Fernandez V, 2002, MOL BIOCHEM PARASIT, V121, P195, DOI 10.1016/S0166-6851(02)00038-5; Frank M, 2007, MOL MICROBIOL, V64, P1486, DOI 10.1111/j.1365-2958.2007.05736.x; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; French JB, 2008, BIOCHEMISTRY-US, V47, P10227, DOI 10.1021/bi800767t; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Kaestli M, 2006, J INFECT DIS, V193, P1567, DOI 10.1086/503776; Kambere MB, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-S3-S2; Kraemer SM, 2003, MOL MICROBIOL, V50, P1527, DOI 10.1046/j.1365-2958.2003.03814.x; Kyes S, 2007, MOL MICROBIOL, V63, P1237, DOI 10.1111/j.1365-2958.2007.05587.x; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lopez-Rubio JJ, 2007, MOL MICROBIOL, V66, P1296, DOI 10.1111/j.1365-2958.2007.06009.x; Marti M, 2005, J CELL BIOL, V171, P587, DOI 10.1083/jcb.200508051; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Oakley MSM, 2007, INFECT IMMUN, V75, P2012, DOI 10.1128/IAI.01236-06; Peters JM, 2007, J INFECT DIS, V195, P748, DOI 10.1086/511436; Ralph SA, 2005, CURR OPIN MICROBIOL, V8, P434, DOI 10.1016/j.mib.2005.06.007; Ralph SA, 2005, P NATL ACAD SCI USA, V102, P5414, DOI 10.1073/pnas.0408883102; Rosenberg E, 2006, J BIOL CHEM, V281, P27039, DOI 10.1074/jbc.M601686200; ROUMANN M, 2006, INFECT IMMUN, V74, P3904; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Sharp S, 2006, EUKARYOT CELL, V5, P1206, DOI 10.1128/EC.00029-06; Tonkin CJ, 2009, PLOS BIOL, V7, P771, DOI 10.1371/journal.pbio.1000084; Voss TS, 2006, NATURE, V439, P1004, DOI 10.1038/nature04407; WAN G, 2002, QJM, V95, P285; Waterkeyn JG, 2000, EMBO J, V19, P2813, DOI 10.1093/emboj/19.12.2813; WOOD JG, 2001, NATURE, V480, P686	41	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2009	4	9							e6991	10.1371/journal.pone.0006991	http://dx.doi.org/10.1371/journal.pone.0006991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YM	19730749	Green Published, gold			2022-12-25	WOS:000207566900001
J	van der Lelij, P; Godthelp, BC; van Zon, W; van Gosliga, D; Oostra, AB; Steltenpool, J; de Groot, J; Scheper, RJ; Wolthuis, RM; Waisfisz, Q; Darroudi, F; Joenje, H; de Winter, JP				van der Lelij, Petra; Godthelp, Barbara C.; van Zon, Wouter; van Gosliga, Djoke; Oostra, Anneke B.; Steltenpool, Jurgen; de Groot, Jan; Scheper, Rik J.; Wolthuis, Rob M.; Waisfisz, Quinten; Darroudi, Firouz; Joenje, Hans; de Winter, Johan P.			The Cellular Phenotype of Roberts Syndrome Fibroblasts as Revealed by Ectopic Expression of ESCO2	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; FANCONI-ANEMIA; SYNDROME CELLS; NUCLEAR FOCI; DNA-DAMAGE; S-PHASE; PROTEIN; ECO1; RECOMBINATION; ESTABLISHMENT	Cohesion between sister chromatids is essential for faithful chromosome segregation. In budding yeast, the acetyltransferase Eco1/Ctf7 establishes cohesion during DNA replication in S phase and in response to DNA double strand breaks in G2/M phase. In humans two Eco1 orthologs exist: ESCO1 and ESCO2. Both proteins are required for proper sister chromatid cohesion, but their exact function is unclear at present. Since ESCO2 has been identified as the gene defective in the rare autosomal recessive cohesinopathy Roberts syndrome (RBS), cells from RBS patients can be used to elucidate the role of ESCO2. We investigated for the first time RBS cells in comparison to isogenic controls that stably express V5- or GFP-tagged ESCO2. We show that the sister chromatid cohesion defect in the transfected cell lines is rescued and suggest that ESCO2 is regulated by proteasomal degradation in a cell cycle-dependent manner. In comparison to the corrected cells ABS cells were hypersensitive to the DNA-damaging agents mitomycin C, camptothecin and etoposide, while no particular sensitivity to UV, ionizing radiation, hydroxyurea or aphidicolin was found. The cohesion defect of RBS cells and their hypersensitivity to DNA-damaging agents were not corrected by a patient-derived ESCO2 acetyltransferase mutant (W539G), indicating that the acetyltransferase activity of ESCO2 is essential for its function. In contrast to a previous study on cells from patients with Cornelia de Lange syndrome, another cohesinopathy, RBS cells failed to exhibit excessive chromosome aberrations after irradiation in G2 phase of the cell cycle. Our results point at an S phase-specific role for ESCO2 in the maintenance of genome stability.	[van der Lelij, Petra; van Gosliga, Djoke; Oostra, Anneke B.; Steltenpool, Jurgen; Waisfisz, Quinten; Joenje, Hans; de Winter, Johan P.] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Godthelp, Barbara C.; Darroudi, Firouz] Leiden Univ, Med Ctr, Dept Toxicogenet, Leiden, Netherlands; [van Zon, Wouter; Wolthuis, Rob M.] Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands; [de Groot, Jan; Scheper, Rik J.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Cancer Institute; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van der Lelij, P (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands.	j.dewinter@vumc.nl		van der Lelij, Petra/0000-0002-7461-9645; Waisfisz, Quinten/0000-0002-7384-9182; Wolthuis, Rob/0000-0002-3109-1588				Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; CHEN GL, 1984, J BIOL CHEM, V259, P3560; GIOSK R, 2000, MOL CELL, V5, P243; Gordillo M, 2008, HUM MOL GENET, V17, P2172, DOI 10.1093/hmg/ddn116; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; Hou FJ, 2005, MOL BIOL CELL, V16, P3908, DOI 10.1091/mbc.E04-12-1063; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Schule B, 2005, AM J HUM GENET, V77, P1117, DOI 10.1086/498695; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Sonoda E, 1999, MOL CELL BIOL, V19, P5166; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; van de Vrugt HJ, 2002, GENES CELLS, V7, P333, DOI 10.1046/j.1365-2443.2002.00518.x; VANDENBERG DJ, 1993, SOMAT CELL MOLEC GEN, V19, P377; VANDENBERG DJ, 1993, AM J MED GENET, V47, P1104, DOI 10.1002/ajmg.1320470735; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Vrouwe MG, 2007, HUM MOL GENET, V16, P1478, DOI 10.1093/hmg/ddm098; Waisfisz Q, 1999, P NATL ACAD SCI USA, V96, P10320, DOI 10.1073/pnas.96.18.10320; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006	29	51	52	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2009	4	9							e6936	10.1371/journal.pone.0006936	http://dx.doi.org/10.1371/journal.pone.0006936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YL	19738907	Green Published, gold, Green Submitted			2022-12-25	WOS:000207566800001
J	Morand, PC; Drab, M; Rajalingam, K; Nassif, X; Meyer, TF				Morand, Philippe C.; Drab, Marek; Rajalingam, Krishnaraj; Nassif, Xavier; Meyer, Thomas F.			Neisseria meningitidis Differentially Controls Host Cell Motility through PilC1 and PilC2 Components of Type IV Pili	PLOS ONE			English	Article								Neisseria meningitidis is a strictly human pathogen that has two facets since asymptomatic carriage can unpredictably turn into fulminant forms of infection. Meningococcal pathogenesis relies on the ability of the bacteria to break host epithelial or endothelial cellular barriers. Highly restrictive, yet poorly understood, mechanisms allow meningococcal adhesion to cells of only human origin. Adhesion of encapsulated and virulent meningococci to human cells relies on the expression of bacterial type four pili (T4P) that trigger intense host cell signalling. Among the components of the meningococcal T4P, the concomitantly expressed PilC1 and PilC2 proteins regulate pili exposure at the bacterial surface, and until now, PilC1 was believed to be specifically responsible for T4P-mediated meningococcal adhesion to human cells. Contrary to previous reports, we show that, like PilC1, the meningococcal PilC2 component is capable of mediating adhesion to human ME180 epithelial cells, with cortical plaque formation and F-actin condensation. However, PilC1 and PilC2 promote different effects on infected cells. Cellular tracking analysis revealed that PilC1-expressing meningococci caused a severe reduction in the motility of infected cells, which was not the case when cells were infected with PilC2-expressing strains. The amount of both total and phosphorylated forms of EGFR was dramatically reduced in cells upon PilC1-mediated infection. In contrast, PilC2-mediated infection did not notably affect the EGFR pathway, and these specificities were shared among unrelated meningococcal strains. These results suggest that meningococci have evolved a highly discriminative tool for differential adhesion in specific microenvironments where different cell types are present. Moreover, the fine-tuning of cellular control through the combined action of two concomitantly expressed, but distinctly regulated, T4P-associated variants of the same molecule (i.e. PilC1 and PilC2) brings a new model to light for the analysis of the interplay between pathogenic bacteria and human host cells.			Morand, PC (corresponding author), Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany.	philippe.morand@cch.aphp.fr	Meyer, Thomas F. F/J-2485-2013; Rajalingam, krishnaraj/D-3081-2011; Morand, Philippe/C-1213-2016; Drab, Marek/AAQ-1892-2020; Drab, Marek/J-5196-2013	Meyer, Thomas F. F/0000-0002-6120-8679; Morand, Philippe/0000-0003-0306-8759; Drab, Marek/0000-0002-2771-1692				Caugant DA, 2008, INFECT GENET EVOL, V8, P558, DOI 10.1016/j.meegid.2008.04.002; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; Gill DB, 2005, CELL MICROBIOL, V7, P1672, DOI 10.1111/j.1462-5822.2005.00584.x; Higashi DL, 2007, INFECT IMMUN, V75, P4743, DOI 10.1128/IAI.00687-07; Hoffmann I, 2001, J CELL BIOL, V155, P133, DOI 10.1083/jcb.200106148; Jones A, 2007, FASEB J, V21, P345, DOI 10.1096/fj.06-6675com; JONSSON AB, 1991, EMBO J, V10, P477, DOI 10.1002/j.1460-2075.1991.tb07970.x; JONSSON AB, 1995, MICROBIOL-SGM, V141, P2367, DOI 10.1099/13500872-141-10-2367; Kallstrom H, 1998, J BIOL CHEM, V273, P21777, DOI 10.1074/jbc.273.34.21777; KELLOGG DS, 1968, J BACTERIOL, V96, P596, DOI 10.1128/JB.96.3.596-605.1968; Lambotin M, 2005, J CELL SCI, V118, P3805, DOI 10.1242/jcs.02514; Merz AJ, 1999, MOL MICROBIOL, V32, P1316, DOI 10.1046/j.1365-2958.1999.01459.x; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; Miller KE, 2006, AM FAM PHYSICIAN, V73, P1779; Morand PC, 2004, EMBO J, V23, P2009, DOI 10.1038/sj.emboj.7600200; Morand PC, 2001, MOL MICROBIOL, V40, P846, DOI 10.1046/j.1365-2958.2001.02452.x; Nassif X, 1999, MOL MICROBIOL, V32, P1124, DOI 10.1046/j.1365-2958.1999.01416.x; NASSIF X, 1994, P NATL ACAD SCI USA, V91, P3769, DOI 10.1073/pnas.91.9.3769; NASSIF X, 1993, MOL MICROBIOL, V8, P719, DOI 10.1111/j.1365-2958.1993.tb01615.x; Nassif X, 1999, CURR OPIN MICROBIOL, V2, P71, DOI 10.1016/S1369-5274(99)80012-5; Neil RB, 2009, MICROBES INFECT, V11, P281, DOI 10.1016/j.micinf.2008.12.001; Opitz D, 2009, CHEMPHYSCHEM, V10, P1614, DOI 10.1002/cphc.200800654; Otsuki Y, 2003, PROG HISTOCHEM CYTO, V38, P275, DOI 10.1016/S0079-6336(03)80002-5; Pron B, 1997, J INFECT DIS, V176, P1285, DOI 10.1086/514124; Pujol C, 1997, INFECT IMMUN, V65, P4836, DOI 10.1128/IAI.65.11.4836-4842.1997; Rahman M, 1997, MOL MICROBIOL, V25, P11, DOI 10.1046/j.1365-2958.1997.4601823.x; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; RUDEL T, 1995, P NATL ACAD SCI USA, V92, P7986, DOI 10.1073/pnas.92.17.7986; RUDEL T, 1995, NATURE, V373, P357, DOI 10.1038/373357a0; RUDEL T, 1995, MOL MICROBIOL, V17, P1057, DOI 10.1111/j.1365-2958.1995.mmi_17061057.x; Ryll RR, 1997, MOL MICROBIOL, V23, P879, DOI 10.1046/j.1365-2958.1997.2631630.x; Scheuerpflug I, 1999, INFECT IMMUN, V67, P834, DOI 10.1128/IAI.67.2.834-843.1999; Schweitzer KM, 1997, LAB INVEST, V76, P25; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Snyder LAS, 2005, PLASMID, V54, P191, DOI 10.1016/j.plasmid.2005.04.005; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Stins MF, 1997, J NEUROIMMUNOL, V76, P81, DOI 10.1016/S0165-5728(97)00036-2; Taha MK, 1998, MOL MICROBIOL, V28, P1153, DOI 10.1046/j.1365-2958.1998.00876.x; Tinsley CR, 1996, P NATL ACAD SCI USA, V93, P11109, DOI 10.1073/pnas.93.20.11109; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0	41	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6834	10.1371/journal.pone.0006834	http://dx.doi.org/10.1371/journal.pone.0006834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718432	Green Submitted, Green Published, gold			2022-12-25	WOS:000269415900007
J	Tomasi, D; Wang, GJ; Wang, RL; Backus, W; Geliebter, A; Telang, F; Jayne, MC; Wong, C; Fowler, JS; Volkow, ND				Tomasi, Dardo; Wang, Gene-Jack; Wang, Ruiliang; Backus, Walter; Geliebter, Allan; Telang, Frank; Jayne, Millar C.; Wong, Christopher; Fowler, Joanna S.; Volkow, Nora D.			Association of Body Mass and Brain Activation during Gastric Distention: Implications for Obesity	PLOS ONE			English	Article								Background: Gastric distention (GD), as it occurs during meal ingestion, signals a full stomach and it is one of the key mechanisms controlling food intake. Previous studies on GD showed lower activation of the amygdala for subjects with higher body mass index (BMI). Since obese subjects have dopaminergic deficits that correlate negatively with BMI and the amygdala is innervated by dopamine neurons, we hypothesized that BMI would correlate negatively with activation not just in the amygdala but also in other dopaminergic brain regions (midbrain and hypothalamus). Methodology/Principal Findings: We used functional magnetic resonance imaging (fMRI) to evaluate brain activation during GD in 24 healthy subjects with BMI range of 20-39 kg/m(2). Using multiple regression and cross-correlation analyses based on a family-wise error corrected threshold P = 0.05, we show that during slow GD to maximum volumes of 500 ml and 700 ml subjects with increased BMI had increased activation in cerebellum and left posterior insula, and decreased activation of dopaminergic (amygdala, midbrain, hypothalamus, thalamus) and serotonergic (pons) brain regions and anterior insula, regions that were functionally interconnected with one another. Conclusions: The negative correlation between BMI and BOLD responses to gastric distention in dopaminergic (midbrain, hypothalamus, amygdala, thalamus) and serotonergic (pons) brain regions is consistent with disruption of dopaminergic and serotonergic signaling in obesity. In contrast the positive correlation between BMI and BOLD responses in posterior insula and cerebellum suggests an opposing mechanism that promotes food intake in obese subjects that may underlie their ability to consume at once large food volumes despite increasing gastric distention.			Tomasi, D (corresponding author), NIAAA, NIH, Bethesda, MD USA.	tomasi@bnl.gov	Tomasi, Dardo/J-2127-2015		NCRR NIH HHS [M01 RR010710, 5-M01-RR-10710] Funding Source: Medline; NIAAA NIH HHS [Y1AA3009, R01 AA009481, R01AA09481] Funding Source: Medline; NIDA NIH HHS [R01DA006278, R01 DA006891, R01DA006891, R01 DA006278] Funding Source: Medline; NIDDK NIH HHS [R56 DK080153-01A1, R01 DK054318-02, R01 DK080153-04, R01 DK080153-01A2, R01 DK080153-03, R01 DK080153, R56 DK080153, R01 DK054318-03, R01 DK054318, R01 DK080153-02, R01 DK054318-01A1] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK080153, R01DK054318, R01DK080153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006278, R01DA006891] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aguirre GK, 1998, NEUROIMAGE, V8, P302, DOI 10.1006/nimg.1998.0367; Baicy K, 2007, P NATL ACAD SCI USA, V104, P18276, DOI 10.1073/pnas.0706481104; Balcioglu A, 1998, INT J OBESITY, V22, P325, DOI 10.1038/sj.ijo.0800589; Caparelli EC, 2008, BIOMED SIGNAL PROCES, V3, P107, DOI 10.1016/j.bspc.2007.11.003; Caparelli EC, 2003, NEUROIMAGE, V20, P1411, DOI 10.1016/S1053-8119(03)00339-2; Carlini VP, 2004, BIOCHEM BIOPH RES CO, V313, P635, DOI 10.1016/j.bbrc.2003.11.150; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P625, DOI 10.1093/chemse/26.6.625; Cheung S, 1998, BRAIN RES, V808, P174, DOI 10.1016/S0006-8993(98)00809-9; Craig AD, 2006, J COMP NEUROL, V499, P953, DOI 10.1002/cne.21155; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2005, TRENDS COGN SCI, V9, P566, DOI 10.1016/j.tics.2005.10.005; DelParigi A, 2004, INT J OBESITY, V28, P370, DOI 10.1038/sj.ijo.0802558; DIETRICHS E, 1986, BRAIN RES, V364, P241, DOI 10.1016/0006-8993(86)90836-X; DIETRICHS E, 1984, SCIENCE, V223, P591, DOI 10.1126/science.6198719; Erritzoe D, 2009, NEUROIMAGE, V46, P23, DOI 10.1016/j.neuroimage.2009.01.050; Fiset P, 1999, J NEUROSCI, V19, P5506; Frank GKW, 2008, NEUROIMAGE, V39, P1559, DOI 10.1016/j.neuroimage.2007.10.061; Frankle WG, 2004, J NUCL MED, V45, P682; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Garcia-Cabezas MA, 2007, NEUROIMAGE, V34, P965, DOI 10.1016/j.neuroimage.2006.07.032; Gautier JF, 2001, OBES RES, V9, P676, DOI 10.1038/oby.2001.92; Gautier JF, 2000, DIABETES, V49, P838, DOI 10.2337/diabetes.49.5.838; Gavrilescu M, 2002, NEUROIMAGE, V17, P532, DOI 10.1006/nimg.2002.1226; GELIEBTER A, 1988, AM J CLIN NUTR, V48, P592, DOI 10.1093/ajcn/48.3.592; Govindaiah G, 2005, J NEUROPHYSIOL, V94, P3708, DOI 10.1152/jn.00583.2005; HAINES DE, 1984, BRAIN BEHAV EVOLUT, V24, P198, DOI 10.1159/000121317; Heimer L., 1994, HUMAN BRAIN SPINAL C; Heisler LK, 2003, ANN NY ACAD SCI, V994, P169, DOI 10.1111/j.1749-6632.2003.tb03177.x; HENKE PG, 1991, DIGEST DIS SCI, V36, P1633, DOI 10.1007/BF01296409; Hennig J, 2001, MAGNET RESON MED, V46, P6, DOI 10.1002/mrm.1153; HOUPT KA, 1982, NEUROSCI BIOBEHAV R, V6, P145; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; King BM, 2006, AM J PHYSIOL-REG I, V291, pR1201, DOI 10.1152/ajpregu.00199.2006; Krowicki ZK, 1997, J PHARMACOL EXP THER, V282, P14; Ladabaum U, 2001, GASTROENTEROLOGY, V120, P369, DOI 10.1053/gast.2001.21201; Ladabaum U, 2007, NEUROIMAGE, V34, P724, DOI 10.1016/j.neuroimage.2006.07.033; LEE JH, 1995, MAGN RESON MED, V34, P308, DOI 10.1002/mrm.1910340305; Liu YJ, 2000, NATURE, V405, P1058, DOI 10.1038/35016590; Lu CL, 2004, NEUROGASTROENT MOTIL, V16, P575, DOI 10.1111/j.1365-2982.2004.00562.x; MAEDA T, 1994, MICROSC RES TECHNIQ, V29, P211, DOI 10.1002/jemt.1070290306; MAHLER P, 1993, PHYSIOL BEHAV, V54, P1063, DOI 10.1016/0031-9384(93)90325-A; Matharu MS, 2006, ANN NEUROL, V59, P535, DOI 10.1002/ana.20763; Matsuda M, 1999, DIABETES, V48, P1801, DOI 10.2337/diabetes.48.9.1801; Miranda MI, 2002, P NATL ACAD SCI USA, V99, P11417, DOI 10.1073/pnas.182200499; Monckton JE, 2002, J NEUROPHYSIOL, V87, P2124, DOI 10.1152/jn.00650.2001; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Munsch T, 2005, EUR J NEUROSCI, V21, P290, DOI 10.1111/j.1460-9568.2004.03842.x; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Petrovich GD, 2003, ANN NY ACAD SCI, V985, P251; Petrovich GD, 2002, J NEUROSCI, V22, P8748; Price JL, 2003, ANN NY ACAD SCI, V985, P50; Rollins BL, 2000, AM J PHYSIOL-REG I, V279, pR1348, DOI 10.1152/ajpregu.2000.279.4.R1348; Rolls ET, 2007, P NUTR SOC, V66, P96, DOI 10.1017/S0029665107005332; Rothemund Y, 2007, NEUROIMAGE, V37, P410, DOI 10.1016/j.neuroimage.2007.05.008; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sherwood L., 1997, HUMAN PHYSL CELLS SY; Sobel N, 1998, J NEUROSCI, V18, P8990; Stice E, 2008, J ABNORM PSYCHOL, V117, P924, DOI 10.1037/a0013600; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; TACHE Y, 1995, PEPTIDES, V16, P431, DOI 10.1016/0196-9781(94)00212-O; Tataranni PA, 1999, P NATL ACAD SCI USA, V96, P4569, DOI 10.1073/pnas.96.8.4569; Tecott LH, 2007, CELL METAB, V6, P352, DOI 10.1016/j.cmet.2007.09.012; Tomasi D, 2005, NEUROIMAGE, V27, P377, DOI 10.1016/j.neuroimage.2005.04.010; Van Oudenhove L, 2008, NEUROGASTROENT MOTIL, V20, P479, DOI 10.1111/j.1365-2982.2007.01045.x; VOLKOW ND, 1995, NEUROPSYCHOPHARMACOL, V12, P123, DOI 10.1038/sj.npp.1380246; Wang GJ, 2008, NEUROIMAGE, V39, P1824, DOI 10.1016/j.neuroimage.2007.11.008; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Zhao YQ, 2001, NEUROREPORT, V12, P2939, DOI 10.1097/00001756-200109170-00037; Zhou LG, 2005, PEPTIDES, V26, P1728, DOI 10.1016/j.peptides.2004.12.028; Zhu JN, 2006, J NEUROSCI RES, V84, P1597, DOI 10.1002/jnr.21059; Zhu JN, 2006, BRAIN RES REV, V52, P93, DOI 10.1016/j.brainresrev.2006.01.003	73	39	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6847	10.1371/journal.pone.0006847	http://dx.doi.org/10.1371/journal.pone.0006847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718256	Green Submitted, Green Published, gold			2022-12-25	WOS:000269415900019
J	Zhou, L; Choi, HY; Li, WP; Xu, F; Herz, J				Zhou, Li; Choi, Hong Y.; Li, Wei-Ping; Xu, Fang; Herz, Joachim			LRP1 Controls cPLA(2) Phosphorylation, ABCA1 Expression and Cellular Cholesterol Export	PLOS ONE			English	Article								Background: ATP-binding cassette transporter A1 mediates apolipoprotein AI-dependent efflux of cholesterol and thereby removes cholesterol from peripheral tissues. ABCA1 expression is tightly regulated and deficiency of this cholesterol transporter results in cholesterol accumulation within cells. Low-density lipoprotein receptor-related protein 1 (LRP1) participates in lipid metabolism and energy homeostasis by endocytosis of apolipoprotein E-containing lipoproteins and modulation of cellular proliferation signals. Methods and Principal Findings: In the present study, we demonstrate a new role for LRP1 in reverse cholesterol transport. Absence of LRP1 expression results in increased PDGFR beta signaling and sequential activation of the mitogen-activated protein kinase signaling pathway, which increases phosphorylation of cytosolic phospholipase A(2) (cPLA(2)). Phosphorylated and activated cPLA(2) releases arachidonic acid from the phospholipid pool. Overproduction of arachidonic acid suppresses the activation of LXR/RXR heterodimers bound to the promoter of LXR regulated genes such as ABCA1, resulting in greatly reduced ABCA1 expression. Conclusions and Significance: LRP1 regulates LXR-mediated gene transcription and participates in reverse cholesterol transport by controlling cPLA(2) activation and ABCA1 expression. LRP1 thus functions as a physiological integrator of cellular lipid homeostasis with signals that regulate cellular proliferation and vascular wall integrity.			Zhou, L (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	joachim.herz@utsouthwestern.edu	黎, 伟/GXM-4040-2022; li, wj/HGD-7322-2022		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063762, R37HL063762, P01HL020948] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL63762, P01 HL020948, HL20948, R37 HL063762, R01 HL063762] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brunham LR, 2009, ARTERIOSCL THROM VAS, V29, P548, DOI 10.1161/ATVBAHA.108.182303; Choi HY, 2003, J BIOL CHEM, V278, P32569, DOI 10.1074/jbc.M304553200; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Clarke F. H., 1995, J CONVEX ANAL, V2, P117; Costet P, 2000, J BIOL CHEM, V275, P28240; DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477; FRANCIS GA, 1995, J CLIN INVEST, V96, P78, DOI 10.1172/JCI118082; Gijon MA, 1997, SEMIN CELL DEV BIOL, V8, P297, DOI 10.1006/scdb.1997.0151; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; Guyton JR, 1996, ARTERIOSCL THROM VAS, V16, P4, DOI 10.1161/01.ATV.16.1.4; HERZ J, 1995, P NATL ACAD SCI USA, V92, P4611, DOI 10.1073/pnas.92.10.4611; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; HOFMANN SM, 2007, J CLIN INVEST; Joyce CW, 2002, P NATL ACAD SCI USA, V99, P407, DOI 10.1073/pnas.012587699; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; KOWAL RC, 1990, J BIOL CHEM, V265, P10771; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; LIN LL, 1992, P NATL ACAD SCI USA, V89, P6147, DOI 10.1073/pnas.89.13.6147; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Newton CS, 2005, J BIOL CHEM, V280, P27872, DOI 10.1074/jbc.M505410200; Oram JF, 2002, CURR OPIN LIPIDOL, V13, P373, DOI 10.1097/00041433-200208000-00004; Oram JF, 2002, TRENDS MOL MED, V8, P168, DOI 10.1016/S1471-4914(02)02289-X; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Remaley AT, 2001, BIOCHEM BIOPH RES CO, V280, P818, DOI 10.1006/bbrc.2000.4219; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Santamarina-Fojo S, 2001, J LIPID RES, V42, P1339; Schmitz G, 2005, BBA-MOL CELL BIOL L, V1735, P1, DOI 10.1016/j.bbalip.2005.04.004; Schmitz G, 2001, CURR OPIN LIPIDOL, V12, P129, DOI 10.1097/00041433-200104000-00006; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Singaraja RR, 2001, J BIOL CHEM, V276, P33969, DOI 10.1074/jbc.M102503200; Srivastava N, 2002, MOL CELL BIOCHEM, V237, P155, DOI 10.1023/A:1016506221047; Takayama Y, 2005, J BIOL CHEM, V280, P18504, DOI 10.1074/jbc.M410265200; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Xu F, 2005, P NATL ACAD SCI USA, V102, P14551, DOI 10.1073/pnas.0503590102; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; ZHOU YTL, 2009, LRP1 REGULATES UNPUB	49	32	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6853	10.1371/journal.pone.0006853	http://dx.doi.org/10.1371/journal.pone.0006853			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718435	Green Published, Green Submitted, gold			2022-12-25	WOS:000269415900022
J	Distler, U; Souady, J; Huelsewig, M; Drmic-Hofman, I; Haier, J; Friedrich, AW; Karch, H; Senninger, N; Dreisewerd, K; Berkenkamp, S; Schmidt, MA; Peter-Katalinic, J; Muthing, J				Distler, Ute; Souady, Jamal; Huelsewig, Marcel; Drmic-Hofman, Irena; Haier, Joerg; Friedrich, Alexander W.; Karch, Helge; Senninger, Norbert; Dreisewerd, Klaus; Berkenkamp, Stefan; Schmidt, M. Alexander; Peter-Katalinic, Jasna; Muething, Johannes			Shiga Toxin Receptor Gb3Cer/CD77: Tumor-Association and Promising Therapeutic Target in Pancreas and Colon Cancer	PLOS ONE			English	Article								Background: Despite progress in adjuvant chemotherapy in the recent decades, pancreatic and colon cancers remain common causes of death worldwide. Bacterial toxins, which specifically bind to cell surface-exposed glycosphingolipids, are a potential novel therapy. We determined the expression of globotriaosylceramide (Gb3Cer/CD77), the Shiga toxin receptor, in human pancreatic and colon adenocarcinomas. Methodology/Principal Findings: Tissue lipid extracts of matched pairs of cancerous and adjacent normal tissue from 21 pancreatic and 16 colon cancer patients were investigated with thin-layer chromatography overlay assay combined with a novel mass spectrometry approach. Gb3Cer/CD77 was localized by immunofluorescence microscopy of cryosections from malignant and corresponding healthy tissue samples. 62% of pancreatic and 81% of colon adenocarcinomas showed increased Gb3Cer/CD77 expression, whereas 38% and 19% of malignant pancreas and colon tissue, respectively, did not, indicating an association of this marker with neoplastic transformation. Also, Gb3Cer/CD77 was associated with poor differentiation (G>2) in pancreatic cancer (P = 0.039). Mass spectrometric analysis evidenced enhanced expression of Gb3Cer/CD77 with long (C24) and short chain fatty acids (C16) in malignant tissues and pointed to the presence of hydroxylated fatty acid lipoforms, which are proposed to be important for receptor targeting. They could be detected in 86% of pancreatic and about 19% of colon adenocarcinomas. Immunohistology of tissue cryosections indicated tumor-association of these receptors. Conclusions/Significance: Enhanced expression of Gb3Cer/CD77 in most pancreatic and colon adenocarcinomas prompts consideration of Shiga toxin, its B-subunit or B-subunit-derivatives as novel therapeutic strategies for the treatment of these challenging malignancies.			Distler, U (corresponding author), Univ Munster, Inst Hyg, Munster, Germany.	jm@uni-muenster.de	Friedrich, Alex/ABG-9823-2020; Drmic Hofman, Irena/D-5026-2017; Dreisewerd, Klaus/K-3884-2015	Drmic Hofman, Irena/0000-0002-4986-9589; Dreisewerd, Klaus/0000-0002-7619-808X; Distler, Ute/0000-0002-8031-6384				Andre Thierry, 2004, Clin Colorectal Cancer, V4 Suppl 1, pS22; Bielaszewska M, 2006, CLIN INFECT DIS, V43, P1160, DOI 10.1086/508195; Binnington B, 2002, NEUROCHEM RES, V27, P807, DOI 10.1023/A:1020261125008; Chester MA, 1999, GLYCOCONJUGATE J, V16, P1; Chu KU, 2000, CANCER, V88, P1828, DOI 10.1002/(SICI)1097-0142(20000415)88:8<1828::AID-CNCR11>3.3.CO;2-6; Distler U, 2008, MOL CANCER THER, V7, P2464, DOI 10.1158/1535-7163.MCT-08-0353; Distler U, 2008, ANAL CHEM, V80, P1835, DOI 10.1021/ac702071x; Dobrindt U, 2005, INT J MED MICROBIOL, V295, P357, DOI 10.1016/j.ijmm.2005.07.009; Durrant LG, 2006, CANCER RES, V66, P5901, DOI 10.1158/0008-5472.CAN-05-3812; Falguieres T, 2008, MOL CANCER THER, V7, P2498, DOI 10.1158/1535-7163.MCT-08-0430; FARKASHIMSLEY H, 1995, P NATL ACAD SCI USA, V92, P6996, DOI 10.1073/pnas.92.15.6996; FEIZI T, 1985, NATURE, V314, P53, DOI 10.1038/314053a0; Fredman P, 2003, BIODRUGS, V17, P155, DOI 10.2165/00063030-200317030-00002; Gehrmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001925; Ghaneh P, 2007, GUT, V56, P1134, DOI 10.1136/gut.2006.103333; Hakomori S, 1996, CANCER RES, V56, P5309; HAKOMORI S, 1984, J BIOL CHEM, V259, P4672; Janssen KP, 2006, CANCER RES, V66, P7230, DOI 10.1158/0008-5472.CAN-06-0631; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Johannes L, 2005, GENE THER, V12, P1360, DOI 10.1038/sj.gt.3302557; Kannagi R, 2008, BBA-GEN SUBJECTS, V1780, P525, DOI 10.1016/j.bbagen.2007.10.007; Kaper JB, 2008, P NATL ACAD SCI USA, V105, P4535, DOI 10.1073/pnas.0801435105; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; KIARASH A, 1994, J BIOL CHEM, V269, P11138; Kiguchi K, 2006, CANCER SCI, V97, P1321, DOI 10.1111/j.1349-7006.2006.00326.x; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; Kovbasnjuk Olga, 2005, Gastroenterology, V129, P1354, DOI 10.1053/j.gastro.2005.08.032; LaCasse EC, 1999, BLOOD, V94, P2901; Lencer WI, 2005, BBA-MOL CELL RES, V1746, P314, DOI 10.1016/j.bbamcr.2005.07.007; Levery SB, 2005, METHOD ENZYMOL, V405, P300, DOI 10.1016/S0076-6879(05)05012-3; LEVERY SB, 1988, CARBOHYD RES, V178, P121, DOI 10.1016/0008-6215(88)80106-X; Lingwood CA, 1999, BIOSCIENCE REP, V19, P345, DOI 10.1023/A:1020299819637; Lingwood CA, 1996, TRENDS MICROBIOL, V4, P147, DOI 10.1016/0966-842X(96)10017-2; Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f; Meisen I, 2005, RAPID COMMUN MASS SP, V19, P3659, DOI 10.1002/rcm.2241; Miller-Podraza H, 2005, J BIOL CHEM, V280, P19695, DOI 10.1074/jbc.M412688200; Muthing J, 2009, THROMB HAEMOSTASIS, V101, P252, DOI 10.1160/TH08-05-0317; Muthing J, 2004, FASEB J, V18, P103, DOI 10.1096/fj.04-2494fje; Muthing J, 1999, GLYCOBIOLOGY, V9, P459, DOI 10.1093/glycob/9.5.459; Muthing J, 1998, METH MOL B, V76, P183; PETRIC M, 1987, FEMS MICROBIOL LETT, V41, P63; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Roque-Navarro L, 2008, MOL CANCER THER, V7, P2033, DOI 10.1158/1535-7163.MCT-08-0222; Salhia B, 2002, NEOPLASIA, V4, P304, DOI 10.1038/sj.neo.7900243; Sandvig K, 2001, TOXICON, V39, P1629, DOI 10.1016/S0041-0101(01)00150-7; Schweppe CH, 2008, GLYCOCONJUGATE J, V25, P291, DOI 10.1007/s10719-007-9091-7; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Smith DC, 2004, SEMIN CELL DEV BIOL, V15, P397, DOI 10.1016/j.semcdb.2004.03.005; SMITH HW, 1971, J MED MICROBIOL, V4, P301, DOI 10.1099/00222615-4-3-301; SOBIN LH, 2002, INT UNION CANC UICC, P272; Sonnino S, 2006, CHEM REV, V106, P2111, DOI 10.1021/cr0100446; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Thies A, 2008, BRIT J CANCER, V98, P106, DOI 10.1038/sj.bjc.6604106; Wilkinson N, 2008, GASTROENTEROL CLIN N, V37, P253, DOI 10.1016/j.gtc.2007.12.012; YANG HJ, 1971, J BIOL CHEM, V246, P1192; Yin J, 2006, CANCER RES, V66, P2937, DOI 10.1158/0008-5472.CAN-05-2615; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005	58	65	68	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2009	4	8							e6813	10.1371/journal.pone.0006813	http://dx.doi.org/10.1371/journal.pone.0006813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JG	19714252	Green Published, Green Submitted, gold			2022-12-25	WOS:000269415800003
J	Bacon, DJ; Tang, D; Salas, C; Roncal, N; Lucas, C; Gerena, L; Tapia, L; Llanos-Cuentas, AA; Garcia, C; Solari, L; Kyle, D; Magill, AJ				Bacon, David J.; Tang, Doug; Salas, Carola; Roncal, Norma; Lucas, Carmen; Gerena, Lucia; Tapia, Lorena; Alejandro Llanos-Cuentas, A.; Garcia, Coralith; Solari, Lelv; Kyle, Dennis; Magill, Alan J.			Effects of Point Mutations in Plasmodium falciparum Dihydrofolate Reductase and Dihydropterate Synthase Genes on Clinical Outcomes and In Vitro Susceptibility to Sulfadoxine and Pyrimethamine	PLOS ONE			English	Article								Background: Sulfadoxine-pyrimethamine was a common first line drug therapy to treat uncomplicated falciparum malaria, but increasing therapeutic failures associated with the development of significant levels of resistance worldwide has prompted change to alternative treatment regimes in many national malaria control programs. Methodology and Finding: We conducted an in vivo therapeutic efficacy trial of sulfadoxine-pyrimethamine at two locations in the Peruvian Amazon enrolling 99 patients of which, 86 patients completed the protocol specified 28 day follow up. Our objective was to correlate the presence of polymorphisms in P. falciparum dihydrofolate reductase and dihydropteroate synthase to in vitro parasite susceptibility to sulfadoxine and pyrimethamine and to in vivo treatment outcomes. Inhibitory concentration 50 values of isolates increased with numbers of mutations (single [108N], sextuplet [BR/51I/108N/164L and 437G/581G]) and septuplet (BR/51I/108N/164L and 437G/540E/581G) with geometric means of 76 nM (35-166 nM), 582 nM (49-6890-nM) and 4909 (3575-6741 nM) nM for sulfadoxine and 33 nM (22-51 nM), 81 nM (19-345 nM), and 215 nM (176-262 nM) for pyrimethamine. A single mutation present in the isolate obtained at the time of enrollment from either dihydrofolate reductase (164L) or dihydropteroate synthase (540E) predicted treatment failure as well as any other single gene alone or in combination. Patients with the dihydrofolate reductase 164L mutation were 3.6 times as likely to be treatment failures [failures 85.4% (164L) vs 23.7% (I164); relative risk = 3.61; 95% CI: 2.14-6.64] while patients with the dihydropteroate synthase 540E were 2.6 times as likely to fail treatment (96.7% (540E) vs 37.5% (K540); relative risk = 2.58; 95% CI: 1.88-3.73). Patients with both dihydrofolate reductase 164L and dihydropteroate synthase 540E mutations were 4.1 times as likely to be treatment failures [96.7% vs 23.7%; RR = 4.08; 95% CI: 2.45-7.46] compared to patients having both wild forms (I164 and K540). Conclusions: In this part of the Amazon basin, it may be possible to predict treatment failure with sulfadoxine-pyrimethamine equally well by determination of either of the single mutations dihydrofolate reductase 164L or dihydropteroate synthase 540E.			Bacon, DJ (corresponding author), Naval Med Res Ctr Detachment, Parasitol Program, Lima, Peru.	david.bacon@med.navy.mil	Solari, Lely/ABH-2674-2020	Solari, Lely/0000-0002-8041-8807; Llanos-Cuentas, Alejandro/0000-0002-7567-5534; Kyle, Dennis/0000-0002-0238-965X; Garcia, Coralith/0000-0002-7933-1843; Salas, Carola Janette/0000-0003-4122-9541				Ayala E, 2006, AM J TROP MED HYG, V74, P546, DOI 10.4269/ajtmh.2006.74.546; Barnes KI, 2006, CLIN PHARMACOL THER, V80, P582, DOI 10.1016/j.clpt.2006.08.016; Basco LK, 1999, AM J TROP MED HYG, V61, P802, DOI 10.4269/ajtmh.1999.61.802; Basco LK, 2003, AM J TROP MED HYG, V69, P174, DOI 10.4269/ajtmh.2003.69.174; BERENBAUM MC, 1978, J INFECT DIS, V137, P122, DOI 10.1093/infdis/137.2.122; Berzosa PJ, 2005, PARASITOL RES, V97, P287, DOI 10.1007/s00436-005-1424-5; Chenet SM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-93; Cortese JF, 2002, J INFECT DIS, V186, P999, DOI 10.1086/342946; Cortese JF, 1998, MOL BIOCHEM PARASIT, V94, P205, DOI 10.1016/S0166-6851(98)00075-9; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Djaman JA, 2007, ANN TROP MED PARASIT, V101, P103, DOI 10.1179/136485907X154584; Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010014; Durand S, 2007, AM J TROP MED HYG, V76, P614, DOI 10.4269/ajtmh.2007.76.614; Enevold A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-153; Francis D, 2006, J INFECT DIS, V193, P978, DOI 10.1086/500951; Gebru-Woldearegai T, 2005, AM J TROP MED HYG, V73, P1131, DOI 10.4269/ajtmh.2005.73.1131; Green MD, 1999, J CHROMATOGR B, V727, P159, DOI 10.1016/S0378-4347(99)00080-8; Hallett RL, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010015; Hoffman IF, 1999, AIDS, V13, P487, DOI 10.1097/00002030-199903110-00007; Johnson JD, 2007, ANTIMICROB AGENTS CH, V51, P1926, DOI 10.1128/AAC.01607-06; Juliano JJ, 2008, AM J TROP MED HYG, V78, P892, DOI 10.4269/ajtmh.2008.78.892; Kublin JG, 1998, LANCET, V351, P1629, DOI 10.1016/S0140-6736(98)24022-0; Le Bras J, 2003, FUND CLIN PHARMACOL, V17, P147, DOI 10.1046/j.1472-8206.2003.00164.x; Lee SA, 2006, J INFECT DIS, V193, P1160, DOI 10.1086/501473; Magill Alan J., 2004, Rev. Soc. Bras. Med. Trop., V37, P273, DOI 10.1590/S0037-86822004000300015; Marquino W, 2003, AM J TROP MED HYG, V68, P608, DOI 10.4269/ajtmh.2003.68.608; Marquino W, 2003, AM J TROP MED HYG, V68, P120, DOI 10.4269/ajtmh.2003.68.120; Mbugi EV, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-94; Mendez F, 2002, AM J EPIDEMIOL, V156, P230, DOI 10.1093/aje/kwf030; Mendez F, 2006, AM J TROP MED HYG, V75, P640, DOI 10.4269/ajtmh.2006.75.640; MILHOUS WK, 1985, ANTIMICROB AGENTS CH, V27, P525, DOI 10.1128/AAC.27.4.525; Mockenhaupt FP, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-42; Ndiaye D, 2005, TROP MED INT HEALTH, V10, P1176, DOI 10.1111/j.1365-3156.2005.01506.x; Nirmalan N, 2004, MOL BIOCHEM PARASIT, V136, P63, DOI 10.1016/j.molbiopara.2004.02.013; Noranate N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000139; Nsimba B, 2005, TROP MED INT HEALTH, V10, P1030, DOI 10.1111/j.1365-3156.2005.01490.x; Nzila A, 2005, TRENDS PARASITOL, V21, P292, DOI 10.1016/j.pt.2005.04.002; Nzila A, 2005, T ROY SOC TROP MED H, V99, P341, DOI 10.1016/j.trstmh.2004.07.002; ODUOLA AMJ, 1987, LANCET, V2, P1304, DOI 10.1016/S0140-6736(87)91195-0; Pattanapanyasat Kovit, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P64; Pearce R, 2005, MOL BIOL EVOL, V22, P1834, DOI 10.1093/molbev/msi177; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Schonfeld M, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-2; Sendagire H, 2005, ACTA TROP, V95, P172, DOI 10.1016/j.actatropica.2005.06.003; Sutherland CJ, 2002, AM J TROP MED HYG, V67, P578, DOI 10.4269/ajtmh.2002.67.578; TRAGER W, 1978, NATURE, V273, P621, DOI 10.1038/273621a0; Vasconcelos KF, 2000, MEM I OSWALDO CRUZ, V95, P721, DOI 10.1590/S0074-02762000000500020; *WHO, 2003, ASS MON AN DRUG EFF; *WHO, 1973, WHO TECH REP SER, V529, P30; Zhang K, 2002, SCIENCE, V296, P545, DOI 10.1126/science.1068274	52	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6762	10.1371/journal.pone.0006762	http://dx.doi.org/10.1371/journal.pone.0006762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707564	Green Published, Green Submitted, gold			2022-12-25	WOS:000269335000008
J	Berns, GS; Moore, S; Capra, CM				Berns, Gregory S.; Moore, Sara; Capra, C. Monica			Adolescent Engagement in Dangerous Behaviors Is Associated with Increased White Matter Maturity of Frontal Cortex	PLOS ONE			English	Article							RISK-TAKING; ORBITOFRONTAL CORTEX; COGNITIVE FUNCTIONS; BRAIN-DEVELOPMENT; AGE-DIFFERENCES; SELF-REPORT; MATURATION; CHILDHOOD; MICROSTRUCTURE; PERSPECTIVE	Background: Myelination of white matter in the brain continues throughout adolescence and early adulthood. This cortical immaturity has been suggested as a potential cause of dangerous and impulsive behaviors in adolescence. Methodology/Principal Findings: We tested this hypothesis in a group of healthy adolescents, age 12-18 (N = 91), who underwent diffusion tensor imaging (DTI) to delineate cortical white matter tracts. As a measure of real-world risk taking, participants completed the Adolescent Risk Questionnaire (ARQ) which measures engagement in dangerous activities. After adjusting for age-related changes in both DTI and ARQ, engagement in dangerous behaviors was found to be positively correlated with fractional anisotropy and negatively correlated with transverse diffusivity in frontal white matter tracts, indicative of increased myelination and/or density of fibers (ages 14-18, N = 60). Conclusions/Significance: The direction of correlation suggests that rather than having immature cortices, adolescents who engage in dangerous activities have frontal white matter tracts that are more adult in form than their more conservative peers.			Berns, GS (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.	gberns@emory.edu	Capra, C. Monica/H-6686-2017		NIDA NIH HHS [R01 DA20116, R01 DA020116, R01 DA020116-04, R01 DA016434] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020116, R01DA016434] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aharoni E, 2008, ANN NY ACAD SCI, V1124, P145, DOI 10.1196/annals.1440.007; American Bar Association, 2004, AD BRAIN DEV LEG CUL; ARNETT J, 1992, DEV REV, V12, P339, DOI 10.1016/0273-2297(92)90013-R; Ashtari M, 2007, NEUROIMAGE, V35, P501, DOI 10.1016/j.neuroimage.2006.10.047; Barry H, 1991, ADOLESCENCE ANTHR IN; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Boyer TW, 2006, DEV REV, V26, P291, DOI 10.1016/j.dr.2006.05.002; Brener ND, 2002, J ADOLESCENT HEALTH, V31, P336, DOI 10.1016/S1054-139X(02)00339-7; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Chumlea WC, 2003, PEDIATRICS, V111, P110, DOI 10.1542/peds.111.1.110; Cohen J., 2003, APPL MULTIPLE REGRES; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P1, DOI 10.1196/annals.1308.001; Deutsch GK, 2005, CORTEX, V41, P354, DOI 10.1016/S0010-9452(08)70272-7; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Eluvathingal TJ, 2007, CEREB CORTEX, V17, P2760, DOI 10.1093/cercor/bhm003; EPSTEIN R, 2007, SCI AM MIND      APR, P56; Eshel N, 2007, NEUROPSYCHOLOGIA, V45, P1270, DOI 10.1016/j.neuropsychologia.2006.10.004; Figner B, 2009, J EXP PSYCHOL LEARN, V35, P709, DOI 10.1037/a0014983; Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Galvan A, 2007, DEVELOPMENTAL SCI, V10, pF8, DOI 10.1111/j.1467-7687.2006.00579.x; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Gerrard M, 1996, HEALTH PSYCHOL, V15, P344, DOI 10.1037/0278-6133.15.5.344; Giedd JN, 2008, J ADOLESCENT HEALTH, V42, P335, DOI 10.1016/j.jadohealth.2008.01.007; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giorgio A, 2008, NEUROIMAGE, V39, P52, DOI 10.1016/j.neuroimage.2007.07.043; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldberg JH, 2002, HEALTH PSYCHOL, V21, P477, DOI 10.1037//0278-6133.21.5.477; Gullone E, 2000, J ADOLESCENT RES, V15, P231, DOI 10.1177/0743558400152003; LENROOT RK, 2007, HUMAN BRAIN MAPPING; Liston C, 2006, CEREB CORTEX, V16, P553, DOI 10.1093/cercor/bhj003; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; National Research Council, 2007, PREV TEEN MOT CRASH; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niogi SN, 2006, NEUROPSYCHOLOGIA, V44, P2178, DOI 10.1016/j.neuropsychologia.2006.01.011; OLSON EA, 2009, J COGNITIVE IN PRESS; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Qiu DQ, 2008, NEUROIMAGE, V41, P223, DOI 10.1016/j.neuroimage.2008.02.023; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; Smith S, 2008, NEUROIMAGE IN PRESS; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Snook L, 2007, NEUROIMAGE, V34, P243, DOI 10.1016/j.neuroimage.2006.07.021; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Steinberg L, 2008, DEV PSYCHOL, V44, P1764, DOI 10.1037/a0012955; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; Williams JM, 1999, J ADOLESCENCE, V22, P157, DOI 10.1006/jado.1998.0208; Williams RJ, 2005, SUBST USE MISUSE, V40, P299, DOI 10.1081/JA-200049327; Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002	55	69	72	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6773	10.1371/journal.pone.0006773	http://dx.doi.org/10.1371/journal.pone.0006773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	488FQ	19707512	Green Submitted, Green Published, gold			2022-12-25	WOS:000269335000018
J	Bohn, KM; Schmidt-French, B; Schwartz, C; Smotherman, M; Pollak, GD				Bohn, Kirsten M.; Schmidt-French, Barbara; Schwartz, Christine; Smotherman, Michael; Pollak, George D.			Versatility and Stereotypy of Free-Tailed Bat Songs	PLOS ONE			English	Article							BIRD SONG; SYNTAX; COMMUNICATION; CHIROPTERA; EVOLUTION; BEHAVIOR; CONTEXT	In mammals, complex songs are uncommon and few studies have examined song composition or the order of elements in songs, particularly with respect to regional and individual variation. In this study we examine how syllables and phrases are ordered and combined, ie "syntax'', of the song of Tadarida brasiliensis, the Brazilian free-tailed bat. Specifically, we test whether phrase and song composition differ among individuals and between two regions, we determine variability across renditions within individuals, and test whether phrases are randomly ordered and combined. We report three major findings. First, song phrases were highly stereotyped across two regions, so much so that some songs from the two colonies were almost indistinguishable. All males produced songs with the same four types of syllables and the same three types of phrases. Second, we found that although song construction was similar across regions, the number of syllables within phrases, and the number and order of phrases in songs varied greatly within and among individuals. Last, we determined that phrase order, although diverse, deviated from random models. We found broad scale phrase-order rules and certain higher order combinations that were highly preferred. We conclude that free-tailed bat songs are composed of highly stereotyped phrases hierarchically organized by a common set of syntactical rules. However, within global species-specific patterns, songs male free-tailed bats dynamically vary syllable number, phrase order, and phrase repetitions across song renditions.			Bohn, KM (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	kbohn@bio.tamu.edu		Bohn, Kirsten/0000-0002-8405-3833	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC007962] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC 20068, DC007962, R03 DC007962, R03 DC007962-02] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		[Anonymous], 2004, NEOLITHIC REVOLUTION; Baker MC, 2003, IBIS, V145, P465, DOI 10.1046/j.1474-919X.2003.00190.x; BALABAN E, 1988, P NATL ACAD SCI USA, V85, P3657, DOI 10.1073/pnas.85.10.3657; BECKER PH, 1982, ACOUSTIC COMMUNICATI; Behr O, 2004, BEHAV ECOL SOCIOBIOL, V56, P106, DOI 10.1007/s00265-004-0768-7; Behr O, 2006, BEHAV ECOL, V17, P810, DOI 10.1093/beheco/arl013; Bohn KM, 2008, J ACOUST SOC AM, V124, P1838, DOI 10.1121/1.2953314; Bradbury Jack W., 1998, pi; Catchpole C., 1995, BIRD SONG BIOL THEME; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Clarke E, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000073; Clucas BA, 2004, BEHAV ECOL SOCIOBIOL, V57, P187, DOI 10.1007/s00265-004-0847-9; Davidson SM, 2004, ANIM BEHAV, V67, P883, DOI 10.1016/j.anbehav.2003.06.016; FICKEN MS, 1994, CONDOR, V96, P70, DOI 10.2307/1369065; French B, 1998, SOUTHWEST NAT, V43, P484; HAILMAN JP, 1987, ETHOLOGY, V75, P62; HAILMAN JP, 1986, ANIM BEHAV, V34, P1899, DOI 10.1016/S0003-3472(86)80279-2; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; KANWAL JS, 1994, J ACOUST SOC AM, V96, P1229, DOI 10.1121/1.410273; Lollar A, 2002, CAPTIVE CARE MED REF; Marler P, 1999, DESIGN OF ANIMAL COMMUNICATION, P293; Marler P., 2004, NATURES MUSIC SCI BI; MITANI JC, 1989, BEHAVIOUR, V109, P20, DOI 10.1163/156853989X00141; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; Rusch KM, 1996, CONDOR, V98, P557, DOI 10.2307/1369568; Russell AL, 2005, MOL ECOL, V14, P2207, DOI 10.1111/j.1365-294X.2005.02552.x; SCHMIDLY DJ, 1977, TEX J SCI, V28, P127; Schwartz C, 2007, J COMP PHYSIOL A, V193, P853, DOI 10.1007/s00359-007-0237-7; SEARCY WA, 1986, ANNU REV ECOL SYST, V17, P507, DOI 10.1146/annurev.es.17.110186.002451; SIBLY RM, 1990, ANIM BEHAV, V39, P63, DOI 10.1016/S0003-3472(05)80726-2; Simmons A., 2003, ACOUSTIC COMMUNICATI; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Suzuki R, 2006, J ACOUST SOC AM, V119, P1849, DOI 10.1121/1.2161827; Wright TF, 2007, BEHAVIOUR, V144, P207, DOI 10.1163/156853907779947346	34	66	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6746	10.1371/journal.pone.0006746	http://dx.doi.org/10.1371/journal.pone.0006746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707550	Green Published, Green Submitted, gold			2022-12-25	WOS:000269278400013
J	Hakami, T; Jones, NC; Tolmacheva, EA; Gaudias, J; Chaumont, J; Salzberg, M; O'Brien, TJ; Pinault, D				Hakami, Tahir; Jones, Nigel C.; Tolmacheva, Elena A.; Gaudias, Julien; Chaumont, Joseph; Salzberg, Michael; O'Brien, Terence J.; Pinault, Didier			NMDA Receptor Hypofunction Leads to Generalized and Persistent Aberrant gamma Oscillations Independent of Hyperlocomotion and the State of Consciousness	PLOS ONE			English	Article							40 HZ; CEREBELLAR DYSFUNCTION; NETWORK OSCILLATIONS; NUCLEUS-ACCUMBENS; WORKING-MEMORY; IN-VIVO; KETAMINE; SCHIZOPHRENIA; NEURONS; MECHANISMS	Background: The psychotomimetics ketamine and MK-801, non-competitive NMDA receptor (NMDAr) antagonists, induce cognitive impairment and aggravate schizophrenia symptoms. In conscious rats, they produce an abnormal behavior associated with a peculiar brain state characterized by increased synchronization in ongoing gamma (30-80 Hz) oscillations in the frontoparietal (sensorimotor) electrocorticogram (ECoG). This study investigated whether NMDAr antagonists-induced aberrant gamma oscillations are correlated with locomotion and dependent on hyperlocomotion-related sensorimotor processing. This also implied to explore the contribution of intracortical and subcortical networks in the generation of these pathophysiological ECoG c oscillations. Methodology/Principal Findings: Quantitative locomotion data collected with a computer-assisted video tracking system in combination with ECoG revealed that ketamine and MK-801 induce highly correlated hyperlocomotion and aberrant gamma oscillations. This abnormal gamma hyperactivity was recorded over the frontal, parietal and occipital cortices. ECoG conducted under diverse consciousness states (with diverse anesthetics) revealed that NMDAr antagonists dramatically increase the power of basal gamma oscillations. Paired ECoG and intracortical local field potential recordings showed that the ECoG mainly reflects gamma oscillations recorded in underlying intracortical networks. In addition, multisite recordings revealed that NMDAr antagonists dramatically enhance the amount of ongoing gamma oscillations in multiple cortical and subcortical structures, including the prefrontal cortex, accumbens, amygdala, basalis, hippocampus, striatum and thalamus. Conclusions/Significance: NMDAr antagonists acutely produces, in the rodent CNS, generalized aberrant gamma oscillations, which are not dependent on hyperlocomotion-related brain state or conscious sensorimotor processing. These findings suggest that NMDAr hypofunction-related generalized gamma hypersynchronies represent an aberrant diffuse network noise, a potential electrophysiological correlate of a psychotic-like state. Such generalized noise might cause dysfunction of brain operations, including the impairments in cognition and sensorimotor integration seen in schizophrenia.			Hakami, T (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia.	pinault@unistra.fr	Jones, Nigel C/K-7773-2012; Pinault, Didier/H-7816-2016; Hakami, Tahir/GVT-1058-2022; O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021	Pinault, Didier/0000-0003-3807-4817; O'Brien, Terence/0000-0002-7198-8621; Jones, Nigel/0000-0002-1080-8439; Hakami, Tahir/0000-0002-1933-6044				Adler CM, 1998, BIOL PSYCHIAT, V43, P811, DOI 10.1016/S0006-3223(97)00556-8; Alonso A, 1996, EUR J NEUROSCI, V8, P169, DOI 10.1111/j.1460-9568.1996.tb01178.x; Baldeweg T, 1998, LANCET, V352, P620, DOI 10.1016/S0140-6736(05)79575-1; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Basar-Eroglu C, 2007, INT J PSYCHOPHYSIOL, V64, P39, DOI 10.1016/j.ijpsycho.2006.07.007; Bauer EP, 2007, J NEUROSCI, V27, P9369, DOI 10.1523/JNEUROSCI.2153-07.2007; Becker C, 2009, CONSCIOUS COGN, V18, P266, DOI 10.1016/j.concog.2008.05.001; Behrendt RP, 2003, CONSCIOUS COGN, V12, P413, DOI 10.1016/S1053-8100(03)00017-5; Buzsaki G., 2006, RHYTHMS BRAIN; Chrobak JJ, 2008, J NEUROSCI, V28, P4512, DOI 10.1523/JNEUROSCI.0742-07.2008; Cohen MX, 2009, J COGNITIVE NEUROSCI, V21, P875, DOI 10.1162/jocn.2009.21062; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Deshmukh A, 2002, SCHIZOPHR RES, V57, P281, DOI 10.1016/S0920-9964(01)00300-0; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Friston Karl J, 2002, World Psychiatry, V1, P66; Gonzalez-Burgos G, 2008, SCHIZOPHRENIA BULL, V34, P944, DOI 10.1093/schbul/sbn070; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Heinze A, 2008, HUM PSYCHOPHARM CLIN, V23, P549, DOI 10.1002/hup.960; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; Hetem LAB, 2000, PSYCHOPHARMACOLOGY, V152, P283, DOI 10.1007/s002130000511; Ho BC, 2004, BIOL PSYCHIAT, V55, P1146, DOI 10.1016/j.biopsych.2004.02.020; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Hunt MJ, 2006, BIOL PSYCHIAT, V60, P1206, DOI 10.1016/j.biopsych.2006.01.020; Imre G, 2006, BRAIN RES BULL, V69, P338, DOI 10.1016/j.brainresbull.2006.01.010; JANSEN KLR, 1993, BRIT MED J, V306, P601, DOI 10.1136/bmj.306.6878.601; Jasper H H, 1936, Science, V83, P259, DOI 10.1126/science.83.2150.259; Javitt DC, 2007, INT REV NEUROBIOL, V78, P69, DOI 10.1016/S0074-7742(06)78003-5; Jeon HJ, 2007, PSYCHIAT RES, V152, P155, DOI 10.1016/j.psychres.2006.09.001; JOLIOT M, 1994, P NATL ACAD SCI USA, V91, P11748, DOI 10.1073/pnas.91.24.11748; Kanahara N, 2008, PSYCHOPHARMACOLOGY, V198, P363, DOI 10.1007/s00213-008-1151-6; Kapur S, 2002, MOL PSYCHIATR, V7, P837, DOI 10.1038/sj.mp.4001093; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Lee GM, 2003, IEEE SPECTRUM, V40, P8; Lewis DA, 2008, AM J PSYCHIAT, V165, P1585, DOI 10.1176/appi.ajp.2008.08030395; Light GA, 2006, BIOL PSYCHIAT, V60, P1231, DOI 10.1016/j.biopsych.2006.03.055; LLINAS RR, 1991, P NATL ACAD SCI USA, V88, P897, DOI 10.1073/pnas.88.3.897; Ma JY, 2007, PSYCHOPHARMACOLOGY, V191, P961, DOI 10.1007/s00213-006-0667-x; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Masimore B, 2005, NEUROREPORT, V16, P2021, DOI 10.1097/00001756-200512190-00010; Moghaddam B, 2003, NEURON, V40, P881, DOI 10.1016/S0896-6273(03)00757-8; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Newcomer JW, 1999, NEUROPSYCHOPHARMACOL, V20, P106, DOI 10.1016/S0893-133X(98)00067-0; NUNEZ A, 1992, NEUROSCIENCE, V51, P7, DOI 10.1016/0306-4522(92)90464-D; Olney JW, 1999, J PSYCHIAT RES, V33, P523, DOI 10.1016/S0022-3956(99)00029-1; PANTEV C, 1991, P NATL ACAD SCI USA, V88, P8996, DOI 10.1073/pnas.88.20.8996; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Pinault D, 2001, NEUROSCIENCE, V105, P181, DOI 10.1016/S0306-4522(01)00182-8; PINAULT D, 1992, NEUROSCIENCE, V51, P245, DOI 10.1016/0306-4522(92)90312-P; Pinault D, 2008, BIOL PSYCHIAT, V63, P730, DOI 10.1016/j.biopsych.2007.10.006; Pitsikas N, 2008, NEUROSCIENCE, V154, P454, DOI 10.1016/j.neuroscience.2008.04.001; Ramanathan S, 2002, J NEUROSCI, V22, P8158; Razoux F, 2007, NEUROPSYCHOPHARMACOL, V32, P719, DOI 10.1038/sj.npp.1301057; REGAN D, 1986, VISION RES, V26, P1461, DOI 10.1016/0042-6989(86)90168-9; Roopun AK, 2008, SCHIZOPHRENIA BULL, V34, P962, DOI 10.1093/schbul/sbn059; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Rujescu D, 2006, BIOL PSYCHIAT, V59, P721, DOI 10.1016/j.biopsych.2005.08.029; Seeman P, 2005, SYNAPSE, V58, P275, DOI 10.1002/syn.20210; Serrano A, 2008, GLIA, V56, P1648, DOI 10.1002/glia.20717; Sheer DE., 1975, BEHAV BRAIN ELECT AC; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; Spencer KM, 2004, P NATL ACAD SCI USA, V101, P17288, DOI 10.1073/pnas.0406074101; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; STERIADE M, 1993, NEUROSCIENCE, V56, P1, DOI 10.1016/0306-4522(93)90556-U; Sullivan EV, 2004, AM J PSYCHIAT, V161, P751, DOI 10.1176/appi.ajp.161.4.751; Tomitaka S, 2000, EUR J NEUROSCI, V12, P1420, DOI 10.1046/j.1460-9568.2000.00018.x; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Vanderwolf CH, 2000, BRAIN RES, V855, P217, DOI 10.1016/S0006-8993(99)02351-3; WHITE PF, 1976, J PHARMACOL EXP THER, V196, P545; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Woo TUW, 2004, ARCH GEN PSYCHIAT, V61, P649, DOI 10.1001/archpsyc.61.7.649	73	168	169	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6755	10.1371/journal.pone.0006755	http://dx.doi.org/10.1371/journal.pone.0006755			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487MJ	19707548	Green Published, gold, Green Submitted			2022-12-25	WOS:000269278400020
J	Pawelczyk, E; Jordan, EK; Balakumaran, A; Chaudhry, A; Gormley, N; Smith, M; Lewis, BK; Childs, R; Robey, PG; Frank, JA				Pawelczyk, Edyta; Jordan, Elaine K.; Balakumaran, Arun; Chaudhry, Aneeka; Gormley, Nicole; Smith, Melissa; Lewis, Bobbi K.; Childs, Richard; Robey, Pamela G.; Frank, Joseph A.			In Vivo Transfer of Intracellular Labels from Locally Implanted Bone Marrow Stromal Cells to Resident Tissue Macrophages	PLOS ONE			English	Article								Intracellular labels such as dextran coated superparamagnetic iron oxide nanoparticles (SPION), bromodeoxyuridine (BrdU) or green fluorescent protein (GFP) are frequently used to study the fate of transplanted cells by in vivo magnetic resonance imaging or fluorescent microscopy. Bystander uptake of labeled cells by resident tissue macrophages (TM) can confound the interpretation of the presence of intracellular labels especially during direct implantation of cells, which can result in more than 70% cell death. In this study we determined the percentages of TM that took up SPION, BrdU or GFP from labeled bone marrow stromal cells (BMSCs) that were placed into areas of angiogenesis and inflammation in a mouse model known as Matrigel (TM) plaque perfusion assay. Cells recovered from digested plaques at various time points were analyzed by fluorescence microscopy and flow cytometry. The analysis of harvested plaques revealed 5% of BrdU(+), 5-10% of GFP(+) and 5-15% of dextran(+) macrophages. The transfer of the label was not dependent on cell dose or viability. Collectively, this study suggests that care should be taken to validate donor origin of cells using an independent marker by histology and to assess transplanted cells for TM markers prior to drawing conclusions about the in vivo behavior of transplanted cells.			Pawelczyk, E (corresponding author), NIH, Ctr Clin, Bethesda, MD 20892 USA.	pawelczyke@cc.nih.gov	Robey, Pamela Gehron/H-1429-2011; Frank, Joseph/W-2021-2019	Robey, Pamela Gehron/0000-0002-5316-5576; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002345, ZIAHL006090, Z01HL002345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000380] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090007] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); CLINICAL CENTER; Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Amsalem Y, 2007, CIRCULATION, V116, pI38, DOI 10.1161/CIRCULATIONAHA.106.680231; Anderson SA, 2005, BLOOD, V105, P420, DOI 10.1182/blood-2004-06-2222; Arai T, 2006, MAGN RESON MED, V55, P203, DOI 10.1002/mrm.20702; Arbab AS, 2006, STEM CELLS, V24, P671, DOI 10.1634/stemcells.2005-0017; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Arbab AS, 2004, HUM GENE THER, V15, P351, DOI 10.1089/104303404322959506; Bexell D, 2009, MOL THER, V17, P183, DOI 10.1038/mt.2008.229; Bianco P, 2006, METHOD ENZYMOL, V419, P117, DOI 10.1016/S0076-6879(06)19006-0; Bourrinet P, 2006, INVEST RADIOL, V41, P313, DOI 10.1097/01.rli.0000197669.80475.dd; Burns TC, 2006, STEM CELLS, V24, P1121, DOI 10.1634/stemcells.2005-0463; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Coyne TM, 2006, STEM CELLS, V24, P2483, DOI 10.1634/stemcells.2006-0174; Ebert SN, 2007, STEM CELLS, V25, P2936, DOI 10.1634/stemcells.2007-0216; Evgenov NV, 2006, DIABETES, V55, P2419, DOI 10.2337/db06-0484; Frank JA, 2004, CYTOTHERAPY, V6, P621, DOI 10.1080/14653240410005267-1; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Guzman R, 2008, J NEUROSCI RES, V86, P873, DOI 10.1002/jnr.21542; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Kondziolka D, 2004, CELL TRANSPLANT, V13, P749, DOI 10.3727/000000004783983350; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Lepore AC, 2006, EXP NEUROL, V201, P49, DOI 10.1016/j.expneurol.2006.03.032; Li Y, 2001, CELL TRANSPLANT, V10, P31; MCCONNELL SK, 1985, SCIENCE, V229, P1268, DOI 10.1126/science.4035355; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; Muldoon LL, 2005, NEUROSURGERY, V57, P785, DOI 10.1227/01.NEU.0000175731.25414.4c; Munoz-Elias G, 2004, J NEUROSCI, V24, P4585, DOI 10.1523/JNEUROSCI.5060-03.2004; Nasef A, 2008, REGEN MED, V3, P531, DOI 10.2217/17460751.3.4.531; Pawelczyk E, 2008, STEM CELLS, V26, P1366, DOI 10.1634/stemcells.2007-0707; Ren C, 2008, GENE THER, V15, P1446, DOI 10.1038/gt.2008.101; Rogers WJ, 2006, NAT CLIN PRACT CARD, V3, P554, DOI 10.1038/ncpcardio0659; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Shaked Y, 2005, CANCER CELL, V7, P101, DOI 10.1016/j.ccr.2004.11.023; Silvestre JS, 2003, CIRC RES, V93, P114, DOI 10.1161/01.RES.0000081594.21764.44; Spaeth E, 2008, GENE THER, V15, P730, DOI 10.1038/gt.2008.39; Stepanenko OV, 2008, CURR PROTEIN PEPT SC, V9, P338, DOI 10.2174/138920308785132668; Stuckey DJ, 2006, STEM CELLS, V24, P1968, DOI 10.1634/stemcells.2006-0074; Tallheden T, 2006, LIFE SCI, V79, P999, DOI 10.1016/j.lfs.2006.05.021; Tamarat R, 2002, LAB INVEST, V82, P747, DOI 10.1097/01.LAB.0000017372.76297.EB; Taupin P, 2007, REGEN MED, V2, P51, DOI 10.2217/17460751.2.1.51; Terrovitis J, 2008, CIRCULATION, V117, P1555, DOI 10.1161/CIRCULATIONAHA.107.732073; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; van den Bos EJ, 2006, EUR HEART J, V27, P1620, DOI 10.1093/eurheartj/ehl059; Winkler T, 2008, TISSUE ENG PT A, V14, P1149, DOI [10.1089/ten.tea.2007.0179, 10.1089/tea.2007.0179]	47	79	82	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6712	10.1371/journal.pone.0006712	http://dx.doi.org/10.1371/journal.pone.0006712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696933	Green Published, Green Submitted, gold			2022-12-25	WOS:000269267600004
J	Obrdlik, A; Louvet, E; Kukalev, A; Naschekin, D; Kiseleva, E; Fahrenkrog, B; Percipalle, P				Obrdlik, Ales; Louvet, Emilie; Kukalev, Alexander; Naschekin, Dmitri; Kiseleva, Elena; Fahrenkrog, Birthe; Percipalle, Piergiorgio			Nuclear myosin 1 is in complex with mature rRNA transcripts and associates with the nuclear pore basket	FASEB JOURNAL			English	Article						preribosomal subunits; NPC; rRNA nuclear export	POLYMERASE-I TRANSCRIPTION; CHAIN-LIKE POLYPEPTIDE; GENE-EXPRESSION; EXPORT; SUBUNITS; ACTIN; NUP153; TRANSPORT; NUCLEOLUS; MESSENGER	In rRNA biogenesis, nuclear myosin 1 (NM1) and actin synergize to activate rRNA gene transcription. Evidence that actin is in preribosomal subunits and NM1 may control rRNA biogenesis post-transcriptionally prompted us to investigate whether NM1 associates with and accompanies rRNA to nuclear pores (NPC). Ultracentrifugation on HeLa nucleolar extracts showed RNA-dependent NM1 coelution with preribosomal subunits. In RNA immunoprecipitations (RIPs), NM1 coprecipitated with pre-rRNAs and 18S, 5.8S, and 28S rRNAs, but failed to precipitate 5S rRNA and 7SL RNA. In isolated nuclei and living HeLa cells, NM1 or actin inhibition and selective alterations in actin polymerization impaired 36S pre-rRNA processing. Immunoelectron microscopy (IEM) on sections of manually isolated Xenopus oocyte nuclei showed NM1 localization at the NPC basket. Field emission scanning IEM on isolated nuclear envelopes and intranuclear content confirmed basket localization and showed that NM1 decorates actin-rich pore-linked filaments. Finally, RIP and successive RIPs ( reRIPs) on cross-linked HeLa cells demonstrated that NM1, CRM1, and Nup153 precipitate same 18S and 28S rRNAs but not 5S rRNA. We conclude that NM1 facilitates maturation and accompanies export-competent preribosomal subunits to the NPC, thus modulating export.-Obrdlik, A., Louvet, E., Kukalev, A., Naschekin, D., Kiseleva, E., Fahrenkrog, B., Percipalle, P. Nuclear myosin 1 is in complex with mature rRNA transcripts and associates with the nuclear pore basket. FASEB J. 24, 146-157 ( 2010). www.fasebj.org	[Obrdlik, Ales; Louvet, Emilie; Kukalev, Alexander; Naschekin, Dmitri; Percipalle, Piergiorgio] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Kiseleva, Elena] Russian Acad Sci, Inst Cytol & Genet, Novosibirsk 630090, Russia; [Fahrenkrog, Birthe] Univ Basel, Biozentrum, Basel, Switzerland	Karolinska Institutet; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; University of Basel	Percipalle, P (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Box 285, SE-17177 Stockholm, Sweden.	piergiorgio.percipalle@ki.se	Fahrenkrog, Birthe/D-5840-2011	Nashchekin, Dmitry/0000-0001-7372-0752; Fahrenkrog, Birthe/0000-0003-4080-9413; Kiseleva, Elena/0000-0001-6949-182X; Obrdlik, Ales/0000-0001-8499-3879	Swedish Research Council (Vetenskapsradet); Fondation pour la Recherche Medicale; Wenner-Gren Foundation; Wellcome Trust; Russian Foundation for Basic Research; Russian Academy of Sciences Molecular and Cellular Biology (MCB RAS) program	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Wenner-Gren Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences Molecular and Cellular Biology (MCB RAS) program(Russian Academy of Sciences)	This work was supported by grants from the Swedish Research Council (Vetenskapsradet) to P. P. E. L. received postdoctoral fellowships from the Fondation pour la Recherche Medicale and the Wenner-Gren Foundation. E. K. was supported with grants from the Wellcome Trust, the Russian Foundation for Basic Research, and the Russian Academy of Sciences Molecular and Cellular Biology (MCB RAS) program.	Ball JR, 2004, RNA, V10, P19, DOI 10.1261/rna.5109104; BASCHONG W, 1990, J ELECTRON MICR TECH, V14, P313, DOI 10.1002/jemt.1060140405; BERRIOS M, 1986, J CELL BIOL, V103, P711, DOI 10.1083/jcb.103.3.711; BERRIOS M, 1991, P NATL ACAD SCI USA, V88, P219, DOI 10.1073/pnas.88.1.219; Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200; Cisterna B, 2006, FASEB J, V20, P1901, DOI 10.1096/fj.05-5278fje; Cisterna B, 2009, HISTOCHEM CELL BIOL, V131, P743, DOI 10.1007/s00418-009-0583-3; Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Granneman S, 2005, CURR OPIN CELL BIOL, V17, P281, DOI 10.1016/j.ceb.2005.04.001; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Hase ME, 2001, MOL BIOL CELL, V12, P2433, DOI 10.1091/mbc.12.8.2433; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Hofmann WA, 2006, BIOCHEM CELL BIOL, V84, P418, DOI 10.1139/O06-069; Hofmann WA, 2009, J CELL SCI, V122, P636, DOI 10.1242/jcs.030205; Holaska JM, 2007, BIOCHEMISTRY-US, V46, P8897, DOI 10.1021/bi602636m; Johnson AW, 2002, TRENDS BIOCHEM SCI, V27, P580, DOI 10.1016/S0968-0004(02)02208-9; Kahle M, 2007, HISTOCHEM CELL BIOL, V127, P139, DOI 10.1007/s00418-006-0231-0; Kiseleva E, 2004, J CELL SCI, V117, P2481, DOI 10.1242/jcs.01098; Louvet E, 2009, INT REV CEL MOL BIO, V272, P107, DOI 10.1016/S1937-6448(08)01603-1; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Obrdlik A, 2008, MOL CELL BIOL, V28, P6342, DOI 10.1128/MCB.00766-08; OCHS RL, 1985, CHROMOSOMA, V92, P330, DOI 10.1007/BF00327463; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Orru S, 2007, MOL CELL PROTEOMICS, V6, P382, DOI 10.1074/mcp.M600156-MCP200; PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603; Pante N, 2000, J STRUCT BIOL, V129, P306, DOI 10.1006/jsbi.2000.4232; Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034; Pederson T, 2000, J CELL BIOL, V148, P1091, DOI 10.1083/jcb.148.6.1091; Percipalle P, 2006, EMBO REP, V7, P525, DOI 10.1038/sj.embor.7400657; Percipalle P, 2009, CELL MOL LIFE SCI, V66, P2151, DOI 10.1007/s00018-009-0012-8; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Politz JCR, 2003, MOL BIOL CELL, V14, P4805, DOI 10.1091/mbc.E03-06-0395; Rouquette J, 2005, EMBO J, V24, P2862, DOI 10.1038/sj.emboj.7600752; SCHINDLER M, 1986, J CELL BIOL, V102, P859, DOI 10.1083/jcb.102.3.859; Smythe C, 2000, EMBO J, V19, P3918, DOI 10.1093/emboj/19.15.3918; Soop T, 2005, MOL BIOL CELL, V16, P5610, DOI 10.1091/mbc.E05-08-0715; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; Thomas F, 2003, J CELL SCI, V116, P2409, DOI 10.1242/jcs.00464; Trotta CR, 2003, EMBO J, V22, P2841, DOI 10.1093/emboj/cdg249; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Ullman KS, 1999, MOL BIOL CELL, V10, P649, DOI 10.1091/mbc.10.3.649; Wilson DN, 2005, CRIT REV BIOCHEM MOL, V40, P243, DOI 10.1080/10409230500256523; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013	47	31	33	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					146	157		10.1096/fj.09-135863	http://dx.doi.org/10.1096/fj.09-135863			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19729515				2022-12-25	WOS:000273233600017
J	Chen, PI; Kong, C; Su, X; Stahl, PD				Chen, Pin-I; Kong, Chen; Su, Xiong; Stahl, Philip D.			Rab5 Isoforms Differentially Regulate the Trafficking and Degradation of Epidermal Growth Factor Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; SMALL GTPASE RAB5; EGF RECEPTOR; SIGNAL-TRANSDUCTION; ENDOCYTIC TRAFFICKING; ENDOSOMAL COMPARTMENT; MEDIATED ENDOCYTOSIS; CELL-MIGRATION; EFFECTOR EEA1; E-CADHERIN	Ligand-mediated endocytosis is an intricate regulatory mechanism for epidermal growth factor receptor (EGFR) signal transduction. Coordinated trafficking of EGFR ensures its temporal and spatial communication with downstream signaling effectors. We focused our work on Rab5, a monomeric GTPase shown to participate in early stages of the endocytic pathway. Rab5 has three isoforms (A, B, and C) sharing more than 90% of sequence identity. We individually ablated endogenous isoforms in HeLa cells with short interfering RNAs and examined the loss-of-function phenotypes. We found that suppression of Rab5A or 5B hampered the degradation of EGFR, whereas Rab5C depletion had very little effect. The differential delay of EGFR degradation also corresponds with retarded progression of EGFR from early to late endosomes. We investigated the activators/effectors of Rab5A that can potentially separate its potency in EGFR degradation from other isoforms and found that Rin1, a Rab5 exchange factor, preferably associated with Rab5A. Moreover, Rab5A activation is sensitive to EGF stimulation, and suppression of Rin1 diminished this sensitivity. Based on our results together with previous work showing that Rin1 interacts with signal transducing adapter molecule to facilitate the degradation of EGFR (Kong, C., Su, X., Chen, P. I., and Stahl, P. D. (2007) J. Biol. Chem. 282, 15294 - 15301), we hypothesize that the selective association of Rab5A and Rin1 contributes to the dominance of Rab5A in EGFR trafficking, whereas the other isoforms may have major functions unrelated to the EGFR degradation pathway.	[Chen, Pin-I; Kong, Chen; Su, Xiong; Stahl, Philip D.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Stahl, PD (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Campus Box 8228,660 S Euclid, St Louis, MO 63110 USA.	pstahl@wustl.edu	Stahl, Philip/D-6315-2012		National Institutes of Health [2R01GM42259]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01GM42259.	Alvarez-Dominguez C, 1998, J BIOL CHEM, V273, P33901, DOI 10.1074/jbc.273.51.33901; Alvarez-Dominguez C, 1999, J BIOL CHEM, V274, P11459, DOI 10.1074/jbc.274.17.11459; Arnett ALH, 2004, BRAIN RES, V1028, P59, DOI 10.1016/j.brainres.2004.08.064; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Barbieri MA, 2004, EUR J CELL BIOL, V83, P305, DOI 10.1078/0171-9335-00381; Barbieri MA, 2003, J BIOL CHEM, V278, P32027, DOI 10.1074/jbc.M304324200; Blaabjerg M, 2003, MOL BRAIN RES, V117, P196, DOI 10.1016/s0169-328X(03)00321-8; Bronfman FC, 2007, DEV NEUROBIOL, V67, P1183, DOI 10.1002/dneu.20513; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Burgdorf S, 2008, CURR OPIN IMMUNOL, V20, P89, DOI 10.1016/j.coi.2007.12.002; Carney DS, 2006, TRENDS CELL BIOL, V16, P27, DOI 10.1016/j.tcb.2005.11.001; Chiariello M, 1999, FEBS LETT, V453, P20, DOI 10.1016/S0014-5793(99)00686-9; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Dinneen JL, 2004, TRAFFIC, V5, P606, DOI 10.1111/j.1398-9219.2004.00204.x; Dinneen JL, 2004, EXP CELL RES, V294, P509, DOI 10.1016/j.yexcr.2003.12.006; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Gros-Louis F, 2003, ANN NEUROL, V53, P144, DOI 10.1002/ana.10422; Grovdal LM, 2004, EXP CELL RES, V300, P388, DOI 10.1016/j.yexcr.2004.07.003; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Gurkan C, 2005, MOL BIOL CELL, V16, P3847, DOI 10.1091/mbc.E05-01-0062; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Kajiho H, 2003, J CELL SCI, V116, P4159, DOI 10.1242/jcs.00718; Kimura T, 2006, J BIOL CHEM, V281, P10598, DOI 10.1074/jbc.M510531200; Kong C, 2007, J BIOL CHEM, V282, P15294, DOI 10.1074/jbc.M611538200; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mills IG, 2001, J CELL SCI, V114, P1959; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Satoh D, 2008, NAT CELL BIOL, V10, P1164, DOI 10.1038/ncb1776; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Spaargaren M, 1999, MOL BIOL CELL, V10, P3239, DOI 10.1091/mbc.10.10.3239; STOSCHECK CM, 1984, J CELL BIOL, V98, P1048, DOI 10.1083/jcb.98.3.1048; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Tear G, 2008, NAT CELL BIOL, V10, P1131, DOI 10.1038/ncb1008-1131; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Wainszelbaum MJ, 2006, EXP CELL RES, V312, P2238, DOI 10.1016/j.yexcr.2006.03.025; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777	54	75	77	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30328	30338		10.1074/jbc.M109.034546	http://dx.doi.org/10.1074/jbc.M109.034546			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19723633	hybrid, Green Published			2022-12-25	WOS:000271090000036
J	Pratto, F; Suzuki, Y; Takeyasu, K; Alonso, JC				Pratto, Florencia; Suzuki, Yuki; Takeyasu, Kunio; Alonso, Juan C.			Single-molecule Analysis of Protein.DNA Complexes Formed during Partition of Newly Replicated Plasmid Molecules in Streptococcus pyogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DNA SEGREGATION; PSM19035; GENES; ACTIN; MECHANISM; REPRESSOR; BINDING; SYSTEM; PARS	The Streptococcus pyogenes pSM19035 partition locus is ubiquitous among plasmids from vancomycin- or methicillin-resistant bacteria. An increasing understanding of this segregation system may highlight novel protein targets that could be blocked to curb bacterial proliferation. pSM19035 segregation depends on two homodimeric (delta(2) (ParA) and omega(2) (ParB)) proteins and six cis-acting centromeric noncurved parS sites. In the presence of ATP.Mg2+, delta(2) (delta.ATP.Mg2+)(2) binds DNA in a sequence-independent manner. Protein omega(2) binds with high affinity and cooperatively to B-form parS DNA. Atomic force microscopy experiments indicate that about 10 omega(2) molecules bind parS, consisting of 10 contiguous iterons. Protein (delta.ATP.Mg2+)(2), by interacting with the N terminus of omega(2) bound to parS, loses its association with DNA and relocalizes with omega(2).parS to form a ternary complex ((delta.ATP.Mg2+)(2).omega(2).parS) with the DNA remaining in straight B-form. Then, the interaction of two (delta.ATP.Mg2+)(2).omega(2).parS complexes via delta(2) promotes pairing of a plasmid subfraction. (delta D60A.ATP.Mg2+)(2), which binds but does not hydrolyze ATP, leads to accumulation of pairing intermediates, suggesting that ATP hydrolysis induces plasmid separation. We propose that the molar omega(2):delta(2) ratio regulates the different stages of pSM19035 segregation, pairing, and delta(2) polymerization, before cell division.	[Pratto, Florencia; Alonso, Juan C.] CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, E-28049 Madrid, Spain; [Suzuki, Yuki; Takeyasu, Kunio] Kyoto Univ, Grad Sch Biostudies, Lab Plasma Membrane & Nucl Signaling, Sakyo Ku, Kyoto 6068501, Japan	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Kyoto University	Alonso, JC (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, C Darwin 3, E-28049 Madrid, Spain.	jcalonso@cnb.csic.es	Alonso, Juan Carlos/D-2595-2009; Suzuki, Yuki/H-9950-2015	Alonso, Juan Carlos/0000-0002-5178-7179; Suzuki, Yuki/0000-0003-1848-0105; Pratto, Florencia/0000-0002-9678-8044	Ministerio de Ciencia e Innovacion [BFU2009-07167, CSD2007-00010]; Direccion General de Investigacion; Comunidad de Madrid [S-0505/-MAT0283]; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Direccion General de Investigacion(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants BFU2009-07167 and CSD2007-00010 from the Ministerio de Ciencia e Innovacion, Direccion General de Investigacion, and S-0505/-MAT0283 from Comunidad de Madrid (to J. C. A.) and Grant-in-aid for Priority Area from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K. T.).	Alonso JC, 1996, FEMS MICROBIOL LETT, V142, P1; BARRETT SD, 2008, IMAGE SXM VERSION 1; CEGLOWSKI P, 1994, GENE, V145, P33, DOI 10.1016/0378-1119(94)90319-0; CEGLOWSKI P, 1993, GENE, V136, P1, DOI 10.1016/0378-1119(93)90441-5; CEGLOWSKI P, 1993, MOL GEN GENET, V241, P579, DOI 10.1007/BF00279900; DAVIS MA, 1990, EMBO J, V9, P991, DOI 10.1002/j.1460-2075.1990.tb08201.x; de la Hoz AB, 2000, P NATL ACAD SCI USA, V97, P728, DOI 10.1073/pnas.97.2.728; de la Hoz AB, 2004, NUCLEIC ACIDS RES, V32, P3136, DOI 10.1093/nar/gkh633; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Edgar R, 2006, MOL MICROBIOL, V59, P276, DOI 10.1111/j.1365-2958.2005.04933.x; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Hizume K, 2005, BIOCHEMISTRY-US, V44, P12978, DOI 10.1021/bi050623v; Jensen RB, 1998, P NATL ACAD SCI USA, V95, P8550, DOI 10.1073/pnas.95.15.8550; Kim SK, 1999, P NATL ACAD SCI USA, V96, P8557, DOI 10.1073/pnas.96.15.8557; Leonard TA, 2005, PHILOS T R SOC B, V360, P523, DOI 10.1098/rstb.2004.1608; LYNCH AS, 1994, J MOL BIOL, V236, P679, DOI 10.1006/jmbi.1994.1179; LYNCH AS, 1995, P NATL ACAD SCI USA, V92, P1896, DOI 10.1073/pnas.92.6.1896; Margeat E, 1998, BIOPHYS J, V75, P2712, DOI 10.1016/S0006-3495(98)77715-X; Meinhart A, 2003, P NATL ACAD SCI USA, V100, P1661, DOI 10.1073/pnas.0434325100; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Moller-Jensen J, 2007, EMBO J, V26, P4413, DOI 10.1038/sj.emboj.7601864; Murayama K, 2001, J MOL BIOL, V314, P789, DOI 10.1006/jmbi.2001.5157; Nettikadan S, 1996, BIOCHEM BIOPH RES CO, V226, P645, DOI 10.1006/bbrc.1996.1409; Pietrasanta LI, 1999, P NATL ACAD SCI USA, V96, P3757, DOI 10.1073/pnas.96.7.3757; Pratto F, 2008, NUCLEIC ACIDS RES, V36, P3676, DOI 10.1093/nar/gkn170; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; Salje J, 2008, EMBO J, V27, P2230, DOI 10.1038/emboj.2008.152; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; Schumacher MA, 2008, BIOCHEM J, V412, P1, DOI 10.1042/BJ20080359; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Schumacher MA, 2007, CURR OPIN STRUC BIOL, V17, P103, DOI 10.1016/j.sbi.2006.11.005; Sherratt DJ, 2003, SCIENCE, V301, P780, DOI 10.1126/science.1084780; Thanbichler M, 2008, NAT REV MICROBIOL, V6, P28, DOI 10.1038/nrmicro1795; VESENKA J, 1992, ULTRAMICROSCOPY, V42, P1243, DOI 10.1016/0304-3991(92)90430-R; Weihofen WA, 2006, NUCLEIC ACIDS RES, V34, P1450, DOI 10.1093/nar/gkl015; Welfle K, 2005, BIOL CHEM, V386, P881, DOI 10.1515/BC.2005.103; WYMAN C, 1995, EMBO J, V14, P117, DOI 10.1002/j.1460-2075.1995.tb06981.x	37	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30298	30306		10.1074/jbc.M109.035410	http://dx.doi.org/10.1074/jbc.M109.035410			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726689	Green Published, hybrid			2022-12-25	WOS:000271090000033
J	Guo, RT; Chong, YE; Guo, M; Yang, XL				Guo, Rey-Ting; Chong, Yeeting E.; Guo, Min; Yang, Xiang-Lei			Crystal Structures and Biochemical Analyses Suggest a Unique Mechanism and Role for Human Glycyl-tRNA Synthetase in Ap4A Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSYL-TRANSFER-RNA; MARIE-TOOTH-DISEASE; ZINC-DEPENDENT SYNTHESIS; ACTIVATED MAST-CELLS; ESCHERICHIA-COLI; DIADENOSINE 5',5'''-P1,P4-TETRAPHOSPHATE; THERMUS-THERMOPHILUS; RAT-LIVER; TETRAPHOSPHATE; POLYPHOSPHATES	Aminoacyl-tRNA synthetases catalyze the attachment of amino acids to their cognate tRNAs for protein synthesis. However, the aminoacylation reaction can be diverted to produce diadenosine tetraphosphate (Ap4A), a universal pleiotropic signaling molecule needed for cell regulation pathways. The only known mechanism for Ap4A production by a tRNA synthetase is through the aminoacylation reaction intermediate aminoacyl-AMP, thus making Ap4A synthesis amino acid-dependent. Here, we demonstrate a new mechanism for Ap4A synthesis. Crystal structures and biochemical analyses show that human glycyl-tRNA synthetase (GlyRS) produces Ap4A by direct condensation of two ATPs, independent of glycine concentration. Interestingly, whereas the first ATP-binding pocket is conserved for all class II tRNA synthetases, the second ATP pocket is formed by an insertion domain that is unique to GlyRS, suggesting that GlyRS is the only tRNA synthetase catalyzing direct Ap4A synthesis. A special role for GlyRS in Ap4A homeostasis is proposed.	[Yang, Xiang-Lei] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Yang, XL (corresponding author), Scripps Res Inst, Dept Mol Biol, BCC110,N Torrey Pines Rd, La Jolla, CA 92037 USA.	xlyang@scripps.edu	Chong, Yeeting/AAE-3792-2020; Yang, Xiang-Lei/AAR-7107-2020	Guo, Rey-Ting/0000-0003-2942-7246; Yang, Xiang-Lei/0000-0003-2554-084X	National Institutes of Health [CA092577]; NCI [GM015539, U54RR025204]; NATIONAL CANCER INSTITUTE [R01CA092577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015539, R37GM015539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA092577 from NCI and Grants GM015539 and U54RR025204.	Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Arnez JG, 1999, J MOL BIOL, V286, P1449, DOI 10.1006/jmbi.1999.2562; Barisic N, 2008, ANN HUM GENET, V72, P416, DOI 10.1111/j.1469-1809.2007.00412.x; Beebe K, 2007, ANAL BIOCHEM, V368, P111, DOI 10.1016/j.ab.2007.05.013; BELRHALI H, 1995, STRUCTURE, V3, P341, DOI 10.1016/S0969-2126(01)00166-6; BREVET A, 1982, J BIOL CHEM, V257, P4613; Brunger AT, 1998, CURR OPIN STRUC BIOL, V8, P606, DOI 10.1016/S0959-440X(98)80152-8; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Cader MZ, 2007, FEBS LETT, V581, P2959, DOI 10.1016/j.febslet.2007.05.046; CUSACK S, 1995, NAT STRUCT BIOL, V2, P824, DOI 10.1038/nsb1095-824; GOERLICH O, 1982, EUR J BIOCHEM, V126, P135, DOI 10.1111/j.1432-1033.1982.tb06757.x; Hausmann CD, 2008, FEMS MICROBIOL REV, V32, P705, DOI 10.1111/j.1574-6976.2008.00119.x; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Kisselev LL, 1998, FEBS LETT, V427, P157, DOI 10.1016/S0014-5793(98)00420-7; Ko YG, 2001, J BIOL CHEM, V276, P6030, DOI 10.1074/jbc.M006189200; Kovaleski BJ, 2006, J BIOL CHEM, V281, P19449, DOI 10.1074/jbc.M601189200; LED JJ, 1983, EUR J BIOCHEM, V136, P469, DOI 10.1111/j.1432-1033.1983.tb07765.x; Lee YN, 2005, MOL CELL BIOL, V25, P8904, DOI 10.1128/MCB.25.20.8904-8912.2005; Lee YN, 2004, IMMUNITY, V20, P145, DOI 10.1016/S1074-7613(04)00020-2; LOGAN DT, 1995, EMBO J, V14, P4156, DOI 10.1002/j.1460-2075.1995.tb00089.x; Martin F, 1998, FASEB J, V12, P1499, DOI 10.1096/fasebj.12.14.1499; Mazauric MH, 1998, EUR J BIOCHEM, V251, P744, DOI 10.1046/j.1432-1327.1998.2510744.x; McLennan AG, 2000, PHARMACOL THERAPEUT, V87, P73, DOI 10.1016/S0163-7258(00)00041-3; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miras-Portugal MT, 2003, J MEMBRANE BIOL, V194, P1, DOI 10.1007/s00232-003-2024-x; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; Nishimura A, 1997, GENES CELLS, V2, P401, DOI 10.1046/j.1365-2443.1997.1300328.x; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; PLATEAU P, 1982, BIOCHEMISTRY-US, V21, P5273, DOI 10.1021/bi00264a024; Roy H, 2009, MOL MICROBIOL, V71, P547, DOI 10.1111/j.1365-2958.2008.06563.x; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Schluter H, 1996, J AUTON PHARMACOL, V16, P357, DOI 10.1111/j.1474-8673.1996.tb00053.x; Sissler M, 2008, METHODS, V44, P176, DOI 10.1016/j.ymeth.2007.11.002; Tzima E, 2005, J BIOL CHEM, V280, P2405, DOI 10.1074/jbc.C400431200; VARSHAVSKY A, 1983, CELL, V34, P711, DOI 10.1016/0092-8674(83)90526-3; WAHAB SZ, 1985, J BIOL CHEM, V260, P2735; WAHAB SZ, 1985, J BIOL CHEM, V260, P5286; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wright M, 2006, FEBS J, V273, P3534, DOI 10.1111/j.1742-4658.2006.05361.x; Xie W, 2007, P NATL ACAD SCI USA, V104, P9976, DOI 10.1073/pnas.0703908104; Xie W, 2006, ACTA CRYSTALLOGR F, V62, P1243, DOI 10.1107/S1744309106046434; ZAMECNIK PC, 1966, BIOCHEM BIOPH RES CO, V24, P91, DOI 10.1016/0006-291X(66)90415-3	44	27	47	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28968	28976		10.1074/jbc.M109.030692	http://dx.doi.org/10.1074/jbc.M109.030692			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19710017	Green Published, hybrid			2022-12-25	WOS:000270678900054
J	Trevisson, E; Burlina, A; Doimo, M; Pertegato, V; Casarin, A; Cesaro, L; Navas, P; Basso, G; Sartori, G; Salviati, L				Trevisson, Eva; Burlina, Alberto; Doimo, Mara; Pertegato, Vanessa; Casarin, Alberto; Cesaro, Luca; Navas, Placido; Basso, Giuseppe; Sartori, Geppo; Salviati, Leonardo			Functional Complementation in Yeast Allows Molecular Characterization of Missense Argininosuccinate Lyase Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAGENIC COMPLEMENTATION; SACCHAROMYCES-CEREVISIAE; DEFICIENCY; GENE; IDENTIFICATION; METABOLISM; MODEL; SITE	Deficiency of argininosuccinate lyase (ASL) causes argininosuccinic aciduria, an urea cycle defect that may present with a severe neonatal onset form or with a late onset phenotype. To date phenotype-genotype correlations are still not clear because biochemical assays of ASL activity correlate poorly with clinical severity in patients. We employed a yeast-based functional complementation assay to assess the pathogenicity of 12 missense ASL mutations, to establish genotype-phenotype correlations, and to screen for intragenic complementation. Rather than determining ASL enzyme activity directly, we have measured the growth rate in arginine-free medium of a yeast ASL(null) strain transformed with individual mutant ASL alleles. Individual haploid strains were also mated to obtain diploid, "compound heterozygous" yeast. We show that the late onset phenotypes arise in patients because they harbor individual alleles retaining high residual enzymatic activity or because of intragenic complementation among different mutated alleles. In these cases complementation occurs because in the hybrid tetrameric enzyme at least one active site without mutations can be formed or because the differently mutated alleles can stabilize each other, resulting in partial recovery of enzymatic activity. Functional complementation in yeast is simple and reproducible and allows the analysis of large numbers of mutant alleles. Moreover, it can be easily adapted for the analysis of mutations in other genes involved in urea cycle disorders.	[Trevisson, Eva; Doimo, Mara; Pertegato, Vanessa; Casarin, Alberto; Salviati, Leonardo] Univ Padua, Dept Pediat, Clin Genet Unit, I-35128 Padua, Italy; [Trevisson, Eva; Doimo, Mara; Pertegato, Vanessa; Casarin, Alberto; Basso, Giuseppe; Salviati, Leonardo] Univ Padua, Dept Pediat, Pediat Oncol Lab, I-35128 Padua, Italy; [Burlina, Alberto] Univ Padua, Dept Pediat, Metab Disorders Unit, I-35128 Padua, Italy; [Cesaro, Luca; Sartori, Geppo] Univ Padua, Dept Biochem, I-35128 Padua, Italy; [Navas, Placido] Univ Pablo Olavide, CSIC, Inst Salud Carlos III, Ctr Andaluz Biol Desarrollo, Seville 41013, Spain; [Navas, Placido] Univ Pablo Olavide, CSIC, Inst Salud Carlos III, CIBERER, Seville 41013, Spain	University of Padua; University of Padua; University of Padua; University of Padua; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Salud Carlos III; Universidad Pablo de Olavide	Salviati, L (corresponding author), Univ Padua, Dept Pediat, Clin Genet Unit, Via Giustiniani 3, I-35128 Padua, Italy.	leonardo.salviati@unipd.it	burlina, alberto/AHE-6095-2022; NAVAS, PLACIDO/R-5943-2019; Salviati, Leonardo/L-1007-2016; Trevisson, Eva/K-8462-2016	NAVAS, PLACIDO/0000-0002-4115-7966; Salviati, Leonardo/0000-0001-5642-9963; Trevisson, Eva/0000-0002-5380-6265; BASSO, GIUSEPPE/0000-0002-2634-9302; Cesaro, Luca/0000-0002-6707-2282; Doimo, Mara/0000-0002-6771-5233	Telethon Italy [GGP06256]; Fondazione Citta della Speranza	Telethon Italy(Fondazione Telethon); Fondazione Citta della Speranza	This work was supported by Telethon Italy Grant GGP06256 and by Fondazione Citta della Speranza.	BARBOSA P, 1991, J BIOL CHEM, V266, P5286; BASTONE A, 1990, ANAL BIOCHEM, V191, P384, DOI 10.1016/0003-2697(90)90236-3; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Brusilow S., 2001, METABOLIC MOL BASES, V8th, P1909; BURKE D, 2000, METHODS YEAST GENETI, P113; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Kleijer WJ, 2002, J INHERIT METAB DIS, V25, P399, DOI 10.1023/A:1020108002877; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanpher B, 2006, NAT REV GENET, V7, P449, DOI 10.1038/nrg1880; Linnebank M, 2000, J INHERIT METAB DIS, V23, P308, DOI 10.1023/A:1005690005439; Linnebank M, 2002, HUM GENET, V111, P350, DOI 10.1007/s00439-002-0793-4; Lodi T, 2006, BIOCHEM BIOPH RES CO, V341, P810, DOI 10.1016/j.bbrc.2006.01.034; MCINNES RR, 1984, P NATL ACAD SCI-BIOL, V81, P4480, DOI 10.1073/pnas.81.14.4480; Mollet J, 2007, J CLIN INVEST, V117, P765, DOI 10.1172/JCI29089; Morillas M, 2002, J BIOL CHEM, V277, P11473, DOI 10.1074/jbc.M111628200; OBRIEN WE, 1986, P NATL ACAD SCI USA, V83, P7211, DOI 10.1073/pnas.83.19.7211; Sampaleanu LM, 2001, BIOCHEMISTRY-US, V40, P15570, DOI 10.1021/bi011525m; Trevisson E, 2007, HUM MUTAT, V28, P694, DOI 10.1002/humu.20498; Turner MA, 1997, P NATL ACAD SCI USA, V94, P9063, DOI 10.1073/pnas.94.17.9063; Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245; Walker DC, 1997, J BIOL CHEM, V272, P6777, DOI 10.1074/jbc.272.10.6777; WALKER DC, 1990, P NATL ACAD SCI USA, V87, P9625, DOI 10.1073/pnas.87.24.9625; Yu BM, 2004, J BIOL CHEM, V279, P40972, DOI 10.1074/jbc.M405300200	24	25	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28926	28934		10.1074/jbc.M109.050195	http://dx.doi.org/10.1074/jbc.M109.050195			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19703900	Green Published, hybrid			2022-12-25	WOS:000270678900049
J	Chanvorachote, P; Nimmannit, U; Lu, YJ; Talbott, S; Jiang, BH; Rojanasakul, Y				Chanvorachote, Pithi; Nimmannit, Ubonthip; Lu, Yongju; Talbott, Siera; Jiang, Bing-Hua; Rojanasakul, Yon			Nitric Oxide Regulates Lung Carcinoma Cell Anoikis through Inhibition of Ubiquitin-Proteasomal Degradation of Caveolin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; MEDIATED S-NITROSYLATION; TUMOR-SUPPRESSOR GENE; MAP KINASE CASCADE; PROSTATE-CANCER; SCAFFOLDING DOMAIN; TRANSFORMED-CELLS; INDUCED APOPTOSIS; SYNTHASE ACTIVITY; GROWTH-FACTOR	Anoikis, a detachment-induced apoptosis, is a principal mechanism of inhibition of tumor cell metastasis. Tumor cells can acquire anoikis resistance which is frequently observed in metastatic lung cancer. This phenomenon becomes an important obstacle of efficient cancer therapy. Recently, signaling mediators such as caveolin-1 (Cav-1) and nitric oxide (NO) have garnered attention in metastasis research; however, their role and the underlying mechanisms of metastasis regulation are largely unknown. Using human lung carcinoma H460 cells, we show that NO impairs the apoptotic function of the cells after detachment. The NO donors sodium nitroprusside and diethylenetriamine NONOate inhibit detachment-induced apoptosis, whereas the NO inhibitors aminoguanidine and 2-(4-carboxyphenyl) tetramethylimidazoline-1-oxyl-3-oxide promote this effect. Resistance to anoikis in H460 cells is mediated by Cav-1, which is significantly down-regulated after cell detachment through a non-transcriptional mechanism involving ubiquitin-proteasomal degradation. NO inhibits this down-regulation by interfering with Cav-1 ubiquitination through a process that involves protein S-nitrosylation, which prevents its proteasomal degradation and induction of anoikis by cell detachment. These findings indicate a novel pathway for NO regulation of Cav-1, which could be a key mechanism of anoikis resistance in tumor cells.	[Chanvorachote, Pithi] Chulalongkorn Univ, Dept Physiol, Bangkok 10330, Thailand; [Nimmannit, Ubonthip] Chulalongkorn Univ, Pharmaceut Technol Int Program, Bangkok 10330, Thailand; [Talbott, Siera; Jiang, Bing-Hua; Rojanasakul, Yon] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Lu, Yongju; Talbott, Siera; Rojanasakul, Yon] W Virginia Univ, Dept Pharmaceut Sci, Morgantown, WV 26506 USA	Chulalongkorn University; Chulalongkorn University; West Virginia University; West Virginia University	Chanvorachote, P (corresponding author), Chulalongkorn Univ, Dept Physiol, Bangkok 10330, Thailand.	pithi_chan@yahoo.com; yrojan@hsc.wvu.edu		chanvorachote, pithi/0000-0002-3103-3249; Jiang, Bing-Hua/0000-0003-4526-2031; Rojanasakul, Yon/0000-0002-8839-6462	National Institutes of Health [R01-HL076340]; Thailand Research Fund; Commission on Higher Education [MRG G5080134]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thailand Research Fund(Thailand Research Fund (TRF)); Commission on Higher Education; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL076340. This work was also supported by Thailand Research Fund and Commission on Higher Education (MRG G5080134).	Ambs S, 1998, BRIT J CANCER, V78, P233, DOI 10.1038/bjc.1998.470; Ambs S, 1998, CANCER RES, V58, P334; Antonova GN, 2007, AM J PHYSIOL-HEART C, V292, pH893, DOI 10.1152/ajpheart.00498.2006; ARIASDIAZ J, 1994, CANCER, V74, P1546, DOI 10.1002/1097-0142(19940901)74:5<1546::AID-CNCR2820740509>3.0.CO;2-F; Azad N, 2006, J BIOL CHEM, V281, P34124, DOI 10.1074/jbc.M602551200; Borutaite V, 2003, FREE RADICAL BIO MED, V35, P1457, DOI 10.1016/j.freeradbiomed.2003.08.003; Campbell L, 1999, BIOCHEM BIOPH RES CO, V262, P744, DOI 10.1006/bbrc.1999.1280; Chanvorachote P, 2005, J BIOL CHEM, V280, P42044, DOI 10.1074/jbc.M510080200; Chanvorachote P, 2006, CANCER RES, V66, P6353, DOI 10.1158/0008-5472.CAN-05-4533; Choi BM, 2003, FREE RADICAL BIO MED, V34, P1136, DOI 10.1016/S0891-5849(03)00064-9; COBBS CS, 1995, CANCER RES, V55, P727; Dimmeler S, 1999, CELL DEATH DIFFER, V6, P964, DOI 10.1038/sj.cdd.4400581; Engelman JA, 1998, FEBS LETT, V428, P205, DOI 10.1016/S0014-5793(98)00470-0; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; Fujimoto H, 1997, JPN J CANCER RES, V88, P1190, DOI 10.1111/j.1349-7006.1997.tb00348.x; Galbiati F, 2001, MOL BIOL CELL, V12, P2229, DOI 10.1091/mbc.12.8.2229; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; Heigold S, 2002, CARCINOGENESIS, V23, P929, DOI 10.1093/carcin/23.6.929; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Ho CC, 2002, AM J PATHOL, V161, P1647, DOI 10.1016/S0002-9440(10)64442-2; Hurlstone AFL, 1999, ONCOGENE, V18, P1881, DOI 10.1038/sj.onc.1202491; Iyer AKV, 2008, NITRIC OXIDE-BIOL CH, V19, P146, DOI 10.1016/j.niox.2008.04.019; JENKINS DC, 1995, P NATL ACAD SCI USA, V92, P4392, DOI 10.1073/pnas.92.10.4392; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; KOLESKE AJ, 1995, P NATL ACAD SCI USA, V92, P1381, DOI 10.1073/pnas.92.5.1381; Lala PK, 2001, LANCET ONCOL, V2, P149, DOI 10.1016/S1470-2045(00)00256-4; Lee SW, 1998, ONCOGENE, V16, P1391, DOI 10.1038/sj.onc.1201661; Li JR, 1997, BIOCHEM BIOPH RES CO, V240, P419, DOI 10.1006/bbrc.1997.7672; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Li LK, 2001, CANCER RES, V61, P4386; Liu CY, 1998, BRIT J CANCER, V78, P534, DOI 10.1038/bjc.1998.528; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mikol DD, 1999, GLIA, V27, P39; Mocellin S, 2007, MED RES REV, V27, P317, DOI 10.1002/med.20092; Monteiro HP, 2004, NITRIC OXIDE-BIOL CH, V10, P1, DOI 10.1016/j.niox.2004.02.002; Moon KH, 2005, FEBS LETT, V579, P6115, DOI 10.1016/j.febslet.2005.09.082; Park SW, 2003, INT J CANCER, V107, P729, DOI 10.1002/ijc.11498; Racine C, 1999, BIOCHEM BIOPH RES CO, V255, P580, DOI 10.1006/bbrc.1999.0236; Ravid D, 2005, ONCOGENE, V24, P1338, DOI 10.1038/sj.onc.1208337; Razani B, 2001, BIOCHEM SOC T, V29, P494, DOI 10.1042/BST0290494; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Ryu SD, 2004, LIFE SCI, V75, P2559, DOI 10.1016/j.lfs.2004.05.018; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; Shack S, 2003, MOL CELL BIOL, V23, P2407, DOI 10.1128/MCB.23.7.2407-2414.2003; Souici AC, 2000, CARCINOGENESIS, V21, P281, DOI 10.1093/carcin/21.2.281; Thompson TC, 1998, CANCER METAST REV, V17, P439, DOI 10.1023/A:1006110326366; THOMSEN LL, 1995, BRIT J CANCER, V72, P41, DOI 10.1038/bjc.1995.274; Timme TL, 2000, ONCOGENE, V19, P3256, DOI 10.1038/sj.onc.1203654; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Williams TM, 2004, J BIOL CHEM, V279, P24745, DOI 10.1074/jbc.M402064200; Xu L, 2008, J BIOL CHEM, V283, P3077, DOI 10.1074/jbc.M705709200; Yang G, 1998, CLIN CANCER RES, V4, P1873; Zundel W, 2000, MOL CELL BIOL, V20, P1507, DOI 10.1128/MCB.20.5.1507-1514.2000	55	47	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28476	28484		10.1074/jbc.M109.050864	http://dx.doi.org/10.1074/jbc.M109.050864			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19706615	Green Published, hybrid			2022-12-25	WOS:000270676300072
J	Sorensen, RB; Berge-Hansen, L; Junker, N; Hansen, CA; Hadrup, SR; Schumacher, TNM; Svane, IM; Becker, JC; Straten, PT; Andersen, MH				Sorensen, Rikke Baek; Berge-Hansen, Linda; Junker, Niels; Hansen, Christina Aaen; Hadrup, Sine Reker; Schumacher, Ton N. M.; Svane, Inge Marie; Becker, Juergen C.; Straten, Per Thor; Andersen, Mads Hald			The Immune System Strikes Back: Cellular Immune Responses against Indoleamine 2,3-dioxygenase	PLOS ONE			English	Article								Background: The enzyme indoleamine 2,3-dioxygenase (IDO) exerts an well established immunosuppressive function in cancer. IDO is expressed within the tumor itself as well as in antigen-presenting cells in tumor-draining lymph nodes, where it promotes the establishment of peripheral immune tolerance to tumor antigens. In the present study, we tested the notion whether IDO itself may be subject to immune responses. Methods and Findings: The presence of naturally occurring IDO-specific CD8 T cells in cancer patients was determined by MHC/peptide stainings as well as ELISPOT. Antigen specific cytotoxic T lymphocytes (CTL) from the peripheral blood of cancer patients were cloned and expanded. The functional capacity of the established CTL clones was examined by chrome release assays. The study unveiled spontaneous cytotoxic T-cell reactivity against IDO in peripheral blood as well as in the tumor microenvironment of different cancer patients. We demonstrate that these IDO reactive T cells are indeed peptide specific, cytotoxic effector cells. Hence, IDO reactive T cells are able to recognize and kill tumor cells including directly isolated AML blasts as well as IDO-expressing dendritic cells, i.e. one of the major immune suppressive cell populations. Conclusion: IDO may serve as an important and widely applicable target for anti-cancer immunotherapeutic strategies. Furthermore, as emerging evidence suggests that IDO constitutes a significant counter-regulatory mechanism induced by pro-inflammatory signals, IDO-based immunotherapy holds the promise to boost anti-cancer immunotherapy in general.			Sorensen, RB (corresponding author), Herlev Univ Hosp, Dept Hematol, CCIT, DK-2730 Herlev, Denmark.	mahaan01@heh.regionh.dk	Schumacher, Ton/Y-2432-2019; Junker, Niels/M-8683-2018; Hadrup, Sine Reker/P-3388-2014	Schumacher, Ton/0000-0003-0517-8804; Hadrup, Sine Reker/0000-0002-5937-4344; Svane, Inge Marie/0000-0002-9451-6037; thor Straten, Per/0000-0002-4731-4969; Andersen, Mads Hald/0000-0002-2914-9605; Junker, Niels/0000-0001-8348-9363				Andersen MH, 2001, CANCER RES, V61, P869; Andersen MH, 2000, TISSUE ANTIGENS, V55, P519, DOI 10.1034/j.1399-0039.2000.550603.x; Andersen MH, 1999, TISSUE ANTIGENS, V54, P185, DOI 10.1034/j.1399-0039.1999.540210.x; Andersen MH, 1999, J IMMUNOL, V163, P3812; Baban B, 2005, INT IMMUNOL, V17, P909, DOI 10.1093/intimm/dxh271; Bauer TM, 2005, TRANSPL INT, V18, P95, DOI 10.1111/j.1432-2277.2004.00031.x; Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785; Chamuleau MED, 2008, HAEMATOL-HEMATOL J, V93, P1894, DOI 10.3324/haematol.13113; ELVIN J, 1991, EUR J IMMUNOL, V21, P2025, DOI 10.1002/eji.1830210909; Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8; Grohmann U, 2003, J EXP MED, V198, P153, DOI 10.1084/jem.20030633; Hayashi T, 2004, J CLIN INVEST, V114, P270, DOI 10.1172/JCI200421275; Herr W, 1999, P NATL ACAD SCI USA, V96, P12033, DOI 10.1073/pnas.96.21.12033; Keilholz U, 2002, J IMMUNOTHER, V25, P97, DOI 10.1097/00002371-200203000-00001; Kuball J, 2005, IMMUNITY, V22, P117, DOI 10.1016/j.immuni.2004.12.005; Kuball J, 2007, BLOOD, V109, P2331, DOI 10.1182/blood-2006-05-023069; Lee KH, 1998, J IMMUNOL, V161, P4183; LEHMANN F, 1995, EUR J IMMUNOL, V25, P340, DOI 10.1002/eji.1830250206; Lob S, 2008, BLOOD, V111, P2152, DOI 10.1182/blood-2007-10-116111; Lutsiak MEC, 2005, BLOOD, V105, P2862, DOI 10.1182/blood-2004-06-2410; McCutcheon M, 1997, J IMMUNOL METHODS, V210, P149, DOI 10.1016/S0022-1759(97)00182-8; Miki T, 2001, TRANSPLANT P, V33, P129, DOI 10.1016/S0041-1345(00)02792-5; Morgan RA, 2003, J IMMUNOL, V171, P3287, DOI 10.4049/jimmunol.171.6.3287; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Morris E, 2006, BLOOD REV, V20, P61, DOI 10.1016/j.blre.2005.05.001; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Nguyen XD, 2002, TRANSFUSION, V42, P428, DOI 10.1046/j.1525-1438.2002.00067.x; Okamoto A, 2005, CLIN CANCER RES, V11, P6030, DOI 10.1158/1078-0432.CCR-04-2671; Pawelec G, 2006, CANCER IMMUNOL IMMUN, V55, P623, DOI 10.1007/s00262-005-0117-3; Pawelec G, 1997, CRIT REV ONCOGENESIS, V8, P111, DOI 10.1615/CritRevOncog.v8.i2-3.10; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; POPOV A, 2007, J MOL MED; Rammensee HG, 1995, CURR BIOL, V5, P35, DOI DOI 10.1016/S0960-9822(95)00011-X; Riker A, 1999, SURGERY, V126, P112, DOI 10.1067/msy.1999.98739; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Scheibenbogen C, 2002, INT J CANCER, V98, P409, DOI 10.1002/ijc.10205; Scheler M, 2007, AM J PATHOL, V171, P1936, DOI 10.2353/ajpath.2007.070281; Schmidt SM, 2003, BLOOD, V102, P571, DOI 10.1182/blood-2002-08-2554; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Straten PT, 1999, J IMMUNOL, V163, P443; Thebault P, 2007, AM J TRANSPLANT, V7, P2472, DOI 10.1111/j.1600-6143.2007.01960.x; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Wang ZG, 1998, CANCER RES, V58, P2149; Weinlich G, 2007, DERMATOLOGY, V214, P8, DOI 10.1159/000096906; Wills MR, 2002, J IMMUNOL, V168, P5455, DOI 10.4049/jimmunol.168.11.5455; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	50	59	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2009	4	9							e6910	10.1371/journal.pone.0006910	http://dx.doi.org/10.1371/journal.pone.0006910			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZH	19738905	Green Published, gold, Green Submitted			2022-12-25	WOS:000269622300007
J	Michno, K; Knight, D; Campussano, JM; van de Hoef, D; Boulianne, GL				Michno, Kinga; Knight, David; Campussano, Jorge M.; van de Hoef, Diana; Boulianne, Gabrielle L.			Intracellular Calcium Deficits in Drosophila Cholinergic Neurons Expressing Wild Type or FAD-Mutant Presenilin	PLOS ONE			English	Article								Much of our current understanding about neurodegenerative diseases can be attributed to the study of inherited forms of these disorders. For example, mutations in the presenilin 1 and 2 genes have been linked to early onset familial forms of Alzheimer's disease ( FAD). Using the Drosophila central nervous system as a model we have investigated the role of presenilin in one of the earliest cellular defects associated with Alzheimer's disease, intracellular calcium deregulation. We show that expression of either wild type or FAD-mutant presenilin in Drosophila CNS neurons has no impact on resting calcium levels but does give rise to deficits in intracellular calcium stores. Furthermore, we show that a loss-of-function mutation in calmodulin, a key regulator of intracellular calcium, can suppress presenilin-induced deficits in calcium stores. Our data support a model whereby presenilin plays a role in regulating intracellular calcium stores and demonstrate that Drosophila can be used to study the link between presenilin and calcium deregulation.			Michno, K (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	gboul@sickkids.ca	Campusano, Jorge M/CAF-8833-2022; Campusano, Jorge M/A-1592-2014; Knight, David/U-4162-2017	Campusano, Jorge M/0000-0001-5254-8340; Campusano, Jorge M/0000-0001-5254-8340; 				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ahn EY, 2004, J BIOL CHEM, V279, P5661, DOI 10.1074/jbc.M311040200; Amtul Z, 2002, NEUROBIOL DIS, V9, P269, DOI 10.1006/nbdi.2001.0473; Balshaw DM, 2002, J MEMBRANE BIOL, V185, P1, DOI 10.1007/s00232-001-0111-4; Baumeister R, 1997, Genes Funct, V1, P149; Boulianne GL, 1997, NEUROREPORT, V8, P1025, DOI 10.1097/00001756-199703030-00041; Buxbaum JD, 1998, NAT MED, V4, P1177, DOI 10.1038/2673; Cai CX, 2006, J BIOL CHEM, V281, P16649, DOI 10.1074/jbc.M512026200; Campusano JM, 2007, DEV NEUROBIOL, V67, P1520, DOI 10.1002/dneu.20527; Chen Q, 2008, J NEUROSCI RES, V86, P1615, DOI 10.1002/jnr.21601; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; Dermaut B, 2004, ANN NEUROL, V55, P617, DOI 10.1002/ana.20083; Etcheberrigaray R, 1998, NEUROBIOL DIS, V5, P37, DOI 10.1006/nbdi.1998.0176; GEULA C, 1989, NEUROSCIENCE, V33, P469, DOI 10.1016/0306-4522(89)90399-0; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Guo YQ, 1999, J NEUROSCI, V19, P8435; Harvie PD, 1998, GENETICS, V149, P217; Hayrapetyan V, 2008, CELL CALCIUM, V44, P507, DOI 10.1016/j.ceca.2008.03.004; Heiman RG, 1996, P NATL ACAD SCI USA, V93, P2420, DOI 10.1073/pnas.93.6.2420; Kasri NN, 2006, CELL CALCIUM, V40, P41, DOI 10.1016/j.ceca.2006.03.005; Knight D, 2007, DEV NEUROBIOL, V67, P1598, DOI 10.1002/dneu.20532; Leissring MA, 2000, J CELL BIOL, V149, P793, DOI 10.1083/jcb.149.4.793; Leissring MA, 2001, NEUROBIOL DIS, V8, P469, DOI 10.1006/nbdi.2001.0382; Levitan D, 1996, P NATL ACAD SCI USA, V93, P14940, DOI 10.1073/pnas.93.25.14940; Li ZG, 2001, J BIOL CHEM, V276, P17354, DOI 10.1074/jbc.M010238200; Lu YS, 2007, FASEB J, V21, P2368, DOI 10.1096/fj.06-6380com; Maezawa I, 2002, PATHOL INT, V52, P551, DOI 10.1046/j.1440-1827.2002.01398.x; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; O'Day DH, 2004, BIOCHEM BIOPH RES CO, V320, P1051, DOI 10.1016/j.bbrc.2004.06.070; Pack-Chung E, 2000, J BIOL CHEM, V275, P14440, DOI 10.1074/jbc.M909882199; Periz G, 1999, EMBO J, V18, P5983, DOI 10.1093/emboj/18.21.5983; Raux G, 2000, NEUROLOGY, V55, P1577, DOI 10.1212/WNL.55.10.1577; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rybalchenko V, 2008, INT J BIOCHEM CELL B, V40, P84, DOI 10.1016/j.biocel.2007.06.023; Salvaterra Paul M., 2001, Gene Expression Patterns, V1, P73, DOI 10.1016/S1567-133X(01)00011-4; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Seidner GA, 2006, CURR BIOL, V16, P1026, DOI 10.1016/j.cub.2006.04.004; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sicaeros Beatriz, 2007, J Vis Exp, P200, DOI 10.3791/200; Smith IF, 2002, BRAIN RES, V949, P105, DOI 10.1016/S0006-8993(02)02970-0; Stabler SM, 1999, J CELL BIOL, V145, P1277, DOI 10.1083/jcb.145.6.1277; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Stull JT, 2001, J BIOL CHEM, V276, P2311, DOI 10.1074/jbc.R000030200; Stutzmann GE, 2007, ANN NY ACAD SCI, V1097, P265, DOI 10.1196/annals.1379.025; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; VANDEHOEF D, 2009, GENESIS IN PRESS; Wang B, 2003, GENETICS, V165, P1255; Ye YH, 1999, J CELL BIOL, V146, P1351, DOI 10.1083/jcb.146.6.1351; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Zatti G, 2004, NEUROBIOL DIS, V15, P269, DOI 10.1016/j.nbd.2003.11.002; Zatti G, 2006, CELL CALCIUM, V39, P539, DOI 10.1016/j.ceca.2006.03.002; Zhu JS, 2004, EXP CELL RES, V300, P440, DOI 10.1016/j.yexcr.2004.07.020	54	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2009	4	9							e6904	10.1371/journal.pone.0006904	http://dx.doi.org/10.1371/journal.pone.0006904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZF	19730737	Green Published, gold			2022-12-25	WOS:000269622100009
J	Ma, K; Xiao, R; Tseng, HT; Shan, L; Fu, LN; Moore, DD				Ma, Ke; Xiao, Rui; Tseng, Hsiu-Ting; Shan, Lu; Fu, Loning; Moore, David D.			Circadian Dysregulation Disrupts Bile Acid Homeostasis	PLOS ONE			English	Article							FARNESOID-X-RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; NEGATIVE FEEDBACK-REGULATION; NUCLEAR RECEPTOR; CHOLESTEROL 7-ALPHA-HYDROXYLASE; GENE-EXPRESSION; PERIPHERAL-TISSUES; LIVER; CLOCK; TRANSCRIPTION	Background: Bile acids are potentially toxic compounds and their levels of hepatic production, uptake and export are tightly regulated by many inputs, including circadian rhythm. We tested the impact of disrupting the peripheral circadian clock on integral steps of bile acid homeostasis. Methodology/Principal Findings: Both restricted feeding, which phase shifts peripheral clocks, and genetic ablation in Per1(-/-)/Per2(-/-) (PERDKO) mice disrupted normal bile acid control and resulted in hepatic cholestasis. Restricted feeding caused a dramatic, transient elevation in hepatic bile acid levels that was associated with activation of the xenobiotic receptors CAR and PXR and elevated serum aspartate aminotransferase (AST), indicative of liver damage. In the PERDKO mice, serum bile acid levels were elevated and the circadian expression of key bile acid synthesis and transport genes, including Cyp7A1 and NTCP, was lost. This was associated with blunted expression of a primary clock output, the transcription factor DBP, which transactivates the promoters of both genes. Conclusions/Significance: We conclude that disruption of the circadian clock results in dysregulation of bile acid homeostasis that mimics cholestatic disease.			Ma, K (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	moore@bcm.edu		Shan, Lu/0000-0003-2334-9216	NIDDK NIH HHS [R01 DK068804, DK068804] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068804] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alvarez L, 2004, HUM MOL GENET, V13, P2451, DOI 10.1093/hmg/ddh261; Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200; ANGELIN B, 1982, J CLIN INVEST, V70, P724, DOI 10.1172/JCI110668; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Challet E, 2003, BIOL CHEM, V384, P711, DOI 10.1515/BC.2003.079; Chiang JYL, 2004, J HEPATOL, V40, P539, DOI 10.1016/j.jhep.2003.11.006; CRESTANI M, 1995, J LIPID RES, V36, P2419; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; De Vree JML, 1998, P NATL ACAD SCI USA, V95, P282, DOI 10.1073/pnas.95.1.282; Denson LA, 2001, GASTROENTEROLOGY, V121, P140, DOI 10.1053/gast.2001.25503; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; EDWARDS PA, 1972, J LIPID RES, V13, P396; Eloranta JJ, 2006, MOL ENDOCRINOL, V20, P65, DOI 10.1210/me.2005-0159; Escobar C, 1998, AM J PHYSIOL-REG I, V274, pR1309, DOI 10.1152/ajpregu.1998.274.5.R1309; Gachon F, 2004, CHROMOSOMA, V113, P103, DOI 10.1007/s00412-004-0296-2; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; GIELEN J, 1975, EUR J BIOCHEM, V55, P41, DOI 10.1111/j.1432-1033.1975.tb02136.x; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Guo GL, 2003, J BIOL CHEM, V278, P45062, DOI 10.1074/jbc.M307145200; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; KAI MH, 1995, J LIPID RES, V36, P367; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5; Kudo T, 2008, AM J PHYSIOL-ENDOC M, V294, pE120, DOI 10.1152/ajpendo.00061.2007; Kullak-Ublick GA, 2004, GASTROENTEROLOGY, V126, P322, DOI 10.1053/j.gastro.2003.06.005; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; MITROPOULOS KA, 1976, BIOCHEM J, V160, P49, DOI 10.1042/bj1600049; MOOREEDE MC, 1985, ANNU REV MED, V36, P607, DOI 10.1146/annurev.me.36.020185.003135; Mukai M, 2002, DIGEST DIS SCI, V47, P549, DOI 10.1023/A:1017959801493; Nakamura K, 1998, IND HEALTH, V36, P218, DOI 10.2486/indhealth.36.218; NAKANO A, 1990, AM J PHYSIOL, V258, pG653, DOI 10.1152/ajpgi.1990.258.5.G653; Noshiro M, 2007, J BIOL RHYTHM, V22, P299, DOI 10.1177/0748730407302461; Oishi K, 2004, BIOCHEM BIOPH RES CO, V317, P330, DOI 10.1016/j.bbrc.2004.03.055; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; REEVES SL, 2004, NUTR FOOD SCI, V34, P5; Ripperger JA, 2000, GENE DEV, V14, P679; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Satoh Y, 2006, AM J PHYSIOL-REG I, V290, pR1276, DOI 10.1152/ajpregu.00775.2005; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; SHAPIRO DJ, 1971, J BIOL CHEM, V246, P3210; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Sorrentino P, 2005, DIGEST DIS SCI, V50, P1130, DOI 10.1007/s10620-005-2719-1; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; THIIS-EVENSEN E, 1958, Ind Med Surg, V27, P493; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; WUARIN J, 1992, J CELL SCI, P123; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zhang J, 2004, J BIOL CHEM, V279, P49517, DOI 10.1074/jbc.M409041200; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	62	85	89	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6843	10.1371/journal.pone.0006843	http://dx.doi.org/10.1371/journal.pone.0006843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718444	Green Submitted, Green Published, gold			2022-12-25	WOS:000269415900016
J	Lutgers, HL; Gerrits, EG; Sluiter, WJ; Ubink-Veltmaat, LJ; Landman, GWD; Links, TP; Gans, ROB; Smit, AJ; Bilo, HJG				Lutgers, Helen L.; Gerrits, Esther G.; Sluiter, Wim J.; Ubink-Veltmaat, Lielith J.; Landman, Gijs W. D.; Links, Thera P.; Gans, Reinold O. B.; Smit, Andries J.; Bilo, Henk J. G.			Life Expectancy in a Large Cohort of Type 2 Diabetes Patients Treated in Primary Care (ZODIAC-10)	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; CONTROLLED-TRIAL; MORTALITY; MELLITUS; POPULATION; FRAMINGHAM; OUTCOMES; TRENDS; ATORVASTATIN; PREVALENCE	Background: Most longitudinal studies showed increased relative mortality in individuals with type 2 diabetes mellitus until now. As a result of major changes in treatment regimes over the past years, with more stringent goals for metabolic control and cardiovascular risk management, improvement of life expectancy should be expected. In our study, we aimed to assess present-day life expectancy of type 2 diabetes patients in an ongoing cohort study. Methodology and Principal Findings: We included 973 primary care type 2 diabetes patients in a prospective cohort study, who were all participating in a shared care project in The Netherlands. Vital status was assessed from May 2001 till May 2007. Main outcome measurement was life expectancy assessed by transforming actual survival time to standardised survival time allowing adjustment for the baseline mortality rate of the general population. At baseline, mean age was 66 years, mean HbA(1c) 7.0%. During a median follow-up of 5.4 years, 165 patients died (78 from cardiovascular causes), and 17 patients were lost to follow-up. There were no differences in life expectancy in subjects with type 2 diabetes compared to life expectancy in the general population. In multivariate Cox regression analyses, concentrating on the endpoints 'all-cause' and cardiovascular mortality, a history of cardiovascular disease: hazard ratio (HR) 1.71 (95% confidence interval (CI) 1.23-2.37), and HR 2.59 (95% CI 1.56-4.28); and albuminuria: HR 1.72 (95% CI 1.26-2.35), and HR 1.83 (95% CI 1.17-2.89), respectively, were significant predictors, whereas smoking, HbA(1c), systolic blood pressure and diabetes duration were not. Conclusions: This study shows a normal life expectancy in a cohort of subjects with type 2 diabetes patients in primary care when compared to the general population. A history of cardiovascular disease and albuminuria, however, increased the risk of a reduction of life expectancy. These results show that, in a shared care environment, a normal life expectancy is achievable in type 2 diabetes patients.			Lutgers, HL (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9713 AV Groningen, Netherlands.	e.g.gerrits@isala.nl	Landman, Gijs/AAJ-5540-2021	Landman, Gijs/0000-0002-6852-6450; Gans, Reinold/0000-0001-5481-2387				Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Dale CA, 2008, BRIT MED J, V337, P1; Fox CS, 2007, CIRCULATION, V115, P1544, DOI 10.1161/CIRCULATIONAHA.106.658948; Fox CS, 2006, CIRCULATION, V113, P2914, DOI 10.1161/CIRCULATIONAHA.106.613828; Franco OH, 2007, ARCH INTERN MED, V167, P1145, DOI 10.1001/archinte.167.11.1145; Gregg EW, 2007, ANN INTERN MED, V147, P149, DOI 10.7326/0003-4819-147-3-200708070-00167; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Gu K, 1998, DIABETES CARE, V21, P1138, DOI 10.2337/diacare.21.7.1138; KANNEL WB, 1979, CIRCULATION, V59, P8, DOI 10.1161/01.CIR.59.1.8; Links TP, 2005, ENDOCR-RELAT CANCER, V12, P273, DOI 10.1677/erc.1.00892; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Lutgers HL, 2006, DIABETES CARE, V29, P2654, DOI 10.2337/dc05-2173; PANZRAM G, 1987, DIABETOLOGIA, V30, P123, DOI 10.1007/BF00274216; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Roper NA, 2002, DIABETES CARE, V25, P43, DOI 10.2337/diacare.25.1.43; Roper NA, 2001, BRIT MED J, V322, P1389, DOI 10.1136/bmj.322.7299.1389; Rutten G.E.H.M., 2006, HUIS WETEN, V49, P137; Sever PS, 2005, DIABETES CARE, V28, P1151, DOI 10.2337/diacare.28.5.1151; Tan HH, 2004, DIABETES CARE, V27, P2797, DOI 10.2337/diacare.27.12.2797; Tierney EF, 2004, DIABETES CARE, V27, P2723, DOI 10.2337/diacare.27.11.2723; Ubink-Veltmaat LJ, 2003, EUR J EPIDEMIOL, V18, P793, DOI 10.1023/A:1025369623365; Ubink-Vetmaat LJ, 2005, NETH J MED, V63, P103	23	50	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2009	4	8							e6817	10.1371/journal.pone.0006817	http://dx.doi.org/10.1371/journal.pone.0006817			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JG	19714245	Green Published, gold, Green Submitted			2022-12-25	WOS:000269415800007
J	Pang, YP; Ekstrom, F; Polsinelli, GA; Gao, Y; Rana, S; Hua, DH; Andersson, B; Andersson, PO; Peng, L; Singh, SK; Mishra, RK; Zhu, KY; Fallon, AM; Ragsdale, DW; Brimijoin, S				Pang, Yuan-Ping; Ekstrom, Fredrik; Polsinelli, Gregory A.; Gao, Yang; Rana, Sandeep; Hua, Duy H.; Andersson, Bjorn; Andersson, Per Ola; Peng, Lei; Singh, Sanjay K.; Mishra, Rajesh K.; Zhu, Kun Yan; Fallon, Ann M.; Ragsdale, David W.; Brimijoin, Stephen			Selective and Irreversible Inhibitors of Mosquito Acetylcholinesterases for Controlling Malaria and Other Mosquito-Borne Diseases	PLOS ONE			English	Article							INVERTEBRATE ACETYLCHOLINESTERASE; ORGANOPHOSPHATE RESISTANCE; SULFHYDRYL-REAGENTS; TORPEDO-CALIFORNICA; CRYSTAL-STRUCTURES; ALPHA-LACTALBUMIN; CHOLINESTERASE; GENE; INSENSITIVITY; INACTIVATION	New insecticides are urgently needed because resistance to current insecticides allows resurgence of disease-transmitting mosquitoes while concerns for human toxicity from current compounds are growing. We previously reported the finding of a free cysteine (Cys) residue at the entrance of the active site of acetylcholinesterase (AChE) in some insects but not in mammals, birds, and fish. These insects have two AChE genes (AP and AO), and only AP-AChE carries the Cys residue. Most of these insects are disease vectors such as the African malaria mosquito (Anopheles gambiae sensu stricto) or crop pests such as aphids. Recently we reported a Cys-targeting small molecule that irreversibly inhibited all AChE activity extracted from aphids while an identical exposure caused no effect on the human AChE. Full inhibition of AChE in aphids indicates that AP-AChE contributes most of the enzymatic activity and suggests that the Cys residue might serve as a target for developing better aphicides. It is therefore worth investigating whether the Cys-targeting strategy is applicable to mosquitocides. Herein, we report that, under conditions that spare the human AChE, a methanethiosulfonate-containing molecule at 6 mu M irreversibly inhibited 95% of the AChE activity extracted from An. gambiae s. str. and > 80% of the activity from the yellow fever mosquito (Aedes aegypti L.) or the northern house mosquito (Culex pipiens L.) that is a vector of St. Louis encephalitis. This type of inhibition is fast (similar to 30 min) and due to conjugation of the inhibitor to the active-site Cys of mosquito AP-AChE, according to our observed reactivation of the methanethiosulfonate-inhibited AChE by 2-mercaptoethanol. We also note that our sulfhydryl agents partially and irreversibly inhibited the human AChE after prolonged exposure (> 4 hr). This slow inhibition is due to partial enzyme denaturation by the inhibitor and/or micelles of the inhibitor, according to our studies using atomic force microscopy, circular dichroism spectroscopy, X-ray crystallography, time-resolved fluorescence spectroscopy, and liquid chromatography triple quadrupole mass spectrometry. These results support our view that the mosquito-specific Cys is a viable target for developing new mosquitocides to control disease vectors and to alleviate resistance problems with reduced toxicity toward non-target species.			Pang, YP (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	pang@mayo.edu; fredrik.ekstrom@foi.se; brimijoi@mayo.edu	Rana, Sandeep/N-1579-2019	Pang, Yuan-Ping/0000-0003-0838-2560; Zhu, Kun Yan/0000-0001-9372-8030	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070864] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI070864] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baek JH, 2005, PESTIC BIOCHEM PHYS, V81, P164, DOI 10.1016/j.pestbp.2004.12.003; Beier JC, 1998, ANNU REV ENTOMOL, V43, P519, DOI 10.1146/annurev.ento.43.1.519; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; BRIMIJOIN S, 1979, MOL PHARMACOL, V15, P641; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Carlier PR, 2008, CHEM-BIOL INTERACT, V175, P368, DOI 10.1016/j.cbi.2008.04.037; Ekstrom F, 2006, BIOCHEMISTRY-US, V45, P74, DOI 10.1021/bi051286t; Ekstrom FJ, 2007, CLIN PHARMACOL THER, V82, P282, DOI 10.1038/sj.clpt.6100151; Ekstrom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005957; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FIALKA JJ, 2006, WALL STREET J W 0525; FLEISHER JH, 1967, J PHARMACOL EXP THER, V156, P345; Frisch M J, 1999, GAUSSIAN 98 REVISION; Gao JR, 2002, PESTIC BIOCHEM PHYS, V73, P164, DOI 10.1016/S0048-3575(02)00105-0; Gao JR, 2002, INSECT BIOCHEM MOLEC, V32, P765, DOI 10.1016/S0965-1748(01)00159-X; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268; Hammond PI, 2003, J PHARMACOL EXP THER, V307, P190, DOI 10.1124/jpet.103.053405; Hong HS, 2009, J NEUROCHEM, V108, P1097, DOI 10.1111/j.1471-4159.2008.05866.x; Hornberg A, 2007, BIOCHEMISTRY-US, V46, P4815, DOI 10.1021/bi0621361; JOHNSON CD, 1975, ANAL BIOCHEM, V64, P229, DOI 10.1016/0003-2697(75)90423-6; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kono Y, 2006, PESTIC BIOCHEM PHYS, V85, P123, DOI 10.1016/j.pestbp.2005.12.002; KUWAJIMA K, 1990, BIOCHEMISTRY-US, V29, P8240, DOI 10.1021/bi00488a007; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mamiya A, 1997, APPL ENTOMOL ZOOL, V32, P37, DOI 10.1303/aez.32.37; Millard CB, 2003, PROTEIN SCI, V12, P2337, DOI 10.1110/ps.03110703; MONATH TP, 1987, AM J TROP MED HYG, V37, pS40, DOI 10.4269/ajtmh.1987.37.40S; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otzen DE, 2009, J COLLOID INTERF SCI, V329, P273, DOI 10.1016/j.jcis.2008.10.021; Pang YP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000058; Pang YP, 2007, BIOORG MED CHEM LETT, V17, P197, DOI 10.1016/j.bmcl.2006.09.073; Pang YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004349; Pezzementi Leo, 2006, Invertebrate Neuroscience, V6, P47, DOI 10.1007/s10158-006-0017-z; Ravelli RBG, 2000, STRUCTURE, V8, P315, DOI 10.1016/S0969-2126(00)00109-X; Raves ML, 1997, NAT STRUCT BIOL, V4, P57, DOI 10.1038/nsb0197-57; Rowland M, 2008, CHEM-BIOL INTERACT, V175, P73, DOI 10.1016/j.cbi.2008.02.006; Shin I, 1997, P NATL ACAD SCI USA, V94, P2848, DOI 10.1073/pnas.94.7.2848; Shin I, 2002, PROTEIN SCI, V11, P2022, DOI 10.1110/ps.0205102; SMITH DJ, 1974, J BIOL CHEM, V249, P3317; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; Viseu MI, 2007, BIOPHYS J, V93, P3601, DOI 10.1529/biophysj.106.101667; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Warr GG, 2000, CURR OPIN COLLOID IN, V5, P88, DOI 10.1016/S1359-0294(00)00038-8; Weik M, 2002, J SYNCHROTRON RADIAT, V9, P342, DOI 10.1107/S0909049502014589; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122; WILSON IB, 1962, J BIOL CHEM, V237, P1323	52	28	29	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2009	4	8							e6851	10.1371/journal.pone.0006851	http://dx.doi.org/10.1371/journal.pone.0006851			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JG	19714254	Green Published, Green Submitted, gold			2022-12-25	WOS:000269415800016
J	Christley, S; Nie, Q; Xie, XH				Christley, Scott; Nie, Qing; Xie, Xiaohui			Incorporating Existing Network Information into Gene Network Inference	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; REGULATORY NETWORKS; TRANSCRIPTIONAL NETWORK; COMPOUND-MODE; SELF-RENEWAL; MICROARRAY; GENERATION; INTEGRATION; SIMULATION; ALGORITHM	One methodology that has met success to infer gene networks from gene expression data is based upon ordinary differential equations (ODE). However new types of data continue to be produced, so it is worthwhile to investigate how to integrate these new data types into the inference procedure. One such data is physical interactions between transcription factors and the genes they regulate as measured by ChIP-chip or ChIP-seq experiments. These interactions can be incorporated into the gene network inference procedure as a priori network information. In this article, we extend the ODE methodology into a general optimization framework that incorporates existing network information in combination with regularization parameters that encourage network sparsity. We provide theoretical results proving convergence of the estimator for our method and show the corresponding probabilistic interpretation also converges. We demonstrate our method on simulated network data and show that existing network information improves performance, overcomes the lack of observations, and performs well even when some of the existing network information is incorrect. We further apply our method to the core regulatory network of embryonic stem cells utilizing predicted interactions from two studies as existing network information. We show that including the prior network information constructs a more closely representative regulatory network versus when no information is provided.			Christley, S (corresponding author), Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA.	scott.christley@uci.edu		Xie, Xiaohui/0000-0002-5479-6345	NIGMS NIH HHS [R01 GM67247, P50 GM76516, R01 GM075309, R01 GM067247, P50 GM076516, R01 GM75309] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516, R01GM075309, R01GM067247] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANERJEE O, 2006, ICML, P89, DOI DOI 10.1145/1143844.1143856; Bansal M, 2006, BIOINFORMATICS, V22, P815, DOI 10.1093/bioinformatics/btl003; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bonneau R, 2008, NAT CHEM BIOL, V4, P658, DOI 10.1038/nchembio.122; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen YL, 2007, PLOS COMPUT BIOL, V3, P602, DOI 10.1371/journal.pcbi.0030063; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman J., 2008, REGULARIZATION PATHS; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gilbert D, 2006, BRIEF BIOINFORM, V7, P339, DOI 10.1093/bib/bbl043; Gustafsson M, 2005, IEEE ACM T COMPUT BI, V2, P254, DOI 10.1109/TCBB.2005.35; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; KENNARD RW, 2000, RIDGE REGRESSION BIA, P80; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Li H, 2008, BIOINFORMATICS, V24, P1874, DOI 10.1093/bioinformatics/btn332; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Mardis ER, 2007, NAT METHODS, V4, P613, DOI 10.1038/nmeth0807-613; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mordelet F, 2008, BIOINFORMATICS, V24, pI76, DOI 10.1093/bioinformatics/btn273; Mukherjee S, 2008, P NATL ACAD SCI USA, V105, P14313, DOI 10.1073/pnas.0802272105; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tamada Y, 2003, BIOINFORMATICS, V19, pII227, DOI 10.1093/bioinformatics/btg1082; Tan K, 2008, GENOMICS, V91, P219, DOI 10.1016/j.ygeno.2007.11.005; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tseng P, 2001, J OPTIMIZ THEORY APP, V109, P475, DOI 10.1023/A:1017501703105; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396; Werhli Adriano V., 2008, Journal of Bioinformatics and Computational Biology, V6, P543, DOI 10.1142/S0219720008003539; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	51	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2009	4	8							e6799	10.1371/journal.pone.0006799	http://dx.doi.org/10.1371/journal.pone.0006799			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JE	19710931	Green Published, gold			2022-12-25	WOS:000269415600013
J	Leendertse, M; Willems, RJL; Giebelen, IAJ; Roelofs, JJTH; Top, J; Bonten, MJM; van der Poll, T				Leendertse, Masja; Willems, Rob J. L.; Giebelen, Ida A. J.; Roelofs, Joris J. T. H.; Top, Janetta; Bonten, Marc J. M.; van der Poll, Tom			Intestinal Colonization with Enterococcus faecium Does Not Influence Pulmonary Defense against Pseudomonas aeruginosa in Mice	PLOS ONE			English	Article							VANCOMYCIN-RESISTANT ENTEROCOCCUS; GASTROINTESTINAL-TRACT FLORA; IMMUNE FUNCTIONS; RISK-FACTORS; INFECTION; IMPAIRS; SF68; GUT; SUPPLEMENTATION; BACTERIA	Background: Enterococci, and especially multiresistant Enterococcus faecium, are increasingly found colonizing hospitalized patients. This increased prevalence of colonization is not only associated with an increased prevalence of infections caused by enterococci, but also by infections with other nosocomial pathogens. In this study we investigated the causality of this observed relationship, by determining the influence of intestinal colonization with E. faecium on pulmonary defense against Pseudomonas aeruginosa. Methodology/Principal Findings: Three groups of mice were tested; 2 groups of mice were pre-treated with vancomycin, of which one group was subsequently treated by oral gavage of vancomycin-resistant E. faecium (VRE). The third group did not receive any pre-treatment. P. aeruginosa pneumonia was induced in all mice. Vancomycin treatment resulted in intestinal gram-negative bacterial overgrowth and VRE treatment resulted in colonization throughout the intestines. All 3 groups of mice were able to clear P. aeruginosa from the lungs and circulation, with comparable lung cytokine responses and lung damage. Mice treated with vancomycin without VRE colonization displayed modestly increased plasma levels of TNF-alpha and IL-10. Conclusion: Overgrowth of E. faecium and/or gram-negative bacteria does not impact importantly on pulmonary defense against P. aeruginosa pneumonia.			Leendertse, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.leendertse@amc.uva.nl	Willems, Rob JL/E-3681-2010	Willems, Rob JL/0000-0002-7370-0812; Roelofs, Joris/0000-0001-9595-6571; Top, Janetta/0000-0002-4620-8128				Benyacoub J, 2003, J NUTR, V133, P1158, DOI 10.1093/jn/133.4.1158; Bonten M J, 2001, Lancet Infect Dis, V1, P314, DOI 10.1016/S1473-3099(01)00145-1; Bonten MJM, 1998, ARCH INTERN MED, V158, P1127, DOI 10.1001/archinte.158.10.1127; Caballero-Granado FJ, 2001, EUR J CLIN MICROBIOL, V20, P83, DOI 10.1007/s100960000429; de Regt MJA, 2008, J ANTIMICROB CHEMOTH, V62, P1401, DOI 10.1093/jac/dkn390; DEITCH EA, 1991, SURGERY, V109, P269; DEITCH EA, 1987, ARCH SURG-CHICAGO, V122, P1019; DiazGranados CA, 2005, J INFECT DIS, V191, P588, DOI 10.1086/427512; Donskey CJ, 2003, INFECT CONT HOSP EP, V24, P242, DOI 10.1086/502207; Guo WD, 2002, J TRAUMA, V52, P1178, DOI 10.1097/00005373-200206000-00026; Guo WD, 1995, AM J PHYSIOL-GASTR L, V269, pG827, DOI 10.1152/ajpgi.1995.269.6.G827; Harris AD, 2004, INFECT CONT HOSP EP, V25, P105, DOI 10.1086/502358; Isolauri E, 2001, AM J CLIN NUTR, V73, p444S, DOI 10.1093/ajcn/73.2.444s; LEENDERTSE M, 2009, J INFECT DIS; MARSHALL JC, 1988, SURGERY, V104, P404; MARSHALL JC, 1988, ARCH SURG-CHICAGO, V123, P1465; Munford RS, 2001, AM J RESP CRIT CARE, V163, P316, DOI 10.1164/ajrccm.163.2.2007102; Nieuwenhuijzen GAP, 1996, EUR J SURG, V162, P259; Ostendorf U, 2006, CURR OPIN INFECT DIS, V19, P327, DOI 10.1097/01.qco.0000235158.40184.28; Renckens R, 2008, CRIT CARE MED, V36, P580, DOI 10.1097/01.CCM.0B013E3181620652; Safdar N, 2002, ANN INTERN MED, V136, P834, DOI 10.7326/0003-4819-136-11-200206040-00013; Scharek L, 2005, VET IMMUNOL IMMUNOP, V105, P151, DOI 10.1016/j.vetimm.2004.12.022; Scharek L, 2007, ARCH ANIM NUTR, V61, P223, DOI 10.1080/17450390701431540; Schultz MJ, 2003, INFECT IMMUN, V71, P1630, DOI 10.1128/IAI.71.4.1630-1634.2003; Top J, 2007, CLIN MICROBIOL INFEC, V13, P316, DOI 10.1111/j.1469-0691.2006.01631.x; Top J, 2004, J CLIN MICROBIOL, V42, P4503, DOI 10.1128/JCM.42.10.4503-4511.2004; Treitman AN, 2005, J CLIN MICROBIOL, V43, P462, DOI 10.1128/JCM.43.1.462-463.2005; Veir JK, 2007, VET THER, V8, P229; Whitman MS, 1996, ANTIMICROB AGENTS CH, V40, P1526, DOI 10.1128/AAC.40.6.1526; Willems RJL, 2005, EMERG INFECT DIS, V11, P821, DOI 10.3201/1106.041204; INFECT CONTROL HOSP, V165, P105	31	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2009	4	8							e6775	10.1371/journal.pone.0006775	http://dx.doi.org/10.1371/journal.pone.0006775			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JE	19710930	Green Submitted, Green Published, gold			2022-12-25	WOS:000269415600003
J	Tan, J; Lu, J; Huang, W; Dong, ZX; Kong, CF; Li, L; Gao, LN; Guo, JH; Huang, BQ				Tan, Jiang; Lu, Jun; Huang, Wei; Dong, Zhixiong; Kong, Chenfei; Li, Lin; Gao, Lina; Guo, Jianhua; Huang, Baiqu			Genome-Wide Analysis of Histone H3 Lysine9 Modifications in Human Mesenchymal Stem Cell Osteogenic Differentiation	PLOS ONE			English	Article								Mesenchymal stem cells (MSCs) possess self-renewal and multi-lineage differentiation potentials. It has been established that epigenetic mechanisms such as histone modifications could be critical for determining the fate of stem cells. In this study, full human genome promoter microarrays and expression microarrays were used to explore the roles of histone modifications (H3K9Ac and H3K9Me2) upon the induction of MSC osteogenic differentiation. Our results revealed that the enrichment of H3K9Ac was decreased globally at the gene promoters, whereas the number of promoters enriched with H3K9Me2 was increased evidently upon osteogenic induction. By a combined analysis of data from both ChIP-on-chip and expression microarrays, a number of differentially expressed genes regulated by H3K9Ac and/or H3K9Me2 were identified, implicating their roles in several biological events, such as cell cycle withdraw and cytoskeleton reconstruction that were essential to differentiation process. In addition, our results showed that the vitamin D receptor played a trans-repression role via alternations of H3K9Ac and H3K9Me2 upon MSC osteogenic differentiation. Data from this study suggested that gene activation and silencing controlled by changes of H3K9Ac and H3K9Me2, respectively, were crucial to MSC osteogenic differentiation.			Tan, J (corresponding author), NE Normal Univ, Inst Cytol & Genet, Minist Educ, Key Lab Mol Epigenet, Changchun, Peoples R China.	jhguo@nenu.edu.cn; huangbq705@nenu.edu.cn						Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; Bannister AJ, 2004, METHOD ENZYMOL, V376, P269; Boquest AC, 2005, MOL BIOL CELL, V16, P1131, DOI 10.1091/mbc.E04-10-0949; Boquest AC, 2006, STEM CELL REV, V2, P319, DOI 10.1007/BF02698059; BOULIKAS T, 1995, CRIT REV EUKAR GENE, V5, P1; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Caplan A I, 1995, Connect Tissue Res, V31, pS9, DOI 10.3109/03008209509116826; Caplan AI, 2000, CLIN ORTHOP RELAT R, pS67; Chemnitz JM, 2006, CANCER RES, V66, P1114, DOI 10.1158/0008-5472.CAN-05-3252; CHEN YD, 1997, J BIOMEDICAL OPTICS, V4, P11; CHESKIS B, 1994, MOL CELL BIOL, V14, P3329, DOI 10.1128/MCB.14.5.3329; D'Amour KA, 2003, P NATL ACAD SCI USA, V100, P11866, DOI 10.1073/pnas.1834200100; Dai B, 2007, STEM CELLS, V25, P2567, DOI 10.1634/stemcells.2007-0131; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Fujiki R, 2005, EMBO J, V24, P3881, DOI 10.1038/sj.emboj.7600853; Gamble MJ, 2007, CELL, V128, P433, DOI 10.1016/j.cell.2007.01.017; Gerami-Naini B, 2004, ENDOCRINOLOGY, V145, P1517, DOI 10.1210/en.2003-1241; Gibbons FD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r96; Guo Y, 2005, J VIROL, V79, P14392, DOI 10.1128/JVI.79.22.14392-14403.2005; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Heim M, 2004, ENDOCRINOLOGY, V145, P848, DOI 10.1210/en.2003-1014; HOFBAUER R, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P247; Huang WF, 2006, BIOCHEM BIOPH RES CO, V339, P165, DOI 10.1016/j.bbrc.2005.11.010; Izawa I, 2002, J BIOL CHEM, V277, P5345, DOI 10.1074/jbc.M110052200; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Kato S, 2007, J STEROID BIOCHEM, V103, P372, DOI 10.1016/j.jsbmb.2006.12.038; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lanzuolo C, 2007, CELL MOL LIFE SCI, V64, P1043, DOI 10.1007/s00018-007-6420-8; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Ma YL, 2006, STEM CELLS, V24, P315, DOI 10.1634/stemcells.2005-0046; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Miao F, 2005, MOL CELL BIOL, V25, P4650, DOI 10.1128/MCB.25.11.4650-4661.2005; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Neuhuber B, 2004, J NEUROSCI RES, V77, P192, DOI 10.1002/jnr.20147; Qi HL, 2003, P NATL ACAD SCI USA, V100, P3305, DOI 10.1073/pnas.0532693100; Rasmussen Theodore P, 2003, Reprod Biol Endocrinol, V1, P100, DOI 10.1186/1477-7827-1-100; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Sabbattini P, 2007, EMBO J, V26, P4657, DOI 10.1038/sj.emboj.7601875; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; van Steensel B, 2005, NAT GENET, V37, pS18, DOI 10.1038/ng1559; Yeakley JM, 2002, NAT BIOTECHNOL, V20, P353, DOI 10.1038/nbt0402-353; Yuan WH, 2007, J BIOL CHEM, V282, P29821, DOI 10.1074/jbc.M705495200	55	45	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2009	4	8							e6792	10.1371/journal.pone.0006792	http://dx.doi.org/10.1371/journal.pone.0006792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JE	19710927	Green Submitted, Green Published, gold			2022-12-25	WOS:000269415600006
J	Adams, B; Kapan, DD				Adams, Ben; Kapan, Durrell D.			Man Bites Mosquito: Understanding the Contribution of Human Movement to Vector-Borne Disease Dynamics	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; METAPOPULATION DYNAMICS; PUERTO-RICO; DENGUE; TRANSMISSION; DISPERSAL; MODEL; SURVIVAL; SPREAD; OVIPOSITION	In metropolitan areas people travel frequently and extensively but often in highly structured commuting patterns. We investigate the role of this type of human movement in the epidemiology of vector-borne pathogens such as dengue. Analysis is based on a metapopulation model where mobile humans connect static mosquito subpopulations. We find that, due to frequency dependent biting, infection incidence in the human and mosquito populations is almost independent of the duration of contact. If the mosquito population is not uniformly distributed between patches the transmission potential of the pathogen at the metapopulation level, as summarized by the basic reproductive number, is determined by the size of the largest subpopulation and reduced by stronger connectivity. Global extinction of the pathogen is less likely when increased human movement enhances the rescue effect but, in contrast to classical theory, it is not minimized at an intermediate level of connectivity. We conclude that hubs and reservoirs of infection can be places people visit frequently but briefly and the relative importance of human and mosquito populations in maintaining the pathogen depends on the distribution of the mosquito population and the variability in human travel patterns. These results offer an insight in to the paradoxical observation of resurgent urban vector-borne disease despite increased investment in vector control and suggest that successful public health intervention may require a dual approach. Prospective studies can be used to identify areas with large mosquito populations that are also visited by a large fraction of the human population. Retrospective studies can be used to map recent movements of infected people, pinpointing the mosquito subpopulation from which they acquired the infection and others to which they may have transmitted it.			Adams, B (corresponding author), Univ Bath, Dept Math Sci, Bath BA2 7AY, Avon, England.	b.adams@bath.ac.uk		Adams, Ben/0000-0001-9955-5361	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018727] Funding Source: NIH RePORTER; NCRR NIH HHS [RR018727, P20 RR018727] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANDERSON R M, 1991; ANTONOVICS J, 1995, AM NAT, V145, P661, DOI 10.1086/285761; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Canyon DV, 1999, J MED ENTOMOL, V36, P301, DOI 10.1093/jmedent/36.3.301; Carrington CVF, 2005, J VIROL, V79, P14680, DOI 10.1128/JVI.79.23.14680-14687.2005; Chadee DD, 2000, J VECTOR ECOL, V25, P158; CHAN YC, 1971, B WORLD HEALTH ORGAN, V44, P617; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Conner ME, 1923, AM J TROP MED HYG, V4, P4; Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225; DIEKMANN O, 2000, MATH EPIDEMIOLOGY IN, pR16; DYE C, 1986, T ROY SOC TROP MED H, V80, P69, DOI 10.1016/0035-9203(86)90199-9; Effler PV, 2005, EMERG INFECT DIS, V11, P742; Ellner SP, 2003, ECOLOGY, V84, P882, DOI 10.1890/0012-9658(2003)084[0882:EOSDOM]2.0.CO;2; Foster JE, 2004, VIROLOGY, V324, P48, DOI 10.1016/j.virol.2004.03.020; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Hanski I, 1999, METAPOPULATION ECOLO, VIX, P313; HANSKI I, 2004, ECOLOGY GENETICS EVO, pR19; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Heesterbeek JAP, 2007, MATH BIOSCI, V206, P3, DOI 10.1016/j.mbs.2004.10.013; Hsieh YH, 2007, B MATH BIOL, V69, P1355, DOI 10.1007/s11538-006-9169-6; Keeling MJ, 2000, P ROY SOC B-BIOL SCI, V267, P2219, DOI 10.1098/rspb.2000.1272; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; Keeling MJ, 2000, NATURE, V407, P903, DOI 10.1038/35038073; KEELING MJ, 2004, ECOLOGY GENETICS EVO, pR19; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; KUNO G, 1997, DENGUE DENGUE HEMORR, pR11; Liew C, 2004, MED VET ENTOMOL, V18, P351, DOI 10.1111/j.0269-283X.2004.00517.x; LONGINI IM, 1982, BIOMETRICS, V38, P115, DOI 10.2307/2530294; Luz PM, 2003, MEM I OSWALDO CRUZ, V98, P871, DOI 10.1590/S0074-02762003000700002; Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McKenzie FE, 2000, PARASITOL TODAY, V16, P511, DOI 10.1016/S0169-4758(00)01789-0; Morrison AC, 1998, AM J TROP MED HYG, V58, P287, DOI 10.4269/ajtmh.1998.58.287; Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/eid1206.051210; PEARN J, 2004, 39 INT C BAR IT; Perrin L, 2003, LANCET INFECT DIS, V3, P22, DOI 10.1016/S1473-3099(03)00484-5; Peterson AT, 2003, VECTOR-BORNE ZOONOT, V3, P27, DOI 10.1089/153036603765627433; Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630; Roberts MG, 2003, P ROY SOC B-BIOL SCI, V270, P1359, DOI 10.1098/rspb.2003.2339; RODHAIN F, 1997, DENGUE DENGUE HEMORR, pR11; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Snall T, 2005, ECOLOGY, V86, P106, DOI 10.1890/04-0531; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102; Wilcox C, 2006, ECOLOGY, V87, P855, DOI 10.1890/05-0587; Wonham MJ, 2006, ECOL LETT, V9, P706, DOI 10.1111/j.1461-0248.2006.00912.x; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341	52	121	122	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6763	10.1371/journal.pone.0006763	http://dx.doi.org/10.1371/journal.pone.0006763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707544	Green Published, Green Submitted, gold			2022-12-25	WOS:000269335000009
J	Wakayama, S; Kawahara, Y; Li, C; Yamagata, K; Yuge, L; Wakayama, T				Wakayama, Sayaka; Kawahara, Yumi; Li, Chong; Yamagata, Kazuo; Yuge, Louis; Wakayama, Teruhiko			Detrimental Effects of Microgravity on Mouse Preimplantation Development In Vitro	PLOS ONE			English	Article							SPACE-FLIGHT; LONG-TERM; CLINOSTAT ROTATION; SPERM MOTILITY; FERTILIZATION; SPACEFLIGHT; EMBRYOS; TROPHECTODERM; CULTURE; CELLS	Sustaining life beyond Earth either on space stations or on other planets will require a clear understanding of how the space environment affects key phases of mammalian reproduction. However, because of the difficulty of doing such experiments in mammals, most studies of reproduction in space have been carried out with other taxa, such as sea urchins, fish, amphibians or birds. Here, we studied the possibility of mammalian fertilization and preimplantation development under microgravity (mu G) conditions using a three-dimensional (3D) clinostat, which faithfully simulates 10(-3) G using 3D rotation. Fertilization occurred normally in vitro under mG. However, although we obtained 75 healthy offspring from mu G-fertilized and -cultured embryos after transfer to recipient females, the birth rate was lower than among the 1G controls. Immunostaining demonstrated that in vitro culture under mG caused slower development and fewer trophectoderm cells than in 1G controls but did not affect polarization of the blastocyst. These results suggest for the first time that fertilization can occur normally under mG environment in a mammal, but normal preimplantation embryo development might require 1G.			Wakayama, S (corresponding author), RIKEN, Ctr Dev Biol, Lab Genom Reprogramming, Kobe, Hyogo, Japan.	teru@cdb.riken.jp						Aimar C, 2000, BIOL REPROD, V63, P551, DOI 10.1095/biolreprod63.2.551; AMANN RP, 1992, J APPL PHYSIOL, V73, pS174, DOI 10.1152/jappl.1992.73.2.S174; Burden HW, 1997, J REPROD FERTIL, V109, P193, DOI 10.1530/jrf.0.1090193; Burden HW, 1999, J REPROD FERTIL, V116, P229; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Dournon C, 2003, ADV SPACE B, V9, P101, DOI 10.1016/S1569-2574(03)09005-1; Endoh K, 2007, J REPROD DEVELOP, V53, P1199, DOI 10.1262/jrd.19058; ENGELMANN U, 1992, J ANDROL, V13, P433; FEDOROVA N. L., 1967, KOSM BIOL MED, V1, P28; Gualandris-Parisot Lydie, 2002, Biol Sci Space, V16, P3, DOI 10.2187/bss.16.3; Hirasaka K, 2005, BBA-MOL CELL RES, V1743, P130, DOI 10.1016/j.bbamcr.2004.09.013; Ijiri K, 1995, Biol Sci Space, V9, P3, DOI 10.2187/bss.9.3; Ijiri Kenichi, 2004, Biol Sci Space, V18, P138; Jedrusik A, 2008, GENE DEV, V22, P2692, DOI 10.1101/gad.486108; KEEFE JR, 1985, FINAL REPORT NASA MA, P46; Kojima Y, 2000, FERTIL STERIL, V74, P1142, DOI 10.1016/S0015-0282(00)01583-1; KULESH DA, 1994, J CELL BIOCHEM, V55, P530, DOI 10.1002/jcb.240550412; LANE M, 1992, HUM REPROD, V7, P558, DOI 10.1093/oxfordjournals.humrep.a137690; Makihira S, 2008, CELL BIOL INT, V32, P1176, DOI 10.1016/j.cellbi.2008.04.027; Margolis L, 1999, J UROLOGY, V161, P290, DOI 10.1016/S0022-5347(01)62134-7; MARIMUTHU KM, 1970, RADIAT RES, V42, P105, DOI 10.2307/3572921; Melin J, 2009, DEV DYNAM, V238, P950, DOI 10.1002/dvdy.21918; Nagy A., 2003, MANIPULATING MOUSE E; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Ohta H, 2004, J REPROD DEVELOP, V50, P429, DOI 10.1262/jrd.50.429; Ohta H, 2008, REPRODUCTION, V136, P581, DOI 10.1530/REP-08-0184; Ohta H, 2008, J REPROD DEVELOP, V54, P295, DOI 10.1262/jrd.20027; Ohta H, 2008, BIOL REPROD, V79, P486, DOI 10.1095/biolreprod.107.067116; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; PARIA BC, 1990, P NATL ACAD SCI USA, V87, P4756, DOI 10.1073/pnas.87.12.4756; Philpott D E, 1985, Physiologist, V28, pS211; Ralston A, 2008, DEV BIOL, V313, P614, DOI 10.1016/j.ydbio.2007.10.054; Ronca AE, 2000, J APPL PHYSIOL, V89, P2318, DOI 10.1152/jappl.2000.89.6.2318; Ronca AE, 2000, J APPL PHYSIOL, V89, P849, DOI 10.1152/jappl.2000.89.2.849; Ronca AE, 2003, ADV SPACE B, V9, P217, DOI 10.1016/S1569-2574(03)09009-9; Russell CA, 2005, PLOS BIOL, V3, P382, DOI 10.1371/journal.pbio.0030088; SAPP WJ, 1990, FASEB J, V4, P101, DOI 10.1096/fasebj.4.1.2295370; Sarkar D, 2000, J BONE MINER RES, V15, P489, DOI 10.1359/jbmr.2000.15.3.489; Schatten H, 2001, ACTA ASTRONAUT, V49, P399, DOI 10.1016/S0094-5765(01)00116-3; Schatten H, 1999, CELL BIOL INT, V23, P407, DOI 10.1006/cbir.1999.0371; Schenker E., 1998, MAMMALIAN MICE EMBRY, P5; Serova L V, 1982, Physiologist, V25, pS9; SEROVA LV, 1989, KOSM BIOL AVIAK MED+, V23, P11; SOUZA KA, 1995, P NATL ACAD SCI USA, V92, P1975, DOI 10.1073/pnas.92.6.1975; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tash JS, 2001, BIOL REPROD, V65, P1224, DOI 10.1095/biolreprod65.4.1224; Tash JS, 1999, FASEB J, V13, pS43; Toyoda Y., 1971, JAPANESE J ANIMAL RE, V16, P152, DOI [10.1262/jrd1955.16.152, DOI 10.1262/JRD1955.16.152]; TREMOR JW, 1972, SPACE LIFE SCI, V3, P179, DOI 10.1007/BF00928162; Ubbels G A, 1989, Adv Space Res, V9, P187, DOI 10.1016/0273-1177(89)90073-2; Ueda O, 2003, BIOL REPROD, V69, P1085, DOI 10.1095/biolreprod.103.017608; Wakayama S, 2004, J REPROD DEVELOP, V50, P627, DOI 10.1262/jrd.50.627; Wakayama S, 2007, CURR BIOL, V17, pR120, DOI 10.1016/j.cub.2006.12.020; WAKAYAMA T, 1995, J VET MED SCI, V57, P545, DOI 10.1292/jvms.57.545; YAMAGATA K, 2009, HUM REPROD; Yamagata K, 2009, J REPROD DEVELOP, V55, P343, DOI 10.1262/jrd.20166; Yuge L, 2003, IN VITRO CELL DEV-AN, V39, P89; Yuge L, 2006, STEM CELLS DEV, V15, P921, DOI 10.1089/scd.2006.15.921	59	34	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6753	10.1371/journal.pone.0006753	http://dx.doi.org/10.1371/journal.pone.0006753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707597	Green Published, gold, Green Submitted			2022-12-25	WOS:000269278400018
J	Laver, JR; Stevanin, TM; Messenger, SL; Lunn, AD; Lee, ME; Moir, JWB; Poole, RK; Read, RC				Laver, Jay R.; Stevanin, Tania M.; Messenger, Sarah L.; Lunn, Amy Dehn; Lee, Margaret E.; Moir, James W. B.; Poole, Robert K.; Read, Robert C.			Bacterial nitric oxide detoxification prevents host cell S-nitrosothiol formation: a novel mechanism of bacterial pathogenesis	FASEB JOURNAL			English	Article						S-nitrosylation; infection; macrophage; nitrosative stress	ENTERICA SEROVAR TYPHIMURIUM; COLI FLAVOHAEMOGLOBIN HMP; NEISSERIA-MENINGITIDIS; ESCHERICHIA-COLI; FLAVOHEMOGLOBIN HMP; NITROSATIVE STRESS; HUMAN MACROPHAGES; SALMONELLA FLAVOHEMOGLOBIN; SKELETAL-MUSCLE; REPRESSOR NSRR	S-nitrosylation is an important mediator of multiple nitric oxide-dependent biological processes, including eukaryotic cellular events such as macrophage apoptosis and proinflammatory signaling. Many pathogenic bacteria possess NO detoxification mechanisms, such as the nitric oxide reductase (NorB) of Neisseria meningitidis and the flavohemoglobins (Hmp) of Salmonella enterica and Escherichia coli, which serve to protect the microorganism from nitrosative stress within the intracellular environment. In this study, we demonstrate that expression of meningococcal NorB increases the rate at which low-molecular-weight S-nitrosothiol (SNO) decomposes in vitro. To determine whether this effect occurs in cells during infection by bacteria, we induced SNO formation in murine macrophages by activation with lipopolysaccharide and gamma-interferon and observed a reduced abundance of SNO during coincubation with N. meningitidis, S. enterica, or E. coli. In each case, this effect was shown to be dependent on bacterial NO detoxification genes, which act to prevent SNO formation through the removal of NO. This may represent a novel mechanism of host cell injury by bacteria.-Laver, J. R., Stevanin, T. M., Messenger, S. L., Dehn Lunn, A., Lee, M. E., Moir, J. W. B., Poole, R. K., Read, R. C. Bacterial nitric oxide detoxification prevents host cell S-nitrosothiol formation: a novel mechanism of bacterial pathogenesis. FASEB J. 24, 286-295 (2010). www.fasebj.org	[Laver, Jay R.; Stevanin, Tania M.; Messenger, Sarah L.; Lunn, Amy Dehn; Lee, Margaret E.; Read, Robert C.] Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England; [Poole, Robert K.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Moir, James W. B.] Univ York, Dept Biol, Heslington, England	University of Sheffield; University of Sheffield; University of York - UK	Laver, JR (corresponding author), Royal Hallamshire Hosp, Sch Med, Dept Infect & Immun, Beech Hill Rd, Sheffield, S Yorkshire, England.	j.r.laver@sheffield.ac.uk	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; Read, Robert/0000-0002-4297-6728; Moir, James/0000-0003-2972-5235	Wellcome Trust [069791]; Sheffield Hospitals Charitable Trust [7866]; Meningitis Research Foundation [0902.0]; Biotechnology and Biological Sciences Research Council [BB/F000952/1, BB/E015883/1] Funding Source: researchfish; BBSRC [BB/F000952/1, BB/E015883/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Sheffield Hospitals Charitable Trust; Meningitis Research Foundation(Meningitis Research Foundation (MRF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We acknowledge the assistance of Prof. Neil Hogg for advice on the measurement of SNO using the Sievers NOA and of Dr. Jonathan Shaw for advice in the preparation of this manuscript. This work has been supported by grants to R. C. R. from the Wellcome Trust (grant 069791) and the Sheffield Hospitals Charitable Trust (grant 7866). J. R. L. and R. C. R. are supported by the Meningitis Research Foundation (project 0902.0).	Anjum MF, 2002, J BACTERIOL, V184, P2987, DOI 10.1128/JB.184.11.2987-2993.2002; Bang IS, 2006, J BIOL CHEM, V281, P28039, DOI 10.1074/jbc.M605174200; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Bizzozero O, 2005, NEUROCHEM RES, V30, P139, DOI 10.1007/s11064-004-9695-2; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Broniowska KA, 2006, J BIOL CHEM, V281, P33835, DOI 10.1074/jbc.M603248200; Busch T, 2000, INTENS CARE MED, V26, P391, DOI 10.1007/s001340051172; Chen B, 1998, BIOPHYS J, V75, P745, DOI 10.1016/S0006-3495(98)77564-2; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Crawford MJ, 1998, J BIOL CHEM, V273, P12543, DOI 10.1074/jbc.273.20.12543; Darton T, 2009, CLIN INFECT DIS, V48, P587, DOI 10.1086/596707; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; Fang JG, 2007, P NATL ACAD SCI USA, V104, P18742, DOI 10.1073/pnas.0705904104; Fang KZ, 1998, BIOCHEM BIOPH RES CO, V252, P535, DOI 10.1006/bbrc.1998.9688; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Farres J, 2005, BIOCHEMISTRY-US, V44, P4125, DOI 10.1021/bi047389d; Forrester MT, 2006, ACS CHEM BIOL, V1, P355, DOI 10.1021/cb600244c; GERLACH H, 1994, LANCET, V343, P518, DOI 10.1016/S0140-6736(94)91465-6; Gilberthorpe NJ, 2007, MICROBIOL-SGM, V153, P1756, DOI 10.1099/mic.0.2006/003731-0; Gow AJ, 2002, J BIOL CHEM, V277, P9637, DOI 10.1074/jbc.C100746200; Hara MR, 2006, CELL MOL NEUROBIOL, V26, P527, DOI 10.1007/s10571-006-9011-6; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; Hausladen A, 2001, P NATL ACAD SCI USA, V98, P10108, DOI 10.1073/pnas.181199698; Hernandez-Urzua E, 2003, J BIOL CHEM, V278, P34975, DOI 10.1074/jbc.M303629200; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Heurlier K, 2008, J BACTERIOL, V190, P2488, DOI 10.1128/JB.01869-07; Hoffmann J, 2003, FEBS LETT, V551, P153, DOI 10.1016/S0014-5793(03)00917-7; Iwakiri Y, 2006, P NATL ACAD SCI USA, V103, P19777, DOI 10.1073/pnas.0605907103; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; JAMES JH, 1990, METABOLISM, V39, P335, DOI 10.1016/0026-0495(90)90245-8; Kim SO, 1999, FEBS LETT, V445, P389, DOI 10.1016/S0014-5793(99)00157-X; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Kimberly B, 1996, AM J RESP CRIT CARE, V153, P829, DOI 10.1164/ajrccm.153.2.8564139; Lancaster JR, 2004, AM J PHYSIOL-LUNG C, V287, pL465, DOI 10.1152/ajplung.00151.2004; Lander HM, 1997, J BIOL CHEM, V272, P4323, DOI 10.1074/jbc.272.7.4323; Laver JR, 2008, METHOD ENZYMOL, V436, P113, DOI 10.1016/S0076-6879(08)36007-8; Li HF, 1999, AM J PHYSIOL-CELL PH, V276, pC803, DOI 10.1152/ajpcell.1999.276.4.C803; Li JR, 1997, BIOCHEM BIOPH RES CO, V240, P419, DOI 10.1006/bbrc.1997.7672; Li S, 2007, AM J PHYSIOL-CELL PH, V292, pC1263, DOI 10.1152/ajpcell.00382.2006; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Mannick JB, 2002, ARCH BIOCHEM BIOPHYS, V408, P1, DOI 10.1016/S0003-9861(02)00490-3; Mannick JB, 2001, J CELL BIOL, V154, P1111, DOI 10.1083/jcb.200104008; Mannick JB, 1997, J BIOL CHEM, V272, P24125, DOI 10.1074/jbc.272.39.24125; Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y; MCGUINNESS BT, 1991, LANCET, V337, P514, DOI 10.1016/0140-6736(91)91297-8; Membrillo-Hernandez J, 1998, MOL MICROBIOL, V29, P1101, DOI 10.1046/j.1365-2958.1998.01000.x; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Padgett C. M., 1995, AM J PHYSIOL, V269, pC739; Paige JS, 2008, CHEM BIOL, V15, P1307, DOI 10.1016/j.chembiol.2008.10.013; Poole RK, 2000, MOL MICROBIOL, V36, P775, DOI 10.1046/j.1365-2958.2000.01889.x; POOLE RK, 1994, P ROY SOC B-BIOL SCI, V255, P251, DOI 10.1098/rspb.1994.0036; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Que LG, 2009, AM J RESP CRIT CARE, V180, P226, DOI 10.1164/rccm.200901-0158OC; Rabkin SW, 2007, NITRIC OXIDE-BIOL CH, V16, P339, DOI 10.1016/j.niox.2006.10.007; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Rock JD, 2005, MOL MICROBIOL, V58, P800, DOI 10.1111/j.1365-2958.2005.04866.x; Rock JD, 2007, J BACTERIOL, V189, P1138, DOI 10.1128/JB.01368-06; Schonhoff CM, 2006, P NATL ACAD SCI USA, V103, P2404, DOI 10.1073/pnas.0507243103; Singh RJ, 1996, J BIOL CHEM, V271, P18596, DOI 10.1074/jbc.271.31.18596; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; Stevanin TM, 2007, GENE, V398, P62, DOI 10.1016/j.gene.2007.03.021; Stevanin TM, 2007, MICROBES INFECT, V9, P981, DOI 10.1016/j.micinf.2007.04.002; Stevanin TM, 2002, INFECT IMMUN, V70, P4399, DOI 10.1128/IAI.70.8.4399-4405.2002; Stevanin TM, 2005, INFECT IMMUN, V73, P3322, DOI 10.1128/IAI.73.6.3322-3329.2005; Stevanin TM, 2000, J BIOL CHEM, V275, P35868, DOI 10.1074/jbc.M002471200; Sun JH, 2001, P NATL ACAD SCI USA, V98, P11158, DOI 10.1073/pnas.201289098; Tunbridge AJ, 2006, INFECT IMMUN, V74, P729, DOI 10.1128/IAI.74.1.729-733.2006; Zhang YH, 2004, AM J PHYSIOL-LUNG C, V287, pL467, DOI 10.1152/ajplung.00350.2003; ZHU H, 1992, P NATL ACAD SCI USA, V89, P5015, DOI 10.1073/pnas.89.11.5015	71	43	43	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2010	24	1					286	295		10.1096/fj.08-128330	http://dx.doi.org/10.1096/fj.08-128330			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19720623	Green Published			2022-12-25	WOS:000273233600029
J	Kuhn, ML; Falaschetti, CA; Ballicora, MA				Kuhn, Misty L.; Falaschetti, Christine A.; Ballicora, Miguel A.			Ostreococcus tauri ADP-glucose Pyrophosphorylase Reveals Alternative Paths for the Evolution of Subunit Roles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL REDOX-MODIFICATION; SITE-DIRECTED MUTAGENESIS; POTATO-TUBER; ESCHERICHIA-COLI; CHLAMYDOMONAS-REINHARDTII; PHYLOGENETIC ANALYSIS; STRUCTURAL-PROPERTIES; BACTERIAL GLYCOGEN; STARCH SYNTHESIS; GENOME ANALYSIS	ADP-glucose pyrophosphorylase controls starch synthesis in plants and is an interesting case to study the evolution and differentiation of roles in heteromeric enzymes. It includes two homologous subunits, small (S) and large (L), that originated from a common photosynthetic eukaryotic ancestor. In present day organisms, these subunits became complementary after loss of certain roles in a process described as subfunctionalization. For instance, the potato tuber enzyme has a noncatalytic L subunit that complements an S subunit with suboptimal allosteric properties. To understand the evolution of catalysis and regulation in this family, we artificially synthesized both subunit genes from the unicellular alga Ostreococcus tauri. This is among the most ancient species in the green lineage that diverged from the ancestor of all green plants and algae. After heterologous gene expression, we purified and characterized the proteins. The O. tauri enzyme was not redox-regulated, suggesting that redox regulation of ADP-glucose pyrophosphorylases appeared later in evolution. The S subunit had a typical low apparent affinity for the activator 3-phosphoglycerate, but it was atypically defective in the catalytic efficiency (V-max/K-m) for the substrate Glc1-P. The L subunit needed the S subunit for soluble expression. In the presence of a mutated S subunit (to avoid interference), the L subunit had a high apparent affinity for 3-phosphoglycerate and substrates suggesting a leading role in catalysis. Therefore, the subfunctionalization of the O. tauri enzyme was different from previously described cases. To the best of our knowledge, this is the first biochemical description of a system with alternative subfunctionalization paths.	[Kuhn, Misty L.; Falaschetti, Christine A.; Ballicora, Miguel A.] Loyola Univ, Dept Chem, Chicago, IL 60626 USA	Loyola University Chicago	Ballicora, MA (corresponding author), Loyola Univ, Dept Chem, 6525 N Sheridan Rd, Chicago, IL 60626 USA.	mballic@luc.edu		Ballicora, Miguel/0000-0002-5324-0724	National Science Foundation [MCB 0615982]	National Science Foundation(National Science Foundation (NSF))	This work was supported in part by National Science Foundation Grant MCB 0615982.	Ballicora MA, 2005, J BIOL CHEM, V280, P10189, DOI 10.1074/jbc.M413540200; Ballicora MA, 1998, PLANT PHYSIOL, V118, P265, DOI 10.1104/pp.118.1.265; Ballicora MA, 2004, PHOTOSYNTH RES, V79, P1, DOI 10.1023/B:PRES.0000011916.67519.58; Ballicora MA, 2000, J BIOL CHEM, V275, P1315, DOI 10.1074/jbc.275.2.1315; BALLICORA MA, 1995, PLANT PHYSIOL, V109, P245, DOI 10.1104/pp.109.1.245; Bejar CM, 2006, J BIOL CHEM, V281, P40473, DOI 10.1074/jbc.M607088200; Bejar CM, 2004, FEBS LETT, V573, P99, DOI 10.1016/j.febslet.2004.07.060; Boehlein SK, 2005, PLANT PHYSIOL, V138, P1552, DOI 10.1104/pp.105.060699; Courties C, 1998, J PHYCOL, V34, P844, DOI 10.1046/j.1529-8817.1998.340844.x; Crevillen P, 2005, J BIOL CHEM, V280, P8143, DOI 10.1074/jbc.M411713200; Cross JM, 2004, PLANT PHYSIOL, V135, P137, DOI 10.1104/pp.103.036699; D'Ovidio R, 2004, PLANT PHYSIOL, V135, P2424, DOI 10.1104/pp.104.044644; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Doan DNP, 1999, PLANT PHYSIOL, V121, P965, DOI 10.1104/pp.121.3.965; Force A, 1999, GENETICS, V151, P1531; Frueauf JB, 2003, PLANT J, V33, P503, DOI 10.1046/j.1365-313X.2003.01643.x; Frueauf JB, 2001, J BIOL CHEM, V276, P46319, DOI 10.1074/jbc.M107408200; Fu YB, 1998, PLANT PHYSIOL, V117, P989, DOI 10.1104/pp.117.3.989; Fu YB, 1998, J BIOL CHEM, V273, P25045, DOI 10.1074/jbc.273.39.25045; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HAUGEN TH, 1979, J BIOL CHEM, V254, P127; Hendriks JHM, 2003, PLANT PHYSIOL, V133, P838, DOI 10.1104/pp.103.024513; Hicks GR, 2001, PLANT PHYSIOL, V127, P1334; HILL MA, 1991, J BIOL CHEM, V266, P12455; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Hwang SK, 2008, J BIOL CHEM, V283, P6640, DOI 10.1074/jbc.M707447200; Hwang SK, 2007, PHYTOCHEMISTRY, V68, P464, DOI 10.1016/j.phytochem.2006.11.027; Hwang SK, 2006, FEBS LETT, V580, P6741, DOI 10.1016/j.febslet.2006.11.029; Hwang SK, 2005, FEBS LETT, V579, P983, DOI 10.1016/j.febslet.2004.12.067; IGLESIAS AA, 1993, J BIOL CHEM, V268, P1081; IGLESIAS AA, 1994, PLANT PHYSIOL, V104, P1287, DOI 10.1104/pp.104.4.1287; IGLESIAS AA, 1991, PLANT PHYSIOL, V97, P1187, DOI 10.1104/pp.97.3.1187; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jin XS, 2005, EMBO J, V24, P694, DOI 10.1038/sj.emboj.7600551; Laughlin MJ, 1998, PHYTOCHEMISTRY, V47, P621, DOI 10.1016/S0031-9422(97)00578-5; Lynch M, 2006, MOL BIOL EVOL, V23, P450, DOI 10.1093/molbev/msj050; Misumi O, 2008, J PLANT RES, V121, P3, DOI 10.1007/s10265-007-0133-9; Muller T, 2000, J COMPUT BIOL, V7, P761, DOI 10.1089/10665270050514918; Pedro CN, 2003, J BIOL CHEM, V278, P28508, DOI 10.1074/jbc.M304280200; Piganeau G, 2007, GENE, V406, P184, DOI 10.1016/j.gene.2007.09.015; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; PRESS WH, 1988, NUMERICAL RECIPES C, P347; Ral JP, 2004, PLANT PHYSIOL, V136, P3333, DOI 10.1104/pp.104.044131; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; Sambrook J, 2001, MOL CLONING LAB MANU; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tiessen A, 2002, PLANT CELL, V14, P2191, DOI 10.1105/tpc.003640; Tocchini-Valentini GD, 2005, P NATL ACAD SCI USA, V102, P8933, DOI 10.1073/pnas.0502350102; Todd AE, 2002, STRUCTURE, V10, P1435, DOI 10.1016/S0969-2126(02)00861-4; Truman AW, 2008, CHEM BIOL, V15, P476, DOI 10.1016/j.chembiol.2008.03.019; Ventriglia T, 2008, PLANT PHYSIOL, V148, P65, DOI 10.1104/pp.108.122846; Wang SM, 1998, PLANT J, V13, P63, DOI 10.1046/j.1365-313X.1998.00009.x; Xiong AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh094; Yep A, 2004, ANAL BIOCHEM, V324, P52, DOI 10.1016/j.ab.2003.09.024	56	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34092	34102		10.1074/jbc.M109.037614	http://dx.doi.org/10.1074/jbc.M109.037614			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19737928	hybrid, Green Published			2022-12-25	WOS:000272165200042
J	Arlt, A; Bauer, I; Schafmayer, C; Tepel, J; Muerkoster, SS; Brosch, M; Roder, C; Kalthoff, H; Hampe, J; Moyer, MP; Folsch, UR; Schafer, H				Arlt, A.; Bauer, I.; Schafmayer, C.; Tepel, J.; Mueerkoester, S. Sebens; Brosch, M.; Roeder, C.; Kalthoff, H.; Hampe, J.; Moyer, M. P.; Foelsch, U. R.; Schaefer, H.			Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)	ONCOGENE			English	Article						regulated proteolysis; ubiquitination; gene transcription; oxidative stress; tumorigenesis	NF-KAPPA-B; ANTIOXIDANT RESPONSE ELEMENT; GENE-EXPRESSION; 26S PROTEASOME; BREAST-CANCER; NRF2-DEFICIENT MICE; UBIQUITIN RECEPTORS; ADAPTIVE RESPONSE; 20S PROTEASOME; EMERGING ROLES	An elevated proteasome activity contributes to tumorigenesis, particularly by providing cancer cells with antiapoptotic protection and efficient clearance from irregular proteins. Still, the underlying mechanisms are poorly known. In this study, we report that in colon cancer patients, higher proteasome activity was detected in tumoral tissue compared with surrounding normal tissue, and also that increased levels of proteasomal subunit proteins, such as S5a/PSMD4 and alpha-5/PSMA5, could be detected. Colon tumors showed higher nuclear levels of nuclear factor E2-related factor 2 (Nrf2), a transcription factor supposed to be involved in the control of proteasomal subunit protein expression. The induction or overexpression of Nrf2 led to stronger S5a and alpha-5 expression in the human colon cancer cell lines, Colo320 and Lovo, as well as in NCM460 colonocytes along with higher proteasome activity. The small interfering RNA (siRNA)-mediated Nrf2 knockdown decreased S5a and alpha-5 expression and reduced proteasome activity. Additionally, Nrf2-dependent S5a and alpha-5 expression conferred protection from tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis, an effect preceded by an increased nuclear factor (NF)-kappa B activation and higher expression of antiapoptotic NF-kappa B target genes. These findings point to an important role of Nrf2 in the gain of proteasome activity, thereby contributing to colorectal carcinogenesis. Nrf2 may therefore serve as a potential target in anticancer therapy. Oncogene (2009) 28, 3983-3996; doi:10.1038/onc.2009.264; published online 7 September 2009	[Arlt, A.; Bauer, I.; Mueerkoester, S. Sebens; Brosch, M.; Hampe, J.; Foelsch, U. R.; Schaefer, H.] Univ Hosp Schleswig Holstein UKSH, Dept Internal Med, D-24105 Kiel, Germany; [Schafmayer, C.; Tepel, J.; Roeder, C.; Kalthoff, H.] UKSH, Dept Gen & Thorac Surg, Kiel, Germany; [Moyer, M. P.] INCELL Corp LLC, San Antonio, TX USA	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Schafer, H (corresponding author), Univ Hosp Schleswig Holstein UKSH, Dept Internal Med, Campus Kiel,Schittenhelmstr 12, D-24105 Kiel, Germany.	hschaef@1med.uni-kiel.de	Sebens, Susanne/C-1222-2010; Roeder, Christian/F-1068-2010; Hampe, Jochen/A-2555-2010; Kalthoff, Holger/B-1618-2010; 高, 雨莉/HGU-8187-2022; Arlt, Alexander/G-7308-2019; Schäfer, Heiner/C-1055-2011	Roeder, Christian/0000-0001-7881-9110; Hampe, Jochen/0000-0002-2421-6127; Arlt, Alexander/0000-0002-6160-1059; Brosch, Mario/0000-0001-8983-6557	German Research Society [DFG/SFB415-A13]; German Cluster of Excellence 'Inflammation at Interfaces'	German Research Society(German Research Foundation (DFG)); German Cluster of Excellence 'Inflammation at Interfaces'	The authors thank Maike Grossmann and Dagmar Leisner for technical support, and the German Research Society (DFG/SFB415-A13) and the German Cluster of Excellence 'Inflammation at Interfaces' for funding.	Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Almond JB, 2002, LEUKEMIA, V16, P433, DOI 10.1038/sj.leu.2402417; Arlt A, 2003, ONCOGENE, V22, P3343, DOI 10.1038/sj.onc.1206524; Arlt A, 2007, BIOCHEM J, V402, P367, DOI 10.1042/BJ20061072; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Chen L, 2005, CANCER RES, V65, P5599, DOI 10.1158/0008-5472.CAN-05-0201; Chen W, 2009, ONCOL REP, V21, P531, DOI 10.3892/or_00000254; Cho HY, 2005, FREE RADICAL BIO MED, V38, P325, DOI 10.1016/j.freeradbiomed.2004.10.013; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dahlmann B, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S3; Devoy A, 2005, ESSAYS BIOCHEM, V41, P187, DOI 10.1042/EB0410187; Ehrhardt H, 2003, ONCOGENE, V22, P3842, DOI 10.1038/sj.onc.1206520; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goy A, 2003, BLOOD, V102, p180A; Gudmundsdottir K, 2007, ONCOGENE, V26, P7601, DOI 10.1038/sj.onc.1210579; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hu R, 2006, CANCER LETT, V243, P170, DOI 10.1016/j.canlet.2005.11.050; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kang Y, 2007, J MOL BIOL, V369, P168, DOI 10.1016/j.jmb.2007.03.008; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kepa JK, 2003, BIOCHEM BIOPH RES CO, V311, P446, DOI 10.1016/j.bbrc.2003.10.021; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Kwak MK, 2006, BIOCHEM BIOPH RES CO, V345, P1350, DOI 10.1016/j.bbrc.2006.05.043; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; McBride WH, 2003, ONCOGENE, V22, P5755, DOI 10.1038/sj.onc.1206676; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Muerkoster SS, 2008, ONCOGENE, V27, P1122, DOI 10.1038/sj.onc.1210728; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nair S, 2008, BRIT J CANCER, V99, P2070, DOI 10.1038/sj.bjc.6604703; Nioi P, 2007, BIOCHEM BIOPH RES CO, V362, P816, DOI 10.1016/j.bbrc.2007.08.051; Orlowski RZ, 2003, BREAST CANCER RES, V5, P1, DOI 10.1186/bcr460; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Osburn WO, 2007, INT J CANCER, V121, P1883, DOI 10.1002/ijc.22943; Pitts TM, 2009, MOL CANCER THER, V8, P342, DOI 10.1158/1535-7163.MCT-08-0534; Ren SR, 2000, ONCOGENE, V19, P1419, DOI 10.1038/sj.onc.1203462; Rho JH, 2008, J PROTEOME RES, V7, P2959, DOI 10.1021/pr8000892; Schmidtke G, 1996, EMBO J, V15, P6887, DOI 10.1002/j.1460-2075.1996.tb01081.x; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Shibata T, 2008, GASTROENTEROLOGY, V135, P1358, DOI 10.1053/j.gastro.2008.06.082; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Sobin, 2009, UICC TNM CLASSIFICAT; Song MY, 2009, TOXICOL APPL PHARM, V235, P57, DOI 10.1016/j.taap.2008.11.007; Sun XM, 2004, MOL CELL, V14, P81, DOI 10.1016/S1097-2765(04)00156-X; Sun Y, 2006, NEOPLASIA, V8, P645, DOI 10.1593/neo.06376; Trauzold A, 2001, ONCOGENE, V20, P4258, DOI 10.1038/sj.onc.1204559; van Tijn P, 2008, PROG NEUROBIOL, V85, P176, DOI 10.1016/j.pneurobio.2008.03.001; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wyke SM, 2004, BRIT J CANCER, V91, P1742, DOI 10.1038/sj.bjc.6602165; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Zhang HG, 2004, ONCOGENE, V23, P2009, DOI 10.1038/sj.onc.1207373	68	168	179	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 12	2009	28	45					3983	3996		10.1038/onc.2009.264	http://dx.doi.org/10.1038/onc.2009.264			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	530AC	19734940				2022-12-25	WOS:000272560300004
J	Chandra, M; Mamidi, R; Ford, S; Hidalgo, C; Witt, C; Ottenheijm, C; Labeit, S; Granzier, H				Chandra, Murali; Mamidi, Ranganath; Ford, Steven; Hidalgo, Carlos; Witt, Christian; Ottenheijm, Coen; Labeit, Siegfried; Granzier, Henk			Nebulin Alters Cross-bridge Cycling Kinetics and Increases Thin Filament Activation A NOVEL MECHANISM FOR INCREASING TENSION AND REDUCING TENSION COST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; NEMALINE MYOPATHY; STRIATED-MUSCLE; PSOAS FIBERS; LENGTH; ACTIN; EXPRESSION; FRAGMENTS; ARCHITECTURE; CONTRACTION	Nebulin is a giant filamentous F-actin-binding protein (similar to 800 kDa) that binds along the thin filament of the skeletal muscle sarcomere. Nebulin is one of the least well understood major muscle proteins. Although nebulin is usually viewed as a structural protein, here we investigated whether nebulin plays a role in muscle contraction by using skinned muscle fiber bundles from a nebulin knock-out (NEB KO) mouse model. We measured force-pCa (-log[Ca2+]) and force-ATPase relations, as well as the rate of tension re-development (k(tr)) in tibialis cranialis muscle fibers. To rule out any alterations in troponin (Tn) isoform expression and/or status of Tn phosphorylation, we studied fiber bundles that had been reconstituted with bacterially expressed fast skeletal muscle recombinant Tn. We also performed a detailed analysis of myosin heavy chain, myosin light chain, and myosin light chain 2 phosphorylation, which showed no significant differences between wild type and NEB KO. Our mechanical studies revealed that NEB KO fibers had increased tension cost (5.9 versus 4.4 pmol millinewtons(-1) mm(-1) s(-1)) and reductions in ktr (4.7 versus 7.3 s(-1)), calcium sensitivity (pCa(50) 5.74 versus 5.90), and cooperativity of activation (n(H) 3.64 versus 4.38). Our findings indicate the following: 1) in skeletal muscle nebulin increases thin filament activation, and 2) through altering cross-bridge cycling kinetics, nebulin increases force and efficiency of contraction. These novel properties of nebulin add a new level of understanding of skeletal muscle function and provide a mechanism for the severe muscle weakness in patients with nebulin-based nemaline myopathy.	[Hidalgo, Carlos; Ottenheijm, Coen; Granzier, Henk] Univ Arizona, Dept Physiol, Sarver Mol Cardiovasc Res Program, Tucson, AZ 85724 USA; [Chandra, Murali; Mamidi, Ranganath; Ford, Steven] Washington State Univ, Dept VCAPP, Pullman, WA 99163 USA; [Witt, Christian; Labeit, Siegfried] Heidelberg Univ, Med Fac Mannheim, D-68167 Mannheim, Germany	University of Arizona; Washington State University; Ruprecht Karls University Heidelberg	Granzier, H (corresponding author), Univ Arizona, Dept Physiol, Sarver Mol Cardiovasc Res Program, MRB 325,POB 245217, Tucson, AZ 85724 USA.	granzier@arizona.edu			National Institutes of Health [AR053897, HL062881, HL075643]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075643, R01HL062881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR053897 and HL062881 (to H. G.) and HL075643 (to M. C.).	Bang ML, 2006, J CELL BIOL, V173, P905, DOI 10.1083/jcb.200603119; BRENNER B, 1988, P NATL ACAD SCI USA, V85, P3265, DOI 10.1073/pnas.85.9.3265; Campbell KB, 2001, ANN BIOMED ENG, V29, P384, DOI 10.1114/1.1366669; Castillo A, 2009, BIOPHYS J, V96, P1856, DOI 10.1016/j.bpj.2008.10.053; Chandra M, 2005, AM J PHYSIOL-HEART C, V289, pH2112, DOI 10.1152/ajpheart.00571.2005; DETOMBE PP, 1995, CIRC RES, V76, P734, DOI 10.1161/01.RES.76.5.734; Ding W, 2002, EXP PHYSIOL, V87, P691, DOI 10.1113/eph8702448; Gallon CE, 2006, ARCH BIOCHEM BIOPHYS, V456, P127, DOI 10.1016/j.abb.2006.06.008; Gokhin DS, 2009, AM J PHYSIOL-CELL PH, V296, pC1123, DOI 10.1152/ajpcell.00503.2008; Gordon AM, 2001, NEWS PHYSIOL SCI, V16, P49; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Hidalgo C, 2006, ARCH BIOCHEM BIOPHYS, V456, P216, DOI 10.1016/j.abb.2006.06.026; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; JIN JP, 1991, J BIOL CHEM, V266, P21215; KRUGER M, 1991, J CELL BIOL, V115, P97, DOI 10.1083/jcb.115.1.97; LABEIT S, 1991, FEBS LETT, V282, P313, DOI 10.1016/0014-5793(91)80503-U; LABEIT S, 1995, J MOL BIOL, V248, P308, DOI 10.1016/S0022-2836(95)80052-2; Lukoyanova N, 2002, CURR BIOL, V12, P383, DOI 10.1016/S0960-9822(02)00678-4; Lutz GJ, 2001, J EXP BIOL, V204, P4237; McElhinny AS, 2003, TRENDS CARDIOVAS MED, V13, P195, DOI 10.1016/S1050-1738(03)00076-8; McElhinny AS, 2001, J BIOL CHEM, V276, P583, DOI 10.1074/jbc.M005693200; Ogut O, 2003, J BIOL CHEM, V278, P3089, DOI 10.1074/jbc.M205853200; Ottenheijm CAC, 2009, HUM MOL GENET, V18, P2359, DOI 10.1093/hmg/ddp168; Pappas CT, 2008, MOL BIOL CELL, V19, P1837, DOI 10.1091/mbc.E07-07-0690; ROOT DD, 1994, BIOCHEMISTRY-US, V33, P12581, DOI 10.1021/bi00208a008; Root DD, 2001, BIOCHEMISTRY-US, V40, P1171, DOI 10.1021/bi0015010; Sewry CA, 2001, NEUROMUSCULAR DISORD, V11, P146, DOI 10.1016/S0960-8966(00)00172-3; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; Wallgren-Pettersson C, 2004, NEUROMUSCULAR DISORD, V14, P461, DOI 10.1016/j.nmd.2004.03.006; Wang K, 1996, J BIOL CHEM, V271, P4304; Wang K, 1996, ADV BIOPHYS, V33, P123; Witt CC, 2006, EMBO J, V25, P3843, DOI 10.1038/sj.emboj.7601242	32	79	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30889	30896		10.1074/jbc.M109.049718	http://dx.doi.org/10.1074/jbc.M109.049718			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19736309	hybrid, Green Published			2022-12-25	WOS:000271378400017
J	Chawengsub, Y; Gauthier, KM; Nithipatikom, K; Hammock, BD; Falck, JR; Narsimhaswamy, D; Campbell, WB				Chawengsub, Yuttana; Gauthier, Kathryn M.; Nithipatikom, Kasem; Hammock, Bruce D.; Falck, John R.; Narsimhaswamy, Dubasi; Campbell, William B.			Identification of 13-Hydroxy-14,15-epoxyeicosatrienoic Acid as an Acid-stable Endothelium-derived Hyperpolarizing Factor in Rabbit Arteries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-INDUCED HYPOTENSION; ARACHIDONIC-ACID; SMOOTH-MUSCLE; DEPENDENT RELAXATION; NITRIC-OXIDE; TRIHYDROXYEICOSATRIENOIC ACIDS; 15-LIPOXYGENASE METABOLITE; EPOXYEICOSATRIENOIC ACIDS; VASCULAR RELAXATION; HEPOXILIN A(3)	Arachidonic acid (AA) is metabolized by endothelial 15-lipoxygenase (15-LO) to several vasodilatory eicosanoids such as 11,12,15-trihydroxyeicosatrienoic acid (11,12,15-THETA) and its proposed unstable precursor 15-hydroxy-11,12-epoxyeicosatrienoic acid (15-H-11,12-EETA). In the present study, the acid-stable 13-hydroxy-trans-14,15-epoxy-eicosatrienoic acid (13-H-14,15-EETA) was identified and its vascular activities characterized. Rabbit aorta, mesenteric arteries, and the combination of 15-LO and cytochrome P450 2J2 converted AA to two distinct HEETA metabolites. The HEETA metabolites were resistant to acidic hydrolysis but were hydrolyzed by recombinant sEH to a more polar metabolite identified by mass spectrometry as 13,14,15-THETA. Mass spectrometric analyses and HPLC comigration identified the HEETAs as threo-and erythro-diastereomers of 13-H-trans-14,15-EETA. Erythro-and threo-diastereomers of 13-H-trans-14,15-EETA relaxed endothelium-denuded rabbit small mesenteric arteries with maximum relaxations of 22.6 +/- 6.0% and 8.6 +/- 4.3%, respectively. Apamin (10(-7) M) inhibited the relaxations to the erythro-isomer(maximumrelaxation = 1.2 +/- 5.6%) and increasing [K+](o) from 4.6 to 30 mM blocked relaxations to both isomers. In cell-attached patches of mesenteric arterial smooth muscle cells (SMCs), erythro-13-H-trans-14,15-EETA (1-3 x 10(-6) M) increased mean open time of small conductance K+ channels (13-14 pS) from 0.0007 +/- 0.0007 to 0.0053 +/- 0.0042. This activation was inhibited by apamin. The erythro, but not the threo, isomer blocked angiotensin II-stimulated aortic SMC migration. These studies demonstrate that 13-H-14,15-EETAs induces vascular relaxation via K+ channel activation to cause SMC hyperpolarization. Thus, 13-H-14,15-EETA represents a new endothelial factor.	[Chawengsub, Yuttana; Gauthier, Kathryn M.; Nithipatikom, Kasem; Campbell, William B.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Falck, John R.; Narsimhaswamy, Dubasi] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Hammock, Bruce D.] Univ Calif Davis, Canc Res Ctr, Davis, CA 95616 USA	Medical College of Wisconsin; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Davis; University of California System; University of California Davis	Campbell, WB (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	wbcamp@mcw.edu	Dubasi, Narsimhaswamy/AAY-1958-2021; Falck, John R/B-3030-2011	Dubasi, Narsimhaswamy/0000-0002-6401-6293; Falck, John R/0000-0002-9219-7845	National Institutes of Health [HL-37981, GM-31278, ES-04699, ES-02710]; Robert A. Welch Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699, R37ES002710, R01ES002710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-37981, GM-31278, ES-04699, and ES-02710. This work was also supported by the Robert A. Welch Foundation.	Aggarwal NT, 2008, ARTERIOSCL THROM VAS, V28, P2209, DOI 10.1161/ATVBAHA.108.177113; Aggarwal NT, 2008, HYPERTENSION, V51, P246, DOI 10.1161/HYPERTENSIONAHA.107.104125; BOLTON TB, 1986, BRIT J PHARMACOL, V87, P713, DOI 10.1111/j.1476-5381.1986.tb14589.x; Brandes RP, 1997, ATHEROSCLEROSIS, V135, P49, DOI 10.1016/S0021-9150(97)00145-7; BRASH AR, 1994, ANN NY ACAD SCI, V744, P25, DOI 10.1111/j.1749-6632.1994.tb52720.x; Campbell WB, 2003, AM J PHYSIOL-HEART C, V285, pH2648, DOI 10.1152/ajpheart.00412.2003; Chang MS, 1996, BIOCHEMISTRY-US, V35, P464, DOI 10.1021/bi952081v; Chawengsub Y, 2008, AM J PHYSIOL-HEART C, V294, pH1348, DOI 10.1152/ajpheart.01326.2007; CHEN G, 1988, BRIT J PHARMACOL, V95, P1165, DOI 10.1111/j.1476-5381.1988.tb11752.x; COREY EJ, 1983, TETRAHEDRON LETT, V24, P4921, DOI 10.1016/S0040-4039(01)99811-9; COREY EJ, 1984, TETRAHEDRON LETT, V25, P5123, DOI 10.1016/S0040-4039(01)81540-9; Cui LJ, 2008, J AM SOC MASS SPECTR, V19, P569, DOI 10.1016/j.jasms.2008.01.007; DEMBINSKAKIEC A, 1977, PROSTAGLANDINS, V14, P1025, DOI 10.1016/0090-6980(77)90282-9; DIETZE EC, 1991, BIOCHEM PHARMACOL, V42, P1163, DOI 10.1016/0006-2952(91)90250-9; Feletou M, 2004, PHARMACOL RES, V49, P565, DOI 10.1016/j.phrs.2003.10.017; FELETOU M, 1988, BRIT J PHARMACOL, V93, P515, DOI 10.1111/j.1476-5381.1988.tb10306.x; Feletou M, 2007, ANN MED, V39, P495, DOI 10.1080/07853890701491000; Fisslthaler B, 2001, HYPERTENSION, V38, P1427, DOI 10.1161/hy1201.096532; FORSTERMANN U, 1984, BRIT J PHARMACOL, V81, P623; Gauthier KM, 2008, AM J PHYSIOL-HEART C, V294, pH1467, DOI 10.1152/ajpheart.01052.2007; Gauthier KM, 2004, HYPERTENSION, V43, P413, DOI 10.1161/01.HYP.0000110945.84443.d2; GEBREMEDHIN D, 1992, AM J PHYSIOL, V263, pH519, DOI 10.1152/ajpheart.1992.263.2.H519; GILL SS, 1979, BIOCHEM BIOPH RES CO, V89, P965, DOI 10.1016/0006-291X(79)91872-2; Hamberg M, 1999, LIPIDS, V34, P1131, DOI 10.1007/s11745-999-0464-7; HAMBERG M, 1990, ARCH BIOCHEM BIOPHYS, V283, P409, DOI 10.1016/0003-9861(90)90662-I; HERLIHY JT, 1973, CIRC RES, V33, P275, DOI 10.1161/01.RES.33.3.275; Honda H, 2001, JPN J PHARMACOL, V85, P203, DOI 10.1254/jjp.85.203; Jiang HL, 2008, J PHARMACOL EXP THER, V326, P330, DOI 10.1124/jpet.107.134858; McCallum GP, 1996, J PHARMACOL EXP THER, V278, P1188; MONCADA S, 1987, TRENDS PHARMACOL SCI, V8, P365, DOI 10.1016/0165-6147(87)90090-3; MONCADA S, 1978, PHARMACOL REV, V30, P293; Mrsny RJ, 2004, P NATL ACAD SCI USA, V101, P7421, DOI 10.1073/pnas.0400832101; NARUMIYA S, 1981, J BIOL CHEM, V256, P9583; Natarajan R, 2003, FRONT BIOSCI-LANDMRK, V8, pS783, DOI 10.2741/1144; Nie D, 2007, FRONT BIOSCI, V12, P1574, DOI 10.2741/2170; Nigam S, 2004, J BIOL CHEM, V279, P29023, DOI 10.1074/jbc.M307576200; Pace-Asciak CR, 1999, ADV EXP MED BIOL, V447, P123; PANZA JA, 1993, CIRCULATION, V87, P1468, DOI 10.1161/01.CIR.87.5.1468; Pfister SL, 1996, AM J PHYSIOL-HEART C, V270, pH1021, DOI 10.1152/ajpheart.1996.270.3.H1021; Pfister SL, 2003, ARCH BIOCHEM BIOPHYS, V420, P142, DOI 10.1016/j.abb.2003.09.026; PFISTER SL, 1992, HYPERTENSION, V20, P682, DOI 10.1161/01.HYP.20.5.682; Pfister SL, 1997, HYPERTENSION, V29, P303, DOI 10.1161/01.HYP.29.1.303; Pfister SL, 1998, J BIOL CHEM, V273, P30879, DOI 10.1074/jbc.273.47.30879; PFISTER SL, 1988, PROSTAGLANDINS, V36, P515, DOI 10.1016/0090-6980(88)90047-0; PFISTER SL, 2001, IDENTIFICATION 11 12; POWELL WS, 1980, PROSTAGLANDINS, V20, P947, DOI 10.1016/0090-6980(80)90144-6; Reynaud D, 2003, THROMB RES, V112, P245, DOI 10.1016/j.thromres.2003.12.014; Roy U, 2005, BIOCHEM J, V390, P719, DOI 10.1042/BJ20050681; Russo G, 2002, VASC PHARMACOL, V38, P259, DOI 10.1016/S1537-1891(02)00250-1; SINGER HA, 1983, J PHARMACOL EXP THER, V226, P790; Taddei S, 2006, J AM COLL CARDIOL, V48, P508, DOI 10.1016/j.jacc.2006.04.074; Tang X, 2006, ARTERIOSCL THROM VAS, V26, P78, DOI 10.1161/01.ATV.0000191640.73313.ad; Tang X, 2006, AM J PHYSIOL-HEART C, V290, pH37, DOI 10.1152/ajpheart.00491.2005; TAYLOR SG, 1988, BRIT J PHARMACOL, V94, P853, DOI 10.1111/j.1476-5381.1988.tb11597.x; Vanhoutte PM, 2004, PHARMACOL RES, V49, P503, DOI 10.1016/j.phrs.2003.11.015; Voetsch B, 2004, HISTOCHEM CELL BIOL, V122, P353, DOI 10.1007/s00418-004-0675-z; WEISS RH, 1987, ARCH BIOCHEM BIOPHYS, V252, P334, DOI 10.1016/0003-9861(87)90039-7; Wittwer J, 2007, PROSTAG LEUKOTR ESS, V77, P67, DOI 10.1016/j.plefa.2007.08.001; Yeh HC, 2007, ARCH BIOCHEM BIOPHYS, V461, P159, DOI 10.1016/j.abb.2007.03.012; Zhang DX, 2005, AM J PHYSIOL-HEART C, V288, pH302, DOI 10.1152/ajpheart.00661.2004; Zhang DX, 2004, ENDOCRINOLOGY, V145, P1571, DOI 10.1210/en.2003-1448	61	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31280	31290		10.1074/jbc.M109.025627	http://dx.doi.org/10.1074/jbc.M109.025627			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19737933	hybrid, Green Published			2022-12-25	WOS:000271378400055
J	Fox, JT; Shin, WK; Caudill, MA; Stover, PJ				Fox, Jennifer T.; Shin, William K.; Caudill, Marie A.; Stover, Patrick J.			A UV-responsive Internal Ribosome Entry Site Enhances Serine Hydroxymethyltransferase 1 Expression for DNA Damage Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; IRES-MEDIATED TRANSLATION; MESSENGER-RNA TRANSLATION; TRACT-BINDING-PROTEIN; ONE-CARBON METABOLISM; THYMIDYLATE BIOSYNTHESIS; INDUCED PHOSPHORYLATION; DEPENDENT TRANSLATION; INHIBITS TRANSLATION; MYOTONIC-DYSTROPHY	Thymidine nucleotides are required for faithful DNA synthesis and repair, and their de novo biosynthesis is regulated by serine hydroxymethyltransferase 1 (SHMT1). The SHMT1 transcript contains a heavy chain ferritin, heterogeneous nuclear ribonucleoprotein H2, and CUG-binding protein 1-responsive internal ribosome entry site (IRES) that regulates SHMT1 translation. In this study a non-lethal dose of UVC is shown to increase SHMT1 IRES activity and protein levels in four different cell lines. The mechanism for the UV-induced activation of the SHMT1 IRES involves an increase in heavy chain ferritin and heterogeneous nuclear ribonucleoprotein H2 expression and the translocation of CUG-binding protein 1 from the nucleus to the cytoplasm. The UV-induced increase in SHMT1 translation is accompanied by an increase in the small ubiquitin-like modifier-dependent nuclear localization of the de novo thymidylate biosynthesis pathway and a decrease in DNA strand breaks, indicating a role for SHMT1 and nuclear folate metabolism in DNA repair.	[Fox, Jennifer T.; Stover, Patrick J.] Cornell Univ, Grad Field Biochem & Mol & Cellular Biol, Ithaca, NY 14853 USA; [Shin, William K.; Caudill, Marie A.; Stover, Patrick J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Stover, PJ (corresponding author), Cornell Univ, Grad Field Biochem & Mol & Cellular Biol, 315 Savage Hall, Ithaca, NY 14853 USA.	pjs13@cornell.edu			USPHS [DK58144]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058144, R01DK058144] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK58144 from the USPHS.	Anderson DD, 2007, CLIN CHEM LAB MED, V45, P1760, DOI 10.1515/CCLM.2007.355; Anderson DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005839; BALLA G, 1992, J BIOL CHEM, V267, P18148; Bender K, 1997, J PHOTOCH PHOTOBIO B, V37, P1, DOI 10.1016/S1011-1344(96)07459-3; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Bushell M, 2006, MOL CELL, V23, P401, DOI 10.1016/j.molcel.2006.06.012; Cheng Z, 2008, ONCOGENE, V27, P931, DOI 10.1038/sj.onc.1210710; Cormier Patrick, 2003, Prog Cell Cycle Res, V5, P469; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; Dobbyn HC, 2008, ONCOGENE, V27, P1167, DOI 10.1038/sj.onc.1210723; Fox JT, 2009, J BIOL CHEM, V284, P31085, DOI 10.1074/jbc.M109.035576; Fritz G, 1999, MOL CELL BIOL, V19, P1768; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Girgis S, 1998, GENE, V210, P315, DOI 10.1016/S0378-1119(98)00085-7; GREEN JM, 1988, BIOCHEMISTRY-US, V27, P8014, DOI 10.1021/bi00421a007; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Holcik M, 2000, TRENDS GENET, V16, P469, DOI 10.1016/S0168-9525(00)02106-5; HORI TA, 1984, CANCER RES, V44, P703; Jiang HY, 2005, BIOCHEM J, V385, P371, DOI 10.1042/BJ20041164; Laiho M, 2003, ANN MED, V35, P391, DOI 10.1080/07853890310014605; Legrand-Poels S, 1998, J PHOTOCH PHOTOBIO B, V45, P1, DOI 10.1016/S1011-1344(98)00118-3; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; Mazan-Mamczarz K, 2003, P NATL ACAD SCI USA, V100, P8354, DOI 10.1073/pnas.1432104100; Michalowski S, 1999, NUCLEIC ACIDS RES, V27, P3534, DOI 10.1093/nar/27.17.3534; Oppenheim EW, 2001, J BIOL CHEM, V276, P19855, DOI 10.1074/jbc.M100039200; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Reed MC, 2006, J NUTR, V136, P2653, DOI 10.1093/jn/136.10.2653; Sachs AB, 2000, CELL, V101, P243, DOI 10.1016/S0092-8674(00)80834-X; SCHIRCH V, 1989, ARCH BIOCHEM BIOPHYS, V269, P371, DOI 10.1016/0003-9861(89)90120-3; SCOTT JM, 1981, LANCET, V2, P337; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; STRONG WB, 1990, J BIOL CHEM, V265, P12149; Suh JR, 2001, ANNU REV NUTR, V21, P255, DOI 10.1146/annurev.nutr.21.1.255; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Tornaletti S, 1999, BIOCHIMIE, V81, P139, DOI 10.1016/S0300-9084(99)80046-7; Ungureanu NH, 2006, J BIOL CHEM, V281, P15155, DOI 10.1074/jbc.M511319200; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang QE, 2005, NUCLEIC ACIDS RES, V33, P4023, DOI 10.1093/nar/gki684; Woeller CF, 2007, J BIOL CHEM, V282, P29927, DOI 10.1074/jbc.M706264200; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200; Wu SY, 2002, J BIOL CHEM, V277, P18077, DOI 10.1074/jbc.M110164200; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	55	31	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31097	31108		10.1074/jbc.M109.015800	http://dx.doi.org/10.1074/jbc.M109.015800			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19734144	Green Published, hybrid			2022-12-25	WOS:000271378400038
J	Panasyuk, G; Nemazanyy, I; Zhyvoloup, A; Filonenko, V; Davies, D; Robson, M; Pedley, RB; Waterfield, M; Gout, I				Panasyuk, Ganna; Nemazanyy, Ivan; Zhyvoloup, Aleksander; Filonenko, Valeriy; Davies, Derek; Robson, Mathew; Pedley, R. Barbara; Waterfield, Michael; Gout, Ivan			mTOR beta Splicing Isoform Promotes Cell Proliferation and Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; RAPAMYCIN; PHOSPHORYLATION; PATHWAY; KINASE; RAPTOR; LOCALIZATION; COMPLEX; CANCER; RICTOR	The mTOR (mammalian target of rapamycin) promotes growth in response to nutrients and growth factors and is deregulated in numerous pathologies, including cancer. The mechanisms by which mTOR senses and regulates energy metabolism and cell growth are relatively well understood, whereas the molecular events underlining how it mediates survival and proliferation remain to be elucidated. Here, we describe the existence of the mTOR splicing isoform, TOR beta, which, in contrast to the full-length protein(mTOR beta), has the potential to regulate the G(1) phase of the cell cycle and to stimulate cell proliferation. mTOR beta is an active protein kinase that mediates downstream signaling through complexing with Rictor and Raptor proteins. Remarkably, overexpression of mTOR beta transforms immortal cells and is tumorigenic in nude mice and therefore could be a proto-oncogene.	[Gout, Ivan] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, UA-143 Kiev, Ukraine; [Panasyuk, Ganna; Gout, Ivan] UCL, Inst Struct & Mol Biol, London WC1E 6BT, England; [Robson, Mathew; Pedley, R. Barbara] UCL, Dept Tumor Biol, Inst Canc, London WC1E 6BT, England; [Waterfield, Michael] UCL, Prote Unit, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Davies, Derek] Canc Res UK London Res Inst, FACS Lab, London WC2A 3PX, England; [Zhyvoloup, Aleksander] Piramed Pharma, Slough SL1 4NL, Berks, England	National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; University of London; Birkbeck University London; University College London; University of London; University College London; University of London; University College London; Cancer Research UK	Gout, I (corresponding author), Natl Acad Sci Ukraine, Inst Mol Biol & Genet, UA-143 Kiev, Ukraine.	i.gout@ucl.ac.uk	Filonenko, Valeriy V/D-5447-2015; Panasyuk, Ganna/AAF-4350-2021; Panasyuk, Ganna/A-4133-2018	Filonenko, Valeriy V/0000-0003-1839-3335; Panasyuk, Ganna/0000-0002-5591-848X; Panasyuk, Ganna/0000-0002-5591-848X; Davies, Derek/0000-0002-6977-4181	New Independent States of the former Soviet; Atlantic Philanthropies/Ludwig Institute for Cancer Research Clinical Discovery Program	New Independent States of the former Soviet; Atlantic Philanthropies/Ludwig Institute for Cancer Research Clinical Discovery Program	We thank P. Driscoll, D. Saggerson, J. Brockes, and N. Shaikh for critical comments on the manuscript and J. Downward for providing NIH 3T3 RasG12/C40 cells.; This work was supported in part by an International Association for the promotion of co-operation with scientists from the New Independent States of the former Soviet grant and the Atlantic Philanthropies/Ludwig Institute for Cancer Research Clinical Discovery Program ( to I. G.).	Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Desai BN, 2002, P NATL ACAD SCI USA, V99, P4319, DOI 10.1073/pnas.261702698; Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555; El Emir E, 2007, CANCER RES, V67, P11896, DOI 10.1158/0008-5472.CAN-07-2967; GRATZNER HG, 1975, EXP CELL RES, V95, P88, DOI 10.1016/0014-4827(75)90612-6; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Liu XY, 2007, MOL BIOL CELL, V18, P1073, DOI 10.1091/mbc.E06-05-0406; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Nemazanyy I, 2008, HYBRIDOMA, V27, P395, DOI 10.1089/hyb.2008.0035; Obaya AJ, 1999, ONCOGENE, V18, P2934, DOI 10.1038/sj.onc.1202749; Reynolds TH, 2002, J BIOL CHEM, V277, P17657, DOI 10.1074/jbc.M201142200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sekulic A, 2000, CANCER RES, V60, P3504; Takahara T, 2006, J BIOL CHEM, V281, P28605, DOI 10.1074/jbc.M606087200; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200	26	28	29	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30807	30814		10.1074/jbc.M109.056085	http://dx.doi.org/10.1074/jbc.M109.056085			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19726679	Green Published, hybrid			2022-12-25	WOS:000271378400008
J	Gong, HBA; He, JH; Lee, JH; Mallick, E; Gao, X; Li, S; Homanics, GE; Xie, W				Gong, Haibiao; He, Jinhan; Lee, Jung Hoon; Mallick, Edward; Gao, Xiang; Li, Song; Homanics, Gregg E.; Xie, Wen			Activation of the Liver X Receptor Prevents Lipopolysaccharide-induced Lung Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR RECEPTOR; OXIDATIVE STRESS; GENE; LXR; GAMMA; EXPRESSION; MICE; INFLAMMATION; GLUTATHIONE; SURFACTANT	The liver X receptors (LXRs) have been known as sterol sensors that impact cholesterol and lipid homeostasis, as well as inflammation. Although the hepatic functions of LXRs are well documented, whether and how LXRs play a pathophysiological role in the lung remain largely unknown. Here we show that LXR alpha and LXR beta are expressed in both type I and type II mouse lung epithelial cells, as well as in human lung cancer cells. To study the role of LXR alpha in vivo including the pulmonary function of this LXR isoform, we created LXR alpha knock-in (LXR-KI) mice in which a constitutively activated LXR alpha (VP-LXR alpha) was inserted into the mouse LXR alpha locus. We show that activation of LXR in LXR-KI mice or LXR agonist-treated wild type mice induced pulmonary expression of genes encoding multiple antioxidant enzymes. Consistent with the induction of antioxidant enzymes, LXR-KI mice and LXR ligand-treated wild type mice showed a substantial resistance to lipopolysaccharide-induced lung injury and decreased production of reactive oxygen species. In summary, we have uncovered a novel role of LXR in regulating antioxidant enzymes in the lung and the implication of this regulation in pulmonary tissue protection.	[Gong, Haibiao; He, Jinhan; Lee, Jung Hoon; Gao, Xiang; Li, Song; Xie, Wen] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA; [Gong, Haibiao; He, Jinhan; Lee, Jung Hoon; Gao, Xiang; Li, Song; Xie, Wen] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Mallick, Edward; Homanics, Gregg E.] Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Homanics, Gregg E.; Xie, Wen] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xie, W (corresponding author), Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA.	wex6@pitt.edu	Xie, Wen/M-1768-2016	Homanics, Gregg/0000-0003-3641-8153	National Institutes of Health [ES014626, DK076962, N01-DK-7-0004/HHSN267200700004C]; National Institutes of Health Shared Instrument [S10RR022515]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Shared Instrument(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES014626 and DK076962 (to W. X.) and National Institutes of Health Shared Instrument Grant S10RR022515 (to Robert Gibbs).; We thank Carolyn Ferguson for technical assistance with the embryonic stem cell work, Dr. Robert Gibbs for assistance with the use of the confocal microscope, and Dr. Steve Strom for primary human hepatocytes. Normal human hepatocytes were obtained through the Liver Tissue Procurement and Distribution System, Pittsburgh, Pennsylvania, which was funded by National Institutes of Health Contract N01-DK-7-0004/HHSN267200700004C.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Albers M, 2006, J BIOL CHEM, V281, P4920, DOI 10.1074/jbc.M510101200; Asada K, 2004, AM J RESP CRIT CARE, V169, P195, DOI 10.1164/rccm.200207-740OC; Been JV, 2007, EUR J PEDIATR, V166, P889, DOI 10.1007/s00431-007-0501-4; Birrell MA, 2007, J BIOL CHEM, V282, P31882, DOI 10.1074/jbc.M703278200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Castrillo A, 2003, J BIOL CHEM, V278, P10443, DOI 10.1074/jbc.M213071200; Castrillo A, 2003, MOL CELL, V12, P805, DOI 10.1016/S1097-2765(03)00384-8; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Chow CW, 2003, AM J RESP CELL MOL, V29, P427, DOI 10.1165/rcmb.F278; Christensen PJ, 1999, AM J PATHOL, V155, P1773, DOI 10.1016/S0002-9440(10)65493-4; Christofidou-Solomidou Melpo, 2006, Treat Respir Med, V5, P47, DOI 10.2165/00151829-200605010-00004; Cummins CL, 2006, J CLIN INVEST, V116, P1902, DOI 10.1172/JCI28400; Gong HB, 2006, MOL ENDOCRINOL, V20, P279, DOI 10.1210/me.2005-0205; Gong HB, 2004, EXPERT OPIN THER TAR, V8, P49, DOI 10.1517/14728222.8.1.49; Guo RF, 2007, ANTIOXID REDOX SIGN, V9, P1991, DOI 10.1089/ars.2007.1785; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Homanics GE, 1997, MOL PHARMACOL, V51, P588, DOI 10.1124/mol.51.4.588; JENKINS JK, 1991, AM REV RESPIR DIS, V143, P155, DOI 10.1164/ajrccm/143.1.155; Jia LY, 2008, AM J PHYSIOL-CELL PH, V294, pC47, DOI 10.1152/ajpcell.00019.2007; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kennedy MA, 2001, J BIOL CHEM, V276, P39438, DOI 10.1074/jbc.M105863200; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Lang JD, 2002, CHEST, V122, p314S, DOI 10.1378/chest.122.6_suppl.314S; Mastruzzo C, 2002, Monaldi Arch Chest Dis, V57, P173; Matsukawa A, 1999, J IMMUNOL, V163, P6148; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakamura T, 2005, ANTIOXID REDOX SIGN, V7, P60, DOI 10.1089/ars.2005.7.60; PAOLETTI F, 1990, METHOD ENZYMOL, V186, P209; Park EY, 2004, CANCER RES, V64, P3701, DOI 10.1158/0008-5472.CAN-03-3924; Rahman I, 2005, ANTIOXID REDOX SIGN, V7, P42, DOI 10.1089/ars.2005.7.42; Rahman Irfan, 2008, Ther Adv Respir Dis, V2, P351, DOI 10.1177/1753465808098224; Reddy RC, 2004, AM J PHYSIOL-LUNG C, V286, pL613, DOI 10.1152/ajplung.00206.2003; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Ritter C, 2004, CRIT CARE MED, V32, P342, DOI 10.1097/01.CCM.0000109454.13145.CA; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Szarka RJ, 1997, J IMMUNOL METHODS, V202, P49, DOI 10.1016/S0022-1759(96)00236-0; Tangirala RK, 2002, P NATL ACAD SCI USA, V99, P11896, DOI 10.1073/pnas.182199799; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Uppal H, 2007, HEPATOLOGY, V45, P422, DOI 10.1002/hep.21494; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; VOORHOUT WF, 1992, AM J PHYSIOL, V263, pL479, DOI 10.1152/ajplung.1992.263.4.L479; Wells Christine A, 2003, BMC Immunol, V4, P5, DOI 10.1186/1471-2172-4-5; Wesselkamper SC, 2006, AM J RESP CELL MOL, V34, P73, DOI 10.1165/rcmb.2005-0248OC; Willson DF, 2008, PEDIATR CLIN N AM, V55, P545, DOI 10.1016/j.pcl.2008.02.016; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	54	36	39	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30113	30121		10.1074/jbc.M109.047753	http://dx.doi.org/10.1074/jbc.M109.047753			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19717840	hybrid, Green Published			2022-12-25	WOS:000271090000014
J	Link, S; Meissner, M; Held, B; Beck, A; Weissgerber, P; Freichel, M; Flockerzi, V				Link, Sabine; Meissner, Marcel; Held, Brigitte; Beck, Andreas; Weissgerber, Petra; Freichel, Marc; Flockerzi, Veit			Diversity and Developmental Expression of L-type Calcium Channel beta 2 Proteins and Their Influence on Calcium Current in Murine Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CA2+ CHANNEL; ALPHA(1) SUBUNIT; FUNCTIONAL EXPRESSION; CA(V)1.2 CHANNEL; SPLICE VARIANTS; BETA(2) SUBUNIT; TRANSGENIC MICE; CONTRACTION; MODULATION; SITES	By now, little is known on L-type calcium channel (LTCC) subunits expressed in mouse heart. We show that CaV beta 2 proteins are the major CaV beta components of the LTCC in embryonic and adult mouse heart, but that in embryonic heart CaV beta 3 proteins are also detectable. At least two CaV beta 2 variants of similar to 68 and similar to 72 kDa are expressed. To identify the underlying CaV beta 2 variants, cDNA libraries were constructed from poly(A)(+) RNA isolated from hearts of 7-day-old and adult mice. Screening identified 60 independent CaV beta 2 cDNA clones coding for four types of CaV beta 2 proteins only differing in their 5' sequences. CaV beta 2-N1, -N4, and -N5 but not -N3 were identified in isolated cardiomyocytes by RT-PCR and were sufficient to reconstitute the CaV beta 2 protein pattern in vitro. Significant L-type Ca2+ currents (I-Ca) were recorded in HEK293 cells after co-expression of CaV1.2 and CaV beta 2. Current kinetics were determined by the type of CaV beta 2 protein, with the similar to 72-kDa CaV beta 2a-N1 shifting the activation of I-Ca significantly to depolarizing potentials compared with the other CaV beta 2 variants. Inactivation of I-Ca was accelerated by CaV beta 2a-N1 and -N4, which also lead to slower activation compared with CaV beta 2a-N3 and -N5. In summary, this study reveals the molecular LTCC composition in mouse heart and indicates that expression of various CaV beta 2 proteins may be used to adapt the properties of LTCCs to changing myocardial requirements during development and that CaV beta 2a-N1-induced changes of I-Ca kinetics might be essential in embryonic heart.	[Link, Sabine; Flockerzi, Veit] Univ Saarland, Klin Pharmakol & Toxikol, D-66421 Homburg, Germany	Saarland University	Link, S (corresponding author), Univ Saarland, Klin Pharmakol & Toxikol, D-66421 Homburg, Germany.	sabine.link@uks.eu; veit.flockerzi@uks.eu	Tuluc, Petronel/C-2527-2011		HOMFOR; Deutsche Forschungsgemeinschaft; Forschungskommission der Universitat des Saarlandes; Fonds der Chemischen Industrie	HOMFOR; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungskommission der Universitat des Saarlandes; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported in part by HOMFOR (to M. M. and V. F.), Deutsche Forschungsgemeinschaft and Forschungskommission der Universitat des Saarlandes (to V. F.), and Fonds der Chemischen Industrie (to V. F.).	Allen TJA, 1998, PFLUG ARCH EUR J PHY, V436, P238, DOI 10.1007/s004240050628; Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen XW, 2005, CIRC RES, V97, P1009, DOI 10.1161/01.RES.0000189270.72915.D1; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; Cordeiro JM, 2009, J MOL CELL CARDIOL, V46, P695, DOI 10.1016/j.yjmcc.2009.01.014; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; Ding S, 1999, J BIOCHEM, V125, P750, DOI 10.1093/oxfordjournals.jbchem.a022346; Dolphin AC, 2003, PHARMACOL REV, V55, P607, DOI 10.1124/pr.55.4.3; FABIATO A, 1979, ANNU REV PHYSIOL, V41, P473, DOI 10.1146/annurev.ph.41.030179.002353; Foell JD, 2004, PHYSIOL GENOMICS, V17, P183, DOI 10.1152/physiolgenomics.00207.2003; Gerhardstein BL, 1999, BIOCHEMISTRY-US, V38, P10361, DOI 10.1021/bi990896o; Gong HC, 2001, J MEMBRANE BIOL, V184, P35, DOI 10.1007/s00232-001-0072-7; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Groner F, 2004, BIOCHEM BIOPH RES CO, V314, P878, DOI 10.1016/j.bbrc.2003.12.174; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Haase H, 2000, J CELL BIOCHEM, V76, P695, DOI 10.1002/(SICI)1097-4644(20000315)76:4<695::AID-JCB17>3.0.CO;2-Q; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; Harry JB, 2004, J BIOL CHEM, V279, P46367, DOI 10.1074/jbc.M409523200; Herzig S, 2007, FASEB J, V21, P1527, DOI 10.1096/fj.06-7377com; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; Hullin R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000292; Jaleel N, 2008, CIRC RES, V103, P1109, DOI 10.1161/CIRCRESAHA.108.185611; Jones LP, 1998, J GEN PHYSIOL, V112, P125, DOI 10.1085/jgp.112.2.125; KAESTNER L, 2007, P SPIE, V6633; MASSA E, 1995, MOL PHARMACOL, V47, P707; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MITTERDORFER J, 1994, FEBS LETT, V352, P141, DOI 10.1016/0014-5793(94)00938-4; Murakami M, 2003, J BIOL CHEM, V278, P43261, DOI 10.1074/jbc.M211380200; Muth JN, 1999, J BIOL CHEM, V274, P21503, DOI 10.1074/jbc.274.31.21503; Namkung Y, 1998, P NATL ACAD SCI USA, V95, P12010, DOI 10.1073/pnas.95.20.12010; PEARSON HA, 1993, PFLUG ARCH EUR J PHY, V425, P518, DOI 10.1007/BF00374880; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; REUTER H, 1983, NATURE, V301, P569, DOI 10.1038/301569a0; Takahashi SX, 2003, BIOPHYS J, V84, P3007, DOI 10.1016/S0006-3495(03)70027-7; Takemura H, 2005, CIRC J, V69, P1405, DOI 10.1253/circj.69.1405; Tang ZZ, 2008, BBA-MOL CELL RES, V1783, P118, DOI 10.1016/j.bbamcr.2007.11.003; Tang ZZ, 2004, J BIOL CHEM, V279, P44335, DOI 10.1074/jbc.M407023200; Viatchenko-Karpinski S, 1999, P NATL ACAD SCI USA, V96, P8259, DOI 10.1073/pnas.96.14.8259; WAHLER GM, 1994, AM J PHYSIOL, V267, pH1157, DOI 10.1152/ajpheart.1994.267.3.H1157; Walker D, 1998, TRENDS NEUROSCI, V21, P148, DOI 10.1016/S0166-2236(97)01200-9; Weissgerber P, 2006, CIRC RES, V99, P749, DOI 10.1161/01.RES.0000243978.15182.c1	49	44	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30129	30137		10.1074/jbc.M109.045583	http://dx.doi.org/10.1074/jbc.M109.045583			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19723630	Green Published, hybrid			2022-12-25	WOS:000271090000016
J	Masuda, T; Ito, Y; Terada, T; Shibata, T; Mikawa, T				Masuda, Tokiha; Ito, Yutaka; Terada, Tohru; Shibata, Takehiko; Mikawa, Tsutomu			A Non-canonical DNA Structure Enables Homologous Recombination in Various Genetic Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI RECA PROTEIN; SINGLE-STRANDED-DNA; ELECTRON-MICROSCOPIC VISUALIZATION; MOLECULAR-STRUCTURE DETERMINATION; HUMAN RAD52 PROTEIN; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; DUPLEX DNA; BACTERIOPHAGE-LAMBDA; RNA RECOMBINATION	Homologous recombination, which is critical to genetic diversity, depends on homologous pairing (HP). HP is the switch from parental to recombinant base pairs, which requires expansion of inter-base pair spaces. This expansion unavoidably causes untwisting of the parental double-stranded DNA. RecA/Rad51-catalyzed ATP-dependent HP is extensively stimulated in vitro by negative supercoils, which compensates for untwisting. However, in vivo, double-stranded DNA is relaxed by bound proteins and thus is an unfavorable substrate for RecA/Rad51. In contrast, Mhr1, an ATP-independent HP protein required for yeast mitochondrial homologous recombination, catalyzes HP without the net untwisting of double-stranded DNA. Therefore, we questioned whether Mhr1 uses a novel strategy to promote HP. Here, we found that, like RecA, Mhr1 induced the extension of bound single-stranded DNA. In addition, this structure was induced by all evolutionarily and structurally distinct HP proteins so far tested, including bacterial RecO, viral RecT, and human Rad51. Thus, HP includes the common non-canonical DNA structure and uses a common core mechanism, independent of the species of HP proteins. We discuss the significance of multiple types of HP proteins.	[Mikawa, Tsutomu] RIKEN, Adv Sci Inst, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Masuda, Tokiha; Shibata, Takehiko; Mikawa, Tsutomu] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Terada, Tohru] RIKEN, Computat Sci Res Program, Wako, Saitama 3510198, Japan; [Ito, Yutaka] Tokyo Metropolitan Univ, Dept Chem, Tokyo 1920397, Japan; [Terada, Tohru] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Mikawa, Tsutomu] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	RIKEN; Yokohama City University; RIKEN; Tokyo Metropolitan University; University of Tokyo; RIKEN	Mikawa, T (corresponding author), RIKEN, Adv Sci Inst, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	mikawa@riken.jp	Mikawa, Tsutomu/E-6510-2013; Ito, Yutaka/P-2604-2015; Terada, Tohru/W-2956-2019	Mikawa, Tsutomu/0000-0003-2325-5084; Ito, Yutaka/0000-0002-1030-4660; Terada, Tohru/0000-0002-7091-0646	Japan Society for the Promotion of Science (JSPS); Research and Development of the Next-Generation Integrated Simulation of Living Matter; Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research and Development of the Next-Generation Integrated Simulation of Living Matter(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant-in-aid from the Japan Society for the Promotion of Science (JSPS), and Research and Development of the Next-Generation Integrated Simulation of Living Matter, a part of the Development and Use of the Next-Generation Supercomputer Project of the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant from the JSPS.	Baumann P, 1997, EMBO J, V16, P5198, DOI 10.1093/emboj/16.17.5198; CARON F, 1979, P NATL ACAD SCI USA, V76, P4265, DOI 10.1073/pnas.76.9.4265; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Chetverin AB, 1999, FEBS LETT, V460, P1, DOI 10.1016/S0014-5793(99)01282-X; CLARK AJ, 1993, J BACTERIOL, V175, P7673, DOI 10.1128/JB.175.23.7673-7682.1993; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; CUNNINGHAM RP, 1979, NATURE, V281, P191, DOI 10.1038/281191a0; DUNN K, 1982, CELL, V28, P757, DOI 10.1016/0092-8674(82)90055-1; Egel R, 2007, DNA REPAIR, V6, P669, DOI 10.1016/j.dnarep.2006.12.013; FISHER RP, 1992, J BIOL CHEM, V267, P3358; FLORY J, 1984, P NATL ACAD SCI-BIOL, V81, P7026, DOI 10.1073/pnas.81.22.7026; HEUSER J, 1989, J MOL BIOL, V210, P473, DOI 10.1016/0022-2836(89)90124-1; Inoue J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl350; Inoue J, 2008, NUCLEIC ACIDS RES, V36, P94, DOI 10.1093/nar/gkm1004; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Kagawa W, 2001, J BIOL CHEM, V276, P35201, DOI 10.1074/jbc.M104938200; Kagawa W, 2008, J BIOL CHEM, V283, P24264, DOI 10.1074/jbc.M802204200; KAHN R, 1981, P NATL ACAD SCI-BIOL, V78, P4786, DOI 10.1073/pnas.78.8.4786; KING AMQ, 1982, CELL, V29, P921, DOI 10.1016/0092-8674(82)90454-8; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; KRAULIS PJ, 1989, J MAGN RESON, V84, P627, DOI 10.1016/0022-2364(89)90130-3; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Kurumizaka H, 2001, P NATL ACAD SCI USA, V98, P5538, DOI 10.1073/pnas.091603098; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; Leiros I, 2005, EMBO J, V24, P906, DOI 10.1038/sj.emboj.7600582; Ling F, 2002, EMBO J, V21, P4730, DOI 10.1093/emboj/cdf466; Ling F, 2009, J BIOL CHEM, V284, P9341, DOI 10.1074/jbc.M900023200; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; LUISIDELUCA C, 1995, J BACTERIOL, V177, P566, DOI 10.1128/jb.177.3.566-572.1995; Matsuo Y, 2006, FEBS J, V273, P3148, DOI 10.1111/j.1742-4658.2006.05323.x; Mazloum N, 2008, P NATL ACAD SCI USA, V105, P524, DOI 10.1073/pnas.0707031105; MCENTEE K, 1979, P NATL ACAD SCI USA, V76, P2615, DOI 10.1073/pnas.76.6.2615; MIKAWA T, 1995, J MOL BIOL, V250, P471, DOI 10.1006/jmbi.1995.0391; Nishinaka T, 1997, P NATL ACAD SCI USA, V94, P6623, DOI 10.1073/pnas.94.13.6623; Nishinaka T, 1998, P NATL ACAD SCI USA, V95, P11071, DOI 10.1073/pnas.95.19.11071; Noirot P, 2003, EMBO J, V22, P324, DOI 10.1093/emboj/cdg027; Noirot P, 1998, J BIOL CHEM, V273, P12274, DOI 10.1074/jbc.273.20.12274; Passy SI, 1999, P NATL ACAD SCI USA, V96, P4279, DOI 10.1073/pnas.96.8.4279; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Post CB, 2003, CURR OPIN STRUC BIOL, V13, P581, DOI 10.1016/j.sbi.2003.09.012; ROUVIEREYANIV J, 1979, CELL, V17, P265, DOI 10.1016/0092-8674(79)90152-1; Rybalchenko N, 2004, P NATL ACAD SCI USA, V101, P17056, DOI 10.1073/pnas.0408046101; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P5100, DOI 10.1073/pnas.76.10.5100; SHIBATA T, 1981, J BIOL CHEM, V256, P7557; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P1638, DOI 10.1073/pnas.76.4.1638; Shibata T, 2001, P NATL ACAD SCI USA, V98, P8425, DOI 10.1073/pnas.111005198; SHIBATA T, 1981, J BIOL CHEM, V256, P7565; STASIAK A, 1982, NATURE, V299, P185, DOI 10.1038/299185a0; STASIAK A, 1981, J MOL BIOL, V151, P557, DOI 10.1016/0022-2836(81)90010-3; THRESHER RJ, 1995, J MOL BIOL, V254, P364, DOI 10.1006/jmbi.1995.0623; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Vlieghe D, 1996, SCIENCE, V273, P1702, DOI 10.1126/science.273.5282.1702; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Yoshimasu M, 2003, NUCLEIC ACIDS RES, V31, P1735, DOI 10.1093/nar/gkg256; YU X, 1992, J MOL BIOL, V227, P334, DOI 10.1016/0022-2836(92)90702-L	59	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30230	30239		10.1074/jbc.M109.043810	http://dx.doi.org/10.1074/jbc.M109.043810			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19729448	Green Published, hybrid			2022-12-25	WOS:000271090000026
J	Datta, K; Guan, T; Gerace, L				Datta, Kaustuv; Guan, Tinglu; Gerace, Larry			NET37, a Nuclear Envelope Transmembrane Protein with Glycosidase Homology, Is Involved in Myoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; LIVER MICROSOMAL GLUCOSIDASES; MUSCLE-CELL SURVIVAL; GROWTH-FACTOR-II; SKELETAL-MUSCLE; ALPHA-GLUCOSIDASE; MEMBRANE PROTEIN; LAMIN-A/C; MYOCYTE MATURATION; LEM-DOMAIN	The nuclear lamina and its associated proteins are important for nuclear structure and chromatin organization and also have been implicated in the regulation of cell signaling and gene expression. In this study we demonstrate that the lamina-associated nuclear envelope transmembrane protein NET37 is required for myogenic differentiation of C2C12 cells. NET37, a member of glycosidase family 31, is highly expressed in mouse skeletal muscle and is strongly up-regulated during C2C12 differentiation. By protease mapping we show that its glycosidase homology domain is located in the lumen of the nuclear envelope/endoplasmic reticulum. When NET37 is depleted from proliferating myoblasts by RNAi, myogenic differentiation is significantly impaired, and there is a concomitant delay in up-regulation of the late myogenic transcription factor myogenin. We expressed silencing-resistant NET37 mutated at a conserved residue in the glycosidase domain and found that this predicted catalytically inactive protein is unable to support myogenesis in cells depleted of wild type NET37. Therefore, the enzymatic function of NET37 appears to be important for myogenic differentiation. C2C12 cells depleted of NET37 have reduced activation of Akt after shifting to differentiation medium and are defective in insulin like growth factor-II (IGF-II) secretion, an autocrine/paracrine factor involved in Akt activation. We also observed that pro-IGF-II co-immunoprecipitates with NET37. Based on our results, we propose that NET37 has a role in IGF-II maturation in the secretory pathway during myoblast differentiation. The localization of NET37 at the nuclear envelope raises the possibility that it may coordinate myogenic events between the nuclear interior and the endoplasmic reticulum lumen via transmembrane communication.	[Gerace, Larry] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Gerace, L (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd IMM10, La Jolla, CA 92037 USA.	lgerace@scripps.edu	Datta, Kaustuv/GLT-0146-2022	Datta, Kaustuv/0000-0002-6834-2192	National Institutes of Health [GM28521]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028521] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM28521 (to L. G.).	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; BURNS DM, 1982, J BIOL CHEM, V257, P9991; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen IHB, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-38; Cohen TV, 2008, BIOCHEM SOC T, V36, P1329, DOI 10.1042/BST0361329; Crisp M, 2008, FEBS LETT, V582, P2023, DOI 10.1016/j.febslet.2008.05.001; Duguay SJ, 1998, J BIOL CHEM, V273, P18443, DOI 10.1074/jbc.273.29.18443; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; FLORINI JR, 1991, ANNU REV PHYSIOL, V53, P201, DOI 10.1146/annurev.ph.53.030191.001221; Frandsen TP, 1998, PLANT MOL BIOL, V37, P1, DOI 10.1023/A:1005925819741; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; GRINNA LS, 1980, J BIOL CHEM, V255, P2255; GRINNA LS, 1979, J BIOL CHEM, V254, P8814; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Guo K, 1997, J BIOL CHEM, V272, P791, DOI 10.1074/jbc.272.2.791; GUO K, 1995, MOL CELL BIOL, V15, P3823; Hellemans J, 2004, NAT GENET, V36, P1213, DOI 10.1038/ng1453; HENRISSAT B, 1995, BIOCHEM J, V311, P350, DOI 10.1042/bj3110350; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HERMANS MMP, 1991, J BIOL CHEM, V266, P13507; Lawlor MA, 2000, MOL CELL BIOL, V20, P8983, DOI 10.1128/MCB.20.23.8983-8995.2000; Lawlor MA, 2000, J CELL BIOL, V151, P1131, DOI 10.1083/jcb.151.6.1131; Lee SS, 2002, J AM CHEM SOC, V124, P4948, DOI 10.1021/ja0255610; Lee SS, 2001, BIOCHEM J, V359, P381, DOI 10.1042/0264-6021:3590381; Lin F, 2000, J BIOL CHEM, V275, P4840, DOI 10.1074/jbc.275.7.4840; Lluis F, 2006, TRENDS CELL BIOL, V16, P36, DOI 10.1016/j.tcb.2005.11.002; Manilal S, 1996, HUM MOL GENET, V5, P801, DOI 10.1093/hmg/5.6.801; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mauro A, 2002, J CELL SCI, V115, P3587, DOI 10.1242/jcs.00037; Mounkes L, 2003, CURR OPIN GENET DEV, V13, P223, DOI 10.1016/S0959-437X(03)00058-3; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; Muchir A, 2007, HUM MOL GENET, V16, P1884, DOI 10.1093/hmg/ddm137; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Musaro A, 2004, P NATL ACAD SCI USA, V101, P1206, DOI 10.1073/pnas.0303792101; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Okuyama M, 2001, EUR J BIOCHEM, V268, P2270, DOI 10.1046/j.1432-1327.2001.02104.x; Ostrovsky O, 2009, MOL BIOL CELL, V20, P1855, DOI 10.1091/mbc.E08-04-0346; Pan D, 2005, J BIOL CHEM, V280, P15992, DOI 10.1074/jbc.M411234200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Qiang L, 2007, MOL CELL BIOL, V27, P4698, DOI 10.1128/MCB.02279-06; Ren HX, 2008, J CELL BIOL, V182, P979, DOI 10.1083/jcb.200712110; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; SALAMITOU S, 1994, J BACTERIOL, V176, P2828, DOI 10.1128/JB.176.10.2828-2834.1994; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Shaklai S, 2007, FEBS J, V274, P1383, DOI 10.1111/j.1742-4658.2007.05697.x; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Trombetta ES, 2003, GLYCOBIOLOGY, V13, p77R, DOI 10.1093/glycob/cwg075; Wagner N, 2007, INT REV CYTOL, V261, P1, DOI 10.1016/S0074-7696(07)61001-8; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Waterham HR, 2003, AM J HUM GENET, V72, P1013, DOI 10.1086/373938; Wilson EM, 2007, J BIOL CHEM, V282, P5106, DOI 10.1074/jbc.C600315200; Wilson EM, 2004, MOL BIOL CELL, V15, P497, DOI 10.1091/mbc.E03-05-0351; Wilson EM, 2003, J BIOL CHEM, V278, P41109, DOI 10.1074/jbc.C300299200; Worman HJ, 2005, INT REV CYTOL, V246, P231, DOI 10.1016/S0074-7696(05)46006-4; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028	60	28	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29666	29676		10.1074/jbc.M109.034041	http://dx.doi.org/10.1074/jbc.M109.034041			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19706595	Green Published, hybrid			2022-12-25	WOS:000270896800048
J	Lee, KS; Iijima-Ando, K; Iijima, K; Lee, WJ; Lee, JH; Yu, K; Lee, DS				Lee, Kyu-Sun; Iijima-Ando, Kanae; Iijima, Koichi; Lee, Won-Jae; Lee, Joon H.; Yu, Kweon; Lee, Dong-Seok			JNK/FOXO-mediated Neuronal Expression of Fly Homologue of Peroxiredoxin II Reduces Oxidative Stress and Extends Life Span	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; MITOCHONDRIAL DYSFUNCTION; GENE FAMILY; DROSOPHILA; PROTEIN; CELLS; JNK; GROWTH; BRAIN; BODY	Activation of c-Jun N-terminal kinase (JNK) signaling in neurons increases stress resistance and extends life span, in part through FOXO-mediated transcription in Drosophila. However, the JNK/FOXO target genes are unknown. Here, we identified Jafrac1, a Drosophila homolog of human Peroxiredoxin II (hPrxII), as a downstream effecter of JNK/FOXO signaling in neurons that enhances stress resistance and extends life span. We found that Jafrac1 was expressed in the adult brain and induced by paraquat, a reactive oxygen species-generating chemical. RNA interference-mediated neuronal knockdown of Jafrac1 enhanced, while neuronal overexpression of Jafrac1 and hPrxII suppressed, paraquat-induced lethality in flies. Neuronal expression of Jafrac1 also significantly reduced ROS levels, restored mitochondrial function, and attenuated JNK activation caused by paraquat. Activation of JNK/FOXO signaling in neurons increased the Jafrac1 expression level under both normal and oxidative stressed conditions. Moreover, neuronal knockdown of Jafrac1 shortened, while overexpression of Jafrac1 and hPrxII extended, the life span in flies. These results support the hypothesis that JNK/FOXO signaling extends life span via amelioration of oxidative damage and mitochondrial dysfunction in neurons.	[Lee, Won-Jae] Natl Creat Res Initiat Ctr Symbiosyst, Seoul 120750, South Korea; [Lee, Won-Jae] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea; [Lee, Dong-Seok] Kyungpook Natl Univ, Coll Nat Sci, Taegu 702701, South Korea; [Lee, Joon H.] Konyang Univ, Coll Med, Kims Eye Hosp, Myung Gok Eye Res Inst, Chungnam 302718, South Korea; [Lee, Kyu-Sun; Yu, Kweon] Korea Res Inst Biosci & Biotechnol, Aging Res Ctr, Taejon 305806, South Korea; [Iijima, Koichi] Thomas Jefferson Univ, Farber Inst Neurosci, Dept Biochem & Mol Biol, Lab Neurodegenerat & Metab Dis, Philadelphia, PA 19107 USA; [Iijima-Ando, Kanae] Thomas Jefferson Univ, Farber Inst Neurosci, Dept Biochem & Mol Biol, Lab Neurogenet & Pathobiol, Philadelphia, PA 19107 USA	Ewha Womans University; Kyungpook National University; Konyang University; Konyang University Hospital; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Jefferson University; Jefferson University	Yu, K (corresponding author), 111 Gwahangno Yuseong Gu, Taejon 305806, South Korea.	kweonyu@kribb.re.kr; lee1@knu.ac.kr		Yu, Kweon/0000-0002-4942-2576	National Institutes of Health [R01AG032279]; Korea Science & Engineering Foundation [2009-0074555, R01-2008-000-21076-0]; BioGreen21 Program [20080401034-050-008-01-00]; Rural Development Administration; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program, Republic of Korea [KGM3310912]; Thomas Jefferson University; Gilbert Foundation/the American Federation for Aging Research; Alzheimer's Association [NIRG-08-91985]; NATIONAL INSTITUTE ON AGING [R01AG032279] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Science & Engineering Foundation(Korea Science and Engineering Foundation); BioGreen21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Korea Research Institute of Bioscience and Biotechnology Research Initiative Program, Republic of Korea; Thomas Jefferson University; Gilbert Foundation/the American Federation for Aging Research; Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AG032279 (to K. I. and K. I.-A.). This work was also supported by the Korea Science & Engineering Foundation (Grants 2009-0074555 and R01-2008-000-21076-0), by the BioGreen21 Program (Grant 20080401034-050-008-01-00), by the Rural Development Administration, and by the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program (Grant KGM3310912), Republic of Korea, by a pilot research grant from the Thomas Jefferson University (to K. I.), and by grants from the Gilbert Foundation/the American Federation for Aging Research (to K. I.) and the Alzheimer's Association (Grant NIRG-08-91985 to K. I.).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fridell YWC, 2005, CELL METAB, V1, P145, DOI 10.1016/j.cmet.2005.01.005; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Jin MH, 2005, NEUROSCI LETT, V381, P252, DOI 10.1016/j.neulet.2005.02.048; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; LIM YS, 1993, BIOCHEM BIOPH RES CO, V192, P273, DOI 10.1006/bbrc.1993.1410; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Matsumoto A, 1999, FEBS LETT, V443, P246, DOI 10.1016/S0014-5793(98)01736-0; Morrow G, 2004, FASEB J, V18, P598, DOI 10.1096/fj.03-0860fje; Mourikis P, 2006, P NATL ACAD SCI USA, V103, P1307, DOI 10.1073/pnas.0510564103; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Radyuk SN, 2003, BIOCHEM J, V371, P743, DOI 10.1042/BJ20021522; Radyuk SN, 2001, FREE RADICAL BIO MED, V31, P1090, DOI 10.1016/S0891-5849(01)00692-X; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; Salvaterra Paul M., 2001, Gene Expression Patterns, V1, P73, DOI 10.1016/S1567-133X(01)00011-4; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Strayer A, 2003, FASEB J, V17, P2305, DOI 10.1096/fj.03-0376fje; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273	30	101	106	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29454	29461		10.1074/jbc.M109.028027	http://dx.doi.org/10.1074/jbc.M109.028027			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19720829	Green Published, hybrid			2022-12-25	WOS:000270896800027
J	O'Donnell, CD; Shukla, D				O'Donnell, Christopher D.; Shukla, Deepak			A Novel Function of Heparan Sulfate in the Regulation of Cell-Cell Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMPLEX-VIRUS TYPE-1; MYOBLAST FUSION; CYTOSKELETAL ORGANIZATION; SYNDECAN-1 EXPRESSION; SYNCYTIUM FORMATION; ENCEPHALITIS-VIRUS; GLYCOPROTEINS GB; MEMBRANE-FUSION; CO-RECEPTORS; GIANT-CELLS	Despite the important contribution of cell-cell fusion in the development and physiology of eukaryotes, little is known about the mechanisms that regulate this process. Our study shows that glycosaminoglycans and more specifically heparan sulfate (HS) expressed on the cell surface and extracellular matrix may act as negative regulator of cell-cell fusion. Using herpes simplex virus type-1 as a tool to enhance cell-cell fusion, we demonstrate that the absence of HS expression on the cell surface results in a significant increase in cell-cell fusion. An identical phenomenon was observed when other viruses or polyethylene glycol was used as fusion enhancer. Cells deficient in HS biosynthesis showed increased activity of two Rho GTPases, RhoA and Cdc42, both of which showed a correlation between increased activity and increased cell-cell fusion. This could serve as a possible explanation as to why HS-deficient cells showed significantly enhanced cell-cell fusion and suggests that HS could regulate fusion via fine tuning of RhoA and Cdc42 activities.	Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shukla, D (corresponding author), 1905 W Taylor St,LIERI 227, Chicago, IL 60612 USA.	dshukla@uic.edu		Shukla, Deepak/0000-0002-3039-6953	National Institutes of Health [RO1 AI057860]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI057860 (to D. S.).	Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Ambrosius M, 2009, CLIN BIOCHEM, V42, P1, DOI 10.1016/j.clinbiochem.2008.10.013; Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008; Barretto N, 2003, VIROLOGY, V313, P33, DOI 10.1016/S0042-6822(03)00288-5; Bass MD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.264pe18; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Bernard KA, 2000, VIROLOGY, V276, P93, DOI 10.1006/viro.2000.0546; Blattman JN, 2004, SCIENCE, V305, P200, DOI 10.1126/science.1100369; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Bussey H, 2004, PHARMACOTHERAPY, V24, P103; Carey DJ, 1997, BIOCHEM J, V327, P1; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chen EH, 2004, TRENDS CELL BIOL, V14, P452, DOI 10.1016/j.tcb.2004.07.008; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; Day RM, 1999, VIRCHOWS ARCH, V434, P121, DOI 10.1007/s004280050315; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; ESKO JD, 1988, SCIENCE, V241, P1092, DOI 10.1126/science.3137658; FARKASBARGETON E, 1988, J NEUROL SCI, V83, P145, DOI 10.1016/0022-510X(88)90064-0; Forsberg E, 2001, J CLIN INVEST, V108, P175, DOI 10.1172/JCI13561; FUKUDOME K, 1992, J VIROL, V66, P1394, DOI 10.1128/JVI.66.3.1394-1401.1992; FULTON AB, 1981, J CELL BIOL, V91, P103, DOI 10.1083/jcb.91.1.103; Geraghty RJ, 2000, VIROLOGY, V268, P147, DOI 10.1006/viro.1999.0157; Gotting C, 2007, CELL MOL LIFE SCI, V64, P1498, DOI 10.1007/s00018-007-7069-z; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Harris LK, 2008, PLACENTA, V29, P332, DOI 10.1016/j.placenta.2008.01.012; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Hoppe S, 2006, J GEN VIROL, V87, P3483, DOI 10.1099/vir.0.82231-0; Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Hulst MM, 2001, J VIROL, V75, P9585, DOI 10.1128/JVI.75.20.9585-9595.2001; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Kinzler ER, 2005, J VIROL, V79, P7827, DOI 10.1128/JVI.79.12.7827-7837.2005; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Larrain J, 1997, J BIOL CHEM, V272, P18418, DOI 10.1074/jbc.272.29.18418; Larrain J, 1998, J BIOL CHEM, V273, P32288, DOI 10.1074/jbc.273.48.32288; Lee E, 2002, J VIROL, V76, P4901, DOI 10.1128/JVI.76.10.4901-4911.2002; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; LIU N, 1993, VIROLOGY, V196, P703, DOI 10.1006/viro.1993.1527; Lopes CC, 2006, BRAZ J MED BIOL RES, V39, P157, DOI 10.1590/S0100-879X2006000200001; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Miyamoto Takeshi, 2003, Keio J Med, V52, P1; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Muggeridge MI, 2000, J GEN VIROL, V81, P2017, DOI 10.1099/0022-1317-81-8-2017; Mythreye K, 2009, CELL SIGNAL, V21, P1548, DOI 10.1016/j.cellsig.2009.05.001; Nackaerts K, 1997, INT J CANCER, V74, P335, DOI 10.1002/(SICI)1097-0215(19970620)74:3<335::AID-IJC18>3.3.CO;2-4; NAKAJIMA M, 1983, SCIENCE, V220, P611, DOI 10.1126/science.6220468; OKADA Y, 1962, EXP CELL RES, V26, P98, DOI 10.1016/0014-4827(62)90205-7; Peng T, 1998, J VIROL, V72, P6092, DOI 10.1128/JVI.72.7.6092-6103.1998; Pertel PE, 2001, VIROLOGY, V279, P313, DOI 10.1006/viro.2000.0713; Pomerantz J, 2004, NAT CELL BIOL, V6, P810, DOI 10.1038/ncb0904-810; Potgens AJG, 2002, PLACENTA, V23, pS107, DOI 10.1053/plac.2002.0772; Primakoff P, 2002, SCIENCE, V296, P2183, DOI 10.1126/science.1072029; Pulkkinen JO, 1997, ACTA OTO-LARYNGOL, V117, P312, DOI 10.3109/00016489709117794; Redman CWG, 2000, PLACENTA, V21, P597, DOI 10.1053/plac.2000.0560; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rosenberg RD, 1997, J CLIN INVEST, V99, P2062, DOI 10.1172/JCI119377; Ryman KD, 2004, VIROLOGY, V322, P1, DOI 10.1016/j.virol.2004.01.003; SaCarvalho D, 1997, J VIROL, V71, P5115, DOI 10.1128/JVI.71.7.5115-5123.1997; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Scanlan PM, 2005, J VIROL METHODS, V128, P104, DOI 10.1016/j.jviromet.2005.04.008; Schroter RH, 2004, DEVELOPMENT, V131, P4501, DOI 10.1242/dev.01309; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; SPEAR PG, 1992, ADV EXP MED BIOL, V313, P341; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; STANLEY MJ, 1995, J BIOL CHEM, V270, P5077, DOI 10.1074/jbc.270.10.5077; Sun JF, 2001, VIROLOGY, V284, P26, DOI 10.1006/viro.2001.0889; Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893; Takahashi I, 2009, BIOCHEM BIOPH RES CO, V383, P113, DOI 10.1016/j.bbrc.2009.03.140; Takeda Y, 2003, J CELL BIOL, V161, P945, DOI 10.1083/jcb.200212031; TAKEICHI M, 1977, J CELL BIOL, V75, P464, DOI 10.1083/jcb.75.2.464; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Tiwari V, 2004, J GEN VIROL, V85, P805, DOI 10.1099/vir.0.19641-0; Trefzer U, 2004, INT J CANCER, V110, P730, DOI 10.1002/ijc.20191; Trefzer U, 2003, MOL BIOTECHNOL, V25, P63, DOI 10.1385/MB:25:1:63; Vignery A, 2000, INT J EXP PATHOL, V81, P291, DOI 10.1046/j.1365-2613.2000.00164.x; Vives RR, 2006, CURR GENE THER, V6, P35, DOI 10.2174/156652306775515565; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wei G, 2000, J BIOL CHEM, V275, P27733; Wockel L, 1998, ACTA NEUROPATHOL, V95, P547, DOI 10.1007/s004010050836; Xiang YY, 2001, ONCOGENE, V20, P7408, DOI 10.1038/sj.onc.1204925; Yoneda A, 2003, MATRIX BIOL, V22, P25, DOI 10.1016/S0945-053X(03)00010-6; Yoon M, 2003, J VIROL, V77, P9221, DOI 10.1128/JVI.77.17.9221-9231.2003; Zimmermann P, 1999, FASEB J, V13, pS91	86	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29654	29665		10.1074/jbc.M109.037960	http://dx.doi.org/10.1074/jbc.M109.037960			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19726670	Green Published, hybrid			2022-12-25	WOS:000270896800047
J	Ewen, KM; Hannemann, F; Khatri, Y; Perlova, O; Kappl, R; Krug, D; Huttermann, J; Muller, R; Bernhardt, R				Ewen, Kerstin Maria; Hannemann, Frank; Khatri, Yogan; Perlova, Olena; Kappl, Reinhard; Krug, Daniel; Huettermann, Juergen; Mueller, Rolf; Bernhardt, Rita			Genome Mining in Sorangium cellulosum So ce56 IDENTIFICATION AND CHARACTERIZATION OF THE HOMOLOGOUS ELECTRON TRANSFER PROTEINS OF A MYXOBACTERIAL CYTOCHROME P450	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-COELICOLOR A3(2); IRON-SULFUR PROTEINS; ADRENODOXIN REDUCTASE; ESCHERICHIA-COLI; FERREDOXIN REDUCTASE; MYCOBACTERIUM-TUBERCULOSIS; CYTOCHROME-P450 COMPLEMENT; SCHIZOSACCHAROMYCES-POMBE; CLOSTRIDIUM-PASTEURIANUM; 2FE-2S FERREDOXIN	Myxobacteria, especially members of the genus Sorangium, are known for their biotechnological potential as producers of pharmaceutically valuable secondary metabolites. The biosynthesis of several of those myxobacterial compounds includes cytochrome P450 activity. Although class I cytochrome P450 enzymes occur wide-spread in bacteria and rely on ferredoxins and ferredoxin reductases as essential electron mediators, the study of these proteins is often neglected. Therefore, we decided to search in the Sorangium cellulosum So ce56 genome for putative interaction partners of cytochromes P450. In this work we report the investigation of eight myxobacterial ferredoxins and two ferredoxin reductases with respect to their activity in cytochrome P450 systems. Intriguingly, we found not only one, but two ferredoxins whose ability to sustain an endogenous So ce56 cytochrome P450 was demonstrated by CYP260A1-dependent conversion of nootkatone. Moreover, we could demonstrate that the two ferredoxins were able to receive electrons from both ferredoxin reductases. These findings indicate that S. cellulosum can alternate between different electron transport pathways to sustain cytochrome P450 activity.	[Bernhardt, Rita] Univ Saarland, Dept Biochem, D-66041 Saarbrucken, Germany; [Perlova, Olena; Krug, Daniel; Mueller, Rolf] Univ Saarland, Dept Pharmaceut Biotechnol, D-66041 Saarbrucken, Germany; [Kappl, Reinhard; Huettermann, Juergen] Univ Saarland, Dept Biophys, D-66421 Homburg, Germany	Saarland University; Saarland University; Saarland University	Bernhardt, R (corresponding author), Univ Saarland, Dept Biochem, FR 8-3 Biochem,Bldg B2-2, D-66041 Saarbrucken, Germany.	ritabern@mx.uni-saarland.de	Müller, Rolf/B-1559-2008; Mahmud, Taifo/A-1492-2015; khatri, Yogan/W-2218-2017	Müller, Rolf/0000-0002-1042-5665; Mahmud, Taifo/0000-0001-9639-526X; Krug, Daniel/0000-0002-3664-1884; Hannemann, Frank/0000-0001-7991-9033; Khatri, Yogan/0000-0002-2432-7679; Kappl, Reinhard/0000-0003-0223-6642	Fonds der Chemischen Industrie; Bundesministerium fur Bildung und Forschung	Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported in part by a grant from the Fonds der Chemischen Industrie (to R. B.) and by a grant from the Saarland LGF (to K. M. E.). Research in the Muller laboratory was funded by the Bundesministerium fur Bildung und Forschung.	Aliverti A, 1999, METH MOL B, V131, P9; ALTMAN KH, 2008, SOIL CLIN EPOTHILONE, P16; Arakawa T, 2007, AMINO ACIDS, V33, P587, DOI 10.1007/s00726-007-0506-3; Bell SG, 2006, BIOCHEM BIOPH RES CO, V342, P191, DOI 10.1016/j.bbrc.2006.01.133; Bernhardt R, 1996, REV PHYSIOL BIOCH P, V127, P137, DOI 10.1007/BFb0048267; BERNHARDT R, 2007, UBIQUITOUS ROLES CYT, P361; Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; Bode HB, 2004, ANGEW CHEM INT EDIT, V43, P4163, DOI 10.1002/anie.200454240; Bode HB, 2006, J IND MICROBIOL BIOT, V33, P577, DOI 10.1007/s10295-006-0082-7; Buntin K, 2008, ANGEW CHEM INT EDIT, V47, P4595, DOI 10.1002/anie.200705569; CASPERS P, 1994, CELL MOL BIOL, V40, P635; Chatelet C, 1999, J BIOL INORG CHEM, V4, P311, DOI 10.1007/s007750050317; Chun YJ, 2007, J BIOL CHEM, V282, P17486, DOI 10.1074/jbc.M700863200; Ewen KM, 2008, FEMS YEAST RES, V8, P432, DOI 10.1111/j.1567-1364.2008.00360.x; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Frank B, 2007, J MOL BIOL, V374, P24, DOI 10.1016/j.jmb.2007.09.015; Frank B, 2007, CHEM BIOL, V14, P221, DOI 10.1016/j.chembiol.2006.11.013; FUJINAGA J, 1993, BIOCHEM BIOPH RES CO, V192, P1115, DOI 10.1006/bbrc.1993.1532; Gaitatzis N, 2002, J BIOL CHEM, V277, P13082, DOI 10.1074/jbc.M111738200; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Grinberg AV, 2000, PROTEINS, V40, P590, DOI 10.1002/1097-0134(20000901)40:4<590::AID-PROT50>3.0.CO;2-P; Guigliarelli B, 1999, ADV INORG CHEM, V47, P421, DOI 10.1016/S0898-8838(08)60084-7; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Hanukoglu I, 2006, DRUG METAB REV, V38, P171, DOI 10.1080/03602530600570040; HANUKOGLU I, 1993, ARCH BIOCHEM BIOPHYS, V305, P489, DOI 10.1006/abbi.1993.1452; HUANG K, 1969, BIOCHEM BIOPH RES CO, V34, P48, DOI 10.1016/0006-291X(69)90526-9; KITAGAWA T, 1982, J BIOL CHEM, V257, P2075; LAMBETH JD, 1976, J BIOL CHEM, V251, P4299; Leadbeater C, 2000, BIOCHEM J, V352, P257, DOI 10.1042/0264-6021:3520257; Lei L, 2004, P NATL ACAD SCI USA, V101, P494, DOI 10.1073/pnas.2435922100; Lovenberg W., 1973, IRON SULPHUR PROTEIN, VII; McLean KJ, 2006, BIOCHEMISTRY-US, V45, P8427, DOI 10.1021/bi0601609; McLean KJ, 2003, BIOCHEM J, V372, P317, DOI 10.1042/BJ20021692; Meyer J, 2008, J BIOL INORG CHEM, V13, P157, DOI 10.1007/s00775-007-0318-7; Murataliev MB, 1999, METH MOL B, V131, P97; Ogura H, 2004, BIOCHEMISTRY-US, V43, P14712, DOI 10.1021/bi048980d; Parajuli N, 2004, ARCH BIOCHEM BIOPHYS, V425, P233, DOI 10.1016/j.abb.2004.03.011; PORTER TD, 1991, METHOD ENZYMOL, V206, P108; RAMACHANDRA M, 1991, J BACTERIOL, V173, P7106, DOI 10.1128/jb.173.22.7106-7112.1991; Reichenbach H, 2001, J IND MICROBIOL BIOT, V27, P149, DOI 10.1038/sj.jim.7000025; SAGARA Y, 1993, BIOL PHARM BULL, V16, P627; Sambrook J., 2001, MOL CLONING LAB MANU, V3; Schiffler B, 2004, J INORG BIOCHEM, V98, P1229, DOI 10.1016/j.jinorgbio.2004.02.006; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; Schuster I, 2007, DRUG METAB REV, V39, P481, DOI 10.1080/03602530701498455; Sevrioukova IF, 2002, J BIOL CHEM, V277, P25831, DOI 10.1074/jbc.M201110200; Sielaff B, 2005, FEBS J, V272, P1148, DOI 10.1111/j.1742-4658.2005.04550.x; Simunovic V, 2006, CHEMBIOCHEM, V7, P1206, DOI 10.1002/cbic.200600075; Sticht H, 1998, PROG BIOPHYS MOL BIO, V70, P95, DOI 10.1016/S0079-6107(98)00027-3; Takubo K, 2003, PLANT MOL BIOL, V52, P817, DOI 10.1023/A:1025015811141; Thomas JG, 1997, PROTEIN EXPRES PURIF, V11, P289, DOI 10.1006/prep.1997.0796	51	35	35	5	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28590	28598		10.1074/jbc.M109.021717	http://dx.doi.org/10.1074/jbc.M109.021717			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19696019	Green Published, hybrid			2022-12-25	WOS:000270678900013
J	Ferreira, LT; Dale, LB; Ribeiro, FM; Babwah, AV; Pampillo, M; Ferguson, SSG				Ferreira, Lucimar T.; Dale, Lianne B.; Ribeiro, Fabiola M.; Babwah, Andy V.; Pampillo, Macarena; Ferguson, Stephen S. G.			Calcineurin Inhibitor Protein (CAIN) Attenuates Group I Metabotropic Glutamate Receptor Endocytosis and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION-INDEPENDENT REGULATION; SYNAPTIC VESICLE ENDOCYTOSIS; 2ND INTRACELLULAR LOOP; NEGATIVE REGULATOR; RGS PROTEINS; DESENSITIZATION; KINASE-2; BINDING; MGLUR5; SEQUESTRATION	Group I metabotropic glutamate receptors (mGluRs) are coupled via phospholipase C beta to the hydrolysis of phosphoinositides and function to modulate neuronal excitability and synaptic transmission at glutamatergic synapses. The desensitization of Group I mGluR signaling is thought to be mediated primarily via second messenger-dependent protein kinases and G protein-coupled receptor kinases. We show here that both mGluR1 and mGluR5 interact with the calcineurin inhibitor protein (CAIN). CAIN is co-immunoprecipitated in a complex with Group I mGluRs from both HEK 293 cells and mouse cortical brain lysates. Purified CAIN and its C-terminal domain specifically interact with glutathione S-transferase fusion proteins corresponding to the second intracellular loop and the distal C-terminal tail domains of mGluR1. The interaction of CAIN with mGluR1 could also be blocked using a Tat-tagged peptide corresponding to the mGluR1 second intracellular loop domain. Overexpression of full-length CAIN attenuates the agonist-stimulated endocytosis of both mGluR1a and mGluR5a in HEK 293 cells, but expression of the CAIN C-terminal domain does not alter mGluR5a internalization. In contrast, overexpression of either full-length CAIN or the CAIN C-terminal domain impairs agonist-stimulated inositol phosphate formation in HEK 293 cells expressing mGluR1a. This CAIN-mediated antagonism of mGluR1a signaling appears to involve the disruption of receptor-G alpha(q/11) complexes. Taken together, these observations suggest that the association of CAIN with intracellular domains involved in mGluR/G protein coupling provides an additional mechanism by which Group I mGluR endocytosis and signaling are regulated.	[Ferreira, Lucimar T.; Dale, Lianne B.; Ribeiro, Fabiola M.; Babwah, Andy V.; Pampillo, Macarena; Ferguson, Stephen S. G.] Robarts Res Inst, Mol Brain Res Grp, J Allyn Taylor Ctr Cell Biol, London, ON N6A 5K8, Canada; [Ferguson, Stephen S. G.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Ferguson, SSG (corresponding author), Robarts Res Inst, Mol Brain Res Grp, J Allyn Taylor Ctr Cell Biol, 100 Perth Dr,POB 5015, London, ON N6A 5K8, Canada.	ferguson@robarts.ca	Ribeiro, Fabiola/E-8831-2013	Ribeiro, Fabiola/0000-0001-7042-9433	Canadian Institutes of Health Research [MA-15506, MOP-62738]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grants MA-15506 and MOP-62738 (to S. S. G. F.).	Alagarsamy S, 2005, NEUROPHARMACOLOGY, V49, P135, DOI 10.1016/j.neuropharm.2005.05.005; Anborgh PH, 2005, J BIOL CHEM, V280, P34840, DOI 10.1074/jbc.M504508200; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dale LB, 2001, J BIOL CHEM, V276, P35900, DOI 10.1074/jbc.M103847200; Dhami GK, 2005, J BIOL CHEM, V280, P24420, DOI 10.1074/jbc.M501650200; Dhami GK, 2004, J BIOL CHEM, V279, P16614, DOI 10.1074/jbc.M314090200; Dhami GK, 2002, J BIOL CHEM, V277, P25266, DOI 10.1074/jbc.M203593200; Dhami GK, 2006, PHARMACOL THERAPEUT, V111, P260, DOI 10.1016/j.pharmthera.2005.01.008; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782, DOI 10.1074/jbc.270.42.24782; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; Francesconi A, 1998, J BIOL CHEM, V273, P5615, DOI 10.1074/jbc.273.10.5615; Gereau RW, 1998, NEURON, V20, P143, DOI 10.1016/S0896-6273(00)80442-0; Gomeza J, 1996, J BIOL CHEM, V271, P2199, DOI 10.1074/jbc.271.4.2199; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Ishikawa K, 1999, GENES CELLS, V4, P381, DOI 10.1046/j.1365-2443.1999.00269.x; Jang H, 2007, BIOCHEM BIOPH RES CO, V359, P129, DOI 10.1016/j.bbrc.2007.05.066; Krueger KM, 1997, J BIOL CHEM, V272, P5; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lai MM, 2000, J BIOL CHEM, V275, P34017, DOI 10.1074/jbc.C000429200; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; Lee JH, 2008, P NATL ACAD SCI USA, V105, P12575, DOI 10.1073/pnas.0712033105; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Minakami R, 1997, J BIOL CHEM, V272, P20291, DOI 10.1074/jbc.272.32.20291; NAKANISHI S, 1994, ANNU REV BIOPH BIOM, V23, P319, DOI 10.1146/annurev.bb.23.060194.001535; Ribeiro FM, 2009, J BIOL CHEM, V284, P23444, DOI 10.1074/jbc.M109.000778; Sato M, 2004, EUR J NEUROSCI, V20, P947, DOI 10.1111/j.1460-9568.2004.03552.x; Siderovski DP, 1999, CRIT REV BIOCHEM MOL, V34, P215, DOI 10.1080/10409239991209273; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790	35	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28986	28994		10.1074/jbc.M109.050872	http://dx.doi.org/10.1074/jbc.M109.050872			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19717561	hybrid, Green Published			2022-12-25	WOS:000270678900056
J	Home, P; Ray, S; Dutta, D; Bronshteyn, I; Larson, M; Paul, S				Home, Pratik; Ray, Soma; Dutta, Debasree; Bronshteyn, Illya; Larson, Melissa; Paul, Soumen			GATA3 Is Selectively Expressed in the Trophectoderm of Peri-implantation Embryo and Directly Regulates Cdx2 Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-2; MOUSE BLASTOCYST; CELL DIFFERENTIATION; TARGETED MUTATION; TROPHOBLAST; LINEAGE; MICE; SPECIFICATION; FATE; DOWNSTREAM	During early mammalian development, genesis of the first two cell lineages, inner cell mass (ICM) and trophectoderm (TE), is dependent upon functions of key transcription factors that are expressed in a regulated and spatially restricted fashion. In this study, we demonstrate that during early mouse development, mRNA expression of transcription factor GATA3 is induced at the 4-cell stage and is consistently present during pre-implantation embryonic development. Interestingly, at the blastocyst stage, Gata3 mRNAis selectively up-regulated within the TE lineage, and GATA3 protein is abundantly present only in the TE but not in the ICM. Using mouse trophoblast stem cells (TS cells) as a model, we found that, knockdown of GATA3 by RNA interference (RNAi) down-regulates expression of caudal-type homeobox 2 (CDX2), a key regulator of the TE lineage. Chromatin immunoprecipitation (ChIP) analyses revealed that, in TS cells, GATA3 directly regulates Cdx2 transcription from a conserved GATA motif at the intron 1 region of the Cdx2 locus. ChIP analyses with mouse blastocysts also detected GATA3 occupancy at intron 1 of the Cdx2 locus. In addition, down-regulation of GATA3 in pre-implantation mouse embryos reduces Cdx2 expression and inhibits morula to blastocyst transformation. Our results indicate a novel function of GATA3, in which it is selectively expressed in TE, regulates expression of key genes in TE lineage, and is involved in morula to blastocyst transformation.	[Home, Pratik; Ray, Soma; Dutta, Debasree; Paul, Soumen] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Inst Maternal Fetal Biol, Kansas City, KS 66160 USA; [Bronshteyn, Illya; Larson, Melissa] Univ Kansas, Med Ctr, Transgen & Gene Targeting Inst Facil, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Paul, S (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Inst Maternal Fetal Biol, Kansas City, KS 66160 USA.	spaul2@kumc.edu	Home, Pratik/D-5061-2014		National Institutes of Health [P20 RRO16475, P20 RRO24214]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024214, P20RR016475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RRO16475 and P20 RRO24214.	Acevedo LG, 2007, BIOTECHNIQUES, V43, P791, DOI 10.2144/000112625; Asnagli H, 2002, J IMMUNOL, V168, P4268, DOI 10.4049/jimmunol.168.9.4268; Benahmed F, 2008, GASTROENTEROLOGY, V135, P1238, DOI 10.1053/j.gastro.2008.06.045; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Donnison M, 2005, DEVELOPMENT, V132, P2299, DOI 10.1242/dev.01819; Dutta D, 2008, J BIOL CHEM, V283, P25404, DOI 10.1074/jbc.M804349200; Ferreira R, 2007, BLOOD, V109, P5481, DOI 10.1182/blood-2006-11-060491; Flavell RA, 1999, COLD SPRING HARB SYM, V64, P563, DOI 10.1101/sqb.1999.64.563; Fujiwara Y, 2004, BLOOD, V103, P583, DOI 10.1182/blood-2003-08-2870; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; Jedrusik A, 2008, GENE DEV, V22, P2692, DOI 10.1101/gad.486108; Kobayashi-Osaki M, 2005, MOL CELL BIOL, V25, P7005, DOI 10.1128/MCB.25.16.7005-7020.2005; Kunath T, 2004, PLACENTA, V25, pS32, DOI 10.1016/j.placenta.2004.01.015; Ma GT, 1997, DEVELOPMENT, V124, P907; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; NG YK, 1994, DEVELOPMENT, V120, P3257; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Ralston A, 2008, DEV BIOL, V313, P614, DOI 10.1016/j.ydbio.2007.10.054; Ray S, 2009, J BIOL CHEM, V284, P4978, DOI 10.1074/jbc.M807329200; Rossant J, 2004, SEMIN CELL DEV BIOL, V15, P573, DOI 10.1016/j.semcdb.2004.04.003; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Scheinman EJ, 2009, J BIOL CHEM, V284, P3037, DOI 10.1074/jbc.M807302200; SIMON MC, 1992, NAT GENET, V1, P92, DOI 10.1038/ng0592-92; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Wang WCH, 2007, J EXP ZOOL PART B, V308B, P308, DOI 10.1002/jez.b.21154; Wen F, 2007, DEV BIOL, V312, P284, DOI 10.1016/j.ydbio.2007.09.024; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Zernicka-Goetz MZ, 2005, NAT REV MOL CELL BIO, V6, P919, DOI 10.1038/nrm1782; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	37	149	155	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28729	28737		10.1074/jbc.M109.016840	http://dx.doi.org/10.1074/jbc.M109.016840			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19700764	Green Published, hybrid			2022-12-25	WOS:000270678900029
J	Madathil, S; Fahmy, K				Madathil, Sineej; Fahmy, Karim			Lipid Protein Interactions Couple Protonation to Conformation in a Conserved Cytosolic Domain of G Protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYLIC-ACID GROUP; RHODOPSIN ACTIVATION; CRYSTAL-STRUCTURE; BETA(2)-ADRENERGIC RECEPTOR; TRANSMEMBRANE SEGMENT-3; STRUCTURAL INSIGHTS; FUNCTIONAL-ROLE; BOND NETWORK; IONIC LOCK; HELIX	The visual photoreceptor rhodopsin is a prototypical class I (rhodopsin-like) G protein-coupled receptor. Photoisomerization of the covalently bound ligand 11-cis-retinal leads to restructuring of the cytosolic face of rhodopsin. The ensuing protonation of Glu-134 in the class-conserved D(E)RY motif at the C-terminal end of transmembrane helix-3 promotes the formation of the G protein-activating state. Using transmembrane segments derived from helix-3 of bovine rhodopsin, we show that lipid protein interactions play a key role in this cytosolic "proton switch." Infrared and fluorescence spectroscopic pK(a) determinations reveal that the D(E) RY motif is an autonomous functional module coupling side chain neutralization to conformation and helix positioning as evidenced by side chain to lipid headgroup Foerster resonance energy transfer. The free enthalpies of helix stabilization and hydrophobic burial of the neutral carboxyl shift the side chain pKa into the range typical of Glu134 in photoactivated rhodopsin. The lipid-mediated coupling mechanism is independent of interhelical contacts allowing its conservation without interference with the diversity of ligand-specific interactions in class I G protein-coupled receptors.	[Madathil, Sineej; Fahmy, Karim] Forschungszentrum Dresden Rossendorf, Inst Radiochem, Div Biophys, D-01314 Dresden, Germany	Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR)	Fahmy, K (corresponding author), Forschungszentrum Dresden Rossendorf, Inst Radiochem, Div Biophys, PF 510119, D-01314 Dresden, Germany.	k.fahmy@fzd.de	Fahmy, Karim/B-2708-2017	Fahmy, Karim/0000-0002-8752-5824	Deutsche Forschungsgemeinschaft [Fa 248-4]; Bundesministerium fur Bildung und Forschung [IND06/030]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported in part by the Deutsche Forschungsgemeinschaft Grant Fa 248-4 and in part by the Bundesministerium fur Bildung und Forschung Grant IND06/030.	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; ARNIS S, 1994, J BIOL CHEM, V269, P23879; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Botelho AV, 2006, BIOPHYS J, V91, P4464, DOI 10.1529/biophysj.106.082776; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Fahmy K, 2000, METHOD ENZYMOL, V315, P178; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; Fahmy K, 2000, BIOCHEMISTRY-US, V39, P10607, DOI 10.1021/bi000912d; Fahmy K., 2001, RRD BIOPHYS CHEM, V2, P1; GIBSON NJ, 1993, BIOCHEMISTRY-US, V32, P2438, DOI 10.1021/bi00060a040; Greasley PJ, 2002, MOL PHARMACOL, V61, P1025, DOI 10.1124/mol.61.5.1025; Huber T, 2004, BIOPHYS J, V86, P2078, DOI 10.1016/S0006-3495(04)74268-X; Isele J, 2000, BIOPHYS J, V79, P3063, DOI 10.1016/S0006-3495(00)76541-6; JAGER F, 1994, BIOCHEMISTRY-US, V33, P10878; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Koike T, 1996, J AM CHEM SOC, V118, P12696, DOI 10.1021/ja962527a; Krishna AG, 2002, BIOCHEMISTRY-US, V41, P8298, DOI 10.1021/bi025534m; Krishnakumar SS, 2007, J MOL BIOL, V374, P1251, DOI 10.1016/j.jmb.2007.10.032; Kusnetzow AK, 2006, BIOCHEMISTRY-US, V45, P5538, DOI 10.1021/bi060101v; Lehmann N, 2007, J MOL BIOL, V366, P1129, DOI 10.1016/j.jmb.2006.11.098; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liu W, 2004, J MOL BIOL, V337, P713, DOI 10.1016/j.jmb.2004.02.001; Lowe MP, 2001, INORG CHIM ACTA, V317, P163, DOI 10.1016/S0020-1693(01)00346-2; Ludeke S, 2009, PHOTOCHEM PHOTOBIOL, V85, P437, DOI 10.1111/j.1751-1097.2008.00490.x; Madathil S, 2006, BIOPOLYMERS, V82, P329, DOI 10.1002/bip.20466; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; Mustafi D, 2009, MOL PHARMACOL, V75, P1, DOI 10.1124/mol.108.051938; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Periole X, 2004, BIOCHEMISTRY-US, V43, P6858, DOI 10.1021/bi049949e; Rao VR, 1996, ANNU REV BIOPH BIOM, V25, P287; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scheer A, 1997, P NATL ACAD SCI USA, V94, P808, DOI 10.1073/pnas.94.3.808; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SCHOLTZ JM, 1991, P NATL ACAD SCI USA, V88, P2854, DOI 10.1073/pnas.88.7.2854; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Shukla AK, 2008, MOL PHARMACOL, V73, P1333, DOI 10.1124/mol.108.045849; Soubias O, 2008, J AM CHEM SOC, V130, P12465, DOI 10.1021/ja803599x; Soubias O, 2006, J BIOL CHEM, V281, P33233, DOI 10.1074/jbc.M603059200; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Vogel R, 2007, PHOTOCHEM PHOTOBIOL, V83, P286, DOI 10.1562/2006-06-19-IR-937; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Weis WI, 2008, CURR OPIN STRUC BIOL, V18, P734, DOI 10.1016/j.sbi.2008.09.010; Wimley WC, 1996, BIOCHEMISTRY-US, V35, P5109, DOI 10.1021/bi9600153	48	18	18	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28801	28809		10.1074/jbc.M109.002030	http://dx.doi.org/10.1074/jbc.M109.002030			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706606	hybrid, Green Published			2022-12-25	WOS:000270678900037
J	Mairhofer, M; Steiner, M; Salzer, U; Prohaska, R				Mairhofer, Mario; Steiner, Marianne; Salzer, Ulrich; Prohaska, Rainer			Stomatin-like Protein-1 Interacts with Stomatin and Is Targeted to Late Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVERHYDRATED HEREDITARY STOMATOCYTOSIS; INTEGRAL MEMBRANE-PROTEIN; CAENORHABDITIS-ELEGANS; LIPID RAFTS; BAND 7.2B; CHOLESTEROL TRANSPORT; VOLATILE ANESTHETICS; GLUCOSE-TRANSPORTER; RECEPTOR NEURONS; PLASMA-MEMBRANE	The human stomatin-like protein-1 (SLP-1) is a membrane protein with a characteristic bipartite structure containing a stomatin domain and a sterol carrier protein-2 (SCP-2) domain. This structure suggests a role for SLP-1 in sterol/lipid transfer and transport. Because SLP-1 has not been investigated, we first studied the molecular and cell biological characteristics of the expressed protein. We show here that SLP-1 localizes to the late endosomal compartment, like stomatin. Unlike stomatin, SLP-1 does not localize to the plasma membrane. Overexpression of SLP-1 leads to the redistribution of stomatin from the plasma membrane to late endosomes suggesting a complex formation between these proteins. We found that the targeting of SLP-1 to late endosomes is caused by a GYXX Phi (Phi being a bulky, hydrophobic amino acid) sorting signal at the N terminus. Mutation of this signal results in plasma membrane localization. SLP-1 and stomatin co-localize in the late endosomal compartment, they co-immunoprecipitate, thus showing a direct interaction, and they associate with detergent-resistant membranes. In accordance with the proposed lipid transfer function, we show that, under conditions of blocked cholesterol efflux from late endosomes, SLP-1 induces the formation of enlarged, cholesterol-filled, weakly LAMP-2-positive, acidic vesicles in the perinuclear region. This massive cholesterol accumulation clearly depends on the SCP-2 domain of SLP-1, suggesting a role for this domain in cholesterol transfer to late endosomes.	[Mairhofer, Mario; Salzer, Ulrich; Prohaska, Rainer] Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, A-1030 Vienna, Austria; [Steiner, Marianne] Med Univ Vienna, Ctr Anat & Cell Biol, Dept Nucl & Dev Biol & Funct Microscopy, A-1090 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna	Prohaska, R (corresponding author), Dr Bohr Gasse 9-3, A-1030 Vienna, Austria.	rainer.prohaska@meduniwien.ac.at		Mairhofer, Mario/0000-0002-7218-6284; Salzer, Ulrich/0000-0002-3721-7225	Austrian Science Fund/Fonds zur Foerderung der wissenschaftlichen Forschung (FWF)	Austrian Science Fund/Fonds zur Foerderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from the Austrian Science Fund/Fonds zur Foerderung der wissenschaftlichen Forschung (FWF).	Alpy F, 2006, BIOCHEM SOC T, V34, P343, DOI 10.1042/BST0340343; Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07; Barnes TM, 1996, J NEUROCHEM, V67, P46; Bauer M, 2006, FEBS LETT, V580, P5559, DOI 10.1016/j.febslet.2006.08.077; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BONIFACINO JS, 2001, CURRENT PROTOCOLS CE; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Bruce LJ, 2009, BLOOD, V113, P1350, DOI 10.1182/blood-2008-07-171140; Das K, 1999, J BIOL CHEM, V274, P18721, DOI 10.1074/jbc.274.26.18721; Epand RF, 2006, BIOCHEMISTRY-US, V45, P6105, DOI 10.1021/bi060245+; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Fricke B, 2003, BLOOD, V102, P2268, DOI 10.1182/blood-2002-06-1705; Fricke B, 2005, BRIT J HAEMATOL, V131, P265, DOI 10.1111/j.1365-2141.2005.05742.x; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Gilles F, 2000, EUR J HAEMATOL, V64, P104, DOI 10.1034/j.1600-0609.2000.90054.x; Goldstein BJ, 2003, JARO-J ASSOC RES OTO, V4, P74, DOI 10.1007/s10162-002-2039-5; Green JB, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-44; HIEBLDIRSCHMIED CM, 1991, BIOCHIM BIOPHYS ACTA, V1065, P195, DOI 10.1016/0005-2736(91)90230-6; HIEBLDIRSCHMIED CM, 1991, BIOCHIM BIOPHYS ACTA, V1090, P123, DOI 10.1016/0167-4781(91)90047-P; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Kobayakawa K, 2002, J NEUROSCI, V22, P5931; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Liu J, 2005, J BIOL CHEM, V280, P16125, DOI 10.1074/jbc.M500940200; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; LOWRY OH, 1957, METHOD ENZYMOL, V4, P366, DOI 10.1016/0076-6879(57)04065-3; Meyers JM, 2002, J BIOL CHEM, V277, P49003, DOI 10.1074/jbc.M205728200; Montel-Hagen A, 2008, CELL, V132, P1039, DOI 10.1016/j.cell.2008.01.042; MORGAN PG, 1990, P NATL ACAD SCI USA, V87, P2965, DOI 10.1073/pnas.87.8.2965; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Price MP, 2004, J BIOL CHEM, V279, P53886, DOI 10.1074/jbc.M407708200; Rajaram S, 1998, P NATL ACAD SCI USA, V95, P8761, DOI 10.1073/pnas.95.15.8761; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Salzer U., 2007, DYN CELL BIOL, V1, P20; Schroeder F, 2007, BBA-MOL CELL BIOL L, V1771, P700, DOI 10.1016/j.bbalip.2007.04.005; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI200112849; Scott C, 2004, BBA-MOL CELL BIOL L, V1685, P8, DOI 10.1016/j.bbalip.2004.08.006; Sedensky MM, 2001, AM J PHYSIOL-CELL PH, V280, pC1340, DOI 10.1152/ajpcell.2001.280.5.C1340; Seidel G, 1998, GENE, V225, P23, DOI 10.1016/S0378-1119(98)00532-0; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Smith M, 2000, AM J MED GENET, V96, P765, DOI 10.1002/1096-8628(20001204)96:6<765::AID-AJMG13>3.0.CO;2-L; Snyers L, 1997, EUR J CELL BIOL, V73, P281; Snyers L, 1999, EUR J CELL BIOL, V78, P802, DOI 10.1016/S0171-9335(99)80031-4; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; STEINER M, 1994, HISTOCHEM J, V26, P934; Stewart GW, 2004, CURR OPIN HEMATOL, V11, P244, DOI 10.1097/01.moh.0000132240.20671.33; STEWART GW, 1992, BLOOD, V79, P1593, DOI 10.1182/blood.V79.6.1593.bloodjournal7961593; Tavernarakis N, 1999, TRENDS BIOCHEM SCI, V24, P425, DOI 10.1016/S0968-0004(99)01467-X; Tomiyama Y, 2004, CELL TISSUE RES, V317, P253, DOI 10.1007/s00441-004-0941-3; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Umlauf E, 2006, J BIOL CHEM, V281, P23349, DOI 10.1074/jbc.M513720200; Wang YJ, 2000, J BIOL CHEM, V275, P8062, DOI 10.1074/jbc.275.11.8062; Wirtz KWA, 2006, FEBS LETT, V580, P5436, DOI 10.1016/j.febslet.2006.06.065; Yokoyama H, 2008, J MOL BIOL, V376, P868, DOI 10.1016/j.jmb.2007.12.024; Zhang JZ, 1999, ARCH BIOCHEM BIOPHYS, V372, P173, DOI 10.1006/abbi.1999.1489; Zhang JZ, 2001, AM J PHYSIOL-CELL PH, V280, pC1277, DOI 10.1152/ajpcell.2001.280.5.C1277; Zhang M, 2002, J BIOL CHEM, V277, P33300, DOI 10.1074/jbc.M200003200; Zhang SF, 2004, CURR BIOL, V14, P1888, DOI 10.1016/j.cub.2004.10.030	67	27	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29218	29229		10.1074/jbc.M109.014993	http://dx.doi.org/10.1074/jbc.M109.014993			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19696025	hybrid, Green Published			2022-12-25	WOS:000270678900076
J	Ono, M; Matsubara, J; Honda, K; Sakuma, T; Hashiguchi, T; Nose, H; Nakamori, S; Okusaka, T; Kosuge, T; Sata, N; Nagai, H; Ioka, T; Tanaka, S; Tsuchida, A; Aoki, T; Shimahara, M; Yasunami, Y; Itoi, T; Moriyasu, F; Negishi, A; Kuwabara, H; Shoji, A; Hirohashi, S; Yamada, T				Ono, Masaya; Matsubara, Junichi; Honda, Kazufumi; Sakuma, Tomohiro; Hashiguchi, Tomoyo; Nose, Hiroshi; Nakamori, Shoji; Okusaka, Takuji; Kosuge, Tomoo; Sata, Naohiro; Nagai, Hideo; Ioka, Tatsuya; Tanaka, Sachiko; Tsuchida, Akihiko; Aoki, Tatsuya; Shimahara, Masashi; Yasunami, Yohichi; Itoi, Takao; Moriyasu, Fuminori; Negishi, Ayako; Kuwabara, Hideya; Shoji, Ayako; Hirohashi, Setsuo; Yamada, Tesshi			Prolyl 4-Hydroxylation of alpha-Fibrinogen A NOVEL PROTEIN MODIFICATION REVEALED BY PLASMA PROTEOMICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; QUANTITATIVE-ANALYSIS; BETA-CATENIN; COMPLEX; IDENTIFICATION; EXPRESSION; ABUNDANCE; PROLINE; ANTIGEN	Plasma proteome analysis requires sufficient power to compare numerous samples and detect changes in protein modification, because the protein content of human samples varies significantly among individuals, and many plasma proteins undergo changes in the bloodstream. A label-free proteomics platform developed in our laboratory, termed "Two-Dimensional Image Converted Analysis of Liquid chromatography and mass spectrometry (2DICAL)," is capable of these tasks. Here, we describe successful detection of novel prolyl hydroxylation of alpha-fibrinogen using 2DICAL, based on comparison of plasma samples of 38 pancreatic cancer patients and 39 healthy subjects. Using a newly generated monoclonal antibody 11A5, we confirmed the increase in prolyl-hydroxylated alpha-fibrinogen plasma levels and identified prolyl 4-hydroxylase A1 as a key enzyme for the modification. Competitive enzyme-linked immunosorbent assay of 685 blood samples revealed dynamic changes in prolyl-hydroxylated alpha-fibrinogen plasma level depending on clinical status. Prolyl-hydroxylated alpha-fibrinogen is presumably controlled by multiple biological mechanisms, which remain to be clarified in future studies.	[Ono, Masaya; Matsubara, Junichi; Honda, Kazufumi; Negishi, Ayako; Hirohashi, Setsuo; Yamada, Tesshi] Natl Canc Ctr, Natl Canc Ctr Res Inst, Div Chemotherapy, Chuo Ku, Tokyo 1040045, Japan; [Okusaka, Takuji] Natl Canc Ctr, Pancreat Oncol Div, Chuo Ku, Tokyo 1040045, Japan; [Kosuge, Tomoo] Natl Canc Ctr, Hepatobiliary & Pancreat Surg Div, Chuo Ku, Tokyo 1040045, Japan; [Sakuma, Tomohiro; Ioka, Tatsuya; Tanaka, Sachiko; Kuwabara, Hideya; Shoji, Ayako] Mitsui Knowledge Ind, Consulting Business Unit, Biosci Team, Minato Ku, Tokyo 1056215, Japan; [Hashiguchi, Tomoyo; Nose, Hiroshi] Transgenic Inc, Kobe Res Ctr, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Nakamori, Shoji] Osaka Natl Hosp, Dept Surg, Chuo Ku, Osaka 5400006, Japan; [Sata, Naohiro; Nagai, Hideo] Jichi Med Sch, Dept Surg, Minami Kawachi, Tochigi 3290498, Japan; [Ioka, Tatsuya; Tanaka, Sachiko] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hepatobiliary & Pancreat Oncol, Osaka 5378511, Japan; [Tsuchida, Akihiko; Aoki, Tatsuya] Tokyo Med Univ, Dept Surg 3, Shinjuku Ku, Tokyo 1600023, Japan; [Itoi, Takao; Moriyasu, Fuminori; Yamada, Tesshi] Tokyo Med Univ, Dept Internal Med 4, Shinjuku Ku, Tokyo 1600023, Japan; [Shimahara, Masashi] Osaka Med Coll, Dept Oral Surg, Takatsuki, Osaka 5698686, Japan; [Yasunami, Yohichi] Fukuoka Univ, Fac Med, Dept Regenerat Med & Transplantat, Jonan Ku, Fukuoka 8140180, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Osaka National Hospital; Jichi Medical University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Tokyo Medical University; Tokyo Medical University; Osaka Medical College; Fukuoka University	Ono, M (corresponding author), Natl Canc Ctr, Natl Canc Ctr Res Inst, Div Chemotherapy, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	masono@ncc.go.jp			National Institute of Biomedical Innovation of Japan; Ministry of Health, Labor and Welfare of Japan	National Institute of Biomedical Innovation of Japan(National Institute of Biomedical Innovation); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Program for Promotion of Fundamental Studies in Health Sciences conducted by the National Institute of Biomedical Innovation of Japan and by the Third-Term Comprehensive Control Research for Cancer conducted by the Ministry of Health, Labor and Welfare of Japan.	Blomback B, 2001, ANN NY ACAD SCI, V936, P1; DeSouza L, 2005, J PROTEOME RES, V4, P377, DOI 10.1021/pr049821j; Gao J, 2003, J PROTEOME RES, V2, P643, DOI 10.1021/pr034038x; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; Harlow E., 1988, ANTIBODIES LAB MANUA; HENSCHEN AH, 1991, THROMB HAEMOSTASIS, V65, P821; Henschen-Edman AH, 2001, ANN NY ACAD SCI, V936, P580; Honda K, 2005, CANCER RES, V65, P10613, DOI 10.1158/0008-5472.CAN-05-1851; Huang L, 2007, GASTROENTEROLOGY, V133, P1569, DOI 10.1053/j.gastro.2007.08.011; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ishihama Y, 2005, J CHROMATOGR A, V1067, P73, DOI 10.1016/j.chroma.2004.10.107; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kukkola L, 2003, J BIOL CHEM, V278, P47685, DOI 10.1074/jbc.M306806200; Kumamoto K, 1998, BIOCHEM BIOPH RES CO, V247, P514, DOI 10.1006/bbrc.1998.8824; Kuwahara K, 2000, BLOOD, V95, P2321, DOI 10.1182/blood.V95.7.2321.007k33_2321_2328; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Matsubara J, 2009, J CLIN ONCOL, V27, P2261, DOI 10.1200/JCO.2008.19.9745; Mueller LN, 2008, J PROTEOME RES, V7, P51, DOI 10.1021/pr700758r; Myllyharju J, 1999, EMBO J, V18, P306, DOI 10.1093/emboj/18.2.306; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Nedelkov D, 2005, P NATL ACAD SCI USA, V102, P10852, DOI 10.1073/pnas.0500426102; Negishi A, 2009, CANCER SCI, V100, P514, DOI 10.1111/j.1349-7006.2008.01055.x; OGATA S, 1975, J BIOCHEM, V78, P687, DOI 10.1093/oxfordjournals.jbchem.a130956; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ono M, 2003, GLYCOCONJUGATE J, V20, P71, DOI 10.1023/B:GLYC.0000018019.22070.7d; Ono M, 2006, MOL CELL PROTEOMICS, V5, P1338, DOI 10.1074/mcp.T500039-MCP200; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Sakaguchi N, 2005, J IMMUNOL, V174, P4485, DOI 10.4049/jimmunol.174.8.4485; Sato S, 2005, GASTROENTEROLOGY, V129, P1225, DOI 10.1053/j.gastro.2005.07.025; Shitashige M, 2008, GASTROENTEROLOGY, V134, P1961, DOI 10.1053/j.gastro.2008.03.010; States DJ, 2006, NAT BIOTECHNOL, V24, P333, DOI 10.1038/nbt1183; Takahashi N, 2003, J NUTR, V133, p2090S, DOI 10.1093/jn/133.6.2090S; Zhang H, 2005, MOL CELL PROTEOMICS, V4, P144, DOI 10.1074/mcp.M400090-MCP200	34	42	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29041	29049		10.1074/jbc.M109.041749	http://dx.doi.org/10.1074/jbc.M109.041749			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19696023	hybrid, Green Published			2022-12-25	WOS:000270678900061
J	Shimada, H; Hirai, KI; Simamura, E; Hatta, T; Iwakiri, H; Mizuki, K; Hatta, T; Sawasaki, T; Matsunaga, S; Endo, Y; Shimizu, S				Shimada, Hiroki; Hirai, Kei-Ichi; Simamura, Eriko; Hatta, Toshihisa; Iwakiri, Hiroki; Mizuki, Keiji; Hatta, Taizo; Sawasaki, Tatsuya; Matsunaga, Satoko; Endo, Yaeta; Shimizu, Shigeomi			Paraquat Toxicity Induced by Voltage-dependent Anion Channel 1 Acts as an NADH-dependent Oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; PROTEIN-SYNTHESIS SYSTEM; SUPEROXIDE-DISMUTASE; HERBICIDE PARAQUAT; MEDIATED TOXICITY; RADICAL FORMATION; OUTER-MEMBRANE; CELLS; LIVER; LUNG	Paraquat (PQ), a herbicide used worldwide, causes fatal injury to organs upon high dose ingestion. Treatments for PQ poisoning areunreliable, and numerous deaths have been attributed inappropriate usage of the agent. It is generally speculated that a microsomal drug-metabolizing enzyme system is responsible for PQ toxicity. However, recent studies have demonstrated cytotoxicity via mitochondria, and therefore, the cytotoxic mechanism remains controversial. Here, we demonstrated that mitochondrial NADH-dependent PQ reductase containing a voltage-dependent anion channel 1 (VDAC1) is responsible for PQ cytotoxicity. When mitochondria were incubated with NADH and PQ, superoxide anion (O-(2) over dot(-)) was produced, and the mitochondria ruptured. Outer membrane extract oxidized NADH in a PQ dose-dependent manner, and oxidation was suppressed by VDAC inhibitors. Zymographic analysis revealed the presence of VDAC1 protein in the oxidoreductase, and the direct binding of PQ to VDAC1 was demonstrated using biotinylated PQ. VDAC1-overexpressing cells showed increased O-(2) over dot(-). production and cytotoxicity, both of which were suppressed in VDAC1 knockdown cells. These results indicated that a VDAC1-containing mitochondrial system is involved in PQ poisoning. These insights into the mechanism of PQ poisoning not only demonstrated novel physiological functions of VDAC protein, but they may facilitate the development of new therapeutic approaches.	Kanazawa Med Univ, Mol & Cell Struct Sci, Uchinada, Ishikawa 9200293, Japan; [Hirai, Kei-Ichi] Niwa Inst Immunol, Kochi 7870306, Japan; [Iwakiri, Hiroki; Mizuki, Keiji; Hatta, Taizo] Sojo Univ, Dept Neurosci, Kumamoto 8600082, Japan; [Sawasaki, Tatsuya; Matsunaga, Satoko; Endo, Yaeta] Ehime Univ, Venture Business Lab, Matsuyama, Ehime 7908577, Japan; [Sawasaki, Tatsuya; Matsunaga, Satoko; Endo, Yaeta] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime 7908577, Japan; [Sawasaki, Tatsuya; Endo, Yaeta] RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Shimizu, Shigeomi] Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Cell Biol, Bunkyo Ku, Tokyo 1138510, Japan	Kanazawa Medical University; Sojo University; Ehime University; Ehime University; RIKEN; Tokyo Medical & Dental University (TMDU)	Shimada, H (corresponding author), Kanazawa Med Univ, Mol & Cell Struct Sci, Uchinada, Ishikawa 9200293, Japan.	simada-h@kanazawa-med.ac.jp		Sawasaki, Tatsuya/0000-0002-7952-0556	Japan Society for the Promotion of Science [15591664, 17591899, 19390291, 21791045]; Kanazawa Medical University [S2003-12, S2004-12, C2007-4, S2007-9, C2008-1, S2008-10, C2009-3, S2009-10]; High-Tech Research Center of Kanazawa Medical University [H2009-14]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [S0801085]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanazawa Medical University; High-Tech Research Center of Kanazawa Medical University; Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research 15591664, 17591899, 19390291, and 21791045 from the Japan Society for the Promotion of Science, Grants for Promoted Research S2003-12, S2004-12, C2007-4, S2007-9, C2008-1, S2008-10, C2009-3, and S2009-10 from Kanazawa Medical University, Grant for Project Research H2009-14 from High-Tech Research Center of Kanazawa Medical University, and in part by The Ministry of Education, Culture, Sports, Science, and Technology, Japan Grant S0801085.	Ariyama J, 2000, INTENS CARE MED, V26, P981, DOI 10.1007/s001340051291; Baker MA, 2004, J BIOL CHEM, V279, P4811, DOI 10.1074/jbc.M311020200; BALDWIN RC, 1975, TOXICOL APPL PHARM, V32, P298, DOI 10.1016/0041-008X(75)90220-3; BUS JS, 1976, TOXICOL APPL PHARM, V35, P501, DOI 10.1016/0041-008X(76)90073-9; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Dinis-Oliveira RJ, 2008, CRIT REV TOXICOL, V38, P13, DOI 10.1080/10408440701669959; GAGE JC, 1968, BIOCHEM J, V109, P757, DOI 10.1042/bj1090757; HIRAI KI, 1985, EXP MOL PATHOL, V43, P242, DOI 10.1016/0014-4800(85)90044-9; HIRAI KI, 1992, TOXICOLOGY, V72, P1, DOI 10.1016/0300-483X(92)90081-O; Hirai KI, 1999, J ELECTRON MICROSC, V48, P289, DOI 10.1093/oxfordjournals.jmicro.a023680; Lee AC, 1996, J BIOL CHEM, V271, P26724, DOI 10.1074/jbc.271.43.26724; LEE AC, 1994, J BIOL CHEM, V269, P30974; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; Nakayama S, 2002, BIOCHEM BIOPH RES CO, V290, P23, DOI 10.1006/bbrc.2001.6185; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; OLIVER PD, 1992, INVEST OPHTH VIS SCI, V33, P1909; SAOTOME K, 1989, TOXICOL IN VITRO, V3, P317, DOI 10.1016/0887-2333(89)90039-8; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Sawasaki T, 2002, FEBS LETT, V514, P102, DOI 10.1016/S0014-5793(02)02329-3; Sawasaki T, 2008, FEBS LETT, V582, P221, DOI 10.1016/j.febslet.2007.12.004; Sawasaki T, 2005, METH MOL B, V310, P131; Shimada H, 1998, ARCH BIOCHEM BIOPHYS, V351, P75, DOI 10.1006/abbi.1997.0557; Shimada H, 2002, ARCH BIOCHEM BIOPHYS, V402, P149, DOI 10.1016/S0003-9861(02)00059-0; Simamura E, 2008, ANAT SCI INT, V83, P261, DOI 10.1111/j.1447-073X.2008.00241.x; Simamura E, 2006, CANCER BIOL THER, V5, P1523, DOI 10.4161/cbt.5.11.3302; STCLAIR DK, 1991, FEBS LETT, V293, P199, DOI 10.1016/0014-5793(91)81186-C; Teraoka K, 1999, Nihon Rinsho, V57 Suppl, P784; Vyssokikh M, 2004, MOL CELL BIOCHEM, V256, P117, DOI 10.1023/B:MCBI.0000009863.69249.d9; WANG GY, 1992, J ELECTRON MICROSC, V41, P181; Wesseling C, 2001, Int J Occup Environ Health, V7, P275; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yamamoto T, 2006, J PROTEOME RES, V5, P3336, DOI 10.1021/pr060291w; Yang WS, 2005, J TOXICOL ENV HEAL A, V68, P1939, DOI 10.1080/15287390500226987; Yehezkel G, 2006, J BIOL CHEM, V281, P5938, DOI 10.1074/jbc.M510104200; Zizi M, 1998, BIOPHYS J, V75, P704, DOI 10.1016/S0006-3495(98)77560-5	35	21	34	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28642	28649		10.1074/jbc.M109.033431	http://dx.doi.org/10.1074/jbc.M109.033431			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19717555	Green Published, hybrid			2022-12-25	WOS:000270678900019
J	Wang, ZL; Kumamoto, Y; Wang, P; Gan, XQ; Lehmann, D; Smrcka, AV; Cohn, L; Iwasaki, A; Li, L; Wu, DQ				Wang, Zhenglong; Kumamoto, Yosuke; Wang, Ping; Gan, Xiaoqing; Lehmann, David; Smrcka, Alan V.; Cohn, Lauren; Iwasaki, Akiko; Li, Lin; Wu, Dianqing			Regulation of Immature Dendritic Cell Migration by RhoA Guanine Nucleotide Exchange Factor Arhgef5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY GTPASES; BONE-MARROW; ACTIVATION; PROTEIN; RAC; CDC42; P-REX1; NEUTROPHILS; GEF; ORGANIZATION	There are a large number of Rho guanine nucleotide exchange factors, most of which have no known functions. Here, we carried out a short hairpin RNA-based functional screen of Rho-GEFs for their roles in leukocyte chemotaxis and identified Arhgef5 as an important factor in chemotaxis of a macrophage phage-like RAW264.7 cell line. Arhgef5 can strongly activate RhoA and RhoB and weakly RhoC and RhoG, but not Rac1, RhoQ, RhoD, or RhoV, in transfected human embryonic kidney 293 cells. In addition, G beta gamma interacts with Arhgef5 and can stimulate Arhgef5-mediated activation of RhoA in an in vitro assay. In vivo roles of Arhgef5 were investigated using an Arhgef-5-null mouse line. Arhgef5 deficiency did not affect chemotaxis of mouse macrophages, T and B lymphocytes, and bone marrow-derived mature dendritic cells (DC), but it abrogated MIP1 alpha-induced chemotaxis of immature DCs and impaired migration of DCs from the skin to lymph node. In addition, Arhgef5 deficiency attenuated allergic airway inflammation. Therefore, this study provides new insights into signaling mechanisms for DC migration regulation.	[Li, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Gan, Xiaoqing; Wu, Dianqing] Yale Univ, Sch Med, Program Vasc Biol & Therapeut, New Haven, CT 06520 USA; [Gan, Xiaoqing; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Kumamoto, Yosuke; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Cohn, Lauren] Yale Univ, Sch Med, Pulm & Crit Care Med Sect, New Haven, CT 06520 USA; [Lehmann, David; Smrcka, Alan V.] Univ Rochester, Dept Pharmacol, Rochester, NY 14642 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Yale University; Yale University; Yale University; Yale University; University of Rochester	Li, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China.	lli@sibs.ac.cn; Dan.Wu@Yale.edu	Li, Li/AEM-3636-2022; Iwasaki, Akiko/Z-1591-2019; LI, LI/GVS-5344-2022; li, li/HII-4157-2022	Iwasaki, Akiko/0000-0002-7824-9856; Lehmann, David/0000-0003-0174-344X; Kumamoto, Yosuke/0000-0001-9369-4934	National Institutes of Health [HL080706, HL070694]; American Heart Association; Ministry of Science and Technology of China [2002CB513000]; National Science Foundation of China [30521005]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070694, R01HL080706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054597, R01GM081772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL080706 and HL070694 (to D. W.), grants from the American Heart Association (to P. W.), Ministry of Science and Technology of China Grant 2002CB513000, and National Science Foundation of China Grant 30521005 (to L. L.).	Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buchsbaum RJ, 2007, J CELL SCI, V120, P1149, DOI 10.1242/jcs.03428; Burns S, 2004, CURR BIOL, V14, pR965, DOI 10.1016/j.cub.2004.10.044; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Dong XM, 2005, CURR BIOL, V15, P1874, DOI 10.1016/j.cub.2005.09.014; Ellerbroek SM, 2004, MOL BIOL CELL, V15, P3309, DOI 10.1091/mbc.E04-02-0146; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feng QY, 2004, EMBO J, V23, P3492, DOI 10.1038/sj.emboj.7600331; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Iijima N, 2007, P NATL ACAD SCI USA, V104, P19061, DOI 10.1073/pnas.0707179104; Li Z, 2005, PROSTAG OTH LIPID M, V76, P95, DOI 10.1016/j.prostaglandins.2005.02.002; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; Mao JH, 1998, J BIOL CHEM, V273, P27118, DOI 10.1074/jbc.273.42.27118; Meili R, 2003, CELL, V114, P153, DOI 10.1016/S0092-8674(03)00553-1; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Obermeier A, 1998, EMBO J, V17, P4328, DOI 10.1093/emboj/17.15.4328; Ogita H, 2003, CIRC RES, V93, P23, DOI 10.1161/01.RES.0000079310.81429.C8; REMMERS AE, 1994, J BIOL CHEM, V269, P13771; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Rojas RJ, 2003, COMB CHEM HIGH T SCR, V6, P409; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sato A, 2004, P NATL ACAD SCI USA, V101, P16274, DOI 10.1073/pnas.0406268101; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Welch HCE, 2005, CURR BIOL, V15, P1867, DOI 10.1016/j.cub.2005.09.050; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Xie XZ, 2005, CELL SIGNAL, V17, P461, DOI 10.1016/j.cellsig.2004.09.012; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5	47	33	37	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28599	28606		10.1074/jbc.M109.047282	http://dx.doi.org/10.1074/jbc.M109.047282			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19713215	hybrid, Green Published			2022-12-25	WOS:000270678900014
J	Baisamy, L; Cavin, S; Jurisch, N; Diviani, D				Baisamy, Laurent; Cavin, Sabrina; Jurisch, Nathalie; Diviani, Dario			The Ubiquitin-like Protein LC3 Regulates the Rho-GEF Activity of AKAP-Lbc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; KINASE-A; ACTIN CYTOSKELETON; SIGNALING COMPLEX; ANCHORING PROTEIN; SCAFFOLD PROTEIN; BINDING; AUTOPHAGY; GTPASES; IDENTIFICATION	AKAP-Lbc is a member of the A-kinase anchoring protein (AKAP) family that has been recently associated with the development of pathologies, such as cardiac hypertrophy and cancer. We have previously demonstrated that, at the molecular level, AKAP-Lbc functions as a guanine nucleotide exchange factor (GEF) that promotes the specific activation of RhoA. In the present study, we identified the ubiquitin-like protein LC3 as a novel regulatory protein interacting with AKAP-Lbc. Mutagenesis studies revealed that LC3, through its NH2-terminal alpha-helical domain, interacts with two binding sites located within the NH2-terminal regulatory region of AKAP-Lbc. Interestingly, LC3 overexpression strongly reduced the ability of AKAP-Lbc to interact with RhoA, profoundly impairing the Rho-GEF activity of the anchoring protein and, as a consequence, its ability to promote cytoskeletal rearrangements associated with the formation of actin stress fibers. Moreover, AKAP-Lbc mutants that fail to interact with LC3 show a higher basal Rho-GEF activity as compared with the wild type protein and become refractory to the inhibitory effect of LC3. This suggests that LC3 binding maintains AKAP-Lbc in an inactive state that displays a reduced ability to promote downstream signaling. Collectively, these findings provide evidence for a previously uncharacterized role of LC3 in the regulation of Rho signaling and in the reorganization of the actin cytoskeleton.	[Baisamy, Laurent; Cavin, Sabrina; Jurisch, Nathalie; Diviani, Dario] Fac Biol & Med, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland		Diviani, D (corresponding author), Fac Biol & Med, Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	Dario.diviani@unil.ch	Jurisch-Yaksi, Nathalie/A-3219-2019; Cavin, Sabrina/AAE-9866-2019	Jurisch-Yaksi, Nathalie/0000-0002-8767-6120; Cavin, Sabrina/0000-0002-1993-4503; Diviani, Dario/0000-0003-4375-3718	Fonds National Suisse de la Recherche Scientifique [3100A0-109440, 3100A0-122020]	Fonds National Suisse de la Recherche Scientifique	This work was supported by Fonds National Suisse de la Recherche Scientifique Grants 3100A0-109440 and 3100A0-122020 (to D. D.).	Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Baisamy L, 2005, J BIOL CHEM, V280, P15405, DOI 10.1074/jbc.M414440200; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Chahdi A, 2008, MOL CELL BIOL, V28, P1679, DOI 10.1128/MCB.00898-07; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2004, EMBO J, V23, P2811, DOI 10.1038/sj.emboj.7600287; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Furuta S, 2002, ONCOGENE, V21, P7060, DOI 10.1038/sj.onc.1205790; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Kouno T, 2005, J BIOL CHEM, V280, P24610, DOI 10.1074/jbc.M413565200; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Longhurst DM, 2006, J BIOL CHEM, V281, P12030, DOI 10.1074/jbc.M513756200; MANN SS, 1994, J BIOL CHEM, V269, P11492; Marino G, 2004, CELL MOL LIFE SCI, V61, P1439, DOI 10.1007/s00018-004-4012-4; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Nassar N, 2006, CURR TOP MED CHEM, V6, P1109, DOI 10.2174/156802606777812095; Nauert JB, 1997, CURR BIOL, V7, P52, DOI 10.1016/S0960-9822(06)00027-3; Nymann-Andersen J, 2002, NEUROPHARMACOLOGY, V43, P476, DOI 10.1016/S0028-3908(02)00165-X; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Takahashi M, 1999, J BIOL CHEM, V274, P17267, DOI 10.1074/jbc.274.24.17267; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; TOKSOZ D, 1994, ONCOGENE, V9, P621; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Zenke FT, 2004, J BIOL CHEM, V279, P18392, DOI 10.1074/jbc.M400084200; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	40	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28232	28242		10.1074/jbc.M109.054668	http://dx.doi.org/10.1074/jbc.M109.054668			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19696020	Green Published, hybrid			2022-12-25	WOS:000270676300051
J	Sengupta, A; Molkentin, JD; Yutzey, KE				Sengupta, Arunima; Molkentin, Jeffery D.; Yutzey, Katherine E.			FoxO Transcription Factors Promote Autophagy in Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CELL-DEATH; IN-VIVO; CARDIAC MYOCYTES; MYOCARDIAL ISCHEMIA/REPERFUSION; SIGNALING PATHWAYS; HEMODYNAMIC STRESS; ANOREXIA-NERVOSA; HEART-DISEASE; HYPERTROPHY	In the heart, autophagy is required for normal cardiac function and also has been implicated in cardiovascular disease. FoxO transcription factors promote autophagy in skeletal muscle and have additional roles in regulation of cell size, proliferation, and metabolism. Here we investigate the role of FoxO transcription factors in regulating autophagy and cell size in cardiomyocytes. In cultured rat neonatal cardiomyocytes, glucose deprivation leads to decreased cell size and induction of autophagy pathway genes LC3, Gabarapl1, and Atg12. Likewise, overexpression of either FoxO1 or FoxO3 reduces cardiomyocyte cell size and induces expression of autophagy pathway genes. Moreover, inhibition of FoxO activity by dominant negative FoxO1 (Delta 256) blocks cardiomyocyte cell size reduction upon starvation, suggesting the necessity of FoxO function in cardiomyocyte cell size regulation. Under starvation conditions, endogenous FoxO1 and FoxO3 are localized to the nucleus and bind to promoter sequences of Gabarapl1 and Atg12. In vivo studies show that cellular stress, such as starvation or ischemia/reperfusion in mice, results in induction of autophagy in the heart with concomitant dephosphorylation of FoxO, consistent with increased activity of nuclear FoxO transcription factors. Together these results provide evidence for an important role for FoxO1 and FoxO3 in regulating autophagy and cell size in cardiomyocytes.	[Sengupta, Arunima; Molkentin, Jeffery D.; Yutzey, Katherine E.] Cincinnati Childrens Med Ctr, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Yutzey, KE (corresponding author), Cincinnati Childrens Med Ctr, Div Mol Cardiovasc Biol, ML 7020,240 Albert Sabin Way, Cincinnati, OH 45229 USA.	katherine.yutzey@cchmc.org		Molkentin, Jeffery/0000-0002-3558-6529; Yutzey, Katherine/0000-0002-1444-7124	National Institutes of Health [P01 HL069779]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL069779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL069779.	Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; De Windt LJ, 2000, J BIOL CHEM, V275, P13571, DOI 10.1074/jbc.275.18.13571; DESIMONE GD, 1994, BRIT HEART J, V71, P287; Elsasser A, 2004, J AM COLL CARDIOL, V43, P2191, DOI 10.1016/j.jacc.2004.02.053; Evans-Anderson HJ, 2008, CIRC RES, V102, P686, DOI 10.1161/CIRCRESAHA.107.163428; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Gustafsson AB, 2008, AUTOPHAGY, V4, P416, DOI 10.4161/auto.5655; Gustafsson AB, 2008, J MOL CELL CARDIOL, V44, P654, DOI 10.1016/j.yjmcc.2008.01.010; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Hannenhalli S, 2006, CIRCULATION, V114, P1269, DOI 10.1161/CIRCULATIONAHA.106.632430; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; HEMMERICH P, 1993, NUCLEIC ACIDS RES, V21, P223, DOI 10.1093/nar/21.2.223; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Kaiser RA, 2005, J BIOL CHEM, V280, P32602, DOI 10.1074/jbc.M500684200; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kanfi Y, 2008, FEBS LETT, V582, P543, DOI [10.1016/j.febslet.2008.01.019, 10.1016/j.febslet.2008.06.005]; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kunapuli S, 2006, J CARD FAIL, V12, P381, DOI 10.1016/j.cardfail.2006.02.002; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Maruyama R, 2008, AM J PHYSIOL-HEART C, V295, pH1599, DOI 10.1152/ajpheart.91449.2007; Matsui T, 2001, CIRCULATION, V104, P330; Matsui Y, 2008, AUTOPHAGY, V4, P409, DOI 10.4161/auto.5638; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Melendez A, 2008, DEVELOPMENT, V135, P2347, DOI 10.1242/dev.016105; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Nishida K, 2009, CELL DEATH DIFFER, V16, P31, DOI 10.1038/cdd.2008.163; Nishida K, 2008, CIRC RES, V103, P343, DOI 10.1161/CIRCRESAHA.108.175448; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; PAPADIMITRIOU JM, 1974, CIRC RES, V35, P127, DOI 10.1161/01.RES.35.1.127; SANDRI M, 2004, CELL, P117; Senzaki H, 2006, CIRCULATION, V113, pE759, DOI 10.1161/CIRCULATIONAHA.105.555565; Shelton EL, 2007, DEV BIOL, V302, P376, DOI 10.1016/j.ydbio.2006.09.047; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Tsujita Y, 2006, P NATL ACAD SCI USA, V103, P11946, DOI 10.1073/pnas.0510138103; Valentim L, 2006, J MOL CELL CARDIOL, V40, P846, DOI 10.1016/j.yjmcc.2006.03.428; Vellai T, 2008, AUTOPHAGY, V4, P507, DOI 10.4161/auto.5670; Zafeiridis A, 1998, CIRCULATION, V98, P656, DOI 10.1161/01.CIR.98.7.656; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	62	318	334	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28319	28331		10.1074/jbc.M109.024406	http://dx.doi.org/10.1074/jbc.M109.024406			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19696026	hybrid, Green Published			2022-12-25	WOS:000270676300058
J	Baumann, F; Pahnke, J; Radovanovic, I; Rulicke, T; Bremer, J; Tolnay, M; Aguzzi, A				Baumann, Frank; Pahnke, Jens; Radovanovic, Ivan; Ruelicke, Thomas; Bremer, Juliane; Tolnay, Markus; Aguzzi, Adriano			Functionally Relevant Domains of the Prion Protein Identified In Vivo	PLOS ONE			English	Article							CELLULAR PRION; 3-DIMENSIONAL STRUCTURES; MICE DEFICIENT; NMR STRUCTURE; PRP; DOPPEL; DEGENERATION; LACKING; ATAXIA; TOXICITY	The prion consists essentially of PrPSc, a misfolded and aggregated conformer of the cellular protein PrPC. Whereas PrPC deficient mice are clinically healthy, expression of PrPC variants lacking its central domain (PrP Delta CD), or of the PrP-related protein Dpl, induces lethal neurodegenerative syndromes which are repressed by full-length PrP. Here we tested the structural basis of these syndromes by grafting the amino terminus of PrPC (residues 1-134), or its central domain (residues 90-134), onto Dpl. Further, we constructed a soluble variant of the neurotoxic PrP Delta CD mutant that lacks its glycosyl phosphatidyl inositol (GPI) membrane anchor. Each of these modifications abrogated the pathogenicity of Dpl and PrP Delta CD in transgenic mice. The PrP-Dpl chimeric molecules, but not anchorless PrP Delta CD, ameliorated the disease of mice expressing truncated PrP variants. We conclude that the amino proximal domain of PrP exerts a neurotrophic effect even when grafted onto a distantly related protein, and that GPI-linked membrane anchoring is necessary for both beneficial and deleterious effects of PrP and its variants.			Baumann, F (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch	Bremer, Juliane/AAH-9487-2020; Bremer, Juliane/E-2298-2012; Baumann, Frank/F-7737-2016; Aguzzi, Adriano/A-3351-2008; Pahnke, Jens/G-1757-2010	Pahnke, Jens/0000-0001-7355-4213; Aguzzi, Adriano/0000-0002-0344-6708				Aguzzi A, 2005, SCIENCE, V308, P1420, DOI 10.1126/science.1114168; Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348; Atarashi R, 2003, J BIOL CHEM, V278, P28944, DOI 10.1074/jbc.M303655200; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Behrens A, 2002, TRENDS NEUROSCI, V25, P150, DOI 10.1016/S0166-2236(00)02089-0; Behrens A, 2002, EMBO J, V21, P3652, DOI 10.1093/emboj/cdf386; BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Chacon MA, 2003, MOL PSYCHIATR, V8, P853, DOI [10.1038/sj.mp.4001400, 10.1038/sj.mp.4001414]; Chen SZ, 2003, MOL CELL NEUROSCI, V22, P227, DOI 10.1016/S1044-7431(02)00014-3; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Drisaldi B, 2004, J BIOL CHEM, V279, P55443, DOI 10.1074/jbc.M404794200; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Hornemann S, 2004, EMBO REP, V5, P1159, DOI 10.1038/sj.embor.7400297; Karapetyan YE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005730; Khosravani Houman, 2008, J Gen Physiol, V131, pi5, DOI 10.1085/JGP1316OIA5; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Luhrs T, 2003, J MOL BIOL, V326, P1549, DOI 10.1016/S0022-2836(02)01471-7; Mattei V, 2004, FEBS LETT, V560, P14, DOI 10.1016/S0014-5793(04)00029-8; Mitteregger G, 2007, BRAIN PATHOL, V17, P174, DOI 10.1111/j.1750-3639.2007.00061.x; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; Nazor KE, 2007, BBA-MOL BASIS DIS, V1772, P645, DOI 10.1016/j.bbadis.2007.04.004; Nishida N, 1999, LAB INVEST, V79, P689; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Polymenidou M, 2008, VACCINE, V26, P2601, DOI 10.1016/j.vaccine.2008.03.035; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; Riek R, 2003, CLIN LAB MED, V23, P209, DOI 10.1016/S0272-2712(02)00070-7; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Rulicke T, 2004, METH MOL B, V254, P165; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Toni M, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/69469; Trifilo MJ, 2008, J VIROL, V82, P9890, DOI 10.1128/JVI.00486-08; Trifilo MJ, 2006, SCIENCE, V313, P94, DOI 10.1126/science.1128635; Varela-Nallar L, 2006, BIOL RES, V39, P39, DOI 10.4067/S0716-97602006000100005; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200; Weissmann C, 1999, SCIENCE, V286, P914, DOI 10.1126/science.286.5441.914; Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55; Yamaguchi N, 2004, BIOCHEM BIOPH RES CO, V319, P1247, DOI 10.1016/j.bbrc.2004.05.115; Yoshikawa D, 2008, J BIOL CHEM, V283, P24202, DOI 10.1074/jbc.M804212200; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325	54	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2009	4	9							e6707	10.1371/journal.pone.0006707	http://dx.doi.org/10.1371/journal.pone.0006707			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZH	19738901	Green Published, gold, Green Submitted			2022-12-25	WOS:000269622300001
J	Oh, YM; Kim, JK; Choi, Y; Choi, S; Yoo, JY				Oh, Young Min; Kim, Jong Kyoung; Choi, Yongwook; Choi, Seungjin; Yoo, Joo-Yeon			Prediction and Experimental Validation of Novel STAT3 Target Genes in Human Cancer Cells	PLOS ONE			English	Article								The comprehensive identification of functional transcription factor binding sites (TFBSs) is an important step in understanding complex transcriptional regulatory networks. This study presents a motif-based comparative approach, STAT-Finder, for identifying functional DNA binding sites of STAT3 transcription factor. STAT-Finder combines STAT-Scanner, which was designed to predict functional STAT TFBSs with improved sensitivity, and a motif-based alignment to minimize false positive prediction rates. Using two reference sets containing promoter sequences of known STAT3 target genes, STAT-Finder identified functional STAT3 TFBSs with enhanced prediction efficiency and sensitivity relative to other conventional TFBS prediction tools. In addition, STAT-Finder identified novel STAT3 target genes among a group of genes that are over-expressed in human cancer cells. The binding of STAT3 to the predicted TFBSs was also experimentally confirmed through chromatin immunoprecipitation. Our proposed method provides a systematic approach to the prediction of functional TFBSs that can be applied to other TFs.			Oh, YM (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea.	seungjin@postech.ac.kr; jyoo@postech.ac.kr	Kim, Jong Kyoung/AAF-3414-2021; Kim, Jong Kyoung/C-2971-2008	Kim, Jong Kyoung/0000-0002-0257-0547				Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bai Y, 2008, J BIOL CHEM, V283, P6832, DOI 10.1074/jbc.M706021200; Berezikov E, 2004, GENOME RES, V14, P170; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chang LW, 2006, GENOME RES, V16, P405, DOI 10.1101/gr.4303406; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Claverie JM, 1996, COMPUT APPL BIOSCI, V12, P431; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; COFFER P, 1995, ONCOGENE, V10, P985; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Della Gatta G, 2008, GENOME RES, V18, P939, DOI 10.1101/gr.073601.107; Doniger SW, 2007, PLOS COMPUT BIOL, V3, P932, DOI 10.1371/journal.pcbi.0030099; Doniger SW, 2005, GENOME RES, V15, P701, DOI 10.1101/gr.3578205; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Emerson BM, 2002, CELL, V109, P267, DOI 10.1016/S0092-8674(02)00740-7; Fan SC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001184; Firestone GL, 2003, CELL PHYSIOL BIOCHEM, V13, P1, DOI 10.1159/000070244; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Hannenhalli S, 2008, BIOINFORMATICS, V24, P1325, DOI 10.1093/bioinformatics/btn198; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hartner A, 1997, KIDNEY INT, V51, P1754, DOI 10.1038/ki.1997.241; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Ihle JN, 2001, CURR OPIN CELL BIOL, V13, P211, DOI 10.1016/S0955-0674(00)00199-X; Jensen ST, 2008, J AM STAT ASSOC, V103, P188, DOI 10.1198/016214507000000365; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kheradpour P, 2007, GENOME RES, V17, P1919, DOI 10.1101/gr.7090407; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Kiryu-Seo S, 2008, J BIOL CHEM, V283, P6988, DOI 10.1074/jbc.M707514200; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lerner L, 2003, GENE DEV, V17, P2564, DOI 10.1101/gad.1135003; Leung MK, 1999, GENOMICS, V61, P307, DOI 10.1006/geno.1999.5970; Liu XD, 2007, AM J RESP CELL MOL, V37, P121, DOI 10.1165/rcmb.2005-0253OC; Marzolf B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-286; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Palin K, 2006, NAT PROTOC, V1, P368, DOI 10.1038/nprot.2006.56; Pritsker M, 2004, GENOME RES, V14, P99; RAHMANN S, 2003, STAT APPL GENET MOL, V2, DOI DOI 10.2202/1544-6115.1032; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; SCHAEFER TS, 1995, P NATL ACAD SCI USA, V92, P9097, DOI 10.1073/pnas.92.20.9097; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smit A, 1996, REPEATMASKER OPEN 30; Snyder M, 2008, J BIOL CHEM, V283, P3791, DOI 10.1074/jbc.M706976200; Song JI, 2000, ONCOGENE, V19, P2489, DOI 10.1038/sj.onc.1203483; Spano JP, 2006, EUR J CANCER, V42, P2668, DOI 10.1016/j.ejca.2006.07.006; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; STADEN R, 1989, COMPUT APPL BIOSCI, V5, P89; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Thijs G, 2002, BIOINFORMATICS, V18, P331, DOI 10.1093/bioinformatics/18.2.331; Tomida M, 2008, J CANCER RES CLIN, V134, P551, DOI 10.1007/s00432-007-0318-6; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Urnov FD, 2003, J CELL BIOCHEM, V88, P684, DOI 10.1002/jcb.10397; Vallania F, 2009, P NATL ACAD SCI USA, V106, P5117, DOI 10.1073/pnas.0900473106; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xie XH, 2009, BIOINFORMATICS, V25, P167, DOI 10.1093/bioinformatics/btn605; Yang Y, 2005, J IMMUNOL, V174, P2720, DOI 10.4049/jimmunol.174.5.2720; Yoo JY, 2002, CELL, V108, P331, DOI 10.1016/S0092-8674(02)00636-0; Yoo JY, 2001, J BIOL CHEM, V276, P26421, DOI 10.1074/jbc.M009935200	80	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2009	4	9							e6911	10.1371/journal.pone.0006911	http://dx.doi.org/10.1371/journal.pone.0006911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZF	19730699	Green Submitted, gold, Green Published			2022-12-25	WOS:000269622100014
J	Xie, ZM; Zou, HF; Lei, G; Wei, W; Zhou, QY; Niu, CF; Liao, Y; Tian, AG; Ma, B; Zhang, WK; Zhang, JS; Chen, SY				Xie, Zong-Ming; Zou, Hong-Feng; Lei, Gang; Wei, Wei; Zhou, Qi-Yun; Niu, Can-Fang; Liao, Yong; Tian, Ai-Guo; Ma, Biao; Zhang, Wan-Ke; Zhang, Jin-Song; Chen, Shou-Yi			Soybean Trihelix Transcription Factors GmGT-2A and GmGT-2B Improve Plant Tolerance to Abiotic Stresses in Transgenic Arabidopsis	PLOS ONE			English	Article								Background: Trihelix transcription factors play important roles in light-regulated responses and other developmental processes. However, their functions in abiotic stress response are largely unclear. In this study, we identified two trihelix transcription factor genes GmGT-2A and GmGT-2B from soybean and further characterized their roles in abiotic stress tolerance. Findings: Both genes can be induced by various abiotic stresses, and the encoded proteins were localized in nuclear region. In yeast assay, GmGT-2B but not GmGT-2A exhibits ability of transcriptional activation and dimerization. The N-terminal peptide of 153 residues in GmGT-2B was the minimal activation domain and the middle region between the two trihelices mediated the dimerization of the GmGT-2B. Transactivation activity of the GmGT-2B was also confirmed in plant cells. DNA binding analysis using yeast one-hybrid assay revealed that GmGT-2A could bind to GT-1bx, GT-2bx, mGT-2bx-2 and D1 whereas GmGT-2B could bind to the latter three elements. Overexpression of the GmGT-2A and GmGT-2B improved plant tolerance to salt, freezing and drought stress in transgenic Arabidopsis plants. Moreover, GmGT-2B-transgenic plants had more green seedlings compared to Col-0 under ABA treatment. Many stress-responsive genes were altered in GmGT-2A-and GmGT-2B-transgenic plants. Conclusion: These results indicate that GmGT-2A and GmGT-2B confer stress tolerance through regulation of a common set of genes and specific sets of genes. GmGT-2B also affects ABA sensitivity.			Xie, ZM (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Plant Gene Res Ctr, Natl Key Lab Plant Genom, Beijing, Peoples R China.	jszhang@genetics.ac.cn; sychen@genetics.ac.cn	Tian, AG/E-8177-2010	Tian, Aiguo/0000-0001-5011-6034	NIAAA NIH HHS [R01 AA021402] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021402] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Almeida AM, 2005, EUPHYTICA, V146, P165, DOI 10.1007/s10681-005-7080-0; Arondel V, 2000, PLANT SCI, V157, P1, DOI 10.1016/S0168-9452(00)00232-6; Ayadi M, 2004, FEBS LETT, V562, P147, DOI 10.1016/S0014-5793(04)00222-4; Boxall SF, 2005, PLANT PHYSIOL, V137, P969, DOI 10.1104/pp.104.054577; Brewer PB, 2004, DEVELOPMENT, V131, P4035, DOI 10.1242/dev.01279; Buchel AS, 1996, PLANT MOL BIOL, V30, P493, DOI 10.1007/BF00049327; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Cuevas JC, 2008, PLANT PHYSIOL, V148, P1094, DOI 10.1104/pp.108.122945; Davletova S, 2005, PLANT PHYSIOL, V139, P847, DOI 10.1104/pp.105.068254; DEHESH K, 1990, SCIENCE, V250, P1397, DOI 10.1126/science.2255908; FLUHR R, 1986, SCIENCE, V232, P1106, DOI 10.1126/science.232.4754.1106; Gao MJ, 2009, PLANT CELL, V21, P54, DOI 10.1105/tpc.108.061309; GILMARTIN PM, 1992, PLANT CELL, V4, P839, DOI 10.1105/tpc.4.7.839; Gong ZZ, 2001, PLANT PHYSIOL, V126, P363, DOI 10.1104/pp.126.1.363; GREEN PJ, 1987, EMBO J, V6, P2543, DOI 10.1002/j.1460-2075.1987.tb02542.x; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; HIRATSUKA K, 1994, PLANT CELL, V6, P1805, DOI 10.1105/tpc.6.12.1805; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Kaliff M, 2007, MOL PLANT MICROBE IN, V20, P335, DOI 10.1094/MPMI-20-4-0335; Kamei A, 2005, PLANT CELL ENVIRON, V28, P1267, DOI 10.1111/j.1365-3040.2005.01363.x; Kim S, 2004, PLANT PHYSIOL, V136, P3639, DOI 10.1104/pp.104.049189; KUHN RM, 1993, PLANT MOL BIOL, V23, P337, DOI 10.1007/BF00029009; LAWTON MA, 1991, PLANT MOL BIOL, V16, P235, DOI 10.1007/BF00020555; Le Gourrierec J, 1999, PLANT J, V18, P663, DOI 10.1046/j.1365-313x.1999.00482.x; Le Gourrierec J., 2002, GENOME LETT, V1, P77; Leshem Y, 2006, P NATL ACAD SCI USA, V103, P18008, DOI 10.1073/pnas.0604421103; Liao Y, 2008, CELL RES, V18, P1047, DOI 10.1038/cr.2008.280; Liao Y, 2008, PLANTA, V228, P225, DOI 10.1007/s00425-008-0731-3; Lin ZW, 2007, PLANTA, V226, P11, DOI 10.1007/s00425-006-0460-4; Liu JX, 2007, PLANT J, V51, P897, DOI 10.1111/j.1365-313X.2007.03195.x; Llorente F, 2002, PLANT J, V32, P13, DOI 10.1046/j.1365-313X.2002.01398.x; McCarty DR, 2000, CELL, V103, P201, DOI 10.1016/S0092-8674(00)00113-6; Mittler R, 2006, FEBS LETT, V580, P6537, DOI 10.1016/j.febslet.2006.11.002; MIZOGUCHI T, 1995, FEBS LETT, V358, P199, DOI 10.1016/0014-5793(94)01423-X; Nagano Y, 2001, J BIOL CHEM, V276, P22238, DOI 10.1074/jbc.M102474200; Nakashima K, 2006, PHYSIOL PLANTARUM, V126, P62, DOI 10.1111/j.1399-3054.2005.00592.x; Ni M, 1996, PLANT CELL, V8, P1041, DOI 10.1105/tpc.8.6.1041; Nylander M, 2001, PLANT MOL BIOL, V45, P263, DOI 10.1023/A:1006469128280; O'Grady K, 2001, PLANT MOL BIOL, V47, P367, DOI 10.1023/A:1011629307051; Park HC, 2004, PLANT PHYSIOL, V135, P2150, DOI 10.1104/pp.104.041442; PERISIC O, 1992, PLANT CELL, V4, P831, DOI 10.1105/tpc.4.7.831; Priest DM, 2006, PLANT J, V46, P492, DOI 10.1111/j.1365-313X.2006.02701.x; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Song CP, 2005, PLANT CELL, V17, P2384, DOI 10.1105/tpc.105.033043; Tan BC, 2003, PLANT J, V35, P44, DOI 10.1046/j.1365-313X.2003.01786.x; Tian AG, 2004, THEOR APPL GENET, V108, P903, DOI 10.1007/s00122-003-1499-2; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; VILLAIN P, 1994, J BIOL CHEM, V269, P16626; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Wang HW, 2007, PLANT J, V52, P716, DOI 10.1111/j.1365-313X.2007.03268.x; Yanagisawa S, 2004, PLANT CELL PHYSIOL, V45, P386, DOI 10.1093/pcp/pch055; Yang CY, 2005, PLANT PHYSIOL, V139, P836, DOI 10.1104/pp.105.065458; Zhang JS, 1999, THEOR APPL GENET, V99, P1006, DOI 10.1007/s001220051408; Zhou DX, 1999, TRENDS PLANT SCI, V4, P210, DOI 10.1016/S1360-1385(99)01418-1; ZHOU DX, 1992, J BIOL CHEM, V267, P23515; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x	65	78	106	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2009	4	9							e6898	10.1371/journal.pone.0006898	http://dx.doi.org/10.1371/journal.pone.0006898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZF	19730734	Green Submitted, gold, Green Published			2022-12-25	WOS:000269622100004
J	Kurth, A; Straube, M; Kuczka, A; Dunsche, AJ; Meyer, H; Nitsche, A				Kurth, Andreas; Straube, Martin; Kuczka, Annette; Dunsche, Anton Josef; Meyer, Hermann; Nitsche, Andreas			Cowpox Virus Outbreak in Banded Mongooses (Mungos mungo) and Jaguarundis (Herpailurus yagouaroundi) with a Time-Delayed Infection to Humans	PLOS ONE			English	Article								Background: Often described as an extremely rare zoonosis, cowpox virus (CPXV) infections are on the increase in Germany. CPXV is rodent-borne with a broad host range and contains the largest and most complete genome of all poxviruses, including parts with high homology to variola virus (smallpox). So far, most CPXV cases have occurred individually in unvaccinated animals and humans and were caused by genetically distinguishable virus strains. Methodology/Principal Findings: Generalized CPXV infections in banded mongooses (Mungos mungo) and jaguarundis (Herpailurus yagouaroundi) at a Zoological Garden were observed with a prevalence of the affected animal group of 100% and a mortality of 30%. A subsequent serological investigation of other exotic animal species provided evidence of subclinical cases before the onset of the outbreak. Moreover, a time-delayed human cowpox virus infection caused by the identical virus strain occurred in a different geographical area indicating that handling/feeding food rats might be the common source of infection. Conclusions/Significance: Reports on the increased zoonotic transmission of orthopoxviruses have renewed interest in understanding interactions between these viruses and their hosts. The list of animals known to be susceptible to CPXV is still growing. Thus, the likely existence of unknown CPXV hosts and their distribution may present a risk for other exotic animals but also for the general public, as was shown in this outbreak. Animal breeders and suppliers of food rats represent potential multipliers and distributors of CPXV, in the context of increasingly pan-European trading. Taking the cessation of vaccination against smallpox into account, this situation contributes to the increased incidence of CPXV infections in man, particularly in younger age groups, with more complicated courses of clinical infections.			Kurth, A (corresponding author), Robert Koch Inst, German Consultant Lab Poxviruses, D-1000 Berlin, Germany.	kurtha@rki.de		Nitsche, Andreas/0000-0001-8185-3176				BASSE A, 1964, VERH BER ERKRG ZOOTI, V6, P55; BAXBY D, 1982, J HYG-CAMBRIDGE, V89, P365, DOI 10.1017/S0022172400070935; BAXBY D, 1997, ARCH VIROL         S, V13, P1; Begon M, 1999, P ROY SOC B-BIOL SCI, V266, P1939, DOI 10.1098/rspb.1999.0870; Bennett M, 1997, J COMP PATHOL, V116, P35, DOI 10.1016/S0021-9975(97)80041-2; BIEL SS, 1999, VIRUS CELL CULTURE P, P11; Coras B, 2005, LANCET, V365, P446; EISHUBINGER AM, 1990, LANCET, V336, P880, DOI 10.1016/0140-6736(90)92387-W; Essbauer S., 2007, POXVIRUSES BIRKH USE; Eulenberger K., 2005, Proceedings of the Institute for Zoo and Wildlife Research, Berlin, P77; Fenner F., 1989, MONKEYPOX VIRUS ORTH, P227; Hentschke J, 1999, TIERAERZTL UMSCHAU, V54, P311; Kik MJL, 2006, VET QUART, V28, P42, DOI 10.1080/01652176.2006.9695206; KUBIN G, 1975, Wiener Tieraerztliche Monatsschrift, V62, P271; Kurth A, 2008, EMERG INFECT DIS, V14, P670, DOI 10.3201/eid1404.070817; Kurth A, 2007, FUTURE VIROL, V2, P467, DOI 10.2217/17460794.2.5.467; MAIBORODA AD, 1982, ACTA VIROL, V26, P288; MARENNIKOVA SS, 1976, ACTA VIROL, V20, P442; MARENNIKOVA SS, 1978, LAB ANIM, V12, P33, DOI 10.1258/002367778780953288; MARENNIKOVA SS, 1977, J INFECT DIS, V135, P358, DOI 10.1093/infdis/135.3.358; Martina BEE, 2006, EMERG INFECT DIS, V12, P1005, DOI 10.3201/eid1206.051513; Matz-Rensing K, 2006, VET PATHOL, V43, P212, DOI 10.1354/vp.43-2-212; Muller T, 1996, J WILDLIFE DIS, V32, P348; NAKANO JH, 1989, DIAGNOSTIC PROCEDURE, P257; Nitsche A, 2004, J CLIN MICROBIOL, V42, P1207, DOI 10.1128/JCM.42.3.1207-1213.2004; Pastoret PP, 2000, REV SCI TECH OIE, V19, P23, DOI 10.20506/rst.19.1.1213; Pelkonen PM, 2003, EMERG INFECT DIS, V9, P1458, DOI 10.3201/eid0911.020814; PILASKI J, 1993, VERH ERKRG ZOOTIERE, V35, P39; Potel K., 1963, Zoologische Garten Leipzig (N F), V27, P1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandvik T, 1998, J CLIN MICROBIOL, V36, P2542, DOI 10.1128/JCM.36.9.2542-2547.1998; Schaudien D, 2007, J COMP PATHOL, V137, P151, DOI 10.1016/j.jcpa.2007.05.007; Schuppel K.F., 1997, VERH BER ERKRG ZOOTI, V38, P259; Wisser J, 2001, VET REC, V149, P244, DOI 10.1136/vr.149.8.244; Wolfs TFW, 2002, EMERG INFECT DIS, V8, P1495, DOI 10.3201/eid0812.020089; Yang G, 2005, J VIROL, V79, P13139, DOI 10.1128/JVI.79.20.13139-13149.2005; ZWART P, 1971, BRIT VET J, V127, P20, DOI 10.1016/S0007-1935(17)37783-7	37	41	41	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6883	10.1371/journal.pone.0006883	http://dx.doi.org/10.1371/journal.pone.0006883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19727399	Green Published, Green Submitted, gold			2022-12-25	WOS:000269522900012
J	Gur-Wahnon, D; Borovsky, Z; Liebergall, M; Rachmilewitz, J				Gur-Wahnon, Devorah; Borovsky, Zipora; Liebergall, Meir; Rachmilewitz, Jacob			The Induction of APC with a Distinct Tolerogenic Phenotype via Contact-Dependent STAT3 Activation	PLOS ONE			English	Article								Background: Activation of the signal transducer and activator of transcription 3 (STAT3) within antigen presenting cells (APCs) is linked to abnormal APCs differentiation and function. We have previously shown that STAT3 is activated within APC by a novel contact-dependent mechanism, which plays a key role in mediating the immunomodulatory effects of hMSC. In order to better understand the underlying mechanisms that control APC maturation in a contact dependent manner, we extended our observation to tumor cells. Tumors were shown to secrete a variety of tumor-derived factors that activate STAT3 within infiltrating APCs. We now tested whether tumor cells can activate STAT3 within APC using the contact-dependent mechanism, in addition to soluble factors, and compared these two STAT3 activating pathways. Principal Findings: We demonstrate that in addition to tumor-derived secreted factors tumor cells activate STAT3 by a mechanism that is based on cell-cell interaction. We further demonstrate that these two STAT3 activating mechanisms differ in their JAK usage and their susceptibility to JSI-124 inhibition thereby representing two distinct pathways. Significantly, although both pathways activate STAT3, they modulate DCs maturation in a different manner that results in disparate phenotypic outcomes. Whereas the soluble-dependent pathway results in an immature phenotype, the contact-dependent pathway results in an apparently mature phenotype. Albeit their mature-like phenotype these latter cells express the tolerogenic markers ILT3 and ILT4 and possess T cell inhibitory activity. Significance: This data suggests that, in at least certain cellular microenvironments, cell: cell interactions represent a novel way to activate STAT3 signaling, uncouple APC activation events and consequently regulate immunity and tolerance. Significantly, we have now demonstrated that this contact-dependent signaling pathway differs from that mediated by soluble factors and cytokines, inducing disparate phenotypic outcome, suggesting these two mechanisms have different and possibly complementary biological functions.			Gur-Wahnon, D (corresponding author), Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	rjacob@cc.huji.ac.il						Adler HS, 2007, EUR J DERMATOL, V17, P476; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Blaskovich MA, 2003, CANCER RES, V63, P1270; Bromberg JF, 2001, BIOESSAYS, V23, P161, DOI 10.1002/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Cheng FD, 2003, IMMUNITY, V19, P425, DOI 10.1016/S1074-7613(03)00232-2; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gur-Wahnon D, 2007, EXP HEMATOL, V35, P426, DOI 10.1016/j.exphem.2006.11.001; Hagemann T, 2006, J IMMUNOL, V176, P5023, DOI 10.4049/jimmunol.176.8.5023; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Nefedova Y, 2005, J IMMUNOL, V175, P4338, DOI 10.4049/jimmunol.175.7.4338; Nefedova Y, 2007, CURR CANCER DRUG TAR, V7, P71, DOI 10.2174/156800907780006887; Rane SG, 2000, ONCOGENE, V19, P5662, DOI 10.1038/sj.onc.1203925; Sato K, 2003, BLOOD, V101, P3581, DOI 10.1182/blood-2002-09-2712; Sato K, 2002, CELL IMMUNOL, V215, P186, DOI 10.1016/S0008-8749(02)00021-7; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Svajger U, 2008, INT IMMUNOPHARMACOL, V8, P997, DOI 10.1016/j.intimp.2008.03.006; Verbovetski I, 2002, J EXP MED, V196, P1553, DOI 10.1084/jem.20020263; Vultur A, 2004, ONCOGENE, V23, P2600, DOI 10.1038/sj.onc.1207378; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Willimsky G, 2008, J EXP MED, V205, P1687, DOI 10.1084/jem.20072016; Yanagihara S, 1998, J IMMUNOL, V161, P3096; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zhang B, 2009, BLOOD, V113, P46, DOI 10.1182/blood-2008-04-154138; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	27	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6846	10.1371/journal.pone.0006846	http://dx.doi.org/10.1371/journal.pone.0006846			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718269	Green Submitted, Green Published, gold			2022-12-25	WOS:000269415900018
J	Beilharz, TH; Humphreys, DT; Clancy, JL; Thermann, R; Martin, DIK; Hentze, MW; Preiss, T				Beilharz, Traude H.; Humphreys, David T.; Clancy, Jennifer L.; Thermann, Rolf; Martin, David I. K.; Hentze, Matthias W.; Preiss, Thomas			microRNA-Mediated Messenger RNA Deadenylation Contributes to Translational Repression in Mammalian Cells	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; LET-7 MICRORNA; CAENORHABDITIS-ELEGANS; GENE-REGULATION; IN-VITRO; INITIATION; ARGONAUTE; CAP; EXPRESSION; GW182	Animal microRNAs (miRNAs) typically regulate gene expression by binding to partially complementary target sites in the 39 untranslated region (UTR) of messenger RNA (mRNA) reducing its translation and stability. They also commonly induce shortening of the mRNA 39 poly(A) tail, which contributes to their mRNA decay promoting function. The relationship between miRNA-mediated deadenylation and translational repression has been less clear. Using transfection of reporter constructs carrying three imperfectly matching let-7 target sites in the 39 UTR into mammalian cells we observe rapid target mRNA deadenylation that precedes measureable translational repression by endogenous let-7 miRNA. Depleting cells of the argonaute co-factors RCK or TNRC6A can impair let-7-mediated repression despite ongoing mRNA deadenylation, indicating that deadenylation alone is not sufficient to effect full repression. Nevertheless, the magnitude of translational repression by let-7 is diminished when the target reporter lacks a poly(A) tail. Employing an antisense strategy to block deadenylation of target mRNA with poly(A) tail also partially impairs translational repression. On the one hand, these experiments confirm that tail removal by deadenylation is not strictly required for translational repression. On the other hand they show directly that deadenylation can augment miRNA-mediated translational repression in mammalian cells beyond stimulating mRNA decay. Taken together with published work, these results suggest a dual role of deadenylation in miRNA function: it contributes to translational repression as well as mRNA decay and is thus critically involved in establishing the quantitatively appropriate physiological response to miRNAs.			Beilharz, TH (corresponding author), Victor Chang Cardiac Res Inst, Div Mol Genet, Sydney, NSW, Australia.	t.preiss@victorchang.edu.au	Beilharz, Traude/I-1438-2014; Preiss, Thomas/F-7355-2010; Hentze, Matthias W/V-3980-2017; Beilharz, Traude/O-5457-2019	Beilharz, Traude/0000-0002-8942-9502; Preiss, Thomas/0000-0001-6273-784X; Hentze, Matthias W/0000-0002-4023-7876; Beilharz, Traude/0000-0002-8942-9502; Humphreys, David/0000-0003-4140-0089				Amrani N, 2008, NATURE, V453, P1276, DOI 10.1038/nature06974; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barreau C, 2006, RNA, V12, P1790, DOI 10.1261/rna.191706; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Beilharz TH, 2007, RNA, V13, P982, DOI 10.1261/rna.569407; Beilharz TH, 2009, METHODS, V48, P294, DOI 10.1016/j.ymeth.2009.02.003; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Bergamini G, 2000, RNA, V6, P1781, DOI 10.1017/S1355838200001679; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Chekulaeva M, 2009, RNA, V15, P794, DOI 10.1261/rna.1364909; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Clancy JL, 2007, METHOD ENZYMOL, V431, P83, DOI 10.1016/S0076-6879(07)31006-9; Ding XC, 2008, CELL CYCLE, V7, P3083, DOI 10.4161/cc.7.19.6778; Ding XC, 2009, EMBO J, V28, P213, DOI 10.1038/emboj.2008.275; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Eulalio A, 2009, RNA, V15, P1067, DOI 10.1261/rna.1605509; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Ferrari A, 2003, J BIOL CHEM, V278, P40162, DOI 10.1074/jbc.M308243200; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Gill RM, 1998, EXP CELL RES, V244, P157, DOI 10.1006/excr.1998.4197; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; IWASAKI S, 2009, MOL CELL; Jacobson A., 1996, TRANSLATIONAL CONTRO, P451; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kong YW, 2008, P NATL ACAD SCI USA, V105, P8866, DOI 10.1073/pnas.0800650105; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lazzaretti D, 2009, RNA, V15, P1059, DOI 10.1261/rna.1606309; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Muckenthaler M, 1997, RNA, V3, P983; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Nissan T, 2008, RNA, V14, P1480, DOI 10.1261/rna.1072808; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Preiss T, 2003, BIOESSAYS, V25, P1201, DOI 10.1002/bies.10362; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Standart N, 2007, GENE DEV, V21, P1975, DOI 10.1101/gad.1591507; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707; Wang BB, 2008, P NATL ACAD SCI USA, V105, P5343, DOI 10.1073/pnas.0801102105; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; Westman B, 2005, RNA, V11, P1505, DOI 10.1261/rna.2132505; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Yoshida M, 2006, EMBO J, V25, P1934, DOI 10.1038/sj.emboj.7601079; Zipprich JT, 2009, RNA, V15, P781, DOI 10.1261/rna.1448009	78	74	76	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2009	4	8							e6783	10.1371/journal.pone.0006783	http://dx.doi.org/10.1371/journal.pone.0006783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JE	19710908	gold, Green Published			2022-12-25	WOS:000269415600004
J	Loyola, RD; Oliveira-Santos, LGR; Almeida-Neto, M; Nogueira, DM; Kubota, U; Diniz, JAF; Lewinsohn, TM				Loyola, Rafael Dias; Rodrigues Oliveira-Santos, Luiz Gustavo; Almeida-Neto, Mario; Nogueira, Denise Martins; Kubota, Umberto; Felizola Diniz-Filho, Jose Alexandre; Lewinsohn, Thomas Michael			Integrating Economic Costs and Biological Traits into Global Conservation Priorities for Carnivores	PLOS ONE			English	Article							EXTINCTION RISK; BIODIVERSITY CONSERVATION; ECOREGIONS; POPULATION; BENEFITS; MODELS; AREAS	Background: Prioritization schemes usually highlight species-rich areas, where many species are at imminent risk of extinction. To be ecologically relevant these schemes should also include species biological traits into area-setting methods. Furthermore, in a world of limited funds for conservation, conservation action is constrained by land acquisition costs. Hence, including economic costs into conservation priorities can substantially improve their conservation cost-effectiveness. Methodology/Principal Findings: We examined four global conservation scenarios for carnivores based on the joint mapping of economic costs and species biological traits. These scenarios identify the most cost-effective priority sets of ecoregions, indicating best investment opportunities for safeguarding every carnivore species, and also establish priority sets that can maximize species representation in areas harboring highly vulnerable species. We compared these results with a scenario that minimizes the total number of ecoregions required for conserving all species, irrespective of other factors. We found that cost-effective conservation investments should focus on 41 ecoregions highlighted in the scenario that consider simultaneously both ecoregion vulnerability and economic costs of land acquisition. Ecoregions included in priority sets under these criteria should yield best returns of investments since they harbor species with high extinction risk and have lower mean land cost. Conclusions/Significance: Our study highlights ecoregions of particular importance for the conservation of the world's carnivores defining global conservation priorities in analyses that encompass socioeconomic and life-history factors. We consider the identification of a comprehensive priority-set of areas as a first step towards an in-situ biodiversity maintenance strategy.			Loyola, RD (corresponding author), Univ Fed Goias, Inst Ciencias Biol, Dept Ecol, Goiania, Go, Brazil.	avispa@gmail.com	Loyola, Rafael/A-4425-2008; Loyola, Rafael/S-3978-2019; Diniz-Filho, José Alexandre Felizola/D-9405-2013; Oliveira-Santos, Luiz Gustavo Rodrigues/F-9562-2012; Almeida-Neto, M./A-6389-2009; Lewinsohn, Thomas M/D-5880-2012	Loyola, Rafael/0000-0001-5323-2735; Loyola, Rafael/0000-0001-5323-2735; Diniz-Filho, José Alexandre Felizola/0000-0002-0967-9684; Oliveira-Santos, Luiz Gustavo Rodrigues/0000-0001-9632-5173; Almeida-Neto, M./0000-0002-2161-2968; Lewinsohn, Thomas M/0000-0001-5950-5343				ANDELMAN S, 1999, SITES V 1 0 AN TOOLB; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Becker CG, 2008, BIODIVERS CONSERV, V17, P2297, DOI 10.1007/s10531-007-9298-8; Bode M, 2008, P NATL ACAD SCI USA, V105, P6498, DOI 10.1073/pnas.0710705105; Boyd C, 2008, CONSERV LETT, V1, P37, DOI 10.1111/j.1755-263X.2008.00002.x; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; BURGESS DN, 2004, TERRESTRIAL ECOREGIO; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Cardillo M, 2006, P NATL ACAD SCI USA, V103, P4157, DOI 10.1073/pnas.0510541103; Cardillo M, 2004, PLOS BIOL, V2, P909, DOI 10.1371/journal.pbio.0020197; Center for International Earth Science Information Network (CIESIN) Columbia University Centro Internacional de Agricultura Tropical (CIAT), 2005, GRIDD POP WORLD GPW; Cowling RM, 2003, BIOL CONSERV, V112, P191, DOI 10.1016/S0006-3207(02)00425-1; Das A, 2006, BIOL CONSERV, V133, P16, DOI 10.1016/j.biocon.2006.05.023; Davis FW, 2006, ECOL SOC, V11; Dinerstein E., 1995, CONSERVATION ASSESSM; Dirzo R., 1991, PLANT ANIMAL INTERAC, P273; Galvan DV, 2008, ANIM CONSERV, V11, P215, DOI 10.1111/j.1469-1795.2008.00171.x; GITTLEMAN JL, 1993, SYM ZOOL S, P65; Gittleman JL, 2001, CONSERV BIOL SER, V5, P1; *INT MON FUND, 2004, INT FIN STAT; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; LAURANCE WF, 2006, EMERGING THREATS TRO; Loyola RD, 2008, DIVERS DISTRIB, V14, P949, DOI 10.1111/j.1472-4642.2008.00508.x; Loyola RD, 2007, DIVERS DISTRIB, V13, P389, DOI 10.1111/j.1472-4642.2007.00345.x; Loyola RD, 2009, BIODIVERS CONSERV, V18, P2017, DOI 10.1007/s10531-008-9570-6; Loyola RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002120; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; Mittermeier Russell A., 2004, P1; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Urbina-Cardona JN, 2008, TROP CONSERV SCI, V1, P417, DOI 10.1177/194008290800100408; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Possingham Hugh, 2000, P291, DOI 10.1007/0-387-22648-6_17; Pressey RL, 1997, BIOL CONSERV, V80, P207, DOI 10.1016/S0006-3207(96)00045-6; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Rondinini C, 2005, CONSERV BIOL, V19, P1488, DOI 10.1111/j.1523-1739.2005.00204.x; Rondinini C, 2007, CONSERV BIOL, V21, P1455, DOI 10.1111/j.1523-1739.2007.00834.x; Smith RJ, 2006, ORYX, V40, P400, DOI 10.1017/S0030605306001232; Soutullo A, 2008, DIVERS DISTRIB, V14, P604, DOI 10.1111/j.1472-4642.2007.00445.x; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Underwood EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001515; Valenzuela-Galvan D, 2008, BIODIVERS CONSERV, V17, P539, DOI 10.1007/s10531-007-9269-0; Wilson DE, 1993, MAMMAL SPECIES WORLD; *WWF, 2006, WILFINDER ONL DAT SP	48	41	43	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2009	4	8							e6807	10.1371/journal.pone.0006807	http://dx.doi.org/10.1371/journal.pone.0006807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JE	19710911	Green Published, Green Submitted, gold			2022-12-25	WOS:000269415600019
J	Chanraud, S; Leroy, C; Martelli, C; Kostogianni, N; Delain, F; Aubin, HJ; Reynaud, M; Martinot, JL				Chanraud, Sandra; Leroy, Claire; Martelli, Catherine; Kostogianni, Nikoleta; Delain, Francoise; Aubin, Henri-Jean; Reynaud, Michel; Martinot, Jean-Luc			Episodic Memory in Detoxified Alcoholics: Contribution of Grey Matter Microstructure Alteration	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; MILD COGNITIVE IMPAIRMENT; LONG-TERM-MEMORY; PREFRONTAL CORTEX; HIPPOCAMPAL NEUROGENESIS; WORKING-MEMORY; FRONTAL LOBES; HUMAN BRAINS; GRAY-MATTER; PERFORMANCE	Even though uncomplicated alcoholics may likely have episodic memory deficits, discrepancies exist regarding to the integrity of brain regions that underlie this function in healthy subjects. Possible relationships between episodic memory and 1) brain microstructure assessed by magnetic resonance diffusion tensor imaging (DTI), 2) brain volumes assessed by voxel-based morphometry (VBM) were investigated in uncomplicated, detoxified alcoholics. Diffusion and morphometric analyses were performed in 24 alcohol dependent men without neurological or somatic complications and in 24 healthy men. The mean apparent coefficient of diffusion ( ADC) and grey matter volumes were measured in the whole brain. Episodic memory performance was assessed using a French version of the Free and Cued Selective Reminding Test (FCSRT). Correlation analyses between verbal episodic memory, brain microstructure, and brain volumes were carried out using SPM2 software. In those with alcohol dependence, higher ADC was detected mainly in frontal, temporal and parahippocampal regions, and in the cerebellum. In alcoholics, regions with higher ADC typically also had lower grey matter volume. Low verbal episodic memory performance in alcoholism was associated with higher mean ADC in parahippocampal areas, in frontal cortex and in the left temporal cortex; no correlation was found between regional volumes and episodic memory scores. Regression analyses for the control group were not significant. These findings support the hypothesis that regional microstructural but no macrostructural alteration of the brain might be responsible, at least in part, for episodic memory deficits in alcohol dependence.			Chanraud, S (corresponding author), Univ Paris 11, INSERM, Res Unit Neuroimaging & Psychiat U797, IFR49, F-91405 Orsay, France.	chanraud@stanford.edu	Martinot, Jean-Luc/N-3704-2018; , Aubin/AAT-9739-2021; Aubin, Henri-Jean/AAP-8605-2021	Aubin, Henri-Jean/0000-0002-6604-6672; Chanraud, Sandra/0000-0002-4299-3050				ARRIA AM, 1991, ALCOHOL CLIN EXP RES, V15, P956, DOI 10.1111/j.1530-0277.1991.tb05195.x; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; BEATTY WW, 1995, DRUG ALCOHOL DEPEN, V37, P247, DOI 10.1016/0376-8716(94)01072-S; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; Burns J, 2003, BRIT J PSYCHIAT, V182, P439, DOI 10.1192/bjp.182.5.439; CHANRAUD S, 2008, NEUROPSYCHIATRIC IMA; Chanraud S, 2007, NEUROPSYCHOPHARMACOL, V32, P429, DOI 10.1038/sj.npp.1301219; COHEN JA, 1979, DIGEST DIS SCI, V24, P835, DOI 10.1007/BF01324898; Dubois J, 2006, MAGN RESON MATER PHY, V19, P134, DOI 10.1007/s10334-006-0036-0; Duka T, 2003, ALCOHOL CLIN EXP RES, V27, P1563, DOI 10.1097/01.ALC.0000090142.11260.D7; Duvernoy HM, 1998, HUMAN HIPPOCAMPUS FU; Ergis AM, 1995, CORTEX, V31, P699, DOI 10.1016/S0010-9452(13)80021-4; Fernandez G, 1998, J NEUROSCI, V18, P1841; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gabrieli JDE, 1998, NEUROBIOL LEARN MEM, V70, P275, DOI 10.1006/nlme.1998.3853; Goldstein RZ, 2004, NEUROPSYCHOLOGIA, V42, P1447, DOI 10.1016/j.neuropsychologia.2004.04.002; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Harding AJ, 1997, HIPPOCAMPUS, V7, P78, DOI 10.1002/(SICI)1098-1063(1997)7:1<78::AID-HIPO8>3.3.CO;2-B; Harper C, 2003, PROG NEURO-PSYCHOPH, V27, P951, DOI 10.1016/S0278-5846(03)00155-6; Harper C, 1998, J NEUROPATH EXP NEUR, V57, P101, DOI 10.1097/00005072-199802000-00001; He J, 2005, EUR J NEUROSCI, V21, P2711, DOI 10.1111/j.1460-9568.2005.04120.x; Helenius J, 2002, AM J NEURORADIOL, V23, P194; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; JERNIGAN TL, 1991, ALCOHOL CLIN EXP RES, V15, P418, DOI 10.1111/j.1530-0277.1991.tb00540.x; JOYCE EM, 1991, NEUROPSYCHOLOGIA, V29, P709, DOI 10.1016/0028-3932(91)90067-I; KAPUR S, 1994, P NATL ACAD SCI USA, V91, P2008, DOI 10.1073/pnas.91.6.2008; Korbo L, 1999, ALCOHOL CLIN EXP RES, V23, P164, DOI 10.1097/00000374-199901000-00024; Lekeu F, 2003, ALZ DIS ASSOC DIS, V17, P35, DOI 10.1097/00002093-200301000-00005; Levine B, 2004, J COGNITIVE NEUROSCI, V16, P1633, DOI 10.1162/0898929042568587; Matsumoto H, 2008, EXPERT REV PROTEOMIC, V5, P321, DOI 10.1586/14789450.5.2.321; Meyerhoff DJ, 2006, ALCOHOL CLIN EXP RES, V30, P253, DOI 10.1111/j.1530-0277.2006.00034.x; Milner B, 2005, PSYCHIAT CLIN N AM, V28, P599, DOI 10.1016/j.psc.2005.06.002; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Nixon K, 2004, J NEUROSCI, V24, P9714, DOI 10.1523/JNEUROSCI.3063-04.2004; Nixon SJ, 1998, ALCOHOL CLIN EXP RES, V22, P1065, DOI 10.1097/00000374-199808000-00011; O'Sullivan M, 2004, J NEUROL NEUROSUR PS, V75, P441, DOI 10.1136/jnnp.2003.014910; Oscar-Berman M, 2003, ALCOHOL RES HEALTH, V27, P125; Pennanen C, 2004, NEUROBIOL AGING, V25, P303, DOI 10.1016/S0197-4580(03)00084-8; Pitel AL, 2007, ALCOHOL CLIN EXP RES, V31, P1169, DOI 10.1111/j.1530-0277.2007.00418.x; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; Ray KM, 2006, RADIOLOGY, V241, P197, DOI 10.1148/radiol.2411051051; Reinert DF, 2002, ALCOHOL CLIN EXP RES, V26, P272, DOI 10.1111/j.1530-0277.2002.tb02534.x; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rugg MD, 2003, TRENDS COGN SCI, V7, P313, DOI 10.1016/S1364-6613(03)00131-1; Schmitz N, 2006, BIOL PSYCHIAT, V59, P7, DOI 10.1016/j.biopsych.2005.06.007; Shimamura AP, 1995, ANN NY ACAD SCI, V769, P151, DOI 10.1111/j.1749-6632.1995.tb38136.x; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Staresina BP, 2006, J NEUROSCI, V26, P9162, DOI 10.1523/JNEUROSCI.2877-06.2006; Sullivan EV, 2003, ALCOHOL CLIN EXP RES, V27, P1409, DOI 10.1097/01.ALC.0000085586.91726.46; SULLIVAN EV, 1995, ALCOHOL CLIN EXP RES, V19, P110, DOI 10.1111/j.1530-0277.1995.tb01478.x; SULLIVAN EV, 2008, NEUROBIOL AGING; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1394, DOI 10.1016/j.neuropsychologia.2004.04.006; Weingartner HJ, 1996, BIOL PSYCHIAT, V40, P43, DOI 10.1016/0006-3223(95)00290-1; WEISSMAN MM, 1976, ARCH GEN PSYCHIAT, V33, P1111; Weschler D., 2001, WESCHLER ADULT INTEL; Wheeler MA, 1997, PSYCHOL BULL, V121, P331, DOI 10.1037/0033-2909.121.3.331; Zinn S, 2004, ALCOHOL CLIN EXP RES, V28, P1338, DOI 10.1097/01.ALC.0000139814.81811.62	62	40	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6786	10.1371/journal.pone.0006786	http://dx.doi.org/10.1371/journal.pone.0006786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	488FQ	19707568	Green Published, Green Submitted, gold			2022-12-25	WOS:000269335000028
J	Koeppen, M; Eckle, T; Eltzschig, HK				Koeppen, Michael; Eckle, Tobias; Eltzschig, Holger K.			Selective Deletion of the A1 Adenosine Receptor Abolishes Heart-Rate Slowing Effects of Intravascular Adenosine In Vivo	PLOS ONE			English	Article								Objective: Intravenous adenosine induces temporary bradycardia. This is due to the activation of extracellular adenosine receptors (ARs). While adenosine can signal through any of four ARs (A1AR, A2AAR, A2BAR, A3AR), previous ex vivo studies implicated the A1AR in the heart-rate slowing effects. Here, we used comparative genetic in vivo studies to address the contribution of individual ARs to the heart-rate slowing effects of intravascular adenosine. Methods and Results: We studied gene-targeted mice for individual ARs to define their in vivo contribution to the heart-rate slowing effects of adenosine. Anesthetized mice were treated with a bolus of intravascular adenosine, followed by measurements of heart-rate and blood pressure via a carotid artery catheter. These studies demonstrated dose-dependent slowing of the heart rate with adenosine treatment in wild-type, A2AAR(-/-), A2BAR(-/-), or A3AR(-/-) mice. In contrast, adenosine-dependent slowing of the heart-rate was completely abolished in A1AR(-/-) mice. Moreover, pre-treatment with a specific A1AR antagonist ( DPCPX) attenuated the heart-rate slowing effects of adenosine in wild-type, A2AAR(-/-), or A2BAR(-/-) mice, but did not alter hemodynamic responses of A1AR(-/-) mice. Conclusions: The present studies combine pharmacological and genetic in vivo evidence for a selective role of the A1AR in slowing the heart rate during adenosine bolus injection.			Koeppen, M (corresponding author), Univ Colorado Denver, Mucosal Inflammat Program, Dept Anesthesiol & Perioperat Med, Aurora, CO USA.	holger.eltzschig@uchsc.edu	Koeppen, Michael/M-1873-2019; Eckle, Tobias/AAE-6705-2020; , Michael/AGR-2361-2022	Eckle, Tobias/0000-0002-6065-4669; , Michael/0000-0002-5002-1286	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092188] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01-HL092188, R01 HL092188] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARRACO RA, 1988, BRAIN RES BULL, V20, P129, DOI 10.1016/0361-9230(88)90016-0; BELARDINELLI L, 1988, J PHYSIOL-LONDON, V405, P615, DOI 10.1113/jphysiol.1988.sp017352; BELARDINELLI L, 1995, FASEB J, V9, P359, DOI 10.1096/fasebj.9.5.7896004; BELHASSEN B, 1984, J AM COLL CARDIOL, V4, P414, DOI 10.1016/S0735-1097(84)80233-8; Bertolet BD, 1996, J AM COLL CARDIOL, V28, P396, DOI 10.1016/0735-1097(96)00162-3; Delacretaz E, 2006, NEW ENGL J MED, V354, P1039, DOI 10.1056/NEJMcp051145; Drury AN, 1929, J PHYSIOL-LONDON, V68, P213, DOI 10.1113/jphysiol.1929.sp002608; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eckle T, 2006, AM J PHYSIOL-HEART C, V291, pH2533, DOI 10.1152/ajpheart.00472.2006; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Gauthier NS, 1998, J MOL CELL CARDIOL, V30, P187, DOI 10.1006/jmcc.1997.0585; Grenz A, 2007, AM J PHYSIOL-RENAL, V293, pF1501, DOI 10.1152/ajprenal.00243.2007; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Headrick JP, 2000, CLIN EXP PHARMACOL P, V27, P185, DOI 10.1046/j.1440-1681.2000.03218.x; Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; Kapicka CL, 2003, LIFE SCI, V72, P2825, DOI 10.1016/S0024-3205(03)00199-1; Keddie JR, 1996, EUR J PHARMACOL, V301, P107, DOI 10.1016/0014-2999(96)00020-9; Koeppen M, 2004, HYPERTENSION, V44, P952, DOI 10.1161/01.HYP.0000147661.80059.ca; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; LINDEN J, 1985, CIRC RES, V56, P728, DOI 10.1161/01.RES.56.5.728; Matherne GP, 1997, P NATL ACAD SCI USA, V94, P6541, DOI 10.1073/pnas.94.12.6541; Nicholls J., 2002, Autonomic & Autacoid Pharmacology, V22, P209, DOI 10.1046/j.1474-8673.2002.00259.x; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; OLSSON RA, 1990, PHYSIOL REV, V70, P761, DOI 10.1152/physrev.1990.70.3.761; Reichelt ME, 2005, CIRC RES, V96, P363, DOI 10.1161/01.RES.0000156075.00127.C3; Rivkees SA, 1999, J BIOL CHEM, V274, P14204, DOI 10.1074/jbc.274.20.14204; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Salvatore CA, 2000, J BIOL CHEM, V275, P4429, DOI 10.1074/jbc.275.6.4429; Siegl D, 2005, CIRC RES, V97, P781, DOI 10.1161/01.RES.0000186193.22438.6c; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sun DQ, 2001, P NATL ACAD SCI USA, V98, P9983, DOI 10.1073/pnas.171317998; Thengchaisri N, 2009, MICROVASC RES, V77, P356, DOI 10.1016/j.mvr.2009.01.004; WEST GA, 1985, PFLUG ARCH EUR J PHY, V403, P75, DOI 10.1007/BF00583285; Yang JN, 2007, ACTA PHYSIOL, V190, P63, DOI 10.1111/j.1365-201X.2007.01690.x; Yang JN, 2009, AM J PHYSIOL-HEART C, V296, pH1141, DOI 10.1152/ajpheart.00754.2008; Yilmaz MS, 2008, EUR J PHARMACOL, V584, P125, DOI 10.1016/j.ejphar.2008.01.044	44	67	67	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6784	10.1371/journal.pone.0006784	http://dx.doi.org/10.1371/journal.pone.0006784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707555	Green Published, Green Submitted, gold			2022-12-25	WOS:000269335000026
J	Kolodkin-Gal, I; Verdiger, R; Shlosberg-Fedida, A; Engelberg-Kulka, H				Kolodkin-Gal, Ilana; Verdiger, Reut; Shlosberg-Fedida, Ayalla; Engelberg-Kulka, Hanna			Differential Effect of E. coli Toxin-Antitoxin Systems on Cell Death in Liquid Media and Biofilm Formation	PLOS ONE			English	Article							ESCHERICHIA-COLI; MAZEF; TRANSLATION; CLEAVAGE; SEQUENCE; MODULE; MAINTENANCE; INHIBITION; MECHANISM; RIBOSOME	Toxin-antitoxin ( TA) modules are gene pairs specifying for a toxin and its antitoxin and are found on the chromosomes of many bacteria including pathogens. Here we report how each of five such TA systems in E. coli affect bacterial cell death differently in liquid media and during biofilm formation. Of all these systems, only the TA system mazEF mediated cell death both in liquid media and during biofilm formation. At the other extreme, as our results have revealed here, the TA system dinJ-YafQ is unique in that it is involved only in the death process during biofilm formation. Cell death governed by mazEF and dinJ-YafQ seems to participate in biofilm formation through a novel mechanism.			Kolodkin-Gal, I (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91010 Jerusalem, Israel.	hanita@cc.huji.ac.il	Gal, Ilana Kolodkin/AFE-8494-2022	Gal, Ilana Kolodkin/0000-0002-8464-5660	NIGMS NIH HHS [R01 GM069509, GM069509] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069509] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aguilar C, 2007, CURR OPIN MICROBIOL, V10, P638, DOI 10.1016/j.mib.2007.09.006; Ahmad SI, 1998, ANNU REV MICROBIOL, V52, P591, DOI 10.1146/annurev.micro.52.1.591; Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Amitai S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000390; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; BECH FW, 1985, EMBO J, V4, P1059, DOI 10.1002/j.1460-2075.1985.tb03739.x; Cherny I, 2004, J BIOL CHEM, V279, P8252, DOI 10.1074/jbc.M308263200; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIES W, 1998, ANTIBIOTIC RESISTANC, P239; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Engelberg-Kulka H, 2004, TRENDS MICROBIOL, V12, P66, DOI 10.1016/j.tim.2003.12.008; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Godoy VG, 2006, EMBO J, V25, P868, DOI 10.1038/sj.emboj.7600986; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Grady R, 2003, MOL MICROBIOL, V47, P1419, DOI 10.1046/j.1365-2958.2003.03387.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Kim YH, 2009, J BACTERIOL, V191, P1258, DOI 10.1128/JB.01465-08; Kolodkin-Gal A, 2008, J BACTERIOL, V190, P3169, DOI 10.1128/JB.01918-07; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; MASUDA Y, 1994, J BACTERIOL, V176, P5861, DOI 10.1128/JB.176.18.5861-5863.1994; MASUDA YJ, 1993, J BACTERIOL, V175, P6850, DOI 10.1128/jb.175.21.6850-6856.1993; METZGER S, 1988, J BIOL CHEM, V263, P15699; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Sat B, 2003, J BACTERIOL, V185, P1803, DOI 10.1128/JB.185.6.1803-1807.2003; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; ZHANG Y, 2009, J BIOL IN PRESS 0318, DOI DOI 10.1074/JBC.M809656200; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200	38	74	82	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6785	10.1371/journal.pone.0006785	http://dx.doi.org/10.1371/journal.pone.0006785			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707553	Green Submitted, Green Published, gold			2022-12-25	WOS:000269335000027
J	Rokop, ME; Grossman, AD				Rokop, Megan E.; Grossman, Alan D.			Intragenic and Extragenic Suppressors of Temperature Sensitive Mutations in the Replication Initiation Genes dnaD and dnaB of Bacillus subtilis	PLOS ONE			English	Article								Background: The Bacillus subtilis genes dnaD and dnaB are essential for the initiation of DNA replication and are required for loading of the replicative helicase at the chromosomal origin of replication oriC. Wild type DnaD and DnaB interact weakly in vitro and this interaction has not been detected in vivo or in yeast two-hybrid assays. Methodology/Principal Findings: We isolated second site suppressors of the temperature sensitive phenotypes caused by one dnaD mutation and two different dnaB mutations. Five different intragenic suppressors of the dnaD23ts mutation were identified. One intragenic suppressor was a deletion of two amino acids in DnaD. This deletion caused increased and detectable interaction between the mutant DnaD and wild type DnaB in a yeast two-hybrid assay, similar to the increased interaction caused by a missense mutation in dnaB that is an extragenic suppressor of dnaD23ts. We isolated both intragenic and extragenic suppressors of the two dnaBts alleles. Some of the extragenic suppressors were informational suppressors (missense suppressors) in tRNA genes. These suppressor mutations caused a change in the anticodon of an alanine tRNA so that it would recognize the mutant codon (threonine) in dnaB and likely insert the wild type amino acid (alanine). Conclusions/Significance: The intragenic suppressors should provide insights into structure-function relationships in DnaD and DnaB, and interactions between DnaD and DnaB. The extragenic suppressors in the tRNA genes have important implications regarding the amount of wild type DnaB needed in the cell. Since missense suppressors are typically inefficient, these findings indicate that production of a small amount of wild type DnaB, in combination with the mutant protein, is sufficient to restore some DnaB function.			Rokop, ME (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	adg@mit.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041934, R01GM041934] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R37 GM041934, GM41934, R01 GM041934] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN PN, 1991, CELL, V66, P141, DOI 10.1016/0092-8674(91)90146-P; ANDERSSON DI, 1983, MOL GEN GENET, V191, P378, DOI 10.1007/BF00425749; Bruand C, 2005, MOL MICROBIOL, V55, P1138, DOI 10.1111/j.1365-2958.2004.04451.x; Bruand C, 2001, MOL MICROBIOL, V42, P245, DOI 10.1046/j.1365-2958.2001.02631.x; BRUAND C, 1995, MICROBIOL-UK, V141, P321, DOI 10.1099/13500872-141-2-321; Carneiro MJVM, 2006, MOL MICROBIOL, V60, P917, DOI 10.1111/j.1365-2958.2006.05152.x; GORINI L, 1970, ANNU REV GENET, V4, P107, DOI 10.1146/annurev.ge.04.120170.000543; Harwood C.R., 1990, MOL BIOL METHODS BAC; HOSHINO T, 1987, P NATL ACAD SCI USA, V84, P653, DOI 10.1073/pnas.84.3.653; Ishigo-oka D, 2001, J BACTERIOL, V183, P2148, DOI 10.1128/JB.183.6.2148-2150.2001; James P, 1996, GENETICS, V144, P1425; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Li Y, 2004, MOL GENET GENOMICS, V271, P447, DOI 10.1007/s00438-004-0996-6; Li Y, 2007, MICROBIOL-SGM, V153, P3370, DOI 10.1099/mic.0.2007/009001-0; Marsin S, 2001, J BIOL CHEM, V276, P45818, DOI 10.1074/jbc.M101996200; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; Nunez-Ramirez R, 2007, J MOL BIOL, V367, P764, DOI 10.1016/j.jmb.2006.12.075; OCONNOR M, 1992, NUCLEIC ACIDS RES, V20, P4221, DOI 10.1093/nar/20.16.4221; Polard P, 2002, NUCLEIC ACIDS RES, V30, P1593, DOI 10.1093/nar/30.7.1593; Rokop ME, 2004, MOL MICROBIOL, V52, P1757, DOI 10.1111/j.1365-2958.2004.04091.x; ROSSET R, 1969, J MOL BIOL, V39, P95, DOI 10.1016/0022-2836(69)90336-2; Sambrook J, 2001, MOL CLONING LAB MANU; Sandler SJ, 1999, MOL MICROBIOL, V34, P91, DOI 10.1046/j.1365-2958.1999.01576.x; Sandler SJ, 1996, GENETICS, V143, P5; SANDMAN K, 1987, GENETICS, V117, P603; SATO Y, 1991, J BACTERIOL, V173, P7732, DOI 10.1128/jb.173.23.7732-7735.1991; Schneider S, 2008, J MOL BIOL, V376, P1237, DOI 10.1016/j.jmb.2007.12.045; Sueoka N, 1998, PROG NUCLEIC ACID RE, V59, P35; Tsai FC, 1998, RNA, V4, P1514, DOI 10.1017/S1355838298981274; Turner IJ, 2004, FEBS LETT, V577, P460, DOI 10.1016/j.febslet.2004.10.051; VANDEYAR MA, 1986, J BACTERIOL, V167, P530, DOI 10.1128/jb.167.2.530-534.1986; Velten M, 2003, MOL CELL, V11, P1009, DOI 10.1016/S1097-2765(03)00130-8; YOUNGMAN P, 1989, REGULATION OF PROCARYOTIC DEVELOPMENT, P65; YOUNGMAN P, 1984, MOL GEN GENET, V195, P424, DOI 10.1007/BF00341443; Zakrzewska-Czerwinska J, 2007, FEMS MICROBIOL REV, V31, P378, DOI 10.1111/j.1574-6976.2007.00070.x; Zhang W, 2008, J MOL BIOL, V377, P706, DOI 10.1016/j.jmb.2008.01.067; Zhang WK, 2006, J BACTERIOL, V188, P5487, DOI 10.1128/JB.00339-06; Zhang WK, 2005, J MOL BIOL, V351, P66, DOI 10.1016/j.jmb.2005.05.065	39	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6774	10.1371/journal.pone.0006774	http://dx.doi.org/10.1371/journal.pone.0006774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707554	Green Published, Green Submitted, gold			2022-12-25	WOS:000269335000019
J	Vlachos, P; Joseph, B				Vlachos, P.; Joseph, B.			The Cdk inhibitor p57(Kip2) controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics	ONCOGENE			English	Article						p57(Kip2); LIMK-1; actin cytoskeleton dynamic; cell mobility	CELL-MIGRATION; PROTEIN-KINASE; PROSTATE-CANCER; FOCAL ADHESIONS; DOWN-REGULATION; STRESS FIBERS; EXPRESSION; PHOSPHORYLATION; ACTIVATION; COFILIN	The cyclin-dependent kinase inhibitor p57(Kip2) gene has been suggested to be a tumor suppressor gene, being inactivated in various cancer types, linked to tumor progression and poor patient outcome. Here, we report that p57(Kip2) interacts with the actin cytoskeleton modifying enzyme, LIM-kinase 1 (LIMK-1) but not LIMK-2. This interaction enhances activity of LIMK-1, independently of its activator Rho-associated kinase. This resulted in an increased phosphorylation and consequent inactivation of the actin depolymerization factor, cofilin. In accordance, selective p57(Kip2) expression promotes actin stress fiber formation in cancer cells. Fluorescence recovery after photobleaching analysis of fluorescent-labeled actin further demonstrated that p57(Kip2) expression results in reduction of actin protein mobile fraction, which affects its turnover rate in cell. Finally, we present evidence that the p57(Kip2) control of LIMK-1 ultimately affects cell mobility negatively. Thus, in addition to its established function in control of proliferation and cell death, these results indicate that p57(Kip2) is critical in the regulation of actin cytoskeleton dynamic and by this means migration ability of cancer cells. Oncogene (2009) 28, 4175-4188; doi: 10.1038/onc.2009.269; published online 7 September 2009	[Vlachos, P.; Joseph, B.] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, S-17176 Stockholm, Sweden	Karolinska Institutet	Joseph, B (corresponding author), Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, R8-03, S-17176 Stockholm, Sweden.	Bertrand.Joseph@ki.se			Swedish Research Council; Swedish Cancer Society; Ake Wiberg Foundation; Swedish Medical Society; Karolinska Institutet Foundations (KI Cancer)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Ake Wiberg Foundation; Swedish Medical Society; Karolinska Institutet Foundations (KI Cancer)(Karolinska Institutet)	We thank Dr Y Xiong (University of North Carolina, USA), Dr S Leibovitch (Centre National de la Recherche Scientifique, France), Dr K Mizuno (Tohoku University, Japan), Dr H Toyoshima (Tsukuba University, Japan), Dr P Hotulainen (University of Helsinki, Finland) and Dr S Okret (Karolinska Institute) for providing us with different DNA constructs and HeLa cell line, respectively. This work was supported by the Swedish Research Council, the Swedish Cancer Society, the Ake Wiberg Foundation, the Swedish Medical Society and the Karolinska Institutet Foundations (KI Cancer).	Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Balint E, 2002, P NATL ACAD SCI USA, V99, P3529, DOI 10.1073/pnas.062491899; Barbe L, 2008, MOL CELL PROTEOMICS, V7, P499, DOI 10.1074/mcp.M700325-MCP200; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bozidogan O, 2008, TUMORI J, V94, P556; Chim CS, 2005, AM J HEMATOL, V80, P282, DOI 10.1002/ajh.20503; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Davila M, 2003, J BIOL CHEM, V278, P36868, DOI 10.1074/jbc.M306196200; Denicourt C, 2004, GENE DEV, V18, P851, DOI 10.1101/gad.1205304; Dyer MA, 2000, DEVELOPMENT, V127, P3593; Fan GK, 2006, ACTA OTO-LARYNGOL, V126, P301, DOI 10.1080/00016480500388851; Gonzalez S, 2005, CANCER RES, V65, P2186, DOI 10.1158/0008-5472.CAN-04-3047; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Itoh Y, 2007, J BIOL CHEM, V282, P390, DOI 10.1074/jbc.M609944200; Jia JL, 2007, MOL CELL BIOL, V27, P7236, DOI 10.1128/MCB.00780-07; Jin RJ, 2008, CANCER RES, V68, P3601, DOI 10.1158/0008-5472.CAN-08-0073; Joseph B, 2003, P NATL ACAD SCI USA, V100, P15619, DOI 10.1073/pnas.2635658100; Joseph B, 2002, ONCOGENE, V21, P65, DOI 10.1038/sj/onc/1205018; JOSEPH B, 2009, CELL DEATH IN PRESS; Kobatake T, 2004, ONCOL REP, V12, P1087; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Lee S, 2004, J BIOL CHEM, V279, P1885, DOI 10.1074/jbc.M306968200; Li JQ, 2003, INT J ONCOL, V23, P1537; Matsumoto M, 2000, ANTICANCER RES, V20, P1947; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; MIZUNO K, 1994, ONCOGENE, V9, P1605; Nakai S, 2002, INT J ONCOL, V20, P769; Nan KJ, 2005, WORLD J GASTROENTERO, V11, P1237, DOI 10.3748/wjg.v11.i8.1237; NUNOUE K, 1995, ONCOGENE, V11, P701; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Pateras IS, 2006, INT J CANCER, V119, P2546, DOI 10.1002/ijc.22214; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sakai K, 2004, J NEURO-ONCOL, V68, P217, DOI 10.1023/B:NEON.0000033380.08940.c8; Samuelsson MKR, 2002, BIOCHEM BIOPH RES CO, V296, P702, DOI 10.1016/S0006-291X(02)00912-9; Shin JY, 2000, EXP MOL MED, V32, P79, DOI 10.1038/emm.2000.14; Sidani M, 2007, J CELL BIOL, V179, P777, DOI 10.1083/jcb.200707009; Sui L, 2002, ANTICANCER RES, V22, P3191; Sumi T, 2006, EXP CELL RES, V312, P1021, DOI 10.1016/j.yexcr.2005.12.030; Sumi T, 2001, J BIOL CHEM, V276, P670, DOI 10.1074/jbc.M007074200; Suzuki A, 1999, MOL CELL BIOL, V19, P3842; Vlachos P, 2007, CELL DEATH DIFFER, V14, P1497, DOI 10.1038/sj.cdd.4402158; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Watanabe H, 1998, P NATL ACAD SCI USA, V95, P1392, DOI 10.1073/pnas.95.4.1392; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yokoo T, 2003, J BIOL CHEM, V278, P52919, DOI 10.1074/jbc.M309334200; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100; Zebda N, 2000, J CELL BIOL, V151, P1119, DOI 10.1083/jcb.151.5.1119; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0	51	40	44	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 26	2009	28	47					4175	4188		10.1038/onc.2009.269	http://dx.doi.org/10.1038/onc.2009.269			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DQ	19734939				2022-12-25	WOS:000272876100004
J	Sakamoto, T; Seiki, M				Sakamoto, Takeharu; Seiki, Motoharu			Mint3 Enhances the Activity of Hypoxia-inducible Factor-1 (HIF-1) in Macrophages by Suppressing the Activity of Factor Inhibiting HIF-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS PRECURSOR PROTEIN; TRANS-GOLGI NETWORK; ASPARAGINYL HYDROXYLASE; TRANSCRIPTIONAL ACTIVITY; PDZ-DOMAINS; FIH; HIF-1-ALPHA; SUBSTRATE; RECEPTOR; MECHANISMS	Hypoxia-inducible factor-1 (HIF-1) is a key transcription factor regulating cellular responses to hypoxia and is composed of alpha and beta subunits. During normoxia, factor inhibiting HIF-1 (FIH-1) inhibits the activity of HIF-1 by preventing HIF-1 alpha binding to p300/CBP via modification of the Asn(803) residue. However, it is not known whether FIH-1 activity can be regulated in an oxygen-independent manner. In this study, we survey possible binding proteins to FIH-1 and identify Mint3/APBA3, which has been reported to bind Alzheimer beta-amyloid precursor protein. Purified Mint3 binds FIH-1 and inhibits the ability of FIH-1 to modify HIF-1 alpha in vitro. In a reporter assay, the activity of HIF-1 alpha is suppressed because of endogenous FIH-1 in HEK293 cells, and expression of Mint3 antagonizes this suppression. Macrophages are known to depend on glycolysis for ATP production because of elevated HIF-1 activity. FIH-1 activity is suppressed in macrophages by Mint3 so as to maintain HIF-1 activity. FIH-1 forms a complex with Mint3, and these two factors co-localize within the perinuclear region. Knockdown of Mint3 expression in macrophages leads to redistribution of FIH-1 to the cytoplasm and decreases glycolysis and ATP production. Thus, Mint3 regulates the FIH-1-HIF-1 pathway, which controls ATP production in macrophages and therefore represents a potential new therapeutic target to regulate macrophagemediated inflammation.	[Sakamoto, Takeharu; Seiki, Motoharu] Univ Tokyo, Inst Med Sci, Div Canc Cell Res, Minato Ku, Tokyo 1088639, Japan	University of Tokyo	Seiki, M (corresponding author), 4-6-1 Shirokanedai,Minato Ku, Tokyo 1088639, Japan.	mseiki@ims.u-tokyo.ac.jp	Sakamoto, Takeharu/Y-6062-2019; Seiki, Motoharu/K-9443-2015	Sakamoto, Takeharu/0000-0002-1225-1902; 	Specific Coordination Fund for Promoting Science; Ministry of Education, Culture, Sports, Science and Technology of Japan	Specific Coordination Fund for Promoting Science; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Specific Coordination Fund for Promoting Science (to T. S.), by a Grant-in-Aid for Scientific Research on Priority Areas (to M. S.), and by the Global COE (Centers of Excellence) Program "Center of Education and Research for the Advanced Genome-Based Medicine, for personalized medicine and the control of worldwide infectious diseases (to T. S. and M. S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; Ferguson JE, 2007, MOL CELL BIOL, V27, P6407, DOI 10.1128/MCB.00511-07; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Han JB, 2008, J CELL SCI, V121, P2217, DOI 10.1242/jcs.019745; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hill K, 2003, J BIOL CHEM, V278, P36032, DOI 10.1074/jbc.M301632200; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lancaster DE, 2004, BIOCHEM J, V383, P429, DOI 10.1042/BJ20040735; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Linke S, 2004, J BIOL CHEM, V279, P14391, DOI 10.1074/jbc.M313614200; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Malmberg EK, 2004, J CELL SCI, V117, P5535, DOI 10.1242/jcs.01472; MICHL J, 1976, J EXP MED, V144, P1465, DOI 10.1084/jem.144.6.1465; Miller CCJ, 2006, TRENDS NEUROSCI, V29, P280, DOI 10.1016/j.tins.2006.03.001; Okamoto M, 2001, NEUROSCIENCE, V104, P653, DOI 10.1016/S0306-4522(01)00124-5; Okamoto M, 1998, EUR J CELL BIOL, V77, P161, DOI 10.1016/S0171-9335(98)80103-9; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Shrivastava-Ranjan P, 2008, MOL BIOL CELL, V19, P51, DOI 10.1091/mbc.E07-05-0465; Tanahashi H, 1999, BIOCHEM BIOPH RES CO, V255, P663, DOI 10.1006/bbrc.1999.0265	29	46	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30350	30359		10.1074/jbc.M109.019216	http://dx.doi.org/10.1074/jbc.M109.019216			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726677	Green Published, hybrid			2022-12-25	WOS:000271090000038
J	Hayashi, H; Campenot, RB; Vance, DE; Vance, JE				Hayashi, Hideki; Campenot, Robert B.; Vance, Dennis E.; Vance, Jean E.			Protection of Neurons from Apoptosis by Apolipoprotein E-containing Lipoproteins Does Not Require Lipoprotein Uptake and Involves Activation of Phospholipase C gamma 1 and Inhibition of Calcineurin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; GLYCOGEN-SYNTHASE KINASE-3; LONG-TERM POTENTIATION; DENSITY-LIPOPROTEIN; ALZHEIMERS-DISEASE; CHOLESTEROL-METABOLISM; SIGNALING MECHANISMS; PARKINSONS-DISEASE; NEURITE OUTGROWTH; DEFICIENT MICE	Apolipoprotein E-containing lipoproteins (LpE) are generated in the central nervous system by glial cells, primarily astrocytes, and are recognized as key players in lipid metabolism and transport in the brain. We previously reported that LpE protect retinal ganglion neurons from apoptosis induced by withdrawal of trophic additives (Hayashi, H., Campenot, R. B., Vance, D. E., and Vance, J. E. (2007) J. Neurosci. 27, 1933-1941). LpE bind to low density lipoprotein receptor-related protein-1 and initiate a signaling pathway that involves activation of protein kinase C delta and inhibition of the pro-apoptotic glycogen synthase kinase 3 beta. We now show that uptake of LpE is not required for the neuroprotection. Experiments with inhibitors of phospholipase C gamma 1 and RNAi knockdown studies demonstrate that activation of phospholipase C gamma 1 is required for the anti-apoptotic signaling pathway induced by LpE. In addition, the protein phosphatase-2B, calcineurin, is involved in a neuronal death pathway induced by removal of trophic additives, and LpE inhibit calcineurin activation. LpE also attenuate neuronal death caused by oxidative stress. Moreover, physiologically relevant apoE3-containing lipoproteins generated by apoE3 knock-in mouse astrocytes more effectively protect neurons from apoptosis than do apoE4-containing lipoproteins. Because inheritance of the apoE4 allele is the strongest known genetic risk factor for Alzheimer disease, the reduced neuroprotection afforded by apoE4-containing LpE might contribute to the neurodegeneration characteristic of this disease.	[Hayashi, Hideki; Vance, Dennis E.; Vance, Jean E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Vance, Dennis E.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2S2, Canada; [Campenot, Robert B.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2S2, Canada; [Hayashi, Hideki; Vance, Jean E.] Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada; [Hayashi, Hideki] Kumamoto Univ, Prior Org Innovat & Excellence, Kumamoto 8608556, Japan	University of Alberta; University of Alberta; University of Alberta; University of Alberta; Kumamoto University	Vance, JE (corresponding author), Univ Alberta, Grp Mol & Cell Biol Lipids, 328 Heritage Med Res Ctr, Edmonton, AB T6G 2S2, Canada.	jean.vance@ualberta.ca			Canadian Institutes for Health Research [20890174]; Ministry of Education, Culture, Sport, Science and Technology, Japan	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ministry of Education, Culture, Sport, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Canadian Institutes for Health Research and in part by Grant-in-aid for Young Scientists (Start-up) 20890174 and the Special Coordination Funds for Promoting Science and Technology from the Ministry of Education, Culture, Sport, Science and Technology, Japan.	Agostinho P, 2008, NEUROCHEM INT, V52, P1226, DOI 10.1016/j.neuint.2008.01.005; Albanesi D, 2004, J BACTERIOL, V186, P2655, DOI 10.1128/JB.186.9.2655-2663.2004; Almeida S, 2004, NEUROBIOL DIS, V17, P435, DOI 10.1016/j.nbd.2004.07.002; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Belinson H, 2007, NEUROBIOL AGING, V28, P689, DOI 10.1016/j.neurobiolaging.2006.06.027; Bi XN, 2007, AUTOPHAGY, V3, P646, DOI 10.4161/auto.5074; BOYLES JK, 1989, J CLIN INVEST, V83, P1015, DOI 10.1172/JCI113943; BROWN MS, 1976, SCIENCE, V191, P150, DOI 10.1126/science.174194; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cserepes J, 2004, BIOCHEM BIOPH RES CO, V320, P860, DOI 10.1016/j.bbrc.2004.06.037; de Chaves EIP, 1997, J BIOL CHEM, V272, P30766, DOI 10.1074/jbc.272.49.30766; DeMattos RB, 1998, J BIOL CHEM, V273, P4206, DOI 10.1074/jbc.273.7.4206; DeMattos RB, 2001, J LIPID RES, V42, P976; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Ellman PI, 2008, J AM COLL SURGEONS, V206, P993, DOI 10.1016/j.jamcollsurg.2007.12.010; ENAN E, 1992, BIOCHEM PHARMACOL, V43, P1777, DOI 10.1016/0006-2952(92)90710-Z; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gong JS, 2002, J BIOL CHEM, V277, P29919, DOI 10.1074/jbc.M203934200; GRIFFITH JP, 1995, CELL, V82, P507, DOI 10.1016/0092-8674(95)90439-5; Han X, 2004, CELL MOL LIFE SCI, V61, P1896, DOI 10.1007/s00018-004-4009-z; Hayashi H, 2004, J BIOL CHEM, V279, P14009, DOI 10.1074/jbc.M313828200; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; Herz J, 2001, NEURON, V29, P571, DOI 10.1016/S0896-6273(01)00234-3; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Huang W, 2005, P NATL ACAD SCI USA, V102, P12242, DOI 10.1073/pnas.0505138102; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; Ito J, 1999, J NEUROCHEM, V72, P2362, DOI 10.1046/j.1471-4159.1999.0722362.x; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Jordan J, 1998, J NEUROSCI, V18, P195; Koch S, 2001, J LIPID RES, V42, P1143; Krzywkowski P, 1999, NEUROSCIENCE, V92, P1273, DOI 10.1016/S0306-4522(99)00061-5; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MASLIAH E, 1995, EXP NEUROL, V136, P107, DOI 10.1006/exnr.1995.1088; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Mora A, 2001, J NEUROCHEM, V78, P199, DOI 10.1046/j.1471-4159.2001.00410.x; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Norris CM, 2005, J NEUROSCI, V25, P4649, DOI 10.1523/JNEUROSCI.0365-05.2005; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Poulter MO, 2004, NEUROSCIENCE, V128, P1, DOI 10.1016/j.neuroscience.2004.06.016; Qiu ZH, 2002, J BIOL CHEM, V277, P14458, DOI 10.1074/jbc.M112066200; Ruiz J, 2005, J LIPID RES, V46, P1721, DOI 10.1194/jlr.M500114-JLR200; Sheng HX, 1999, STROKE, V30, P1118, DOI 10.1161/01.STR.30.5.1118; Shioda N, 2006, J NEUROCHEM, V98, P310, DOI 10.1111/j.1471-4159.2006.03874.x; Shou Y, 2004, BIOCHEM J, V379, P805, DOI 10.1042/BJ20031107; Siegel GJ, 2000, BRAIN RES REV, V33, P199, DOI 10.1016/S0165-0173(00)00030-8; Springer JE, 2000, J NEUROSCI, V20, P7246; STRITTMATTER WJ, 1995, P NATL ACAD SCI USA, V92, P4725, DOI 10.1073/pnas.92.11.4725; Su Y, 2004, BIOCHEMISTRY-US, V43, P6899, DOI 10.1021/bi035627j; Sun X, 2002, NEUROSCI LETT, V321, P61, DOI 10.1016/S0304-3940(01)02583-6; Szaszi K, 2002, J BIOL CHEM, V277, P42623, DOI 10.1074/jbc.M206629200; Szydlowska K, 2006, J NEUROCHEM, V99, P965, DOI 10.1111/j.1471-4159.2006.04136.x; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wu ZZ, 2006, NEUROSCIENCE, V141, P407, DOI 10.1016/j.neuroscience.2006.03.023; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637; Zhuo M, 2000, J NEUROSCI, V20, P542, DOI 10.1523/JNEUROSCI.20-02-00542.2000	62	46	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29605	29613		10.1074/jbc.M109.039560	http://dx.doi.org/10.1074/jbc.M109.039560			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19717566	Green Published, hybrid			2022-12-25	WOS:000270896800042
J	Motamedi-Shad, N; Monsellier, E; Torrassa, S; Relini, A; Chiti, F				Motamedi-Shad, Neda; Monsellier, Elodie; Torrassa, Silvia; Relini, Annalisa; Chiti, Fabrizio			Kinetic Analysis of Amyloid Formation in the Presence of Heparan Sulfate FASTER UNFOLDING AND CHANGE OF PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRIL FORMATION; IN-VITRO; MUSCLE ACYLPHOSPHATASE; ALZHEIMERS-DISEASE; EXTRACELLULAR-MATRIX; PROTEIN AGGREGATION; PRION PROTEIN; GLYCOSAMINOGLYCANS; PROTEOGLYCANS; INSIGHTS	A number of human diseases are associated with the conversion of proteins from their native state into well defined fibrillar aggregates, depositing in the extracellular space and generally termed amyloid fibrils. Heparan sulfate (HS), a glycosaminoglycan normally present in the extracellular matrix, has been found to be universally associated with amyloid deposits and to promote amyloid fibril formation by all studied protein systems. We have studied the impact of HS on the amyloidogenesis of human muscle acylphosphatase, monitoring the process with an array of techniques, such as normal and stopped-flow far-UV circular dichroism, thioflavin T fluorescence, static and dynamic light scattering, and atomic force microscopy. The results show that HS accelerates the conversion of the studied protein from the native state into the amyloidogenic, yet monomeric, partially folded state. They also indicate that HS does not simply accelerate the conversion of the resulting partially folded state into amyloid species but splits the process into two distinct pathways occurring in parallel: a very fast phase in which HS interacts with a fraction of protein molecules, causing their rapid aggregation into ThT-positive and beta-sheet containing oligomers, and a slow phase resulting from the normal aggregation of partially folded molecules that cannot interact with HS. The HS-mediated aggregation pathway is several-fold faster than that observed in the absence of HS. Two aggregation phases are generally observed when proteins aggregate in the presence of HS, underlying the importance of a detailed kinetic analysis to fully understand the effect of this glycosaminoglycan on amyloidogenesis.	[Motamedi-Shad, Neda; Monsellier, Elodie; Chiti, Fabrizio] Univ Florence, Dept Biochem, I-50134 Florence, Italy; [Torrassa, Silvia; Relini, Annalisa] Univ Genoa, Dipartimento Fis, I-16146 Genoa, Italy; [Relini, Annalisa; Chiti, Fabrizio] Consorzio Interuniv Ist Nazl Biostrutture & Biosi, I-00136 Rome, Italy	University of Florence; University of Genoa	Chiti, F (corresponding author), Univ Florence, Dept Biochem, Viale Morgagni 50, I-50134 Florence, Italy.	fabrizio.chiti@unifi.it	Relini, Annalisa/AHC-3105-2022; Monsellier, Elodie/GRF-5106-2022	RELINI, ANNALISA/0000-0002-4040-9279; Monsellier, Elodie/0000-0001-7944-7531	Italian Ministero dell'Istruzione; dell'Universita e della Ricerca [PRIN 2006058958, FIRB RBNE03PX83]; European Union; European Molecular Biology Organization Young Investigator Program	Italian Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission); European Molecular Biology Organization Young Investigator Program(European Molecular Biology Organization (EMBO))	This work was supported in part by grants from the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (Projects PRIN 2006058958 and FIRB RBNE03PX83), the European Union (Project EURAMY), and the European Molecular Biology Organization Young Investigator Program (YIP 2005).	Alexandrescu AT, 2005, PROTEIN SCI, V14, P1; Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Bemporad F, 2006, PROTEIN SCI, V15, P862, DOI 10.1110/ps.051915806; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437; Calamai M, 2005, BIOPHYS J, V89, P4201, DOI 10.1529/biophysj.105.068726; Calamai M, 2003, BIOCHEMISTRY-US, V42, P15078, DOI 10.1021/bi030135s; Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653; Castillo GM, 1998, DIABETES, V47, P612, DOI 10.2337/diabetes.47.4.612; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 1999, NAT STRUCT BIOL, V6, P380; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752; Chiti F, 2001, PROTEIN SCI, V10, P879, DOI 10.1110/ps.42401; Chiti F, 2000, EMBO J, V19, P1441, DOI 10.1093/emboj/19.7.1441; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Cotman SL, 2000, MOL CELL NEUROSCI, V15, P183, DOI 10.1006/mcne.1999.0816; DEBEER MC, 1993, J BIOL CHEM, V268, P20606; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Kim YS, 2002, J BIOL CHEM, V277, P27240, DOI 10.1074/jbc.M202492200; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; MAGNUS JH, 1991, SCAND J IMMUNOL, V34, P63, DOI 10.1111/j.1365-3083.1991.tb01521.x; MCCUBBIN WD, 1988, BIOCHEM J, V256, P775, DOI 10.1042/bj2560775; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Meng F, 2007, BIOCHEMISTRY-US, V46, P12091, DOI 10.1021/bi7004834; Modesti A, 1995, PROTEIN EXPRES PURIF, V6, P799, DOI 10.1006/prep.1995.0011; Monti M, 2004, J MOL BIOL, V336, P253, DOI 10.1016/j.jmb.2003.10.082; PASTORE A, 1992, J MOL BIOL, V224, P427, DOI 10.1016/0022-2836(92)91005-A; Raffen R, 1999, PROTEIN SCI, V8, P509; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Smith DP, 2003, J MOL BIOL, V330, P943, DOI 10.1016/S0022-2836(03)00687-9; SNOW AD, 1987, LAB INVEST, V56, P665; SNOW AD, 1988, AM J PATHOL, V133, P456; SNOW AD, 1990, LAB INVEST, V63, P601; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stefani M, 1997, CELL MOL LIFE SCI, V53, P141, DOI 10.1007/PL00000585; Suk JY, 2006, BIOCHEMISTRY-US, V45, P2234, DOI 10.1021/bi0519295; Taddei N, 2001, J BIOL CHEM, V276, P37149, DOI 10.1074/jbc.M105720200; Takase K, 1998, FEBS LETT, V441, P271, DOI 10.1016/S0014-5793(98)01563-4; van Nuland NAJ, 1998, J MOL BIOL, V283, P883, DOI 10.1006/jmbi.1998.2009; VANDUINEN SG, 1995, LAB INVEST, V73, P183; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Yamaguchi I, 2003, KIDNEY INT, V64, P1080, DOI 10.1046/j.1523-1755.2003.00167.x; YOUNG ID, 1992, ARCH PATHOL LAB MED, V116, P951; YOUNG ID, 1989, ACTA NEUROPATHOL, V78, P202, DOI 10.1007/BF00688210	49	50	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29921	29934		10.1074/jbc.M109.018747	http://dx.doi.org/10.1074/jbc.M109.018747			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19700762	Green Published, hybrid			2022-12-25	WOS:000270896800071
J	Zhang, SB; Hisatsune, C; Matsu-Ura, T; Mikoshiba, K				Zhang, Songbai; Hisatsune, Chihiro; Matsu-ura, Toru; Mikoshiba, Katsuhiko			G-protein-coupled Receptor Kinase-interacting Proteins Inhibit Apoptosis by Inositol 1,4,5-Triphosphate Receptor-mediated Ca2+ Signal Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,4,5-TRISPHOSPHATE RECEPTOR; TRISPHOSPHATE RECEPTOR; ENDOPLASMIC-RETICULUM; CALCIUM-RELEASE; TERMINAL TAIL; IP3 RECEPTOR; CELL-DEATH; ACTIVATION; TYPE-1; NEF	The inositol 1,4,5-trisphosphate (IP3) receptor (IP3R) is an intracellular IP3-gated calcium (Ca2+) release channel and plays important roles in regulation of numerous Ca2+-dependent cellular responses. Many intracellular modulators and IP3R-binding proteins regulate the IP3R channel function. Here we identified G-protein-coupled receptor kinase-interacting proteins (GIT), GIT1 and GIT2, as novel IP3R-binding proteins. We found that both GIT1 and GIT2 directly bind to all three sub-types of IP3R. The interaction was favored by the cytosolic Ca2+ concentration and it functionally inhibited IP3R activity. Knockdown of GIT induced and accelerated caspase-dependent apoptosis in both unstimulated and staurosporine-treated cells, which was attenuated by wild-type GIT1 overexpression or pharmacological inhibitors of IP3R, but not by a mutant form of GIT1 that abrogates the interaction. Thus, we conclude that GIT inhibits apoptosis by modulating the IP3R-mediated Ca2+ signal through a direct interaction with IP3R in a cytosolic Ca2+-dependent manner.	[Zhang, Songbai; Hisatsune, Chihiro; Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; [Zhang, Songbai; Hisatsune, Chihiro; Matsu-ura, Toru; Mikoshiba, Katsuhiko] Japan Sci & Technol Agcy, Calcium Oscillat Project, Int Cooperat Res Project Solut Oriented Res Sci &, Wako, Saitama 3510198, Japan	RIKEN; Japan Science & Technology Agency (JST)	Mikoshiba, K (corresponding author), RIKEN, Brain Sci Inst, Dev Neurobiol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	Mikosiba@brain.riken.jp	Matsu-ura, Toru/P-3461-2017; Mikoshiba, Katsuhiko/N-7943-2015; Hisatsune, Chihiro/C-6661-2017	Matsu-ura, Toru/0000-0002-9876-3086; Hisatsune, Chihiro/0000-0001-7811-7784; Zhang, Songbai/0000-0002-2033-8389	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Albertinazzi C, 2003, MOL BIOL CELL, V14, P1295, DOI 10.1091/mbc.E02-07-0406; Ando H, 2006, MOL CELL, V22, P795, DOI 10.1016/j.molcel.2006.05.017; Assefa Z, 2004, J BIOL CHEM, V279, P43227, DOI 10.1074/jbc.M403872200; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Brown A, 1999, J VIROL, V73, P9899, DOI 10.1128/JVI.73.12.9899-9907.1999; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Greenway AL, 2003, J BIOSCIENCES, V28, P323, DOI 10.1007/BF02970151; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hamada K, 2002, J BIOL CHEM, V277, P21115, DOI 10.1074/jbc.C200244200; Hattori M, 2004, J BIOL CHEM, V279, P11967, DOI 10.1074/jbc.M311456200; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Iwai M, 2005, J BIOL CHEM, V280, P10305, DOI 10.1074/jbc.M413824200; Joseph SK, 2007, APOPTOSIS, V12, P951, DOI 10.1007/s10495-007-0719-7; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Luzzi V, 1998, J BIOL CHEM, V273, P28657, DOI 10.1074/jbc.273.44.28657; Manninen A, 2002, J EXP MED, V195, P1023, DOI 10.1084/jem.20012039; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Miyakawa T, 1999, EMBO J, V18, P1303, DOI 10.1093/emboj/18.5.1303; Nagata S, 2000, EXP CELL RES, V256, P12, DOI 10.1006/excr.2000.4834; Nakayama T, 2004, BIOCHEM J, V377, P299, DOI 10.1042/BJ20030599; Nutt LK, 2002, J BIOL CHEM, V277, P20301, DOI 10.1074/jbc.M201604200; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Rong YP, 2008, MOL CELL, V31, P255, DOI 10.1016/j.molcel.2008.06.014; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; SUGIYAMA T, 1994, FEBS LETT, V349, P191, DOI 10.1016/0014-5793(94)00662-8; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Zhang HY, 2003, J CELL BIOL, V161, P131, DOI 10.1083/jcb.200211002; Zhang SB, 2003, J BIOL CHEM, V278, P4048, DOI 10.1074/jbc.M209960200; Zhang SB, 2006, J BIOL CHEM, V281, P21954, DOI 10.1074/jbc.M601578200	38	27	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29158	29169		10.1074/jbc.M109.041509	http://dx.doi.org/10.1074/jbc.M109.041509			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706611	Green Published, hybrid			2022-12-25	WOS:000270678900071
J	Folegatti, A; de Vignemont, F; Pavani, F; Rossetti, Y; Farne, A				Folegatti, Alessia; de Vignemont, Frederique; Pavani, Francesco; Rossetti, Yves; Farne, Alessandro			Losing One's Hand: Visual-Proprioceptive Conflict Affects Touch Perception	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; RIGHT-HEMISPHERE; REACTION-TIME; BODY; ILLUSION; DISOWNERSHIP; ENHANCEMENT; RECOGNITION; EXTINCTION; OWNERSHIP	Background: While the sense of bodily ownership has now been widely investigated through the rubber hand illusion (RHI), very little is known about the sense of disownership. It has been hypothesized that the RHI also affects the ownership feelings towards the participant's own hand, as if the rubber hand replaced the participant's actual hand. Somatosensory changes observed in the participants' hand while experiencing the RHI have been taken as evidence for disownership of their real hand. Here we propose a theoretical framework to disambiguate whether such somatosensory changes are to be ascribed to the disownership of the real hand or rather to the anomalous visuo-proprioceptive conflict experienced by the participant during the RHI. Methodology/Principal Findings: In experiment 1, reaction times (RTs) to tactile stimuli delivered to the participants' hand slowed down following the establishment of the RHI. In experiment 2, the misalignment of visual and proprioceptive inputs was obtained via prismatic displacement, a situation in which ownership of the seen hand was doubtless. This condition slowed down the participants' tactile RTs. Thus, similar effects on touch perception emerged following RHI and prismatic displacement. Both manipulations also induced a proprioceptive drift, toward the fake hand in the first experiment and toward the visual position of the participants' hand in the second experiment. Conclusions/Significance: These findings reveal that somatosensory alterations in the experimental hand resulting from the RHI result from cross-modal mismatch between the seen and felt position of the hand. As such, they are not necessarily a signature of disownership.			Folegatti, A (corresponding author), INSERM, UMR S Espace & Act 864, F-69500 Bron, France.	Alessia.Folegatti@inserm.fr	Pavani, Francesco/B-4836-2010; FARNE, ALESSANDRO/G-1238-2015; Rossetti, Yves/H-3693-2017	Pavani, Francesco/0000-0003-0426-5578; FARNE, ALESSANDRO/0000-0001-5769-3491; Rossetti, Yves/0000-0001-8867-4496				Aglioti S, 1996, NEUROREPORT, V8, P293, DOI 10.1097/00001756-199612200-00058; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Bottini G, 2002, NEUROREPORT, V13, P249, DOI 10.1097/00001756-200202110-00015; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; De Vignemont F, 2007, MIND LANG, V22, P427, DOI 10.1111/j.1468-0017.2007.00315.x; Driver J., 1996, ATTENTION PERFORM, P209; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Frassinetti F, 2008, J COGNITIVE NEUROSCI, V20, P1507, DOI 10.1162/jocn.2008.20067; HOLMES N, 2007, BEHAV BRAIN SCI, V30, P189; Holmes NP, 2004, COGN AFFECT BEHAV NE, V4, P193, DOI 10.3758/CABN.4.2.193; Holmes NP, 2009, BRAIN TOPOGR, V21, P168, DOI 10.1007/s10548-009-0097-2; Holmes NP, 2007, BEHAV BRAIN SCI, V30, P211, DOI 10.1017/S0140525X07001501; HONORE J, 1989, NEUROPSYCHOLOGIA, V27, P367, DOI 10.1016/0028-3932(89)90025-0; HONORE J, 1982, NEUROPSYCHOLOGIA, V20, P727, DOI 10.1016/0028-3932(82)90075-6; Jeannerod M, 2003, BEHAV BRAIN RES, V142, P1, DOI 10.1016/S0166-4328(02)00384-4; Kammers MPM, 2009, NEUROPSYCHOLOGIA, V47, P204, DOI 10.1016/j.neuropsychologia.2008.07.028; Kennett S, 2001, CURR BIOL, V11, P1188, DOI 10.1016/S0960-9822(01)00327-X; LARMANDE P, 1981, REV NEUROL, V137, P285; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Longo MR, 2008, CONSCIOUS COGN, V17, P1181, DOI 10.1016/j.concog.2008.01.001; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; Moro V, 2004, NEUROCASE, V10, P437, DOI 10.1080/13554790490894020; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Pavani F, 2007, PERCEPTION, V36, P1547, DOI 10.1068/p5853; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; PIERSON JM, 1991, NEUROPSYCHOLOGIA, V29, P925, DOI 10.1016/0028-3932(91)90056-E; Press C, 2004, EXP BRAIN RES, V154, P238, DOI 10.1007/s00221-003-1651-x; Schutz-Bosbach S, 2009, BRAIN COGNITION, V70, P136, DOI 10.1016/j.bandc.2009.01.006; Tastevin J, 1937, ENCEPHALE, V32, P57; Taylor-Clarke M, 2002, CURR BIOL, V12, P233, DOI 10.1016/S0960-9822(01)00681-9; Tipper SP, 1998, NEUROREPORT, V9, P1741, DOI 10.1097/00001756-199806010-00013; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Tsakiris M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004040; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; Vallar G, 2009, EXP BRAIN RES, V192, P533, DOI 10.1007/s00221-008-1562-y	42	70	70	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2009	4	9							e6920	10.1371/journal.pone.0006920	http://dx.doi.org/10.1371/journal.pone.0006920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	491ZH	19738900	Green Published, gold, Green Submitted			2022-12-25	WOS:000269622300009
J	Jiang, L; Wang, Q; Yu, Y; Zhao, F; Huang, P; Zeng, R; Qi, RZ; Li, WJ; Liu, Y				Jiang, Lei; Wang, Qiong; Yu, Yue; Zhao, Feng; Huang, Ping; Zeng, Rong; Qi, Robert Z.; Li, Wenjun; Liu, Yong			Leptin Contributes to the Adaptive Responses of Mice to High-Fat Diet Intake through Suppressing the Lipogenic Pathway	PLOS ONE			English	Article							LIPID-METABOLISM; GENE-EXPRESSION; INDUCED OBESITY; ADIPOSE-TISSUE; BODY-WEIGHT; RECEPTOR; PROTEIN; LIVER; CLONING	Background: Leptin is an adipocyte-derived hormone that plays a critical role in energy homeostasis and lipid metabolism. Overnutrition-associated obesity is known to be accompanied by hyperleptinemia. However, the physiological actions of leptin in the metabolic responses to high-fat diet (HFD) intake remain to be completely elucidated. Here we characterized the metabolic features of mice fed high-fat diets and investigated the impact of leptin upon the lipogenic program which was found to be suppressed by HFD feeding through a proteomics approach. Results: When maintained on two types of high-fat diets for up to 16 weeks, mice with a higher fat intake exhibited increased body fat accumulation at a greater pace, developing more severely impaired glucose tolerance. Notably, HFD feeding at 4 weeks elicited the onset of marked hyperleptinemia, prior to the occurrence of apparent insulin resistance and hyperinsulinemia. Proteomic analysis revealed dramatically decreased expression of lipogenic enzymes in the white adipose tissue (WAT) from HFD-fed mice, including ATP-citrate lyase (ACL) and fatty acid synthase (FAS). The expression of ACL and FAS in the liver was similarly suppressed in response to HFD feeding. By contrast, HFD-induced downregulation of hepatic ACL and FAS was significantly attenuated in leptin receptor-deficient db/db mice. Furthermore, in the liver and WAT of wild type animals, intraperitoneal leptin administration was able to directly suppress the expression of these two lipogenic enzymes, accompanied by reduced triglyceride levels both in the liver and serum. Conclusions: These results suggest that leptin contributes to the metabolic responses in adaptation to overnutrition through suppressing the expression of lipogenic enzymes, and that the lipogenic pathway represents a key targeted peripheral component in exerting leptin's liporegulatory actions.			Jiang, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	liuy@sibs.ac.cn		Wang, Qiong/0000-0003-2224-4287; Qi, Robert Zhong/0000-0001-5596-8172; LIU, YONG/0000-0001-7771-4181				Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102; Ahren B, 1998, EUR J ENDOCRINOL, V139, P461, DOI 10.1530/eje.0.1390461; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bassilian S, 2002, AM J PHYSIOL-ENDOC M, V282, pE507, DOI 10.1152/ajpendo.00211.2001; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; de Fourmestraux V, 2004, J BIOL CHEM, V279, P50743, DOI 10.1074/jbc.M408014200; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gallardo N, 2007, ENDOCRINOLOGY, V148, P5604, DOI 10.1210/en.2007-0933; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hick RW, 2006, J IMMUNOL, V177, P169, DOI 10.4049/jimmunol.177.1.169; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Lee WNP, 2000, AM J PHYSIOL-ENDOC M, V279, pE425, DOI 10.1152/ajpendo.2000.279.2.E425; Lee Y, 2001, J BIOL CHEM, V276, P5629, DOI 10.1074/jbc.M008553200; Mantzoros CS, 1999, ANN INTERN MED, V130, P671, DOI 10.7326/0003-4819-130-8-199904200-00014; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Moraes RC, 2003, ENDOCRINOLOGY, V144, P4773, DOI 10.1210/en.2003-0456; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Prieur X, 2008, ENDOCRINOLOGY, V149, P5432, DOI 10.1210/en.2008-0498; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Sampath H, 2005, ANNU REV NUTR, V25, P317, DOI 10.1146/annurev.nutr.25.051804.101917; Shimabukuro M, 1997, P NATL ACAD SCI USA, V94, P4637, DOI 10.1073/pnas.94.9.4637; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; SRERE PA, 1959, J BIOL CHEM, V234, P2544; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Wang MY, 1999, J BIOL CHEM, V274, P17541, DOI 10.1074/jbc.274.25.17541; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	35	65	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6884	10.1371/journal.pone.0006884	http://dx.doi.org/10.1371/journal.pone.0006884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19727392	Green Published, gold, Green Submitted			2022-12-25	WOS:000269522900013
J	Yilmaz, A; Gisslen, M; Spudich, S; Lee, E; Jayewardene, A; Aweeka, F; Price, RW				Yilmaz, Aylin; Gisslen, Magnus; Spudich, Serena; Lee, Evelyn; Jayewardene, Anura; Aweeka, Francesca; Price, Richard W.			Raltegravir Cerebrospinal Fluid Concentrations in HIV-1 Infection	PLOS ONE			English	Article								Introduction: Raltegravir is an HIV-1 integrase inhibitor currently used in treatment-experienced HIV-1-infected patients resistant to other drug classes. In order to assess its central nervous system penetration, we measured raltegravir concentrations in cerebrospinal fluid (CSF) and plasma in subjects receiving antiretroviral treatment regimens containing this drug. Methods: Raltegravir concentrations were determined by liquid chromatography tandem mass spectrometry in 25 paired CSF and plasma samples from 16 HIV-1-infected individuals. The lower limit of quantitation was 2.0 ng/ml for CSF and 10 ng/ml for plasma. Results: Twenty-four of the 25 CSF samples had detectable raltegravir concentrations with a median raltegravir concentration of 18.4 ng/ml (range, <2.0-126.0). The median plasma raltegravir concentration was 448 ng/ml (range, 37-5180). CSF raltegravir concentrations correlated with CSF:plasma albumin ratios and CSF albumin concentrations. Conclusions: Approximately 50% of the CSF specimens exceeded the IC(95) levels reported to inhibit HIV-1 strains without resistance to integrase inhibitors. In addition to contributing to control of systemic HIV-1 infection, raltegravir achieves local inhibitory concentrations in CSF in most, but not all, patients. Blood-brain and blood-CSF barriers likely restrict drug entry, while enhanced permeability of these barriers enhances drug entry.			Yilmaz, A (corresponding author), Univ Gothenburg, Dept Infect Dis, Sahlgrenska Acad, Gothenburg, Sweden.	aylin.yilmaz@gu.se	Gisslen, Magnus/D-7454-2015	Gisslen, Magnus/0000-0002-2357-1020	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083520] Funding Source: NIH RePORTER; NCRR NIH HHS [UL1 RR024131] Funding Source: Medline; NIMH NIH HHS [R21-MH083520-01, R21 MH083520] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Cocohoba J, 2008, CLIN THER, V30, P1747, DOI 10.1016/j.clinthera.2008.10.012; GISSLEN M, 2006, J NEUROIMMU IN PRESS; Iwamoto M, 2008, CLIN PHARMACOL THER, V83, P293, DOI 10.1038/sj.clpt.6100281; Kassahun K, 2007, DRUG METAB DISPOS, V35, P1657, DOI 10.1124/dmd.107.016196; LETENDRE S, 2006, C RETR OPP INF DENV; Monforte AD, 2004, ANN NEUROL, V55, P320, DOI 10.1002/ana.10827; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; POWER C, 1993, ANN NEUROL, V34, P339, DOI 10.1002/ana.410340307; Price RW, 2008, J INFECT DIS, V197, pS294, DOI 10.1086/533419; Price RW, 1997, ANN NEUROL, V42, P675, DOI 10.1002/ana.410420502; Sinclair E, 2008, JAIDS-J ACQ IMM DEF, V47, P544, DOI 10.1097/QAI.0b013e318162754f; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; TIBBLING G, 1977, SCAND J CLIN LAB INV, V37, P385, DOI 10.3109/00365517709091496; VARATHARAJAN L, 2009, ANTIVIRAL RES; WENNING L, 2009, CLIN PHARM THER	15	73	75	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2009	4	9							e6877	10.1371/journal.pone.0006877	http://dx.doi.org/10.1371/journal.pone.0006877			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489XX	19721718	gold, Green Published, Green Submitted			2022-12-25	WOS:000269461100006
J	Green, RM; Gally, F; Keeney, JG; Alper, S; Gao, BF; Han, M; Martin, RJ; Weinberger, AR; Case, SR; Minor, MN; Chu, HW				Green, Rebecca M.; Gally, Fabienne; Keeney, Jonathon G.; Alper, Scott; Gao, Bifeng; Han, Min; Martin, Richard J.; Weinberger, Andrew R.; Case, Stephanie R.; Minor, Maisha N.; Chu, Hong Wei			Impact of Cigarette Smoke Exposure on Innate Immunity: A Caenorhabditis elegans Model	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA INFECTION; FATTY-ACID; EXPRESSION; PATHWAY; PROTEIN; CELLS	Background: Cigarette smoking is the major cause of chronic obstructive pulmonary disease (COPD) and lung cancer. Respiratory bacterial infections have been shown to be involved in the development of COPD along with impaired airway innate immunity. Methodology/Principal Findings: To address the in vivo impact of cigarette smoke (CS) exclusively on host innate defense mechanisms, we took advantage of Caenorhabditis elegans (C. elegans), which has an innate immune system but lacks adaptive immune function. Pseudomonas aeruginosa (PA) clearance from intestines of C. elegans was dampened by CS. Microarray analysis identified 6 candidate genes with a 2-fold or greater reduction after CS exposure, that have a human orthologue, and that may participate in innate immunity. To confirm a role of CS-down-regulated genes in the innate immune response to PA, RNA interference (RNAi) by feeding was carried out in C. elegans to inhibit the gene of interest, followed by PA infection to determine if the gene affected innate immunity. Inhibition of lbp-7, which encodes a lipid binding protein, resulted in increased levels of intestinal PA. Primary human bronchial epithelial cells were shown to express mRNA of human Fatty Acid Binding Protein 5 (FABP-5), the human orthologue of lpb-7. Interestingly, FABP-5 mRNA levels from human smokers with COPD were significantly lower (p = 0.036) than those from smokers without COPD. Furthermore, FABP-5 mRNA levels were up-regulated (7-fold) after bacterial (i.e., Mycoplasma pneumoniae) infection in primary human bronchial epithelial cell culture (air-liquid interface culture). Conclusions: Our results suggest that the C. elegans model offers a novel in vivo approach to specifically study innate immune deficiencies resulting from exposure to cigarette smoke, and that results from the nematode may provide insight into human airway epithelial cell biology and cigarette smoke exposure.			Green, RM (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO USA.	chuhw@njhealth.org		Green, Rebecca/0000-0001-7319-0755; Gally, Fabienne/0000-0003-0503-7411				Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Belinda LWC, 2008, MOL IMMUNOL, V45, P1732, DOI 10.1016/j.molimm.2007.09.030; BRENNER S, 1974, GENETICS, V77, P71; Chu HW, 2007, J IMMUNOL, V179, P3995, DOI 10.4049/jimmunol.179.6.3995; Chu HW, 2004, AM J PATHOL, V165, P1097, DOI 10.1016/S0002-9440(10)63371-8; Feng ZY, 2006, CELL, V127, P621, DOI 10.1016/j.cell.2006.09.035; Garcia-Medina R, 2005, INFECT IMMUN, V73, P8298, DOI 10.1128/IAI.73.12.8298-8305.2005; Gravato-Nobre MJ, 2005, CELL MICROBIOL, V7, P741, DOI 10.1111/j.1462-5822.2005.00523.x; Jiang N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-284; Jones D, 1999, J EXP ZOOL, V284, P147, DOI 10.1002/(SICI)1097-010X(19990701)284:2&lt;147::AID-JEZ4&gt;3.0.CO;2-Z; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kniazeva M, 2008, GENE DEV, V22, P2102, DOI 10.1101/gad.1692008; Kuijpers ALA, 1997, ACTA DERM-VENEREOL, V77, P14; Lin MC, 2005, WORLD J GASTROENTERO, V11, P7564, DOI 10.3748/wjg.v11.i48.7564; Martin Richard J, 2006, COPD, V3, P3, DOI 10.1080/15412550500493162; Martinez-Solano L, 2008, CLIN INFECT DIS, V47, P1526, DOI 10.1086/593186; Masouye I, 1997, CIRC RES, V81, P297, DOI 10.1161/01.RES.81.3.297; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; O'Grady EP, 2006, INFECT IMMUN, V74, P5893, DOI 10.1128/IAI.00489-06; Plenefisch J, 2000, MOL BIOCHEM PARASIT, V105, P223, DOI 10.1016/S0166-6851(99)00179-6; Ren Q, 2008, COMP FUNCT GENOM, DOI 10.1155/2008/634283; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; TEAGUE SV, 1994, INHAL TOXICOL, V6, P79, DOI 10.3109/08958379409029697; Thaikoottathil JV, 2009, EUR RESPIR J, V33, P835, DOI 10.1183/09031936.00080708; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Triantafilou M, 2004, BIOCHEM SOC T, V32, P636, DOI 10.1042/BST0320636; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Zhu Z, 2007, CANCER RES, V67, P12018, DOI 10.1158/0008-5472.CAN-07-2834	31	31	32	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6860	10.1371/journal.pone.0006860	http://dx.doi.org/10.1371/journal.pone.0006860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718433	Green Published, gold, Green Submitted			2022-12-25	WOS:000269415900024
J	Tsetsarkin, KA; Mcgee, CE; Volk, SM; Vanlandingham, DL; Weaver, SC; Higgs, S				Tsetsarkin, Konstantin A.; McGee, Charles E.; Volk, Sara M.; Vanlandingham, Dana L.; Weaver, Scott C.; Higgs, Stephen			Epistatic Roles of E2 Glycoprotein Mutations in Adaption of Chikungunya Virus to Aedes Albopictus and Ae. Aegypti Mosquitoes	PLOS ONE			English	Article								Between 2005 and 2007 Chikungunya virus (CHIKV) caused its largest outbreak/epidemic in documented history. An unusual feature of this epidemic is the involvement of Ae. albopictus as a principal vector. Previously we have demonstrated that a single mutation E1-A226V significantly changed the ability of the virus to infect and be transmitted by this vector when expressed in the background of well characterized CHIKV strains LR2006 OPY1 and 37997. However, in the current study we demonstrate that introduction of the E1-A226V mutation into the background of an infectious clone derived from the Ag41855 strain (isolated in Uganda in 1982) does not significantly increase infectivity for Ae. albopictus. In order to elucidate the genetic determinants that affect CHIKV sensitivity to the E1-A226V mutation in Ae. albopictus, the genomes of the LR2006 OPY1 and Ag41855 strains were used for construction of chimeric viruses and viruses with a specific combination of point mutations at selected positions. Based upon the midgut infection rates of the derived viruses in Ae. albopictus and Ae. aegypti mosquitoes, a critical role of the mutations at positions E2-60 and E2-211 on vector infection was revealed. The E2-G60D mutation was an important determinant of CHIKV infectivity for both Ae. albopictus and Ae. aegypti, but only moderately modulated the effect of the E1-A226V mutation in Ae. albopictus. However, the effect of the E2-I211T mutation with respect to mosquito infections was much more specific, strongly modifying the effect of the E1-A226V mutation in Ae. albopictus. In contrast, CHIKV infectivity for Ae. aegypti was not influenced by the E2-1211T mutation. The occurrence of the E2-60G and E2-211I residues among CHIKV isolates was analyzed, revealing a high prevalence of E2-211I among strains belonging to the Eastern/Central/South African (ECSA) clade. This suggests that the E2-211I might be important for adaptation of CHIKV to some particular conditions prevalent in areas occupied by ECSA stains. These newly described determinants of CHIKV mosquito infectivity for Ae. albopictus and Ae. aegypti are of particular importance for studies aimed at the investigation of the detailed mechanisms of CHIKV adaptations to its vector species.			Tsetsarkin, KA (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	kotsetsa@utmb.edu	Weaver, Scott C/D-6490-2011	Weaver, Scott C/0000-0001-8016-8556	NIAID NIH HHS [R21 AI073389, 1 R21 AI073389] Funding Source: Medline; PHS HHS [T32 A107536] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073389] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anishchenko M, 2006, P NATL ACAD SCI USA, V103, P4994, DOI 10.1073/pnas.0509961103; Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; Arpino C, 2009, REV MED VIROL, V19, P121, DOI 10.1002/rmv.606; BEAMAN JR, 1991, J MED ENTOMOL, V28, P161, DOI 10.1093/jmedent/28.1.161; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144; Brault AC, 2002, J VIROL, V76, P6387, DOI 10.1128/JVI.76.12.6387-6392.2002; Brault AC, 2004, P NATL ACAD SCI USA, V101, P11344, DOI 10.1073/pnas.0402905101; BURNESS ATH, 1988, VIROLOGY, V167, P639, DOI 10.1016/S0042-6822(88)90129-8; Cherian SS, 2009, INFECT GENET EVOL, V9, P16, DOI 10.1016/j.meegid.2008.09.004; de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33; Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003; Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281; Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864; Enserink M, 2007, SCIENCE, V317, P1485, DOI 10.1126/science.317.5844.1485a; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez Z, 2003, J MED ENTOMOL, V40, P522, DOI 10.1603/0022-2585-40.4.522; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Heil ML, 2001, J VIROL, V75, P6303, DOI 10.1128/JVI.75.14.6303-6309.2001; HIGGS S, 1997, MOL BIOL DIS VECTORS, P457; Jupp P. G., 1988, The arboviruses: epidemiology and ecology. Volume II., P137; KERR PJ, 1993, VIROLOGY, V193, P446, DOI 10.1006/viro.1993.1143; Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326; LEVINE B, 1993, J VIROL, V67, P6872, DOI 10.1128/JVI.67.11.6872-6875.1993; Lu YPE, 1999, J VIROL, V73, P4272, DOI 10.1128/JVI.73.5.4272-4278.1999; Mandl CW, 2001, J VIROL, V75, P5627, DOI 10.1128/JVI.75.12.5627-5637.2001; MCCRAE AWR, 1971, T ROY SOC TROP MED H, V65, P152, DOI 10.1016/0035-9203(71)90212-4; McElroy KL, 2006, J GEN VIROL, V87, P2993, DOI 10.1099/vir.0.82023-0; MCINTOSH BM, 1977, S AFR J SCI, V73, P267; McKnight KL, 1996, J VIROL, V70, P1981, DOI 10.1128/JVI.70.3.1981-1989.1996; MITCHELL CJ, 1987, J AM MOSQUITO CONTR, V3, P460; MITCHELL CJ, 1992, SCIENCE, V257, P526, DOI 10.1126/science.1321985; Moutailler S, 2008, VECTOR-BORNE ZOONOT, V8, P749, DOI 10.1089/vbz.2008.0009; Myles KM, 2003, J VIROL, V77, P8872, DOI 10.1128/JVI.77.16.8872-8881.2003; Njenga MK, 2008, J GEN VIROL, V89, P2754, DOI 10.1099/vir.0.2008/005413-0; Pages F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004691; Pierro DJ, 2008, J VIROL, V82, P2966, DOI 10.1128/JVI.02060-07; Pierro DJ, 2007, J GEN VIROL, V88, P1545, DOI 10.1099/vir.0.82577-0; PILITT DR, 1972, J MED ENTOMOL, V9, P334, DOI 10.1093/jmedent/9.4.334; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sardelis MR, 2002, J AM MOSQUITO CONTR, V18, P284; Sardelis MR, 2001, EMERG INFECT DIS, V7, P1018, DOI 10.3201/eid0706.010617; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; SCOTT TW, 1990, J AM MOSQUITO CONTR, V6, P274; Simon F, 2008, MED CLIN N AM, V92, P1323, DOI 10.1016/j.mcna.2008.07.008; Smit JM, 2002, J VIROL, V76, P10128, DOI 10.1128/JVI.76.20.10128-10137.2002; Smit JM, 2001, J VIROL, V75, P11196, DOI 10.1128/JVI.75.22.11196-11204.2001; SMITH TJ, 1995, P NATL ACAD SCI USA, V92, P10648, DOI 10.1073/pnas.92.23.10648; STRAUSS EG, 1991, J VIROL, V65, P4654, DOI 10.1128/JVI.65.9.4654-4664.1991; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; Vanlandingham DL, 2006, AM J TROP MED HYG, V74, P663, DOI 10.4269/ajtmh.2006.74.663; Vanlandingham DL, 2005, INSECT BIOCHEM MOLEC, V35, P1162, DOI 10.1016/j.ibmb.2005.05.008; Vashishtha M, 1998, J CELL BIOL, V140, P91, DOI 10.1083/jcb.140.1.91; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; WANG KS, 1991, VIROLOGY, V181, P694, DOI 10.1016/0042-6822(91)90903-O; WANG KS, 1991, J VIROL, V65, P7037, DOI 10.1128/JVI.65.12.7037-7040.1991; WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P253, DOI 10.1016/0035-9203(58)90084-1; Weng MH, 1997, J MED ENTOMOL, V34, P745, DOI 10.1093/jmedent/34.6.745; Zhang W, 2005, VIROLOGY, V332, P511, DOI 10.1016/j.virol.2004.11.043	65	157	163	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6835	10.1371/journal.pone.0006835	http://dx.doi.org/10.1371/journal.pone.0006835			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718263	gold, Green Published, Green Submitted			2022-12-25	WOS:000269415900008
J	Albrecht, M; Duelli, P; Obrist, MK; Kleijn, D; Schmid, B				Albrecht, Matthias; Duelli, Peter; Obrist, Martin K.; Kleijn, David; Schmid, Bernhard			Effective Long-Distance Pollen Dispersal in Centaurea jacea	PLOS ONE			English	Article								Background: Agri-environment schemes play an increasingly important role for the conservation of rare plants in intensively managed agricultural landscapes. However, little is known about their effects on gene flow via pollen dispersal between populations of these species. Methodology/Principal Findings: In a 2-year experiment, we observed effective pollen dispersal from source populations of Centaurea jacea in restored meadows, the most widespread Swiss agri-environment scheme, to potted plants in adjacent intensively managed meadows without other individuals of this species. Potted plants were put in replicated source populations at 25, 50, 100 m and where possible 200 m distance from these source populations. Pollen transfer among isolated plants was prevented by temporary bagging, such that only one isolated plant was accessible for flower visitors at any one time. Because C. jacea is self-incompatible, seed set in single-plant isolates indicated insect mediated effective pollen dispersal from the source population. Seed set was higher in source populations (35.7 +/- 4.4) than in isolates (4.8 +/- 1.0). Seed set declined from 18.9% of that in source populations at a distance of 25 m to 7.4% at 200 m. At a distance of 200 m seed set was still significantly higher in selfed plants, indicating long-distance effective pollen dispersal up to 200 m. Analyses of covariance suggested that bees contributed more than flies to this long-distance pollen dispersal. We found evidence that pollen dispersal to single-plant isolates was positively affected by the diversity and flower abundance of neighboring plant species in the intensively managed meadow. Furthermore, the decline of the dispersal was less steep when the source population of C. jacea was large. Conclusions: We conclude that insect pollinators can effectively transfer pollen from source populations of C. jacea over at least 200 m, even when "recipient populations'' consisted of single-plant isolates, suggesting that gene flow by pollen over this distance is very likely. Source population size and flowering environment surrounding recipient plants appear to be important factors affecting pollen dispersal in C. jacea. It is conceivable that most insect-pollinated plants in a network of restored sites within intensively managed grassland can form metapopulations, if distances between sites are of similar magnitude as tested here.			Albrecht, M (corresponding author), Univ Zurich, Inst Environm Sci, Zurich, Switzerland.	matthias.albrecht@uwinst.uzh.ch	Schmid, Bernhard/C-8625-2009; Obrist, Martin/AAR-1563-2020; Kleijn, David/HCH-3477-2022	Schmid, Bernhard/0000-0002-8430-3214; Obrist, Martin/0000-0001-6766-044X; Kleijn, David/0000-0003-2500-7164; Duelli, Peter/0000-0001-8862-8262				Austerlitz F, 2004, MOL ECOL, V13, P937, DOI 10.1111/j.1365-294X.2004.02100.x; Baur B, 1997, OKOLOGISCHER AUSGLEI; *BLW, 2004, AGR; CAMPBELL DR, 1985, EVOLUTION, V39, P418, DOI [10.2307/2408374, 10.1111/j.1558-5646.1985.tb05678.x]; CAMPBELL DR, 1989, EVOLUTION, V43, P1444, DOI 10.1111/j.1558-5646.1989.tb02595.x; Crawley MJ., 2007, STAT INTRO USING R; de Jong TJ, 2005, ACTA OECOL, V28, P331, DOI 10.1016/j.actao.2005.07.001; Duncan DH, 2004, J ECOL, V92, P977, DOI 10.1111/j.1365-2745.2004.00933.x; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; *FBS, 2004, BIOD SCHWEIZ; FENSTER CB, 1991, EVOLUTION, V45, P398, DOI 10.1111/j.1558-5646.1991.tb04413.x; Fischer M, 2000, ECOL LETT, V3, P530, DOI 10.1046/j.1461-0248.2000.00188.x; GARDOU C, 1972, Feddes Repertorium, V83, P311; Ghazoul J, 2006, J ECOL, V94, P295, DOI 10.1111/j.1365-2745.2006.01098.x; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Groom MJ, 1998, AM NAT, V151, P487, DOI 10.1086/286135; Hardy OJ, 2001, HEREDITY, V87, P136, DOI 10.1046/j.1365-2540.2001.00862.x; Harrison S, 1999, ECOGRAPHY, V22, P225, DOI 10.1111/j.1600-0587.1999.tb00496.x; Herzog F, 2005, AGR ECOSYST ENVIRON, V108, P189, DOI 10.1016/j.agee.2005.02.003; Hooftman DAP, 2004, CONSERV BIOL, V18, P1043, DOI 10.1111/j.1523-1739.2004.00223.x; KARRON JD, 1995, HEREDITY, V75, P175, DOI 10.1038/hdy.1995.121; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Klein EK, 2006, J APPL ECOL, V43, P141, DOI 10.1111/j.1365-2664.2005.01108.x; KLINKHAMER PGL, 1990, OIKOS, V57, P399, DOI 10.2307/3565970; Kolb A, 2005, J ECOL, V93, P1226, DOI 10.1111/j.1365-2745.2005.01049.x; Kwak M.M., 1991, Acta Horticulturae (Wageningen), V288, P303; Kwak MM, 1998, APPL VEG SCI, V1, P37, DOI 10.2307/1479084; LAMONT BB, 1993, OECOLOGIA, V94, P446, DOI 10.1007/BF00317122; LEVIN DA, 1968, EVOLUTION, V22, P130, DOI 10.1111/j.1558-5646.1968.tb03457.x; Lienert J, 2002, BASIC APPL ECOL, V3, P101, DOI 10.1078/1439-1791-00089; Moeller DA, 2004, ECOLOGY, V85, P3289, DOI 10.1890/03-0810; MORRIS WF, 1994, OIKOS, V71, P431, DOI 10.2307/3545831; Ohashi K, 1999, OIKOS, V86, P386, DOI 10.2307/3546457; Organisation for Economic Co-operation and Development, 2003, AGR POL OECD COUNTR; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Paschke M, 2002, AM J BOT, V89, P1250, DOI 10.3732/ajb.89.8.1250; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Richards CM, 1999, EVOLUTION, V53, P63, DOI [10.2307/2640920, 10.1111/j.1558-5646.1999.tb05333.x]; Rusterholz HP, 1998, OECOLOGIA, V113, P341, DOI 10.1007/s004420050385; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; SCHMITT J, 1980, EVOLUTION, V34, P934, DOI 10.1111/j.1558-5646.1980.tb04031.x; Schulke B, 2001, OECOLOGIA, V127, P239, DOI 10.1007/s004420000586; Schweiger O, 2005, J APPL ECOL, V42, P1129, DOI 10.1111/j.1365-2664.2005.01085.x; Swetnam RD, 2004, J ENVIRON MANAGE, V71, P79, DOI 10.1016/j.jenvman.2004.01.006; Vanhoenacker D, 2006, NEW PHYTOL, V169, P615, DOI 10.1111/j.1469-8137.2005.01615.x; Wagenius S, 2006, ECOLOGY, V87, P931, DOI 10.1890/0012-9658(2006)87[931:SDORFI]2.0.CO;2; Waser N.M., 1983, P277; WIDEN B, 1990, OECOLOGIA, V83, P191, DOI 10.1007/BF00317751	49	21	23	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6751	10.1371/journal.pone.0006751	http://dx.doi.org/10.1371/journal.pone.0006751			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707542	Green Published, gold			2022-12-25	WOS:000269278400016
J	Minami, SS; Sung, YM; Dumanis, SB; Chi, SH; Burns, MP; Ann, EJ; Suzuki, T; Turner, RS; Park, HS; Pak, DTS; Rebeck, GW; Hoe, HS				Minami, S. Sakura; Sung, You Me; Dumanis, Sonya B.; Chi, Seong Hwan; Burns, Mark P.; Ann, Eun-Jung; Suzuki, Toshiharu; Turner, R. Scott; Park, Hee-Sae; Pak, Daniel T. S.; Rebeck, G. William; Hoe, Hyang-Sook			The cytoplasmic adaptor protein X11 alpha and extracellular matrix protein Reelin regulate ApoE receptor 2 trafficking and cell movement	FASEB JOURNAL			English	Article						Mint; wound healing; cell migration	AMYLOID PRECURSOR PROTEIN; DENSITY-LIPOPROTEIN RECEPTOR; APOLIPOPROTEIN-E RECEPTORS; NEURONAL MIGRATION; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; INTERACTION DOMAINS; BRAIN-DEVELOPMENT; TRANSGENIC MICE; FE65	The goal of this study was to determine the effect of X11 alpha on ApoE receptor 2 (ApoEr2) trafficking and the functional significance of this interaction on cell movement in MCF 10A epithelial cells. We found that X11 alpha increased surface levels of ApoEr2 by 64% compared to vector control, as determined by surface protein biotinylation. To examine the functional significance of this effect, we tested whether ApoEr2 played a novel role in cell movement in a wound-healing assay. We found that overexpression of ApoEr2 in MCF 10A cells increased cell migration velocity by 87% (P<0.01, n = 4) compared to GFP control. Cotransfection of X11 alpha had an additive effect on average velocity compared to ApoEr2 alone (13%; P<0.05, n = 4). In addition, we tested whether ApoEr2 ligands altered the effect of ApoEr2 on cell movement. We found that treatment with concentrated medium containing the extracellular matrix protein Reelin, but not control medium, further increased the velocity of ApoEr2-but not APP-transfected cells (20%; P<0.001, n = 4). Similarly, Reelin treatment increased cell velocity on the presence of ApoEr2 and X11 alpha (10%; P<0.05, n = 4). In the present study, we are the first to demonstrate that ApoEr2 regulates cell movement, and both X11 alpha and Reelin enhance this effect.-Minami, S. S., Sung, Y. M., Dumanis, S. B., Chi, S. H., Burns, M. P., Ann, E.-J., Suzuki, T., Turner, R. S., Park, H.-S., Pak, D. T. S., Rebeck, G. W., Hoe, H.- S. The cytoplasmic adaptor protein X11 alpha and extracellular matrix protein Reelin regulate ApoE receptor 2 trafficking and cell movement. FASEB J. 24, 58-69 ( 2010). www.fasebj.org	[Turner, R. Scott] Georgetown Univ, Dept Neurol, Med Ctr, Washington, DC 20057 USA; [Minami, S. Sakura; Dumanis, Sonya B.; Chi, Seong Hwan; Burns, Mark P.; Rebeck, G. William; Hoe, Hyang-Sook] Georgetown Univ, Dept Neurosci, Med Ctr, Washington, DC 20057 USA; [Sung, You Me] Georgetown Univ, Dept Oncol, Med Ctr, Washington, DC 20057 USA; [Pak, Daniel T. S.] Georgetown Univ, Dept Pharmacol, Med Ctr, Washington, DC 20057 USA; [Ann, Eun-Jung; Park, Hee-Sae] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju, South Korea; [Suzuki, Toshiharu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Neurosci Lab, Sapporo, Hokkaido, Japan	Georgetown University; Georgetown University; Georgetown University; Georgetown University; Chonnam National University; Hokkaido University	Hoe, HS (corresponding author), Georgetown Univ, Dept Neurol, Med Ctr, 4000 Reservoir Rd NW, Washington, DC 20057 USA.	hh69@georgetown.edu	Suzuki, Toshiharu/B-5342-2013; Rebeck, George William/J-2192-2012; Turner, Raymond Scott/G-2263-2011	Rebeck, George William/0000-0001-6276-248X; Turner, Raymond Scott/0000-0001-7534-2935; Dumanis, Sonya/0000-0002-3345-9497; Burns, Mark P/0000-0003-4750-2000	U. S. National Institutes of Health [AG032330, AG030060, AG026478, AG014473]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG030128, R01AG026478, R29AG014473, R03AG032330, R01AG014473, R03AG030060] Funding Source: NIH RePORTER	U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by U. S. National Institutes of Health grants AG032330 ( H. S. H.), AG030060 ( G. W. R.), AG026478 ( R. S. T.), and AG014473 ( G. W. R.). We thank Dr. Christopher Miller and Dr. Declan McLoughlin ( King's College London, London, UK) for X11 plasmid DNA, Dr. Joachim Herz ( University of Texas Southwestern Medical Center, Dallas, TX, USA) for ApoEr2 ( without exon19) plasmid DNA, and Dr. Andre Goffinet ( Catholic University of Leuven, Brussels, Belgium) and Dr. Suzanne Guenette ( Massachusetts General Hospital, Charlestown, MA, USA) for Dab1 and FE65 antibodies, respectively. We also thank Ji-yun Lee for her generous contribution toward the yeast 2-hybrid experiments.	Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Borg JP, 1998, J BIOL CHEM, V273, P31633, DOI 10.1074/jbc.273.48.31633; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chai XJ, 2009, J NEUROSCI, V29, P288, DOI 10.1523/JNEUROSCI.2934-08.2009; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Guenette SY, 1996, P NATL ACAD SCI USA, V93, P10832, DOI 10.1073/pnas.93.20.10832; Hack I, 2007, DEVELOPMENT, V134, P3883, DOI 10.1242/dev.005447; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Herz J, 2000, NAT REV NEUROSCI, V1, P51, DOI 10.1038/35036221; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Herz J, 2009, CURR OPIN LIPIDOL, V20, P190, DOI 10.1097/MOL.0b013e32832d3a10; Hoe HS, 2005, MOL BRAIN RES, V137, P31, DOI 10.1016/j.molbrainres.2005.02.013; Hoe HS, 2008, J BIOL CHEM, V283, P6288, DOI 10.1074/jbc.M704140200; Hoe HS, 2006, J BIOL CHEM, V281, P35176, DOI 10.1074/jbc.M602162200; Hoe HS, 2006, J BIOL CHEM, V281, P24521, DOI 10.1074/jbc.M600728200; Lau KF, 2000, NEUROREPORT, V11, P3607, DOI 10.1097/00001756-200011090-00041; Lee JH, 2004, J BIOL CHEM, V279, P49099, DOI 10.1074/jbc.M405602200; Lee JH, 2003, J BIOL CHEM, V278, P47025, DOI 10.1074/jbc.M300503200; Mayer H, 2006, MOL CELL BIOL, V26, P19, DOI 10.1128/MCB.26.1.19-27.2006; Mueller HT, 2000, J BIOL CHEM, V275, P39302, DOI 10.1074/jbc.M008453200; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Parisiadou L, 2007, NEUROBIOL AGING, V28, P377, DOI 10.1016/j.neurobiolaging.2005.12.015; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Perkinton MS, 2004, J BIOL CHEM, V279, P22084, DOI 10.1074/jbc.M311479200; Pramatarova A, 2008, MOL CELL NEUROSCI, V37, P178, DOI 10.1016/j.mcn.2007.09.008; Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403; Sastre M, 1998, J BIOL CHEM, V273, P22351, DOI 10.1074/jbc.273.35.22351; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SOULE HD, 1990, CANCER RES, V50, P6075; Tomita S, 1999, J BIOL CHEM, V274, P2243, DOI 10.1074/jbc.274.4.2243; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Vishnu S, 2006, DEV BIOL, V289, P296, DOI 10.1016/j.ydbio.2005.09.016; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007	39	22	23	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					58	69		10.1096/fj.09-138123	http://dx.doi.org/10.1096/fj.09-138123			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19720620	Green Published			2022-12-25	WOS:000273233600009
J	Jian, Y; Gao, Z; Sun, J; Shen, Q; Feng, F; Jing, Y; Yang, C				Jian, Y.; Gao, Z.; Sun, J.; Shen, Q.; Feng, F.; Jing, Y.; Yang, C.			RNA aptamers interfering with nucleophosmin oligomerization induce apoptosis of cancer cells	ONCOGENE			English	Article						nucleophosmin; RNA aptamer; p14ARF; p53; apoptosis	PROTEIN B23; BINDING; ARF; NUCLEOLI	Nucleophosmin (NPM) is a multifunctional protein involved in both proliferation and apoptosis. Importantly, NPM negatively regulates p53 and is frequently overexpressed in a wide variety of cancers. To identify inhibitory molecules of NPM, we used an in vitro selection method termed systematic evolution of ligands by exponential enrichment (SELEX) to select RNA aptamers that bind to NPM with high affinity and specificity. The selected RNA aptamers bind to the central acidic region of NPM and affect its oligomerization both in vitro and in vivo. Remarkably, expression of NPM-specific aptamers causes mislocalization of NPM in the nucleoplasm rather than in the nucleolus, suggesting that NPM oligomerization is important for its proper localization. Moreover, p14ARF is mislocalized in the nucleoplasm and p53 is upregulated in cells expressing NPM aptamers. In addition, cancer cells expressing NPM aptamers not only undergo apoptosis on their own, but are more susceptible to apoptosis induced by DNA-damaging agents as well. These results suggest that interfering with NPM oligomerization can inhibit NPM function and aptamers targeting NPM can serve as potential lead for developing anticancer drugs. Oncogene (2009) 28, 4201-4211; doi: 10.1038/onc.2009.275; published online 7 September 2009	[Jian, Y.; Gao, Z.; Sun, J.; Shen, Q.; Jing, Y.; Yang, C.] Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China; [Feng, F.] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Yang, C (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol & Dev Biol, Datun Rd, Beijing 100101, Peoples R China.	clyang@genetics.ac.cn			National 863 Program [2006AA02Z147]; National Basic Research Program [2006CB504100, 2007CB947201]; National Natural Science Foundation [30871266]; Chinese Academy of Sciences [KSC1-YW-R-70]; CAS 100-Talents Program	National 863 Program(National High Technology Research and Development Program of China); National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); CAS 100-Talents Program(Chinese Academy of Sciences)	We thank Dr S Luo and Dr D Wu for providing NPM and p14ARF cDNAs; Dr Y Liu for help with protein purification; Dr X Wang for helpful suggestions and critical reading of the paper. This research was supported by grants from National 863 Program (no. 2006AA02Z147), National Basic Research Program (nos. 2006CB504100 and 2007CB947201), National Natural Science Foundation (no. 30871266) and Chinese Academy of Sciences (no. KSC1-YW-R-70). CY was supported by the CAS 100-Talents Program.	Ahn JY, 2005, MOL CELL, V18, P435, DOI 10.1016/j.molcel.2005.04.010; Apte RS, 2008, EXPERT OPIN PHARMACO, V9, P499, DOI [10.1517/14656566.9.3.499, 10.1517/14656566.9.3.499 ]; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Chan PK, 1999, BIOCHEM BIOPH RES CO, V264, P305, DOI 10.1006/bbrc.1999.1255; Chu TC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl388; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Enomoto T, 2006, J BIOL CHEM, V281, P18463, DOI 10.1074/jbc.M602788200; Gjerset RA, 2006, CELL CYCLE, V5, P686, DOI 10.4161/cc.5.7.2623; Good PD, 1997, GENE THER, V4, P45, DOI 10.1038/sj.gt.3300354; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; Ireson CR, 2006, MOL CANCER THER, V5, P2957, DOI 10.1158/1535-7163.MCT-06-0172; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Lee HZ, 2005, INT J CANCER, V113, P971, DOI 10.1002/ijc.20676; Levy-Nissenbaum E, 2008, TRENDS BIOTECHNOL, V26, P442, DOI 10.1016/j.tibtech.2008.04.006; Maiguel DA, 2004, MOL CELL BIOL, V24, P3703, DOI 10.1128/MCB.24.9.3703-3711.2004; McNamara JO, 2006, NAT BIOTECHNOL, V24, P1005, DOI 10.1038/nbt1223; Namboodiri VMH, 2004, STRUCTURE, V12, P2149, DOI 10.1016/j.str.2004.09.017; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Qi W, 2008, ONCOGENE, V27, P4210, DOI 10.1038/onc.2008.54; Sambrook J, 2001, MOL CLONING LAB MANU; Savkur RS, 1998, NUCLEIC ACIDS RES, V26, P4508, DOI 10.1093/nar/26.19.4508; SZEBENI A, 1995, BIOCHEMISTRY-US, V34, P8037, DOI 10.1021/bi00025a009; WANG DR, 1994, J BIOL CHEM, V269, P30994; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; Yang CL, 2006, J BIOL CHEM, V281, P9137, DOI 10.1074/jbc.M511742200; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	31	49	51	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 26	2009	28	47					4201	4211		10.1038/onc.2009.275	http://dx.doi.org/10.1038/onc.2009.275			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DQ	19734942				2022-12-25	WOS:000272876100006
J	Undurti, A; Huang, Y; Lupica, JA; Smith, JD; DiDonato, JA; Hazen, SL				Undurti, Arundhati; Huang, Ying; Lupica, Joseph A.; Smith, Jonathan D.; DiDonato, Joseph A.; Hazen, Stanley L.			Modification of High Density Lipoprotein by Myeloperoxidase Generates a Pro-inflammatory Particle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; REVERSE CHOLESTEROL TRANSPORT; RECEPTOR CLASS-B; CYTOKINE-INDUCED EXPRESSION; CELL-ADHESION MOLECULE-1; ESTER TRANSFER PROTEIN; NITRIC-OXIDE SYNTHASE; SCAVENGER RECEPTOR; ENDOTHELIAL-CELLS; ANTIINFLAMMATORY PROPERTIES	High density lipoprotein (HDL) is the major atheroprotective particle in plasma. Recent studies demonstrate that myeloperoxidase (MPO) binds to HDL in vivo, selectively targeting apolipoprotein A1 (apoA1) of HDL for oxidative modification and concurrent loss in cholesterol efflux and lecithin cholesterol acyl transferase activating activities, generating a "dysfunctional HDL" particle. We now show that (patho) physiologically relevant levels of MPO-catalyzed oxidation result in loss of non-cholesterol efflux activities of HDL including anti-apoptotic and anti-inflammatory functions. One mechanism responsible is shown to involve the loss of modified HDL binding to the HDL receptor, scavenger receptor B1, and concurrent acquisition of saturable and specific binding to a novel unknown receptor independent of scavenger receptors CD36 and SR-A1. HDL modification by MPO is further shown to confer pro-inflammatory gain of function activities as monitored by NF-kappa B activation and surface vascular cell adhesion molecule levels on aortic endothelial cells exposed to MPO-oxidized HDL. The loss of non-cholesterol efflux activities and the gain of pro-inflammatory functions requires modification of the entire particle and can be recapitulated by oxidation of reconstituted HDL particles comprised of apoA1 and nonoxidizable phosphatidylcholine species. Multiple site-directed mutagenesis studies of apoA1 suggest that the pro-inflammatory activity of MPO-modified HDL does not involve methionine, tyrosine, or tryptophan, oxidant-sensitive residues previously mapped as sites of apoA1 oxidation within human atheroma. Thus, MPO-catalyzed oxidation of HDL results not only in the loss of classic atheroprotective reverse cholesterol transport activities of the lipoprotein but also both the loss of non-cholesterol efflux related activities and the gain of pro-inflammatory functions.	[Hazen, Stanley L.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA; [Smith, Jonathan D.; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Undurti, Arundhati; Huang, Ying; Lupica, Joseph A.; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Undurti, Arundhati] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University	Hazen, SL (corresponding author), Cleveland Clin, Dept Cell Biol, 9500 Euclid Ave,NE10, Cleveland, OH 44195 USA.	hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021; Smith, Jonathan D./H-9723-2013	Lupica, Joseph/0000-0003-1476-037X; Smith, Jonathan D./0000-0002-0415-386X	National Institutes of Health [P01 HL076491-055328, P01 HL077107-050004, P01 HL087018-02001]; Case Western Reserve University; Cleveland Clinic Clinical and Translational Science [1KL2RR024990]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024990] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, P50HL077107, P01HL087018, R01HL066082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University; Cleveland Clinic Clinical and Translational Science; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL076491-055328, P01 HL077107-050004, P01 HL087018-02001. This work was also supported by Case Western Reserve University/Cleveland Clinic Clinical and Translational Science Award 1KL2RR024990.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Askari AT, 2003, J EXP MED, V197, P615, DOI 10.1084/jem.20021426; Baker PW, 1999, J LIPID RES, V40, P345; Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bauer JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001313; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; BLANCHE PJ, 1981, BIOCHIM BIOPHYS ACTA, V665, P408, DOI 10.1016/0005-2760(81)90253-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; COCKERILL GW, 1995, ARTERIOSCL THROM VAS, V15, P1987, DOI 10.1161/01.ATV.15.11.1987; Cockerill GW, 2001, CIRCULATION, V103, P108; CYBULSKY MI, 1991, SCIENCE, V251, P788, DOI 10.1126/science.1990440; de Winther MPJ, 2000, ARTERIOSCL THROM VAS, V20, P290, DOI 10.1161/01.ATV.20.2.290; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; FIELDING CJ, 1995, J LIPID RES, V36, P211; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; HESSLER JR, 1979, ATHEROSCLEROSIS, V32, P213, DOI 10.1016/0021-9150(79)90166-7; IADEMARCO MF, 1992, J BIOL CHEM, V267, P16323; Kimura T, 2008, J IMMUNOL, V181, P7332, DOI 10.4049/jimmunol.181.10.7332; Li XA, 2005, J BIOL CHEM, V280, P19087, DOI 10.1074/jbc.M500944200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATZ CE, 1982, J BIOL CHEM, V257, P4535; McGillicuddy FC, 2009, CIRCULATION, V119, P1135, DOI 10.1161/CIRCULATIONAHA.108.810721; Meuwese MC, 2007, J AM COLL CARDIOL, V50, P159, DOI 10.1016/j.jacc.2007.03.033; Mineo C, 2003, J BIOL CHEM, V278, P9142, DOI 10.1074/jbc.M211394200; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; Navab M, 2009, J LIPID RES, V50, pS145, DOI 10.1194/jlr.R800036-JLR200; Nicholls SJ, 2005, TRENDS CARDIOVAS MED, V15, P212, DOI 10.1016/j.tcm.2005.06.004; Nofer JR, 2001, J BIOL CHEM, V276, P34480, DOI 10.1074/jbc.M103782200; OSBORNE JCJ, 1968, METHODS ENZYMOL A, V128, P213; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Paromov VM, 2003, J BIOL CHEM, V278, P40859, DOI 10.1074/jbc.M306580200; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Rosen H, 2002, J BIOL CHEM, V277, P30463, DOI 10.1074/jbc.M202331200; RYE KA, 1992, J LIPID RES, V33, P215; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; STELMASZYNSKA T, 1978, EUR J BIOCHEM, V92, P301, DOI 10.1111/j.1432-1033.1978.tb12748.x; Tall AR, 1998, EUR HEART J, V19, pA31; Tolle M, 2008, ARTERIOSCL THROM VAS, V28, P1542, DOI 10.1161/ATVBAHA.107.161042; Van Lenten BJ, 2001, CIRCULATION, V103, P2283; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Tang WHW, 2007, J AM COLL CARDIOL, V49, P2364, DOI 10.1016/j.jacc.2007.02.053; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	57	205	210	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30825	30835		10.1074/jbc.M109.047605	http://dx.doi.org/10.1074/jbc.M109.047605			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19726691	Green Published, hybrid			2022-12-25	WOS:000271378400010
J	Xia, CW; Misra, I; Iyanagi, T; Kim, JJP				Xia, Chuanwu; Misra, Ila; Iyanagi, Takashi; Kim, Jung-Ja P.			Regulation of Interdomain Interactions by Calmodulin in Inducible Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME P450 OXIDOREDUCTASE; ELECTRON FLOW-THROUGH; CRYSTAL-STRUCTURE; REDUCTASE DOMAIN; STRUCTURAL BASIS; FLAVIN DOMAIN; BINDING DOMAINS; CONTROL ELEMENT; NO SYNTHASE; DIMER	Nitric-oxide synthases (NOSs) catalyze the conversion of L-arginine to nitric oxide and citrulline. There are three NOS isozymes, each with a different physiological role: neuronal NOS, endothelial NOS, and inducible NOS ( iNOS). NOSs consist of an N-terminal oxygenase domain and a C-terminal reductase domain, linked by a calmodulin (CaM)-binding region. CaM is required for NO production, but unlike other NOS isozymes, iNOS binds CaM independently of the exogenous Ca2+ concentration. We have co-expressed CaM and the FMN domain of human iNOS, which includes the CaM-binding region. The Ca2+-bound protein complex (CaCaM.FMN) forms an air-stable semiquinone when reduced with NADPH and reduces cytochrome c when reconstituted with the iNOS FAD/NADPH domain. We have solved the crystal structure of the CaCaM.FMN complex in four different conformations, each with a different relative orientation, between the FMN domain and the bound CaM. The CaM-binding region together with bound CaM forms a hinge, pivots on the conserved Arg(536), and regulates electron transfer from FAD to FMN and from FMN to heme by adjusting the relative orientation and distance among the three cofactors. In addition, the relative orientations of the N- and C-terminal lobes of CaM are also different among the four conformations, suggesting that the flexibility between the two halves of CaM also contributes to the fine tuning of the orientation/distance between the redox centers. The data demonstrate a possible mode for precise control of electron transfer by altering the distance and orientation	[Xia, Chuanwu; Misra, Ila; Kim, Jung-Ja P.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Iyanagi, Takashi] SPring 8 Ctr, Biomet Sci Lab, RIKEN, Mikazuki, Hyogo 6795148, Japan	Medical College of Wisconsin; Japan Synchrotron Radiation Research Institute; RIKEN	Kim, JJP (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jjkim@mcw.edu			National Institutes of Health [GM52682]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM52682 ( to J. J. K.).	ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Aoyagi M, 2003, EMBO J, V22, P766, DOI 10.1093/emboj/cdg078; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Censarek P, 2004, FEBS LETT, V577, P465, DOI 10.1016/j.febslet.2004.10.048; Censarek P, 2002, BIOCHEMISTRY-US, V41, P8598, DOI 10.1021/bi025681k; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Daff S, 2003, BIOCHEM SOC T, V31, P502, DOI 10.1042/bst0310502; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng CJ, 2009, J BIOL INORG CHEM, V14, P133, DOI 10.1007/s00775-008-0431-2; Fischmann TO, 1999, NAT STRUCT BIOL, V6, P233, DOI 10.1038/6675; Gachhui R, 1998, J BIOL CHEM, V273, P5451, DOI 10.1074/jbc.273.10.5451; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Gribovskaja I, 2005, BIOCHEMISTRY-US, V44, P7593, DOI 10.1021/bi0474517; Guan ZW, 2003, ARCH BIOCHEM BIOPHYS, V412, P65, DOI 10.1016/S0003-9861(03)00009-2; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Haque MM, 2007, P NATL ACAD SCI USA, V104, P9254, DOI 10.1073/pnas.0700332104; Harrison DG, 1996, CLIN EXP PHARMACOL P, V23, P251, DOI 10.1111/j.1440-1681.1996.tb02606.x; Hooper WC, 2007, VASC PHARMACOL, V46, P315, DOI 10.1016/j.vph.2006.10.014; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Ilagan RP, 2009, BIOCHEMISTRY-US, V48, P3864, DOI 10.1021/bi8021087; Jachymova M, 2005, P NATL ACAD SCI USA, V102, P15833, DOI 10.1073/pnas.0506522102; Jones RJ, 2004, J BIOL CHEM, V279, P36876, DOI 10.1074/jbc.M402808200; Knott AB, 2009, ANTIOXID REDOX SIGN, V11, P541, DOI [10.1089/ars.2008.2234, 10.1089/ARS.2008.2234]; Knudsen GM, 2003, J BIOL CHEM, V278, P31814, DOI 10.1074/jbc.M303267200; Li HG, 2002, NITRIC OXIDE-BIOL CH, V7, P132, DOI 10.1016/S1089-8603(02)00127-1; Li HY, 2005, J INORG BIOCHEM, V99, P293, DOI 10.1016/j.jinorgbio.2004.10.016; LOWENSTEIN CJ, 1994, ANN INTERN MED, V120, P227, DOI 10.7326/0003-4819-120-3-199402010-00009; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Matsubara M, 1997, J BIOL CHEM, V272, P23050, DOI 10.1074/jbc.272.37.23050; Matsuda H, 1999, BBA-GEN SUBJECTS, V1473, P345, DOI 10.1016/S0304-4165(99)00193-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Nishida CR, 1999, J BIOL CHEM, V274, P14692, DOI 10.1074/jbc.274.21.14692; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; Panda K, 2006, J BIOL CHEM, V281, P36819, DOI 10.1074/jbc.M606129200; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; RodriguezCrespo I, 1996, J BIOL CHEM, V271, P11462, DOI 10.1074/jbc.271.19.11462; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Roman LJ, 2000, J BIOL CHEM, V275, P29225, DOI 10.1074/jbc.M004766200; Roman LJ, 2000, J BIOL CHEM, V275, P21914, DOI 10.1074/jbc.M002449200; Roman LJ, 2002, CHEM REV, V102, P1179, DOI 10.1021/cr000661e; Sagami I, 2001, J BIOL CHEM, V276, P30036, DOI 10.1074/jbc.M104123200; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Siddhanta U, 1996, J BIOL CHEM, V271, P7309, DOI 10.1074/jbc.271.13.7309; Simonovic M, 2006, J BIOL CHEM, V281, P34333, DOI 10.1074/jbc.M604613200; SMITH GCM, 1994, P NATL ACAD SCI USA, V91, P8710, DOI 10.1073/pnas.91.18.8710; Spratt DE, 2006, FEBS J, V273, P1759, DOI 10.1111/j.1742-4658.2006.05193.x; Spratt DE, 2007, BBA-PROTEINS PROTEOM, V1774, P1351, DOI 10.1016/j.bbapap.2007.07.019; STEVENSTRUSS R, 1995, BIOCHEMISTRY-US, V34, P15638, DOI 10.1021/bi00048a006; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Tiso M, 2007, BIOCHEMISTRY-US, V46, P14418, DOI 10.1021/bi701646k; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Venema RC, 1996, J BIOL CHEM, V271, P6435, DOI 10.1074/jbc.271.11.6435; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Welland A, 2008, BIOCHEMISTRY-US, V47, P9771, DOI 10.1021/bi800787m; Wolthers KR, 2007, BIOCHEMISTRY-US, V46, P11833, DOI 10.1021/bi701209p; Yamamoto K, 2005, ARCH BIOCHEM BIOPHYS, V440, P65, DOI 10.1016/j.abb.2005.05.027; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zhang J, 2001, J BIOL CHEM, V276, P37506, DOI 10.1074/jbc.M105503200	62	76	77	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30708	30717		10.1074/jbc.M109.031682	http://dx.doi.org/10.1074/jbc.M109.031682			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19737939	Green Published, hybrid			2022-12-25	WOS:000271090000072
J	Arumugam, SR; Lee, TH; Benkovic, SJ				Arumugam, Sri Ranjini; Lee, Tae-Hee; Benkovic, Stephen J.			Investigation of Stoichiometry of T4 Bacteriophage Helicase Loader Protein (gp59)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE GP43; LOADING PROTEIN; T4 HELICASE; BACTERIOPHAGE-T4 PRIMOSOME; DEPENDENT REPLICATION; SINGLE-MOLECULE; COMPLEX; ARCHITECTURE; RECOMBINATION; REPLISOME	The T4 bacteriophage helicase loader (gp59) is one of the main eight proteins that play an active role in the replisome. gp59 is a small protein (26 kDa) that exists as a monomer in solution and in the crystal. It binds preferentially to forked DNA and interacts directly with the T4 helicase (gp41), single-stranded DNA-binding protein (gp32), and polymerase (gp43). However, the stoichiometry and structure of the functional form are not very well understood. There is experimental evidence for a hexameric structure for the helicase (gp41) and the primase (gp61), inferring that the gp59 structure might also be hexameric. Various experimental approaches, including gel shift, fluorescence anisotropy, light scattering, and fluorescence correlation spectroscopy, have not provided a clearer understanding of the stoichiometry. In this study, we employed single-molecule photobleaching (smPB) experiments to elucidate the stoichiometry of gp59 on a forked DNA and to investigate its interaction with other proteins forming the primosome complex. smPB studies were performed with Alexa 555-labeled gp59 proteins and a forked DNA substrate. Co-localization experiments were performed using Cy5-labeled forked DNA and Alexa 555-labeled gp59 in the presence and absence of gp32 and gp41 proteins. A systematic study of smPB experiments and subsequent data analysis using a simple model indicated that gp59 on the forked DNA forms a hexamer. In addition, the presence of gp32 and gp41 proteins increases the stability of the gp59 complex, emphasizing their functional role in T4 DNA replication machinery.	[Arumugam, Sri Ranjini; Lee, Tae-Hee; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lee, TH (corresponding author), Penn State Univ, Dept Chem, 414 Wartik Lab, University Pk, PA 16802 USA.	txl18@psu.edu; sjb1@psu.edu	Lee, Tae-Hee/A-1266-2010		National Institutes of Health [GM13306]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM013306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM13306 (to S. J. B.).	Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; BIOCHEXU H, 2001, BIOCHEMISTRY-US, V40, P7651; Chastain PD, 2003, J BIOL CHEM, V278, P21276, DOI 10.1074/jbc.M301573200; Das SK, 2007, CHEMBIOCHEM, V8, P994, DOI 10.1002/cbic.200600474; Delagoutte E, 2005, J MOL BIOL, V347, P257, DOI 10.1016/j.jmb.2005.01.036; Dudas KC, 2005, J BIOL CHEM, V280, P21561, DOI 10.1074/jbc.m502351200; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Ishmael FT, 2002, J BIOL CHEM, V277, P20555, DOI 10.1074/jbc.M111951200; Ishmael FT, 2001, J BIOL CHEM, V276, P25236, DOI 10.1074/jbc.M100783200; Jones CE, 2001, P NATL ACAD SCI USA, V98, P8312, DOI 10.1073/pnas.121009398; Jones CE, 2000, J BIOL CHEM, V275, P27145; Kreuzer KN, 2000, TRENDS BIOCHEM SCI, V25, P165, DOI 10.1016/S0968-0004(00)01559-0; KREUZER KN, 1988, J BIOL CHEM, V263, P11366; Lefebvre SD, 1999, J BIOL CHEM, V274, P22830, DOI 10.1074/jbc.274.32.22830; Mueser TC, 2000, J MOL BIOL, V296, P597, DOI 10.1006/jmbi.1999.3438; Nelson SW, 2006, J BIOL CHEM, V281, P8697, DOI 10.1074/jbc.M512185200; Norcum MT, 2005, P NATL ACAD SCI USA, V102, P3623, DOI 10.1073/pnas.0500713102; Nossal NG, 2007, J BIOL CHEM, V282, P1098, DOI 10.1074/jbc.M606772200; Raney KD, 1996, J BIOL CHEM, V271, P14074, DOI 10.1074/jbc.271.24.14074; San Martin C, 1998, STRUCTURE, V6, P501; Shu D, 2007, EMBO J, V26, P527, DOI 10.1038/sj.emboj.7601506; van Oijen AM, 2008, NAT CHEM BIOL, V4, P440, DOI 10.1038/nchembio0808-440; Xi J, 2005, BIOCHEMISTRY-US, V44, P7747, DOI 10.1021/bi047296w; Xi J, 2005, BIOCHEMISTRY-US, V44, P2305, DOI 10.1021/bi0479508; Yang JS, 2003, J BIOL CHEM, V278, P49828, DOI 10.1074/jbc.M307406200; YONESAKI T, 1994, J BIOL CHEM, V269, P1284; Zhang ZQ, 2005, P NATL ACAD SCI USA, V102, P3254, DOI 10.1073/pnas.0500327102	27	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29283	29289		10.1074/jbc.M109.029926	http://dx.doi.org/10.1074/jbc.M109.029926			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19700405	hybrid, Green Published			2022-12-25	WOS:000270896800007
J	Gell, DA; Feng, L; Zhou, SP; Jeffrey, PD; Bendak, K; Gow, A; Weiss, MJ; Shi, YG; Mackay, JP				Gell, David A.; Feng, Liang; Zhou, Suiping; Jeffrey, Philip D.; Bendak, Katerina; Gow, Andrew; Weiss, Mitchell J.; Shi, Yigong; Mackay, Joel P.			A cis-Proline in alpha-Hemoglobin Stabilizing Protein Directs the Structural Reorganization of alpha-Hemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATE PROLYL ISOMERIZATION; LIGAND-BINDING PROPERTIES; TRANS ISOMERIZATION; CRYSTAL-STRUCTURE; BETA-THALASSEMIA; REVERSIBLE HEXACOORDINATION; SECONDARY STRUCTURE; ESCHERICHIA-COLI; RIBONUCLEASE-A; GLOBIN	alpha-Hemoglobin (alpha Hb) stabilizing protein (AHSP) is expressed in erythropoietic tissues as an accessory factor in hemoglobin synthesis. AHSP forms a specific complex with alpha Hb and suppresses the heme-catalyzed evolution of reactive oxygen species by converting alpha Hb to a conformation in which the heme is coordinated at both axial positions by histidine side chains (bis-histidyl coordination). Currently, the detailed mechanism by which AHSP induces structural changes in alpha Hb has not been determined. Here, we present x-ray crystallography, NMR spectroscopy, and mutagenesis data that identify, for the first time, the importance of an evolutionarily conserved proline, Pro(30), in loop 1 of AHSP. Mutation of Pro(30) to a variety of residue types results in reduced ability to convert alpha Hb. In complex with alpha Hb, AHSP Pro(30) adopts a cis-peptidyl conformation and makes contact with the N terminus of helix G in alpha Hb. Mutations that stabilize the cis-peptidyl conformation of free AHSP, also enhance the alpha Hb conversion activity. These findings suggest that AHSP loop 1 can transmit structural changes to the heme pocket of alpha Hb, and, more generally, highlight the importance of cis-peptidyl prolyl residues in defining the conformation of regulatory protein loops.	[Gell, David A.; Mackay, Joel P.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Gow, Andrew] Rutgers State Univ, Dept Pharmacol & Toxicol, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA; [Zhou, Suiping; Weiss, Mitchell J.] Univ Penn, Philadelphia, PA 19104 USA; [Zhou, Suiping; Weiss, Mitchell J.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Feng, Liang; Jeffrey, Philip D.; Shi, Yigong] Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA	University of Sydney; Rutgers State University New Brunswick; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Princeton University	Gell, DA (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia.	dagell@mail.usyd.edu.au	Gow, Andrew/N-8566-2013; Weiss, Mitchell J/W-9814-2018; Weiss, Mitchell J/A-1245-2013; Mackay, Joel P/D-6834-2011; Gow, Andrew/AAR-2309-2020	Gow, Andrew/0000-0003-0876-5158; Weiss, Mitchell J/0000-0003-2460-3036; Mackay, Joel P/0000-0001-7508-8033; Gow, Andrew/0000-0003-0876-5158; Gell, David/0000-0003-0382-1181; Shi, Yigong/0000-0003-2030-168X; Jeffrey, Philip/0000-0002-4351-5341	National Institutes of Health [R01 DK61692, R01 HL087427]; Australian Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK61692 and R01 HL087427 (to M. J. W.). This work was also supported by grants from the Australian Research Council (to D. A. G. and J. P. M.).	Alayash AI, 2004, NAT REV DRUG DISCOV, V3, P152, DOI 10.1038/nrd1307; Bacik JP, 2007, J MOL BIOL, V365, P1545, DOI 10.1016/j.jmb.2006.11.002; Balagopalakrishna C, 1996, BIOCHEMISTRY-US, V35, P6393, DOI 10.1021/bi952875+; Bauer F, 2007, FEBS LETT, V581, P1555, DOI 10.1016/j.febslet.2007.03.012; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrell RW, 1999, SCIENCE, V285, P1861, DOI 10.1126/science.285.5435.1861; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; de Sanctis D, 2004, IUBMB LIFE, V56, P643, DOI 10.1080/15216540500059640; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; DOU Y, 1995, J BIOL CHEM, V270, P15993, DOI 10.1074/jbc.270.27.15993; Feng L, 2005, NATURE, V435, P697, DOI 10.1038/nature03609; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; FESSAS P, 1963, BLOOD, V21, P21, DOI 10.1182/blood.V21.1.21.21; Fischer G, 2000, CHEM SOC REV, V29, P119, DOI 10.1039/a803742f; FOTHERGILL J, 1982, NATURE, V298, P705, DOI 10.1038/298705a0; GABUZDA TG, 1963, J CLIN INVEST, V42, P1678, DOI 10.1172/JCI104854; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; GRATHWOHL C, 1981, BIOPOLYMERS, V20, P2623, DOI 10.1002/bip.1981.360201209; Halder P, 2007, PROTEINS, V66, P172, DOI 10.1002/prot.21210; Hamdane D, 2007, J BIOL CHEM, V282, P6398, DOI 10.1074/jbc.M610543200; Jakob RP, 2008, J MOL BIOL, V377, P1560, DOI 10.1016/j.jmb.2008.02.010; Jakob RP, 2009, J MOL BIOL, V387, P1017, DOI 10.1016/j.jmb.2009.02.021; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kadokura H, 2005, J BACTERIOL, V187, P1519, DOI 10.1128/JB.187.4.1519-1522.2005; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; Krieger F, 2005, J AM CHEM SOC, V127, P3346, DOI 10.1021/ja042798i; Lecomte JTJ, 2001, BIOCHEMISTRY-US, V40, P6541, DOI 10.1021/bi010226u; LEVY A, 1985, BIOCHEMISTRY-US, V24, P6050, DOI 10.1021/bi00343a005; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Luzzatto L, 2002, NATURE, V417, P703, DOI 10.1038/417703a; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; McHarg J, 1999, EUR J BIOCHEM, V259, P939, DOI 10.1046/j.1432-1327.1999.00133.x; MONTELIONE GT, 1992, J AM CHEM SOC, V114, P10974, DOI 10.1021/ja00053a051; Mulcair MD, 2006, CELL, V125, P1309, DOI 10.1016/j.cell.2006.04.040; Nam GH, 2003, BIOCHEM J, V375, P297, DOI 10.1042/BJ20030263; NATHAN DG, 1969, J CLIN INVEST, V48, P33, DOI 10.1172/JCI106156; Nathaniel C, 2003, BIOCHEM J, V372, P241, DOI 10.1042/BJ20021765; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Noble CG, 2005, NAT STRUCT MOL BIOL, V12, P144, DOI 10.1038/nsmb887; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouyang N, 2006, PROTEINS, V65, P1021, DOI 10.1002/prot.21184; Pahlke D, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-8; Paoli M, 1996, J MOL BIOL, V256, P775, DOI 10.1006/jmbi.1996.0124; Pesce A, 2004, IUBMB LIFE, V56, P657, DOI 10.1080/15216540500078830; PETERSONKENNEDY SE, 1986, J AM CHEM SOC, V108, P1739, DOI 10.1021/ja00268a004; RACHMILEWITZ EA, 1971, J BIOL CHEM, V246, P3356; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Riccio A, 2002, P NATL ACAD SCI USA, V99, P9801, DOI 10.1073/pnas.132182099; Rifkind JM, 2003, REDOX REP, V8, P234, DOI 10.1179/135100003225002817; Robinson VL, 2003, BIOCHEMISTRY-US, V42, P10113, DOI 10.1021/bi030059t; Russell BS, 2003, J BIOL INORG CHEM, V8, P156, DOI 10.1007/s00775-002-0401-z; Sadelain M, 2007, HUM GENE THER, V18, P1, DOI 10.1089/hum.2006.151; Santiveri CM, 2004, J BIOL CHEM, V279, P34963, DOI 10.1074/jbc.M405016200; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Schultz DA, 2005, PROTEIN SCI, V14, P2862, DOI 10.1110/ps.051610505; SCHULTZ DA, 1992, PROTEIN SCI, V1, P910, DOI 10.1002/pro.5560010709; Seidman JG, 2002, J CLIN INVEST, V109, P451, DOI 10.1172/JC1200215043; Shan L, 2007, BIOCHEMISTRY-US, V46, P11504, DOI 10.1021/bi7009794; Shaw PE, 2007, EMBO REP, V8, P40, DOI 10.1038/sj.embor.7400873; Smith CA, 2006, ACTA CRYSTALLOGR D, V62, P548, DOI 10.1107/S0907444906009796; STURGEON P, 1957, BLOOD, V12, P64, DOI 10.1182/blood.V12.1.64.64; Su D, 2007, BIOCHEMISTRY-US, V46, P6903, DOI 10.1021/bi700152b; Wedemeyer WJ, 2002, BIOCHEMISTRY-US, V41, P14637, DOI 10.1021/bi020574b; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664; Zhou SP, 2006, J BIOL CHEM, V281, P32611, DOI 10.1074/jbc.M607311200	69	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29462	29469		10.1074/jbc.M109.027045	http://dx.doi.org/10.1074/jbc.M109.027045			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19706593	Green Published, hybrid			2022-12-25	WOS:000270896800028
J	Jeong, KW; Lee, YH; Stallcup, MR				Jeong, Kwang Won; Lee, Young-Ho; Stallcup, Michael R.			Recruitment of the SWI/SNF Chromatin Remodeling Complex to Steroid Hormone-regulated Promoters by Nuclear Receptor Coactivator Flightless-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-RELATED PROTEINS; BREAST-CANCER CELLS; ESTROGEN-RECEPTOR; TRANSCRIPTIONAL ACTIVATION; GLUCOCORTICOID-RECEPTOR; MEDIATOR REQUIREMENT; BINDING; GENES; ATP; TRANSACTIVATION	ATP-dependent chromatin remodeling complexes, such as SWI/SNF, are required for transcriptional activation of specific genes and are believed to be recruited to gene promoters by direct interaction with DNA binding transcription factors. However, we report here that recruitment of SWI/SNF to target genes of estrogen receptor alpha (ER alpha) requires the previously described nuclear receptor coactivator protein Flightless-I (Fli-I). Fli-I can bind directly to both ER and BAF53, an actin-related component of the SWI/SNF complex, suggesting that Fli-I may recruit SWI/SNF to ER target genes via interaction with BAF53. Point mutations in Fli-I that disrupt binding to ER or BAF53 compromised the ability of Fli-I to enhance ER-mediated activation of a transiently transfected reporter gene. Depletion of endogenous Fli-I or BAF53 inhibited estrogen-responsive expression of endogenous target genes of ER, indicating a critical role for Fli-I and BAF53. Moreover, depletion of endogenous Fli-I or BAF53 specifically eliminated part of the complex cyclical pattern of recruitment of SWI/SNF to estrogen-responsive promoters in a way that indicates multiple roles and multiple mechanisms of recruitment for SWI/SNF in estrogen-dependent target gene expression. These results begin to establish the functional relationships and interdependencies that coordinate the actions of the many coactivators participating in the transcriptional activation process.	[Stallcup, Michael R.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA	University of Southern California	Stallcup, MR (corresponding author), Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Keck Sch Med, Dept Biochem & Mol Biol, 1441 Eastlake Ave,NOR 6316, Los Angeles, CA 90089 USA.	stallcup@usc.edu	Lee, Young-Ho/G-2361-2014	Lee, Young-Ho/0000-0001-6415-4912	National Institutes of Health [DK43093]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK43093 (to M. R. S.).	Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Burakov D, 2002, J BIOL CHEM, V277, P14359, DOI 10.1074/jbc.C200099200; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen YH, 2005, MOL CELL BIOL, V25, P5965, DOI 10.1128/MCB.25.14.5965-5972.2005; CHIBA H, 1994, NUCLEIC ACIDS RES, V22, P1815, DOI 10.1093/nar/22.10.1815; Davy DA, 2001, J CELL SCI, V114, P549; Davy DA, 2000, IMMUNOL CELL BIOL, V78, P423, DOI 10.1046/j.1440-1711.2000.00926.x; DiRenzo J, 2000, MOL CELL BIOL, V20, P7541, DOI 10.1128/MCB.20.20.7541-7549.2000; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Eberharter A, 2004, J CELL SCI, V117, P3707, DOI 10.1242/jcs.01175; Fan HY, 2003, MOL CELL, V11, P1311, DOI 10.1016/S1097-2765(03)00192-8; Garcia-Pedrero JM, 2006, J BIOL CHEM, V281, P22656, DOI 10.1074/jbc.M602561200; Goodson HV, 2002, J CELL SCI, V115, P2619; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; He QY, 2008, J BIOL CHEM, V283, P5276, DOI 10.1074/jbc.M708266200; Hong CY, 2005, MOL CELL BIOL, V25, P4841, DOI 10.1128/MCB.25.12.4841-4852.2005; Hsiao PW, 2003, MOL CELL BIOL, V23, P6210, DOI 10.1128/MCB.23.17.6210-6220.2003; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Ito M, 2001, TRENDS ENDOCRIN MET, V12, P127, DOI 10.1016/S1043-2760(00)00355-6; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; Johnson TA, 2008, MOL BIOL CELL, V19, P3308, DOI 10.1091/mbc.E08-02-0123; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Lee YH, 2004, MOL CELL BIOL, V24, P2103, DOI 10.1128/MCB.24.5.2103-2117.2004; Lemieux K, 2004, EMBO J, V23, P4040, DOI 10.1038/sj.emboj.7600416; Link KA, 2005, MOL CELL BIOL, V25, P2200, DOI 10.1128/MCB.25.6.2200-2215.2005; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Nie ZQ, 2000, MOL CELL BIOL, V20, P8879, DOI 10.1128/MCB.20.23.8879-8888.2000; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Oxelmark E, 2006, MOL CELL BIOL, V26, P5205, DOI 10.1128/MCB.00009-06; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Rae JM, 2005, BREAST CANCER RES TR, V92, P141, DOI 10.1007/s10549-005-1483-4; Rando OJ, 2002, P NATL ACAD SCI USA, V99, P2824, DOI 10.1073/pnas.032662899; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Stallcup MR, 2003, J STEROID BIOCHEM, V85, P139, DOI 10.1016/S0960-0760(03)00222-X; Sun J, 2007, MOL ENDOCRINOL, V21, P2651, DOI 10.1210/me.2007-0082; Takata H, 2007, FEBS LETT, V581, P3783, DOI 10.1016/j.febslet.2007.06.076; Trotter KW, 2007, MOL CELL ENDOCRINOL, V265, P162, DOI 10.1016/j.mce.2006.12.015; Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004; Urosev D, 2006, J MOL BIOL, V357, P765, DOI 10.1016/j.jmb.2006.01.027; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; WAY M, 1992, J CELL BIOL, V116, P1135, DOI 10.1083/jcb.116.5.1135; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; Yoon S, 2003, MOL CELL BIOL, V23, P8829, DOI 10.1128/MCB.23.23.8829-9945.2003; YOSHINAGA SK, 1992, SCIENCE, V258, P1598, DOI 10.1126/science.1360703; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	50	42	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29298	29309		10.1074/jbc.M109.037010	http://dx.doi.org/10.1074/jbc.M109.037010			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19720835	Green Published, hybrid			2022-12-25	WOS:000270896800009
J	Kinne, M; Poraj-Kobielska, M; Ralph, SA; Ullrich, R; Hofrichter, M; Hammel, KE				Kinne, Matthias; Poraj-Kobielska, Marzena; Ralph, Sally A.; Ullrich, Rene; Hofrichter, Martin; Hammel, Kenneth E.			Oxidative Cleavage of Diverse Ethers by an Extracellular Fungal Peroxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3,4-DIMETHOXYBENZYL ALCOHOL; PHANEROCHAETE-CHRYSOSPORIUM; LIGNIN; BIODEGRADATION; HALOPEROXIDASE; CHROMATOGRAPHY; DEMETHYLATION; 1,4-DIOXANE; GROUNDWATER; MECHANISMS	Many litter-decay fungi secrete heme-thiolate peroxygenases that oxidize various organic chemicals, but little is known about the role or mechanism of these enzymes. We found that the extracellular peroxygenase of Agrocybe aegerita catalyzed the H2O2-dependent cleavage of environmentally significant ethers, including methyl t-butyl ether, tetrahydrofuran, and 1,4-dioxane. Experiments with tetrahydrofuran showed the reaction was a two-electron oxidation that generated one aldehyde group and one alcohol group, yielding the ring-opened product 4-hydroxybutanal. Investigations with several model substrates provided information about the route for ether cleavage: (a) steady-state kinetics results with methyl 3,4-dimethoxybenzyl ether, which was oxidized to 3,4-dimethoxybenzaldehyde, gave parallel double reciprocal plots suggestive of a ping-pong mechanism (K-m(peroxide), 1.99 +/- 0.25 mM; K-m(ether), 1.43 +/- 0.23 mM; kcat, 720 +/- 87 s(-1)), (b) the cleavage of methyl 4-nitrobenzyl ether in the presence of H-2 O-18(2) resulted in incorporation of O-18 into the carbonyl group of the resulting 4-nitrobenzaldehyde, and (c) the demethylation of 1-methoxy-4-trideuteromethoxybenzene showed an observed intramolecular deuterium isotope effect [(k(H)/k(D))(obs)] of 11.9 +/- 0.4. These results suggest a hydrogen abstraction and oxygen rebound mechanism that oxidizes ethers to hemiacetals, which subsequently hydrolyze. The peroxygenase appeared to lack activity on macromolecular ethers, but otherwise exhibited a broad substrate range. It may accordingly have a role in the biodegradation of natural and anthropogenic low molecular weight ethers in soils and plant litter.	[Ralph, Sally A.; Hammel, Kenneth E.] USDA, Forest Prod Lab, Madison, WI 53726 USA; [Kinne, Matthias; Poraj-Kobielska, Marzena; Ullrich, Rene; Hofrichter, Martin] Int Grad Sch Zittau, Unit Environm Biotechnol, D-02763 Zittau, Germany; [Hammel, Kenneth E.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	United States Department of Agriculture (USDA); United States Forest Service; Technische Universitat Dresden; University of Wisconsin System; University of Wisconsin Madison	Hammel, KE (corresponding author), USDA, Forest Prod Lab, 1 Gifford Pinchot Dr, Madison, WI 53726 USA.	kehammel@wisc.edu	Hammel, Kenneth E/G-1890-2011	Hammel, Kenneth E/0000-0002-2935-5847; Hofrichter, Martin/0000-0001-5174-7604	Deutsche Bundesstiftung Umwelt Project [13225-32]; European Union; Office of Biological and Environmental Research, United States Dept. of Energy [DE-AI02-07ER64480]; Konrad Adenauer Foundation; German-American Fulbright Commission	Deutsche Bundesstiftung Umwelt Project; European Union(European Commission); Office of Biological and Environmental Research, United States Dept. of Energy; Konrad Adenauer Foundation; German-American Fulbright Commission	This work was supported in part by Deutsche Bundesstiftung Umwelt Project Number 13225-32 (to M. H.), European Union Integrated Project Biorenew (to M. H.), and Grant DE-AI02-07ER64480 from the Office of Biological and Environmental Research, United States Dept. of Energy (to K. E. H.).; Supported by the Konrad Adenauer Foundation.; Supported by the German-American Fulbright Commission.	Anh DH, 2007, APPL ENVIRON MICROB, V73, P5477, DOI 10.1128/AEM.00026-07; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; COOKE MP, 1974, BIOCHEM BIOPH RES CO, V57, P1032, DOI 10.1016/0006-291X(74)90800-6; Delserone LM, 1999, PHYSIOL MOL PLANT P, V55, P317, DOI 10.1006/pmpp.1999.0237; Ferreira NL, 2006, APPL MICROBIOL BIOT, V72, P252, DOI 10.1007/s00253-006-0494-3; FOSTER AB, 1974, CHEM-BIOL INTERACT, V9, P327, DOI 10.1016/0009-2797(74)90128-8; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Hernandez A, 1998, BIOINFORMATICS, V14, P227, DOI 10.1093/bioinformatics/14.2.227; Hofrichter M, 2006, APPL MICROBIOL BIOT, V71, P276, DOI 10.1007/s00253-006-0417-3; Isaacson C, 2006, ENVIRON SCI TECHNOL, V40, P7305, DOI 10.1021/es0615270; Kerem Z, 1999, FEBS LETT, V446, P49, DOI 10.1016/S0014-5793(99)00180-5; Kim D, 2004, ARCH BIOCHEM BIOPHYS, V432, P102, DOI 10.1016/j.abb.2004.09.001; Kinne M, 2008, TETRAHEDRON LETT, V49, P5950, DOI 10.1016/j.tetlet.2008.07.152; Kinne M, 2009, BIOORG MED CHEM LETT, V19, P3085, DOI 10.1016/j.bmcl.2009.04.015; Kluge M, 2009, APPL MICROBIOL BIOT, V81, P1071, DOI 10.1007/s00253-008-1704-y; KOK GL, 1980, ATMOS ENVIRON, V14, P653, DOI 10.1016/0004-6981(80)90048-7; LAWSON T, 1995, J AGR FOOD CHEM, V43, P2627, DOI 10.1021/jf00058a014; Leonowicz A, 1999, FUNGAL GENET BIOL, V27, P175, DOI 10.1006/fgbi.1999.1150; Li H, 2007, J CHROMATOGR A, V1175, P133, DOI 10.1016/j.chroma.2007.10.040; Mahendra S, 2007, ENVIRON SCI TECHNOL, V41, P7330, DOI 10.1021/es0705745; McLafferty F. W., 1993, INTERPRETATION MASS; Nelson SD, 2003, DRUG METAB DISPOS, V31, P1481, DOI 10.1124/dmd.31.12.1481; Ortiz de Montellano P.R., 2005, CYTOCHROME P450 STRU, P183, DOI [10.1007/b139087, DOI 10.1007/B139087]; PECYNA MJ, 2009, APPL MICROB IN PRESS; Pedersen DS, 2001, SYNTHESIS-STUTTGART, P2431, DOI 10.1055/s-2001-18722; SAMUEL D, 1965, ADV PHYS ORG CHEM, V3, P121; SCHMIDT HWH, 1989, BIOCHEMISTRY-US, V28, P1776, DOI 10.1021/bi00430a053; Scow KM, 2005, CURR OPIN BIOTECH, V16, P246, DOI 10.1016/j.copbio.2005.03.009; TIEN M, 1986, J BIOL CHEM, V261, P1687; TIEN M, 1984, P NATL ACAD SCI-BIOL, V81, P2280, DOI 10.1073/pnas.81.8.2280; Tortella GR, 2005, CRIT REV MICROBIOL, V31, P197, DOI 10.1080/10408410500304066; Ullrich R, 2005, FEBS LETT, V579, P6247, DOI 10.1016/j.febslet.2005.10.014; Ullrich R, 2007, CELL MOL LIFE SCI, V64, P271, DOI 10.1007/s00018-007-6362-1; Ulrich R, 2004, APPL ENVIRON MICROB, V70, P4575, DOI 10.1128/AEM.70.8.4575-4581.2004; White GF, 1996, MICROBIOL REV, V60, P216, DOI 10.1128/MMBR.60.1.216-232.1996; Whiting DA, 2001, NAT PROD REP, V18, P583, DOI 10.1039/b003686m; Yun CH, 2005, J BIOL CHEM, V280, P12279, DOI 10.1074/jbc.M411019200	37	70	70	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29343	29349		10.1074/jbc.M109.040857	http://dx.doi.org/10.1074/jbc.M109.040857			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19713216	hybrid, Green Published			2022-12-25	WOS:000270896800014
J	Farzan, SF; Stegman, MA; Ogden, SK; Ascano, M; Black, KE; Tacchelly, O; Robbins, DJ				Farzan, Shohreh F.; Stegman, Melanie A.; Ogden, Stacey K.; Ascano, Manuel, Jr.; Black, Kendall E.; Tacchelly, Ofelia; Robbins, David J.			A Quantification of Pathway Components Supports a Novel Model of Hedgehog Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINESIN-RELATED PROTEIN; DROSOPHILA CUBITUS INTERRUPTUS; GLYCOGEN-SYNTHASE KINASE-3; SEGMENT POLARITY GENE; STEROL-SENSING DOMAIN; SUBCELLULAR-LOCALIZATION; REQUIRES PHOSPHORYLATION; VESICULAR TRAFFICKING; SMOOTHENED ACTIVITY; MEMBRANE-PROTEIN	The secreted protein Hedgehog (Hh) plays a critical instructional role during metazoan development. In Drosophila, Hh signaling is interpreted by a set of conserved, downstream effectors that differentially localize and interact to regulate the stability and activity of the transcription factor Cubitus interruptus. Two-essential models that integrate genetic, cell biological, and biochemical information have been proposed to explain how these signaling components relate to one another within the cellular context. As the molar ratios of the signaling effectors required in each of these models are quite different, quantitating the cellular ratio of pathway components could distinguish these two models. Here, we address this important question using a set of purified protein standards to perform a quantitative analysis of Drosophila cell lysates for each downstream pathway component. We determine each component's steady-state concentration within a given cell, demonstrate the molar ratio of Hh signaling effectors differs more than two orders of magnitude and that this ratio is conserved in vivo. We find that the G-protein-coupled transmembrane protein Smoothened, an activating component, is present in limiting amounts, while a negative pathway regulator, Suppressor of Fused, is present in vast molar excess. Interestingly, despite large differences in the steady-state ratio, all downstream signaling components exist in an equimolar membrane-associated complex. We use these quantitative results to re-evaluate the current models of Hh signaling and now propose a novel model of signaling that accounts for the stoichiometric differences observed between various Hh pathway components.	[Tacchelly, Ofelia; Robbins, David J.] Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA; [Robbins, David J.] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Robbins, DJ (corresponding author), Dartmouth Med Sch, Dept Pharmacol & Toxicol, HB 7650, Hanover, NH 03755 USA.	David.J.Robbins@Dartmouth.edu	Ascano, Manuel/ABA-3586-2020; Ogden, Stacey K/P-9585-2019; Ogden, Stacey K/N-2528-2018	Ascano, Manuel/0000-0002-9370-5493; Ogden, Stacey K/0000-0001-8991-3065; 	National Institutes of Health [CA8628]; Ryan Fellowship; Rosaline Borison Predoctoral Fellowship; NATIONAL CANCER INSTITUTE [R01CA082628] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ryan Fellowship; Rosaline Borison Predoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA8628 (to D. J. R.). This work was also supported by a Ryan Fellowship (to S. F. F.) and a Rosaline Borison Predoctoral Fellowship (to S. F. F.).	Aikin RA, 2008, EMBO REP, V9, P330, DOI 10.1038/embor.2008.38; Alberts B., 2010, MOL BIOL CELL; Alcedo J, 2000, MOL CELL, V6, P457, DOI 10.1016/S1097-2765(00)00044-7; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; Alves G, 1998, MECH DEVELOP, V78, P17, DOI 10.1016/S0925-4773(98)00130-0; Ascano M, 2004, MOL CELL BIOL, V24, P10397, DOI 10.1128/MCB.24.23.10397-10405.2004; Ascano M, 2002, MOL CELL BIOL, V22, P1555, DOI 10.1128/MCB.22.5.1555-1566.2002; AZA BP, 1997, CELL, V89, P1043; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chen Y, 1998, DEVELOPMENT, V125, P4943; CURRIE DA, 1988, DEVELOPMENT, V102, P805; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dussillol-Godar F, 2006, DEV BIOL, V291, P53, DOI 10.1016/j.ydbio.2005.12.004; Farzan SF, 2008, CURR BIOL, V18, P1215, DOI 10.1016/j.cub.2008.07.026; FORBES AJ, 1993, DEVELOPMENT, P115; Fouix S, 2003, GENES CELLS, V8, P897, DOI 10.1046/j.1365-2443.2003.00685.x; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; HEEMSKERK J, 1994, CELL, V76, P449, DOI 10.1016/0092-8674(94)90110-4; Ho KS, 2005, DEVELOPMENT, V132, P1401, DOI 10.1242/dev.01689; Hooper JE, 2003, DEVELOPMENT, V130, P3951, DOI 10.1242/dev.00594; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; HORTSCH M, 1990, J BIOL CHEM, V265, P15104; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; INGHAM PW, 1993, NATURE, V366, P560, DOI 10.1038/366560a0; Jia JH, 2003, GENE DEV, V17, P2709, DOI 10.1101/gad.1136603; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Kalderon D, 2004, CURR BIOL, V14, pR67, DOI 10.1016/j.cub.2003.12.047; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Martin V, 2001, CURR BIOL, V11, P601, DOI 10.1016/S0960-9822(01)00178-6; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Meng XW, 2001, J BIOL CHEM, V276, P40113, DOI 10.1074/jbc.M105317200; Methot N, 2000, DEVELOPMENT, V127, P4001; Monnier V, 1998, CURR BIOL, V8, P583, DOI 10.1016/S0960-9822(98)70227-1; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; Nakano Y, 2004, MECH DEVELOP, V121, P507, DOI 10.1016/j.mod.2004.04.015; Norton AW, 2005, J BIOL CHEM, V280, P1248, DOI 10.1074/jbc.M410475200; Ogden SK, 2006, J BIOL CHEM, V281, P7237, DOI 10.1074/jbc.M510169200; Ogden SK, 2004, BIOCHEM PHARMACOL, V67, P805, DOI 10.1016/j.bcp.2004.01.002; Ogden SK, 2003, CURR BIOL, V13, P1998, DOI 10.1016/j.cub.2003.10.004; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; ORENIC TV, 1990, GENE DEV, V4, P1053, DOI 10.1101/gad.4.6.1053; PHAM A, 1995, GENETICS, V140, P587; PREAT T, 1992, GENETICS, V132, P725; PREAT T, 1993, GENETICS, V135, P1047; Price MA, 1999, DEVELOPMENT, V126, P4331; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Riches Z, 2009, DRUG METAB DISPOS, V37, P2255, DOI 10.1124/dmd.109.028399; Robbins DJ, 2007, EMBO REP, V8, P451, DOI 10.1038/sj.embor.7400959; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Ruel L, 2003, NAT CELL BIOL, V5, P907, DOI 10.1038/ncb1052; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sasse J., 2009, CURR PROT MOL BIOL, V85, P1; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; SHAFFER CD, 1994, METHOD CELL BIOL, V44, P99, DOI 10.1016/S0091-679X(08)60908-5; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; Sisson JC, 1997, CELL, V90, P235, DOI 10.1016/S0092-8674(00)80332-3; Smelkinson MG, 2007, DEV CELL, V13, P481, DOI 10.1016/j.devcel.2007.09.006; Stegman MA, 2000, J BIOL CHEM, V275, P21809, DOI 10.1074/jbc.C000043200; Stegman MA, 2004, J BIOL CHEM, V279, P7064, DOI 10.1074/jbc.M311794200; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Therond PP, 1996, P NATL ACAD SCI USA, V93, P4224, DOI 10.1073/pnas.93.9.4224; Torroja C, 2005, J NEUROBIOL, V64, P334, DOI 10.1002/neu.20168; Umenishi F, 2002, KIDNEY INT, V62, P2288, DOI 10.1046/j.1523-1755.2002.00686.x; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; VonOhlen T, 1997, P NATL ACAD SCI USA, V94, P2404, DOI 10.1073/pnas.94.6.2404; Wang GL, 2000, GENE DEV, V14, P2893, DOI 10.1101/gad.843900; Wang QT, 1999, DEVELOPMENT, V126, P5097; Yao WD, 2001, J NEUROPHYSIOL, V85, P1384, DOI 10.1152/jn.2001.85.4.1384; Zhang WS, 2005, DEV CELL, V8, P267, DOI 10.1016/j.devcel.2005.01.001; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225	81	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28874	28884		10.1074/jbc.M109.041608	http://dx.doi.org/10.1074/jbc.M109.041608			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19717563	Green Published, hybrid			2022-12-25	WOS:000270678900044
J	Howlett, NG; Harney, JA; Rego, MA; Kolling, FW; Glover, TW				Howlett, Niall G.; Harney, Julie A.; Rego, Meghan A.; Kolling, Frederick W.; Glover, Thomas W.			Functional Interaction between the Fanconi Anemia D2 Protein and Proliferating Cell Nuclear Antigen (PCNA) via a Conserved Putative PCNA Interaction Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; CORE COMPLEX; POLYMERASE-ETA; S-PHASE; FANCD2 MONOUBIQUITINATION; CROSS-LINKS; REPAIR; REPLICATION; PATHWAY; BRCA2	Fanconi Anemia (FA) is a rare recessive disease characterized by congenital abnormalities, bone marrow failure, and cancer susceptibility. The FA proteins and the familial breast cancer susceptibility gene products, BRCA1 and FANCD1/BRCA2, function cooperatively in the FA-BRCA pathway to repair damaged DNA and to prevent cellular transformation. Activation of this pathway occurs via the mono-ubiquitination of the FANCD2 protein, targeting it to nuclear foci where it co-localizes with FANCD1/BRCA2, RAD51, and PCNA. The regulation of the mono-ubiquitination of FANCD2, as well as its function in DNA repair remain poorly understood. In this study, we have further characterized the interaction between the FANCD2 and PCNA proteins. We have identified a highly conserved, putative FANCD2 PCNA interaction motif (PIP-box), and demonstrate that mutation of this motif disrupts FANCD2-PCNA binding and precludes the mono-ubiquitination of FANCD2. Consequently, the FANCD2 PIP-box mutant protein fails to correct the mitomycin C hypersensitivity of FA-D2 patient cells. Our results suggest that PCNA may function as a molecular platform to facilitate the mono-ubiquitination of FANCD2 and activation of the FA-BRCA pathway.	[Howlett, Niall G.; Harney, Julie A.; Rego, Meghan A.; Kolling, Frederick W.] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA; [Glover, Thomas W.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Glover, Thomas W.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA	University of Rhode Island; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Howlett, NG (corresponding author), 379 CBLS,120 Flagg Rd, Kingston, RI 02881 USA.	nhowlett@mail.uri.edu			National Institutes of Health [R01CA043222-21]; Fanconi Anemia Research Foundation; Leukemia Research Foundation New Investigator; RIINBRE, National Center for Research Resources [P20RR016457-09]; NATIONAL CANCER INSTITUTE [R01CA043222] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fanconi Anemia Research Foundation; Leukemia Research Foundation New Investigator; RIINBRE, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA043222-21 (to T. W. G.). This work was also supported by a Fanconi Anemia Research Foundation grant (to N. G. H. and T. W. G.), a Leukemia Research Foundation New Investigator grant (to N. G. H.), and a RIINBRE Grant P20RR016457-09 from the National Center for Research Resources.	Acharya N, 2008, P NATL ACAD SCI USA, V105, P17724, DOI 10.1073/pnas.0809844105; Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Alpi A, 2007, MOL CELL BIOL, V27, P8421, DOI 10.1128/MCB.00504-07; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; de Oca RM, 2005, BLOOD, V105, P1003, DOI 10.1182/blood-2003-11-3997; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; *FANC AN RES FUND, FANC AN STAND CLIN C; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gary R, 1997, J BIOL CHEM, V272, P24522, DOI 10.1074/jbc.272.39.24522; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Haracska L, 2001, MOL CELL BIOL, V21, P7199, DOI 10.1128/MCB.21.21.7199-7206.2001; Ho GPH, 2006, MOL CELL BIOL, V26, P7005, DOI 10.1128/MCB.02018-05; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Howlett NG, 2005, HUM MOL GENET, V14, P693, DOI 10.1093/hmg/ddi065; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Hussain S, 2004, HUM MOL GENET, V13, P1241, DOI 10.1093/hmg/ddh135; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Mi J, 2005, BLOOD, V105, P759, DOI 10.1182/blood-2004-01-0001; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Mosedale G, 2005, NAT STRUCT MOL BIOL, V12, P763, DOI 10.1038/nsmb981; Naf D, 1998, MOL CELL BIOL, V18, P5952; Nagaraju G, 2007, DNA REPAIR, V6, P1018, DOI 10.1016/j.dnarep.2007.02.020; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Pace P, 2002, EMBO J, V21, P3414, DOI 10.1093/emboj/cdf355; Rego MA, 2009, MUTAT RES-FUND MOL M, V668, P27, DOI 10.1016/j.mrfmmm.2008.11.018; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang XZ, 2007, MOL CELL BIOL, V27, P3098, DOI 10.1128/MCB.02357-06; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	45	47	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28935	28942		10.1074/jbc.M109.016352	http://dx.doi.org/10.1074/jbc.M109.016352			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19704162	hybrid, Green Published			2022-12-25	WOS:000270678900050
J	Pardossi-Piquard, R; Bohm, C; Chen, FS; Kanemoto, S; Checler, F; Schmitt-Ulms, G; George-Hyslop, PS; Fraser, PE				Pardossi-Piquard, Raphaelle; Boehm, Christopher; Chen, Fusheng; Kanemoto, Soshi; Checler, Frederic; Schmitt-Ulms, Gerold; George-Hyslop, Peter St.; Fraser, Paul E.			TMP21 Transmembrane Domain Regulates gamma-Secretase Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; BETA-APP; MISSENSE MUTATIONS; PRESENILIN; NICASTRIN; METABOLISM; COMPLEXES; EPSILON; APH-1	TMP21 has been shown to be associated with the gamma-secretase complex and can specifically regulate gamma-cleavage without affecting epsilon-mediated proteolysis. To explore the basis of this activity, TMP21 modulation of gamma-secretase activity was investigated independent of epsilon-cleavage using an amyloid-beta precursor protein epsilon (APP epsilon) construct which lacks the amyloid intracellular domain domain. The APP epsilon construct behaves similarly to the full-length precursor protein with respect to alpha-and beta-cleavages and is able to undergo normal gamma-processing. Co-expression of APP epsilon and TMP21 resulted in the accumulation of membrane-embedded higher molecular weight A beta-positive fragments, consistent with an inhibition of gamma-secretase cleavage. The APP epsilon system was used to examine the functional domains of TMP21 through the investigation of a series of TMP21-p24a chimera proteins. It was found that chimeras containing the transmembrane domain bound to the gamma-secretase complex and could decrease gamma-secretase proteolytic processing. This was confirmed though investigation of a synthetic peptide corresponding to the TMP21 transmembrane helix. The isolated TMP21 TM peptide but not the homologous p24a domain was able to reduce A beta production in a dose-dependent fashion. These observations suggest that the TMP21 transmembrane domain promotes its association with the presenilin complex that results in decreased gamma-cleavage activity.	[Schmitt-Ulms, Gerold; George-Hyslop, Peter St.; Fraser, Paul E.] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; [Checler, Frederic] Equipe Labellisee Fdn Rech Med, CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [George-Hyslop, Peter St.] Univ Hlth Network, Toronto Western Hosp, Dept Med, Res Inst,Div Neurol, Toronto, ON M5G 2M9, Canada; [Fraser, Paul E.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [George-Hyslop, Peter St.] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 OXY, England	University of Toronto; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Cambridge	Fraser, PE (corresponding author), Univ Toronto, Ctr Res Neurodegenerat Dis, 6 Queens Pk Crescent W, Toronto, ON M5S 3H2, Canada.	paul.fraser@utoronto.ca	Pardossi-Piquard, Raphaëlle/ABA-4472-2021; Pardossi-Piquard, Raphaëlle/D-6263-2012; Checler, Frederic/C-1241-2009	Pardossi-Piquard, Raphaëlle/0000-0001-5292-4414; Checler, Frederic/0000-0003-2098-1750	Canadian Institutes of Health Research; Howard Hughes Medical Institute; Alzheimer Society of Ontario; Ontario Research and Development Challenge Fund; Canada Foundation for Innovation; Fondation pour la Recherche Medicale; Conseil General des Alpes Maritimes	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Alzheimer Society of Ontario; Ontario Research and Development Challenge Fund(General Electric); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur)	This work was supported by grants from the Canadian Institutes of Health Research, Howard Hughes Medical Institute, Alzheimer Society of Ontario, The Ontario Research and Development Challenge Fund and the Canada Foundation for Innovation, the Fondation pour la Recherche Medicale, and the Conseil General des Alpes Maritimes.	Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Blum R, 1996, J BIOL CHEM, V271, P17183, DOI 10.1074/jbc.271.29.17183; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dolcini V, 2008, BIOCHEM BIOPH RES CO, V371, P69, DOI 10.1016/j.bbrc.2008.03.151; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Gorman PM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-17; Grandori R, 1997, PROTEIN ENG, V10, P1099, DOI 10.1093/protein/10.9.1099; Gu YJ, 2004, J BIOL CHEM, V279, P31329, DOI 10.1074/jbc.M401548200; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Lefranc-Jullien S, 2006, J NEUROCHEM, V97, P807, DOI 10.1111/j.1471-4159.2006.03748.x; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Pardossi-Piquard R, 2006, J NEUROCHEM, V97, P1052, DOI 10.1111/j.1471-4159.2006.03822.x; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Ren Z, 2007, J BIOL CHEM, V282, P35350, DOI 10.1074/jbc.M702739200; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Ryan KA, 2005, J CELL BIOL, V171, P327, DOI 10.1083/jcb.200505078; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Vardy ERLC, 2005, TRENDS MOL MED, V11, P464, DOI 10.1016/j.molmed.2005.08.004; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104; Zhao GJ, 2004, J BIOL CHEM, V279, P50647, DOI 10.1074/jbc.C400473200	36	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28634	28641		10.1074/jbc.M109.059345	http://dx.doi.org/10.1074/jbc.M109.059345			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19710022	Green Published, hybrid			2022-12-25	WOS:000270678900018
J	Cooley, K; Szczurko, O; Perri, D; Mills, EJ; Bernhardt, B; Zhou, Q; Seely, D				Cooley, Kieran; Szczurko, Orest; Perri, Dan; Mills, Edward J.; Bernhardt, Bob; Zhou, Qi; Seely, Dugald			Naturopathic Care for Anxiety: A Randomized Controlled Trial ISRCTN78958974	PLOS ONE			English	Article							WHOLE SYSTEMS RESEARCH; WITHANIA-SOMNIFERA; ADAPTOGENIC ACTIVITY; DISORDERS; COMPLEMENTARY; EPIDEMIOLOGY; MEDICINE; HEALTH; PREVALENCE; VALIDATION	Background: Anxiety is a serious personal health condition and represents a substantial burden to overall quality of life. Additionally anxiety disorders represent a significant cost to the health care system as well as employers through benefits coverage and days missed due to incapacity. This study sought to explore the effectiveness of naturopathic care on anxiety symptoms using a randomized trial. Methods: Employees with moderate to severe anxiety of longer than 6 weeks duration were randomized based on age and gender to receive naturopathic care (NC) (n = 41) or standardized psychotherapy intervention (PT) (n = 40) over a period of 12 weeks. Blinding of investigators and participants during randomization and allocation was maintained. Participants in the NC group received dietary counseling, deep breathing relaxation techniques, a standard multi-vitamin, and the herbal medicine, ashwagandha (Withania somnifera) (300 mg b.i.d. standardized to 1.5% withanolides, prepared from root). The PT intervention received psychotherapy, and matched deep breathing relaxation techniques, and placebo. The primary outcome measure was the Beck Anxiety Inventory (BAI) and secondary outcome measures included the Short Form 36 (SF-36), Fatigue Symptom Inventory (FSI), and Measure Yourself Medical Outcomes Profile (MY-MOP) to measure anxiety, mental health, and quality of life respectively. Participants were blinded to the placebo-controlled intervention. Results: Seventy-five participants (93%) were followed for 8 or more weeks on the trial. Final BAI scores decreased by 56.5% (p < 0.0001) in the NC group and 30.5% (p < 0.0001) in the PT group. BAI group scores were significantly decreased in the NC group compared to PT group (p = 0.003). Significant differences between groups were also observed in mental health, concentration, fatigue, social functioning, vitality, and overall quality of life with the NC group exhibiting greater clinical benefit. No serious adverse reactions were observed in either group. Relevance: Many patients seek alternatives and/or complementary care to conventional anxiety treatments. To date, no study has evaluated the potential of a naturopathic treatment protocol to effectively treat anxiety. Knowledge of the efficacy, safety or risk of natural health products, and naturopathic treatments is important for physicians and the public in order to make informed decisions. Interpretation: Both NC and PT led to significant improvements in patients' anxiety. Group comparison demonstrated a significant decrease in anxiety levels in the NC group over the PT group. Significant improvements in secondary quality of life measures were also observed in the NC group as compared to PT. The whole system of naturopathic care for anxiety needs to be investigated further including a closer examination of the individual components within the context of their additive effect. Trial Registration: Controlled-Trials.com ISRCTN78958974			Cooley, K (corresponding author), Canadian Coll Naturopath Med, Dept Res & Clin Epidemiol, Toronto, ON, Canada.	kcooley@ccnm.edu	Cooley, Kieran/L-3080-2019; Zhou, Qi/GSM-9583-2022	Cooley, Kieran/0000-0001-7960-6504; 				Alonso J, 2007, J CLIN PSYCHIAT, V68, P3; [Anonymous], 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003383; Archana R, 1999, J ETHNOPHARMACOL, V64, P91, DOI 10.1016/S0378-8741(98)00107-X; Bhattacharya SK, 2003, PHARMACOL BIOCHEM BE, V75, P547, DOI 10.1016/S0091-3057(03)00110-2; Bhattacharya SK, 2000, PHYTOMEDICINE, V7, P463, DOI 10.1016/S0944-7113(00)80030-6; Borgerson K, 2005, PERSPECT BIOL MED, V48, P502, DOI 10.1353/pbm.2005.0084; Bower P, 2003, PSYCHOL MED, V33, P203, DOI 10.1017/S0033291702006979; Brawman-Mintzer O, 2004, CNS SPECTRUMS, V9, P19, DOI 10.1017/S1092852900002339; Brown R P, 2001, J Psychiatr Pract, V7, P75, DOI 10.1097/00131746-200103000-00002; *CAN H, 2009, NAT HLTH PROD REG; Dhuley JN, 1998, J ETHNOPHARMACOL, V60, P173, DOI 10.1016/S0378-8741(97)00151-7; Elder C, 2006, J ALTERN COMPLEM MED, V12, P843, DOI 10.1089/acm.2006.12.843; Erickson DH, 2007, PSYCHIAT SERV, V58, P1205, DOI 10.1176/appi.ps.58.9.1205; Faragher EB, 2005, OCCUP ENVIRON MED, V62, P105, DOI 10.1136/oem.2002.006734; Furukawa TA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004364.pub2; Godwin Marshall, 2003, BMC Med Res Methodol, V3, P28, DOI 10.1186/1471-2288-3-28; Grunze H, 2000, NEUROPSYCHOBIOLOGY, V42, P28, DOI 10.1159/000054849; Hann DM, 1998, QUAL LIFE RES, V7, P301, DOI 10.1023/A:1024929829627; Herman PM, 2008, ALTERN THER HEALTH M, V14, P32; Hotopf M, 1999, BRIT J PSYCHIAT, V175, P217, DOI 10.1192/bjp.175.3.217; Howell HB, 2001, PSYCHIAT CLIN N AM, V24, P165, DOI 10.1016/S0193-953X(05)70212-4; JONAS WB, 2002, CLIN RES METHODS COM, P3; KICK SD, 1994, PSYCHOSOM MED, V56, P570, DOI 10.1097/00006842-199411000-00014; KIRSANAPRAKOMKI.T, 2006, COCHRANE DB SYST REV; LE CP, 2001, HLTH NUMBERS PROBLEM; Leahy, 2017, COGNITIVE THERAPY TE; Lepine JP, 2002, J CLIN PSYCHIAT, V63, P4; Marciniak M, 2004, DEPRESS ANXIETY, V19, P112, DOI 10.1002/da.10131; Mishra L C, 2000, Altern Med Rev, V5, P334; MONTEIRO MG, 1990, J CLIN PSYCHIAT, V51, P12; Nutt DJ, 2007, J CLIN PSYCHIAT, V68, P42; Osman A, 2004, PSYCHOL ASSESSMENT, V16, P120, DOI 10.1037/1040-3590.16.2.120; Paterson C, 2000, QUAL LIFE RES, V9, P521, DOI 10.1023/A:1008930521566; Paterson C, 1996, BRIT MED J, V312, P1016; Paterson C, 2000, J Health Serv Res Policy, V5, P27; Pilkington K, 2006, HOMEOPATHY, V95, P151, DOI 10.1016/j.homp.2006.05.005; Rafferty AP, 2002, AM J PUBLIC HEALTH, V92, P1598, DOI 10.2105/AJPH.92.10.1598; RAINEY JM, 1984, PSYCHOPHARMACOL BULL, V20, P45; Ritenbaugh C, 2003, ALTERN THER HEALTH M, V9, P32; ROSNER B, 2001, FUNDAMENTALS BIOSTAT; Roy-Byrne PP, 2005, PSYCHOSOMATICS, V46, P117, DOI 10.1176/appi.psy.46.2.117; Sarris J, 2007, PHYTOTHER RES, V21, P703, DOI 10.1002/ptr.2187; SEELY D, 2007, ECAM, V4, P75; Singh B, 2003, PHYTOTHER RES, V17, P531, DOI 10.1002/ptr.1189; Smith MJ, 2002, MED CLIN N AM, V86, P173, DOI 10.1016/S0025-7125(03)00079-8; Somer E, 2005, BEHAV RES THER, V43, P669, DOI 10.1016/j.brat.2004.05.006; STRAZNICKY NE, 1993, J HYPERTENS, V11, P427, DOI 10.1097/00004872-199304000-00014; SZCZURKO O, 2007, PUBLIC LIB IN PRESS; Timmermans S, 2003, GOLD STANDARD CHALLE; USTUN TB, 1995, MENTAL ILLNESS GEN H; Van der Windt DAWM, 2000, BRIT J GEN PRACT, V50, P371; Verhoef MJ, 2005, COMPLEMENT THER MED, V13, P206, DOI 10.1016/j.ctim.2005.05.001; Ware DL, 1996, QUALITY LIFE PHARMAC, P337; ALTERN MED REV, V9, P211	54	62	62	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6628	10.1371/journal.pone.0006628	http://dx.doi.org/10.1371/journal.pone.0006628			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	489JH	19718255	Green Published, gold			2022-12-25	WOS:000269415900001
J	Ridgway, CL; Ong, KK; Tammelin, TH; Sharp, S; Ekelund, U; Jarvelin, MR				Ridgway, Charlotte L.; Ong, Ken K.; Tammelin, Tuija H.; Sharp, Stephen; Ekelund, Ulf; Jarvelin, Marjo-Riitta			Infant Motor Development Predicts Sports Participation at Age 14 Years: Northern Finland Birth Cohort of 1966	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SKILL PROFICIENCY; MILLENNIUM COHORT; WEIGHT-GAIN; CHILDREN; PERFORMANCE; ADOLESCENTS; CHILDHOOD; FITNESS; YOUTH	Background: Motor proficiency is positively associated with physical activity levels. The aim of this study is to investigate associations between the timing of infant motor development and subsequent sports participation during adolescence. Methods: Prospective observational study. The study population consisted of 9,009 individuals from the Northern Finland Birth Cohort 1966. Motor development was assessed by parental report at age 1 year, using age at walking with support and age at standing unaided. At follow up aged 14 years, data were collected on the school grade awarded for physical education (PE). Self report was used to collect information on the frequency of sports participation and number of different sports reported. Principal Findings: Earlier infant motor development was associated with improved school PE grade, for age at walking supported (p < 0.001) and standing unaided (p = <0.001). Earlier infant motor development, in terms of age at walking supported, was positively associated with the number of different sports reported (p = 0.003) and with a greater frequency of sports participation (p = 0.043). These associations were independent of gestational age and birth weight, as well as father's social class and body mass index at age 14 years. Conclusions: Earlier infant motor development may predict higher levels of physical activity as indicated by higher school PE grade, participation in a greater number of different types of sports and increased frequency of sports participation. Identification of young children with slower motor development may allow early targeted interventions to improve motor skills and thereby increase physical activity in later life.			Ridgway, CL (corresponding author), MRC, Epidemiol Unit, Inst Metab Sci, Cambridge, England.	ulf.ekelund@mrc-epid.cam.ac.uk	Curtis, Charlotte/AAV-1156-2020; Ridgway, Charlotte/H-4378-2013	Curtis, Charlotte/0000-0002-1022-3887; Ridgway, Charlotte/0000-0002-1022-3887; Jarvelin, Marjo-Riitta/0000-0002-2149-0630	MRC [MC_U106179473, MC_U106179472] Funding Source: UKRI; Medical Research Council [MC_U106179472, MC_U106179473] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aarnio M, 2002, SCAND J MED SCI SPOR, V12, P179, DOI 10.1034/j.1600-0838.2002.00250.x; Barnett LM, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-40; Barnett LM, 2008, MED SCI SPORT EXER, V40, P2137, DOI 10.1249/MSS.0b013e31818160d3; Hediger ML, 2002, PAEDIATR PERINAT EP, V16, P33, DOI 10.1046/j.1365-3016.2002.00393.x; Brodersen NH, 2007, BRIT J SPORT MED, V41, P140, DOI 10.1136/bjsm.2006.031138; Kelly Y, 2006, DEV MED CHILD NEUROL, V48, P825, DOI 10.1017/S0012162206001770; Kuh D, 2006, J GERONTOL A-BIOL, V61, P702, DOI 10.1093/gerona/61.7.702; Kuh D, 2006, AM J EPIDEMIOL, V164, P110, DOI 10.1093/aje/kwj193; McPhillips M, 2007, J CHILD PSYCHOL PSYC, V48, P1214, DOI 10.1111/j.1469-7610.2007.01814.x; Musch J, 2001, DEV REV, V21, P147, DOI 10.1006/drev.2000.0516; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Nelson MC, 2006, PEDIATRICS, V118, pE1627, DOI 10.1542/peds.2006-0926; Okely AD, 2004, RES Q EXERCISE SPORT, V75, P238, DOI 10.1080/02701367.2004.10609157; Osika W, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a699; Pfeiffer KA, 2006, J ADOLESCENT HEALTH, V39, P523, DOI 10.1016/j.jadohealth.2006.03.005; RANTAKALLIO P, 1979, SOC SCI MED-MED SOC, V13, P423, DOI 10.1016/0160-7979(79)90131-0; Rantakallio P, 1988, Paediatr Perinat Epidemiol, V2, P59, DOI 10.1111/j.1365-3016.1988.tb00180.x; Ridgway CL, 2009, MED SCI SPORT EXER, V41, P1212, DOI 10.1249/MSS.0b013e31819794ab; Sacker A, 2006, PEDIATRICS, V118, pE682, DOI 10.1542/peds.2005-3141; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Salmon J, 2008, INT J OBESITY, V32, P601, DOI 10.1038/sj.ijo.0803805; Steele RM, 2008, J APPL PHYSIOL, V105, P342, DOI 10.1152/japplphysiol.00072.2008; Strohle A, 2007, PSYCHOL MED, V37, P1657, DOI 10.1017/S003329170700089X; Tammelin T, 2003, AM J PREV MED, V24, P22, DOI 10.1016/S0749-3797(02)00575-5; U.S. Department of Health and Human Services, 2008, PHYS ACT GUID ADV CO; Vestergaard M, 1999, ACTA PAEDIATR, V88, P1327, DOI 10.1080/080352599750030022; *WHO MULT GROWTH R, ACTA PAEDIAT S, V450, P86; Wickel EE, 2007, MED SCI SPORT EXER, V39, P1493, DOI 10.1249/mss.0b013e318093f56a; Williams HG, 2008, OBESITY, V16, P1421, DOI 10.1038/oby.2008.214; Wrotniak BH, 2006, PEDIATRICS, V118, pE1758, DOI 10.1542/peds.2006-0742; ACTA PAEDIAT S, V450, P66	31	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6837	10.1371/journal.pone.0006837	http://dx.doi.org/10.1371/journal.pone.0006837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	489JH	19718258	Green Submitted, Green Published, gold			2022-12-25	WOS:000269415900010
J	Van Haastert, PJM; Bosgraaf, L				Van Haastert, Peter J. M.; Bosgraaf, Leonard			Food Searching Strategy of Amoeboid Cells by Starvation Induced Run Length Extension	PLOS ONE			English	Article							WIN-STAY; LOSE-SHIFT; CHEMOTAXIS; SUCCESS; ABSENCE; MOTION	Food searching strategies of animals are key to their success in heterogeneous environments. The optimal search strategy may include specialized random walks such as Levy walks with heavy power-law tail distributions, or persistent walks with preferred movement in a similar direction. We have investigated the movement of the soil amoebae Dictyostelium searching for food. Dictyostelium cells move by extending pseudopodia, either in the direction of the previous pseudopod (persistent step) or in a different direction (turn). The analysis of similar to 4000 pseudopodia reveals that step and turn pseudopodia are drawn from a probability distribution that is determined by cGMP/PLA2 signaling pathways. Starvation activates these pathways thereby suppressing turns and inducing steps. As a consequence, starved cells make very long nearly straight runs and disperse over similar to 30-fold larger areas, without extending more or larger pseudopodia than vegetative cells. This 'win-stay/lose-shift' strategy for food searching is called Starvation Induced Run-length Extension. The SIRE walk explains very well the observed differences in search behavior between fed and starving organisms such as bumble-bees, flower bug, hoverfly and zooplankton.			Van Haastert, PJM (corresponding author), Univ Groningen, Dept Cell Biochem, Haren, Netherlands.	P.J.M.van.haastert@rug.nl						Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Bartumeus F, 2008, J THEOR BIOL, V252, P43, DOI 10.1016/j.jtbi.2008.01.009; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Benhamou S, 2006, ECOLOGY, V87, P518, DOI 10.1890/05-0495; Bicca-Marques JC, 2005, J COMP PSYCHOL, V119, P343, DOI 10.1037/0735-7036.119.3.343; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; BOSGRAAF L, 2009, QUIMP3 AUTOMATED PSE; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005253; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; CODLING EA, 2008, J R SOC INTERFACE, V15, P15; Conradt L, 2003, AM NAT, V161, P905, DOI 10.1086/375298; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Henaut Y, 2002, J APPL ENTOMOL, V126, P501, DOI 10.1046/j.1439-0418.2002.00694.x; HOHL HR, 1963, J BACTERIOL, V85, P191, DOI 10.1128/JB.85.1.191-198.1963; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Mayer-Scholl A, 2004, CURR OPIN MICROBIOL, V7, P62, DOI 10.1016/j.mib.2003.12.004; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; Posch M, 1999, J THEOR BIOL, V198, P183, DOI 10.1006/jtbi.1999.0909; POTEL MJ, 1979, J CELL SCI, V36, P281; ROTHERAY GE, 1984, ENTOMOL EXP APPL, V36, P17, DOI 10.1007/BF00345199; Shlesinger MF, 2006, NATURE, V443, P281, DOI 10.1038/443281a; Stephens D.W., 1986, pi; Takagi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002648; van Haastert PJM, 2007, J CELL BIOL, V177, P809, DOI 10.1083/jcb.200701134; Veltman DM, 2008, J CELL BIOL, V180, P747, DOI 10.1083/jcb.200709180; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831	29	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2009	4	8							e6814	10.1371/journal.pone.0006814	http://dx.doi.org/10.1371/journal.pone.0006814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JG	19714242	Green Published, Green Submitted, gold			2022-12-25	WOS:000269415800004
J	Imamura, F; Greer, CA				Imamura, Fumiaki; Greer, Charles A.			Dendritic Branching of Olfactory Bulb Mitral and Tufted Cells: Regulation by TrkB	PLOS ONE			English	Article								Background: Projection neurons of mammalian olfactory bulb (OB), mitral and tufted cells, have dendrites whose morphologies are specifically differentiated for efficient odor information processing. The apical dendrite extends radially and arborizes in single glomerulus where it receives primary input from olfactory sensory neurons that express the same odor receptor. The lateral dendrites extend horizontally in the external plexiform layer and make reciprocal dendrodendritic synapses with granule cells, which moderate mitral/tufted cell activity. The molecular mechanisms regulating dendritic development of mitral/tufted cells is one of the unsolved important problems in the olfactory system. Here, we focused on TrkB receptors to test the hypothesis that neurotrophin-mediate mechanisms contributed to dendritic differentiation of OB mitral/tufted cells. Principal Findings: With immunohistochemical analysis, we found that the TrkB neurotrophin receptor is expressed by both apical and lateral dendrites of mitral/tufted cells and that expression is evident during the early postnatal days when these dendrites exhibit their most robust growth and differentiation. To examine the effect of TrkB activation on mitral/tufted cell dendritic development, we cultured OB neurons. When BDNF or NT4 were introduced into the cultures, there was a significant increase in the number of primary neurites and branching points among the mitral/tufted cells. Moreover, BDNF facilitated filopodial extension along the neurites of mitral/tufted cells. Significance: In this report, we show for the first time that TrkB activation stimulates the dendritic branching of mitral/tufted cells in developing OB. This suggests that arborization of the apical dendrite in a glomerulus is under the tight regulation of TrkB activation.			Imamura, F (corresponding author), Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA.	charles.greer@yale.edu		Imamura, Fumiaki/0000-0003-1410-3126	NIA NIH HHS [P01 AG028054, AG028054] Funding Source: Medline; NIDCD NIH HHS [R01 DC006291, R01 DC006972, R01 DC007880, F32 DC000210, DC000210, DC006972, R01 DC000210, DC006291] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG028054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007880, R01DC006291, R01DC006972, R01DC000210] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adachi N, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-42; BAYER SA, 1983, EXP BRAIN RES, V50, P329; Bhattacharyya A, 1997, J NEUROSCI, V17, P7007; BIJU KC, 2008, NEUROSCI LETT; Blanchart A, 2006, J COMP NEUROL, V496, P529, DOI 10.1002/cne.20941; CAO L, 2007, CURR BIOL; CLEVENGER AC, 2008, CHEM SENSES; Dijkhuizen PA, 2005, J NEUROBIOL, V62, P278, DOI 10.1002/neu.20100; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feron F, 2008, BRAIN RES, V1196, P13, DOI 10.1016/j.brainres.2007.12.003; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Gabellec MM, 2007, EUR J NEUROSCI, V25, P1373, DOI 10.1111/j.1460-9568.2007.05400.x; GONG QZ, 1994, J COMP NEUROL, V344, P336, DOI 10.1002/cne.903440303; HINDS JW, 1976, J COMP NEUROL, V169, P15, DOI 10.1002/cne.901690103; HINDS JW, 1968, J COMP NEUROL, V134, P305, DOI 10.1002/cne.901340305; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Imamura F, 2006, J COMP NEUROL, V495, P754, DOI 10.1002/cne.20896; JOHNSON EM, 2007, J PHYSL; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; Kobayakawa K, 2007, NATURE; Kosaka K, 2001, J COMP NEUROL, V440, P219, DOI 10.1002/cne.1381; Leo JMC, 2003, DEV BRAIN RES, V140, P277, DOI 10.1016/S0165-3806(02)00614-4; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Liu XR, 2007, J NEUROSCI, V27, P7256, DOI 10.1523/JNEUROSCI.0779-07.2007; Lopez-Mascaraque L, 2005, DEV DYNAM, V232, P325, DOI 10.1002/dvdy.20239; Malun D, 1996, J COMP NEUROL, V368, P1, DOI 10.1002/(SICI)1096-9861(19960422)368:1<1::AID-CNE1>3.0.CO;2-7; MASANA Y, 1993, J NEUROSCI RES, V35, P468, DOI 10.1002/jnr.490350503; Matsutani S, 2000, J COMP NEUROL, V418, P402; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; MORI K, 1983, J COMP NEUROL, V219, P339, DOI 10.1002/cne.902190308; Nef S, 2001, DEV BIOL, V234, P80, DOI 10.1006/dbio.2001.0240; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; ORONA E, 1984, J COMP NEUROL, V226, P346, DOI 10.1002/cne.902260305; PRICE JL, 1970, J CELL SCI, V7, P631; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tran H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003816; Treloar HB, 1999, J COMP NEUROL, V413, P289; Whitman MC, 2007, DEV NEUROBIOL, V67, P1079, DOI 10.1002/dneu.20389; Xu BJ, 2000, NEURON, V26, P233, DOI 10.1016/S0896-6273(00)81153-8; Yuan Q, 2004, LEARN MEMORY, V11, P406, DOI 10.1101/lm.75204; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	48	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6729	10.1371/journal.pone.0006729	http://dx.doi.org/10.1371/journal.pone.0006729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707543	gold, Green Published, Green Submitted			2022-12-25	WOS:000269278400002
J	Pottier, N; Maurin, T; Chevalier, B; Puissegur, MP; Lebrigand, K; Robbe-Sermesant, K; Bertero, T; Cardenas, CLL; Courcot, E; Rios, G; Fourre, S; Lo-Guidice, JM; Marcet, B; Cardinaud, B; Barbry, P; Mari, B				Pottier, Nicolas; Maurin, Thomas; Chevalier, Benoit; Puissegur, Marie-Pierre; Lebrigand, Kevin; Robbe-Sermesant, Karine; Bertero, Thomas; Cardenas, Christian L. Lino; Courcot, Elisabeth; Rios, Geraldine; Fourre, Sandra; Lo-Guidice, Jean-Marc; Marcet, Brice; Cardinaud, Bruno; Barbry, Pascal; Mari, Bernard			Identification of Keratinocyte Growth Factor as a Target of microRNA-155 in Lung Fibroblasts: Implication in Epithelial-Mesenchymal Interactions	PLOS ONE			English	Article								Background: Epithelial-mesenchymal interactions are critical in regulating many aspects of vertebrate embryo development, and for the maintenance of homeostatic equilibrium in adult tissues. The interactions between epithelium and mesenchyme are believed to be mediated by paracrine signals such as cytokines and extracellular matrix components secreted from fibroblasts that affect adjacent epithelia. In this study, we sought to identify the repertoire of microRNAs ( miRNAs) in normal lung human fibroblasts and their potential regulation by the cytokines TNF-alpha, IL-1 beta and TGF-beta. Methodology/Principal Findings: MiR-155 was significantly induced by inflammatory cytokines TNF-alpha and IL-1 beta while it was down-regulated by TGF-beta. Ectopic expression of miR-155 in human fibroblasts induced modulation of a large set of genes related to "cell to cell signalling'', "cell morphology'' and "cellular movement''. This was consistent with an induction of caspase-3 activity and with an increase in cell migration in fibroblasts tranfected with miR-155. Using different miRNA bioinformatic target prediction tools, we found a specific enrichment for miR-155 predicted targets among the population of down-regulated transcripts. Among fibroblast-selective targets, one interesting hit was keratinocyte growth factor (KGF, FGF-7), a member of the fibroblast growth factor (FGF) family, which owns two potential binding sites for miR-155 in its 3'-UTR. Luciferase assays experimentally validated that miR-155 can efficiently target KGF 3'-UTR. Site-directed mutagenesis revealed that only one out of the 2 potential sites was truly functional. Functional in vitro assays experimentally validated that miR-155 can efficiently target KGF 3'-UTR. Furthermore, in vivo experiments using a mouse model of lung fibrosis showed that miR-155 expression level was correlated with the degree of lung fibrosis. Conclusions/Significance: Our results strongly suggest a physiological function of miR-155 in lung fibroblasts. Altogether, this study implicates this miRNA in the regulation by mesenchymal cells of surrounding lung epithelium, making it a potential key player during tissue injury.			Pottier, N (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, UMR6097, Sophia Antipolis, France.	direction@ipmc.cnrs.fr; mari@unice.fr	GUIDICE, Jean-Marc LO/O-3177-2017; Mari, Bernard P/GVS-3100-2022; Marcet, Brice/Q-1218-2016; Mari, Bernard/Q-5832-2019; Mari, Bernard P/F-8960-2013; maurin, thomas O/O-7494-2016; Mari, Bernard P/D-7445-2015; Robbe-Sermesant, Karine/Q-2253-2016; Barbry, Pascal/O-5021-2016	GUIDICE, Jean-Marc LO/0000-0003-3486-6809; Mari, Bernard P/0000-0002-0422-9182; Marcet, Brice/0000-0001-5015-2297; Mari, Bernard/0000-0002-0422-9182; Mari, Bernard P/0000-0002-0422-9182; maurin, thomas O/0000-0002-8467-3135; Mari, Bernard P/0000-0002-0422-9182; Robbe-Sermesant, Karine/0000-0003-0580-3817; Barbry, Pascal/0000-0001-9632-6483; BERTERO, Thomas/0000-0002-4801-9902; lino cardenas, christian/0000-0001-5491-4375; Rios Munera, Geraldine/0000-0002-2993-1859; Puissegur, Marie-Pierre/0000-0001-9016-8621; pottier, nicolas/0000-0001-8913-6286; Chevalier, Benoit/0000-0003-0863-6022				Atabai K, 2002, AM J PHYSIOL-LUNG C, V283, pL163, DOI 10.1152/ajplung.00396.2001; Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BRAUCHLE M, 1994, ONCOGENE, V9, P3199; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Cheng C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001989; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Donjacour A A, 1991, Cancer Treat Res, V53, P335; Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Faraoni I., 2009, BIOCH BIOPHYS ACTA; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; FINCH PW, 1995, J BIOL CHEM, V270, P11230, DOI 10.1074/jbc.270.19.11230; Finch PW, 2004, ADV CANCER RES, V91, P69, DOI 10.1016/S0065-230X(04)91003-2; Fromigue O, 2003, ONCOGENE, V22, P8487, DOI 10.1038/sj.onc.1206918; Gharaee-Kermani M, 2001, CURR PHARM DESIGN, V7, P1083, DOI 10.2174/1381612013397573; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Huang J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705116200; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jung I, 2009, BRIT J HAEMATOL, V144, P138, DOI 10.1111/j.1365-2141.2008.07424.x; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Kluiver J, 2007, ONCOGENE, V26, P3769, DOI 10.1038/sj.onc.1210147; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Le Brigand K, 2007, BIOINFORMATICS, V23, P1304, DOI 10.1093/bioinformatics/btm106; Le Brigand K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl485; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Marchand-Adam S, 2005, AM J RESP CELL MOL, V32, P470, DOI 10.1165/rcmb.2004-0205OC; Mari BP, 1998, J BIOL CHEM, V273, P618, DOI 10.1074/jbc.273.1.618; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; Mercier I, 2008, CANCER BIOL THER, V7, P1212, DOI 10.4161/cbt.7.8.6220; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Moreilhon C, 2005, PHYSIOL GENOMICS, V20, P244, DOI 10.1152/physiolgenomics.00135.2004; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Pardo A, 2002, FRONT BIOSCI-LANDMRK, V7, pD1743, DOI 10.2741/pardo; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Pottier N, 2007, AM J RESP CRIT CARE, V176, P1098, DOI 10.1164/rccm.200607-1051OC; Rai D, 2008, CANCER GENET CYTOGEN, V181, P8, DOI 10.1016/j.cancergencyto.2007.10.008; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; SAUMET A, 2008, BLOOD; Selman M, 2004, SARCOIDOSIS VASC DIF, V21, P165; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Tang AM, 1996, J DERMATOL SCI, V11, P41, DOI 10.1016/0923-1811(95)00418-1; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; ULICH TR, 1994, J CLIN INVEST, V93, P1298, DOI 10.1172/JCI117086; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu KI, 1998, AM J PHYSIOL-LUNG C, V275, pL780, DOI 10.1152/ajplung.1998.275.4.L780; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yi ES, 1996, AM J PATHOL, V149, P1963; Yin QY, 2008, J VIROL, V82, P5295, DOI 10.1128/JVI.02380-07; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200	74	165	188	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2009	4	8							e6718	10.1371/journal.pone.0006718	http://dx.doi.org/10.1371/journal.pone.0006718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JF	19701459	Green Published, gold, Green Submitted			2022-12-25	WOS:000269268300004
J	Li, CL; Yu, HY; Ma, Y; Shi, GL; Jiang, J; Gu, JJ; Yang, Y; Jin, SB; Wei, Z; Jiang, H; Li, JS; Jin, Y				Li, Chunliang; Yu, Hongyao; Ma, Yu; Shi, Guilai; Jiang, Jing; Gu, Junjie; Yang, Ying; Jin, Shibo; Wei, Zhe; Jiang, Hua; Li, Jinsong; Jin, Ying			Germline-Competent Mouse-Induced Pluripotent Stem Cell Lines Generated on Human Fibroblasts without Exogenous Leukemia Inhibitory Factor	PLOS ONE			English	Article							ABSENCE; SYSTEM	Induced pluripotent stem (iPS) cells have attracted enormous attention due to their vast potential in regenerative medicine, pharmaceutical screening and basic research. Most prior established iPS cell lines were derived and maintained on mouse embryonic fibroblast (MEF) cells supplemented with exogenous leukemia inhibitory factor (LIF). Drawbacks of MEF cells impede optimization as well as dissection of reprogramming events and limit the usage of iPS cell derivatives in therapeutic applications. In this study, we develop a reproducible protocol for efficient reprogramming mouse neural progenitor cells (NPCs) on human foreskin fibroblast (HFF) cells via retroviral transfer of human transcriptional factors OCT4/SOX2/KLF4/C-MYC. Two independent iPS cell lines are derived without exogenous LIF. They display typical undifferentiated morphology and express pluripotency markers Oct4 and Sox2. Transgenes are inactivated and the endogenous Oct4 promoter is completely demethylated in the established iPS cell lines, indicating a fully reprogrammed state. Moreover, the iPS cells can spontaneously differentiate or be induced into various cell types of three embryonic germ layers in vitro and in vivo when they are injected into immunodeficient mice for teratoma formation. Importantly, iPS cells extensively integrate with various host tissues and contribute to the germline when injected into the blastocysts. Interestingly, these two iPS cell lines, while both pluripotent, exhibit distinctive differentiation tendencies towards different lineages. Taken together, the data describe the first genuine mouse iPS cell lines generated on human feeder cells without exogenous LIF, providing a reliable tool for understanding the molecular mechanisms of nuclear reprogramming.			Li, CL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Biol Sci,Chinese Acad Sci, Key Lab Stem Cell Biol,Inst Hlth Sci, Shanghai 200030, Peoples R China.	yjin@sibs.ac.cn	Wei, Zhe/N-8462-2015; , chunliang.li@stjude.org/P-4373-2018	Wei, Zhe/0000-0001-8558-4639; , chunliang.li@stjude.org/0000-0002-5938-5510; li, jin song/0000-0003-3456-662X; Yu, Hongyao/0000-0003-3752-8442				Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hu YG, 2008, HUM MOL GENET, V17, P2654, DOI 10.1093/hmg/ddn165; Jiang H, 2007, CELL RES, V17, P792, DOI 10.1038/cr.2007.70; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Li CL, 2009, CELL RES, V19, P173, DOI 10.1038/cr.2008.301; LOH YH, 2009, BLOOD; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	24	27	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6724	10.1371/journal.pone.0006724	http://dx.doi.org/10.1371/journal.pone.0006724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696928	Green Published, Green Submitted, gold			2022-12-25	WOS:000269267600012
J	Rammes, G; Hosp, C; Eisensamer, B; Tanasic, S; Nothdurfter, C; Zieglgansberger, W; Rupprecht, R				Rammes, Gerhard; Hosp, Christine; Eisensamer, Brigitte; Tanasic, Sascha; Nothdurfter, Caroline; Zieglgaensberger, Walter; Rupprecht, Rainer			Identification of a Domain which Affects Kinetics and Antagonistic Potency of Clozapine at 5-HT3 Receptors	PLOS ONE			English	Article							SUPERIOR CERVICAL-GANGLION; SINGLE-CHANNEL CONDUCTANCE; VENTRAL TEGMENTAL AREA; DOPAMINE RELEASE; FUNCTIONAL EXPRESSION; SEROTONIN-RECEPTOR; 5-HYDROXYTRYPTAMINE(3) RECEPTOR; NICOTINIC ACETYLCHOLINE; MOLECULAR-CLONING; SCHIZOPHRENIA	The widely used atypical antipsychotic clozapine is a potent competitive antagonist at 5-HT3 receptors which may contribute to its unique psychopharmacological profile. Clozapine binds to 5-HT3 receptors of various species. However, the structural requirements of the respective binding site for clozapine remain to be determined. Differences in the primary sequences within the 5-HT3A receptor gene in schizophrenic patients may result in an alteration of the antipsychotic potency and/or the side effect profile of clozapine. To determine these structural requirements we constructed chimeras with different 5-HT3A receptor sequences of murine and human origin and expressed these mutants in human embryonic kidney (HEK) 293 cells. Clozapine antagonises recombinant mouse 5-HT3A receptors with higher potency compared to recombinant human 5-HT3A receptors. 5-HT activation curves and clozapine inhibition curves yielded the parameters EC50 and IC50 for all receptors tested in the range of 0.6 - 2.7 mu M and 1.5 - 83.3 nM, respectively. The use of the Cheng-Prusoff equation to calculate the dissociation constant K-b values for clozapine revealed that an extracellular sequence (length 86 aa) close to the transmembrane domain M1 strongly determines the binding affinity of clozapine. K-b values of clozapine were significantly lower (0.3-1.1 nM) for receptors containing the murine sequence and higher when compared with receptors containing the respective human sequence (5.8-13.4 nM). Thus, individual differences in the primary sequence of 5-HT3 receptors may be crucial for the antipsychotic potency and/or the side effect profile of clozapine.			Rammes, G (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	rammes@mpipsykl.mpg.de						Abi-Dargham A, 2003, NEUROSCIENTIST, V9, P404, DOI 10.1177/1073858403252674; Akhondzadeh S, 2009, SCHIZOPHR RES, V107, P206, DOI 10.1016/j.schres.2008.08.004; Arnsten AFT, 1997, NEUROBIOL AGING, V18, P21, DOI 10.1016/S0197-4580(96)00162-5; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Belelli D, 1995, MOL PHARMACOL, V48, P1054; BLANDINA P, 1988, EUR J PHARMACOL, V155, P349, DOI 10.1016/0014-2999(88)90528-6; Boddeke HWGM, 1996, BRIT J PHARMACOL, V118, P1836, DOI 10.1111/j.1476-5381.1996.tb15611.x; Boyd GW, 2002, MOL CELL NEUROSCI, V21, P38, DOI 10.1006/mcne.2002.1160; BRUNELLO N, 1995, NEUROPSYCHOPHARMACOL, V13, P177, DOI 10.1038/sj.npp.1380287; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Costall B., 2000, SEROTONINERGIC NEURO, P409; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; De Deurwaerdere P, 1998, J NEUROSCI, V18, P6528; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Fletcher S, 1998, TRENDS PHARMACOL SCI, V19, P212, DOI 10.1016/S0165-6147(98)01210-3; Gu B, 2008, PHARMACOGENET GENOM, V18, P721, DOI 10.1097/FPC.0b013e32830500e2; Gutierrez B, 2002, SCHIZOPHR RES, V58, P93, DOI 10.1016/S0920-9964(02)00205-0; Hapfelmeier G, 2003, BIOPHYS J, V84, P1720, DOI 10.1016/S0006-3495(03)74980-7; Hermann B, 1996, BIOCHEM BIOPH RES CO, V225, P957, DOI 10.1006/bbrc.1996.1278; Hodges H, 1996, PSYCHOPHARMACOLOGY, V125, P146, DOI 10.1007/BF02249414; Hu XQ, 2006, J BIOL CHEM, V281, P21781, DOI 10.1074/jbc.M600676200; HUSSY N, 1994, J PHYSIOL-LONDON, V481, P311, DOI 10.1113/jphysiol.1994.sp020441; Iqbal Mohammad Masud, 2003, Ann Clin Psychiatry, V15, P33, DOI 10.3109/10401230309085668; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Koyama S, 2000, J PHYSIOL-LONDON, V529, P373, DOI 10.1111/j.1469-7793.2000.00373.x; Kracun S, 2008, BRIT J PHARMACOL, V153, P1474, DOI 10.1038/sj.bjp.0707676; KRIEM B, 1995, NEUROSCI LETT, V197, P57, DOI 10.1016/0304-3940(95)11900-H; Lankiewicz S, 1998, MOL PHARMACOL, V53, P202, DOI 10.1124/mol.53.2.202; Liu W, 2006, ALCOHOL, V40, P167, DOI 10.1016/j.alcohol.2007.01.001; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; Meisenzahl EM, 2007, INT REV PSYCHIATR, V19, P337, DOI 10.1080/09540260701502468; Meneses A, 1999, NEUROSCI BIOBEHAV R, V23, P1111, DOI 10.1016/S0149-7634(99)00067-6; MIYAKE A, 1995, MOL PHARMACOL, V48, P407; Mylecharane EJ, 1996, BEHAV BRAIN RES, V73, P1; Niesler B, 2001, PHARMACOGENETICS, V11, P21, DOI 10.1097/00008571-200102000-00003; Peters JA, 2005, TRENDS PHARMACOL SCI, V26, P587, DOI 10.1016/j.tips.2005.09.011; Rammes G, 2004, MOL PSYCHIATR, V9, P846, DOI 10.1038/sj.mp.4001490; Rammes G, 2007, MOL NEUROBIOL, V35, P160, DOI 10.1007/s12035-007-0006-1; Reeves DC, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-27; REYNOLDS GP, 1992, TRENDS PHARMACOL SCI, V13, P116, DOI 10.1016/0165-6147(92)90041-4; Roerig B, 1997, J NEUROSCI, V17, P8353; SUGITA S, 1992, NEURON, V8, P199, DOI 10.1016/0896-6273(92)90121-S; Thompson AJ, 2007, EXPERT OPIN THER TAR, V11, P527, DOI 10.1517/14728222.11.4.527; Thompson AJ, 2006, J MOL NEUROSCI, V30, P273, DOI 10.1385/JMN:30:3:273; van Hooft JA, 1998, P NATL ACAD SCI USA, V95, P11456, DOI 10.1073/pnas.95.19.11456; van Hooft JA, 2000, TRENDS NEUROSCI, V23, P605, DOI 10.1016/S0166-2236(00)01662-3; vanHooft JA, 1996, BRIT J PHARMACOL, V117, P839; WATLING KJ, 1990, EUR J PHARMACOL, V182, P465, DOI 10.1016/0014-2999(90)90043-6; Wetzel CHR, 1998, MOL ENDOCRINOL, V12, P1441, DOI 10.1210/me.12.9.1441; Widschwendter CG, 2005, FORTSCHR NEUROL PSYC, V73, pS32, DOI 10.1055/s-2005-915546; YAKEL JL, 1988, NEURON, V1, P615, DOI 10.1016/0896-6273(88)90111-0; YANG J, 1992, J PHYSIOL-LONDON, V448, P237, DOI 10.1113/jphysiol.1992.sp019039	52	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6715	10.1371/journal.pone.0006715	http://dx.doi.org/10.1371/journal.pone.0006715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696922	Green Published, Green Submitted, gold			2022-12-25	WOS:000269267600006
J	Myette, JR; Soundararajan, V; Shriver, Z; Raman, R; Sasisekharan, R				Myette, James R.; Soundararajan, Venkataramanan; Shriver, Zachary; Raman, Rahul; Sasisekharan, Ram			Heparin/Heparan Sulfate 6-O-Sulfatase from Flavobacterium heparinum INTEGRATED STRUCTURAL AND BIOCHEMICAL INVESTIGATION OF ENZYME ACTIVE SITE AND SUBSTRATE SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; RECOMBINANT EXPRESSION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; HUMAN ARYLSULFATASE; MOLECULAR-CLONING; PURIFICATION; MECHANISM; COMPLEX	Heparin and heparan sulfate glycosaminoglycans (HSGAGs) comprise a chemically heterogeneous class of sulfated polysaccharides. The development of structure-activity relationships for this class of polysaccharides requires the identification and characterization of degrading enzymes with defined substrate specificity and enzymatic activity. Toward this end, we report here the molecular cloning and extensive structure-function analysis of a 6-O-sulfatase from the Gram-negative bacterium Flavobacterium heparinum. In addition, we report the recombinant expression of this enzyme in Escherichia coli in a soluble, active form and identify it as a specific HSGAG sulfatase. We further define the mechanism of action of the enzyme through biochemical and structural studies. Through the use of defined substrates, we investigate the kinetic properties of the enzyme. This analysis was complemented by homology-based molecular modeling studies that sought to rationalize the substrate specificity of the enzyme and mode of action through an analysis of the active-site topology of the enzyme including identifying key enzyme-substrate interactions and assigning key amino acids within the active site of the enzyme. Taken together, our structural and biochemical studies indicate that 6-O-sulfatase is a predominantly exolytic enzyme that specifically acts on N-sulfated or N-acetylated 6-O-sulfated glucosamines present at the non-reducing end of HSGAG oligosaccharide substrates. This requirement for the N-acetyl or N-sulfo groups on the glucosamine substrate can be explained through eliciting favorable interactions with key residues within the active site of the enzyme. These findings provide a framework that enables the use of 6-O-sulfatase as a tool for HSGAG structure-activity studies as well as expand our biochemical and structural understanding of this important class of enzymes.	MIT, Harvard Mit Div Hlth Sci & Technol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sasisekharan, R (corresponding author), 77 Massachusetts Ave,Rm 16-561, Cambridge, MA 02139 USA.	rams@mit.edu			National Institutes of Health [GM57073]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057073, R01GM057073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM57073.	Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BEIL S, 1995, EUR J BIOCHEM, V229, P385, DOI 10.1111/j.1432-1033.1995.0385k.x; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Boltes I, 2001, STRUCTURE, V9, P483, DOI 10.1016/S0969-2126(01)00609-8; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dierks T, 2005, CELL, V121, P541, DOI 10.1016/j.cell.2005.03.001; Dierks T, 1998, J BIOL CHEM, V273, P25560, DOI 10.1074/jbc.273.40.25560; DIETRICH CP, 1973, J BIOL CHEM, V248, P6408; Ernst S, 1996, BIOCHEM J, V315, P589, DOI 10.1042/bj3150589; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Godavarti R, 1996, BIOCHEM BIOPH RES CO, V225, P751, DOI 10.1006/bbrc.1996.1246; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW100, DOI 10.1093/nar/gkh464; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; HUIGE CJM, 1995, J COMPUT CHEM, V16, P56, DOI 10.1002/jcc.540160106; Kertesz MA, 2000, FEMS MICROBIOL REV, V24, P135, DOI 10.1016/S0168-6445(99)00033-9; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Liu J, 2002, J BIOL CHEM, V277, P33456, DOI 10.1074/jbc.M202034200; LOHSE DL, 1992, J BIOL CHEM, V267, P24347; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Myette JR, 2009, J BIOL CHEM, V284, P35189, DOI 10.1074/jbc.M109.053835; Myette JR, 2003, J BIOL CHEM, V278, P12157, DOI 10.1074/jbc.M211420200; Myette JR, 2002, BIOCHEMISTRY-US, V41, P7424, DOI 10.1021/bi012147o; NAKAMURA T, 1988, J CLIN MICROBIOL, V26, P1070, DOI 10.1128/JCM.26.5.1070-1071.1988; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Prince JM, 2002, DEV DYNAM, V223, P497, DOI 10.1002/dvdy.10070; Raman R, 2003, J BIOL CHEM, V278, P12167, DOI 10.1074/jbc.M211425200; Roberton AM, 2000, METH MOL B, V125, P417; Rusnati M, 2005, CURR PHARM DESIGN, V11, P2489, DOI 10.2174/1381612054367553; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; SASISEKHARAN R, 1993, P NATL ACAD SCI USA, V90, P3660, DOI 10.1073/pnas.90.8.3660; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; Shriver Z, 2002, TRENDS CARDIOVAS MED, V12, P71, DOI 10.1016/S1050-1738(01)00150-5; Uchimura Kenji, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-2; Venkataraman G, 1999, SCIENCE, V286, P537, DOI 10.1126/science.286.5439.537; Vives RR, 2006, CURR GENE THER, V6, P35, DOI 10.2174/156652306775515565; von Bulow R, 2001, J MOL BIOL, V305, P269, DOI 10.1006/jmbi.2000.4297	39	17	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35177	35188		10.1074/jbc.M109.053801	http://dx.doi.org/10.1074/jbc.M109.053801			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19726671	hybrid, Green Published			2022-12-25	WOS:000272439600071
J	Rampon, C; Bouzaffour, M; Ostuni, MA; Dufourcq, P; Girard, C; Freyssinet, JM; Lacapere, JJ; Schweizer-Groyer, G; Vriz, S				Rampon, Christine; Bouzaffour, Mohamed; Ostuni, Mariano A.; Dufourcq, Pascale; Girard, Christelle; Freyssinet, Jean Marie; Lacapere, Jean-Jacques; Schweizer-Groyer, Ghislaine; Vriz, Sophie			Translocator protein (18 kDa) is involved in primitive erythropoiesis in zebrafish	FASEB JOURNAL			English	Article						peripheral-type benzodiazepine receptor; hematopoiesis; transcription factor GATA-1	PERIPHERAL BENZODIAZEPINE-RECEPTOR; DIAZEPAM-BINDING INHIBITOR; CHOLESTEROL TRANSPORT; MITOCHONDRIAL-MEMBRANES; TRANSGENIC ZEBRAFISH; CELL-PROLIFERATION; ENDOGENOUS LIGANDS; DEATH RECEPTOR; HEMATOPOIESIS; EXPRESSION	The translocator protein (18 kDa) (TSPO), also known as peripheral-type benzodiazepine receptor, is directly or indirectly associated with many biological processes. Although extensively characterized, the specific function of TSPO during development remains unclear. It has been reported that TSPO is involved in a variety of mechanisms, including cell proliferation, apoptosis, regulation of mitochondrial functions, cholesterol transport and steroidogenesis, and porphyrin transport and heme synthesis. Although the literature has reported a murine knockout model, the experiment did not generate information because of early lethality. We then used the zebrafish model to address the function of tspo during development. Information about spatiotemporal expression showed that tspo has a maternal and a zygotic contribution which, during somatogenesis, seems to be erythroid restricted to the intermediate cell mass. Genetic and pharmacological approaches used to invalidate Tspo function resulted in embryos with specific erythropoietic cell depletion. Although unexpected, this lack of blood cells is independent of the Tspo cholesterol binding site and reveals a new in vivo key role for Tspo during erythropoiesis.-Rampon, C., Bouzaffour, M., Ostuni, M. A., Dufourcq, P., Girard, C., Freyssinet, J. M., Lacapere, J.-J., Schweizer-Groyer, G., Vriz, S. Translocator protein (18 kDa) is involved in primitive erythropoiesis in zebrafish. FASEB J. 23, 4181-4192 (2009). www.fasebj.org	[Rampon, Christine; Bouzaffour, Mohamed; Ostuni, Mariano A.; Dufourcq, Pascale; Lacapere, Jean-Jacques; Vriz, Sophie] Univ Paris 07, Paris, France; [Rampon, Christine; Bouzaffour, Mohamed; Dufourcq, Pascale; Freyssinet, Jean Marie; Vriz, Sophie] INSERM, U770, F-94275 Le Kremlin Bicetre, France; [Girard, Christelle; Schweizer-Groyer, Ghislaine] INSERM, U788, F-94275 Le Kremlin Bicetre, France; [Girard, Christelle; Schweizer-Groyer, Ghislaine] Univ Paris 11, Orsay, France; [Ostuni, Mariano A.; Lacapere, Jean-Jacques] CRB3, INSERM, U773, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm)	Rampon, C (corresponding author), Coll France, CNRS, UMR 8542, 11 Pl Marcelin Berthelot, F-75231 Paris 05, France.	christine.rampon@college-de-france.fr	Freyssinet, Jean-Marie/G-2719-2013; girard, christelle/A-6564-2011; OSTUNI, Mariano/J-2930-2015	OSTUNI, Mariano/0000-0001-6769-3786; /0000-0002-9058-9378; rampon, christine/0000-0002-1444-3166; /0000-0003-2029-5750				Ach M, 2009, LEUKEMIA, V23, P712, DOI 10.1038/leu.2008.363; ALEXANDER BEE, 1992, BIOCHEM PHARMACOL, V44, P269, DOI 10.1016/0006-2952(92)90009-8; ALHO H, 1994, CELL GROWTH DIFFER, V5, P1005; Amatruda JF, 1999, DEV BIOL, V216, P1, DOI 10.1006/dbio.1999.9462; ANHOLT RRH, 1985, J PHARMACOL EXP THER, V233, P517; BERNASSAU JM, 1993, J MOL GRAPHICS, V11, P236, DOI 10.1016/0263-7855(93)80003-A; BRAESTRUP C, 1977, NATURE, V269, P702, DOI 10.1038/269702a0; Burgi B, 1999, J NEUROENDOCRINOL, V11, P85; CANAT X, 1993, LIFE SCI, V52, P107, DOI 10.1016/0024-3205(93)90293-C; Carradice D, 2008, BLOOD, V111, P3331, DOI 10.1182/blood-2007-10-052761; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; DOBLE A, 1985, EUR J PHARMACOL, V119, P153, DOI 10.1016/0014-2999(85)90291-2; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; Dufourcq P, 2006, MOL CELL NEUROSCI, V33, P180, DOI 10.1016/j.mcn.2006.07.005; Dufourcq P, 2006, DEV GENES EVOL, V216, P635, DOI 10.1007/s00427-006-0066-7; FARGES R, 1994, MOL PHARMACOL, V46, P1160; Galiegue S, 1999, J BIOL CHEM, V274, P2938, DOI 10.1074/jbc.274.5.2938; Galloway JL, 2005, DEV CELL, V8, P109, DOI 10.1016/j.devcel.2004.12.001; GARNIER M, 1993, ENDOCRINOLOGY, V132, P444, DOI 10.1210/en.132.1.444; Gavish M, 1999, PHARMACOL REV, V51, P629; Golani I, 2001, BIOCHEMISTRY-US, V40, P10213, DOI 10.1021/bi010431+; GUIDOTTI A, 1983, P NATL ACAD SCI-BIOL, V80, P3531, DOI 10.1073/pnas.80.11.3531; Hardwick M, 1999, CANCER RES, V59, P831; Hauet T, 2002, TRANSPLANTATION, V74, P1507, DOI 10.1097/00007890-200212150-00006; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Hsia N, 2005, EXP HEMATOL, V33, P1007, DOI 10.1016/j.exphem.2005.06.013; Hsu HJ, 2006, NATURE, V439, P480, DOI 10.1038/nature04436; Hsu HJ, 2003, DEVELOPMENT, V130, P2107, DOI 10.1242/dev.00427; Hsu Hwei-Jan, 2002, Gene Expression Patterns, V2, P219, DOI 10.1016/S1567-133X(02)00059-5; James ML, 2006, CURR MED CHEM, V13, P1991, DOI 10.2174/092986706777584979; Jamin N, 2005, MOL ENDOCRINOL, V19, P588, DOI 10.1210/me.2004-0308; Joseph-Liauzun E, 1998, J BIOL CHEM, V273, P2146, DOI 10.1074/jbc.273.4.2146; KRUEGER KE, 1990, J BIOL CHEM, V265, P15015; Kwan TT, 2006, EXP HEMATOL, V34, P27, DOI 10.1016/j.exphem.2005.09.017; Lacapere JJ, 2003, STEROIDS, V68, P569, DOI 10.1016/S0039-128X(03)00101-6; Lacapere JJ, 2001, BIOCHEM BIOPH RES CO, V284, P536, DOI 10.1006/bbrc.2001.4975; Lacor P, 1999, BRAIN RES, V815, P70, DOI 10.1016/S0006-8993(98)01105-6; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; LEFUR G, 1983, LIFE SCI, V32, P1839, DOI 10.1016/0024-3205(83)90062-0; Li H, 2001, MOL ENDOCRINOL, V15, P2211, DOI 10.1210/me.15.12.2211; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Liao EC, 2002, DEVELOPMENT, V129, P649; Long QM, 2000, NAT CELL BIOL, V2, P549, DOI 10.1038/35019592; Maeda S, 1998, LIFE SCI, V63, P1423, DOI 10.1016/S0024-3205(98)00409-3; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; MEYER UA, 1991, HARRISONS PRINCIPLES, P1829; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nowak M, 2005, CELL DEATH DIFFER, V12, P52, DOI 10.1038/sj.cdd.4401519; OBEIRNE GB, 1990, EUR J BIOCHEM, V188, P131, DOI 10.1111/j.1432-1033.1990.tb15380.x; OKE BO, 1992, MOL CELL ENDOCRINOL, V87, pR1, DOI 10.1016/0303-7207(92)90248-5; OLSON JMM, 1988, EUR J PHARMACOL, V152, P47, DOI 10.1016/0014-2999(88)90834-5; Ostuni MA, 2004, AM J PHYSIOL-GASTR L, V286, pG1069, DOI 10.1152/ajpgi.00290.2003; PAPADOPOULOS V, 1993, ENDOCR REV, V14, P222, DOI 10.1210/er.14.2.222; Papadopoulos V, 2006, NEUROSCIENCE, V138, P749, DOI 10.1016/j.neuroscience.2005.05.063; Papadopoulos V, 1997, STEROIDS, V62, P21, DOI 10.1016/S0039-128X(96)00154-7; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Ransom DG, 1996, DEVELOPMENT, V123, P311; SNYDER SH, 1987, FASEB J, V1, P282, DOI 10.1096/fasebj.1.4.2820823; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Wang H, 1998, NAT GENET, V20, P239, DOI 10.1038/3041; Weinstein BM, 1996, DEVELOPMENT, V123, P303; Wendler G, 2003, BIOCHEM BIOPH RES CO, V311, P847, DOI 10.1016/j.bbrc.2003.10.070; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wilms H, 2003, NEUROBIOL DIS, V14, P417, DOI 10.1016/j.nbd.2003.07.002; Yergeau DA, 2005, DEV BIOL, V283, P97, DOI 10.1016/j.ydbio.2005.04.006	66	28	28	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4181	4192		10.1096/fj.09-129262	http://dx.doi.org/10.1096/fj.09-129262			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19723704				2022-12-25	WOS:000272193700014
J	Kaulfuss, S; von Hardenberg, S; Schweyer, S; Herr, AM; Laccone, F; Wolf, S; Burfeind, P				Kaulfuss, S.; von Hardenberg, S.; Schweyer, S.; Herr, A. M.; Laccone, F.; Wolf, S.; Burfeind, P.			Leupaxin acts as a mediator in prostate carcinoma progression through deregulation of p120catenin expression	ONCOGENE			English	Article						leupaxin; prostate cancer progression; p120CTN-mediated pathways	CELL-ADHESION PROTEINS; BETA-CATENIN; E-CADHERIN; MATRIX METALLOPROTEINASE-7; ANDROGEN RECEPTOR; FOCAL ADHESIONS; DOWN-REGULATION; ALPHA-CATENIN; LIM PROTEIN; CANCER	Recently, we could show that the focal adhesion protein leupaxin (LPXN) is expressed in human prostate carcinomas (PCa) and induces invasiveness of androgen-independent PCa cells. In this study we show that LPXN enhanced the progression of existing PCa in vivo by breeding transgenic mice with prostate-specific LPXN expression and TRAMP mice (transgenic adenocarcinoma of mouse prostate). Double transgenic LPXN/TRAMP mice showed a significant increase in poorly differentiated PCa and distant metastases as compared with control TRAMP mice. Additional studies on primary PCa cells generated from both transgenic backgrounds confirmed the connection regarding LPXN overexpression and increased motility and invasiveness of PCa cells. One mediator of LPXN-induced invasion was found to be the cell-cell adhesion protein p120catenin (p120CTN). Both in vitro and in vivo experiments revealed that p120CTN expression negatively correlates with LPXN expression, followed by a redistribution of beta-catenin. Downregulation of LPXN using small interfering RNAs (siRNAs) resulted in a membranous localization of beta-catenin, whereas strong nuclear accumulation of beta-catenin was observed in p120CTN knockdown cells leading to enhanced transcription of the beta-catenin target gene matrix metalloprotease-7. In conclusion, the present results indicate that LPXN enhances the progression of PCa through downregulation of p120CTN expression and that LPXN could function as a marker for aggressive PCa in the future. Oncogene (2009) 28, 3971-3982; doi:10.1038/onc.2009.254; published online 24 August 2009	[Kaulfuss, S.; von Hardenberg, S.; Herr, A. M.; Wolf, S.; Burfeind, P.] Univ Gottingen, Inst Human Genet, D-37073 Gottingen, Niedersachsen, Germany; [Schweyer, S.] Univ Gottingen, Dept Pathol, D-37073 Gottingen, Niedersachsen, Germany; [Laccone, F.] Med Univ Vienna, Dept Med Genet, Vienna, Austria	University of Gottingen; University of Gottingen; Medical University of Vienna	Kaulfuss, S (corresponding author), Univ Gottingen, Inst Human Genet, Heinrich Duker Weg 12, D-37073 Gottingen, Niedersachsen, Germany.	svoigt1@gwdg.de	Laccone, Franco A/B-3655-2018	Kaulfuss, Silke/0000-0003-2577-9711	Forschungs-forderungsprogramm of the Universitatsmedizin Gottingen; Deutsche Forschungsgemeinschaft [SK KA 2946/1-1]; Deutsche Krebshilfe [108065]; Horst Muggenburg and Gerhard Muggenburg-Stiftung	Forschungs-forderungsprogramm of the Universitatsmedizin Gottingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Horst Muggenburg and Gerhard Muggenburg-Stiftung	We thank R Kampe, B Konig and A Klages for their excellent technical assistance. We also thank M Schindler and H Riedesel for their assistance in generation of transgenic LPXN mice. This project was supported in part by the Forschungs-forderungsprogramm of the Universitatsmedizin Gottingen (to SK), by the Deutsche Forschungsgemeinschaft (to SK KA 2946/1-1), the Deutsche Krebshilfe (to PB and SS, no. 108065) and the Horst Muggenburg and Gerhard Muggenburg-Stiftung (to PB and SS).	ANASTASIADIS PZ, 2006, BIOCHIM BIOPHYS ACTA, V1773, P34; Becker-Hapak M, 2001, METHODS, V24, P247, DOI 10.1006/meth.2001.1186; Bidard FC, 2008, CANCER METAST REV, V27, P5, DOI 10.1007/s10555-007-9103-x; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Deakin NO, 2009, J CELL SCI, V122, P1654, DOI 10.1242/jcs.049130; Ellerbroek SM, 1999, BIOESSAYS, V21, P940, DOI 10.1002/(SICI)1521-1878(199911)21:11<940::AID-BIES6>3.3.CO;2-A; Fuchs SY, 2005, CELL CYCLE, V4, P1522; Fujimoto N, 1999, J BIOL CHEM, V274, P8316, DOI 10.1074/jbc.274.12.8316; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Grzmil M, 2003, AM J PATHOL, V163, P543, DOI 10.1016/S0002-9440(10)63682-6; Gupta A, 2003, J BONE MINER RES, V18, P669, DOI 10.1359/jbmr.2003.18.4.669; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hatzfeld M, 2005, EUR J CELL BIOL, V84, P205, DOI 10.1016/j.ejcb.2004.12.016; Ii M, 2006, EXP BIOL MED, V231, P20; Jagadeeswaran R, 2008, CANCER RES, V68, P132, DOI 10.1158/0008-5472.CAN-07-1998; Jaggi M, 2005, UROL ONCOL-SEMIN ORI, V23, P402, DOI 10.1016/j.urolonc.2005.03.024; Jones LE, 2004, CLIN CANCER RES, V10, P2832, DOI 10.1158/1078-0432.CCR-1157-03; Kallakury BVS, 2001, CANCER, V92, P2786, DOI 10.1002/1097-0142(20011201)92:11<2786::AID-CNCR10128>3.0.CO;2-I; Kallakury BVS, 2001, HUM PATHOL, V32, P849, DOI 10.1053/hupa.2001.26463; Kasai M, 2003, CANCER RES, V63, P4927; Kaulfuss S, 2008, MOL ENDOCRINOL, V22, P1606, DOI 10.1210/me.2006-0546; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lipsky BP, 1998, J BIOL CHEM, V273, P11709, DOI 10.1074/jbc.273.19.11709; Liu SC, 2002, J BIOL CHEM, V277, P20887, DOI 10.1074/jbc.M110928200; MCDONNELL S, 1991, MOL CARCINOGEN, V4, P527, DOI 10.1002/mc.2940040617; Millikan RE, 2008, J CLIN ONCOL, V26, P5936, DOI 10.1200/JCO.2007.15.9830; Nong CZ, 2006, WORLD J GASTROENTERO, V12, P1187, DOI 10.3748/wjg.v12.i8.1187; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Reynolds AB, 2004, SEMIN CELL DEV BIOL, V15, P657, DOI 10.1016/j.semcdb.2004.09.003; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Sahu SN, 2007, AM J PHYSIOL-CELL PH, V292, pC581, DOI 10.1152/ajpcell.00636.2005; Shibanuma M, 2004, J CELL BIOCHEM, V91, P633, DOI 10.1002/jcb.10754; Shibanuma M, 2003, MOL BIOL CELL, V14, P1158, DOI 10.1091/mbc.02-06-0099; Shiomi T, 2003, CANCER METAST REV, V22, P145, DOI 10.1023/A:1023039230052; Stetler-Stevenson W G, 2001, Surg Oncol Clin N Am, V10, P383; van Oort IM, 2007, PROSTATE, V67, P1432, DOI 10.1002/pros.20626; Wang H, 2005, J BIOL CHEM, V280, P5154, DOI 10.1074/jbc.M411575200; Wang H, 2008, ONCOGENE, V27, P6791, DOI 10.1038/onc.2008.291; Wegener KL, 2008, MOL MEMBR BIOL, V25, P376, DOI 10.1080/09687680802269886; Whitaker HC, 2008, PROSTATE, V68, P1196, DOI 10.1002/pros.20780; Yang L, 2000, MOL BIOL CELL, V11, P2007, DOI 10.1091/mbc.11.6.2007	47	7	10	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 12	2009	28	45					3971	3982		10.1038/onc.2009.254	http://dx.doi.org/10.1038/onc.2009.254			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	530AC	19701244				2022-12-25	WOS:000272560300003
J	Fox, JT; Stover, PJ				Fox, Jennifer T.; Stover, Patrick J.			Mechanism of the Internal Ribosome Entry Site-mediated Translation of Serine Hydroxymethyltransferase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(A) BINDING-PROTEIN; INITIATION-FACTOR 4A; MESSENGER-RNA; C-MYC; POLY(A)-BINDING PROTEIN; 3'-UNTRANSLATED REGION; DEPENDENT TRANSLATION; MYOTONIC-DYSTROPHY; HEPATITIS-C; IN-VITRO	The 5'-untranslated region (UTR) of serine hydroxymethyltransferase 1 (SHMT1) contains an internal ribosome entry site (IRES) that regulates SHMT1 expression, a rate-limiting enzyme in de novo thymidylate biosynthesis. In this study, we show that the SHMT1 IRES is the first example of a cellular IRES that is poly(A) tail-independent. Interactions between the 5'-UTR and 3'-UTR functionally replaced interactions between the poly( A) tail and the poly(A)-binding protein (PABP) to achieve maximal IRES-mediated translational efficiency. Depletion of the SHMT1 IRES-specific trans-acting factor (ITAF) CUG-binding protein 1 (CUGBP1) from in vitro translation extracts or deletion of the CUGBP1 binding site on the 3'-UTR of the SHMT1 transcript decreased the IRES activity of non-polyadenylylated biscis-tronic mRNAs relative to polyadenylylated biscistronic mRNAs and resulted in a requirement for PABP. We also identified a novel ITAF, heterogeneous nuclear ribonucleoprotein H2 (hnRNP H2), that stimulates SHMT1 IRES activity by binding to the 5'-UTR of the transcript and interacting with CUGBP1. Collectively, these data support a model for the IRES-mediated translation of SHMT1 whereby the circularization of the mRNA typically provided by the eukaryotic initiation factor (eIF) 4G/PABP/poly(A) tail interaction is achieved instead through the hnRNP H2/CUGBP1-mediated interaction of the 5'- and 3'-UTRs of the SHMT1 transcript. This circularization enhances the IRES activity of SHMT1 by facilitating the recruitment and/or recycling of ribosomal subunits, which bind to the transcript in the middle of the 5'UTR and migrate to the initiation codon via eIF4A-mediated scanning.	[Stover, Patrick J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; Cornell Univ, Grad Field Biochem & Mol & Cellular Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Stover, PJ (corresponding author), Cornell Univ, Div Nutr Sci, 315 Savage Hall, Ithaca, NY 14853 USA.	pjs13@cornell.edu			Public Health Service [DK58144]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058144, R37DK058144] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK58144 from the Public Health Service.	BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Bonnal S, 2005, J BIOL CHEM, V280, P4144, DOI 10.1074/jbc.M411492200; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Caputi M, 2001, J BIOL CHEM, V276, P43850, DOI 10.1074/jbc.M102861200; DANTHINNE X, 1993, MOL CELL BIOL, V13, P3340, DOI 10.1128/MCB.13.6.3340; Fox JT, 2009, J BIOL CHEM, V284, P31097, DOI 10.1074/jbc.M109.015800; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Giraud S, 2001, J BIOL CHEM, V276, P5668, DOI 10.1074/jbc.M005928200; Good PJ, 2000, J BIOL CHEM, V275, P28583, DOI 10.1074/jbc.M003083200; Hahn B, 1998, J VIROL, V72, P8782, DOI 10.1128/JVI.72.11.8782-8788.1998; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Holcik M, 2003, MOL CELL BIOL, V23, P280, DOI 10.1128/MCB.23.1.280-288.2003; Honore B, 2004, EXP CELL RES, V294, P199, DOI 10.1016/j.yexcr.2003.11.011; Ito T, 1998, J VIROL, V72, P8789, DOI 10.1128/JVI.72.11.8789-8796.1998; Jacobson A., 1996, TRANSLATIONAL CONTRO, P451; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Jopling CL, 2004, RNA, V10, P287, DOI 10.1261/rna.5138804; Khaleghpour K, 2001, MOL CELL, V7, P205, DOI 10.1016/S1097-2765(01)00168-X; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Le Quesne JPC, 2001, J MOL BIOL, V310, P111, DOI 10.1006/jmbi.2001.4745; LUUKKONEN BGM, 1995, J VIROL, V69, P4086, DOI 10.1128/JVI.69.7.4086-4094.1995; Meulewaeter F, 2004, NUCLEIC ACIDS RES, V32, P1721, DOI 10.1093/nar/gkh338; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; MUNROE D, 1990, MOL CELL BIOL, V10, P3441, DOI 10.1128/MCB.10.7.3441; Paul S, 2006, EMBO J, V25, P4271, DOI 10.1038/sj.emboj.7601296; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Roberts R, 1997, P NATL ACAD SCI USA, V94, P13221, DOI 10.1073/pnas.94.24.13221; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; SACHS AB, 1989, CELL, V58, P857, DOI 10.1016/0092-8674(89)90938-0; Sachs AB, 2000, NAT STRUCT BIOL, V7, P356, DOI 10.1038/75120; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Svitkin YV, 2001, RNA, V7, P1743; Tarun SZ, 1997, P NATL ACAD SCI USA, V94, P9046, DOI 10.1073/pnas.94.17.9046; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Thoma C, 2004, MOL CELL, V15, P925, DOI 10.1016/j.molcel.2004.08.021; Thoma C, 2008, RNA, V14, P1579, DOI 10.1261/rna.1043908; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Timchenko NA, 2005, J BIOL CHEM, V280, P20549, DOI 10.1074/jbc.M409563200; Uchida N, 2002, J BIOL CHEM, V277, P50286, DOI 10.1074/jbc.M203029200; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Wang SP, 1997, EMBO J, V16, P4107, DOI 10.1093/emboj/16.13.4107; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Woeller CF, 2007, J BIOL CHEM, V282, P29927, DOI 10.1074/jbc.M706264200	48	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31085	31096		10.1074/jbc.M109.035576	http://dx.doi.org/10.1074/jbc.M109.035576			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19734143	Green Published, hybrid			2022-12-25	WOS:000271378400037
J	Sato, M; Jiao, QB; Honda, T; Kurotani, R; Toyota, E; Okumura, S; Takeya, T; Minamisawa, S; Lanier, SM; Ishikawa, Y				Sato, Motohiko; Jiao, Qibin; Honda, Takashi; Kurotani, Reiko; Toyota, Eiji; Okumura, Satoshi; Takeya, Tatsuo; Minamisawa, Susumu; Lanier, Stephen M.; Ishikawa, Yoshihiro			Activator of G Protein Signaling 8 (AGS8) Is Required for Hypoxia-induced Apoptosis of Cardiomyocytes ROLE OF G beta gamma AND CONNEXIN 43 (CX43)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-INDEPENDENT ACTIVATOR; MITOCHONDRIAL-MEMBRANE; CARDIAC MYOCYTES; GROWTH-FACTOR; CONNEXIN-43; PHOSPHORYLATION; HEMICHANNELS; SELECTIVITY; ISCHEMIA; SUBUNITS	Ischemic injury of the heart is associated with activation of multiple signal transduction systems including the heterotrimeric G-protein system. Here, we report a role of the ischemia-inducible regulator of G beta gamma subunit, AGS8, in survival of cardiomyocytes under hypoxia. Cultured rat neonatal cardiomyocytes (NCM) were exposed to hypoxia or hypoxia/reoxygenation following transfection of AGS8siRNA or pcDNA::AGS8. Hypoxia-induced apoptosis of NCM was completely blocked by AGS8siRNA, whereas overexpression of AGS8 increased apoptosis. AGS8 formed complexes with G-proteins and channel protein connexin 43 (CX43), which regulates the permeability of small molecules under hypoxic stress. AGS8 initiated CX43 phosphorylation in a G beta gamma-dependent manner by providing a scaffold composed of G beta gamma and CX43. AGS8siRNA blocked internalization of CX43 following exposure of NCM to repetitive hypoxia; however it did not influence epidermal growth factor-mediated internalization of CX43. The decreased dye flux through CX43 that occurred with hypoxic stress was also prevented by AGS8siRNA. Interestingly, the G beta gamma inhibitor Gallein mimicked the effect of AGS8 knockdown on both the CX43 internalization and the changes in cell permeability elicited by hypoxic stress. These data indicate that AGS8 is required for hypoxia-induced apoptosis of NCM, and that AGS8-G beta gamma signal input increased the sensitivity of cells to hypoxic stress by influencing CX43 regulation and associated cell permeability. Under hypoxic stress, this unrecognized response program plays a critical role in the fate of NCM.	[Sato, Motohiko] Yokohama City Univ, Cardiovasc Res Inst, Sch Med, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Toyota, Eiji] Kawasaki Med Sch, Dept Cardiol, Kurashiki, Okayama 7010192, Japan; [Takeya, Tatsuo] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; [Minamisawa, Susumu] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo 1628480, Japan; [Lanier, Stephen M.] Med Univ S Carolina, Dept Pharmacol, Charleston, SC 29425 USA	Yokohama City University; Kawasaki Medical School; Nara Institute of Science & Technology; Waseda University; Medical University of South Carolina	Sato, M (corresponding author), Yokohama City Univ, Cardiovasc Res Inst, Sch Med, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	motosato@yokohama-cu.ac.jp; yishikaw@med.yokohama-cu.ac.jp		Minamisawa, Susumu/0000-0003-4728-2116; Lanier, Stephen/0000-0002-2740-7607	National Institutes of Health [NS24821, DA025896]; Yokohama City University, Japan [18599006, 20590212, 18057018, 193902217, K18017, K19021]; Takeda Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024821, R29NS024821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yokohama City University, Japan; Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS24821 and DA025896 (to S. M. L.). This work was also supported by Grants-in-Aid for Scientific Research (C) 18599006 and 20590212 (to M. S.) and 18057018 and 193902217 (to Y. I.), the Yokohama Foundation for Advancement of Medical Science (to M. S.), grants from the Strategic Research Project K18017 and K19021 of Yokohama City University, Japan (to M. S.), and a grant from the Takeda Science Foundation (to Y. I.).	Bao XY, 2007, P NATL ACAD SCI USA, V104, P4919, DOI 10.1073/pnas.0603154104; Birnbaumer L, 2007, BBA-BIOMEMBRANES, V1768, P772, DOI 10.1016/j.bbamem.2006.12.002; Bishopric Nanette H., 2001, Current Opinion in Pharmacology, V1, P141, DOI 10.1016/S1471-4892(01)00032-7; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Cismowski MJ, 2006, SEMIN CELL DEV BIOL, V17, P334, DOI 10.1016/j.semcdb.2006.03.003; Cook SA, 1999, CIRC RES, V85, P940; Ek-Vitorin JF, 2006, CIRC RES, V98, P1498, DOI 10.1161/01.RES.0000227572.45891.2c; Fernandes R, 2004, J BIOL CHEM, V279, P27219, DOI 10.1074/jbc.M400446200; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Hausenloy DJ, 2007, PHARMACOL THERAPEUT, V116, P173, DOI 10.1016/j.pharmthera.2007.06.005; Heinzel FR, 2005, CIRC RES, V97, P583, DOI 10.1161/01.RES.0000181171.65293.65; Hendriks-Balk MC, 2008, EUR J PHARMACOL, V585, P278, DOI 10.1016/j.ejphar.2008.02.088; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; Lampe PD, 2006, J CELL SCI, V119, P3435, DOI 10.1242/jcs.03089; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Li JX, 2008, J BIOL CHEM, V283, P34260, DOI 10.1074/jbc.M806087200; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Rodriguez-Sinovas A, 2007, PROG BIOPHYS MOL BIO, V94, P219, DOI 10.1016/j.pbiomolbio.2007.03.003; Rodriguez-Sinovas A, 2006, CIRC RES, V99, P93, DOI 10.1161/01.RES.0000230315.56904.de; Rogers JH, 1999, J CLIN INVEST, V104, P567, DOI 10.1172/JCI6713; Ruiz-Meana M, 2008, CARDIOVASC RES, V77, P325, DOI 10.1093/cvr/cvm062; Saffitz JE, 2005, ANN NY ACAD SCI, V1047, P336, DOI 10.1196/annals.1341.030; Sato M, 2006, P NATL ACAD SCI USA, V103, P797, DOI 10.1073/pnas.0507467103; Sato M, 2004, J BIOL CHEM, V279, P13375, DOI 10.1074/jbc.M312660200; Sato M, 1996, J BIOL CHEM, V271, P30052, DOI 10.1074/jbc.271.47.30052; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Sato Motohiko, 2010, Pathophysiology, V17, P89, DOI 10.1016/j.pathophys.2009.03.011; Schulz R, 2003, FASEB J, V17, P1355, DOI 10.1096/fj.02-0975fje; Schwanke U, 2002, AM J PHYSIOL-HEART C, V283, pH1740, DOI 10.1152/ajpheart.00442.2002; Shintani-Ishida K, 2007, AM J PHYSIOL-HEART C, V293, pH1714, DOI 10.1152/ajpheart.00022.2007; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Solan JL, 2007, J CELL BIOL, V179, P1301, DOI 10.1083/jcb.200707060; Toyota E, 2005, CIRCULATION, V112, P2108, DOI 10.1161/CIRCULATIONAHA.104.526954; Turner MS, 2004, CIRC RES, V95, P726, DOI 10.1161/01.RES.0000144805.11519.1e; Webster KA, 2007, TRENDS PHARMACOL SCI, V28, P492, DOI 10.1016/j.tips.2007.07.004; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yogo K, 2002, FEBS LETT, V531, P132, DOI 10.1016/S0014-5793(02)03441-5; Yuan CJ, 2007, J BIOL CHEM, V282, P19938, DOI 10.1074/jbc.M700396200	42	54	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31431	31440		10.1074/jbc.M109.014068	http://dx.doi.org/10.1074/jbc.M109.014068			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19723622	Green Published, hybrid			2022-12-25	WOS:000271378400068
J	Shiryaev, SA; Remacle, AG; Savinov, AY; Chernov, AV; Cieplak, P; Radichev, IA; Williams, R; Shiryaeva, TN; Gawlik, K; Postnova, TI; Ratnikov, BI; Eroshkin, AM; Motamedchaboki, K; Smith, JW; Strongin, AY				Shiryaev, Sergey A.; Remacle, Albert G.; Savinov, Alexei Y.; Chernov, Andrei V.; Cieplak, Piotr; Radichev, Ilian A.; Williams, Roy; Shiryaeva, Tatiana N.; Gawlik, Katarzyna; Postnova, Tatiana I.; Ratnikov, Boris I.; Eroshkin, Alexei M.; Motamedchaboki, Khatereh; Smith, Jeffrey W.; Strongin, Alex Y.			Inflammatory Proprotein Convertase-Matrix Metalloproteinase Proteolytic Pathway in Antigen-presenting Cells as a Step to Autoimmune Multiple Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN BASIC-PROTEIN; ALPHA-B-CRYSTALLIN; ALTERED PEPTIDE LIGANDS; ENCEPHALOMYELITIS; EXPRESSION; IMMUNE; FURIN; MICE; GENE; EPITOPE	Multiple sclerosis ( MS) is a disease of the central nervous system with autoimmune etiology. Susceptibility to MS is linked to viral and bacterial infections. Matrix metalloproteinases ( MMPs) play a significant role in the fragmentation of myelin basic protein (MBP) and demyelination. The splice variants of the single MBP gene are expressed in the oligodendrocytes of the central nervous system ( classic MBP) and in the immune cells (Golli-MBPs). Our data suggest that persistent inflammation caused by environmental risk factors is a step to MS. We have discovered biochemical evidence suggesting the presence of the inflammatory proteolytic pathway leading to MS. The pathway involves the self-activated furin and PC2 proprotein convertases and membrane type-6 MMP (MT6-MMP/MMP-25) that is activated by furin/PC2. These events are followed by MMP-25 proteolysis of the Golli-MBP isoforms in the immune system cells and stimulation of the specific autoimmune T cell clones. It is likely that the passage of these autoimmune T cell clones through the disrupted blood-brain barrier to the brain and the recognition of neuronal, classic MBP causes inflammation leading to the further up-regulation of the activity of the multiple individual MMPs, the massive cleavage of MBP in the brain, demyelination, and MS. In addition to the cleavage of Golli-MBPs, MMP-25 proteolysis readily inactivates crystallin alpha B that is a suppressor of MS. These data suggest that MMP-25 plays an important role in MS pathology and that MMP-25, especially because of its restricted cell/tissue expression pattern and cell surface/lipid raft localization, is a promising drug target in MS.	[Shiryaev, Sergey A.; Remacle, Albert G.; Savinov, Alexei Y.; Chernov, Andrei V.; Cieplak, Piotr; Radichev, Ilian A.; Williams, Roy; Shiryaeva, Tatiana N.; Gawlik, Katarzyna; Postnova, Tatiana I.; Ratnikov, Boris I.; Eroshkin, Alexei M.; Motamedchaboki, Khatereh; Smith, Jeffrey W.; Strongin, Alex Y.] Burnham Inst Med Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), Burnham Inst Med Res, La Jolla, CA 92037 USA.	strongin@burnham.org	Strongin, Alex/R-6609-2019; Chernov, Andrei/I-1623-2019; Messier, Claude/A-2322-2008	Strongin, Alex/0000-0003-3765-3016; Chernov, Andrei/0000-0002-3294-5418; Messier, Claude/0000-0002-4791-1763; Williams, Roy/0000-0002-5442-9166	National Institutes of Health [CA83017, CA77470, RR020843]; NATIONAL CANCER INSTITUTE [R01CA083017, R01CA077470] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA83017 and CA77470 ( to A. Y. S.) and RR020843 ( to J. W. S. and A. Y. S.).	ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; Bar-Or A, 2007, ARCH NEUROL-CHICAGO, V64, P1407, DOI 10.1001/archneur.64.10.nct70002; CAMPAGNONI AT, 1993, J BIOL CHEM, V268, P4930; Chen EI, 2003, J BIOL CHEM, V278, P17158, DOI 10.1074/jbc.M210324200; Cheng M, 1997, INT J CANCER, V71, P966, DOI 10.1002/(SICI)1097-0215(19970611)71:6<966::AID-IJC10>3.3.CO;2-A; DaSliva AG, 2008, J NEUROIMMUNOL, V199, P24, DOI 10.1016/j.jneuroim.2008.04.034; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Feng JM, 2007, NEUROCHEM RES, V32, P273, DOI 10.1007/s11064-006-9164-1; Feng JM, 2004, J NEUROIMMUNOL, V152, P57, DOI 10.1016/j.jneuroim.2004.03.021; Folgueras AR, 2008, J BIOL CHEM, V283, P9465, DOI 10.1074/jbc.M709522200; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; FUGGER L, 2009, NAT REV IMM IN PRESS; Gawlik K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005031; Goodin DS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004565; Hellings N, 2001, J NEUROSCI RES, V63, P290, DOI 10.1002/1097-4547(20010201)63:3<290::AID-JNR1023>3.0.CO;2-4; Jacobs EC, 2005, J NEUROSCI, V25, P7004, DOI 10.1523/JNEUROSCI.0288-05.2005; Katsara M, 2008, J MED CHEM, V51, P3971, DOI 10.1021/jm8000554; Kridel SJ, 2002, J BIOL CHEM, V277, P23788, DOI 10.1074/jbc.M111574200; Matsoukas J, 2005, J MED CHEM, V48, P1470, DOI 10.1021/jm040849g; Menezes JS, 2007, J CLIN INVEST, V117, P2176, DOI 10.1172/JCI28277; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; PRIBYL TM, 1993, P NATL ACAD SCI USA, V90, P10695, DOI 10.1073/pnas.90.22.10695; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; Rosenberg GA, 2002, NEUROSCIENTIST, V8, P586, DOI 10.1177/1073858402238517; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seo J, 2002, COMPUTER, V35, P80; Shiryaev SA, 2007, J BIOL CHEM, V282, P20847, DOI 10.1074/jbc.M703847200; Shiryaev SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004952; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Starckx S, 2003, J NEUROIMMUNOL, V141, P47, DOI 10.1016/S0165-5728(03)00217-0; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Steinman L, 2001, J CLIN IMMUNOL, V21, P93, DOI 10.1023/A:1011020225433; STEINMAN L, 1995, MOL MED TODAY, V1, P79, DOI 10.1016/S1357-4310(95)92366-7; Stoevring B, 2005, CLIN CHIM ACTA, V356, P95, DOI 10.1016/j.cccn.2005.01.034; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Thoua NM, 2000, J NEUROIMMUNOL, V104, P47, DOI 10.1016/S0165-5728(99)00246-5; Toft-Hansen H, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-24; Tselios T, 2002, J MED CHEM, V45, P275, DOI 10.1021/jm0102147; Ulrich R, 2006, J NEUROPATH EXP NEUR, V65, P783, DOI 10.1097/01.jnen.0000229990.32795.0d; van Horssen J, 2006, NEUROPATH APPL NEURO, V32, P585, DOI 10.1111/j.1365-2990.2006.00766.x; VANNOORT JM, 1995, NATURE, V375, P798, DOI 10.1038/375798a0; Vos CMP, 2003, J NEUROIMMUNOL, V138, P106, DOI 10.1016/S0165-5728(03)00036-5; Voskuhl RR, 1996, J NEUROIMMUNOL, V70, P103, DOI 10.1016/S0165-5728(96)00054-9; Weaver A, 2005, FASEB J, V19, P1668, DOI 10.1096/fj.04-2030fje; Werner SR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-83; Wucherpfennig KW, 1997, J CLIN INVEST, V100, P1114, DOI 10.1172/JCI119622	48	40	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30615	30626		10.1074/jbc.M109.041244	http://dx.doi.org/10.1074/jbc.M109.041244			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726693	hybrid, Green Published			2022-12-25	WOS:000271090000064
J	Donkor, J; Zhang, PX; Wong, S; O'Loughlin, L; Dewald, J; Kok, BPC; Brindley, DN; Reue, K				Donkor, Jimmy; Zhang, Peixiang; Wong, Samantha; O'Loughlin, Lauren; Dewald, Jay; Kok, Bernard P. C.; Brindley, David N.; Reue, Karen			A Conserved Serine Residue Is Required for the Phosphatidate Phosphatase Activity but Not the Transcriptional Coactivator Functions of Lipin-1 and Lipin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECURRENT MULTIFOCAL OSTEOMYELITIS; DYSTROPHY FLD MUTATION; ENDOPLASMIC-RETICULUM; ACID PHOSPHATASE; MAJEED-SYNDROME; RAT-LIVER; GENE; METABOLISM; EXPRESSION; DISTINCT	Mammalian lipins (lipin-1, lipin-2, and lipin-3) are Mg2+-dependent phosphatidate phosphatase (PAP) enzymes, which catalyze a key reaction in glycerolipid biosynthesis. Lipin-1 also functions as a transcriptional coactivator in conjunction with members of the peroxisome proliferator-activated receptor family. An S734L mutation in LPIN2 causes Majeed syndrome, a human inflammatory disorder characterized by recurrent osteomyelitis, fever, dyserythropoietic anemia, and cutaneous inflammation. Here we demonstrate that mutation of the equivalent serine in mouse lipin-1 and lipin-2 to leucine or aspartate abolishes PAP activity but does not impair lipin association with microsomal membranes, the major site of glycerolipid synthesis. We also determined that lipin-2 has transcriptional coactivator activity for peroxisome proliferator-activated receptor-response elements similar to lipin-1 and that this activity is not affected by mutating the conserved serine. Therefore, our results indicate that the symptoms of the Majeed syndrome result from a loss of lipin-2 PAP activity. To characterize sites of lipin-2 action, we detected lipin-2 expression by in situ hybridization on whole mouse sections and by quantitative PCR of tissues relevant to Majeed syndrome. Lipin-2 was most prominently expressed in liver, where levels were much higher than lipin-1, and also in kidney, lung, gastrointestinal tract, and specific regions of the brain. Lipin-2 was also expressed in circulating red blood cells and sites of lymphopoiesis (bone marrow, thymus, and spleen). These results raise the possibility that the loss of lipin-2 PAP activity in erythrocytes and lymphocytes may contribute to the anemia and inflammation phenotypes observed in Majeed syndrome patients.	[Donkor, Jimmy; Zhang, Peixiang; Wong, Samantha; O'Loughlin, Lauren; Reue, Karen] Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Donkor, Jimmy; Zhang, Peixiang; Wong, Samantha; O'Loughlin, Lauren; Reue, Karen] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Dewald, Jay; Kok, Bernard P. C.; Brindley, David N.] Univ Alberta, Signal Transduct Res Grp, Dept Biochem, Edmonton, AB T6G 252, Canada	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Alberta	Reue, K (corresponding author), Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Gonda 6506A,,695 Charles E Young Dr S, Los Angeles, CA 90095 USA.	reuek@ucla.edu		Kok, Bernard/0000-0002-9073-9700	National Institutes of Health [HL28481, HL90553, S-T32-HG002536]; Canadian Institute of Health Research [MOP 89726]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553, P01HL028481] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL28481 and HL90553 (to K. R.) and S-T32-HG002536 (to J. D.). This work was also supported by Canadian Institute of Health Research Grant MOP 89726 (to D. N. B.).	Al-Mosawi ZS, 2007, ARTHRITIS RHEUM, V56, P960, DOI 10.1002/art.22431; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538; Donkor J, 2008, J CLIN ENDOCR METAB, V93, P233, DOI 10.1210/jc.2007-1535; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; El-Shanti HI, 2007, CLIN ORTHOP RELAT R, P11, DOI 10.1097/BLO.0b013e3180986d73; Ferguson PJ, 2005, J MED GENET, V42, P551, DOI 10.1136/jmg.2005.030759; Ferguson PJ, 2007, CURR OPIN RHEUMATOL, V19, P492, DOI 10.1097/BOR.0b013e32825f5492; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; GOMEZMUNOZ A, 1992, FEBS LETT, V301, P103, DOI 10.1016/0014-5793(92)80219-7; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Grkovich A, 2009, ADV ENZYME REGUL, V49, P114, DOI 10.1016/j.advenzreg.2009.01.005; Gropler MC, 2009, J BIOL CHEM, V284, P6763, DOI 10.1074/jbc.M807882200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; HOPEWELL R, 1985, BIOCHEM J, V232, P485, DOI 10.1042/bj2320485; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; LANGNER CA, 1991, J BIOL CHEM, V266, P11955; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; Manmontri B, 2008, J LIPID RES, V49, P1056, DOI 10.1194/jlr.M800013-JLR200; MARTIN A, 1991, METHOD ENZYMOL, V197, P553; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Reue K, 2000, J LIPID RES, V41, P1067; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002	32	95	104	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29968	29978		10.1074/jbc.M109.023663	http://dx.doi.org/10.1074/jbc.M109.023663			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19717560	Green Published, hybrid			2022-12-25	WOS:000270896800075
J	Dries, DR; Shah, S; Han, YH; Yu, C; Yu, S; Shearman, MS; Yu, G				Dries, Daniel R.; Shah, Sanjiv; Han, Yu-Hong; Yu, Cong; Yu, Sophie; Shearman, Mark S.; Yu, Gang			Glu-333 of Nicastrin Directly Participates in gamma-Secretase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY INTRAMEMBRANE PROTEASE; ALZHEIMERS-DISEASE; PRESENILIN ENDOPROTEOLYSIS; TERMINAL FRAGMENTS; BINDING-SITE; COMPLEX; CLEAVAGE; PEN-2; MECHANISM; MEMBRANE	gamma-Secretase is a proteolytic membrane complex that processes a variety of substrates including the amyloid precursor protein and the Notch receptor. Earlier we showed that one of the components of this complex, nicastrin (NCT), functions as a receptor for gamma-secretase substrates. A recent report challenged this, arguing instead that the Glu-333 residue of NCT predicted to participate in substrate recognition only participates in gamma-secretase complex maturation and not in activity per se. Here, we present evidence that Glu-333 directly participates in gamma-secretase activity. By normalizing to the active pool of gamma-secretase with two separate methods, we establish that gamma-secretase complexes containing NCT-E333A are indeed deficient in intrinsic activity. We also demonstrate that the NCT-E333A mutant is deficient in its binding to substrates. Moreover, we find that the cleavage of substrates by gamma-secretase activity requires a free N-terminal amine but no minimal length of the extracellular N-terminal stub. Taken together, these studies provide further evidence supporting the role of NCT in substrate recognition. Finally, because gamma-secretase cleaves itself during its maturation and because NCT-E333A also shows defects in gamma-secretase complex maturation, we present a model whereby Glu-333 can serve a dual role via similar mechanisms in the recruitment of both Type 1 membrane proteins for activity and the presenilin intracellular loop during complex maturation.	[Yu, Gang] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Shah, Sanjiv; Yu, Sophie; Shearman, Mark S.] Merck Res Labs, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Merck & Company	Yu, G (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	Gang.Yu@UTSouthwestern.edu		DRIES, DANIEL/0000-0002-0530-5212	National Institutes of Health [F32 AG031625, R01 AG023104, R01 AG029547]; Welch Foundation [I-1566]; Ted Nash Long Life Foundation; NATIONAL INSTITUTE ON AGING [R01AG029547, F32AG031625, R01AG023104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Ted Nash Long Life Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants F32 AG031625 (to D. R. D.), R01 AG023104, and R01 AG029547. This work was also supported by the Welch Foundation (I-1566) and the Ted Nash Long Life Foundation.	ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Brunkan AL, 2005, MOL CELL NEUROSCI, V29, P65, DOI 10.1016/j.mcn.2004.12.012; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; Clarke EE, 2006, J BIOL CHEM, V281, P31279, DOI 10.1074/jbc.M605051200; Das C, 2003, J AM CHEM SOC, V125, P11794, DOI 10.1021/ja037131v; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Dries DR, 2009, P NATL ACAD SCI USA, V106, P14737, DOI 10.1073/pnas.0908124106; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fagan R, 2001, TRENDS BIOCHEM SCI, V26, P213, DOI 10.1016/S0968-0004(01)01789-3; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hayashi I, 2004, J BIOL CHEM, V279, P38040, DOI 10.1074/jbc.M405597200; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Hulko M, 2007, PROTEIN SCI, V16, P644, DOI 10.1110/ps.062478607; Khan AR, 1998, PROTEIN SCI, V7, P815; Kim SH, 2004, J BIOL CHEM, V279, P48615, DOI 10.1074/jbc.C400396200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Knappenberger KS, 2004, BIOCHEMISTRY-US, V43, P6208, DOI 10.1021/bi036072v; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Laudon H, 2004, J NEUROCHEM, V89, P44, DOI 10.1046/j.1471-4159.2003.02298.x; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Levitan D, 2001, P NATL ACAD SCI USA, V98, P12186, DOI 10.1073/pnas.211321898; Li XC, 2009, P NATL ACAD SCI USA, V106, P14837, DOI 10.1073/pnas.0903289106; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Luciani N, 1998, BIOCHEMISTRY-US, V37, P686, DOI 10.1021/bi971705p; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Martin L, 2009, J BIOL CHEM, V284, P5662, DOI 10.1074/jbc.M807485200; Nyborg AC, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-3; PerezTur J, 1995, NEUROREPORT, V7, P297; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shiraishi H, 2004, J NEUROCHEM, V90, P1402, DOI 10.1111/j.1471-4159.2004.02597.x; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Steiner H, 2008, CURR ALZHEIMER RES, V5, P147, DOI 10.2174/156720508783954677; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Vazeux G, 1998, BIOCHEM J, V334, P407, DOI 10.1042/bj3340407; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Wolfe MS, 2006, BIOCHEMISTRY-US, V45, P7931, DOI 10.1021/bi060799c; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Yu G, 2000, J BIOL CHEM, V275, P27348; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhang LL, 2005, BIOCHEMISTRY-US, V44, P4450, DOI 10.1021/bi0481500; Zhao GJ, 2007, J NEUROCHEM, V100, P1234, DOI 10.1111/j.1471-4159.2006.04302.x	57	54	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29714	29724		10.1074/jbc.M109.038737	http://dx.doi.org/10.1074/jbc.M109.038737			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19729449	Green Published, hybrid			2022-12-25	WOS:000270896800053
J	Sabina, J; Johnston, M				Sabina, Jeffrey; Johnston, Mark			Asymmetric Signal Transduction through Paralogs That Comprise a Genetic Switch for Sugar Sensing in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE SENSORS; CATABOLITE REPRESSION; KLUYVEROMYCES-LACTIS; CANDIDA-ALBICANS; MESSENGER-RNAS; DNA-BINDING; YEAST; EXPRESSION; RGT1; MTH1	Efficient uptake of glucose is especially critical to Saccharomyces cerevisiae because its preference to ferment this carbon source demands high flux through glycolysis. Glucose induces expression of HXT genes encoding hexose transporters through a signal generated by the Snf3 and Rgt2 glucose sensors that leads to depletion of the transcriptional regulators Mth1 and Std1. These paralogous proteins bind to Rgt1 and enable it to repress expression of HXT genes. Here we show that Mth1 and Std1 can substitute for one another and provide nearly normal regulation of their targets. However, their roles in the glucose signal transduction cascade have diverged significantly. Mth1 is the prominent effector of Rgt1 function because it is the more abundant of the two paralogs under conditions in which both are active (in the absence of glucose). Moreover, the cellular level of Mth1 is quite sensitive to the amount of available glucose. The abundance of Std1 protein, on the other hand, remains essentially constant over a similar range of glucose concentrations. The signal generated by low levels of glucose is amplified by rapid depletion of Mth1; the velocity of this depletion is dependent on both its rate of degradation and swift repression of MTH1 transcription by the Snf1-Mig1 glucose repression pathway. Quantitation of the contributions of Mth1 and Std1 to regulation of HXT expression reveals the unique roles played by each paralog in integrating nutrient availability with metabolic capacity: Mth1 is the primary regulator; Std1 serves to buffer the response to glucose.	[Johnston, Mark] Univ Colorado Denver, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Sabina, Jeffrey; Johnston, Mark] Washington Univ, Dept Genet, St Louis, MO 63108 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Washington University (WUSTL)	Johnston, M (corresponding author), Univ Colorado Denver, Dept Biochem & Mol Genet, Anschutz Med Campus,Mail Stop 8101,POB 6511, Aurora, CO 80045 USA.	Mark.Johnston@ucdenver.edu	Johnston, Mark/K-3543-2019; Johnston, Mark/R-6156-2019	Johnston, Mark/0000-0002-4932-7229; 	National Institutes of Health [GM32540]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032540, F32GM076967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32540 (to M. J.).	ALON U, 2007, INTRO SYSTEMS BIOL D, P5; Betina S, 2001, GENETICS, V158, P541; Brachmann CB, 1998, YEAST, V14, P115; Braud S, 2005, J PROTEOME RES, V4, P2137, DOI 10.1021/pr050230i; Brown V, 2006, EUKARYOT CELL, V5, P1726, DOI 10.1128/EC.00186-06; FLICK JS, 1991, MOL CELL BIOL, V11, P5101, DOI 10.1128/MCB.11.10.5101; Flick KM, 2003, MOL BIOL CELL, V14, P3230, DOI 10.1091/mbc.E03-03-0135; GAMO FJ, 1994, J BACTERIOL, V176, P7423, DOI 10.1128/JB.176.24.7423-7429.1994; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; Gerke JP, 2006, GENETICS, V174, P985, DOI 10.1534/genetics.106.058453; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Gordon JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000485; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hnatova M, 2008, EUKARYOT CELL, V7, P1299, DOI 10.1128/EC.00454-07; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Kaniak A, 2004, EUKARYOT CELL, V3, P221, DOI 10.1128/EC.3.1.221-231.2004; KARPEISKY MY, 1994, FEBS LETT, V339, P209, DOI 10.1016/0014-5793(94)80417-6; Kelemen BR, 1999, NUCLEIC ACIDS RES, V27, P3696, DOI 10.1093/nar/27.18.3696; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kim JH, 2006, J BIOL CHEM, V281, P26144, DOI 10.1074/jbc.M603636200; Kim JH, 2009, BIOCHIMIE, V91, P300, DOI 10.1016/j.biochi.2008.09.002; Kim JH, 2006, EUKARYOT CELL, V5, P167, DOI 10.1128/EC.5.1.167-173.2006; Kim JH, 2003, MOL CELL BIOL, V23, P5208, DOI 10.1128/MCB.23.15.5208-5216.2003; Kuchin S, 2003, GENETICS, V163, P507; Lafuente MJ, 2000, MOL MICROBIOL, V35, P161, DOI 10.1046/j.1365-2958.2000.01688.x; Lakshmanan J, 2003, CURR GENET, V44, P19, DOI 10.1007/s00294-003-0423-2; Lindsley JE, 2004, COMP BIOCHEM PHYS B, V139, P543, DOI 10.1016/j.cbpc.2004.06.014; Lutfiyya LL, 1998, GENETICS, V150, P1377; Miller JH., 1972, EXPT MOL GENETICS; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; OZCAN S, 1993, J BACTERIOL, V175, P5520, DOI 10.1128/JB.175.17.5520-5528.1993; Ozcan S, 1998, EMBO J, V17, P2566, DOI 10.1093/emboj/17.9.2566; OZCAN S, 1995, MOL CELL BIOL, V15, P1564; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; Pasula S, 2007, FEBS LETT, V581, P3230, DOI 10.1016/j.febslet.2007.06.013; Polish JA, 2005, GENETICS, V169, P583, DOI 10.1534/genetics.104.034512; Poulsen P, 2005, BIOCHEM SOC T, V33, P261, DOI 10.1042/BST0330261; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Schmidt MC, 1999, MOL CELL BIOL, V19, P4561; Schulte F, 2000, J BACTERIOL, V182, P540, DOI 10.1128/JB.182.2.540-542.2000; Sexton JA, 2007, YEAST, V24, P847, DOI 10.1002/yea.1514; SIKORSKI RS, 1989, GENETICS, V122, P19; Spielewoy N, 2004, MOL CELL BIOL, V24, P8994, DOI 10.1128/MCB.24.20.8994-9005.2004; Stasyk OG, 2008, EUKARYOT CELL, V7, P735, DOI 10.1128/EC.00028-08; ULLMANN A, 1967, J MOL BIOL, V24, P339, DOI 10.1016/0022-2836(67)90341-5; Westholm JO, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-601; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Yin ZK, 1996, MOL MICROBIOL, V20, P751, DOI 10.1111/j.1365-2958.1996.tb02514.x; Yin ZK, 2000, MOL MICROBIOL, V35, P553, DOI 10.1046/j.1365-2958.2000.01723.x	52	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29635	29643		10.1074/jbc.M109.032102	http://dx.doi.org/10.1074/jbc.M109.032102			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19720826	Green Published, hybrid			2022-12-25	WOS:000270896800045
J	de Luca, A; Vassallo, S; Benitez-Temino, B; Menichetti, G; Rossi, F; Buffo, A				de Luca, Annarita; Vassallo, Stefania; Benitez-Temino, Beatriz; Menichetti, Gianluca; Rossi, Ferdinando; Buffo, Annalisa			Distinct Modes of Neuritic Growth in Purkinje Neurons at Different Developmental Stages: Axonal Morphogenesis and Cellular Regulatory Mechanisms	PLOS ONE			English	Article							CEREBELLAR PURKINJE; POSTNATAL-DEVELOPMENT; CELLS; EXPRESSION; PROTEIN; REGENERATION; PARVALBUMIN; DEGRADATION; SURVIVAL; AXOTOMY	Background: During development, neurons modify their axon growth mode switching from an elongating phase, in which the main axon stem reaches the target territory through growth cone-driven extension, to an arborising phase, when the terminal arbour is formed to establish synaptic connections. To investigate the relative contribution of cell-autonomous factors and environmental signals in the control of these distinct axon growth patterns, we examined the neuritogenesis of Purkinje neurons in cerebellar cultures prepared at elongating ( embryonic day 17) or arborising ( postnatal day zero) stages of Purkinje axon maturation. Methodology/Principal Findings: When placed in vitro, Purkinje cells of both ages undergo an initial phase of neurite elongation followed by the development of terminal ramifications. Nevertheless, elongation of the main axon stem prevails in embryonic Purkinje axons, and many of these neurons are totally unable to form terminal branches. On the contrary, all postnatal neurites switch to arbour growth within a few days in culture and spread extensive terminal trees. Regardless of their elongating or arborising pattern, defined growth features ( e. g. growth rate and tree extension) of embryonic Purkinje axons remain distinct from those of postnatal neurites. Thus, Purkinje neurons of different ages are endowed with intrinsic stage-specific competence for neuritic growth. Such competence, however, can be modified by environmental cues. Indeed, while exposure to the postnatal environment stimulates the growth of embryonic axons without modifying their phenotype, contact-mediated signals derived from granule cells specifically induce arborising growth and modulate the dynamics of neuritic elongation. Conclusions/Significance: Cultured Purkinje cells recapitulate an intrinsically coded neuritogenic program, involving initial navigation of the axon towards the target field and subsequent expansion of the terminal arborisation. The execution of this program is regulated by environmental signals that modify the growth competence of Purkinje cells, so to adapt their endogenous properties to the different phases of neuritic morphogenesis.			de Luca, A (corresponding author), Univ Turin, Dept Neurosci, Turin, Italy.	annalisa.buffo@unito.it	Buffo, Annalisa/O-7207-2019; Benítez Temiño, Beatriz/F-8888-2015; Buffo, Annalisa/K-4560-2016	Buffo, Annalisa/0000-0001-7637-0006; Benítez Temiño, Beatriz/0000-0002-3852-1093; Buffo, Annalisa/0000-0001-7637-0006				Aloy EM, 2006, BRAIN CELL BIOL, V35, P137, DOI 10.1007/s11068-007-9014-3; Altman J, 1997, DEV CEREBELLAR SYSTE; BAPTISTA CA, 1994, NEURON, V12, P243, DOI 10.1016/0896-6273(94)90268-2; BEATTIE CE, 1993, J NEUROSCI, V13, P1784; Behringer KA, 1996, J NEUROCHEM, V66, P1347; Bhide PG, 1999, J COMP NEUROL, V411, P119; Buffo A, 1997, J NEUROSCI, V17, P8778; Buffo A, 2000, J NEUROSCI, V20, P2275; Canal I, 1998, J NEUROSCI, V18, P999; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Chan-Palay V, 1977, CEREBELLAR DENTATE N; CHEDOTAL A, 1993, DEV BRAIN RES, V76, P207, DOI 10.1016/0165-3806(93)90209-S; Corvetti L, 2005, J NEUROSCI, V25, P7150, DOI 10.1523/JNEUROSCI.0683-05.2005; DAVIES AM, 1989, NATURE, V337, P553, DOI 10.1038/337553a0; DAVIES AM, 1994, CURR BIOL, V4, P1142, DOI 10.1016/S0960-9822(00)00258-X; Dusart I, 1999, J COMP NEUROL, V408, P399; DUSART I, 1994, J COMP NEUROL, V347, P211, DOI 10.1002/cne.903470206; Dusart I, 1997, J NEUROSCI, V17, P3710; EISENMAN LM, 1991, DEV BRAIN RES, V60, P261, DOI 10.1016/0165-3806(91)90055-N; ERZURUMLU RS, 1995, EXP NEUROL, V135, P1, DOI 10.1006/exnr.1995.1061; FAWCETT J, 2001, BRAIN DAMAGE BRAIN R; GARDETTE R, 1985, DEV BRAIN RES, V19, P47, DOI 10.1016/0165-3806(85)90230-5; Gianola S, 2003, J NEUROSCI, V23, P4613; Gianola S, 2002, EXP NEUROL, V176, P25, DOI 10.1006/exnr.2002.7924; Gianola S, 2009, NEUROSCIENCE, V158, P570, DOI 10.1016/j.neuroscience.2008.10.022; Gianola S, 2001, J COMP NEUROL, V430, P101, DOI 10.1002/1096-9861(20010129)430:1<101::AID-CNE1017>3.0.CO;2-Z; Goldberg JL, 2003, GENE DEV, V17, P941, DOI 10.1101/gad.1062303; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Goslin, 1998, CULTURING NERVE CELL, P419; Grusser-Cornehls U, 2001, PROG NEUROBIOL, V63, P489, DOI 10.1016/S0301-0082(00)00024-1; Hirai H, 2000, J NEUROSCI, V20, P5217, DOI 10.1523/JNEUROSCI.20-14-05217.2000; HOKFELT T, 1994, TRENDS NEUROSCI, V17, P22, DOI 10.1016/0166-2236(94)90031-0; KAPFHAMMER JP, 1994, J COMP NEUROL, V340, P194, DOI 10.1002/cne.903400206; Maricich SM, 1999, J NEUROBIOL, V41, P281, DOI 10.1002/(SICI)1097-4695(19991105)41:2<281::AID-NEU10>3.0.CO;2-5; Morrison ME, 1998, J NEUROSCI, V18, P3563; Oldreive CE, 2008, NEUROSCI LETT, V438, P17, DOI 10.1016/j.neulet.2008.04.045; Ozdinler PH, 2002, J NEUROSCI, V22, P4540, DOI 10.1523/JNEUROSCI.22-11-04540.2002; Pfister BJ, 2004, J NEUROSCI, V24, P7978, DOI 10.1523/JNEUROSCI.1974-04.2004; Poulain FE, 2008, J NEUROSCI, V28, P7387, DOI 10.1523/JNEUROSCI.1942-08.2008; Rossi F, 2007, PROG NEUROBIOL, V81, P1, DOI 10.1016/j.pneurobio.2006.12.001; Rossi F, 2006, CEREBELLUM, V5, P174, DOI 10.1080/14734220600786444; SCHREYER DJ, 1991, J NEUROSCI, V11, P3738; SKENE JHP, 1989, ANNU REV NEUROSCI, V12, P127, DOI 10.1146/annurev.ne.12.030189.001015; Smith DS, 1997, J NEUROSCI, V17, P646; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; SOTELO C, 2009, NEUROSCIENC IN PRESS; Ulupinar E, 1999, MOL CELL NEUROSCI, V13, P281, DOI 10.1006/mcne.1999.0747; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Weisheit G, 2006, EUR J NEUROSCI, V24, P466, DOI 10.1111/j.1460-9568.2006.04915.x; Yamada Keiko, 2002, Anatomical Science International, V77, P94, DOI 10.1046/j.0022-7722.2002.00021.x	51	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6848	10.1371/journal.pone.0006848	http://dx.doi.org/10.1371/journal.pone.0006848			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718257	Green Published, Green Submitted, gold			2022-12-25	WOS:000269415900020
J	de la Fuente, H; Lamana, A; Mittelbrunn, M; Perez-Gala, S; Gonzalez, S; Garcia-Diez, A; Vega, M; Sanchez-Madrid, F				de la Fuente, Hortensia; Lamana, Amalia; Mittelbrunn, Maria; Perez-Gala, Silvia; Gonzalez, Salvador; Garcia-Diez, Amaro; Vega, Miguel; Sanchez-Madrid, Francisco			Identification of Genes Responsive to Solar Simulated UV Radiation in Human Monocyte-Derived Dendritic Cells	PLOS ONE			English	Article							HUMAN KERATINOCYTES; ULTRAVIOLET-RADIATION; T-CELL; NEGATIVE REGULATOR; LANGERHANS CELLS; DOWN-REGULATION; EXPRESSION; MATURATION; PSORIASIS; EXPOSURE	Ultraviolet (UV) irradiation has profound effects on the skin and the systemic immune system. Several effects of UV radiation on Dendritic cells (DCs) functions have been described. However, gene expression changes induced by UV radiation in DCs have not been addressed before. In this report, we irradiated human monocyte-derived DCs with solar-simulated UVA/UVB and analyzed regulated genes on human whole genome arrays. Results were validated by RT-PCR and further analyzed by Gene Set Enrichment Analysis (GSEA). Solar-simulated UV radiation up-regulated expression of genes involved in cellular stress and inflammation, and down-regulated genes involved in chemotaxis, vesicular transport and RNA processing. Twenty four genes were selected for comparison by RT-PCR with similarly treated human primary keratinocytes and human melanocytes. Several genes involved in the regulation of the immune response were differentially regulated in UVA/UVB irradiated human monocyte-derived DCs, such as protein tyrosine phosphatase, receptor type E (PTPRE), thrombospondin-1 (THBS1), inducible costimulator ligand (ICOSL), galectins, Src-like adapter protein (SLA), IL-10 and CCR7. These results indicate that UV-exposure triggers the regulation of a complex gene repertoire involved in human-DC-mediated immune responses.	[de la Fuente, Hortensia] Univ Autonoma Madrid, Hosp Princesa, Serv Immunol, Madrid, Spain; [de la Fuente, Hortensia; Mittelbrunn, Maria; Sanchez-Madrid, Francisco] Fdn Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain; [Perez-Gala, Silvia; Garcia-Diez, Amaro] Univ Autonoma Madrid, Hosp Princesa, Serv Dermatol, Madrid, Spain; [Gonzalez, Salvador] Mem Sloan Kettering Canc Ctr, Dermatol Serv, 1275 York Ave, New York, NY 10021 USA; [Vega, Miguel] CSIC, Ctr Invest Biol CIB, Madrid, Spain	Autonomous University of Madrid; Hospital de La Princesa; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous University of Madrid; Hospital de La Princesa; Memorial Sloan Kettering Cancer Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	de la Fuente, H (corresponding author), Univ Autonoma Madrid, Hosp Princesa, Serv Immunol, Madrid, Spain.	fsanchez.hlpr@salud.madrid.org	Sanchez-Madrid, Francisco/M-7889-2016; Mittelbrunn, Maria/I-5882-2015; Mittelbrunn, Maria/J-9146-2019; Gonzalez, Salvador/AFK-2480-2022; de la Fuente, Hortensia/J-9890-2014; LAMANA, AMALIA/I-6971-2017; Vega, Miguel A/M-1367-2016	Sanchez-Madrid, Francisco/0000-0001-5303-0762; Mittelbrunn, Maria/0000-0003-3487-8762; Mittelbrunn, Maria/0000-0003-3487-8762; Gonzalez, Salvador/0000-0001-9282-4784; de la Fuente, Hortensia/0000-0001-8708-753X; LAMANA, AMALIA/0000-0001-8779-5034; Vega, Miguel A/0000-0001-6151-4193				Aubin F, 2003, EUR J DERMATOL, V13, P515; Bechetoille N, 2007, TISSUE ENG, V13, P2667, DOI 10.1089/ten.2006.0405; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Doyen V, 2003, J EXP MED, V198, P1277, DOI 10.1084/jem.20030705; Dragone LL, 2006, J IMMUNOL, V176, P335, DOI 10.4049/jimmunol.176.1.335; Elliott J, 2004, TRENDS IMMUNOL, V25, P434, DOI 10.1016/j.it.2004.05.012; ENK CD, 1995, J IMMUNOL, V154, P4851; Furio L, 2005, J INVEST DERMATOL, V125, P1032, DOI 10.1111/j.0022-202X.2005.23904.x; Garcia-Lopez MA, 2005, J INVEST DERMATOL, V125, P1001, DOI 10.1111/j.0022-202X.2005.23882.x; Halliday GA, 2005, MUTAT RES-FUND MOL M, V571, P107, DOI 10.1016/j.mrfmmm.2004.09.013; Hamakawa M, 2006, PHOTODERMATOL PHOTO, V22, P116, DOI 10.1111/j.1600-0781.2006.00187.x; Howell BG, 2004, J DERMATOL SCI, V34, P185, DOI 10.1016/j.jdermsci.2004.01.004; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Kist Joseph M, 2005, Adv Dermatol, V21, P235, DOI 10.1016/j.yadr.2005.03.001; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Kondo S, 1998, J CELL PHYSIOL, V177, P493, DOI 10.1002/(SICI)1097-4652(199812)177:3<493::AID-JCP12>3.0.CO;2-B; Le Naour F, 2001, J BIOL CHEM, V276, P17920, DOI 10.1074/jbc.M100156200; Legitimo A, 2007, CLIN EXP IMMUNOL, V148, P564, DOI 10.1111/j.1365-2249.2007.03372.x; LENZ A, 1993, J CLIN INVEST, V92, P2587, DOI 10.1172/JCI116873; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mittelbrunn M, 2005, J INVEST DERMATOL, V125, P334, DOI 10.1111/j.0022-202X.2005.23824.x; Mizuno K, 2004, J INVEST DERMATOL, V122, P300, DOI 10.1046/j.0022-202X.2004.22206.x; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; NESTLE FO, 1993, J IMMUNOL, V151, P6535; Nestle FO, 2007, J CLIN INVEST, V117, P2382, DOI 10.1172/JCI33349; NICKOLOFF BJ, 1994, AM J PATHOL, V144, P820; Penas PF, 2000, J INVEST DERMATOL, V114, P1126, DOI 10.1046/j.1523-1747.2000.00998.x; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; Reinhardt P, 2006, CAN J PHYSIOL PHARM, V84, P221, DOI 10.1139/Y05-126; Rieger KE, 2004, NUCLEIC ACIDS RES, V32, P4786, DOI 10.1093/nar/gkh783; Salvador JM, 2005, NAT IMMUNOL, V6, P396, DOI 10.1038/ni1176; Schwarz T, 2005, INT ARCH ALLERGY IMM, V137, P187, DOI 10.1159/000086330; Schwarz T, 1999, ALLERGY, V54, P1252, DOI 10.1034/j.1398-9995.1999.00105.x; Sesto A, 2002, P NATL ACAD SCI USA, V99, P2965, DOI 10.1073/pnas.052678999; Sosinowski T, 2000, J EXP MED, V191, P463, DOI 10.1084/jem.191.3.463; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Stern RS, 2007, NEW ENGL J MED, V357, P682, DOI 10.1056/NEJMct072317; Stoebner PE, 2007, BRIT J DERMATOL, V156, P1315, DOI 10.1111/j.1365-2133.2007.07895.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanuma N, 1999, EUR J BIOCHEM, V259, P46, DOI 10.1046/j.1432-1327.1999.00004.x; Tanuma N, 2001, BLOOD, V98, P3030, DOI 10.1182/blood.V98.10.3030; Teunissen MBM, 1997, CLIN EXP IMMUNOL, V107, P213, DOI 10.1046/j.1365-2249.1997.d01-900.x; Wallet MA, 2005, CLIN MED RES, V3, P166, DOI 10.3121/cmr.3.3.166; Yang G, 2006, J INVEST DERMATOL, V126, P2490, DOI 10.1038/sj.jid.5700470; Yoshizumi M, 2008, CELL BIOL INT, V32, P1405, DOI 10.1016/j.cellbi.2008.08.011; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	51	17	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6735	10.1371/journal.pone.0006735	http://dx.doi.org/10.1371/journal.pone.0006735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707549	gold, Green Published, Green Submitted			2022-12-25	WOS:000269335000005
J	Tordjman, S; Anderson, GM; Botbol, M; Brailly-Tabard, S; Perez-Diaz, F; Graignic, R; Carlier, M; Schmit, G; Rolland, AC; Bonnot, O; Trabado, S; Roubertoux, P; Bronsard, G				Tordjman, Sylvie; Anderson, George M.; Botbol, Michel; Brailly-Tabard, Sylvie; Perez-Diaz, Fernando; Graignic, Rozenn; Carlier, Michele; Schmit, Gerard; Rolland, Anne-Catherine; Bonnot, Olivier; Trabado, Severine; Roubertoux, Pierre; Bronsard, Guillaume			Pain Reactivity and Plasma beta-Endorphin in Children and Adolescents with Autistic Disorder	PLOS ONE			English	Article							SELF-INJURIOUS-BEHAVIOR; DOUBLE-BLIND; SCHIZOPHRENIC-PATIENTS; NALTREXONE; SEROTONIN; NALOXONE; INDIVIDUALS; CAREGIVERS; EXPRESSION; MANAGEMENT	Background: Reports of reduced pain sensitivity in autism have prompted opioid theories of autism and have practical care ramifications. Our objective was to examine behavioral and physiological pain responses, plasma beta-endorphin levels and their relationship in a large group of individuals with autism. Methodology/Principal Findings: The study was conducted on 73 children and adolescents with autism and 115 normal individuals matched for age, sex and pubertal stage. Behavioral pain reactivity of individuals with autism was assessed in three observational situations (parents at home, two caregivers at day-care, a nurse and child psychiatrist during blood drawing), and compared to controls during venepuncture. Plasma beta-endorphin concentrations were measured by radioimmunoassay. A high proportion of individuals with autism displayed absent or reduced behavioral pain reactivity at home (68.6%), at day-care (34.2%) and during venepuncture (55.6%). Despite their high rate of absent behavioral pain reactivity during venepuncture (41.3 vs. 8.7% of controls, P < 0.0001), individuals with autism displayed a significantly increased heart rate in response to venepuncture (P < 0.05). Moreover, this response (D heart rate) was significantly greater than for controls (mean +/- SEM; 6.4 +/- 2.5 vs. 1.3 +/- 0.8 beats/min, P < 0.05). Plasma beta-endorphin levels were higher in the autistic group (P < 0.001) and were positively associated with autism severity (P < 0.001) and heart rate before or after venepuncture (P < 0.05), but not with behavioral pain reactivity. Conclusions/Significance: The greater heart rate response to venepuncture and the elevated plasma beta-endorphin found in individuals with autism reflect enhanced physiological and biological stress responses that are dissociated from observable emotional and behavioral reactions. The results suggest strongly that prior reports of reduced pain sensitivity in autism are related to a different mode of pain expression rather than to an insensitivity or endogenous analgesia, and do not support opioid theories of autism. Clinical care practice and hypotheses regarding underlying mechanisms need to assume that children with autism are sensitive to pain.			Tordjman, S (corresponding author), Univ Paris 05, Lab Psychol Percept, UMR 8158, CNRS, Paris, France.	s.tordjman@ch-guillaumeregnier.fr		Trabado, Severine/0000-0002-1925-1999; Bonnot, Olivier/0000-0003-0005-4765; Rolland, Anne-Catherine/0000-0002-5013-2373				American Psychiatric Association, 1987, DIAGN STAT MAN MENT, P567; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th, P943; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Anastasi A., 1988, PSYCHOL TESTING; ANGELOGIANNI P, 1989, NEUROENDOCRINOLOGY, V50, P372, DOI 10.1159/000125251; BARRON J, 1983, AM J MENT DEF, V88, P177; BARRON J, 1985, AM J MENT DEF, V90, P124; BIERSDORFF KK, 1994, AM J MENT RETARD, V98, P619; BONNOT O, 2008, CLIN J PAIN IN PRESS; BOUVARD MP, 1995, PSYCHIAT RES, V58, P191, DOI 10.1016/0165-1781(95)02601-R; BOUVARD MP, 1992, EXERPTA MED, P245; Brambilla F, 1997, NEUROPSYCHOBIOLOGY, V35, P1, DOI 10.1159/000119322; CAMPBELL M, 1990, PSYCHOPHARMACOL BULL, V26, P130; Cazzullo AG, 1999, EUR NEUROPSYCHOPHARM, V9, P361; CHAMBERLAIN RS, 1990, BIOL PSYCHIAT, V28, P773, DOI 10.1016/0006-3223(90)90513-2; Chambers CT, 1996, CHILD FACIAL CODING; DERBYSHIRE SWG, 1994, LANCET, V344, P615, DOI 10.1016/S0140-6736(94)92001-X; ERNST M, 1993, PSYCHOPHARMACOL BULL, V29, P221; Fanurik D, 1999, J DEV BEHAV PEDIATR, V20, P228, DOI 10.1097/00004703-199908000-00005; Frescka E., 1991, NEUROPEPTIDES PSYCHI, P169; GERRA G, 1992, PSYCHIAT RES, V41, P179, DOI 10.1016/0165-1781(92)90109-G; Gilbert-Macleod CA, 2000, J PEDIATR PSYCHOL, V25, P301, DOI 10.1093/jpepsy/25.5.301; GILLBERG C, 1990, BRAIN DEV-JPN, V12, P88, DOI 10.1016/S0387-7604(12)80185-9; GILLBERG C, 1985, ARCH GEN PSYCHIAT, V42, P780; Gillberg C., 1988, ASPECTS AUTISM BIOL, P31; Glover V, 1996, BRIT MED J, V313, P796; HERMAN B H, 1986, Society for Neuroscience Abstracts, V12, P1172; HERMAN BH, 1978, PHARMACOL BIOCHEM BE, V9, P213, DOI 10.1016/0091-3057(78)90167-3; KALAT JW, 1978, J AUTISM CHILD SCHIZ, V8, P477, DOI 10.1007/BF01538051; KAPLAN HI, 1994, KAPLAN SADOCKS SYNOP, P1052; KATZ E, 1990, ISRAEL J MED SCI, V26, P275; KJAER A, 1992, NEUROENDOCRINOLOGY, V56, P419, DOI 10.1159/000126258; Kuritzky A, 1999, CEPHALALGIA, V19, P725, DOI 10.1046/j.1468-2982.1999.019008725.x; LaChapelle DL, 1999, CLIN J PAIN, V15, P13, DOI 10.1097/00002508-199903000-00004; LAUTENBACHER S, 1994, J PSYCHIAT RES, V28, P109, DOI 10.1016/0022-3956(94)90023-X; LEBOYER M, 1994, AM J PSYCHIAT, V151, P1797; Leboyer M, 1999, BIOL PSYCHIAT, V45, P158, DOI 10.1016/S0006-3223(97)00532-5; Lewin DS, 1999, J DEV BEHAV PEDIATR, V20, P244, DOI 10.1097/00004703-199908000-00007; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; MALMO RB, 1951, J PERS, V19, P359, DOI 10.1111/j.1467-6494.1951.tb01500.x; MANNE SL, 1992, PAIN, V48, P45, DOI 10.1016/0304-3959(92)90130-4; McGrath PJ, 1996, CLIN J PAIN, V12, P135, DOI 10.1097/00002508-199606000-00009; McGrath PJ, 1998, DEV MED CHILD NEUROL, V40, P340; MISES R, 1993, INT STAT DIS RELATED, pCH5; Nader R, 2004, CLIN J PAIN, V20, P88, DOI 10.1097/00002508-200403000-00005; Nagamitsu S, 1997, J AUTISM DEV DISORD, V27, P155, DOI 10.1023/A:1025839807431; Nagamitsu Shinichiro, 1993, Kurume Medical Journal, V40, P233; Oberlander TF, 1999, J DEV BEHAV PEDIATR, V20, P235, DOI 10.1097/00004703-199908000-00006; PANKSEPP J, 1979, TRENDS NEUROSCI, V2, P174, DOI 10.1016/0166-2236(79)90071-7; PANKSEPP J, 1978, BRAIN RES BULL, V3, P663, DOI 10.1016/0361-9230(78)90014-X; Panksepp J., 1987, NEUROBIOLOGICAL ISSU, P357; POZNANSKI EO, 1976, CLIN PEDIATR, V15, P1114, DOI 10.1177/000992287601501205; Prior M., 1986, PSYCHOPATHOLOGICAL D, P156; Rhudy JL, 2000, PAIN, V84, P65, DOI 10.1016/S0304-3959(99)00183-9; RICHARDSON JS, 1983, BIOL PSYCHIAT, V18, P99; ROSS DL, 1987, PEDIATR NEUROL, V3, P83, DOI 10.1016/0887-8994(87)90032-4; SAHLEY TL, 1987, J AUTISM DEV DISORD, V17, P201, DOI 10.1007/BF01495056; SANDMAN CA, 1983, APPL RES MENT RETARD, V4, P5, DOI 10.1016/S0270-3092(83)80014-9; SANDMAN CA, 1979, LIFE SCI, V25, P1755, DOI 10.1016/0024-3205(79)90479-X; SANDMAN CA, 1992, J AUTISM DEV DISORD, V22, P132, DOI 10.1007/BF01046410; SANDMAN CA, 1991, J AUTISM DEV DISORD, V21, P83, DOI 10.1007/BF02207000; Sher L, 1997, MED HYPOTHESES, V48, P413, DOI 10.1016/S0306-9877(97)90039-6; Singh Manpreet K, 2006, J Psychiatr Pract, V12, P90, DOI 10.1097/00131746-200603000-00004; Tanner J.H., 1962, GROWTH ADOLESCENTS; Tordjman S, 1997, J CHILD PSYCHOL PSYC, V38, P705, DOI 10.1111/j.1469-7610.1997.tb01697.x; Tordjman S, 1999, ENCEPHALE, V25, P122; Tordjman S, 2001, MOL PSYCHIATR, V6, P434, DOI 10.1038/sj.mp.4000873; TORDJMAN S, MANUAL SELF IN PRESS; WEIZMAN R, 1988, J AM ACAD CHILD PSY, V27, P430, DOI 10.1097/00004583-198807000-00009; WEIZMAN R, 1984, PSYCHOPHARMACOLOGY, V82, P368, DOI 10.1007/BF00427687; Wickens T. D., 1989, MULTIWAY CONTINGENCY; WILLEMSENSWINKELS SHN, 1995, ARCH GEN PSYCHIAT, V52, P766; WING L, 1996, AUTISTIC SPECTRUM, P335	73	90	95	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e5289	10.1371/journal.pone.0005289	http://dx.doi.org/10.1371/journal.pone.0005289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	488FQ	19707566	Green Published, gold, Green Submitted			2022-12-25	WOS:000269335000001
J	Azzouz, N; Panasenko, OO; Colau, G; Collart, MA				Azzouz, Nowel; Panasenko, Olesya O.; Colau, Geoffroy; Collart, Martine A.			The CCR4-NOT Complex Physically and Functionally Interacts with TRAMP and the Nuclear Exosome	PLOS ONE			English	Article								Background: Ccr4-Not is a highly conserved multi-protein complex consisting in yeast of 9 subunits, including Not5 and the major yeast deadenylase Ccr4. It has been connected functionally in the nucleus to transcription by RNA polymerase II and in the cytoplasm to mRNA degradation. However, there has been no evidence so far that this complex is important for RNA degradation in the nucleus. Methodology/Principal Findings: In this work we point to a new role for the Ccr4-Not complex in nuclear RNA metabolism. We determine the importance of the Ccr4-Not complex for the levels of non-coding nuclear RNAs, such as mis-processed and polyadenylated snoRNAs, whose turnover depends upon the nuclear exosome and TRAMP. Consistently, mutation of both the Ccr4-Not complex and the nuclear exosome results in synthetic slow growth phenotypes. We demonstrate physical interactions between the Ccr4-Not complex and the exosome. First, Not5 co-purifies with the exosome. Second, several exosome subunits co-purify with the Ccr4-Not complex. Third, the Ccr4-Not complex is important for the integrity of large exosome-containing complexes. Finally, we reveal a connection between the Ccr4-Not complex and TRAMP through the association of the Mtr4 helicase with the Ccr4-Not complex and the importance of specific subunits of Ccr4-Not for the association of Mtr4 with the nuclear exosome subunit Rrp6. Conclusions/Significance: We propose a model in which the Ccr4-Not complex may provide a platform contributing to dynamic interactions between the nuclear exosome and its co-factor TRAMP. Our findings connect for the first time the different players involved in nuclear and cytoplasmic RNA degradation.			Azzouz, N (corresponding author), Univ Geneva, Fac Med, Dept Microbiol & Mol Med, Geneva, Switzerland.	martine.collart@unige.ch	Panasenko, Olesya/AAC-1194-2021	Panasenko, Olesya/0000-0002-0990-7472; Collart, Martine/0000-0001-6955-1773				Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Araki Y, 2001, EMBO J, V20, P4684, DOI 10.1093/emboj/20.17.4684; Azzouz N, 2009, RNA, V15, P377, DOI 10.1261/rna.1348209; Badarinarayana V, 2000, GENETICS, V155, P1045; Brachmann CB, 1998, YEAST, V14, P115; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; Callahan KP, 2008, NUCLEIC ACIDS RES, V36, P6645, DOI 10.1093/nar/gkn743; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Chanfreau G, 1998, EMBO J, V17, P3726, DOI 10.1093/emboj/17.13.3726; Collart MA, 2004, PROG NUCLEIC ACID RE, V77, P289, DOI 10.1016/S0079-6603(04)77008-7; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; COLLART MA, 1993, EMBO J, V12, P177, DOI 10.1002/j.1460-2075.1993.tb05643.x; COLLART MA, 1994, GENE DEV, V8, P525, DOI 10.1101/gad.8.5.525; Deluen C, 2002, MOL CELL BIOL, V22, P6735, DOI 10.1128/MCB.22.19.6735-6749.2002; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206; EISENMANN DM, 1992, GENE DEV, V6, P1319, DOI 10.1101/gad.6.7.1319; Funfschilling U, 1999, MOL BIOL CELL, V10, P3289, DOI 10.1091/mbc.10.10.3289; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; James N, 2007, GENETICS, V177, P123, DOI 10.1534/genetics.107.076299; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lenssen E, 2005, MOL CELL BIOL, V25, P488, DOI 10.1128/MCB.25.1.488-498.2005; Lenssen E, 2007, EUKARYOT CELL, V6, P2251, DOI 10.1128/EC.00327-06; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Maillet L, 2000, J MOL BIOL, V303, P131, DOI 10.1006/jmbi.2000.4131; Martens JA, 2005, GENE DEV, V19, P2695, DOI 10.1101/gad.1367605; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mohibullah N, 2008, GENE DEV, V22, P2994, DOI 10.1101/gad.1724408; Panasenko O, 2006, J BIOL CHEM, V281, P31389, DOI 10.1074/jbc.M604986200; Panasenko OO, 2009, GENETICS, V181, P447, DOI 10.1534/genetics.108.095422; Petfalski E, 1998, MOL CELL BIOL, V18, P1181, DOI 10.1128/MCB.18.3.1181; Qiu HF, 2004, MOL CELL BIOL, V24, P4104, DOI 10.1128/MCB.24.10.4104-4117.2004; Rospert S, 2002, CELL MOL LIFE SCI, V59, P1632, DOI 10.1007/PL00012490; Stead JA, 2007, NUCLEIC ACIDS RES, V35, P5556, DOI 10.1093/nar/gkm614; SYNOWSKY SA, 2008, J MOL BIOL; Synowsky SA, 2006, MOL CELL PROTEOMICS, V5, P1581, DOI 10.1074/mcp.M600043-MCP200; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Traven A, 2005, GENETICS, V169, P65, DOI 10.1534/genetics.104.030940; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Wang HW, 2007, P NATL ACAD SCI USA, V104, P16844, DOI 10.1073/pnas.0705526104; Westmoreland TJ, 2004, EUKARYOT CELL, V3, P430, DOI 10.1128/EC.3.2.430-446.2004; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; ZAGORSKI J, 1988, MOL CELL BIOL, V8, P3282, DOI 10.1128/MCB.8.8.3282; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002	55	47	49	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6760	10.1371/journal.pone.0006760	http://dx.doi.org/10.1371/journal.pone.0006760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707589	gold, Green Published, Green Submitted			2022-12-25	WOS:000269278400023
J	Sloboda, DM; Howie, GJ; Pleasants, A; Gluckman, PD; Vickers, MH				Sloboda, Deborah M.; Howie, Graham J.; Pleasants, Anthony; Gluckman, Peter D.; Vickers, Mark H.			Pre- and Postnatal Nutritional Histories Influence Reproductive Maturation and Ovarian Function in the Rat	PLOS ONE			English	Article								Background: While prepubertal nutritional influences appear to play a role in sexual maturation, there is a need to clarify the potential contributions of maternal and childhood influences in setting the tempo of reproductive maturation. In the present study we employed an established model of nutritional programming to evaluate the relative influences of prenatal and postnatal nutrition on growth and ovarian function in female offspring. Methods: Pregnant Wistar rats were fed either a calorie-restricted diet, a high fat diet, or a control diet during pregnancy and/or lactation. Offspring then were fed either a control or a high fat diet from the time of weaning to adulthood. Pubertal age was monitored and blood samples collected in adulthood for endocrine analyses. Results: We report that in the female rat, pubertal timing and subsequent ovarian function is influenced by the animal's nutritional status in utero, with both maternal caloric restriction and maternal high fat nutrition resulting in early pubertal onset. Depending on the offspring's nutritional history during the prenatal and lactational periods, subsequent nutrition and body weight gain did not further influence offspring reproductive tempo, which was dominated by the effect of prenatal nutrition. Whereas maternal calorie restriction leads to early pubertal onset, it also leads to a reduction in adult progesterone levels later in life. In contrast, we found that maternal high fat feeding which also induces early maturation in offspring was associated with elevated progesterone concentrations. Conclusions: These observations are suggestive of two distinct developmental pathways leading to the acceleration of pubertal timing but with different consequences for ovarian function. We suggest different adaptive explanations for these pathways and for their relationship to altered metabolic homeostasis.			Sloboda, DM (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	d.sloboda@auckland.ac.nz		Vickers, Mark/0000-0003-4876-9356				Ahima RS, 1997, J CLIN INVEST, V99, P391, DOI 10.1172/JCI119172; Almog B, 2001, MOL CELL ENDOCRINOL, V183, P179, DOI 10.1016/S0303-7207(01)00543-3; Armitage JA, 2008, FRONT HORM RES, V36, P73, DOI 10.1159/000115355; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bautista CJ, 2008, PEDIATR RES, V63, P358, DOI 10.1203/01.pdr.0000304938.78998.21; Bavdekar A, 1999, DIABETES, V48, P2422, DOI 10.2337/diabetes.48.12.2422; Bellinger L, 2004, BRIT J NUTR, V92, P513, DOI 10.1079/BJN20041224; Bellis MA, 2006, J EPIDEMIOL COMMUN H, V60, P910, DOI 10.1136/jech.2006.049379; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Catalano PM, 2007, DIABETES CARE, V30, pS156, DOI 10.2337/dc07-s209; Catalano PM, 2007, OBSTET GYNECOL, V110, P743, DOI 10.1097/01.AOG.0000284990.84982.ba; CHISHOLM JS, 1993, CURR ANTHROPOL, V34, P1, DOI 10.1086/204131; Cooper C, 1996, BRIT J OBSTET GYNAEC, V103, P814, DOI 10.1111/j.1471-0528.1996.tb09879.x; Cunningham MJ, 1999, BIOL REPROD, V60, P216, DOI 10.1095/biolreprod60.2.216; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Desai M, 2007, AM J OBSTET GYNECOL, V196, P555, DOI 10.1016/j.ajog.2006.11.036; Domig JK, 2006, AGRO FOOD IND HI TEC, V17, P25; Ellis BJ, 2004, PSYCHOL BULL, V130, P920, DOI 10.1037/0033-2909.130.6.920; ELLISON PT, 1982, HUM BIOL, V54, P269; ELLISON PT, 1993, HUM REPROD, V8, P2248, DOI 10.1093/oxfordjournals.humrep.a138015; Ellison PT, 2003, AM J HUM BIOL, V15, P342, DOI 10.1002/ajhb.10152; Euling SY, 2008, PEDIATRICS, V121, pS172, DOI 10.1542/peds.2007-1813D; FRISCH RE, 1987, HUM REPROD, V2, P521, DOI 10.1093/oxfordjournals.humrep.a136582; FRISCH RE, 1970, SCIENCE, V169, P397, DOI 10.1126/science.169.3943.397; Garnett SP, 2001, INT J OBESITY, V25, P1667, DOI 10.1038/sj.ijo.0801821; Gluckman PD, 2006, MOL CELL ENDOCRINOL, V254, P26, DOI 10.1016/j.mce.2006.04.005; Gluckman PD, 2006, TRENDS ENDOCRIN MET, V17, P7, DOI 10.1016/j.tem.2005.11.006; Gluckman PD, 2005, TRENDS ECOL EVOL, V20, P527, DOI 10.1016/j.tree.2005.08.001; Gluckman PD, 2005, P ROY SOC B-BIOL SCI, V272, P671, DOI 10.1098/rspb.2004.3001; Gluckman PD, 2008, TRENDS ENDOCRIN MET, V19, P109, DOI 10.1016/j.tem.2008.02.002; Gluckman PD, 2007, P NATL ACAD SCI USA, V104, P12796, DOI 10.1073/pnas.0705667104; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Goumenou AG, 2003, EUR J OBSTET GYN R B, V106, P118, DOI 10.1016/S0301-2115(02)00359-7; Hamdoun A, 2007, P NATL ACAD SCI USA, V104, P1745, DOI 10.1073/pnas.0610108104; Hamrick MW, 2004, J BONE MINER RES, V19, P1607, DOI 10.1359/JBMR.040712; HilakiviClarke L, 1997, P NATL ACAD SCI USA, V94, P9372, DOI 10.1073/pnas.94.17.9372; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Hubscher CH, 2005, BIOTECH HISTOCHEM, V80, P79, DOI 10.1080/10520290500138422; Jasienska G, 2006, P NATL ACAD SCI USA, V103, P12759, DOI 10.1073/pnas.0605488103; Jimenez-Chillaron JC, 2006, DIABETOLOGIA, V49, P1974, DOI 10.1007/s00125-006-0311-7; Karlberg J, 2002, HORM RES, V57, P19, DOI 10.1159/000058096; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Nunez-de la Mora A, 2007, PLOS MED, V4, P813, DOI 10.1371/journal.pmed.0040167; Ojeda SR, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2061; Ong KK, 2004, J CLIN ENDOCR METAB, V89, P2647, DOI 10.1210/jc.2003-031848; Ozanne SE, 2005, MECH AGEING DEV, V126, P852, DOI 10.1016/j.mad.2005.03.005; Papadimitriou A, 2008, ACTA PAEDIATR, V97, P812, DOI 10.1111/j.1651-2227.2008.00806.x; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Parent AS, 2005, HORM RES, V64, P41, DOI 10.1159/000087753; Reusens B, 2009, ADV EXP MED BIOL, V646, P125, DOI 10.1007/978-1-4020-9173-5_14; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Seidell JC, 2000, BRIT J NUTR, V83, pS5, DOI 10.1017/S000711450000088X; SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611; Sloboda DM, 2007, J CLIN ENDOCR METAB, V92, P46, DOI 10.1210/jc.2006-1378; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; SYDDALL HE, 2005, COHORT PROFILE HERTF; Teilmann G, 2007, J CLIN ENDOCR METAB, V92, P2538, DOI 10.1210/jc.2006-2096; Teilmann G, 2006, PEDIATRICS, V118, pE391, DOI 10.1542/peds.2005-2939; Uller T, 2008, TRENDS ECOL EVOL, V23, P432, DOI 10.1016/j.tree.2008.04.005; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003; VICKERS MH, 2008, ENDOCRINOLOGY; Vitzthum VJ, 2002, HUM REPROD, V17, P1906, DOI 10.1093/humrep/17.7.1906; Whincup PH, 2001, BRIT MED J, V322, P1095, DOI 10.1136/bmj.322.7294.1095	64	127	127	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6744	10.1371/journal.pone.0006744	http://dx.doi.org/10.1371/journal.pone.0006744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707592	Green Published, Green Accepted, gold			2022-12-25	WOS:000269278400011
J	Gruber, F; Mayer, H; Lengauer, B; Mlitz, V; Sanders, JM; Kadl, A; Bilban, M; de Martin, R; Wagner, O; Kensler, TW; Yamamoto, M; Leitinger, N; Tschachler, E				Gruber, Florian; Mayer, Herbert; Lengauer, Barbara; Mlitz, Veronika; Sanders, John M.; Kadl, Alexandra; Bilban, Martin; de Martin, Rainer; Wagner, Oswald; Kensler, Thomas W.; Yamamoto, Masayuki; Leitinger, Norbert; Tschachler, Erwin			NF-E2-related factor 2 regulates the stress response to UVA-1-oxidized phospholipids in skin cells	FASEB JOURNAL			English	Article						lipid oxidation; antioxidant response; redox-sensitive transcription; long-wavelength ultraviolet; phototherapy	SYSTEMIC-LUPUS-ERYTHEMATOSUS; ARYL-HYDROCARBON RECEPTOR; NRF2 TRANSCRIPTION FACTOR; LIPID OXIDATION-PRODUCTS; ULTRAVIOLET-B RADIATION; LOW-DENSITY-LIPOPROTEIN; OXIDIZED PHOSPHOLIPIDS; HEME OXYGENASE-1; ANTIOXIDANT RESPONSE; SIGNALING PATHWAY	Long-wavelength ultraviolet (UVA-1) radiation causes oxidative stress that modifies cellular molecules. To defend themselves against noxious oxidation products, skin cells produce detoxifying enzymes and antioxidants. We have recently shown that UVA-1 oxidized the abundant membrane phospholipid 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (PAPC), which then induced the stress-response protein heme oxygenase 1 (HO-1) in dermal fibroblasts. Here we examined the effects of UVA-1- and UV-oxidized phospholipids on global gene expression in human dermal fibroblasts and keratinocytes. We identified a cluster of genes that were coinduced by UVA-1-oxidized PAPC and UVA-1 radiation. The cluster included HO-1, glutamate-cysteine ligase modifier subunit, aldo-keto reductases-1-C1 and -C2, and IL-8. These genes are members of the cellular stress response system termed "antioxidant response." Accordingly, the regulatory regions of all of these genes contain binding sites for NF-E2-related factor 2 (NRF2), a major regulator of the antioxidant response. Both UVA-1 irradiation and treatment with oxidized lipids led to increased nuclear accumulation and DNA binding of NRF2. Silencing and deficiency of NRF2 suppressed the antioxidant response. Taken together, our data show that UVA-1- mediated lipid oxidation induces expression of antioxidant response genes, which is dependent on the redox-regulated transcription factor NRF2. Our findings suggest a different view on UV-generated lipid mediators that were commonly regarded as detrimental.-Gruber, F., Mayer, H., Lengauer, B., Mlitz, V., Sanders, J. M., Kadl, A., Bilban, M., de Martin, R., Wagner, O., Kensler, T. W., Yamamoto, M., Leitinger, N., Tschachler, E. NF-E2-related factor 2 regulates the stress response to UVA1- oxidized phospholipids in skin cells. FASEB J. 24, 39-48 ( 2010). www.fasebj.org	[Gruber, Florian; Sanders, John M.; Kadl, Alexandra; Leitinger, Norbert] Univ Virginia, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Gruber, Florian; Lengauer, Barbara; Mlitz, Veronika; Tschachler, Erwin] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Mayer, Herbert; de Martin, Rainer] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Vienna, Austria; [Bilban, Martin; Wagner, Oswald] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Kensler, Thomas W.] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Yamamoto, Masayuki] Univ Tsukuba, Tsukuba, Ibaraki, Japan; [Tschachler, Erwin] Ctr Rech & Invest Epiderm & Sensorielles, Neuilly, France	University of Virginia; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Tsukuba	Leitinger, N (corresponding author), Univ Virginia, Cardiovasc Res Ctr, POB 801394, Charlottesville, VA 22908 USA.	nl2q@virginia.edu	Kensler, Thomas W/D-8686-2014; Yamamoto, Masayuki/A-4873-2010; Kadl, Alexandra/AAV-3395-2021	Kensler, Thomas W/0000-0002-6676-261X; Yamamoto, Masayuki/0000-0002-9073-9436; Gruber, Florian/0000-0003-1094-5641; Tschachler, Erwin/0000-0002-0248-1798; Bilban, Martin/0000-0001-7043-7142	NIH [R01 HL084422-01]; American Heart Association; Max Kade Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [R01CA094076] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084422] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Max Kade Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Maria Buchberger-Mosser and Joanne Lannigan for their contributions. This work was supported in part by NIH grant R01 HL084422-01 and a grant in aid from the American Heart Association ( to N.L.). F. G. was supported in part by a Max Kade Postdoctoral Fellowship.	Aerts S, 2005, NUCLEIC ACIDS RES, V33, pW393, DOI 10.1093/nar/gki354; Aerts S, 2003, NUCLEIC ACIDS RES, V31, P1753, DOI 10.1093/nar/gkg268; Afaq F, 2001, J PHOTOCH PHOTOBIO B, V63, P61, DOI 10.1016/S1011-1344(01)00217-2; Alam J, 2000, J BIOL CHEM, V275, P27694; Balla J, 2007, ANTIOXID REDOX SIGN, V9, P2119, DOI 10.1089/ars.2007.1787; Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06; Birukova AA, 2007, MICROVASC RES, V73, P173, DOI 10.1016/j.mvr.2006.12.004; Bochkov VN, 2006, CIRC RES, V99, P900, DOI 10.1161/01.RES.0000245485.04489.ee; Bochkov VN, 2003, J MOL MED, V81, P613, DOI 10.1007/s00109-003-0467-2; Braun S, 2002, MOL CELL BIOL, V22, P5492, DOI 10.1128/MCB.22.15.5492-5505.2002; Burczynski ME, 2001, J BIOL CHEM, V276, P2890, DOI 10.1074/jbc.M006655200; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dickinson DA, 2004, FREE RADICAL BIO MED, V37, P1152, DOI 10.1016/j.freeradbiomed.2004.06.011; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eicheler W, 1998, ARCH DERMATOL RES, V290, P126, DOI 10.1007/s004030050277; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; Frostegard J, 2005, ARTHRITIS RHEUM-US, V52, P192, DOI 10.1002/art.20780; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Gao XQ, 2004, P NATL ACAD SCI USA, V101, P10446, DOI 10.1073/pnas.0403886101; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; George TC, 2004, CYTOM PART A, V59A, P237, DOI 10.1002/cyto.a.20048; Giudice A, 2006, BIOESSAYS, V28, P169, DOI 10.1002/bies.20359; Gruber F, 2007, J BIOL CHEM, V282, P16934, DOI 10.1074/jbc.M702523200; Hirota A, 2005, J INVEST DERMATOL, V124, P825, DOI 10.1111/j.0022-202X.2005.23670.x; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Hubatsch I, 2002, CHEM RES TOXICOL, V15, P1114, DOI 10.1021/tx020027r; Ishikawa K, 1997, J CLIN INVEST, V100, P1209, DOI 10.1172/JCI119634; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kann S, 2005, TOXICOL SCI, V87, P365, DOI 10.1093/toxsci/kfi253; Kawamoto Y, 2000, J BIOL CHEM, V275, P11291, DOI 10.1074/jbc.275.15.11291; Keller UAD, 2006, MOL CELL BIOL, V26, P3773, DOI 10.1128/MCB.26.10.3773-3784.2006; Konger RL, 2008, PROSTAG OTH LIPID M, V87, P1, DOI 10.1016/j.prostaglandins.2008.04.002; Kvam E, 1999, FREE RADICAL BIO MED, V26, P511, DOI 10.1016/S0891-5849(98)00224-X; Kwak MK, 2004, MUTAT RES-FUND MOL M, V555, P133, DOI 10.1016/j.mrfmmm.2004.06.041; Lee S, 2009, J LIPID RES, V50, P265, DOI 10.1194/jlr.M800317-JLR200; Leitinger N, 2003, CURR OPIN LIPIDOL, V14, P421, DOI 10.1097/00041433-200310000-00002; Leitinger N, 1999, P NATL ACAD SCI USA, V96, P12010, DOI 10.1073/pnas.96.21.12010; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Lou H, 2006, MOL PHARMACOL, V69, P1662, DOI 10.1124/mol.105.019794; Ma Q, 2006, AM J PATHOL, V168, P1960, DOI 10.2353/ajpath.2006.051113; Mang R, 2005, PHOTODERMATOL PHOTO, V21, P103, DOI 10.1111/j.1600-0781.2005.00146.x; Marathe GK, 2005, J BIOL CHEM, V280, P35448, DOI 10.1074/jbc.M503811200; Mayer H, 2004, ARTERIOSCL THROM VAS, V24, P1192, DOI 10.1161/01.ATV.0000131263.06296.77; MCGRATH H, 1994, CLIN EXP RHEUMATOL, V12, P129; McMillan BJ, 2007, P NATL ACAD SCI USA, V104, P1412, DOI 10.1073/pnas.0607296104; Mildner M, 1999, PHOTOCHEM PHOTOBIOL, V70, P674, DOI 10.1562/0031-8655(1999)070<0674:UAURDR>2.3.CO;2; Moeller LC, 2005, J CLIN ENDOCR METAB, V90, P936, DOI 10.1210/jc.2004-1768; Moinova HR, 1999, BIOCHEM BIOPH RES CO, V261, P661, DOI 10.1006/bbrc.1999.1109; Motohashi H, 2004, P NATL ACAD SCI USA, V101, P6379, DOI 10.1073/pnas.0305902101; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Penning TM, 2007, ARCH BIOCHEM BIOPHYS, V464, P241, DOI 10.1016/j.abb.2007.04.024; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reis A, 2005, BIOMED CHROMATOGR, V19, P129, DOI 10.1002/bmc.429; Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07; Subbanagounder G, 2002, J BIOL CHEM, V277, P7271, DOI 10.1074/jbc.M107602200; Theilgaard-Monch K, 2004, J IMMUNOL, V172, P7684, DOI 10.4049/jimmunol.172.12.7684; Tyrrell RM, 2004, ANTIOXID REDOX SIGN, V6, P835, DOI 10.1089/1523086041798033; Valencia A, 2008, J INVEST DERMATOL, V128, P214, DOI 10.1038/sj.jid.5700960; VILE GF, 1995, FREE RADICAL BIO MED, V18, P721, DOI 10.1016/0891-5849(94)00192-M; VILE GF, 1994, P NATL ACAD SCI USA, V91, P2607, DOI 10.1073/pnas.91.7.2607; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Wondrak GT, 2007, CURR OPIN INVEST DR, V8, P390; Yeh M, 2004, J BIOL CHEM, V279, P30175, DOI 10.1074/jbc.M312198200; Yoh K, 2001, KIDNEY INT, V60, P1343, DOI 10.1046/j.1523-1755.2001.00939.x; Zhang XL, 2005, EUR J IMMUNOL, V35, P3258, DOI 10.1002/eji.200526116	74	65	68	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					39	48		10.1096/fj.09-133520	http://dx.doi.org/10.1096/fj.09-133520			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19720622	Green Published			2022-12-25	WOS:000273233600007
J	Chen, HL; Li, CF; Grigorian, A; Tian, WQ; Demetriou, M				Chen, Hung-Lin; Li, Carey Fei; Grigorian, Ani; Tian, Wenqiang; Demetriou, Michael			T Cell Receptor Signaling Co-regulates Multiple Golgi Genes to Enhance N-Glycan Branching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; ACETYLGLUCOSAMINYLTRANSFERASE-V; GLYCOPROTEIN-SYNTHESIS; IN-VIVO; GLYCOSYLATION; MICE; COMPLEX; ACTIVATION; BIOSYNTHESIS; ORGANIZATION	T cell receptor (TCR) signaling enhances beta 1,6GlcNAc-branching in N-glycans, a phenotype that promotes growth arrest and inhibits autoimmunity by increasing surface retention of cytotoxic T lymphocyte antigen-4 (CTLA-4) via interactions with galectins. N-Acetylglucosaminyltransferase V (MGAT5) mediates beta 1,6GlcNAc-branching by transferring N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to N-glycan substrates produced by the sequential action of Golgi alpha 1,2-mannosidase I (MIa,b,c), MGAT1, alpha 1,2-mannosidase II (MII, IIx), and MGAT2. Here we report that TCR signaling enhances mRNA levels of MIa, b, c and MII, IIx in parallel with MGAT5, whereas limiting levels of MGAT1 and MGAT2. Blocking the increase in MI or MII enzyme activity induced by TCR signaling with deoxymannojirimycin or swainsonine, respectively, limits beta 1,6GlcNAc-branching, suggesting that enhanced MI and MII activity are both required for this phenotype. MGAT1 and MGAT2 have an similar to 250- and similar to 20-fold higher affinity for UDP-GlcNAc than MGAT5, respectively, and increasing MGAT1 expression paradoxically inhibits beta 1,6GlcNAc branching by limiting UDP-GlcNAc supply to MGAT5, suggesting that restricted changes in MGAT1 and MGAT2 mRNA levels in TCR-stimulated cells serves to enhance availability of UDP-GlcNAc to MGAT5. Together, these data suggest that TCR signaling differentially regulates multiple N-glycan-processing enzymes at the mRNA level to cooperatively promote beta 1,6GlcNAc branching, and by extension, CTLA-4 surface expression, T cell growth arrest, and self-tolerance.	[Li, Carey Fei; Grigorian, Ani; Tian, Wenqiang; Demetriou, Michael] Univ Calif Irvine, Dept Neurol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Demetriou, M (corresponding author), Univ Calif Irvine, Dept Neurol, 250 Sprague Hall, Irvine, CA 92697 USA.	mdemetri@uci.edu		Demetriou, Michael/0000-0002-2224-7798; Chen, Hung-Lin/0000-0001-7900-3391	National Institutes of Health [AI053331, AI082266]; NIAID [F32AI081456]; National Institutes of Health Immunology [T32 AI-060573]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI081456, R56AI082266, R01AI053331, R01AI082266, T32AI060573] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Immunology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI053331 and AI082266 (to M. D.) and F32AI081456 (to A. G. and M. D.) through the NIAID and National Institutes of Health Immunology Training Grant T32 AI-060573 (to C. L.).	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Akama TO, 2002, SCIENCE, V295, P124, DOI 10.1126/science.1065570; Akama TO, 2006, P NATL ACAD SCI USA, V103, P8983, DOI 10.1073/pnas.0603248103; Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; BENDIAK B, 1987, J BIOL CHEM, V262, P5784; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Buckhaults P, 1997, J BIOL CHEM, V272, P19575, DOI 10.1074/jbc.272.31.19575; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; Chui D, 2001, P NATL ACAD SCI USA, V98, P1142, DOI 10.1073/pnas.98.3.1142; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; CUMMINGS RD, 1984, J BIOL CHEM, V259, P6253; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; Granovsky M, 2000, NAT MED, V6, P306; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Grigorian A, 2009, IMMUNOL REV, V230, P232, DOI 10.1111/j.1600-065X.2009.00796.x; Herscovics A, 2001, BIOCHIMIE, V83, P757, DOI 10.1016/S0300-9084(01)01319-0; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Ko JH, 1999, J BIOL CHEM, V274, P22941, DOI 10.1074/jbc.274.33.22941; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Leclerc Guy J, 2002, Cancer Cell Int, V2, P1, DOI 10.1186/1475-2867-2-1; Lee SU, 2007, J BIOL CHEM, V282, P33725, DOI 10.1074/jbc.M704839200; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHACHTER H, 1991, Glycobiology, V1, P453, DOI 10.1093/glycob/1.5.453; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Tremblay LO, 2007, J BIOL CHEM, V282, P2558, DOI 10.1074/jbc.M608661200; Wang Y, 2001, GLYCOBIOLOGY, V11, P1051, DOI 10.1093/glycob/11.12.1051; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Yip B, 1997, BIOCHEM J, V321, P465, DOI 10.1042/bj3210465	38	43	48	5	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32454	32461		10.1074/jbc.M109.023630	http://dx.doi.org/10.1074/jbc.M109.023630			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19706602	Green Published, hybrid			2022-12-25	WOS:000272028400028
J	Draghetti, C; Salvat, C; Zanoguera, F; Curchod, ML; Vignaud, C; Peixoto, H; Di Cara, A; Fischer, D; Dhanabal, M; Andreas, G; Abderrahim, H; Rommel, C; Camps, M				Draghetti, Cristina; Salvat, Catherine; Zanoguera, Francisca; Curchod, Marie-Laure; Vignaud, Chloe; Peixoto, Helene; Di Cara, Alessandro; Fischer, David; Dhanabal, Mohanraj; Andreas, Goutopoulos; Abderrahim, Hadi; Rommel, Christian; Camps, Montserrat			Functional Whole-genome Analysis Identifies Polo-like Kinase 2 and Poliovirus Receptor as Essential for Neuronal Differentiation Upstream of the Negative Regulator alpha B-crystallin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; CYCLASE-ACTIVATING POLYPEPTIDE; INDUCED NEURITE OUTGROWTH; PROTEIN-KINASE; PC12 CELLS; GENE-EXPRESSION; PHEOCHROMOCYTOMA CELLS; MAP KINASE; CYCLIC-AMP; CANDIDATE AUTOANTIGEN	This study aimed at identifying transcriptional changes associated to neuronal differentiation induced by six distinct stimuli using whole-genome microarray hybridization analysis. Bioinformatics analyses revealed the clustering of these six stimuli into two categories, suggesting separate gene/pathway dependence. Treatment with specific inhibitors demonstrated the requirement of both Janus kinase and microtubule-associated protein kinase activation to trigger differentiation with nerve growth factor (NGF) and dibutyryl cAMP. Conversely, activation of protein kinase A, phosphatidylinositol-3-kinase alpha, and mammalian target of rapamycin, although required for dibutyryl cAMP-induced differentiation, exerted a negative feedback on NGF-induced differentiation. We identified Polo-like kinase 2 (Plk2) and poliovirus receptor (PVR) as indispensable for NGF-driven neuronal differentiation and alpha B-crystallin (Cryab) as an inhibitor of this process. Silencing of Plk2 or PVR blocked NGF-triggered differentiation and Cryab down-regulation, while silencing of Cryab enhanced NGF-induced differentiation. Our results position both Plk2 and PVR upstream of the negative regulator Cryab in the pathway(s) leading to neuronal differentiation triggered by NGF.	[Draghetti, Cristina; Rommel, Christian; Camps, Montserrat] Merck Serono Int SA, Dept Target Res, Geneva Res Ctr, CH-1202 Geneva, Switzerland; [Zanoguera, Francisca; Di Cara, Alessandro] Merck Serono Int SA, Dept Drug Discovery Informat & New Chem Entities, Geneva Res Ctr, CH-1202 Geneva, Switzerland; [Salvat, Catherine; Curchod, Marie-Laure; Peixoto, Helene; Abderrahim, Hadi] Merck Serono Int SA, Dept Genet & Biomarkers, Geneva Res Ctr, CH-1202 Geneva, Switzerland; [Vignaud, Chloe] Merck Serono Int SA, Dept Stratified Med, Geneva Res Ctr, CH-1202 Geneva, Switzerland; [Fischer, David; Dhanabal, Mohanraj] EMD Serono, Dept Lead Discovery, Rockland, MA 02370 USA; [Andreas, Goutopoulos] EMD Serono, Dept Chem, Rockland, MA 02370 USA	Merck & Company; Serono International S.A.; Merck KGaA; EMD Serono Inc.; Merck & Company; Serono International S.A.; Merck KGaA; EMD Serono Inc.; Merck & Company; Serono International S.A.; Merck KGaA; EMD Serono Inc.; Merck & Company; Serono International S.A.; Merck KGaA; EMD Serono Inc.	Camps, M (corresponding author), Merck Serono Int SA, Inflammat Dept, Geneva Res Ctr, 9 Chemin Mines, CH-1202 Geneva, Switzerland.	montserrat.camps@merckserono.net		Camps, Montserrat/0000-0002-9849-8657				AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Angelastro JM, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-3; Bajramovic JJ, 2000, J IMMUNOL, V164, P4359, DOI 10.4049/jimmunol.164.8.4359; Camps M, 1998, FEBS LETT, V425, P271, DOI 10.1016/S0014-5793(98)00250-6; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Dijkmans TF, 2008, J NEUROCHEM, V105, P2388, DOI 10.1111/j.1471-4159.2008.05338.x; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; FANGER GR, 1993, J NEUROCHEM, V61, P1977, DOI 10.1111/j.1471-4159.1993.tb09844.x; Farias-Eisner R, 2001, J NEUROSCI RES, V63, P341, DOI 10.1002/1097-4547(20010215)63:4<341::AID-JNR1028>3.0.CO;2-P; Farias-Eisner R, 2000, J NEUROSCI, V20, P230, DOI 10.1523/JNEUROSCI.20-01-00230.2000; Fischer D, 2008, MOL CELL NEUROSCI, V37, P471, DOI 10.1016/j.mcn.2007.11.002; Goold RG, 2005, MOL CELL NEUROSCI, V28, P524, DOI 10.1016/j.mcn.2004.11.005; Goold RG, 2001, J CELL SCI, V114, P4273; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grumolato L, 2003, ENDOCRINOLOGY, V144, P2368, DOI 10.1210/en.2002-0106; GUNNING PW, 1981, J CELL BIOL, V89, P240, DOI 10.1083/jcb.89.2.240; Gutacker C, 1999, BIOCHEM J, V339, P759, DOI 10.1042/0264-6021:3390759; Hadari YR, 1998, MOL CELL BIOL, V18, P3966, DOI 10.1128/MCB.18.7.3966; Hansen TVO, 2008, J NEUROCHEM, V104, P1450, DOI 10.1111/j.1471-4159.2007.05076.x; Hansen TV, 2003, NEUROSCI LETT, V347, P57, DOI 10.1016/S0304-3940(03)00581-0; HASHIMOTO S, 1989, J NEUROCHEM, V53, P1675, DOI 10.1111/j.1471-4159.1989.tb09230.x; HENDERSON LP, 1994, J NEUROSCI, V14, P1153, DOI 10.1523/JNEUROSCI.14-03-01153.1994; HERNANDEZ A, 1995, PEPTIDES, V16, P927, DOI 10.1016/0196-9781(95)00059-S; IFUNE CK, 1990, BRAIN RES, V506, P243, DOI 10.1016/0006-8993(90)91257-H; Ihara S, 1996, J BIOCHEM, V120, P865; Jackson TR, 1996, J CELL SCI, V109, P289; Kang SW, 2005, EXP CELL RES, V309, P305, DOI 10.1016/j.yexcr.2005.06.012; Kiermayer S, 2005, MOL BIOL CELL, V16, P5639, DOI 10.1091/mbc.E05-05-0432; Lee KH, 2005, NEUROCHEM RES, V30, P533, DOI 10.1007/s11064-005-2688-y; LEONARD DGB, 1987, MOL CELL BIOL, V7, P3156, DOI 10.1128/MCB.7.9.3156; Levkovitz Y, 2002, J NEUROSCI, V22, P3845, DOI 10.1523/JNEUROSCI.22-10-03845.2002; Liedtke T, 2007, MOL CELL PROTEOMICS, V6, P895, DOI 10.1074/mcp.M600245-MCP200; LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153; Marampon F, 2008, MOL BIOL CELL, V19, P2566, DOI 10.1091/mbc.E06-12-1110; Nagamatsu Y, 2008, J BIOL CHEM, V283, P14532, DOI 10.1074/jbc.M801647200; NYE SH, 1992, MOL BIOL CELL, V3, P677, DOI 10.1091/mbc.3.6.677; OBERMEIER A, 1994, EMBO J, V13, P1585, DOI 10.1002/j.1460-2075.1994.tb06421.x; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; PEUNOVA N, 1995, NATURE, V375, P68, DOI 10.1038/375068a0; Ravni A, 2008, MOL PHARMACOL, V73, P1688, DOI 10.1124/mol.107.044792; Ravni A, 2006, J NEUROCHEM, V98, P1229, DOI 10.1111/j.1471-4159.2006.03962.x; Ravni A, 2006, J NEUROCHEM, V98, P321, DOI 10.1111/J.1471-4159.2006.03884.X; RUECKLE T, 2004, Patent No. 2004007491; Seeburg DP, 2005, ONCOGENE, V24, P292, DOI 10.1038/sj.onc.1208277; Shin EY, 2002, J BIOL CHEM, V277, P44417, DOI 10.1074/jbc.M203754200; Shin KS, 2002, EXP MOL MED, V34, P172, DOI 10.1038/emm.2002.25; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Stoevring B, 2005, CLIN CHIM ACTA, V356, P95, DOI 10.1016/j.cccn.2005.01.034; STRITTMATTER SM, 1995, CELL, V80, P445, DOI 10.1016/0092-8674(95)90495-6; Torocsik B, 2002, J NEUROSCI, V22, P8971; Uittenbogaard M, 2004, J NEUROCHEM, V91, P1332, DOI 10.1111/j.1471-4159.2004.02814.x; van Noort JM, 2006, MULT SCLER J, V12, P287, DOI 10.1191/135248506ms1271oa; VANNOORT JM, 1995, NATURE, V375, P798, DOI 10.1038/375798a0; Vaudry D, 2002, J NEUROCHEM, V83, P1272, DOI 10.1046/j.1471-4159.2002.01242.x; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Willard MD, 2007, EMBO J, V26, P2029, DOI 10.1038/sj.emboj.7601659; Wu YY, 2000, J BIOL CHEM, V275, P2147, DOI 10.1074/jbc.275.3.2147; Yan GZ, 1997, J NEUROSCI, V17, P6122; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zamvil SS, 2003, NEURON, V38, P685, DOI 10.1016/S0896-6273(03)00326-X; Zhang WS, 2007, J NEUROCHEM, V103, P1157, DOI 10.1111/j.1471-4159.2007.04813.x	62	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32053	32065		10.1074/jbc.M109.009324	http://dx.doi.org/10.1074/jbc.M109.009324			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19700763	Green Published, hybrid			2022-12-25	WOS:000271572700060
J	Pletnev, S; Gurskaya, NG; Pletneva, NV; Lukyanov, KA; Chudakov, DM; Martynov, VI; Popov, VO; Kovalchuk, MV; Wlodawer, A; Dauter, Z; Pletnev, V				Pletnev, Sergei; Gurskaya, Nadya G.; Pletneva, Nadya V.; Lukyanov, Konstantin A.; Chudakov, Dmitri M.; Martynov, Vladimir I.; Popov, Vladimir O.; Kovalchuk, Mikhail V.; Wlodawer, Alexander; Dauter, Zbigniew; Pletnev, Vladimir			Structural Basis for Phototoxicity of the Genetically Encoded Photosensitizer KillerRed	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED FLUORESCENT PROTEIN; INTERNAL WATER CHAIN; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; CHROMOPHORE FORMATION; MONOMERIC RED; CYTOCHROME F; CANCER-CELLS; WHOLE-BODY; PATHWAYS	KillerRed is the only known fluorescent protein that demonstrates notable phototoxicity, exceeding that of the other green and red fluorescent proteins by at least 1,000-fold. KillerRed could serve as an instrument to inactivate target proteins or to kill cell populations in photodynamic therapy. However, the nature of KillerRed phototoxicity has remained unclear, impeding the development of more phototoxic variants. Here we present the results of a high resolution crystallographic study of KillerRed in the active fluorescent and in the photobleached non-fluorescent states. A unique and striking feature of the structure is a water-filled channel reaching the chromophore area from the end cap of the beta-barrel that is probably one of the key structural features responsible for phototoxicity. A study of the structure-function relationship of KillerRed, supported by structure-based, site-directed mutagenesis, has also revealed the key residues most likely responsible for the phototoxic effect. In particular, Glu(68) and Ser(119), located adjacent to the chromophore, have been assigned as the primary trigger of the reaction chain.	[Dauter, Zbigniew] NCI, Synchrotron Radiat Res Sect, Macromol Crystallog Lab, SAIC Frederick Inc, Argonne, IL 60439 USA; [Gurskaya, Nadya G.; Pletneva, Nadya V.; Lukyanov, Konstantin A.; Chudakov, Dmitri M.; Martynov, Vladimir I.; Pletnev, Vladimir] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Popov, Vladimir O.] Russian Acad Sci, AN Bach Inst Biochem, Moscow 117234, Russia; [Kovalchuk, Mikhail V.] Russian Acad Sci, Inst Crystallog, Moscow 119333, Russia; [Wlodawer, Alexander] NCI, Prot Struct Sect, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Research Center of Biotechnology RAS; Russian Academy of Sciences; Russian Academy of Sciences; FSRC Crystallography & Photonics RAS; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pletnev, S (corresponding author), SAIC Frederick Inc, Basic Res Program, Argonne, IL 60439 USA.	svp@ncifcrf.gov	Gurskaya, Nadya G/Q-1750-2016; Chudakov, Dmitriy M/G-7741-2014; Martynov, Vladimir I./S-3483-2016; Pletneva, Nadya/F-7839-2014; Pletnev, Vladimir/Q-6151-2016; Lukyanov, Konstantin A/D-4030-2013	Gurskaya, Nadya G/0000-0002-8028-8176; Chudakov, Dmitriy M/0000-0003-0430-790X; Martynov, Vladimir I./0000-0003-4923-6842; Lukyanov, Konstantin A/0000-0001-9845-2088; Popov, Vladimir/0000-0002-0133-7962; Pletneva, Nadya/0000-0001-9681-4022	National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research; National Institutes of Health, NCI [HHSN2612008000001E]; Russian Foundation for Basic Research [07-04-00054, 08-04-01702-a]; Russian Federal Agency for Science and Innovations [02.513.12.3013]; Molecular and Cell Biology Program RAS; President of the Russian Federation [MD-2780.2009.4]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL CANCER INSTITUTE [ZIABC010348, ZIABC010378] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R24MD002780] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federal Agency for Science and Innovations(Federal Agency for Science & Innovations (FASI)); Molecular and Cell Biology Program RAS; President of the Russian Federation; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NCI, Center for Cancer Research and by National Institutes of Health, NCI, Contract HHSN2612008000001E. This project was also supported in part by Russian Foundation for Basic Research Grants 07-04-00054 and 08-04-01702-a; by Russian Federal Agency for Science and Innovations Grant 02.513.12.3013; by the Molecular and Cell Biology Program RAS; and by grants from the President of the Russian Federation (MD-2780.2009.4). Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	Agmon N, 2005, BIOPHYS J, V88, P2452, DOI 10.1529/biophysj.104.055541; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barondeau DP, 2006, J AM CHEM SOC, V128, P4685, DOI 10.1021/ja056635l; Barondeau DP, 2003, P NATL ACAD SCI USA, V100, P12111, DOI 10.1073/pnas.2133463100; Bisby RH, 1998, BIOCHEM BIOPH RES CO, V244, P263, DOI 10.1006/bbrc.1998.8245; Bulina ME, 2006, NAT PROTOC, V1, P947, DOI 10.1038/nprot.2006.89; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Carpentier P, 2009, FEBS LETT, V583, P2839, DOI 10.1016/j.febslet.2009.07.041; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Evdokimov AG, 2006, EMBO REP, V7, P1006, DOI 10.1038/sj.embor.7400787; Gilbert DL, 1999, REACTIVE OXYGEN SPEC, P138; Gurskaya NG, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-6; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffman RM, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1992485; Hoffman RM, 2005, CURR TOP DEV BIOL, V70, P121, DOI 10.1016/S0070-2153(05)70006-5; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Krasnovskii AA, 2004, BIOFIZIKA+, V49, P305; Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin JP, 2005, SCIENCE, V310, P1311, DOI 10.1126/science.1118316; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Miyashita O, 2005, P NATL ACAD SCI USA, V102, P3558, DOI 10.1073/pnas.0409600102; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paschenko VZ, 2001, BIOELECTROCHEMISTRY, V53, P233, DOI 10.1016/S0302-4598(01)00098-8; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petersen J, 2003, J BIOL CHEM, V278, P44626, DOI 10.1074/jbc.M307896200; Pletnev S, 2008, J BIOL CHEM, V283, P28980, DOI 10.1074/jbc.M800599200; Pletneva NV, 2007, RUSS J BIOORG CHEM+, V33, P390, DOI 10.1134/S1068162007040048; Pletneva N, 2007, ACTA CRYSTALLOGR D, V63, P1082, DOI 10.1107/S0907444907042461; Ponamarev MV, 1998, BIOCHEMISTRY-US, V37, P17199, DOI 10.1021/bi981814j; Pouwels LJ, 2008, BIOCHEMISTRY-US, V47, P10111, DOI 10.1021/bi8007164; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; ROSENTHAL I, 1995, INT J RADIAT BIOL, V67, P85, DOI 10.1080/09553009514550111; Sainz G, 2000, BIOCHEMISTRY-US, V39, P9164, DOI 10.1021/bi0004596; Schuttrigkeit TA, 2006, CHEM PHYS, V323, P149, DOI 10.1016/j.chemphys.2005.09.039; Seitz G, 2006, J PEDIATR SURG, V41, P1369, DOI 10.1016/j.jpedsurg.2006.04.039; Serebrovskaya EO, 2009, P NATL ACAD SCI USA, V106, P9221, DOI 10.1073/pnas.0904140106; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Sniegowski JA, 2005, J BIOL CHEM, V280, P26248, DOI 10.1074/jbc.M412327200; Tubbs JL, 2005, BIOCHEMISTRY-US, V44, P9833, DOI 10.1021/bi0472907; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Verkhusha VV, 2004, NAT BIOTECHNOL, V22, P289, DOI 10.1038/nbt943; Wall MA, 2000, NAT STRUCT BIOL, V7, P1133; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang YT, 2008, J COMMUN NETW-S KOR, V10, P38, DOI 10.1109/JCN.2008.6388326; Wilmann PG, 2005, J MOL BIOL, V349, P223, DOI 10.1016/j.jmb.2005.03.020; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yanushevich YG, 2002, FEBS LETT, V511, P11, DOI 10.1016/S0014-5793(01)03263-X; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462; ZUBOVA NN, 2005, USP BIOL KHIM, V45, P1	58	103	110	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32028	32039		10.1074/jbc.M109.054973	http://dx.doi.org/10.1074/jbc.M109.054973			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19737938	Green Published, hybrid			2022-12-25	WOS:000271572700058
J	Fusca, T; Bonza, MC; Luoni, L; Meneghelli, S; Marrano, CA; De Michelis, MI				Fusca, Tiziana; Bonza, Maria Cristina; Luoni, Laura; Meneghelli, Silvia; Marrano, Claudia Adriana; De Michelis, Maria Ida			Single Point Mutations in the Small Cytoplasmic Loop of ACA8, a Plasma Membrane Ca2+-ATPase of Arabidopsis thaliana, Generate Partially Deregulated Pumps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-PUMP; CA2+ PUMP; H+-ATPASE; BINDING SITE; CA-2+ PUMP; DOMAIN; ACTIVATION; AUTOINHIBITION; INTERACTS; CONTAINS	ACA8 is a type 2B Ca2+-ATPase having a regulatory N terminus whose auto-inhibitory action can be suppressed by binding of calmodulin (CaM) or of acidic phospholipids. ACA8 N terminus is able to interact with a region of the small cytoplasmic loop connecting transmembrane domains 2 and 3. To determine the role of this interaction in auto-inhibition we analyzed single point mutants produced by mutagenesis of ACA8 Glu(252) to Asn(345) sequence. Mutation to Ala of any of six tested acidic residues (Glu(252), Asp(273), Asp(291), Asp(303), Glu(302), or Asp(332)) renders an enzyme that is less dependent on CaM for activity. These results highlight the relevance in ACA8 auto-inhibition of a negative charge of the surface area of the small cytoplasmic loop. The most deregulated of these mutants is D291A ACA8, which is less activated by controlled proteolysis or by acidic phospholipids; the D291A mutant has an apparent affinity for CaM higher than wildtype ACA8. Moreover, its phenotype is stronger than that of D291NACA8, suggesting a more direct involvement of this residue in the mechanism of auto-inhibition. Among the other produced mutants (I284A, N286A, P289A, P322A, V344A, and N345A), only P322A ACA8 is less dependent on CaM for activity than the wild type. The results reported in this study provide the first evidence that the small cytoplasmic loop of a type 2B Ca2+-ATPase plays a role in the attainment of the auto-inhibited state.	[Fusca, Tiziana; Bonza, Maria Cristina; Luoni, Laura; Meneghelli, Silvia; Marrano, Claudia Adriana; De Michelis, Maria Ida] Univ Milan, Dipartimento Biol L Gorini, Ist Biofis Consiglio Nazl Ric, Sez Milano, I-20133 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan	De Michelis, MI (corresponding author), Univ Milan, Dipartimento Biol L Gorini, Ist Biofis Consiglio Nazl Ric, Sez Milano, Via G Celoria 26, I-20133 Milan, Italy.	mariaida.demichelis@unimi.it	Bonza, Maria Cristina/B-1351-2017; De Michelis, Maria/A-7151-2011	Bonza, Maria Cristina/0000-0001-7096-2967; De Michelis, Maria/0000-0001-7684-9252; Luoni, Laura/0000-0002-6485-5417; MARRANO, Claudia Adriana/0000-0001-9525-6444	Italian Ministry for Instruction, University; Research in the PRIN 2005 and PRIN 2007 frames	Italian Ministry for Instruction, University; Research in the PRIN 2005 and PRIN 2007 frames(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by the Italian Ministry for Instruction, University, and Research in the PRIN 2005 and PRIN 2007 frames.	Anthonisen AN, 2006, J BIOL CHEM, V281, P31572, DOI 10.1074/jbc.M605194200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baekgaard L, 2005, J BIOENERG BIOMEMBR, V37, P369, DOI 10.1007/s10863-005-9473-0; Baekgaard L, 2006, J BIOL CHEM, V281, P1058, DOI 10.1074/jbc.M508299200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bonza C, 1998, PLANT PHYSIOL, V116, P845, DOI 10.1104/pp.116.2.845; Bonza MC, 2000, PLANT PHYSIOL, V123, P1495, DOI 10.1104/pp.123.4.1495; Bonza MC, 2004, PLANTA, V218, P814, DOI 10.1007/s00425-003-1160-y; Bonza MC, 2001, PHYSIOL PLANTARUM, V112, P315, DOI 10.1034/j.1399-3054.2001.1120303.x; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bredeston LM, 2004, J BIOL CHEM, V279, P41619, DOI 10.1074/jbc.M403116200; CARAFOLI E, 1991, PHYSIOL REV, V71, P129, DOI 10.1152/physrev.1991.71.1.129; CHIESI M, 1991, BIOCHEMISTRY-US, V30, P7978, DOI 10.1021/bi00246a015; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Corradi GR, 2007, J BIOL CHEM, V282, P35440, DOI 10.1074/jbc.M703377200; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Curran AC, 2000, J BIOL CHEM, V275, P30301, DOI 10.1074/jbc.M002047200; DEMICHELIS MI, 1993, BOT ACTA, V106, P20, DOI 10.1111/j.1438-8677.1993.tb00333.x; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; FALCHETTO R, 1991, J BIOL CHEM, V266, P2930; Geisler M, 2000, BBA-BIOMEMBRANES, V1465, P52, DOI 10.1016/S0005-2736(00)00131-0; Hetherington AM, 2004, ANNU REV PLANT BIOL, V55, P401, DOI 10.1146/annurev.arplant.55.031903.141624; Hwang I, 2000, PLANT PHYSIOL, V122, P157, DOI 10.1104/pp.122.1.157; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Luoni L, 2006, PHYSIOL PLANTARUM, V126, P175, DOI 10.1111/j.1399-3054.2006.00588.x; Luoni L, 2004, FEBS LETT, V574, P20, DOI 10.1016/j.febslet.2004.08.003; Mangialavori I, 2009, J BIOL CHEM, V284, P4823, DOI 10.1074/jbc.M806912200; Meneghelli S, 2008, MOL MEMBR BIOL, V25, P539, DOI 10.1080/09687680802508747; Meneghelli S, 2008, J BIOCHEM, V143, P253, DOI 10.1093/jb/mvm218; Morsomme P, 1996, EMBO J, V15, P5513, DOI 10.1002/j.1460-2075.1996.tb00936.x; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; RASICALDOGNO F, 1995, PLANT PHYSIOL, V108, P105, DOI 10.1104/pp.108.1.105; RASICALDOGNOV F, 1993, PLANT PHYSIOL, V103, P391, DOI 10.1104/pp.103.2.391; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899	37	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30881	30888		10.1074/jbc.M109.006148	http://dx.doi.org/10.1074/jbc.M109.006148			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740735	Green Published, hybrid			2022-12-25	WOS:000271378400016
J	Kapur, A; Zhao, PW; Sharir, H; Bai, YS; Caron, MG; Barak, LS; Abood, ME				Kapur, Ankur; Zhao, Pingwei; Sharir, Haleli; Bai, Yushi; Caron, Marc G.; Barak, Larry S.; Abood, Mary E.			Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; BETA-ARRESTIN; CLATHRIN ADAPTER; BINDING; CB1; IDENTIFICATION; VISUALIZATION; PHARMACOLOGY; TRAFFICKING; ENDOCYTOSIS	The cannabinoid receptor 1 (CB1) and CB2 cannabinoid receptors, associated with drugs of abuse, may provide a means to treat pain, mood, and addiction disorders affecting widespread segments of society. Whether the orphan G-protein coupled receptor GPR55 is also a cannabinoid receptor remains unclear as a result of conflicting pharmacological studies. GPR55 has been reported to be activated by exogenous and endogenous cannabinoid compounds but surprisingly also by the endogenous non-cannabinoid mediator lysophosphatidylinositol (LPI). We examined the effects of a representative panel of cannabinoid ligands and LPI on GPR55 using a beta-arrestin-green fluorescent protein biosensor as a direct readout of agonist- mediated receptor activation. Our data demonstrate that AM251 and SR141716A (rimonabant), which are cannabinoid antagonists, and the lipid LPI, which is not a cannabinoid receptor ligand, are GPR55 agonists. They possess comparable efficacy in inducing beta-arrestin trafficking and, moreover, activate the G-protein-dependent signaling of protein kinase C beta II. Conversely, the potent synthetic cannabinoid agonist CP55,940 acts as a GPR55 antagonist/partial agonist. CP55,940 blocks GPR55 internalization, the formation of beta-arrestin GPR55 complexes, and the phosphorylation of ERK1/2; CP55,940 produces only a slight amount of protein kinase C beta II membrane recruitment but does not stimulate membrane remodeling like LPI, AM251, or rimonabant. Our studies provide a paradigm for measuring the responsiveness of GPR55 to a variety of ligand scaffolds comprising cannabinoid and novel compounds and suggest that at best GPR55 is an atypical cannabinoid responder. The activation of GPR55 by rimonabant may be responsible for some of the off-target effects that led to its removal as a potential obesity therapy.	[Abood, Mary E.] Temple Univ, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; Temple Univ, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA; [Bai, Yushi; Caron, Marc G.; Barak, Larry S.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Duke University	Abood, ME (corresponding author), Temple Univ, Dept Anat & Cell Biol, 3400 N Broad St, Philadelphia, PA 19140 USA.	mabood@temple.edu		Abood, Mary/0000-0002-1744-2820	National Institutes of Health [DA023204, DA05274]; National Institute on Drug Abuse [DA022950]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023204, U01DA022950, P50DA005274] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA023204 and DA05274 (to M. E. A.) and DA022950 (National Institute on Drug Abuse; to M. G. C. and L. S. B.).	Baker D, 2006, TRENDS PHARMACOL SCI, V27, P1, DOI 10.1016/j.tips.2005.11.003; Barak LS, 1999, J BIOL CHEM, V274, P7565, DOI 10.1074/jbc.274.11.7565; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Breivogel CS, 2001, MOL PHARMACOL, V60, P155, DOI 10.1124/mol.60.1.155; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; FELDER CC, 1995, MOL PHARMACOL, V48, P443; Feng X, 1998, J BIOL CHEM, V273, P10755, DOI 10.1074/jbc.273.17.10755; GALLAGHER S, 2008, CURR PROTOC IMMUNOL, pCH8; Gonzalez-Maeso J, 2009, CURR MED CHEM, V16, P1017, DOI 10.2174/092986709787581851; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; Griffin G, 1999, EUR J PHARMACOL, V377, P117, DOI 10.1016/S0014-2999(99)00402-1; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Haasen D, 2006, METHOD ENZYMOL, V414, P121, DOI 10.1016/S0076-6879(06)14008-2; Hajos N, 2002, CHEM PHYS LIPIDS, V121, P73, DOI 10.1016/S0009-3084(02)00149-4; Henstridge CM, 2009, FASEB J, V23, P183, DOI 10.1096/fj.08-108670; Hurst DP, 2002, MOL PHARMACOL, V62, P1274, DOI 10.1124/mol.62.6.1274; Johns DG, 2007, BRIT J PHARMACOL, V152, P825, DOI 10.1038/sj.bjp.0707419; Kapur A, 2008, J PHARMACOL EXP THER, V325, P341, DOI 10.1124/jpet.107.133256; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Lan RX, 1999, J MED CHEM, V42, P769, DOI 10.1021/jm980363y; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Luttrell DK, 2003, ASSAY DRUG DEV TECHN, V1, P327, DOI 10.1089/15406580360545143; Marion S, 2006, J BIOL CHEM, V281, P2932, DOI 10.1074/jbc.M508074200; McAllister SD, 2003, J MED CHEM, V46, P5139, DOI 10.1021/jm0302647; Mcguinness D, 2009, J BIOMOL SCREEN, V14, P49, DOI 10.1177/1087057108327329; Murray RM, 2007, NAT REV NEUROSCI, V8, P885, DOI 10.1038/nrn2253; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Offertaler L, 2003, MOL PHARMACOL, V63, P699, DOI 10.1124/mol.63.3.699; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Oka S, 2009, J BIOCHEM, V145, P13, DOI 10.1093/jb/mvn136; Ross RA, 2009, TRENDS PHARMACOL SCI, V30, P156, DOI 10.1016/j.tips.2008.12.004; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sawzdargo M, 1999, MOL BRAIN RES, V64, P193, DOI 10.1016/S0169-328X(98)00277-0; Shenoy SK, 2005, NAT CELL BIOL, V7, P1159, DOI 10.1038/ncb1205-1159; Showalter VM, 1996, J PHARMACOL EXP THER, V278, P989; Staton PC, 2008, PAIN, V139, P225, DOI 10.1016/j.pain.2008.04.006; Sugiura T, 2000, CHEM PHYS LIPIDS, V108, P89, DOI 10.1016/S0009-3084(00)00189-4; van der Lee MMC, 2009, J BIOMOL SCREEN, V14, P811, DOI 10.1177/1087057109337937; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Wagner JA, 1999, HYPERTENSION, V33, P429, DOI 10.1161/01.HYP.33.1.429; Yin H, 2009, J BIOL CHEM, V284, P12328, DOI 10.1074/jbc.M806516200; Zhao ZZ, 1996, J BIOL CHEM, V271, P22251, DOI 10.1074/jbc.271.36.22251	45	204	213	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29817	29827		10.1074/jbc.M109.050187	http://dx.doi.org/10.1074/jbc.M109.050187			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19723626	Green Published, hybrid			2022-12-25	WOS:000270896800062
J	Yan, D; Dong, XD; Chen, XY; Wang, LH; Lu, CJ; Wang, J; Qu, J; Tu, LL				Yan, Dongsheng; Dong, Xiang Da (Eric); Chen, Xiaoyan; Wang, Lihua; Lu, Chunjing; Wang, Jiao; Qu, Jia; Tu, Lili			MicroRNA-1/206 Targets c-Met and Inhibits Rhabdomyosarcoma Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALVEOLAR RHABDOMYOSARCOMA; BREAST-CANCER; EXPRESSION; CELL; METASTASIS; RECEPTOR; DIFFERENTIATION; DYSREGULATION; PAX3; MICE	MicroRNAs (miRNAs) are endogenous short (similar to 22) nucleotide RNAs that regulate gene function by modification of target mRNAs. miRNA-1 (miR-1) and miRNA-206 (miR-206) are highly expressed in skeletal muscle. Due to the tissue-specific nature of miR-1/206 for skeletal muscles, we investigated the role of miR-1/206 in the development of rhabdomyosarcoma. Initially, we demonstrated that miR-1/206 expression was suppressed in rhabdomyosarcomas and found at very low levels in a rhabdomyosarcoma RD cell line. Transient transfection of miR-1/206 into cultured RD cells led to a significant decrease in cell growth and migration. Using bioinformatics, we identified two putative miR-1/206 binding sites within the 3'-untranslated region of the human c-Met mRNA. miR-1/206 was then shown to have activity on mRNA expression by targeting the c-Met 3'-untranslated region. The expression of c-Met protein was shown to be down-regulated by subsequent Western blot analysis. Conversely, up-regulation of c-Met was confirmed in tissue samples of human rhabdomyosarcoma, with its level inversely correlated with miR-1/206 expression. In vivo, miR-1/206-expressing tumor cells showed growth delay in comparison with negative control. Our results demonstrated that miR-1/206 suppressed c-Met expression in rhabdomyosarcoma and could function as a potent tumor suppressor in c-Met-overexpressing tumors. Inhibition of miR-1/206 function could contribute to aberrant cell proliferation and migration, leading to rhabdomyosarcoma development.	[Dong, Xiang Da (Eric)] Columbia Univ, Stamford Hosp, Dept Surg, Stamford, CT 06904 USA; [Tu, Lili] Wenzhou Med Coll, Hosp Eye, Sch Ophthalmol & Optometry, Wenzhou 325003, Zhejiang, Peoples R China; [Yan, Dongsheng; Chen, Xiaoyan; Wang, Lihua; Lu, Chunjing; Wang, Jiao; Qu, Jia; Tu, Lili] Zhejiang Prov Key Lab Ophthalmol & Optometry, Minist Hlth Peoples Republ China, Key Lab Vis Sci, Wenzhou 325003, Zhejiang, Peoples R China	Columbia University; Stamford Hospital; Wenzhou Medical University	Tu, LL (corresponding author), Wenzhou Med Coll, Hosp Eye, Sch Ophthalmol & Optometry, 270 Xueyuan Rd, Wenzhou 325003, Zhejiang, Peoples R China.	jqu@wzmc.net; tulili@mail.eye.ac.cn	Yan, Dongsheng/B-1861-2018; Vickers, Michael M/E-4095-2010	Yan, Dongsheng/0000-0003-0551-2219; 	National Natural Science Foundation of China [30772385]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported, in part, by the National Natural Science Foundation of China Grant 30772385.	Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Breitfeld PP, 2005, ONCOLOGIST, V10, P518, DOI 10.1634/theoncologist.10-7-518; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Danilkovitch-Miagkova A, 2002, J CLIN INVEST, V109, P863; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; Ferracini R, 1996, ONCOGENE, V12, P1697; Ferrari A, 2003, CANCER-AM CANCER SOC, V98, P571, DOI 10.1002/cncr.11550; Ginsberg JP, 1998, CANCER RES, V58, P3542; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mazzone M, 2006, FASEB J, V20, P1611, DOI 10.1096/fj.06-5947rev; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; NAITO S, 1986, CANCER RES, V46, P4109; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Sharp R, 2002, NAT MED, V8, P1276, DOI 10.1038/nm787; Subramanian S, 2008, ONCOGENE, V27, P2015, DOI 10.1038/sj.onc.1210836; Taulli R, 2006, CANCER RES, V66, P4742, DOI 10.1158/0008-5472.CAN-05-4292; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	26	232	250	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29596	29604		10.1074/jbc.M109.020511	http://dx.doi.org/10.1074/jbc.M109.020511			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19710019	Green Published, hybrid			2022-12-25	WOS:000270896800041
J	Dean, J; Hashimoto, K; Tsuji, T; Gautier, V; Hall, WW; Sheehy, N				Dean, J.; Hashimoto, K.; Tsuji, T.; Gautier, V.; Hall, W. W.; Sheehy, N.			Functional interaction of HTLV-1 Tax protein with the POZ domain of the transcriptional repressor BCL6	ONCOGENE			English	Article						HTLV-1; BCL6; Tax 1	T-CELL LEUKEMIA; VIRUS TYPE-I; CENTER B-CELLS; FINGER ENCODING GENE; NF-KAPPA-B; LAZ3/BCL6 ONCOPROTEIN; HISTONE DEACETYLASES; DOWN-REGULATION; TYPE-1 HTLV-1; PDCD2 GENE	The Tax protein encoded by human T-cell leukaemia virus type 1 (HTLV-1) has a pivotal role in T-cell transformation by deregulating cellular signalling pathways. Using the yeast two-hybrid system to screen a human leukocyte cDNA library, we identified BCL6 (B-cell lymphoma 6) as a cellular protein, which interacts with Tax 1. The BCL6 gene encodes a sequence-specific transcriptional repressor that contains a conserved N-terminal poxvirus and zinc finger (POZ) repressor domain and a C-terminal Kruppel-like zinc finger DNA binding domain. Using both in vivo and in vitro methods, we demonstrate that the POZ domain of BCL6 is sufficient for its interaction with Tax 1. Using functional assays, we demonstrate that Tax 1 enhanced the repressive activity of BCL6 and increased the levels of apoptosis induced by BCL6 in osteosarcoma cells indicating that both proteins cooperate in vivo to cause a physiological affect. Furthermore, BCL6 recruited Tax 1 into punctate nuclear structures, which suggests that Tax 1 colocalizes with BCL6 in repressor complexes in vivo. BCL6 expression significantly downregulated both basal and Tax-induced nuclear factor-kappa B and long terminal repeat activation. This suggests that the expression of BCL6 in HTLV infected cells may contribute to the silencing of viral gene expression and to the long clinical latency associated with HTLV infection. Oncogene (2009) 28, 3723-3734; doi: 10.1038/onc.2009.230;published online 24 August 2009	[Dean, J.; Hashimoto, K.; Tsuji, T.; Gautier, V.; Hall, W. W.; Sheehy, N.] Univ Coll Dublin, Sch Med & Med Sci, Ctr Res Infect Dis, Dublin D4, Ireland; [Hashimoto, K.] Itoh Hosp, Dept Neurol, Ibusuki City, Kagoshima, Japan; [Tsuji, T.] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan	University College Dublin; National Institute of Infectious Diseases (NIID)	Sheehy, N (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Ctr Res Infect Dis, Dublin D4, Ireland.	Noreen.sheehy@ucd.ie	Gautier, virginie/K-4057-2012	Gautier, virginie/0000-0003-1862-2644; Sheehy, Noreen/0000-0001-5004-0228				Albagli O, 1999, ONCOGENE, V18, P5063, DOI 10.1038/sj.onc.1202892; Albagli O, 2000, MOL CELL BIOL, V20, P8560, DOI 10.1128/MCB.20.22.8560-8570.2000; Albagli O, 1996, BIOCHEM BIOPH RES CO, V220, P911, DOI 10.1006/bbrc.1996.0505; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Baron BW, 2007, P NATL ACAD SCI USA, V104, P7449, DOI 10.1073/pnas.0701770104; Baron BW, 2002, P NATL ACAD SCI USA, V99, P2860, DOI 10.1073/pnas.042702599; BARON BW, 1993, P NATL ACAD SCI USA, V90, P5262, DOI 10.1073/pnas.90.11.5262; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Chen WY, 1998, BLOOD, V91, P603, DOI 10.1182/blood.V91.2.603.603_603_607; Cheng J, 2007, BLOOD, V110, P2110, DOI 10.1182/blood-2006-11-058388; Delebecque F, 2002, J VIROL, V76, P7883, DOI 10.1128/JVI.76.15.7883-7889.2002; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dhordain P, 1998, NUCLEIC ACIDS RES, V26, P4645, DOI 10.1093/nar/26.20.4645; Dhordain P, 1995, ONCOGENE, V11, P2689; Dhordain P, 2000, ONCOGENE, V19, P6240, DOI 10.1038/sj.onc.1203976; Gabet AS, 2003, ONCOGENE, V22, P3734, DOI 10.1038/sj.onc.1206468; GAIDANO G, 1994, BLOOD, V84, P397; GESSAIN A, 1985, LANCET, V2, P407; Giebler HA, 1997, MOL CELL BIOL, V17, P5156, DOI 10.1128/MCB.17.9.5156; GRASSMANN R, 1992, J VIROL, V66, P4570, DOI 10.1128/JVI.66.7.4570-4575.1992; GRASSMANN R, 1989, P NATL ACAD SCI USA, V86, P3351, DOI 10.1073/pnas.86.9.3351; Hasegawa H, 2006, NAT MED, V12, P466, DOI 10.1038/nm1389; Hironaka N, 2004, NEOPLASIA, V6, P266, DOI 10.1593/neo.03388; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Huynh KD, 2000, GENE DEV, V14, P1810; Hyjek E, 2001, BLOOD, V97, P270, DOI 10.1182/blood.V97.1.270; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Ichii H, 2007, INT IMMUNOL, V19, P427, DOI 10.1093/intimm/dxm007; JEANG KT, 1990, SCIENCE, V247, P1082, DOI 10.1126/science.2309119; Jiang H, 1999, MOL CELL BIOL, V19, P8136; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; Kibler KV, 2001, J VIROL, V75, P2161, DOI 10.1128/JVI.75.5.2161-2173.2001; Lemasson I, 2004, MOL CELL BIOL, V24, P6117, DOI 10.1128/MCB.24.14.6117-6126.2004; Lemercier C, 2002, J BIOL CHEM, V277, P22045, DOI 10.1074/jbc.M201736200; Li ZP, 2005, J IMMUNOL, V174, P205, DOI 10.4049/jimmunol.174.1.205; Lu HX, 2004, J VIROL, V78, P6735, DOI 10.1128/JVI.78.13.6735-6743.2004; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; Mori N, 1999, BLOOD, V93, P2360; Nakayama T, 2008, ONCOGENE, V27, P3221, DOI 10.1038/sj.onc.1210984; ONIZUKA T, 1995, BLOOD, V86, P28, DOI 10.1182/blood.V86.1.28.bloodjournal86128; OSAME M, 1986, LANCET, V1, P1031; Perez-Rosado A, 2008, J PATHOL, V214, P498, DOI 10.1002/path.2279; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; POZZATTI R, 1990, MOL CELL BIOL, V10, P413, DOI 10.1128/MCB.10.1.413; Ranuncolo SM, 2008, J BIOL CHEM, V283, P22565, DOI 10.1074/jbc.M803490200; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; Seyfert VL, 1996, ONCOGENE, V12, P2331; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Sheehy N, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-20; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Sun SC, 2005, ONCOGENE, V24, P5952, DOI 10.1038/sj.onc.1208969; SUZUKI T, 1993, P NATL ACAD SCI USA, V90, P610, DOI 10.1073/pnas.90.2.610; TANAKA A, 1990, P NATL ACAD SCI USA, V87, P1071, DOI 10.1073/pnas.87.3.1071; Tsuji T, 2007, J BIOL CHEM, V282, P13875, DOI 10.1074/jbc.M611629200; Yamochi T, 1999, ONCOGENE, V18, P487, DOI 10.1038/sj.onc.1202334; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Zhang H, 2001, BBA-MOL CELL RES, V1540, P188, DOI 10.1016/S0167-4889(01)00128-8; ZHAO LJ, 1991, P NATL ACAD SCI USA, V88, P11445, DOI 10.1073/pnas.88.24.11445	64	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 22	2009	28	42					3723	3734		10.1038/onc.2009.230	http://dx.doi.org/10.1038/onc.2009.230			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	509MY	19701248				2022-12-25	WOS:000271023200005
J	Liu, YY; Mosher, DF				Liu, Yuanyuan; Mosher, Deane F.			Interactions among Stalk Modules of Thrombospondin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PLATELET THROMBOSPONDIN; N-TERMINAL DOMAIN; TYPE-1 REPEATS; O-FUCOSYLATION; BIOPHYSICAL CHARACTERIZATION; MONOCLONAL-ANTIBODIES; SIGNATURE DOMAINS; CRYSTAL-STRUCTURE; BINDING; POLYMORPHISM	Thrombospondin-1 is a trimeric, modular calcium-binding glycoprotein. The subunit is composed of an N-terminal module; oligomerization domain; stalk modules including a von Willebrand factor type C module, three properdin or thrombospondin type 1 repeat (TSR) modules, and two thrombospondin-type EGF-like modules; and a C-terminal signature domain comprising single copies of the epidermal growth factor (EGF)-like, wire, and lectin-like modules. Conformational changes in the signature domain influence ligand binding to the N-terminal modules. Interactions have been demonstrated among the modules of the signature domain and the thrombospondin-type EGF-like modules. We have extended this analysis to the rest of the stalk modules. Differential scanning calorimetry revealed interactions between the most C-terminal TSR module and the EGF-like modules. Calorimetry and differences in expression levels of single versus tandem modules indicated that the three TSRs interact with each other as well. No evidence of interactions between the von Willebrand factor type C and TSR modules were detected by differential scanning calorimetry, circular dichroism, or intrinsic fluorescence. These results indicate that the TSR and thrombospondin-type EGF-like stalk modules act as a unit that may relay conformational information between the N-terminal and C-terminal parts of the protein.	Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), 4285 Med Sci Ctr,1300 Univ Ave, Madison, WI 53706 USA.	dfmosher@wisc.edu	Liu, Yuanyuan/E-9439-2013		National Institutes of Health [ROIHL054462]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant ROIHL054462.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Annis DS, 2007, J BIOL CHEM, V282, P27067, DOI 10.1074/jbc.M703804200; Annis DS, 2006, J THROMB HAEMOST, V4, P459, DOI 10.1111/j.1538-7836.2006.01723.x; BEYCHOK S, 1966, SCIENCE, V154, P1288, DOI 10.1126/science.154.3754.1288; Bonnefoy A, 2008, CELL MOL LIFE SCI, V65, P713, DOI 10.1007/s00018-007-7487-y; Calzada MJ, 2008, MATRIX BIOL, V27, P339, DOI 10.1016/j.matbio.2007.12.002; Calzada MJ, 2004, J BIOL CHEM, V279, P41734, DOI 10.1074/jbc.M406267200; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Carlson CB, 2008, J BIOL CHEM, V283, P20069, DOI 10.1074/jbc.M800223200; Carlson CB, 2005, NAT STRUCT MOL BIOL, V12, P910, DOI 10.1038/nsmb997; COLIGAN JE, 1984, J BIOL CHEM, V259, P3944; GALVIN NJ, 1985, J CELL BIOL, V101, P1434, DOI 10.1083/jcb.101.4.1434; Hambleton S, 2004, STRUCTURE, V12, P2173, DOI 10.1016/j.str.2004.09.012; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Huwiler KG, 2002, BIOCHEMISTRY-US, V41, P14329, DOI 10.1021/bi026463u; Isenberg JS, 2008, CELL MOL LIFE SCI, V65, P728, DOI 10.1007/s00018-007-7488-x; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; LAWLER J, 1985, J BIOL CHEM, V260, P3762; LAWLER J, 1992, BIOCHEMISTRY-US, V31, P1173, DOI 10.1021/bi00119a029; Lee NV, 2006, EMBO J, V25, P5270, DOI 10.1038/sj.emboj.7601400; Liu YY, 2009, J BIOL CHEM, V284, P22206, DOI 10.1074/jbc.M109.026120; MACH H, 1992, ANAL BIOCHEM, V200, P74, DOI 10.1016/0003-2697(92)90279-G; MARRIOTT G, 1988, BIOCHEMISTRY-US, V27, P6214, DOI 10.1021/bi00417a004; Misenheimer TM, 2005, J BIOL CHEM, V280, P41229, DOI 10.1074/JBC.M504696200; Misenheimer TM, 2000, J BIOL CHEM, V275, P40938, DOI 10.1074/jbc.M007022200; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; Narizhneva NV, 2004, J BIOL CHEM, V279, P21651, DOI 10.1074/jbc.M311090200; NISHIMURA H, 1992, J BIOCHEM-TOKYO, V111, P460, DOI 10.1093/oxfordjournals.jbchem.a123780; O'Leary JM, 2004, J BIOL CHEM, V279, P53857, DOI 10.1074/jbc.M409225200; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Roszmusz E, 2002, BIOCHEM BIOPH RES CO, V296, P156, DOI 10.1016/S0006-291X(02)00826-4; SMITH CA, 1984, J BIOL CHEM, V259, P4582; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Sun Z, 2004, J MOL BIOL, V343, P1327, DOI 10.1016/j.jmb.2004.09.001; Tan K, 2006, STRUCTURE, V14, P33, DOI 10.1016/j.str.2005.09.017; Tan K, 2008, J BIOL CHEM, V283, P3932, DOI 10.1074/jbc.M705203200; Tan KM, 2009, FASEB J, V23, P2490, DOI 10.1096/fj.08-128090; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Young GD, 2004, J BIOL CHEM, V279, P47633, DOI 10.1074/jbc.M404918200; Zhang JL, 2008, DEV CELL, V14, P739, DOI 10.1016/j.devcel.2008.02.017	43	5	5	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28563	28570		10.1074/jbc.M109.035089	http://dx.doi.org/10.1074/jbc.M109.035089			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706610	hybrid, Green Published			2022-12-25	WOS:000270678900010
J	Xu, Y; Zhang, SL; Malhotra, A; Edelman-Novemsky, I; Ma, JP; Kruppa, A; Cernicica, C; Blais, S; Neubert, TA; Ren, MD; Schlame, M				Xu, Yang; Zhang, Shali; Malhotra, Ashim; Edelman-Novemsky, Irit; Ma, Jinping; Kruppa, Antonina; Cernicica, Carolina; Blais, Steven; Neubert, Thomas A.; Ren, Mindong; Schlame, Michael			Characterization of Tafazzin Splice Variants from Humans and Fruit Flies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MASS-SPECTROMETRIC ANALYSIS; BARTH-SYNDROME; GENE; CARDIOLIPIN; TRANSACYLATION; EXPRESSION; DROSOPHILA; PATTERN; PROTEIN; MUTANT	The tafazzin gene encodes a phospholipid-lysophospholipid transacylase involved in cardiolipin metabolism, but it is not known why it forms multiple transcripts as a result of alternative splicing. Here we studied the intracellular localization, enzymatic activity, and metabolic function of four isoforms of human tafazzin and three isoforms of Drosophila tafazzin upon expression in different mammalian and insect systems. When expressed in HeLa cells, all isoforms were localized in mitochondria except for the B-form of Drosophila tafazzin, which was associated with multiple intracellular membranes. Among the human isoforms, only full-length tafazzin (FL) and tafazzin lacking exon 5 (Delta 5) had transacylase activity, and only these two isoforms were able to restore a normal cardiolipin pattern, normal respiratory activity of mitochondria, and male fertility in tafazzin-deficient flies. Both FL and Delta 5 were associated with large protein complexes in 293T cell mitochondria, but treatment with alkali and proteinase K suggested that the Delta 5 isoform was more integrated into the hydrophobic core of the membrane than the FL isoform. Although all Drosophila isoforms showed transacylase activity in vitro, only the A-form supported cardiolipin remodeling in flies. The data suggest that humans express two mitochondrial isoenzymes of tafazzin that have similar transacylase activities but different membrane topologies. Furthermore, the data show that the expression of human tafazzin in flies creates cardiolipin with a Drosophila pattern, suggesting that the characteristic fatty acid profile of cardiolipin is not determined by the substrate specificity of tafazzin.	[Zhang, Shali; Edelman-Novemsky, Irit; Ma, Jinping; Kruppa, Antonina; Ren, Mindong; Schlame, Michael] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Cernicica, Carolina; Schlame, Michael] NYU, Sch Med, Dept Anesthesiol, New York, NY 10016 USA; [Blais, Steven; Neubert, Thomas A.] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Blais, Steven; Neubert, Thomas A.] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA	New York University; New York University; New York University; New York University	Ren, MD (corresponding author), NYU, Sch Med, Dept Cell Biol, 550 1st Ave, New York, NY 10016 USA.	mindong.ren@nyumc.org; michael.schlame@med.nyu.edu			National Institutes of Health [R01 HL078788, S10 RR14662, P30 NS050276]; Barth Syndrome Foundation; United Mitochondrial Disease Foundation; Howard Hughes Medical Institute Summer Research Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014662] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barth Syndrome Foundation; United Mitochondrial Disease Foundation; Howard Hughes Medical Institute Summer Research Fellowship(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL078788 ( to M. S.) and S10 RR14662 and P30 NS050276 ( to T. A. N.). This work was also supported by the Barth Syndrome Foundation and the United Mitochondrial Disease Foundation ( both to M. R.) and a Howard Hughes Medical Institute Summer Research Fellowship ( to A. K.).	BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRAND AH, 1993, DEVELOPMENT, V118, P401; Claypool SM, 2008, MOL BIOL CELL, V19, P5143, DOI 10.1091/mbc.E08-09-0896; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; Gonzalez IL, 2005, AM J MED GENET A, V134A, P409, DOI 10.1002/ajmg.a.30661; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; KELLEY RI, 1991, J PEDIATR-US, V119, P738, DOI 10.1016/S0022-3476(05)80289-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu B, 2004, BIOCHEM CELL BIOL, V82, P569, DOI 10.1139/O04-055; Ma LN, 2004, J BIOL CHEM, V279, P44394, DOI 10.1074/jbc.M405479200; Magalhaes PJ, 1998, MOL BIOL CELL, V9, P2375, DOI 10.1091/mbc.9.9.2375; Malhotra A, 2009, BBA-MOL CELL BIOL L, V1791, P314, DOI 10.1016/j.bbalip.2009.01.004; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; Oberstein A, 2005, NAT METHODS, V2, P583, DOI 10.1038/NMETH775; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2009, BBA-MOL CELL BIOL L, V1791, P321, DOI 10.1016/j.bbalip.2009.01.018; Spencer CT, 2006, PEDIATRICS, V118, pE337, DOI 10.1542/peds.2005-2667; Sun G, 2008, ANAL CHEM, V80, P7576, DOI 10.1021/ac801200w; Testet E, 2005, BIOCHEM J, V387, P617, DOI 10.1042/BJ20041491; Tress ML, 2007, P NATL ACAD SCI USA, V104, P5495, DOI 10.1073/pnas.0700800104; Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200	28	50	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29230	29239		10.1074/jbc.M109.016642	http://dx.doi.org/10.1074/jbc.M109.016642			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19700766	Green Published, hybrid			2022-12-25	WOS:000270678900077
J	Sorby, R; Austbo, L; Press, CM; Skretting, G; Landsverk, T; Espenes, A				Sorby, Randi; Austbo, Lars; Press, Charles McL.; Skretting, Grethe; Landsverk, Thor; Espenes, Arild			PrP Expression, PrPSc Accumulation and Innervation of Splenic Compartments in Sheep Experimentally Infected with Scrapie	PLOS ONE			English	Article								Background: In prion disease, the peripheral expression of PrPC is necessary for the transfer of infectivity to the central nervous system. The spleen is involved in neuroinvasion and neural dissemination in prion diseases but the nature of this involvement is not known. The present study undertook the investigation of the spatial relationship between sites of PrPSc accumulation, localisation of nerve fibres and PrPC expression in the tissue compartments of the spleen of scrapie-inoculated and control sheep. Methodology/Principal Findings: Laser microdissection and quantitative PCR were used to determine PrP mRNA levels and results were compared with immunohistochemical protocols to distinguish PrPC and PrPSc in tissue compartments of the spleen. In sheep experimentally infected with scrapie, the major sites of accumulation of PrPSc in the spleen, namely the lymphoid nodules and the marginal zone, expressed low levels of PrP mRNA. Double immunohistochemical labelling for PrPSc and the pan-nerve fibre marker, PGP, was used to evaluate the density of innervation of splenic tissue compartments and the intimacy of association between PrPSc and nerves. Some nerve fibres were observed to accompany blood vessels into the PrPSc-laden germinal centres. However, the close association between nerves and PrPSc was most apparent in the marginal zone. Other sites of close association were adjacent to the wall of the central artery of PALS and the outer rim of germinal centres. Conclusions/Significance: The findings suggest that the degree of PrPSc accumulation does not depend on the expression level of PrPC. Though several splenic compartments may contribute to neuroinvasion, the marginal zone may play a central role in being the compartment with most apparent association between nerves and PrPSc.			Sorby, R (corresponding author), Norwegian Sch Vet Sci, Dept Basic Sci & Aquat Med, Oslo, Norway.	randi.sorby@veths.no						Aguzzi A, 2001, NAT REV MOL CELL BIO, V2, P118, DOI 10.1038/35052063; Aucouturier P, 2001, J CLIN INVEST, V108, P703, DOI 10.1172/JCI200113155; Austbo L, 2007, J GEN VIROL, V88, P2083, DOI 10.1099/vir.0.82791-0; Austbo L, 2006, J GEN VIROL, V87, P3463, DOI 10.1099/vir.0.82008-0; Beekes M, 1996, J GEN VIROL, V77, P1925, DOI 10.1099/0022-1317-77-8-1925; Blattler T, 1997, NATURE, V389, P69, DOI 10.1038/37981; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; Bruce ME, 2000, IMMUNOL TODAY, V21, P442, DOI 10.1016/S0167-5699(00)01696-0; Crozet C, 2007, J INFECT DIS, V195, P997, DOI 10.1086/512085; Ersdal C, 2005, VET PATHOL, V42, P258, DOI 10.1354/vp.42-3-258; FELTEN D L, 1988, Brain Behavior and Immunity, V2, P293, DOI 10.1016/0889-1591(88)90031-1; FELTEN DL, 1987, J NEUROSCI RES, V18, P28, DOI 10.1002/jnr.490180107; FELTEN DL, 1985, J IMMUNOL, V135, pS755; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Follet J, 2002, J VIROL, V76, P2434, DOI 10.1128/JVI.76.5.2434-2439.2002; Glatzel M, 2000, J GEN VIROL, V81, P2813, DOI 10.1099/0022-1317-81-11-2813; Glatzel M, 2001, NEURON, V31, P25, DOI 10.1016/S0896-6273(01)00331-2; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; Heggebo R, 2003, J COMP PATHOL, V128, P172, DOI 10.1053/jcpa.2002.0625; Heggebo R, 2002, J GEN VIROL, V83, P479, DOI 10.1099/0022-1317-83-2-479; KIMBERLIN RH, 1982, J ROY SOC MED, V75, P618; KIMBERLIN RH, 1989, VIRUS RES, V12, P213, DOI 10.1016/0168-1702(89)90040-3; KIMBERLIN RH, 1989, VIRUS RES, V12, P201, DOI 10.1016/0168-1702(89)90039-7; Kubosaki A, 2000, BIOCHEM BIOPH RES CO, V273, P890, DOI 10.1006/bbrc.2000.3035; LORTON D, 1991, BRAIN BEHAV IMMUN, V5, P29, DOI 10.1016/0889-1591(91)90005-U; MCBRIDE PA, 1992, J PATHOL, V168, P413, DOI 10.1002/path.1711680412; McGovern G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001304; McLennan NF, 2001, NEUROPATH APPL NEURO, V27, P373, DOI 10.1046/j.0305-1846.2001.00343.x; Prinz M, 2003, NATURE, V425, P957, DOI 10.1038/nature02072; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Raymond CR, 2007, J NEUROIMMUNOL, V187, P114, DOI 10.1016/j.jneuroim.2007.05.006; REYNOLDS JD, 1985, ADV EXP MED BIOL, V186, P111	33	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6885	10.1371/journal.pone.0006885	http://dx.doi.org/10.1371/journal.pone.0006885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19727393	Green Submitted, Green Published, gold			2022-12-25	WOS:000269522900014
J	Nishide, K; Nakatani, Y; Kiyonari, H; Kondo, T				Nishide, Kenji; Nakatani, Yuka; Kiyonari, Hiroshi; Kondo, Toru			Glioblastoma Formation from Cell Population Depleted of Prominin1-Expressing Cells	PLOS ONE			English	Article							CANCER STEM-CELLS; DIPHTHERIA-TOXIN FRAGMENT; CD133 EXPRESSION; MARKER; CRE; IDENTIFICATION; MOLECULE; SHOW	Prominin1 (Prom1, also known as CD133 in human) has been widely used as a marker for cancer stem cells (CSCs), which self-renew and are tumorigenic, in malignant tumors including glioblastoma multiforme (GBM). However, there is other evidence showing that Prom1-negative cancer cells also form tumors in vivo. Thus it remains controversial whether Prom1 is a bona fide marker for CSCs. To verify if Prom1-expressing cells are essential for tumorigenesis, we established a mouse line, whose Prom1-expressing cells can be eliminated conditionally by a Cre-inducible DTA gene on the Prom1 locus together with a tamoxifen-inducible CreER (TM), and generated glioma-initiating cells (GICs-LD) by overexpressing both the SV40 Large T antigen and an oncogenic H-Ras(L61) in neural stem cells of the mouse line. We show here that the tamoxifen-treated GICs-LD (GICs-DTA) form tumor-spheres in culture and transplantable GBM in vivo. Thus, our studies demonstrate that Prom1-expressing cells are dispensable for gliomagenesis in this mouse model.			Nishide, K (corresponding author), RIKEN, Ctr Dev Biol, Lab Cell Lineage Modulat, Kobe, Hyogo, Japan.	tkondo@cdb.riken.jp	Kiyonari, Hiroshi/N-7936-2015; Kondo, Toru/F-9420-2012					Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Corbeil D, 2009, GLIA, V57, P860, DOI 10.1002/glia.20812; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Florek M, 2005, CELL TISSUE RES, V319, P15, DOI 10.1007/s00441-004-1018-z; Griguer CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003655; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Jeuken J, 2007, ACTA NEUROPATHOL, V114, P121, DOI 10.1007/s00401-007-0239-0; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; McLendon R., 2006, RUSSELL RUBINSTEINS, P103; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Murata T, 2004, GENE EXPR PATTERNS, V5, P171, DOI 10.1016/j.modgep.2004.08.007; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Srivastava VK, 2008, CYTOM PART A, V73A, P940, DOI 10.1002/cyto.a.20633; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; Tabu K, 2008, CELL RES, V18, P1037, DOI 10.1038/cr.2008.270; Takanaga H, 2009, STEM CELLS, V27, P165, DOI 10.1634/stemcells.2008-0580; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	33	49	49	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6869	10.1371/journal.pone.0006869	http://dx.doi.org/10.1371/journal.pone.0006869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718438	Green Published, Green Submitted, gold			2022-12-25	WOS:000269415900030
J	Dischinger, J; Josten, M; Szekat, C; Sahl, HG; Bierbaum, G				Dischinger, Jasmin; Josten, Michaele; Szekat, Christiane; Sahl, Hans-Georg; Bierbaum, Gabriele			Production of the Novel Two-Peptide Lantibiotic Lichenicidin by Bacillus licheniformis DSM 13	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; BIOSYNTHETIC GENE-CLUSTER; PEPTIDE PEP-5; AERIAL HYPHAE; LACTICIN-3147; MERSACIDIN; SYSTEM; MODE; IDENTIFICATION; GALLIDERMIN	Background: Lantibiotics are small microbial peptide antibiotics that are characterized by the presence of the thioether amino acids lanthionine and methyllanthionine. Lantibiotics possess structural genes which encode inactive prepeptides. During maturation, the prepeptide undergoes posttranslational modifications including the introduction of rare amino acids as lanthionine and methyllanthione as well as the proteolytic removal of the leader. The structural gene (lanA) as well as the other genes which are involved in lantibiotic modification (lanM, lanB, lanC, lanP), regulation (lanR, lanK), export (lanT(P)) and immunity (lanEFG) are organized in biosynthetic gene clusters. Methodology/Principal Findings: Sequence comparisons in the NCBI database showed that Bacillus licheniformis DSM 13 harbours a putative lantibiotic gene cluster which comprises two structural genes (licA1, licA2) and two modification enzymes (licM1, licM2) in addition to 10 ORFs that show sequence similarities to proteins involved in lantibiotic production. A heat labile antimicrobial activity was detected in the culture supernatant and a heat stabile activity was present in the isopropanol cell wash extract of this strain. In agar well diffusion assays both fractions exhibited slightly different activity spectra against Gram-positive bacteria. In order to demonstrate the connection between the lantibiotic gene cluster and one of the antibacterial activities, two Bacillus licheniformis DSM 13 mutant strains harbouring insertions in the structural genes of the modification enzymes licM1 and licM2 were constructed. These strains were characterized by a loss of activity in the isopropanol extract and substractive MALDI-TOF predicted masses of 3020.6 Da and 3250.6 Da for the active peptides. Conclusions/Significance: In conclusion, B. licheniformis DSM 13 produces an antimicrobial substance that represents the two-peptide lantibiotic lichenicidin and that shows activity against a wide range of Gram-positive bacteria including methicillin resistant Staphylococcus aureus strains.			Dischinger, J (corresponding author), Univ Bonn, IMMIP, D-5300 Bonn, Germany.	bierbaum@mibi03.meb.uni-bonn.de						ALLGAIER H, 1986, EUR J BIOCHEM, V160, P9, DOI 10.1111/j.1432-1033.1986.tb09933.x; Altena K, 2000, APPL ENVIRON MICROB, V66, P2565, DOI 10.1128/AEM.66.6.2565-2571.2000; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; BIERBAUM G, 1995, FEMS MICROBIOL LETT, V127, P121, DOI 10.1016/0378-1097(95)00048-A; Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; BIERBAUM G, 1987, J BACTERIOL, V169, P5452, DOI 10.1128/jb.169.12.5452-5458.1987; Bierbaum G, 1996, APPL ENVIRON MICROB, V62, P385, DOI 10.1128/AEM.62.2.385-392.1996; Bonelli RR, 2006, ANTIMICROB AGENTS CH, V50, P1449, DOI 10.1128/AAC.50.4.1449-1457.2006; Brotz H, 1998, ANTIMICROB AGENTS CH, V42, P154, DOI 10.1128/AAC.42.1.154; Castiglione F, 2007, BIOCHEMISTRY-US, V46, P5884, DOI 10.1021/bi700131x; CHATTERJEE S, 1992, J ANTIBIOT, V45, P832, DOI 10.7164/antibiotics.45.832; Cooper LE, 2008, CHEM BIOL, V15, P1035, DOI 10.1016/j.chembiol.2008.07.020; Cotter PD, 2006, MOL MICROBIOL, V62, P735, DOI 10.1111/j.1365-2958.2006.05398.x; Cox CR, 2005, CURR PROTEIN PEPT SC, V6, P77, DOI 10.2174/1389203053027557; Dougherty BA, 1998, MOL MICROBIOL, V29, P1029, DOI 10.1046/j.1365-2958.1998.00988.x; GILMORE MS, 1994, J BACTERIOL, V176, P7335, DOI 10.1128/JB.176.23.7335-7344.1994; Hamoen LW, 2003, MICROBIOL-SGM, V149, P9, DOI 10.1099/mic.0.26003-0; Holo H, 2001, MICROBIOL-SGM, V147, P643, DOI 10.1099/00221287-147-3-643; Hyink O, 2005, FEMS MICROBIOL LETT, V252, P235, DOI 10.1016/j.femsle.2005.09.003; KELLNER R, 1988, EUR J BIOCHEM, V177, P53, DOI 10.1111/j.1432-1033.1988.tb14344.x; Kodani S, 2005, MOL MICROBIOL, V58, P1368, DOI 10.1111/j.1365-2958.2005.04921.x; Kodani S, 2004, P NATL ACAD SCI USA, V101, P11448, DOI 10.1073/pnas.0404220101; Lawton EM, 2007, MINI-REV MED CHEM, V7, P1236, DOI 10.2174/138955707782795638; Lawton EM, 2007, FEMS MICROBIOL LETT, V267, P64, DOI 10.1111/j.1574-6968.2006.00539.x; LECLERCQ R, 1988, NEW ENGL J MED, V319, P157, DOI 10.1056/NEJM198807213190307; Limbert M, 1991, NISIN NOVEL LANTIBIO, P448; Martin NI, 2004, BIOCHEMISTRY-US, V43, P3049, DOI 10.1021/bi0362065; McClerren AL, 2006, P NATL ACAD SCI USA, V103, P17243, DOI 10.1073/pnas.0606088103; MEYER C, 1995, EUR J BIOCHEM, V232, P478, DOI 10.1111/j.1432-1033.1995.tb20834.x; Mikkola R, 2000, EUR J BIOCHEM, V267, P4068, DOI 10.1046/j.1432-1033.2000.01467.x; Morgan SM, 2005, ANTIMICROB AGENTS CH, V49, P2606, DOI 10.1128/AAC.49.7.2606-2611.2005; Navaratna MADB, 1998, APPL ENVIRON MICROB, V64, P4803; Navaratna MADB, 1999, INFECT IMMUN, V67, P4268, DOI 10.1128/IAI.67.8.4268-4271.1999; PODLESEK Z, 1995, MOL MICROBIOL, V16, P969, DOI 10.1111/j.1365-2958.1995.tb02322.x; Rey MW, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r77; Ryan MP, 1999, J BIOL CHEM, V274, P37544, DOI 10.1074/jbc.274.53.37544; SAHL HG, 1985, J BACTERIOL, V162, P833, DOI 10.1128/JB.162.2.833-836.1985; SAHL HG, 1985, ANTIMICROB AGENTS CH, V27, P836, DOI 10.1128/AAC.27.5.836; SASS P, 2009, INT J MED MICROBIOL; SCHLEIFER KH, 1982, INT J SYST BACTERIOL, V32, P153, DOI 10.1099/00207713-32-2-153; Schmitz S, 2006, APPL ENVIRON MICROB, V72, P7270, DOI 10.1128/AEM.00723-06; TAGG JR, 1971, APPL MICROBIOL, V21, P943, DOI 10.1128/AEM.21.5.943-943.1971; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; Veith B, 2004, J MOL MICROB BIOTECH, V7, P204, DOI 10.1159/000079829; Waschkau B, 2008, APPL MICROBIOL BIOT, V78, P181, DOI 10.1007/s00253-007-1278-0; Widdick DA, 2003, P NATL ACAD SCI USA, V100, P4316, DOI 10.1073/pnas.0230516100; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Wiedemann I, 2006, MOL MICROBIOL, V61, P285, DOI 10.1111/j.1365-2958.2006.05223.x; WILIMOWSKAPELC A, 1976, ACTA MICROBIOL POL, V25, P71; Willey JM, 2006, MOL MICROBIOL, V59, P731, DOI 10.1111/j.1365-2958.2005.05018.x; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; YAKIMOV MM, 1995, APPL ENVIRON MICROB, V61, P1706, DOI 10.1128/AEM.61.5.1706-1713.1995; Yakimov MM, 1997, BIOTECHNOL PROGR, V13, P757, DOI 10.1021/bp9700622; Yonezawa H, 2005, ANTIMICROB AGENTS CH, V49, P541, DOI 10.1128/AAC.49.2.541-548.2005	54	95	100	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6788	10.1371/journal.pone.0006788	http://dx.doi.org/10.1371/journal.pone.0006788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707558	Green Submitted, gold, Green Published			2022-12-25	WOS:000269335000030
J	Nascimento, EJM; Silva, AM; Cordeiro, MT; Brito, CA; Gil, LHVG; Braga-Neto, U; Marques, ETA				Nascimento, Eduardo J. M.; Silva, Ana M.; Cordeiro, Marli T.; Brito, Carlos A.; Gil, Laura H. V. G.; Braga-Neto, Ulisses; Marques, Ernesto T. A.			Alternative Complement Pathway Deregulation Is Correlated with Dengue Severity	PLOS ONE			English	Article								Background: The complement system, a key component that links the innate and adaptive immune responses, has three pathways: the classical, lectin, and alternative pathways. In the present study, we have analyzed the levels of various complement components in blood samples from dengue fever (DF) and dengue hemorrhagic fever (DHF) patients and found that the level of complement activation is associated with disease severity. Methods and Results: Patients with DHF had lower levels of complement factor 3 (C3; p = 0.002) and increased levels of C3a, C4a and C5a (p<0.0001) when compared to those with the less severe form, DF. There were no significant differences between DF and DHF patients in the levels of C1q, immunocomplexes (CIC-CIq) and CRP. However, small but statistically significant differences were detected in the levels of MBL. In contrast, the levels of two regulatory proteins of the alternative pathway varied widely between DF and DHF patients: DHF patients had higher levels of factor D (p = 0.01), which cleaves factor B to yield the active (C3bBb) C3 convertase, and lower levels of factor H (p = 0.03), which inactivates the (C3bBb) C3 convertase, than did DF patients. When we considered the levels of factors D and H together as an indicator of (C3bBb) C3 convertase regulation, we found that the plasma levels of these regulatory proteins in DHF patients favored the formation of the (C3bBb) C3 convertase, whereas its formation was inhibited in DF patients (p<0.0001). Conclusion: The data suggest that an imbalance in the levels of regulatory factors D and H is associated with an abnormal regulation of complement activity in DHF patients.			Nascimento, EJM (corresponding author), Johns Hopkins Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21218 USA.	emarques@jhmi.edu	Braga-Neto, Ulisses/ABI-2677-2020; Marques, Ernesto T. A/L-4967-2013; Marques, Ernesto/L-4514-2013; Publica, Inct Saude/J-9544-2013; Nascimento, Eduardo/J-4590-2014; Gil, Laura Helena Vega Gonzales/AAX-5319-2021	Marques, Ernesto T. A/0000-0003-3826-9358; Marques, Ernesto/0000-0003-3826-9358; Nascimento, Eduardo/0000-0002-9851-2332; Gil, Laura Helena Vega Gonzales/0000-0002-8796-6080	Direct For Computer & Info Scie & Enginr [0845407] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056541] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI056541, U19 AI56541] Funding Source: Medline	Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Acioli-Santos B, 2008, HUM IMMUNOL, V69, P122, DOI 10.1016/j.humimm.2008.01.005; ACIOLISANTOS B, PNAS UNPUB; Ault BH, 2000, PEDIATR NEPHROL, V14, P1045, DOI 10.1007/s004670050069; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; Avirutnan P, 1998, J IMMUNOL, V161, P6338; Biro A, 2007, IMMUNOLOGY, V121, P40, DOI 10.1111/j.1365-2567.2007.02535.x; Bokisch V A, 1973, Trans Assoc Am Physicians, V86, P102; BOONPUCKNAVIG S, 1979, AM J TROP MED HYG, V28, P881, DOI 10.4269/ajtmh.1979.28.881; Chen LJ, 2006, MOL VIS, V12, P1536; Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103; Conley YP, 2006, HUM MOL GENET, V15, P3206, DOI 10.1093/hmg/ddl396; Coppo Paul, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P36; Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128; Cordeiro MT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004945; Cummings DAT, 2005, P NATL ACAD SCI USA, V102, P15259, DOI 10.1073/pnas.0507320102; de Kruif MD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000215; Fakhouri F, 2008, BLOOD, V112, P4542, DOI 10.1182/blood-2008-03-144691; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; HARBOE M, 2008, J CELL MOL MED; Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Karpman D, 2006, SEMIN THROMB HEMOST, V32, P128, DOI 10.1055/s-2006-939769; Kavanagh D, 2008, ANNU REV MED, V59, P293, DOI 10.1146/annurev.med.59.060106.185110; Kittigul L, 2007, J CLIN VIROL, V39, P76, DOI 10.1016/j.jcv.2007.04.006; Kuraya M, 2005, IMMUNOBIOLOGY, V209, P689, DOI 10.1016/j.imbio.2004.11.001; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; LARUSSA VF, 1995, BAILLIERE CLIN HAEM, V8, P249, DOI 10.1016/S0950-3536(05)80240-9; Lin CF, 2001, J MED VIROL, V63, P143, DOI 10.1002/1096-9071(20000201)63:2&lt;143::AID-JMV1009&gt;3.0.CO;2-L; Lin CF, 2006, VIRAL IMMUNOL, V19, P127, DOI 10.1089/vim.2006.19.127; Lutz HU, 2007, MOL IMMUNOL, V44, P3862, DOI 10.1016/j.molimm.2007.06.146; Mehlhop E, 2007, CELL HOST MICROBE, V2, P417, DOI 10.1016/j.chom.2007.09.015; Meri S, 2007, ANN NY ACAD SCI, V1109, P93, DOI 10.1196/annals.1398.011; MITRAKUL C, 1977, AM J TROP MED HYG, V26, P975, DOI 10.4269/ajtmh.1977.26.975; Morrison TE, 2008, CURR DRUG TARGETS, V9, P165; NASCIMENTO EJM, J CLIN INVESTI UNPUB; Navarro-Sanchez E, 2005, ARCH MED RES, V36, P425, DOI 10.1016/j.arcmed.2005.04.007; Nishioka K, 1974, Allerg Immunol (Leipz), V20-21, P385; Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665; Saito M, 2004, CLIN EXP IMMUNOL, V138, P299, DOI 10.1111/j.1365-2249.2004.02626.x; SOBEL AT, 1975, J EXP MED, V142, P139, DOI 10.1084/jem.142.1.139; Srichaikul T, 2000, BEST PRACT RES CL HA, V13, P261, DOI 10.1053/beha.2000.0073; Stahl AL, 2008, BLOOD, V111, P5307, DOI 10.1182/blood-2007-08-106153; Su DHW, 2007, OPHTHALMOLOGY, V114, P1743, DOI 10.1016/j.ophtha.2007.03.054; Trouw LA, 2008, MOL IMMUNOL, V45, P1199, DOI 10.1016/j.molimm.2007.09.008; Ubol S, 2008, J INFECT DIS, V197, P1459, DOI 10.1086/587699; Villar-Centeno LA, 2008, AM J TROP MED HYG, V78, P370, DOI 10.4269/ajtmh.2008.78.370; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635; Wiersinga WJ, 2006, CLIN INFECT DIS, V43, P800, DOI 10.1086/507111; Yamanaka A, 2008, J VIROL, V82, P927, DOI 10.1128/JVI.00992-07	51	92	93	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6782	10.1371/journal.pone.0006782	http://dx.doi.org/10.1371/journal.pone.0006782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707565	Green Submitted, Green Published, gold			2022-12-25	WOS:000269335000025
J	Rivera-Meza, M; Quintanilla, ME; Tampier, L; Mura, CV; Sapag, A; Israel, Y				Rivera-Meza, Mario; Elena Quintanilla, Maria; Tampier, Lutske; Mura, Casilda V.; Sapag, Amalia; Israel, Yedy			Mechanism of protection against alcoholism by an alcohol dehydrogenase polymorphism: development of an animal model	FASEB JOURNAL			English	Article						ethanol; acetaldehyde; alcohol consumption; ADH1B*2; hormesis	SPONTANEOUSLY HYPERTENSIVE RAT; ALDEHYDE DEHYDROGENASE; ADH2-ASTERISK-2 ALLELE; GENETIC-POLYMORPHISM; HUMAN BETA-1-BETA-1; ETHANOL; LIVER; CONSUMPTION; METABOLISM; HORMESIS	Humans who carry a point mutation in the gene coding for alcohol dehydrogenase-1B (ADH1B*2; Arg47His) are markedly protected against alcoholism. Although this mutation results in a 100-fold increase in enzyme activity, it has not been reported to cause higher levels of acetaldehyde, a metabolite of ethanol known to deter alcohol intake. Hence, the mechanism by which this mutation confers protection against alcoholism is unknown. To study this protective effect, the wild-type rat cDNA encoding rADH-47Arg was mutated to encode rADH-47His, mimicking the human mutation. The mutated cDNA was incorporated into an adenoviral vector and administered to genetically selected alcohol-preferring rats. The V-max of rADH-47His was 6-fold higher (P<0.001) than that of the wild-type rADH-47Arg. Animals transduced with rAdh-47His showed a 90% (P<0.01) increase in liver ADH activity and a 50% reduction (P<0.001) in voluntary ethanol intake. In animals transduced with rAdh-47His, administration of ethanol (1g/kg) produced a short-lived increase of arterial blood acetaldehyde concentration to levels that were 3.5- to 5-fold greater than those in animals transduced with the wild-type rAdh-47Arg vector or with a noncoding vector. This brief increase (burst) in arterial acetaldehyde concentration after ethanol ingestion may constitute the mechanism by which humans carrying the ADH1B*2 allele are protected against alcoholism.-Rivera-Meza, M., Quintanilla, M. E., Tampier, L., Mura, C. V., Sapag, A., Israel, Y. Mechanism of protection against alcoholism by an alcohol dehydrogenase polymorphism: development of an animal model. FASEB J. 24, 266-274 (2010). www.fasebj.org	[Rivera-Meza, Mario; Sapag, Amalia; Israel, Yedy] Univ Chile, Lab Gene Therapy, Dept Pharmacol & Toxicol Chem, Fac Chem & Pharmaceut Sci, Santiago 8380492, Chile; [Elena Quintanilla, Maria; Tampier, Lutske; Israel, Yedy] Univ Chile, Fac Med, Dept Mol & Clin Pharmacol, Lab Pharmacogenet Alcoholism, Santiago 8380492, Chile; [Mura, Casilda V.; Israel, Yedy] Millennium Inst Cell Dynam & Biotechnol, Santiago, Chile	Universidad de Chile; Universidad de Chile	Israel, Y (corresponding author), Univ Chile, Lab Gene Therapy, Dept Pharmacol & Toxicol Chem, Fac Chem & Pharmaceut Sci, Olivos 1007, Santiago 8380492, Chile.	yisrael@uchile.cl	Sapag, Amalia/I-2574-2013	Sapag, Amalia/0000-0002-7029-2331; Quintanilla, Maria Elena/0000-0002-0278-3219; Israel, Yedy/0000-0003-3468-7966	U.S. National Institutes of Health [R01-AA 015421]; Millennium Scientific Initiative [ICM P05-001]; CONICYT-Chile; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015421] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Millennium Scientific Initiative; CONICYT-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from the U.S. National Institutes of Health (R01-AA 015421) and the Millennium Scientific Initiative (ICM P05-001). M. R. held a doctoral fellowship from CONICYT-Chile. We thank Dr. Fernando Ezquer for pAAV-rADH-47Arg direction reversal, Juan Santibanez for skillful technical assistance, and Prof. Harold Kalant for his critical review of the manuscript.	Borras E, 2000, HEPATOLOGY, V31, P984, DOI 10.1053/he.2000.5978; Calabrese EJ, 2003, ANNU REV PHARMACOL, V43, P175, DOI 10.1146/annurev.pharmtox.43.100901.140223; Chambers GK, 2002, ALCOHOL CLIN EXP RES, V26, P949, DOI 10.1097/01.ALC.0000021145.47616.38; Chen CC, 1999, AM J HUM GENET, V65, P795, DOI 10.1086/302540; Chen YC, 2009, CHEM-BIOL INTERACT, V178, P2, DOI 10.1016/j.cbi.2008.10.029; Chen YJ, 2006, INT J CANCER, V119, P2827, DOI 10.1002/ijc.22199; CRABB DW, 1986, GENE, V48, P287, DOI 10.1016/0378-1119(86)90087-9; CRONHOLM T, 1985, BIOCHEM J, V229, P315, DOI 10.1042/bj2290315; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Duranceaux NCE, 2006, ALCOHOL CLIN EXP RES, V30, P1470, DOI 10.1111/j.1530-0277.2006.00178.x; Fechner H, 1999, GENE THER, V6, P1520, DOI 10.1038/sj.gt.3301030; Feinendegen LE, 2005, BRIT J RADIOL, V78, P3, DOI 10.1259/bjr/63353075; Garver E, 2001, J EXP MED, V194, P571, DOI 10.1084/jem.194.5.571; HARADA S, 1982, LANCET, V2, P827, DOI 10.1016/s0140-6736(82)92722-2; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Higuchi S, 1994, Alcohol Alcohol Suppl, V2, P29; Hilakivi L, 1984, Alcohol, V1, P71; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HURLEY NF, 1990, STRATIGRAPHIC TRAPS, V1, P1; HURLEY TD, 1990, J BIOL CHEM, V265, P16366; Kang MJ, 2008, FEBS J, V275, P5969, DOI 10.1111/j.1742-4658.2008.06725.x; Kim DJ, 2008, HUM MOL GENET, V17, P854, DOI 10.1093/hmg/ddm357; Le AD, 2001, ALCOHOL CLIN EXP RES, V25, P1613, DOI 10.1111/j.1530-0277.2001.tb02168.x; Lecky FE, 2002, CRIT CARE MED, V30, P981, DOI 10.1097/00003246-200205000-00005; Li N, 2007, DNA REPAIR, V6, P1297, DOI 10.1016/j.dnarep.2007.02.027; LI TK, 1995, CLIN NEUROSCI, V3, P182; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; MARDONES J, 1983, NEUROBEH TOXICOL TER, V5, P171; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; MIZOI Y, 1983, PHARMACOL BIOCHEM BE, V18, P127, DOI 10.1016/0091-3057(83)90159-4; MIZOI Y, 1994, ALCOHOL ALCOHOLISM, V29, P707; Morral N, 1999, P NATL ACAD SCI USA, V96, P12816, DOI 10.1073/pnas.96.22.12816; Neumark YD, 1998, J STUD ALCOHOL, V59, P133, DOI 10.15288/jsa.1998.59.133; Neumark YD, 2004, ALCOHOL CLIN EXP RES, V28, P10, DOI 10.1097/01.ALC.0000108667.79219.4D; Ni L, 1997, J BIOL CHEM, V272, P18823, DOI 10.1074/jbc.272.30.18823; NUUTINEN HU, 1984, EUR J CLIN INVEST, V14, P306, DOI 10.1111/j.1365-2362.1984.tb01186.x; PARSONS PA, 1989, BIOL J LINN SOC, V37, P183, DOI 10.1111/j.1095-8312.1989.tb01900.x; Peng GS, 2007, PHARMACOGENET GENOM, V17, P845, DOI 10.1097/FPC.0b013e3282609e67; Quintanilla ME, 2006, ADDICT BIOL, V11, P310, DOI 10.1111/j.1369-1600.2006.00030.x; Quintanilla ME, 2007, AM J PHYSIOL-ENDOC M, V293, pE531, DOI 10.1152/ajpendo.00187.2007; RACHAMIN G, 1980, BIOCHEM J, V186, P483, DOI 10.1042/bj1860483; Rehm J, 2006, DRUG ALCOHOL REV, V25, P503, DOI 10.1080/09595230600944453; SCHMIDT W, 1987, BRIT J ADDICT, V82, P775; Schwartz DR, 2008, CURR OPIN PHARMACOL, V8, P160, DOI 10.1016/j.coph.2007.12.008; Simon FR, 2002, AM J PHYSIOL-GASTR L, V283, pG646, DOI 10.1152/ajpgi.00438.2001; STONE CL, 1993, J BIOL CHEM, V268, P892; Tampier L, 2008, ALCOHOL CLIN EXP RES, V32, P937, DOI 10.1111/j.1530-0277.2008.00658.x; THOMASSON HR, 1991, AM J HUM GENET, V48, P677; Toietta G, 2005, P NATL ACAD SCI USA, V102, P3930, DOI 10.1073/pnas.0500930102; TU GC, 1995, BEHAV GENET, V25, P59, DOI 10.1007/BF02197242; WAHID S, 1981, BIOCHEM PHARMACOL, V30, P1277, DOI 10.1016/0006-2952(81)90309-9; Wall TL, 2005, J ABNORM PSYCHOL, V114, P456, DOI 10.1037/0021-843X.114.3.456; WHO, 2007, WHO TECH REP SER, V935, P1; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yokoyama A, 2001, CARCINOGENESIS, V22, P433, DOI 10.1093/carcin/22.3.433; Zintzaras E, 2006, HEPATOLOGY, V43, P352, DOI 10.1002/hep.21023	57	34	35	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					266	274		10.1096/fj.09-132563	http://dx.doi.org/10.1096/fj.09-132563			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19710201	Green Published			2022-12-25	WOS:000273233600027
J	Jaskelioff, M; Song, W; Xia, J; Liu, C; Kramer, J; Koido, S; Gendler, SJ; Calderwood, SK; Gong, J				Jaskelioff, M.; Song, W.; Xia, J.; Liu, C.; Kramer, J.; Koido, S.; Gendler, S. J.; Calderwood, S. K.; Gong, J.			Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene	ONCOGENE			English	Article						telomerase; telomeres; PyMT; MUC1; mammary carcinoma	LIFE-SPAN; IMMORTAL CELLS; CANCER; MICE; TUMORIGENESIS; EXPRESSION; CARCINOMA; SKIN; P53; TRANSLOCATIONS	Mice transgenic for MUC1 (mucin 1) and polyomavirus middle T (PyMT) develop mammary carcinomas within 15 weeks with 100% penetrance. PyMT-induced mammary tumorigenesis is closely correlated with robust telomerase expression and activity. To assess the role of telomerase activation and telomere maintenance in mammary carcinoma tumorigenesis, we generated mice expressing MUC1 and PyMT (MMT mice) but deficient in the telomerase RNA component, mTerc, on the C57BL/6 background. Successive generational intercrosses of mTerc(-/-)MMT mice produced cohorts with progressively shorter telomeres that were audited for mammary tumor formation. Relative to MMT (N=14) and G0 mTerc(+/-) female controls (G0=14), mTerc(-/-)MMT females (G1=11, G2=15, G3=15 and G4=5) showed decreased tumor volumes and increased tumor latency-MMT=95.6 days; G0 mTerc(+/-) MMT=98.6 days versus G1, G2, G3 and G4 mTerc(-/-)MMT mice with latencies of 122.6, 138.9, 140.7 and 220.9 days, respectively (controls versus G1-G4, P<0.005). The progressive impairment of lung metastasis was also observed with each successive mTerc(-/-)MMT generation. The impairment of tumorigenesis was associated with decreased proliferation of mammary epithelial and tumor cells and increased apoptosis of tumor cells. Together, these results indicate that, in the setting of viral oncoprotein mammary tumorigenesis, telomerase-dependent telomere maintenance facilitates the formation and metastatic progression of mammary tumors. Oncogene (2009) 28, 4225-4236; doi: 10.1038/onc.2009.268; published online 7 September 2009	[Gong, J.] Boston Univ, Sch Med, Dept Med, Med Ctr, Boston, MA 02215 USA; [Jaskelioff, M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Koido, S.] Jikei Univ, Sch Med, Dept Internal Med, Tokyo, Japan; [Gendler, S. J.] Mayo Clin, Dept Biochem & Mol Biol, Scottsdale, AZ USA; [Calderwood, S. K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Boston University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Jikei University; Mayo Clinic; Mayo Clinic Phoenix; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Gong, J (corresponding author), Boston Univ, Sch Med, Dept Med, Med Ctr, 650 Albany St,Room 309, Boston, MA 02215 USA.	jgong@bu.edu		Gong, Jianlin/0000-0003-0910-014X	Susan G Komen Breast Cancer Foundation [BCTR0503792, PDF060881]; US Department of Defense Breast Cancer Research	Susan G Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); US Department of Defense Breast Cancer Research(United States Department of Defense)	This work was supported by the Susan G Komen Breast Cancer Foundation (BCTR0503792 to JG and PDF060881 to MJ) and the US Department of Defense Breast Cancer Research programs (JG). We thank Dr Ronald A DePinho for providing mTerc<SUP>-/-</SUP> mice, advice and comments on the paper.	Argilla D, 2004, CANCER CELL, V6, P373, DOI 10.1016/j.ccr.2004.08.032; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Artandi SE, 2005, BIOCHEM BIOPH RES CO, V331, P881, DOI 10.1016/j.bbrc.2005.03.211; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Artandi SE, 2000, CURR OPIN GENET DEV, V10, P39, DOI 10.1016/S0959-437X(99)00047-7; Blanco R, 2007, GENE DEV, V21, P206, DOI 10.1101/gad.406207; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Canela A, 2004, MOL CELL BIOL, V24, P4275, DOI 10.1128/MCB.24.10.4275-4293.2004; Canela Andres, 2007, Methods Mol Biol, V371, P45; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; Chen DS, 2000, BREAST CANCER RES TR, V60, P107, DOI 10.1023/A:1006332009414; Chen DS, 2003, IMMUNOLOGY, V109, P300, DOI 10.1046/j.1365-2567.2003.01656.x; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; Cosme-Blanco W, 2007, EMBO REP, V8, P497, DOI 10.1038/sj.embor.7400937; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; COUNTER CM, 1994, J VIROL, V68, P3410, DOI 10.1128/JVI.68.5.3410-3414.1994; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DePinho RA, 2004, NAT GENET, V36, P932, DOI 10.1038/ng0904-932; Espejel S, 2004, J CELL BIOL, V167, P627, DOI 10.1083/jcb.200407178; Farazi PA, 2003, CANCER RES, V63, P5021; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARA E, 1991, BIOCHEM BIOPH RES CO, V179, P528, DOI 10.1016/0006-291X(91)91403-Y; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Khoo CM, 2007, P NATL ACAD SCI USA, V104, P3931, DOI 10.1073/pnas.0700093104; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Martinez P, 2009, AGING CELL, V8, P2, DOI 10.1111/j.1474-9726.2008.00441.x; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; McClintock B, 1941, GENETICS, V26, P234; Meeker AK, 2004, J MAMMARY GLAND BIOL, V9, P285, DOI 10.1023/B:JOMG.0000048775.04140.92; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Perera SA, 2008, CARCINOGENESIS, V29, P747, DOI 10.1093/carcin/bgn050; Pulaski BA, 1998, CANCER RES, V58, P1486; Qi L, 2005, NAT CELL BIOL, V7, P706, DOI 10.1038/ncb1276; Qi L, 2003, CANCER RES, V63, P8188; Rasband W., 2006, IMAGEJ; Rowse GJ, 1998, CANCER RES, V58, P315; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Siegl-Cachedenier I, 2007, GENE DEV, V21, P2234, DOI 10.1101/gad.430107; Sun BC, 2004, CANCER RES, V64, P6144, DOI 10.1158/0008-5472.CAN-04-1376; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Vasiljeva O, 2008, ONCOGENE, V27, P4191, DOI 10.1038/onc.2008.59; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Xia JC, 2003, J IMMUNOL, V170, P1980, DOI 10.4049/jimmunol.170.4.1980; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723	54	15	16	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 3	2009	28	48					4225	4236		10.1038/onc.2009.268	http://dx.doi.org/10.1038/onc.2009.268			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DS	19734944				2022-12-25	WOS:000272876300001
J	Obexer, P; Hagenbuchner, J; Rupp, M; Salvador, C; Holzner, M; Deutsch, M; Porto, V; Kofler, R; Unterkircher, T; Ausserlechner, MJ				Obexer, Petra; Hagenbuchner, Judith; Rupp, Martina; Salvador, Christina; Holzner, Markus; Deutsch, Martin; Porto, Verena; Kofler, Reinhard; Unterkircher, Thomas; Ausserlechner, Michael J.			p16(INK4A) Sensitizes Human Leukemia Cells to FAS- and Glucocorticoid-induced Apoptosis via Induction of BBC3/Puma and Repression of MCL1 and BCL2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TUMOR-SUPPRESSOR GENE; BH3-ONLY PROTEINS; C-MYC; CYCLE; PUMA; EXPRESSION; CANCER; DEATH; P53	Loss of CDKN2A/p16(INK4A) in hematopoietic stem cells is associated with enhanced self-renewal capacity and might facilitate progression of damaged stem cells into pre-cancerous cells that give rise to leukemia. This is also reflected by the frequent loss of the INK4A locus in acute lymphoblastic T-cell leukemia. T-cell acute lymphoblastic leukemia cells designed to conditionally express p16(INK4A) arrest in the G(0)/G(1) phase of the cell cycle and show increased sensitivity to glucocorticoid-and tumor necrosis factor receptor superfamily 6-induced apoptosis. To investigate the underlying molecular mechanism for increased death sensitivity, we interfered with specific steps of apoptosis signaling by expression of anti-apoptotic proteins. We found that alterations in cell death susceptibility resulted from changes in the composition of pro-and anti-apoptotic BCL2 proteins, i.e. repression of MCL1, BCL2, and PMAIP1/Noxa and the induction of pro-apoptotic BBC3/Puma. Interference with Puma induction by short hairpin RNA technology or retroviral expression of MCL1 or BCL2 significantly reduced both glucocorticoid-and FAS-induced cell death in p16(INK4A) reconstituted leukemia cells. These results suggest that Puma, in concert with MCL1 and BCL2 repression, critically mediates p16(INK4A) induced death sensitization and that in human T-cell leukemia the deletion of p(16INK4A) confers apoptosis resistance by shifting the balance of pro-and anti-apoptotic BCL2 proteins toward apoptosis protection.	[Salvador, Christina; Unterkircher, Thomas; Ausserlechner, Michael J.] Med Univ Innsbruck, Dept Pediat 2, Bioctr, A-6020 Innsbruck, Austria; [Obexer, Petra; Hagenbuchner, Judith; Rupp, Martina; Holzner, Markus; Deutsch, Martin; Porto, Verena; Kofler, Reinhard; Unterkircher, Thomas; Ausserlechner, Michael J.] Med Univ Innsbruck, Tyrolean Canc Res Inst, A-6020 Innsbruck, Austria; [Obexer, Petra; Hagenbuchner, Judith; Rupp, Martina] Med Univ Innsbruck, Dept Pediat 4, Bioctr, A-6020 Innsbruck, Austria; [Kofler, Reinhard] Med Univ Innsbruck, Div Mol Pathophysiol, Bioctr, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Ausserlechner, MJ (corresponding author), Med Univ Innsbruck, Dept Pediat 2, Bioctr, Innrain 66, A-6020 Innsbruck, Austria.	Michael.J.Ausserlechner@i-med.ac.at	Holzner, Markus/A-6215-2008; Salvador, Christina/AAQ-4798-2021	Holzner, Markus/0000-0003-2702-8612; Ausserlechner, Michael/0000-0002-1015-2302; Unterkircher, Thomas/0000-0001-5028-0571; Hagenbuchner, Judith/0000-0003-1396-3407	Kinderkrebshilfe Tirol; Vorarlberg; Provita Kinderleukamie Stiftung; Kinderkrebshilfe Sudtirol-Regenbogen; SVP-Frauen; Medizinischer Forschungsfond; Sudtiroler Krebshilfe; Austrian Science Fund [SFB-F021]; COMET Center ONCOTYROL; Tyrolean Cancer Research Institute; Tyrolean Cancer Societ; Department of Health-Care, Autonomy of South Tyrol	Kinderkrebshilfe Tirol; Vorarlberg; Provita Kinderleukamie Stiftung; Kinderkrebshilfe Sudtirol-Regenbogen; SVP-Frauen; Medizinischer Forschungsfond; Sudtiroler Krebshilfe; Austrian Science Fund(Austrian Science Fund (FWF)); COMET Center ONCOTYROL; Tyrolean Cancer Research Institute; Tyrolean Cancer Societ; Department of Health-Care, Autonomy of South Tyrol	This work was supported by grants from "Kinderkrebshilfe Tirol and Vorarlberg," "Provita Kinderleukamie Stiftung," "Kinderkrebshilfe Sudtirol-Regenbogen," "SVP-Frauen," "Medizinischer Forschungsfond," "Sudtiroler Krebshilfe," Austrian Science Fund SFB-F021, and the COMET Center ONCOTYROL. " The Tyrolean Cancer Research Institute is supported by the "Tiroler Landeskrankenanstalten Ges.m.b.H. Tiroler Landeskrankenanstalten Ges.m.b.H.," Tyrolean Cancer Society, and the Department of Health-Care, Autonomy of South Tyrol.	Ausserlechner MJ, 2006, MOL CANCER THER, V5, P1927, DOI 10.1158/1535-7163.MCT-05-0500; Ausserlechner MJ, 2005, LEUKEMIA, V19, P1051, DOI 10.1038/sj.leu.2403729; Ausserlechner MJ, 2001, J BIOL CHEM, V276, P10984, DOI 10.1074/jbc.M008188200; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; CHENG J, 1990, MOL CELL BIOL, V10, P5502, DOI 10.1128/MCB.10.10.5502; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Distelhorst CW, 2002, CELL DEATH DIFFER, V9, P6, DOI 10.1038/sj.cdd.4400969; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; FIZZOTTI M, 1995, BLOOD, V85, P2685, DOI 10.1182/blood.V85.10.2685.bloodjournal85102685; Han J, 2006, J BIOL CHEM, V281, P10153, DOI 10.1074/jbc.M510349200; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Hartmann BL, 1999, ONCOGENE, V18, P713, DOI 10.1038/sj.onc.1202339; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; Kees UR, 1997, BLOOD, V89, P4161, DOI 10.1182/blood.V89.11.4161; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; Loffler M, 1999, ONCOGENE, V18, P4626, DOI 10.1038/sj.onc.1202820; Marchetti MC, 2003, BLOOD, V101, P585, DOI 10.1182/blood-2002-06-1779; Mimeault M, 2009, AGEING RES REV, V8, P94, DOI 10.1016/j.arr.2008.12.001; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Obexer P, 2007, CELL DEATH DIFFER, V14, P534, DOI 10.1038/sj.cdd.4402017; OKUDA T, 1995, BLOOD, V85, P2321, DOI 10.1182/blood.V85.9.2321.bloodjournal8592321; Parson W, 2005, FASEB J, V19, P434, DOI 10.1096/fj.04-3062fje; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; QUELLE DE, 1995, CELL, V83, P993; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Werner AB, 2002, J BIOL CHEM, V277, P40760, DOI 10.1074/jbc.M204351200; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	38	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30933	30940		10.1074/jbc.M109.051441	http://dx.doi.org/10.1074/jbc.M109.051441			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19737931	hybrid, Green Published			2022-12-25	WOS:000271378400022
J	Yang, PF; Yang, C; Wirschell, M; Davis, S				Yang, Pinfen; Yang, Chun; Wirschell, Maureen; Davis, Stephanie			Novel LC8 Mutations Have Disparate Effects on the Assembly and Stability of Flagellar Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNEIN LIGHT-CHAIN; RETROGRADE INTRAFLAGELLAR TRANSPORT; INTERMEDIATE CHAIN; CHLAMYDOMONAS FLAGELLA; RADIAL SPOKES; ARM DYNEIN; I1 DYNEIN; MOTOR; DIMERIZATION; IDENTIFICATION	LC8 functions as a dimer crucial for a variety of molecular motors and non-motor complexes. Emerging models, founded on structural studies, suggest that the LC8 dimer promotes the stability and refolding of dimeric target proteins in molecular complexes, and its interactions with selective target proteins, including dynein subunits, is regulated by LC8 phosphorylation, which is proposed to prevent LC8 dimerization. To test these hypotheses in vivo, we determine the impacts of two new LC8 mutations on the assembly and stability of defined LC8-containing complexes in Chlamydomonas flagella. The three types of dyneins and the radial spoke are disparately affected by dimeric LC8 with a C-terminal extension. The defects include the absence of specific subunits, complex instability, and reduced incorporation into the axonemal super complex. Surprisingly, a phosphomimetic LC8 mutation, which is largely monomeric in vitro, is still dimeric in vivo and does not significantly change flagellar generation and motility. The differential defects in these flagellar complexes support the structural model and indicate that modulation of target proteins by LC8 leads to the proper assembly of complexes and ultimately higher level complexes. Furthermore, the ability of flagellar complexes to incorporate the phosphomimetic LC8 protein and the modest defects observed in the phosphomimetic LC8 mutant suggest that LC8 phosphorylation is not an effective mechanism for regulating molecular complexes.	Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA; [Wirschell, Maureen] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA	Marquette University; Emory University	Yang, PF (corresponding author), 530 N 15th St, Milwaukee, WI 53233 USA.	pinfen.yang@marquette.edu			National Institutes of Health [GM068101]; National Research Service Award Postdoctoral Fellowship [GM075446]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068101, F32GM075446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM068101 (to P. Y.) and National Research Service Award Postdoctoral Fellowship GM075446 (to M. W.).	Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Benashski SE, 1997, J BIOL CHEM, V272, P20929, DOI 10.1074/jbc.272.33.20929; Bower R, 2009, MOL BIOL CELL, V20, P3055, DOI 10.1091/mbc.E09-04-0277; Delanoue R, 2007, DEV CELL, V13, P523, DOI 10.1016/j.devcel.2007.08.022; DiBella LM, 2005, MOL BIOL CELL, V16, P5661, DOI 10.1091/mbc.E05-08-0732; Dick T, 1996, MOL CELL BIOL, V16, P1966; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Ghosh-Roy A, 2005, MOL BIOL CELL, V16, P3107, DOI 10.1091/mbc.E05-02-0103; HARRIS HH, 2009, CHLAMYDOMONAS SOURCE, V1, P242; Harrison A, 1998, J CELL BIOL, V140, P1137, DOI 10.1083/jcb.140.5.1137; Hendrickson TW, 2004, MOL BIOL CELL, V15, P5431, DOI 10.1091/mbc.E04-08-0694; Hou YQ, 2004, MOL BIOL CELL, V15, P4382, DOI 10.1091/mbc.E04-05-0377; HUANG B, 1981, J CELL BIOL, V88, P80, DOI 10.1083/jcb.88.1.80; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; Kamiya R, 2002, INT REV CYTOL, V219, P115; KING SM, 1995, J BIOL CHEM, V270, P11445, DOI 10.1074/jbc.270.19.11445; Lechtreck KF, 2007, J CELL BIOL, V176, P473, DOI 10.1083/jcb.200611115; LEDIZET M, 1995, MOL BIOL CELL, V6, P697, DOI 10.1091/mbc.6.6.697; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lo KWH, 2006, J BIOL CHEM, V281, P9552, DOI 10.1074/jbc.M511721200; Lo KWH, 2005, J BIOL CHEM, V280, P8172, DOI 10.1074/jbc.M411408200; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Perrone CA, 2003, MOL BIOL CELL, V14, P2041, DOI 10.1091/mbc.e02-10-0682; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; PIPERNO G, 1979, J BIOL CHEM, V254, P3084; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Rompolas P, 2007, J CELL SCI, V120, P3653, DOI 10.1242/jcs.012773; Song CY, 2008, J BIOL CHEM, V283, P4004, DOI 10.1074/jbc.M704512200; Song YJ, 2007, J BIOL CHEM, V282, P17272, DOI 10.1074/jbc.M610445200; Stelter P, 2007, NAT CELL BIOL, V9, P788, DOI 10.1038/ncb1604; Tan GS, 2007, P NATL ACAD SCI USA, V104, P7229, DOI 10.1073/pnas.0701397104; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Wang WN, 2003, J BIOL CHEM, V278, P41491, DOI 10.1074/jbc.M307118200; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Wirschell M, 2009, MOL BIOL CELL, V20, P3044, DOI 10.1091/mbc.E09-04-0276; Yang C, 2008, J CELL BIOL, V180, P403, DOI 10.1083/jcb.200705069; Yang PF, 2006, J CELL SCI, V119, P1165, DOI 10.1242/jcs.02811; Yang PF, 1998, MOL BIOL CELL, V9, P3335, DOI 10.1091/mbc.9.12.3335; Yang PF, 2001, J CELL BIOL, V153, P1315, DOI 10.1083/jcb.153.6.1315	41	13	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31412	31421		10.1074/jbc.M109.050666	http://dx.doi.org/10.1074/jbc.M109.050666			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19696030	hybrid, Green Published			2022-12-25	WOS:000271378400066
J	Seckinger, A; Meissner, T; Moreaux, J; Goldschmidt, H; Fuhler, GM; Benner, A; Hundemer, M; Reme, T; Shaughnessy, JD; Barlogie, B; Bertsch, U; Hillengass, J; Ho, AD; Pantesco, V; Jauch, A; De Vos, J; Rossi, JF; Mohler, T; Klein, B; Hose, D				Seckinger, A.; Meissner, T.; Moreaux, J.; Goldschmidt, H.; Fuhler, G. M.; Benner, A.; Hundemer, M.; Reme, T.; Shaughnessy, J. D., Jr.; Barlogie, B.; Bertsch, U.; Hillengass, J.; Ho, A. D.; Pantesco, V.; Jauch, A.; De Vos, J.; Rossi, J. F.; Moehler, T.; Klein, B.; Hose, D.			Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis	ONCOGENE			English	Article						gene expression profiling; multiple myeloma; angiogenesis; proliferation; survival	MESENCHYMAL STEM-CELLS; MULTIPLE-MYELOMA; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; HEPARAN-SULFATE; PROSTATE-CANCER; GROWTH-FACTOR; UP-REGULATION; B-CELLS; BMP-6	Pathogenesis of multiple myeloma is associated with an aberrant expression of pro-proliferative, pro-angiogenic and bone-metabolism-modifying factors by malignant plasma cells. Given the frequently long time span from diagnosis of early-stage plasma cell dyscrasias to overt myeloma and the mostly low proliferation rate of malignant plasma cells, we hypothesize these to similarly express a novel class of inhibitory factors of potential prognostic relevance. Bone morphogenic proteins (BMPs) represent possible candidates as they inhibit proliferation, stimulate bone formation and have an effect on the survival of cancer patients. We assessed the expression of BMPs and their receptors by Affymetrix DNA microarrays (n=779) including CD138-purified primary myeloma cell samples (n=635) of previously untreated patients. BMP6 is the only BMP expressed by malignant and normal plasma cells. Its expression is significantly lower in proliferating myeloma cells, myeloma cell lines or plasmablasts. BMP6 significantly inhibits the proliferation of myeloma cell lines, survival of primary myeloma cells and in vitro angiogenesis. A high BMP6 expression in primary myeloma cell samples delineates significantly superior overall survival for patients undergoing high-dose chemotherapy independent of conventional prognostic factors (International Staging System (ISS) stage, beta(2) microglobulin). Oncogene (2009) 28, 3866-3879; doi:10.1038/onc.2009.257; published online 31 August 2009	[Seckinger, A.; Meissner, T.; Goldschmidt, H.; Hundemer, M.; Bertsch, U.; Hillengass, J.; Ho, A. D.; Moehler, T.; Hose, D.] Univ Klinikum Heidelberg, Med Klin 5, D-69120 Heidelberg, Germany; [Moreaux, J.; Reme, T.; Pantesco, V.; De Vos, J.; Rossi, J. F.; Klein, B.] Hop St Eloi, Inst Res Biotherapy, CHU Montpellier, Montpellier, France; [Moreaux, J.; Reme, T.; Pantesco, V.; De Vos, J.; Rossi, J. F.; Klein, B.] INSERM, U847, Montpellier, France; [Moreaux, J.; Reme, T.; Pantesco, V.; De Vos, J.; Rossi, J. F.; Klein, B.] Univ Montpellier, F-34059 Montpellier, France; [Goldschmidt, H.; Moehler, T.; Hose, D.] Natl Ctr Tumorerkrankungen, Heidelberg, Germany; [Fuhler, G. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, NL-9713 AV Groningen, Netherlands; [Benner, A.] Deutsch Krebsforschungszentrum, Biostat Abt, D-6900 Heidelberg, Germany; [Shaughnessy, J. D., Jr.; Barlogie, B.] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA; [Jauch, A.] Univ Klinikum Heidelberg, Inst Humangenet, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Groningen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Arkansas System; University of Arkansas Medical Sciences; Ruprecht Karls University Heidelberg	Hose, D (corresponding author), Univ Klinikum Heidelberg, Med Klin 5, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.	dirk.hose@med.uni-heidelberg.de	J, Moreaux/ABA-2974-2021; De Vos, John/A-5703-2010; moreaux, jerome/HGA-5649-2022	J, Moreaux/0000-0002-5717-3207; De Vos, John/0000-0003-1880-4130; Ho, Anthony D./0000-0002-1656-0833	Hopp-Foundation (Germany); University of Heidelberg (Germany); National Centre for Tumor Diseases (Heidelberg, Germany); Tumorzentrum Heidelberg/Mannheim (Germany); European Community; Ligue Nationale Contre Le Cancer (equipe labellisee) (Paris, France); Ligue Nationale Contre le Cancer (France)	Hopp-Foundation (Germany); University of Heidelberg (Germany); National Centre for Tumor Diseases (Heidelberg, Germany); Tumorzentrum Heidelberg/Mannheim (Germany); European Community(European Commission); Ligue Nationale Contre Le Cancer (equipe labellisee) (Paris, France); Ligue Nationale Contre le Cancer (France)(Ligue nationale contre le cancer)	We thank Katrin Heimlich, Maria Dorner and Gabriele Hoock for technical assistance. This work was supported in part by grants from the Hopp-Foundation (Germany), the University of Heidelberg (Germany), the National Centre for Tumor Diseases (Heidelberg, Germany), the Tumorzentrum Heidelberg/Mannheim (Germany), the European Myeloma Stem Cell Network (MSCNET) funded within the 6th framework program of the European Community, Novartis Pharma GmbH (Nuremberg, Germany), the Ligue Nationale Contre Le Cancer (equipe labellisee) (Paris, France). It is also part of a national program called 'Carte d'Identite des Tumeurs' (CIT) funded by the Ligue Nationale Contre le Cancer (France).	Barlogie B, 2006, BLOOD, V107, P2633, DOI 10.1182/blood-2005-10-4084; Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Clement JH, 1999, INT J CANCER, V80, P250, DOI 10.1002/(SICI)1097-0215(19990118)80:2<250::AID-IJC14>3.0.CO;2-D; Corre J, 2007, LEUKEMIA, V21, P1079, DOI 10.1038/sj.leu.2404621; Cremer FW, 2005, GENE CHROMOSOME CANC, V44, P194, DOI 10.1002/gcc.20231; Dai JL, 2005, CANCER RES, V65, P8274, DOI 10.1158/0008-5472.CAN-05-1891; De Vos J, 2006, IMMUNOL REV, V210, P86, DOI 10.1111/j.0105-2896.2006.00362.x; De Vos J, 2001, BLOOD, V98, P771, DOI 10.1182/blood.V98.3.771; Du J, 2008, J CELL BIOCHEM, V103, P1584, DOI 10.1002/jcb.21547; DURIE BGM, 1986, SEMIN ONCOL, V13, P300; Ebisawa T, 1999, J CELL SCI, V112, P3519; Goldschmidt H, 2003, ANN HEMATOL, V82, P654, DOI 10.1007/s00277-003-0685-2; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Hamdy FC, 1997, CANCER RES, V57, P4427; Haudenschild DR, 2004, CANCER RES, V64, P8276, DOI 10.1158/0008-5472.CAN-04-2251; Hoang B, 2006, BLOOD, V107, P4484, DOI 10.1182/blood-2005-09-3926; Hose D, 2009, BLOOD, V114, P128, DOI 10.1182/blood-2008-10-184226; Hose D, 2009, BLOOD, V113, P4331, DOI 10.1182/blood-2008-09-178350; Irie A, 2003, BIOCHEM BIOPH RES CO, V308, P858, DOI 10.1016/S0006-291X(03)01500-6; Jourdan M, 1998, BRIT J HAEMATOL, V100, P637, DOI 10.1046/j.1365-2141.1998.00623.x; Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1; Kersten C, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-9; Kersten C, 2006, EXP HEMATOL, V34, P72, DOI 10.1016/j.exphem.2005.09.010; Kim IY, 2003, CLIN CANCER RES, V9, P6046; Klein B, 2003, INT J HEMATOL, V78, P106, DOI 10.1007/BF02983377; Kochanowska I, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-128; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Mahtouk K, 2006, ONCOGENE, V25, P7180, DOI 10.1038/sj.onc.1209699; Mahtouk K, 2005, ONCOGENE, V24, P3512, DOI 10.1038/sj.onc.1208536; Mahtouk K, 2007, BLOOD, V109, P4914, DOI 10.1182/blood-2006-08-043232; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Moreaux J, 2005, BLOOD, V106, P1021, DOI 10.1182/blood-2004-11-4512; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Ren RQ, 2007, BLOOD, V109, P2847, DOI 10.1182/blood-2006-08-039743; Ro TB, 2004, ONCOGENE, V23, P3024, DOI 10.1038/sj.onc.1207386; Tarte K, 2002, BLOOD, V100, P1113, DOI 10.1182/blood.V100.4.1113.h81602001113_1113_1122; Trojan A, 2006, SWISS MED WKLY, V136, P400; VACCA A, 1994, BRIT J HAEMATOL, V87, P503, DOI 10.1111/j.1365-2141.1994.tb08304.x; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; Witzig TE, 1999, BRIT J HAEMATOL, V104, P131, DOI 10.1046/j.1365-2141.1999.01136.x; Wutzl A, 2006, J BIOMED MATER RES A, V77A, P75, DOI 10.1002/jbm.a.30615; Zhan FH, 2002, BLOOD, V99, P1745, DOI 10.1182/blood.V99.5.1745; ZHANG XG, 1994, BLOOD, V83, P3654	46	64	65	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2009	28	44					3866	3879		10.1038/onc.2009.257	http://dx.doi.org/10.1038/onc.2009.257			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	515LJ	19718049	Green Submitted, Green Accepted			2022-12-25	WOS:000271471900002
J	Eichinger, CS; Mizuno, T; Mizuno, K; Miyake, Y; Yanagi, K; Imamoto, N; Hanaoka, F				Eichinger, Christian S.; Mizuno, Takeshi; Mizuno, Keiko; Miyake, Yasuyuki; Yanagi, Ken-ichiro; Imamoto, Naoko; Hanaoka, Fumio			Aberrant DNA Polymerase alpha Is Excluded from the Nucleus by Defective Import and Degradation in the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPERATURE-SENSITIVE MUTANT; UBIQUITIN-PROTEASOME SYSTEM; MOUSE FM3A CELLS; HEAT-LABILE; TSFT20 STRAIN; CATALYTIC SUBUNIT; PRIMASE COMPLEX; RESTRICTIVE TEMPERATURE; PROTEIN STABILITY; EUKARYOTIC CELLS	DNA polymerase alpha is essential for the onset of eukaryotic DNA replication. Its correct folding and assembly within the nuclear replication pre-initiation complex is crucial for normal cell cycle progression and genome maintenance. Due to a single point mutation in the largest DNA polymerase alpha subunit, p180, the temperature-sensitive mouse cell line tsFT20 exhibits heat-labile DNA polymerase alpha activity and S phase arrest at restrictive temperature. In this study, we show that an aberrant form of endogenous p180 in tsFT20 cells (p180(tsFT20)) is strictly localized in the cytoplasm while its wild-type counterpart enters the nucleus. Time-lapse fluorescence microscopy with enhanced green fluorescent protein-tagged or photoactivatable green fluorescent protein-tagged p180(tsFT20) variants and inhibitor analysis revealed that the exclusion of aberrant p180(tsFT20) from the nucleus is due to two distinct mechanisms: first, the inability of newly synthesized ( cytoplasmic) p180(tsFT20) to enter the nucleus and second, proteasome-dependent degradation of nuclear-localized protein. The nuclear import defect seems to result from an impaired association of aberrant de novo synthesized p180(tsFT20) with the second subunit of DNA polymerase alpha, p68. In accordance, we show that RNA interference of p68 results in a decrease of the overall p180 protein level and in a specific increase of cytoplasmic localized p180 in NIH3T3 cells. Taken together, our data suggest two mechanisms that prevent the nuclear expression of aberrant DNA polymerase alpha.	[Mizuno, Takeshi; Mizuno, Keiko; Yanagi, Ken-ichiro; Imamoto, Naoko] Japan Sci & Technology Corp, Cellular Dynam Lab, Adv Sci Inst, RIKEN, Wako, Saitama 3510198, Japan; [Eichinger, Christian S.; Mizuno, Takeshi; Miyake, Yasuyuki; Yanagi, Ken-ichiro; Hanaoka, Fumio] Japan Sci & Technology Corp, Cellular Physiol Lab, Wako, Saitama 3510198, Japan; [Mizuno, Takeshi; Hanaoka, Fumio] Japan Sci & Technology Corp, SORST, Wako, Saitama 3510198, Japan; [Hanaoka, Fumio] Osaka Univ, Grad Sch Frontier Biosci, Osaka 5650871, Japan	Japan Science & Technology Agency (JST); RIKEN; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Osaka University	Mizuno, T (corresponding author), Japan Sci & Technology Corp, Cellular Dynam Lab, Adv Sci Inst, RIKEN, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tmizuno@riken.jp	Miyake, Yasuyuki/AAS-1504-2021; Mizuno, Takeshi/I-4432-2017; Imamoto, Naoko/A-7458-2015	Miyake, Yasuyuki/0000-0001-6250-0260; Mizuno, Takeshi/0000-0003-3664-7212; Imamoto, Naoko/0000-0002-2886-3022	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Human Frontier Science Program; Bioarchitect Research Project and the Chemical Biology Project of RIKEN; RIKEN; Studienstiftung des deutschen Volkes ( German National Merit Foundation); Center of Excellence (COE) from the Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); Bioarchitect Research Project and the Chemical Biology Project of RIKEN; RIKEN; Studienstiftung des deutschen Volkes ( German National Merit Foundation); Center of Excellence (COE) from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a grant from the Human Frontier Science Program, grants from the Bioarchitect Research Project and the Chemical Biology Project of RIKEN ( to T. M. and N. I.) and the director fund of RIKEN ( to T. M.), research fellowships from the Studienstiftung des deutschen Volkes ( German National Merit Foundation) ( to C. S. E.) and the Center of Excellence (COE) from the Japan Society for the Promotion of Science ( to Y. M.).	Arezi B, 2000, TRENDS BIOCHEM SCI, V25, P572, DOI 10.1016/S0968-0004(00)01680-7; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Dahlen M, 2003, MOL CELL BIOL, V23, P3031, DOI 10.1128/MCB.23.9.3031-3042.2003; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; EKI T, 1988, ARCH BIOCHEM BIOPHYS, V260, P552, DOI 10.1016/0003-9861(88)90481-X; EKI T, 1987, EXP CELL RES, V171, P24, DOI 10.1016/0014-4827(87)90248-5; EKI T, 1986, J BIOL CHEM, V261, P8888; EKI T, 1987, CANCER RES, V47, P5162; EKI T, 1990, J BIOL CHEM, V265, P26; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GORBY GL, 1994, J HISTOCHEM CYTOCHEM, V42, P297, DOI 10.1177/42.3.7508470; Grossi S, 2004, GENE DEV, V18, P992, DOI 10.1101/gad.300004; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hua XH, 1997, J CELL BIOL, V137, P183, DOI 10.1083/jcb.137.1.183; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Ikehata H, 1997, MOL CELL BIOL, V17, P1484, DOI 10.1128/MCB.17.3.1484; Izumi M, 2000, BBA-GENE STRUCT EXPR, V1492, P341, DOI 10.1016/S0167-4781(00)00117-2; IZUMI M, 1994, J BIOL CHEM, V269, P7639; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Martin AD, 2000, MOL CELL BIOL, V20, P786, DOI 10.1128/MCB.20.3.786-796.2000; MIYAZAWA H, 1986, BIOCHEM BIOPH RES CO, V139, P637, DOI 10.1016/S0006-291X(86)80038-9; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; Mizuno T, 1998, MOL CELL BIOL, V18, P3552, DOI 10.1128/MCB.18.6.3552; MURAKAMI Y, 1986, EXP CELL RES, V163, P135, DOI 10.1016/0014-4827(86)90565-3; MURAKAMI Y, 1985, P NATL ACAD SCI USA, V82, P1761, DOI 10.1073/pnas.82.6.1761; Nakamura M, 2005, MOL CELL BIOL, V25, P11073, DOI 10.1128/MCB.25.24.11073-11088.2005; Nakayama J, 2001, EMBO J, V20, P2857, DOI 10.1093/emboj/20.11.2857; Ott RD, 2002, MOL CELL BIOL, V22, P5669, DOI 10.1128/MCB.22.16.5669-5678.2002; Parsons JL, 2008, MOL CELL, V29, P477, DOI 10.1016/j.molcel.2007.12.027; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; PEARSON BE, 1991, MOL CELL BIOL, V11, P2081, DOI 10.1128/MCB.11.4.2081; PENDERGRASS WR, 1994, J CELL PHYSIOL, V158, P270, DOI 10.1002/jcp.1041580209; Qi HY, 2000, GENE DEV, V14, P1777; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Schub O, 2001, J BIOL CHEM, V276, P38076; TAKADATAKAYAMA R, 1991, J BIOL CHEM, V266, P15716; Voitenleitner C, 1999, MOL CELL BIOL, V19, P646; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WANG TSF, 1991, ANNU REV BIOCHEM, V60, P513, DOI 10.1146/annurev.biochem.60.1.513; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wimmer U, 2008, EMBO REP, V9, P1027, DOI 10.1038/embor.2008.148; YAGURA T, 1987, BIOCHEMISTRY-US, V26, P7749, DOI 10.1021/bi00398a032; YAMAGUCHI K, 1995, CELL STRUCT FUNCT, V20, P285, DOI 10.1247/csf.20.285; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhou YJ, 2004, MOL CELL BIOL, V24, P9568, DOI 10.1128/MCB.24.21.9568-9579.2004; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	54	5	5	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30604	30614		10.1074/jbc.M109.024760	http://dx.doi.org/10.1074/jbc.M109.024760			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726690	hybrid, Green Published			2022-12-25	WOS:000271090000063
J	Collier, DM; Snyder, PM				Collier, Daniel M.; Snyder, Peter M.			Extracellular Chloride Regulates the Epithelial Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+ SELF-INHIBITION; INTRACELLULAR SODIUM; HISTIDINE-RESIDUES; OPEN PROBABILITY; ACTIVATION; EXPRESSION; BINDING; CLONING; ENAC	The extracellular domain of the epithelial sodium channel ENaC is exposed to a wide range of Cl- concentrations in the kidney and in other epithelia. We tested whether Cl- alters ENaC activity. In Xenopus oocytes expressing human ENaC, replacement of Cl- with SO42-, H2PO4-, or SCN- produced a large increase in ENaC current, indicating that extracellular Cl- inhibits ENaC. Extracellular Cl- also inhibited ENaC in Na+-transporting epithelia. The anion selectivity sequence was SCN- < SO42- < H2PO4- < F- < I- < Cl- < Br-. Crystallization of ASIC1a revealed a Cl- binding site in the extracellular domain. We found that mutation of corresponding residues in ENaC (alpha(H418A) and beta(R388A)) disrupted the response to Cl-, suggesting that Cl- might regulate ENaC through an analogous binding site. Maneuvers that lock ENaC in an open state (a DEG mutation and trypsin) abolished ENaC regulation by Cl-. The response to Cl- was also modulated by changes in extracellular pH; acidic pH increased and alkaline pH reduced ENaC inhibition by Cl-. Cl- regulated ENaC activity in part through enhanced Na+ self-inhibition, a process by which extracellular Na+ inhibits ENaC. Together, the data indicate that extracellular Cl- regulates ENaC activity, providing a potential mechanism by which changes in extracellular Cl- might modulate epithelial Na+ absorption.	[Snyder, Peter M.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Snyder, PM (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, 371 EMRB, Iowa City, IA 52242 USA.	peter-snyder@uiowa.edu	Collier, Daniel/GVU-0199-2022		National Institutes of Health [HL058812, HL72256]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072256, R29HL058812, R01HL058812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL058812 and HL72256 (to P. M. S.).	Abriel H, 1999, J PHYSIOL-LONDON, V516, P31, DOI 10.1111/j.1469-7793.1999.031aa.x; Anantharam A, 2006, J PHYSIOL-LONDON, V574, P333, DOI 10.1113/jphysiol.2006.109173; Awayda MS, 1999, AM J PHYSIOL-CELL PH, V277, pC216, DOI 10.1152/ajpcell.1999.277.2.C216; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; DANI JA, 1983, J GEN PHYSIOL, V81, P255, DOI 10.1085/jgp.81.2.255; DINUDOM A, 1993, J MEMBRANE BIOL, V135, P289; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; HILLE B, 1992, IONIC CHANNELS EXCIT, P288; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Knight KK, 2008, J BIOL CHEM, V283, P27477, DOI 10.1074/jbc.M804176200; Komwatana P, 1996, P NATL ACAD SCI USA, V93, P8107, DOI 10.1073/pnas.93.15.8107; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Rose B. D., 1984, CLIN PHYSL ACID BASE, P274; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146/annurev.physiol.59.1.659; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329	31	58	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29320	29325		10.1074/jbc.M109.046771	http://dx.doi.org/10.1074/jbc.M109.046771			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19713212	Green Published, hybrid			2022-12-25	WOS:000270896800011
J	Park, JH; Mangal, D; Frey, AJ; Harvey, RG; Blair, IA; Penning, TM				Park, Jong-Heum; Mangal, Dipti; Frey, Alexander J.; Harvey, Ronald G.; Blair, Ian A.; Penning, Trevor M.			Aryl Hydrocarbon Receptor Facilitates DNA Strand Breaks and 8-Oxo-2 '-deoxyguanosine Formation by the Aldo-Keto Reductase Product Benzo[a]pyrene-7,8-dione	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; PAH O-QUINONES; TOBACCO-SMOKE CARCINOGENS; GENE-EXPRESSION; NUCLEAR TRANSLOCATOR; HYDANTOIN PRODUCTS; CYTOCHROME P4501B1; P53 MUTATIONS; ABASIC SITES; DIOL-EPOXIDE	Polycyclic aromatic hydrocarbon (PAH) o-quinones produced by aldo-keto reductases are ligands for the aryl hydrocarbon receptor (AhR) (Burczynski, M. E., and Penning, T. M. (2000) Cancer Res. 60, 908-915). They induce oxidative DNA lesions (reactive oxygen species-mediated DNA strand breaks and 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dGuo) formation) in human lung cells. We tested whether the AhR enhances PAH o-quinone-mediated oxidative DNA damage by translocating these ligands to the nucleus. Using the single cell gel electrophoresis (comet) assay to detect DNA strand breaks in murine hepatoma Hepa1c1c7 cells and its AhR-and aryl hydrocarbon receptor nuclear translocator-deficient variants, benzo[a] pyrene-7,8-dione (B[a] P-7,8-dione) produced fewer DNA strand breaks in AhR-deficient cells compared with aryl hydrocarbon receptor nuclear translocator-deficient and wild type Hepa1c1c7 cells. Decreased DNA strand breaks were also observed in human bronchoalveolar H358 cells in which the AhR was silenced by siRNA. The antioxidant alpha-tocopherol and the iron chelator/antioxidant desferal decreased the formation of B[a] P-7,8-dione-mediated DNA strand breaks indicating that they were reactive oxygen species-dependent. By coupling the comet assay to 8-oxoguanine glycosylase (hOGG1), which excises 8-oxo-Gua, strand breaks dependent upon this lesion were measured. hOGG1 treatment produced more DNA single strand breaks in B[a] P-7,8- dione-treated Hepa cells and H358 cells than in its absence. The levels of hOGG1-dependent DNA strand breaks mediated by B[a] P-7,8-dione were lower in AhR-deficient Hepa and AhR knockdown H358 cells. The AhR antagonist alpha-naphthoflavone also attenuated B[a] P-7,8-dione-mediated DNA strand breaks. The decrease in 8-oxo-dGuo levels in AhR-deficient Hepa cells and AhR knockdown H358 cells was validated by immunoaffinity capture stable isotope dilution ([N-15(5)] 8-oxo-dGuo) liquid chromatography-electrospray ionization/multiple reaction monitoring/mass spectrometry. We conclude that the AhR shuttles PAH o-quinone genotoxins to the nucleus and enhances oxidative DNA damage.	[Park, Jong-Heum; Mangal, Dipti; Blair, Ian A.; Penning, Trevor M.] Univ Penn, Dept Pharmacol, Sch Med, Philadelphia, PA 19104 USA; [Park, Jong-Heum; Mangal, Dipti; Frey, Alexander J.; Blair, Ian A.; Penning, Trevor M.] Univ Penn, Ctr Excellence Environm Toxicol, Sch Med, Philadelphia, PA 19104 USA; [Mangal, Dipti; Frey, Alexander J.; Blair, Ian A.; Penning, Trevor M.] Univ Penn, Ctr Canc Pharmacol, Sch Med, Philadelphia, PA 19104 USA; [Harvey, Ronald G.] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Chicago	Penning, TM (corresponding author), Univ Penn, Dept Pharmacol, Sch Med, 130C John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	penning@mail.med.upenn.edu	Blair, Ian A/B-3320-2010	Penning, Trevor/0000-0002-3937-1066	National Institutes of Health [RO1-CA39504, P30-ES013508, RO1-CA130038]; NATIONAL CANCER INSTITUTE [R01CA039504, R01CA130038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-CA39504 and P30-ES013508 (to T. M. P.) and RO1-CA130038 (to I. A. B.).	Balu N, 2004, CHEM RES TOXICOL, V17, P827, DOI 10.1021/tx034207s; Balu N, 2006, ANAL BIOCHEM, V355, P213, DOI 10.1016/j.ab.2006.05.023; Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314; Bohonowych JE, 2007, TOXICOL SCI, V98, P99, DOI 10.1093/toxsci/kfm085; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burczynski ME, 2000, CANCER RES, V60, P908; Burrows CJ, 2002, ENVIRON HEALTH PERSP, V110, P713, DOI 10.1289/ehp.02110s5713; CONNEY AH, 1982, CANCER RES, V42, P4875; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; DIPPLE A, 1983, CANCER RES, V43, P2422; Flowers L, 1996, BIOCHEMISTRY-US, V35, P13664, DOI 10.1021/bi961077w; GRIMMER G, 1975, J ASSOC OFF ANA CHEM, V58, P725; Hailer MK, 2005, CHEM RES TOXICOL, V18, P1378, DOI 10.1021/tx0501379; Harvey RG, 2004, J ORG CHEM, V69, P2024, DOI 10.1021/jo030348n; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; JENNETTE KW, 1977, BIOCHEMISTRY-US, V16, P932, DOI 10.1021/bi00624a019; Jiang H, 2006, CHEM RES TOXICOL, V19, P68, DOI 10.1021/tx0502488; KOREEDA M, 1978, SCIENCE, V199, P778, DOI 10.1126/science.622566; Liu XM, 2002, CHEM RES TOXICOL, V15, P512, DOI 10.1021/tx0101649; Luo WC, 2001, CHEM RES TOXICOL, V14, P927, DOI 10.1021/tx010072j; Mangal D, 2009, CHEM RES TOXICOL, V22, P788, DOI 10.1021/tx800343c; MARSHALL CJ, 1984, NATURE, V310, P586, DOI 10.1038/310586a0; McCoull KD, 1999, CHEM RES TOXICOL, V12, P237, DOI 10.1021/tx980182z; MERCHANT M, 1990, ARCH BIOCHEM BIOPHYS, V281, P84, DOI 10.1016/0003-9861(90)90416-V; Neeley WL, 2006, CHEM RES TOXICOL, V19, P491, DOI 10.1021/tx0600043; NumayamaTsuruta K, 1997, EUR J BIOCHEM, V246, P486, DOI 10.1111/j.1432-1033.1997.00486.x; Ohnishi S, 2002, BIOCHEM BIOPH RES CO, V290, P778, DOI 10.1006/bbrc.2001.6249; Palackal NT, 2002, J BIOL CHEM, V277, P24799, DOI 10.1074/jbc.M112424200; Palackal NT, 2001, BIOCHEMISTRY-US, V40, P10901, DOI 10.1021/bi010872t; Park JH, 2005, CHEM RES TOXICOL, V18, P1026, DOI 10.1021/tx050001a; Park JH, 2008, CHEM RES TOXICOL, V21, P1039, DOI 10.1021/tx700404a; Park JH, 2008, P NATL ACAD SCI USA, V105, P6846, DOI 10.1073/pnas.0802776105; Park JH, 2006, CHEM RES TOXICOL, V19, P719, DOI 10.1021/tx0600245; Penning TM, 1999, CHEM RES TOXICOL, V12, P1, DOI 10.1021/tx980143n; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; ROTHMAN N, 1990, CARCINOGENESIS, V11, P1241, DOI 10.1093/carcin/11.7.1241; Seike K, 2003, CHEM RES TOXICOL, V16, P1470, DOI 10.1021/tx034103h; SHIBUTANI S, 1993, BIOCHEMISTRY-US, V32, P7531, DOI 10.1021/bi00080a027; Shimada T, 1999, CHEM RES TOXICOL, V12, P623, DOI 10.1021/tx990028s; Shimada T, 2001, DRUG METAB DISPOS, V29, P1176; SHOU M, 1993, CARCINOGENESIS, V14, P475, DOI 10.1093/carcin/14.3.475; Smith CC, 2006, MUTAGENESIS, V21, P185, DOI 10.1093/mutage/gel019; Soshilov A, 2008, J BIOL CHEM, V283, P32995, DOI 10.1074/jbc.M802414200; Wang ZC, 2009, J BIOL CHEM, V284, P8624, DOI 10.1074/jbc.M807860200; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117; Xie ZW, 2003, BIOCHEMISTRY-US, V42, P11253, DOI 10.1021/bi0346704; Yu DS, 2002, CHEM RES TOXICOL, V15, P832, DOI 10.1021/tx010177m; Zhang JZ, 1996, MOL PHARMACOL, V50, P1454	49	55	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29725	29734		10.1074/jbc.M109.042143	http://dx.doi.org/10.1074/jbc.M109.042143			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19726680	hybrid, Green Published			2022-12-25	WOS:000270896800054
J	Rafikova, ER; Melikov, K; Ramos, C; Dye, L; Chernomordik, LV				Rafikova, Elvira R.; Melikov, Kamran; Ramos, Corinne; Dye, Louis; Chernomordik, Leonid V.			Transmembrane Protein-free Membranes Fuse into Xenopus Nuclear Envelope and Promote Assembly of Functional Pores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; CELL-CYCLE; EGG EXTRACTS; FORMATION INVITRO; FUSION; COMPLEXES; SNARE; CHROMATIN; DYNAMICS; ROLES	Post-mitotic reassembly of nuclear envelope (NE) and the endoplasmic reticulum (ER) has been reconstituted in a cell-free system based on interphase Xenopus egg extract. To evaluate the relative contributions of cytosolic and transmembrane proteins in NE and ER assembly, we replaced a part of native membrane vesicles with ones either functionally impaired by trypsin or N-ethylmaleimide treatments or with protein-free liposomes. Although neither impaired membrane vesicles nor liposomes formed ER and nuclear membrane, they both supported assembly reactions by fusing with native membrane vesicles. At membrane concentrations insufficient to generate full-sized functional nuclei, addition of liposomes and their fusion with membrane vesicles resulted in an extensive expansion of NE, further chromatin decondensation, restoration of the functionality, and spatial distribution of the nuclear pore complexes (NPCs), and, absent newly delivered transmembrane proteins, an increase in NPC numbers. This rescue of the nuclear assembly by liposomes was inhibited by wheat germ agglutinin and thus required active nuclear transport, similarly to the assembly of full-sized functional NE with membrane vesicles. Mechanism of fusion between liposomes and between liposomes and membrane vesicles was investigated using lipid mixing assay. This fusion required interphase cytosol and, like fusion between native membrane vesicles, was inhibited by guanosine 5'-3-O-(thio) triphosphate, soluble N-ethylmaleimide-sensitive factor attachment protein, and N-ethylmaleimide. Our findings suggest that interphase cytosol contains proteins that mediate the fusion stage of ER and NE reassembly, emphasize an unexpected tolerance of nucleus assembly to changes in concentrations of transmembrane proteins, and reveal the existence of a feedback mechanism that couples NE expansion with NPC assembly.	[Rafikova, Elvira R.; Melikov, Kamran; Chernomordik, Leonid V.] Eunice Kennedy Shriver NICHD, Sect Membrane Biol, Lab Cellular & Mol Biophys, NIH, Bethesda, MD 20892 USA; [Ramos, Corinne] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California San Diego	Chernomordik, LV (corresponding author), Bldg 10,Rm 10D04A,10 Ctr Dr, Bethesda, MD 20892 USA.	chernoml@mail.nih.gov			National Institutes of Health Intramural Research Program of the Eunice Kennedy Shriver NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001501] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001501] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of the Eunice Kennedy Shriver NICHD (to L. V. C.).	Anderson DJ, 2008, CURR OPIN CELL BIOL, V20, P386, DOI 10.1016/j.ceb.2008.03.016; Anderson DJ, 2008, J CELL SCI, V121, P137, DOI 10.1242/jcs.005777; Anderson DJ, 2007, NAT CELL BIOL, V9, P1160, DOI 10.1038/ncb1636; Antonin W, 2005, MOL CELL, V17, P83, DOI 10.1016/j.molcel.2004.12.010; Antonin W, 2008, FEBS LETT, V582, P2004, DOI 10.1016/j.febslet.2008.02.067; Barszczewski M, 2008, MOL BIOL CELL, V19, P776, DOI 10.1091/mbc.E07-05-0498; Baur T, 2007, J CELL SCI, V120, P2895, DOI 10.1242/jcs.010181; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Brandhorst D, 2006, P NATL ACAD SCI USA, V103, P2701, DOI 10.1073/pnas.0511138103; Brugger B, 2000, EMBO J, V19, P1272, DOI 10.1093/emboj/19.6.1272; Burger KNJ, 2000, TRAFFIC, V1, P605, DOI 10.1034/j.1600-0854.2000.010804.x; Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Byrne RD, 2007, CELL SIGNAL, V19, P913, DOI 10.1016/j.cellsig.2006.10.011; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; D'Angelo MA, 2006, SCIENCE, V312, P440, DOI 10.1126/science.1124196; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883; Drummond S, 1999, J CELL BIOL, V144, P225, DOI 10.1083/jcb.144.2.225; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; FINLAY DR, 1987, J CELL BIOL, V104, P189, DOI 10.1083/jcb.104.2.189; FOLCH J, 1957, J BIOL CHEM, V226, P497; Franz C, 2005, EMBO J, V24, P3519, DOI 10.1038/sj.emboj.7600825; Fukasawa M, 2004, P NATL ACAD SCI USA, V101, P4815, DOI 10.1073/pnas.0401183101; Gant TM, 1999, J CELL BIOL, V144, P1083, DOI 10.1083/jcb.144.6.1083; GOLDBERG M, 1995, J CELL SCI, V108, P3451; Goldberg MW, 1997, J CELL SCI, V110, P409; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Haraguchi T, 2000, J CELL SCI, V113, P779; Hawryluk-Gara LA, 2008, MOL BIOL CELL, V19, P1753, DOI 10.1091/mbc.E07-08-0820; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Howe JA, 1996, P NATL ACAD SCI USA, V93, P2060, DOI 10.1073/pnas.93.5.2060; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Jun Y, 2007, EMBO J, V26, P4935, DOI 10.1038/sj.emboj.7601915; Larijani B, 2001, BIOCHEM J, V356, P495, DOI 10.1042/0264-6021:3560495; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Liu Q, 2007, J CELL BIOL, V178, P785, DOI 10.1083/jcb.200704108; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; LOHKA MJ, 1984, J CELL BIOL, V98, P1222, DOI 10.1083/jcb.98.4.1222; LOHKA MJ, 1988, CELL BIOL INT REP, V12, P833, DOI 10.1016/0309-1651(88)90091-4; Ma Y, 2007, J CELL SCI, V120, P520, DOI 10.1242/jcs.03355; Macaulay C, 1996, J CELL BIOL, V132, P5, DOI 10.1083/jcb.132.1.5; Maeshima K, 2006, J CELL SCI, V119, P4442, DOI 10.1242/jcs.03207; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Mattaj IW, 2004, NAT REV MOL CELL BIO, V5, P65, DOI 10.1038/nrm1263; MILLER M, 1991, PHYSIOL REV, V71, P909, DOI 10.1152/physrev.1991.71.3.909; Murakami MS, 1998, DEVELOPMENT, V125, P237; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; NEWMEYER DD, 1986, J CELL BIOL, V103, P2091, DOI 10.1083/jcb.103.6.2091; NEWPORT J, 1992, J CELL BIOL, V116, P295, DOI 10.1083/jcb.116.2.295; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; Otter-Nilsson M, 1999, EMBO J, V18, P2074, DOI 10.1093/emboj/18.8.2074; POWERS M, 2001, CURR PROTOC CELL BIO, V11; Prescott GR, 2009, J NEUROCHEM, V110, P1135, DOI 10.1111/j.1471-4159.2009.06205.x; Pyrpasopoulou A, 1996, EMBO J, V15, P7108, DOI 10.1002/j.1460-2075.1996.tb01102.x; Ramos C, 2006, BIOCHEM J, V400, P393, DOI 10.1042/BJ20061218; RIZZO AM, 1994, CELL BIOL INT, V18, P1085, DOI 10.1006/cbir.1994.1032; Rothman JE, 1996, PROTEIN SCI, V5, P185; Salpingidou G, 2008, J CELL SCI, V121, P706, DOI 10.1242/jcs.019968; Sapir A, 2008, DEV CELL, V14, P11, DOI 10.1016/j.devcel.2007.12.008; Sasagawa S, 1999, EUR J CELL BIOL, V78, P593, DOI 10.1016/S0171-9335(99)80025-9; Scarcelli JJ, 2007, J CELL BIOL, V178, P799, DOI 10.1083/jcb.200702120; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; SHEEHAN MA, 1988, J CELL BIOL, V106, P1, DOI 10.1083/jcb.106.1.1; Shen S, 2009, MOL BIOL CELL, V20, P2438, DOI 10.1091/mbc.E08-10-0987; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stavru F, 2006, J CELL BIOL, V173, P509, DOI 10.1083/jcb.200601001; VIGERS GPA, 1991, J CELL BIOL, V112, P545, DOI 10.1083/jcb.112.4.545; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Vogel K, 2000, J BIOL CHEM, V275, P2959, DOI 10.1074/jbc.275.4.2959; Whyte JRC, 2002, J CELL SCI, V115, P2627; Wiese C, 1997, J CELL SCI, V110, P1489; WILSON KL, 1988, J CELL BIOL, V107, P57, DOI 10.1083/jcb.107.1.57; Xie LX, 2009, INFLAMM RES, V58, P407, DOI 10.1007/s00011-009-0006-x; Zhang CM, 2000, SCIENCE, V288, P1429, DOI 10.1126/science.288.5470.1429; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104	78	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29847	29859		10.1074/jbc.M109.044453	http://dx.doi.org/10.1074/jbc.M109.044453			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19696024	Green Published, hybrid			2022-12-25	WOS:000270896800065
J	Taniguchi, K; Takeya, R; Suetsugu, S; Kan-o, M; Narusawa, M; Shiose, A; Tominaga, R; Sumimoto, H				Taniguchi, Kenichiro; Takeya, Ryu; Suetsugu, Shiro; Kan-o, Meikun; Narusawa, Megumi; Shiose, Akira; Tominaga, Ryuji; Sumimoto, Hideki			Mammalian Formin Fhod3 Regulates Actin Assembly and Sarcomere Organization in Striated Muscles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; THIN FILAMENT LENGTH; HOMOLOGY-2 DOMAIN; CARDIAC MYOCYTES; CAPPING PROTEIN; ARP2/3 COMPLEX; FISSION YEAST; POINTED ENDS; POLYMERIZATION; ELONGATION	Actin filament assembly in nonmuscle cells is regulated by the actin polymerization machinery, including the Arp2/3 complex and formins. However, little is known about the regulation of actin assembly in muscle cells, where straight actin filaments are organized into the contractile unit sarcomere. Here, we show that Fhod3, a myocardial formin that localizes to thin actin filaments in a striated pattern, regulates sarcomere organization in cardiomyocytes. RNA interference-mediated depletion of Fhod3 results in a marked reduction in filamentous actin and disruption of the sarcomeric structure. These defects are rescued by expression of wild-type Fhod3 but not by that of mutant proteins carrying amino acid substitution for conserved residues for actin assembly. These findings suggest that actin dynamics regulated by Fhod3 are critical for sarcomere organization in striated muscle cells.	[Sumimoto, Hideki] Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Higashi Ku, Fukuoka 8128582, Japan; [Taniguchi, Kenichiro; Shiose, Akira; Tominaga, Ryuji] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Surg, Higashi Ku, Fukuoka 8128582, Japan; [Taniguchi, Kenichiro; Takeya, Ryu; Kan-o, Meikun; Narusawa, Megumi; Sumimoto, Hideki] Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan; [Suetsugu, Shiro] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Membrane & Cytoskeleton Dynam, Bunkyo Ku, Tokyo 1130032, Japan; [Suetsugu, Shiro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kyushu University; Kyushu University; Kyushu University; University of Tokyo; Japan Science & Technology Agency (JST)	Sumimoto, H (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	hsumi@med.kyushu-u.ac.jp	Suetsugu, Shiro/B-3300-2010; Suetsugu, Shiro/ABB-6033-2020; Suetsugu, Shiro/AAF-4427-2019	Suetsugu, Shiro/0000-0002-4612-0628; Suetsugu, Shiro/0000-0002-4612-0628	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development; Takeda Science Foundation; CREST of Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kyushu University Interdisciplinary Programs in Education and Projects in Research Development; Takeda Science Foundation(Takeda Science Foundation (TSF)); CREST of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	This work was supported in part by Grants-in-aid for Scientific Research and Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by Kyushu University Interdisciplinary Programs in Education and Projects in Research Development, by the Takeda Science Foundation, and by CREST of Japan Science and Technology Agency.	Bai J, 2007, DEV CELL, V13, P828, DOI 10.1016/j.devcel.2007.10.003; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; GREGORIO CC, 1995, NATURE, V377, P83, DOI 10.1038/377083a0; Gregorio CC, 2000, TRENDS CELL BIOL, V10, P355, DOI 10.1016/S0962-8924(00)01793-1; GROVE BK, 1984, J CELL BIOL, V98, P518, DOI 10.1083/jcb.98.2.518; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Kanaya H, 2005, GENES CELLS, V10, P665, DOI 10.1111/j.1365-2443.2005.00867.x; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; LIN DC, 1980, ANAL BIOCHEM, V103, P316; Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517; Littlefield RS, 2008, SEMIN CELL DEV BIOL, V19, P511, DOI 10.1016/j.semcdb.2008.08.009; MANASEK FJ, 1972, P NATL ACAD SCI USA, V69, P308, DOI 10.1073/pnas.69.2.308; MARKWALD RR, 1973, J MOL CELL CARDIOL, V5, P341, DOI 10.1016/0022-2828(73)90026-6; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Sanger JW, 2005, J MUSCLE RES CELL M, V26, P343, DOI 10.1007/s10974-005-9016-7; SCHAFER DA, 1995, J CELL BIOL, V128, P61, DOI 10.1083/jcb.128.1.61; SIMPSON P, 1985, CIRC RES, V56, P884, DOI 10.1161/01.RES.56.6.884; Skau CT, 2009, MOL BIOL CELL, V20, P2160, DOI 10.1091/mbc.E08-12-1201; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Suematsu N, 2003, CIRCULATION, V107, P1418, DOI 10.1161/01.CIR.0000055318.09997.1F; Suetsugu S, 2001, J BIOL CHEM, V276, P33175, DOI 10.1074/jbc.M102866200; Takeya R, 2003, J CELL SCI, V116, P4567, DOI 10.1242/jcs.00769; Westendorf JJ, 2001, J BIOL CHEM, V276, P46453, DOI 10.1074/jbc.M105162200; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	32	72	74	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29873	29881		10.1074/jbc.M109.059303	http://dx.doi.org/10.1074/jbc.M109.059303			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19706596	Green Published, hybrid			2022-12-25	WOS:000270896800067
J	Wells, J; Lee, B; Cai, AQ; Karapetyan, A; Lee, WJ; Rugg, E; Sinha, S; Nie, Q; Dai, X				Wells, Julie; Lee, Briana; Cai, Anna Qianyao; Karapetyan, Adrine; Lee, Wan-Ju; Rugg, Elizabeth; Sinha, Satrajit; Nie, Qing; Dai, Xing			Ovol2 Suppresses Cell Cycling and Terminal Differentiation of Keratinocytes by Directly Repressing c-Myc and Notch1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL STEM-CELLS; GROWTH-FACTOR-BETA; DROSOPHILA-OVO; MOUSE HOMOLOG; GENE; TRANSCRIPTION; EXPRESSION; ACTIVATION; INHIBITORS; COMPLEX	Ovol2 belongs to the Ovo family of evolutionarily conserved zinc finger transcription factors that act downstream of key developmental signaling pathways including Wg/Wnt and BMP/TGF-beta. We previously reported Ovol2 expression in the basal layer of epidermis, where epidermal stem/progenitor cells reside. In this work, we use HaCaT human keratinocytes to investigate the cellular and molecular functions of Ovol2. We show that depletion of Ovol2 leads to transient cell expansion but a loss of cells with long term proliferation potential. Mathematical modeling and experimental findings suggest that both faster cycling and precocious withdrawal from the cell cycle underlie this phenotype. Ovol2 depletion also accelerates extracellular signal-induced terminal differentiation in two-and three-dimensional culture models. By chromatin immunoprecipitation, luciferase reporter, and functional rescue assays, we demonstrate that Ovol2 directly represses two critical downstream targets, c-Myc and Notch1, thereby suppressing keratinocyte transient proliferation and terminal differentiation, respectively. These findings shed light on how an epidermal cell maintains a proliferation-competent and differentiation-resistant state.	[Dai, Xing] Univ Calif Irvine, Dept Biol Chem, Sch Med, Irvine, CA 92697 USA; [Cai, Anna Qianyao; Nie, Qing] Univ Calif Irvine, Dept Math, Irvine, CA 92697 USA; [Cai, Anna Qianyao; Nie, Qing] Univ Calif Irvine, Ctr Math & Computat Biol, Irvine, CA 92697 USA; [Karapetyan, Adrine; Rugg, Elizabeth] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92697 USA; [Sinha, Satrajit] SUNY Buffalo, Dept Biochem, Buffalo, NY 14203 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Dai, X (corresponding author), Univ Calif Irvine, Dept Biol Chem, Sch Med, D250 Med Sci 1, Irvine, CA 92697 USA.	xdai@uci.edu		Dai, Xing/0000-0001-8134-1365	National Institutes of Health [R01-AR47320, K02-AR51482, R01-AR47320-08S1, R01GM75309, R01GM67247, P50GM76516]; National Science Foundation [DMS0511169]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060555] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K02AR051482, R01AR047320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067247, R01GM075309, P50GM076516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AR47320 and K02-AR51482 (to X. D.); R01-AR47320-08S1 (to X. D. and Q. N.); and R01GM75309, R01GM67247, and P50GM76516 (to Q. N.). This work was also supported by National Science Foundation Grant DMS0511169 (to Q. N.).	Andrews J, 2000, DEVELOPMENT, V127, P881; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chidambaram A, 1997, MAMM GENOME, V8, P950, DOI 10.1007/s003359900620; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Dai X, 1998, GENE DEV, V12, P3452, DOI 10.1101/gad.12.21.3452; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; EUSTICE DC, 1991, BIOTECHNIQUES, V11, P739; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Frye M, 2003, DEVELOPMENT, V130, P2793, DOI 10.1242/dev.00462; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Hirata A, 2004, J HISTOCHEM CYTOCHEM, V52, P1503, DOI 10.1369/jhc.4A6285.2004; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Jones P, 2008, NAT REV MOL CELL BIO, V9, P82, DOI 10.1038/nrm2292x; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Lander AD, 2009, PLOS BIOL, V7, P84, DOI 10.1371/journal.pbio.1000015; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Li B, 2002, GENOMICS, V80, P319, DOI 10.1006/geno.2002.6831; Li BA, 2005, DEVELOPMENT, V132, P1463, DOI 10.1242/dev.01658; Li BA, 2002, P NATL ACAD SCI USA, V99, P6064, DOI 10.1073/pnas.092137099; Lo WC, 2009, MATH BIOSCI ENG, V6, P59, DOI 10.3934/mbe.2009.6.59; Maas-Szabowski N, 2003, J CELL SCI, V116, P2937, DOI 10.1242/jcs.00474; Mackay DR, 2006, DEV BIOL, V291, P38, DOI 10.1016/j.ydbio.2005.12.003; Margulis A, 2004, METH MOL B, V289, P61; Masu Y, 1998, FEBS LETT, V421, P224, DOI 10.1016/S0014-5793(97)01567-6; MEVELNINIO M, 1995, MECH DEVELOP, V49, P83, DOI 10.1016/0925-4773(94)00305-7; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Nair M, 2006, J CELL BIOL, V173, P253, DOI 10.1083/jcb.200508196; Nair M, 2007, NUCLEIC ACIDS RES, V35, P1687, DOI 10.1093/nar/gkl1141; OLIVER B, 1994, DEVELOPMENT, V120, P3185; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Potten C S, 1981, Int Rev Cytol, V69, P271; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; RYLE CM, 1989, DIFFERENTIATION, V40, P42, DOI 10.1111/j.1432-0436.1989.tb00812.x; Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; TENG A, 2006, BIOCHIM BIOPHYS ACTA, V1772, P89; Unezaki S, 2004, GENE, V336, P47, DOI 10.1016/j.gene.2004.03.013; Waikel RL, 1999, ONCOGENE, V18, P4870, DOI 10.1038/sj.onc.1203040; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Wan H, 2007, STEM CELLS, V25, P1286, DOI 10.1634/stemcells.2006-0304; Watt FM, 2008, NAT REV CANCER, V8, P234, DOI 10.1038/nrc2328; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Yagi K, 2002, J BIOL CHEM, V277, P854, DOI 10.1074/jbc.M104170200; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641	60	41	45	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29125	29135		10.1074/jbc.M109.008847	http://dx.doi.org/10.1074/jbc.M109.008847			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19700410	Green Published, hybrid			2022-12-25	WOS:000270678900068
J	Portillo, IJG; Gleiser, PM				Portillo, Ignacio J. Gomez; Gleiser, Pablo M.			An Adaptive Complex Network Model for Brain Functional Networks	PLOS ONE			English	Article							HIERARCHICAL ORGANIZATION; CONNECTIVITY; SYNCHRONIZATION; NEUROANATOMY; EVOLUTION	Brain functional networks are graph representations of activity in the brain, where the vertices represent anatomical regions and the edges their functional connectivity. These networks present a robust small world topological structure, characterized by highly integrated modules connected sparsely by long range links. Recent studies showed that other topological properties such as the degree distribution and the presence ( or absence) of a hierarchical structure are not robust, and show different intriguing behaviors. In order to understand the basic ingredients necessary for the emergence of these complex network structures we present an adaptive complex network model for human brain functional networks. The microscopic units of the model are dynamical nodes that represent active regions of the brain, whose interaction gives rise to complex network structures. The links between the nodes are chosen following an adaptive algorithm that establishes connections between dynamical elements with similar internal states. We show that the model is able to describe topological characteristics of human brain networks obtained from functional magnetic resonance imaging studies. In particular, when the dynamical rules of the model allow for integrated processing over the entire network scale-free non-hierarchical networks with well defined communities emerge. On the other hand, when the dynamical rules restrict the information to a local neighborhood, communities cluster together into larger ones, giving rise to a hierarchical structure, with a truncated power law degree distribution.			Gleiser, PM (corresponding author), Ctr Atom Bariloche, Stat & Interdisciplinary Phys Grp, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.	gleiser@cab.cnea.gov.ar						Acebron JA, 2005, REV MOD PHYS, V77, P137, DOI 10.1103/RevModPhys.77.137; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Arenas A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.114102; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Dorogovtsev SN, 2002, ADV PHYS, V51, P1079, DOI 10.1080/00018730110112519; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; FERRARINI L, 2008, HUM BRAIN MAPP  1001; Gleiser PM, 2006, EUR PHYS J B, V53, P233, DOI [10.1140/epjb/e2006-00362-y, 10.1140/opjh/e2006-00362-y]; Gong P, 2004, EUROPHYS LETT, V67, P328, DOI 10.1209/epl/i2003-10287-7; Gong PL, 2003, PHYSICA A, V321, P679, DOI 10.1016/S0378-4371(02)01735-1; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; MANRUBIA SC, 2004, EMERGENCE DYNAMICAL; Motter AE, 2006, PHYSICA D, V224, pVII, DOI 10.1016/j.physd.2006.09.012; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.036122; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Park CH, 2008, PHYSICA A, V387, P5958, DOI 10.1016/j.physa.2008.06.048; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Sporns O, 2000, NEURAL NETWORKS, V13, P909, DOI 10.1016/S0893-6080(00)00053-8; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Sporns O, 2006, P NATL ACAD SCI USA, V103, P19219, DOI 10.1073/pnas.0609523103; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Strogatz S.H., 2003, SYNC EMERGING SCI SP; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; van den Berg D, 2004, EUROPHYS LETT, V65, P459, DOI 10.1209/epl/i2003-10116-1; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zamora-Lopez G, 2009, CHAOS, V19, DOI 10.1063/1.3089559; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103	39	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2009	4	9							e6863	10.1371/journal.pone.0006863	http://dx.doi.org/10.1371/journal.pone.0006863			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZH	19738902	Green Submitted, Green Published, gold			2022-12-25	WOS:000269622300005
J	Dunn, LK; Mohammad, KS; Fournier, PGJ; McKenna, CR; Davis, HW; Niewolna, M; Peng, XH; Chirgwin, JM; Guise, TA				Dunn, Lauren K.; Mohammad, Khalid S.; Fournier, Pierrick G. J.; McKenna, C. Ryan; Davis, Holly W.; Niewolna, Maria; Peng, Xiang Hong; Chirgwin, John M.; Guise, Theresa A.			Hypoxia and TGF-beta Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment	PLOS ONE			English	Article								Background: Most patients with advanced breast cancer develop bone metastases, which cause pain, hypercalcemia, fractures, nerve compression and paralysis. Chemotherapy causes further bone loss, and bone-specific treatments are only palliative. Multiple tumor-secreted factors act on the bone microenvironment to drive a feed-forward cycle of tumor growth. Effective treatment requires inhibiting upstream regulators of groups of prometastatic factors. Two central regulators are hypoxia and transforming growth factor (TGF)-beta. We asked whether hypoxia (via HIF-1 alpha) and TGF-beta signaling promote bone metastases independently or synergistically, and we tested molecular versus pharmacological inhibition strategies in an animal model. Methodology/Principal Findings: We analyzed interactions between HIF-1 alpha and TGF-beta pathways in MDA-MB-231 breast cancer cells. Only vascular endothelial growth factor (VEGF) and the CXC chemokine receptor 4 (CXCR4), of 16 genes tested, were additively increased by both TGF-beta and hypoxia, with effects on the proximal promoters. We inhibited HIF-1 alpha and TGF-beta pathways in tumor cells by shRNA and dominant negative receptor approaches. Inhibition of either pathway decreased bone metastasis, with no further effect of double blockade. We tested pharmacologic inhibitors of the pathways, which target both the tumor and the bone microenvironment. Unlike molecular blockade, combined drug treatment decreased bone metastases more than either alone, with effects on bone to decrease osteoclastic bone resorption and increase osteoblast activity, in addition to actions on tumor cells. Conclusions/Significance: Hypoxia and TGF-beta signaling in parallel drive tumor bone metastases and regulate a common set of tumor genes. In contrast, small molecule inhibitors, by acting on both tumor cells and the bone microenvironment, additively decrease tumor burden, while improving skeletal quality. Our studies suggest that inhibitors of HIF-1 alpha and TGF-beta may improve treatment of bone metastases and increase survival.			Dunn, LK (corresponding author), Univ Virginia, Dept Med, Div Endocrinol, Charlottesville, VA 22903 USA.	tguise@iupui.edu	Mohammad, Khalid/AFE-4205-2022; Fournier, Pierrick/B-6560-2015; Mohammad, Khalid/AAE-9569-2022	Fournier, Pierrick/0000-0001-7633-8129; 	NATIONAL CANCER INSTITUTE [R01CA069158, T32CA009109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA69158, T32 CA009109, PC061185, T32-CA009109, PC040341, PC051194, BC073157, R01 CA069158] Funding Source: Medline; NIGMS NIH HHS [T32-GM007267, T32 GM007267] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akagi Y, 1998, CANCER RES, V58, P4008; Albertella MR, 2008, CLIN CANCER RES, V14, P1096, DOI 10.1158/1078-0432.CCR-07-4020; Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Arnett TR, 2003, J CELL PHYSIOL, V196, P2, DOI 10.1002/jcp.10321; Bauerle T, 2008, NEOPLASIA, V10, P511, DOI 10.1593/neo.08220; Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; Bartholin L, 2007, CANCER LETT, V246, P230, DOI 10.1016/j.canlet.2006.02.019; BAUERLE T, 2008, EUR J RADIOL; Bendre MS, 2005, CANCER RES, V65, P11001, DOI 10.1158/0008-5472.CAN-05-2630; Bendre MS, 2002, CANCER RES, V62, P5571; Bozec A, 2008, NATURE, V454, P221, DOI 10.1038/nature07019; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; CABIOGLU N, 2009, ANN ONCOL; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Caruz A, 1998, FEBS LETT, V426, P271, DOI 10.1016/S0014-5793(98)00359-7; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Cicek M, 2007, CANCER RES, V67, P10106, DOI 10.1158/0008-5472.CAN-07-1362; Coleman RE, 2008, BRIT J CANCER, V98, P1736, DOI 10.1038/sj.bjc.6604382; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; DIAMOND P, 2009, J BONE MINER RES; Duivenvoorden WCM, 1999, CLIN EXP METASTAS, V17, P27; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Ehata S, 2007, CANCER SCI, V98, P127, DOI 10.1111/j.1349-7006.2006.00357.x; Ge RR, 2006, CLIN CANCER RES, V12, P4315, DOI 10.1158/1078-0432.CCR-06-0162; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Guise TA, 2006, ONCOLOGIST, V11, P1121, DOI 10.1634/theoncologist.11-10-1121; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hayashi T, 2004, CLIN CANCER RES, V10, P7540, DOI 10.1158/1078-0432.CCR-04-0632; Hiraga T, 2007, CANCER RES, V67, P4157, DOI 10.1158/0008-5472.CAN-06-2355; Hirao M, 2007, J BONE MINER METAB, V25, P266, DOI 10.1007/s00774-007-0765-9; Iida J, 2007, MELANOMA RES, V17, P205, DOI 10.1097/CMR.0b013e3282a660ad; Janssen HLK, 2002, INT J RADIAT ONCOL, V54, P1537, DOI 10.1016/S0360-3016(02)03935-4; Javelaud D, 2007, CANCER RES, V67, P2317, DOI 10.1158/0008-5472.CAN-06-3950; Jeon SH, 2007, J LEUKOCYTE BIOL, V81, P557, DOI 10.1189/jlb.0806517; Kakonen SM, 2002, J BIOL CHEM, V277, P24571, DOI 10.1074/jbc.M202561200; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Knowles HJ, 2008, J PATHOL, V215, P56, DOI 10.1002/path.2319; KNOWLES HJ, 2009, J PATHOL; Komatsu DE, 2007, J BONE MINER RES, V22, P366, DOI 10.1359/JBMR.061207; LaVallee TM, 2008, MOL CANCER THER, V7, P1472, DOI 10.1158/1535-7163.MCT-08-0107; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Lipton A, 2008, CANCER TREAT REV, V34, pS25, DOI 10.1016/j.ctrv.2008.03.008; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mohammad KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005275; Mooberry SL, 2003, DRUG RESIST UPDATE, V6, P355, DOI 10.1016/j.drup.2003.10.001; Mooberry Susan L., 2003, Current Opinion in Oncology, V15, P425, DOI 10.1097/00001622-200311000-00004; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Raleigh JA, 1998, CANCER RES, V58, P3765; Richert MM, 2009, ONCOL REP, V21, P761, DOI 10.3892/or_00000282; Ricker JL, 2004, CLIN CANCER RES, V10, P8665, DOI 10.1158/1078-0432.CCR-04-1393; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Sanchez-Elsner T, 2001, J BIOL CHEM, V276, P38527, DOI 10.1074/jbc.M104536200; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sibonga JD, 2003, ENDOCRINOLOGY, V144, P785, DOI 10.1210/en.2002-220632; Tamamura H, 2003, FEBS LETT, V550, P79, DOI 10.1016/S0014-5793(03)00824-X; Tevaarwerk AJ, 2009, CLIN CANCER RES, V15, P1460, DOI 10.1158/1078-0432.CCR-08-1599; Uhl M, 2004, CANCER RES, V64, P7954, DOI 10.1158/0008-5472.CAN-04-1013; Varia MA, 1998, GYNECOL ONCOL, V71, P270, DOI 10.1006/gyno.1998.5163; Wang JH, 2006, CANCER METAST REV, V25, P573, DOI 10.1007/s10555-006-9019-x; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Yang YA, 2002, J CLIN INVEST, V109, P1607, DOI 10.1172/JCI200215333; Yin JJ, 2003, P NATL ACAD SCI USA, V100, P10954, DOI 10.1073/pnas.1830978100; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Zhang Q, 2008, J BIOL CHEM, V283, P13491, DOI 10.1074/jbc.M708055200; Zhong H, 1999, CANCER RES, V59, P5830; Zhou DC, 2008, NEUROL RES, V30, P268, DOI 10.1179/016164107X229920	72	164	170	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6896	10.1371/journal.pone.0006896	http://dx.doi.org/10.1371/journal.pone.0006896			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19727403	gold, Green Submitted, Green Published			2022-12-25	WOS:000269522900023
J	Huang, SMA; Hancock, MK; Pitman, JL; Orth, AP; Gekakis, N				Huang, Shih-Min A.; Hancock, Michael K.; Pitman, Jeffrey L.; Orth, Anthony P.; Gekakis, Nicholas			Negative Regulators of Insulin Signaling Revealed in a Genome-Wide Functional Screen	PLOS ONE			English	Article								Background: Type 2 diabetes develops due to a combination of insulin resistance and beta-cell failure and current therapeutics aim at both of these underlying causes. Several negative regulators of insulin signaling are known and are the subject of drug discovery efforts. We sought to identify novel contributors to insulin resistance and hence potentially novel targets for therapeutic intervention. Methodology: An arrayed cDNA library encoding 18,441 human transcripts was screened for inhibitors of insulin signaling and revealed known inhibitors and numerous potential novel regulators. The novel hits included proteins of various functional classes such as kinases, phosphatases, transcription factors, and GTPase associated proteins. A series of secondary assays confirmed the relevance of the primary screen hits to insulin signaling and provided further insight into their modes of action. Conclusion/Significance: Among the novel hits was PALD (KIAA1274, paladin), a previously uncharacterized protein that when overexpressed led to inhibition of insulin's ability to down regulate a FOXO1A-driven reporter gene, reduced upstream insulin-stimulated AKT phosphorylation, and decreased insulin receptor (IR) abundance. Conversely, knockdown of PALD gene expression resulted in increased IR abundance, enhanced insulin-stimulated AKT phosphorylation, and an improvement in insulin's ability to suppress FOXO1A-driven reporter gene activity. The present data demonstrate that the application of arrayed genome-wide screening technologies to insulin signaling is fruitful and is likely to reveal novel drug targets for insulin resistance and the metabolic syndrome.			Huang, SMA (corresponding author), Novartis Inst Biomed Res Dev & Mol Pathways, Cambridge, MA USA.	gekakis@scripps.edu						Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Brachmann SM, 2005, MOL CELL BIOL, V25, P1596, DOI 10.1128/MCB.25.5.1596-1607.2005; Cai DS, 2003, J BIOL CHEM, V278, P25323, DOI 10.1074/jbc.M212430200; Cho YJ, 2007, MOL CELL BIOL, V27, P899, DOI 10.1128/MCB.00756-06; CHUANG TH, 1995, P NATL ACAD SCI USA, V92, P10282, DOI 10.1073/pnas.92.22.10282; Condorelli G, 1998, EMBO J, V17, P3858, DOI 10.1093/emboj/17.14.3858; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Kaartinen V, 2001, DEVELOPMENT, V128, P4217; Kurlawalla-Martinez C, 2005, MOL CELL BIOL, V25, P2498, DOI 10.1128/MCB.25.6.2498-2510.2005; Nagase T, 1999, DNA Res, V6, P337, DOI 10.1093/dnares/6.5.337; Ono H, 2001, MOL ENDOCRINOL, V15, P1411, DOI 10.1210/me.15.8.1411; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; TAN EC, 1993, J BIOL CHEM, V268, P27291; Tu YZ, 2001, BIOCHEM J, V354, P315, DOI 10.1042/0264-6021:3540315; Ueki K, 2002, P NATL ACAD SCI USA, V99, P419, DOI 10.1073/pnas.012581799; Vander Kooi BT, 2003, J BIOL CHEM, V278, P11782, DOI 10.1074/jbc.M212570200; Vigliotta G, 2004, MOL CELL BIOL, V24, P5005, DOI 10.1128/MCB.24.11.5005-5015.2004; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Wick KR, 2003, J BIOL CHEM, V278, P8460, DOI 10.1074/jbc.M208518200; Xu H., 2005, J BIOL CHEM; Xu HY, 2003, J BIOL CHEM, V278, P30187, DOI 10.1074/jbc.M302010200; Zeller C, 2003, ONCOGENE, V22, P2972, DOI 10.1038/sj.onc.1206474	28	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6871	10.1371/journal.pone.0006871	http://dx.doi.org/10.1371/journal.pone.0006871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19727444	Green Published, gold, Green Submitted			2022-12-25	WOS:000269522900008
J	Lynch, VJ; Brayer, K; Gellersen, B; Wagner, GP				Lynch, Vincent J.; Brayer, Kathryn; Gellersen, Birgit; Wagner, Guenter P.			HoxA-11 and FOXO1A Cooperate to Regulate Decidual Prolactin Expression: Towards Inferring the Core Transcriptional Regulators of Decidual Genes	PLOS ONE			English	Article							BINDING-PROTEIN-BETA; HUMAN-ENDOMETRIUM; CYCLIC-AMP; PROMOTER; RECEPTOR; HOXA10; ACTIVATION; FKHR	Background: During the menstrual cycle, the ovarian steroid hormones estrogen and progesterone control a dramatic transcriptional reprogramming of endometrial stromal cells (ESCs) leading to a receptive state for blastocyst implantation and the establishment of pregnancy. A key marker gene of this decidualization process is the prolactin gene. Several transcriptional regulators have been identified that are essential for decidualization of ESCs, including the Hox genes HoxA-10 and HoxA-11, and the forkhead box gene FOXO1A. While previous studies have identified downstream target genes for HoxA-10 and FOXO1A, the role of HoxA-11 in decidualization has not been investigated. Here, we show that HoxA-11 is required for prolactin expression in decidualized ESC. While HoxA-11 alone is a repressor on the decidual prolactin promoter, it turns into an activator when combined with FOXO1A. Conversely, HoxA-10, which has been previously shown to associate with FOXO1A to upregulate decidual IGFBP-1 expression, is unable to upregulate PRL expression when co-expressed with FOXO1A. By co-immunoprecipitation and chromatin immunoprecipitation, we demonstrate physical association of HoxA-11 and FOXO1A, and binding of both factors to an enhancer region (2395 to 2148 relative to the PRL transcriptional start site) of the decidual prolactin promoter. Because FOXO1A is induced upon decidualization, it serves to assemble a decidual-specific transcriptional complex including HoxA-11. These data highlight cooperativity between numerous transcription factors to upregulate PRL in differentiating ESC, and suggest that this core set of transcription factors physically and functionally interact to drive the expression of a gene battery upregulated in differentiated ESC. In addition, the functional non-equivalence of HoxA-11 and HoxA-10 with respect to PRL regulation suggests that these transcription factors regulate distinct sets of target genes during decidualization.			Lynch, VJ (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	vincent.j.lynch@yale.edu		Lynch, Vincent/0000-0001-5311-3824; Wagner, Gunter/0000-0002-3097-002X				Bao L, 2007, ENDOCRINOLOGY, V148, P2326, DOI 10.1210/en.2006-1643; BenJonathan N, 1996, ENDOCR REV, V17, P639, DOI 10.1210/er.17.6.639; Brar AK, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290099; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Buzzio OL, 2006, ENDOCRINOLOGY, V147, P3870, DOI 10.1210/en.2006-0167; Christian M, 2002, J BIOL CHEM, V277, P20825, DOI 10.1074/jbc.M201018200; Christian M, 2002, MOL ENDOCRINOL, V16, P141, DOI 10.1210/me.16.1.141; Daftary GS, 2002, MOL ENDOCRINOL, V16, P571, DOI 10.1210/me.16.3.571; DALY DC, 1983, AM J OBSTET GYNECOL, V145, P672, DOI 10.1016/0002-9378(83)90572-0; Deb S, 1999, ENDOCRINOLOGY, V140, P4442, DOI 10.1210/en.140.10.4442; DIMATTIA GE, 1990, J BIOL CHEM, V265, P16412; Featherstone M, 2003, AD DEV BIOL, V13, P1; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Gendron RL, 1997, BIOL REPROD, V56, P1097, DOI 10.1095/biolreprod56.5.1097; Gerlo S, 2006, BIOESSAYS, V28, P1051, DOI 10.1002/bies.20468; Grinius L, 2006, J ENDOCRINOL, V189, P179, DOI 10.1677/joe.1.06451; HSIEHLI HM, 1995, DEVELOPMENT, V121, P1373; Jabbour HN, 2001, REPRODUCTION, V121, P197, DOI 10.1530/rep.0.1210197; Kessler CA, 2006, MOL HUM REPROD, V12, P71, DOI 10.1093/molehr/gal008; Kim JJ, 2007, MOL HUM REPROD, V13, P323, DOI 10.1093/molehr/gam005; Kim JJ, 2003, BIOL REPROD, V68, P24, DOI 10.1095/biolreprod.102.009316; Labied S, 2006, MOL ENDOCRINOL, V20, P35, DOI 10.1210/me.2005-0275; Lynch VJ, 2008, P NATL ACAD SCI USA, V105, P14928, DOI 10.1073/pnas.0802355105; Ma L, 1999, SEMIN REPROD ENDOCR, V17, P205, DOI 10.1055/s-2007-1016228; Mantena SR, 2006, P NATL ACAD SCI USA, V103, P1870, DOI 10.1073/pnas.0507261103; MASLAR IA, 1979, AM J OBSTET GYNECOL, V135, P751, DOI 10.1016/0002-9378(79)90386-7; Pohnke Y, 1999, J BIOL CHEM, V274, P24808, DOI 10.1074/jbc.274.35.24808; Reem GH, 1999, J MOL ENDOCRINOL, V22, P285, DOI 10.1677/jme.0.0220285; Roth JJ, 2005, J EXP ZOOL PART B, V304B, P468, DOI 10.1002/jez.b.21061; Ryoo HD, 1999, DEVELOPMENT, V126, P5137; SATOKATA I, 1995, NATURE, V374, P460, DOI 10.1038/374460a0; Taylor HS, 2000, SEMIN REPROD MED, V18, P81, DOI 10.1055/s-2000-13478; Telgmann R, 1998, HUM REPROD UPDATE, V4, P472, DOI 10.1093/humupd/4.5.472; Troy PJ, 2003, MOL CELL BIOL, V23, P1, DOI 10.1128/MCB.23.1.1-13.2003; Watanabe K, 2001, MOL ENDOCRINOL, V15, P638, DOI 10.1210/me.15.4.638; WU WX, 1995, J MOL ENDOCRINOL, V14, P255, DOI 10.1677/jme.0.0140255; Zhong L, 1997, BIOCHEM BIOPH RES CO, V235, P587, DOI 10.1006/bbrc.1997.6833	38	64	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6845	10.1371/journal.pone.0006845	http://dx.doi.org/10.1371/journal.pone.0006845			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19727442	Green Submitted, Green Published, gold			2022-12-25	WOS:000269522900004
J	Rasanen, K; Virtanen, I; Salmenpera, P; Grenman, R; Vaheri, A				Rasanen, Kati; Virtanen, Ismo; Salmenpera, Pertteli; Grenman, Reidar; Vaheri, Antti			Differences in the Nemosis Response of Normal and Cancer-Associated Fibroblasts from Patients with Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							GROWTH-FACTOR; SKIN FIBROBLASTS; TUMOR; EXPRESSION; ACTIVATION; INDUCTION; RADIOSENSITIVITY; MYOFIBROBLAST; HETEROGENEITY; INVASION	Background: Tumor-stroma reaction is associated with activation of fibroblasts. Nemosis is a novel type of fibroblast activation. It leads to an increased production of growth factors and proinflammatory and proteolytic proteins, while at the same time cytoskeletal proteins are degraded. Here we used paired normal skin fibroblasts and cancer-associated fibroblasts (CAF) and primary and recurrent oral squamous cell carcinoma (SCC) cells to study the nemosis response. Principal Findings: Fibroblast nemosis was analyzed by protein and gene expression and the paracrine regulation with colony formation assay. One of the normal fibroblast strains, FB-43, upregulated COX-2 in nemosis, but FB-74 cells did not. In contrast, CAF-74 spheroids expressed COX-2 but CAF-43 cells did not. Alpha-SMA protein was expressed in both CAF strains and in FB-74 cells, but not in FB-43 fibroblasts. Its mRNA levels were downregulated in nemosis, but the CAFs started to regain the expression. FSP1 mRNA was downregulated in normal fibroblasts and CAF-74 cells, but not in CAF-43 fibroblasts. Serine protease FAP was upregulated in all fibroblasts, more so in nemotic CAFs. VEGF, HGF/SF and FGF7 mRNA levels were upregulated to variable degree in nemosis. CAFs increased the colony formation of primary tumor cell lines UT-SCC-43A and UT-SCC-74A, but normal fibroblasts inhibited the anchorage-independent growth of recurrent UT-SCC-43B and UT-SCC-74B cells. Conclusions: Nemosis response, as observed by COX-2 and growth factor induction, and expression of CAF markers alpha-SMA, FSP1 and FAP, varies between fibroblast populations. The expression of CAF markers differs between normal fibroblasts and CAFs in nemosis. These results emphasize the heterogeneity of fibroblasts and the evolving tumor-promoting properties of CAFs.			Rasanen, K (corresponding author), Univ Helsinki, Haartman Inst, Helsinki, Finland.	kati.rasanen@helsinki.fi	Vaheri, Antti/AAV-1523-2020; Räsänen, Kati/I-5769-2014					Ali MALS, 2008, CANCER SCI, V99, P1589, DOI 10.1111/j.1349-7006.2008.00861.x; Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Augsten M, 2009, P NATL ACAD SCI USA, V106, P3414, DOI 10.1073/pnas.0813144106; Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023; Barclay WW, 2005, ENDOCRINOLOGY, V146, P13, DOI 10.1210/en.2004-1123; Bizik J, 2004, CELL DEATH DIFFER, V11, P183, DOI 10.1038/sj.cdd.4401317; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Daly AJ, 2008, ORAL ONCOL, V44, P646, DOI 10.1016/j.oraloncology.2007.08.012; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Enzerink A, 2009, MOL IMMUNOL, V46, P1787, DOI 10.1016/j.molimm.2009.01.018; Francisco IFS, 2004, INT J CANCER, V112, P213, DOI 10.1002/ijc.20388; Fukumura D, 1998, CELL, V94, P715, DOI 10.1016/S0092-8674(00)81731-6; Gold KA, 2009, CANCER-AM CANCER SOC, V115, P922, DOI 10.1002/cncr.24123; Haikonen J, 2003, INT J CANCER, V103, P784, DOI 10.1002/ijc.10890; Hamakawa H, 2008, HEAD NECK-J SCI SPEC, V30, P800, DOI 10.1002/hed.20830; Hassan NMM, 2008, CANCER LETT, V270, P108, DOI 10.1016/j.canlet.2008.04.052; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Honkanen J, 1998, J CANCER RES CLIN, V124, P415, DOI 10.1007/s004320050193; Jin CL, 2004, CANCER RES, V64, P4555, DOI 10.1158/0008-5472.CAN-03-3752; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kankuri E, 2005, CANCER RES, V65, P9914, DOI 10.1158/0008-5472.CAN-05-1559; Kellermann MG, 2008, ORAL ONCOL, V44, P509, DOI 10.1016/j.oraloncology.2007.07.001; Kelly T, 2005, DRUG RESIST UPDATE, V8, P51, DOI 10.1016/j.drup.2005.03.002; Kramer RH, 2005, CANCER METAST REV, V24, P35, DOI 10.1007/s10555-005-5046-2; Micke P, 2005, EXPERT OPIN THER TAR, V9, P1217, DOI 10.1517/14728222.9.6.1217; Ohtani N, 2009, CANCER SCI, V100, P792, DOI 10.1111/j.1349-7006.2009.01123.x; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Rasanen K, 2008, MOL ONCOL, V2, P340, DOI 10.1016/j.molonc.2008.09.002; Ruutu M, 2005, ONCOL REP, V14, P1511; Salmenpera P, 2008, EXP CELL RES, V314, P3444, DOI 10.1016/j.yexcr.2008.09.004; SCHOR SL, 1987, BIOESSAYS, V7, P200, DOI 10.1002/bies.950070503; Shannon DB, 2006, WOUND REPAIR REGEN, V14, P172, DOI 10.1111/j.1743-6109.2006.00107.x; Shaoul R, 2006, BIOCHEM BIOPH RES CO, V350, P825, DOI 10.1016/j.bbrc.2006.08.198; Sherbet GV, 2009, CANCER LETT, V280, P15, DOI 10.1016/j.canlet.2008.10.037; Siren V, 2006, ANN MED, V38, P212, DOI 10.1080/07853890500494999; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Sund M, 2009, CANCER METAST REV, V28, P177, DOI 10.1007/s10555-008-9175-2; Tsellou E, 2008, FUTURE ONCOL, V4, P427, DOI 10.2217/14796694.4.3.427; Vaheri A, 2009, EXP CELL RES, V315, P1633, DOI 10.1016/j.yexcr.2009.03.005; VIRTANEN I, 1985, ANN NY ACAD SCI, V455, P635, DOI 10.1111/j.1749-6632.1985.tb50441.x; ZHENG J, 1995, INT J CANCER, V61, P658, DOI 10.1002/ijc.2910610512	46	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2009	4	9							e6879	10.1371/journal.pone.0006879	http://dx.doi.org/10.1371/journal.pone.0006879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489XX	19721715	Green Published, Green Submitted, gold			2022-12-25	WOS:000269461100008
J	Khiabanian, H; Farrell, GM; St George, K; Rabadan, R				Khiabanian, Hossein; Farrell, Gregory M.; St George, Kirsten; Rabadan, Raul			Differences in Patient Age Distribution between Influenza A Subtypes	PLOS ONE			English	Article								Since the spring of 1977, two subtypes of influenza A virus (H3N2 and H1N1) have been seasonally infecting the human population. In this work we study the distribution of patient ages within the populations that exhibit the symptomatic disease caused by each of the different subtypes of seasonal influenza viruses. When the publicly available extensive information is pooled across multiple geographical locations and seasons, striking differences emerge between these subtypes. We report that the symptomatic flu due to H1N1 is distributed mainly in a younger population relative to H3N2. (The median age of the H3N2 patients is 23 years while H1N1 patients are 9 years old.) These distinct characteristic spectra of age groups, possibly carried over from previous pandemics, are consistent with previous reports from various regional population studies and also findings on the evolutionary dynamics of each subtype. Moreover, they are relevant to age-related risk assessments, modeling of epidemiological networks for specific age groups, and age-specific vaccine design. Recently, a novel H1N1 virus has spread around the world. Preliminary reports suggest that this new strain causes symptomatic disease in the younger population in a similar fashion to the seasonal H1N1 strains.			Khiabanian, H (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biomed Informat, 630 W 168th St, New York, NY 10032 USA.	hossein@c2b2.columbia.edu	Khiabanian, Hossein/N-7207-2019; Rabadan, Raul/AAZ-7367-2020	Khiabanian, Hossein/0000-0003-1446-4394; Rabadan, Raul/0000-0001-7946-9255				Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; BEVERIDGE WIB, 1978, NEW SCI, V77, P790; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; FOX JP, 1982, AM J EPIDEMIOL, V116, P228, DOI 10.1093/oxfordjournals.aje.a113408; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; GLEZEN WP, 1991, AM J EPIDEMIOL, V133, P296, DOI 10.1093/oxfordjournals.aje.a115874; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kelly H, 2009, INFLUENZA OTHER RESP, V3, P183, DOI 10.1111/j.1750-2659.2009.00088.x; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; KILBOURNE ED, 1976, NY TIMES        0413, V33; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; MONTO AS, 1995, AM J EPIDEMIOL, V141, P502, DOI 10.1093/oxfordjournals.aje.a117464; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Trifonov V, 2009, EUROSURVEILLANCE, V14, P6	17	37	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6832	10.1371/journal.pone.0006832	http://dx.doi.org/10.1371/journal.pone.0006832			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718262	Green Published, Green Submitted, gold			2022-12-25	WOS:000269415900005
J	Mori, S; Chang, JT; Andrechek, ER; Potti, A; Nevins, JR				Mori, Seiichi; Chang, Jeffrey T.; Andrechek, Eran R.; Potti, Anil; Nevins, Joseph R.			Utilization of Genomic Signatures to Identify Phenotype-Specific Drugs	PLOS ONE			English	Article							HUMAN BREAST-CANCER; EXPRESSION SIGNATURES; ESTROGEN-RECEPTOR; DISCOVERY; GROWTH; IDENTIFICATION; PREVENTION; ONCOGENES; PROFILES; THERAPY	Genetic and genomic studies highlight the substantial complexity and heterogeneity of human cancers and emphasize the general lack of therapeutics that can match this complexity. With the goal of expanding opportunities for drug discovery, we describe an approach that makes use of a phenotype-based screen combined with the use of multiple cancer cell lines. In particular, we have used the NCI-60 cancer cell line panel that includes drug sensitivity measures for over 40,000 compounds assayed on 59 independent cells lines. Targets are cancer-relevant phenotypes represented as gene expression signatures that are used to identify cells within the NCI-60 panel reflecting the signature phenotype and then connect to compounds that are selectively active against those cells. As a proof-of-concept, we show that this strategy effectively identifies compounds with selectivity to the RAS or PI3K pathways. We have then extended this strategy to identify compounds that have activity towards cells exhibiting the basal phenotype of breast cancer, a clinically-important breast cancer characterized as ER-, PR-, and Her2- that lacks viable therapeutic options. One of these compounds, Simvastatin, has previously been shown to inhibit breast cancer cell growth in vitro and importantly, has been associated with a reduction in ER-, PR-breast cancer in a clinical study. We suggest that this approach provides a novel strategy towards identification of therapeutic agents based on clinically relevant phenotypes that can augment the conventional strategies of target-based screens.			Mori, S (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Genom Oncol Programme, Singapore 117548, Singapore.	nevin001@mc.duke.edu		Andrechek, Eran/0000-0002-8680-3423	NATIONAL CANCER INSTITUTE [U54CA112952] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R00LM009837] Funding Source: NIH RePORTER; NCI NIH HHS [5U54CA-112952-05, U54 CA112952] Funding Source: Medline; NLM NIH HHS [R00 LM009837] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Balis FM, 2002, J NATL CANCER I, V94, P78, DOI 10.1093/jnci/94.2.78; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Campbell MJ, 2006, CANCER RES, V66, P8707, DOI 10.1158/0008-5472.CAN-05-4061; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Dressman HK, 2007, J CLIN ONCOL, V25, P517, DOI 10.1200/JCO.2006.06.3743; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Gibbs JB, 2000, SCIENCE, V287, P1969, DOI 10.1126/science.287.5460.1969; Hehlmann R, 2007, LANCET, V370, P342, DOI 10.1016/S0140-6736(07)61165-9; Herbst RS, 2006, J CLIN ONCOL, V24, P190, DOI 10.1200/JCO.2005.04.8678; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hsu DS, 2007, J CLIN ONCOL, V25, P4350, DOI 10.1200/JCO.2007.11.0593; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kumar AS, 2008, CANCER EPIDEM BIOMAR, V17, P1028, DOI 10.1158/1055-9965.EPI-07-0726; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nevins JR, 2007, NAT REV GENET, V8, P601, DOI 10.1038/nrg2137; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Prochownik Edward V, 2004, Expert Rev Anticancer Ther, V4, P289, DOI 10.1586/14737140.4.2.289; RAMASWAMY S, 2003, NAT GENET, V33, P59; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Stegmaier K, 2007, PLOS MED, V4, P702, DOI 10.1371/journal.pmed.0040122; TAKAHASHI K, 1979, J ANTIBIOT, V32, P36, DOI 10.7164/antibiotics.32.36; Takata R, 2005, CLIN CANCER RES, V11, P2625, DOI 10.1158/1078-0432.CCR-04-1988; Tanaka H, 1999, JPN J CANCER RES, V90, P1139, DOI 10.1111/j.1349-7006.1999.tb00688.x; THOMPSON EW, 1992, J CELL PHYSIOL, V150, P534, DOI 10.1002/jcp.1041500314; TOBERT JA, 1987, CIRCULATION, V76, P534, DOI 10.1161/01.CIR.76.3.534; Trusheim MR, 2007, NAT REV DRUG DISCOV, V6, P287, DOI 10.1038/nrd2251; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; von Tresckow B, 2007, HAEMATOL-HEMATOL J, V92, P682, DOI 10.3324/haematol.11020; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Yaziji H, 2004, JAMA-J AM MED ASSOC, V291, P1972, DOI 10.1001/jama.291.16.1972; Zanders E D, 2000, Pharmacogenomics, V1, P375, DOI 10.1517/14622416.1.4.375	48	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2009	4	8							e6772	10.1371/journal.pone.0006772	http://dx.doi.org/10.1371/journal.pone.0006772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JG	19714244	gold, Green Submitted, Green Published			2022-12-25	WOS:000269415800002
J	Hale, MB; Krutzik, PO; Samra, SS; Crane, JM; Nolan, GP				Hale, Matthew B.; Krutzik, Peter O.; Samra, Shamsher S.; Crane, Janelle M.; Nolan, Garry P.			Stage Dependent Aberrant Regulation of Cytokine-STAT Signaling in Murine Systemic Lupus Erythematosus	PLOS ONE			English	Article								Systemic lupus erythematosus (SLE) is a complex autoimmune disease of unknown etiology that involves multiple interacting cell types driven by numerous cytokines and autoimmune epitopes. Although the initiating events leading to SLE pathology are not understood, there is a growing realization that dysregulated cytokine action on immune cells plays an important role in promoting the inflammatory autoimmune state. We applied phospho-specific flow cytometry to characterize the extent to which regulation of cytokine signal transduction through the STAT family of transcription factors is disturbed during the progression of SLE. Using a panel of 10 cytokines thought to have causal roles in the disease, we measured signaling responses at the single-cell level in five immune cell types from the MRL/pr murine model. This generated a highly multiplexed view of how cytokine stimuli are processed by intracellular signaling networks in adaptive and innate immune cells during different stages of SLE pathogenesis. We report that robust changes in cytokine signal transduction occur during the progression of SLE in multiple immune cell subtypes including increased T cell responsiveness to IL-10 and ablation of Stat1 responses to IFN alpha, IFN gamma, IL-6, and IL-21, Stat3 responses to IL-6, Stat5 responses to IL-15, and Stat6 responses to IL-4. We found increased intracellular expression of Suppressor of Cytokine Signaling 1 protein correlated with negative regulation of Stat1 responses to inflammatory cytokines. The results provide evidence of negative feedback regulation opposing inflammatory cytokines that have self-sustaining activities and suggest a cytokine-driven oscillator circuit may drive the periodic disease activity observed in many SLE patients.			Hale, MB (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab Genet Pharmacol, Stanford, CA 94305 USA.	gnolan@stanford.edu	Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [N01HV28183, N01-HV-28183] Funding Source: Medline; NIAID NIH HHS [U19 AI057229] Funding Source: Medline; PHS HHS [8-PA1036535C] Funding Source: Medline; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028183] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Baechler EC, 2004, CURR OPIN IMMUNOL, V16, P801, DOI 10.1016/j.coi.2004.09.014; Balomenos D, 1998, J CLIN INVEST, V101, P364, DOI 10.1172/JCI750; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bengtsson AA, 2000, LUPUS, V9, P664, DOI 10.1191/096120300674499064; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Braun D, 2003, J AUTOIMMUN, V20, P15, DOI 10.1016/S0896-8411(02)00109-9; Chaussabel D, 2005, ANN NY ACAD SCI, V1062, P146, DOI 10.1196/annals.1358.017; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Cross JT, 1999, INFLAMM RES, V48, P255, DOI 10.1007/s000110050456; Csiszar A, 2000, CLIN EXP IMMUNOL, V122, P464, DOI 10.1046/j.1365-2249.2000.01369.x; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; ENGLEMAN EG, 1981, ARTHRITIS RHEUM, V24, P1396, DOI 10.1002/art.1780241110; Fischer P, 2004, BIOCHEM J, V378, P449, DOI 10.1042/BJ20030893; Haring JS, 2005, J IMMUNOL, V174, P6791, DOI 10.4049/jimmunol.174.11.6791; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Ilangumaran S, 2004, SEMIN IMMUNOL, V16, P351, DOI 10.1016/j.smim.2004.08.015; Ilangumaran S, 2003, IMMUNOL REV, V192, P196, DOI 10.1034/j.1600-065X.2003.00020.x; Ingolia N, 2005, CURR BIOL, V15, pR961, DOI 10.1016/j.cub.2005.11.012; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; ISHIDA H, 1994, J EXP MED, V179, P305, DOI 10.1084/jem.179.1.305; Kotzin BL, 1996, CELL, V85, P303, DOI 10.1016/S0092-8674(00)81108-3; Krutzik PO, 2005, J IMMUNOL, V175, P2366, DOI 10.4049/jimmunol.175.4.2366; Krutzik PO, 2005, J IMMUNOL, V175, P2357, DOI 10.4049/jimmunol.175.4.2357; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lawson BR, 2000, J CLIN INVEST, V106, P207, DOI 10.1172/JCI10167; Lehmann U, 2003, J BIOL CHEM, V278, P661, DOI 10.1074/jbc.M210552200; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Liu J, 2006, GENES IMMUN, V7, P156, DOI 10.1038/sj.gene.6364286; Llorente L, 2000, ARTHRITIS RHEUM, V43, P1790, DOI 10.1002/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2; Mandik-Nayak L, 1999, J EXP MED, V189, P1799, DOI 10.1084/jem.189.11.1799; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; MORSE HC, 1982, J IMMUNOL, V129, P2612; Narazaki M, 1998, P NATL ACAD SCI USA, V95, P13130, DOI 10.1073/pnas.95.22.13130; OHTEKI T, 1990, J EXP MED, V172, P7, DOI 10.1084/jem.172.1.7; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Pascual V, 2008, IMMUNOL REV, V223, P39, DOI 10.1111/j.1600-065X.2008.00643.x; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Petri M, 1998, RHEUM DIS CLIN N AM, V24, P423, DOI 10.1016/S0889-857X(05)70016-8; Reilly CM, 2002, IMMUNOL RES, V25, P143, DOI 10.1385/IR:25:2:143; RONNBLOM LE, 1991, ACTA ONCOL, V30, P537; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Viallard JF, 1999, CLIN EXP IMMUNOL, V115, P189; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yu CR, 2004, J IMMUNOL, V173, P737, DOI 10.4049/jimmunol.173.2.737	51	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6756	10.1371/journal.pone.0006756	http://dx.doi.org/10.1371/journal.pone.0006756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707593	Green Published, gold, Green Submitted			2022-12-25	WOS:000269278400021
J	Kasinathan, RS; Goronga, T; Messerli, SM; Webb, TR; Greenberg, RM				Kasinathan, Ravi S.; Goronga, Tinopiwa; Messerli, Shanta M.; Webb, Thomas R.; Greenberg, Robert M.			Modulation of a Schistosoma mansoni multidrug transporter by the antischistosomal drug praziquantel	FASEB JOURNAL			English	Article						verapamil; drug resistance; efflux transporter	GATED CA2+ CHANNELS; P-GLYCOPROTEIN; EXCRETORY SYSTEM; ABC TRANSPORTERS; IVERMECTIN RESISTANCE; HAEMONCHUS-CONTORTUS; MOLECULAR-BASIS; BINDING; MECHANISMS; SELECTION	P-glycoprotein (Pgp) is an ATP-dependent efflux pump involved in transport of xenobiotics from cells that, when overexpressed, can mediate multidrug resistance in mammalian cells. Pgp may be a candidate target for new anthelmintics, as it plays critical roles in normal cell physiology, in removal of drugs from cells, and potentially in the development of drug resistance. Schistosomes are parasitic flatworms that cause schistosomiasis, which affects hundreds of millions of people worldwide. Here, we express SMDR2, a Pgp homologue from Schistosoma mansoni ( Platyhelminthes), in Chinese hamster ovary (CHO) cells and use fluorescence-based assays to examine the functional and pharmacological properties of this transporter. Membrane vesicles from stably transfected CHO cells expressing recombinant SMDR2 show significant increases in rhodamine transport and ATP hydrolysis compared with those from control cells or cells transfected with empty vector. SMDR2-mediated transport is inhibited by the Pgp modulators verapamil (IC50 = 12.1 mu M) and nifedipine, and also by praziquantel, the current drug of choice against schisotosomiasis (IC50 = 17.4 mu M). Efflux measurements of a fluorescent analog of praziquantel indicate that it is also a substrate for SMDR2. The interaction of praziquantel with SMDR2 may offer new strategies for potentiating the action of praziquantel and possibly overcoming drug resistance.-Kasinathan, R. S., Goronga, T., Messerli, S. M., Webb, T. R., Greenberg, R. M. Modulation of a Schistosoma mansoni multidrug transporter by the antischistosomal drug praziquantel. FASEB J. 24, 128-135 ( 2010). www.fasebj.org	[Kasinathan, Ravi S.; Greenberg, Robert M.] Univ Penn, Dept Pathobiol, Sch Vet Med, Philadelphia, PA 19104 USA; [Goronga, Tinopiwa; Webb, Thomas R.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Messerli, Shanta M.] Marine Biol Lab, Woods Hole, MA 02543 USA	University of Pennsylvania; St Jude Children's Research Hospital; Marine Biological Laboratory - Woods Hole	Greenberg, RM (corresponding author), Univ Penn, Dept Pathobiol, Sch Vet Med, 3800 Spruce St, Philadelphia, PA 19104 USA.	rgree@vet.upenn.edu	Kasinathan, Ravi/B-7657-2013		National Institutres of Health (NIH) [R01 AI-40522, R01 AI-73660, P41 RR-001395]; NIH/National Science Foundation Woods Hole Center for Oceans and Human Health [WHOI-A100354/A100360]; American Lebanese Syrian Associated Charities, St. Jude Children's Research Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073660, R01AI040522, R21AI082390] Funding Source: NIH RePORTER	National Institutres of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Science Foundation Woods Hole Center for Oceans and Human Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities, St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank William Morgan, Christina Evola, and Jessica Roberts-Misterly for excellent technical assistance. We also thank Fred Lewis and the National Institute of Allergy and Infectious Diseases Schistosome Resource Center for supplying the schistosome life cycle. Flow cytometry experiments were performed at the Flow Cytometry Core Facility at the University of Pennsylvania School of Veterinary Medicine. This work was supported by National Institutres of Health (NIH) grants R01 AI-40522 and R01 AI-73660 (to R. M. G.). R. M. G. and S. M. M. were also supported in part by NIH/National Science Foundation Woods Hole Center for Oceans and Human Health grant WHOI-A100354/A100360. Support was also received from the NIH Biocurrents Research Center at the Marine Biological Laboratory (P41 RR-001395). This work was also supported in part by the American Lebanese Syrian Associated Charities, St. Jude Children's Research Hospital.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; ANDREWS P, 1985, PHARMACOL THERAPEUT, V29, P129, DOI 10.1016/0163-7258(85)90020-8; Angelucci F, 2007, PARASITOLOGY, V134, P1215, DOI 10.1017/S0031182007002600; Aragon AD, 2009, MOL BIOCHEM PARASIT, V164, P57, DOI 10.1016/j.molbiopara.2008.11.007; Blackhall WJ, 2008, VET PARASITOL, V152, P101, DOI 10.1016/j.vetpar.2007.12.001; Bonn D, 2004, LANCET INFECT DIS, V4, P190, DOI 10.1016/S1473-3099(04)00986-7; BOSCH IB, 1994, MOL BIOCHEM PARASIT, V65, P351, DOI 10.1016/0166-6851(94)90085-X; Bourguinat C, 2008, MOL BIOCHEM PARASIT, V158, P101, DOI 10.1016/j.molbiopara.2007.11.017; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Day TA, 2006, PARASITIC FLATWORMS: MOLECULAR BIOLOGY, BIOCHEMISTRY, IMMUNOLOGY AND PHYSIOLOGY, P256, DOI 10.1079/9780851990279.0256; DAY TA, 1992, PARASITOL TODAY, V8, P342, DOI 10.1016/0169-4758(92)90070-I; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1; Gnanasekar M, 2009, ANTIMICROB AGENTS CH, V53, P1054, DOI 10.1128/AAC.01222-08; Greenberg RM, 2005, PARASITOLOGY, V131, pS97, DOI 10.1017/S0031182005008346; Greenway GM, 2005, CHEM WORLD-UK, V2, P9; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Hayeshi R, 2006, EUR J PHARM SCI, V29, P70, DOI 10.1016/j.ejps.2006.05.009; Jeziorski MC, 2000, J EXP BIOL, V203, P841; Jeziorski MC, 2006, INT J PARASITOL, V36, P625, DOI 10.1016/j.ijpara.2006.02.002; Jones PM, 2005, INT J PARASITOL, V35, P555, DOI 10.1016/j.ijpara.2005.01.012; Kerboeuf D, 2003, INT J ANTIMICROB AG, V22, P332, DOI 10.1016/S0924-8579(03)00221-8; Kohler S, 2003, BIOTECHNOL BIOENG, V81, P507, DOI 10.1002/bit.10488; Kusel JR, 2006, MEM I OSWALDO CRUZ, V101, P293, DOI 10.1590/S0074-02762006000900046; Kusell JR, 2009, TRENDS PARASITOL, V25, P353, DOI 10.1016/j.pt.2009.05.003; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Lespine A, 2008, TRENDS PARASITOL, V24, P293, DOI 10.1016/j.pt.2008.03.011; Messerli SM, 2009, MOL BIOCHEM PARASIT, V167, P54, DOI 10.1016/j.molbiopara.2009.04.007; Oliveira FA, 2006, PARASITOLOGY, V132, P321, DOI 10.1017/S0031182005009169; Paulsen IT, 2003, CURR OPIN MICROBIOL, V6, P446, DOI 10.1016/j.mib.2003.08.005; Pica-Mattoccia L, 2008, EXP PARASITOL, V119, P332, DOI 10.1016/j.exppara.2008.03.012; Redman CA, 1996, PARASITOL TODAY, V12, P14, DOI 10.1016/0169-4758(96)80640-5; Sangster NC, 1999, EXP PARASITOL, V91, P250, DOI 10.1006/expr.1998.4373; Sato H, 2004, PARASITOLOGY, V128, P43, DOI 10.1017/S0031182003004177; Sato H, 2002, PARASITOLOGY, V125, P527, DOI 10.1017/S0031182002002536; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Shapiro AB, 1998, ACTA PHYSIOL SCAND, V163, P227; Tallima H, 2007, INT J ANTIMICROB AG, V29, P570, DOI 10.1016/j.ijantimicag.2006.12.018; Valderramos SG, 2006, TRENDS PHARMACOL SCI, V27, P594, DOI 10.1016/j.tips.2006.09.005; Walter M., 2003, US Patent, Patent No. [6,514,963 B2, 6514963]; Xu M, 1998, MOL BIOCHEM PARASIT, V91, P327, DOI 10.1016/S0166-6851(97)00215-6; Zhou SF, 2008, CURR MED CHEM, V15, P1981, DOI 10.2174/092986708785132870	44	27	29	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					128	135		10.1096/fj.09-137091	http://dx.doi.org/10.1096/fj.09-137091			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19726755	Green Published			2022-12-25	WOS:000273233600015
J	Liu, RJ; Ramani, B; Soto, D; De Arcangelis, V; Xiang, Y				Liu, Ruijie; Ramani, Biswarathan; Soto, Dagoberto; De Arcangelis, Vania; Xiang, Yang			Agonist Dose-dependent Phosphorylation by Protein Kinase A and G Protein-coupled Receptor Kinase Regulates beta(2) Adrenoceptor Coupling to G(i) Proteins in Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-ADRENERGIC RECEPTOR; CARDIAC MYOCYTES; CELL-DEATH; DESENSITIZATION; BINDING; STIMULATION; TRAFFICKING; ACTIVATION; ARRESTINS; MICE	Adrenoceptors receptors (ARs) play a pivotal role in regulating cardiovascular response to catecholamines during stress. beta(2)ARs, prototypical G protein-coupled receptors (GPCRs), expressed in animal hearts, display dual coupling to both G(s) and G(i) proteins to control the adenylyl cyclase-cAMP dependent protein kinase A (PKA) pathway to regulate contraction responses. Here, we showed that the beta(2)AR coupling to G(i) proteins was agonist dose-dependent and occurred only at high concentrations in mouse cardiac myocytes. Both the beta(2)AR-induced PKA activity, measured by fluorescence resonance energy transfer (FRET) imaging, and the increase in myocyte contraction rate displayed sensitivity to the G(i) inhibitor pertussis toxin (PTX). Further studies revealed that activated beta(2)ARs underwent PKA phosphorylation at a broad range of agonist concentrations. Disruption of the PKA phosphorylation sites on the beta(2)AR blocked receptor/G(i) coupling. However, a sufficient beta 2AR/G(i) coupling was also dependent on the G protein-coupled receptor kinase (GRK)-mediated phosphorylation of the receptors, which only occurred at high concentrations of agonist (>= 100 nM). Disruption of the GRK phosphorylation sites on the beta(2)AR blocked receptor internalization and coupling to G(i) proteins, probably by preventing the receptor's transportation to access G(i) proteins. Furthermore, neither PKA nor GRK site mutated receptors displayed sensitivity to the G(i)-specific inhibitor, G(i)CT. Together, our studies revealed distinct roles of PKA and GRK phosphorylation of the beta(2)AR for agonist dose-dependent coupling to G(i) proteins in cardiac myocytes, which may protect cells from overstimulation under high concentrations of catecholamines.	[Liu, Ruijie; Ramani, Biswarathan; Soto, Dagoberto; De Arcangelis, Vania] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Xiang, Yang] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Xiang, Y (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, 523 Burrill Hall,407 S Goodwin Ave, Urbana, IL 61801 USA.	kevinyx@illinois.edu	Soto, Dagoberto I/N-6817-2014	Soto, Dagoberto I/0000-0002-7350-1530; liu, ruijie/0000-0002-2468-0579	National Institutes of Health [HL082846, AHA 0635331N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL082846 and AHA 0635331N (to Y.X.).	ASANO T, 1984, J BIOL CHEM, V259, P9351; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Chesley A, 2000, CIRC RES, V87, P1172, DOI 10.1161/01.RES.87.12.1172; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; DeGeorge BR, 2008, CIRCULATION, V117, P1378, DOI 10.1161/CIRCULATIONAHA.107.752618; Devic E, 2001, MOL PHARMACOL, V60, P577; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Geng YJ, 1999, CIRC RES, V84, P34; HAUSDORFF WP, 1990, SYM SOC EXP BIOL, V44, P225; Iyer V, 2006, BRIT J PHARMACOL, V147, P249, DOI 10.1038/sj.bjp.0706551; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Singh K, 2001, J CELL PHYSIOL, V189, P257, DOI 10.1002/jcp.10024; Soto D, 2009, CIRC RES, V104, P770, DOI 10.1161/CIRCRESAHA.108.187880; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Tepe NM, 2000, J RECEPT SIGNAL TR R, V20, P75, DOI 10.3109/10799890009150038; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Wang Y, 2008, J BIOL CHEM, V283, P1799, DOI 10.1074/jbc.M705747200; Wang YY, 2007, MOL PHARMACOL, V72, P429, DOI 10.1124/mol.107.037747; Xiang Y, 2003, P NATL ACAD SCI USA, V100, P10776, DOI 10.1073/pnas.1831718100; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Xiao R P, 2001, Sci STKE, V2001, pre15, DOI 10.1126/stke.2001.104.re15; Zamah AM, 2002, J BIOL CHEM, V277, P31249, DOI 10.1074/jbc.M202753200; Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326; Zhu WZ, 2001, P NATL ACAD SCI USA, V98, P1607, DOI 10.1073/pnas.98.4.1607	27	47	48	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32279	32287		10.1074/jbc.M109.021428	http://dx.doi.org/10.1074/jbc.M109.021428			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19706594	hybrid, Green Published			2022-12-25	WOS:000272028400009
J	Hoover, AC; Strand, GL; Nowicki, PN; Anderson, ME; Vermeer, PD; Klingelhutz, AJ; Bossler, AD; Pottala, JV; Hendriks, WJAJ; Lee, JH				Hoover, A. C.; Strand, G. L.; Nowicki, P. N.; Anderson, M. E.; Vermeer, P. D.; Klingelhutz, A. J.; Bossler, A. D.; Pottala, J. V.; Hendriks, W. J. A. J.; Lee, J. H.			Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling through the MAP kinase pathway	ONCOGENE			English	Article						human papilloma virus; HPV E6 oncogene; PTPN13; MAP Kinase; ErbB2	TUMOR-SUPPRESSOR GENE; ANCHORAGE-INDEPENDENT GROWTH; ORAL MEK INHIBITOR; HEPATOCELLULAR-CARCINOMA; HUMAN-PAPILLOMAVIRUS; PROGNOSTIC IMPACT; EPITHELIAL-CELLS; INVASIVE GROWTH; CERVICAL-CANCER; FACTOR RECEPTOR	Human papillomaviruses (HPVs) are a causative factor in over 90% of cervical and 25% of head and neck squamous cell carcinomas (HNSCCs). The C terminus of the high-risk HPV 16 E6 oncoprotein physically associates with and degrades a non-receptor protein tyrosine phosphatase (PTPN13), and PTPN13 loss synergizes with H-Ras(V12) or ErbB2 for invasive growth in vivo. Oral keratinocytes that have lost PTPN13 and express H-Ras(V12) or ErbB2 show enhanced Ras/RAF/MEK/Erk signaling. In co-transfection studies, wild-type PTPN13 inhibited Ras/RAF/MEK/Erk signaling in HEK 293 cells that overexpress ErbB2, EGFR or H-Ras(V12), whereas an enzymatically inactive PTPN13 did not. Twenty percent of HPV-negative HNSCCs had PTPN13 phosphatase mutations that did not inhibit Ras/RAF/MEK/Erk signaling. Inhibition of Ras/RAF/MEK/Erk signaling using MEK inhibitor U0126 blocked anchorage-independent growth in cells lacking PTPN13. These findings show that PTPN13 phosphatase activity has a physiologically significant role in regulating MAP kinase signaling. Oncogene (2009) 28, 3960-3970; doi:10.1038/onc.2009.251; published online 7 September 2009	[Hoover, A. C.; Anderson, M. E.] Univ Iowa, Dept Otolaryngol Head & Neck Surg, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Strand, G. L.; Bossler, A. D.] Univ Iowa, Dept Pathol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Vermeer, P. D.; Pottala, J. V.; Lee, J. H.] Sanford Res USD, Canc Biol Res Ctr, Sioux Falls, SD USA; [Klingelhutz, A. J.] Univ Iowa, Dept Microbiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Hendriks, W. J. A. J.] Radboud Univ Nijmegen, Med Ctr, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands; [Lee, J. H.] Sanford Hlth, Sanford ENT Head & Neck Surg, Sioux Falls, SD USA	University of Iowa; University of Iowa; Sanford Health; University of Iowa; Radboud University Nijmegen; Sanford Health	Lee, JH (corresponding author), Sanford HPV Res Inst, Dept Otolaryngol, 1310 22nd St, Sioux Falls, SD 57105 USA.	leej@sanfordhealth.org	Klingelhutz, Aloysius/L-9081-2018; Hendriks, Wiljan J.A.J./A-5214-2013; Hendriks, Wiljan/Q-4325-2019; Vermeer, Paola D/O-2572-2013	Klingelhutz, Aloysius/0000-0003-4258-5046; Hendriks, Wiljan J.A.J./0000-0001-9481-8281; Hendriks, Wiljan/0000-0001-9481-8281; Bossler, Aaron/0000-0002-8748-2510	NIDCR [1R01DE018386-01A1]; HHMI; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018386] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	JHL was supported by an NIDCR 1R01DE018386-01A1 and ACH was supported by an HHMI medical student fellowship. We acknowledge Jan Schepens' technical expertise for completing the phosphatase assays and Catherine Christopherson for manuscript preparation.	Abaan OD, 2008, CANCER METAST REV, V27, P205, DOI 10.1007/s10555-008-9114-2; Adjei AA, 2008, J CLIN ONCOL, V26, P2139, DOI 10.1200/JCO.2007.14.4956; Al Moustafa AE, 2004, ONCOGENE, V23, P350, DOI 10.1038/sj.onc.1207148; Avila MA, 2006, ONCOGENE, V25, P3866, DOI 10.1038/sj.onc.1209550; Barault L, 2008, INT J CANCER, V122, P2255, DOI 10.1002/ijc.23388; Cavalot A, 2007, HEAD NECK-J SCI SPEC, V29, P655, DOI 10.1002/hed.20574; Dromard M, 2007, CANCER RES, V67, P6806, DOI 10.1158/0008-5472.CAN-07-0513; Erdmann KS, 2003, EUR J BIOCHEM, V270, P4789, DOI 10.1046/j.1432-1033.2003.03895.x; Landro ME, 2008, J MED VIROL, V80, P694, DOI 10.1002/jmv.21076; Ford AC, 2003, HEAD NECK-J SCI SPEC, V25, P67, DOI 10.1002/hed.10224; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hardisson D, 2003, EUR ARCH OTO-RHINO-L, V260, P502, DOI 10.1007/s00405-003-0581-3; Hopfner M, 2008, WORLD J GASTROENTERO, V14, P1, DOI 10.3748/wjg.14.1; Hoover AC, 2007, ARCH OTOLARYNGOL, V133, P495, DOI 10.1001/archotol.133.5.495; Hsu J. C, 1992, J COMPUTATIONAL STAT, V1, P151, DOI DOI 10.2307/1390839; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Lee JH, 1996, GYNECOL ONCOL, V62, P49, DOI 10.1006/gyno.1996.0188; Longworth MS, 2004, MICROBIOL MOL BIOL R, V68, P362, DOI 10.1128/MMBR.68.2.362-372.2004; LoRusso PM, 2005, J CLIN ONCOL, V23, P5281, DOI 10.1200/JCO.2005.14.415; Lu SL, 2006, GENE DEV, V20, P1331, DOI 10.1101/gad.1413306; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Nakahira M, 2007, IMMUNITY, V26, P163, DOI 10.1016/j.immuni.2007.01.010; Perez-Regadera J, 2009, ONCOLOGY-BASEL, V76, P133, DOI 10.1159/000195539; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Revillion F, 2009, INT J CANCER, V124, P638, DOI 10.1002/ijc.23989; Rinehart J, 2004, J CLIN ONCOL, V22, P4456, DOI 10.1200/JCO.2004.01.185; Schreiber K, 2004, ONCOGENE, V23, P3972, DOI 10.1038/sj.onc.1207507; Spanos WC, 2008, J VIROL, V82, P2493, DOI 10.1128/JVI.02188-07; Spanos WC, 2008, HEAD NECK-J SCI SPEC, V30, P139, DOI 10.1002/hed.20673; Villa F, 2005, J BIOL CHEM, V280, P8180, DOI 10.1074/jbc.M412211200; Wang D, 2007, BBA-MOL CELL RES, V1773, P1248, DOI 10.1016/j.bbamcr.2006.11.009; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Wansink DG, 2004, PHYSIOL GENOMICS, V19, P50, DOI 10.1152/physiolgenomics.00079.2004; YARBROUGH WG, 1994, LARYNGOSCOPE, V104, P1337; Yeh SH, 2006, CLIN CANCER RES, V12, P1097, DOI 10.1158/1078-0432.CCR-05-1383; Ying J, 2006, LEUKEMIA, V20, P1173, DOI 10.1038/sj.leu.2404193; Zhu JH, 2008, ONCOGENE, V27, P2525, DOI 10.1038/sj.onc.1210922	39	55	55	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 12	2009	28	45					3960	3970		10.1038/onc.2009.251	http://dx.doi.org/10.1038/onc.2009.251			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	530AC	19734941	Green Accepted			2022-12-25	WOS:000272560300002
J	Klundt, T; Bocola, M; Lutge, M; Beuerle, T; Liu, BY; Beerhues, L				Klundt, Tim; Bocola, Marco; Luetge, Maren; Beuerle, Till; Liu, Benye; Beerhues, Ludger			A Single Amino Acid Substitution Converts Benzophenone Synthase into Phenylpyrone Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III POLYKETIDE SYNTHASES; CENTAURIUM-ERYTHRAEA RAFN; CHAIN-LENGTH CONTROL; CHALCONE SYNTHASE; HYPERICUM-ANDROSAEMUM; CELL-CULTURES; SWISS-MODEL; FORCE-FIELD; BIOSYNTHESIS; PLANT	Benzophenone metabolism provides a number of plant natural products with fascinating chemical structures and intriguing pharmacological activities. Formation of the carbon skeleton of benzophenone derivatives from benzoyl-CoA and three molecules of malonyl-CoA is catalyzed by benzophenone synthase (BPS), a member of the superfamily of type III polyketide synthases. A point mutation in the active site cavity (T135L) transformed BPS into a functional phenylpyrone synthase (PPS). The dramatic change in both substrate and product specificities of BPS was rationalized by homology modeling. The mutation may open a new pocket that accommodates the phenyl moiety of the triketide intermediate but limits polyketide elongation to two reactions, resulting in phenylpyrone formation. 3-Hydroxybenzoyl-CoA is the second best starter molecule for BPS but a poor substrate for PPS. The aryl moiety of the triketide intermediate may be trapped in the new pocket by hydrogen bond formation with the backbone, thereby acting as an inhibitor. PPS is a promising biotechnological tool for manipulating benzoate-primed biosynthetic pathways to produce novel compounds.	[Liu, Benye] Chinese Acad Sci, Key Lab Photosynth & Environm Mol Physiol, Inst Bot, Beijing 100093, Peoples R China; Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmaceut Biol, D-38106 Braunschweig, Germany; [Bocola, Marco] Max Planck Inst Coal Res, D-45470 Mulheim, Germany	Chinese Academy of Sciences; Institute of Botany, CAS; Braunschweig University of Technology; Max Planck Society	Liu, BY (corresponding author), Chinese Acad Sci, Key Lab Photosynth & Environm Mol Physiol, Inst Bot, Nanxincun 20, Beijing 100093, Peoples R China.	benyel@ibcas.ac.cn; l.beerhues@tu-bs.de	Liu, Benye/AAF-4840-2020	Beuerle, Till/0000-0001-5037-6653; Liu, Benye/0000-0001-8527-565X; Beerhues, Ludger/0000-0002-2147-2731	Deutsche Forschungsgemeinschaft [SPP 1152]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Priority Programme "Evolution of Metabolic Diversity" (SPP 1152) of the Deutsche Forschungsgemeinschaft.	Abd El-Mawla AMA, 2002, PLANTA, V214, P727, DOI 10.1007/s004250100657; Abd El-Mawla AMA, 2001, PLANTA, V212, P288, DOI 10.1007/s004250000394; Abe I, 2006, FEBS J, V273, P208, DOI 10.1111/j.1742-4658.2005.05059.x; Abe I, 2005, J AM CHEM SOC, V127, P12709, DOI 10.1021/ja053945v; Abe I, 2001, EUR J BIOCHEM, V268, P3354, DOI 10.1046/j.1432-1327.2001.02255.x; Abe I, 2007, J AM CHEM SOC, V129, P5976, DOI 10.1021/ja070375l; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Austin MB, 2004, CHEM BIOL, V11, P1179, DOI 10.1016/j.chembiol.2004.05.024; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Beerhues L, 1996, FEBS LETT, V383, P264, DOI 10.1016/0014-5793(96)00265-7; DURL L, 2004, FITOTERAPIA, V75, P520; Eckermann S, 1998, NATURE, V396, P387, DOI 10.1038/24652; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Gerber PR, 1998, J COMPUT AID MOL DES, V12, P37, DOI 10.1023/A:1007902804814; GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456; Gronquist M, 2001, P NATL ACAD SCI USA, V98, P13745, DOI 10.1073/pnas.231471698; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Helariutta Y, 1996, P NATL ACAD SCI USA, V93, P9033, DOI 10.1073/pnas.93.17.9033; Hong JG, 2006, CARCINOGENESIS, V27, P278, DOI 10.1093/carcin/bgi208; Hu LH, 2000, TETRAHEDRON, V56, P1379, DOI 10.1016/S0040-4020(00)00010-7; Jez JM, 2002, P NATL ACAD SCI USA, V99, P5319, DOI 10.1073/pnas.082590499; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; Jez JM, 2001, BIOCHEMISTRY-US, V40, P14829, DOI 10.1021/bi015621z; JUNGHANNS KT, 1995, PLANT MOL BIOL, V27, P681, DOI 10.1007/BF00020222; LEETE E, 1982, TETRAHEDRON LETT, V23, P2635, DOI 10.1016/S0040-4039(00)87416-X; Liu B, 2007, PLANTA, V225, P1495, DOI 10.1007/s00425-006-0435-5; Liu BY, 2003, PLANT J, V34, P847, DOI 10.1046/j.1365-313X.2003.01771.x; MCINNES AG, 1965, TETRAHEDRON, V21, P2939, DOI 10.1016/S0040-4020(01)98380-2; Moore BS, 2002, NAT PROD REP, V19, P70, DOI 10.1039/b003939j; Morita H, 2007, CHEM BIOL, V14, P359, DOI 10.1016/j.chembiol.2007.02.003; Peters S, 1998, PLANTA, V204, P64, DOI 10.1007/s004250050230; PRASAD JVNV, 1995, J AM CHEM SOC, V117, P11070, DOI 10.1021/ja00150a005; Rebecca W, 2003, PHYTOCHEM ANALYSIS, V14, P83, DOI 10.1002/pca.682; Schroder J., 1999, COMPREHENSIVE NATURA, V1, P749, DOI DOI 10.1016/b978-0-08-091283-7.00029-1; Yamazaki Y, 2001, PLANTA, V214, P75, DOI 10.1007/s004250100586; Yoshida K, 2005, CANCER LETT, V221, P29, DOI 10.1016/j.canlet.2004.08.016; Zhang HZ, 2004, BIOORGAN MED CHEM, V12, P309, DOI 10.1016/j.bmc.2003.11.013	37	19	22	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30957	30964		10.1074/jbc.M109.038927	http://dx.doi.org/10.1074/jbc.M109.038927			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19710020	Green Published, hybrid			2022-12-25	WOS:000271378400025
J	De Rosa, L; Antonini, D; Ferone, G; Russo, MT; Yu, PB; Han, R; Missero, C				De Rosa, Laura; Antonini, Dario; Ferone, Giustina; Russo, Monia T.; Yu, Paul B.; Han, Rong; Missero, Caterina			p63 Suppresses Non-epidermal Lineage Markers in a Bone Morphogenetic Protein-dependent Manner via Repression of Smad7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOGENIC PROTEIN-1; HAIR FOLLICLE; SIGNALING PATHWAYS; GENE-EXPRESSION; I RECEPTORS; P53 HOMOLOG; STEM-CELLS; MOUSE; DIFFERENTIATION; TARGET	p63, a p53 family member, plays an essential role in epidermal development by regulating its transcriptional program. Here we report a previously uncovered role of p63 in controlling bone morphogenetic protein (BMP) signaling, which is required for maintaining low expression levels of several non-epidermal genes. p63 represses transcription of the inhibitory Smad7 and activates Bmp7, thereby sustaining BMP signaling. In the absence of p63, compromised BMP signaling leads to inappropriate non-epidermal gene expression in postnatal mouse keratinocytes and in embryonic epidermis. Reactivation of BMP signaling by Smad7 knockdown and/or, to a lesser extent, by BMP treatment suppresses expression of non-epidermal genes in the absence of p63. Canonical BMP/Smad signaling is essential for control of non-epidermal genes as use of a specific inhibitor, or simultaneous knockdown of Smad1 and Smad5 counteract suppression of non-epidermal genes. Our data indicate that p63 prevents ectopic expression of non-epidermal genes by a mechanism involving Smad7 repression and, to a lesser extent, Bmp7 induction, with consequent enhancement of BMP/Smad signaling.	[De Rosa, Laura; Antonini, Dario; Ferone, Giustina; Russo, Monia T.; Missero, Caterina] CEINGE Biotecnol Avanzate, I-80145 Naples, Italy; [De Rosa, Laura; Missero, Caterina] IRCCS Fdn SDN, I-80143 Naples, Italy; [Yu, Paul B.] Harvard Univ, Div Cardiol, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA; [Han, Rong] Harvard Univ, Cutaneous Biol Res Ctr, Massachusetts Gen Hosp, Sch Med, Charlestown, MA 02129 USA	CEINGE Biotecnologie Avanzate; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Missero, C (corresponding author), CEINGE Biotecnol Avanzate, Via Comunale Margherita 482, I-80145 Naples, Italy.	missero@ceinge.unina.it	Russo, Monia Teresa/AGI-3134-2022; Yu, Paul B./J-7540-2019; russo, monia t/Q-5774-2016; De Rosa, Laura/H-7504-2015	Yu, Paul B./0000-0003-2145-4944; russo, monia t/0000-0003-2001-5384; De Rosa, Laura/0000-0001-9020-8451; Missero, Caterina/0000-0003-0905-5123; Han, Rong/0000-0002-5766-8277	Italian Telethon Foundation [GGP06243]; National Foundation for Ectodermal Dysplasia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079943] Funding Source: NIH RePORTER	Italian Telethon Foundation(Fondazione Telethon); National Foundation for Ectodermal Dysplasia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Italian Telethon Foundation Grant GGP06243 and the National Foundation for Ectodermal Dysplasia.	Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Antonini D, 2006, MOL CELL BIOL, V26, P3308, DOI 10.1128/MCB.26.8.3308-3318.2006; Antonini D, 2008, J INVEST DERMATOL, V128, P1676, DOI 10.1038/jid.2008.12; AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Brancaccio A, 2004, HUM MOL GENET, V13, P2595, DOI 10.1093/hmg/ddh292; Della Gatta G, 2008, GENOME RES, V18, P939, DOI 10.1101/gr.073601.107; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Han GW, 2006, DEV CELL, V11, P301, DOI 10.1016/j.devcel.2006.06.014; He W, 2002, EMBO J, V21, P2580, DOI 10.1093/emboj/21.11.2580; Helton ES, 2006, J BIOL CHEM, V281, P2533, DOI 10.1074/jbc.M507964200; Hoover LL, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.146pe48; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Kobielak K, 2003, J CELL BIOL, V163, P609, DOI 10.1083/jcb.200309042; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Koster MI, 2007, P NATL ACAD SCI USA, V104, P3255, DOI 10.1073/pnas.0611376104; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Liu X, 2003, CANCER RES, V63, P7760; Liu XB, 2007, BBA-GENE STRUCT EXPR, V1769, P149, DOI 10.1016/j.bbaexp.2007.01.001; LYONS KM, 1989, GENE DEV, V3, P1657, DOI 10.1101/gad.3.11.1657; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mitu GM, 2007, AM J PHYSIOL-RENAL, V293, pF1641, DOI 10.1152/ajprenal.00179.2007; Mou C, 2006, P NATL ACAD SCI USA, V103, P9075, DOI 10.1073/pnas.0600825103; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Perez CA, 2007, CELL CYCLE, V6, P246, DOI 10.4161/cc.6.3.3801; Romano RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005623; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shukla A, 2008, MOL CANCER RES, V6, P509, DOI 10.1158/1541-7786.MCR-07-0396; Stern CD, 2006, CURR OPIN CELL BIOL, V18, P692, DOI 10.1016/j.ceb.2006.09.002; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki K, 2008, EUR J HUM GENET, V16, P36, DOI 10.1038/sj.ejhg.5201925; Takahashi H, 1996, DEV DYNAM, V207, P439, DOI 10.1002/(SICI)1097-0177(199612)207:4<439::AID-AJA8>3.0.CO;2-I; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; VERSCHUEREN K, 1995, MECH DEVELOP, V52, P109, DOI 10.1016/0925-4773(95)00395-H; Vukicevic S, 1998, J CLIN INVEST, V102, P202, DOI 10.1172/JCI2237; WALL NA, 1993, J CELL BIOL, V120, P493, DOI 10.1083/jcb.120.2.493; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Yabe T, 2002, J NEUROSCI RES, V68, P161, DOI 10.1002/jnr.10210; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; Yan WS, 2007, CANCER RES, V67, P9117, DOI 10.1158/0008-5472.CAN-07-0996; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018; Yang S, 2008, CANCER RES, V68, P198, DOI 10.1158/0008-5472.CAN-07-5074; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888	54	30	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30574	30582		10.1074/jbc.M109.049619	http://dx.doi.org/10.1074/jbc.M109.049619			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19717565	hybrid, Green Published			2022-12-25	WOS:000271090000060
J	Catalucci, D; Latronico, MVG; Ceci, M; Rusconi, F; Young, HS; Gallo, P; Santonastasi, M; Bellacosa, A; Brown, JH; Condorelli, G				Catalucci, Daniele; Latronico, Michael V. G.; Ceci, Marcello; Rusconi, Francesca; Young, Howard S.; Gallo, Paolo; Santonastasi, Marco; Bellacosa, Alfonso; Brown, Joan Heller; Condorelli, Gianluigi			At Increases Sarcoplasmic Reticulum Ca2+ Cycling by Direct Phosphorylation of Phospholamban at Thr(17)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-II; GROWTH-FACTOR-I; CARDIAC MYOCYTES; MYOCARDIAL-CONTRACTILITY; SER(16) PHOSPHORYLATION; MOLECULAR DETERMINANTS; TRANSGENIC MICE; HEART GROWTH; CELL-SIZE; AKT	Cardiomyocytes adapt to physical stress by increasing their size while maintaining cell function. The serine/threonine kinase Akt plays a critical role in this process of adaptation. We previously reported that transgenic overexpression of an active form of Akt (Akt-E40K) in mice results in increased cardiac contractility and cell size, as well as improved sarcoplasmic reticulum (SR) Ca2+ handling. Because it is not fully elucidated, we decided to study the molecular mechanism by which Akt-E40K overexpression improves SR Ca2+ handling. To this end, SR Ca2+ uptake and the phosphorylation status of phospholamban (PLN) were evaluated in heart extracts from wild-type and Akt-E40K mice and mice harboring inducible and cardiac specific knock-out of phosphatidylinositol-dependent kinase-1, the upstream activator of Akt. Moreover, the effect of Akt was assessed in vitro by overexpressing a mutant Akt targeted preferentially to the SR, and by biochemical assays to evaluate potential interaction with PLN. We found that when activated, Akt interacts with and phosphorylates PLN at Thr(17), the Ca2+-calmodulin-dependent kinase II delta site, whereas silencing Akt signaling, through the knock-out of phosphatidylinositol-dependent kinase-1, resulted in reduced phosphorylation of PLN at Thr(17). Furthermore, overexpression of SR-targeted Akt in cardiomyocytes improved Ca2+ handling without affecting cell size. Thus, we describe here a new mechanism whereby the preferential translocation of Akt to the SR is responsible for enhancement of contractility without stimulation of hypertrophy.	[Catalucci, Daniele; Rusconi, Francesca; Condorelli, Gianluigi] CNR, Ist Tecnol Biomed, I-20090 Milan, Italy; [Catalucci, Daniele; Latronico, Michael V. G.; Ceci, Marcello; Rusconi, Francesca; Gallo, Paolo; Santonastasi, Marco; Condorelli, Gianluigi] Ist Ric & Cura Carattere Sci Multimed, I-20138 Milan, Italy; [Catalucci, Daniele; Condorelli, Gianluigi] Univ Calif San Diego, Dept Med, Div Cardiol, La Jolla, CA 92093 USA; [Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Bellacosa, Alfonso] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Brown, Joan Heller] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of California System; University of California San Diego; University of Alberta; Fox Chase Cancer Center; University of California System; University of California San Diego	Catalucci, D (corresponding author), CNR, Ist Tecnol Biomed, Via Fratelli Cervi 93, I-20090 Milan, Italy.	daniele.catalucci@itb.cnr.it; gcondorelli@ucsd.edu	Catalucci, Daniele/AAA-6056-2022; Catalucci, Daniele/B-6745-2015; Latronico, Michael/AAB-3691-2019; Condorelli, Gianluigi/Q-6736-2017	Catalucci, Daniele/0000-0001-7041-6114; Catalucci, Daniele/0000-0001-7041-6114; Condorelli, Gianluigi/0000-0003-0481-6843; Ceci, Marcello/0000-0002-5066-1590; Latronico, Michele/0000-0003-4017-5764; Young, Howard/0000-0002-5990-8422	National Institutes of Health [HL078797-01A1]; Marie Curie International Fellowship; Italian Ministry of University and Research, the Italian Ministry of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie International Fellowship(European Commission); Italian Ministry of University and Research, the Italian Ministry of Health(Ministry of Health, Italy); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL078797-01A1. This work was also supported in part by a Marie Curie International Fellowship within the 6th European Framework Programme (to D. C.) and the Italian Ministry of University and Research, the Italian Ministry of Health.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Catalucci D, 2008, FRONT BIOSCI-LANDMRK, V13, P312, DOI 10.2741/2681; Catalucci D, 2006, CIRC RES, V99, P339, DOI 10.1161/01.RES.0000239409.90634.a9; Catalucci D, 2009, J CELL BIOL, V184, P923, DOI 10.1083/jcb.200805063; Ceci M, 2004, J MOL CELL CARDIOL, V37, P905, DOI 10.1016/j.yjmcc.2004.06.020; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Douglas JL, 2005, PROTEIN EXPRES PURIF, V40, P118, DOI 10.1016/j.pep.2004.11.015; Drago GA, 1998, ANN NY ACAD SCI, V853, P273, DOI 10.1111/j.1749-6632.1998.tb08278.x; Gao MH, 2008, J BIOL CHEM, V283, P33527, DOI 10.1074/jbc.M805825200; Hagemann D, 2000, J BIOL CHEM, V275, P22532, DOI 10.1074/jbc.C000253200; Ji Y, 2003, J BIOL CHEM, V278, P25063, DOI 10.1074/jbc.M302193200; Kanemitsu N, 2006, J HEART LUNG TRANSPL, V25, P1253, DOI 10.1016/j.healun.2006.05.012; Kim YK, 2003, J BIOL CHEM, V278, P47622, DOI 10.1074/jbc.M305909200; Luo WS, 1998, J BIOL CHEM, V273, P4734, DOI 10.1074/jbc.273.8.4734; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200; McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100; Morisco C, 2000, J BIOL CHEM, V275, P14466, DOI 10.1074/jbc.275.19.14466; Netticadan T, 1999, AM J PHYSIOL-CELL PH, V277, pC384, DOI 10.1152/ajpcell.1999.277.3.C384; PAGANI ED, 1984, METHOD PHARMACOL, V5, P49; Richey PA, 1998, J SPORT SCI, V16, P129; Rota M, 2005, CIRC RES, V97, P1332, DOI 10.1161/01.RES.0000196568.11624.ae; Said M, 2003, AM J PHYSIOL-HEART C, V285, pH1198, DOI 10.1152/ajpheart.00209.2003; SCHWORER CM, 1993, J BIOL CHEM, V268, P14443; Serneri GGN, 2001, CIRC RES, V89, P977, DOI 10.1161/hh2301.100982; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Shiojima I, 2002, J BIOL CHEM, V277, P37670, DOI 10.1074/jbc.M204572200; Sun H, 2006, CIRC RES, V98, P1390, DOI 10.1161/01.RES.0000223321.34482.8c; Yu J, 2006, ACTA PHARMACOL SIN, V27, P919, DOI 10.1111/j.1745-7254.2006.00388.x; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200	38	51	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28180	28187		10.1074/jbc.M109.036566	http://dx.doi.org/10.1074/jbc.M109.036566			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19696029	Green Published, hybrid			2022-12-25	WOS:000270676300045
J	Wozniak, KL; Ravi, S; Macias, S; Young, ML; Olszewski, MA; Steele, C; Wormley, FL				Wozniak, Karen L.; Ravi, Sailatha; Macias, Sandra; Young, Mattie L.; Olszewski, Michal A.; Steele, Chad; Wormley, Floyd L., Jr.			Insights into the Mechanisms of Protective Immunity against Cryptococcus neoformans Infection Using a Mouse Model of Pulmonary Cryptococcosis	PLOS ONE			English	Article								Cryptococcus neoformans is an opportunistic fungal pathogen that causes life-threatening pneumonia and meningoencephalitis in immune compromised individuals. Previous studies have shown that immunization of BALB/c mice with an IFN gamma-producing C. neoformans strain, H99 gamma, results in complete protection against a second pulmonary challenge with an otherwise lethal cryptococcal strain. The current study evaluated local anamnestic cell-mediated immune responses against pulmonary cryptococcosis in mice immunized with C. neoformans strain H99 gamma compared to mice immunized with heat-killed C. neoformans (HKC.n.). Mice immunized with C. neoformans strain H99 gamma had significantly reduced pulmonary fungal burden post-secondary challenge compared to mice immunized with HKC.n. Protection against pulmonary cryptococcosis was associated with increased pulmonary granulomatous formation and leukocyte infiltration followed by a rapid resolution of pulmonary inflammation, which protected the lungs from severe allergic bronchopulmonary mycosis (ABPM)-pathology that developed in the lungs of mice immunized with HKC.n. Pulmonary challenge of interleukin (IL)-4 receptor, IL-12p40, IL-12p35, IFN-gamma, T cell and B cell deficient mice with C. neoformans strain H99 gamma demonstrated a requirement for Th1-type T cell-mediated immunity, but not B cell-mediated immunity, for the induction of H99 gamma-mediated protective immune responses against pulmonary C. neoformans infection. CD4(+) T cells, CD11c(+) cells, and Gr-1(+) cells were increased in both proportion and absolute number in protected mice. In addition, significantly increased production of Th1-type/pro-inflammatory cytokines and chemokines, and conversely, reduced Th2-type cytokine production was observed in the lungs of protected mice. Interestingly, protection was not associated with increased production of cytokines IFN-gamma or TNF-alpha in lungs of protected mice. In conclusion, immunization with C. neoformans strain H99 gamma results in the development of protective anti-cryptococcal immune responses that may be measured and subsequently used in the development of immune-based therapies to combat pulmonary cryptococcosis.			Wozniak, KL (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX USA.	floyd.wormley@utsa.edu	RAVI, Sailatha/AAT-2514-2020	RAVI, Sailatha/0000-0002-5527-4805; OLSZEWSKI, MICHAL/0000-0001-7474-0843; Wozniak, Karen/0000-0003-1798-2146	NHLBI NIH HHS [R01 HL080317, HL080317] Funding Source: Medline; NIAID NIH HHS [R01 AI071752-03, R01 AI071752] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071752] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allendoerfer R, 1998, J IMMUNOL, V160, P6072; Allendoerfer Ruth, 1998, Revista Iberoamericana de Micologia, V15, P256; Arora S, 2005, J IMMUNOL, V174, P6346, DOI 10.4049/jimmunol.174.10.6346; Bauman SK, 2003, INFECT IMMUN, V71, P68, DOI 10.1128/IAI.71.1.68-74.2003; Biondo C, 2002, INFECT IMMUN, V70, P2383, DOI 10.1128/IAI.70.5.2383-2391.2002; Blackstock R, 1999, INFECT IMMUN, V67, P3601, DOI 10.1128/IAI.67.7.3601-3609.1999; BLASI E, 1994, INFECT IMMUN, V62, P3189, DOI 10.1128/IAI.62.8.3189-3196.1994; Buchanan KL, 2000, INFECT IMMUN, V68, P456, DOI 10.1128/IAI.68.2.456-462.2000; Cain JA, 1998, INFECT IMMUN, V66, P1473, DOI 10.1128/IAI.66.4.1473-1481.1998; Casadevall A, 2005, CURR MOL MED, V5, P421, DOI 10.2174/1566524054022567; CASADEVALL A, 1995, INFECT IMMUN, V63, P4211, DOI 10.1128/IAI.63.11.4211-4218.1995; Casadevall A, 1998, TRENDS MICROBIOL, V6, P102, DOI 10.1016/S0966-842X(98)01208-6; Chen GH, 2008, INFECT IMMUN, V76, P2379, DOI 10.1128/IAI.01143-07; Chen GH, 2007, AM J PATHOL, V170, P1028, DOI 10.2353/ajpath.2007.060595; CHUCK SL, 1989, NEW ENGL J MED, V321, P794, DOI 10.1056/NEJM198909213211205; CLEMONS KV, 1994, ANTIMICROB AGENTS CH, V38, P460, DOI 10.1128/AAC.38.3.460; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Cox GM, 2001, MOL MICROBIOL, V39, P166, DOI 10.1046/j.1365-2958.2001.02236.x; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Dalod M, 2003, J EXP MED, V197, P885, DOI 10.1084/jem.20021522; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Decken K, 1998, INFECT IMMUN, V66, P4994, DOI 10.1128/IAI.66.10.4994-5000.1998; Deepe GS, 2006, J INFECT DIS, V193, P322; DROMER F, 1987, INFECT IMMUN, V55, P749, DOI 10.1128/IAI.55.3.749-752.1987; Graybill JR, 1997, J MED VET MYCOL, V35, P243; Herring AC, 2002, INFECT IMMUN, V70, P2959, DOI 10.1128/IAI.70.6.2959-2964.2002; Herring AC, 2005, INFECT IMMUN, V73, P39, DOI 10.1128/IAI.73.1.39-49.2005; HILL JO, 1991, J EXP MED, V173, P755, DOI 10.1084/jem.173.3.755; Huang C, 2002, INFECT IMMUN, V70, P5485, DOI 10.1128/IAI.70.10.5485-5493.2002; Huffnagle GB, 1996, J IMMUNOL, V157, P4529; Huffnagle GB, 1998, RES IMMUNOL, V149, P387, DOI 10.1016/S0923-2494(98)80762-1; HUFFNAGLE GB, 1994, J LEUKOCYTE BIOL, V55, P35, DOI 10.1002/jlb.55.1.35; HUFFNAGLE GB, 1991, INFECT IMMUN, V59, P1423, DOI 10.1128/IAI.59.4.1423-1433.1991; HUFFNAGLE GB, 1991, J EXP MED, V173, P793, DOI 10.1084/jem.173.4.793; JOLY V, 1994, J INFECT DIS, V170, P1331, DOI 10.1093/infdis/170.5.1331; Kawakami K, 1996, CLIN EXP IMMUNOL, V106, P468, DOI 10.1046/j.1365-2249.1996.d01-870.x; Kawakami K, 1997, INFECT IMMUN, V65, P1307, DOI 10.1128/IAI.65.4.1307-1312.1997; Kawakami K, 1996, CLIN EXP IMMUNOL, V104, P208, DOI 10.1046/j.1365-2249.1996.14723.x; Kawakami K, 1996, FEMS IMMUNOL MED MIC, V13, P123, DOI 10.1016/0928-8244(95)00093-3; Kawakami K, 1997, J IMMUNOL, V159, P5528; Koguchi Yoshinobu, 2002, Int Rev Immunol, V21, P423, DOI 10.1080/08830180213274; Levitz SM, 2001, P NATL ACAD SCI USA, V98, P10422, DOI 10.1073/pnas.181331398; LEVITZ SM, 1991, REV INFECT DIS, V13, P1163; Luberto C, 2003, J CLIN INVEST, V112, P1080, DOI 10.1172/JCI200318309; Lutz JE, 2000, J ANTIMICROB CHEMOTH, V46, P437, DOI 10.1093/jac/46.3.437; Mandel MA, 2000, INFECT IMMUN, V68, P6196, DOI 10.1128/IAI.68.11.6196-6201.2000; Mednick AJ, 2003, EUR J IMMUNOL, V33, P1744, DOI 10.1002/eji.200323626; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; MODY CH, 1990, J IMMUNOL, V144, P1472; Mordue DG, 2003, J LEUKOCYTE BIOL, V74, P1015, DOI 10.1189/jlb.0403164; Muller U, 2007, J IMMUNOL, V179, P5367, DOI 10.4049/jimmunol.179.8.5367; MUKHERJEE J, 1993, P NATL ACAD SCI USA, V90, P3636, DOI 10.1073/pnas.90.8.3636; Murphy JW, 1998, INFECT IMMUN, V66, P2632, DOI 10.1128/IAI.66.6.2632-2639.1998; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Osterholzer JJ, 2008, J IMMUNOL, V181, P610, DOI 10.4049/jimmunol.181.1.610; Pappas PG, 2004, J INFECT DIS, V189, P2185, DOI 10.1086/420829; Santangelo R, 2004, INFECT IMMUN, V72, P2229, DOI 10.1128/IAI.72.4.2229-2239.2004; Shoham S, 2005, BRIT J HAEMATOL, V129, P569, DOI 10.1111/j.1365-2141.2005.05397.x; Singh N, 1997, CLIN TRANSPLANT, V11, P66; Singh N, 2008, CLIN INFECT DIS, V47, P1321, DOI 10.1086/592690; Voelz K, 2009, INFECT IMMUN; Wormley FL, 2007, INFECT IMMUN, V75, P1453, DOI 10.1128/IAI.00274-06; Wuthrich M, 2002, J IMMUNOL, V169, P6969, DOI 10.4049/jimmunol.169.12.6969; Yauch LE, 2006, PLOS PATHOG, V2, P1060, DOI 10.1371/journal.ppat.0020120; Young M, 2009, PROTEOMICS, V9, P2578, DOI 10.1002/pmic.200800713; Zhou P, 1998, J IMMUNOL, V160, P1359; Zhou Q, 2007, J IMMUNOL, V178, P5753, DOI 10.4049/jimmunol.178.9.5753	67	76	79	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6854	10.1371/journal.pone.0006854	http://dx.doi.org/10.1371/journal.pone.0006854			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19727388	gold, Green Published, Green Submitted			2022-12-25	WOS:000269522900006
J	Rosenblum, EB; Poorten, TJ; Settles, M; Murdoch, GK; Robert, J; Maddox, N; Eisen, MB				Rosenblum, Erica Bree; Poorten, Thomas J.; Settles, Matthew; Murdoch, Gordon K.; Robert, Jacques; Maddox, Nicole; Eisen, Michael B.			Genome-Wide Transcriptional Response of Silurana (Xenopus) tropicalis to Infection with the Deadly Chytrid Fungus	PLOS ONE			English	Article								Emerging infectious diseases are of great concern for both wildlife and humans. Several highly virulent fungal pathogens have recently been discovered in natural populations, highlighting the need for a better understanding of fungal-vertebrate host-pathogen interactions. Because most fungal pathogens are not fatal in the absence of other predisposing conditions, host-pathogen dynamics for deadly fungal pathogens are of particular interest. The chytrid fungus Batrachochytrium dendrobatidis (hereafter Bd) infects hundreds of species of frogs in the wild. It is found worldwide and is a significant contributor to the current global amphibian decline. However, the mechanism by which Bd causes death in amphibians, and the response of the host to Bd infection, remain largely unknown. Here we use whole-genome microarrays to monitor the transcriptional responses to Bd infection in the model frog species, Silurana (Xenopus) tropicalis, which is susceptible to chytridiomycosis. To elucidate the immune response to Bd and evaluate the physiological effects of chytridiomycosis, we measured gene expression changes in several tissues (liver, skin, spleen) following exposure to Bd. We detected a strong transcriptional response for genes involved in physiological processes that can help explain some clinical symptoms of chytridiomycosis at the organismal level. However, we detected surprisingly little evidence of an immune response to Bd exposure, suggesting that this susceptible species may not be mounting efficient innate and adaptive immune responses against Bd. The weak immune response may be partially explained by the thermal conditions of the experiment, which were optimal for Bd growth. However, many immune genes exhibited decreased expression in Bd-exposed frogs compared to control frogs, suggesting a more complex effect of Bd on the immune system than simple temperature-mediated immune suppression. This study generates important baseline data for ongoing efforts to understand differences in response to Bd between susceptible and resistant frog species and the effects of chytridiomycosis in natural populations.			Rosenblum, EB (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	rosenblum@uidaho.edu	Settles, Matthew L/F-2031-2011; Robert, Jacques/B-2179-2008	Settles, Matthew L/0000-0002-3424-1086; Robert, Jacques/0000-0003-4380-1476; Eisen, Michael/0000-0002-7528-738X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI059830] Funding Source: NIH RePORTER; NIAID NIH HHS [R24 AI059830, R24-AI-059830-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger L, 2005, DIS AQUAT ORGAN, V68, P47, DOI 10.3354/dao068047; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Blanco JL, 2008, VET IMMUNOL IMMUNOP, V125, P47, DOI 10.1016/j.vetimm.2008.04.020; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Daszak P, 2004, HERPETOL J, V14, P201; Dery MAC, 2005, INT J BIOCHEM CELL B, V37, P535, DOI 10.1016/j.biocel.2004.08.012; DUPASQUIER L, 1989, ANNU REV IMMUNOL, V7, P251, DOI 10.1146/annurev.immunol.7.1.251; DYMOCK IW, 1975, BRIT J HAEMATOL, V29, P385, DOI 10.1111/j.1365-2141.1975.tb01836.x; Evans BJ, 2007, GENETICS, V176, P1119, DOI 10.1534/genetics.106.069690; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Hung CY, 2005, INFECT IMMUN, V73, P6689, DOI 10.1128/IAI.73.10.6689-6703.2005; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kurtz J, 2007, ANIM CONSERV, V10, P422, DOI 10.1111/j.1469-1795.2007.00149.x; Letterio JJ, 2001, INFECT IMMUN, V69, P5115, DOI 10.1128/IAI.69.8.5115-5120.2001; LEWIS JH, 1989, HEPATOLOGY, V9, P710, DOI 10.1002/hep.1840090509; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Maniero GD, 1997, J COMP PHYSIOL B, V167, P256, DOI 10.1007/s003600050072; Masubuchi Y, 2004, DRUG METAB DISPOS, V32, P437, DOI 10.1124/dmd.32.4.437; MEIER E, 2003, T CELL DEV DIVERSIFI; Mescher AL, 2007, DEV COMP IMMUNOL, V31, P383, DOI 10.1016/j.dci.2006.07.001; Parker JM, 2002, COMPARATIVE MED, V52, P265; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Ramanayake T, 2007, TRANSPLANTATION, V83, P159, DOI 10.1097/01.tp.0000250562.35175.06; Richmond JQ, 2009, BIOSCIENCE, V59, P311, DOI 10.1525/bio.2009.59.4.9; Robert J, 2009, DEV DYNAM, V238, P1249, DOI 10.1002/dvdy.21891; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Rosenblum EB, 2008, P NATL ACAD SCI USA, V105, P17034, DOI 10.1073/pnas.0804173105; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Schaechter M., 1993, MECH MICROBIAL DIS; Schmid-Hempel P, 2009, PHILOS T R SOC B, V364, P85, DOI 10.1098/rstb.2008.0157; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Smith FJD, 2003, AM J CLIN DERMATOL, V4, P347, DOI 10.2165/00128071-200304050-00005; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; SMYTH GK, 2005, IIMMA LINEAR MODELS, P397; VANDERSAR AM, 2009, MOL IMMUNOL IN PRESS; Vogl G, 2008, MOL IMMUNOL, V45, P1485, DOI 10.1016/j.molimm.2007.08.011; Voyles J, 2007, DIS AQUAT ORGAN, V77, P113, DOI 10.3354/dao01838; WABL MR, 1976, NATURE, V264, P642, DOI 10.1038/264642a0; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2006, OECOLOGIA, V146, P531, DOI 10.1007/s00442-005-0228-8; Woods JP, 2003, CURR OPIN MICROBIOL, V6, P327, DOI 10.1016/S1369-5274(03)00080-8	50	74	75	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2009	4	8							e6494	10.1371/journal.pone.0006494	http://dx.doi.org/10.1371/journal.pone.0006494			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479CW	19701481	gold, Green Submitted, Green Published			2022-12-25	WOS:000268637800007
J	Ma, ZZ; Li, QF; An, HQ; Pankonin, MS; Wang, JJ; Loeb, JA				Ma, Zhenzhong; Li, Qunfang; An, Haiqian; Pankonin, Mark S.; Wang, Jiajing; Loeb, Jeffrey A.			Targeting Human Epidermal Growth Factor Receptor Signaling with the Neuregulin's Heparin-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTATIC BREAST-CANCER; EPITHELIAL-CELLS; NERVOUS-SYSTEM; IN-VIVO; HEREGULIN; TUMORIGENICITY; ANTIBODY; FORMS; ARIA; HER2	A major limitation in biopharmaceutical development is selectively targeting drugs to diseased tissues. Growth factors and viruses have solved this problem by targeting tissue-specific cell-surface heparan sulfates. Neuregulin (NRG), a growth factor important in both nervous system development and cancer, has a unique heparin-binding domain (HBD) that targets to cell surfaces expressing its HER2/3/4 receptors (Esper, R. M., Pankonin, M. S., and Loeb, J. A. (2006) Brain Res. Rev. 51, 161-175). We have harnessed this natural targeting ability of NRG by fusing the HBD of NRG to soluble HER4. This fusion protein retains high affinity heparin binding to heparin and to cells that express heparan sulfates resulting in a more potent NRG antagonist. In vivo, it is targeted to peripheral nerve segments where it blocks the activity of NRG as a Schwann cell survival factor. The fusion protein also efficiently blocks autocrine and paracrine signaling and reduces the proliferation of MCF10CA1 breast cancer cells. These findings demonstrate the utility of the HBD of NRG in biopharmaceutical targeting and provide a new way to block HER signaling in cancer cells.	[An, Haiqian; Loeb, Jeffrey A.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Loeb, JA (corresponding author), 421 E Canfield,3122 Elliman Bldg, Detroit, MI 48201 USA.	jloeb@med.wayne.edu	Ma, Zhenzhong/ABA-7242-2021; Ma, Zhenzhong Zack/AEO-1528-2022	Ma, Zhenzhong Zack/0000-0002-1235-3765	National Multiple Sclerosis Society [RG 3410B3]; Michigan Universities Commercialization Initiative	National Multiple Sclerosis Society(National Multiple Sclerosis Society); Michigan Universities Commercialization Initiative	This work was supported by the National Multiple Sclerosis Society (Grant RG 3410B3) and the Michigan Universities Commercialization Initiative.	Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Atlas E, 2003, MOL CANCER RES, V1, P165; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Esper RM, 2006, BRAIN RES REV, V51, P161, DOI 10.1016/j.brainresrev.2005.11.006; Esper RM, 2004, J NEUROSCI, V24, P6218, DOI 10.1523/JNEUROSCI.1692-04.2004; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gorsi B, 2007, TRENDS CELL BIOL, V17, P173, DOI 10.1016/j.tcb.2007.02.006; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Krane IM, 1996, ONCOGENE, V12, P1781; Li QF, 2004, CANCER RES, V64, P7078, DOI 10.1158/0008-5472.CAN-04-1152; Li QF, 2001, J BIOL CHEM, V276, P38068; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; LOEB JA, 1995, J CELL BIOL, V130, P127, DOI 10.1083/jcb.130.1.127; Loeb JA, 1999, DEVELOPMENT, V126, P781; Lupu R, 1996, BREAST CANCER RES TR, V38, P57, DOI 10.1007/BF01803784; Mahoney DJ, 2004, ANAL BIOCHEM, V330, P123, DOI 10.1016/j.ab.2004.03.055; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Montero JC, 2008, CLIN CANCER RES, V14, P3237, DOI 10.1158/1078-0432.CCR-07-5133; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Pankonin MS, 2009, BRAIN RES, V1258, P1, DOI 10.1016/j.brainres.2008.12.047; Pankonin MS, 2005, J BIOL CHEM, V280, P383, DOI 10.1074/jbc.M402645200; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Tsai MS, 2003, ONCOGENE, V22, P761, DOI 10.1038/sj.onc.1206130; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Winseck AK, 2002, J NEUROSCI, V22, P4509, DOI 10.1523/JNEUROSCI.22-11-04509.2002; Yao B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-99	31	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32108	32115		10.1074/jbc.M109.032714	http://dx.doi.org/10.1074/jbc.M109.032714			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19717564	Green Published, hybrid			2022-12-25	WOS:000271572700065
J	Yu, HB; Kunarso, G; Hong, FH; Stanton, LW				Yu, Hong-bing; Kunarso, Galih; Hong, Felicia Huimei; Stanton, Lawrence W.			Zfp206, Oct4, and Sox2 Are Integrated Components of a Transcriptional Regulatory Network in Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; PLURIPOTENCY; NANOG; MAINTENANCE; EXPRESSION; DNA	Zfp206 (recently renamed Zscan10) encodes a zinc finger transcription factor specifically expressed in human and mouse embryonic stem cells (ESC). It has been shown that Zfp206 is required to maintain ESC in an undifferentiated, pluripotent state. Presented here are data showing that Zfp206 works together with two other transcription factors, Oct4 and Sox2, which are also essential regulators of ESC pluripotency. We show that Zfp206 binds to the Oct4 promoter and directly regulates Oct4 expression. Genome-wide mapping of Zfp206-binding sites in ESC identifies more than 3000 target genes, many of which encode transcription factors that are also targeted for regulation by Oct4 and Sox2. In addition, we show that Zfp206 physically interacts with both Oct4 and Sox2. These data demonstrate that Zfp206 is a key component of the core transcriptional regulatory network and together with Oct4 and Sox2 regulates differentiation of ESC.	Natl Univ Singapore, Dept Biol Sci, Singapore 117542, Singapore; [Yu, Hong-bing; Hong, Felicia Huimei; Stanton, Lawrence W.] Genome Inst Singapore, Dept Cell & Dev Biol, Singapore 138672, Singapore; [Kunarso, Galih] Genome Inst Singapore, Dept Computat & Math Biol, Singapore 138672, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Stanton, LW (corresponding author), Genome Inst Singapore, Dept Cell & Dev Biol, 60 Biopolis St, Singapore 138672, Singapore.	stantonl@gis.a-star.edu.sg			Singapore's Agency for Science Technology and Research	Singapore's Agency for Science Technology and Research(Agency for Science Technology & Research (A*STAR))	This work was supported by Singapore's Agency for Science Technology and Research.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Davidson EH, 2008, P NATL ACAD SCI USA, V105, P20063, DOI 10.1073/pnas.0806007105; Edelstein LC, 2005, GENE, V359, P1, DOI 10.1016/j.gene.2005.06.022; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Lim LS, 2007, MOL BIOL CELL, V18, P1348, DOI 10.1091/mbc.E06-07-0624; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Pavesi G, 2001, Bioinformatics, V17 Suppl 1, pS207; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang ZX, 2007, STEM CELLS, V25, P2173, DOI 10.1634/stemcells.2007-0085; Wang ZX, 2007, J BIOL CHEM, V282, P12822, DOI 10.1074/jbc.M611814200; Wang ZX, 2008, STEM CELLS, V26, P2791, DOI 10.1634/stemcells.2008-0443; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhang W, 2006, NUCLEIC ACIDS RES, V34, P4780, DOI 10.1093/nar/gkl631; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200	22	48	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31327	31335		10.1074/jbc.M109.016162	http://dx.doi.org/10.1074/jbc.M109.016162			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740739	Green Published, hybrid			2022-12-25	WOS:000271378400059
J	Kang, DS; Kern, RC; Puthenveedu, MA; von Zastrow, M; Williams, JC; Benovic, JL				Kang, Dong Soo; Kern, Ronald C.; Puthenveedu, Manojkumar A.; von Zastrow, Mark; Williams, John C.; Benovic, Jeffrey L.			Structure of an Arrestin2-Clathrin Complex Reveals a Novel Clathrin Binding Domain That Modulates Receptor Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; CRYSTAL-STRUCTURE; VISUAL ARRESTIN; TERMINAL DOMAIN; ARRESTIN/CLATHRIN INTERACTION; MACROMOLECULAR STRUCTURES; ANOMALOUS DIFFRACTION; MODEL; AP-2	Non-visual arrestins play a pivotal role as adaptor proteins in regulating the signaling and trafficking of multiple classes of receptors. Although arrestin interaction with clathrin, AP-2, and phosphoinositides contributes to receptor trafficking, little is known about the configuration and dynamics of these interactions. Here, we identify a novel interface between arrestin2 and clathrin through x-ray diffraction analysis. The intrinsically disordered clathrin binding box of arrestin2 interacts with a groove between blades 1 and 2 in the clathrin beta-propeller domain, whereas an 8-amino acid splice loop found solely in the long isoform of arrestin2 (arrestin2L) interacts with a binding pocket formed by blades 4 and 5 in clathrin. The apposition of the two binding sites in arrestin2L suggests that they are exclusive and may function in higher order macromolecular structures. Biochemical analysis demonstrates direct binding of clathrin to the splice loop in arrestin2L, whereas functional analysis reveals that both binding domains contribute to the receptor-dependent redistribution of arrestin2L to clathrin-coated pits. Mutagenesis studies reveal that the clathrin binding motif in the splice loop is (L/I)(2)GXL. Taken together, these data provide a framework for understanding the dynamic interactions between arrestin2 and clathrin and reveal an essential role for this interaction in arrestin-mediated endocytosis.	[Williams, John C.] City Hope Natl Med Ctr, Dept Mol Med, Duarte, CA 91010 USA; [Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Puthenveedu, Manojkumar A.; von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Puthenveedu, Manojkumar A.; von Zastrow, Mark] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA	City of Hope; Jefferson University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Williams, JC (corresponding author), City Hope Natl Med Ctr, Dept Mol Med, 1500 E Duarte Rd, Duarte, CA 91010 USA.	JWilliams@coh.org; benovic@mail.jci.tju.edu	Puthenveedu, Manojkumar/A-3795-2016	Puthenveedu, Manojkumar/0000-0002-3177-4231	National Institutes of Health [GM047417, GM068857, DA010711]; Pennsylvania Department of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047417, R37GM047417, R01GM068857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010711, R37DA010711, R29DA010711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants GM047417 and GM068857 (to J. L. B.) and DA010711 (M. v. Z.). This project was also funded, in part, under a grant with the Pennsylvania Department of Health.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burtey A, 2007, TRAFFIC, V8, P914, DOI 10.1111/j.1600-0854.2007.00578.x; Carter JM, 2005, J MOL BIOL, V351, P865, DOI 10.1016/j.jmb.2005.06.048; Cheng YF, 2007, J MOL BIOL, V365, P892, DOI 10.1016/j.jmb.2006.10.036; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; Drake MT, 2000, J BIOL CHEM, V275, P6479, DOI 10.1074/jbc.275.9.6479; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Gaidarov I, 1999, EMBO J, V18, P871, DOI 10.1093/emboj/18.4.871; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Goodman OB, 1997, J BIOL CHEM, V272, P15017, DOI 10.1074/jbc.272.23.15017; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kern RC, 2009, BIOCHEMISTRY-US, V48, P7190, DOI 10.1021/bi900369c; Kim YM, 2002, J BIOL CHEM, V277, P16340, DOI 10.1074/jbc.M200678200; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Krupnick JG, 1997, J BIOL CHEM, V272, P15011, DOI 10.1074/jbc.272.23.15011; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Miele AE, 2004, NAT STRUCT MOL BIOL, V11, P242, DOI 10.1038/nsmb736; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; MORRIS SA, 1993, EMBO J, V12, P667, DOI 10.1002/j.1460-2075.1993.tb05700.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Orem NR, 2006, J CELL SCI, V119, P3141, DOI 10.1242/jcs.03052; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmitessa A, 2005, J BIOL CHEM, V280, P24649, DOI 10.1074/jbc.M502637200; Penn RB, 2001, J BIOL CHEM, V276, P32648, DOI 10.1074/jbc.M104143200; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Shih W, 1995, J BIOL CHEM, V270, P31083, DOI 10.1074/jbc.270.52.31083; Shilton BH, 2002, EUR J BIOCHEM, V269, P3801, DOI 10.1046/j.1432-1033.2002.03071.x; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; Terwilliger TC, 2004, ACTA CRYSTALLOGR D, V60, P2144, DOI 10.1107/S0907444904019535; Trapani S, 2008, ACTA CRYSTALLOGR D, V64, P11, DOI 10.1107/S0907444907044460; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200	59	84	85	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29860	29872		10.1074/jbc.M109.023366	http://dx.doi.org/10.1074/jbc.M109.023366			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19710023	Green Published, hybrid			2022-12-25	WOS:000270896800066
J	Roy, H; Ibba, M				Roy, Herve; Ibba, Michael			Broad Range Amino Acid Specificity of RNA-dependent Lipid Remodeling by Multiple Peptide Resistance Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSYL-PHOSPHATIDYLGLYCEROL; ANTIMICROBIAL PEPTIDES; BACILLUS-SUBTILIS; MEMBRANE; MPRF; DAPTOMYCIN; PROTEIN; SUSCEPTIBILITY; IDENTIFICATION; ADAPTATION	Aminoacylphosphatidylglycerol synthases (aaPGSs) are multiple peptide resistance factors that transfer amino acids from aminoacyl-tRNAs to phosphatidylglycerol (PG) in the cytoplasmic membrane. Aminoacylation of PG is used by bacteria to decrease the net negative charge of the cell envelope, diminishing affinity for charged molecules and allowing for adaptation to environmental changes. Lys-PGS, which transfers lysine to PG, is essential for the virulence of certain pathogens, providing resistance to both host cationic antimicrobial peptides and therapeutic antibiotics. Ala-PGS was also recently described, but little is known about the possible activities of other members of the highly diverse aaPGS family of proteins. Systematic deletion of the predicted membrane-inserted domains of several aaPGSs revealed that the carboxyl-terminal hydrophilic domain alone is sufficient for aminoacylphosphatidylglycerol transferase catalytic activity. In contrast to previously characterized aaPGSs, the Enterococcus faecium enzyme used an expanded repertoire of amino acids to modify PG with Ala, Arg, or Lys. Reexamination of previously characterized aaPGSs also revealed broader than anticipated substrate specificity, for example Bacillus subtilis Lys-PGS was shown to also catalyze Ala-PG synthesis. The relaxed substrate specificities of these aaPGSs allows for more elaborate remodeling of membrane lipids than previously thought, potentially providing bacteria that harbor these enzymes resistance to a broad spectrum of antibiotics and environmental stresses.	[Roy, Herve; Ibba, Michael] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Ibba, Michael] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Roy, Herve; Ibba, Michael] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ibba, M (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	ibba.1@osu.edu			National Institutes of Health [GM 65183]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 65183.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ataide SF, 2004, BIOCHEMISTRY-US, V43, P11836, DOI 10.1021/bi0490542; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P1079, DOI 10.1128/AAC.50.3.1079-1082.2006; DOSSANTO.JM, 1970, J BACTERIOL, V104, P611, DOI 10.1128/JB.104.2.611-619.1970; Fischer AE, 1999, J BIOL CHEM, V274, P37093, DOI 10.1074/jbc.274.52.37093; Hachmann AB, 2009, ANTIMICROB AGENTS CH, V53, P1598, DOI 10.1128/AAC.01329-08; Hendrickson TL, 2003, MOL B INT U, P34; Hogg J, 2008, PROTEIN EXPRES PURIF, V61, P163, DOI 10.1016/j.pep.2008.05.008; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jones T, 2008, ANTIMICROB AGENTS CH, V52, P269, DOI 10.1128/AAC.00719-07; Klein S, 2009, MOL MICROBIOL, V71, P551, DOI 10.1111/j.1365-2958.2008.06562.x; Komatsuzawa H, 2001, FEMS MICROBIOL LETT, V203, P49, DOI 10.1111/j.1574-6968.2001.tb10819.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LENNARZ WJ, 1966, P NATL ACAD SCI USA, V55, P934, DOI 10.1073/pnas.55.4.934; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lloyd AJ, 2008, J BIOL CHEM, V283, P6402, DOI 10.1074/jbc.M708105200; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; Nishi H, 2004, ANTIMICROB AGENTS CH, V48, P4800, DOI 10.1128/AAC.48.12.4800-4807.2004; Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067; Reeve WG, 2006, MICROBIOL-SGM, V152, P3049, DOI 10.1099/mic.0.28764-0; ROY H, 2009, IUBMB LIFE IN PRESS; Roy H, 2008, P NATL ACAD SCI USA, V105, P4667, DOI 10.1073/pnas.0800006105; Roy H, 2008, METHODS, V44, P164, DOI 10.1016/j.ymeth.2007.09.002; Roy H, 2009, MOL MICROBIOL, V71, P547, DOI 10.1111/j.1365-2958.2008.06563.x; Salzberg LI, 2008, J BACTERIOL, V190, P7797, DOI 10.1128/JB.00720-08; Samant S, 2009, J BACTERIOL, V191, P1311, DOI 10.1128/JB.01345-08; Sohlenkamp C, 2007, MOL PLANT MICROBE IN, V20, P1421, DOI 10.1094/MPMI-20-11-1421; Staubitz P, 2004, FEMS MICROBIOL LETT, V231, P67, DOI 10.1016/S0378-1097(03)00921-2; Thedieck K, 2006, MOL MICROBIOL, V62, P1325, DOI 10.1111/j.1365-2958.2006.05452.x; THOMPSON JD, 2003, CURRENT PROTOCOLS BI; Villet R, 2007, NUCLEIC ACIDS RES, V35, P6870, DOI 10.1093/nar/gkm778; Weidenmaier C, 2005, INFECT IMMUN, V73, P8033, DOI 10.1128/IAI.73.12.8033-8038.2005; Yang SJ, 2009, ANTIMICROB AGENTS CH, V53, P2636, DOI 10.1128/AAC.01415-08; Zemansky J, 2009, J BACTERIOL, V191, P3950, DOI 10.1128/JB.00016-09	36	50	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29677	29683		10.1074/jbc.M109.046367	http://dx.doi.org/10.1074/jbc.M109.046367			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19734140	Green Published, hybrid			2022-12-25	WOS:000270896800049
J	Yasuda, S; Kai, M; Imai, S; Takeishi, K; Taketomi, A; Toyota, M; Kanoh, H; Sakane, F				Yasuda, Satoshi; Kai, Masahiro; Imai, Shin-ichi; Takeishi, Kazuki; Taketomi, Akinobu; Toyota, Minoru; Kanoh, Hideo; Sakane, Fumio			Diacylglycerol Kinase eta Augments C-Raf Activity and B-Raf/C-Raf Heterodimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER; ACTIVATION; ZETA; IDENTIFICATION; MUTATIONS; MEMBRANE; GROWTH; ALPHA; DELTA; PHOSPHORYLATION	The Ras/B-Raf/C-Raf/MEK/ERK signaling cascade is critical for the control of many fundamental cellular processes, including proliferation, survival, and differentiation. This study demonstrated that small interfering RNA-dependent knockdown of diacylglycerol kinase eta (DGK eta) impaired the Ras/B-Raf/C-Raf/MEK/ERK pathway activated by epidermal growth factor (EGF) in HeLa cells. Conversely, the overexpression of DGK eta 1 could activate the Ras/B-Raf/C-Raf/MEK/ERK pathway in a DGK activity-independent manner, suggesting that DGK eta serves as a scaffold/adaptor protein. By determining the activity of all the components of the pathway in DGK eta-silenced HeLa cells, this study revealed that DGK eta activated C-Raf but not B-Raf. Moreover, this study demonstrated that DGK eta enhanced EGF-induced heterodimerization of C-Raf with B-Raf, which transmits the signal to C-Raf. DGK eta physically interacted with B-Raf and C-Raf, regulating EGF-induced recruitment of B-Raf and C-Raf from the cytosol to membranes. The DGK eta-dependent activation of C-Raf occurred downstream or independently of the already known C-Raf modifications, such as dephosphorylation at Ser-259, phosphorylation at Ser-338, and interaction with 14-3-3 protein. Taken together, the results obtained strongly support that DGK eta acts as a novel critical regulatory component of the Ras/B-Raf/C-Raf/MEK/ERK signaling cascade via a previously unidentified mechanism.	[Kanoh, Hideo] Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Sakane, Fumio] Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, Chiba 2638522, Japan; [Takeishi, Kazuki; Taketomi, Akinobu] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan	Sapporo Medical University; Chiba University; Kyushu University		sayasu@sapmed.ac.jp; sakane@faculty.chiba-u.jp	Takeishi, Kazuki/AAC-9087-2019; Sakane, Fumio/H-2693-2017	Takeishi, Kazuki/0000-0002-8448-5396; Sakane, Fumio/0000-0003-0857-0377; YASUDA, Satoshi/0000-0002-1011-0815	Ministry of Education, Culture, Sports, Science and Technology of Japan; Northern Advancement Center for Science and Technology of Hokkaido, Japan; Japan Diabetes Foundation; Suhara Memorial Foundation; Novo Nordisk Pharma Ltd. (Japan); Takeda Science Foundation; Suzuken Memorial Foundation; Akiyama Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Northern Advancement Center for Science and Technology of Hokkaido, Japan; Japan Diabetes Foundation; Suhara Memorial Foundation; Novo Nordisk Pharma Ltd. (Japan)(Novo Nordisk); Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation; Akiyama Foundation	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Northern Advancement Center for Science and Technology of Hokkaido, Japan, the Japan Diabetes Foundation, The Suhara Memorial Foundation, Novo Nordisk Pharma Ltd. (Japan), The Takeda Science Foundation, The Suzuken Memorial Foundation, and The Akiyama Foundation.	Balan V, 2006, MOL BIOL CELL, V17, P1141, DOI 10.1091/mbc.E04-12-1123; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; Crotty T, 2006, P NATL ACAD SCI USA, V103, P15485, DOI 10.1073/pnas.0604104103; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Fischer A, 2009, J BIOL CHEM, V284, P3183, DOI 10.1074/jbc.M804795200; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Hagemann C, 1999, EXP CELL RES, V253, P34, DOI 10.1006/excr.1999.4689; Imai S, 2005, J BIOL CHEM, V280, P39870, DOI 10.1074/jbc.M500669200; Imai S, 2002, J BIOL CHEM, V277, P35323, DOI 10.1074/jbc.M202035200; Karbowniczek M, 2006, J BIOL CHEM, V281, P25447, DOI 10.1074/jbc.M605273200; Kawasaki T, 2008, BIOCHEM J, V409, P471, DOI 10.1042/BJ20070755; Kim K, 2009, EMBO J, V28, P1170, DOI 10.1038/emboj.2009.44; Klauck TM, 1996, J BIOL CHEM, V271, P19781, DOI 10.1074/jbc.271.33.19781; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Luo B, 2004, CELL SIGNAL, V16, P891, DOI 10.1016/j.cellsig.2004.01.010; Luo B, 2003, J CELL BIOL, V160, P929, DOI 10.1083/jcb.200208120; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Mizutani S, 2001, FEBS LETT, V507, P295, DOI 10.1016/S0014-5793(01)02992-1; Murakami T, 2003, J BIOL CHEM, V278, P34364, DOI 10.1074/jbc.M301542200; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Regier DS, 2005, P NATL ACAD SCI USA, V102, P7595, DOI 10.1073/pnas.0500663102; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Sakane F, 2002, J BIOL CHEM, V277, P43519, DOI 10.1074/jbc.M206895200; Sakane F, 1996, J BIOL CHEM, V271, P8394, DOI 10.1074/jbc.271.14.8394; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Sanjuan MA, 2003, J IMMUNOL, V170, P2877, DOI 10.4049/jimmunol.170.6.2877; Sharma A, 2005, CANCER RES, V65, P2412, DOI 10.1158/0008-5472.CAN-04-2423; Terai K, 2005, EMBO REP, V6, P251, DOI 10.1038/sj.embor.7400349; Topham MK, 2009, BBA-GEN SUBJECTS, V1790, P416, DOI 10.1016/j.bbagen.2009.01.010; Topham MK, 2001, J CELL BIOL, V152, P1135, DOI 10.1083/jcb.152.6.1135; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yasuda S, 2008, BIOCHEM J, V409, P95, DOI 10.1042/BJ20070848; Yasuda S, 2007, FEBS LETT, V581, P551, DOI 10.1016/j.febslet.2007.01.022; Zebisch A, 2006, CANCER RES, V66, P3401, DOI 10.1158/0008-5472.CAN-05-0115	43	49	55	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29559	29570		10.1074/jbc.M109.043604	http://dx.doi.org/10.1074/jbc.M109.043604			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19710016	Green Published, hybrid			2022-12-25	WOS:000270896800038
J	Schmeisser, MJ; Grabrucker, AM; Bockmann, J; Boeckers, TM				Schmeisser, Michael J.; Grabrucker, Andreas M.; Bockmann, Juergen; Boeckers, Tobias M.			Synaptic Cross-talk between N-Methyl-D-aspartate Receptors and LAPSER1-beta-Catenin at Excitatory Synapses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTSYNAPTIC DENSITY; BETA-CATENIN; TRANSLATIONAL CONTROL; TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; WNT; PROTEIN; PLASTICITY; GENE; DIFFERENTIATION	Memory formation in the brain is thought to be depending upon long lasting plastic changes of synaptic contacts that require alterations on the transcriptional level. Here, we characterize LAPSER1, a putative cytokinetic tumor suppressor that binds directly to ProSAP2/Shank3 and the synaptic Rap-Gap protein SPAR1 as a novel postsynaptic density component. Postsynaptic LAPSER1 is in complex with all important members of the canonical Wnt pathway including beta-catenin. Upon N-methyl-D-aspartate receptor-dependent activation, LAPSER1 and beta-catenin comigrate from the postsynaptic density to the nucleus and induce the transcription and translation of known beta-catenin target genes, including Tcfe2a and c-Myc. The nuclear export and cytoplasmic redistribution of beta-catenin is tightly regulated by LAPSER1. We postulate a postsynaptic cross-talk between N-methyl-D-aspartate receptors and a LAPSER1-beta-catenin complex that results in a self-regulated, synaptic activity-dependent expression of beta-catenin target genes. This calls for a novel role of Tcfe2a and c-Myc in plastic changes of neural tissue.	[Schmeisser, Michael J.; Grabrucker, Andreas M.; Bockmann, Juergen; Boeckers, Tobias M.] Univ Ulm, Inst Anat & Cell Biol, D-89081 Ulm, Germany	Ulm University	Boeckers, TM (corresponding author), Univ Ulm, Inst Anat & Cell Biol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	tobias.boeckers@uni-ulm.de	Schmeisser, Michael/S-6347-2019	Grabrucker, Andreas/0000-0003-0005-4810	Deutsche Forschungsgemeinschaft [SFB497-B8, BO 1718;3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB497-B8 (to T. M. B.) and BO 1718;3-1.	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Alberini CM, 1999, J EXP BIOL, V202, P2887; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Baudino TA, 2001, MOL CELL BIOL, V21, P691, DOI 10.1128/MCB.21.3.691-702.2001; Boeckers TM, 2006, CELL TISSUE RES, V326, P409, DOI 10.1007/s00441-006-0274-5; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Cabeza-Arvelaiz Y, 2001, ONCOGENE, V20, P6707, DOI 10.1038/sj.onc.1204866; Caricasole A, 2005, BIOSCIENCE REP, V25, P309, DOI 10.1007/s10540-005-2893-6; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; DIETERICH DC, 2008, BIOLOGY, V6, pE34; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Gundelfinger ED, 2006, TRENDS BIOCHEM SCI, V31, P366, DOI 10.1016/j.tibs.2006.05.007; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Ishii H, 2001, P NATL ACAD SCI USA, V98, P10374, DOI 10.1073/pnas.181222898; Jordan BA, 2007, NAT NEUROSCI, V10, P427, DOI 10.1038/nn1867; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Knoepfler PS, 2007, CANCER RES, V67, P5061, DOI 10.1158/0008-5472.CAN-07-0426; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Konno D, 2002, J CELL SCI, V115, P4695, DOI 10.1242/jcs.00127; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Murillas R, 2002, J BIOL CHEM, V277, P2897, DOI 10.1074/jbc.M110047200; Nishimura W, 2002, J NEUROSCI, V22, P757, DOI 10.1523/JNEUROSCI.22-03-00757.2002; Packard M, 2003, NAT REV NEUROSCI, V4, P113, DOI 10.1038/nrn1036; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Proepper C, 2007, EMBO J, V26, P1397, DOI 10.1038/sj.emboj.7601569; Salinas PC, 2005, CURR OPIN NEUROBIOL, V15, P73, DOI 10.1016/j.conb.2005.01.001; Seidenbecher CI, 1998, J BIOL CHEM, V273, P21324, DOI 10.1074/jbc.273.33.21324; Sheng M, 2000, J CELL SCI, V113, P1851; Speese SD, 2007, TRENDS NEUROSCI, V30, P268, DOI 10.1016/j.tins.2007.04.003; Spilker C, 2008, J NEUROCHEM, V104, P187, DOI 10.1111/j.1471-4159.2007.04991.x; Sudo H, 2007, FASEB J, V21, P2086, DOI 10.1096/fj.06-7254com; Takeichi M, 2005, TRENDS CELL BIOL, V15, P216, DOI 10.1016/j.tcb.2005.02.002; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tang SJ, 2007, SYNAPSE, V61, P866, DOI 10.1002/syn.20434; Thyssen G, 2006, MOL CELL BIOL, V26, P8857, DOI 10.1128/MCB.01031-06; Tsai IC, 2007, DEV CELL, V12, P335, DOI 10.1016/j.devcel.2007.02.009; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wendholt D, 2006, J BIOL CHEM, V281, P13805, DOI 10.1074/jbc.M601101200; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Wu H, 2007, FEBS J, V274, P3218, DOI 10.1111/j.1742-4658.2007.05891.x; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522	56	43	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29146	29157		10.1074/jbc.M109.020628	http://dx.doi.org/10.1074/jbc.M109.020628			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19703901	Green Published, hybrid			2022-12-25	WOS:000270678900070
J	Carlson, AE; Burnett, LA; del Camino, D; Quill, TA; Hille, B; Chong, JA; Moran, MM; Babcock, DF				Carlson, Anne E.; Burnett, Lindsey A.; del Camino, Donato; Quill, Timothy A.; Hille, Bertil; Chong, Jayhong A.; Moran, Magdalene M.; Babcock, Donner F.			Pharmacological Targeting of Native CatSper Channels Reveals a Required Role in Maintenance of Sperm Hyperactivation	PLOS ONE			English	Article								The four sperm-specific CatSper ion channel proteins are required for hyperactivated motility and male fertility, and for Ca(2+) entry evoked by alkaline depolarization. In the absence of external Ca(2+), Na(+) carries current through CatSper channels in voltage-clamped sperm. Here we show that CatSper channel activity can be monitored optically with the [Na(+)](i)-reporting probe SBFI in populations of intact sperm. Removal of external Ca(2+) increases SBFI signals in wild-type but not CatSper2-null sperm. The rate of the indicated rise of [Na(+)](i) is greater for sperm alkalinized with NH(4)Cl than for sperm acidified with propionic acid, reflecting the alkaline-promoted signature property of CatSper currents. In contrast, the [Na(+)](i) rise is slowed by candidate CatSper blocker HC-056456 (IC(50) similar to 3 mu M). HC-056456 similarly slows the rise of [Ca(2+)](i) that is evoked by alkaline depolarization and reported by fura-2. HC-056456 also selectively and reversibly decreased CatSper currents recorded from patch-clamped sperm. HC-056456 does not prevent activation of motility by HCO(3)(-) but does prevent the development of hyperactivated motility by capacitating incubations, thus producing a phenocopy of the CatSper-null sperm. When applied to hyperactivated sperm, HC-056456 causes a rapid, reversible loss of flagellar waveform asymmetry, similar to the loss that occurs when Ca(2+) entry through the CatSper channel is terminated by removal of external Ca(2+). Thus, open CatSper channels and entry of external Ca(2+) through them sustains hyperactivated motility. These results indicate that pharmacological targeting of the CatSper channel may impose a selective late-stage block to fertility, and that high-throughput screening with an optical reporter of CatSper channel activity may identify additional selective blockers with potential for male-directed contraception.			Carlson, AE (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	donner@u.washington.edu	Carlson, Anne/I-9495-2019	Carlson, Anne/0000-0003-2724-1325; Burnett, Lindsey/0000-0002-6430-4498; Babcock, Donner/0000-0002-4461-4544	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R43HD045028, R01HD036022, P50HD012629] Funding Source: NIH RePORTER; NICHD NIH HHS [HD12629-27, R01 HD036022, R43 HD045028, HD-36022, U54 HD012629, R43 HD045028-01, P50 HD012629] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BABCOCK DF, 1983, J BIOL CHEM, V258, P6380; Carlson AE, 2005, J BIOL CHEM, V280, P32238, DOI 10.1074/jbc.M501430200; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Carlson AE, 2007, DEV BIOL, V312, P183, DOI 10.1016/j.ydbio.2007.09.017; COOPER TG, 1984, GAMETE RES, V9, P55, DOI 10.1002/mrd.1120090106; Dunlop J, 2008, NAT REV DRUG DISCOV, V7, P358, DOI 10.1038/nrd2552; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Garbers D L, 1980, Adv Cyclic Nucleotide Res, V13, P251; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Ho K, 2009, REPROD FERT DEVELOP, V21, P345, DOI 10.1071/RD08183; Jin JL, 2007, BIOL REPROD, V77, P37, DOI 10.1095/biolreprod.107.060186; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Liu J, 2007, J BIOL CHEM, V282, P18945, DOI 10.1074/jbc.M701083200; Marquez B, 2007, BIOL REPROD, V76, P660, DOI 10.1095/biolreprod.106.055038; Meier SD, 2006, J NEUROSCI METH, V155, P251, DOI 10.1016/j.jneumeth.2006.01.009; Morgan DJ, 2008, P NATL ACAD SCI USA, V105, P20740, DOI 10.1073/pnas.0810971105; Nass SJ, 2004, NAT REV DRUG DISCOV, V3, P885, DOI 10.1038/nrd1526; Navarro B, 2008, INT J DEV BIOL, V52, P607, DOI 10.1387/ijdb.072554bn; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Quill TA, 2003, P NATL ACAD SCI USA, V100, P14869, DOI 10.1073/pnas.2136654100; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Schuh SM, 2006, BIOL REPROD, V74, P492, DOI 10.1095/biolreprod.105.047837; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; Wennemuth G, 2003, DEVELOPMENT, V130, P1317, DOI 10.1242/dev.00353; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; YANAGIMACHI R, 1982, GAMETE RES, V5, P323, DOI 10.1002/mrd.1120050404	28	63	64	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6844	10.1371/journal.pone.0006844	http://dx.doi.org/10.1371/journal.pone.0006844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718436	Green Published, gold, Green Submitted			2022-12-25	WOS:000269415900017
J	Locasale, JW; Wolf-Yadlin, A				Locasale, Jason W.; Wolf-Yadlin, Alejandro			Maximum Entropy Reconstructions of Dynamic Signaling Networks from Quantitative Proteomics Data	PLOS ONE			English	Article							KINASE ACTIVATION; MASS-SPECTROMETRY; GENE-EXPRESSION; PROTEIN; COMPLEX; TRANSDUCTION; REVEALS; MODELS; CELLS	Advances in mass spectrometry among other technologies have allowed for quantitative, reproducible, proteome-wide measurements of levels of phosphorylation as signals propagate through complex networks in response to external stimuli under different conditions. However, computational approaches to infer elements of the signaling network strictly from the quantitative aspects of proteomics data are not well established. We considered a method using the principle of maximum entropy to infer a network of interacting phosphotyrosine sites from pairwise correlations in a mass spectrometry data set and derive a phosphorylation-dependent interaction network solely from quantitative proteomics data. We first investigated the applicability of this approach by using a simulation of a model biochemical signaling network whose dynamics are governed by a large set of coupled differential equations. We found that in a simulated signaling system, the method detects interactions with significant accuracy. We then analyzed a growth factor mediated signaling network in a human mammary epithelial cell line that we inferred from mass spectrometry data and observe a biologically interpretable, small-world structure of signaling nodes, as well as a catalog of predictions regarding the interactions among previously uncharacterized phosphotyrosine sites. For example, the calculation places a recently identified tumor suppressor pathway through ARHGEF7 and Scribble, in the context of growth factor signaling. Our findings suggest that maximum entropy derived network models are an important tool for interpreting quantitative proteomics data.			Locasale, JW (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Signal Transduct,Dept Syst Biol, Boston, MA 02215 USA.	jlocasal@bidmc.harvard.edu	Locasale, Jason W/ABE-6505-2020; Wolf-Yadlin, Alejandro/E-6574-2011	Locasale, Jason W/0000-0002-7766-3502; Wolf-Yadlin, Alejandro/0000-0003-2909-3880	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI071195] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI071195, P01AI071195-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alon U, 2007, INTRO SYSTEMS BIOL D; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; del Sol A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r92; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kumar N, 2007, PLOS COMPUT BIOL, V3, P35, DOI 10.1371/journal.pcbi.0030004; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Lezon TR, 2006, P NATL ACAD SCI USA, V103, P19033, DOI 10.1073/pnas.0609152103; Ma BY, 2009, P NATL ACAD SCI USA, V106, P6887, DOI 10.1073/pnas.0903024106; Maeda A, 2006, GENES CELLS, V11, P1071, DOI 10.1111/j.1365-2443.2006.01001.x; Nielsen UB, 2003, P NATL ACAD SCI USA, V100, P9330, DOI 10.1073/pnas.1633513100; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimomura Y, 2003, J DERMATOL SCI, V31, P43, DOI 10.1016/S0923-1811(02)00140-8; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Thomas MC, 2006, ELEMENTS INFORM THEO; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	30	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6522	10.1371/journal.pone.0006522	http://dx.doi.org/10.1371/journal.pone.0006522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707567	gold, Green Submitted, Green Published			2022-12-25	WOS:000269335000002
J	Kumar, A; Hoffman, TA; DeRicco, J; Naqvi, A; Jain, MK; Irani, K				Kumar, Ajay; Hoffman, Timothy A.; DeRicco, Jeremy; Naqvi, Asma; Jain, Mukesh K.; Irani, Kaikobad			Transcriptional repression of Kruppel like factor-2 by the adaptor protein p66shc	FASEB JOURNAL			English	Article						KLF2; MEF2A; reactive oxygen species; ShcA; thrombomodulin; endothelial	ENHANCER FACTOR 2A; OXIDATIVE STRESS; GENE-EXPRESSION; CELL APOPTOSIS; LIFE-SPAN; MEF2; KLF2; INHIBITION; REGULATOR; DIFFERENTIATION	The adaptor protein p66shc promotes cellular oxidative stress and apoptosis. Here, we demonstrate a novel mechanistic relationship between p66shc and the kruppel like factor-2 (KLF2) transcription factor and show that this relationship has biological relevance to p66shc-regulated cellular oxidant level, as well as KLF2-induced target gene expression. Genetic knockout of p66shc in mouse embryonic fibroblasts (MEFs) stimulates activity of the core KLF2 promoter and increases KLF2 mRNA and protein expression. Similarly, shRNA-induced knockdown of p66shc increases KLF2-promoter activity in HeLa cells. The increase in KLF2-promoter activity in p66shc-knockout MEFs is dependent on a myocyte enhancing factor-2A (MEF2A)-binding sequence in the core KLF2 promoter. Short-hairpin RNA-induced knockdown of p66shc in endothelial cells also stimulates KLF2 mRNA and protein expression, as well as expression of the endothelial KLF2 target gene thrombomodulin. MEF2A protein and mRNA are more abundant in p66shc-knockout MEFs, resulting in greater occupancy of the KLF2 promoter by MEF2A. In endothelial cells, the increase in KLF2 and thrombomodulin protein by shRNA-induced decrease in p66shc expression is partly abrogated by knockdown of MEF2A. Finally, knockdown of KLF2 abolishes the decrease in the cellular reactive oxygen species hydrogen peroxide observed with knockdown of p66shc, and KLF2 overexpression suppresses cellular hydrogen peroxide levels, independent of p66shc expression. These findings illustrate a novel mechanism by which p66shc promotes cellular oxidative stress, through suppression of MEF2A expression and consequent repression of KLF2 transcription.-Kumar, A., Hoffman, T. A., DeRicco, J., Naqvi, A., Jain, M. K., Irani, K. Transcriptional repression of Kruppel like factor-2 by the adaptor protein p66shc. FASEB J. 23, 4344-4352 (2009). www.fasebj.org	[Kumar, Ajay; Hoffman, Timothy A.; DeRicco, Jeremy; Naqvi, Asma; Irani, Kaikobad] Univ Pittsburgh, Med Ctr, Cardiovasc Inst, Pittsburgh, PA 15213 USA; [Jain, Mukesh K.] Case Western Reserve Univ, Sch Med, Case Cardiovasc Res Inst, Cleveland, OH USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Case Western Reserve University	Kumar, A (corresponding author), Univ Pittsburgh, Med Ctr, Cardiovasc Inst, 623S Scaife Hall,200 Lothrop St, Pittsburgh, PA 15213 USA.	kumara@upmc.edu; iranik@upmc.edu		Irani, Kaikobad/0000-0001-9194-7387	National Institutes of Health [R01 HL094959, R01 HL070929, P01 HL065608]; American Heart association [BGIA 0865419D]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL065608, R01HL070929, R01HL076754, R01HL094959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank T. Finkel (National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA) for the gift of the p66<SUP>-/-</SUP> and WT MEFs, A. Hoffmann and D. Baltimore (California Institute of Technology, Pasadena, CA, USA) for the p65 and p50-null MEFs, and Huck Hui Ng (Genome Institute of Singapore, Singapore) for the KLF2 antibody. This work was supported by National Institutes of Health grants R01 HL094959, R01 HL070929, and P01 HL065608 (KI), and an American Heart association BGIA 0865419D (AK).	ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; Banerjee SS, 2003, J BIOL CHEM, V278, P2581, DOI 10.1074/jbc.M210859200; Bhattacharya R, 2005, J BIOL CHEM, V280, P28848, DOI 10.1074/jbc.C500200200; Bieker JJ, 1996, DNA CELL BIOL, V15, P347, DOI 10.1089/dna.1996.15.347; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Bonfini L, 1996, TRENDS BIOCHEM SCI, V21, P257, DOI 10.1016/S0968-0004(96)10033-5; De S, 2005, P NATL ACAD SCI USA, V102, P7589, DOI 10.1073/pnas.0502935102; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; GOLDSTONE SD, 1995, BBA-GENE STRUCT EXPR, V1263, P114, DOI 10.1016/0167-4781(95)00088-X; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jackson JG, 2000, CLIN CANCER RES, V6, P1135; Janssen-Heininger YMW, 2000, FREE RADICAL BIO MED, V28, P1317, DOI 10.1016/S0891-5849(00)00218-5; Kato Y, 2000, J BIOL CHEM, V275, P18534, DOI 10.1074/jbc.M001573200; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Khanday FA, 2006, J CELL BIOL, V172, P817, DOI 10.1083/jcb.200506001; Kumar A, 2005, MOL CELL BIOL, V25, P5893, DOI 10.1128/MCB.25.14.5893-5903.2005; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Lin ZY, 2005, CIRC RES, V96, pE48, DOI 10.1161/01.RES.0000159707.05637.a1; Luzi L, 2000, CURR OPIN GENET DEV, V10, P668, DOI 10.1016/S0959-437X(00)00146-5; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Menini S, 2006, DIABETES, V55, P1642, DOI 10.2337/db05-1477; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200; Pacini S, 2004, MOL CELL BIOL, V24, P1747, DOI 10.1128/MCB.24.4.1747-1757.2004; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Pellegrini M, 2007, CELL DEATH DIFFER, V14, P338, DOI 10.1038/sj.cdd.4401997; PERKINS AC, 1995, NATURE, V375, P318; Ramachandran B, 2008, J BIOL CHEM, V283, P11935, DOI 10.1074/jbc.M707389200; Ramachandran B, 2008, J BIOL CHEM, V283, P10318, DOI 10.1074/jbc.M707623200; Sen-Banerjee S, 2005, CIRCULATION, V112, P720, DOI 10.1161/CIRCULATIONAHA.104.525774; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; Veeramani S, 2005, ONCOGENE, V24, P7203, DOI 10.1038/sj.onc.1208852; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Yamamori T, 2005, J MOL CELL CARDIOL, V39, P992, DOI 10.1016/j.yjmcc.2005.09.003; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790	46	21	21	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4344	4352		10.1096/fj.09-138743	http://dx.doi.org/10.1096/fj.09-138743			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19696221	Green Published			2022-12-25	WOS:000272193700029
J	Ablonczy, Z; Prakasam, A; Fant, J; Fauq, A; Crosson, C; Sambamurti, K				Ablonczy, Zsolt; Prakasam, Annamalai; Fant, James; Fauq, Abdul; Crosson, Craig; Sambamurti, Kumar			Pigment Epithelium-derived Factor Maintains Retinal Pigment Epithelium Function by Inhibiting Vascular Endothelial Growth Factor-R2 Signaling through gamma-Secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; FACTOR VEGF EXPRESSION; MACULAR DEGENERATION; AMYLOID-BETA; CHOROIDAL NEOVASCULARIZATION; DIABETIC-RETINOPATHY; OXIDATIVE STRESS; FACTOR PEDF; A-BETA; CELLS	Wet age-related macular degeneration (AMD) attacks the integrity of the retinal pigment epithelium (RPE) barrier system. The pathogenic process was hypothesized to be mediated by vascular endothelial growth factor (VEGF) and antagonized by pigment epithelium-derived factor (PEDF). To dissect these functional interactions, monolayer cultures of RPE cells were established, and changes in transepithelial resistance were evaluated after administration of PEDF, placenta growth factor (VEGF-R1 agonist), and VEGF-E (VEGF-R2 agonist). A recently described mechanism of VEGF inhibition in endothelia required the release of VEGF-R1 intracellular domain by gamma-secretase. To evaluate this pathway in the RPE, cells were pretreated with inhibitors DAPT or LY411575. Processing of VEGF receptors was assessed by Western blot analysis. Administration of VEGF-E rapidly increased RPE permeability, and PEDF inhibited the VEGF-E response dose-dependently. Both gamma-secretase antagonists prevented the inhibitory effects of PEDF. The co-administration of PEDF and VEGF-E depleted the amount of VEGF-R2 in the membrane and increased the amount of VEGF-R2 ectodomain in the media. Therefore, the inhibitory effect of PEDF appears to be mediated via the processing of VEGF-R2 by gamma-secretase. gamma-Secretase generates the amyloid-beta(A beta) peptide of Alzheimer disease from its precursor (amyloid precursor protein). This peptide is also a component of drusen in dry AMD. The results support the hypothesis that misregulation of gamma-secretase may not only lead to A beta deposits in dry AMD but can also be damaging to RPE function by blocking the protective effects of PEDF to prevent VEGF from driving the dry to wet AMD transition.	[Ablonczy, Zsolt; Fant, James; Crosson, Craig] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Prakasam, Annamalai; Sambamurti, Kumar] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Fauq, Abdul] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	Medical University of South Carolina; Medical University of South Carolina; Mayo Clinic	Ablonczy, Z (corresponding author), 167 Ashley Ave,SEI 518E, Charleston, SC 29425 USA.	ablonczy@musc.edu	Sambamurti, Kumar/A-1620-2012	Sambamurti, Kumar/0000-0001-9507-9214	National Institutes of Health [EY14793, AG023055, EY009741]; NEI; NIA; Medical University of South Carolina (MUSC) [P28918]; Research to Prevent Blindness, New York, NY; NIH/NEI [EY13520]; NATIONAL EYE INSTITUTE [R01EY013520, R01EY009741, R24EY014793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical University of South Carolina (MUSC); Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants EY14793, AG023055, and EY009741 from NEI, NIA, and NEI, respectively. This work was also supported by Medical University of South Carolina (MUSC) Grant URC P28918 and an unrestricted grant to MUSC from Research to Prevent Blindness, New York, NY. The Leica DM LFSA confocal microscope was obtained through a supplement to NIH/NEI EY13520.	Ablonczy Z, 2007, EXP EYE RES, V85, P762, DOI 10.1016/j.exer.2007.08.010; Ahir A, 2002, INVEST OPHTH VIS SCI, V43, P458; Alberdi E, 1999, J BIOL CHEM, V274, P31605, DOI 10.1074/jbc.274.44.31605; Anderson DH, 2004, EXP EYE RES, V78, P243, DOI 10.1016/j.exer.2003.10.011; Antcliff R J, 1999, Semin Ophthalmol, V14, P223, DOI 10.3109/08820539909069541; Augustin AJ, 2007, RETINA-J RET VIT DIS, V27, P133, DOI 10.1097/IAE.0b013e3180323de7; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; De Strooper B, 2003, NATURE, V423, P392, DOI 10.1038/423392a; Dentchev T, 2003, MOL VIS, V9, P184; Dijkstra A, 2009, VIRCHOWS ARCH, V454, P441, DOI 10.1007/s00428-009-0748-4; Ebos JML, 2004, MOL CANCER RES, V2, P315; Ghassemifar R, 2006, CELL TISSUE RES, V323, P117, DOI 10.1007/s00441-005-0046-7; Gillies MC, 1999, DOC OPHTHALMOL, V97, P251, DOI 10.1023/A:1002196930726; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Hartnett ME, 2003, EXP EYE RES, V77, P593, DOI 10.1016/S0014-4835(03)00189-1; HEIER JS, 2006, OPHTHALMOLOGY, V642, pE641; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; Kannan R, 2006, MOL VIS, V12, P1649; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kou BJ, 2004, EXP MOL PATHOL, V76, P129, DOI 10.1016/j.yexmp.2003.10.010; Maminishkis A, 2006, INVEST OPHTH VIS SCI, V47, P3612, DOI 10.1167/iovs.05-1622; Marmor MF, 1999, DOC OPHTHALMOL, V97, P239, DOI 10.1023/A:1002192829817; Marneros AG, 2005, AM J PATHOL, V167, P1451, DOI 10.1016/S0002-9440(10)61231-X; Miyamoto N, 2007, DIABETOLOGIA, V50, P461, DOI 10.1007/s00125-006-0539-2; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Ohno-Matsui K, 2001, J CELL PHYSIOL, V189, P323, DOI 10.1002/jcp.10026; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; Sambamurti K, 2002, NEUROMOL MED, V1, P1, DOI 10.1385/NMM:1:1:1; Sambamurti Kumar, 2006, Current Alzheimer Research, V3, P81, DOI 10.2174/156720506775697142; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Slomiany MG, 2004, INVEST OPHTH VIS SCI, V45, P2838, DOI 10.1167/iovs.03-0565; Small DH, 2002, PEPTIDES, V23, P1317, DOI 10.1016/S0196-9781(02)00072-4; Spaide RF, 2006, RETINA-J RET VIT DIS, V26, P383, DOI 10.1097/00006982-200604000-00001; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Tombran-Tink J, 2005, FRONT BIOSCI-LANDMRK, V10, P2131, DOI 10.2741/1686; TOMBRANTINK J, 1995, J NEUROSCI, V15, P4992; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Tranos PG, 2004, SURV OPHTHALMOL, V49, P470, DOI 10.1016/j.survophthal.2004.06.002; Wang RS, 2006, P NATL ACAD SCI USA, V103, P353, DOI 10.1073/pnas.0509822102; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Yamagishi S, 2006, MICROVASC RES, V71, P222, DOI 10.1016/j.mvr.2006.03.001; Yoshida T, 2005, J CLIN INVEST, V115, P2793, DOI 10.1172/JCI24635; Zhang SX, 2006, J MOL ENDOCRINOL, V37, P1, DOI 10.1677/jme.1.02008; Zhou Y, 2008, FASEB J, V22, P47, DOI 10.1096/fj.07-8175com	47	55	61	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30177	30186		10.1074/jbc.M109.032391	http://dx.doi.org/10.1074/jbc.M109.032391			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19723623	hybrid, Green Published			2022-12-25	WOS:000271090000021
J	Biswas, T; Yi, L; Aggarwal, P; Wu, J; Rubin, JR; Stuckey, JA; Woodard, RW; Tsodikov, OV				Biswas, Tapan; Yi, Li; Aggarwal, Parag; Wu, Jing; Rubin, John R.; Stuckey, Jeanne A.; Woodard, Ronald W.; Tsodikov, Oleg V.			The Tail of KdsC CONFORMATIONAL CHANGES CONTROL THE ACTIVITY OF A HALOACID DEHALOGENASE SUPERFAMILY PHOSPHATASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAD SUPERFAMILY; PHOSPHATASE; ASPARTATE; YRBI	The phosphatase KdsC cleaves 3-deoxy-D-manno-octulosonate 8-phosphate to generate a molecule of inorganic phosphate and Kdo. Kdo is an essential component of the lipopolysaccharide envelope in Gram-negative bacteria. Because lipopolysaccharide is an important determinant of bacterial resistance and toxicity, KdsC is a potential target for novel antibacterial agents. KdsC belongs to the broad haloacid dehalogenase superfamily. In haloacid dehalogenase superfamily enzymes, substrate specificity and catalytic efficiency are generally dictated by a fold feature called the cap domain. It is therefore not clear why KdsC, which lacks a cap domain, is catalytically efficient and highly specific to 3-deoxy-D-manno-octulosonate 8-phosphate. Here, we present a set of seven structures of tetrameric Escherichia coli KdsC ( ranging from 1.4 to 3.06 angstrom in resolution) that model different intermediate states in its catalytic mechanism. A crystal structure of product-bound E. coli KdsC shows how the interface between adjacent monomers defines the active site pocket. Kdo is engaged in a network of polar and nonpolar interactions with residues at this interface, which explains substrate specificity. Furthermore, this structural and kinetic analysis strongly suggests that the binding of the flexible C-terminal region ( tail) to the active site makes KdsC catalytically efficient by facilitating product release.	[Biswas, Tapan; Yi, Li; Aggarwal, Parag; Wu, Jing; Woodard, Ronald W.; Tsodikov, Oleg V.] Univ Michigan, Dept Med Chem, Coll Pharm, Ann Arbor, MI 48109 USA; [Rubin, John R.; Stuckey, Jeanne A.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Woodard, RW (corresponding author), 428 Church St, Ann Arbor, MI 48109 USA.	rww@umich.edu; olegt@umich.edu		Woodard, Ronald/0000-0002-7472-3653	National Institutes of Health [AI61531]; College of Pharmacy, University of Michigan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061531] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Pharmacy, University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI61531 ( to R. W. W.). This work was also supported by the start-up funds from the College of Pharmacy, University of Michigan ( to O.V.T.).	Allen KN, 2004, TRENDS BIOCHEM SCI, V29, P495, DOI 10.1016/j.tibs.2004.07.008; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Cho H, 2001, P NATL ACAD SCI USA, V98, P8525, DOI 10.1073/pnas.131213698; Deshpande RA, 2004, BIOCHEMISTRY-US, V43, P8579, DOI 10.1021/bi049434n; Diaz AR, 2008, J BIOL CHEM, V283, P2962, DOI 10.1074/jbc.M709032200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghosh A, 2008, MOL CELL, V32, P478, DOI 10.1016/j.molcel.2008.09.021; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Lahiri SD, 2004, BIOCHEMISTRY-US, V43, P2812, DOI 10.1021/bi0356810; Lahiri SD, 2002, BIOCHEMISTRY-US, V41, P8351, DOI 10.1021/bi0202373; Lu ZB, 2009, J BIOL CHEM, V284, P1224, DOI 10.1074/jbc.M807056200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen HP, 2003, NAT STRUCT BIOL, V10, P1019, DOI 10.1038/nsb1014; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsons JF, 2002, PROTEINS, V46, P393, DOI 10.1002/prot.10057; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Wu J, 2003, J BIOL CHEM, V278, P18117, DOI 10.1074/jbc.M301983200	21	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30594	30603		10.1074/jbc.M109.012278	http://dx.doi.org/10.1074/jbc.M109.012278			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726684	hybrid, Green Published			2022-12-25	WOS:000271090000062
J	Genkov, T; Spreitzer, RJ				Genkov, Todor; Spreitzer, Robert J.			Highly Conserved Small Subunit Residues Influence Rubisco Large Subunit Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE OXYGENASE; RIBULOSE-BISPHOSPHATE CARBOXYLASE/OXYGENASE; CHLAMYDOMONAS CHLOROPLAST GENE; SUBSTRATE-SPECIFICITY FACTOR; BETA-B LOOP; CO2/O-2 SPECIFICITY; THERMAL-STABILITY; CRYSTAL-STRUCTURE; COMPLEMENTING SUBSTITUTIONS; SUPPRESSOR MUTATIONS	The chloroplast enzyme ribulose 1,5-bisphosphate carboxylase/oxygenase (Rubisco) catalyzes the rate-limiting step of photosynthetic CO2 fixation. With a deeper understanding of its structure-function relationships and competitive inhibition by O-2, it may be possible to engineer an increase in agricultural productivity and renewable energy. The chloroplast-encoded large subunits form the active site, but the nuclear-encoded small subunits can also influence catalytic efficiency and CO2/O-2 specificity. To further define the role of the small subunit in Rubisco function, the 10 most conserved residues in all small subunits were substituted with alanine by transformation of a Chlamydomonas reinhardtii mutant that lacks the small subunit gene family. All the mutant strains were able to grow photosynthetically, indicating that none of the residues is essential for function. Three of the substitutions have little or no effect (S16A, P19A, and E92A), one primarily affects holoenzyme stability (L18A), and the remainder affect catalysis with or without some level of associated structural instability (Y32A, E43A, W73A, L78A, P79A, and F81A). Y32A and E43A cause decreases in CO2/O-2 specificity. Based on the x-ray crystal structure of Chlamydomonas Rubisco, all but one (Glu-92) of the conserved residues are in contact with large subunits and cluster near the amino-or carboxyl-terminal ends of large subunit alpha-helix 8, which is a structural element of the alpha/beta-barrel active site. Small subunit residues Glu-43 and Trp-73 identify a possible structural connection between active site alpha-helix 8 and the highly variable small subunit loop between beta-strands A and B, which can also influence Rubisco CO2/O-2 specificity.	[Genkov, Todor; Spreitzer, Robert J.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Spreitzer, RJ (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	rspreitzer1@unl.edu			United States Department of Energy [DE-FG02-00ER15044]	United States Department of Energy(United States Department of Energy (DOE))	This work was supported in part by Grant DE-FG02-00ER15044 from the United States Department of Energy.	Andersson I, 1996, J MOL BIOL, V259, P160, DOI 10.1006/jmbi.1996.0310; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN Z, 1988, P NATL ACAD SCI USA, V85, P4696, DOI 10.1073/pnas.85.13.4696; CHEN ZX, 1992, PHOTOSYNTH RES, V31, P157, DOI 10.1007/BF00028792; CHEN ZX, 1993, PLANT PHYSIOL, V101, P1189, DOI 10.1104/pp.101.4.1189; Chua N. H, 1980, METHOD ENZYMOL, V69, P434; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; CLONEY LP, 1993, PLANT MOL BIOL, V23, P1285, DOI 10.1007/BF00042362; Dhingra A, 2004, P NATL ACAD SCI USA, V101, P6315, DOI 10.1073/pnas.0400981101; Du YC, 2000, P NATL ACAD SCI USA, V97, P14206, DOI 10.1073/pnas.260503997; Du YC, 2000, J BIOL CHEM, V275, P19844, DOI 10.1074/jbc.M002321200; Esquivel MG, 2006, BIOCHEMISTRY-US, V45, P5745, DOI 10.1021/bi052588y; FITCHEN JH, 1990, P NATL ACAD SCI USA, V87, P5768, DOI 10.1073/pnas.87.15.5768; Flachmann R, 1997, PLANT PHYSIOL, V114, P131, DOI 10.1104/pp.114.1.131; FLACHMANN R, 1992, J BIOL CHEM, V267, P10576; Genkov T, 2006, ARCH BIOCHEM BIOPHYS, V451, P167, DOI 10.1016/j.abb.2006.04.012; Hansen S, 1999, J MOL BIOL, V288, P609, DOI 10.1006/jmbi.1999.2701; HARTMAN FC, 1994, ANNU REV BIOCHEM, V63, P197, DOI 10.1146/annurev.biochem.63.1.197; Hong SK, 1997, J BIOL CHEM, V272, P11114; JORDAN DB, 1981, NATURE, V291, P513, DOI 10.1038/291513a0; JORDAN DB, 1981, PLANT PHYSIOL, V67, P237, DOI 10.1104/pp.67.2.237; Kanevski I, 1999, PLANT PHYSIOL, V119, P133, DOI 10.1104/pp.119.1.133; Karkehabadi S, 2005, BIOCHEMISTRY-US, V44, P9851, DOI 10.1021/bi050537v; Khrebtukova I, 1996, P NATL ACAD SCI USA, V93, P13689, DOI 10.1073/pnas.93.24.13689; Kostov RV, 1997, PHOTOSYNTH RES, V54, P127, DOI 10.1023/A:1005967106993; KUEHN GD, 1978, BIOCHEM J, V175, P909, DOI 10.1042/bj1750909; LAING WA, 1974, PLANT PHYSIOL, V54, P678, DOI 10.1104/pp.54.5.678; LEE B, 1991, J BIOL CHEM, V266, P7417; NEWMAN J, 1993, J BIOL CHEM, V268, P25876; Papworth C.B., 1996, STRATEGIES, V9, P3, DOI DOI 10.1080/08924562.1996.11000299; PAUL K, 1991, BIOCHEMISTRY-US, V30, P10019, DOI 10.1021/bi00105a029; READ BA, 1992, BIOCHEMISTRY-US, V31, P5553, DOI 10.1021/bi00139a018; READ BA, 1994, ARCH BIOCHEM BIOPHYS, V312, P210, DOI 10.1006/abbi.1994.1301; READ BA, 1992, BIOCHEMISTRY-US, V31, P519, DOI 10.1021/bi00117a031; SCHNEIDER G, 1990, EMBO J, V9, P2045, DOI 10.1002/j.1460-2075.1990.tb07371.x; SCHREUDER HA, 1993, PROTEIN SCI, V2, P1136, DOI 10.1002/pro.5560020708; Shimogawara K, 1998, GENETICS, V148, P1821; Spreitzer RJ, 2005, P NATL ACAD SCI USA, V102, P17225, DOI 10.1073/pnas.0508042102; SPREITZER RJ, 1981, PLANT PHYSIOL, V67, P565, DOI 10.1104/pp.67.3.565; Spreitzer RJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P141, DOI 10.1016/S0003-9861(03)00171-1; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Spreitzer RJ, 2001, BIOCHEMISTRY-US, V40, P5615, DOI 10.1021/bi002943e; SPREITZER RJ, 1982, FEBS LETT, V148, P117, DOI 10.1016/0014-5793(82)81255-6; SPREITZER RJ, 1985, P NATL ACAD SCI USA, V82, P5460, DOI 10.1073/pnas.82.16.5460; SPREITZER RJ, 1987, CURR GENET, V11, P611, DOI 10.1007/BF00393924; SUGAWARA H, 1999, J BIOL CHEM, V276, P48159; Tabita FR, 2008, J EXP BOT, V59, P1515, DOI 10.1093/jxb/erm361; THOW G, 1994, BIOCHEMISTRY-US, V33, P5109, DOI 10.1021/bi00183a014; Uemura K, 1997, BIOCHEM BIOPH RES CO, V233, P568, DOI 10.1006/bbrc.1997.6497; VOORDOUW G, 1987, EUR J BIOCHEM, V163, P591, DOI 10.1111/j.1432-1033.1987.tb10908.x; WASMANN CC, 1989, P NATL ACAD SCI USA, V86, P1198, DOI 10.1073/pnas.86.4.1198	52	49	52	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30105	30112		10.1074/jbc.M109.044081	http://dx.doi.org/10.1074/jbc.M109.044081			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19734149	Green Published, hybrid			2022-12-25	WOS:000271090000013
J	Naamati, A; Regev-Rudzki, N; Galperin, S; Lill, R; Pines, O				Naamati, Adi; Regev-Rudzki, Neta; Galperin, Shlomi; Lill, Roland; Pines, Ophry			Dual Targeting of Nfs1 and Discovery of Its Novel Processing Enzyme, Icp55	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE-T-ANTIGEN; MITOCHONDRIAL PROTEINS; SACCHAROMYCES-CEREVISIAE; NUCLEAR-LOCALIZATION; SYNTHETIC PEPTIDE; THIO-MODIFICATION; YEAST FUMARASE; LOCATION; SEQUENCE; IMPORT	In eukaryotes, each subcellular compartment harbors a specific group of proteins that must accomplish specific tasks. Nfs1 is a highly conserved mitochondrial cysteine desulfurase that participates in iron-sulfur cluster assembly as a sulfur donor. Previous genetic studies, in Saccharomyces cerevisiae, have suggested that this protein distributes between the mitochondria and the nucleus with biochemically undetectable amounts in the nucleus (termed "eclipsed distribution"). Here, we provide direct evidence for Nfs1 nuclear localization (in addition to mitochondria) using both alpha-complementation and subcellular fractionation. We also demonstrate that mitochondrial and nuclear Nfs1 are derived from a single translation product. Our data suggest that the Nfs1 distribution mechanism involves at least partial entry of the Nfs1 precursor into mitochondria, and then retrieval of a minor subpopulation (probably by reverse translocation) into the cytosol and then the nucleus. To further elucidate the mechanism of Nfs1 distribution we determined the N-terminal mitochondrial sequence of Nfs1 by Edman degradation. This led to the discovery of a novel mitochondrial processing enzyme, Icp55. This enzyme removes three amino acids from the N terminus of Nfs1 after cleavage by mitochondrial processing peptidase. Intriguingly, Icp55 protease (like its substrate Nfs1) appears to be dual distributed between the nucleus and mitochondria.	[Naamati, Adi; Regev-Rudzki, Neta; Galperin, Shlomi; Pines, Ophry] Hebrew Univ Jerusalem, Fac Med, IMRIC, Dept Microbiol & Mol Genet, IL-91120 Jerusalem, Israel; [Lill, Roland] Univ Marburg, Inst Cytobiol & Cytopathol, D-35033 Marburg, Germany	Hebrew University of Jerusalem; Philipps University Marburg	Pines, O (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Mol Biol, IL-91120 Jerusalem, Israel.	ophryp@ekmd.huji.ac.il	pines, ophry/C-4086-2011	pines, ophry/0000-0001-7126-2575; Lill, Roland/0000-0002-8345-6518; Naamati, Adi/0000-0001-6989-3634	Deutsche Forschungsgemeinschaft [SFB 593, TR1, GRK 1216]; Rhon Klinikum AG; von Behring-Rontgen Stiftung; Max-Planck Gesellschaft; Fonds der chemischen Industrie; German Israeli Foundation; Israel Science Foundation; The Niedersachsen-Israeli Research Cooperation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Rhon Klinikum AG; von Behring-Rontgen Stiftung; Max-Planck Gesellschaft(Max Planck Society); Fonds der chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); The Niedersachsen-Israeli Research Cooperation	Supported by the Deutsche Forschungsgemeinschaft (Grants SFB 593 and TR1, Gottfried-Wilhelm Leibniz program, and Grant GRK 1216), Rhon Klinikum AG, von Behring-Rontgen Stiftung, Max-Planck Gesellschaft, and Fonds der chemischen Industrie.; Supported by the German Israeli Foundation.; Supported by the Israel Science Foundation and The Niedersachsen-Israeli Research Cooperation.	Andreoli C, 2004, NUCLEIC ACIDS RES, V32, pD459, DOI 10.1093/nar/gkh137; DANPURE CJ, 1995, TRENDS CELL BIOL, V5, P230, DOI 10.1016/S0962-8924(00)89016-9; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; Fosset C, 2006, J BIOL CHEM, V281, P25398, DOI 10.1074/jbc.M602979200; Ito A, 1999, BIOCHEM BIOPH RES CO, V265, P611, DOI 10.1006/bbrc.1999.1703; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kambacheld M, 2005, J BIOL CHEM, V280, P20132, DOI 10.1074/jbc.M500398200; Karniely S, 2006, J MOL BIOL, V358, P396, DOI 10.1016/j.jmb.2006.02.023; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Karniely S, 2006, EXP CELL RES, V312, P3835, DOI 10.1016/j.yexcr.2006.08.021; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Knox C, 1998, J BIOL CHEM, V273, P25587, DOI 10.1074/jbc.273.40.25587; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6; LANFORD RE, 1986, CELL, V46, P575, DOI 10.1016/0092-8674(86)90883-4; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nakai Y, 2004, J BIOL CHEM, V279, P12363, DOI 10.1074/jbc.M312448200; Nakai Y, 1998, FEBS LETT, V433, P143, DOI 10.1016/S0014-5793(98)00897-7; Nakai Y, 2001, J BIOL CHEM, V276, P8314, DOI 10.1074/jbc.M007878200; Nakai Y, 2007, MOL CELL BIOL, V27, P2841, DOI 10.1128/MCB.01321-06; NIIDOME T, 1994, J BIOL CHEM, V269, P24719; Prokisch H, 2006, NUCLEIC ACIDS RES, V34, pD705, DOI 10.1093/nar/gkj127; Regev-Rudzki N, 2005, MOL BIOL CELL, V16, P4163, DOI 10.1091/mbc.e04-11-1028; Regev-Rudzki N, 2008, J CELL SCI, V121, P2423, DOI 10.1242/jcs.029207; Regev-Rudzki N, 2007, BIOESSAYS, V29, P772, DOI 10.1002/bies.20609; Sass E, 2003, J BIOL CHEM, V278, P45109, DOI 10.1074/jbc.M302344200; Sass E, 2001, J BIOL CHEM, V276, P46111, DOI 10.1074/jbc.M106061200; Schricker R, 2002, J BIOL CHEM, V277, P28757, DOI 10.1074/jbc.M201561200; Shlevin L, 2007, TRAFFIC, V8, P169, DOI 10.1111/j.1600-0854.2006.00518.x; Yogev O, 2007, J BIOL CHEM, V282, P29222, DOI 10.1074/jbc.M704201200; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754	34	63	65	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30200	30208		10.1074/jbc.M109.034694	http://dx.doi.org/10.1074/jbc.M109.034694			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19720832	Green Published, hybrid			2022-12-25	WOS:000271090000023
J	Griessmeier, K; Cuny, H; Rotzer, K; Griesbeck, O; Harz, H; Biel, M; Wahl-Schott, C				Griessmeier, Kristina; Cuny, Hartmut; Roetzer, Katrin; Griesbeck, Oliver; Harz, Hartmann; Biel, Martin; Wahl-Schott, Christian			Calmodulin Is a Functional Regulator of Cav1.4 L-type Ca2+ Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STATIONARY NIGHT BLINDNESS; GREEN FLUORESCENT PROTEINS; EF-HAND MOTIF; CALCIUM-CHANNEL; CA2+-DEPENDENT INACTIVATION; SYNAPTIC-TRANSMISSION; MOUSE RETINA; FRET; DOMAIN; COMPLEX	Cav1.4 channels are unique among the high voltage-activated Ca2+ channel family because they completely lack Ca2+-dependent inactivation and display very slow voltage-dependent inactivation. Both properties are of crucial importance in ribbon synapses of retinal photoreceptors and bipolar cells, where sustained Ca2+ influx through Cav1.4 channels is required to couple slow graded changes of the membrane potential with tonic glutamate release. Loss of Cav1.4 function causes severe impairment of retinal circuitry function and has been linked to night blindness in humans and mice. Recently, an inhibitory domain (ICDI: inhibitor of Ca2+-dependent inactivation) in the C-terminal tail of Cav1.4 has been discovered that eliminates Ca2+-dependent inactivation by binding to upstream regulatory motifs within the proximal C terminus. The mechanism underlying the action of ICDI is unclear. It was proposed that ICDI competitively displaces the Ca2+ sensor calmodulin. Alternatively, the ICDI domain and calmodulin may bind to different portions of the C terminus and act independently of each other. In the present study, we used fluorescence resonance energy transfer experiments with genetically engineered cyan fluorescent protein variants to address this issue. Our data indicate that calmodulin is preassociated with the C terminus of Cav1.4 but may be tethered in a different steric orientation as compared with other Ca2+ channels. We also find that calmodulin is important for Cav1.4 function because it increases current density and slows down voltage-dependent inactivation. Our data show that the ICDI domain selectively abolishes Ca2+-dependent inactivation, whereas it does not interfere with other calmodulin effects.	[Biel, Martin; Wahl-Schott, Christian] Univ Munich, Dept Pharm, Zentrum Pharmaforsch, D-81377 Munich, Germany; [Wahl-Schott, Christian] Univ Munich, CIPS M, D-81377 Munich, Germany; [Harz, Hartmann] Univ Munich, BioImaging Zentrum, D-81377 Munich, Germany; [Griesbeck, Oliver] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	University of Munich; University of Munich; University of Munich; Max Planck Society	Biel, M (corresponding author), Univ Munich, Dept Pharm, Zentrum Pharmaforsch, Butenandtstr 5-13, D-81377 Munich, Germany.	martin.biel@cup.uni-muenchen.de; christian.wahl@cup.uni-muenchen.de	Wahl-Schott, Christian A/J-2623-2015; Biel, Martin/G-1175-2014	Biel, Martin/0000-0002-9974-3052; Griesbeck, Oliver/0000-0001-5883-5594; Cuny, Hartmut/0000-0002-1551-2354	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG).	Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Barnes S, 2002, ADV EXP MED BIOL, V514, P465; Baumann L, 2004, INVEST OPHTH VIS SCI, V45, P708, DOI 10.1167/iovs.03-0937; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Bernatchez G, 1998, BIOPHYS J, V75, P1727, DOI 10.1016/S0006-3495(98)77614-3; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; Doering CJ, 2007, CHANNELS, V1; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Erickson MG, 2003, BIOPHYS J, V85, P599, DOI 10.1016/S0006-3495(03)74504-4; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Fallon JL, 2003, STRUCTURE, V11, P1303, DOI 10.1016/j.str.2003.09.004; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Hamilton S. L., 2005, SCI STKE; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Mank M, 2006, BIOPHYS J, V90, P1790, DOI 10.1529/biophysj.105.073536; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; Mc Intyre J, 2007, EMBO J, V26, P3783, DOI 10.1038/sj.emboj.7601793; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mori MX, 2008, STRUCTURE, V16, P607, DOI 10.1016/j.str.2008.01.011; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Pedersen M, 2008, J BIOL CHEM, V283, P2663, DOI 10.1074/jbc.M708194200; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Thoreson WB, 2007, MOL NEUROBIOL, V36, P205, DOI 10.1007/s12035-007-0019-9; Topell S, 1999, FEBS LETT, V457, P283, DOI 10.1016/S0014-5793(99)01044-3; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Van Petegem F, 2006, BIOCHEM SOC T, V34, P887, DOI 10.1042/BST0340887; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Wahl-Schott C, 2006, P NATL ACAD SCI USA, V103, P15657, DOI 10.1073/pnas.0604621103; Wang HG, 2007, J NEUROSCI, V27, P9086, DOI 10.1523/JNEUROSCI.1720-07.2007; Wang L, 2008, MOL BIOL CELL, V19, P3944, DOI 10.1091/mbc.E08-04-0344; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287	43	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29809	29816		10.1074/jbc.M109.048082	http://dx.doi.org/10.1074/jbc.M109.048082			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19717559	Green Published, hybrid			2022-12-25	WOS:000270896800061
J	Angelucci, F; Sayed, AA; Williams, DL; Boumis, G; Brunori, M; Dimastrogiovanni, D; Miele, AE; Pauly, F; Bellelli, A				Angelucci, Francesco; Sayed, Ahmed A.; Williams, David L.; Boumis, Giovanna; Brunori, Maurizio; Dimastrogiovanni, Daniela; Miele, Adriana E.; Pauly, Frida; Bellelli, Andrea			Inhibition of Schistosoma mansoni Thioredoxin-glutathione Reductase by Auranofin STRUCTURAL AND KINETIC ASPECTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLD(I) COMPLEXES; DRUGS; MITOCHONDRIAL; PRAZIQUANTEL; MECHANISM; SELENIUM; LIGANDS; SYSTEMS	Schistosomiasis is a parasitic disease affecting over 200 million people currently treated with one drug, praziquantel. A possible drug target is the seleno-protein thioredoxin-glutathione reductase (TGR), a key enzyme in the pathway of the parasite for detoxification of reactive oxygen species. The enzyme is a unique fusion of a glutaredoxin domain with a thioredoxin reductase domain, which contains a selenocysteine (Sec) as the penultimate amino acid. Auranofin (AF), a gold-containing compound already in clinical use as an anti-arthritic drug, has been shown to inhibit TGR and to substantially reduce worm burden in mice. Using x-ray crystallography we solved (at 2.5 angstrom resolution) the structure of wild type TGR incubated with AF. The electron density maps show that the actual inhibitor is gold, released from AF. Gold is bound at three different sites not directly involving the C-terminal Sec residue; however, because the C terminus in the electron density maps is disordered, we cannot exclude the possibility that gold may also bind to Sec. To investigate the possible role of Sec in the inactivation kinetics, we tested the effect of AF on a model enzyme of the same superfamily, i.e. the naturally Sec-lacking glutathione reductase, and on truncated TGR. We demonstrate that the role of selenium in the onset of inhibition by AF is catalytic and can be mimicked by an external source of selenium (benzeneselenol). Therefore, we propose that Sec mediates the transfer of gold from its ligands in AF to the redox-active Cys couples of TGR.	[Angelucci, Francesco; Boumis, Giovanna; Brunori, Maurizio; Dimastrogiovanni, Daniela; Miele, Adriana E.; Pauly, Frida; Bellelli, Andrea] Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, I-00185 Rome, Italy; [Angelucci, Francesco; Boumis, Giovanna; Brunori, Maurizio; Dimastrogiovanni, Daniela; Miele, Adriana E.; Pauly, Frida; Bellelli, Andrea] Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Sayed, Ahmed A.; Williams, David L.] Illinois State Univ, Dept Biol Sci, Normal, IL 61790 USA; [Williams, David L.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60302 USA	Sapienza University Rome; Fondazione Cenci Bolognetti; Illinois State University; Rush University	Bellelli, A (corresponding author), Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, P Le Aldo Moro 5, I-00185 Rome, Italy.	andrea.bellelli@uniroma1.it	Bellelli, Andrea/D-2785-2009; Miele, Adriana E./F-4083-2011	Miele, Adriana E./0000-0002-4637-2606; BOUMIS, Giovanna/0000-0001-5323-7288; Brunori, Maurizio/0000-0002-7795-1635	National Institutes of Health [AI065622]; Fondazione Roma Project "Rational Approach to the Specific Inhibition of Plasmodium falciparum and Schistosoma mansoni,"; "Sapienza" University of Rome Progetto Universita; Progetto Ateneo Federato; Ministero dell'Universita e della Ricerca Italy Fondo per gli Investimenti della Ricerca di Base/Proteomica [2007-protRBRN07BMCT]; European Community Research Infrastructure [R II 3-CT-2004-506008]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondazione Roma Project "Rational Approach to the Specific Inhibition of Plasmodium falciparum and Schistosoma mansoni,"; "Sapienza" University of Rome Progetto Universita; Progetto Ateneo Federato; Ministero dell'Universita e della Ricerca Italy Fondo per gli Investimenti della Ricerca di Base/Proteomica(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); European Community Research Infrastructure(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI065622. This work was also supported by the Fondazione Roma Project "Rational Approach to the Specific Inhibition of Plasmodium falciparum and Schistosoma mansoni," the "Sapienza" University of Rome Progetto Universita 2006 and 2007 and Progetto Ateneo Federato 2006 and 2007, the Ministero dell'Universita e della Ricerca Italy Fondo per gli Investimenti della Ricerca di Base/Proteomica 2007-protRBRN07BMCT, and the European Community Research Infrastructure Action under FP6 "Structuring the European Research Area" Contract R II 3-CT-2004-506008.	Alger HM, 2002, MOL BIOCHEM PARASIT, V121, P129, DOI 10.1016/S0166-6851(02)00031-2; Angelucci F, 2007, PARASITOLOGY, V134, P1215, DOI 10.1017/S0031182007002600; Angelucci F, 2008, PROTEINS, V72, P936, DOI 10.1002/prot.21986; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Becker K, 2000, EUR J BIOCHEM, V267, P6118, DOI 10.1046/j.1432-1327.2000.01703.x; Biterova EI, 2005, P NATL ACAD SCI USA, V102, P15018, DOI 10.1073/pnas.0504218102; Bonilla M, 2008, J BIOL CHEM, V283, P17898, DOI 10.1074/jbc.M710609200; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Cioli D, 2008, TRENDS PARASITOL, V24, P379, DOI 10.1016/j.pt.2008.05.006; COFFER MT, 1987, J INORG BIOCHEM, V30, P177, DOI 10.1016/0162-0134(87)80062-4; Deponte M, 2005, J BIOL CHEM, V280, P20628, DOI 10.1074/jbc.M412519200; Doenhoff MJ, 2002, T ROY SOC TROP MED H, V96, P465, DOI 10.1016/S0035-9203(02)90405-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engst S, 1999, BIOCHEMISTRY-US, V38, P3519, DOI 10.1021/bi982680c; Filipovska A, 2005, J BIOL CHEM, V280, P24113, DOI 10.1074/jbc.M501148200; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Ho YP, 1999, INT J MASS SPECTROM, V182, P175, DOI 10.1016/S1387-3806(98)14245-8; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; ISAB AA, 1988, J AM CHEM SOC, V110, P3278, DOI 10.1021/ja00218a044; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lothrop AP, 2009, BIOCHEMISTRY-US, V48, P6213, DOI 10.1021/bi802146w; Loukas A, 2008, NAT MED, V14, P365, DOI 10.1038/nm0408-365; Mezailles N, 1999, ANGEW CHEM INT EDIT, V38, P3194, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3194::AID-ANIE3194>3.0.CO;2-O; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rendon JL, 2004, MOL BIOCHEM PARASIT, V133, P61, DOI 10.1016/j.molbiopara.2003.09.003; Salinas G, 2004, TRENDS PARASITOL, V20, P340, DOI 10.1016/j.pt.2004.05.002; Sayed AA, 2008, NAT MED, V14, P407, DOI 10.1038/nm1737; Schroder D, 1998, INORG CHEM, V37, P624, DOI 10.1021/ic970986m; SCHRODER D, 1995, ORGANOMETALLICS, V14, P312, DOI 10.1021/om00001a045; Sharma M, 2009, J MOL GRAPH MODEL, V27, P665, DOI 10.1016/j.jmgm.2008.10.009; Shaw CF, 1999, CHEM REV, V99, P2589, DOI 10.1021/cr980431o; SIMCONOV A, 2008, PLOS NEGL TROP, V2, pE127; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Urig S, 2006, ANGEW CHEM INT EDIT, V45, P1881, DOI 10.1002/anie.200502756; Viry E, 2008, CHEMMEDCHEM, V3, P1667, DOI 10.1002/cmdc.200800210	39	146	153	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28977	28985		10.1074/jbc.M109.020701	http://dx.doi.org/10.1074/jbc.M109.020701			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19710012	Green Published, hybrid			2022-12-25	WOS:000270678900055
J	Botelho, RJ; Harrison, RE; Stone, JC; Hancock, JF; Philips, MR; Jongstra-Bilen, J; Mason, D; Plumb, J; Gold, MR; Grinstein, S				Botelho, Roberto J.; Harrison, Rene E.; Stone, James C.; Hancock, John F.; Philips, Mark R.; Jongstra-Bilen, Jenny; Mason, David; Plumb, Jonathan; Gold, Michael R.; Grinstein, Sergio			Localized Diacylglycerol-dependent Stimulation of Ras and Rap1 during Phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RECEPTOR-MEDIATED PHAGOCYTOSIS; NUCLEOTIDE-RELEASING PROTEIN; KAPPA-B ACTIVATION; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNALING SYSTEMS; RESPIRATORY BURST; CELL-DEVELOPMENT; PHORBOL ESTERS; BINDING MOTIFS	We describe a role for diacylglycerol in the activation of Ras and Rap1 at the phagosomal membrane. During phagocytosis, Ras density was similar on the surface and invaginating areas of the membrane, but activation was detectable only in the latter and in sealed phagosomes. Ras activation was associated with the recruitment of RasGRP3, a diacylglycerol-dependent Ras/ Rap1 exchange factor. Recruitment to phagosomes of RasGRP3, which contains a C1 domain, parallels and appears to be due to the formation of diacylglycerol. Accordingly, Ras and Rap1 activation was precluded by antagonists of phospholipase C and of diacylglycerol binding. Ras is dispensable for phagocytosis but controls activation of extracellular signal-regulated kinase, which is partially impeded by diacylglycerol inhibitors. By contrast, cross-activation of complement receptors by stimulation of Fc gamma receptors requires Rap1 and involves diacylglycerol. We suggest a role for diacylglycerol-dependent exchange factors in the activation of Ras and Rap1, which govern distinct processes induced by Fc gamma receptor-mediated phagocytosis to enhance the innate immune response.	[Botelho, Roberto J.] Ryerson Univ, Dept Biol & Chem, Toronto, ON M5B 2K3, Canada; [Harrison, Rene E.] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON M1C 1A4, Canada; [Jongstra-Bilen, Jenny] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5S 1A1, Canada; [Jongstra-Bilen, Jenny] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A1, Canada; [Mason, David] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A1, Canada; [Mason, David; Plumb, Jonathan; Grinstein, Sergio] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Stone, James C.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2R3, Canada; [Hancock, John F.] Univ Texas Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77225 USA; [Philips, Mark R.] NYU, Sch Med, Dept Med Cell Biol & Pharmacol, New York, NY 10016 USA; [Gold, Michael R.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada	Toronto Metropolitan University; University of Toronto; University Toronto Scarborough; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta; University of Texas System; University of Texas Health Science Center Houston; New York University; University of British Columbia	Botelho, RJ (corresponding author), Ryerson Univ, Dept Biol & Chem, 350 Victoria St, Toronto, ON M5B 2K3, Canada.	rbotelho@ryerson.ca	Gold, Michael/AAF-2081-2021; Botelho, Roberto J/B-9145-2013	Gold, Michael/0000-0003-1222-3191; Botelho, Roberto J/0000-0002-7820-0999; Mark, Philips/0000-0002-1179-8156; Mason, David/0000-0002-8773-5274; Hancock, John/0000-0003-0542-4710	National Institutes of Health [GM55279, CA116034]; Canadian Institutes of Health Research (CIHR) [7075]; Natural Sciences and Engineering Research Council of Canada; NATIONAL CANCER INSTITUTE [R01CA116034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055279, R01GM066717] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM55279 and CA116034 (to the laboratory of M. R. P.). This work was also supported by Canadian Institutes of Health Research (CIHR) grant 7075. Work in the laboratory of R. E. H. was supported by CIHR.; Supported by the Natural Sciences and Engineering Research Council of Canada.	Aiba Y, 2004, P NATL ACAD SCI USA, V101, P16612, DOI 10.1073/pnas.0407468101; Allen LAH, 1996, CURR OPIN IMMUNOL, V8, P36, DOI 10.1016/S0952-7915(96)80102-6; ARECES LB, 1994, J BIOL CHEM, V269, P19553; Bivona TG, 2003, CURR OPIN CELL BIOL, V15, P136, DOI 10.1016/S0955-0674(03)00016-4; Bivona TG, 2004, J CELL BIOL, V164, P461, DOI 10.1083/jcb.200311093; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Booth JW, 2002, EMBO J, V21, P251, DOI 10.1093/emboj/21.3.251; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Brumell JH, 1999, J IMMUNOL, V163, P3388; Caloca MJ, 2003, EMBO J, V22, P3326, DOI 10.1093/emboj/cdg316; Caron E, 2000, CURR BIOL, V10, P974, DOI 10.1016/S0960-9822(00)00641-2; Castellano F, 2001, SEMIN IMMUNOL, V13, P347, DOI 10.1006/smim.2001.0331; Cheeseman KL, 2006, MOL BIOL CELL, V17, P799, DOI 10.1091/mbc.E04-12-1100; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DELLABIANCA V, 1990, J IMMUNOL, V144, P1411; DELLABIANCA V, 1993, J LEUKOCYTE BIOL, V53, P427; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; DIVIRGILIO F, 1988, J CELL BIOL, V106, P657, DOI 10.1083/jcb.106.3.657; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Drechsler Y, 2002, J LEUKOCYTE BIOL, V72, P657; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Ebinu JO, 2000, BLOOD, V95, P3199; Garcia-Garcia E, 2001, J LEUKOCYTE BIOL, V70, P649; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; GREENBERG S, 1991, J CELL BIOL, V113, P757, DOI 10.1083/jcb.113.4.757; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Jongstra-Bilen J, 2003, J BIOL CHEM, V278, P45720, DOI 10.1074/jbc.M303704200; Karimi K, 1998, INFLAMMATION, V22, P67, DOI 10.1023/A:1022347808042; Karimi K, 1999, J LEUKOCYTE BIOL, V65, P854, DOI 10.1002/jlb.65.6.854; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P10777, DOI 10.1074/jbc.270.18.10777; Larsen EC, 2002, J CELL BIOL, V159, P939, DOI 10.1083/jcb.200205140; Larsen EC, 2000, J IMMUNOL, V165, P2809, DOI 10.4049/jimmunol.165.5.2809; Lorenzo PS, 2000, MOL PHARMACOL, V57, P840; Lorenzo PS, 2001, CANCER RES, V61, P943; Marshall JG, 2001, J CELL BIOL, V153, P1369, DOI 10.1083/jcb.153.7.1369; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; Matallanas D, 2003, J BIOL CHEM, V278, P4572, DOI 10.1074/jbc.M209807200; McLeod SJ, 1998, J BIOL CHEM, V273, P29218, DOI 10.1074/jbc.273.44.29218; Oancea E, 1998, J CELL BIOL, V140, P485, DOI 10.1083/jcb.140.3.485; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Park RK, 1999, J IMMUNOL, V163, P6023; Patel JC, 2002, MOL BIOL CELL, V13, P1215, DOI 10.1091/mbc.02-01-0002; PIZON V, 1994, J CELL SCI, V107, P1661; Prior IA, 2001, J CELL SCI, V114, P1603; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Rose DM, 1997, J IMMUNOL, V158, P3433; Seastone DJ, 1999, MOL BIOL CELL, V10, P393, DOI 10.1091/mbc.10.2.393; Teixeira C, 2003, BLOOD, V102, P1414, DOI 10.1182/blood-2002-11-3621; Topham MK, 2001, J CELL BIOL, V152, P1135, DOI 10.1083/jcb.152.6.1135; Trotta R, 1996, J EXP MED, V184, P1027, DOI 10.1084/jem.184.3.1027; Yamanashi Y, 2000, GENE DEV, V14, P11; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200; Yang Y, 2002, J BIOL CHEM, V277, P25756, DOI 10.1074/jbc.M202575200; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551; Zheng Y, 2005, BLOOD, V105, P3648, DOI 10.1182/blood-2004-10-3916; Zhong XP, 2002, J BIOL CHEM, V277, P31089, DOI 10.1074/jbc.M203818200	61	23	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28522	28532		10.1074/jbc.M109.009514	http://dx.doi.org/10.1074/jbc.M109.009514			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19700408	Green Published, hybrid			2022-12-25	WOS:000270678900006
J	Stucki, M; Suormala, T; Fowler, B; Valle, D; Baumgartner, MR				Stucki, Martin; Suormala, Terttu; Fowler, Brian; Valle, David; Baumgartner, Matthias R.			Cryptic Exon Activation by Disruption of Exon Splice Enhancer NOVEL MECHANISM CAUSING 3-METHYLCROTONYL-CoA CARBOXYLASE DEFICIENCY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY; GENE-EXPRESSION; IN-VIVO; MUTATIONS; NONSENSE; MECHANISM; DEFECTS; DISEASE; IDENTIFICATION; THERAPY	3-Methylcrotonyl-CoA carboxylase (MCC) deficiency is an autosomal recessive disorder of leucine catabolism. MCC is a heteromeric mitochondrial enzyme composed of biotin-containing alpha (MCCA) and smaller beta (MCCB) subunits encoded by MCCA and MCCB, respectively. We report studies of the c.1054G -> A mutation in exon 11 of MCCB detected in the homozygous state in a patient with MCC deficiency. Sequence analysis of MCCB cDNA revealed two overlapping transcripts, one containing the normal 73 bp of exon 11 including the missense mutation c.1054G -> A (p.G352R), the other with exon 11 replaced by a 64-bp sequence from intron 10 (cryptic exon 10a) that maintains the reading frame and is flanked by acceptable splice consensus sites. In expression studies, we show that both transcripts lack detectable MCC activity. Western blot analysis showed slightly reduced levels of MCCB using the transcript containing the missense mutation, whereas no MCCB was detected with the transcript containing the cryptic exon 10a. Analysis of the region harboring the mutation revealed that the c.1054G -> A mutation is located in an exon splice enhancer sequence. Using MCCB minigene constructs to transfect MCCB-deficient fibroblasts, we demonstrate that the reduction in utilization of exon 11 associated with the c.1054G -> A mutation is due to alteration of this exon splice enhancer. Further, we show that optimization of the weak splice donor site of exon 11 corrects the splicing defect. To our knowledge, this is the first demonstration of a point mutation disrupting an exon splice enhancer that causes exon skipping along with utilization of a cryptic exon.	[Stucki, Martin; Baumgartner, Matthias R.] Univ Childrens Hosp, Div Metab, CH-8032 Zurich, Switzerland; [Stucki, Martin] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Suormala, Terttu; Fowler, Brian] Univ Childrens Hosp, Metab Unit, CH-4005 Basel, Switzerland; [Valle, David] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	University Children's Hospital Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Johns Hopkins University	Baumgartner, MR (corresponding author), Univ Childrens Hosp, Div Metab, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	Matthias.Baumgartner@kispi.uzh.ch	Baumgartner, Matthias R/Q-2855-2017	Baumgartner, Matthias R/0000-0002-9270-0826	Swiss National Science Foundation [3200AO-109219/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 3200AO-109219/1.	Antonarakis S. E., 2001, METABOLIC MOL BASES, P343; Baumgartner MR, 2001, J CLIN INVEST, V107, P495, DOI 10.1172/JCI11948; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Black DL, 2005, P NATL ACAD SCI USA, V102, P4927, DOI 10.1073/pnas.0501414102; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; Buratti E, 2007, NUCLEIC ACIDS RES, V35, P4369, DOI 10.1093/nar/gkm447; Buratti E, 2006, NUCLEIC ACIDS RES, V34, P3494, DOI 10.1093/nar/gkl498; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NAT STRUCT BIOL, V10, P120, DOI 10.1038/nsb887; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Dantas Maria Fernanda, 2005, Hum Mutat, V26, P164, DOI 10.1002/humu.9352; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; Fairbrother WG, 2004, NUCLEIC ACIDS RES, V32, pW187, DOI 10.1093/nar/gkh393; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Goyenvalle A, 2009, MOL THER, V17, P1234, DOI 10.1038/mt.2009.113; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Gregersen N, 2001, J INHERIT METAB DIS, V24, P189, DOI 10.1023/A:1010319001722; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Metherell Louise A., 2001, American Journal of Human Genetics, V69, P641, DOI 10.1086/323266; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; Nielsen KB, 2007, AM J HUM GENET, V80, P416, DOI 10.1086/511992; Ridout CK, 2008, HUM MUTAT, V29, P451, DOI 10.1002/humu.9525; Schaal TD, 1999, MOL CELL BIOL, V19, P1705; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Skordis LA, 2003, P NATL ACAD SCI USA, V100, P4114, DOI 10.1073/pnas.0633863100; Stadler SC, 2006, HUM MUTAT, V27, P748, DOI 10.1002/humu.20349; Sun HZ, 2000, MOL CELL BIOL, V20, P6414, DOI 10.1128/MCB.20.17.6414-6425.2000; SUORMALA T, 1985, CLIN CHIM ACTA, V145, P151, DOI 10.1016/0009-8981(85)90282-7; Teraoka SN, 1999, AM J HUM GENET, V64, P1617, DOI 10.1086/302418; Tran VK, 2005, J HUM GENET, V50, P425, DOI 10.1007/s10038-005-0272-6; Wimmer K, 2007, HUM MUTAT, V28, P599, DOI 10.1002/humu.20493	36	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28953	28957		10.1074/jbc.M109.050674	http://dx.doi.org/10.1074/jbc.M109.050674			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706617	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000270678900052
J	Ferwerda, B; McCall, MBB; de Vries, MC; Hopman, J; Maiga, B; Dolo, A; Doumbo, O; Daou, M; de Jong, D; Joosten, LAB; Tissingh, RA; Reubsaet, FAG; Sauerwein, R; van der Meer, JWM; van der Ven, AJAM; Netea, MG				Ferwerda, Bart; McCall, Matthew B. B.; de Vries, Maaike C.; Hopman, Joost; Maiga, Boubacar; Dolo, Amagana; Doumbo, Ogobara; Daou, Modibo; de Jong, Dirk; Joosten, Leo A. B.; Tissingh, Rudi A.; Reubsaet, Frans A. G.; Sauerwein, Robert; van der Meer, Jos W. M.; van der Ven, Andre J. A. M.; Netea, Mihai G.			Caspase-12 and the Inflammatory Response to Yersinia pestis	PLOS ONE			English	Article								Background: Caspase-12 functions as an antiinflammatory enzyme inhibiting caspase-1 and the NOD2/RIP2 pathways. Due to increased susceptibility to sepsis in individuals with functional caspase-12, an early-stop mutation leading to the loss of caspase-12 has replaced the ancient genotype in Eurasia and a significant proportion of individuals from African populations. In African-Americans, it has been shown that caspase-12 inhibits the pro-inflammatory cytokine production. Methodology/Principal Findings: We assessed whether similar mechanisms are present in African individuals, and whether evolutionary pressures due to plague may have led to the present caspase-12 genotype population frequencies. No difference in cytokine induction through the caspase-1 and/or NOD2/RIP2 pathways was observed in two independent African populations, among individuals with either an intact or absent caspase-12. In addition, stimulations with Yersinia pestis and two other species of Yersinia were preformed to investigate whether caspase-12 modulates the inflammatory reaction induced by Yersinia. We found that caspase-12 did not modulate cytokine production induced by Yersinia spp. Conclusions: Our experiments demonstrate for the first time the involvement of the NOD2/RIP2 pathway for recognition of Yersinia. However, caspase-12 does not modulate innate host defense against Y. pestis and alternative explanations for the geographical distribution of caspase-12 should be sought.			Ferwerda, B (corresponding author), Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	E.ferwerda@aig.umcn.nl	van der Meer, Jos W.M./C-8521-2013; van der Ven, A.J.A.M./H-8102-2014; Joosten, Leo AB/H-3138-2015; Sauerwein, Robert/C-8519-2013; de Vries, M.C./L-4735-2015; Netea, Mihai/N-5155-2014	van der Meer, Jos W.M./0000-0001-5120-3690; van der Ven, A.J.A.M./0000-0003-1833-3391; Joosten, Leo AB/0000-0001-6166-9830; Ferwerda, Bart/0000-0002-7050-5931; McCall, Matthew/0000-0002-5738-1401				Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; Dolo A, 2005, AM J TROP MED HYG, V72, P243, DOI 10.4269/ajtmh.2005.72.243; Eckhart L, 2008, MOL BIOL EVOL, V25, P831, DOI 10.1093/molbev/msn012; Fischer H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Grebenchtchikov N, 2005, EUR CYTOKINE NETW, V16, P215; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kachapati Kritika, 2006, Hum Mutat, V27, P975, DOI 10.1002/humu.9448; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; LeBlanc PM, 2008, CELL HOST MICROBE, V3, P146, DOI 10.1016/j.chom.2008.02.004; Levasseur A, 2007, BIOL REV, V82, P551, DOI 10.1111/j.1469-185X.2007.00024.x; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Nadiri A, 2006, J IMMUNOL, V177, P4239, DOI 10.4049/jimmunol.177.7.4239; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Netea MG, 2005, NETH J MED, V63, P305; O'Brien TR, 2007, SCAND J GASTROENTERO, V42, P416, DOI 10.1080/00365520601076074; Saleh M, 2006, NATURE, V440, P1064, DOI 10.1038/nature04656; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; Schotte P, 2004, J BIOL CHEM, V279, P25134, DOI 10.1074/jbc.M401245200; Scott AM, 2007, CELL DEATH DIFFER, V14, P23, DOI 10.1038/sj.cdd.4402026; Sing A, 2003, INT J MED MICROBIOL, V293, P341, DOI 10.1078/1438-4221-00277; Wang XX, 2006, PLOS BIOL, V4, P366, DOI 10.1371/journal.pbio.0040052; Xue YL, 2006, AM J HUM GENET, V78, P659, DOI 10.1086/503116	30	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2009	4	9							e6870	10.1371/journal.pone.0006870	http://dx.doi.org/10.1371/journal.pone.0006870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489XX	19721713	Green Submitted, gold, Green Published			2022-12-25	WOS:000269461100002
J	Samoshkin, A; Arnaoutov, A; Jansen, LET; Ouspenski, I; Dye, L; Karpova, T; McNally, J; Dasso, M; Cleveland, DW; Strunnikov, A				Samoshkin, Alexander; Arnaoutov, Alexei; Jansen, Lars E. T.; Ouspenski, Ilia; Dye, Louis; Karpova, Tatiana; McNally, James; Dasso, Mary; Cleveland, Don W.; Strunnikov, Alexander			Human Condensin Function Is Essential for Centromeric Chromatin Assembly and Proper Sister Kinetochore Orientation	PLOS ONE			English	Article							MITOTIC CHROMOSOME ARCHITECTURE; AURORA-B; HISTONE H3; MICROTUBULE ATTACHMENT; STRUCTURAL INTEGRITY; OUTER PLATE; COMPLEX; SEGREGATION; PROTEIN; PHOSPHORYLATION	Condensins I and II in vertebrates are essential ATP-dependent complexes necessary for chromosome condensation in mitosis. Condensins depletion is known to perturb structure and function of centromeres, however the mechanism of this functional link remains elusive. Depletion of condensin activity is now shown to result in a significant loss of loading of CENP-A, the histone H3 variant found at active centromeres and the proposed epigenetic mark of centromere identity. Absence of condensins and/or CENP-A insufficiency produced a specific kinetochore defect, such that a functional mitotic checkpoint cannot prevent chromosome missegregation resulting from improper attachment of sister kinetochores to spindle microtubules. Spindle microtubule-dependent deformation of both inner kinetochores and the HEC1/Ndc80 microtubule-capturing module, then results in kinetochore separation from the Aurora B pool and ensuing reduced kinase activity at centromeres. Moreover, recovery from mitosis-inhibition by monastrol revealed a high incidence of merotelic attachment that was nearly identical with condensin depletion, Aurora B inactivation, or both, indicating that the Aurora B dysfunction is the key defect leading to chromosome missegregation in condensin-depleted cells. Thus, beyond a requirement for global chromosome condensation, condensins play a pivotal role in centromere assembly, proper spatial positioning of microtubule-capturing modules and positioning complexes of the inner centromere versus kinetochore plates.			Samoshkin, A (corresponding author), NICHHD, Unit Chromosome Struct & Funct, NICHD, LGRD, Bethesda, MD 20892 USA.	strunnik@mail.nih.gov	Cleveland, Don/AAN-9783-2021	Dasso, Mary/0000-0002-5410-1371; Cleveland, Don/0000-0002-1934-3682; Karpova, Tatiana/0000-0001-6025-2128; Strunnikov, Alexander/0000-0002-9058-2256; Jansen, Lars/0000-0002-2158-0345; Arnaoutov, Alexei/0000-0001-7647-7217; Samoshkin, Alexander/0000-0001-6296-2254	Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [R01 GM074150, GM074150] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074150] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Bhat MA, 1996, CELL, V87, P1103, DOI 10.1016/S0092-8674(00)81804-8; Boyarchuk Y, 2007, J CELL BIOL, V176, P919, DOI 10.1083/jcb.200609044; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Cimini D, 2004, CURR BIOL, V14, P2149, DOI 10.1016/j.cub.2004.11.029; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852; Dong YM, 2007, NAT CELL BIOL, V9, P516, DOI 10.1038/ncb1576; Freeman L, 2000, J CELL BIOL, V149, P811, DOI 10.1083/jcb.149.4.811; Gassmann R, 2004, EXP CELL RES, V296, P35, DOI 10.1016/j.yexcr.2004.03.006; Gerlich D, 2006, CURR BIOL, V16, P333, DOI 10.1016/j.cub.2005.12.040; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Ham MF, 2007, CANCER SCI, V98, P1041, DOI 10.1111/j.1349-7006.2007.00500.x; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; Hirano T, 2004, CELL CYCLE, V3, P26; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Hudson DF, 2003, DEV CELL, V5, P323, DOI 10.1016/S1534-5807(03)00199-0; Jager H, 2005, CHROMOSOMA, V113, P350, DOI 10.1007/s00412-004-0322-4; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kimura K, 1999, CELL, V98, P239, DOI 10.1016/S0092-8674(00)81018-1; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lipp JJ, 2007, J CELL SCI, V120, P1245, DOI 10.1242/jcs.03425; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Maddox PS, 2006, P NATL ACAD SCI USA, V103, P15097, DOI 10.1073/pnas.0606993103; Maresca TJ, 2009, J CELL BIOL, V184, P373, DOI 10.1083/jcb.200808130; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Moore LL, 2005, MOL CELL BIOL, V25, P2583, DOI 10.1128/MCB.25.7.2583-2592.2005; Nakazawa N, 2008, J CELL BIOL, V180, P1115, DOI 10.1083/jcb.200708170; Ohi R, 2003, DEV CELL, V5, P309, DOI 10.1016/S1534-5807(03)00229-6; Oliveira RA, 2005, MOL CELL BIOL, V25, P8971, DOI 10.1128/MCB.25.20.8971-8984.2005; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Ribeiro SA, 2009, MOL BIOL CELL, V20, P2371, DOI 10.1091/mbc.E08-11-1127; Salmon ED, 2005, PHILOS T R SOC B, V360, P553, DOI 10.1098/rstb.2004.1610; Stear JH, 2002, GENE DEV, V16, P1498, DOI 10.1101/gad.989102; Steffensen S, 2001, CURR BIOL, V11, P295, DOI 10.1016/S0960-9822(01)00096-3; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Sutani T, 1999, GENE DEV, V13, P2271, DOI 10.1101/gad.13.17.2271; Takemoto A, 2007, NUCLEIC ACIDS RES, V35, P2403, DOI 10.1093/nar/gkm157; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Uchida KSK, 2009, J CELL BIOL, V184, P383, DOI 10.1083/jcb.200811028; Vader G, 2007, MOL BIOL CELL, V18, P4553, DOI 10.1091/mbc.E07-04-0328; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Vas ACJ, 2007, MOL BIOL CELL, V18, P557, DOI 10.1091/mbc.E06-05-0454; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Wang BD, 2005, MOL CELL BIOL, V25, P7216, DOI 10.1128/MCB.25.16.7216-7225.2005; Wang BD, 2006, CELL CYCLE, V5, P2260, DOI 10.4161/cc.5.19.3292; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Yeh E, 2008, CURR BIOL, V18, P81, DOI 10.1016/j.cub.2007.12.019; Yeong FM, 2003, CURR BIOL, V13, P2058, DOI 10.1016/j.cub.2003.10.032; Yoda K, 2004, METHOD ENZYMOL, V375, P270; Yong-Gonzalez V, 2007, GENES CELLS, V12, P1075, DOI 10.1111/j.1365-2443.2007.01109.x; ZINKOWSKI RP, 1991, J CELL BIOL, V113, P1091, DOI 10.1083/jcb.113.5.1091	61	62	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2009	4	8							e6831	10.1371/journal.pone.0006831	http://dx.doi.org/10.1371/journal.pone.0006831			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JG	19714251	Green Submitted, gold, Green Published			2022-12-25	WOS:000269415800015
J	Panek, AN; Posch, MG; Alenina, N; Ghadge, SK; Erdmann, B; Popova, E; Perrot, A; Geier, C; Dietz, R; Morano, I; Bader, M; Ozcelik, C				Panek, Anna N.; Posch, Maximilian G.; Alenina, Natalia; Ghadge, Santhosh K.; Erdmann, Bettina; Popova, Elena; Perrot, Andreas; Geier, Christian; Dietz, Rainer; Morano, Ingo; Bader, Michael; Oezcelik, Cemil			Connective Tissue Growth Factor Overexpression in Cardiomyocytes Promotes Cardiac Hypertrophy and Protection against Pressure Overload	PLOS ONE			English	Article								Connective tissue growth factor (CTGF) is a secreted protein that is strongly induced in human and experimental heart failure. CTGF is said to be profibrotic; however, the precise function of CTGF is unclear. We generated transgenic mice and rats with cardiomyocyte-specific CTGF overexpression (CTGF-TG). To investigate CTGF as a fibrosis inducer, we performed morphological and gene expression analyses of CTGF-TG mice and rat hearts under basal conditions and after stimulation with angiotensin II (Ang II) or isoproterenol, respectively. Surprisingly, cardiac tissues of both models did not show increased fibrosis or enhanced gene expression of fibrotic markers. In contrast to controls, Ang II treated CTGF-TG mice displayed preserved cardiac function. However, CTGF-TG mice developed age-dependent cardiac dysfunction at the age of 7 months. CTGF related heart failure was associated with Akt and JNK activation, but not with the induction of natriuretic peptides. Furthermore, cardiomyocytes from CTGF-TG mice showed unaffected cellular contractility and an increased Ca(2+) reuptake from sarcoplasmatic reticulum. In an ischemia/reperfusion model CTGF-TG hearts did not differ from controls. Our data suggest that CTGF itself does not induce cardiac fibrosis. Moreover, it is involved in hypertrophy induction and cellular remodeling depending on the cardiac stress stimulus. Our new transgenic animals are valuable models for reconsideration of CTGF's profibrotic function in the heart.			Panek, AN (corresponding author), Max Delbruck Ctr Mol Med, Dept Cardiovasc & Metab Dis Res, Berlin, Germany.	cemil.oezcelik@charite.de	Bader, Michael/K-2124-2013	Bader, Michael/0000-0003-4780-4164; Popova, Elena/0000-0002-3043-9650; Perrot, Andreas/0000-0002-8800-342X				Ahmed MS, 2005, ACTA PHYSIOL SCAND, V184, P27, DOI 10.1111/j.1365-201X.2005.01416.x; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Blom IE, 2002, MATRIX BIOL, V21, P473, DOI 10.1016/S0945-053X(02)00055-0; Bonniaud P, 2003, AM J RESP CRIT CARE, V168, P770, DOI 10.1164/rccm.200210-1254OC; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; Chen H, 2004, PHYSIOL GENOMICS, V18, P273, DOI 10.1152/physiolgenomics.00104.2004; Chien KR, 2000, NATURE, V407, P227, DOI 10.1038/35025196; Dean RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1245, DOI 10.1369/jhc.4A6560.2005; Gabrielsen A, 2007, J MOL CELL CARDIOL, V42, P870, DOI 10.1016/j.yjmcc.2006.12.016; Gauldie J, 2002, AM J RESP CRIT CARE, V165, P1205, DOI 10.1164/rccm.2202054; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Hayata N, 2008, BIOCHEM BIOPH RES CO, V370, P274, DOI 10.1016/j.bbrc.2008.03.100; He ZH, 2005, J BIOL CHEM, V280, P15719, DOI 10.1074/jbc.M413493200; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Kannel W B, 2000, Heart Fail Rev, V5, P167; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Koitabashi N, 2008, EUR J HEART FAIL, V10, P373, DOI 10.1016/j.ejheart.2008.02.011; Koitabashi N, 2007, HYPERTENSION, V49, P1120, DOI 10.1161/HYPERTENSIONAHA.106.077537; Lang C, 2008, J MOL MED-JMM, V86, P49, DOI 10.1007/s00109-007-0249-3; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Matsui Y, 2004, J MOL CELL CARDIOL, V37, P477, DOI 10.1016/j.yjmcc.2004.05.012; Mori Y, 2008, EXP CELL RES, V314, P1094, DOI 10.1016/j.yexcr.2007.12.010; Ohnishi H, 1998, J MOL CELL CARDIOL, V30, P2411, DOI 10.1006/jmcc.1998.0799; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; RE RN, 2006, MOL MECH HYPERTENSIO, P75; Riser BL, 2000, J AM SOC NEPHROL, V11, P25, DOI 10.1681/ASN.V11125; Roestenberg P, 2006, AM J PHYSIOL-RENAL, V290, pF1344, DOI 10.1152/ajprenal.00174.2005; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Whitfield ML, 2003, P NATL ACAD SCI USA, V100, P12319, DOI 10.1073/pnas.1635114100; Yokoi H, 2008, KIDNEY INT, V73, P446, DOI 10.1038/sj.ki.5002722	32	110	111	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6743	10.1371/journal.pone.0006743	http://dx.doi.org/10.1371/journal.pone.0006743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707545	Green Published, gold, Green Accepted			2022-12-25	WOS:000269278400010
J	Beck, L; Leroy, C; Salaun, C; Margall-Ducos, G; Desdouets, C; Friedlander, G				Beck, Laurent; Leroy, Christine; Salauen, Christine; Margall-Ducos, Germain; Desdouets, Chantal; Friedlander, Gerard			Identification of a Novel Function of PiT1 Critical for Cell Proliferation and Independent of Its Phosphate Transport Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APE LEUKEMIA-VIRUS; RETROVIRUS RECEPTOR; INORGANIC-PHOSPHATE; VITAMIN-D; EXPRESSION; CLONING; PROTEIN; KIDNEY; MOUSE; LOOP	PiT1 is a Na+-phosphate (P-i) cotransporter located at the plasma membrane that enables P-i entry into the cell. Its broad tissue expression pattern has led to the idea that together with the closely related family member PiT2, PiT1 is the ubiquitous supplier of P-i to the cell. Moreover, the role of P-i in phosphorylation reactions, ATP production, DNA structure, and synthesis has led to the view that P-i availability could be an important determinant of cell growth. However, these issues have not been clearly addressed to date, and the role of either P-i or PiT proteins in cell proliferation is unknown. Using RNA interference in HeLa and HepG2 cells, we show that transient or stable PiT1 depletion markedly reduces cell proliferation, delays cell cycle, and impairs mitosis and cytokinesis. In vivo, PiT1 depletion greatly reduced tumor growth when engineered HeLa cells were injected into nude mice. We provide evidence that this effect on cell proliferation is specific to PiT1 and not shared by PiT2 and is not the consequence of impaired membrane Na+-Pi transport. Moreover, we show that modulation of cell proliferation by PiT1 is independent from its transport function because the proliferation of PiT1-depleted cells can be rescued by nontransporting PiT1 mutants. PiT1 depletion leads to the phosphorylation of p38 mitogen-activated protein (MAP) kinase, whereas other MAP kinases and downstream targets of mammalian target of rapamycin (mTOR) remain unaffected. This study is the first to describe the effects of a P-i transporter in cell proliferation, tumor growth, and cell signaling.	[Beck, Laurent; Leroy, Christine; Salauen, Christine; Friedlander, Gerard] INSERM, Growth & Signalling Res Ctr, U845, F-75015 Paris, France; [Beck, Laurent; Leroy, Christine; Salauen, Christine; Margall-Ducos, Germain; Desdouets, Chantal; Friedlander, Gerard] INSERM, U567, Cochin Inst, F-75015 Paris, France; [Margall-Ducos, Germain; Desdouets, Chantal] CNRS, UMR8104, Cochin Inst, F-75015 Paris, France; [Beck, Laurent] Univ Paris 05, Ctr Rech, INSERM, Fac Med,U845, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Beck, L (corresponding author), Univ Paris 05, Ctr Rech, INSERM, Fac Med,U845, 156 Rue Vaugirard, F-75015 Paris, France.	laurent.beck@inserm.fr	BECK, Laurent/P-2952-2014; Desdouets, Chantal/M-3430-2017	BECK, Laurent/0000-0002-6730-2762; Friedlander, Gerard/0000-0002-6854-4261; Salaun, Christine/0000-0003-3002-6810	INSERM; CNRS; Universite Paris Descartes; Association Laboratoire de Recherches Physiologiques; Agence Nationale pour la Recherche (ANR)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Descartes; Association Laboratoire de Recherches Physiologiques; Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by grants from INSERM, CNRS, Universite Paris Descartes, Association Laboratoire de Recherches Physiologiques, and Agence Nationale pour la Recherche (ANR).	Barac-Nieto M, 2001, EXP NEPHROL, V9, P258; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Beck L, 2000, J BIOL CHEM, V275, P11880, DOI 10.1074/jbc.275.16.11880; BINGGELI R, 1986, J THEOR BIOL, V123, P377, DOI 10.1016/S0022-5193(86)80209-0; Bottger P, 2005, FEBS J, V272, P3060, DOI 10.1111/j.1742-4658.2005.04720.x; Bottger P, 2002, J BIOL CHEM, V277, P42741, DOI 10.1074/jbc.M207096200; Bottger P, 2006, AM J PHYSIOL-CELL PH, V291, pC1377, DOI 10.1152/ajpcell.00015.2006; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Cha HJ, 2007, J BIOL CHEM, V282, P22984, DOI 10.1074/jbc.M700735200; Chien ML, 1997, J VIROL, V71, P4564, DOI 10.1128/JVI.71.6.4564-4570.1997; CONE CD, 1971, J THEOR BIOL, V30, P151, DOI 10.1016/0022-5193(71)90042-7; Crook M, 1996, ANN CLIN BIOCHEM, V33, P376, DOI 10.1177/000456329603300502; Dreyer K, 2000, J VIROL, V74, P2926, DOI 10.1128/JVI.74.6.2926-2929.2000; ESCOUBET B, 1992, J ENDOCRINOL, V133, P301, DOI 10.1677/joe.0.1330301; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Guillemain G, 2000, J CELL SCI, V113, P841; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MILLER DG, 1994, P NATL ACAD SCI USA, V91, P78, DOI 10.1073/pnas.91.1.78; OHARA B, 1990, CELL GROWTH DIFFER, V1, P119; Palmer G, 1999, BONE, V24, P1, DOI 10.1016/S8756-3282(98)00151-3; Prie D, 2009, KIDNEY INT, V75, P882, DOI 10.1038/ki.2008.643; Ravera S, 2007, AM J PHYSIOL-CELL PH, V293, pC606, DOI 10.1152/ajpcell.00064.2007; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Salaun C, 2004, J MOL BIOL, V340, P39, DOI 10.1016/j.jmb.2004.04.050; Salaun C, 2001, J VIROL, V75, P5584, DOI 10.1128/JVI.75.12.5584-5592.2001; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sundelacruz S, 2009, STEM CELL REV REP, V5, P231, DOI 10.1007/s12015-009-9080-2; TENENHOUSE HS, 1989, BIOCHIM BIOPHYS ACTA, V984, P207, DOI 10.1016/0005-2736(89)90218-6; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Uckert W, 1998, HUM GENE THER, V9, P2619, DOI 10.1089/10430349850019454; Virkki LV, 2007, AM J PHYSIOL-RENAL, V293, pF643, DOI 10.1152/ajprenal.00228.2007; Werner A, 2001, AM J PHYSIOL-REG I, V280, pR301, DOI 10.1152/ajpregu.2001.280.2.R301; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000	39	81	85	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31363	31374		10.1074/jbc.M109.053132	http://dx.doi.org/10.1074/jbc.M109.053132			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19726692	Green Published, hybrid			2022-12-25	WOS:000271378400062
J	Nagelin, MH; Srinivasan, S; Nadler, JL; Hedrick, CC				Nagelin, Melissa H.; Srinivasan, Suseela; Nadler, Jerry L.; Hedrick, Catherine C.			Murine 12/15-Lipoxygenase Regulates ATP-binding Cassette Transporter G1 Protein Degradation through p38-and JNK2-dependent Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; 12-HYDROXYEICOSATETRAENOIC ACID; DEPENDENT DEGRADATION; ANGIOTENSIN-II; MONOCYTE/ENDOTHELIAL INTERACTIONS; MACROPHAGE 12/15-LIPOXYGENASE; 15-LIPOXYGENASE EXPRESSION; 12-LIPOXYGENASE PRODUCT; CELLULAR CHOLESTEROL; ENDOTHELIAL-CELLS	12/15-Lipoxygenase (12/15LO) plays a role in the pathogenesis of atherosclerosis and diabetes and has been implicated in low density lipoprotein oxidation. Murine macrophages express high levels of 12/15LO and are key cells involved in the accumulation and efflux of oxidized low density lipoprotein in the arterial wall. During this process, macrophages up-regulates cavenger receptors that regulate lipid uptake, and ATP-binding cassette (ABC) transporters, that regulate lipid efflux. We have previously demonstrated that 12/15LO enhances the turnover and serine phosphorylation of ABCG1. In the current study, we further elucidate the mechanisms by which 12/15LO regulates ABCG1. Proteasomal inhibitors blocked the down-regulation of ABCG1 expression and resulted in accumulation of phosphorylated ABCG1. Macrophages that lack 12/15LO have enhanced transporter expression, reduced ABCG1 phosphorylation, and increased cholesterol efflux. Conversely, macrophages that overexpress 12/15LO have reduced ABCG1 expression, increased transporter phosphorylation, and reduced cholesterol efflux. 12/15LO plays a key role in activating the MAPK pathway. Inhibition of the p38 or JNK pathways with pharmacological inhibitors or dominant negative constructs blocked 12S-hydroxyeicosatetranoic acid-mediated degradation of ABCG1. Moreover, we isolated macrophages from JNK1-, JNK2-, and MKK3-deficient mice to analyze the involvement of specific MAPK pathways. JNK2- and MKK3-, but not JNK1-deficient macrophages were resistant to the down-regulation of ABCG1 protein, reduction in efflux, and increase in serine phosphorylation by 12S-hydroxyeicosatetranoic acid. These findings provide evidence that 12/15LO regulates ABCG1 expression and function through p38- and JNK2-dependent mechanisms, and that targeting these pathways may provide novel approaches for regulating cholesterol homeostasis.	[Nagelin, Melissa H.; Hedrick, Catherine C.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Nagelin, Melissa H.; Srinivasan, Suseela; Hedrick, Catherine C.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Hedrick, Catherine C.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Nadler, Jerry L.] Eastern Virginia Med Sch, Dept Med, Norfolk, VA 23501 USA	University of Virginia; University of Virginia; University of Virginia; Eastern Virginia Medical School	Hedrick, CC (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, 9420 Athena Circle, La Jolla, CA 92037 USA.	Hedrick@liai.org	Hedrick, Catherine/D-1106-2012		National Institutes of Health [P01 HL55798, R01 HL085790]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL055798, R01HL085790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL55798 (to C. C. H. and to J. L. N.) and R01 HL085790 (to C. C. H.).	ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; ANGEL A, 1974, J LIPID RES, V15, P491; Antonipillai I, 1996, J CLIN ENDOCR METAB, V81, P1940, DOI 10.1210/jc.81.5.1940; Belkner J, 2005, ARTERIOSCL THROM VAS, V25, P797, DOI 10.1161/01.ATV.0000157580.26858.2d; Brinckmann R, 1996, BIOCHEM J, V318, P305, DOI 10.1042/bj3180305; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; CHEN XS, 1994, J BIOL CHEM, V269, P13979; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; Cyrus T, 2001, CIRCULATION, V103, P2277; DEBRUIJN MFTR, 1994, EUR J IMMUNOL, V24, P2279, DOI 10.1002/eji.1830241003; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Funk CD, 1996, BBA-LIPID LIPID MET, V1304, P65, DOI 10.1016/S0005-2760(96)00107-5; Hatley ME, 2003, J BIOL CHEM, V278, P25369, DOI 10.1074/jbc.M301175200; Heydeck D, 1998, BLOOD, V92, P2503, DOI 10.1182/blood.V92.7.2503.2503_2503_2510; Huo YQ, 2004, CIRCULATION, V110, P2024, DOI 10.1161/01.CIR.0000143628.37680.F6; Kida A, 2007, ONCOGENE, V26, P6630, DOI 10.1038/sj.onc.1210490; KUHN H, 1994, J LIPID RES, V35, P1749; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1168, P73, DOI 10.1016/0005-2760(93)90268-E; Kuma Y, 2004, BIOCHEM J, V379, P133, DOI 10.1042/BJ20031559; Lange CA, 2000, P NATL ACAD SCI USA, V97, P1032, DOI 10.1073/pnas.97.3.1032; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Marchetti S, 2005, MOL CELL BIOL, V25, P854, DOI 10.1128/MCB.25.2.854-864.2005; Martinez LO, 2003, J BIOL CHEM, V278, P37368, DOI 10.1074/jbc.M307161200; Mauldin JP, 2006, J BIOL CHEM, V281, P21216, DOI 10.1074/jbc.M510952200; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; MILLIKEN GA, 1995, STAT MED, V14, P701, DOI 10.1002/sim.4780140530; Nagelin MH, 2008, ARTERIOSCL THROM VAS, V28, P1811, DOI 10.1161/ATVBAHA.108.167908; NATARAJAN R, 1994, MOL CELL ENDOCRINOL, V101, P59, DOI 10.1016/0303-7207(94)90219-4; NICHOLS AB, 1976, JAMA-J AM MED ASSOC, V236, P1948, DOI 10.1001/jama.236.17.1948; Obinata H, 2005, J BIOL CHEM, V280, P40676, DOI 10.1074/jbc.M507787200; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; PARKS JS, 1979, J BIOL CHEM, V254, P6716; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Rao GN, 1996, J BIOL CHEM, V271, P27760, DOI 10.1074/jbc.271.44.27760; Reddy MA, 2002, J BIOL CHEM, V277, P9920, DOI 10.1074/jbc.M111305200; Reilly KB, 2004, J BIOL CHEM, V279, P9440, DOI 10.1074/jbc.M303857200; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Roosbeek S, 2004, J BIOL CHEM, V279, P37779, DOI 10.1074/jbc.M401821200; Schwabedissen HEMZ, 2006, DRUG METAB DISPOS, V34, P524, DOI 10.1124/dmd.105.007591; See RH, 2002, J BIOL CHEM, V277, P41835, DOI 10.1074/jbc.M204923200; SETTY BNY, 1987, J BIOL CHEM, V262, P17613; Shen JH, 1996, J CLIN INVEST, V98, P2201, DOI 10.1172/JCI119029; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; SPECTOR AA, 1988, PROG LIPID RES, V27, P271, DOI 10.1016/0163-7827(88)90009-4; Srinivasan S, 2004, J BIOL CHEM, V279, P31930, DOI 10.1074/jbc.M400753200; Toda A, 2002, PROSTAG OTH LIPID M, V68-9, P575, DOI 10.1016/S0090-6980(02)00056-4; Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; Wang YT, 2007, J LIPID RES, V48, P1062, DOI 10.1194/jlr.M600437-JLR200; Weibel GL, 2009, ARTERIOSCL THROM VAS, V29, P837, DOI 10.1161/ATVBAHA.109.186163; Wen Y, 2000, BIOCHEM J, V349, P481, DOI 10.1042/0264-6021:3490481; Wen YS, 2007, ENDOCRINOLOGY, V148, P1313, DOI 10.1210/en.2006-0665; Wen YS, 1996, AM J PHYSIOL-CELL PH, V271, pC1212, DOI 10.1152/ajpcell.1996.271.4.C1212; Wen YS, 1997, CIRC RES, V81, P651; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Xie Y, 2008, J BIOL CHEM, V283, P3349, DOI 10.1074/jbc.M707773200; Yamamoto SY, 1997, ADV EXP MED BIOL, V400, P127; YLAHERTTUALA S, 1990, P NATL ACAD SCI USA, V87, P6959, DOI 10.1073/pnas.87.18.6959; Yoshimoto T, 2002, PROSTAG OTH LIPID M, V68-9, P245, DOI 10.1016/S0163-7827(97)00002-7	64	35	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31303	31314		10.1074/jbc.M109.028910	http://dx.doi.org/10.1074/jbc.M109.028910			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19713213	hybrid, Green Published			2022-12-25	WOS:000271378400057
J	Wada, T; Kikuchi, J; Nishimura, N; Shimizu, R; Kitamura, T; Furukawa, Y				Wada, Taeko; Kikuchi, Jiro; Nishimura, Noriko; Shimizu, Rumi; Kitamura, Toshio; Furukawa, Yusuke			Expression Levels of Histone Deacetylases Determine the Cell Fate of Hematopoietic Progenitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; STEM-CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; DEFICIENT MICE; SELF-RENEWAL; DIFFERENTIATION; ACID; PROLIFERATION; INHIBITORS	Histone deacetylases (HDACs) are globally implicated in the growth and differentiation of mammalian cells; however, relatively little is known about their specific roles in hematopoiesis. In this study, we investigated the expression of HDACs in human hematopoietic cells and their functions during hematopoiesis. The expression of HDACs was very low in hematopoietic progenitor cells, which was accompanied by histone hyperacetylation. HDACs were detectable in more differentiated progenitors and erythroid precursors but down-regulated in mature myeloid cells especially granulocytes. In contrast, acute myeloid leukemias showed HDAC overexpression and histone hypoacetylation. Transcription of the HDAC1 gene was repressed by CCAAT/enhancer binding proteins during myeloid differentiation, and activated by GATA-1 during erythromegakaryocytic differentiation. Small interfering RNA-mediated knockdown of HDAC1 enhanced myeloid differentiation in immature hematopoietic cell lines and perturbed erythroid differentiation in progenitor cells. Myeloid but not erythromegakaryocytic differentiation was blocked in mice transplanted with HDAC1-overexpressing hematopoietic progenitor cells. These findings suggest that HDAC is not merely an auxiliary factor of genetic elements but plays a direct role in the cell fate decision of hematopoietic progenitors.	[Furukawa, Yusuke] Jichi Med Univ, Div Stem Cell Regulat, Ctr Mol Med, Jichi Med Sch, Shimotsuke, Tochigi 3290498, Japan; [Kitamura, Toshio] Univ Tokyo, Div Cellular Therapy, Inst Med Sci, Tokyo 1088639, Japan; [Kitamura, Toshio] Univ Tokyo, Div Stem Cell Signaling, Inst Med Sci, Tokyo 1088639, Japan	Jichi Medical University; University of Tokyo; University of Tokyo	Furukawa, Y (corresponding author), Jichi Med Univ, Div Stem Cell Regulat, Ctr Mol Med, Jichi Med Sch, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	furuyu@jichi.ac.jp	Furukawa, Yusuke/Y-1342-2018; Kitamura, Toshio/AAA-2071-2021	Furukawa, Yusuke/0000-0002-7249-6418; 	High-Tech Research Center Project for Private Universities; MEXT; Vehicle Racing Commemorative Foundation; Sankyo Foundation of Life Science	High-Tech Research Center Project for Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation; Sankyo Foundation of Life Science	This work was supported in part by the High-Tech Research Center Project for Private Universities: Matching Fund Subsidy from MEXT 2002-2006 and grants from the Vehicle Racing Commemorative Foundation and the Sankyo Foundation of Life Science ( to Y. F.).	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bug G, 2005, CANCER RES, V65, P2537, DOI 10.1158/0008-5472.CAN-04-3011; Byrd JC, 2005, BLOOD, V105, P959, DOI 10.1182/blood-2004-05-1693; De Felice LD, 2005, CANCER RES, V65, P1505, DOI 10.1158/0008-5472.CAN-04-3063; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Frohling S, 2005, J CLIN ONCOL, V23, P6285, DOI 10.1200/JCO.2005.05.010; Furukawa Y, 2000, BRIT J HAEMATOL, V110, P663, DOI 10.1046/j.1365-2141.2000.02253.x; Gaboli M, 2001, GENE DEV, V15, P1625, DOI 10.1101/gad.902301; Gilliland DG, 2002, SEMIN HEMATOL, V39, P6, DOI 10.1053/shem.2002.36921; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; GURNEY AL, 1994, SCIENCE, V265, P1445, DOI 10.1126/science.8073287; Haumaitre C, 2008, MOL CELL BIOL, V28, P6373, DOI 10.1128/MCB.00413-08; Heyworth C, 1999, GENE DEV, V13, P1847, DOI 10.1101/gad.13.14.1847; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Inoue K, 2006, J CELL SCI, V119, P1985, DOI 10.1242/jcs.02913; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Kikuchi J, 2007, STEM CELLS, V25, P2439, DOI 10.1634/stemcells.2007-0207; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; Li JW, 2002, GENE DEV, V16, P687, DOI 10.1101/gad.962502; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; NAGAI T, 1994, BLOOD, V84, P1074, DOI 10.1182/blood.V84.4.1074.bloodjournal8441074; O'Connor OA, 2006, J CLIN ONCOL, V24, P166, DOI 10.1200/JCO.2005.01.9679; Ono R, 2005, J CLIN INVEST, V115, P919, DOI 10.1172/JCI200522725; Orkin S H, 1998, Stem Cells, V16 Suppl 2, P79; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Parcells BW, 2006, STEM CELLS, V24, P1174, DOI 10.1634/stemcells.2005-0519; Schuettengruber B, 2003, MOL CELL BIOL, V23, P6993, DOI 10.1128/MCB.23.19.6993-7004.2003; Senese S, 2007, MOL CELL BIOL, V27, P4784, DOI 10.1128/MCB.00494-07; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; STELZER GT, 1993, ANN NY ACAD SCI, V677, P265, DOI 10.1111/j.1749-6632.1993.tb38783.x; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Terui Y, 1998, EXP HEMATOL, V26, P236; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; Wang JX, 1998, P NATL ACAD SCI USA, V95, P10860, DOI 10.1073/pnas.95.18.10860; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yamamura K, 2006, BRIT J HAEMATOL, V135, P242, DOI 10.1111/j.1365-2141.2006.06275.x; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang ZH, 2005, BREAST CANCER RES TR, V94, P11, DOI 10.1007/s10549-005-6001-1; Zhao KW, 2004, BLOOD, V104, P3731, DOI 10.1182/blood-2004-04-1630; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X	50	59	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30673	30683		10.1074/jbc.M109.042242	http://dx.doi.org/10.1074/jbc.M109.042242			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19736310	hybrid, Green Published			2022-12-25	WOS:000271090000069
J	Aiken, CT; Steffan, JS; Guerrero, CM; Khashwji, H; Lukacsovich, T; Simmons, D; Purcell, JM; Menhaji, K; Zhu, YZ; Green, K; LaFerla, F; Huang, L; Thompson, LM; Marsh, JL				Aiken, Charity T.; Steffan, Joan S.; Guerrero, Cortnie M.; Khashwji, Hasan; Lukacsovich, Tamas; Simmons, Danielle; Purcell, Judy M.; Menhaji, Kimia; Zhu, Ya-Zhen; Green, Kim; LaFerla, Frank; Huang, Lan; Thompson, Leslie Michels; Marsh, J. Lawrence			Phosphorylation of Threonine 3 IMPLICATIONS FOR HUNTINGTIN AGGREGATION AND NEUROTOXICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; SUBCELLULAR-LOCALIZATION; MUTANT HUNTINGTIN; TRANSGENIC MICE; MASS-SPECTROMETRY; MOUSE MODEL; EARLY MOTOR; GERM-LINE; DISEASE; GENE	Huntingtin (Htt) is a widely expressed protein that causes tissue-specific degeneration when mutated to contain an expanded polyglutamine (poly(Q)) domain. Although Htt is large, 350 kDa, the appearance of amino-terminal fragments of Htt in extracts of postmortem brain tissue from patients with Huntington disease (HD), and the fact that an amino-terminal fragment, Htt exon 1 protein (Httex1p), is sufficient to cause disease in models of HD, points to the importance of the aminoterminal region of Htt in the disease process. The first exon of Htt encodes 17 amino acids followed by a poly(Q) repeat of variable length and culminating with a proline-rich domain of 50 amino acids. Because modifications to this fragment have the potential to directly affect pathogenesis in several ways, we have surveyed this fragment for potential post-translational modifications that might affect Htt behavior and detected several modifications of Httex1p. Here we report that the most prevalent modifications of Httex1p are NH2-terminal acetylation and phosphorylation of threonine 3 (pThr-3). We demonstrate that pThr-3 occurs on full-length Htt in vivo, and that this modification affects the aggregation and pathogenic properties of Htt. Thus, therapeutic strategies that modulate these events could in turn affect Htt pathogenesis.	[Aiken, Charity T.; Lukacsovich, Tamas; Purcell, Judy M.; Menhaji, Kimia; Huang, Lan; Marsh, J. Lawrence] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Steffan, Joan S.; Simmons, Danielle; Zhu, Ya-Zhen; Thompson, Leslie Michels] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; [Guerrero, Cortnie M.; Huang, Lan] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Khashwji, Hasan; Green, Kim; LaFerla, Frank; Thompson, Leslie Michels] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Thompson, Leslie Michels] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Marsh, J. Lawrence] Univ Calif Irvine, Dept Pathol, Irvine, CA 92697 USA; [Marsh, J. Lawrence] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Marsh, JL (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, 4244 McGaugh Hall, Irvine, CA 92697 USA.	jlmarsh@uci.edu			National Institutes of Health [NS52789, HD36081, NS045283, T32GM0731130, GM-74830]; Optical Biology Shared Resource of the Cancer Center [CA-62203]; Hereditary Disease Foundation; Fox Family Foundation; High Q Foundation; Huntington's Disease Society of America Coalition for the Cure; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036081] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052789, R01NS045283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Optical Biology Shared Resource of the Cancer Center; Hereditary Disease Foundation; Fox Family Foundation; High Q Foundation; Huntington's Disease Society of America Coalition for the Cure; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS52789 (to L. M. T. and J. L. M.), HD36081 (to J. L. M.), NS045283 (to J. L. M. and L. M. T.), T32GM0731130 (to C. T. A.), and GM-74830 (to L. H.). This work was also supported by Optical Biology Shared Resource of the Cancer Center Support Grant CA-62203 at the University of California, Irvine, and grants from the Hereditary Disease Foundation (to J. S. S., L. M. T., and J. L. M.), the Fox Family Foundation (to J. S. S.), the High Q Foundation (to J. S. S., L. M. T., and J. L. M.), and the Huntington's Disease Society of America Coalition for the Cure (to L. M. T.).	Agrawal N, 2005, P NATL ACAD SCI USA, V102, P3777, DOI 10.1073/pnas.0500055102; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; BARNES GT, 1994, SOMAT CELL MOLEC GEN, V20, P87, DOI 10.1007/BF02290678; BAYER TA, 1992, DEVELOPMENT, V115, P421; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chalkley RJ, 2005, MOL CELL PROTEOMICS, V4, P1194, DOI 10.1074/mcp.D500002-MCP200; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Ehrlich ME, 2001, EXP NEUROL, V167, P215, DOI 10.1006/exnr.2000.7551; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; FLINTA C, 1986, EUR J BIOCHEM, V154, P193, DOI 10.1111/j.1432-1033.1986.tb09378.x; Franceschini N., 1972, PUPIL PSEUDOPUPIL CO; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Hazeki N, 2000, BIOCHEM BIOPH RES CO, V277, P386, DOI 10.1006/bbrc.2000.3682; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Hickey MA, 2008, NEUROSCIENCE, V157, P280, DOI 10.1016/j.neuroscience.2008.08.041; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; JAENISCH R, 1981, CELL, V24, P519, DOI 10.1016/0092-8674(81)90343-3; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Kalchman MA, 1996, J BIOL CHEM, V271, P19385, DOI 10.1074/jbc.271.32.19385; LACY E, 1983, CELL, V34, P343, DOI 10.1016/0092-8674(83)90369-0; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; Marsh JL, 2003, HUM MOL GENET, V12, pR187, DOI 10.1093/hmg/ddg271; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Pardo R, 2006, J NEUROSCI, V26, P1635, DOI 10.1523/JNEUROSCI.3706-05.2006; PERSICHETTI F, 1995, MOL MED, V1, P374, DOI 10.1007/BF03401575; Petersen BO, 1999, EMBO J, V18, P396, DOI 10.1093/emboj/18.2.396; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Quelo I, 2005, GENE EXPRESSION, V12, P151, DOI 10.3727/000000005783992070; Reimer T, 2003, J MOL BIOL, V330, P955, DOI 10.1016/S0022-2836(03)00713-7; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Schilling G, 2007, J NEUROPATH EXP NEUR, V66, P313, DOI 10.1097/nen.0b013e318040b2c8; Schroeder MJ, 2005, J PROTEOME RES, V4, P1832, DOI 10.1021/pr0502020; SHERMAN F, 1985, BIOESSAYS, V3, P27, DOI 10.1002/bies.950030108; Simmons DA, 2009, P NATL ACAD SCI USA, V106, P4906, DOI 10.1073/pnas.0811228106; Sipione S, 2002, HUM MOL GENET, V11, P1953, DOI 10.1093/hmg/11.17.1953; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Warby SC, 2005, HUM MOL GENET, V14, P1569, DOI 10.1093/hmg/ddi165; Wolfgang WJ, 2005, P NATL ACAD SCI USA, V102, P11563, DOI 10.1073/pnas.0505321102; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	59	117	120	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29427	29436		10.1074/jbc.M109.013193	http://dx.doi.org/10.1074/jbc.M109.013193			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19710014	Green Published, hybrid			2022-12-25	WOS:000270896800024
J	Huang, YW; Su, P; Liu, GY; Crow, MR; Chaukos, D; Yan, H; Robinson, LA				Huang, Yi-Wei; Su, Paul; Liu, Guang Ying; Crow, Min Rui; Chaukos, Deanna; Yan, Harry; Robinson, Lisa A.			Constitutive Endocytosis of the Chemokine CX(3)CL1 Prevents Its Degradation by Cell Surface Metalloproteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; AMYLOID-PRECURSOR-PROTEIN; ALPHA-CONVERTING-ENZYME; TRANSMEMBRANE CONDUCTANCE REGULATOR; COATED VESICLE FORMATION; FRACTALKINE CX3CL1; ENDOTHELIAL-CELLS; RECEPTOR-BINDING; SORTING SIGNALS; DYNAMIN	CX(3)CL1, a chemokine with transmembrane and soluble species, plays a key role in inflammation by acting as both chemoattractant and adhesion molecule. CX(3)CL1 is the only chemokine known to undergo constitutive internalization, raising the possibility that dynamic equilibrium between the endocytic compartment and the plasma membrane critically regulates the availability and processing of CX(3)CL1 at the cell surface. We therefore investigated how transmembrane CX(3)CL1 is internalized. Inhibition of dynamin using a nonfunctional allele or of clathrin using specific small interfering RNA prevented endocytosis of the chemokine in CX(3)CL1-expressing human ECV-304 cells. Perusal of the cytoplasmic domain of CX(3)CL1 revealed two putative adaptor protein-2 (AP-2)-binding motifs. Accordingly, CX(3)CL1 co-localized with AP-2 at the plasma membrane. We generated a mutant allele of CX(3)CL1 lacking the cytoplasmic tail. Deletion of the cytosolic tail precluded internalization of the chemokine. We used site-directed mutagenesis to disrupt AP-2-binding motifs, singly or in combination, which resulted in diminished internalization of CX(3)CL1. Although CX(3)CL1 was present in both superficial and endomembrane compartments, ADAM10 (a disintegrin and metalloprotease 10) and tumor necrosis factor-converting enzyme, the two metalloproteases that cleave CX(3)CL1, localized predominantly to the plasmalemma. Inhibition of endocytosis using the dynamin inhibitor, Dynasore, promoted rapid metalloprotease-dependent shedding of CX(3)CL1 from the cell surface into the surrounding medium. These findings indicate that the cytoplasmic tail of CX(3)CL1 facilitates its constitutive clathrin-mediated endocytosis. Such regulation enables intracellular storage of a sizable pool of presynthesized CX(3)CL1 that protects the chemokine from degradation by metalloproteases at the plasma membrane.	[Huang, Yi-Wei; Su, Paul; Liu, Guang Ying; Crow, Min Rui; Chaukos, Deanna; Yan, Harry; Robinson, Lisa A.] Hosp Sick Children, Res Inst, Cell Biol Program, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Robinson, LA (corresponding author), Hosp Sick Children, Res Inst, Cell Biol Program, 555 Univ Ave,Rm 5264, Toronto, ON M5G 1X8, Canada.	lisa.robinson@sickkids.ca			Heart and Stroke Foundation of Canada	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by an operating grant from the Heart and Stroke Foundation of Canada.	Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Altschuler Y, 2000, MOL BIOL CELL, V11, P819, DOI 10.1091/mbc.11.3.819; Barlic J, 1999, J BIOL CHEM, V274, P16287, DOI 10.1074/jbc.274.23.16287; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Chapman GA, 2000, EUR J PHARMACOL, V392, P189, DOI 10.1016/S0014-2999(00)00117-5; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; Durkan AM, 2007, J AM SOC NEPHROL, V18, P74, DOI 10.1681/ASN.2006080862; Fan GH, 2003, BLOOD, V101, P2115, DOI 10.1182/blood-2002-07-1965; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Fong AM, 2000, J BIOL CHEM, V275, P3781, DOI 10.1074/jbc.275.6.3781; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; Haller C, 1998, EUR J CELL BIOL, V75, P353, DOI 10.1016/S0171-9335(98)80068-X; Harrison JK, 1999, J LEUKOCYTE BIOL, V66, P937, DOI 10.1002/jlb.66.6.937; Harrison JK, 2001, J BIOL CHEM, V276, P21632, DOI 10.1074/jbc.M010261200; Haskell CA, 2001, J CLIN INVEST, V108, P679, DOI 10.1172/JCI12976; Haskell CA, 2000, J BIOL CHEM, V275, P34183, DOI 10.1074/jbc.M005731200; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hermand P, 2008, J BIOL CHEM, V283, P30225, DOI 10.1074/jbc.M802638200; Hughes SE, 1996, EXP CELL RES, V225, P171, DOI 10.1006/excr.1996.0168; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Inoue A, 2005, ARTHRITIS RHEUM-US, V52, P1522, DOI 10.1002/art.21007; JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Liu GY, 2005, J BIOL CHEM, V280, P19858, DOI 10.1074/jbc.M413073200; Ludwig A, 2002, J IMMUNOL, V168, P604, DOI 10.4049/jimmunol.168.2.604; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; McDermott DH, 2003, J CLIN INVEST, V111, P1241, DOI 10.1172/JCI200316790; McDermott DH, 2001, CIRC RES, V89, P401, DOI 10.1161/hh1701.095642; Mero P, 2006, J BIOL CHEM, V281, P33242, DOI 10.1074/jbc.M605372200; Mizoue LS, 2001, J BIOL CHEM, V276, P33906, DOI 10.1074/jbc.M101348200; Moatti D, 2001, BLOOD, V97, P1925, DOI 10.1182/blood.V97.7.1925; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Muehlhoefer A, 2000, J IMMUNOL, V164, P3368, DOI 10.4049/jimmunol.164.6.3368; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Otero C, 2006, J IMMUNOL, V177, P2314, DOI 10.4049/jimmunol.177.4.2314; Pietrzyk MC, 2004, TRANSPLANT P, V36, P2659, DOI 10.1016/j.transproceed.2004.09.029; Robinson LA, 2000, J IMMUNOL, V165, P6067, DOI 10.4049/jimmunol.165.11.6067; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rodionov DG, 1998, J BIOL CHEM, V273, P6005, DOI 10.1074/jbc.273.11.6005; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Schulte A, 2007, BIOCHEM BIOPH RES CO, V358, P233, DOI 10.1016/j.bbrc.2007.04.100; Signoret N, 2005, MOL BIOL CELL, V16, P902, DOI 10.1091/mbc.e04-08-0687; Signoret N, 2004, TRAFFIC, V5, P529, DOI 10.1111/j.1600-0854.2004.00200.x; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Sun TX, 2002, AM J PHYSIOL-RENAL, V282, pF998, DOI 10.1152/ajprenal.00257.2001; TAKAHASHI K, 1990, IN VITRO CELL DEV, V25, P265; TAKAHASI K, 1992, IN VITRO CELL DEV-AN, V28A, P380; Terebiznik MR, 2002, NAT CELL BIOL, V4, P766, DOI 10.1038/ncb854; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; Tsou CL, 2001, J BIOL CHEM, V276, P44622, DOI 10.1074/jbc.M107327200; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Walcheck B, 2006, EUR J IMMUNOL, V36, P968, DOI 10.1002/eji.200535257; Weixel KM, 2001, J BIOL CHEM, V276, P46251, DOI 10.1074/jbc.M104545200; Weixel KM, 2000, J BIOL CHEM, V275, P3655, DOI 10.1074/jbc.275.5.3655; Yang W, 1999, J BIOL CHEM, V274, P11328, DOI 10.1074/jbc.274.16.11328; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	70	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29644	29653		10.1074/jbc.M109.045682	http://dx.doi.org/10.1074/jbc.M109.045682			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19723636	Green Published, hybrid			2022-12-25	WOS:000270896800046
J	Crawford, NPS; Yang, HL; Mattaini, KR; Hunter, KW				Crawford, Nigel P. S.; Yang, Hailiu; Mattaini, Katherine R.; Hunter, Kent W.			The Metastasis Efficiency Modifier Ribosomal RNA Processing 1 Homolog B (RRP1B) Is a Chromatin-associated Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROMODOMAIN PROTEIN BRD4; TRANSGENIC MOUSE MODEL; BREAST-CANCER SURVIVAL; EXPRESSION SIGNATURE; IDENTIFICATION; NUCLEOPHOSMIN; POLYMORPHISMS; TRANSCRIPTION; LOCALIZATION; PROGRESSION	There is accumulating evidence for a role of germ line variation in breast cancer metastasis. We have recently identified a novel metastasis susceptibility gene, Rrp1b (ribosomal RNA processing 1 homolog B). Overexpression of Rrp1b in a mouse mammary tumor cell line induces a gene expression signature that predicts survival in breast cancer. Here we extend the analysis of RRP1B function by demonstrating that the Rrp1b activation gene expression signature accurately predicted the outcome in three of four publicly available breast carcinoma gene expression data sets. In addition, we provide insights into the mechanism of RRP1B. Tandem affinity purification demonstrated that RRP1B physically interacts with many nucleosome binding factors, including histone H1X, poly(ADP-ribose) polymerase 1, TRIM28 (tripartite motif-containing 28), and CSDA (cold shock domain protein A). Co-immunofluorescence and co-immunoprecipitation confirmed these interactions and also interactions with heterochromatin protein-1 alpha and acetyl-histone H4 lysine 5. Finally, we investigated the effects of ectopic expression of an RRP1B allelic variant previously associated with improved survival in breast cancer. Gene expression analyses demonstrate that, compared with ectopic expression of wild type RRP1B in HeLa cells, the variant RRP1B differentially modulates various transcription factors controlled by TRIM28 and CSDA. These data suggest that RRP1B, a tumor progression and metastasis susceptibility candidate gene, is potentially a dynamic modulator of transcription and chromatin structure.	[Hunter, Kent W.] NCI, Lab Canc Biol & Genet, CCR, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hunter, KW (corresponding author), NCI, Lab Canc Biol & Genet, CCR, NIH, Bldg 37,Rm 5046,37 Convent Dr, Bethesda, MD 20892 USA.	hunter@mail.nih.gov			National Institutes of Health; NCI; Center for Cancer Research; Intramural Research Program; NATIONAL CANCER INSTITUTE [ZIABC011255] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200366] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by the National Institutes of Health, NCI, Center for Cancer Research, Intramural Research Program.	ANDERSON DF, 2002, INT J COMMUTATIVE RI, V1, P11; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Crawford NPS, 2008, CLIN EXP METASTAS, V25, P357, DOI 10.1007/s10585-008-9146-6; Crawford NPS, 2007, PLOS GENET, V3, P2296, DOI 10.1371/journal.pgen.0030214; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Crawford NPS, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1389; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; DUMBAR TS, 1989, BIOCHEMISTRY-US, V28, P9495, DOI 10.1021/bi00450a037; Farina A, 2004, MOL CELL BIOL, V24, P9059, DOI 10.1128/MCB.24.20.9059-9069.2004; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Gurumurthy M, 2008, J MOL BIOL, V378, P302, DOI 10.1016/j.jmb.2008.02.055; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Ho J, 2009, J PROTEOME RES, V8, P583, DOI 10.1021/pr8007368; Horsey EW, 2004, RNA, V10, P813, DOI 10.1261/rna.5255804; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jing Z, 2004, J BIOCHEM MOL BIOL, V37, P663; Lifsted T, 1998, INT J CANCER, V77, P640, DOI 10.1002/(SICI)1097-0215(19980812)77:4<640::AID-IJC26>3.0.CO;2-8; Lukes L, 2009, CANCER RES, V69, P310, DOI 10.1158/0008-5472.CAN-08-3520; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; MUCENSKI ML, 1986, MOL CELL BIOL, V6, P4236, DOI 10.1128/MCB.6.12.4236; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Park YG, 2005, NAT GENET, V37, P1055, DOI 10.1038/ng1635; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Peralta-Leal A, 2008, CLIN TRANSL ONCOL, V10, P318, DOI 10.1007/s12094-008-0207-8; Pollard AJ, 2002, J BIOL CHEM, V277, P15241, DOI 10.1074/jbc.M109046200; Rae JM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1842; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Skotheim RI, 2007, INT J BIOCHEM CELL B, V39, P1432, DOI 10.1016/j.biocel.2007.02.016; Storck Sebastien, 2007, Subcell Biochem, V41, P125; Tobita H, 2006, INT J ONCOL, V29, P673; Tuteja R, 1998, CRIT REV BIOCHEM MOL, V33, P407, DOI 10.1080/10409239891204260; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vecerova J, 2004, MOL BIOL CELL, V15, P4904, DOI 10.1091/mbc.E04-07-0645; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Yang HY, 2005, CLIN EXP METASTAS, V22, P593, DOI 10.1007/s10585-005-6244-6; Yang HY, 2004, CLIN EXP METASTAS, V21, P719, DOI 10.1007/s10585-004-8251-4; Ye Q, 1996, J BIOL CHEM, V271, P14653, DOI 10.1074/jbc.271.25.14653; Zhou Mi, 2004, In Silico Biol, V4, P323	45	26	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28660	28673		10.1074/jbc.M109.023457	http://dx.doi.org/10.1074/jbc.M109.023457			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19710015	Green Published, hybrid			2022-12-25	WOS:000270678900021
J	Gayen, JR; Saberi, M; Schenk, S; Biswas, N; Vaingankar, SM; Cheung, WW; Najjar, SM; O'Connor, DT; Bandyopadhyay, G; Mahata, SK				Gayen, Jiaur R.; Saberi, Maziyar; Schenk, Simon; Biswas, Nilima; Vaingankar, Sucheta M.; Cheung, Wai W.; Najjar, Sonia M.; O'Connor, Daniel T.; Bandyopadhyay, Gautam; Mahata, Sushil K.			A Novel Pathway of Insulin Sensitivity in Chromogranin A Null Mice A CRUCIAL ROLE FOR PANCREASTATIN IN GLUCOSE HOMEOSTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; RAT SKELETAL-MUSCLE; C-TERMINAL FRAGMENT; RECEPTOR SUBSTRATE-1; DIABETES-MELLITUS; HEPATOCYTES; RESISTANCE; ADIPONECTIN; CELLS	Chromogranin A (CHGA/Chga), a proprotein, widely distributed in endocrine and neuroendocrine tissues (not expressed in muscle, liver, and adipose tissues), generates at least four bioactive peptides. One of those peptides, pancreastatin (PST), has been reported to interfere with insulin action. We generated a Chga knock-out (KO) mouse by the targeted deletion of the Chga gene in neuroendocrine tissues. KO mice displayed hypertension, higher plasma catecholamine, and adipokine levels and lower IL-6 and lipid levels compared with wild type mice. Liver glycogen content was elevated, but the nitric oxide (NO) level was diminished. Glucose, insulin, and pyruvate tolerance tests and hyperinsulinemic-euglycemic clamp studies established increased insulin sensitivity in liver but decreased glucose disposal in muscle. Despite higher catecholamine and ketone body levels and muscle insulin resistance, KO mice maintained euglycemia due to increased liver insulin sensitivity. Suppressed mRNA abundance of phosphoenolpyruvate carboxykinase and glucose-6-phosphatase (G6Pase) in KO mice further support this conclusion. PST administration in KO mice stimulated phosphoenolpyruvate carboxykinase and G6Pase mRNA abundance and raised the blood glucose level. In liver cells transfected with G6Pase promoter, PST caused transcriptional activation in a protein kinase C (PKC)-and NO synthase-dependent manner. Thus, PST action may be mediated by suppressing IRS1/2-phosphatidylinositol 3-kinase-Akt-FOXO-1 signaling and insulin-induced maturation of SREBP1c by PKC and a high level of NO. The combined effects of conventional PKC and endothelial NO synthase activation by PST can suppress insulin signaling. The rise in blood PST level with age and in diabetes suggests that PST is a negative regulator of insulin sensitivity and glucose homeostasis.	[Gayen, Jiaur R.; Saberi, Maziyar; Schenk, Simon; Biswas, Nilima; Vaingankar, Sucheta M.; O'Connor, Daniel T.; Bandyopadhyay, Gautam; Mahata, Sushil K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Cheung, Wai W.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [O'Connor, Daniel T.] Univ Calif San Diego, Dept Mol Genet, La Jolla, CA 92093 USA; [O'Connor, Daniel T.; Mahata, Sushil K.] Vet Affairs San Diego Healthcare Syst, La Jolla, CA USA; [Najjar, Sonia M.] Univ Toledo, Coll Med, Ctr Diabet & Endocrine Res, Toledo, OH 43614 USA; [Najjar, Sonia M.] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Mahata, SK (corresponding author), Univ Calif San Diego, Sch Med, Dept Med 0838, 9500 Gilman Dr, La Jolla, CA 92093 USA.	smahata@ucsd.edu	Mahata, Sushil/AAF-8781-2021; Najjar, Sonia M/GXW-2217-2022	Schenk, Simon/0000-0002-8224-3203	National Institutes of Health [R01 DA011311, DK60702, P01 HL58120, U01 HL69758, DK54254]; Department of Veterans Affairs; United States Department of Agriculture [USDA 38903-02315]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058120, U01HL069758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054254, R01DK060702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DA011311 (to S. K. M.), DK60702 (to D. T. O.), P01 HL58120 and U01 HL69758 (to S. K. M. and D. T. O.), and DK54254 (to S. M. N.). This work was also supported by grants from the Department of Veterans Affairs (to S. K. M. and D. T. O.) and United States Department of Agriculture Grant USDA 38903-02315 (to S. M. N.).	AARDAL S, 1993, J NEUROENDOCRINOL, V5, P405, DOI 10.1111/j.1365-2826.1993.tb00501.x; Ahren B, 1996, ACTA PHYSIOL SCAND, V158, P63, DOI 10.1046/j.1365-201X.1996.525291000.x; Azzout-Marniche D, 2000, BIOCHEM J, V350, P389, DOI 10.1042/0264-6021:3500389; BACKER JM, 1992, J BIOL CHEM, V267, P1367; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959; Ceddia RB, 2005, DIABETOLOGIA, V48, P132, DOI 10.1007/s00125-004-1609-y; Chakravarty K, 2007, NUTR REV, V65, pS47, DOI [10.1111/j.1753-4887.2007.tb00328.x, 10.1301/nr.2007.jun.S47-S56]; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; Cook S, 2004, DIABETES, V53, P2067, DOI 10.2337/diabetes.53.8.2067; EFENDIC S, 1987, P NATL ACAD SCI USA, V84, P7257, DOI 10.1073/pnas.84.20.7257; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/bj3490013; Fujimoto M, 2005, DIABETES, V54, P1340, DOI 10.2337/diabetes.54.5.1340; FUNAKOSHI A, 1990, REGUL PEPTIDES, V30, P159, DOI 10.1016/0167-0115(90)90056-3; Gonzalez-Yanes C, 1999, BBA-MOL CELL RES, V1451, P153, DOI 10.1016/S0167-4889(99)00084-1; Gonzalez-Yanes C, 2000, DIABETES, V49, P1288, DOI 10.2337/diabetes.49.8.1288; Hertelendy ZI, 1996, CELL CALCIUM, V19, P125, DOI 10.1016/S0143-4160(96)90081-0; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Higaki Y, 2001, DIABETES, V50, P241, DOI 10.2337/diabetes.50.2.241; Joost HG, 2007, ENDOCRINOLOGY, V148, P4545, DOI 10.1210/en.2007-0866; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; KARNIELI E, 1981, J BIOL CHEM, V256, P4772; Li HY, 2008, AM J HYPERTENS, V21, P471, DOI 10.1038/ajh.2008.5; Lira VA, 2007, AM J PHYSIOL-ENDOC M, V293, pE1062, DOI 10.1152/ajpendo.00045.2007; Ma HT, 1996, REGUL PEPTIDES, V61, P143, DOI 10.1016/0167-0115(95)00160-3; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Mahata SK, 1997, J CLIN INVEST, V100, P1623, DOI 10.1172/JCI119686; Matsumoto M, 2002, DIABETES, V51, P1672, DOI 10.2337/diabetes.51.6.1672; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; O'Connor DT, 2005, J CLIN ENDOCR METAB, V90, P5414, DOI 10.1210/jc.2005-0408; Osei K, 2007, METABOLISM, V56, P24, DOI 10.1016/j.metabol.2006.08.018; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Roden M, 2008, WIEN MED WOCHENSCHR, V158, P558, DOI 10.1007/s10354-008-0595-y; SACCA L, 1983, AM J PHYSIOL, V245, pE294, DOI 10.1152/ajpendo.1983.245.3.E294; SANCHEZ V, 1992, BIOCHEM J, V284, P659, DOI 10.1042/bj2840659; Sanchez-Margalet V, 1998, DIABETES CARE, V21, P1951, DOI 10.2337/diacare.21.11.1951; Sanchez-Margalet V, 1999, DIABETOLOGIA, V42, P317, DOI 10.1007/s001250051157; Sanchez-Margalet V, 1998, AM J PHYSIOL-ENDOC M, V275, pE1055, DOI 10.1152/ajpendo.1998.275.6.E1055; SanchezGutierrez JC, 1997, ENDOCRINOLOGY, V138, P2443, DOI 10.1210/en.138.6.2443; SANCHEZMARGALET V, 1992, GEN PHARMACOL, V23, P637, DOI 10.1016/0306-3623(92)90140-F; SANCHEZMARGALET V, 1992, HORM METAB RES, V24, P455, DOI 10.1055/s-2007-1003361; SANCHEZMARGALET V, 1994, BIOCHEM J, V303, P51, DOI 10.1042/bj3030051; SEIFTER S, 1950, ARCH BIOCHEM, V25, P191; SMEDSROD B, 1985, J LEUKOCYTE BIOL, V38, P213, DOI 10.1002/jlb.38.2.213; TATEMOTO K, 1986, NATURE, V324, P476, DOI 10.1038/324476a0; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; THOMPSON JR, 1991, COMP BIOCHEM PHYS B, V100, P209, DOI 10.1016/0305-0491(91)90363-I; Tsuchiya K, 2007, ENDOCRINOLOGY, V148, P4548, DOI 10.1210/en.2006-1371; WINKLER H, 1992, NEUROSCIENCE, V49, P497, DOI 10.1016/0306-4522(92)90222-N; Yamamoto T, 2004, J BIOL CHEM, V279, P12027, DOI 10.1074/jbc.M310333200; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Zhou H, 2005, BIOCHEM BIOPH RES CO, V338, P793, DOI 10.1016/j.bbrc.2005.10.007	57	75	77	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28498	28509		10.1074/jbc.M109.020636	http://dx.doi.org/10.1074/jbc.M109.020636			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706599	hybrid, Green Published			2022-12-25	WOS:000270678900004
J	Barbosa-Sicard, E; Fromel, T; Keseru, B; Brandes, RP; Morisseau, C; Hammock, BD; Braun, T; Kruger, M; Fleming, I				Barbosa-Sicard, Eduardo; Froemel, Timo; Keserue, Benjamin; Brandes, Ralf P.; Morisseau, Christophe; Hammock, Bruce D.; Braun, Thomas; Krueger, Marcus; Fleming, Ingrid			Inhibition of the Soluble Epoxide Hydrolase by Tyrosine Nitration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPOXYEICOSATRIENOIC ACIDS; ENDOTHELIAL-CELLS; PEPTIDE IDENTIFICATION; RETICULUM CA2+-ATPASE; BLOOD-PRESSURE; SHEAR-STRESS; IN-VIVO; EXPRESSION; ACTIVATION; METABOLISM	Inhibition of the soluble epoxide hydrolase (sEH) has beneficial effects on vascular inflammation and hypertension indicating that the enzyme may be a promising target for drug development. As the enzymatic core of the hydrolase domain of the human sEH contains two tyrosine residues (Tyr(383) and Tyr(466)) that are theoretically crucial for enzymatic activity, we addressed the hypothesis that the activity of the sEH may be affected by nitrosative stress. Epoxide hydrolase activity was detected in human and murine endothelial cells as well in HEK293 cells and could be inhibited by either authentic peroxynitrite (ONOO-) or the ONOO- generator 3-morpholinosydnonimine (SIN-1). Protection of the enzymatic core with 1-adamantyl-3-cyclohexylurea in vitro decreased sensitivity to SIN-1. Both ONOO- and SIN-1 elicited the tyrosine nitration of the sEH protein and mass spectrometry analysis of tryptic fragments revealed nitration on several tyrosine residues including Tyr(383) and Tyr(466). Mutation of the latter residues to phenylalanine was sufficient to abrogate epoxide hydrolase activity. In vivo, streptozotocin-induced diabetes resulted in the tyrosine nitration of the sEH in murine lungs and a significant decrease in its activity. Taken together, these data indicate that the activity of the sEH can be regulated by the tyrosine nitration of the protein. Moreover, nitrosative stress would be expected to potentiate the physiological actions of arachidonic acid epoxides by preventing their metabolism to the corresponding diols.	[Barbosa-Sicard, Eduardo; Froemel, Timo; Keserue, Benjamin; Fleming, Ingrid] Goethe Univ Frankfurt, Ctr Mol Med, Inst Vasc Signaling, D-60590 Frankfurt, Germany; [Brandes, Ralf P.] Goethe Univ Frankfurt, Inst Kardiovaskulare Physiol, D-60590 Frankfurt, Germany; [Braun, Thomas; Krueger, Marcus] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodeling, D-61231 Bad Nauheim, Germany; [Morisseau, Christophe; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	Goethe University Frankfurt; Goethe University Frankfurt; Max Planck Society; University of California System; University of California Davis	Fleming, I (corresponding author), Goethe Univ Frankfurt, Ctr Mol Med, Inst Vasc Signaling, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	fleming@em.uni-frankfurt.de	Fleming, Ingrid/AAB-6123-2022; Braun, Thomas/B-2310-2008; Fleming, Ingrid/L-1225-2014; Brandes, Ralf P/L-3058-2017	Fleming, Ingrid/0000-0003-1881-3635; Fleming, Ingrid/0000-0003-1881-3635; Brandes, Ralf P/0000-0002-8035-0048; Braun, Thomas/0000-0002-6165-4804	National Institutes of Health [HL 85727, R37 ES02710, P42 ES004699, R01 ES013933]; NIEHS; Deutsche Forschungsgemeinschaft; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699, R37ES002710, R01ES013933] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health Grant HL 85727 and by NIEHS, National Institutes of Health Grants R37 ES02710, P42 ES004699, R01 ES013933. This work was also supported by research grants from the Deutsche Forschungsgemeinschaft (Transiregional Collaborative Research Center 23, Project A6, Research Unit 784 and by Exzellenzcluster 147 "Cardio-PuImonary Systems").	Ai D, 2007, P NATL ACAD SCI USA, V104, P9018, DOI 10.1073/pnas.0703229104; Argiriadi MA, 2000, J BIOL CHEM, V275, P15265, DOI 10.1074/jbc.M000278200; Bartesaghi S, 2007, AMINO ACIDS, V32, P501, DOI 10.1007/s00726-006-0425-8; Ceriello A, 2001, DIABETOLOGIA, V44, P834; Corenblum MJ, 2008, HYPERTENSION, V51, P567, DOI 10.1161/HYPERTENSIONAHA.107.102160; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cronin A, 2003, P NATL ACAD SCI USA, V100, P1552, DOI 10.1073/pnas.0437829100; de Ross B, 2009, PROTEOMICS, V9, P3244, DOI 10.1002/pmic.200800761; Dixit M, 2005, CIRC RES, V97, P1236, DOI 10.1161/01.RES.0000195611.59811.ab; Enayetallah AE, 2004, J HISTOCHEM CYTOCHEM, V52, P447, DOI 10.1177/002215540405200403; Fang X, 2002, AM J PHYSIOL-HEART C, V283, pH2306, DOI 10.1152/ajpheart.00448.2002; Fang X, 2001, J BIOL CHEM, V276, P14867, DOI 10.1074/jbc.M011761200; Fleming I, 2005, J CELL SCI, V118, P4103, DOI 10.1242/jcs.02541; GILL SS, 1980, BIOCHEM PHARMACOL, V29, P389, DOI 10.1016/0006-2952(80)90518-3; Goldstein S, 2008, METHOD ENZYMOL, V436, P49, DOI 10.1016/S0076-6879(08)36004-2; Gschwendtner A, 2008, STROKE, V39, P1593, DOI 10.1161/STROKEAHA.107.502179; Hopmann KH, 2006, J PHYS CHEM B, V110, P21299, DOI 10.1021/jp063830t; Hutchens MP, 2008, RESUSCITATION, V76, P89, DOI 10.1016/j.resuscitation.2007.06.031; Imig JD, 2002, HYPERTENSION, V39, P690, DOI 10.1161/hy0202.103788; Jung O, 2005, HYPERTENSION, V45, P759, DOI 10.1161/01.HYP.0000153792.29478.1d; Liu Y, 2005, P NATL ACAD SCI USA, V102, P16747, DOI 10.1073/pnas.0508081102; Maresh JG, 2005, PHYSIOL GENOMICS, V21, P308, DOI 10.1152/physiolgenomics.00310.2004; Michaelis UR, 2006, PHARMACOL THERAPEUT, V111, P584, DOI 10.1016/j.pharmthera.2005.11.003; Morisseau C, 2002, BIOCHEM PHARMACOL, V63, P1599, DOI 10.1016/S0006-2952(02)00952-8; Morisseau C, 2001, CHEM RES TOXICOL, V14, P409, DOI 10.1021/tx0001732; Muller DN, 2007, BIOCHEM J, V403, P109, DOI 10.1042/BJ20061328; Newman JW, 2005, PROG LIPID RES, V44, P1, DOI 10.1016/j.plipres.2004.10.001; Newman JW, 2003, P NATL ACAD SCI USA, V100, P1558, DOI 10.1073/pnas.0437724100; Ohtoshi K, 2005, BIOCHEM BIOPH RES CO, V331, P347, DOI 10.1016/j.bbrc.2005.03.171; Olsen JV, 2004, P NATL ACAD SCI USA, V101, P13417, DOI 10.1073/pnas.0405549101; Peluffo G, 2007, CARDIOVASC RES, V75, P291, DOI 10.1016/j.cardiores.2007.04.024; Pokreisz P, 2006, HYPERTENSION, V47, P762, DOI 10.1161/01.HYP.0000208299.62535.58; Randriamboavonjy V, 2008, CIRCULATION, V117, P52, DOI 10.1161/CIRCULATIONAHA.107.719807; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rodriguez M, 2006, ANN NY ACAD SCI, V1079, P130, DOI 10.1196/annals.1375.019; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; SEIDEGARD J, 1984, CANCER RES, V44, P3654; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Smith KR, 2005, P NATL ACAD SCI USA, V102, P2186, DOI 10.1073/pnas.0409591102; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Sura P, 2008, J HISTOCHEM CYTOCHEM, V56, P551, DOI 10.1369/jhc.2008.950659; THOMAS H, 1989, BIOCHEM PHARMACOL, V38, P4291, DOI 10.1016/0006-2952(89)90528-5; VANROLLINS M, 1993, J LIPID RES, V34, P1931; Viner RI, 1999, BIOCHEM J, V340, P657, DOI 10.1042/0264-6021:3400657; Weintraub NL, 1999, AM J PHYSIOL-HEART C, V277, pH2098, DOI 10.1152/ajpheart.1999.277.5.H2098; Yamada T, 2000, J BIOL CHEM, V275, P23082, DOI 10.1074/jbc.M001464200; Yu ZG, 2000, CIRC RES, V87, P992, DOI 10.1161/01.RES.87.11.992; Zhao XY, 2005, AM J PHYSIOL-REG I, V288, pR188, DOI 10.1152/ajpregu.00018.2004; Zheng J, 2001, AM J RESP CELL MOL, V25, P434, DOI 10.1165/ajrcmb.25.4.4104; Zou MH, 1997, BIOL CHEM, V378, P707, DOI 10.1515/bchm.1997.378.7.707	51	24	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28156	28163		10.1074/jbc.M109.054759	http://dx.doi.org/10.1074/jbc.M109.054759			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19704161	Green Published, hybrid			2022-12-25	WOS:000270676300042
J	Azdad, K; Chavez, M; Bischop, PD; Wetzelaer, P; Marescau, B; De Deyn, PP; Gall, D; Schiffmann, SN				Azdad, Karima; Chavez, Marcelo; Bischop, Patrick Don; Wetzelaer, Pim; Marescau, Bart; De Deyn, Peter Paul; Gall, David; Schiffmann, Serge N.			Homeostatic Plasticity of Striatal Neurons Intrinsic Excitability following Dopamine Depletion	PLOS ONE			English	Article								The striatum is the major input structure of basal ganglia and is involved in adaptive control of behaviour through the selection of relevant informations. Dopaminergic neurons that innervate striatum die in Parkinson disease, leading to inefficient adaptive behaviour. Neuronal activity of striatal medium spiny neurons (MSN) is modulated by dopamine receptors. Although dopamine signalling had received substantial attention, consequences of dopamine depletion on MSN intrinsic excitability remain unclear. Here we show, by performing perforated patch clamp recordings on brain slices, that dopamine depletion leads to an increase in MSN intrinsic excitability through the decrease of an inactivating A-type potassium current, I-A. Despite the large decrease in their excitatory synaptic inputs determined by the decreased dendritic spines density and the increase in minimal current to evoke the first EPSP, this increase in intrinsic excitability resulted in an enhanced responsiveness to their remaining synapses, allowing them to fire similarly or more efficiently following input stimulation than in control condition. Therefore, this increase in intrinsic excitability through the regulation of IA represents a form of homeostatic plasticity allowing neurons to compensate for perturbations in synaptic transmission and to promote stability in firing. The present observations show that this homeostatic ability to maintain firing rates within functional range also occurs in pathological conditions, allowing stabilizing neural computation within affected neuronal networks.	[Azdad, Karima; Chavez, Marcelo; Bischop, Patrick Don; Wetzelaer, Pim; Gall, David; Schiffmann, Serge N.] Univ Brussels ULB, Neurophysiol Lab, Brussels, Belgium; [Marescau, Bart; De Deyn, Peter Paul] Univ Antwerp, Inst Born Bunge, Dept Biomed Sci, Lab Neurochem & Behaviour, Antwerp, Belgium; [Azdad, Karima; Chavez, Marcelo; Bischop, Patrick Don; Wetzelaer, Pim; Gall, David; Schiffmann, Serge N.] European Grad Sch Neurosci EURON, Maastricht, Netherlands	Universite Libre de Bruxelles; University of Antwerp; Maastricht University	Azdad, K (corresponding author), Univ Brussels ULB, Neurophysiol Lab, Brussels, Belgium.	kazdad@ulb.ac.be; sschiffm@ulb.ac.be		Wetzelaer, Pim/0000-0002-7450-0046; Schiffmann, Serge/0000-0002-0118-9816	FMRE (Belgium); FNRS (Belgium); Van Buuren Foundation; FER from ULB; Action de Recherche Concertee; EC fellowship [QLG3-20001-01056]; FRS-FNRS Belgium [7.4.531.06 .F]; EC Marie Curie Early Training Site program fellowship [MEST-CT-2005-020589]	FMRE (Belgium); FNRS (Belgium)(Fonds de la Recherche Scientifique - FNRS); Van Buuren Foundation; FER from ULB; Action de Recherche Concertee; EC fellowship; FRS-FNRS Belgium(Fonds de la Recherche Scientifique - FNRS); EC Marie Curie Early Training Site program fellowship	This work was supported by FMRE (Belgium), FNRS (Belgium), Van Buuren Foundation, FER from ULB, Action de Recherche Concertee (2008-2013) from the CFWB. K.A. was supported by an EC fellowship (QLG3-20001-01056), M.C. by a grant Televie from the FRS-FNRS Belgium (7.4.531.06 .F) and P.W. by an EC Marie Curie Early Training Site program fellowship (MEST-CT-2005-020589). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZDAD K, 2008, NEUROPSYCHOPHARMACOL; CALABRESI P, 1993, BRAIN, V116, P433; Calabresi P, 2000, TRENDS NEUROSCI, V23, pS57, DOI 10.1016/S1471-1931(00)00017-3; COVARRUBIAS M, 1994, NEURON, V13, P1403, DOI 10.1016/0896-6273(94)90425-1; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; DUCREUX C, 1995, J PHYSIOL-LONDON, V486, P439, DOI 10.1113/jphysiol.1995.sp020824; Fino E, 2007, NEUROSCI RES, V58, P305, DOI 10.1016/j.neures.2007.04.002; Gabel LA, 1998, J NEUROPHYSIOL, V79, P1989, DOI 10.1152/jn.1998.79.4.1989; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hernandez-Echeagaray E, 2004, EUR J NEUROSCI, V19, P2455, DOI 10.1111/j.0953-816X.2004.03344.x; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hopf FW, 2003, J NEUROSCI, V23, P5079; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; Ingham CA, 1998, J NEUROSCI, V18, P4732; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; KOMBIAN SB, 1994, NATURE, V368, P242, DOI 10.1038/368242a0; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Mahon S, 2003, J PHYSIOL-LONDON, V550, P947, DOI 10.1113/jphysiol.2003.043125; Mahon S, 2000, LEARN MEMORY, V7, P357, DOI 10.1101/lm.34800; MOODY CA, 1992, PSYCHOPHARMACOLOGY, V107, P39, DOI 10.1007/BF02244963; Nakamura TY, 1997, AM J PHYSIOL-HEART C, V273, pH1775, DOI 10.1152/ajpheart.1997.273.4.H1775; Neely MD, 2007, NEUROSCIENCE, V149, P457, DOI 10.1016/j.neuroscience.2007.06.044; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Nisenbaum ES, 1998, SYNAPSE, V29, P213, DOI 10.1002/(SICI)1098-2396(199807)29:3<213::AID-SYN3>3.3.CO;2-3; NISENBAUM ES, 1995, J NEUROSCI, V15, P4449; PENNARTZ CMA, 1992, J NEUROPHYSIOL, V67, P1325, DOI 10.1152/jn.1992.67.5.1325; PENNARTZ CMA, 1992, NEUROSCI LETT, V136, P109, DOI 10.1016/0304-3940(92)90660-Y; Perez MF, 2006, J NEUROPHYSIOL, V96, P2217, DOI 10.1152/jn.00254.2006; Sacco T, 2002, J PHYSIOL-LONDON, V543, P505, DOI 10.1113/jphysiol.2002.022525; SCHIFFMANN SN, 1993, J NEUROSCI, V13, P1080; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Thompson SM, 2007, NEURON, V54, P850, DOI 10.1016/j.neuron.2007.06.008; Tkatch T, 2000, J NEUROSCI, V20, P579, DOI 10.1523/JNEUROSCI.20-02-00579.2000; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; TWERY MJ, 1993, SYNAPSE, V13, P322, DOI 10.1002/syn.890130405; Van Dam D, 2005, NEUROCHEM INT, V46, P409, DOI 10.1016/j.neuint.2004.11.005; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	40	55	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2009	4	9							e6908	10.1371/journal.pone.0006908	http://dx.doi.org/10.1371/journal.pone.0006908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZF	19730738	Green Published, gold, Green Submitted			2022-12-25	WOS:000269622100013
J	Wei, HY; Wang, R; Yuan, ZQ; Chen, CY; Huang, D; Halliday, L; Zhong, WH; Zeng, GC; Shen, Y; Shen, L; Wang, YQ; Chen, ZW				Wei, Huiyong; Wang, Richard; Yuan, Zhuqing; Chen, Crystal Y.; Huang, Dan; Halliday, Lisa; Zhong, Weihua; Zeng, Gucheng; Shen, Yun; Shen, Ling; Wang, Yunqi; Chen, Zheng W.			DR*W201/P65 Tetramer Visualization of Epitope-Specific CD4 T-Cell during M. tuberculosis Infection and Its Resting Memory Pool after BCG Vaccination	PLOS ONE			English	Article								Background: In vivo kinetics and frequencies of epitope-specific CD4 T cells in lymphoid compartments during M. tuberculosis infection and their resting memory pool after BCG vaccination remain unknown. Methodology/Findings: Macaque DR*W201 tetramer loaded with Ag85B peptide 65 was developed to directly measure epitope-specific CD4 T cells in blood and tissues form macaques after M. tuberculosis infection or BCG vaccination via direct staining and tetramer-enriched approach. The tetramer-based enrichment approach showed that P65 epitope-specific CD4 T cells emerged at mean frequencies of similar to 500 and similar to 4500 per 10(7) PBL at days 28 and 42, respectively, and at day 63 increased further to similar to 22,000/10(7) PBL after M. tuberculosis infection. Direct tetramer staining showed that the tetramer-bound P65-specific T cells constituted about 0.2-0.3% of CD4 T cells in PBL, lymph nodes, spleens, and lungs at day 63 post-infection. 10-fold expansion of these tetramer-bound epitope-specific CD4 T cells was seen after the P65 peptide stimulation of PBL and tissue lymphocytes. The tetramer-based enrichment approach detected BCG-elicited resting memory P65-specific CD4 T cells at a mean frequency of 2,700 per 10(7) PBL. Significance: Our work represents the first elucidation of in vivo kinetics and frequencies for tetramer-bound epitope-specific CD4 T cells in the blood, lymphoid tissues and lungs over times after M. tuberculosis infection, and BCG immunization.			Wei, HY (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	zchen@uic.edu	Zeng, Gucheng/N-9397-2015; WANG, YUNQI/F-4668-2014		NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR013601] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064560] Funding Source: NIH RePORTER; NCRR NIH HHS [R01 RR13601, R01 RR013601] Funding Source: Medline; NHLBI NIH HHS [R01 HL64560, R01 HL064560] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ali Z, 2007, J IMMUNOL, V179, P8287, DOI 10.4049/jimmunol.179.12.8287; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Bieganowska K, 1999, J IMMUNOL, V162, P1765; Bronke C, 2005, HUM IMMUNOL, V66, P950, DOI 10.1016/j.humimm.2005.06.011; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Chen ZW, 2001, J IMMUNOL, V166, P4525, DOI 10.4049/jimmunol.166.7.4525; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; D'Souza S, 2003, INFECT IMMUN, V71, P483, DOI 10.1128/IAI.71.1.483-493.2003; de Groot N, 2004, J IMMUNOL, V172, P6152, DOI 10.4049/jimmunol.172.10.6152; Dzuris JL, 2001, J VIROL, V75, P10958, DOI 10.1128/JVI.75.22.10958-10968.2001; GASTON JSH, 1990, J EXP MED, V171, P831, DOI 10.1084/jem.171.3.831; GONG G, 2008, BLOOD; Hammond AS, 2008, J INFECT DIS, V197, P295, DOI 10.1086/524685; Hohn H, 2007, SCAND J IMMUNOL, V65, P467, DOI 10.1111/j.1365-3083.2007.01924.x; Huang D, 2008, INFECT IMMUN, V76, P426, DOI 10.1128/IAI.01008-07; Kotzin BL, 2000, P NATL ACAD SCI USA, V97, P291, DOI 10.1073/pnas.97.1.291; Kuroda MJ, 2000, J VIROL, V74, P8751, DOI 10.1128/JVI.74.18.8751-8756.2000; Kwok WW, 2000, J IMMUNOL, V164, P4244, DOI 10.4049/jimmunol.164.8.4244; Lalvani A, 2008, AUTOIMMUN REV, V8, P147, DOI 10.1016/j.autrev.2008.07.011; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Meyer AL, 2000, P NATL ACAD SCI USA, V97, P11433, DOI 10.1073/pnas.190335897; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Murali-Krishna K, 1998, ADV EXP MED BIOL, V452, P123; Novak EJ, 1999, J CLIN INVEST, V104, pR63, DOI 10.1172/JCI8476; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Scriba TJ, 2005, J IMMUNOL, V175, P6334, DOI 10.4049/jimmunol.175.10.6334; Shen Y, 2004, J VIROL, V78, P14023, DOI 10.1128/JVI.78.24.14023-14032.2004; Tan LC, 1999, J IMMUNOL, V162, P1827; Tully G, 2005, J IMMUNOL, V174, P2174, DOI 10.4049/jimmunol.174.4.2174; Vollers SS, 2008, IMMUNOLOGY, V123, P305, DOI 10.1111/j.1365-2567.2007.02801.x; Wei HY, 2008, J IMMUNOL, V181, P4798, DOI 10.4049/jimmunol.181.7.4798; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	32	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2009	4	9							e6905	10.1371/journal.pone.0006905	http://dx.doi.org/10.1371/journal.pone.0006905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZF	19730727	gold, Green Published, Green Submitted			2022-12-25	WOS:000269622100010
J	Adler, PB; Leiker, J; Levine, JM				Adler, Peter B.; Leiker, James; Levine, Jonathan M.			Direct and Indirect Effects of Climate Change on a Prairie Plant Community	PLOS ONE			English	Article							SPECIES INTERACTIONS; VARIABILITY; COMPETITION	Background: Climate change directly affects species by altering their physical environment and indirectly affects species by altering interspecific interactions such as predation and competition. Recent studies have shown that the indirect effects of climate change may amplify or counteract the direct effects. However, little is known about the the relative strength of direct and indirect effects or their potential to impact population persistence. Methodology/Principal Findings: We studied the effects of altered precipitation and interspecific interactions on the low-density tiller growth rates and biomass production of three perennial grass species in a Kansas, USA mixed prairie. We transplanted plugs of each species into local neighborhoods of heterospecific competitors and then exposed the plugs to a factorial manipulation of growing season precipitation and neighbor removal. Precipitation treatments had significant direct effects on two of the three species. Interspecific competition also had strong effects, reducing low-density tiller growth rates and aboveground biomass production for all three species. In fact, in the presence of competitors, ( log) tiller growth rates were close to or below zero for all three species. However, we found no convincing evidence that per capita competitive effects changed with precipitation, as shown by a lack of significant precipitation x competition interactions. Conclusions/Significance: We found little evidence that altered precipitation will influence per capita competitive effects. However, based on species' very low growth rates in the presence of competitors in some precipitation treatments, interspecific interactions appear strong enough to affect the balance between population persistence and local extinction. Therefore, ecological forecasting models should include the effect of interspecific interactions on population growth, even if such interaction coefficients are treated as constants.			Adler, PB (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	peter.adler@usu.edu	Levine, Jonathan/A-7167-2014; Adler, Peter B./D-3781-2009	Levine, Jonathan/0000-0003-2857-7904				Adler PB, 2007, OIKOS, V116, P221, DOI [10.1111/j.2006.0030-1299.15327.x, 10.1111/j.0030-1299.2007.15327.x]; Adler PB, 2006, P NATL ACAD SCI USA, V103, P12793, DOI 10.1073/pnas.0600599103; Adler PB, 2008, ECOLOGY, V89, P3049, DOI 10.1890/07-1569.1; ALBERTSON F. W., 1965, ECOLOGY, V46, P714, DOI 10.2307/1935011; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; CHESSON P, 1994, THEOR POPUL BIOL, V45, P227, DOI 10.1006/tpbi.1994.1013; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Franco M, 2004, ECOLOGY, V85, P531, DOI 10.1890/02-0651; IVES AR, 1995, ECOLOGY, V76, P926, DOI 10.2307/1939357; Klanderud K, 2005, J ECOL, V93, P127, DOI 10.1111/j.1365-2745.2004.00944.x; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; LEVINE JM, ECOLOGY IN PRESS; Liang XZ, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006685; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; R Core Team, 2022, R LANG ENV STAT COMP; Reece PE, 2007, RANGELAND ECOL MANAG, V60, P203, DOI 10.2111/05-147R1.1; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; Sears ALW, 2007, ECOLOGY, V88, P2240, DOI 10.1890/06-0645.1; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; WOOTTON JT, 1994, ANNU REV ECOL SYST, V25, P443, DOI 10.1146/annurev.es.25.110194.002303; Yahdjian L, 2002, OECOLOGIA, V133, P95, DOI 10.1007/s00442-002-1024-3	23	47	52	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6887	10.1371/journal.pone.0006887	http://dx.doi.org/10.1371/journal.pone.0006887			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19727390	Green Submitted, Green Published, gold			2022-12-25	WOS:000269522900016
J	Schulz, H; Kolde, R; Adler, P; Aksoy, I; Anastassiadis, K; Bader, M; Billon, N; Boeuf, H; Bourillot, PY; Buchholz, F; Dani, C; Doss, MX; Forrester, L; Gitton, M; Henrique, D; Hescheler, J; Himmelbauer, H; Hubner, N; Karantzali, E; Kretsovali, A; Lubitz, S; Pradier, L; Rai, M; Reimand, J; Rolletschek, A; Sachinidis, A; Savatier, P; Stewart, F; Storm, MP; Trouillas, M; Vilo, J; Welham, MJ; Winkler, J; Wobus, AM; Hatzopoulos, AK				Schulz, Herbert; Kolde, Raivo; Adler, Priit; Aksoy, Irene; Anastassiadis, Konstantinos; Bader, Michael; Billon, Nathalie; Boeuf, Helene; Bourillot, Pierre-Yves; Buchholz, Frank; Dani, Christian; Doss, Michael Xavier; Forrester, Lesley; Gitton, Murielle; Henrique, Domingos; Hescheler, Juergen; Himmelbauer, Heinz; Huebner, Norbert; Karantzali, Efthimia; Kretsovali, Androniki; Lubitz, Sandra; Pradier, Laurent; Rai, Meena; Reimand, Jueri; Rolletschek, Alexandra; Sachinidis, Agapios; Savatier, Pierre; Stewart, Francis; Storm, Mike P.; Trouillas, Marina; Vilo, Jaak; Welham, Melanie J.; Winkler, Johannes; Wobus, Anna M.; Hatzopoulos, Antonis K.		Functional Genomics Embryonic Stem	The FunGenES Database: A Genomics Resource for Mouse Embryonic Stem Cell Differentiation	PLOS ONE			English	Article							SELF-RENEWAL; TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; REGULATORY NETWORKS; GENE-FUNCTION; EXPRESSION; PLURIPOTENCY; NANOG; EMBRYOGENESIS; ESTABLISHMENT	Embryonic stem (ES) cells have high self-renewal capacity and the potential to differentiate into a large variety of cell types. To investigate gene networks operating in pluripotent ES cells and their derivatives, the "Functional Genomics in Embryonic Stem Cells'' consortium (FunGenES) has analyzed the transcriptome of mouse ES cells in eleven diverse settings representing sixty-seven experimental conditions. To better illustrate gene expression profiles in mouse ES cells, we have organized the results in an interactive database with a number of features and tools. Specifically, we have generated clusters of transcripts that behave the same way under the entire spectrum of the sixty-seven experimental conditions; we have assembled genes in groups according to their time of expression during successive days of ES cell differentiation; we have included expression profiles of specific gene classes such as transcription regulatory factors and Expressed Sequence Tags; transcripts have been arranged in "Expression Waves'' and juxtaposed to genes with opposite or complementary expression patterns; we have designed search engines to display the expression profile of any transcript during ES cell differentiation; gene expression data have been organized in animated graphs of KEGG signaling and metabolic pathways; and finally, we have incorporated advanced functional annotations for individual genes or gene clusters of interest and links to microarray and genomic resources. The FunGenES database provides a comprehensive resource for studies into the biology of ES cells.	[Rai, Meena; Hatzopoulos, Antonis K.] Vanderbilt Univ, Dept Cell & Dev Biol, Dept Med, Div Cardiovasc Med, Nashville, TN USA; [Schulz, Herbert; Bader, Michael; Huebner, Norbert] Max Delbruck Ctr Mol Med Berlin Buch, Berlin, Germany; [Kolde, Raivo; Adler, Priit; Reimand, Jueri; Vilo, Jaak] Univ Tartu, Inst Comp Sci, Tartu, Estonia; [Aksoy, Irene; Bourillot, Pierre-Yves; Savatier, Pierre] INSERM U846, Stem Cell & Brain Res Inst, Bron, France; [Anastassiadis, Konstantinos; Lubitz, Sandra; Stewart, Francis] Tech Univ Dresden, BioInnovat Zent, Dresden, Germany; [Billon, Nathalie; Dani, Christian] CNRS, UMR 6543, Ctr Biochim, Nice, France; [Boeuf, Helene; Trouillas, Marina] Univ Bordeaux 2, CNRS, UMR 5164, F-33076 Bordeaux, France; [Buchholz, Frank] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Doss, Michael Xavier; Hescheler, Juergen; Sachinidis, Agapios; Winkler, Johannes] Univ Cologne, Inst Neurophysiol, D-5000 Cologne, Germany; [Forrester, Lesley] Univ Edinburgh, Queens Med Res Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Gitton, Murielle; Pradier, Laurent] Sanofi Aventis, Ctr Rech Paris, Paris, France; [Henrique, Domingos] Inst Med Mol, Fac Med Lisboa, Lisbon, Portugal; [Himmelbauer, Heinz] Max Planck Inst Mol Genet, Berlin, Germany; [Himmelbauer, Heinz] UPF, CRG, Barcelona, Spain; [Karantzali, Efthimia; Kretsovali, Androniki] Inst Mol Biol & Biotechnol, FORTH, Iraklion, Greece; [Rolletschek, Alexandra; Wobus, Anna M.] Leibniz Inst IPK, Gatersleben, Germany; [Storm, Mike P.; Welham, Melanie J.] Univ Bath, Ctr Regenerat Med, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Hatzopoulos, Antonis K.] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Clin Mol Biol & Tumor Genet, Munich, Germany	Vanderbilt University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Tartu; Institut National de la Sante et de la Recherche Medicale (Inserm); Technische Universitat Dresden; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Max Planck Society; University of Cologne; University of Edinburgh; Sanofi-Aventis; Sanofi France; Universidade de Lisboa; Max Planck Society; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of Bath; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Hatzopoulos, AK (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, Dept Med, Div Cardiovasc Med, Nashville, TN USA.	antonis.hatzopoulos@vanderbilt.edu	Bader, Michael/K-2124-2013; Bourillot, Pierre-Yves/M-6956-2014; Rai, Meena/AAI-6381-2021; Sachinidis, Agapios/AAD-4178-2020; Winkler, Johannes/A-7615-2011; Anastassiadis, Konstantinos/A-8944-2010; Kolde, Raivo/AAB-8149-2022; Hatzopoulos, Antonis/D-2049-2010; Vilo, Jaak/A-7183-2008; Hatzopoulos, Antonis/X-2043-2019; Storm, Mike/AAC-8733-2020; Aksoy, Irene/O-2238-2013; Sachinidis, Agapios/AAM-7988-2020; SAVATIER, Pierre/J-4663-2014; Henrique, Domingos M/E-5460-2010; Buchholz, Frank/B-4700-2017; Reimand, Jüri/U-9264-2019; DANI, Christian/G-3639-2014; Stewart, A. Francis/E-7789-2010; Vilo, Jaak/AAK-2228-2020; Jesudoss, Michael Xavier Doss/D-1983-2015	Bourillot, Pierre-Yves/0000-0003-1657-8555; Anastassiadis, Konstantinos/0000-0002-9814-0559; Kolde, Raivo/0000-0003-2886-6298; Vilo, Jaak/0000-0001-5604-4107; Hatzopoulos, Antonis/0000-0001-5610-0017; Aksoy, Irene/0000-0003-4353-5876; Henrique, Domingos M/0000-0001-8869-1894; Buchholz, Frank/0000-0002-4577-3344; Reimand, Jüri/0000-0002-2299-2309; DANI, Christian/0000-0003-3228-0230; Vilo, Jaak/0000-0001-5604-4107; Bader, Michael/0000-0003-4780-4164; Himmelbauer, Heinz/0000-0001-8897-2928; Jesudoss, Michael Xavier Doss/0000-0001-6339-9782	NHLBI NIH HHS [R01 HL083958-01, R01 HL083958-03, R01 HL083958-02, R01 HL083958, R01 HL083958-04S1, R01 HL083958-04, HL08395] Funding Source: Medline; Medical Research Council [G0700711B, G9900991B] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083958] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adler P, 2008, BIOINFORMATICS, V24, P588, DOI 10.1093/bioinformatics/btm581; *AFF, 1999, GEN EXPR AN TECHN MA; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Barrow JR, 2007, DEV BIOL, V312, P312, DOI 10.1016/j.ydbio.2007.09.030; *BIOM TEAM, 2009, BIOMART PROJ; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Burt RK, 2008, JAMA-J AM MED ASSOC, V299, P925, DOI 10.1001/jama.299.8.925; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cinelli P, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-57; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Doss MX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r56; Doss MX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r184; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Gasch AP, 2002, GENOME BIOL, V3; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hatzopoulos AK, 1999, ANGIOGENESIS AND CARDIOVASCULAR DISEASE, P3; Hong Y, 2007, MUTAT RES-FUND MOL M, V614, P48, DOI 10.1016/j.mrfmmm.2006.06.006; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karantzali E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r65; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mariappan D, 2009, GENES CELLS, V14, P243, DOI 10.1111/j.1365-2443.2008.01268.x; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Ogawa K, 2007, DEV BIOL, V306, P391, DOI 10.1016/j.ydbio.2007.03.575; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; Porter Christopher J., 2007, V407, P137, DOI 10.1007/978-1-59745-536-7_11; Potta SP, 2009, HYPERTENSION, V53, P196, DOI 10.1161/HYPERTENSIONAHA.108.121863; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; ROLLETSCHEK A, 2009, INT J DEV B IN PRESS; Saretzki G, 2004, STEM CELLS, V22, P962, DOI 10.1634/stemcells.22-6-962; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Savatier P, 1996, ONCOGENE, V12, P309; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; Sekkai D, 2005, STEM CELLS, V23, P1634, DOI 10.1634/stemcells.2005-0182; Singec I, 2007, ANNU REV MED, V58, P313, DOI 10.1146/annurev.med.58.070605.115252; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takaoka K, 2007, CURR OPIN GENET DEV, V17, P344, DOI 10.1016/j.gde.2007.06.001; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Trouillas M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-73; Tu Y, 2002, P NATL ACAD SCI USA, V99, P14031, DOI 10.1073/pnas.222164199; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang ZX, 2007, J BIOL CHEM, V282, P12822, DOI 10.1074/jbc.M611814200; Wei CL, 2005, STEM CELLS, V23, P166, DOI 10.1634/stemcells.2004-0162; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	76	47	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6804	10.1371/journal.pone.0006804	http://dx.doi.org/10.1371/journal.pone.0006804			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19727443	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000269522900003
J	Chen, XN; Sun, CE; Chen, Q; O'Neill, FA; Walsh, D; Fanous, AH; Chowdari, KV; Nimgaonkar, VL; Scott, A; Schwab, SG; Wildenauer, DB; Che, RL; Tang, W; Shi, YY; He, L; Luo, XJ; Su, B; Edwards, TL; Zhao, ZM; Kendler, KS				Chen, Xiangning; Sun, Cuie; Chen, Qi; O'Neill, F. Anthony; Walsh, Dermot; Fanous, Ayman H.; Chowdari, Kodavali V.; Nimgaonkar, Vishwajit L.; Scott, Adrian; Schwab, Sibylle G.; Wildenauer, Dieter B.; Che, Ronglin; Tang, Wei; Shi, Yongyong; He, Lin; Luo, Xiong-jian; Su, Bing; Edwards, Todd L.; Zhao, Zhongming; Kendler, Kenneth S.			Apoptotic Engulfment Pathway and Schizophrenia	PLOS ONE			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; CELL CORPSE ENGULFMENT; GENE-GENE INTERACTIONS; ALZHEIMERS-DISEASE; NUCLEAR FAMILIES; RECEPTOR CED-1; ASSOCIATION; ABCA1; LINKAGE; PHAGOCYTOSIS	Background: Apoptosis has been speculated to be involved in schizophrenia. In a previously study, we reported the association of the MEGF10 gene with the disease. In this study, we followed the apoptotic engulfment pathway involving the MEGF10, GULP1, ABCA1 and ABCA7 genes and tested their association with the disease. Methodology/Principal Findings: Ten, eleven and five SNPs were genotyped in the GULP1, ABCA1 and ABCA7 genes respectively for the ISHDSF and ICCSS samples. In all 3 genes, we observed nominally significant associations. Rs2004888 at GULP1 was significant in both ISHDSF and ICCSS samples (p = 0.0083 and 0.0437 respectively). We sought replication in independent samples for this marker and found highly significant association (p = 0.0003) in 3 Caucasian replication samples. But it was not significant in the 2 Chinese replication samples. In addition, we found a significant 2-marker (rs2242436 * rs3858075) interaction between the ABCA1 and ABCA7 genes in the ISHDSF sample (p = 0.0022) and a 3-marker interaction (rs246896 * rs4522565 * rs3858075) amongst the MEGF10, GULP1 and ABCA1 genes in the ICCSS sample (p = 0.0120). Rs3858075 in the ABCA1 gene was involved in both 2- and 3-marker interactions in the two samples. Conclusions/Significance: From these data, we concluded that the GULP1 gene and the apoptotic engulfment pathway are involved in schizophrenia in subjects of European ancestry and multiple genes in the pathway may interactively increase the risks to the disease.			Chen, XN (corresponding author), Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA 23284 USA.	xchen@vcu.edu	Shi, Yongyong/GSO-1627-2022; O'Neill, Francis A/C-5582-2008; Tang, Wei/H-7103-2013; Fanous, Ayman H/O-1263-2017; Edwards, Todd/B-9750-2012; Kendler, Kenneth/AAF-2876-2019	Shi, Yongyong/0000-0003-1710-1505; O'Neill, Francis A/0000-0002-7531-7657; Tang, Wei/0000-0002-7089-4391; 	NIMH NIH HHS [R01MH41953, R01 MH041953] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH041953] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Banerjee H, 2003, PLASMID, V49, P30, DOI 10.1016/S0147-619X(02)00106-3; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chen Q, 2008, MOL PSYCHIATR, V13, P930, DOI 10.1038/sj.mp.4002051; Chen Q, 2008, SCHIZOPHR RES, V106, P200, DOI 10.1016/j.schres.2008.08.006; Chen X, 2007, MOL PSYCHIATR, V12, P273, DOI 10.1038/sj.mp.4001932; Chen XN, 2008, AM J MED GENET B, V147B, P1231, DOI 10.1002/ajmg.b.30759; Chen X, 2008, BIOL PSYCHIAT, V63, P441, DOI 10.1016/j.biopsych.2007.11.003; Chen XN, 2006, HUM MOL GENET, V15, P3329, DOI 10.1093/hmg/ddl409; Chowdari KV, 2002, HUM MOL GENET, V11, P1373, DOI 10.1093/hmg/11.12.1373; Chu LW, 2007, AM J MED GENET B, V144B, P1007, DOI 10.1002/ajmg.b.30525; Conradt Barbara, 2005, WormBook, P1; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hamon Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000120; Haskins KA, 2008, DEV CELL, V15, P87, DOI 10.1016/j.devcel.2008.05.006; Hayashi M, 2005, J LIPID RES, V46, P1703, DOI 10.1194/jlr.M500092-JLR200; Jehle AW, 2006, J CELL BIOL, V174, P547, DOI 10.1083/jcb.200601030; Jones AL, 2005, IMMUNOL CELL BIOL, V83, P9, DOI 10.1111/j.1440-1711.2005.01305.x; Katzov H, 2004, HUM MUTAT, V23, P358, DOI 10.1002/humu.20012; Kendler KS, 2000, AM J PSYCHIAT, V157, P402, DOI 10.1176/appi.ajp.157.3.402; Kinchen JM, 2007, J CELL SCI, V120, P2143, DOI 10.1242/jcs.03463; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; Kurant E, 2008, CELL, V133, P498, DOI 10.1016/j.cell.2008.02.052; Lamitina T, 2008, DEV CELL, V15, P3, DOI 10.1016/j.devcel.2008.06.007; Lencz T, 2007, MOL PSYCHIATR, V12, P572, DOI 10.1038/sj.mp.4001983; Liu QA, 1999, CURR BIOL, V9, P1347, DOI 10.1016/S0960-9822(00)80061-5; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Mallat M, 2005, CURR OPIN NEUROBIOL, V15, P101, DOI 10.1016/j.conb.2005.01.006; Mangahas PM, 2005, SEMIN CELL DEV BIOL, V16, P295, DOI 10.1016/j.semcdb.2004.12.005; Martin ER, 2006, GENET EPIDEMIOL, V30, P111, DOI 10.1002/gepi.20128; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2003, GENET EPIDEMIOL, V25, P203, DOI 10.1002/gepi.10258; Martins-Silva C, 2006, BRAIN RES, V1119, P1, DOI 10.1016/j.brainres.2006.08.064; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; MOSKVINA V, 2008, MOL PSYCHIAT; Moynault A, 1998, BIOCHEM SOC T, V26, P629, DOI 10.1042/bst0260629; NAPOLI I, 2008, NEUROSCIENCE; NUNES SO, 2006, SCHIZOPHR RES; O'Donovan MC, 2009, MOL PSYCHIATR, V14, P30, DOI 10.1038/mp.2008.108; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Petryshen TL, 2005, MOL PSYCHIATR, V10, P1074, DOI 10.1038/sj.mp.4001739; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Rodriguez-Rodriguez E, 2007, AM J MED GENET B, V144B, P964, DOI 10.1002/ajmg.b.30552; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schmitz C, 2007, P NATL ACAD SCI USA, V104, P834, DOI 10.1073/pnas.0510527104; Schmitz T, 2008, THESCIENTIFICWORLDJO, V8, P1119, DOI 10.1100/tsw.2008.140; Schwab SG, 1997, MOL PSYCHIATR, V2, P156, DOI 10.1038/sj.mp.4000263; Siegmund KD, 2000, AM J HUM GENET, V67, P244, DOI 10.1086/302973; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Straub RE, 1997, MOL PSYCHIATR, V2, P148, DOI 10.1038/sj.mp.4000258; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Su HP, 2000, J BIOL CHEM, V275, P9542, DOI 10.1074/jbc.275.13.9542; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; Sun SL, 2008, NEUROSCI LETT, V440, P35, DOI 10.1016/j.neulet.2008.05.029; Sundar PD, 2007, NEUROBIOL AGING, V28, P856, DOI 10.1016/j.neurobiolaging.2006.04.005; Suzuki E, 2007, EXP CELL RES, V313, P2451, DOI 10.1016/j.yexcr.2007.03.041; Suzuki E, 2007, EXP CELL RES, V313, P3729, DOI 10.1016/j.yexcr.2007.06.015; Takahashi Kei, 2005, Medical Molecular Morphology, V38, P2, DOI 10.1007/s00795-004-0278-8; van den Oord EJCG, 2003, BIOTECHNIQUES, V34, P610, DOI 10.2144/03343dd04; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Yu XM, 2008, PLOS BIOL, V6, P581, DOI 10.1371/journal.pbio.0060061; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	68	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2009	4	9							e6875	10.1371/journal.pone.0006875	http://dx.doi.org/10.1371/journal.pone.0006875			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489XX	19721717	Green Published, Green Accepted, gold			2022-12-25	WOS:000269461100004
J	Czisch, M; Wehrle, R; Stiegler, A; Peters, H; Andrade, K; Holsboer, F; Samann, PG				Czisch, Michael; Wehrle, Renate; Stiegler, Andrea; Peters, Henning; Andrade, Katia; Holsboer, Florian; Saemann, Philipp G.			Acoustic Oddball during NREM Sleep: A Combined EEG/fMRI Study	PLOS ONE			English	Article								Background: A condition vital for the consolidation and maintenance of sleep is generally reduced responsiveness to external stimuli. Despite this, the sleeper maintains a level of stimulus processing that allows to respond to potentially dangerous environmental signals. The mechanisms that subserve these contradictory functions are only incompletely understood. Methodology/Principal Findings: Using combined EEG/fMRI we investigated the neural substrate of sleep protection by applying an acoustic oddball paradigm during light NREM sleep. Further, we studied the role of evoked K-complexes (KCs), an electroencephalographic hallmark of NREM sleep with a still unknown role for sleep protection. Our main results were: (1) Other than in wakefulness, rare tones did not induce a blood oxygenation level dependent (BOLD) signal increase in the auditory pathway but a strong negative BOLD response in motor areas and the amygdala. (2) Stratification of rare tones by the presence of evoked KCs detected activation of the auditory cortex, hippocampus, superior and middle frontal gyri and posterior cingulate only for rare tones followed by a KC. (3) The typical high frontocentral EEG deflections of KCs were not paralleled by a BOLD equivalent. Conclusions/Significance: We observed that rare tones lead to transient disengagement of motor and amygdala responses during light NREM sleep. We interpret this as a sleep protective mechanism to delimit motor responses and to reduce the sensitivity of the amygdala towards further incoming stimuli. Evoked KCs are suggested to originate from a brain state with relatively increased stimulus processing, revealing an activity pattern resembling novelty processing as previously reported during wakefulness. The KC itself is not reflected by increased metabolic demand in BOLD based imaging, arguing that evoked KCs result from increased neural synchronicity without altered metabolic demand.			Czisch, M (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	czisch@mpipsykl.mpg.de						Amzica F, 2002, SLEEP MED REV, V6, P139, DOI 10.1053/smrv.2001.0181; Amzica F, 1997, NEUROLOGY, V49, P952, DOI 10.1212/WNL.49.4.952; Atienza M, 2002, INT J PSYCHOPHYSIOL, V46, P215, DOI 10.1016/S0167-8760(02)00113-7; Atienza M, 2001, CLIN NEUROPHYSIOL, V112, P2031, DOI 10.1016/S1388-2457(01)00650-2; BASTIEN C, 1992, SLEEP, V15, P236, DOI 10.1093/sleep/15.3.236; Bastuji H, 1999, SLEEP MED REV, V3, P23, DOI 10.1016/S1087-0792(99)90012-6; Born AP, 2002, NEUROIMAGE, V17, P1325, DOI 10.1006/nimg.2002.1249; Campbell KB, 2002, INT J PSYCHOPHYSIOL, V46, P197, DOI 10.1016/S0167-8760(02)00112-5; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; CHURCH MW, 1978, ELECTROEN CLIN NEURO, V45, P443, DOI 10.1016/0013-4694(78)90289-4; Colrain IM, 2007, SLEEP MED REV, V11, P277, DOI 10.1016/j.smrv.2007.05.001; Colrain IM, 2005, SLEEP, V28, P255, DOI 10.1093/sleep/28.2.255; Colrain IM, 2000, SLEEP, V23, P97; Cote KA, 2002, INT J PSYCHOPHYSIOL, V46, P227, DOI 10.1016/S0167-8760(02)00114-9; Crowley KE, 2004, CLIN NEUROPHYSIOL, V115, P732, DOI 10.1016/j.clinph.2003.11.021; Czisch M, 2004, EUR J NEUROSCI, V20, P566, DOI 10.1111/j.1460-9568.2004.03518.x; Czisch M, 2002, NEUROIMAGE, V16, P251, DOI 10.1006/nimg.2002.1071; De Gennaro L, 2000, NEUROSCI LETT, V291, P41, DOI 10.1016/S0304-3940(00)01366-5; Doeller CF, 2003, NEUROIMAGE, V20, P1270, DOI 10.1016/S1053-8119(03)00389-6; Halasz P, 2005, SLEEP MED REV, V9, P391, DOI 10.1016/j.smrv.2005.04.003; Halasz P, 2005, SLEEP MED, V6, P183, DOI 10.1016/j.sleep.2004.12.006; Halasz P, 1998, NEUROPHYSIOL CLIN, V28, P461, DOI 10.1016/S0987-7053(99)80016-1; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; HIRAYASU Y, 1995, PSYCHIAT CLIN NEUROS, V49, P223, DOI 10.1111/j.1440-1819.1995.tb01888.x; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Hull J, 2001, J SLEEP RES, V10, P9, DOI 10.1046/j.1365-2869.2001.00238.x; JOHNSON LC, 1968, PSYCHOPHYSIOLOGY, V4, P444, DOI 10.1111/j.1469-8986.1968.tb02785.x; JOHNSON R, 1988, BRAIN, V111, P1517, DOI 10.1093/brain/111.6.1517; JOHNSON R, 1989, PSYCHOPHYSIOLOGY, V26, P633, DOI 10.1111/j.1469-8986.1989.tb03165.x; Kaufmann C, 2006, BRAIN, V129, P655, DOI 10.1093/brain/awh686; Kiehl KA, 2005, NEUROIMAGE, V25, P899, DOI 10.1016/j.neuroimage.2004.12.035; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Loomis AL, 1938, J NEUROPHYSIOL, V1, P413, DOI 10.1152/jn.1938.1.5.413; Mandelkow H, 2006, NEUROIMAGE, V32, P1120, DOI 10.1016/j.neuroimage.2006.04.231; Mulert C, 2004, NEUROIMAGE, V22, P83, DOI 10.1016/j.neuroimage.2003.10.051; Nicholas CL, 2002, SLEEP, V25, P882; Nittono H, 2001, CLIN NEUROPHYSIOL, V112, P732, DOI 10.1016/S1388-2457(01)00491-6; Novitski N, 2004, COGNITIVE BRAIN RES, V20, P26, DOI 10.1016/j.cogbrainres.2003.12.011; Novitski N, 2006, J NEUROSCI METH, V155, P149, DOI 10.1016/j.jneumeth.2006.01.030; Peszka J, 2002, INT J PSYCHOPHYSIOL, V46, P275, DOI 10.1016/S0167-8760(02)00115-0; Portas CM, 2000, NEURON, V28, P991, DOI 10.1016/S0896-6273(00)00169-0; Rechtschaffen A, 1968, NIH PUBLICATION, V204; Redcay E, 2007, NEUROIMAGE, V38, P696, DOI 10.1016/j.neuroimage.2007.08.005; Rosburg T, 2007, NEUROIMAGE, V37, P274, DOI 10.1016/j.neuroimage.2007.05.002; Ruby P, 2008, J COGNITIVE NEUROSCI, V20, P296, DOI 10.1162/jocn.2008.20023; Sabri M, 2005, J SLEEP RES, V14, P113, DOI 10.1111/j.1365-2869.2005.00446.x; Sabri M, 2004, NEUROIMAGE, V21, P69, DOI 10.1016/j.neuroimage.2003.08.033; Sallinen M, 1997, ELECTROEN CLIN NEURO, V102, P363, DOI 10.1016/S0013-4694(96)96614-6; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; Tanaka H, 2003, AM J NEURORADIOL, V24, P1982; Tse CY, 2008, NEUROIMAGE, V41, P1462, DOI 10.1016/j.neuroimage.2008.03.043; Wilke M, 2003, AM J NEURORADIOL, V24, P42; Wilson MT, 2006, J COMPUT NEUROSCI, V21, P243, DOI 10.1007/s10827-006-7948-6; Wittchen HU, 1998, SOC PSYCH PSYCH EPID, V33, P568, DOI 10.1007/s001270050095; Yang CM, 2007, SLEEP, V30, P585, DOI 10.1093/sleep/30.5.585; Yang CM, 2007, INT J PSYCHOPHYSIOL, V63, P87, DOI 10.1016/j.ijpsycho.2006.08.006	56	43	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6749	10.1371/journal.pone.0006749	http://dx.doi.org/10.1371/journal.pone.0006749			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707599	Green Submitted, Green Published, gold			2022-12-25	WOS:000269278400014
J	Cho, SS; Strafella, AP				Cho, Sang Soo; Strafella, Antonio P.			rTMS of the Left Dorsolateral Prefrontal Cortex Modulates Dopamine Release in the Ipsilateral Anterior Cingulate Cortex and Orbitofrontal Cortex	PLOS ONE			English	Article								Background: Brain dopamine is implicated in the regulation of movement, attention, reward and learning and plays an important role in Parkinson's disease, schizophrenia and drug addiction. Animal experiments have demonstrated that brain stimulation is able to induce significant dopaminergic changes in extrastriatal areas. Given the up-growing interest of non-invasive brain stimulation as potential tool for treatment of neurological and psychiatric disorders, it would be critical to investigate dopaminergic functional interactions in the prefrontal cortex and more in particular the effect of dorsolateral prefrontal cortex (DLPFC) (areas 9/46) stimulation on prefrontal dopamine (DA). Methodology/Principal Findings: Healthy volunteers were studied with a high-affinity DA D2-receptor radioligand, [C-11] FLB 457-PET following 10 Hz repetitive transcranial magnetic stimulation (rTMS) of the left and right DLPFC. rTMS on the left DLPFC induced a significant reduction in [C-11] FLB 457 binding potential (BP) in the ipsilateral subgenual anterior cingulate cortex (ACC) (BA 25/12), pregenual ACC (BA 32) and medial orbitofrontal cortex (BA 11). There were no significant changes in [C-11] FLB 457 BP following right DLPFC rTMS. Conclusions/Significance: To our knowledge, this is the first study to provide evidence of extrastriatal DA modulation following acute rTMS of DLPFC with its effect limited to the specific areas of medial prefrontal cortex. [C-11] FLB 457-PET combined with rTMS may allow to explore the neurochemical functions of specific cortical neural networks and help to identify the neurobiological effects of TMS for the treatment of different neurological and psychiatric diseases.			Cho, SS (corresponding author), Univ Toronto, UHN, Toronto Western Res Inst & Hosp, Toronto, ON, Canada.	antonio.strafella@uhnres.utoronto.ca	cho, sang soo/J-2990-2015	cho, sang soo/0000-0002-4280-5099				Aalto S, 2005, J NEUROSCI, V25, P2471, DOI 10.1523/JNEUROSCI.2097-04.2005; Aalto S, 2005, PSYCHOPHARMACOLOGY, V182, P375, DOI 10.1007/s00213-005-0092-6; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; BEAN AJ, 1991, J NEUROSCI, V11, P2694; BEAN AJ, 1989, J NEUROCHEM, V53, P655, DOI 10.1111/j.1471-4159.1989.tb07384.x; BenShachar D, 1997, J NEURAL TRANSM, V104, P191, DOI 10.1007/BF01273180; Bigliani V, 2000, PSYCHOPHARMACOLOGY, V150, P132, DOI 10.1007/s002130000435; Brooks DJ, 2001, J NEURAL TRANSM, V108, P1283, DOI 10.1007/s007020100005; Brunelin J, 2007, ENCEPHALE, V33, P126; Carlson JN, 1996, BRAIN RES, V711, P1, DOI 10.1016/0006-8993(95)01290-7; CARLSSON M, 1990, TRENDS NEUROSCI, V13, P272, DOI 10.1016/0166-2236(90)90108-M; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Chou YH, 2000, SYNAPSE, V38, P138, DOI 10.1002/1098-2396(200011)38:2<138::AID-SYN4>3.0.CO;2-7; Christian BT, 2006, NEUROIMAGE, V31, P139, DOI 10.1016/j.neuroimage.2005.11.052; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Farde L, 1997, PSYCHOPHARMACOLOGY, V133, P396, DOI 10.1007/s002130050420; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Grace AA, 2000, ADDICTION, V95, pS119; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hagelberg N, 2004, PAIN, V109, P86, DOI 10.1016/j.pain.2004.01.013; Isenberg Keith, 2005, Ann Clin Psychiatry, V17, P153, DOI 10.1080/10401230591002110; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P2015, DOI 10.1016/S1388-2457(01)00673-3; Kanno M, 2004, J NEUROL SCI, V217, P73, DOI 10.1016/j.jns.2003.08.013; Karreman M, 1996, J NEUROCHEM, V66, P589; Keck ME, 2002, NEUROPHARMACOLOGY, V43, P101, DOI 10.1016/S0028-3908(02)00069-2; Keck ME, 2000, EUR J NEUROSCI, V12, P3713, DOI 10.1046/j.1460-9568.2000.00243.x; KESSLER RM, 1993, BRAIN RES, V609, P237, DOI 10.1016/0006-8993(93)90878-Q; Khedr EM, 2003, EUR J NEUROL, V10, P567, DOI 10.1046/j.1468-1331.2003.00649.x; Knoch D, 2006, NEUROIMAGE, V31, P641, DOI 10.1016/j.neuroimage.2005.12.025; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Ko JH, 2008, EUR J NEUROSCI, V28, P2147, DOI 10.1111/j.1460-9568.2008.06501.x; Koch G, 2003, NEUROLOGY, V60, P1844, DOI 10.1212/WNL.60.11.1844; Koski L, 2000, EXP BRAIN RES, V133, P55, DOI 10.1007/s002210000400; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lumme V, 2007, PSYCHIAT RES-NEUROIM, V156, P69, DOI 10.1016/j.pscychresns.2006.12.012; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Middleton FA, 2001, J NEUROSCI, V21, P700, DOI 10.1523/JNEUROSCI.21-02-00700.2001; Montgomery AJ, 2007, J CEREBR BLOOD F MET, V27, P369, DOI 10.1038/sj.jcbfm.9600339; MURASE S, 1993, NEUROSCI LETT, V157, P53, DOI 10.1016/0304-3940(93)90641-W; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Olsson H, 2004, NEUROIMAGE, V22, P794, DOI 10.1016/j.neuroimage.2004.02.002; Olsson H, 1999, J CEREBR BLOOD F MET, V19, P1164, DOI 10.1097/00004647-199910000-00013; Padberg F, 2002, NEUROPSYCHOPHARMACOL, V27, P638; Pascual-Leone A, 1998, J CLIN NEUROPHYSIOL, V15, P333, DOI 10.1097/00004691-199807000-00005; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Paus T, 2001, EUR J NEUROSCI, V14, P1405, DOI 10.1046/j.0953-816x.2001.01757.x; Petrides M, 1999, EUR J NEUROSCI, V11, P1011, DOI 10.1046/j.1460-9568.1999.00518.x; Pogarell O, 2007, PSYCHIAT RES-NEUROIM, V156, P251, DOI 10.1016/j.pscychresns.2007.05.002; Pogarell O, 2006, J PSYCHIATR RES, V40, P307, DOI 10.1016/j.jpsychires.2005.09.001; Sandrini M, 2008, NEUROPSYCHOLOGIA, V46, P2056, DOI 10.1016/j.neuropsychologia.2008.02.003; Schmahmann JD, 1997, J NEUROSCI, V17, P438, DOI 10.1523/JNEUROSCI.17-01-00438.1997; Schultz W, 2001, NEUROSCIENTIST, V7, P293, DOI 10.1177/107385840100700406; Slifstein M, 2004, SYNAPSE, V54, P46, DOI 10.1002/syn.20062; Stern WM, 2007, J NEUROPSYCH CLIN N, V19, P179, DOI 10.1176/appi.neuropsych.19.2.179; Strafella AP, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-15-j0003.2001; Strafella AP, 2005, EUR J NEUROSCI, V22, P2946, DOI 10.1111/j.1460-9568.2005.04476.x; Strafella AP, 2003, BRAIN, V126, P2609, DOI 10.1093/brain/awg268; TABER MT, 1995, J NEUROCHEM, V65, P1407; TABER MT, 1993, NEUROPSYCHOPHARMACOL, V9, P271, DOI 10.1038/npp.1993.63; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208; Volkow ND, 2004, NEUROPHARMACOLOGY, V47, P3, DOI 10.1016/j.neuropharm.2004.07.019; Wassermann EM, 2001, CLIN NEUROPHYSIOL, V112, P1367, DOI 10.1016/S1388-2457(01)00585-5; Westerink BHC, 1998, J PHARMACOL EXP THER, V285, P143; Williams SM, 1998, CEREB CORTEX, V8, P321, DOI 10.1093/cercor/8.4.321	71	268	279	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6725	10.1371/journal.pone.0006725	http://dx.doi.org/10.1371/journal.pone.0006725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696930	Green Published, gold, Green Submitted			2022-12-25	WOS:000269267600013
J	Schneider, DJ; Lindsay, JC; Zhou, Y; Molina, JG; Blackburn, MR				Schneider, Daniel J.; Lindsay, Janci C.; Zhou, Yang; Molina, Jose G.; Blackburn, Michael R.			Adenosine and osteopontin contribute to the development of chronic obstructive pulmonary disease	FASEB JOURNAL			English	Article						neutrophil; macrophage; emphysema; pulmonary fibrosis	BRONCHOALVEOLAR LAVAGE FLUID; SMOKE-INDUCED EMPHYSEMA; CELL-MIGRATION; AIRWAY DISEASE; MICE LACKING; INFLAMMATION; RECEPTOR; EXPRESSION; CD44; LUNG	Chronic obstructive pulmonary disease (COPD) is a major health concern. Adenosine, a signaling molecule generated in response to cell stress, contributes to the pathogenesis of COPD. An established model of adenosine-mediated lung injury is the adenosine deaminase-deficient (Ada(-/-)) mouse. Osteopontin (OPN) is a chemokine that is produced following injury and is implicated in a variety of human pathologies, but its expression and role in the pathogenesis of COPD have not been examined. To investigate the role of OPN in a model of COPD, Ada(-/-) double-knockout mice were generated, and inflammation and air-space enlargement endpoints were examined. Results demonstrate that Ada(-/-) mice exhibit OPN-dependent neutrophilia, alveolar air-space enlargement, and increases in mediators of air-space enlargement. Furthermore, we demonstrate that patients with COPD have increased OPN expression within distal airways in association with clinical airway obstruction. These results suggest that OPN represents a novel biomarker and therapeutic target for patients with COPD.-Schneider, D. J., Lindsay, J. C., Zhou, Y., Molina, J. G., Blackburn, M. R. Adenosine and osteopontin contribute to the development of chronic obstructive pulmonary disease. FASEB J. 24, 70-80 ( 2010). www.fasebj.org	[Schneider, Daniel J.; Lindsay, Janci C.; Zhou, Yang; Molina, Jose G.; Blackburn, Michael R.] Univ Texas Houston Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Blackburn, MR (corresponding author), Univ Texas Houston Med Sch, Dept Biochem & Mol Biol, 6431 Fannin Blvd, Houston, TX 77030 USA.	michael.r.blackburn@uth.tmc.edu	ZHou, Yang/D-3320-2012	Blackburn, Michael/0000-0002-1394-9966	U. S. National Institutes of Health [AI-43572, HL-70952, HL-095403]; National Center for Research Resources [TL1RR024147]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024147] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL095403, R01HL070952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043572] Funding Source: NIH RePORTER	U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Amir Mohsenin, Richard Johnston, and Sandeep Agarwal for comments on the manuscript. This work was supported by U. S. National Institutes of Health grants AI-43572, HL-70952, and HL-095403 awarded to M. R. B. D. J. S. was funded by award TL1RR024147 from the National Center for Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health. The authors declare no conflicting financial interests.	Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Banerjee SK, 2002, AM J PHYSIOL-LUNG C, V282, pL169, DOI 10.1152/ajplung.00243.2001; Berman JS, 2004, AM J PHYSIOL-LUNG C, V286, pL1311, DOI 10.1152/ajplung.00394.2003; Betsuyaku T, 1999, AM J RESP CRIT CARE, V159, P1985, DOI 10.1164/ajrccm.159.6.9809043; Blackburn MR, 2000, J EXP MED, V192, P159, DOI 10.1084/jem.192.2.159; Blackburn MR, 2003, J CLIN INVEST, V112, P332, DOI 10.1172/JCI200316815; Blackburn MR, 2003, TRENDS PHARMACOL SCI, V24, P66, DOI 10.1016/S0165-6147(02)00045-7; Chakraborty G, 2008, J CELL MOL MED, V12, P2305, DOI 10.1111/j.1582-4934.2008.00263.x; Chunn JL, 2005, J IMMUNOL, V175, P1937, DOI 10.4049/jimmunol.175.3.1937; Churg A, 2007, THORAX, V62, P706, DOI 10.1136/thx.2006.068353; Demedts IK, 2006, THORAX, V61, P196, DOI 10.1136/thx.2005.042432; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Desai B, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-18; DRIVER AG, 1993, AM REV RESPIR DIS, V148, P91, DOI 10.1164/ajrccm/148.1.91; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Fitzgerald MF, 2007, DRUG DISCOV TODAY, V12, P479, DOI 10.1016/j.drudis.2007.04.005; Fozard JR, 1999, PULM PHARMACOL THER, V12, P111, DOI 10.1006/pupt.1999.0191; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Frey AB, 2007, HISTOPATHOLOGY, V50, P720, DOI 10.1111/j.1365-2559.2007.02675.x; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Horowitz JC, 2008, AM J RESP CELL MOL, V38, P78, DOI 10.1165/rcmb.2007-0174OC; HUNNINGHAKE GW, 1983, AM REV RESPIR DIS, V128, P833; Huszar E, 2002, EUR RESPIR J, V20, P1393, DOI 10.1183/09031936.02.00005002; Jeffery PK, 1999, CLIN EXP ALLERGY, V29, P14, DOI 10.1046/j.1365-2222.1999.00004.x-i2; Kalla RV, 2009, PURINERG SIGNAL, V5, P21, DOI 10.1007/s11302-008-9119-x; Katagiri YU, 1999, CANCER RES, V59, P219; Keane MP, 2002, J IMMUNOL, V169, P6515, DOI 10.4049/jimmunol.169.11.6515; Koh A, 2007, IMMUNOLOGY, V122, P466, DOI 10.1111/j.1365-2567.2007.02682.x; Kohan M, 2007, CLIN EXP ALLERGY, V37, P1444, DOI 10.1111/j.1365-2222.2007.02801.x; Kolachala VL, 2008, GASTROENTEROLOGY, V135, P861, DOI 10.1053/j.gastro.2008.05.049; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; LACOSTE JY, 1993, J ALLERGY CLIN IMMUN, V92, P537, DOI 10.1016/0091-6749(93)90078-T; Lenga Y, 2008, CIRC RES, V102, P319, DOI 10.1161/CIRCRESAHA.107.160408; LIAW L, 1995, J CLIN INVEST, V95, P713, DOI 10.1172/JCI117718; Liaw L, 1998, J CLIN INVEST, V101, P1468; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma B, 2006, J CLIN INVEST, V116, P1274, DOI 10.1172/JCI26372; Marcondes MCG, 2008, CELL IMMUNOL, V254, P56, DOI 10.1016/j.cellimm.2008.06.012; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; O'Regan AW, 1999, J IMMUNOL, V162, P1024; Ophascharoensuk V, 1999, KIDNEY INT, V56, P571, DOI 10.1046/j.1523-1755.1999.00580.x; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rangaswami H, 2007, ONCOL REP, V18, P909; Senger DR, 1996, BBA-MOL CELL RES, V1314, P13, DOI 10.1016/S0167-4889(96)00067-5; Simoes DCM, 2009, AM J RESP CRIT CARE, V179, P894, DOI 10.1164/rccm.200807-1081OC; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Sun CX, 2005, J CLIN INVEST, V115, P35, DOI 10.1172/JCI200522656; Svetlecic J, 2005, EXP MOL PATHOL, V79, P198, DOI 10.1016/j.yexmp.2005.08.008; Takahashi F, 2004, LUNG, V182, P173; Takahashi F, 2001, AM J RESP CELL MOL, V24, P264, DOI 10.1165/ajrcmb.24.3.4293; Trueblood NA, 2001, CIRC RES, V88, P1080, DOI 10.1161/hh1001.090842; Weber Georg F., 1996, Cytokine and Growth Factor Reviews, V7, P241, DOI 10.1016/S1359-6101(96)00030-5; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Woodruff PG, 2005, AM J RESP CRIT CARE, V172, P1383, DOI 10.1164/rccm.200505-686OC; Xanthou G, 2007, NAT MED, V13, P570, DOI 10.1038/nm1580; Young HWJ, 2004, J IMMUNOL, V173, P1380, DOI 10.4049/jimmunol.173.2.1380; Zohar R, 2000, J CELL PHYSIOL, V184, P118, DOI 10.1002/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.3.CO;2-P	60	37	40	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					70	80		10.1096/fj.09-140772	http://dx.doi.org/10.1096/fj.09-140772			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19720619	Green Published			2022-12-25	WOS:000273233600010
J	Jacinto, FV; Ballestar, E; Esteller, M				Jacinto, F. V.; Ballestar, E.; Esteller, M.			Impaired recruitment of the histone methyltransferase DOT1L contributes to the incomplete reactivation of tumor suppressor genes upon DNA demethylation	ONCOGENE			English	Article						tumor suppressor genes; histone methyltransferase; DNA demethylating agents; CpG island; colon cancer	HUMAN CANCER; DEACETYLASE INHIBITION; COLORECTAL-CANCER; SET DOMAIN; METHYLATION; TRANSCRIPTION; PROTEINS; HYPERMETHYLATION; EPIGENETICS; PATTERNS	Understanding the mechanisms that link changes in DNA methylation with histone modifications is particularly relevant in the case of tumor suppressor genes that undergo transcriptional silencing in cancer cells in association with promoter CpG island hypermethylation. In this study, we show that two histone lysine methylation marks associated with active transcription, dimethylation of H3K79 (H3K79me2) and trimethylation of H3K4 (H3K4me3), are present in all the unmethylated promoters analysed, and both of them are lost when these promoters become hypermethylated. Most importantly, pharmacological and genetic interventions that cause DNA demethylation and partial recovery of gene transcription, result in the restoration of H3K4me3, but not of H3K79me2. We also show that DOT1L, the major H3K79 histone methyltransferase, is no longer recruited to the promoters that are demethylated after 5-azadeoxycytidine treatment or genetic deletion of DNA methyltransferases. Knock-down and transfection experiments for DOT1L show that this enzyme has a direct role in maintaining the euchromatic and active status of these genes when unmethylated. These findings suggest that DNA demethylating interventions alone are not able to restore a complete euchromatic status and a full transcriptional reactivation of the epigenetically silenced tumor suppressor genes, and reinforce the necessity of targeting multiple elements of the epigenetics machinery for a successful treatment of malignancies. Oncogene (2009) 28, 4212-4224; doi: 10.1038/onc.2009.267; published online 7 September 2009	[Jacinto, F. V.; Ballestar, E.; Esteller, M.] Hosp Duran & Reynals, Canc Epigenet & Biol Program PEBC, Bellvitge Biomed Res Inst IDIBELL, Barcelona 8907, Catalonia, Spain; [Jacinto, F. V.] Univ Porto, Grad Program Areas Basic & Appl Biol, P-4100 Oporto, Portugal; [Esteller, M.] ICREA, Barcelona, Catalonia, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Universidade do Porto; ICREA	Esteller, M (corresponding author), Hosp Duran & Reynals, Canc Epigenet & Biol Program PEBC, Bellvitge Biomed Res Inst IDIBELL, 3rd Floor,Avda Gran Via 199-203,08907 Hosp Llobre, Barcelona 8907, Catalonia, Spain.	mesteller@iconcologia.net	Ballestar, Esteban/ABG-8561-2020; Esteller, Manel/L-5956-2014	Esteller, Manel/0000-0003-4490-6093; Ballestar, Esteban/0000-0002-1400-2440	European Union [HEALTH-F2-2007-200620, LSHG-CT-2006-037415, FIS PI08 1345, I + D + I MCYT08-03]; Consolider [MEC09-05]; Departments of the Spanish Government; Health Department of the Catalan Government; Spanish Association Against Cancer (AECC); FCT (Portuguese Foundation for Science and Technology) [SFRH/BD/11757/2003]; ICREA Funding Source: Custom	European Union(European Commission); Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Departments of the Spanish Government; Health Department of the Catalan Government; Spanish Association Against Cancer (AECC); FCT (Portuguese Foundation for Science and Technology)(Portuguese Foundation for Science and Technology); ICREA(ICREA)	We thank Dr Yi Zhang for providing us with the hDOT1L expression vector for the transfection experiments. Supported by the European Union Grants FP7 CANCERDIP (HEALTH-F2-2007-200620) and SMARTER (LSHG-CT-2006-037415), the Health (FIS PI08 1345) and Education and Science (I + D + I MCYT08-03 and Consolider MEC09-05) Departments of the Spanish Government, the Health Department of the Catalan Government and the Spanish Association Against Cancer (AECC). FVJ is funded by FCT (Portuguese Foundation for Science and Technology) SFRH/BD/11757/2003. ME is an ICREA (Institucio Catalana de Recerca i Estudis Avancats) Research Professor.	Akiyama Y, 2003, MOL CELL BIOL, V23, P8429, DOI 10.1128/MCB.23.23.8429-8439.2003; Ballestar E, 2003, EMBO J, V22, P6335, DOI 10.1093/emboj/cdg604; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Esteller M, 2001, CANCER RES, V61, P3225; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fahrner JA, 2002, CANCER RES, V62, P7213; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Garcia-Manero G, 2008, CURR OPIN ONCOL, V20, P705, DOI 10.1097/CCO.0b013e328313699c; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kondo Y, 2003, MOL CELL BIOL, V23, P206, DOI 10.1128/MCB.23.1.206-215.2003; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lopez-Serra L, 2008, BRIT J CANCER, V98, P1881, DOI 10.1038/sj.bjc.6604374; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; Milne TA, 2005, CANCER RES, V65, P11367, DOI 10.1158/0008-5472.CAN-05-1041; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Nguyen CT, 2002, CANCER RES, V62, P6456; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Oki Y, 2007, CRIT REV ONCOL HEMAT, V61, P140, DOI 10.1016/j.critrevonc.2006.07.010; Paz MF, 2003, CANCER RES, V63, P1114; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	30	28	29	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 26	2009	28	47					4212	4224		10.1038/onc.2009.267	http://dx.doi.org/10.1038/onc.2009.267			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DQ	19734945				2022-12-25	WOS:000272876100007
J	Ong, DCT; Ho, YM; Rudduck, C; Chin, K; Kuo, WL; Lie, DKH; Chua, CLM; Tan, PH; Eu, KW; Seow-Choen, F; Wong, CY; Hong, GS; Gray, JW; Lee, ASG				Ong, D. C. T.; Ho, Y. M.; Rudduck, C.; Chin, K.; Kuo, W-L; Lie, D. K. H.; Chua, C. L. M.; Tan, P. H.; Eu, K. W.; Seow-Choen, F.; Wong, C. Y.; Hong, G. S.; Gray, J. W.; Lee, A. S. G.			LARG at chromosome 11q23 has functional characteristics of a tumor suppressor in human breast and colorectal cancer	ONCOGENE			English	Article						LARG; tumor suppressor; breast cancer; colorectal cancer	NUCLEOTIDE-EXCHANGE FACTORS; LEUKEMIA-ASSOCIATED RHOGEF; CELL LUNG-CANCER; PDZ DOMAINS; HETEROZYGOSITY; IDENTIFICATION; CARCINOMA; GENE; PROTEINS; DELETION	Deletion of 11q23-q24 is frequent in a diverse variety of malignancies, including breast and colorectal carcinoma, implicating the presence of a tumor suppressor gene at that chromosomal region. We examined a 6-Mb region on 11q23 by high-resolution deletion mapping, using both loss of heterozygosity analysis and customized microarray comparative genomic hybridization. LARG (leukemia-associated Rho guanine-nucleotide exchange factor) (also called ARHGEF12), identified from the analysed region, is frequently underexpressed in breast and colorectal carcinomas with a reduced expression observed in all breast cancer cell lines (n = 11), in 12 of 38 (32%) primary breast cancers, 5 of 10 (50%) colorectal cell lines and in 20 of 37 (54%) primary colorectal cancers. Underexpression of the LARG transcript was significantly associated with genomic loss (P = 0.00334). Hypermethylation of the LARG promoter was not detected in either breast or colorectal cancer, and treatment of four breast and four colorectal cancer cell lines with 5-aza-2'-deoxycytidine and/or trichostatin A did not result in a reactivation of LARG. Enforced expression of LARG in breast and colorectal cancer cells by stable transfection resulted in reduced cell proliferation and colony formation, as well as in a markedly slower cell migration rate in colorectal cancer cells, providing functional evidence for LARG as a candidate tumor suppressor gene. Oncogene (2009) 28, 4189-4200; doi: 10.1038/onc.2009.266; published online 7 September 2009	[Lee, A. S. G.] Natl Canc Ctr, Div Med Sci, Mol Oncol Lab, Singapore 169610, Singapore; [Rudduck, C.; Tan, P. H.] Singapore Gen Hosp, Dept Pathol, Singapore 0316, Singapore; [Chin, K.; Kuo, W-L; Gray, J. W.] Univ Calif San Francisco, UCSF Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Kuo, W-L; Gray, J. W.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Eu, K. W.; Seow-Choen, F.] Singapore Gen Hosp, Dept Colorectal Surg, Singapore 0316, Singapore; [Wong, C. Y.; Hong, G. S.] Singapore Gen Hosp, Dept Gen Surg, Singapore 0316, Singapore; [Lee, A. S. G.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore	National Cancer Centre Singapore (NCCS); Singapore General Hospital; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Singapore General Hospital; Singapore General Hospital; National University of Singapore	Lee, ASG (corresponding author), Natl Canc Ctr, Div Med Sci, Mol Oncol Lab, Singapore 169610, Singapore.	dmslsg@nccs.com.sg	Gray, Joe/AAX-9549-2020		National Medical Research Council (NMRC) of Singapore [NMRC/0076/1995, NMRC/0440/2000, NMRC/0570/2001, NMRC/0843/2004]; SingHealth Foundation [SHF/FG235P/2005]; Singapore Cancer Society; SGH Research Fund; Cancer Research Education Fund; NCC and Department of Clinical Research, SGH; US Department of Energy [DE-AC02-05CH11231, USAMRMC BC 061995]; National Institutes of Health, National Cancer Institute [P50 CA 58207, P50 CA 83639, P30 CA 82103, U54 CA 112970, U24 CA 126477, P01 CA 64602]; National Human Genome Research Institute [U24 CA 126551]; SmithKline Beecham Corporation; NATIONAL CANCER INSTITUTE [U24CA126551, P50CA058207, U54CA112970, P30CA082103, U24CA126477, P01CA064602, P50CA083639] Funding Source: NIH RePORTER	National Medical Research Council (NMRC) of Singapore(National Medical Research Council, Singapore); SingHealth Foundation(SingHealth); Singapore Cancer Society; SGH Research Fund; Cancer Research Education Fund; NCC and Department of Clinical Research, SGH; US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); SmithKline Beecham Corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Glenn Koh for assistance with review of case notes; YC Seo, Angela Chang, S Tohari, Irene HK Lim and Gan Yar Chze for excellent technical assistance; and Dr Eric Yap for helpful discussions. This study was supported by Grants from the National Medical Research Council (NMRC) of Singapore (NMRC/0076/1995, NMRC/0440/2000, NMRC/0570/2001, NMRC/0843/2004); SingHealth Foundation (SHF/FG235P/2005); the Singapore Cancer Society, SGH Research Fund, Cancer Research Education Fund, NCC and Department of Clinical Research, SGH, to AL. We gratefully acknowledge the grant support from the US Department of Energy under Contract No. DE-AC02-05CH11231, USAMRMC BC 061995; National Institutes of Health, National Cancer Institute (P50 CA 58207, P50 CA 83639, P30 CA 82103, U54 CA 112970, U24 CA 126477 P01 CA 64602); National Human Genome Research Institute (U24 CA 126551) and SmithKline Beecham Corporation, to JWG.	Baffa R, 1996, CANCER RES, V56, P268; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Gabra H, 1996, CANCER RES, V56, P950; Harris BZ, 2001, J CELL SCI, V114, P3219; Hui ABY, 1996, CANCER RES, V56, P3225; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; Koreth J, 1997, ONCOGENE, V14, P431, DOI 10.1038/sj.onc.1200847; Koreth J, 1999, ONCOGENE, V18, P1157, DOI 10.1038/sj.onc.1202372; Kourlas PJ, 2000, P NATL ACAD SCI USA, V97, P2145, DOI 10.1073/pnas.040569197; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Lee ASG, 2000, BRIT J CANCER, V83, P750, DOI 10.1054/bjoc.2000.1366; Lee ASG, 2004, CANCER GENET CYTOGEN, V153, P151, DOI 10.1016/j.cancergencyto.2004.01.007; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; Martin B., 2003, ELECT J E GOVT, V1, P11; Massion PP, 2002, CANCER RES, V62, P3636; Murakami Y, 1998, P NATL ACAD SCI USA, V95, P8153, DOI 10.1073/pnas.95.14.8153; NEGRINI M, 1994, CANCER RES, V54, P1331; NEGRINI M, 1995, CANCER RES, V55, P3003; Plass C, 2002, HUM MOL GENET, V11, P2479, DOI 10.1093/hmg/11.20.2479; Pulido HA, 2000, CANCER RES, V60, P6677; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; RASIO D, 1995, CANCER RES, V55, P3988; Rice KL, 2007, ONCOGENE, V26, P6697, DOI 10.1038/sj.onc.1210755; Robertson G, 1996, CANCER RES, V56, P4487; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Siderovski DP, 1999, CRIT REV BIOCHEM MOL, V34, P215, DOI 10.1080/10409239991209273; Smietana K, 2008, ACTA BIOCHIM POL, V55, P269, DOI 10.18388/abp.2008_3074; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Taya S, 2001, J CELL BIOL, V155, P809, DOI 10.1083/jcb.200106139; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; TOMLINSON IPM, 1995, J CLIN PATHOL, V48, P424, DOI 10.1136/jcp.48.5.424; Tomlinson IPM, 1996, J PATHOL, V180, P38, DOI 10.1002/(SICI)1096-9896(199609)180:1<38::AID-PATH638>3.0.CO;2-C; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200; Young Il Lee, 2003, International Journal of Control, Automation, and Systems, V1, P178	42	20	21	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 26	2009	28	47					4189	4200		10.1038/onc.2009.266	http://dx.doi.org/10.1038/onc.2009.266			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DQ	19734946	Green Accepted			2022-12-25	WOS:000272876100005
J	Farina, AR; Tacconelli, A; Cappabianca, L; Cea, G; Chioda, A; Romanelli, A; Pensato, S; Pedone, C; Gulino, A; Mackay, AR				Farina, A. R.; Tacconelli, A.; Cappabianca, L.; Cea, G.; Chioda, A.; Romanelli, A.; Pensato, S.; Pedone, C.; Gulino, A.; Mackay, A. R.			The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells	ONCOGENE			English	Article						neuroblastoma; TrkAI; TrkAIII; Hsp90; geldanamycin	ENDOPLASMIC-RETICULUM STRESS; NERVE GROWTH-FACTOR; CANCER CHEMOTHERAPEUTIC-AGENTS; PHASE-I; SOLID TUMORS; INHIBITOR GELDANAMYCIN; PEDIATRIC-PATIENTS; ADULT PATIENTS; CHAPERONE; RECEPTOR	Hsp90 chaperones stabilize many tyrosine kinases including several oncogenes, which are inhibited or induced to degrade by the Hsp90 inhibitor geldanamycin (GA). As a consequence, GA has been developed for future chemotherapeutic use in several tumour types including neuroblastoma (NB). Alternative splicing of the neurotrophin receptor tyrosine kinase TrkA may have a pivotal function in regulating NB behaviour, with reports suggesting that tumour-suppressing signals from TrkA may be converted to oncogenic signals by stress-regulated alternative TrkAIII splicing. Within this context, it is important to know whether Hsp90 interacts with TrkA variants in NB cells and how GA influences this. Here, we report that both TrkAI and TrkAIII are Hsp90 clients in human NB cells. TrkAI exhibits GA-sensitive interaction with Hsp90 required for receptor endoplasmic reticulum export, maturation, cell surface stabilization and ligand-mediated activation, whereas TrkAIII exhibits GA-sensitive interactions with Hsp90 required for spontaneous activity and to a lesser extent stability. We show that GA inhibits proliferation and induces apoptosis of TrkAI expressing NB cells, whereas TrkAIII reduces the sensitivity of NB cells to GA-induced elimination. Our data suggest that GA-sensitive interactions with Hsp90 are critical for both TrkAI tumour suppressor and TrkAIII oncogenic function in NB and that TrkAIII expression exerts a negative impact on GA-induced NB cell eradication, which can be counteracted by a novel TrkAIII-specific peptide nucleic acid inhibitor. Oncogene (2009) 28, 4075-4094; doi:10.1038/onc.2009.256; published online 7 September 2009	[Mackay, A. R.] Univ Aquila, Dept Expt Med, Sect Mol Pathol, I-67100 Laquila, AQ, Italy; [Romanelli, A.; Pensato, S.; Pedone, C.] Univ Naples Federico 2, Dept Biol Sci, Naples, Italy; [Gulino, A.] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	University of L'Aquila; University of Naples Federico II; Sapienza University Rome	Mackay, AR (corresponding author), Univ Aquila, Dept Expt Med, Sect Mol Pathol, Coppito 2,Via Vetoio, I-67100 Laquila, AQ, Italy.	andrewreay.mackay@univaq.it		ROMANELLI, Alessandra/0000-0002-7609-4061; cappabianca, lucia/0000-0002-9112-1750; FARINA, Antonietta Rosella/0000-0003-0962-6088; Mackay, Andrew Reay/0000-0001-7096-3759	AIRC; Progetto Speciale Ministero Della Sanita; MURST-Cofin; MIUR-CNR-Oncology; Center of Excellence BEMM	AIRC(Fondazione AIRC per la ricerca sul cancro); Progetto Speciale Ministero Della Sanita; MURST-Cofin(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); MIUR-CNR-Oncology(Ministry of Education, Universities and Research (MIUR)); Center of Excellence BEMM	We thank Dr Pyrwes (University of Michigan) for providing the 5xATF6GL3 reporter gene construct, Drs B Cinque, N Di Ianni and M Zani and post-graduate students Paolo Ciufici, Stefania Merolle and Marzia Ragone for technical assistance. This work was supported by AIRC, Progetto Speciale Ministero Della Sanita, MURST-Cofin, MIUR-CNR-Oncology project and Center of Excellence BEMM. We dedicate this work to all the students of L'Aquila University who lost their lives in the earthquake of L'Aquila, 6 April 2009.	Arevalo JC, 2000, MOL CELL BIOL, V20, P5908, DOI 10.1128/MCB.20.16.5908-5916.2000; Bagatell R, 2007, CLIN CANCER RES, V13, P1783, DOI 10.1158/1078-0432.CCR-06-1892; Becker B, 2004, EXP DERMATOL, V13, P27, DOI 10.1111/j.0906-6705.2004.00114.x; Bijlmakers MJJE, 2000, MOL BIOL CELL, V11, P1585, DOI 10.1091/mbc.11.5.1585; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Crevecoeur J, 2008, BIOCHEM PHARMACOL, V75, P2183, DOI 10.1016/j.bcp.2008.03.009; Dai Chengkai, 2005, Future Oncol, V1, P529; Eggert A, 2002, CANCER RES, V62, P1802; Erdmann F, 2007, FEBS LETT, V581, P5709, DOI 10.1016/j.febslet.2007.11.037; Escobar MA, 2005, J PEDIATR SURG, V40, P349, DOI 10.1016/j.jpedsurg.2004.10.032; Frey S, 2007, J BIOL CHEM, V282, P35612, DOI 10.1074/jbc.M704647200; Geetha T, 2008, TRAFFIC, V9, P1146, DOI 10.1111/j.1600-0854.2008.00751.x; Graner MW, 2005, NEURO-ONCOLOGY, V7, P260, DOI 10.1215/S1152851704001188; Grem JL, 2005, J CLIN ONCOL, V23, P1885, DOI 10.1200/JCO.2005.12.085; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Grenert JP, 1999, J BIOL CHEM, V274, P17525, DOI 10.1074/jbc.274.25.17525; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Jullien J, 2002, J BIOL CHEM, V277, P38700, DOI 10.1074/jbc.M202348200; Kim S, 2003, INT J CANCER, V103, P352, DOI 10.1002/ijc.10820; LAVENIUS E, 1995, CELL GROWTH DIFFER, V6, P727; Lavictoire SJ, 2003, J BIOL CHEM, V278, P5292, DOI 10.1074/jbc.M209494200; Lopez-Maderuelo MD, 2001, FEBS LETT, V490, P23, DOI 10.1016/S0014-5793(01)02130-5; Lucarelli E, 1997, EUR J CANCER, V33, P2068, DOI 10.1016/S0959-8049(97)00266-9; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; MARCZIN N, 1993, AM J PHYSIOL, V265, P34; Marques C, 2004, FASEB J, V18, P1424, DOI 10.1096/fj.04-1743fje; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; Matei D, 2007, J BIOL CHEM, V282, P445, DOI 10.1074/jbc.M607012200; MATSUSHIMA H, 1990, MOL CELL BIOL, V10, P5015, DOI 10.1128/MCB.10.9.5015; Miyata Y, 2005, CURR PHARM DESIGN, V11, P1131, DOI 10.2174/1381612053507585; NAKAGAWARA A, 1992, CANCER RES, V52, P1364; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Nimmanapalli R, 2003, BLOOD, V102, P269, DOI 10.1182/blood-2002-12-3718; Onuoha SC, 2007, J MOL BIOL, V372, P287, DOI 10.1016/j.jmb.2007.06.065; Orike N, 2001, J CELL BIOL, V154, P995, DOI 10.1083/jcb.200101068; Pahlman S, 2000, NEUROBLASTOMA, P9; Peng XY, 2005, J BIOL CHEM, V280, P13148, DOI 10.1074/jbc.M410838200; Puyo S, 2008, MOL DIAGN THER, V12, P225, DOI 10.1007/BF03256288; Ramanathan RK, 2007, CLIN CANCER RES, V13, P1769, DOI 10.1158/1078-0432.CCR-06-2233; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; Rosser MFN, 2004, BIOCHEMISTRY-US, V43, P8835, DOI 10.1021/bi049539q; Scheibel T, 1998, P NATL ACAD SCI USA, V95, P1495, DOI 10.1073/pnas.95.4.1495; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; SHANKOVICH R, 1992, MOL CELL BIOL, V12, P5059; Shen JH, 2007, NEUROSCI LETT, V414, P110, DOI 10.1016/j.neulet.2006.06.050; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; Solit DB, 2007, CLIN CANCER RES, V13, P1775, DOI 10.1158/1078-0432.CCR-06-1863; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Tacconelli A, 2004, CANCER CELL, V6, P347, DOI 10.1016/j.ccr.2004.09.011; TACCONELLI A, 2006, ALTERNATIVE SPLICING, P67; Tacconelli Antonella, 2005, Future Oncol, V1, P689, DOI 10.2217/14796694.1.5.689; Theodoraki MA, 2007, EXP CELL RES, V313, P3851, DOI 10.1016/j.yexcr.2007.06.022; Vega VL, 2003, MOL BIOL CELL, V14, P764, DOI 10.1091/mbc.E02-08-0498; Wang Y, 2000, J BIOL CHEM, V275, P27013; Watson FL, 1999, J NEUROBIOL, V39, P323, DOI 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4; Weigel BJ, 2007, CLIN CANCER RES, V13, P1789, DOI 10.1158/1078-0432.CCR-06-2270; Xu WP, 2007, CLIN CANCER RES, V13, P1625, DOI 10.1158/1078-0432.CCR-06-2966; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Yoshimura S, 2001, J CELL SCI, V114, P4105; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	66	16	17	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 19	2009	28	46					4075	4094		10.1038/onc.2009.256	http://dx.doi.org/10.1038/onc.2009.256			20	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	530AE	19734938				2022-12-25	WOS:000272560500004
J	Lorda-Diez, CI; Montero, JA; Martinez-Cue, C; Garcia-Porrero, JA; Hurle, JM				Lorda-Diez, Carlos I.; Montero, Juan A.; Martinez-Cue, Carmen; Garcia-Porrero, Juan A.; Hurle, Juan M.			Transforming Growth Factors beta Coordinate Cartilage and Tendon Differentiation in the Developing Limb Mesenchyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMAD TRANSCRIPTIONAL COREPRESSOR; CHICK LEG BUD; TGF-BETA; GENE-EXPRESSION; CHONDROCYTE DIFFERENTIATION; PROGENITOR CELLS; ENDOCHONDRAL OSSIFICATION; EMBRYONIC-DEVELOPMENT; PATTERN-FORMATION; KNOCKOUT MICE	Transforming growth factor beta (TGF beta) signaling has an increasing interest in regenerative medicine as a potential tool to repair cartilages, however the chondrogenic effect of this pathway in developing systems is controversial. Here we have analyzed the function of TGF beta signaling in the differentiation of the developing limb mesoderm in vivo and in high density micromass cultures. In these systems highest signaling activity corresponded with cells at stages preceding overt chondrocyte differentiation. Interestingly treatments with TGF beta s shifted the differentiation outcome of the cultures from chondrogenesis to fibrogenesis. This phenotypic reprogramming involved downregulation of Sox9 and Aggrecan and up-regulation of Scleraxis, and Tenomodulin through the Smad pathway. We further show that TGF beta signaling up-regulates Sox9 in the in vivo experimental model system in which TGF beta treatments induce ectopic chondrogenesis. Looking for clues explaining the dual role of TGF beta signaling, we found that TGF beta s appear to be direct inducers of the chondrogenic gene Sox9, but the existence of transcriptional repressors of TGF beta signaling modulates this role. We identified TGF-interacting factor Tgif1 and SKI-like oncogene SnoN as potential candidates for this inhibitory function. Tgif1 gene regulation by TGF beta signaling correlated with the differential chondrogenic and fibrogenic effects of this pathway, and its expression pattern in the limb marks the developing tendons. In functional experiments we found that Tgif1 reproduces the profibrogenic effect of TGF beta treatments.	Univ Cantabria, Dept Anat & Biol Celular, Santander 39011, Spain; [Martinez-Cue, Carmen] Univ Cantabria, Dept Fisiol & Farmacol, Santander 39011, Spain	Universidad de Cantabria; Universidad de Cantabria	Hurle, JM (corresponding author), Fac Med, C Cardenal Herrera Oria S-N, Santander 39011, Spain.	hurlej@unican.es	Montero, Juan A/K-4395-2014; Cue, Carmen Martinez/AAA-2850-2019; Lorda-Diez, Carlos I./J-7990-2019	Montero, Juan A/0000-0001-9099-5344; Lorda-Diez, Carlos I./0000-0002-3248-9918; Martinez-Cue, Carmen/0000-0002-2137-1156; Hurle, Juan M/0000-0002-4685-025X	Sciences and Innovation Ministry [BFU2008-03930]	Sciences and Innovation Ministry	This work was supported by the Sciences and Innovation Ministry ( Grant BFU2008-03930 to J. M. H.).	AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; Akiyama H, 2007, MATRIX BIOL, V26, P224, DOI 10.1016/j.matbio.2006.12.002; Anthwal N, 2008, DEV DYNAM, V237, P1604, DOI 10.1002/dvdy.21567; Asou Y, 2002, J ORTHOPAED RES, V20, P827, DOI 10.1016/S0736-0266(01)00169-3; Baffi MO, 2004, DEV BIOL, V276, P124, DOI 10.1016/j.ydbio.2004.08.027; Bandyopadhyay A, 2008, DEV BIOL, V321, P162, DOI 10.1016/j.ydbio.2008.06.012; Bartholin L, 2006, MOL CELL BIOL, V26, P990, DOI 10.1128/MCB.26.3.990-1001.2006; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; BRAND B, 1985, AM J ANAT, V173, P321, DOI 10.1002/aja.1001730408; CARRINGTON JL, 1990, EXP CELL RES, V186, P368, DOI 10.1016/0014-4827(90)90318-5; CHEN P, 1991, EXP CELL RES, V195, P509, DOI 10.1016/0014-4827(91)90403-H; Chimal-Monroy J, 2003, DEV BIOL, V257, P292, DOI 10.1016/S0012-1606(03)00066-6; Chimal-Monroy J, 1999, INT J DEV BIOL, V43, P59; ChimalMonroy J, 1997, INT J DEV BIOL, V41, P91; CHUONG CM, 1991, AM J PATHOL, V138, P427; Dai CS, 2004, J AM SOC NEPHROL, V15, P1402, DOI 10.1097/01.ASN.0000130568.53923.FD; DENKER AE, 1995, DIFFERENTIATION, V59, P25, DOI 10.1046/j.1432-0436.1995.5910025.x; Dong YF, 2007, MOL ENDOCRINOL, V21, P2805, DOI 10.1210/me.2007-0199; Dunker N, 2002, ANAT EMBRYOL, V206, P73, DOI 10.1007/s00429-002-0273-6; Ferguson CM, 2004, J ORTHOP RES, V22, P687, DOI 10.1016/j.orthres.2003.10.023; Furumatsu T, 2009, INT J BIOCHEM CELL B, V41, P1198, DOI 10.1016/j.biocel.2008.10.032; Ganan Y, 1996, DEVELOPMENT, V122, P2349; Halper J, 2004, GROWTH FACTORS, V22, P121, DOI 10.1080/08977190410001712878; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAYAMIZU TF, 1991, DEV BIOL, V145, P164, DOI 10.1016/0012-1606(91)90222-O; Healy C, 1999, DEV DYNAM, V215, P69, DOI 10.1002/(SICI)1097-0177(199905)215:1<69::AID-DVDY8>3.3.CO;2-E; HURLE JM, 1986, J EMBRYOL EXP MORPH, V94, P231; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Jin EJ, 2008, J CELL PHYSIOL, V214, P345, DOI 10.1002/jcp.21202; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; KIENY M, 1979, J EMBRYOL EXP MORPH, V49, P153; Knepper JL, 2006, DEV DYNAM, V235, P1482, DOI 10.1002/dvdy.20725; KULYK WM, 1989, DEV BIOL, V135, P424, DOI 10.1016/0012-1606(89)90191-7; Kuo CK, 2008, DEV DYNAM, V237, P1477, DOI 10.1002/dvdy.21547; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lejard V, 2007, J BIOL CHEM, V282, P17665, DOI 10.1074/jbc.M610113200; LEONARD CM, 1991, DEV BIOL, V145, P99, DOI 10.1016/0012-1606(91)90216-P; Lincoln J, 2006, DEV BIOL, V294, P292, DOI 10.1016/j.ydbio.2006.03.027; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; Merino R, 1998, DEV BIOL, V200, P35, DOI 10.1006/dbio.1998.8946; MILLAN FA, 1991, DEVELOPMENT, V111, P131; Minina E, 2005, GENE EXPR PATTERNS, V6, P102, DOI 10.1016/j.modgep.2005.04.012; Miura T, 2000, DEV DYNAM, V217, P241, DOI 10.1002/(SICI)1097-0177(200003)217:3<241::AID-DVDY2>3.0.CO;2-K; Montero JA, 2008, DEV BIOL, V321, P343, DOI 10.1016/j.ydbio.2008.06.022; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; NEWMAN SA, 1981, DEV BIOL, V84, P440, DOI 10.1016/0012-1606(81)90413-9; Newman Stuart A., 2007, Birth Defects Research, V81, P305, DOI 10.1002/bdrc.20112; Oka K, 2008, DEV BIOL, V321, P303, DOI 10.1016/j.ydbio.2008.03.046; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; ROARK EF, 1994, DEV DYNAM, V200, P103, DOI 10.1002/aja.1002000203; ROS MA, 1995, ANAT EMBRYOL, V192, P483; Salingcarnboriboon R, 2003, EXP CELL RES, V287, P289, DOI 10.1016/S0014-4827(03)00107-1; Sanford LP, 1997, DEVELOPMENT, V124, P2659; SCHOFIELD JN, 1990, EXP CELL RES, V191, P144, DOI 10.1016/0014-4827(90)90048-F; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Seo HS, 2007, DEV BIOL, V310, P304, DOI 10.1016/j.ydbio.2007.07.040; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Song JJ, 2007, J CELL PHYSIOL, V210, P398, DOI 10.1002/jcp.20850; Spagnoli A, 2007, J CELL BIOL, V177, P1105, DOI 10.1083/jcb.200611031; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; THORP BH, 1992, DEVELOPMENT, V114, P907; Tsuiki H, 1996, TERATOLOGY, V54, P191, DOI 10.1002/(SICI)1096-9926(199610)54:4<191::AID-TERA3>3.0.CO;2-4; Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Wotton D, 2001, CURR TOP MICROBIOL, V254, P145; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yamagishi T, 1999, CELL TISSUE RES, V298, P85, DOI 10.1007/s004419900073; Zhang XP, 2004, BONE, V34, P809, DOI 10.1016/j.bone.2003.12.026	73	128	136	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29988	29996		10.1074/jbc.M109.014811	http://dx.doi.org/10.1074/jbc.M109.014811			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19717568	Green Published, hybrid			2022-12-25	WOS:000270896800077
J	Tyapochkin, E; Cook, PF; Chen, GP				Tyapochkin, Eduard; Cook, Paul F.; Chen, Guangping			para-Nitrophenyl Sulfate Activation of Human Sulfotransferase 1A1 Is Consistent with Intercepting the E center dot PAP Complex and Reformation of E center dot PAPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHENOL SULFOTRANSFERASE; ESTROGEN SULFOTRANSFERASE; SUBSTRATE-INHIBITION; RETINOL DEHYDRATASE; MULTIPLE INHIBITION; CRYSTAL-STRUCTURE; BINDING SITE; ACTIVE-SITE; HUMAN LIVER; MECHANISM	Cytosolic sulfotransferase (SULT)-catalyzed sulfation regulates biological activities of various biosignaling molecules and metabolizes hydroxyl-containing drugs and xenobiotics. The universal sulfuryl group donor for SULT-catalyzed sulfation is adenosine 3'-phosphate 5'-phosphosulfate (PAPS), whereas the reaction products are a sulfated product and adenosine 3',5'-diphosphate (PAP). Although SULT-catalyzed kinetic mechanisms have been studied since the 1980s, they remain unclear. Human SULT1A1 is an important phase II drug-metabolizing enzyme. Previously, isotope exchange at equilibrium indicated steady-state ordered mechanism with PAPS and PAP binding to the free SULT1A1 (Tyapochkin, E., Cook, P. F., and Chen, G. (2008) Biochemistry 47, 11894-11899). On the basis of activation of SULT1A1 by para-nitrophenyl sulfate (pNPS), an ordered bypass mechanism has been proposed where pNPS sulfates PAP prior to its release from the E center dot PAP complex regenerating E center dot PAPS. Data are consistent with uncompetitive substrate inhibition by naphthol as a result of formation of the E center dot PAP center dot naphthol dead-end complex; formation of the complex is corroborated by naphthol/PAP double inhibition experiments. pNPS activation data demonstrate an apparent ping-pong behavior with pNPS adding to E center dot PAP, and competitive inhibition by naphthol consistent with formation of the E center dot PAP center dot naphthol complex. Exchange against forward reaction flux (PAPS plus naphthol) beginning with [S-35] PAPS and generating [S-35] naphthyl sulfate is also consistent with pNPS intercepting the E center dot PAP complex. Overall, data are consistent with the proposed ordered bypass mechanism.	[Cook, Paul F.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Tyapochkin, Eduard; Chen, Guangping] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Physiol Sci, Stillwater, OK 74078 USA	University of Oklahoma System; University of Oklahoma - Norman; Oklahoma State University System; Oklahoma State University - Stillwater	Cook, PF (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA.	pcook@ou.edu; guangping.chen@okstate.edu			National Institutes of Health [GM078606]; Grayce B. Kerr endowment to the University of Oklahoma; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078606] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grayce B. Kerr endowment to the University of Oklahoma; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM078606 (to G. C.). This work was also supported by the Grayce B. Kerr endowment to the University of Oklahoma to support the research of P. F. C.	Barnett AC, 2004, J BIOL CHEM, V279, P18799, DOI 10.1074/jbc.M312253200; Beckmann JD, 2003, BBA-PROTEINS PROTEOM, V1648, P134, DOI 10.1016/S1570-9639(03)00116-X; Chapman E, 2004, ANGEW CHEM INT EDIT, V43, P3526, DOI 10.1002/anie.200300631; Chen GP, 1999, PROTEIN SCI, V8, P2151, DOI 10.1110/ps.8.10.2151; Chen GP, 2000, BIOCHEMISTRY-US, V39, P16000, DOI 10.1021/bi0021479; Cleland W W, 1979, Methods Enzymol, V63, P500; CLELAND WW, 1975, BIOCHEMISTRY-US, V14, P3220, DOI 10.1021/bi00685a029; COOK PF, 2007, ENZYME KINETICS MECH, P191; Coughtrie M. W. H., 2002, Pharmacogenomics Journal, V2, P297; Coughtrie MWH, 2001, DRUG METAB DISPOS, V29, P522; DUFFEL MW, 1981, J BIOL CHEM, V256, P1123; Duffel MW, 2001, DRUG METAB REV, V33, P369, DOI 10.1081/DMR-120001394; FALANY CN, 1995, J STEROID BIOCHEM, V52, P529, DOI 10.1016/0960-0760(95)00015-R; Falany CN, 1997, FASEB J, V11, P206, DOI 10.1096/fasebj.11.4.9068609; FERSHT A, 1985, ENZYME STRUCTURE MEC, P98; Frame LT, 2000, DRUG METAB DISPOS, V28, P1063; Gamage N, 2006, TOXICOL SCI, V90, P5, DOI 10.1093/toxsci/kfj061; Gamage NU, 2003, J BIOL CHEM, V278, P7655, DOI 10.1074/jbc.M207246200; Glatt H, 2000, CHEM-BIOL INTERACT, V129, P141, DOI 10.1016/S0009-2797(00)00202-7; Glatt H, 2000, TOXICOL LETT, V112, P341, DOI 10.1016/S0378-4274(99)00214-3; Kakuta Y, 1997, NAT STRUCT BIOL, V4, P904, DOI 10.1038/nsb1197-904; KIICK DM, 1986, BIOCHEMISTRY-US, V25, P227, DOI 10.1021/bi00349a032; KIM HJ, 1995, DRUG METAB DISPOS, V23, P840; LESKOVAC V, 2003, COMPREHENSIVE ENZYME, P91; Lin ES, 1998, ANAL BIOCHEM, V264, P111, DOI 10.1006/abio.1998.2800; Miksits M, 2005, XENOBIOTICA, V35, P1101, DOI 10.1080/00498250500354253; NORTHROP DB, 1974, J BIOL CHEM, V249, P2928; Pacifici GM, 2004, INT J CLIN PHARM TH, V42, P488; Pakhomova S, 2000, ACTA CRYSTALLOGR D, V56, P1641, DOI 10.1107/S0907444900012671; Pakhomova S, 2005, PROTEIN SCI, V14, P176, DOI 10.1110/ps.041061105; Pakhomova S, 2001, NAT STRUCT BIOL, V8, P447, DOI 10.1038/87617; Rehse PH, 2002, BIOCHEM J, V364, P165, DOI 10.1042/bj3640165; Runge-Morris M, 2005, CURR DRUG METAB, V6, P299, DOI 10.2174/1389200054633871; Shevtsov S, 2003, ENVIRON HEALTH PERSP, V111, P884, DOI 10.1289/ehp.6056; Tyapochkin E, 2008, BIOCHEMISTRY-US, V47, P11894, DOI 10.1021/bi801211t; Wang LQ, 2006, CURR DRUG METAB, V7, P83, DOI 10.2174/138920006774832596; YONETANI T, 1964, ARCH BIOCHEM BIOPHYS, V106, P243, DOI 10.1016/0003-9861(64)90184-5	37	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29357	29364		10.1074/jbc.M109.049312	http://dx.doi.org/10.1074/jbc.M109.049312			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19706609	Green Published, hybrid			2022-12-25	WOS:000270896800016
J	Garcia-Hernandez, R; Moraleda-Munoz, A; Castaneda-Garcia, A; Perez, J; Munoz-Dorado, J				Garcia-Hernandez, Raquel; Moraleda-Munoz, Aurelio; Castaneda-Garcia, Alfredo; Perez, Juana; Munoz-Dorado, Jose			Myxococcus xanthus Pph2 Is a Manganese-dependent Protein Phosphatase Involved in Energy Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; SUBSTRATE-SPECIFICITY; PAS DOMAIN; PHOSPHORYLATION; KINASE; YEAST; 6-PHOSPHOFRUCTOKINASE; PHOSPHOPROTEOME; TRANSFORMATION; TRANSCRIPTION	The multicellular behavior of the myxobacterium Myxococcus xanthus requires the participation of an elevated number of signal-transduction mechanisms to coordinate the cell movements and the sequential changes in gene expression patterns that lead to the morphogenetic and differentiation events. These signal-transduction mechanisms are mainly based on two-component systems and on the reversible phosphorylation of protein targets mediated by eukaryotic-like protein kinases and phosphatases. Among all these factors, protein phosphatases are the elements that remain less characterized. Hence, we have studied in this work the physiological role and biochemical activity of the protein phosphatase of the family PPP (phosphoprotein phosphatases) designated as Pph2, which is forming part of the same operon as the two-component system phoPR1. Wehave demonstrated that this operon is induced upon starvation in response to the depletion of the cell energy levels. The increase in the expression of the operon contributes to an efficient use of the scarce energy resources available for developing cells to ensure the completion of the life cycle. In fact, a Delta pph2 mutant is defective in aggregation, sporulation yield, morphology of the myxospores, and germination efficiency. The yeast two-hybrid technology has shown that Pph2 interacts with the gene products of MXAN_1875 and 5630, which encode a hypothetical protein and a glutamine synthetase, respectively. Because Pph2 exhibits Ser/Thr, and to some extent Tyr, Mn2+-dependent protein phosphatase activity, it is expected that this function is accomplished by dephosphorylation of the specific protein substrates.	[Garcia-Hernandez, Raquel; Moraleda-Munoz, Aurelio; Castaneda-Garcia, Alfredo; Perez, Juana; Munoz-Dorado, Jose] Univ Granada, Fac Ciencias, Dept Microbiol, E-18071 Granada, Spain	University of Granada	Munoz-Dorado, J (corresponding author), Univ Granada, Fac Ciencias, Dept Microbiol, Avda Fuentenueva S-N, E-18071 Granada, Spain.	jdorado@ugr.es	Moraleda-Munoz, Aurelio/AAA-1599-2019; Castaneda, Alfredo/ABF-5497-2020; Torres, Juana Pérez/H-2480-2015; CastaÃeda, Alfredo/AAQ-5815-2020; Munoz-Dorado, Jose/N-6840-2016	Torres, Juana Pérez/0000-0001-8073-9398; CastaÃeda, Alfredo/0000-0002-1441-6125; Munoz-Dorado, Jose/0000-0001-7765-5687; Moraleda-Munoz, Aurelio/0000-0002-3330-5535	Junta de Andalucia [CVI1377)]; Ministerio de Ciencia y Tecnologia [BMC2003-02038, BFU2006-00972/BMC]	Junta de Andalucia(Junta de Andalucia); Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported in part by grants from Junta de Andalucia (CVI1377) and Ministerio de Ciencia y Tecnologia (BMC2003-02038 and BFU2006-00972/BMC), Spain. The yeast two-hybrid library was constructed under the supervision of Montserrat El as-Arnanz during a short term stay of A. C.-G. at the University of Murcia, granted by Ministerio de Ciencia y Tecnologia.	BARTON GJ, 1994, EUR J BIOCHEM, V220, P225, DOI 10.1111/j.1432-1033.1994.tb18618.x; Carrero-Lerida J, 2005, J BACTERIOL, V187, P4976, DOI 10.1128/JB.187.14.4976-4983.2005; Cho KY, 1999, MOL MICROBIOL, V34, P268, DOI 10.1046/j.1365-2958.1999.01594.x; COHEN P, 1991, METHOD ENZYMOL, V201, P389; Cozzone AJ, 2004, ARCH MICROBIOL, V181, P171, DOI 10.1007/s00203-003-0640-6; DUNCAN L, 1995, SCIENCE, V270, P641, DOI 10.1126/science.270.5236.641; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Inouye S, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P191; Iwanicki A, 2002, BIOCHEM J, V366, P929, DOI 10.1042/BJ20011591; Jackson MD, 2001, CHEM REV, V101, P2313, DOI 10.1021/cr000247e; James P, 1996, GENETICS, V144, P1425; Julien B, 2000, P NATL ACAD SCI USA, V97, P9098, DOI 10.1073/pnas.97.16.9098; Kaiser C., 1994, METHODS YEAST GENETI; KASHEFI K, 1995, MOL MICROBIOL, V15, P483, DOI 10.1111/j.1365-2958.1995.tb02262.x; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Mai B, 1998, J BACTERIOL, V180, P4030, DOI 10.1128/JB.180.16.4030-4035.1998; Martinez-Canamero M, 2003, ANTON LEEUW INT J G, V83, P361, DOI 10.1023/A:1023360116904; Missiakas D, 1997, EMBO J, V16, P1670, DOI 10.1093/emboj/16.7.1670; Moraleda-Munoz A, 2003, J BACTERIOL, V185, P1376, DOI 10.1128/JB.185.4.1376-1383.2003; MORRISON CE, 1979, J BACTERIOL, V140, P1036, DOI 10.1128/JB.140.3.1036-1042.1979; Nariya H, 2003, MOL MICROBIOL, V49, P517, DOI 10.1046/j.1365-2958.2003.03572.x; Nariya H, 2002, MOL MICROBIOL, V46, P1353, DOI 10.1046/j.1365-2958.2002.03251.x; Perez J, 2008, P NATL ACAD SCI USA, V105, P15950, DOI 10.1073/pnas.0806851105; ROBZYK K, 1992, NUCLEIC ACIDS RES, V20, P3790, DOI 10.1093/nar/20.14.3790; Sambrook J, 2001, MOL CLONING LAB MANU; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; Shi L, 1998, FEMS MICROBIOL REV, V22, P229, DOI 10.1016/S0168-6445(98)00015-1; Shi L, 2001, J BACTERIOL, V183, P7053, DOI 10.1128/JB.183.24.7053-7057.2001; TAYLOR BL, 1983, ANNU REV MICROBIOL, V37, P551, DOI 10.1146/annurev.mi.37.100183.003003; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Treuner-Lange A, 2001, MOL MICROBIOL, V40, P126, DOI 10.1046/j.1365-2958.2001.02362.x; Umeyama T, 2000, GENE, V258, P55, DOI 10.1016/S0378-1119(00)00450-9; Vijay K, 2000, MOL MICROBIOL, V35, P180, DOI 10.1046/j.1365-2958.2000.01697.x; Voegtli WC, 2000, BIOCHEMISTRY-US, V39, P15365, DOI 10.1021/bi0021030; Wasch SID, 2002, APPL ENVIRON MICROB, V68, P2368, DOI 10.1128/AEM.68.5.2368-23750.2002; Watts KJ, 2006, J BACTERIOL, V188, P2154, DOI 10.1128/JB.188.6.2154-2162.2006; WEINBERG RA, 1990, J BACTERIOL, V172, P2294, DOI 10.1128/jb.172.5.2294-2302.1990; Whitworth DE, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P169; Whitworth DE, 2008, J BACTERIOL, V190, P1997, DOI 10.1128/JB.01781-07; Whitworth DE, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P1; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhang CC, 1998, J BACTERIOL, V180, P2616, DOI 10.1128/JB.180.10.2616-2622.1998; Zhang WW, 2004, MICROBIOL-SGM, V150, P4189, DOI 10.1099/mic.0.27480-0; ZHUO SQ, 1994, J BIOL CHEM, V269, P26234	46	3	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28720	28728		10.1074/jbc.M109.015248	http://dx.doi.org/10.1074/jbc.M109.015248			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706604	Green Published, hybrid			2022-12-25	WOS:000270678900028
J	Irisawa, M; Inoue, J; Ozawa, N; Mori, K; Sato, R				Irisawa, Masato; Inoue, Jun; Ozawa, Nozomi; Mori, Kazutoshi; Sato, Ryuichiro			The Sterol-sensing Endoplasmic Reticulum (ER) Membrane Protein TRC8 Hampers ER to Golgi Transport of Sterol Regulatory Element-binding Protein-2 (SREBP-2)/SREBP Cleavage-activated Protein and Reduces SREBP-2 Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HMG COA REDUCTASE; KIDNEY CANCER GENE; COPII PROTEINS; TRANSCRIPTIONAL REGULATION; PROTEASOME PATHWAY; UBIQUITIN LIGASE; LIPID-SYNTHESIS; CHOLESTEROL; INSIG; SCAP	TRC8 (translocation in renal cancer from chromosome 8) is an intrinsic protein of the endoplasmic reticulum that contains a sterol-sensing domain and a RING finger motif encoding an E3 ubiquitin ligase. Here we show that TRC8 overexpression hinders sterol regulatory element-binding protein-2 (SREBP-2) processing, thereby reducing SREBP-2 target gene expression, TRC8 depletion has the opposite effect. Mutation analyses of TRC8 reveal that the ubiquitin ligase activity is dispensable for these effects. Activating transcription factor 6 (ATF6) is also processed in the Golgi by the same two proteases as those for SREBP, but ATF6 processing is not affected by TRC8. TRC8 is capable of binding both SREBP-2 and SREBP cleavage-activated protein (SCAP), thereby forming a TRC8.SREBP-2.SCAP complex. This complex formation hampers the interaction between SCAP and Sec24, one of the COPII proteins that are involved in SREBP-2 transport to the Golgi, thereby reducing SREBP-2 cleavage. TRC8 conjugated by ubiquitin is unstable, whereas the mutant TRC8, lacking the E3 ubiquitin ligase activity and only slightly modified by ubiquitin, is quite stable. TRC8 becomes stable when cells are cultured with a proteasome inhibitor or under a lipoprotein-depleted condition. Lipoprotein depletion impairs ubiquitination of TRC8. Taken together, TRC8 is a novel sterol-sensing endoplasmic reticulum membrane protein that hinders SREBP-2 processing through interaction with SREBP-2 and SCAP, regulating its own turnover rate by means of its E3 ubiquitin ligase activity.	[Irisawa, Masato; Inoue, Jun; Ozawa, Nozomi; Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Mori, Kazutoshi] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan	University of Tokyo; Kyoto University	Sato, R (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan.	aroysato@mail.ecc.u-tokyo.ac.jp	Mori, Kazutoshi/AAW-5449-2020; Mori, Kazutoshi/K-6106-2015; INOUE, Jun/O-7352-2016	INOUE, Jun/0000-0003-4145-3754	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [19108002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Arito M, 2008, J BIOL CHEM, V283, P15224, DOI 10.1074/jbc.M800910200; Brauweiler A, 2007, ONCOGENE, V26, P2263, DOI 10.1038/sj.onc.1210017; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Espenshade PJ, 2002, P NATL ACAD SCI USA, V99, P11694, DOI 10.1073/pnas.182412799; Gemmill RM, 2002, ONCOGENE, V21, P3507, DOI 10.1038/sj.onc.1205437; Gemmill RM, 1998, P NATL ACAD SCI USA, V95, P9572, DOI 10.1073/pnas.95.16.9572; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hirano Y, 2003, J BIOL CHEM, V278, P16809, DOI 10.1074/jbc.M212448200; Hirano Y, 2001, J BIOL CHEM, V276, P36431, DOI 10.1074/jbc.M105200200; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Inoue J, 1998, J BIOCHEM-TOKYO, V123, P1191; Kanayama T, 2007, J BIOL CHEM, V282, P10290, DOI 10.1074/jbc.M700270200; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; Nadanaka S, 2004, MOL BIOL CELL, V15, P2537, DOI 10.1091/mbc.E03-09-0693; Okada T, 2003, J BIOL CHEM, V278, P31024, DOI 10.1074/jbc.M300923200; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Sato R, 1999, J BIOL CHEM, V274, P24714, DOI 10.1074/jbc.274.35.24714; Sato R, 2000, J BIOL CHEM, V275, P12497, DOI 10.1074/jbc.275.17.12497; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2004, J BIOL CHEM, V279, P28798, DOI 10.1074/jbc.M402442200; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yabe D, 2002, P NATL ACAD SCI USA, V99, P16672, DOI 10.1073/pnas.262669399; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yellaturu CR, 2009, J BIOL CHEM, V284, P7518, DOI 10.1074/jbc.M805746200	35	42	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28995	29004		10.1074/jbc.M109.041376	http://dx.doi.org/10.1074/jbc.M109.041376			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706601	hybrid, Green Published			2022-12-25	WOS:000270678900057
J	Liu, YZ; Pei, YF; Liu, JF; Yang, F; Guo, Y; Zhang, L; Liu, XG; Yan, H; Wang, L; Zhang, YP; Levy, S; Recker, RR; Deng, HW				Liu, Yao-Zhong; Pei, Yu-Fang; Liu, Jian-Feng; Yang, Fang; Guo, Yan; Zhang, Lei; Liu, Xiao-Gang; Yan, Han; Wang, Liang; Zhang, Yin-Ping; Levy, Shawn; Recker, Robert R.; Deng, Hong-Wen			Powerful Bivariate Genome-Wide Association Analyses Suggest the SOX6 Gene Influencing Both Obesity and Osteoporosis Phenotypes in Males	PLOS ONE			English	Article								Background: Current genome-wide association studies (GWAS) are normally implemented in a univariate framework and analyze different phenotypes in isolation. This univariate approach ignores the potential genetic correlation between important disease traits. Hence this approach is difficult to detect pleiotropic genes, which may exist for obesity and osteoporosis, two common diseases of major public health importance that are closely correlated genetically. Principal Findings: To identify such pleiotropic genes and the key mechanistic links between the two diseases, we here performed the first bivariate GWAS of obesity and osteoporosis. We searched for genes underlying co-variation of the obesity phenotype, body mass index (BMI), with the osteoporosis risk phenotype, hip bone mineral density (BMD), scanning similar to 380,000 SNPs in 1,000 unrelated homogeneous Caucasians, including 499 males and 501 females. We identified in the male subjects two SNPs in intron 1 of the SOX6 (SRY-box 6) gene, rs297325 and rs4756846, which were bivariately associated with both BMI and hip BMD, achieving p values of 6.82x10(-7) and 1.47x10(-6), respectively. The two SNPs ranked at the top in significance for bivariate association with BMI and hip BMD in the male subjects among all the similar to 380,000 SNPs examined genome-wide. The two SNPs were replicated in a Framingham Heart Study (FHS) cohort containing 3,355 Caucasians (1,370 males and 1,985 females) from 975 families. In the FHS male subjects, the two SNPs achieved p values of 0.03 and 0.02, respectively, for bivariate association with BMI and femoral neck BMD. Interestingly, SOX6 was previously found to be essential to both cartilage formation/chondrogenesis and obesity-related insulin resistance, suggesting the gene's dual role in both bone and fat. Conclusions: Our findings, together with the prior biological evidence, suggest the SOX6 gene's importance in coregulation of obesity and osteoporosis.			Liu, YZ (corresponding author), Univ Missouri, Sch Med, Kansas City, MO 64108 USA.	dengh@umkc.edu	Liu, Yaozhong/ABD-5544-2020; Guo, Yan/G-8742-2014	Guo, Yan/0000-0002-7364-2392; Liu, Jian-Feng/0000-0002-5766-7864; Deng, Hong-Wen/0000-0002-0387-8818; Levy, Shawn/0000-0002-1369-5740	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050496, P50AR055081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG027110, R01AG026564] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR050496-01, P50 AR055081, R01 AR050496] Funding Source: Medline; NIA NIH HHS [R01 AG026564, R21 AG027110] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allison DB, 2000, MED CLIN N AM, V84, P305, DOI 10.1016/S0025-7125(05)70223-6; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cohen-Barak G, 2001, GENE, V265, P157, DOI 10.1016/S0378-1119(01)00346-8; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Deng FY, 2006, OSTEOPOROSIS INT, V17, P119, DOI 10.1007/s00198-005-1930-4; Deng HW, 2002, AM J HUM GENET, V70, P1138, DOI 10.1086/339934; Di XJ, 2005, BIOINFORMATICS, V21, P1958, DOI 10.1093/bioinformatics/bti275; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Farber CR, 2007, MAMM GENOME, V18, P635, DOI 10.1007/s00335-007-9046-0; Fawcett GL, 2008, OBESITY, V16, P1861, DOI 10.1038/oby.2008.300; FELSON DT, 1993, J BONE MINER RES, V8, P567, DOI 10.1002/jbmr.5650080507; Fisher R.A., 1948, AM STAT, V2, P30, DOI DOI 10.2307/2681650; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Freimer N, 2004, NAT GENET, V36, P1045, DOI 10.1038/ng1433; Gimble JM, 1996, BONE, V19, P421, DOI 10.1016/S8756-3282(96)00258-X; HUI SL, 1989, ANN INTERN MED, V111, P355, DOI 10.7326/0003-4819-111-5-355; Iguchi H, 2005, J BIOL CHEM, V280, P37669, DOI 10.1074/jbc.M505392200; Iguchi H, 2007, J BIOL CHEM, V282, P19052, DOI 10.1074/jbc.M700460200; Ioannidis JPA, 2007, J BONE MINER RES, V22, P173, DOI 10.1359/JBMR.060806; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Khaodhiar L, 1999, Clin Cornerstone, V2, P17, DOI 10.1016/S1098-3597(99)90002-9; Korner A, 2007, INT J OBESITY, V31, P353, DOI 10.1038/sj.ijo.0803428; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lencz T, 2007, MOL PSYCHIATR, V12, P572, DOI 10.1038/sj.mp.4001983; Lewis CE, 2005, INT J OBESITY, V29, P639, DOI 10.1038/sj.ijo.0802916; Liu JF, 2009, GENET EPIDEMIOL, V33, P217, DOI 10.1002/gepi.20372; Ma LJ, 2005, DIABETES, V54, P1598, DOI 10.2337/diabetes.54.5.1598; MARCUS R, 1994, J BONE MINER RES, V9, P1467, DOI 10.1002/jbmr.5650090920; Melton LJ, 2003, J BONE MINER RES, V18, P1139, DOI 10.1359/jbmr.2003.18.6.1139; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Ober C, 2006, CURR ALLERGY ASTHM R, V6, P241, DOI 10.1007/s11882-006-0041-4; PEI YF, 2009, ANN HUM GENET; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Ravn P, 1999, J BONE MINER RES, V14, P1622, DOI 10.1359/jbmr.1999.14.9.1622; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Tang ZH, 2007, J CLIN ENDOCR METAB, V92, P2751, DOI 10.1210/jc.2006-2607; Wolf AM, 1998, OBES RES, V6, P97, DOI 10.1002/j.1550-8528.1998.tb00322.x; XIAO P, 2006, J BONE MINE IN PRESS; XIONG DH, 2006, J BONE MINE IN PRESS; Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572	49	80	90	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2009	4	8							e6827	10.1371/journal.pone.0006827	http://dx.doi.org/10.1371/journal.pone.0006827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JG	19714249	Green Submitted, gold, Green Published			2022-12-25	WOS:000269415800011
J	Cohen, H; Parekh, P; Sercan, Z; Kotekar, A; Weissman, JD; Singer, DS				Cohen, Helit; Parekh, Palak; Sercan, Zeynep; Kotekar, Aparna; Weissman, Jocelyn D.; Singer, Dinah S.			In Vivo Expression of MHC Class I Genes Depends on the Presence of a Downstream Barrier Element	PLOS ONE			English	Article								Regulation of MHC class I gene expression is critical to achieve proper immune surveillance. In this work, we identify elements downstream of the MHC class I promoter that are necessary for appropriate in vivo regulation: a novel barrier element that protects the MHC class I gene from silencing and elements within the first two introns that contribute to tissue specific transcription. The barrier element is located in intergenic sequences 39 to the polyA addition site. It is necessary for stable expression in vivo, but has no effect in transient transfection assays. Accordingly, in both transgenic mice and stably transfected cell lines, truncation of the barrier resulted in transcriptional gene silencing, increased nucleosomal density and decreased histone H3K9/K14 acetylation and H3K4 di-methylation across the gene. Significantly, distinct sequences within the barrier element govern anti-silencing and chromatin modifications. Thus, this novel barrier element functions to maintain transcriptionally permissive chromatin organization and prevent transcriptional silencing of the MHC class I gene, ensuring it is poised to respond to immune signaling.			Cohen, H (corresponding author), NIH, Expt Immunol Branch, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA.	Dinah.singer@nih.gov	Parekh, Palak/B-7042-2015	Parekh, Palak/0000-0001-9201-5194	Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC009255, ZICBC009255] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLISON J, 1988, NATURE, V333, P529, DOI 10.1038/333529a0; Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Bruce K, 2005, NUCLEIC ACIDS RES, V33, P5633, DOI 10.1093/nar/gki874; Burgess-Beusse B, 2002, P NATL ACAD SCI USA, V99, P16433, DOI 10.1073/pnas.162342499; Butcher DT, 2004, INT J CANCER, V111, P669, DOI 10.1002/ijc.20324; CHAMBERLAIN JW, 1991, MOL CELL BIOL, V11, P3564, DOI 10.1128/MCB.11.7.3564; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; EHRLICH R, 1988, MOL CELL BIOL, V8, P695, DOI 10.1128/MCB.8.2.695; EHRLICH R, 1989, IMMUNOGENETICS, V30, P18, DOI 10.1007/BF02421465; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; FRAUMAN AG, 1993, MOL CELL BIOL, V13, P1554, DOI 10.1128/MCB.13.3.1554; FRELS W I, 1990, New Biologist, V2, P1024; FRELS WI, 1985, SCIENCE, V228, P577, DOI 10.1126/science.3885396; GALLAGHER PG, 2008, BLOOD; Giuliani C, 2006, J ENDOCRINOL, V189, P605, DOI 10.1677/joe.1.06486; GIULIANI C, 1995, J BIOL CHEM, V270, P11453, DOI 10.1074/jbc.270.19.11453; Gombert WM, 2003, MOL CELL BIOL, V23, P9338, DOI 10.1128/MCB.23.24.9338-9348.2003; Hino S, 2004, GENE THER, V11, P819, DOI 10.1038/sj.gt.3302227; Howcroft TK, 1999, MOL CELL BIOL, V19, P4788; HOWCROFT TK, 1993, EMBO J, V12, P3163, DOI 10.1002/j.1460-2075.1993.tb05985.x; Howcroft TK, 2003, IMMUNOL RES, V27, P1, DOI 10.1385/IR:27:1:1; Howcroft TK, 2003, MOL CELL BIOL, V23, P3377, DOI 10.1128/MCB.23.10.3377-3391.2003; HOWCROFT TK, 1995, IMMUNITY, V3, P127; HOWCROFT TK, 1993, SCIENCE, V260, P1320, DOI 10.1126/science.8493575; Huang S, 2007, MOL CELL BIOL, V27, P7991, DOI 10.1128/MCB.01326-07; Jacobson S, 2004, MOL CELL BIOL, V24, P6029, DOI 10.1128/MCB.24.13.6029-6039.2004; KALOS M, 1995, MOL CELL BIOL, V15, P198, DOI 10.1128/MCB.15.1.198; Katan-Khaykovich Y, 2005, EMBO J, V24, P2138, DOI 10.1038/sj.emboj.7600692; KAY TWH, 1991, DIABETOLOGIA, V34, P779, DOI 10.1007/BF00408350; Kioussis D, 1997, CURR OPIN GENET DEV, V7, P614, DOI 10.1016/S0959-437X(97)80008-1; KOTEKAR AS, 2008, MOLCELL BIOL; Li H, 2006, BIOCHEM BIOPH RES CO, V349, P1315, DOI 10.1016/j.bbrc.2006.08.182; Luczynski W, 2004, ACTA BIOCHIM POL, V51, P1067; MAGUIRE JE, 1992, MOL CELL BIOL, V12, P3078, DOI 10.1128/MCB.12.7.3078; Majumder P, 2006, J BIOL CHEM, V281, P18435, DOI 10.1074/jbc.M601298200; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Mozes E, 2005, LUPUS, V14, P308, DOI 10.1191/0961203305lu2079oa; MOZES E, 1993, SCIENCE, V261, P91, DOI 10.1126/science.8316860; Murphy C, 1996, J BIOL CHEM, V271, P30992, DOI 10.1074/jbc.271.48.30992; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Nakayama T, 2007, GENE DEV, V21, P552, DOI 10.1101/gad.1503407; Nie Y, 2001, CARCINOGENESIS, V22, P1615, DOI 10.1093/carcin/22.10.1615; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; Ogino T, 2003, CLIN CANCER RES, V9, P4043; Oki M, 2005, MOL CELL, V19, P707, DOI 10.1016/j.molcel.2005.07.022; Oki M, 2004, MOL CELL BIOL, V24, P1956, DOI 10.1128/MCB.24.5.1956-1967.2004; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Pizzato N, 2003, AM J REPROD IMMUNOL, V50, P328, DOI 10.1034/j.1600-0897.2003.00087.x; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Scott KC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001099; Smirnov DA, 2000, VIROLOGY, V268, P319, DOI 10.1006/viro.1999.0181; SPANA C, 1988, GENE DEV, V2, P1414, DOI 10.1101/gad.2.11.1414; Strunnikova M, 2005, MOL CELL BIOL, V25, P3923, DOI 10.1128/MCB.25.10.3923-3933.2005; TURNLEY AM, 1991, NATURE, V353, P566, DOI 10.1038/353566a0; van den Elsen PJ, 2004, CURR OPIN IMMUNOL, V16, P67, DOI 10.1016/j.coi.2003.11.015; Venkatasubrahmanyam S, 2007, P NATL ACAD SCI USA, V104, P16609, DOI 10.1073/pnas.0700914104; Vitale M, 2005, CLIN CANCER RES, V11, P67; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Yusufzai TM, 2004, P NATL ACAD SCI USA, V101, P8620, DOI 10.1073/pnas.0402938101; Zhuma T, 1999, EMBO J, V18, P6396, DOI 10.1093/emboj/18.22.6396	65	2	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6748	10.1371/journal.pone.0006748	http://dx.doi.org/10.1371/journal.pone.0006748			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707598	Green Submitted, Green Published, gold			2022-12-25	WOS:000269335000007
J	Lam, NSN; Pace, K; Campanella, R; LeSage, J; Arenas, H				Lam, Nina S. N.; Pace, Kelley; Campanella, Richard; LeSage, James; Arenas, Helbert			Business Return in New Orleans: Decision Making Amid Post-Katrina Uncertainty	PLOS ONE			English	Article							VULNERABILITY; DISASTERS; EARTHQUAKE; SCIENCE	Background: Empirical observations on how businesses respond after a major catastrophe are rare, especially for a catastrophe as great as Hurricane Katrina, which hit New Orleans, Louisiana on August 29, 2005. We analyzed repeated telephone surveys of New Orleans businesses conducted in December 2005, June 2006, and October 2007 to understand factors that influenced decisions to re-open amid post-disaster uncertainty. Methodology/Principal Findings: Businesses in the group of professional, scientific, and technical services reopened the fastest in the near term, but differences in the rate of reopening for businesses stratified by type became indistinguishable in the longer term (around two years later). A reopening rate of 65% was found for all businesses by October 2007. Discriminant analysis showed significant differences in responses reflecting their attitudes about important factors between businesses that reopened and those that did not. Businesses that remained closed at the time of our third survey (two years after Katrina) ranked levee protection as the top concern immediately after Katrina, but damage to their premises and financing became major concerns in subsequent months reflected in the later surveys. For businesses that had opened (at the time of our third survey), infrastructure protection including levee, utility, and communications were the main concerns mentioned in surveys up to the third survey, when the issue of crime became their top concern. Conclusions/Significance: These findings underscore the need to have public policy and emergency plans in place prior to the actual disaster, such as infrastructure protection, so that the policy can be applied in a timely manner before business decisions to return or close are made. Our survey results, which include responses from both open and closed businesses, overcome the "survivorship bias'' problem and provide empirical observations that should be useful to improve micro-level spatial economic modeling of factors that influence business return decisions.			Lam, NSN (corresponding author), Louisiana State Univ, Dept Environm Sci, Baton Rouge, LA 70803 USA.	nlam@lsu.edu	Arenas, Helbert/K-3037-2014; Lam, Nina/AAQ-1097-2020		Divn Of Social and Economic Sciences [0729264, 0729259] Funding Source: National Science Foundation	Divn Of Social and Economic Sciences(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Alesch D.J., 2001, ORG RISK WHAT HAPPEN; BAKER EJ, 1995, PROF GEOGR, V47, P137, DOI 10.1111/j.0033-0124.1995.00137.x; Bronson JW, 2006, PSYCHOL REP, V99, P960, DOI 10.2466/PRO.99.3.960-962; *BROOK I, 2008, NEW ORL IND 3 YEARS; Campanella R., 2007, STREET SURVEY BUSINE; Campanella Richard, 2008, BIENVILLES DILEMMA H; CHANG S, 1984, GROWTH CHANGE, V15, P24, DOI 10.1111/j.1468-2257.1984.tb00748.x; Cutter SL, 2003, ANN ASSOC AM GEOGR, V93, P1, DOI 10.1111/1467-8306.93101; Cutter SL, 2008, P NATL ACAD SCI USA, V105, P2301, DOI 10.1073/pnas.0710375105; Dahlhamer JM, 1998, SOCIOL SPECTRUM, V18, P121, DOI 10.1080/02732173.1998.9982189; Edmonds B., 1999, COMPUTATIONAL TECHNI, P305, DOI DOI 10.1007/978-1-4615-5029-7_13; Kates RW, 2006, P NATL ACAD SCI USA, V103, P14653, DOI 10.1073/pnas.0605726103; KUNREUTHER H, 1992, SOCIAL THEORIES RISK; PALM R, 1995, ECON GEOGR, V71, P119, DOI 10.2307/144354; Palm R, 1993, NATURAL HAZARDS APPL, V56; PIELKE RA, 1997, HURRICANES THEIR NAT; Simon H.A., 1997, MODELS BOUNDED RATIO, V3; Skidmore M, 2002, ECON INQ, V40, P664, DOI 10.1093/ei/40.4.664; Stewart Thomas R, 2002, EXTREME EVENT DECISI; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; *US DEP HOUS URB D, 2006, CURR HOUS UN DAM EST; WAUGH WL, 2006, ECON DEV Q, P211; Webb G. R., 2000, NAT HAZARDS REV, V1, P83, DOI DOI 10.1061/(ASCE)1527-6988(2000)1:2(83); Webb G.R., 2002, ENV HAZARDS, V4, P45, DOI [10.1016/s1464-2867(03)00005-6, DOI 10.1016/S1464-2867(03)00005-6, https://doi.org/10.1016/S1464-2867(03)00005-6]; Zhang Y, 2009, DISASTERS, V33, P38, DOI 10.1111/j.1467-7717.2008.01061.x	26	36	37	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6765	10.1371/journal.pone.0006765	http://dx.doi.org/10.1371/journal.pone.0006765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	488FQ	19707547	Green Submitted, gold, Green Published			2022-12-25	WOS:000269335000011
J	Raices, RM; Kannan, Y; Bellamkonda-Athmaram, V; Seshadri, S; Wang, HT; Guttridge, DC; Wewers, MD				Raices, Raquel M.; Kannan, Yashaswini; Bellamkonda-Athmaram, Vedavathi; Seshadri, Sudarshan; Wang, Huating; Guttridge, Denis C.; Wewers, Mark D.			A Novel Role for I kappa B zeta in the Regulation of IFN gamma Production	PLOS ONE			English	Article								I kappa b zeta is a novel member of the I kappa B family of NF kappa B regulators, which modulates NF kappa B activity in the nucleus, rather than controlling its nuclear translocation. I kappa B zeta is specifically induced by IL-1 beta and several TLR ligands and positively regulates NF kappa B-mediated transcription of genes such as IL-6 and NGAL as an NF kappa B binding co-factor. We recently reported that the IL-1 family cytokines, IL-1 beta and IL-18, strongly synergize with TNF alpha for IFN gamma production in KG-1 cells, whereas the same cytokines alone have minimal effects on IFN gamma production. Given the striking similarities between the IL-1R and IL-18R signaling pathways we hypothesized that a common signaling event or gene product downstream of these receptors is responsible for the observed synergy. We investigated I kappa b zeta protein expression in KG-1 cells upon stimulation with IL-1 beta, IL-18 and TNF alpha. Our results demonstrated that IL-18, as well as IL-1 beta, induced moderate I kappa b zeta expression in KG-1 cells. However, TNF alpha synergized with IL-1 beta and IL-18, whereas by itself it had a minimal effect on I kappa b zeta expression. NFkB inhibition resulted in decreased IL-1 beta/IL-18/TNF alpha-stimulated IFN gamma release. Moreover, silencing of I kappa b zeta expression led to a specific decrease in IFN gamma production. Overall, our data suggests that I kappa b zeta positively regulates NF kappa B-mediated IFN gamma production in KG-1 cells.			Raices, RM (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	wewers.2@osu.edu	Wewers, Mark/AAB-6202-2021; Seshadri, Sudarshan/J-5544-2016; Wang, Huating/C-6719-2014	Seshadri, Sudarshan/0000-0003-4910-8664; Wang, Huating/0000-0001-5474-2905; Guttridge, Denis/0000-0002-7276-6609	NHLBI NIH HHS [R01 HL076278, HL40871, HL076278] Funding Source: Medline; NIAID NIH HHS [F31 AI061828, F31 AI 061828-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040871, R01HL076278, R29HL040871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI061828] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barbulescu K, 1998, J IMMUNOL, V160, P3642; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Bufler P, 2002, P NATL ACAD SCI USA, V99, P13723, DOI 10.1073/pnas.212519099; Bundy DL, 1997, J BIOL CHEM, V272, P33132, DOI 10.1074/jbc.272.52.33132; Caamano JH, 1996, MOL CELL BIOL, V16, P1342; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; Dinarello CA, 1999, METHODS, V19, P121, DOI 10.1006/meth.1999.0837; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; ELIAS JA, 1990, J IMMUNOL, V145, P161; Esteban DJ, 2004, J GEN VIROL, V85, P1291, DOI 10.1099/vir.0.79902-0; Faggioni R, 2001, J IMMUNOL, V167, P5913, DOI 10.4049/jimmunol.167.10.5913; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; FRANZOSO G, 1993, EMBO J, V12, P3893, DOI 10.1002/j.1460-2075.1993.tb06067.x; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Fukao T, 2000, J IMMUNOL, V164, P64, DOI 10.4049/jimmunol.164.1.64; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Haruta H, 2001, J BIOL CHEM, V276, P12485, DOI 10.1074/jbc.C100075200; HATADA EN, 1992, P NATL ACAD SCI USA, V89, P2489, DOI 10.1073/pnas.89.6.2489; Ito T, 2004, GENE, V342, P137, DOI 10.1016/j.gene.2004.07.032; Kao CY, 2008, J BIOL CHEM, V283, P15309, DOI [10.1074/jbc.M708289200, 10.1074/jbc.M804331200]; KATZ Y, 1989, J IMMUNOL, V142, P3862; KAYAMA H, 2008, J BIOL CHEM; KERR LD, 1992, GENE DEV, V6, P2352, DOI 10.1101/gad.6.12a.2352; Kim SH, 2002, J BIOL CHEM, V277, P10998, DOI 10.1074/jbc.M108311200; Kitamura H, 2003, ARCH HISTOL CYTOL, V66, P53, DOI 10.1679/aohc.66.53; Kitamura H, 2000, FEBS LETT, V485, P53, DOI 10.1016/S0014-5793(00)02185-2; Kitamura H, 2002, J VET MED SCI, V64, P419, DOI 10.1292/jvms.64.419; Kojima H, 1999, J IMMUNOL, V162, P5063; Kojima H, 1998, BIOCHEM BIOPH RES CO, V244, P183, DOI 10.1006/bbrc.1998.8236; Kracht M, 2002, CYTOKINE, V20, P91, DOI 10.1006/cyto.2002.0895; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x; Liu LD, 2003, J IMMUNOL, V170, P575, DOI 10.4049/jimmunol.170.1.575; MACNAUL KL, 1990, J BIOL CHEM, V265, P17238; Matsumoto S, 1997, BIOCHEM BIOPH RES CO, V234, P454, DOI 10.1006/bbrc.1997.6665; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Muta T, 2003, J ENDOTOXIN RES, V9, P187, DOI 10.1179/096805103125001612; Muta T, 2006, VITAM HORM, V74, P301, DOI 10.1016/S0083-6729(06)74012-2; Nakahira M, 2002, J IMMUNOL, V168, P1146, DOI 10.4049/jimmunol.168.3.1146; Nakamura S, 2000, LEUKEMIA, V14, P1052, DOI 10.1038/sj.leu.2401789; NG SB, 1994, J BIOL CHEM, V269, P19021; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Okamura H, 1998, CURR OPIN IMMUNOL, V10, P259, DOI 10.1016/S0952-7915(98)80163-5; Oonuma T, 2007, J VET MED SCI, V69, P279, DOI 10.1292/jvms.69.279; Ortaldo JR, 2006, BLOOD, V107, P1468, DOI 10.1182/blood-2005-04-1579; Pioli PA, 2006, J IMMUNOL, V176, P6647, DOI 10.4049/jimmunol.176.11.6647; RAICES RM, 2008, CYTOKINE; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Rodriguez-Galan MC, 2005, J IMMUNOL, V174, P2796, DOI 10.4049/jimmunol.174.5.2796; Schindler H, 2001, J IMMUNOL, V166, P3075, DOI 10.4049/jimmunol.166.5.3075; Shiina T, 2001, IMMUNOGENETICS, V53, P649, DOI 10.1007/s00251-001-0376-x; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Sorensen OE, 2005, J IMMUNOL, V174, P4870, DOI 10.4049/jimmunol.174.8.4870; Sorensen OE, 2003, J IMMUNOL, V170, P5583, DOI 10.4049/jimmunol.170.11.5583; Stober D, 2001, J IMMUNOL, V167, P957, DOI 10.4049/jimmunol.167.2.957; Tominaga K, 2000, INT IMMUNOL, V12, P151, DOI 10.1093/intimm/12.2.151; Torigoe K, 1997, J BIOL CHEM, V272, P25737, DOI 10.1074/jbc.272.41.25737; Totzke G, 2006, J BIOL CHEM, V281, P12645, DOI 10.1074/jbc.M511956200; Trinh DV, 2008, J MOL BIOL, V379, P122, DOI 10.1016/j.jmb.2008.03.060; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; Viatour P, 2004, MOL CELL, V16, P35, DOI 10.1016/j.molcel.2004.09.004; Wessells J, 2004, J BIOL CHEM, V279, P49995, DOI 10.1074/jbc.M404246200; Wu CB, 2003, J IMMUNOL, V170, P5571, DOI 10.4049/jimmunol.170.11.5571; WULCZYN FG, 1992, NATURE, V358, P597, DOI 10.1038/358597a0; Xiang Y, 1999, P NATL ACAD SCI USA, V96, P11537, DOI 10.1073/pnas.96.20.11537; Xu DM, 1998, J EXP MED, V188, P1485, DOI 10.1084/jem.188.8.1485; Yamamoto M, 2004, MOL IMMUNOL, V40, P861, DOI 10.1016/j.molimm.2003.10.006; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200; Yoshimoto T, 1999, P NATL ACAD SCI USA, V96, P13962, DOI 10.1073/pnas.96.24.13962; Yoshimoto T, 1998, J IMMUNOL, V161, P3400; Yoshimoto T, 1997, P NATL ACAD SCI USA, V94, P3948, DOI 10.1073/pnas.94.8.3948; Young HA, 2007, CURR TOP MICROBIOL, V316, P97; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373; Young HA, 1996, J INTERF CYTOK RES, V16, P563, DOI 10.1089/jir.1996.16.563; Zhang B, 2003, LEUKEMIA RES, V27, P813, DOI 10.1016/S0145-2126(03)00005-5; ZHANG Q, 1994, MOL CELL BIOL, V14, P3915, DOI 10.1128/MCB.14.6.3915	85	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6776	10.1371/journal.pone.0006776	http://dx.doi.org/10.1371/journal.pone.0006776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707556	Green Submitted, Green Published, gold			2022-12-25	WOS:000269335000020
J	Arbour, VM				Arbour, Victoria Megan			Estimating Impact Forces of Tail Club Strikes by Ankylosaurid Dinosaurs	PLOS ONE			English	Article							SEXUAL SELECTION; NECK; MECHANICS; ALLIGATOR; HEAD	Background: It has been assumed that the unusual tail club of ankylosaurid dinosaurs was used actively as a weapon, but the biological feasibility of this behaviour has not been examined in detail. Ankylosaurid tail clubs are composed of interlocking vertebrae, which form the handle, and large terminal osteoderms, which form the knob. Methodology/Principal Findings: Computed tomographic (CT) scans of several ankylosaurid tail clubs referred to Dyoplosaurus and Euoplocephalus, combined with measurements of free caudal vertebrae, provide information used to estimate the impact force of tail clubs of various sizes. Ankylosaurid tails are modeled as a series of segments for which mass, muscle cross-sectional area, torque, and angular acceleration are calculated. Free caudal vertebrae segments had limited vertical flexibility, but the tail could have swung through approximately 100 degrees laterally. Muscle scars on the pelvis record the presence of a large M. longissimus caudae, and ossified tendons alongside the handle represent M. spinalis. CT scans showed that knob osteoderms were predominantly cancellous, which would have lowered the rotational inertia of the tail club and made it easier to wield as a weapon. Conclusions/Significance: Large knobs could generate sufficient force to break bone during impacts, but average and small knobs could not. Tail swinging behaviour is feasible in ankylosaurids, but it remains unknown whether the tail was used for interspecific defense, intraspecific combat, or both.			Arbour, VM (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	arbour@ualberta.ca						Alexander RM, 1999, ZOOL J LINN SOC-LOND, V126, P41, DOI 10.1111/j.1096-3642.1999.tb00606.x; ARBOUR VM, 1924, J VERTEBR P IN PRESS; Bamman MM, 2000, MED SCI SPORT EXER, V32, P1307, DOI 10.1097/00005768-200007000-00019; Carpenter K, 2005, LIFE O PAST, P325; Chiasson R.B., 1962, LAB ANATOMY ALLIGATO; CLOSE RI, 1972, PHYSIOL REV, V52, P129, DOI 10.1152/physrev.1972.52.1.129; Cong L., 1998, GROSS ANATOMY ALLIGA; Coombs W, 1971, THESIS COLUMBIA U NE; COOMBS WP, 1979, J PALEONTOL, V53, P666; COOMBS WP, 1995, CAN J EARTH SCI, V32, P902, DOI 10.1139/e95-075; Currey J.D., 2002, BONES STRUCTURE MECH; CURRIE PJ, 1991, GEOTIMES, V36, P18; Dello SAWG, 2007, WORLD J SURG, V31, P2215, DOI 10.1007/s00268-007-9197-x; Dzemski G, 2007, J MORPHOL, V268, P701, DOI 10.1002/jmor.10542; Erickson GM, 2006, SCIENCE, V313, P213, DOI 10.1126/science.1125721; Fish FE, 2007, J EXP BIOL, V210, P2811, DOI 10.1242/jeb.004267; FREY E, 1989, AM ZOOL, V29, P857; Fukunaga T, 2001, ACTA PHYSIOL SCAND, V172, P249, DOI 10.1046/j.1365-201x.2001.00867.x; Gasc J.-P., 1981, Biology of Reptilia, V11, P355; Gillooly JF, 2006, PLOS BIOL, V4, P1467, DOI 10.1371/journal.pbio.0040248; Gilmore C. W., 1933, American Museum Novitates, V679, P1; Hildebrand M., 2001, ANAL VERTEBRATE STRU; Holmes R, 2007, J PALEONTOL, V81, P411, DOI 10.1666/0022-3360(2007)81[411:AOTTIC]2.0.CO;2; Keshner EA, 1997, EXP BRAIN RES, V115, P257, DOI 10.1007/PL00005695; Lambe L.M., 1910, OTTAWA NATURALIST, V14, P149; Maganaris CN, 2001, J APPL PHYSIOL, V90, P865, DOI 10.1152/jappl.2001.90.3.865; MALEEV E. A., 1952, DOKLADY AKAD NAUK SSSR, V87, P273; MALEEV EA, 1954, WORKS PALEONTOLOGICA, V48, P142; Manter JT, 1940, J EXP ZOOL, V83, P345, DOI 10.1002/jez.1400830302; Martill DM, 2000, PALAEONTOLOGY, V43, P549, DOI 10.1111/j.0031-0239.2000.00139.x; *MAT, 2008, MIM VERS 12; Organ CL, 2006, ANAT REC PART A, V288A, P782, DOI 10.1002/ar.a.20341; Parks W. A., 1924, University of Toronto Studies Geological Series, V18, P1; Peirce Benjamin, 1837, ELEMENTARY TREATISE; Picard K, 1996, ECOSCIENCE, V3, P280, DOI 10.1080/11956860.1996.11682343; Rasband W.S., 1997, IMAGEJ; Reynolds HW., 2003, WILD MAMMALS N AM BI, P1009; Russell AP, 2001, COPEIA, P154, DOI 10.1643/0045-8511(2001)001[0154:MCAIPH]2.0.CO;2; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; Simmons RE, 1996, AM NAT, V148, P771, DOI 10.1086/285955; Snively E, 2008, PALAEONTOL ELECTRON, V11; Snively E, 2007, PALEOBIOLOGY, V33, P610, DOI 10.1666/06059.1; Stevens KA, 1999, SCIENCE, V284, P798, DOI 10.1126/science.284.5415.798; THULBORN T, 1993, RECORD S AUSTR MUSEU, V27, P151; Tsuihiji T, 2007, J MORPHOL, V268, P986, DOI 10.1002/jmor.10565; Vickaryous MK, 2004, DINOSAURIA, 2ND EDITION, P363; Vickaryous MK, 2008, J MORPHOL, V269, P398, DOI 10.1002/jmor.10575; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Zollikofer C.P.E., 2005, VIRTUAL RECONSTRUCTI	49	40	40	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6738	10.1371/journal.pone.0006738	http://dx.doi.org/10.1371/journal.pone.0006738			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707581	Green Published, gold, Green Submitted			2022-12-25	WOS:000269278400006
J	Coxon, CH; Bicknell, KA; Moseley, FL; Brooks, G				Coxon, Carmen H.; Bicknell, Katrina A.; Moseley, Fleur L.; Brooks, Gavin			Over Expression of Plk1 Does Not Induce Cell Division in Rat Cardiac Myocytes In Vitro	PLOS ONE			English	Article								Background: Mammalian cardiac myocytes withdraw from the cell cycle during post-natal development, resulting in a non-proliferating, fully differentiated adult phenotype that is unable to repair damage to the myocardium, such as occurs following a myocardial infarction. We and others previously have shown that forced expression of certain cell cycle molecules in adult cardiac myocytes can promote cell cycle progression and division in these cells. The mitotic serine/threonine kinase, Polo-like kinase-1 (Plk1), is known to phosphorylate and activate a number of mitotic targets, including Cdc2/Cyclin B1, and to promote cell division. Principal Findings: The mammalian Plk family are all differentially regulated during the development of rat cardiac myocytes, with Plk1 showing the most dramatic decrease in both mRNA, protein and activity in the adult. We determined the potential of Plk1 to induce cell cycle progression and division in cultured rat cardiac myocytes. A persistent and progressive loss of Plk1 expression was observed during myocyte development that correlated with the withdrawal of adult rat cardiac myocytes from the cell cycle. Interestingly, when Plk1 was over-expressed in cardiac myocytes by adenovirus infection, it was not able to promote cell cycle progression, as determined by cell number and percent binucleation. Conclusions: We conclude that, in contrast to Cdc2/Cyclin B1 over-expression, the forced expression of Plk1 in adult cardiac myocytes is not sufficient to induce cell division and myocardial repair.			Coxon, CH (corresponding author), Univ Reading, Sch Pharm, Reading, Berks, England.	g.brooks@rdg.ac.uk	Bicknell, Katrina/B-8263-2009	Bicknell, Katrina/0000-0002-5888-1424				Allison SJ, 2003, CANCER RES, V63, P6674; BAHASSI, 2006, MUTAT RES, V596, P166; Bahassi EM, 2002, ONCOGENE, V21, P6633, DOI 10.1038/sj.onc.1205850; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bicknell KA, 2004, BIOCHEM J, V382, P411, DOI 10.1042/BJ20031481; Bicknell KA, 2007, J MOL CELL CARDIOL, V42, P706, DOI 10.1016/j.yjmcc.2007.01.006; Brooks G, 1998, CARDIOVASC RES, V39, P301, DOI 10.1016/S0008-6363(98)00125-4; Brooks G, 1997, J MOL CELL CARDIOL, V29, P2261, DOI 10.1006/jmcc.1997.0471; Burton PBJ, 1999, EUR HEART J, V20, P604, DOI 10.1053/euhj.1998.1231; Burton PBJ, 1999, DEV BIOL, V216, P659, DOI 10.1006/dbio.1999.9524; Busk PK, 2005, EXP CELL RES, V304, P149, DOI 10.1016/j.yexcr.2004.10.022; Casenghi M, 2005, J CELL SCI, V118, P5101, DOI 10.1242/jcs.02622; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Chaudhry HW, 2004, J BIOL CHEM, V279, P35858, DOI 10.1074/jbc.M404975200; Chow JPH, 2003, J BIOL CHEM, V278, P40815, DOI 10.1074/jbc.M306683200; CLUBB FJ, 1984, LAB INVEST, V50, P571; Dai W, 2004, CELL CYCLE, V3, P625; Datwyler DA, 2003, CELLS TISSUES ORGANS, V175, P61, DOI 10.1159/000073750; DESAI D, 1995, MOL CELL BIOL, V15, P345, DOI 10.1128/MCB.15.1.345; DONOHUE PJ, 1995, J BIOL CHEM, V270, P10351, DOI 10.1074/jbc.270.17.10351; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Feng Y, 1999, BIOCHEM J, V339, P435, DOI 10.1042/0264-6021:3390435; Feng Y, 2001, CELL GROWTH DIFFER, V12, P29; Ferrari S, 2006, CELL MOL LIFE SCI, V63, P781, DOI 10.1007/s00018-005-5515-3; Georgescu SP, 1997, J MOL CELL CARDIOL, V29, P929, DOI 10.1006/jmcc.1996.0334; Golan A, 2002, J BIOL CHEM, V277, P15552, DOI 10.1074/jbc.M111476200; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hassink RJ, 2008, CARDIOVASC RES, V78, P18, DOI 10.1093/cvr/cvm101; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huttenbach Y, 2001, CARDIOVASC PATHOL, V10, P119, DOI 10.1016/S1054-8807(01)00065-5; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Kaldis P, 2000, EUR J BIOCHEM, V267, P4213, DOI 10.1046/j.1432-1327.2000.01455.x; Kang MJ, 1997, J MOL CELL CARDIOL, V29, P1767, DOI 10.1006/jmcc.1997.0450; KITADA K, 1993, MOL CELL BIOL, V13, P4445, DOI 10.1128/MCB.13.7.4445; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Lee KS, 2005, ONCOGENE, V24, P217, DOI 10.1038/sj.onc.1208271; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Li FQ, 1997, J MOL CELL CARDIOL, V29, P1541, DOI 10.1006/jmcc.1997.0381; Li FQ, 1997, J MOL CELL CARDIOL, V29, P1553, DOI 10.1006/jmcc.1997.0403; Li JM, 1998, AM J PHYSIOL-HEART C, V275, pH814, DOI 10.1152/ajpheart.1998.275.3.H814; Li JM, 1999, EUR HEART J, V20, P406, DOI 10.1053/euhj.1998.1308; Li JM, 1997, AM J PHYSIOL-HEART C, V273, pH1358, DOI 10.1152/ajpheart.1997.273.3.H1358; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Meckert PC, 2005, CARDIOVASC RES, V67, P116, DOI 10.1016/j.cardiores.2005.02.017; Movassagh M, 2006, J PHARM PHARMACOL, V58, P73, DOI 10.1211/jpp.58.1.0009; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nigg EA, 1998, CURR OPIN CELL BIOL, V10, P776, DOI 10.1016/S0955-0674(98)80121-X; Ohkura H, 2003, CURR BIOL, V13, pR912, DOI 10.1016/j.cub.2003.11.012; OHKURA H, 1995, GENE DEV, V9, P1059, DOI 10.1101/gad.9.9.1059; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Poolman RA, 1999, CIRC RES, V85, P117, DOI 10.1161/01.RES.85.2.117; Poolman RA, 1998, J MOL CELL CARDIOL, V30, P2121, DOI 10.1006/jmcc.1998.0808; Poolman RA, 1998, INT J CARDIOL, V67, P133, DOI 10.1016/S0167-5273(98)00320-9; RUBART M, 2007, CELLS TISSUES ORGANS; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Selvetella G, 2004, CARDIOVASC RES, V63, P373, DOI 10.1016/j.cardiores.2004.04.031; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tamamori-Adachi M, 2004, J BIOL CHEM, V279, P50429, DOI 10.1074/jbc.M403084200; Tamamori-Adachi M, 2003, CIRC RES, V92, pE12, DOI 10.1161/01.RES.0000049105.15329.1C; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; Van Hooser A, 1998, J CELL SCI, V111, P3497; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Vara D, 2003, J BIOL CHEM, V278, P21388, DOI 10.1074/jbc.M212612200; Warnke S, 2004, CURR BIOL, V14, P1200, DOI 10.1016/j.cub.2004.06.059; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Xie SQ, 2002, CELL CYCLE, V1, P424, DOI 10.4161/cc.1.6.271; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002	82	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6752	10.1371/journal.pone.0006752	http://dx.doi.org/10.1371/journal.pone.0006752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707596	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000269278400017
J	Tobin, AE; Cruz-Bermudez, ND; Marder, E; Schulz, DJ				Tobin, Anne-Elise; Cruz-Bermudez, Nelson D.; Marder, Eve; Schulz, David J.			Correlations in Ion Channel mRNA in Rhythmically Active Neurons	PLOS ONE			English	Article								Background: To what extent do identified neurons from different animals vary in their expression of ion channel genes? In neurons of the same type, is ion channel expression highly variable and/or is there any relationship between ion channel expression that is conserved? Methodology/Principal Findings: To address these questions we measured ion channel mRNA in large cells (LCs) of the crab cardiac ganglion. We cloned a calcium channel, caco, and a potassium channel, shaker. Using single-cell quantitative PCR, we measured levels of mRNA for these and 6 other different ion channels in cardiac ganglion LCs. Across the population of LCs we measured 3-9 fold ranges of mRNA levels, and we found correlations in the expression of many pairs of conductances Conclusions/Significance: In previous measurements from the crab stomatogastric ganglion (STG), ion channel expression was variable, but many pairs of channels had correlated expression. However, each STG cell type had a unique combination of ion channel correlations. Our findings from the crab cardiac ganglion are similar, but the correlations in the LCs are different from those in STG neurons, supporting the idea that such correlations could be markers of cell identity or activity.			Tobin, AE (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02254 USA.	atobin@brandeis.edu	Marder, Eve/A-5713-2012	Schulz, David/0000-0003-4532-5362	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH046742, R01MH046742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS059255] Funding Source: NIH RePORTER; NIMH NIH HHS [MH46742, R37 MH046742, R01 MH046742] Funding Source: Medline; NINDS NIH HHS [F32 NS059255, NS059255] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Achard P, 2006, PLOS COMPUT BIOL, V2, P794, DOI 10.1371/journal.pcbi.0020094; Baro DJ, 1997, J NEUROSCI, V17, P6597; Cooke IM, 2002, BIOL BULL-US, V202, P108, DOI 10.2307/1543649; Cruz-Bermudez ND, 2006, J NEUROCHEM, V97, P784, DOI 10.1111/j.1471-4159.2006.03747.x; Cruz-Bermudez ND, 2007, J EXP BIOL, V210, P2873, DOI 10.1242/jeb.002949; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Golowasch J, 2002, J NEUROPHYSIOL, V87, P1129, DOI 10.1152/jn.00412.2001; Golowasch J, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0004.1999; HARTLINE DK, 1979, AM ZOOL, V19, P53; HARTLINE DK, 1967, J EXP BIOL, V47, P327; Kim M, 1998, RECEPTOR CHANNEL, V5, P291; Kim M, 1997, J NEUROSCI, V17, P8213; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; MAYERI E, 1973, J GEN PHYSIOL, V62, P448, DOI 10.1085/jgp.62.4.448; MAYNARD DM, 1955, BIOL BULL, V109, P420, DOI 10.2307/1539174; Peng IF, 2007, J NEUROSCI, V27, P1072, DOI 10.1523/JNEUROSCI.4746-06.2007; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Prinz AA, 2003, J NEUROPHYSIOL, V90, P3998, DOI 10.1152/jn.00641.2003; Rieckhof GE, 2003, J BIOL CHEM, V278, P41099, DOI 10.1074/jbc.M306417200; Schulz DJ, 2007, P NATL ACAD SCI USA, V104, P13187, DOI 10.1073/pnas.0705827104; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Smith LA, 1996, J NEUROSCI, V16, P7868; Spitzer NC, 1999, NAT NEUROSCI, V2, P489, DOI 10.1038/9132; Swensen AM, 2005, J NEUROSCI, V25, P3509, DOI 10.1523/JNEUROSCI.3929-04.2005; Taylor AL, 2006, J NEUROPHYSIOL, V96, P891, DOI 10.1152/jn.00367.2006; Taylor AL, 2009, J NEUROSCI, V29, P5573, DOI 10.1523/JNEUROSCI.4438-08.2009; TAZAKI K, 1979, J NEUROPHYSIOL, V42, P975, DOI 10.1152/jn.1979.42.4.975; TAZAKI K, 1979, J NEUROPHYSIOL, V42, P1000, DOI 10.1152/jn.1979.42.4.1000; TAZAKI K, 1979, J NEUROPHYSIOL, V42, P1022, DOI 10.1152/jn.1979.42.4.1022; TAZAKI K, 1983, SYM SOC EXP BIOL, P129; TAZAKI K, 1990, J NEUROPHYSIOL, V63, P370, DOI 10.1152/jn.1990.63.2.370; TAZAKI K, 1986, J NEUROPHYSIOL, V56, P1739, DOI 10.1152/jn.1986.56.6.1739; Tobin AE, 2006, J NEUROPHYSIOL, V96, P2089, DOI 10.1152/jn.00025.2006; TURRIGIANO G, 1995, J NEUROSCI, V15, P3640; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103	42	72	72	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6742	10.1371/journal.pone.0006742	http://dx.doi.org/10.1371/journal.pone.0006742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707591	Green Published, gold, Green Submitted			2022-12-25	WOS:000269278400009
J	Quinn, JMW; Tam, S; Sims, NA; Saleh, H; McGregor, NE; Poulton, IJ; Scott, JW; Gillespie, MT; Kemp, BE; van Denderen, BJW				Quinn, Julian M. W.; Tam, Shanna; Sims, Natalie A.; Saleh, Hasnawati; McGregor, Narelle E.; Poulton, Ingrid J.; Scott, John W.; Gillespie, Matthew T.; Kemp, Bruce E.; van Denderen, B. J. W.			Germline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or function	FASEB JOURNAL			English	Article						osteolysis; AMPK; AICA-riboside; osteoblast; knockout mouse	ADENOSINE-REGULATING AGENT; ISOLATED RAT HEPATOCYTES; AICA-RIBOSIDE; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOSIDE; MYOCARDIAL-INFARCTION; CONTROLLED-TRIAL; MINERAL DENSITY; SKELETAL-MUSCLE; FOOD-INTAKE; CELL-LINE	Since AMP-activated protein kinase (AMPK) plays important roles in modulating metabolism in response to diet and exercise, both of which influence bone mass, we examined the influence of AMPK on bone mass in mice. AMPK is an alpha beta gamma heterotrimer where the beta subunit anchors the alpha catalytic and gamma regulatory subunits. Germline deletion of either AMPK beta 1 or beta 2 subunit isoforms resulted in reduced trabecular bone density and mass, but without effects on osteoclast (OC) or osteoblast (OB) numbers, as compared to wild-type littermate controls. We tested whether activating AMPK in vivo would enhance bone density but found AICA-riboside treatment caused a profound loss of trabecular bone volume (49.5%) and density and associated increased OC numbers. Consistent with this, AICA-riboside strongly stimulated OC differentiation in vitro, in an adenosine kinase-dependent manner. OCs and macrophages (unlike OBs) lacked AMPK beta 2 subunit expression, and when generated from AMPK beta 1(-/-) mice displayed no detectable AMPK activity. Nevertheless, AICA-riboside was equally effective at stimulating OC differentiation from wildtype or beta 1(-/-) progenitors, indicating that AMPK is not essential for OC differentiation or the stimulatory action of AICA-riboside. These results show that AMPK is required to maintain normal bone density, but not through bone cell differentiation, and does not mediate powerful osteolytic effects of AICA-riboside.-Quinn, J. M. W., Tam, S., Sims, N. A., Saleh, H., McGregor, N. E., Poulton, I. J., Scott, J. W., Gillespie, M. T., Kemp, B. E., van Denderen, B. J. W. Germline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or function. FASEB J. 24, 275-285 (2010). www.fasebj.org	[Tam, Shanna; Sims, Natalie A.; Saleh, Hasnawati; McGregor, Narelle E.; Poulton, Ingrid J.; Scott, John W.; Gillespie, Matthew T.; Kemp, Bruce E.; van Denderen, B. J. W.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Quinn, Julian M. W.; Saleh, Hasnawati; Gillespie, Matthew T.] Monash Med Ctr, Prince Henrys Inst, Clayton, Vic 3168, Australia; [Quinn, Julian M. W.; Tam, Shanna; Sims, Natalie A.; Kemp, Bruce E.; van Denderen, B. J. W.] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic 3010, Australia	St. Vincent's Institute of Medical Research; Monash University; Prince Henry's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne	van Denderen, BJW (corresponding author), St Vincents Inst Med Res, 9 Princes St, Fitzroy, Vic 3065, Australia.	bvandenderen@svi.edu.au	Scott, John W/AAA-2676-2021; van Denderen, Bryce/AAW-5454-2021; Kemp, Bruce/G-9602-2019; Sims, Natalie Ann/A-7192-2012; Kemp, Bruce E/L-2633-2014; Scott, John W/P-1170-2018	Scott, John W/0000-0002-1896-9798; Kemp, Bruce/0000-0001-6735-5082; Sims, Natalie Ann/0000-0003-1421-8468; Kemp, Bruce E/0000-0001-6735-5082; Scott, John W/0000-0002-1896-9798; Gillespie, Matthew/0000-0001-6543-8909	National Health and Medical Research Council (NHMRC)	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC) grants; N. A. S. and B. E. K. are NHMRC Fellows.	Allan EH, 2003, J CELL BIOCHEM, V90, P158, DOI 10.1002/jcb.10614; Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Boyle JG, 2008, J BIOL CHEM, V283, P11210, DOI 10.1074/jbc.M710048200; Brown D, 1996, J EXP BIOL, V199, P2345; Campas C, 2003, BLOOD, V101, P3674, DOI 10.1182/blood-2002-07-2339; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Chen ZP, 1999, FEBS LETT, V460, P343, DOI 10.1016/S0014-5793(99)01371-X; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; DIXON R, 1991, J CLIN PHARMACOL, V31, P342, DOI 10.1002/j.1552-4604.1991.tb03715.x; Drew BG, 2008, EXPERT OPIN PHARMACO, V9, P2137, DOI [10.1517/14656566.9.12.2137, 10.1517/14656566.9.12.2137 ]; Elefteriou F, 2004, P NATL ACAD SCI USA, V101, P3258, DOI 10.1073/pnas.0308744101; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104; Glintborg D, 2008, J CLIN ENDOCR METAB, V93, P1696, DOI 10.1210/jc.2007-2249; Grey A, 2007, J CLIN ENDOCR METAB, V92, P1305, DOI 10.1210/jc.2006-2646; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Gutierrez GE, 2008, J BONE MINER RES, V23, P1722, DOI 10.1359/JBMR.080603; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Herman S, 2008, TRENDS MOL MED, V14, P245, DOI 10.1016/j.molmed.2008.04.001; Horwood NJ, 1998, ENDOCRINOLOGY, V139, P4743, DOI 10.1210/en.139.11.4743; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Iseli TJ, 2005, J BIOL CHEM, V280, P13395, DOI 10.1074/jbc.M412993200; Jorgensen SB, 2007, AM J PHYSIOL-ENDOC M, V292, pE331, DOI 10.1152/ajpendo.00243.2006; Kanazawa I, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-51; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Leboy PS, 2006, ANN NY ACAD SCI, V1068, P14, DOI 10.1196/annals.1346.003; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Longnus SL, 2003, AM J PHYSIOL-REG I, V284, pR936, DOI 10.1152/ajpregu.00319.2002; Mangano DT, 2006, J AM COLL CARDIOL, V48, P206, DOI 10.1016/j.jacc.2006.04.044; Mangano DT, 1997, JAMA-J AM MED ASSOC, V277, P325, DOI 10.1001/jama.277.4.325; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Meier C, 2008, ARCH INTERN MED, V168, P820, DOI 10.1001/archinte.168.8.820; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nath N, 2005, J IMMUNOL, V175, P566, DOI 10.4049/jimmunol.175.1.566; Price JT, 2005, CANCER RES, V65, P4929, DOI 10.1158/0008-5472.CAN-04-4458; Quinn JMW, 1999, BONE, V25, P1, DOI 10.1016/S8756-3282(99)00094-0; Quinn JMW, 2001, J BONE MINER RES, V16, P1787, DOI 10.1359/jbmr.2001.16.10.1787; Quinn JMW, 2002, BONE, V30, P164, DOI 10.1016/S8756-3282(01)00654-8; Quinn JMW, 2008, J IMMUNOL, V181, P5720, DOI 10.4049/jimmunol.181.8.5720; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Scott JW, 2009, FRONT BIOSCI-LANDMRK, V14, P596, DOI 10.2741/3266; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Seibel MJ, 2002, CURR OPIN CLIN NUTR, V5, P525, DOI 10.1097/00075197-200209000-00011; Shang J, 2004, J BIOL CHEM, V279, P12076, DOI 10.1074/jbc.M400431200; Sims NA, 2006, AM J PHYSIOL-ENDOC M, V290, pE456, DOI 10.1152/ajpendo.00311.2005; Sims NA, 2003, J CLIN INVEST, V111, P1319, DOI 10.1172/JCI200317246; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005; Sun W, 2006, CIRCULATION, V114, P2655, DOI 10.1161/CIRCULATIONAHA.106.630194; VINCENT MF, 1991, DIABETES, V40, P1259, DOI 10.2337/diabetes.40.10.1259; VINCENT MF, 1992, BIOCHEM J, V281, P267, DOI 10.1042/bj2810267; Walker EC, 2008, J BONE MINER RES, V23, P2025, DOI 10.1359/JBMR.080706; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; ZIMMERMAN TP, 1978, BIOCHEM PHARMACOL, V27, P709, DOI 10.1016/0006-2952(78)90508-7	58	43	49	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					275	285		10.1096/fj.09-137158	http://dx.doi.org/10.1096/fj.09-137158			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19723702	Green Published			2022-12-25	WOS:000273233600028
J	Wortham, NC; Ahamed, E; Nicol, SM; Thomas, RS; Periyasamy, M; Jiang, J; Ochocka, AM; Shousha, S; Huson, L; Bray, SE; Coombes, RC; Ali, S; Fuller-Pace, FV				Wortham, N. C.; Ahamed, E.; Nicol, S. M.; Thomas, R. S.; Periyasamy, M.; Jiang, J.; Ochocka, A. M.; Shousha, S.; Huson, L.; Bray, S. E.; Coombes, R. C.; Ali, S.; Fuller-Pace, F. V.			The DEAD-box protein p72 regulates ER alpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ER alpha-positive breast cancer	ONCOGENE			English	Article						p68 RNA helicase; p72 RNA helicase; oestrogen receptor-alpha; gene regulation; breast cancer; tamoxifen	ESTROGEN-RECEPTOR-ALPHA; P68 RNA HELICASE; PHOSPHORYLATION; COACTIVATOR; ACTIVATION; TAMOXIFEN; PROMOTER; COMPLEX; DIFFERENTIATION; IDENTIFICATION	The DEAD-box RNA helicases p68 (DDX5) and p72 (DDX17) have been shown to act as transcriptional co-activators for a diverse range of transcription factors, including oestrogen receptor-alpha (ER alpha). Here, we show that, although both proteins interact with and co-activate ER alpha in reporter gene assays, small interfering RNA-mediated knockdown of p72, but not p68, results in a significant inhibition of oestrogen-dependent transcription of endogenous ER alpha-responsive genes and oestrogen-dependent growth of MCF-7 and ZR75-1 breast cancer cells. Furthermore, immunohistochemical staining of ER alpha-positive primary breast cancers for p68 and p72 indicate that p72 expression is associated with an increased period of relapse-free and overall survival (P = 0.006 and 0.016, respectively), as well as being inversely associated with Her2 expression (P = 0.008). Conversely, p68 shows no association with relapse-free period, or overall survival, but it is associated with an increased expression of Her2 (P = 0.001), AIB-1 (P = 0.001) and higher tumour grade (P = 0.044). Our data thus highlight a crucial role for p72 in ER alpha co-activation and oestrogen-dependent cell growth and provide evidence in support of distinct but important roles for both p68 and p72 in regulating ER alpha activity in breast cancer. Oncogene (2009) 28, 4053-4064; doi:10.1038/onc.2009.261; published online 31 August 2009	[Ahamed, E.; Thomas, R. S.; Periyasamy, M.; Jiang, J.; Ochocka, A. M.; Coombes, R. C.; Ali, S.] Univ London Imperial Coll Sci Technol & Med, Dept Oncol, London W12 ONN, England; [Wortham, N. C.; Nicol, S. M.; Fuller-Pace, F. V.] Univ Dundee, Ninewells Hosp & Med Sch, Ctr Oncol & Mol Med, Dundee DD1 9SY, Scotland; [Jiang, J.; Shousha, S.] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Dept Histopathol, London, England; [Huson, L.] Univ London Imperial Coll Sci Technol & Med, Stat Advisory Serv, London, England; [Bray, S. E.] Univ Dundee, Ninewells Hosp & Med Sch, Tayside Tissue Bank, Dundee DD1 9SY, Scotland	Imperial College London; University of Dundee; Imperial College London; Imperial College London; University of Dundee	Ali, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Oncol, Hammersmith Hosp Campus, London W12 ONN, England.	simak.ali@imperial.ac.uk; f.v.fullerpace@dundee.ac.uk	periyasamy, manikandan/AAB-7924-2020; Thomas, Ross/C-6434-2008; Periyasamy, Manikandan/AAL-6211-2020; Ali, Simak/M-6912-2018	Ali, Simak/0000-0002-1320-0816; Coombes, Raoul Charles/0000-0002-4811-1100; Periyasamy, Manikandan/0000-0001-7626-2531	Breast Cancer Campaign; Association for International Cancer Research; Cancer Research UK; Breast Cancer Research Trust; NIHR Biomedical Research Centre	Breast Cancer Campaign; Association for International Cancer Research; Cancer Research UK(Cancer Research UK); Breast Cancer Research Trust; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	This work was supported by grants from the Breast Cancer Campaign, Association for International Cancer Research, Cancer Research UK and the Breast Cancer Research Trust. We are grateful for support from the NIHR Biomedical Research Centre funding scheme, and thank David Meek, Malcolm Parker and lab members for helpful discussions.	ALI S, 1993, EMBO J, V12, P1153, DOI 10.1002/j.1460-2075.1993.tb05756.x; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Buzdar A, 2001, CLIN CANCER RES, V7, P2620; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; Chen DS, 2000, MOL CELL, V6, P127, DOI 10.1016/S1097-2765(00)00014-9; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Endoh H, 1999, MOL CELL BIOL, V19, P5363; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; Goodman RH, 2000, GENE DEV, V14, P1553; Grisouard J, 2007, MOL ENDOCRINOL, V21, P2427, DOI 10.1210/me.2007-0129; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Jacobs AMF, 2007, ONCOGENE, V26, P5866, DOI 10.1038/sj.onc.1210387; Jensen ED, 2008, J CELL BIOCHEM, V103, P1438, DOI 10.1002/jcb.21526; Jiang J, 2007, CLIN CANCER RES, V13, P5769, DOI 10.1158/1078-0432.CCR-07-0822; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; LEGOFF P, 1994, J BIOL CHEM, V269, P4458; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Lopez-Garcia J, 2006, NUCLEIC ACIDS RES, V34, P6126, DOI 10.1093/nar/gkl875; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Medunjanin S, 2005, J BIOL CHEM, V280, P33006, DOI 10.1074/jbc.M506758200; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Morris C, 2002, ENDOCR-RELAT CANCER, V9, P267, DOI 10.1677/erc.0.0090267; Ogilvie VC, 2003, NUCLEIC ACIDS RES, V31, P1470, DOI 10.1093/nar/gkg236; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rossow KL, 2003, ONCOGENE, V22, P151, DOI 10.1038/sj.onc.1206067; Sarwar N, 2006, ENDOCR-RELAT CANCER, V13, P851, DOI 10.1677/erc.1.01123; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shin S, 2007, J CELL BIOCHEM, V101, P1252, DOI 10.1002/jcb.21250; Stevenson RJ, 1998, J PATHOL, V184, P351, DOI 10.1002/(SICI)1096-9896(199804)184:4<351::AID-PATH1235>3.0.CO;2-C; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Thomas RS, 2008, J MOL ENDOCRINOL, V40, P173, DOI 10.1677/JME-07-0165; TORA L, 1989, EMBO J, V8, P1981, DOI 10.1002/j.1460-2075.1989.tb03604.x; Trowbridge JM, 1997, P NATL ACAD SCI USA, V94, P10132, DOI 10.1073/pnas.94.19.10132; Uhlmann-Schiffler H, 2002, J BIOL CHEM, V277, P1066, DOI 10.1074/jbc.M107535200; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; Wilson BJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-11	43	86	94	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 19	2009	28	46					4053	4064		10.1038/onc.2009.261	http://dx.doi.org/10.1038/onc.2009.261			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	530AE	19718048	Green Accepted, Green Submitted			2022-12-25	WOS:000272560500002
J	Bocksteins, E; Labro, AJ; Mayeur, E; Bruyns, T; Timmermans, JP; Adriaensen, D; Snyders, DJ				Bocksteins, Elke; Labro, Alain J.; Mayeur, Evy; Bruyns, Tine; Timmermans, Jean-Pierre; Adriaensen, Dirk; Snyders, Dirk J.			Conserved Negative Charges in the N-terminal Tetramerization Domain Mediate Efficient Assembly of Kv2.1 and Kv2.1/Kv6.4 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED K+ CHANNEL; GREEN FLUORESCENT PROTEIN; RESONANCE ENERGY-TRANSFER; POTASSIUM CHANNEL; ALPHA-SUBUNITS; FUNCTIONAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; LIVING CELLS; T1 DOMAIN; SHAB	Voltage-gated potassium (Kv) channels are transmembrane tetramers of individual alpha-subunits. Eight different Shaker-related Kv subfamilies have been identified in which the tetramerization domain T1, located on the intracellular N terminus, facilitates and controls the assembly of both homo- and heterotetrameric channels. Only the Kv2 alpha-subunits are able to form heterotetramers with members of the silent Kv subfamilies (Kv5, Kv6, Kv8, and Kv9). The T1 domain contains two subdomains, A and B box, which presumably determine subfamily specificity by preventing incompatible subunits to assemble. In contrast, little is known about the involvement of the A/B linker sequence. Both Kv2 and silent Kv subfamilies contain a fully conserved and negatively charged sequence (CDD) in this linker that is lacking in the other subfamilies. Neutralizing these aspartates in Kv2.1 by mutating them to alanines did not affect the gating properties, but reduced the current density moderately. However, charge reversal arginine substitutions strongly reduced the current density of these homotetrameric mutant Kv2.1 channels and immunocytochemistry confirmed the reduced expression at the plasma membrane. Forster resonance energy transfer measurements using confocal microscopy showed that the latter was not due to impaired trafficking, but to a failure to assemble the tetramer. This was further confirmed with co-immunoprecipitation experiments. The corresponding arginine substitution in Kv6.4 prevented its heterotetrameric interaction with Kv2.1. These results indicate that these aspartates (especially the first one) in the A/B box linker of the T1 domain are required for efficient assembly of both homotetrameric Kv2.1 and heterotetrameric Kv2.1/silent Kv6.4 channels.	[Bocksteins, Elke; Labro, Alain J.; Mayeur, Evy; Bruyns, Tine; Snyders, Dirk J.] Univ Antwerp, CDE, Dept Biomed Sci, Lab Mol Biophys Physiol & Pharmacol, B-2610 Antwerp, Belgium; [Timmermans, Jean-Pierre; Adriaensen, Dirk] Univ Antwerp, CGB, Dept Vet Sci, Cell Biol & Histol Lab, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp	Snyders, DJ (corresponding author), Univ Antwerp, CDE, Dept Biomed Sci, Lab Mol Biophys Physiol & Pharmacol, Univ Pl 1, B-2610 Antwerp, Belgium.	dirk.snyders@ua.ac.be	Snyders, Dirk/A-2713-2013	Snyders, Dirk/0000-0001-7142-6672; Timmermans, Jean-Pierre/0000-0003-2506-6252; Labro, Alain J/0000-0002-0871-7511	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); Belgian Federal Science Policy Office, Research Foundation Flanders [G.0085.04, G.0152.06, 1.5.044.07]; University of Antwerp [GOA50.4426]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Belgian Federal Science Policy Office, Research Foundation Flanders(Belgian Federal Science Policy OfficeFWO); University of Antwerp; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a Ph. D. grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) (to E. B.), Interuniversity Attraction Poles program P6/31 of the Belgian Federal Science Policy Office, Research Foundation Flanders (FWO, Fonds voor Wetenschappelijk Onderzoek Vlaanderen) Grants G.0085.04 and G.0152.06 (to D. J. S.) and 1.5.044.07 (to A. J. L.), and GOA50.4426 from the concerted action fund of the University of Antwerp.	Adair B, 2008, BIOPHYS J, V94, P2106, DOI 10.1529/biophysj.107.118562; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Castellano A, 1997, J NEUROSCI, V17, P4652; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; DREWE JA, 1992, J NEUROSCI, V12, P538; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Grailhe R, 2006, CHEMPHYSCHEM, V7, P1442, DOI 10.1002/cphc.200600057; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Hugnot JP, 1996, EMBO J, V15, P3322, DOI 10.1002/j.1460-2075.1996.tb00697.x; Ju M, 2003, J BIOL CHEM, V278, P12769, DOI 10.1074/jbc.M212973200; Kerschensteiner D, 1999, BIOPHYS J, V77, P248, DOI 10.1016/S0006-3495(99)76886-4; Kobertz WR, 1999, NAT STRUCT BIOL, V6, P1122; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; Kobrinsky E, 2006, J BIOL CHEM, V281, P19233, DOI 10.1074/jbc.M601231200; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Kramer JW, 1998, AM J PHYSIOL-CELL PH, V274, pC1501, DOI 10.1152/ajpcell.1998.274.6.C1501; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; LEE TE, 1994, BIOPHYS J, V66, P667, DOI 10.1016/S0006-3495(94)80840-9; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Lukasiewicz S, 2007, PHARMACOL REP, V59, P379; Schnitzler MMY, 2009, J BIOL CHEM, V284, P4695, DOI 10.1074/jbc.M808786200; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Nanao MH, 2003, P NATL ACAD SCI USA, V100, P8670, DOI 10.1073/pnas.1432840100; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Ottschytsch N, 2002, P NATL ACAD SCI USA, V99, P7986, DOI 10.1073/pnas.122617999; Patel AJ, 1997, EMBO J, V16, P6615, DOI 10.1093/emboj/16.22.6615; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Pentcheva T, 2001, J IMMUNOL, V166, P6625, DOI 10.4049/jimmunol.166.11.6625; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Post MA, 1996, FEBS LETT, V399, P177, DOI 10.1016/S0014-5793(96)01316-6; Richardson FC, 2000, HEARING RES, V147, P21, DOI 10.1016/S0378-5955(00)00117-9; Salinas M, 1997, J BIOL CHEM, V272, P24371, DOI 10.1074/jbc.272.39.24371; Salinas M, 1997, J BIOL CHEM, V272, P8774, DOI 10.1074/jbc.272.13.8774; Sano Y, 2002, FEBS LETT, V512, P230, DOI 10.1016/S0014-5793(02)02267-6; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; Shepard AR, 1999, AM J PHYSIOL-CELL PH, V277, pC412, DOI 10.1152/ajpcell.1999.277.3.C412; Stocker M, 1998, BIOCHEM BIOPH RES CO, V248, P927, DOI 10.1006/bbrc.1998.9072; Tu LW, 1996, J BIOL CHEM, V271, P18904, DOI 10.1074/jbc.271.31.18904; Vega-Saenz de Miera E, 2004, MOL BRAIN RES, V123, P91, DOI 10.1016/j.molbrainres.2004.01.004; XU J, 1995, J BIOL CHEM, V270, P24761, DOI 10.1074/jbc.270.42.24761; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797; Zhu XR, 1999, RECEPTOR CHANNEL, V6, P337	45	14	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31625	31634		10.1074/jbc.M109.039479	http://dx.doi.org/10.1074/jbc.M109.039479			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19717558	hybrid, Green Published			2022-12-25	WOS:000271572700017
J	Singh, DK; Rosenhouse-Dantsker, A; Nichols, CG; Enkvetchakul, D; Levitan, I				Singh, Dev K.; Rosenhouse-Dantsker, Avia; Nichols, Colin G.; Enkvetchakul, Decha; Levitan, Irena			Direct Regulation of Prokaryotic Kir Channel by Cholesterol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING K+ CHANNELS; SENSITIVE POTASSIUM CHANNELS; LIPID RAFTS; ACETYLCHOLINE-RECEPTOR; MEMBRANE MICRODOMAINS; ENDOTHELIAL-CELLS; BILAYER-MEMBRANES; CRYSTAL-STRUCTURE; IN-VIVO; CAVEOLAE	Our earlier studies have shown that channel activity of Kir2 subfamily of inward rectifiers is strongly suppressed by the elevation of cellular cholesterol. The goal of this study is to determine whether cholesterol suppresses Kir channels directly. To achieve this goal, purified prokaryotic Kir (KirBac1.1) channels were incorporated into liposomes of defined lipid composition, and channel activity was assayed by Rb-86(+) uptake. Our results show that Rb-86(+) flux through KirBac1.1 is strongly inhibited by cholesterol. Incorporation of 5% ( mass cholesterol/phospholipid) cholesterol into the liposome suppresses Rb-86(+) flux by >50%, and activity is completely inhibited at 12-15%. However, epicholesterol, a stereoisomer of cholesterol with similar physical properties, has significantly less effect on KirBac-mediated Rb-86(+) uptake than cholesterol. Furthermore, analysis of multiple sterols suggests that cholesterol-induced inhibition of KirBac1.1 channels is mediated by specific interactions rather than by changes in the physical properties of the lipid bilayer. In contrast to the inhibition of KirBac1.1 activity, cholesterol had no effect on the activity of reconstituted KscA channels (at up to 250 mu g/mg of phospholipid). Taken together, these observations demonstrate that cholesterol suppresses Kir channels in a pure protein-lipid environment and suggest that the interaction is direct and specific.	[Singh, Dev K.; Rosenhouse-Dantsker, Avia; Levitan, Irena] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Nichols, Colin G.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63104 USA; [Enkvetchakul, Decha] St Louis Univ, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Washington University (WUSTL); Saint Louis University	Singh, DK (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60612 USA.	dksingh@uic.edu; denkvetc@slu.edu; levitan@uic.edu	Nichols, Colin/D-6336-2012; Singh, Dev Karam/AFF-8404-2022; Singh, Dev Karam/AAF-1014-2022		National Institutes of Health [HL073965, HL083298, HL54171, DK069424]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073965, R01HL083298, R01HL054171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL073965 and HL083298 ( to I. L.), HL54171 ( to C. G. N.), and DK069424 ( to D. E.).	Ahn KW, 2000, J BIOCHEM MOL BIOL, V33, P541; Andersen O S, 1999, Methods Enzymol, V294, P208; BARRANTES FJ, 1993, FASEB J, V7, P1460, DOI 10.1096/fasebj.7.15.8262330; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; BITTMAN R, 1972, BIOCHEMISTRY-US, V11, P4831, DOI 10.1021/bi00775a029; Burger K, 2000, CELL MOL LIFE SCI, V57, P1577, DOI 10.1007/PL00000643; CRIADO M, 1982, BIOCHEMISTRY-US, V21, P3622, DOI 10.1021/bi00258a015; Cuello LG, 1998, BIOCHEMISTRY-US, V37, P3229, DOI 10.1021/bi972997x; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Enkvetchakul D, 2005, J BIOL CHEM, V280, P35785, DOI 10.1074/jbc.C500355200; Enkvetchakul D, 2004, J BIOL CHEM, V279, P47076, DOI 10.1074/jbc.C400417200; Enkvetchakul D, 2007, J GEN PHYSIOL, V130, P329, DOI 10.1085/jgp.200709764; Epshtein Y, 2009, P NATL ACAD SCI USA, V106, P8055, DOI 10.1073/pnas.0809847106; EVANS E, 1987, J PHYS CHEM-US, V91, P4219, DOI 10.1021/j100300a003; Fang Y, 2006, CIRC RES, V98, P1064, DOI 10.1161/01.RES.0000218776.87842.43; Fang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1134, DOI 10.1152/ajpcell.00077.2005; Gidwani A, 2001, BIOCHEMISTRY-US, V40, P12422, DOI 10.1021/bi010496c; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Haider S, 2007, BIOCHEMISTRY-US, V46, P3643, DOI 10.1021/bi062210f; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Hibino H, 2007, EUR J NEUROSCI, V26, P2539, DOI 10.1111/j.1460-9568.2007.05876.x; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Inanobe A, 2007, CHANNELS, V1, P40, DOI 10.4161/chan.3842; Kahya N, 2006, MOL MEMBR BIOL, V23, P29, DOI 10.1080/09687860500489099; Krishnan MN, 2005, J GEN PHYSIOL, V126, P271, DOI 10.1085/jgp.200509323; Kubo Y, 2005, PHARMACOL REV, V57, P509, DOI 10.1124/pr.57.4.11; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Levitan I, 2009, IUBMB LIFE, V61, P781, DOI 10.1002/iub.192; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Logothetis DE, 2007, J PHYSIOL-LONDON, V582, P953, DOI 10.1113/jphysiol.2007.133157; Lopatin AN, 2001, J MOL CELL CARDIOL, V33, P625, DOI 10.1006/jmcc.2001.1344; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lundbaek JA, 1996, BIOCHEMISTRY-US, V35, P3825, DOI 10.1021/bi952250b; Lundbaek JA, 2004, J GEN PHYSIOL, V123, P599, DOI 10.1085/jgp.200308996; Maguy A, 2006, CARDIOVASC RES, V69, P798, DOI 10.1016/j.cardiores.2005.11.013; MARSH D, 1978, P NATL ACAD SCI USA, V75, P4329, DOI 10.1073/pnas.75.9.4329; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Martens JR, 2004, TRENDS PHARMACOL SCI, V25, P16, DOI 10.1016/j.tips.2003.11.007; Martens JR, 2001, J BIOL CHEM, V276, P8409, DOI 10.1074/jbc.M009948200; Mohler ER, 2007, BIOCHEM BIOPH RES CO, V358, P317, DOI 10.1016/j.bbrc.2007.04.138; MORRIS S, 2006, RECENT RES DEV BIOPH; MURARI R, 1986, BIOCHEMISTRY-US, V25, P1062, DOI 10.1021/bi00353a017; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; O'Connell KMS, 2005, J CELL SCI, V118, P2155, DOI 10.1242/jcs.02348; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Rohlf F. J., 1994, STAT TABLES; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Sampson LJ, 2007, CARDIOVASC RES, V76, P61, DOI 10.1016/j.cardiores.2007.05.020; Sampson LJ, 2004, CIRC RES, V95, P1012, DOI 10.1161/01.RES.0000148634.47095.ab; SOKAL RR, 1994, BIOMETRY; Tikku S, 2007, AM J PHYSIOL-CELL PH, V293, pC440, DOI 10.1152/ajpcell.00492.2006; Wang S, 2009, J BIOL CHEM, V284, P2854, DOI 10.1074/jbc.M807474200; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; YEAGLE PL, 1991, BIOCHIMIE, V73, P1303, DOI 10.1016/0300-9084(91)90093-G; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	64	54	54	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30727	30736		10.1074/jbc.M109.011221	http://dx.doi.org/10.1074/jbc.M109.011221			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19740741	Green Published, hybrid			2022-12-25	WOS:000271090000074
J	Dickhaut, K; Hoepner, S; Eckhard, J; Wiesmueller, KH; Schindler, L; Jung, G; Falk, K; Roetzschke, O				Dickhaut, Katharina; Hoepner, Sabine; Eckhard, Jamina; Wiesmueller, Karl-Heinz; Schindler, Luise; Jung, Guenther; Falk, Kirsten; Roetzschke, Olaf			Enhancement of Tumour-Specific Immune Responses In Vivo by 'MHC Loading-Enhancer' (MLE)	PLOS ONE			English	Article							T-CELL CLONES; PEPTIDE-RECEPTIVE STATE; PARTICLE VACCINE; LIGAND-EXCHANGE; DENDRITIC CELLS; YOUNG-WOMEN; NY-ESO-1; ANTIGEN; IDENTIFICATION; LYMPHOCYTES	Background: Class II MHC molecules (MHC II) are cell surface receptors displaying short protein fragments for the surveillance by CD4+ T cells. Antigens therefore have to be loaded onto this receptor in order to induce productive immune responses. On the cell surface, most MHC II molecules are either occupied by ligands or their binding cleft has been blocked by the acquisition of a non-receptive state. Direct loading with antigens, as required during peptide vaccinations, is therefore hindered. Principal Findings: Here we show, that the in vivo response of CD4+ T cells can be improved, when the antigens are administered together with 'MHC-loading enhancer' (MLE). MLE are small catalytic compounds able to open up the MHC binding site by triggering ligand-release and stabilizing the receptive state. Their enhancing effect on the immune response was demonstrated here with an antigen from the influenza virus and tumour associated antigens (TAA) derived from the NYESO-1 protein. The application of these antigens in combination with adamantane ethanol (AdEtOH), an MLE compound active on human HLA-DR molecules, significantly increased the frequency of antigen-specific CD4+ T cells in mice transgenic for the human MHC II molecule. Notably, the effect was evident only with the MLE-susceptible HLA-DR molecule and not with murine MHC II molecules non-susceptible for the catalytic effect of the MLE. Conclusion: MLE can specifically increase the potency of a vaccine by facilitating the efficient transfer of the antigen onto the MHC molecule. They may therefore open a new way to improve vaccination efficacy and tumour-immunotherapy.			Dickhaut, K (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	falk@mdc-berlin.de						Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; Call MJ, 2009, J IMMUNOL, V182, P6342, DOI 10.4049/jimmunol.0803464; Chen QY, 2004, P NATL ACAD SCI USA, V101, P9363, DOI 10.1073/pnas.0403271101; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Chu RS, 1997, J EXP MED, V186, P1623, DOI 10.1084/jem.186.10.1623; Corthay A, 2005, IMMUNITY, V22, P371, DOI 10.1016/j.immuni.2005.02.003; DERES K, 1989, NATURE, V342, P561, DOI 10.1038/342561a0; Falk K, 2002, J BIOL CHEM, V277, P2709, DOI 10.1074/jbc.M109098200; FFRENCH RA, 1989, J VIROL, V63, P3087, DOI 10.1128/JVI.63.7.3087-3094.1989; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Gnjatic S, 2006, ADV CANCER RES, V95, P1, DOI 10.1016/S0065-230X(06)95001-5; GREENBERG PD, 1991, ADV IMMUNOL, V49, P281; Gupta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001814; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Hopner S, 2006, J BIOL CHEM, V281, P38535, DOI 10.1074/jbc.M606437200; Hung K, 1998, J EXP MED, V188, P2357, DOI 10.1084/jem.188.12.2357; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jager E, 2000, J EXP MED, V191, P625, DOI 10.1084/jem.191.4.625; JANEWAY C, 1989, COLD SPRING HARB S Q; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; LAMB JR, 1982, NATURE, V300, P66, DOI 10.1038/300066a0; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Marin-Esteban V, 2004, J BIOL CHEM, V279, P50684, DOI 10.1074/jbc.M407598200; Marin-Esteban V, 2003, J AUTOIMMUN, V20, P63, DOI 10.1016/S0896-8411(02)00107-5; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; Nicholson MJ, 2006, J IMMUNOL, V176, P4208, DOI 10.4049/jimmunol.176.7.4208; Ossendorp F, 1998, J EXP MED, V187, P693, DOI 10.1084/jem.187.5.693; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Rosloniec EF, 1997, J EXP MED, V185, P1113, DOI 10.1084/jem.185.6.1113; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Tacken PJ, 2005, BLOOD, V106, P1278, DOI 10.1182/blood-2005-01-0318; Toes REM, 1999, J EXP MED, V189, P753, DOI 10.1084/jem.189.5.753; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; WIESMULLER KH, 1989, VACCINE, V7, P29, DOI 10.1016/0264-410X(89)90007-8; Zarour HM, 2002, CANCER RES, V62, P213; Zarour HM, 2000, CANCER RES, V60, P4946; Zeng G, 2000, J IMMUNOL, V165, P1153, DOI 10.4049/jimmunol.165.2.1153	41	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2009	4	9							e6811	10.1371/journal.pone.0006811	http://dx.doi.org/10.1371/journal.pone.0006811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZH	19738910	Green Published, gold, Green Submitted			2022-12-25	WOS:000269622300003
J	Gutierrez, J				Gutierrez, Jayson			A Developmental Systems Perspective on Epistasis: Computational Exploration of Mutational Interactions in Model Developmental Regulatory Networks	PLOS ONE			English	Article							GAP GENE SYSTEM; DELETERIOUS MUTATIONS; POSITIONAL INFORMATION; DROSOPHILA-MELANOGASTER; STATISTICAL EPISTASIS; EVOLUTION; ROBUSTNESS; ARCHITECTURE; COMPLEXITY; EXPRESSION	The way in which the information contained in genotypes is translated into complex phenotypic traits (i.e. embryonic expression patterns) depends on its decoding by a multilayered hierarchy of biomolecular systems (regulatory networks). Each layer of this hierarchy displays its own regulatory schemes (i.e. operational rules such as +/- feedback) and associated control parameters, resulting in characteristic variational constraints. This process can be conceptualized as a mapping issue, and in the context of highly-dimensional genotype-phenotype mappings (GPMs) epistatic events have been shown to be ubiquitous, manifested in non-linear correspondences between changes in the genotype and their phenotypic effects. In this study I concentrate on epistatic phenomena pervading levels of biological organization above the genetic material, more specifically the realm of molecular networks. At this level, systems approaches to studying GPMs are specially suitable to shed light on the mechanistic basis of epistatic phenomena. To this aim, I constructed and analyzed ensembles of highly-modular (fully interconnected) networks with distinctive topologies, each displaying dynamic behaviors that were categorized as either arbitrary or functional according to early patterning processes in the Drosophila embryo. Spatio-temporal expression trajectories in virtual syncytial embryos were simulated via reaction-diffusion models. My in silico mutational experiments show that: 1) the average fitness decay tendency to successively accumulated mutations in ensembles of functional networks indicates the prevalence of positive epistasis, whereas in ensembles of arbitrary networks negative epistasis is the dominant tendency; and 2) the evaluation of epistatic coefficients of diverse interaction orders indicates that, both positive and negative epistasis are more prevalent in functional networks than in arbitrary ones. Overall, I conclude that the phenotypic and fitness effects of multiple perturbations are strongly conditioned by both the regulatory architecture (i.e. pattern of coupled feedback structures) and the dynamic nature of the spatio-temporal expression trajectories displayed by the simulated networks.	Univ Antioquia, Inst Fis, Grp Fis & Astrofis Computac, Medellin, Colombia	Universidad de Antioquia	Gutierrez, J (corresponding author), Univ Antioquia, Inst Fis, Grp Fis & Astrofis Computac, Medellin, Colombia.	jayson.gutierrez@siu.udea.edu.co						Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Azevedo L, 2006, TRENDS GENET, V22, P581, DOI 10.1016/j.tig.2006.08.001; Azevedo RBR, 2006, NATURE, V440, P87, DOI 10.1038/nature04488; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Carter AJR, 2005, THEOR POPUL BIOL, V68, P179, DOI 10.1016/j.tpb.2005.05.002; Carter GW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100137; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Davis GK, 2002, ANNU REV ENTOMOL, V47, P669, DOI 10.1146/annurev.ento.47.091201.145251; Dayarian A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000256; Dichtel-Danjoy ML, 2004, TRENDS GENET, V20, P268, DOI 10.1016/j.tig.2004.03.010; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Elena SF, 1999, J MOL EVOL, V49, P703, DOI 10.1007/PL00000082; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Giaever G, 2009, NAT BIOTECHNOL, V27, P149, DOI 10.1038/nbt0209-149; Gibson G, 1996, THEOR POPUL BIOL, V49, P58, DOI 10.1006/tpbi.1996.0003; Gjuvsland AB, 2007, GENETICS, V175, P411, DOI 10.1534/genetics.106.058859; Gjuvsland AB, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-57; Gould SJ, 1997, P NATL ACAD SCI USA, V94, P10750, DOI 10.1073/pnas.94.20.10750; Han JDJ, 2008, CELL RES, V18, P224, DOI 10.1038/cr.2008.16; Hansen TF, 2006, EVOLUTION, V60, P1523; Hansen TF, 2006, ANNU REV ECOL EVOL S, V37, P123, DOI 10.1146/annurev.ecolsys.37.091305.110224; Holland JB, 2007, CURR OPIN PLANT BIOL, V10, P156, DOI 10.1016/j.pbi.2007.01.003; Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jaeger J, 2006, BIOESSAYS, V28, P1102, DOI 10.1002/bies.20494; Kwon YK, 2008, BIOINFORMATICS, V24, P987, DOI 10.1093/bioinformatics/btn060; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Liu PZ, 2005, EVOL DEV, V7, P629, DOI 10.1111/j.1525-142X.2005.05066.x; Loewe L, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-27; Loewe L, 2008, LECT N BIOINFORMAT, V5307, P156, DOI 10.1007/978-3-540-88562-7_14; Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Martin G, 2007, NAT GENET, V39, P555, DOI 10.1038/ng1998; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; Munteanu A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000226; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Perkins TJ, 2006, PLOS COMPUT BIOL, V2, P417, DOI 10.1371/journal.pcbi.0020051; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Reinitz J, 1998, DEV GENET, V23, P11, DOI 10.1002/(SICI)1520-6408(1998)23:1<11::AID-DVG2>3.3.CO;2-Q; REINITZ J, 1995, J EXP ZOOL, V271, P47, DOI 10.1002/jez.1402710106; Rifkin SA, 2005, NATURE, V438, P220, DOI 10.1038/nature04114; Rivero A, 2003, EVOLUTION, V57, P1698, DOI 10.1111/j.0014-3820.2003.tb00375.x; Roix J, 2002, HISTOCHEM CELL BIOL, V118, P105, DOI 10.1007/s00418-002-0446-7; ROTH FP, 2009, EPISTASIS J BIOL, V8, P35; Sanjuan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002663; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Sharp DH, 1998, BIOSYSTEMS, V47, P79, DOI 10.1016/S0303-2647(98)00014-8; Slonim N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100047; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Tyler AL, 2009, BIOESSAYS, V31, P220, DOI 10.1002/bies.200800022; Van Driessche N, 2005, NAT GENET, V37, P471, DOI 10.1038/ng1545; Veitia RA, 2006, BIOESSAYS, V28, P282, DOI 10.1002/bies.20377; Wang XW, 2008, CURR OPIN BIOTECH, V19, P482, DOI 10.1016/j.copbio.2008.07.011; Weinreich DM, 2005, EVOLUTION, V59, P1165; Wilke CO, 2001, P ROY SOC B-BIOL SCI, V268, P1469, DOI 10.1098/rspb.2001.1690; Zhu MJ, 2009, INT J BIOL SCI, V5, P161, DOI 10.7150/ijbs.5.161	59	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2009	4	9							e6823	10.1371/journal.pone.0006823	http://dx.doi.org/10.1371/journal.pone.0006823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZH	19738908	Green Published, gold, Green Submitted			2022-12-25	WOS:000269622300004
J	Gratraud, P; Huws, E; Falkard, B; Adjalley, S; Fidock, DA; Berry, L; Jacobs, WR; Baird, MS; Vial, H; Kremer, L				Gratraud, Paul; Huws, Enlli; Falkard, Brie; Adjalley, Sophie; Fidock, David A.; Berry, Laurence; Jacobs, William R., Jr.; Baird, Mark S.; Vial, Henri; Kremer, Laurent			Oleic Acid Biosynthesis in Plasmodium falciparum: Characterization of the Stearoyl-CoA Desaturase and Investigation as a Potential Therapeutic Target	PLOS ONE			English	Article								Background: Plasmodium falciparum parasitization of erythrocytes causes a substantial increase in the levels of intracellular fatty acids, notably oleic acid. How parasites acquire this monounsaturated fatty acid has remained enigmatic. Here, we report on the biochemical and enzymatic characterization of stearoyl-CoA desaturase (SCD) in P. falciparum. Methodology/Principal Findings: Metabolic labeling experiments allowed us to demonstrate the production of oleic acid from stearic acid both in lysates of parasites incubated with [(14)C]-stearoyl-CoA and in parasite-infected erythrocytes labeled with [(14)C]-stearic acid. Optimal SCD activity was detected in schizonts, the stage of maximal membrane synthesis. This activity correlated with a late trophozoite stage-specific induction of PFE0555w transcripts. PFE0555w harbors a typical SCD signature. Similar to mammalian SCDs, this protein was found to be associated with the endoplasmic reticulum, as determined with PFE0555w-GFP tagged transgenic P. falciparum. Importantly, these parasites exhibited increased rates of stearic to oleic acid conversion, providing additional evidence that PFE0555w encodes the plasmodial SCD (PfSCD). These findings prompted us to assess the activity of sterculic acid analogues, known to be specific Delta 9-desaturase inhibitors. Methyl sterculate inhibited the synthesis of oleic acid both with parasite lysates and infected erythrocytes, most likely by targeting PfSCD. This compound exhibited significant, rapid and irreversible antimalarial activity against asexual blood stages. This parasiticidal effect was antagonized by oleic acid. Conclusion/Significance: Our study provides evidence that parasite-mediated fatty acid modification is important for blood-stage survival and provides a new strategy to develop a novel antimalarial therapeutic based on the inhibition of PfSCD.			Gratraud, P (corresponding author), Univ Montpellier 2, CNRS, UMR 5235, Lab Dynam Interact Membranaires Normales & Pathol, Case 107, Montpellier, France.	laurent.kremer@univ-montp2.fr	Adjalley, Sophie/O-6501-2017; Kremer, Laurent/M-4935-2017; Baird, Mark/A-2470-2009	Kremer, Laurent/0000-0002-6604-4458; Baird, Mark/0000-0001-5340-8745; Berry, laurence/0000-0002-8150-7860; Jacobs, William/0000-0003-3321-3080; Fidock, David/0000-0001-6753-8938	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI060342] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI060342] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAIRD MS, 1992, TETRAHEDRON LETT, V33, P1521, DOI 10.1016/S0040-4039(00)91664-2; BAIRD MS, 1993, J CHEM SOC PERK T 1, P1547, DOI 10.1039/p19930001547; BEAUMELLE BD, 1986, BIOCHIM BIOPHYS ACTA, V877, P262, DOI 10.1016/0005-2760(86)90303-6; BERENBAUM MC, 1978, J INFECT DIS, V137, P122, DOI 10.1093/infdis/137.2.122; Chimanuka B, 2001, PARASITOL RES, V87, P795, DOI 10.1007/s004360000358; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; DIECKMANN A, 1986, Z PARASITENKD, V72, P591, DOI 10.1007/BF00925479; ELMENDORF HG, 1993, EMBO J, V12, P4763, DOI 10.1002/j.1460-2075.1993.tb06165.x; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; Fidock DA, 1998, MOL PHARMACOL, V54, P1140, DOI 10.1124/mol.54.6.1140; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; FOGERTY AC, 1972, LIPIDS, V7, P335, DOI 10.1007/BF02532651; FOLCH J, 1957, J BIOL CHEM, V226, P497; FULCO AJ, 1964, J BIOL CHEM, V239, P993; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Gupta S, 2002, ANTIMICROB AGENTS CH, V46, P1510, DOI 10.1128/AAC.46.5.1510-1515.2002; Haldar Kasturi, 1993, Seminars in Cell Biology, V4, P345, DOI 10.1006/scel.1993.1041; Heinemann FS, 2003, PROSTAG LEUKOTR ESS, V68, P123, DOI 10.1016/S0952-3278(02)00262-4; HSIAO LL, 1991, BIOCHEM J, V274, P121, DOI 10.1042/bj2740121; Jackson KE, 2004, MOL MICROBIOL, V54, P109, DOI 10.1111/j.1365-2958.2004.04284.x; JEFFCOAT R, 1977, LIPIDS, V12, P480, DOI 10.1007/BF02535446; JOHNSON AR, 1967, NATURE, V214, P1244, DOI 10.1038/2141244a0; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; Krishnegowda G, 2003, MOL BIOCHEM PARASIT, V132, P55, DOI 10.1016/j.molbiopara.2003.07.003; KRUGLIAK M, 1995, EXP PARASITOL, V81, P97, DOI 10.1006/expr.1995.1097; KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lee SH, 2007, NAT REV MICROBIOL, V5, P287, DOI 10.1038/nrmicro1617; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Man WC, 2006, J BIOL CHEM, V281, P1251, DOI 10.1074/jbc.M508733200; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; Mazumdar J, 2007, EUKARYOT CELL, V6, P1727, DOI 10.1128/EC.00255-07; Mi-ichi F, 2006, PARASITOLOGY, V133, P399, DOI 10.1017/S0031182006000540; Mitamura T, 2003, MICROBES INFECT, V5, P545, DOI 10.1016/S1286-4579(03)00070-4; Mitamura T, 2000, PARASITOL INT, V49, P219, DOI 10.1016/S1383-5769(00)00048-9; Miyazaki M, 2006, J LIPID RES, V47, P700, DOI 10.1194/jlr.C500025-JLR200; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; MOLL GN, 1988, FEBS LETT, V232, P341, DOI 10.1016/0014-5793(88)80765-8; Mouray E, 2007, BIOCHIMIE, V89, P337, DOI 10.1016/j.biochi.2006.11.001; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Naik RS, 2000, J EXP MED, V192, P1563, DOI 10.1084/jem.192.11.1563; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Phetsuksiri B, 2003, J BIOL CHEM, V278, P53123, DOI 10.1074/jbc.M311209200; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Santiago TC, 2004, J BIOL CHEM, V279, P9222, DOI 10.1074/jbc.M310502200; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Skinner TS, 1996, INT J PARASITOL, V26, P519, DOI 10.1016/0020-7519(96)89380-5; STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; Surolia N, 2001, NAT MED, V7, P167, DOI 10.1038/84612; Tilley L, 2007, TRENDS PARASITOL, V23, P268, DOI 10.1016/j.pt.2007.04.001; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trang DTX, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-7; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Vial Henri J., 1992, V18, P259; VIAL HJ, 1982, J PARASITOL, V68, P379, DOI 10.2307/3280946; Vial HJ, 2005, MOLECULAR APPROACHES TO MALARIA, P327; Vial HJ, 2004, P NATL ACAD SCI USA, V101, P15458, DOI 10.1073/pnas.0404037101; VIAL HJ, 1982, J PROTOZOOL, V29, P258, DOI 10.1111/j.1550-7408.1982.tb04023.x; Waller RF, 2003, ANTIMICROB AGENTS CH, V47, P297, DOI 10.1128/AAC.47.1.297-301.2003; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Wang J, 2005, BIOCHEM BIOPH RES CO, V332, P735, DOI 10.1016/j.bbrc.2005.05.013; Wicker-Thomas C, 1997, INSECT BIOCHEM MOLEC, V27, P963, DOI 10.1016/S0965-1748(97)00077-5; Yu Min, 2008, Cell Host Microbe, V4, P567, DOI 10.1016/j.chom.2008.11.001	68	28	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6889	10.1371/journal.pone.0006889	http://dx.doi.org/10.1371/journal.pone.0006889			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19707292	Green Submitted, Green Published, gold			2022-12-25	WOS:000269522900018
J	Vickers, DM; Zhang, Q; Osgood, ND				Vickers, David M.; Zhang, Qian; Osgood, Nathaniel D.			Immunobiological Outcomes of Repeated Chlamydial Infection from Two Models of Within-Host Population Dynamics	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; GENITAL-TRACT INFECTION; TRACHOMATIS INFECTION; PROTECTIVE IMMUNITY; T-CELLS; RESPONSES; ANTIBODY; SUSCEPTIBILITY; EPIDEMIOLOGY; REINFECTION	Background: Chlamydia trachomatis is a common human pathogen that mediates disease processes capable of inflicting serious complications on reproduction. Aggressive inflammatory immune responses are thought to not only direct a person's level of immunity but also the potential for immunopathology. With human immunobiology being debated as a cause of prevailing epidemiological trends, we examined some fundamental issues regarding susceptibility to multiple chlamydial infections that could have implications for infection spread. We argue that, compared to less-frequent exposure, frequent exposure to chlamydia may well produce unique immunobiological characteristics that likely to have important clinical and epidemiological implications. Methods and Results: As a novel tool for studying chlamydia, we applied principles of modeling within-host pathogen dynamics to enable an understanding of some fundamental characteristics of an individual's immunobiology during multiple chlamydial infections. While the models were able to reproduce shorter-term infection kinetics of primary and secondary infections previously observed in animal models, it was also observed that longer periods between initial and second infection may increase an individual's chlamydial load and lengthen their duration of infectiousness. The cessation of short-term repeated exposure did not allow for the formation of long-lasting immunity. However, frequent re-exposure non-intuitively linked the formation of protective immunity, persistent infection, and the potential for immunopathology. Conclusions: Overall, these results provide interesting insights that should be verified with continued study. Nevertheless, these results appear to raise challenges for current evidence of the development of long-lasting immunity against chlamydia, and suggest the existence of a previously unidentified mechanism for the formation of persistent infection. The obvious next goal is to investigate the qualitative impact of these results on the spread of chlamydia.			Vickers, DM (corresponding author), Univ Saskatchewan, Dept Interdisciplinary Studies, Saskatoon, SK, Canada.	david.vickers@usask.ca	Osgood, Nathaniel/L-1805-2016; Zhang, Qian/M-5476-2017	Zhang, Qian/0000-0002-6157-9912				ANDERSON R M, 1991; Antia R, 1998, P NATL ACAD SCI USA, V95, P14926, DOI 10.1073/pnas.95.25.14926; Bavoil PM, 2000, MICROBIOL-UK, V146, P2723, DOI 10.1099/00221287-146-11-2723; Brady LJ, 2005, INFECT IMMUN, V73, P671, DOI 10.1128/IAI.73.2.671-678.2005; Brunham RC, 2005, J INFECT DIS, V192, P1836, DOI 10.1086/497341; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; BRUNHAM RC, 1994, SEX TRANSM DIS, V21, P353, DOI 10.1097/00007435-199411000-00010; BRUNHAM RC, 1999, CHLAMYDIA INTRACELLU; Brunham RC, 2008, SEX TRANSM DIS, V35, P53, DOI 10.1097/OLQ.0b013e31815e41a3; Callard R, 2007, IMMUNOL REV, V216, P119; Casadevall A, 2004, INFECT IMMUN, V72, P6191, DOI 10.1128/IAI.72.11.6191-6196.2004; Debattista J, 2003, FERTIL STERIL, V79, P1273, DOI 10.1016/S0015-0282(03)00396-0; GANTMACHER F. R., 1959, THEORY MATRICES; Garnett GP, 1996, J INFECT DIS, V174, pS150, DOI 10.1093/infdis/174.Supplement_2.S150; Heffernan JM, 2008, THEOR POPUL BIOL, V73, P134, DOI 10.1016/j.tpb.2007.10.003; IGIETSEME JU, 1991, INFECT IMMUN, V59, P1346, DOI 10.1128/IAI.59.4.1346-1351.1991; JAWETZ E, 1965, J AMER MED ASSOC, V194, P620; Johansson M, 1997, INFECT IMMUN, V65, P1032, DOI 10.1128/IAI.65.3.1032-1044.1997; Kaur A, 2008, J VIROL, V82, P1084, DOI 10.1128/JVI.02197-07; Kim PS, 2007, J THEOR BIOL, V246, P33, DOI 10.1016/j.jtbi.2006.12.012; Lena S, 2005, J INFECT DIS, V191, pS78, DOI 10.1086/425289; Leonhardt RM, 2007, INFECT IMMUN, V75, P5105, DOI 10.1128/IAI.00668-07; Low N, 2008, SEX TRANSM INFECT, V84, P80, DOI 10.1136/sti.2008.030338; Miller WC, 2008, SEX TRANSM INFECT, V84, P82, DOI 10.1136/sti.2007.028662; Mims C, 2002, MIMS PATHOGENESIS IN; Molano M, 2005, J INFECT DIS, V191, P907, DOI 10.1086/428287; Morre SA, 2002, INT J STD AIDS, V13, P12, DOI 10.1258/095646202762226092; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; MORRISON RP, 1995, INFECT IMMUN, V63, P4661, DOI 10.1128/IAI.63.12.4661-4668.1995; Morrison SG, 2005, J IMMUNOL, V175, P7536, DOI 10.4049/jimmunol.175.11.7536; Ndoye I, 1998, SEX TRANSM INFECT, V74, pS112; Nowak MA, 1996, SCIENCE, V272, P74, DOI 10.1126/science.272.5258.74; Parks KS, 1997, SEX TRANSM DIS, V24, P229, DOI 10.1097/00007435-199704000-00008; Ramjee G, 1998, SEX TRANSM DIS, V25, P346, DOI 10.1097/00007435-199808000-00004; RANK RG, 1988, INFECT IMMUN, V56, P2243, DOI 10.1128/IAI.56.9.2243-2249.1988; Rekart ML, 2008, SEX TRANSM INFECT, V84, P87, DOI 10.1136/sti.2007.027938; Ribeiro RM, 2002, P NATL ACAD SCI USA, V99, P15572, DOI 10.1073/pnas.242358099; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; Su H, 1999, J INFECT DIS, V180, P1252, DOI 10.1086/315046; Su H, 1997, INFECT IMMUN, V65, P1993, DOI 10.1128/IAI.65.6.1993-1999.1997; Vickers DM, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-49; Wodarz D, 2004, P ROY SOC B-BIOL SCI, V271, P1101, DOI 10.1098/rspb.2003.2664; Wodarz D, 2000, INT IMMUNOL, V12, P467, DOI 10.1093/intimm/12.4.467; Yao W, 2006, P R SOC B, V273, P2193, DOI 10.1098/rspb.2006.3563	46	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6886	10.1371/journal.pone.0006886	http://dx.doi.org/10.1371/journal.pone.0006886			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19727394	gold, Green Published, Green Submitted			2022-12-25	WOS:000269522900015
J	Song, GS; Wang, L				Song, Guisheng; Wang, Li			Nuclear Receptor SHP Activates miR-206 Expression via a Cascade Dual Inhibitory Mechanism	PLOS ONE			English	Article								MicroRNAs play a critical role in many essential cellular functions in the mammalian species. However, limited information is available regarding the regulation of miRNAs gene transcription. Microarray profiling and real-time PCR analysis revealed a marked down-regulation of miR-206 in nuclear receptor SHP-/- mice. To understand the regulatory function of SHP with regard to miR-206 gene expression, we determined the putative transcriptional initiation site of miR-206 and also its full length primary transcript using a database mining approach and RACE. We identified the transcription factor AP1 binding sites on the miR-206 promoter and further showed that AP1 (c-Jun and c-Fos) induced miR-206 promoter transactivity and expression which was repressed by YY1. ChIP analysis confirmed the physical association of AP1 (c-Jun) and YY1 with the endogenous miR-206 promoter. In addition, we also identified nuclear receptor ERR gamma (NR3B3) binding site on the YY1 promoter and showed that YY1 promoter was transactivated by ERR gamma, which was inhibited by SHP (NROB2). ChIP analysis confirmed the ERR gamma binding to the YY1 promoter. Forced expression of SHP and AP1 induced miR-206 expression while overexpression of ERR gamma and YY1 reduced its expression. The effects of AP1, ERR gamma, and YY1 on miR-206 expression were reversed by siRNA knockdown of each gene, respectively. Thus, we propose a novel cascade "dual inhibitory'' mechanism governing miR-206 gene transcription by SHP: SHP inhibition of ERR gamma led to decreased YY1 expression and the derepression of YY1 on AP1 activity, ultimately leading to the activation of miR-206. This is the first report to elucidate a cascade regulatory mechanism governing miRNAs gene transcription.			Song, GS (corresponding author), Univ Utah, Sch Med, Dept Med, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	l.wang@hsc.utah.edu	song, guisheng/E-4913-2011		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080440] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bavner A, 2005, TRENDS ENDOCRIN MET, V16, P478, DOI 10.1016/j.tem.2005.10.005; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fujimori S, 2003, FEBS LETT, V554, P17, DOI 10.1016/S0014-5793(03)01041-X; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; He N, 2008, GASTROENTEROLOGY, V134, P793, DOI 10.1053/j.gastro.2008.01.006; Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Leibovitch BA, 2002, MOL CELL BIOL, V22, P6148, DOI 10.1128/MCB.22.17.6148-6157.2002; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Molina C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-25; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Negrini M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1867; Park SM, 2008, CYTOKINE GROWTH F R, V19, P303, DOI 10.1016/j.cytogfr.2008.04.011; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Roccaro AM, 2009, BLOOD, V113, P4391, DOI 10.1182/blood-2008-09-178228; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; Song GS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003574; Verde P, 2007, CELL CYCLE, V6, P2633, DOI 10.4161/cc.6.21.4850; Walden TB, 2009, J CELL PHYSIOL, V218, P444, DOI 10.1002/jcp.21621; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Ye JP, 1996, MOL CELL BIOL, V16, P4744; Zhang YX, 2008, HEPATOLOGY, V48, P289, DOI 10.1002/hep.22342; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037	34	39	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2009	4	9							e6880	10.1371/journal.pone.0006880	http://dx.doi.org/10.1371/journal.pone.0006880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489XX	19721712	Green Submitted, Green Published, gold			2022-12-25	WOS:000269461100009
J	Rastegar, M; Hotta, A; Pasceri, P; Makarem, M; Cheung, AYL; Elliott, S; Park, KJ; Adachi, M; Jones, FS; Clarke, ID; Dirks, P; Ellis, J				Rastegar, Mojgan; Hotta, Akitsu; Pasceri, Peter; Makarem, Maisam; Cheung, Aaron Y. L.; Elliott, Shauna; Park, Katya J.; Adachi, Megumi; Jones, Frederick S.; Clarke, Ian D.; Dirks, Peter; Ellis, James			MECP2 Isoform-Specific Vectors with Regulated Expression for Rett Syndrome Gene Therapy	PLOS ONE			English	Article							CPG-BINDING PROTEIN; PLURIPOTENT STEM-CELLS; HISTONE DEACETYLASE; BDNF TRANSCRIPTION; MOUSE MODEL; NEURONS; DNA; DEFICIENCY; DISEASE; PHOSPHORYLATION	Background: Rett Syndrome (RTT) is an Autism Spectrum Disorder and the leading cause of mental retardation in females. RTT is caused by mutations in the Methyl CpG-Binding Protein-2 (MECP2) gene and has no treatment. Our objective is to develop viral vectors for MECP2 gene transfer into Neural Stem Cells (NSC) and neurons suitable for gene therapy of Rett Syndrome. Methodology/Principal Findings: We generated self-inactivating (SIN) retroviral vectors with the ubiquitous EF1 alpha promoter avoiding known silencer elements to escape stem-cell-specific viral silencing. High efficiency NSC infection resulted in long-term EGFP expression in transduced NSC and after differentiation into neurons. Infection with Myc-tagged MECP2-isoformspecific (E1 and E2) vectors directed MeCP2 to heterochromatin of transduced NSC and neurons. In contrast, vectors with an internal mouse Mecp2 promoter (MeP) directed restricted expression only in neurons and glia and not NSC, recapitulating the endogenous expression pattern required to avoid detrimental consequences of MECP2 ectopic expression. In differentiated NSC from adult heterozygous Mecp2(tm1.1Bird)+/- female mice, 48% of neurons expressed endogenous MeCP2 due to random inactivation of the X-linked Mecp2 gene. Retroviral MECP2 transduction with EF1a and MeP vectors rescued expression in 95-100% of neurons resulting in increased dendrite branching function in vitro. Insulated MECP2 isoformspecific lentiviral vectors show long-term expression in NSC and their differentiated neuronal progeny, and directly infect dissociated murine cortical neurons with high efficiency. Conclusions/Significance: MeP vectors recapitulate the endogenous expression pattern of MeCP2 in neurons and glia. They have utility to study MeCP2 isoform-specific functions in vitro, and are effective gene therapy vectors for rescuing dendritic maturation of neurons in an ex vivo model of RTT.			Rastegar, M (corresponding author), Univ Manitoba, Regenerat Med Program, Winnipeg, MB, Canada.	jellis@sickkids.ca	Rastegar, Mojgan/T-9394-2019; Ellis, James/F-4789-2011; Adachi, Megumi/M-7746-2017	Rastegar, Mojgan/0000-0003-3619-6116; Ellis, James/0000-0002-4400-0091; Adachi, Megumi/0000-0003-3404-6640; Hotta, Akitsu/0000-0002-2619-7441				Abuhatzira L, 2007, EPIGENETICS-US, V2, P214, DOI 10.4161/epi.2.4.5212; Adachi M, 2005, HUM MOL GENET, V14, P3709, DOI 10.1093/hmg/ddi402; Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Buzina A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000051; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Dalle B, 2005, MOL THER, V11, P591, DOI 10.1016/j.ymthe.2004.11.012; Diamandis P, 2007, NAT CHEM BIOL, V3, P268, DOI 10.1038/nchembio873; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Dragich JM, 2007, J COMP NEUROL, V501, P526, DOI 10.1002/cne.21264; Ellis J, 2007, CELL, V131, P13, DOI 10.1016/j.cell.2007.09.029; Fernandes KJL, 2006, EXP NEUROL, V201, P32, DOI 10.1016/j.expneurol.2006.03.018; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Ghosh RP, 2008, J BIOL CHEM, V283, P20523, DOI 10.1074/jbc.M803021200; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kimura H, 2003, J BIOL CHEM, V278, P4806, DOI 10.1074/jbc.M209923200; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Lorincz MC, 2001, MOL CELL BIOL, V21, P7913, DOI 10.1128/MCB.21.23.7913-7922.2001; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Mnatzakanian GN, 2004, NAT GENET, V36, P339, DOI 10.1038/ng1327; Mullaney BC, 2004, NEUROSCIENCE, V123, P939, DOI 10.1016/j.neuroscience.2003.11.025; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nikitina T, 2007, J BIOL CHEM, V282, P28237, DOI 10.1074/jbc.M704304200; Osborne CS, 1999, J VIROL, V73, P5490, DOI 10.1128/JVI.73.7.5490-5496.1999; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Rastegar M, 2004, MOL CELL BIOL, V24, P8090, DOI 10.1128/MCB.24.18.8090-8103.2004; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Schmid RS, 2008, NEUROREPORT, V19, P393, DOI 10.1097/WNR.0b013e3282f5661c; Slack RS, 1998, J CELL BIOL, V140, P1497, DOI 10.1083/jcb.140.6.1497; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Sun YE, 2006, NEURON, V49, P321, DOI 10.1016/j.neuron.2006.01.014; Swindle CS, 2004, J BIOL CHEM, V279, P34, DOI 10.1074/jbc.M309128200; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Yao SY, 2004, MOL THER, V10, P27, DOI 10.1016/j.ymthe.2004.04.007; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	53	52	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2009	4	8							e6810	10.1371/journal.pone.0006810	http://dx.doi.org/10.1371/journal.pone.0006810			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JE	19710912	Green Published, Green Submitted, gold			2022-12-25	WOS:000269415600021
J	Gupta, GD; Swetha, MG; Kumari, S; Lakshminarayan, R; Dey, G; Mayor, S				Gupta, Gagan D.; Swetha, M. G.; Kumari, Sudha; Lakshminarayan, Ramya; Dey, Gautam; Mayor, Satyajit			Analysis of Endocytic Pathways in Drosophila Cells Reveals a Conserved Role for GBF1 in Internalization via GEECs	PLOS ONE			English	Article								In mammalian cells, endocytosis of the fluid phase and glycosylphosphatidylinositol-anchored proteins (GPI-APs) forms GEECs (GPI-AP enriched early endosomal compartments) via an Arf1- and Cdc42-mediated, dynamin independent mechanism. Here we use four different fluorescently labeled probes and several markers in combination with quantitative kinetic assays, RNA interference and high resolution imaging to delineate major endocytic routes in Drosophila cultured cells. We find that the hallmarks of the pinocytic GEEC pathway are conserved in Drosophila and identify garz, the fly ortholog of the GTP exchange factor GBF1, as a novel component of this pathway. Live confocal and TIRF imaging reveals that a fraction of GBF1 GFP dynamically associates with ABD RFP (a sensor for activated Arf1 present on nascent pinosomes). Correspondingly, a GTP exchange mutant of GBF1 has altered ABD RFP localization in the evanescent field and is impaired in fluid phase uptake. Furthermore, GBF1 activation is required for the GEEC pathway even in the presence of Brefeldin A, implying that, like Arf1, it has a role in endocytosis that is separable from its role in secretion.			Gupta, GD (corresponding author), Chromous Biotech Pvt Ltd, Bangalore, Karnataka, India.	gagan@ncbs.res.in; mayor@ncbs.res.in	Lakshminarayan, Ramya/AAT-9527-2021; Dey, Gautam/AAQ-8917-2020; Dey, Gautam/GON-6083-2022	Dey, Gautam/0000-0003-1416-6223; Dey, Gautam/0000-0003-1416-6223; Gupta, Gagan/0000-0002-1089-965X; Kumari, Sudha/0000-0001-7082-2825				ABRAMS JM, 1992, P NATL ACAD SCI USA, V89, P10375, DOI 10.1073/pnas.89.21.10375; Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Benmerah A, 2007, TRAFFIC, V8, P970, DOI 10.1111/j.1600-0854.2007.00585.x; Biyasheva A, 2004, J CELL SCI, V117, P837, DOI 10.1242/jcs.00921; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brandenburg B, 2007, PLOS BIOL, V5, P1543, DOI 10.1371/journal.pbio.0050183; Chadda R, 2007, TRAFFIC, V8, P702, DOI 10.1111/j.1600-0854.2007.00565.x; CHAM BE, 1976, J LIPID RES, V17, P176; Chatterjee S, 2001, CELL MOL LIFE SCI, V58, P1969, DOI 10.1007/PL00000831; Cheng LW, 2005, P NATL ACAD SCI USA, V102, P13646, DOI 10.1073/pnas.0506461102; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Dubois T, 2005, M S-MED SCI, V21, P692, DOI 10.1051/medsci/2005218-9692; DUNN KW, 1992, J CELL BIOL, V117, P301, DOI 10.1083/jcb.117.2.301; Gauthier NC, 2005, MOL BIOL CELL, V16, P4852, DOI 10.1091/mbc.E05-05-0398; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Guha A, 2003, J CELL SCI, V116, P3373, DOI 10.1242/jcs.00637; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; HABERLAND ME, 1985, P NATL ACAD SCI USA, V82, P2693, DOI 10.1073/pnas.82.9.2693; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; IACOPETTA BJ, 1983, J BIOL CHEM, V258, P9108; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Kalia M, 2006, MOL BIOL CELL, V17, P3689, DOI 10.1091/mbc.E05-10-0980; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; Kochubey O, 2006, TRAFFIC, V7, P1614, DOI 10.1111/j.1600-0854.2006.00492.x; Koke J A, 1991, Protein Expr Purif, V2, P51, DOI 10.1016/1046-5928(91)90009-8; Korolchuk VI, 2007, J CELL SCI, V120, P4367, DOI 10.1242/jcs.012336; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Luzio JP, 2005, BIOCHEM SOC SYMP, V72, P77, DOI 10.1042/bss0720077; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Manolea F, 2008, MOL BIOL CELL, V19, P523, DOI 10.1091/mbc.E07-04-0394; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mayor S, 1998, EMBO J, V17, P4626, DOI 10.1093/emboj/17.16.4626; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Mouratou B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-20; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; SILBERKANG M, 1983, J BIOL CHEM, V258, P8503; Sriram V, 2003, J CELL BIOL, V161, P593, DOI 10.1083/jcb.200210166; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Szul T, 2005, TRAFFIC, V6, P374, DOI 10.1111/j.1600-0854.2005.00282.x; Szul T, 2007, J CELL SCI, V120, P3929, DOI 10.1242/jcs.010769; Teh OK, 2007, NATURE, V448, P493, DOI 10.1038/nature06023; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; Van Hoof D, 2005, INSECT BIOCHEM MOLEC, V35, P117, DOI 10.1016/j.ibmb.2004.09.009; Wessels E, 2006, DEV CELL, V11, P191, DOI 10.1016/j.devcel.2006.06.005; YAMASHIRO DJ, 1987, J CELL BIOL, V105, P2713, DOI 10.1083/jcb.105.6.2713; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	64	51	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6768	10.1371/journal.pone.0006768	http://dx.doi.org/10.1371/journal.pone.0006768			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707569	Green Submitted, Green Published, gold			2022-12-25	WOS:000269335000014
J	Saimpont, A; Pozzo, T; Papaxanthis, C				Saimpont, Arnaud; Pozzo, Thierry; Papaxanthis, Charalambos			Aging Affects the Mental Rotation of Left and Right Hands	PLOS ONE			English	Article							REPRESENTED MOTOR ACTIONS; AGE-RELATED DIFFERENCES; IMAGERY; ARM; PERFORMANCE; EXECUTION; TRANSFORMATIONS; MECHANISMS; GENERATION; HANDEDNESS	Background: Normal aging significantly influences motor and cognitive performance. Little is known about age-related changes in action simulation. Here, we investigated the influence of aging on implicit motor imagery. Methodology/Principal Findings: Twenty young (mean age: 23.9 +/- 2.8 years) and nineteen elderly (mean age: 78.3 +/- 4.5 years) subjects, all right-handed, were required to determine the laterality of hands presented in various positions. To do so, they mentally rotated their hands to match them with the hand-stimuli. We showed that: (1) elderly subjects were affected in their ability to implicitly simulate movements of the upper limbs, especially those requiring the largest amplitude of displacement and/or with strong biomechanical constraints; (2) this decline was greater for movements of the non-dominant arm than of the dominant arm. Conclusions/Significance: These results extend recent findings showing age-related alterations of the explicit side of motor imagery. They suggest that a general decline in action simulation occurs with normal aging, in particular for the non-dominant side of the body.			Saimpont, A (corresponding author), Univ Bourgogne, INSERM, Motricite Plasticite U8887, Dijon, France.	arnaudsaimpont@hotmail.com		Pozzo, Thierry/0000-0002-0585-7965				Amick MM, 2006, NEUROPSYCHOLOGIA, V44, P339, DOI 10.1016/j.neuropsychologia.2005.06.002; Band GPH, 2000, BIOL PSYCHOL, V51, P201, DOI 10.1016/S0301-0511(99)00038-1; Berch DB, 1998, BRAIN COGNITION, V38, P317, DOI 10.1006/brcg.1998.1039; Briggs SD, 1999, PSYCHOL AGING, V14, P427, DOI 10.1037/0882-7974.14.3.427; Buxbaum LJ, 2005, NEUROPSYCHOLOGIA, V43, P917, DOI 10.1016/j.neuropsychologia.2004.09.006; CERELLA J, 1981, J GERONTOL, V36, P620, DOI 10.1093/geronj/36.5.620; COOPER LA, 1975, J EXP PSYCHOL HUMAN, V104, P48, DOI 10.1037/0096-1523.1.1.48; de Lange FP, 2008, CORTEX, V44, P494, DOI 10.1016/j.cortex.2007.09.002; de Lange FP, 2005, J COGNITIVE NEUROSCI, V17, P97, DOI 10.1162/0898929052880039; DECETY J, 1989, BEHAV BRAIN RES, V34, P35, DOI 10.1016/S0166-4328(89)80088-9; DROR IE, 1994, PSYCHOL AGING, V9, P90, DOI 10.1037/0882-7974.9.1.90; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Francis KL, 2000, EXP AGING RES, V26, P169, DOI 10.1080/036107300243632; Gentili R, 2006, NEUROSCIENCE, V137, P761, DOI 10.1016/j.neuroscience.2005.10.013; Gentili R, 2004, BEHAV BRAIN RES, V155, P231, DOI 10.1016/j.bbr.2004.04.027; Gentilucci M, 1998, COGNITIVE BRAIN RES, V6, P185, DOI 10.1016/S0926-6410(97)00034-7; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Helmich RC, 2007, NEUROPSYCHOLOGIA, V45, P2201, DOI 10.1016/j.neuropsychologia.2007.02.024; HERTZOG C, 1993, J GERONTOL, V48, pP150, DOI 10.1093/geronj/48.3.P150; Hoyer W.J., 2006, HDB PSYCHOL AGING, P209, DOI DOI 10.1016/B978-012101264-9/50013-6; Hutchinson S, 2002, NEUROIMAGE, V17, P1720, DOI 10.1006/nimg.2002.1309; Jackson PL, 2004, NEUROREHAB NEURAL RE, V18, P106, DOI 10.1177/0888439004265249; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Jenkins L, 2000, PSYCHOL AGING, V15, P157, DOI 10.1037//0882-7974.15.1.157; Johnson SH, 2000, COGNITION, V74, P33, DOI 10.1016/S0010-0277(99)00063-3; Kalisch T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000090; Ketcham CJ, 2002, J GERONTOL B-PSYCHOL, V57, pP54, DOI 10.1093/geronb/57.1.P54; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; Malouin F, 2004, ARCH PHYS MED REHAB, V85, P177, DOI 10.1016/S0003-9993(03)00771-8; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; McAvinue LP, 2008, EUR J COGN PSYCHOL, V20, P232, DOI 10.1080/09541440701394624; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; MITRUSHINA M, 1995, NEUROPSYCHOLOGIA, V33, P359, DOI 10.1016/0028-3932(94)00113-4; Newell KM, 2006, HDB PSYCHOL AGING, P163; Nico D, 2004, BRAIN, V127, P120, DOI 10.1093/brain/awh006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papaxanthis C, 2003, NEUROSCI LETT, V339, P41, DOI 10.1016/S0304-3940(02)01472-6; Park DC, 1999, PROCESSING OF MEDICAL INFORMATION IN AGING PATIENTS, P3; Park DC, 1996, PSYCHOL AGING, V11, P621, DOI 10.1037/0882-7974.11.4.621; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; PARSONS LM, 1987, COGNITIVE PSYCHOL, V19, P178, DOI 10.1016/0010-0285(87)90011-9; Parsons LM, 1998, J NEUROSCI, V18, P6539; PARSONS LM, 1995, NATURE, V375, P54, DOI 10.1038/375054a0; Personnier P, 2008, BEHAV BRAIN RES, V186, P273, DOI 10.1016/j.bbr.2007.08.018; Pylyshyn Z, 2003, TRENDS COGN SCI, V7, P113, DOI 10.1016/S1364-6613(03)00003-2; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Reuter-Lorenz PA, 2005, CURR OPIN NEUROBIOL, V15, P245, DOI 10.1016/j.conb.2005.03.016; Sainburg RL, 2005, EXERC SPORT SCI REV, V33, P206, DOI 10.1097/00003677-200510000-00010; Sainburg RL, 2002, EXP BRAIN RES, V142, P241, DOI 10.1007/s00221-001-0913-8; Sale MV, 2005, J APPL PHYSIOL, V99, P1483, DOI 10.1152/japplphysiol.00371.2005; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Schwoebel J, 2002, BRAIN COGNITION, V50, P1, DOI 10.1016/S0278-2626(02)00005-2; Schwoebel J, 2001, BRAIN, V124, P2098, DOI 10.1093/brain/124.10.2098; SIRIGU A, 1995, NEUROREPORT, V6, P997, DOI 10.1097/00001756-199505090-00012; Skoura X, 2005, BEHAV BRAIN RES, V165, P229, DOI 10.1016/j.bbr.2005.07.023; Skoura X, 2008, CORTEX, V44, P1271, DOI 10.1016/j.cortex.2007.07.008; Teixeira LA, 2008, CORTEX, V44, P707, DOI 10.1016/j.cortex.2006.10.002; Thayer ZC, 2006, PSYCHOPHYSIOLOGY, V43, P401, DOI 10.1111/j.1469-8986.2006.00404.x; WATSON NV, 1989, NEUROPSYCHOLOGIA, V27, P1399, DOI 10.1016/0028-3932(89)90133-4; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497	63	76	77	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6714	10.1371/journal.pone.0006714	http://dx.doi.org/10.1371/journal.pone.0006714			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	488FQ	19707585	gold, Green Published, Green Submitted			2022-12-25	WOS:000269335000004
J	Drace, K; McLaughlin, S; Darby, C				Drace, Kevin; McLaughlin, Stephanie; Darby, Creg			Caenorhabditis elegans BAH-1 Is a DUF23 Protein Expressed in Seam Cells and Required for Microbial Biofilm Binding to the Cuticle	PLOS ONE			English	Article							CHEMOSENSORY CONTROL; GENETIC-ANALYSIS; YERSINIA-PESTIS; DAUER FORMATION; SURFACE; MUTANT; ATTACHMENT; RESISTANT; INFECTION	The cuticle of Caenorhabditis elegans, a complex, multi-layered extracellular matrix, is a major interface between the animal and its environment. Biofilms produced by the bacterial genus Yersinia attach to the cuticle of the worm, providing an assay for surface characteristics. A C. elegans gene required for biofilm attachment, bah-1, encodes a protein containing the domain of unknown function DUF23. The DUF23 domain is found in 61 predicted proteins in C. elegans, which can be divided into three distinct phylogenetic clades. bah-1 is expressed in seam cells, which are among the hypodermal cells that synthesize the cuticle, and is regulated by a TGF-beta signaling pathway.			Drace, K (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94143 USA.	drace_km@mercer.edu	McLaughlin, Stephanie/AFT-3454-2022	McLaughlin, Stephanie/0000-0002-6658-8260; Drace, Kevin/0000-0002-5511-9207	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI057512, R01AI057512] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; BLAXTER ML, 1993, J BIOL CHEM, V268, P6600; Cipollo JF, 2004, J BIOL CHEM, V279, P52893, DOI 10.1074/jbc.M409557200; COX GN, 1985, MOL CELL BIOL, V5, P363, DOI 10.1128/MCB.5.2.363; COX GN, 1981, J CELL BIOL, V90, P7, DOI 10.1083/jcb.90.1.7; Darby C, 2005, INFECT IMMUN, V73, P7236, DOI 10.1128/IAI.73.11.7236-7242.2005; Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a; Darby C, 2007, GENETICS, V176, P221, DOI 10.1534/genetics.106.067496; Drace K, 2008, APPL ENVIRON MICROB, V74, P4509, DOI 10.1128/AEM.00336-08; Eck R.V., 1966, ATLAS PROTEIN SEQUEN; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; EPSTEIN HF, 1995, CAENORHABDITIS ELEGA, P559; FINN RD, 2007, NUCL ACIDS RES; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Gems D, 1998, GENETICS, V150, P129; Gravato-Nobre MJ, 2005, GENETICS, V171, P1033, DOI 10.1534/genetics.105.045716; Grenache DG, 1996, P NATL ACAD SCI USA, V93, P12388, DOI 10.1073/pnas.93.22.12388; HEMMER RM, 1991, J CELL BIOL, V115, P1237, DOI 10.1083/jcb.115.5.1237; Hoflich J, 2004, J BIOL CHEM, V279, P30440, DOI 10.1074/jbc.M402429200; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu Patrick J, 2007, WormBook, P1; Inoue T, 2000, DEV BIOL, V217, P192, DOI 10.1006/dbio.1999.9545; Jarrett CO, 2004, J INFECT DIS, V190, P783, DOI 10.1086/422695; Joshua GWP, 2003, MICROBIOL-SGM, V149, P3221, DOI 10.1099/mic.0.26475-0; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; LASSANDRO F, 1994, MOL BIOCHEM PARASIT, V65, P147, DOI 10.1016/0166-6851(94)90123-6; LINK CD, 1992, GENETICS, V131, P867; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Liu Tao, 2004, BMC Dev Biol, V4, P11, DOI 10.1186/1471-213X-4-11; Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6; Mattingly RR, 1996, NATURE, V382, P268, DOI 10.1038/382268a0; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; NEI M, 2000, MOL EVOLUTION PHYLOG; Olsen DP, 2007, GENES BRAIN BEHAV, V6, P240, DOI 10.1111/j.1601-183X.2006.00252.x; Page Antony P, 2007, WormBook, P1; PAGE AP, 1992, EXP PARASITOL, V75, P72, DOI 10.1016/0014-4894(92)90123-R; POLITZ SM, 1990, P NATL ACAD SCI USA, V87, P2901, DOI 10.1073/pnas.87.8.2901; POLITZ SM, 1987, GENETICS, V117, P467; PROUDFOOT L, 1993, PARASITOLOGY, V107, P107, DOI 10.1017/S0031182000079464; Sapio MR, 2005, DEV BIOL, V282, P231, DOI 10.1016/j.ydbio.2005.03.011; Savage-Dunn C., 2005, TGF BETA SIGNALING, P1, DOI [10.1895/wormbook.1.22.1, DOI 10.1895/WORMB00K.1.22.1]; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan L, 2004, J BACTERIOL, V186, P5087, DOI 10.1128/jb.186.15.5087-5092.2004; THOMAS JH, 1993, GENETICS, V134, P1105; VOWELS JJ, 1992, GENETICS, V130, P105; Wang YM, 2006, CURR BIOL, V16, P89, DOI 10.1016/j.cub.2005.11.061; Yook K, 2007, GENETICS, V175, P681, DOI 10.1534/genetics.106.060087	51	9	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6741	10.1371/journal.pone.0006741	http://dx.doi.org/10.1371/journal.pone.0006741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707590	Green Published, gold, Green Submitted			2022-12-25	WOS:000269278400008
J	Lin, LI; Chao, SH; Meldrum, DR				Lin, Liang-I; Chao, Shih-hui; Meldrum, Deirdre R.			Practical, Microfabrication-Free Device for Single-Cell Isolation	PLOS ONE			English	Article								Microfabricated devices have great potential in cell-level studies, but are not easily accessible for the broad biology community. This paper introduces the Microscale Oil-Covered Cell Array (MOCCA) as a low-cost device for high throughput single-cell analysis that can be easily produced by researchers without microengineering knowledge. Instead of using microfabricated structures to capture cells, MOCCA isolates cells in discrete aqueous droplets that are separated by oil on patterned hydrophilic areas across a relatively more hydrophobic substrate. The number of randomly seeded Escherichia coli bacteria in each discrete droplet approaches single-cell levels. The cell distribution on MOCCA is well-fit with Poisson distribution. In this pioneer study, we created an array of 900-picoliter droplets. The total time needed to seed cells in,3000 droplets was less than 10 minutes. Compared to traditional microfabrication techniques, MOCCA dramatically lowers the cost of microscale cell arrays, yet enhances the fabrication and operational efficiency for single-cell analysis.			Lin, LI (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Ecogen, Tempe, AZ 85287 USA.	joe.chao@asu.edu	Lin, Liang-In/K-4600-2019; MLSC, Colletion/B-3912-2013		NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001497] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01HG01497, R01 HG001497] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		CARLSON R, 2005, P MICROTAS OCT 9 13, P64; Chao SH, 2007, LAB CHIP, V7, P641, DOI 10.1039/b618269k; Chao SH, 2009, LAB CHIP, V9, P867, DOI 10.1039/b819887j; Di Carlo D, 2006, ANAL CHEM, V78, P4925, DOI 10.1021/ac060541s; Dragavon J, 2008, J R SOC INTERFACE, V5, pS151, DOI [10.1098/rsif.2008.0106.focus, 10.1098/rsif.2008.0106]; FURTH EE, 1981, ANAL BIOCHEM, P1; Grodrian A, 2004, BIOSENS BIOELECTRON, V19, P1421, DOI 10.1016/j.bios.2003.12.021; Huebner A, 2007, CHEM COMMUN, P1218, DOI 10.1039/b618570c; Huebner A, 2008, LAB CHIP, V8, P1244, DOI 10.1039/b806405a; Khademhosseini A, 2005, LAB CHIP, V5, P1380, DOI 10.1039/b508096g; Kim H, 2006, ADV FUNCT MATER, V16, P1313, DOI 10.1002/adfm.200500888; Koster S, 2008, LAB CHIP, V8, P1110, DOI 10.1039/b802941e; Kuang Y, 2004, ANAL CHEM, V76, P6282, DOI 10.1021/ac049053f; Lidstrom ME, 2003, NAT REV MICROBIOL, V1, P158, DOI 10.1038/nrmicro755; Molter TW, 2008, IEEE T AUTOM SCI ENG, V5, P32, DOI 10.1109/TASE.2007.909441; Revzin A, 2004, LANGMUIR, V20, P2999, DOI 10.1021/la035827w	16	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6710	10.1371/journal.pone.0006710	http://dx.doi.org/10.1371/journal.pone.0006710			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696926	Green Submitted, Green Published, gold			2022-12-25	WOS:000269267600002
J	Biterova, EI; Barycki, JJ				Biterova, Ekaterina I.; Barycki, Joseph J.			Mechanistic Details of Glutathione Biosynthesis Revealed by Crystal Structures of Saccharomyces cerevisiae Glutamate Cysteine Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; AMINO-ACID-SEQUENCE; KINETIC MECHANISM; CATALYTIC SUBUNIT; BINDING DETERMINANTS; LIVER GLUTATHIONE; MISSENSE MUTATION; HEAVY SUBUNIT; GENE CAUSES; INHIBITION	Glutathione is a thiol-disulfide exchange peptide critical for buffering oxidative or chemical stress, and an essential cofactor in several biosynthesis and detoxification pathways. The rate-limiting step in its de novo biosynthesis is catalyzed by glutamate cysteine ligase, a broadly expressed enzyme for which limited structural information is available in higher eukaryotic species. Structural data are critical to the understanding of clinical glutathione deficiency, as well as rational design of enzyme modulators that could impact human disease progression. Here, we have determined the structures of Saccharomyces cerevisiae glutamate cysteine ligase (ScGCL) in the presence of glutamate and MgCl2 (2.1 angstrom; R = 18.2%, R-free = 21.9%), and in complex with glutamate, MgCl2, and ADP (2.7 angstrom; R = 19.0%, R-free = 24.2%). Inspection of these structures reveals an unusual binding pocket for the alpha-carboxylate of the glutamate substrate and an ATP-independent Mg2+ coordination site, clarifying the Mg2+ dependence of the enzymatic reaction. The ScGCL structures were further used to generate a credible homology model of the catalytic subunit of human glutamate cysteine ligase (hGCLC). Examination of the hGCLC model suggests that post-translational modifications of cysteine residues may be involved in the regulation of enzymatic activity, and elucidates the molecular basis of glutathione deficiency associated with patient hGCLC mutations.	[Barycki, Joseph J.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Barycki, JJ (corresponding author), Univ Nebraska, Dept Biochem, 1901 Vine St, Lincoln, NE 68588 USA.	jbarycki2@unl.edu			National Institutes of Health [1R01 GM077289]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant Number 1R01 GM077289 (to J. J. B.).	Abbott JJ, 2002, BIOCHEMISTRY-US, V41, P2741, DOI 10.1021/bi0159128; Abbott JJ, 2001, J BIOL CHEM, V276, P42099, DOI 10.1074/jbc.M104672200; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andersen JK, 1996, J NEUROCHEM, V67, P2164; Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1; BEUTLER E, 1990, BLOOD, V75, P271; Beutler E, 1999, BLOOD, V94, P2890, DOI 10.1182/blood.V94.8.2890.420k16_2890_2894; Brekken DL, 1998, J BIOL CHEM, V273, P26317, DOI 10.1074/jbc.273.41.26317; BUHL R, 1989, LANCET, V2, P1294; CHRISTHAZELHOF E, 1976, BIOCHIM BIOPHYS ACTA, V450, P450, DOI 10.1016/0005-2760(76)90018-7; Copley SD, 2002, GENOME BIOL, V3; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraser JA, 2003, J BIOL CHEM, V278, P46369, DOI 10.1074/jbc.M308035200; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Griffith OW, 1999, ADV ENZYMOL RAMB, V73, P209, DOI 10.1002/9780470123195.ch7; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gysin R, 2007, P NATL ACAD SCI USA, V104, P16621, DOI 10.1073/pnas.0706778104; Hamilton D, 2003, BLOOD, V102, P725, DOI 10.1182/blood-2002-11-3622; Hibi T, 2004, P NATL ACAD SCI USA, V101, P15052, DOI 10.1073/pnas.0403277101; HIGASHI T, 1977, J BIOCHEM-TOKYO, V82, P117, DOI 10.1093/oxfordjournals.jbchem.a131659; Hirono A, 1996, BLOOD, V87, P2071; Hothorn M, 2006, J BIOL CHEM, V281, P27557, DOI 10.1074/jbc.M602770200; HUANG CS, 1993, J BIOL CHEM, V268, P19675; HUANG CS, 1993, J BIOL CHEM, V268, P20578; HUANG CS, 1988, P NATL ACAD SCI USA, V85, P2464, DOI 10.1073/pnas.85.8.2464; Huynh TT, 2003, J BIOL CHEM, V278, P39794, DOI 10.1074/jbc.M306306200; Jez JM, 2004, J BIOL CHEM, V279, P33463, DOI 10.1074/jbc.M405127200; Klatt P, 2000, EUR J BIOCHEM, V267, P4928, DOI 10.1046/j.1432-1327.2000.01601.x; Lu SC, 1999, FASEB J, V13, P1169, DOI 10.1096/fasebj.13.10.1169; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Pereira MM, 2007, HAEMATOLOGICA, V92, pE102, DOI 10.3324/haematol.11238; Matte A, 1998, STRUCT FOLD DES, V6, P413, DOI 10.1016/S0969-2126(98)00043-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLSON DW, 1992, J BIOL CHEM, V267, P17849; Ochi T, 1995, ARCH TOXICOL, V70, P96, DOI 10.1007/BF02733669; Ochi T, 1996, TOXICOLOGY, V112, P45, DOI 10.1016/0300-483X(96)03348-3; OHTAKE Y, 1991, YEAST, V7, P953, DOI 10.1002/yea.320070907; ORLOWSKI M, 1971, J BIOL CHEM, V246, P7095; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RICHMAN PG, 1975, J BIOL CHEM, V250, P1422; Ristoff E, 2000, BLOOD, V95, P2193; RODGERS DW, 1994, STRUCTURE, V2, P1135, DOI 10.1016/S0969-2126(94)00116-2; SCHANDLE VB, 1981, J BIOL CHEM, V256, P7590; SEELIG GF, 1984, J BIOL CHEM, V259, P9345; SOFIC E, 1992, NEUROSCI LETT, V142, P128, DOI 10.1016/0304-3940(92)90355-B; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; STRUMEYER DH, 1960, J BIOL CHEM, V235, pPC27; TATEISHI N, 1977, J NUTR, V107, P51, DOI 10.1093/jn/107.1.51; TATEISHI N, 1974, J BIOCHEM, V75, P93, DOI 10.1093/oxfordjournals.jbchem.a130387; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Tu ZH, 1998, BIOCHEM J, V336, P675, DOI 10.1042/bj3360675; VANBUSKIRK GE, 1978, EUR J BIOCHEM, V85, P589; Walsh AC, 1996, CYTOGENET CELL GENET, V75, P14, DOI 10.1159/000134447; Yang Y, 2007, BIOCHEM PHARMACOL, V74, P372, DOI 10.1016/j.bcp.2007.02.003; YIP B, 1976, J BIOL CHEM, V251, P3563	58	17	19	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32700	32708		10.1074/jbc.M109.025114	http://dx.doi.org/10.1074/jbc.M109.025114			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19726687	Green Published, hybrid			2022-12-25	WOS:000272028400054
J	Dobney, S; Chiasson, D; Lam, P; Smith, SP; Snedden, WA				Dobney, Stephanie; Chiasson, David; Lam, Polly; Smith, Steven P.; Snedden, Wayne A.			The Calmodulin-related Calcium Sensor CML42 Plays a Role in Trichome Branching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE; BINDING-PROTEIN; TROPONIN-C; MAGNESIUM BINDING; ARABIDOPSIS; SPECTROSCOPY; GENES; ASSIGNMENT; INTERACTS; SPECTRA	Calcium (Ca2+) is a key second messenger in eukaryotes where it regulates a diverse array of cellular processes in response to external stimuli. An important Ca2+ sensor in both animals and plants is calmodulin (CaM). In addition to evolutionarily conserved CaM, plants possess a unique family of CaM-like (CML) proteins. The majority of these CMLs have not yet been studied, and investigation into their physical properties and cellular functions will provide insight into Ca2+ signal transduction in plants. Here we describe the characterization of CML42, a 191-amino acid Ca2+-binding protein from Arabidopsis. Ca2+ binding to recombinant CML42 was assessed by fluorescence spectroscopy, NMR spectroscopy, microcalorimetry, and CD spectroscopy. CML42 displays significant alpha-helical secondary structure, binds three molecules of Ca2+ with affinities ranging from 30 to 430 nM, and undergoes a Ca2+-induced conformational change that results in the exposure of one or more hydrophobic regions. Gene expression analysis revealed CML42 transcripts at various stages of development and in many cell types, including the support cells, which surround trichomes (leaf hairs) on the leaf surface. Using yeast two-hybrid screening we identified a putative CML42 interactor; kinesin-interacting Ca2+-binding protein (KIC). Because KIC is a protein known to function in trichome development, we examined transgenic CML42 knockout plants and found that they possess aberrant trichomes with increased branching. Collectively, our data support a role for CML42 as a Ca2+ sensor that functions during cell branching in trichomes.	[Snedden, Wayne A.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Smith, Steven P.] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Snedden, WA (corresponding author), Queens Univ, Dept Biol, 116 Barrie St, Kingston, ON K7L 3N6, Canada.	wayne.snedden@queensu.ca		Smith, Steven/0000-0003-2710-4400; Chiasson, David/0000-0002-0770-2684	National Science and Engineering Research Council (NSERC) of Canada [RGPIN-23887-05, RGPGP-312316]; Canadian Institutes of Health Research (CIHR) [PRG-80162]	National Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported in part by National Science and Engineering Research Council (NSERC) of Canada Grants RGPIN-23887-05 (to W. S.) and RGPGP-312316 (to S. P. S.). Operation and maintenance of equipment within the Protein Function Discovery Facility was supported by Canadian Institutes of Health Research (CIHR) Resource Grant PRG-80162.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; Chiasson D, 2005, PLANT MOL BIOL, V58, P887, DOI 10.1007/s11103-005-8395-x; ChinSang ID, 1996, GENE DEV, V10, P2314, DOI 10.1101/gad.10.18.2314; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; Folkers U, 2002, EMBO J, V21, P1280, DOI 10.1093/emboj/21.6.1280; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gilli R, 1998, BIOCHEMISTRY-US, V37, P5450, DOI 10.1021/bi972083a; Gong DM, 2004, PLANT PHYSIOL, V134, P919, DOI 10.1104/pp.103.037440; HERZBERG O, 1988, J MOL BIOL, V203, P761, DOI 10.1016/0022-2836(88)90208-2; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; Ishida T, 2008, ANNU REV PLANT BIOL, V59, P365, DOI 10.1146/annurev.arplant.59.032607.092949; JEFFERSON RA, 1987, EMBO J, V6, P3901; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; Krishnakumar S, 1999, DEVELOPMENT, V126, P3079; KRUDY GA, 1992, BIOCHEMISTRY-US, V31, P1595, DOI 10.1021/bi00121a003; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Luo DL, 1999, DEVELOPMENT, V126, P5547; MANNING MC, 1989, J PHARMACEUT BIOMED, V7, P1103, DOI 10.1016/0731-7085(89)80049-4; Marks MD, 2008, PLANT J, V56, P483, DOI 10.1111/j.1365-313X.2008.03611.x; MARTIN SR, 1986, BIOCHEM J, V238, P485, DOI 10.1042/bj2380485; McCormack E, 2003, NEW PHYTOL, V159, P585, DOI 10.1046/j.1469-8137.2003.00845.x; Oppenheimer DG, 1997, P NATL ACAD SCI USA, V94, P6261, DOI 10.1073/pnas.94.12.6261; POTTER JD, 1975, J BIOL CHEM, V250, P4628; Reddy ASN, 1996, J BIOL CHEM, V271, P7052, DOI 10.1074/jbc.271.12.7052; Reddy VS, 2004, PHYTOCHEMISTRY, V65, P1745, DOI 10.1016/j.phytochem.2004.04.033; Reddy VS, 2004, PLANT CELL, V16, P185, DOI 10.1105/tpc.016600; Reddy VS, 2002, J BIOL CHEM, V277, P9840, DOI 10.1074/jbc.M111626200; Schellmann S, 2005, INT J DEV BIOL, V49, P579, DOI 10.1387/ijdb.051983ss; SLUPSKY CM, 1995, PROTEIN SCI, V4, P1279, DOI 10.1002/pro.5560040704; Smith SP, 1997, J BIOMOL NMR, V10, P77, DOI 10.1023/A:1018397213369; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; Vanderbeld B, 2007, PLANT MOL BIOL, V64, P683, DOI 10.1007/s11103-007-9189-0; VIJAYKUMAR S, 1992, J MOL BIOL, V224, P413, DOI 10.1016/0022-2836(92)91004-9; Yang TB, 2003, TRENDS PLANT SCI, V8, P505, DOI 10.1016/j.tplants.2003.09.004; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zhang XG, 2004, PLANT CELL PHYSIOL, V45, P221, DOI 10.1093/pcp/pch016	49	72	84	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31647	31657		10.1074/jbc.M109.056770	http://dx.doi.org/10.1074/jbc.M109.056770			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19720824	Green Published, hybrid			2022-12-25	WOS:000271572700019
J	Kress, W; Mutschler, H; Weber-Ban, E				Kress, Wolfgang; Mutschler, Hannes; Weber-Ban, Eilika			Both ATPase Domains of ClpA Are Critical for Processing of Stable Protein Structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRIVES FIBER FORMATION; PLUS CHAPERONE CLPB; ESCHERICHIA-COLI; DEPENDENT PROTEASE; SUBSTRATE TRANSLOCATION; DEGRADATION MACHINE; MUTATIONAL ANALYSIS; COMPLEX-FORMATION; BINDING SITES; N-DOMAIN	ClpA is a ring-shaped hexameric chaperone that binds to both ends of the protease ClpP and catalyzes the ATP-dependent unfolding and translocation of substrate proteins through its central pore into the ClpP cylinder. Here we study the relevance of ATP hydrolysis in the two ATPase domains of ClpA. We designed ClpA Walker B variants lacking ATPase activity in the first (D1) or the second ATPase domain (D2) without impairing ATP binding. We found that the two ATPase domains of ClpA operate independently even in the presence of the protease ClpP or the adaptor protein ClpS. Notably, ATP hydrolysis in the first ATPase module is sufficient to process a small, single domain protein of low stability. Substrate proteins of moderate local stability were efficiently processed when D1 was inactivated. However, ATP hydrolysis in both domains was required for efficiently processing substrates of high local stability. Furthermore, we provide evidence for the ClpS-dependent directional translocation of N-end rule substrates from the N to C terminus and propose a mechanistic model for substrate handover from the adaptor protein to the chaperone.	[Kress, Wolfgang; Mutschler, Hannes; Weber-Ban, Eilika] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Weber-Ban, E (corresponding author), Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Schafmattstr 20, CH-8093 Zurich, Switzerland.	eilika@mol.biol.ethz.ch	Mutschler, Hannes/K-5148-2015; Mutschler, Hannes/T-1390-2019	Mutschler, Hannes/0000-0001-8005-1657; Mutschler, Hannes/0000-0001-8005-1657; Weber-Ban, Eilika/0000-0002-5773-9274				Best RB, 2003, ANAL CHIM ACTA, V479, P87, DOI 10.1016/S0003-2670(02)01572-6; Bohon J, 2008, STRUCTURE, V16, P1157, DOI 10.1016/j.str.2008.04.016; BOLIN JT, 1982, J BIOL CHEM, V257, P13650; Burton RE, 2001, EMBO J, V20, P3092, DOI 10.1093/emboj/20.12.3092; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Erbse AH, 2008, FEBS J, V275, P1400, DOI 10.1111/j.1742-4658.2008.06304.x; FERSHT A, 2000, STRUCTURE MECH PROTE, P508; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; GOTTESMAN S, 1990, P NATL ACAD SCI USA, V87, P3513, DOI 10.1073/pnas.87.9.3513; Guo FS, 2002, J BIOL CHEM, V277, P46753, DOI 10.1074/jbc.M208104200; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Hinnerwisch J, 2005, J BIOL CHEM, V280, P40838, DOI 10.1074/jbc.M507879200; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hou JY, 2008, NAT STRUCT MOL BIOL, V15, P288, DOI 10.1038/nsmb.1392; HUANG GS, 1995, BIOCHEMISTRY-US, V34, P3884, DOI 10.1021/bi00012a003; HWANG BJ, 1988, J BIOL CHEM, V263, P8727; KATAYAMAFUJIMURA Y, 1987, J BIOL CHEM, V262, P4477; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kenniston JA, 2004, J STRUCT BIOL, V146, P130, DOI 10.1016/j.jsb.2003.10.023; Kress W, 2007, BIOCHEMISTRY-US, V46, P6183, DOI 10.1021/bi602616t; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Maglica Z, 2008, J MOL BIOL, V384, P503, DOI 10.1016/j.jmb.2008.09.046; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Maurizi MR, 1998, BIOCHEMISTRY-US, V37, P7778, DOI 10.1021/bi973093e; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Ninnis RL, 2009, EMBO J, V28, P1732, DOI 10.1038/emboj.2009.134; OTZEN DE, 1995, BIOCHEMISTRY-US, V34, P13051, DOI 10.1021/bi00040a016; Park EY, 2005, J BIOL CHEM, V280, P22892, DOI 10.1074/jbc.M500035200; Puorger C, 2008, STRUCTURE, V16, P631, DOI 10.1016/j.str.2008.01.013; Reid BG, 2001, P NATL ACAD SCI USA, V98, P3768, DOI 10.1073/pnas.071043698; Rieger CE, 1997, ANAL BIOCHEM, V246, P86, DOI 10.1006/abio.1996.9962; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Schaupp A, 2007, J MOL BIOL, V370, P674, DOI 10.1016/j.jmb.2007.04.070; SEOL JH, 1995, J BIOL CHEM, V270, P8087, DOI 10.1074/jbc.270.14.8087; SERRANO L, 1992, J MOL BIOL, V224, P783, DOI 10.1016/0022-2836(92)90562-X; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; SINGH SK, 1994, J BIOL CHEM, V269, P29537; Striebel F, 2009, CURR OPIN STRUC BIOL, V19, P209, DOI 10.1016/j.sbi.2009.02.006; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Vetsch M, 2006, EMBO REP, V7, P734, DOI 10.1038/sj.embor.7400722; Wang KH, 2008, J BIOL CHEM, V283, P24600, DOI 10.1074/jbc.M802213200; Wang KH, 2008, MOL CELL, V32, P406, DOI 10.1016/j.molcel.2008.08.032; Wang KH, 2007, GENE DEV, V21, P403, DOI 10.1101/gad.1511907; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Werbeck ND, 2008, J MOL BIOL, V378, P178, DOI 10.1016/j.jmb.2008.02.026; Xu JA, 1998, PROTEIN SCI, V7, P158, DOI 10.1002/pro.5560070117; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9; Zeth K, 2002, NAT STRUCT BIOL, V9, P906, DOI 10.1038/nsb869	55	37	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31441	31452		10.1074/jbc.M109.022319	http://dx.doi.org/10.1074/jbc.M109.022319			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19726681	Green Published, hybrid			2022-12-25	WOS:000271378400069
J	Jaric, J; Bilokapic, S; Lesjak, S; Crnkovic, A; Ban, N; Weygand-Durasevic, I				Jaric, Jelena; Bilokapic, Silvija; Lesjak, Sonja; Crnkovic, Ana; Ban, Nenad; Weygand-Durasevic, Ivana			Identification of Amino Acids in the N-terminal Domain of Atypical Methanogenic-type Seryl-tRNA Synthetase Critical for tRNA Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUAL-MODE RECOGNITION; ESCHERICHIA-COLI; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; METHANOSARCINA-BARKERI; SUBSTRATE RECOGNITION; STRUCTURAL-CHANGES; TRANSFER RNA(SER); BINDING DOMAIN; ACTIVE-SITE	Seryl-tRNA synthetase (SerRS) from methanogenic archaeon Methanosarcina barkeri, contains an idiosyncratic N-terminal domain, composed of an antiparallel beta-sheet capped by a helical bundle, connected to the catalytic core by a short linker peptide. It is very different from the coiled-coil tRNA binding domain in bacterial-type SerRS. Because the crystal structure of the methanogenic-type SerRS.tRNA complex has not been obtained, a docking model was produced, which indicated that highly conserved helices H2 and H3 of the N-terminal domain may be important for recognition of the extra arm of tRNA(Ser). Based on structural information and the docking model, we have mutated various positions within the N-terminal region and probed their involvement in tRNA binding and serylation. Total loss of activity and inability of the R76A variant to form the complex with cognate tRNA identifies Arg(76) located in helix H2 as a crucial tRNA-interacting residue. Alteration of Lys(79) positioned in helix H2 and Arg(94) in the loop between helix H2 and beta-strand A4 have a pronounced effect on SerRS.tRNA(Ser) complex formation and dissociation constants (K-D) determined by surface plasmon resonance. The replacement of residues Arg(38) ( located in the loop between helix H1 and beta-strand A2), Lys(141) and Asn(142) (from H3), and Arg(143) (between H3 and H4) moderately affect both the serylation activity and the K-D values. Furthermore, we have obtained a striking correlation between these results and in vivo effects of these mutations by quantifying the efficiency of suppression of bacterial amber mutations, after coexpression of the genes for M. barkeri suppressor tRNA(Ser) and a set of mMbSerRS variants in Escherichia coli.	[Jaric, Jelena; Bilokapic, Silvija; Lesjak, Sonja; Crnkovic, Ana; Weygand-Durasevic, Ivana] Univ Zagreb, Dept Chem, Fac Sci, HR-10000 Zagreb, Croatia; [Ban, Nenad] ETH, Inst Mol Biol & Biophys, Swiss Fed Inst Technol, CH-8093 Zurich, Switzerland	University of Zagreb; Swiss Federal Institutes of Technology Domain; ETH Zurich	Weygand-Durasevic, I (corresponding author), Univ Zagreb, Dept Chem, Fac Sci, Horvatovac 102A, HR-10000 Zagreb, Croatia.	weygand@chem.pmf.hr	Crnkovic, Ana/AAB-7199-2020; Bilokapic, Silvija/H-5108-2018; Crnkovic, Ana/GQZ-1733-2022	Crnkovic, Ana/0000-0002-0581-1887	Ministry of Science, Education and Sports of the Republic of Croatia Project [119-0982913-1358]; Swiss National Science Foundation; Scientific Cooperation between Eastern Europe and Switzerland ( SCOPES); Unity through Knowledge Fund [10/07]	Ministry of Science, Education and Sports of the Republic of Croatia Project; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Scientific Cooperation between Eastern Europe and Switzerland ( SCOPES); Unity through Knowledge Fund	This work was supported by Ministry of Science, Education and Sports of the Republic of Croatia Project (119-0982913-1358), grants from the Swiss National Science Foundation, the Scientific Cooperation between Eastern Europe and Switzerland ( SCOPES) program of the Swiss National Science Foundation, and Unity through Knowledge Fund project 10/07.	Ataide SF, 2006, ACS CHEM BIOL, V1, P285, DOI 10.1021/cb600200k; Bilokapic S, 2004, EUR J BIOCHEM, V271, P694, DOI 10.1111/j.1432-1033.2003.03971.x; Bilokapic S, 2008, FEBS J, V275, P2831, DOI 10.1111/j.1742-4658.2008.06423.x; Bilokapic S, 2006, EMBO J, V25, P2498, DOI 10.1038/sj.emboj.7601129; Bilokapic S, 2009, J BIOL CHEM, V284, P10706, DOI 10.1074/jbc.M808501200; BIOU V, 1994, SCIENCE, V263, P1404, DOI 10.1126/science.8128220; Bullock TL, 2000, NAT STRUCT BIOL, V7, P497; Chenal A, 2002, PROTEIN ENG, V15, P383, DOI 10.1093/protein/15.5.383; Chimnaronk S, 2005, EMBO J, V24, P3369, DOI 10.1038/sj.emboj.7600811; COULONDRE C, 1977, J MOL BIOL, V117, P577, DOI 10.1016/0022-2836(77)90059-6; Cusack S, 1996, EMBO J, V15, P2834, DOI 10.1002/j.1460-2075.1996.tb00644.x; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; de Pouplana LR, 2001, CELL, V104, P191, DOI 10.1016/S0092-8674(01)00204-5; EBEL JP, 1973, BIOCHIMIE, V55, P547, DOI 10.1016/S0300-9084(73)80415-8; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Frugier M, 2000, EMBO J, V19, P2371, DOI 10.1093/emboj/19.10.2371; FUJINAGA M, 1993, J MOL BIOL, V234, P222, DOI 10.1006/jmbi.1993.1576; Geslain R, 2006, J BIOL CHEM, V281, P38217, DOI 10.1074/jbc.M607862200; GIEGE R, 1993, PROG NUCLEIC ACID RE, V45, P129, DOI 10.1016/S0079-6603(08)60869-7; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Gruic-Sovulj I, 2006, J MOL BIOL, V361, P128, DOI 10.1016/j.jmb.2006.06.008; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ibba M, 1997, SCIENCE, V278, P1119, DOI 10.1126/science.278.5340.1119; Itoh Y, 2008, RNA BIOL, V5, P169, DOI 10.4161/rna.5.3.6876; Kim HS, 1998, J BACTERIOL, V180, P6446, DOI 10.1128/JB.180.24.6446-6449.1998; Klipcan L, 2008, STRUCTURE, V16, P1095, DOI 10.1016/j.str.2008.03.020; Korencic D, 2004, J BIOL CHEM, V279, P48780, DOI 10.1074/jbc.M408753200; Lenhard B, 1999, NUCLEIC ACIDS RES, V27, P721, DOI 10.1093/nar/27.3.721; Lesjak S, 2009, FEMS MICROBIOL LETT, V294, P111, DOI 10.1111/j.1574-6968.2009.01560.x; NORMANLY J, 1986, NATURE, V321, P213, DOI 10.1038/321213a0; Nozawa K, 2009, NATURE, V457, P1163, DOI 10.1038/nature07611; Polycarpo CR, 2006, FEBS LETT, V580, P6695, DOI 10.1016/j.febslet.2006.11.028; Rees B, 2000, J MOL BIOL, V299, P1157, DOI 10.1006/jmbi.2000.3792; RIESNER D, 1976, EUR J BIOCHEM, V68, P71, DOI 10.1111/j.1432-1033.1976.tb10765.x; RIGLER R, 1976, EUR J BIOCHEM, V65, P307, DOI 10.1111/j.1432-1033.1976.tb10418.x; ROGERS MJ, 1988, P NATL ACAD SCI USA, V85, P6627, DOI 10.1073/pnas.85.18.6627; Sauter C, 2000, J MOL BIOL, V299, P1313, DOI 10.1006/jmbi.2000.3791; Shimada N, 2001, J BIOL CHEM, V276, P46770, DOI 10.1074/jbc.M105150200; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Tumbula D, 1999, GENETICS, V152, P1269; VINCENT C, 1995, NUCLEIC ACIDS RES, V23, P1113, DOI 10.1093/nar/23.7.1113; WEYGANDDURASEVI.I, 2005, AMINOACYL TRNA SYNTH, P177; WEYGANDDURASEVIC I, 1993, P NATL ACAD SCI USA, V90, P2010, DOI 10.1073/pnas.90.5.2010; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; YAREMCHUK AD, 1992, FEBS LETT, V310, P157, DOI 10.1016/0014-5793(92)81319-H; Yowler BC, 2004, BIOCHEMISTRY-US, V43, P9725, DOI 10.1021/bi0494673; Zhang CM, 2006, J MOL BIOL, V361, P300, DOI 10.1016/j.jmb.2006.06.015; Zhang CM, 2003, BIOCHEMISTRY-US, V42, P10931, DOI 10.1021/bi034812u	52	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30643	30651		10.1074/jbc.M109.044099	http://dx.doi.org/10.1074/jbc.M109.044099			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19734148	Green Published, hybrid			2022-12-25	WOS:000271090000066
J	Richter, K; Brar, S; Ray, M; Pisitkun, P; Bolland, S; Verkoczy, L; Diaz, M				Richter, Kathleen; Brar, Sukhdev; Ray, Madhumita; Pisitkun, Prapaporn; Bolland, Silvia; Verkoczy, Laurent; Diaz, Marilyn			Speckled-like Pattern in the Germinal Center (SLIP-GC), a Nuclear GTPase Expressed in Activation-induced Deaminase-expressing Lymphomas and Germinal Center B Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUPUS NEPHRITIS; MRL/LPR MICE; AID; LINES; HYPERMUTATION; PROTEIN; BURKITTS; GROWTH; BLAST	We identified a novel GTPase, SLIP-GC, with expression limited to a few tissues, in particular germinal center B cells. It lacks homology to any known proteins, indicating that it may belong to a novel family of GTPases. SLIP-GC is expressed in germinal center B cells and in lymphomas derived from germinal center B cells such as large diffuse B cell lymphomas. In cell lines, SLIP-GC is expressed in lymphomas that express activation-induced deaminase ( AID) and that likely undergo somatic hypermutation. SLIP-GC is a nuclear protein, and it localizes to replication factories. Reduction of SLIP-GC levels in the Burkitt lymphoma cell line Raji and in non-Hodgkin lymphoma cell lines resulted in an increase in DNA breaks and apoptosis that was AID-dependent, as simultaneous reduction of AID abrogated the deleterious effects of SLIP-GC reduction. These results strongly suggest that SLIP-GC is a replication-related protein in germinal center B cells whose reduction is toxic to cells through an AID-dependent mechanism.	[Richter, Kathleen; Brar, Sukhdev; Ray, Madhumita; Diaz, Marilyn] NIEHS, Mol Genet Lab, NIH, Res Triangle Pk, NC 27709 USA; [Pisitkun, Prapaporn; Bolland, Silvia] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Verkoczy, Laurent] Duke Univ, Duke Human Vaccine Inst, Med Ctr, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Duke University	Diaz, M (corresponding author), NIEHS, Mol Genet Lab, NIH, D3-01,111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	diaz@niehs.nih.gov		Diaz, Marilyn/0000-0002-3046-2746	National Institutes of Health Grant (Intramural Research Program, NIEHS) [1Z01ES101603-2008]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000912] Funding Source: NIH RePORTER	National Institutes of Health Grant (Intramural Research Program, NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant (Intramural Research Program, NIEHS) 1Z01ES101603-2008.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDRADE LEC, 1991, J EXP MED, V173, P1407, DOI 10.1084/jem.173.6.1407; BECKWITH M, 1990, J NATL CANCER I, V82, P501, DOI 10.1093/jnci/82.6.501; BENJAMIN D, 1982, J IMMUNOL, V129, P1336; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BOGUSKI MS, 1995, NAT GENET, V10, P369, DOI 10.1038/ng0895-369; Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200; Camacho SA, 1998, IMMUNOL TODAY, V19, P511, DOI 10.1016/S0167-5699(98)01327-9; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Faili A, 2002, NAT IMMUNOL, V3, P815, DOI 10.1038/ni826; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; Gabay C, 1999, EUR J HAEMATOL, V63, P180; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Jiang CC, 2007, J IMMUNOL, V178, P7422, DOI 10.4049/jimmunol.178.11.7422; Jiang CC, 2009, IMMUNOLOGY, V126, P102, DOI 10.1111/j.1365-2567.2008.02882.x; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Madden TL, 1996, METHOD ENZYMOL, V266, P131; Morimoto T, 2002, MICROBIOL-SGM, V148, P3539, DOI 10.1099/00221287-148-11-3539; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; PULVERTAFT RJV, 1964, LANCET, V1, P238; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Somanathan S, 2001, J CELL BIOCHEM, V81, P56, DOI 10.1002/1097-4644(20010401)81:1<56::AID-JCB1023>3.0.CO;2-#; Staudt L M, 1999, Int Rev Immunol, V18, P381, DOI 10.3109/08830189909088490; Strausberg RL, 2000, TRENDS GENET, V16, P103, DOI 10.1016/S0168-9525(99)01937-X; WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0; Xiao Z, 2007, MOL IMMUNOL, V44, P2659, DOI 10.1016/j.molimm.2006.12.006; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161	31	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30652	30661		10.1074/jbc.M109.014506	http://dx.doi.org/10.1074/jbc.M109.014506			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19734146	Green Published, hybrid			2022-12-25	WOS:000271090000067
J	Vigetti, D; Genasetti, A; Karousou, E; Viola, M; Clerici, M; Bartolini, B; Moretto, P; De Luca, G; Hascall, VC; Passi, A				Vigetti, Davide; Genasetti, Anna; Karousou, Evgenia; Viola, Manuela; Clerici, Moira; Bartolini, Barbara; Moretto, Paola; De Luca, Giancarlo; Hascall, Vincent C.; Passi, Alberto			Modulation of Hyaluronan Synthase Activity in Cellular Membrane Fractions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; POLYACRYLAMIDE-GEL ELECTROPHORESIS; CHONDROITIN SULFATE DISACCHARIDES; FLUOROPHORE-LABELED HYALURONAN; TUBULAR EPITHELIAL-CELLS; EPIDERMAL-GROWTH-FACTOR; HUMAN SKIN FIBROBLASTS; ACID SYNTHESIS; MESOTHELIAL CELLS; PLASMA-MEMBRANE	Hyaluronan ( HA), the only non-sulfated glycosaminoglycan, is involved in morphogenesis, wound healing, inflammation, angiogenesis, and cancer. In mammals, HA is synthesized by three homologous HA synthases, HAS1, HAS2, and HAS3, that polymerize the HA chain using UDP-glucuronic acid and UDP-N-acetylglucosamine as precursors. Since the amount of HA is critical in several pathophysiological conditions, we developed a non-radioactive assay for measuring the activity of HA synthases (HASs) in eukaryotic cells and addressed the question of HAS activity during intracellular protein trafficking. We prepared three cellular fractions: plasma membrane, cytosol ( containing membrane proteins mainly from the endoplasmic reticulum and Golgi), and nuclei. After incubation with UDP-sugar precursors, newly synthesized HA was quantified by polyacrylamide gel electrophoresis of fluorophore-labeled saccharides and high performance liquid chromatography. This new method measured HAS activity not only in the plasma membrane fraction but also in the cytosolic membranes. This new technique was used to evaluate the effects of 4-methylumbeliferone, phorbol 12-myristate 13-acetate, interleukin 1 beta, platelet-derived growth factor BB, and tunicamycin on HAS activities. We found that HAS activity can be modulated by post-translational modification, such as phosphorylation and N-glycosylation. Interestingly, we detected a significant increase in HAS activity in the cytosolic membrane fraction after tunicamycin treatment. Since this compound is known to induce HA cable structures, this result links HAS activity alteration with the capability of the cell to promote HA cable formation.	[Vigetti, Davide; Genasetti, Anna; Karousou, Evgenia; Viola, Manuela; Clerici, Moira; Bartolini, Barbara; Moretto, Paola; De Luca, Giancarlo; Passi, Alberto] Univ Insubria, Dipartimento Sci Biomed Sperimentali & Clin, I-21100 Varese, Italy; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA	University of Insubria; Cleveland Clinic Foundation	Passi, A (corresponding author), Univ Insubria, Dipartimento Sci Biomed Sperimentali & Clin, Via JH Dunant 5, I-21100 Varese, Italy.	alberto.passi@uninsubria.it	Viola, Manuela/B-7120-2011; passi, alberto g/A-1752-2018; Vigetti, Davide/C-9861-2010	Viola, Manuela/0000-0002-0634-6390; passi, alberto g/0000-0003-3328-3089; Vigetti, Davide/0000-0002-6339-8453	Fondazione Comunitaria del Varesotto-ONLUS; PRIN 2007	Fondazione Comunitaria del Varesotto-ONLUS; PRIN 2007(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by Fondazione Comunitaria del Varesotto-ONLUS ( to D. V.) and PRIN 2007 ( to G. D. L.).	Brown J, 2000, LAB INVEST, V80, P37, DOI 10.1038/labinvest.3780006; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Campo GM, 2006, MOL CELL BIOCHEM, V292, P169, DOI 10.1007/s11010-006-9230-7; Carracedo A, 2006, CANCER CELL, V9, P301, DOI 10.1016/j.ccr.2006.03.005; Chao H, 2005, J BIOL CHEM, V280, P27513, DOI 10.1074/jbc.M411544200; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Ding K, 2001, J BIOL CHEM, V276, P3885, DOI 10.1074/jbc.M005238200; Evanko SP, 1999, J HISTOCHEM CYTOCHEM, V47, P1331, DOI 10.1177/002215549904701013; FURUKAWA K, 1979, BIOCHIM BIOPHYS ACTA, V585, P575, DOI 10.1016/0304-4165(79)90190-9; FURUKAWA K, 1977, BIOCHIM BIOPHYS ACTA, V499, P278, DOI 10.1016/0304-4165(77)90010-1; Gao F, 2006, J BIOMED MATER RES B, V78B, P385, DOI 10.1002/jbm.b.30499; Goentzel BJ, 2006, BIOCHEM J, V396, P347, DOI 10.1042/BJ20051782; HAMILTON TC, 1983, CANCER RES, V43, P5379; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Heldin P, 2003, BRAZ J MED BIOL RES, V36, P967, DOI 10.1590/S0100-879X2003000800002; HELDIN P, 1989, BIOCHEM J, V258, P919, DOI 10.1042/bj2580919; HELDIN P, 1992, BIOCHEM J, V283, P165, DOI 10.1042/bj2830165; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HONDA A, 1991, J CELL SCI, V98, P91; HONDA A, 1989, BIOCHIM BIOPHYS ACTA, V1014, P305, DOI 10.1016/0167-4889(89)90227-9; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 2004, J BIOL CHEM, V279, P18679, DOI 10.1074/jbc.M313178200; Itano N, 1996, J BIOL CHEM, V271, P9875, DOI 10.1074/jbc.271.17.9875; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Karousou EG, 2005, BIOMED CHROMATOGR, V19, P761, DOI 10.1002/bmc.511; Karousou EG, 2004, ELECTROPHORESIS, V25, P2919, DOI 10.1002/elps.200406034; Karousou EG, 2004, J PHARMACEUT BIOMED, V34, P791, DOI 10.1016/S0731-7085(03)00568-5; KLEWES L, 1994, J CELL PHYSIOL, V160, P539, DOI 10.1002/jcp.1041600317; Kyossev Z, 2007, ANAL BIOCHEM, V371, P62, DOI 10.1016/j.ab.2007.08.025; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; LEMBACH KJ, 1976, J CELL PHYSIOL, V89, P277, DOI 10.1002/jcp.1040890211; Mack JA, 2003, FASEB J, V17, P1352, DOI 10.1096/fj.02-0959fje; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Milinkovic M, 2004, BLOOD, V103, P740, DOI 10.1182/blood-2003-05-1500; Mitropoulou TN, 2001, ELECTROPHORESIS, V22, P2458, DOI 10.1002/1522-2683(200107)22:12<2458::AID-ELPS2458>3.0.CO;2-8; Mullegger J, 2003, BIOL CHEM, V384, P175, DOI 10.1515/BC.2003.019; Nakamura T, 1997, BIOCHEM MOL BIOL INT, V43, P263; NAKAMURA T, 1995, BIOCHEM BIOPH RES CO, V208, P470, DOI 10.1006/bbrc.1995.1362; NG KF, 1989, J BIOL CHEM, V264, P11776; OHASHI Y, 1988, BIOCHEM INT, V16, P293; Ori M, 2006, DEVELOPMENT, V133, P631, DOI 10.1242/dev.02225; POOLE RJ, 1984, PLANT PHYSIOL, V74, P549, DOI 10.1104/pp.74.3.549; PREHM P, 1983, BIOCHEM J, V211, P181, DOI 10.1042/bj2110181; Prinetti A, 2000, J BIOL CHEM, V275, P11658, DOI 10.1074/jbc.275.16.11658; Raio L, 2005, MATRIX BIOL, V24, P166, DOI 10.1016/j.matbio.2005.01.006; Recklies AD, 2001, BIOCHEM J, V354, P17, DOI 10.1042/0264-6021:3540017; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; Rilla K, 2004, J INVEST DERMATOL, V123, P708, DOI 10.1111/j.0022-202X.2004.23409.x; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Spicer A P, 2001, Methods Mol Biol, V171, P373; Spicer Andrew P, 2004, Birth Defects Res C Embryo Today, V72, P89, DOI 10.1002/bdrc.20006; SUDHAKARAN PR, 2007, J BIOSCIENCE, V4, P413; SUZUKI M, 1995, BIOCHEM J, V307, P817, DOI 10.1042/bj3070817; TAKAHASHI K, 1990, IN VITRO CELL DEV B, V26, P265; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Tlapak-Simmons VL, 2005, J BIOL CHEM, V280, P13012, DOI 10.1074/jbc.M409788200; TOMIDA M, 1977, J CELL PHYSIOL, V91, P323, DOI 10.1002/jcp.1040910217; Toole BP, 1990, CURR OPIN CELL BIOL, V2, P839, DOI 10.1016/0955-0674(90)90081-O; ULLRICH SJ, 1983, EXP CELL RES, V148, P377, DOI 10.1016/0014-4827(83)90160-X; van den Boom M, 2006, CIRC RES, V98, P36, DOI 10.1161/01.RES.0000199263.67107.c0; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2008, J BIOL CHEM, V283, P4448, DOI 10.1074/jbc.M709051200; Vigetti D, 2006, FASEB J, V20, P1118, DOI 10.1096/fj.05-4504com; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Yamada, 2004, SHORT PROTOCOLS CELL	73	52	53	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30684	30694		10.1074/jbc.M109.040386	http://dx.doi.org/10.1074/jbc.M109.040386			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19737932	hybrid, Green Published			2022-12-25	WOS:000271090000070
J	Corsino, P; Horenstein, N; Ostrov, D; Rowe, T; Law, M; Barrett, A; Aslanidi, G; Cress, WD; Law, B				Corsino, Patrick; Horenstein, Nicole; Ostrov, David; Rowe, Thomas; Law, Mary; Barrett, Amanda; Aslanidi, George; Cress, W. Douglas; Law, Brian			A Novel Class of Cyclin-dependent Kinase Inhibitors Identified by Molecular Docking Act through a Unique Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; TUMOR-GROWTH; PHASE-II; IN-VIVO; CANCER; CDK4; FLAVOPIRIDOL; AMPLIFICATION; AGGREGATION; SPECIFICITY	The cyclin-dependent kinase (Cdk) family is emerging as an important therapeutic target in the treatment of cancer. Cdks 1, 2, 4, and 6 are the key members that regulate the cell cycle, as opposed to Cdks that control processes such as transcription (Cdk7 and Cdk9). For this reason, Cdks 1, 2, 4, and 6 have been the subject of extensive cell cycle-related research, and consequently many inhibitors have been developed to target these proteins. However, the compounds that comprise the current list of Cdk inhibitors are largely ATP-competitive. Here we report the identification of a novel structural site on Cdk2, which is well conserved between the cell cycle Cdks. Small molecules identified by a high throughput in silico screen of this pocket exhibit cytostatic effects and act by reducing the apparent protein levels of cell cycle Cdks. Drug-induced cell cycle arrest is associated with decreased Rb phosphorylation and decreased expression of E2F-dependent genes. Multiple lines of evidence indicate that the primary mechanism of action of these compounds is the direct induction of Cdk1, Cdk2, and Cdk4 protein aggregation.	[Law, Brian] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Corsino, Patrick; Ostrov, David; Rowe, Thomas; Law, Mary; Law, Brian] Univ Florida, Shands Canc Ctr, Gainesville, FL 32610 USA; [Horenstein, Nicole] Univ Florida, Dept Chem, Gainesville, FL 32610 USA; [Ostrov, David; Barrett, Amanda] Univ Florida, Dept Pathol, Gainesville, FL 32610 USA; [Aslanidi, George] Univ Florida, Div Cellular & Mol Therapy, Dept Pediat, Gainesville, FL 32610 USA; [Cress, W. Douglas] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Law, B (corresponding author), 1376 Mowry Rd,Rm 275G, Gainesville, FL 32610 USA.	bklaw@pharmacology.ufl.edu	Law, Brian/L-6043-2019; Aslanidi, George/C-5680-2019	Aslanidi, George/0000-0002-2726-8627	National Institutes of Health [R01-CA93651, CA119997]; Florida Department of Health [07BB-8, 09BB-10, 08BB-05]; Susan G. Komen for the Cure [KG080510]; NATIONAL CANCER INSTITUTE [R01CA093651, P50CA119997, T32CA009126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA93651 and CA119997. This work was also supported by Florida Department of Health Grants 07BB-8 and 09BB-10, the Susan G. Komen for the Cure Grant KG080510 (to B. L.), and Florida Department of Health Grant 08BB-05.	An HX, 1999, AM J PATHOL, V154, P113, DOI 10.1016/S0002-9440(10)65257-1; Andrews MJI, 2004, ORG BIOMOL CHEM, V2, P2735, DOI 10.1039/b409157d; Bagella L, 2007, ONCOGENE, V26, P1829, DOI 10.1038/sj.onc.1209987; BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; Benson C, 2007, BRIT J CANCER, V96, P29, DOI 10.1038/sj.bjc.6603509; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Christian BA, 2007, CURR OPIN ONCOL, V19, P573, DOI 10.1097/CCO.0b013e3282efb9da; Chytil A, 2004, J BIOL CHEM, V279, P47688, DOI 10.1074/jbc.M405938200; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Frye SV, 2009, NAT CHEM BIOL, V5, P448, DOI 10.1038/nchembio.f.11; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Kanoe H, 1998, ANTICANCER RES, V18, P2317; Lacy ER, 2005, J MOL BIOL, V349, P764, DOI 10.1016/j.jmb.2005.04.019; Law BK, 2002, MOL CELL BIOL, V22, P8184, DOI 10.1128/MCB.22.23.8184-8198.2002; MAGARIAN EO, 1969, J PHARM SCI, V58, P1166, DOI 10.1002/jps.2600580937; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Malumbres M, 2003, ADV EXP MED BIOL, V532, P1; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Moustakas DT, 2006, J COMPUT AID MOL DES, V20, P601, DOI 10.1007/s10822-006-9060-4; Raina K, 2007, CANCER RES, V67, P11083, DOI 10.1158/0008-5472.CAN-07-2222; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Sanchez I, 2005, SEMIN CELL DEV BIOL, V16, P311, DOI 10.1016/j.semcdb.2005.02.007; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Schwartz GK, 2001, J CLIN ONCOL, V19, P1985, DOI 10.1200/JCO.2001.19.7.1985; Shapiro GI, 2001, CLIN CANCER RES, V7, P1590; Singh RP, 2007, CARCINOGENESIS, V28, P2567, DOI 10.1093/carcin/bgm218; Slepchenko BM, 2003, MOL BIOL CELL, V14, P4695, DOI 10.1091/mbc.E03-04-0248; Terasaki M, 2003, MOL BIOL CELL, V14, P4685, DOI 10.1091/mbc.E03-04-0249; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577	35	15	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29945	29955		10.1074/jbc.M109.055251	http://dx.doi.org/10.1074/jbc.M109.055251			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19710018	Green Published, hybrid			2022-12-25	WOS:000270896800073
J	McKenna, JMD; Ostap, EM				McKenna, Jennine M. Dawicki; Ostap, E. Michael			Kinetics of the Interaction of myo1c with Phosphoinositides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; MYOSIN-I; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; PHOSPHOLIPID-VESICLES; REGULATORY DOMAIN; HAIR-CELLS; BINDING; PROTEIN; INSULIN	myo1c is a single-headed myosin that dynamically links membranes to the actin cytoskeleton. A putative pleckstrin homology domain has been identified in the myo1c tail that binds phosphoinositides and soluble inositol phosphates with high affinity. However, the kinetics of association and dissociation and the influence of phospholipid composition on the kinetics have not been determined. Stopped-flow spectroscopy was used to measure the binding and dissociation of a recombinant myo1c construct containing the tail and regulatory domains (myo1c(IQ-tail)) to and from 100-nm diameter large unilamellar vesicles (LUVs). We found the time course of association of myo1c(IQ-tail) with LUVs containing 2% phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2) followed a two-exponential time course, and the rate of the predominant fast phase depended linearly upon the total lipid concentration. The apparent second-order rate constant was approximately diffusion-limited. Increasing the molar ratio of anionic phospholipid by adding phosphatidylserine, additional PtdIns(4,5)P-2, or by situating PtdIns(4,5)P-2 in a more physiologically relevant lipid background increased the apparent association rate constant less than 2-fold. myo1c(IQ-tail) dissociated from PtdIns(4,5)P-2 at a slower rate (2.0 s(-1)) than the pleckstrin homology domain of phospholipase C-delta (13 s(-1)). The presence of additional anionic phospholipid reduced the myo1c(IQ-tail) dissociation rate constant > 50-fold but marginally changed the dissociation rate of phospholipase C-delta, suggesting that additional electrostatic interactions in myo1c(IQ-tail) help to stabilize binding. Remarkably, high concentrations of soluble inositol phosphates induce dissociation of myo1c(IQ-tail) from LUVs, suggesting that phosphoinositides are able to bind to and dissociate from myo1c(IQ-tail) as it remains bound to the membrane.	[McKenna, Jennine M. Dawicki; Ostap, E. Michael] Univ Penn, Sch Med, Dept Physiol, Penn Muscle Inst, Philadelphia, PA 19104 USA	University of Pennsylvania	Ostap, EM (corresponding author), B400 Richards Bldg, Philadelphia, PA 19104 USA.	ostap@mail.med.upenn.edu		Dawicki McKenna, Jennine/0000-0002-1293-640X	National Institutes of Health [GM057247]; National Institutes of Health Training [GM07229]; American Heart Association predoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057247, R37GM057247, T32GM007229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association predoctoral fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM057247 to (E. M. O.).; Supported by National Institutes of Health Training Grant GM07229 and an American Heart Association predoctoral fellowship.	ADAMS RJ, 1989, NATURE, V340, P565, DOI 10.1038/340565a0; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; Brozinick JT, 2007, CURR DIABETES REV, V3, P111, DOI 10.2174/157339907780598199; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; COLLINS JH, 1992, ADV EXP MED BIOL, V321, P159; Corbin JA, 2004, BIOCHEMISTRY-US, V43, P16161, DOI 10.1021/bi049017a; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Etournay R, 2005, J CELL SCI, V118, P2891, DOI 10.1242/jcs.02424; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; HAYDEN SM, 1990, J CELL BIOL, V111, P443, DOI 10.1083/jcb.111.2.443; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Hokanson DE, 2006, P NATL ACAD SCI USA, V103, P3118, DOI 10.1073/pnas.0505685103; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Huang SH, 2004, MOL CELL BIOL, V24, P9102, DOI 10.1128/MCB.24.20.9102-9123.2004; Insall RH, 2001, DEV CELL, V1, P743, DOI 10.1016/S1534-5807(01)00086-7; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lemmon MA, 2001, BIOCHEM SOC T, V29, P377, DOI 10.1042/BST0290377; Lu YF, 1996, BIOCHEMISTRY-US, V35, P8193, DOI 10.1021/bi960280o; Macia E, 2000, BIOCHEMISTRY-US, V39, P5893, DOI 10.1021/bi992795w; Manceva S, 2007, BIOCHEMISTRY-US, V46, P11718, DOI 10.1021/bi700894h; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; MIYATA H, 1989, J CELL BIOL, V109, P1519, DOI 10.1083/jcb.109.4.1519; Nakamori Y, 2006, J CELL BIOL, V173, P665, DOI 10.1083/jcb.200601065; NOVAK KD, 1995, J CELL BIOL, V131, P1205, DOI 10.1083/jcb.131.5.1205; RUPPERT C, 1995, J CELL SCI, V108, P3775; Sokac AM, 2006, DEV CELL, V11, P629, DOI 10.1016/j.devcel.2006.09.002; Swanljung-Collins H, 1994, Adv Exp Med Biol, V358, P205; Tang N, 2007, J MUSCLE RES CELL M, V28, P285, DOI 10.1007/s10974-007-9124-7; Tang NY, 2002, J BIOL CHEM, V277, P42763, DOI 10.1074/jbc.M206388200; TONER M, 1988, BIOCHEMISTRY-US, V27, P7435, DOI 10.1021/bi00419a039; Tyska MJ, 2004, J CELL BIOL, V165, P395, DOI 10.1083/jcb.200310031; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	41	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28650	28659		10.1074/jbc.M109.049791	http://dx.doi.org/10.1074/jbc.M109.049791			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706607	Green Published, hybrid			2022-12-25	WOS:000270678900020
J	O'Connell, MP; Fiori, JL; Kershner, EK; Frank, BP; Indig, FE; Taub, DD; Hoek, KS; Weeraratna, AT				O'Connell, Michael P.; Fiori, Jennifer L.; Kershner, Emily K.; Frank, Brittany P.; Indig, Fred E.; Taub, Dennis D.; Hoek, Keith S.; Weeraratna, Ashani T.			Heparan Sulfate Proteoglycan Modulation of Wnt5A Signal Transduction in Metastatic Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPRESSION; GROWTH; DOMAIN; MIGRATION; SYNDECAN-1; PERLECAN; PATHWAY; QSULF1; GENE; PHOSPHORYLATION	Heparan sulfate proteoglycans (HSPGs) are important modulators for optimizing signal transduction of many pathways, including the Wnt pathways. We demonstrate that HSPG glycosaminoglycan levels increased with increasing metastatic potential of melanoma cells. Previous studies have demonstrated that Wnt5A increases the invasiveness of melanoma cells. We further demonstrate that HSPGs potentiate Wnt5A signaling, since enzymatic removal of the HSPG backbone resulted in a decrease in cellular Wnt5A levels, an increase in secreted Wnt5A in cell media, a decrease in downstream signaling, and ultimately, a decrease in invasiveness. Specifically, syndecan 1 and syndecan 4 expression correlated to Wnt5A expression and melanoma malignancy. Knockdown of syndecan 1 or 4 caused decreases in cell invasion, which could be restored by treating the cells with recombinant Wnt5A. These data indicate that syndecan 1 and 4 correlate to increased metastatic potential in melanoma patients and are an important component of the Wnt5A autocrine signaling loop, the activation of which leads to increased metastasis of melanoma.	[Weeraratna, Ashani T.] NIA, Immunol Lab, Res Resources Branch, NIH, Baltimore, MD 21224 USA; [Fiori, Jennifer L.] NIA, Clin Invest Lab, Res Resources Branch, NIH, Baltimore, MD 21224 USA; [Indig, Fred E.] NIA, Confocal Imaging Unit, Res Resources Branch, NIH, Baltimore, MD 21224 USA; [Hoek, Keith S.] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Zurich; University Zurich Hospital	Weeraratna, AT (corresponding author), 251 Bayview Blvd,Suite 100,Rm08C226, Baltimore, MD 21224 USA.	weerarat@mail.nih.gov	O'Connell, Michael/F-9236-2017	O'Connell, Michael/0000-0002-8615-7660	National Institutes of Health Intramural Research Program of the NIA; NATIONAL INSTITUTE ON AGING [ZIAAG000442, ZICAG000615, Z01AG000450, Z01AG000615, ZIAAG000450] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NIA (Baltimore, MD).	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Bachy S, 2008, J CELL PHYSIOL, V214, P238, DOI 10.1002/jcp.21184; Baeg GH, 2001, DEVELOPMENT, V128, P87; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Chalkiadaki G, 2009, INT J BIOCHEM CELL B, V41, P1323, DOI 10.1016/j.biocel.2008.11.008; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; Colombres M, 2008, J CELL PHYSIOL, V216, P805, DOI 10.1002/jcp.21465; Da Forno PD, 2008, CLIN CANCER RES, V14, P5825, DOI 10.1158/1078-0432.CCR-07-5104; Datta S, 2006, INT J BIOCHEM CELL B, V38, P1855, DOI 10.1016/j.biocel.2006.03.022; Dews IC, 2007, P NATL ACAD SCI USA, V104, P20782, DOI 10.1073/pnas.0708909105; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Dissanayake SK, 2008, CANCER RES, V68, P10205, DOI 10.1158/0008-5472.CAN-08-2149; Dissanayake Samudra K., 2008, V468, P157, DOI 10.1007/978-1-59745-249-6_12; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Fjeldstad K, 2005, CURR DRUG TARGETS, V6, P665, DOI 10.2174/1389450054863662; Habuchi H, 2004, GLYCOCONJUGATE J, V21, P47, DOI 10.1023/B:GLYC.0000043747.87325.5e; HIRAGA T, 1995, BONE, V16, P349, DOI 10.1016/8756-3282(94)00048-4; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Ikuta Y, 2005, CLIN CANCER RES, V11, P8079, DOI 10.1158/1078-0432.CCR-05-1074; Jonsson M, 1998, BRIT J CANCER, V78, P430, DOI 10.1038/bjc.1998.511; Kramer KL, 2003, ANNU REV GENET, V37, P461, DOI 10.1146/annurev.genet.37.061103.090226; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Lin FB, 2005, J INVEST DERMATOL, V124, P906, DOI 10.1111/j.0022-202X.2005.23740.x; Lin XH, 2000, MATRIX BIOL, V19, P303, DOI 10.1016/S0945-053X(00)00073-1; Lopes CC, 2006, BRAZ J MED BIOL RES, V39, P157, DOI 10.1590/S0100-879X2006000200001; Mahtouk K, 2006, ONCOGENE, V25, P7180, DOI 10.1038/sj.onc.1209699; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; Melrose J, 2008, BIOESSAYS, V30, P457, DOI 10.1002/bies.20748; Munoz R, 2006, NAT CELL BIOL, V8, P492, DOI 10.1038/ncb1399; O'Callaghan P, 2008, BRAIN PATHOL, V18, P548, DOI 10.1111/j.1750-3639.2008.00152.x; O'Connell MP, 2007, J CELL BIOCHEM, V102, P1493, DOI 10.1002/jcb.21370; O'Connell MP, 2009, J INVEST DERMATOL, V129, P1782, DOI 10.1038/jid.2008.433; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; Reiland J, 2004, J BIOL CHEM, V279, P8047, DOI 10.1074/jbc.M304872200; Roy M, 2009, J CELL BIOCHEM, V106, P200, DOI 10.1002/jcb.22005; Timar J, 2006, CELL IMMUNOL, V244, P154, DOI 10.1016/j.cellimm.2006.12.009; TIMAR J, 1992, AM J PATHOL, V141, P467; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Yan D, 2008, NAT CELL BIOL, V10, P761, DOI 10.1038/ncb0708-761; Yang Y, 2007, BLOOD, V110, P2041, DOI 10.1182/blood-2007-04-082495; Yi JY, 2006, THESCIENTIFICWORLDJO, V6, P457, DOI 10.1100/tsw.2006.92	47	61	63	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28704	28712		10.1074/jbc.M109.028498	http://dx.doi.org/10.1074/jbc.M109.028498			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19696445	Green Published, hybrid			2022-12-25	WOS:000270678900026
J	Takemura, M; Mishima, T; Wang, Y; Kasahara, J; Fukunaga, K; Ohashi, K; Mizuno, K				Takemura, Miyohiko; Mishima, Toshiaki; Wang, Yan; Kasahara, Jiro; Fukunaga, Kohji; Ohashi, Kazumasa; Mizuno, Kensaku			Ca2+/Calmodulin-dependent Protein Kinase IV-mediated LIM Kinase Activation Is Critical for Calcium Signal-induced Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH CONE MOTILITY; COFILIN PHOSPHORYLATION; ACTIN REORGANIZATION; CYTOSKELETAL DYNAMICS; DENDRITIC GROWTH; CELL-MIGRATION; PDZ DOMAIN; SLINGSHOT; ADF/COFILIN; EXTENSION	Actin cytoskeletal remodeling is essential for neurite outgrowth. LIM kinase 1 (LIMK1) regulates actin cytoskeletal remodeling by phosphorylating and inactivating cofilin, an actin filament-disassembling factor. In this study, we investigated the role of LIMK1 in calcium signal-induced neurite outgrowth. The calcium ionophore ionomycin induced LIMK1 activation and cofilin phosphorylation in Neuro-2a neuroblastoma cells. Knockdown of LIMK1 or expression of a kinase-dead mutant of LIMK1 suppressed ionomycin-induced cofilin phosphorylation and neurite outgrowth in Neuro-2a cells. Ionomycin-induced cofilin phosphorylation and neurite outgrowth were also blocked by KN-93, an inhibitor of Ca2+/calmodulin-dependent protein kinases (CaMKs), and STO-609, an inhibitor of CaMK kinase. An active form of CaMKIV but not CaMKI enhanced Thr-508 phosphorylation of LIMK1 and increased the kinase activity of LIMK1. Moreover, the active form of CaMKIV induced cofilin phosphorylation and neurite outgrowth, and a dominant negative form of CaMKIV suppressed ionomycin-induced neurite outgrowth. Taken together, our results suggest that LIMK1-mediated cofilin phosphorylation is critical for ionomycin-induced neurite outgrowth and that CaMKIV mediates ionomycin-induced LIMK1 activation.	[Takemura, Miyohiko; Mishima, Toshiaki; Ohashi, Kazumasa; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan; [Wang, Yan] Jilin Univ, China Japan Union Hosp, Res Ctr Gene Therapy, Changchun 130033, Peoples R China; [Kasahara, Jiro; Fukunaga, Kohji] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi 9808578, Japan	Tohoku University; Jilin University; Tohoku University	Mizuno, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan.	kmizuno@biology.tohoku.ac.jp	Mizuno, Kensaku/G-8631-2015; Ohashi, Kazumasa/U-7028-2019; Fukunaga, Kohji/AAI-8811-2021	Ohashi, Kazumasa/0000-0001-7617-403X; Fukunaga, Kohji/0000-0001-8526-2824	Ministry of Education, Culture, Science, Sports and Technology of Japan	Ministry of Education, Culture, Science, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Science, Sports and Technology of Japan.	Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Amano T, 2002, J BIOL CHEM, V277, P22093, DOI 10.1074/jbc.M201444200; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Endo M, 2003, J NEUROSCI, V23, P2527; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Han F, 2009, BRAIN RES, V1265, P205, DOI 10.1016/j.brainres.2009.02.014; Horita Y, 2008, J BIOL CHEM, V283, P6013, DOI 10.1074/jbc.M706538200; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P2850, DOI 10.1073/pnas.88.7.2850; Kasahara J, 1999, J BIOL CHEM, V274, P9061, DOI 10.1074/jbc.274.13.9061; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Kotera I, 2005, EMBO J, V24, P942, DOI 10.1038/sj.emboj.7600587; Kurita S, 2008, J BIOL CHEM, V283, P32542, DOI 10.1074/jbc.M804627200; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Meberg PJ, 1998, CELL MOTIL CYTOSKEL, V39, P172, DOI 10.1002/(SICI)1097-0169(1998)39:2<172::AID-CM8>3.0.CO;2-8; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Okano I, 1995, J BIOL CHEM, V270, P31321, DOI 10.1074/jbc.270.52.31321; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Rosso S, 2004, MOL BIOL CELL, V15, P3433, DOI 10.1091/mbc.E03-05-0328; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Schmitt JM, 2004, J BIOL CHEM, V279, P24064, DOI 10.1074/jbc.M401501200; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Spencer TK, 2008, MOL CELL NEUROSCI, V38, P110, DOI 10.1016/j.mcn.2008.02.005; Tai YL, 2008, J CELL SCI, V121, P2301, DOI 10.1242/jcs.026906; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Tokumitsu H, 2000, J BIOL CHEM, V275, P20090, DOI 10.1074/jbc.M002193200; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; Uboha NV, 2007, J NEUROSCI, V27, P4413, DOI 10.1523/JNEUROSCI.0725-07.2007; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Wu G, 1998, J NEUROCYTOL, V27, P1, DOI 10.1023/A:1006910001869; Wu JY, 2000, ENDOCRINOLOGY, V141, P4777, DOI 10.1210/en.141.12.4777; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yang N, 1999, BIOCHEM J, V338, P793, DOI 10.1042/0264-6021:3380793; Yang N, 1998, EXP CELL RES, V241, P242, DOI 10.1006/excr.1998.4053	54	55	57	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28554	28562		10.1074/jbc.M109.006296	http://dx.doi.org/10.1074/jbc.M109.006296			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19696021	Green Published, hybrid			2022-12-25	WOS:000270678900009
J	Mo, R; Chew, TL; Maher, MT; Bellipanni, G; Weinberg, ES; Gottardi, CJ				Mo, Rigen; Chew, Teng-Leong; Maher, Meghan T.; Bellipanni, Gianfranco; Weinberg, Eric S.; Gottardi, Cara J.			The Terminal Region of beta-Catenin Promotes Stability by Shielding the Armadillo Repeats from the Axin-scaffold Destruction Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; GENE-EXPRESSION; XENOPUS EMBRYOS; MOLECULAR-BASIS; APC; PHOSPHORYLATION; PROTEIN; BINDING; CELL; ADHESION	Post-translational stabilization of beta-catenin is a key step in Wnt signaling, but the features of beta-catenin required for stabilization are incompletely understood. We show that forms of beta-catenin lacking the unstructured C-terminal domain (CTD) show faster turnover than full-length or minimally truncated beta-catenins. Mutants that exhibit faster turnover show enhanced association with axin in co-transfected cells, and excess CTD polypeptide can compete binding of the beta-catenin armadillo (arm) repeat domain to axin in vitro, indicating that the CTD may restrict beta-catenin binding to the axin-scaffold complex. Fluorescent resonance energy transmission (FRET) analysis of cyan fluorescent protein (CFP)-arm-CTD-yellow fluorescent protein beta-catenin reveals that the CTD of beta-catenin can become spatially close to the N-terminal arm repeat region of beta-catenin. FRET activity is strongly diminished by the coexpression of beta-catenin binding partners, indicating that an unliganded groove is absolutely required for an orientation that allows FRET. Amino acids 733-759 are critical for beta-catenin FRET activity and stability. These data indicate that an N-terminal orientation of the CTD is required for beta-catenin stabilization and suggest a model where the CTD extends toward the N-terminal arm repeats, shielding these repeats from the beta-catenin destruction complex.	[Mo, Rigen; Maher, Meghan T.; Gottardi, Cara J.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Chew, Teng-Leong] Northwestern Univ, Feinberg Sch Med, Dept Cellular & Mol Biol, Chicago, IL 60611 USA; [Maher, Meghan T.] Northwestern Univ, Feinberg Sch Med, Integrated Grad Program Life Sci, Chicago, IL 60611 USA; [Gottardi, Cara J.] Northwestern Univ, Feinberg Sch Med, Robert Lurie Canc Ctr, Chicago, IL 60611 USA; [Bellipanni, Gianfranco; Weinberg, Eric S.] Univ Penn, Dept Biol, Philadelphia, PA 19106 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; University of Pennsylvania	Gottardi, CJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA.	c-gottardi@northwestern.edu	Gottardi, Cara J./AAU-4691-2021	Gottardi, Cara J./0000-0003-0912-7617	National Institutes of Health [T32 GM08061, P30 CA060553, R01 HD39272, GM076561]; American Heart Association [09PRE2261197, 0530304Z]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039272] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076561, T32GM008061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM08061 (to M. T. M.), P30 CA060553 (to the Northwestern Imaging Facility and Robert H. Lurie Comprehensive Cancer Center), R01 HD39272 (to E. S. W. and G. B.), and GM076561 (to C. J. G.). This work was also supported by American Heart Association Pre-doctoral Award 09PRE2261197 (to M. T. M.) and the American Heart Association Grant 0530304Z (to C. J. G.).	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Bellipanni G, 2006, DEVELOPMENT, V133, P1299, DOI 10.1242/dev.02295; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; Castano J, 2002, J BIOL CHEM, V277, P31541, DOI 10.1074/jbc.M204376200; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chew TL, 2002, J CELL BIOL, V156, P543, DOI 10.1083/jcb.200110161; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Cox RT, 1999, GENETICS, V153, P319; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Giannini AL, 2000, EXP CELL RES, V255, P207, DOI 10.1006/excr.1999.4785; Gottardi CJ, 2008, STRUCTURE, V16, P336, DOI 10.1016/j.str.2008.02.005; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Gottardi CJ, 2004, AM J PHYSIOL-CELL PH, V286, pC747, DOI 10.1152/ajpcell.00433.2003; Gottardi CJ, 2001, CURR BIOL, V11, pR792, DOI 10.1016/S0960-9822(01)00473-0; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Guger KA, 2000, DEV BIOL, V223, P441, DOI 10.1006/dbio.2000.9770; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Jho EH, 1999, BIOCHEM BIOPH RES CO, V266, P28, DOI 10.1006/bbrc.1999.1760; Kanamori M, 2003, J BIOL CHEM, V278, P38758, DOI 10.1074/jbc.M306324200; Kelly C, 2000, DEVELOPMENT, V127, P3899; Kidd AR, 2005, CELL, V121, P761, DOI 10.1016/j.cell.2005.03.029; Lee E, 2001, J CELL BIOL, V154, P983, DOI 10.1083/jcb.200102074; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Loureiro J, 1998, CURR BIOL, V8, P622, DOI 10.1016/S0960-9822(98)70249-0; Luo W, 2007, EMBO J, V26, P1511, DOI 10.1038/sj.emboj.7601607; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; Nishimura W, 2002, J NEUROSCI, V22, P757, DOI 10.1523/JNEUROSCI.22-03-00757.2002; PEIFER M, 1994, DEVELOPMENT, V120, P369; Perego C, 2000, EMBO J, V19, P3978, DOI 10.1093/emboj/19.15.3978; Piao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004046; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; Rubinfeld B, 2001, J BIOL CHEM, V276, P39037, DOI 10.1074/jbc.M105148200; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023; Tago K, 2000, GENE DEV, V14, P1741; von Kries JP, 2000, NAT STRUCT BIOL, V7, P800; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Xing Y, 2004, MOL CELL, V15, P523, DOI 10.1016/j.molcel.2004.08.001; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	56	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28222	28231		10.1074/jbc.M109.045039	http://dx.doi.org/10.1074/jbc.M109.045039			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19706613	Green Published, hybrid			2022-12-25	WOS:000270676300050
J	Sloan, CD; Andrew, AD; Duell, EJ; Williams, SM; Karagas, MR; Moore, JH				Sloan, Chantel D.; Andrew, Angeline D.; Duell, Eric J.; Williams, Scott M.; Karagas, Margaret R.; Moore, Jason H.			Genetic Population Structure Analysis in New Hampshire Reveals Eastern European Ancestry	PLOS ONE			English	Article							INFERENCE; EXAMPLE	Genetic structure due to ancestry has been well documented among many divergent human populations. However, the ability to associate ancestry with genetic substructure without using supervised clustering has not been explored in more presumably homogeneous and admixed US populations. The goal of this study was to determine if genetic structure could be detected in a United States population from a single state where the individuals have mixed European ancestry. Using Bayesian clustering with a set of 960 single nucleotide polymorphisms (SNPs) we found evidence of population stratification in 864 individuals from New Hampshire that can be used to differentiate the population into six distinct genetic subgroups. We then correlated self-reported ancestry of the individuals with the Bayesian clustering results. Finnish and Russian/Polish/Lithuanian ancestries were most notably found to be associated with genetic substructure. The ancestral results were further explained and substantiated using New Hampshire census data from 1870 to 1930 when the largest waves of European immigrants came to the area. We also discerned distinct patterns of linkage disequilibrium (LD) between the genetic groups in the growth hormone receptor gene (GHR). To our knowledge, this is the first time such an investigation has uncovered a strong link between genetic structure and ancestry in what would otherwise be considered a homogenous US population.			Sloan, CD (corresponding author), Dartmouth Med Sch, Dept Genet, Computat Genet Lab, Lebanon, NH USA.	jason.h.moore@dartmouth.edu	Williams, Scott/Q-4812-2019; Sloan-Aagard, Chantel/GWC-7572-2022; Williams, Scott/B-9491-2012; Moore, Jason H./AAV-9645-2021	Williams, Scott/0000-0002-4835-9544; Moore, Jason H./0000-0002-5015-1099; Duell, Eric J/0000-0001-5256-0163	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047447] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA057494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009012] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA057494, CA57494] Funding Source: Medline; NICHD NIH HHS [R01 HD047447, HD047447] Funding Source: Medline; NIEHS NIH HHS [P42 ES007373, ES007373] Funding Source: Medline; NLM NIH HHS [R01 LM009012, LM009012] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Andrew AS, 2008, HUM HERED, V65, P105, DOI 10.1159/000108942; Andrew AS, 2009, HUM GENET, V125, P527, DOI 10.1007/s00439-009-0645-6; Arnaiz-Villena A, 2002, TISSUE ANTIGENS, V60, P111, DOI 10.1034/j.1399-0039.2002.600201.x; ArnaizVillena A, 1997, IMMUNOGENETICS, V47, P37, DOI 10.1007/s002510050324; Bosch E, 2000, EUR J HUM GENET, V8, P360, DOI 10.1038/sj.ejhg.5200464; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clegg LX, 2002, ARCH INTERN MED, V162, P1985, DOI 10.1001/archinte.162.17.1985; Crawford MH, 2007, AM J HUM BIOL, V19, P203, DOI 10.1002/ajhb.20631; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Falush D, 2003, GENETICS, V164, P1567; FALUSH D, 2007, MOL ECOL NOTES; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Lappalainen T, 2006, GENE, V376, P207, DOI 10.1016/j.gene.2006.03.004; Lefevre-Witier P, 2006, AM J HUM BIOL, V18, P492, DOI 10.1002/ajhb.20511; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu XQ, 2006, ANN HUM GENET, V70, P496, DOI 10.1111/j.1469-1809.2005.00255.x; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Sinnwell JP, 2009, HAPLO STATS STAT ANA; Sokal RR, 2000, P NATL ACAD SCI USA, V97, P6067, DOI 10.1073/pnas.97.11.6067; Sokal RR, 1997, P NATL ACAD SCI USA, V94, P12728, DOI 10.1073/pnas.94.23.12728; Sokal RR, 2004, AM J HUM BIOL, V16, P1, DOI 10.1002/ajhb.10231; Steffens M, 2006, HUM HERED, V62, P20, DOI 10.1159/000095850; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; *U VIRG GEOSP STAT, 2009, HIST CENS BROWS; WRIGHT S, 1950, NATURE, V166, P247, DOI 10.1038/166247a0	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2009	4	9							e6928	10.1371/journal.pone.0006928	http://dx.doi.org/10.1371/journal.pone.0006928			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZH	19738909	Green Published, Green Submitted, gold			2022-12-25	WOS:000269622300012
J	Chahine, G; Krekelberg, B				Chahine, George; Krekelberg, Bart			Cortical Contributions to Saccadic Suppression	PLOS ONE			English	Article								The stability of visual perception is partly maintained by saccadic suppression: the selective reduction of visual sensitivity that accompanies rapid eye movements. The neural mechanisms responsible for this reduced perisaccadic visibility remain unknown, but the Lateral Geniculate Nucleus (LGN) has been proposed as a likely site. Our data show, however, that the saccadic suppression of a target flashed in the right visual hemifield increased with an increase in background luminance in the left visual hemifield. Because each LGN only receives retinal input from a single hemifield, this hemifield interaction cannot be explained solely on the basis of neural mechanisms operating in the LGN. Instead, this suggests that saccadic suppression must involve processing in higher level cortical areas that have access to a considerable part of the ipsilateral hemifield.			Chahine, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	bart@rutgers.edu	Krekelberg, Bart/N-7938-2019	Krekelberg, Bart/0000-0003-1083-6103	NATIONAL EYE INSTITUTE [R01EY017605] Funding Source: NIH RePORTER; NEI NIH HHS [R01EY17605, R01 EY017605-01A1, R01 EY017605] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; BURR DC, 1982, J PHYSIOL-LONDON, V333, P1; Diamond MR, 2000, J NEUROSCI, V20, P3449, DOI 10.1523/JNEUROSCI.20-09-03449.2000; Ibbotson MR, 2008, J NEUROSCI, V28, P10952, DOI 10.1523/JNEUROSCI.3950-08.2008; KAMMER T, 2005, EXP BRAIN RES, V160; Kleiser R, 2004, CURR BIOL, V14, P386, DOI 10.1016/j.cub.2004.02.036; Krekelberg B, 2003, NEURON, V37, P537, DOI 10.1016/S0896-6273(03)00003-5; MALPELI JG, 1975, J COMP NEUROL, V161; Reppas JB, 2002, NEURON, V35, P961, DOI 10.1016/S0896-6273(02)00823-1; Rossi AF, 1999, J NEUROSCI, V19, P6145, DOI 10.1523/JNEUROSCI.19-14-06145.1999; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; Sylvester R, 2005, CURR BIOL, V15, P37, DOI 10.1016/j.cub.2004.12.061; Sylvester R, 2006, NEUROIMAGE, V30, P214, DOI 10.1016/j.neuroimage.2005.09.014; Thiele A, 2002, SCIENCE, V295, P2460, DOI 10.1126/science.1068788; Thilo KV, 2004, NAT NEUROSCI, V7, P13, DOI 10.1038/nn1171; Vallines I, 2006, J NEUROSCI, V26, P5965, DOI 10.1523/JNEUROSCI.0817-06.2006; Watson TL, 2009, CURR BIOL, V19, P1040, DOI 10.1016/j.cub.2009.04.052; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wurtz RH, 2008, VISION RES, V48, P2070, DOI 10.1016/j.visres.2008.03.021	19	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2009	4	9							e6900	10.1371/journal.pone.0006900	http://dx.doi.org/10.1371/journal.pone.0006900			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZF	19730739	Green Published, gold, Green Submitted			2022-12-25	WOS:000269622100005
J	Outeiro, TF; Klucken, J; Bercury, K; Tetzlaff, J; Putcha, P; Oliveira, LMA; Quintas, A; McLean, PJ; Hyman, BT				Outeiro, Tiago F.; Klucken, Jochen; Bercury, Kathryn; Tetzlaff, Julie; Putcha, Preeti; Oliveira, Luis M. A.; Quintas, Alexandre; McLean, Pamela J.; Hyman, Bradley T.			Dopamine-Induced Conformational Changes in Alpha-Synuclein	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; PARKINSONS-DISEASE; OLIGOMERIZATION; STABILIZATION; AGGREGATION; DICHROWEB; TOXICITY; BINDING; SITE	Background: Oligomerization and aggregation of alpha-synuclein molecules play a major role in neuronal dysfunction and loss in Parkinson's disease [1]. However, alpha-synuclein oligomerization and aggregation have mostly been detected indirectly in cells using detergent extraction methods [2,3,4]. A number of in vitro studies showed that dopamine can modulate the aggregation of alpha-synuclein by inhibiting the formation of or by disaggregating amyloid fibrils [5,6,7]. Methodology/Principal Findings: Here, we show that alpha-synuclein adopts a variety of conformations in primary neuronal cultures using fluorescence lifetime imaging microscopy (FLIM). Importantly, we found that dopamine, but not dopamine agonists, induced conformational changes in alpha-synuclein which could be prevented by blocking dopamine transport into the cell. Dopamine also induced conformational changes in alpha-synuclein expressed in neuronal cell lines, and these changes were also associated with alterations in oligomeric/aggregated species. Conclusion/Significance: Our results show, for the first time, a direct effect of dopamine on the conformation of alpha-synuclein in neurons, which may help explain the increased vulnerability of dopaminergic neurons in Parkinson's disease.			Outeiro, TF (corresponding author), Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Alzheimer Res Unit, Charlestown, MA USA.	touteiro@fm.ul.pt; bhyman@partners.org	Outeiro, Tiago F/C-1067-2008; Tetzlaff, Julie/ABA-3395-2021; Outeiro, Tiago/M-8106-2019; Oliveira, Luis M. A./I-7994-2014; Quintas, Alexandre/J-6436-2012; Outeiro, Tiago/L-7351-2019	Outeiro, Tiago F/0000-0003-1679-1727; Oliveira, Luis M. A./0000-0002-2958-181X; Quintas, Alexandre/0000-0002-5188-0453; Outeiro, Tiago/0000-0003-1679-1727; McLean, Pamela/0000-0003-4870-5715; Klucken, Jochen/0000-0001-6645-9437	NINDS NIH HHS [5P50-NS38372A-06, R01 NS063963, P50 NS038372] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063963, P50NS038372] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bacskai BJ, 2003, J BIOMED OPT, V8, P368, DOI 10.1117/1.1584442; Berezovska O, 2003, J NEUROSCI, V23, P4560; BEREZOVSKA O, 2003, SCI AGING KNOWLEDGE, pPE14; Cappai R, 2005, FASEB J, V19, P1377, DOI 10.1096/fj.04-3437fje; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; CRAWFORD GD, 1992, J NEUROSCI, V12, P3392; Fortin DL, 2005, J NEUROSCI, V25, P10913, DOI 10.1523/JNEUROSCI.2922-05.2005; Galvin JE, 2006, ACTA NEUROPATHOL, V112, P115, DOI 10.1007/s00401-006-0096-2; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kessler JC, 2003, BIOCHEMISTRY-US, V42, P672, DOI 10.1021/bi020429y; KLUCKEN J, 2004, J BIOL CHEM; Klucken J, 2006, FASEB J, V20, P2050, DOI 10.1096/fj.05-5422com; Li J, 2004, FASEB J, V18, P962, DOI 10.1096/fj.03-0770fje; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lucking CB, 2000, CELL MOL LIFE SCI, V57, P1894, DOI 10.1007/PL00000671; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Mazzulli JR, 2007, J BIOL CHEM, V282, P31621, DOI 10.1074/jbc.M704737200; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; Norris EH, 2005, ANTIOXID REDOX SIGN, V7, P673; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Soto C, 2008, ARCH NEUROL-CHICAGO, V65, P184, DOI 10.1001/archneurol.2007.56; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2001, J BIOL CHEM, V276, P43495, DOI 10.1074/jbc.C100551200; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Zhu M, 2003, J BIOL CHEM, V278, P16873, DOI 10.1074/jbc.M210136200	36	50	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2009	4	9							e6906	10.1371/journal.pone.0006906	http://dx.doi.org/10.1371/journal.pone.0006906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZF	19730729	Green Published, Green Submitted, gold			2022-12-25	WOS:000269622100011
J	Wei, H; Cheng, RH; Berriman, J; Rice, WJ; Stokes, DL; Katz, A; Morgan, DG; Gottlieb, P				Wei, Hui; Cheng, R. Holland; Berriman, John; Rice, William J.; Stokes, David L.; Katz, A.; Morgan, David Gene; Gottlieb, Paul			Three-Dimensional Structure of the Enveloped Bacteriophage Phi 12: An Incomplete T=13 Lattice Is Superposed on an Enclosed T=1 Shell	PLOS ONE			English	Article								Background: Bacteriophage phi 12 is a member of the Cystoviridae, a unique group of lipid containing membrane enveloped bacteriophages that infect the bacterial plant pathogen Pseudomonas syringae pv. phaseolicola. The genomes of the virus species contain three double-stranded (dsRNA) segments, and the virus capsid itself is organized in multiple protein shells. The segmented dsRNA genome, the multi-layered arrangement of the capsid and the overall viral replication scheme make the Cystoviridae similar to the Reoviridae. Methodology/Principal Findings: We present structural studies of cystovirus phi 12 obtained using cryo-electron microscopy and image processing techniques. We have collected images of isolated phi 12 virions and generated reconstructions of both the entire particles and the polymerase complex (PC). We find that in the nucleocapsid (NC), the phi 12 P8 protein is organized on an incomplete T = 13 icosahedral lattice where the symmetry axes of the T = 13 layer and the enclosed T = 1 layer of the PC superpose. This is the same general protein-component organization found in phi 6 NC's but the detailed structure of the entire phi 12 P8 layer is distinct from that found in the best classified cystovirus species phi 6. In the reconstruction of the NC, the P8 layer includes protein density surrounding the hexamers of P4 that sit at the 5-fold vertices of the icosahedral lattice. We believe these novel features correspond to dimers of protein P7. Conclusions/Significance: In conclusion, we have determined that the phi 12 NC surface is composed of an incomplete T = 13 P8 layer forming a net-like configuration. The significance of this finding in regard to cystovirus assembly is that vacancies in the lattice could have the potential to accommodate additional viral proteins that are required for RNA packaging and synthesis.			Wei, H (corresponding author), CUNY City Coll, Dept Microbiol & Immunol, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA.	pgottl@med.cuny.edu	Morgan, David Gene/W-3429-2019; Cheng, Holland/A-8973-2008	Rice, William/0000-0002-5187-255X	NCRR NIH HHS [G12 RR003060, G12RR-03060] Funding Source: Medline; NIGMS NIH HHS [R01 GM071044] Funding Source: Medline; Div Of Molecular and Cellular Bioscience [0741914] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071044] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alimova A, 2005, PHOTOCHEM PHOTOBIOL, V81, P879, DOI 10.1562/2005-01-14-RA-416R1.1; Butcher SJ, 1997, EMBO J, V16, P4477, DOI 10.1093/emboj/16.14.4477; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; CROWTHER RA, 1971, PHILOS T R SOC B, V261, P221, DOI 10.1098/rstb.1971.0054; DAY LA, 1980, VIROLOGY, V103, P376, DOI 10.1016/0042-6822(80)90196-8; de Haas F, 1999, J MOL BIOL, V294, P357, DOI 10.1006/jmbi.1999.3260; Eryilmaz E, 2008, J MOL BIOL, V382, P402, DOI 10.1016/j.jmb.2008.07.006; FRANK J, 1990, Q REV BIOPHYS, V23, P281, DOI 10.1017/S0033583500005564; GOTTLIEB P, 1988, J VIROL, V62, P181, DOI 10.1128/JVI.62.1.181-187.1988; Gottlieb P, 2002, VIROLOGY, V295, P266, DOI 10.1006/viro.2002.1436; Gottlieb P, 2002, VIROLOGY, V293, P118, DOI 10.1006/viro.2001.1288; GOTTLIEB P, 1990, J BACTERIOL, V172, P5774, DOI 10.1128/jb.172.10.5774-5782.1990; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Hu GB, 2008, VIROLOGY, V372, P1, DOI 10.1016/j.virol.2007.10.013; Huiskonen JT, 2006, STRUCTURE, V14, P1039, DOI 10.1016/j.str.2006.03.018; Jaalinoja HT, 2007, STRUCTURE, V15, P157, DOI 10.1016/j.str.2006.12.004; Jayaram H, 2004, VIRUS RES, V101, P67, DOI 10.1016/j.virusres.2003.12.007; JOHNSON MD, 1994, J BACTERIOL, V176, P4124, DOI 10.1128/JB.176.13.4124-4132.1994; Juuti JT, 1997, J MOL BIOL, V266, P891, DOI 10.1006/jmbi.1996.0817; Li TC, 2003, VIROLOGY, V311, P115, DOI 10.1016/S0042-6822(03)00141-7; Lisal J, 2004, J BIOL CHEM, V279, P1343, DOI 10.1074/jbc.M309587200; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Mancini EJ, 2004, ACTA CRYSTALLOGR D, V60, P588, DOI 10.1107/S0907444904001052; Mindich L, 1999, J BACTERIOL, V181, P4505, DOI 10.1128/JB.181.15.4505-4508.1999; MINDICH L, 1988, ADV VIRUS RES, V35, P137; Mindich L, 2004, VIRUS RES, V101, P83, DOI 10.1016/j.virusres.2003.12.008; Patton JT, 1996, J VIROL, V70, P7940, DOI 10.1128/JVI.70.11.7940-7947.1996; Qiao J, 2003, J BACTERIOL, V185, P4572, DOI 10.1128/JB.185.15.4572-4577.2003; Qiao XY, 2008, P NATL ACAD SCI USA, V105, P15956, DOI 10.1073/pnas.0807489105; Sen A, 2008, J BIOL CHEM, V283, P12227, DOI 10.1074/jbc.M710508200; SINCLAIR JF, 1975, J VIROL, V16, P685, DOI 10.1128/JVI.16.3.685-695.1975; STITT BL, 1983, VIROLOGY, V127, P459, DOI 10.1016/0042-6822(83)90158-7; VANETTEN J, 1976, J VIROL, V18, P652, DOI 10.1128/JVI.18.2.652-658.1976; VANHEEL M, 1984, ULTRAMICROSCOPY, V13, P165, DOI 10.1016/0304-3991(84)90066-4; Yang HY, 2003, VIROLOGY, V314, P706, DOI 10.1016/S0042-6822(03)00460-4; Zeng CQY, 1998, J VIROL, V72, P201, DOI 10.1128/JVI.72.1.201-208.1998; Zhang X, 2003, NAT STRUCT BIOL, V10, P1011, DOI 10.1038/nsb1009	38	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6850	10.1371/journal.pone.0006850	http://dx.doi.org/10.1371/journal.pone.0006850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19727406	Green Published, gold			2022-12-25	WOS:000269522900005
J	Tabib, A; Krispin, A; Trahtemberg, U; Verbovetski, I; Lebendiker, M; Danieli, T; Mevorach, D				Tabib, Adi; Krispin, Alon; Trahtemberg, Uriel; Verbovetski, Inna; Lebendiker, Mario; Danieli, Tsafi; Mevorach, Dror			Thrombospondin-1-N-Terminal Domain Induces a Phagocytic State and Thrombospondin-1-C-Terminal Domain Induces a Tolerizing Phenotype in Dendritic Cells	PLOS ONE			English	Article								In our previous study, we have found that thrombospondin-1 (TSP-1) is synthesized de novo upon monocyte and neutrophil apoptosis, leading to a phagocytic and tolerizing phenotype of dendritic cells ( DC), even prior to DC-apoptotic cell interaction. Interestingly, we were able to show that heparin binding domain (HBD), the N-terminal portion of TSP-1, was cleaved and secreted simultaneously in a caspase-and serine protease-dependent manner. In the current study we were interested to examine the role of HBD in the clearance of apoptotic cells, and whether the phagocytic and tolerizing state of DCs is mediated by the HBD itself, or whether the entire TSP-1 is needed. Therefore, we have cloned the human HBD, and compared its interactions with DC to those with TSP-1. Here we show that rHBD by itself is not directly responsible for immune paralysis and tolerizing phenotype of DCs, at least in the monomeric form, but has a significant role in rendering DCs phagocytic. Binding of TSP-1-C-terminal domain on the other hand induces a tolerizing phenotype in dendritic cells.			Tabib, A (corresponding author), Hebrew Univ Jerusalem, Rheumatol Res Unit, Lab Cellular & Mol Immunol, Jerusalem, Israel.	mevorachd@hadassah.org.il	Trahtemberg, Uriel/B-3127-2008	Trahtemberg, Uriel/0000-0001-9103-2494				Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Adams JC, 1997, INT J BIOCHEM CELL B, V29, P861, DOI 10.1016/S1357-2725(96)00171-9; Adams JC, 2003, J MOL BIOL, V328, P479, DOI 10.1016/S0022-2836(03)00248-1; Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Bornstein P, 2004, INT J BIOCHEM CELL B, V36, P1115, DOI 10.1016/j.biocel.2004.01.012; Calzada MJ, 2003, J BIOL CHEM, V278, P40679, DOI 10.1074/jbc.M302014200; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Demeure CE, 2000, J IMMUNOL, V164, P2193, DOI 10.4049/jimmunol.164.4.2193; Doyen V, 2003, J EXP MED, V198, P1277, DOI 10.1084/jem.20030705; Elzie CA, 2004, INT J BIOCHEM CELL B, V36, P1090, DOI 10.1016/j.biocel.2003.12.012; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Krispin A, 2006, BLOOD, V108, P3580, DOI 10.1182/blood-2006-03-013334; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Orr AW, 2004, J BIOL CHEM, V279, P48983, DOI 10.1074/jbc.M404881200; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Silverstein RL, 2002, J CELL BIOL, V159, P203, DOI 10.1083/jcb.200209138; Tan K, 2006, STRUCTURE, V14, P33, DOI 10.1016/j.str.2005.09.017; Verbovetski I, 2002, J EXP MED, V196, P1553, DOI 10.1084/jem.20020263; VOGEL T, 1993, J CELL BIOCHEM, V53, P74, DOI 10.1002/jcb.240530109	20	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6840	10.1371/journal.pone.0006840	http://dx.doi.org/10.1371/journal.pone.0006840			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19721725	gold, Green Published			2022-12-25	WOS:000269415900013
J	Ursing, J; Kofoed, PE; Rodrigues, A; Rombo, L				Ursing, Johan; Kofoed, Poul-Erik; Rodrigues, Amabelia; Rombo, Lars			No Seasonal Accumulation of Resistant P-falciparum when High-Dose Chloroquine Is Used	PLOS ONE			English	Article								Background: Potentially chloroquine resistant P. falciparum, identified by the 76T haplotype in the chloroquine resistance transporter (pfcrt 76T), are highly prevalent throughout Africa. In Guinea-Bissau, normal and double dose chloroquine have respective efficacies of 34% and 78% against P. falciparum with pfcrt 76T and approximately three times the normal dose of chloroquine is routinely taken. Proportions of pfcrt 76T generally increase during high transmission seasons, as P. falciparum with pfcrt 76T commonly survive treatment with normal dose chloroquine. In Guinea-Bissau, there should be no seasonal increase of pfcrt 76T if the high doses of CQ commonly used are effective. Methods and Findings: P. falciparum parasite density, age, sex, the proportion of chloroquine resistance associated haplotypes pfcrt 76T and P. falciparum multidrug resistance gene 1 86Y were assessed in 988 samples collected from children between 2002 and 2007. There was no seasonal accumulation of any allele. During the high and low transmission periods the pfcrt 76T proportions were 24% (95% CI, 21-27%) and 26% (95% CI, 20-33%). There was no significant change of pfcrt 76T (OR 1.05, 95% CI; 0.94-1.16 p = 0.39) or pfmdr1 86Y (OR 0.92, 95% CI; 0.83-1.01 p = 0.08) proportions between 2003 and 2007. Lower median parasite density (P. falciparum/mu l) was associated with pfcrt 76T (15254 [95% CI, 12737-17772]; n = 164) compared to pfcrt 76K (18664 [95% CI, 16676-20653]; p = 0.003; n = 591). Similarly, pfmdr1 86Y was associated with a lower median parasite density (16320 [95% CI, 13696-18944]; n = 224) compared to pfmdr1 86N, (18880 [95% CI, 16701-21059]; P = 0.018; n = 445). Conclusions: In contrast to the rest of Africa, P. falciparum parasites resistant to normal dose chloroquine do not have a selective advantage great enough to become the dominant P. falciparum type in Guinea-Bissau. This is most likely due to the efficacy of high-dose chloroquine as used in Guinea-Bissau, combined with a loss of fitness associated with pfcrt 76T.			Ursing, J (corresponding author), Karolinska Hosp, Karolinska Inst, Dept Infect Dis, S-10401 Stockholm, Sweden.	johan.ursing@ki.se		Ursing, Johan/0000-0002-5508-9327				Abdel-Muhsin AMA, 2004, J INFECT DIS, V189, P1239, DOI 10.1086/382509; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Ginsburg H, 2005, ACTA TROP, V96, P16, DOI 10.1016/j.actatropica.2005.06.021; Hastings IM, 2005, ACTA TROP, V94, P218, DOI 10.1016/j.actatropica.2005.04.003; Hayward R, 2005, MOL MICROBIOL, V55, P1285, DOI 10.1111/j.1365-2958.2004.04470.x; HELLGREN U, 1991, T ROY SOC TROP MED H, V85, P36, DOI 10.1016/0035-9203(91)90144-N; Kofoed PE, 2007, T ROY SOC TROP MED H, V101, P231, DOI 10.1016/j.trstmh.2006.05.008; KROGSTAD DJ, 1992, BIOCHEM PHARMACOL, V43, P57, DOI 10.1016/0006-2952(92)90661-2; Laufer MK, 2006, NEW ENGL J MED, V355, P1959, DOI 10.1056/NEJMoa062032; Ord R, 2007, J INFECT DIS, V196, P1613, DOI 10.1086/522154; Rodrigues A, 2008, TROP MED INT HEALTH, V13, P410, DOI 10.1111/j.1365-3156.2008.02016.x; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Ursing J, 2007, INFECT GENET EVOL, V7, P555, DOI 10.1016/j.meegid.2007.03.006; Ursing J, 2007, AM J TROP MED HYG, V76, P844, DOI 10.4269/ajtmh.2007.76.844; Ursing J, 2009, ANTIMICROB AGENTS CH, V53, P180, DOI 10.1128/AAC.01111-08; Veiga MI, 2006, MOL CELL PROBE, V20, P100, DOI 10.1016/j.mcp.2005.10.003; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	18	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6866	10.1371/journal.pone.0006866	http://dx.doi.org/10.1371/journal.pone.0006866			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718439	Green Submitted, Green Published, gold			2022-12-25	WOS:000269415900027
J	Verginelli, F; Bishehsari, F; Napolitano, F; Mahdavinia, M; Cama, A; Malekzadeh, R; Miele, G; Raiconi, G; Tagliaferri, R; Mariani-Costantini, R				Verginelli, Fabio; Bishehsari, Faraz; Napolitano, Francesco; Mahdavinia, Mahboobeh; Cama, Alessandro; Malekzadeh, Reza; Miele, Gennaro; Raiconi, Giancarlo; Tagliaferri, Roberto; Mariani-Costantini, Renato			Transitions at CpG Dinucleotides, Geographic Clustering of TP53 Mutations and Food Availability Patterns in Colorectal Cancer	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; NITRIC-OXIDE SYNTHASE; INFLAMMATORY-BOWEL-DISEASE; ONE-CARBON METABOLISM; N-NITROSO COMPOUNDS; P53 MUTATIONS; COLON-CANCER; ENERGY-INTAKE; RED MEAT; NUTRITION TRANSITION	Background: Colorectal cancer is mainly attributed to diet, but the role exerted by foods remains unclear because involved factors are extremely complex. Geography substantially impacts on foods. Correlations between international variation in colorectal cancer-associated mutation patterns and food availabilities could highlight the influence of foods on colorectal mutagenesis. Methodology: To test such hypothesis, we applied techniques based on hierarchical clustering, feature extraction and selection, and statistical pattern recognition to the analysis of 2,572 colorectal cancer-associated TP53 mutations from 12 countries/geographic areas. For food availabilities, we relied on data extracted from the Food Balance Sheets of the Food and Agriculture Organization of the United Nations. Dendrograms for mutation sites, mutation types and food patterns were constructed through Ward's hierarchical clustering algorithm and their stability was assessed evaluating silhouette values. Feature selection used entropy-based measures for similarity between clusterings, combined with principal component analysis by exhaustive and heuristic approaches. Conclusion/Significance: Mutations clustered in two major geographic groups, one including only Western countries, the other Asia and parts of Europe. This was determined by variation in the frequency of transitions at CpGs, the most common mutation type. Higher frequencies of transitions at CpGs in the cluster that included only Western countries mainly reflected higher frequencies of mutations at CpG codons 175, 248 and 273, the three major TP53 hotspots. Pearson's correlation scores, computed between the principal components of the datamatrices for mutation types, food availability and mutation sites, demonstrated statistically significant correlations between transitions at CpGs and both mutation sites and availabilities of meat, milk, sweeteners and animal fats, the energy-dense foods at the basis of "Western'' diets. This is best explainable by differential exposure to nitrosative DNA damage due to foods that promote metabolic stress and chronic inflammation.			Verginelli, F (corresponding author), Univ G dAnnunzio, Dept Oncol & Neurosci, Chieti, Italy.	rmc@unich.it	Mariani-Costantini, Renato/B-6637-2012; Malekzadeh, Reza/U-1382-2017; Tagliaferri, Roberto/AAZ-6113-2020; Miele, Gennaro/F-3628-2010; Miele, Gennaro/AAG-6782-2020; CAMA, Alessandro/J-3964-2018; Napolitano, Francesco/Q-1669-2016	Mariani-Costantini, Renato/0000-0002-4440-1848; Malekzadeh, Reza/0000-0002-9820-6335; Miele, Gennaro/0000-0002-2028-0578; Miele, Gennaro/0000-0002-2028-0578; CAMA, Alessandro/0000-0003-3647-1368; Napolitano, Francesco/0000-0002-7782-8506; Raiconi, Giancarlo/0000-0001-5307-7173; Malekzadeh, Reza/0000-0003-1043-3814; Tagliaferri, Roberto/0000-0001-8134-9025; VERGINELLI, Fabio/0000-0002-8636-2517; Mahdavinia, mahboobeh/0000-0003-4004-203X; Bishehsari, Faraz/0000-0001-5644-2586				*AM I CANC RES, 1997, FOOD NUTR PREV CANC; Ambs S, 1999, J NATL CANCER I, V91, P86, DOI 10.1093/jnci/91.1.86; Ambs S, 1997, FASEB J, V11, P443, DOI 10.1096/fasebj.11.6.9194524; Ambs S, 1998, CANCER RES, V58, P334; Arasaradnam RP, 2008, EPIGENETICS-US, V3, P193, DOI 10.4161/epi.3.4.6508; Arulampalam V, 2008, J INTERN MED, V263, P607, DOI 10.1111/j.1365-2796.2008.01964.x; Asbeck I, 2002, PUBLIC HEALTH NUTR, V5, P683, DOI 10.1079/PHN2002337; BAKER SJ, 1990, CANCER RES, V50, P7717; Bensaad K, 2007, TRENDS CELL BIOL, V17, P286, DOI 10.1016/j.tcb.2007.04.004; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bingham S, 2004, NAT REV CANCER, V4, P206, DOI 10.1038/nrc1298; Bingham SA, 1996, CARCINOGENESIS, V17, P515, DOI 10.1093/carcin/17.3.515; Bock C, 2008, BIOINFORMATICS, V24, P1, DOI 10.1093/bioinformatics/btm546; Broughton KS, 2002, J NUTR, V132, P88, DOI 10.1093/jn/132.1.88; CASTILLO L, 1993, P NATL ACAD SCI USA, V90, P193, DOI 10.1073/pnas.90.1.193; Collins AR, 2003, CARCINOGENESIS, V24, P511, DOI 10.1093/carcin/24.3.511; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Cross AJ, 2004, ENVIRON MOL MUTAGEN, V44, P44, DOI 10.1002/em.20030; Cross AJ, 2003, CANCER RES, V63, P2358; Cross RK, 2003, INFLAMM BOWEL DIS, V9, P179, DOI 10.1097/00054725-200305000-00006; Curtin K, 2007, CARCINOGENESIS, V28, P1672, DOI 10.1093/carcin/bgm089; Day NE, 2001, INT J EPIDEMIOL, V30, P309, DOI 10.1093/ije/30.2.309; Devaraj S, 2008, METABOLISM, V57, P867, DOI 10.1016/j.metabol.2008.02.016; Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FEIG DI, 1994, P NATL ACAD SCI USA, V91, P6609, DOI 10.1073/pnas.91.14.6609; Ferrari P, 2002, PUBLIC HEALTH NUTR, V5, P1329, DOI 10.1079/PHN2002409; Food and Agriculture Organization of the United Nations, 2001, FOOD BAL SHEETS HDB; Forrester K, 1996, P NATL ACAD SCI USA, V93, P2442, DOI 10.1073/pnas.93.6.2442; Friso S, 2005, CURR DRUG METAB, V6, P37, DOI 10.2174/1389200052997339; Gal A, 1996, P NATL ACAD SCI USA, V93, P15102, DOI 10.1073/pnas.93.26.15102; Gerner EW, 2007, BIOCHEM SOC T, V35, P322, DOI 10.1042/BST0350322; Ghassemi H, 2002, PUBLIC HEALTH NUTR, V5, P149, DOI 10.1079/PHN2001287; Giugliano D, 2006, J AM COLL CARDIOL, V48, P677, DOI 10.1016/j.jacc.2006.03.052; Goldman R, 2003, J NUTR, V133, p965S, DOI 10.1093/jn/133.3.965S; Goodman JE, 2004, ENVIRON MOL MUTAGEN, V44, P3, DOI 10.1002/em.20024; Grisham MB, 2002, J INVEST MED, V50, P272, DOI 10.2310/6650.2002.33281; Gunter MJ, 2006, J NUTR BIOCHEM, V17, P145, DOI 10.1016/j.jnutbio.2005.06.011; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hainaut P, 2002, NAT MED, V8, P21, DOI 10.1038/nm0102-21; Hao XP, 2002, GUT, V50, P834, DOI 10.1136/gut.50.6.834; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Hughes MN, 2008, METHOD ENZYMOL, V436, P3, DOI 10.1016/S0076-6879(08)36001-7; Hussain SP, 2000, MUTAT RES-REV MUTAT, V462, P311, DOI 10.1016/S1383-5742(00)00015-6; Huycke MM, 2004, EXP BIOL MED, V229, P586, DOI 10.1177/153537020422900702; Iacopetta B, 2006, ANN ONCOL, V17, P842, DOI 10.1093/annonc/mdl035; Iacopetta B, 2003, HUM MUTAT, V21, P271, DOI 10.1002/humu.10175; Innis SM, 2007, NUTR REV, V65, pS188, DOI 10.1301/nr.2007.dec.S188-S193; Ishibe N, 2001, CANCER INVEST, V19, P524, DOI 10.1081/CNV-100103850; Jagerstad M, 2005, MUTAT RES-FUND MOL M, V574, P156, DOI 10.1016/j.mrfmmm.2005.01.030; Johansson G, 2001, PUBLIC HEALTH NUTR, V4, P919, DOI 10.1079/PHN2001124; Johnson .T, 2007, ALIMENT PHARM THER, V26, P161, DOI 10.1111/j.1365-2036.2007.03371.x; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kallio P, 2008, AM J CLIN NUTR, V87, P1497, DOI 10.1093/ajcn/87.5.1497; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kim YI, 2005, J NUTR, V135, P2703, DOI 10.1093/jn/135.11.2703; Kolonel LN, 2004, NAT REV CANCER, V4, P519, DOI 10.1038/nrc1389; Kreutzer DA, 1998, P NATL ACAD SCI USA, V95, P3578, DOI 10.1073/pnas.95.7.3578; Lala PK, 2001, LANCET ONCOL, V2, P149, DOI 10.1016/S1470-2045(00)00256-4; Lewin MH, 2006, CANCER RES, V66, P1859, DOI 10.1158/0008-5472.CAN-05-2237; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lopez-Garcia E, 2004, AM J CLIN NUTR, V80, P1029, DOI 10.1093/ajcn/80.4.1029; MacFarlane AJ, 2007, NUTR REV, V65, pS157, DOI [10.1111/j.1753-4887.2007.tb00355.x, 10.1301/nr.2007.dec.S157-S166]; MAGEWU AN, 1994, MOL CELL BIOL, V14, P4225, DOI 10.1128/MCB.14.6.4225; Mahdavinia M, 2008, J CELL PHYSIOL, V216, P543, DOI 10.1002/jcp.21428; MANTEL N, 1970, BIOMETRICS, V26, P547, DOI 10.2307/2529108; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Oates PS, 2006, WORLD J GASTROENTERO, V12, P4281, DOI 10.3748/wjg.v12.i27.4281; Ohshima H, 2003, ARCH BIOCHEM BIOPHYS, V417, P3, DOI 10.1016/S0003-9861(03)00283-2; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Olivier Magali, 2004, IARC Sci Publ, P247; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PARKIN DM, 1997, IARC SCI PUBLICATION, V143; Paul A.A., 1978, MCCANCE WIDDOWSONS C; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pfeifer GP, 2000, MUTAT RES-FUND MOL M, V450, P155, DOI 10.1016/S0027-5107(00)00022-1; Pfeifer GP, 2006, CURR TOP MICROBIOL, V301, P259; Pfeifer GP, 1998, ENVIRON MOL MUTAGEN, V31, P197, DOI 10.1002/(SICI)1098-2280(1998)31:3<197::AID-EM1>3.0.CO;2-I; Pinto D, 2005, EXP CELL RES, V306, P357, DOI 10.1016/j.yexcr.2005.02.022; Potter JD, 1999, JNCI-J NATL CANCER I, V91, P916, DOI 10.1093/jnci/91.11.916; Quinlivan EP, 2005, J NUTR, V135, P389, DOI 10.1093/jn/135.3.389; Rhodes JM, 2002, TRENDS MOL MED, V8, P10, DOI 10.1016/S1471-4914(01)02194-3; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; Royds JA, 2006, CELL DEATH DIFFER, V13, P1017, DOI 10.1038/sj.cdd.4401913; Russo A, 2005, J CLIN ONCOL, V23, P7518, DOI 10.1200/JCO.2005.00.471; Sawa T, 2006, NITRIC OXIDE-BIOL CH, V14, P91, DOI 10.1016/j.niox.2005.06.005; Schernhammer ES, 2008, GASTROENTEROLOGY, V135, P770, DOI 10.1053/j.gastro.2008.06.033; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Serra-Majem L, 2003, J EPIDEMIOL COMMUN H, V57, P74, DOI 10.1136/jech.57.1.74; Slattery ML, 2008, AM J CLIN NUTR, V88, P14, DOI 10.1093/ajcn/88.1.14; Slattery ML, 2002, CANCER EPIDEM BIOMAR, V11, P541; Souici AC, 2000, CARCINOGENESIS, V21, P281, DOI 10.1093/carcin/21.2.281; Soussi T, 2005, HUM MUTAT, V25, P6, DOI 10.1002/humu.20114; TORNALETTI S, 1995, ONCOGENE, V10, P1493; Tricker AR, 1997, EUR J CANCER PREV, V6, P226, DOI 10.1097/00008469-199706000-00003; Ulrich CM, 2005, J NUTR, V135, P2462, DOI 10.1093/jn/135.10.2462; US Department of Agriculture, USDA NUTR DAT STAND; Vaninetti NM, 2008, MOL CARCINOGEN, V47, P275, DOI 10.1002/mc.20382; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WAGNER JR, 1992, P NATL ACAD SCI USA, V89, P3380, DOI 10.1073/pnas.89.8.3380; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WARREN W, 1995, CARCINOGENESIS, V16, P1181, DOI 10.1093/carcin/16.5.1181; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068; Wink DA, 1996, CURR TOP CELL REGUL, V34, P159, DOI 10.1016/S0070-2137(96)80006-9; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Wright BE, 2002, CANCER RES, V62, P5641; Yerushalmi HF, 2006, MOL CARCINOGEN, V45, P93, DOI 10.1002/mc.20168; You YH, 1998, MUTAT RES-GEN TOX EN, V420, P55, DOI 10.1016/S1383-5718(98)00147-8; Zell JA, 2007, INT J CANCER, V120, P459, DOI 10.1002/ijc.22311	114	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6824	10.1371/journal.pone.0006824	http://dx.doi.org/10.1371/journal.pone.0006824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718455	Green Submitted, gold, Green Published			2022-12-25	WOS:000269415900004
J	Diaz, Z; Xavier, KB; Miller, ST				Diaz, Zamia; Xavier, Karina B.; Miller, Stephen T.			The Crystal Structure of the Escherichia coli Autoinducer-2 Processing Protein LsrF	PLOS ONE			English	Article								Many bacteria produce and respond to the quorum sensing signal autoinducer-2 (AI-2). Escherichia coli and Salmonella typhimurium are among the species with the lsr operon, an operon containing AI-2 transport and processing genes that are up regulated in response to AI-2. One of the Lsr proteins, LsrF, has been implicated in processing the phosphorylated form of AI-2. Here, we present the structure of LsrF, unliganded and in complex with two phospho-AI-2 analogues, ribose-5-phosphate and ribulose-5-phosphate. The crystal structure shows that LsrF is a decamer of (alpha beta)(8)-barrels that exhibit a previously unseen N-terminal domain swap and have high structural homology with aldolases that process phosphorylated sugars. Ligand binding sites and key catalytic residues are structurally conserved, strongly implicating LsrF as a class I aldolase.			Diaz, Z (corresponding author), Swarthmore Coll, Dept Chem & Biochem, Swarthmore, PA 19081 USA.	smiller1@swarthmore.edu	Xavier, Karina/B-9425-2008	Xavier, Karina/0000-0001-5210-1434				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], ACTA CRYSTALLOGR D, V50, P760; Chen X, 2002, NATURE, V415, P545, DOI 10.1038/415545a; Choi KH, 2001, BIOCHEMISTRY-US, V40, P13868, DOI 10.1021/bi0114877; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Federle MJ, 2003, J CLIN INVEST, V112, P1291, DOI 10.1172/JCI200320195; Gefflaut T, 1995, PROG BIOPHYS MOL BIO, V63, P301, DOI 10.1016/0079-6107(95)00008-9; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Hammer BK, 2007, P NATL ACAD SCI USA, V104, P11145, DOI 10.1073/pnas.0703860104; Hardie KR, 2008, NAT REV MICROBIOL, V6, P635, DOI 10.1038/nrmicro1916; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Huang K, 1999, STRUCT FOLD DES, V7, P539, DOI 10.1016/S0969-2126(99)80070-7; HUANG Z, 2008, J MOL MICROBIOL BIOT; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laasik E, 2006, FEMS MICROBIOL LETT, V258, P227, DOI 10.1111/j.1574-6968.2006.00222.x; Lenz DH, 2005, MOL MICROBIOL, V58, P1186, DOI 10.1111/j.1365-2958.2005.04902.x; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Li M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-4; Lombardia E, 2006, J BACTERIOL, V188, P4442, DOI 10.1128/JB.00165-06; Lorentzen E, 2005, BIOCHEMISTRY-US, V44, P4222, DOI 10.1021/bi048192o; Lorentzen E, 2003, J BIOL CHEM, V278, P47253, DOI 10.1074/jbc.M305922200; Lupyan D, 2005, BIOINFORMATICS, V21, P3255, DOI 10.1093/bioinformatics/bti527; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Miller ST, 2004, MOL CELL, V15, P677, DOI 10.1016/j.molcel.2004.07.020; Mok KC, 2003, EMBO J, V22, P870, DOI 10.1093/emboj/cdg085; Morar M, 2007, BIOCHEMISTRY-US, V46, P10562, DOI 10.1021/bi700934v; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Neiditch MB, 2005, MOL CELL, V18, P507, DOI 10.1016/j.molcel.2005.04.020; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pereira CS, 2008, MOL MICROBIOL, V70, P1223, DOI 10.1111/j.1365-2958.2008.06477.x; Rader BA, 2007, J BACTERIOL, V189, P6109, DOI 10.1128/JB.00246-07; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Steiner RA, 2003, ACTA CRYSTALLOGR D, V59, P2114, DOI 10.1107/S0907444903018675; Sztajer H, 2008, J BACTERIOL, V190, P401, DOI 10.1128/JB.01086-07; Taga ME, 2003, MOL MICROBIOL, V50, P1411, DOI 10.1046/j.1365-2958.2003.03781.x; Taga ME, 2001, MOL MICROBIOL, V42, P777, DOI 10.1046/j.1365-2958.2001.02669.x; Thorell S, 2002, J MOL BIOL, V319, P161, DOI 10.1016/S0022-2836(02)00258-9; Tropea Joseph E, 2007, Methods Mol Biol, V363, P1, DOI 10.1007/978-1-59745-209-0_1; Waters CM, 2006, GENE DEV, V20, P2754, DOI 10.1101/gad.1466506; Xavier KB, 2007, ACS CHEM BIOL, V2, P128, DOI 10.1021/cb600444h; Xavier KB, 2005, NATURE, V437, P750, DOI 10.1038/nature03960; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Xavier KB, 2005, J BACTERIOL, V187, P238, DOI 10.1128/JB.187.1.238-248.2005	48	11	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2009	4	8							e6820	10.1371/journal.pone.0006820	http://dx.doi.org/10.1371/journal.pone.0006820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JG	19714241	Green Published, gold, Green Submitted			2022-12-25	WOS:000269415800009
J	Scaglia, N; Chisholm, JW; Igal, RA				Scaglia, Natalia; Chisholm, Jeffrey W.; Igal, R. Ariel			Inhibition of StearoylCoA Desaturase-1 Inactivates Acetyl-CoA Carboxylase and Impairs Proliferation in Cancer Cells: Role of AMPK	PLOS ONE			English	Article								Cancer cells activate the biosynthesis of saturated fatty acids (SFA) and monounsaturated fatty acids (MUFA) in order to sustain an increasing demand for phospholipids with appropriate acyl composition during cell replication. We have previously shown that a stable knockdown of stearoyl-CoA desaturase 1 (SCD1), the main Delta 9-desaturase that converts SFA into MUFA, in cancer cells decreases the rate of lipogenesis, reduces proliferation and in vitro invasiveness, and dramatically impairs tumor formation and growth. Here we report that pharmacological inhibition of SCD1 with a novel small molecule in cancer cells promoted the activation of AMP-activated kinase (AMPK) and the subsequent reduction of acetylCoA carboxylase activity, with a concomitant inhibition of glucose-mediated lipogenesis. The pharmacological inhibition of AMPK further decreased proliferation of SCD1-depleted cells, whereas AMPK activation restored proliferation to control levels. Addition of supraphysiological concentrations of glucose or pyruvate, the end product of glycolysis, did not reverse the low proliferation rate of SCD1-ablated cancer cells. Our data suggest that cancer cells require active SCD1 to control the rate of glucose-mediated lipogenesis, and that when SCD1 activity is impaired cells downregulate SFA synthesis via AMPK-mediated inactivation of acetyl-CoA carboxylase, thus preventing the harmful effects of SFA accumulation.			Scaglia, N (corresponding author), Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08903 USA.	igal@aesop.rutgers.edu						ASHCRAFT BA, 1980, J BIOL CHEM, V255, P33; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Blazquez C, 2001, FEBS LETT, V489, P149, DOI 10.1016/S0014-5793(01)02089-0; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOUGNOUX P, 1992, BREAST CANCER RES TR, V20, P185; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Carretero J, 2007, ONCOGENE, V26, P1616, DOI 10.1038/sj.onc.1209951; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x; CLARKE SD, 1985, FED PROC, V44, P2458; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; deVries JE, 1997, J LIPID RES, V38, P1384; Dobrzyn A, 2005, AM J PHYSIOL-ENDOC M, V288, pE599, DOI 10.1152/ajpendo.00439.2004; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; Fediuc S, 2006, J LIPID RES, V47, P412, DOI 10.1194/jlr.M500438-JLR200; GOODRIDGE AG, 1972, J BIOL CHEM, V247, P6946; HA J, 1994, J BIOL CHEM, V269, P22162; Hardy S, 2000, CANCER RES, V60, P6353; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim JE, 2008, BONE, V43, P394, DOI 10.1016/j.bone.2008.03.021; Kim JE, 2008, J PHARMACOL SCI, V106, P394, DOI 10.1254/jphs.FP0071857; Koltun DO, 2009, BIOORG MED CHEM LETT, V19, P3050, DOI 10.1016/j.bmcl.2009.04.004; Koltun DO, 2009, BIOORG MED CHEM LETT, V19, P2048, DOI 10.1016/j.bmcl.2009.02.019; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Kumar-Sinha C, 2003, CANCER RES, V63, P132; LEPAGE G, 1984, J LIPID RES, V25, P1391; LI J, 1994, INT J CANCER, V57, P348, DOI 10.1002/ijc.2910570310; Lu JX, 1997, MOL CARCINOGEN, V20, P204, DOI 10.1002/(SICI)1098-2744(199710)20:2<204::AID-MC7>3.0.CO;2-M; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Menna PL, 2003, CANCER RES, V63, P2284; Milgraum LZ, 1997, CLIN CANCER RES, V3, P2115; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Munday MR, 1999, ADV ENZYME REGUL, V39, P205, DOI 10.1016/S0065-2571(98)00016-8; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; MURAKAMI K, 1986, J BIOL CHEM, V261, P5424; NAKANISHI S, 1970, EUR J BIOCHEM, V16, P161, DOI 10.1111/j.1432-1033.1970.tb01068.x; NIKAWA J, 1979, FEBS LETT, V102, P223, DOI 10.1016/0014-5793(79)80005-8; Ogretmen B, 2001, J BIOL CHEM, V276, P24901, DOI 10.1074/jbc.M100314200; Pizer ES, 1996, CANCER RES, V56, P2745; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; RUGGIERI S, 1979, J LIPID RES, V20, P772; Scaglia N, 2005, J BIOL CHEM, V280, P25339, DOI 10.1074/jbc.M501159200; Scaglia N, 2005, BBA-MOL CELL BIOL L, V1687, P141, DOI 10.1016/j.bbalip.2004.11.015; Scaglia N, 2008, INT J ONCOL, V33, P839, DOI 10.3892/ijo_00000072; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; SHINOMURA T, 1991, P NATL ACAD SCI USA, V88, P5149, DOI 10.1073/pnas.88.12.5149; Swinnen JV, 2000, INT J CANCER, V88, P176, DOI 10.1002/1097-0215(20001015)88:2<176::AID-IJC5>3.0.CO;2-3; Taylor EB, 2005, AM J PHYSIOL-ENDOC M, V288, pE1055, DOI 10.1152/ajpendo.00516.2004; Thai SF, 2001, CARCINOGENESIS, V22, P1317, DOI 10.1093/carcin/22.8.1317; UNDERWOOD AH, 1965, BIOCHEM J, V95, P868, DOI 10.1042/bj0950868; URADE R, 1992, J BIOCH, V91, P1639; Wang HQ, 2005, ONCOGENE, V24, P3574, DOI 10.1038/sj.onc.1208463; Wang X, 2007, BIOCHEM BIOPH RES CO, V352, P463, DOI 10.1016/j.bbrc.2006.11.032; Wilson R, 2001, J CHROMATOGR A, V905, P251, DOI 10.1016/S0021-9673(00)01006-2; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Yahagi N, 2005, EUR J CANCER, V41, P1316, DOI 10.1016/j.ejca.2004.12.037	66	142	155	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2009	4	8							e6812	10.1371/journal.pone.0006812	http://dx.doi.org/10.1371/journal.pone.0006812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JE	19710915	Green Published, gold, Green Submitted			2022-12-25	WOS:000269415600022
J	Vicens, Q; Gooding, AR; Duarte, LF; Batey, RT				Vicens, Quentin; Gooding, Anne R.; Duarte, Luis F.; Batey, Robert T.			Preparation of Group I Introns for Biochemical Studies and Crystallization Assays by Native Affinity Purification	PLOS ONE			English	Article								The study of functional RNAs of various sizes and structures requires efficient methods for their synthesis and purification. Here, 23 group I intron variants ranging in length from 246 to 341 nucleotides-some containing exons-were subjected to a native purification technique previously applied only to shorter RNAs (< 160 nucleotides). For the RNAs containing both exons, we adjusted the original purification protocol to allow for purification of radiolabeled molecules. The resulting RNAs were used in folding assays on native gel electrophoresis and in self-splicing assays. The intron-only RNAs were subjected to the regular native purification scheme, assayed for folding and employed in crystallization screens. All RNAs that contained a 39 overhang of one nucleotide were efficiently cleaved off from the support and were at least 90% pure after the non-denaturing purification. A representative subset of these RNAs was shown to be folded and self-splicing after purification. Additionally, crystals were grown for a 286 nucleotide long variant of the Clostridium botulinum intron. These results demonstrate the suitability of the native affinity purification method for the preparation of group I introns. We hope these findings will stimulate a broader application of this strategy to the preparation of other large RNA molecules.			Vicens, Q (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	quentin.vicens@colorado.edu	Vicens, Quentin/N-6139-2019; Vicens, Quentin/A-8319-2009; Batey, Robert/A-8265-2009	Vicens, Quentin/0000-0003-3751-530X; Vicens, Quentin/0000-0003-3751-530X; Batey, Robert/0000-0002-1384-6625	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073850] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM073850] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PL, 2004, RNA, V10, P1867, DOI 10.1261/rna.7140504; Batey RT, 2007, RNA, V13, P1384, DOI 10.1261/rna.528007; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; BELFORT M, 1987, COLD SPRING HARB SYM, V52, P181, DOI 10.1101/SQB.1987.052.01.023; Bryan TM, 2000, J BIOL CHEM, V275, P24199, DOI 10.1074/jbc.M003246200; Chase E, 2005, ACTA CRYSTALLOGR F, V61, P71, DOI 10.1107/S1744309104028337; Chen X, 2000, J MOL BIOL, V301, P265, DOI 10.1006/jmbi.2000.3963; CHU FK, 1986, CELL, V45, P157, DOI 10.1016/0092-8674(86)90379-X; DANN CE, 2007, RNA CELL, V130, P878; DOUDNA JA, 1993, P NATL ACAD SCI USA, V90, P7829, DOI 10.1073/pnas.90.16.7829; Edwards Andrea L., 2009, V535, P135, DOI 10.1007/978-1-59745-557-2_9; EHRENMAN K, 1989, NUCLEIC ACIDS RES, V17, P9147, DOI 10.1093/nar/17.22.9147; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Gesteland R., 2006, RNA WORLD, V3rd edn. Cold Spring Harbor; Golden BL, 2003, J STRUCT BIOL, V142, P98, DOI 10.1016/S1047-8477(03)00042-X; Hansen CL, 2002, P NATL ACAD SCI USA, V99, P16531, DOI 10.1073/pnas.262485199; Hanson BL, 2003, J STRUCT BIOL, V142, P77, DOI 10.1016/S1047-8477(03)00040-6; Heilman-Miller SL, 2003, J MOL BIOL, V328, P385, DOI 10.1016/S0022-2836(03)00304-8; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Juneau K, 2001, STRUCTURE, V9, P221, DOI 10.1016/S0969-2126(01)00579-2; Kieft JS, 2004, RNA, V10, P988, DOI 10.1261/rna.7040604; Kriminski S, 2002, ACTA CRYSTALLOGR D, V58, P459, DOI 10.1107/S0907444902000112; KUHSEL MG, 1990, SCIENCE, V250, P1570, DOI 10.1126/science.2125748; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Machouart-Dubach M, 2002, FEMS MICROBIOL LETT, V208, P187, DOI 10.1111/j.1574-6968.2002.tb11080.x; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; MICHEL F, 1990, NATURE, V347, P578, DOI 10.1038/347578a0; MOHR G, 1992, CELL, V69, P483, DOI 10.1016/0092-8674(92)90449-M; Perrotta AT, 1999, SCIENCE, V286, P123, DOI 10.1126/science.286.5437.123; Pichler A, 2002, J BIOL CHEM, V277, P17987, DOI 10.1074/jbc.M111798200; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; PUTTARAJU M, 1992, NUCLEIC ACIDS RES, V20, P5357, DOI 10.1093/nar/20.20.5357; Rosenstein SP, 1996, BIOCHEMISTRY-US, V35, P11403, DOI 10.1021/bi9609984; SALVO JLG, 1990, J MOL BIOL, V211, P537, DOI 10.1016/0022-2836(90)90264-M; Vicens Q, 2008, RNA, V14, P2013, DOI 10.1261/rna.1027208; Waldsich C, 2002, GENE DEV, V16, P2300, DOI 10.1101/gad.231302; Williams KP, 2002, NUCLEIC ACIDS RES, V30, P179, DOI 10.1093/nar/30.1.179; XU MQ, 1990, SCIENCE, V250, P1566, DOI 10.1126/science.2125747; ZAUG AJ, 1993, BIOCHEMISTRY-US, V32, P7946, DOI 10.1021/bi00082a016	40	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2009	4	8							e6740	10.1371/journal.pone.0006740	http://dx.doi.org/10.1371/journal.pone.0006740			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JE	19710925	gold, Green Submitted, Green Published			2022-12-25	WOS:000269415600001
J	Shadwick, LL; Spiegel, FW; Shadwick, JDL; Brown, MW; Silberman, JD				Shadwick, Lora L.; Spiegel, Frederick W.; Shadwick, John D. L.; Brown, Matthew W.; Silberman, Jeffrey D.			Eumycetozoa = Amoebozoa?: SSUrDNA Phylogeny of Protosteloid Slime Molds and Its Significance for the Amoebozoan Supergroup	PLOS ONE			English	Article							LEVEL CLASSIFICATION; MOLECULAR PHYLOGENY; TROPHIC CELLS; GENUS; ULTRASTRUCTURE; AMEBAS; ORDER; PROTOSPORANGIUM; MYCETOZOAN; MORPHOLOGY	Amoebae that make fruiting bodies consisting of a stalk and spores and classified as closely related to the myxogastrids have classically been placed in the taxon Eumycetozoa. Traditionally, there are three groups comprising Eumycetozoa: myxogastrids, dictyostelids, and the so-called protostelids. Dictyostelids and myxogastrids both make multicellular fruiting bodies that may contain hundreds of spores. Protostelids are those amoebae that make simple fruiting bodies consisting of a stalk and one or a few spores. Protostelid-like organisms have been suggested as the progenitors of the myxogastrids and dictyostelids, and they have been used to formulate hypotheses on the evolution of fruiting within the group. Molecular phylogenies have been published for both myxogastrids and dictyostelids, but little molecular phylogenetic work has been done on the protostelids. Here we provide phylogenetic trees based on the small subunit ribosomal RNA gene (SSU) that include 21 protostelids along with publicly available sequences from a wide variety of amoebae and other eukaryotes. SSU trees recover seven well supported clades that contain protostelids but do not appear to be specifically related to one another and are often interspersed among established groups of amoebae that have never been reported to fruit. In fact, we show that at least two taxa unambiguously belong to amoebozoan lineages where fruiting has never been reported. These analyses indicate that we can reject a monophyletic Eumycetozoa, s.l. For this reason, we will hereafter refer to those slime molds with simple fruiting as protosteloid amoebae and/or protosteloid slime molds, not as protostelids. These results add to our understanding of amoebozoan biodiversity, and demonstrate that the paradigms for understanding both nonfruiting and sporulating amoebae must be integrated. Finally, we suggest strategies for future research on protosteloid amoebae and nonfruiting amoebae, and discuss the impact of this work for taxonomists and phylogenomicists.			Shadwick, LL (corresponding author), Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA.	lora.lindley@gmail.com	Silberman, Jeffrey D/AAK-8220-2020	Silberman, Jeffrey D/0000-0002-2965-9197; Brown, Matthew/0000-0002-1254-0608				Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Amaral-Zettler LA, 2006, J EUKARYOT MICROBIOL, V53, P522, DOI 10.1111/j.1550-7408.2006.00143.x; [Anonymous], 1988, NEW KEY FRESHWATER S; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Baldauf SL, 1997, P NATL ACAD SCI USA, V94, P12007, DOI 10.1073/pnas.94.22.12007; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; BENNETT WE, 1986, PROTISTOLOGICA, V22, P205; BENNETT WE, 1986, MYCOLOGIA, V78, P857, DOI 10.2307/3807537; Bolivar I, 2001, MOL BIOL EVOL, V18, P2306, DOI 10.1093/oxfordjournals.molbev.a003777; BOVEE EUGENE C., 1965, TRANS AMER MICROSCOP SOC, V84, P217, DOI 10.2307/3224288; Brown MW, 2007, J EUKARYOT MICROBIOL, V54, P511, DOI 10.1111/j.1550-7408.2007.00292.x; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Cavalier-Smith T, 2004, EUR J PROTISTOL, V40, P21, DOI 10.1016/j.ejop.2003.10.001; Cavalier-Smith T, 2003, EUR J PROTISTOL, V39, P338, DOI 10.1078/0932-4739-00002; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dykova I, 2005, ACTA PROTOZOOL, V44, P369; DYKSTRA MJ, 1978, J PROTOZOOL, V25, P44, DOI 10.1111/j.1550-7408.1978.tb03865.x; Fahrni JF, 2003, MOL BIOL EVOL, V20, P1881, DOI 10.1093/molbev/msg201; Fiore-Donno AM, 2005, J EUKARYOT MICROBIOL, V52, P201, DOI 10.1111/j.1550-7408.2005.00032.x; Furtado J.S., 1971, Nova Hedwigia, V21, P537; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUNG CY, 1972, MYCOLOGIA, V64, P1312, DOI 10.2307/3757968; Kudryavtsev A, 2005, PROTIST, V156, P215, DOI 10.1016/j.protis.2005.03.003; Kudryavtsev A, 2009, PROTIST, V160, P21, DOI 10.1016/j.protis.2008.09.004; Lindley Lora A., 2006, Revista Mexicana de Micologia, V23, P75; LISTER A., 1925, MONOGRAPH MYCETOZOA; Maddison DR, 2002, MACCLADE VERSION 4 0; Martin G.W., 1969, MYXOMYCETES; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Michel Rolf, 2006, Protistology, V4, P319; Nikolaev SI, 2006, INT J SYST EVOL MICR, V56, P1449, DOI 10.1099/ijs.0.63763-0; Nikolaev SI, 2005, PROTIST, V156, P191, DOI 10.1016/j.protis.2005.03.002; OLIVE LINDSAY S., 1960, BULL TORREY BOT CLUB, V87, P1, DOI 10.2307/2483057; OLIVE LS, 1971, AM J BOT, V58, P32, DOI 10.2307/2441303; OLIVE LS, 1977, T BRIT MYCOL SOC, V69, P83, DOI 10.1016/S0007-1536(77)80119-8; OLIVE LS, 1962, AM J BOT, V49, P297, DOI 10.2307/2439553; OLIVE LS, 1966, AM J BOT, V53, P344, DOI 10.2307/2439874; OLIVE LS, 1984, MYCOLOGIA, V76, P884, DOI 10.2307/3793145; OLIVE LS, 1972, J PROTOZOOL, V19, P563, DOI 10.1111/j.1550-7408.1972.tb03530.x; OLIVE LS, 1969, AM J BOT, V56, P979, DOI 10.2307/2440919; OLIVE LS, 1970, BOT REV, V36, P59, DOI 10.1007/BF02859155; OLIVE LS, 1966, MYCOLOGIA, V58, P452, DOI 10.2307/3756919; OLIVE LS, 1966, J PROTOZOOL, V13, P164, DOI 10.1111/j.1550-7408.1966.tb01887.x; OLIVE LS, 1976, AM J BOT, V63, P1385, DOI 10.2307/2441847; OLIVE LS, 1982, MYCOLOGIA, V74, P655, DOI 10.2307/3792755; Olive LS, 1975, MYCETOZOANS; OLIVE LS, 1971, J MITCHELL SOC, V4, P115; PAGE FC, 1968, J PROTOZOOL, V15, P9, DOI 10.1111/j.1550-7408.1968.tb02084.x; PAGE FC, 1969, J PROTOZOOL, V16, P437, DOI 10.1111/j.1550-7408.1969.tb02296.x; Parfrey LW, 2006, PLOS GENET, V2, P2062, DOI 10.1371/journal.pgen.0020220; Pawlowski Jan, 2008, Protistology, V5, P281; Pawlowski J, 2009, J EUKARYOT MICROBIOL, V56, P16, DOI 10.1111/j.1550-7408.2008.00379.x; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raper K. B., 1984, DICTYOSTELIDS; Schaap P, 2006, SCIENCE, V314, P661, DOI 10.1126/science.1130670; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Silberman JD, 1999, MOL BIOL EVOL, V16, P1740, DOI 10.1093/oxfordjournals.molbev.a026086; Singer-Sam J, 1989, AMPLIFICATIONS, V3, P11; Smirnov AV, 2008, EUR J PROTISTOL, V44, P35, DOI 10.1016/j.ejop.2007.08.001; Smirnov AV, 2007, PROTIST, V158, P295, DOI 10.1016/j.protis.2007.04.004; Smirnov Alexey V., 2004, Protistology, V3, P148; Spiegel F.W., 1990, P484; SPIEGEL F W, 1981, Journal of the Elisha Mitchell Scientific Society, V97, P183; SPIEGEL FW, 1984, MYCOLOGIA, V76, P443, DOI 10.2307/3793326; SPIEGEL FW, 1989, CAN J BOT, V67, P1285, DOI 10.1139/b89-170; SPIEGEL FW, 1995, MYCOLOGIA, V87, P265, DOI 10.2307/3760912; SPIEGEL FW, 1994, J EUKARYOT MICROBIOL, V41, P511, DOI 10.1111/j.1550-7408.1994.tb06051.x; Spiegel FW, 2006, MYCOLOGIA, V98, P144, DOI 10.3852/mycologia.98.1.144; SPIEGEL FW, 1995, CAN J BOT, V73, pS738; SPIEGEL FW, 1985, BIOSYSTEMS, V18, P377, DOI 10.1016/0303-2647(85)90037-1; SPIEGEL FW, 1988, MYCOLOGIA, V80, P525, DOI 10.2307/3807855; SPIEGEL FW, 1981, BIOSYSTEMS, V14, P491, DOI 10.1016/0303-2647(81)90053-8; SPIEGEL FW, 1982, PROTOPLASMA, V113, P165, DOI 10.1007/BF01280904; SPIEGEL FW, 1982, PROTOPLASMA, V113, P178, DOI 10.1007/BF01280905; SPIEGEL FW, 1991, BIOSYSTEMS, V25, P113, DOI 10.1016/0303-2647(91)90017-F; SPIEGEL FW, 1986, PROTOPLASMA, V132, P115, DOI 10.1007/BF01276991; SPIEGEL FW, 1986, CAN J BOT, V64, P932, DOI 10.1139/b86-125; SPIEGEL FW, 2007, BEGINNERS GUIDE ISOL; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stiller JW, 1999, MOL BIOL EVOL, V16, P1270, DOI 10.1093/oxfordjournals.molbev.a026217; Swanson AR, 2002, MYCOLOGIA, V94, P968, DOI 10.2307/3761864; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tekle YI, 2008, MOL PHYLOGENET EVOL, V47, P339, DOI 10.1016/j.ympev.2007.11.015; WHITNEY KD, 1984, CAN J BOT, V62, P1750, DOI 10.1139/b84-236; WHITNEY KD, 1982, MYCOLOGIA, V74, P677, DOI 10.2307/3792760; WHITNEY KD, 1984, J PROTOZOOL, V31, P253, DOI 10.1111/j.1550-7408.1984.tb02956.x; Yoon HS, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-14; ZOPF W, 1885, PILZTHIERE ODER SCHL; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI	91	83	85	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6754	10.1371/journal.pone.0006754	http://dx.doi.org/10.1371/journal.pone.0006754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707546	Green Published, gold, Green Submitted			2022-12-25	WOS:000269278400019
J	Senkal, CE; Ponnusamy, S; Bielawski, J; Hannun, YA; Ogretmen, B				Senkal, Can E.; Ponnusamy, Suriyan; Bielawski, Jacek; Hannun, Yusuf A.; Ogretmen, Besim			Antiapoptotic roles of ceramide-synthase-6-generated C-16-ceramide via selective regulation of the ATF6/CHOP arm of ER-stress-response pathways	FASEB JOURNAL			English	Article						sphingolipid; cell death; head and neck cancer; unfolded protein response	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; LONGEVITY ASSURANCE GENE-1; SQUAMOUS-CELL CARCINOMAS; HUMAN HEAD; CERAMIDE SYNTHASE; INDUCED APOPTOSIS; FAMILY-MEMBERS; DEATH PROGRAM; CANCER CELLS	Emerging results suggest that ceramides with different fatty acid chain lengths might play distinct functions in the regulation of tumor growth and therapy. Here we report that de novo-generated C-18- and C-16-ceramides by ceramide synthases 1 and 6 (CerS1 and CerS6) play opposing proapoptotic and prosurvival roles, respectively, in human head and neck squamous cell carcinomas (HNSCCs). Unexpectedly, knockdown of CerS6/C-16-ceramide using small interfering RNA induced endoplasmic reticulum (ER)-stress-mediated apoptosis. Reconstitution of C-16-ceramide generation by induced expression of wild-type CerS6, but not its catalytically inactive mutant, protected cells from cell death induced by knockdown of CerS6. Moreover, using molecular tools coupled with analysis of sphingolipid metabolism showed that generation of C-16-ceramide, and not dihydro-C-16-ceramide, by induced expression of CerS6 rescued cells from ER stress and apoptosis. Mechanistically, regulation of ER-stress-induced apoptosis by CerS6/C-16-ceramide was linked to the activation of a specific arm, ATF6/CHOP, of the unfolded protein response pathway. Notably, while expression of CerS1/C-18-ceramide inhibited HNSCC xenograft growth, CerS6/C-16-ceramide significantly protected ER stress, leading to enhanced tumor development and growth in vivo, consistent with their pro-and antiapoptotic roles, respectively. Thus, these data reveal an unexpected and novel prosurvival role of CerS6/C-16-ceramide involved in the protection against ER-stress-induced apoptosis and induction of HNSCC tumor growth.-Senkal, C. E., Ponnusamy, S., Bielawski, J., Hannun, Y. A., Ogretmen, B. Antiapoptotic roles of ceramide-synthase-6-generated C-16-ceramide via selective regulation of the ATF6/CHOP arm of ER-stress-response pathways. FASEB J. 24, 296-308 (2010). www.fasebj.org	[Ogretmen, Besim] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Ogretmen, B (corresponding author), Med Univ S Carolina, Hollings Canc Ctr, 86 Jonathan Lucas St,Rm 512A, Charleston, SC 29425 USA.	ogretmen@musc.edu			National Institutes of Health [C06 RR-015455, CA-88932, DE-016572, CA-97132]; NATIONAL CANCER INSTITUTE [P01CA097132, R01CA088932] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Dr. Jennifer Schnellmann for critically reviewing the manuscript and the members of the B. O. laboratory for helpful discussions. The Flow Cytometry and Cell Sorting, and Lipidomics Core Laboratories are located in a facility constructed with support from the National Institutes of Health (C06 RR-015455). This work was supported by National Institutes of Health grants CA-88932, DE-016572, and CA-97132.	Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Contreras JL, 2003, TRANSPLANT INT, V16, P537, DOI 10.1007/s00147-003-0619-x; Culmsee Carsten, 2006, Current Alzheimer Research, V3, P269, DOI 10.2174/156720506778249461; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; DORNER AJ, 1992, EMBO J, V11, P1563, DOI 10.1002/j.1460-2075.1992.tb05201.x; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Guillas I, 2003, J BIOL CHEM, V278, P37083, DOI 10.1074/jbc.M307554200; Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655; Hamanaka RB, 2009, ONCOGENE, V28, P910, DOI 10.1038/onc.2008.428; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Kadara H, 2007, CANCER BIOL THER, V6, P705, DOI 10.4161/cbt.6.5.3963; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Karahatay S, 2007, CANCER LETT, V256, P101, DOI 10.1016/j.canlet.2007.06.003; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Lee AS, 2006, CANCER BIOL THER, V5, P721, DOI 10.4161/cbt.5.7.3120; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; Liu H, 1997, J BIOL CHEM, V272, P21751, DOI 10.1074/jbc.272.35.21751; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Mehta S, 2000, CANCER CHEMOTH PHARM, V46, P85, DOI 10.1007/s002800000140; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Min JX, 2007, MOL CANCER RES, V5, P801, DOI 10.1158/1541-7786.MCR-07-0100; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mousley CJ, 2008, MOL BIOL CELL, V19, P4785, DOI 10.1091/mbc.E08-04-0426; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nozaki S, 2001, ONCOGENE, V20, P2178, DOI 10.1038/sj.onc.1204292; Oakes SA, 2006, CURR MOL MED, V6, P99, DOI 10.2174/156652406775574587; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Park MA, 2008, CANCER BIOL THER, V7, P1648, DOI 10.4161/cbt.7.10.6623; Rabik CA, 2008, J PHARMACOL EXP THER, V327, P442, DOI 10.1124/jpet.108.141291; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schiffmann S, 2009, CARCINOGENESIS, V30, P745, DOI 10.1093/carcin/bgp061; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Senkal CE, 2006, J PHARMACOL EXP THER, V317, P1188, DOI 10.1124/jpet.106.101949; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wang Y, 2000, J BIOL CHEM, V275, P27013; White-Gilbertson S, 2009, ONCOGENE, V28, P1132, DOI 10.1038/onc.2008.468; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	51	189	190	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2010	24	1					296	308		10.1096/fj.09-135087	http://dx.doi.org/10.1096/fj.09-135087			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19723703	Green Published			2022-12-25	WOS:000273233600030
J	Zhao-Shea, R; Cohen, BN; Just, H; McClure-Begley, T; Whiteaker, P; Grady, SR; Salminen, O; Gardner, PD; Lester, HA; Tapper, AR				Zhao-Shea, Rubing; Cohen, Bruce N.; Just, Herwig; McClure-Begley, Tristan; Whiteaker, Paul; Grady, Sharon R.; Salminen, Outi; Gardner, Paul D.; Lester, Henry A.; Tapper, Andrew R.			Dopamine D-2-receptor activation elicits akinesia, rigidity, catalepsy, and tremor in mice expressing hypersensitive alpha 4 nicotinic receptors via a cholinergic-dependent mechanism	FASEB JOURNAL			English	Article						acetylcholine; striatum; nicotine; parkinsonian; interneuron	TONICALLY-ACTIVE NEURONS; ACETYLCHOLINE-RECEPTORS; PARKINSONS-DISEASE; AUTORECEPTOR FUNCTION; NUCLEUS-ACCUMBENS; STRIATAL FUNCTION; CALCIUM CURRENTS; FOS EXPRESSION; MOUSE STRIATUM; BRAIN-AREAS	Recent studies suggest that high-affinity neuronal nicotinic acetylcholine receptors (nAChRs) containing alpha 4 and beta 2 subunits (alpha 4 beta 2*) functionally interact with G-protein-coupled dopamine (DA) D-2 receptors in basal ganglia. We hypothesized that if a functional interaction between these receptors exists, then mice expressing an M2 point mutation (Leu9'Ala) rendering alpha 4 nAChRs hypersensitive to ACh may exhibit altered sensitivity to a D-2-receptor agonist. When challenged with the D2R agonist, quinpirole (0.5-10 mg/kg), Leu9'Ala mice, but not wild-type (WT) littermates, developed severe, reversible motor impairment characterized by rigidity, catalepsy, akinesia, and tremor. While striatal DA tissue content, baseline release, and quinpirole-induced DA depletion did not differ between Leu9' Ala and WT mice, quinpirole dramatically increased activity of cholinergic striatal interneurons only in mutant animals, as measured by increased c-Fos expression in choline acetyltransferase (ChAT)-positive interneurons. Highlighting the importance of the cholinergic system in this mouse model, inhibiting the effects of ACh by blocking muscarinic receptors, or by selectively activating hypersensitive nAChRs with nicotine, rescued motor symptoms. This novel mouse model mimics the imbalance between striatal DA/ACh function associated with severe motor impairment in disorders such as Parkinson's disease, and the data suggest that a D2R-alpha 4*-nAChR functional interaction regulates cholinergic interneuron activity.-Zhao-Shea, R., Cohen, B. N., Just, H., McClure-Begley, T., Whiteaker, P., Grady, S. R., Salminen, O., Gardner, P. D., Lester, H. A., Tapper, A. R. Dopamine D-2-receptor activation elicits akinesia, rigidity, catalepsy, and tremor in mice expressing hypersensitive alpha 4 nicotinic receptors via a cholinergic-dependent mechanism. FASEB J. 24, 49-57 (2010). www.fasebj.org	[Zhao-Shea, Rubing; Gardner, Paul D.; Tapper, Andrew R.] Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Dept Psychiat, Worcester, MA 01604 USA; [Cohen, Bruce N.; Just, Herwig; Lester, Henry A.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [McClure-Begley, Tristan; Grady, Sharon R.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Whiteaker, Paul] St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Salminen, Outi] Univ Helsinki, Dept Pharm, Div Pharmacol & Toxicol, Helsinki, Finland	University of Massachusetts System; University of Massachusetts Worcester; California Institute of Technology; University of Colorado System; University of Colorado Boulder; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; University of Helsinki	Tapper, AR (corresponding author), Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Dept Psychiat, 303 Belmont St, Worcester, MA 01604 USA.	andrew.tapper@umassmed.edu		Salminen, Outi/0000-0003-0427-858X	National Institute of Neurological Disorders and Stroke [NS059586]; National Institute on Drug Abuse [DA017279, DA12242]; National Institute on Aging [AG033954]; NIH [DA015663]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017279, R01DA012242, P30DA015663] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Ms. Marjo Vaha for excellent technical assistance and Dr. T. Petteri Piepponen for advice with the microdialysis experiments. This work was supported in part by the National Institute of Neurological Disorders and Stroke (NS059586), the National Institute on Drug Abuse (DA017279 and DA12242), and the National Institute on Aging (AG033954). Production of mice in Boulder was supported by NIH animal resources grant DA015663.	Agnati LF, 2003, PHARMACOL REV, V55, P509, DOI 10.1124/pr.55.3.2; Alcantara AA, 2003, BRAIN RES, V986, P22, DOI 10.1016/S0006-8993(03)03165-2; AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; Calabresi P, 2000, TRENDS NEUROSCI, V23, P120, DOI 10.1016/S0166-2236(99)01501-5; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; COWARD DM, 1977, ARZNEIMITTEL-FORSCH, V27-2, P2326; de Rover M, 2002, EUR J NEUROSCI, V16, P2279, DOI 10.1046/j.1460-9568.2002.02289.x; DeBoer P, 1996, EUR J PHARMACOL, V317, P257, DOI 10.1016/S0014-2999(96)00761-3; Ding J, 2006, NAT NEUROSCI, V9, P832, DOI 10.1038/nn1700; Fonck C, 2005, J NEUROSCI, V25, P11396, DOI 10.1523/JNEUROSCI.3597-05.2005; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Goldberg JA, 2005, J NEUROSCI, V25, P10230, DOI 10.1523/JNEUROSCI.2734-05.2005; Gotti C, 2006, NEUROBIOL DIS, V23, P481, DOI 10.1016/j.nbd.2006.04.005; GRADY S, 1992, J NEUROCHEM, V59, P848, DOI 10.1111/j.1471-4159.1992.tb08322.x; Grady SR, 2007, BIOCHEM PHARMACOL, V74, P1235, DOI 10.1016/j.bcp.2007.07.032; GRADY SR, 1994, J NEUROCHEM, V62, P1390, DOI 10.1046/j.1471-4159.1994.62041390.x; HAIKALA H, 1987, J NEUROCHEM, V49, P1033, DOI 10.1111/j.1471-4159.1987.tb09991.x; JANSSEN PAJ, 1965, ARZNEI-FORSCHUNG, V15, P104; Jones S, 1999, TRENDS NEUROSCI, V22, P555, DOI 10.1016/S0166-2236(99)01471-X; Koos T, 2002, J NEUROSCI, V22, P529, DOI 10.1523/JNEUROSCI.22-02-00529.2002; Lester HA, 2003, CURR OPIN DRUG DISC, V6, P633; Lindner MD, 1996, BRAIN RES BULL, V39, P367, DOI 10.1016/0361-9230(96)00027-5; Lindstrom J, 1996, PROG BRAIN RES, V109, P125; MACKENZIE RG, 1989, EUR J PHARMACOL, V168, P43, DOI 10.1016/0014-2999(89)90631-6; Mercuri NB, 1997, NEUROSCIENCE, V79, P323; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Miwa H, 2009, PARKINSONISM RELAT D, V15, P30, DOI 10.1016/j.parkreldis.2008.02.008; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Pisani A, 2006, NEUROBIOL DIS, V24, P318, DOI 10.1016/j.nbd.2006.07.006; Pisani A, 2001, PROG NEURO-PSYCHOPH, V25, P211, DOI 10.1016/S0278-5846(00)00153-6; Pisani A, 2007, TRENDS NEUROSCI, V30, P545, DOI 10.1016/j.tins.2007.07.008; Quarta D, 2007, NEUROPSYCHOPHARMACOL, V32, P35, DOI 10.1038/sj.npp.1301103; Quik M, 2003, MOL PHARMACOL, V63, P1169, DOI 10.1124/mol.63.5.1169; Raz A, 1996, J NEUROPHYSIOL, V76, P2083, DOI 10.1152/jn.1996.76.3.2083; Rice ME, 2004, NAT NEUROSCI, V7, P583, DOI 10.1038/nn1244; Salminen O, 1999, J NEUROSCI, V19, P8145; Salminen O, 2004, MOL PHARMACOL, V65, P1526, DOI 10.1124/mol.65.6.1526; Salminen O, 1996, PHARMACOL BIOCHEM BE, V54, P241, DOI 10.1016/0091-3057(95)02132-9; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Singh N, 2007, PROG NEUROBIOL, V81, P29, DOI 10.1016/j.pneurobio.2006.11.009; Sotnikova TD, 2005, PLOS BIOL, V3, P1488, DOI 10.1371/journal.pbio.0030271; Sullivan MA, 2008, J NEUROSCI, V28, P8682, DOI 10.1523/JNEUROSCI.2411-08.2008; Tammimaki A, 2006, EUR J PHARMACOL, V531, P118, DOI 10.1016/j.ejphar.2005.12.027; Tapper AR, 2006, CELL BIOLOGY OF ADDICTION, P179; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Tepper JM, 1997, J NEUROSCI, V17, P2519; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Whiteaker P, 2000, BRIT J PHARMACOL, V131, P729, DOI 10.1038/sj.bjp.0703616; Wilson CJ, 2005, NEURON, V45, P575, DOI 10.1016/j.neuron.2004.12.053; Wirtshafter D, 2004, EUR J PHARMACOL, V488, P85, DOI 10.1016/j.ejphar.2004.02.025; Yan Z, 1997, J NEUROPHYSIOL, V77, P1003, DOI 10.1152/jn.1997.77.2.1003; Zhang H, 2004, NAT NEUROSCI, V7, P581, DOI 10.1038/nn1243; Zhou FM, 2003, NEUROSCIENTIST, V9, P23, DOI 10.1177/1073858402239588; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	54	10	10	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2010	24	1					49	57		10.1096/fj.09-137034	http://dx.doi.org/10.1096/fj.09-137034			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19720621	Green Published			2022-12-25	WOS:000273233600008
J	Song, B; Wang, Y; Xi, Y; Kudo, K; Bruheim, S; Botchkina, GI; Gavin, E; Wan, Y; Formentini, A; Kornmann, M; Fodstad, O; Ju, J				Song, B.; Wang, Y.; Xi, Y.; Kudo, K.; Bruheim, S.; Botchkina, G. I.; Gavin, E.; Wan, Y.; Formentini, A.; Kornmann, M.; Fodstad, O.; Ju, J.			Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells	ONCOGENE			English	Article						miR-140; chemosensitivity; histone deacetylase 4; cancer stem cells	STEM-CELLS; MICRORNA EXPRESSION; ANIMAL DEVELOPMENT; P53; REPRESSION; TARGETS; CYCLE; INHIBITORS; SIGNATURES; GENE	In this study, high-throughput microRNA (miRNA) expression analysis revealed that the expression of miR-140 was associated with chemosensitivity in osteosarcoma tumor xenografts. Tumor cells ectopically transfected with miR-140 were more resistant to methotrexate and 5-fluorouracil (5-FU). Overexpression of miR-140 inhibited cell proliferation in both osteosarcoma U-2 OS (wt-p53) and colon cancer HCT 116 (wt-p53) cell lines, but less so in osteosarcoma MG63 (mut-p53) and colon cancer HCT 116 (null-p53) cell lines. miR-140 induced p53 and p21 expression accompanied with G(1) and G(2) phase arrest only in cell lines containing wild type of p53. Histone deacetylase 4 (HDAC4) was confirmed to be one of the important targets of miR-140. The expression of endogenous miR-140 was significantly elevated in CD133(+hi)CD44(+hi) colon cancer stem-like cells that exhibit slow proliferating rate and chemoresistance. Blocking endogenous miR-140 by locked nucleic acid-modified anti-miR partially sensitized resistant colon cancer stem-like cells to 5-FU treatment. Taken together, our findings indicate that miR-140 is involved in the chemoresistance by reduced cell proliferation through G(1) and G(2) phase arrest mediated in part through the suppression of HDAC4. miR-140 may be a candidate target to develop novel therapeutic strategy to overcome drug resistance. Oncogene (2009) 28, 4065-4074; doi:10.1038/onc.2009.274; published online 7 September 2009	[Song, B.; Wang, Y.; Ju, J.] SUNY Stony Brook, Dept Pathol, Translat Res Lab, Stony Brook, NY 11794 USA; [Wang, Y.; Wan, Y.] Wuhan Univ, Dept Physiol, Wuhan 430072, Peoples R China; [Xi, Y.; Kudo, K.; Gavin, E.] Univ S Alabama, Mitchell Canc Inst, Canc Genom Lab, Mobile, AL 36688 USA; [Bruheim, S.; Fodstad, O.] Univ Hosp, Rikshosp, Norwegian Radium Hosp, Dept Tumor Biol,Inst Canc Res, Oslo, Norway; [Bruheim, S.; Fodstad, O.] Univ Oslo, Norwegian Radium Hosp, Fac Div, Dept Tumor Biol, Oslo, Norway; [Botchkina, G. I.] SUNY Stony Brook, Dept Surg, Stony Brook, NY 11794 USA; [Formentini, A.; Kornmann, M.] Univ Ulm, Dept Visceral & Transplantat Surg, Ulm, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Wuhan University; University of South Alabama; University of Oslo; National Hospital Norway; University of Oslo; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Ulm University	Ju, J (corresponding author), SUNY Stony Brook, Dept Pathol, Translat Res Lab, Stony Brook, NY 11794 USA.	jiju@notes.cc.sunysb.edu		Ju, Jingfang/0000-0002-4821-7458; Xi, Yaguang/0000-0003-3681-9352	Stony Brook Translational Research Laboratory; NIH [CA114043, MH075020]; NATIONAL CANCER INSTITUTE [R21CA114043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075020] Funding Source: NIH RePORTER	Stony Brook Translational Research Laboratory; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We appreciate the critical reading of the paper by Stephanie Burke (Stony Brook University). This work was supported by Stony Brook Translational Research Laboratory Start-up fund and NIH CA114043 (J Ju) and MH075020 (J Ju).	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros Victor, 2004, Methods Mol Biol, V265, P131; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Botchkina Inna L., 2009, Cancer Genomics & Proteomics, V6, P19; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Bruheim S, 2004, PATHOL ONCOL RES, V10, P133, DOI 10.1007/BF03033741; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; CHANDAR N, 1992, BRIT J CANCER, V65, P208, DOI 10.1038/bjc.1992.43; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; DRESSLER LG, 1988, CANCER, V61, P420, DOI 10.1002/1097-0142(19880201)61:3<420::AID-CNCR2820610303>3.0.CO;2-0; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Izzotti A, 2009, FASEB J, V23, P806, DOI 10.1096/fj.08-121384; Koishi K, 2006, WORLD J GASTROENTERO, V12, P7585, DOI 10.3748/wjg.v12.i47.7585; Kozak M, 2008, GENE, V423, P108, DOI 10.1016/j.gene.2008.07.013; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Moskovits N, 2006, CANCER RES, V66, P10671, DOI 10.1158/0008-5472.CAN-06-2323; Nicolas FE, 2008, RNA, V14, P2513, DOI 10.1261/rna.1221108; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Song B, 2008, CLIN CANCER RES, V14, P8080, DOI 10.1158/1078-0432.CCR-08-1422; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wilson AJ, 2008, MOL BIOL CELL, V19, P4062, DOI 10.1091/mbc.E08-02-0139; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zou GM, 2008, J CELL PHYSIOL, V217, P598, DOI 10.1002/jcp.21541	39	318	349	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 19	2009	28	46					4065	4074		10.1038/onc.2009.274	http://dx.doi.org/10.1038/onc.2009.274			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	530AE	19734943	Green Accepted, Green Published			2022-12-25	WOS:000272560500003
J	Kim, KK; Adelstein, RS; Kawamoto, S				Kim, Kee K.; Adelstein, Robert S.; Kawamoto, Sachiyo			Identification of Neuronal Nuclei (NeuN) as Fox-3, a New Member of the Fox-1 Gene Family of Splicing Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL STEM-CELLS; HEAVY CHAIN-B; DIAGNOSTIC HISTOPATHOLOGY; HUMAN TISSUES; MARKER NEUN; SPINAL-CORD; ADULT MICE; IN-VIVO; PROTEIN; EXPRESSION	NeuN (neuronal nuclei) is a neuron-specific nuclear protein which is identified by immunoreactivity with a monoclonal antibody, anti-NeuN. Anti-NeuN has been used widely as a reliable tool to detect most postmitotic neuronal cell types in neuroscience, developmental biology, and stem cell research fields as well as diagnostic histopathology. To date, however, the identity of its antigen, NeuN itself, has been unknown. Here, we identify NeuN as the Fox-3 gene product by providing the following evidence: 1) Mass spectrometry analysis of anti-NeuN immunoreactive protein yields the Fox-3 amino acid sequence. 2) Recombinant Fox-3 is recognized by anti-NeuN. 3) Short hairpin RNAs targeting Fox-3 mRNA down-regulate NeuN expression. 4) Fox-3 expression is restricted to neural tissues. 5) Anti-Fox-3 immunostaining and anti-NeuN immunostaining overlap completely in neuronal nuclei. We also show that a protein cross-reactive with anti-NeuN is the synaptic vesicle protein, synapsin I. Anti-NeuN recognizes synapsin I in immunoblots with one order of magnitude lower affinity than Fox-3, and does not recognize synapsin I using immunohistology. Fox-3 (also called hexaribonucleotide-binding protein 3 and D11Bwg0517e) contains an RNA recognition motif and is classified as a member of the Fox-1 gene family that binds specifically to an RNA element, UGCAUG. We demonstrate that Fox-3 functions as a splicing regulator using neural cell-specific alternative splicing of the non-muscle myosin heavy chain II-B pre-mRNA as a model. Identification of NeuN as Fox-3 clarifies an important element of neurobiology research.	[Kim, Kee K.; Adelstein, Robert S.; Kawamoto, Sachiyo] NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kawamoto, S (corresponding author), NHLBI, Mol Cardiol Lab, NIH, Bldg 10,Rm 6C209,10 Ctr Dr MSC 1762, Bethesda, MD 20892 USA.	kawamots@mail.nih.gov	Kim, Kee/F-8784-2011	Kim, Keekwang/0000-0002-1088-3383; Adelstein, Robert/0000-0002-8683-2144	Division of Intramural Research; NHLBI; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006019, ZIAHL004236, Z01HL004236, ZICHL005903, ZICHL005905] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the Division of Intramural Research, NHLBI, National Institutes of Health.	Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Baraniak AP, 2006, MOL CELL BIOL, V26, P1209, DOI 10.1128/MCB.26.4.1209-1222.2006; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Brudno M, 2001, NUCLEIC ACIDS RES, V29, P2338, DOI 10.1093/nar/29.11.2338; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Fagel DM, 2009, J NEUROSCI, V29, P1202, DOI 10.1523/JNEUROSCI.4516-08.2009; Gauthier AS, 2007, NEURON, V54, P245, DOI 10.1016/j.neuron.2007.03.027; Gitler D, 2004, J NEUROSCI, V24, P3711, DOI 10.1523/JNEUROSCI.5225-03.2004; Goetz AK, 2006, P NATL ACAD SCI USA, V103, P11063, DOI 10.1073/pnas.0510926103; ITOH K, 1995, J BIOL CHEM, V270, P14533, DOI 10.1074/jbc.270.24.14533; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Kao HT, 1998, P NATL ACAD SCI USA, V95, P4667, DOI 10.1073/pnas.95.8.4667; Kawamoto S, 1996, J BIOL CHEM, V271, P17613; Lieberman AP, 2001, BIOCHEM BIOPH RES CO, V282, P499, DOI 10.1006/bbrc.2001.4617; Lind D, 2005, J NEUROSCI RES, V79, P295, DOI 10.1002/jnr.20354; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mar XF, 2006, MOL BIOL CELL, V17, P2138, DOI 10.1091/mbc.E05-10-0097; McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; PHILLIPS CL, 1995, J MUSCLE RES CELL M, V16, P379, DOI 10.1007/BF00114503; Ponthier JL, 2006, J BIOL CHEM, V281, P12468, DOI 10.1074/jbc.M511556200; Preusser M, 2006, HISTOPATHOLOGY, V48, P438, DOI 10.1111/j.1365-2559.2006.02359.x; Shibata H, 2000, HUM MOL GENET, V9, P1303, DOI 10.1093/hmg/9.9.1303; Sigurjonsson OE, 2005, P NATL ACAD SCI USA, V102, P5227, DOI 10.1073/pnas.0501029102; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Wynder C, 2005, NAT CELL BIOL, V7, P1113, DOI 10.1038/ncb1312; Yang G, 2008, BLOOD, V111, P392, DOI 10.1182/blood-2007-01-068940; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhou HL, 2007, MOL CELL BIOL, V27, P830, DOI 10.1128/MCB.01015-06	40	259	267	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31052	31061		10.1074/jbc.M109.052969	http://dx.doi.org/10.1074/jbc.M109.052969			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19713214	Green Published, hybrid			2022-12-25	WOS:000271378400034
J	Liu, WZ; Zhao, R; McFarland, C; Kieft, J; Niedzwiecka, A; Jankowska-Anyszka, M; Stepinski, J; Darzynkiewicz, E; Jones, DNM; Davis, RE				Liu, Weizhi; Zhao, Rui; McFarland, Craig; Kieft, Jeffrey; Niedzwiecka, Anna; Jankowska-Anyszka, Marzena; Stepinski, Janusz; Darzynkiewicz, Edward; Jones, David N. M.; Davis, Richard E.			Structural Insights into Parasite eIF4E Binding Specificity for m(7)G and m(2,2,7)G mRNA Caps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 4E; SPLICED LEADER RNA; TRANSLATION INITIATION; CAENORHABDITIS-ELEGANS; PROTEIN EIF4E; ISOFORMS; RECOGNITION; AFFINITY; PHOSPHORYLATION; SIMULATION	The eukaryotic translation initiation factor eIF4E recognizes the mRNA cap, a key step in translation initiation. Here we have characterized eIF4E from the human parasite Schistosoma mansoni. Schistosome mRNAs have either the typical monomethylguanosine (m(7)G) or a trimethylguanosine (m(2,2,7)G) cap derived from spliced leader trans-splicing. Quantitative fluorescence titration analyses demonstrated that schistosome eIF4E has similar binding specificity for both caps. We present the first crystal structure of an eIF4E with similar binding specificity for m(7)G and m(2,2,7)G caps. The eIF4E.m(7) GpppG structure demonstrates that the schistosome protein binds monomethyl cap in a manner similar to that of single specificity eIF4Es and exhibits a structure similar to other known eIF4Es. The structure suggests an alternate orientation of a conserved, key Glu-90 in the cap-binding pocket that may contribute to dual binding specificity and a position for mRNA bound to eIF4E consistent with biochemical data. Comparison of NMR chemical shift perturbations in schistosome eIF4E on binding m(7)GpppG and m(2,2,7)GpppG identified key differences between the two complexes. Isothermal titration calorimetry demonstrated significant thermodynamics differences for the binding process with the two caps (m(7)Gversusm(2,2,7)G). Overall the NMR and isothermal titration calorimetry data suggest the importance of intrinsic conformational flexibility in the schistosome eIF4E that enables binding to m(2,2,7)G cap.	[Davis, Richard E.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Jones, David N. M.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [Niedzwiecka, Anna; Stepinski, Janusz; Darzynkiewicz, Edward] Univ Warsaw, Fac Phys, Inst Expt Phys, Div Biophys, PL-02089 Warsaw, Poland; [Jankowska-Anyszka, Marzena] Univ Warsaw, Fac Chem, PL-02093 Warsaw, Poland; [Niedzwiecka, Anna] Polish Acad Sci, Inst Phys, Biol Phys Grp, PL-02668 Warsaw, Poland	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Warsaw; University of Warsaw; Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences	Davis, RE (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, 12801 E 17th Ave, Aurora, CO 80045 USA.	Richard.davis@ucdenver.edu	Jones, David N/C-5764-2013; Niedzwiecka, Anna/E-8940-2010	Niedzwiecka, Anna/0000-0001-5208-0733	National Institutes of Health [AI049558, AI080805, GM081346, GM072560, GM080334]; Howard Hughes Medical Institute [55005604]; Polish Ministry of Science and Higher Education [N301-035936]; Warsaw University [BW 68/179203]; National Science Support Project [PBZ-MNiSW-07/I/2007]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049558, R03AI080805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081346, R01GM080334, R01GM072560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Warsaw University; National Science Support Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI049558 and AI080805 (to R. E. D.), GM081346 and GM072560 (to J. K.), and GM080334 (to R. Z.). This work was also supported by Howard Hughes Medical Institute Grant 55005604 (to E. D.), Polish Ministry of Science and Higher Education Grant N301-035936 (to A. N. and E. D.), Warsaw University Grant BW 68/179203 (to M. J.-A.), and a National Science Support Project Grant PBZ-MNiSW-07/I/2007 (to E. D.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brehm K, 2000, J BIOL CHEM, V275, P38311, DOI 10.1074/jbc.M006091200; Brown CJ, 2007, J MOL BIOL, V372, P7, DOI 10.1016/j.jmb.2007.06.033; Cheng GF, 2007, MOL BIOCHEM PARASIT, V153, P95, DOI 10.1016/j.molbiopara.2007.02.003; Cohen LS, 2005, MOL CELL BIOL, V25, P8779, DOI 10.1128/MCB.25.20.8779-8791.2005; DAVIS RE, 1995, J BIOL CHEM, V270, P21813, DOI 10.1074/jbc.270.37.21813; Davis RE, 1996, PARASITOL TODAY, V12, P33, DOI 10.1016/0169-4758(96)80643-0; DAVIS RE, 1994, J BIOL CHEM, V269, P20026; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fechter P, 2005, J GEN VIROL, V86, P1239, DOI 10.1099/vir.0.80755-0; Friedland DE, 2005, BIOCHEMISTRY-US, V44, P4546, DOI 10.1021/bi047645m; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Ghosh B, 2009, ACS CHEM BIOL, V4, P367, DOI 10.1021/cb9000475; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Gu MG, 2005, CURR OPIN STRUC BIOL, V15, P99, DOI 10.1016/j.sbi.2005.01.009; Haq I, 1997, J MOL BIOL, V271, P244, DOI 10.1006/jmbi.1997.1170; Hotez P.J., 2008, EMERG INFECT DIS; Hu W, 2003, NAT GENET, V35, P139, DOI 10.1038/ng1236; Jankowska M, 1996, COLLECT CZECH CHEM C, V61, pS197; Jankowska-Anyszka M, 1998, J BIOL CHEM, V273, P10538, DOI 10.1074/jbc.273.17.10538; Joshi B, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-48; Keiper BD, 2000, J BIOL CHEM, V275, P10590, DOI 10.1074/jbc.275.14.10590; Lall S, 2004, J BIOL CHEM, V279, P45573, DOI 10.1074/jbc.M407475200; LIOU RF, 1990, MOL CELL BIOL, V10, P1764, DOI 10.1128/MCB.10.4.1764; Magee J, 2005, NUCLEIC ACIDS RES, V33, P6694, DOI 10.1093/nar/gki981; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; MARONEY PA, 1995, RNA, V1, P714; MARONEY PA, 1990, P NATL ACAD SCI USA, V87, P709, DOI 10.1073/pnas.87.2.709; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Miyoshi H, 2002, EMBO J, V21, P4680, DOI 10.1093/emboj/cdf473; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Monzingo AF, 2007, PLANT PHYSIOL, V143, P1504, DOI 10.1104/pp.106.093146; Niedzwiecka A, 2004, BIOCHEMISTRY-US, V43, P13305, DOI 10.1021/bi0491651; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Niedzwiecka A, 2007, METHOD ENZYMOL, V430, P209, DOI 10.1016/S0076-6879(07)30009-8; PELLETIER J, 2007, TRANSLATIONAL CONTRO, P855; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Quiocho FA, 2000, CURR OPIN STRUC BIOL, V10, P78, DOI 10.1016/S0959-440X(99)00053-6; RAJKOVIC A, 1990, P NATL ACAD SCI USA, V87, P8879, DOI 10.1073/pnas.87.22.8879; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; Rosettani P, 2007, J MOL BIOL, V368, P691, DOI 10.1016/j.jmb.2007.02.019; Ruszczynska K, 2003, BIOPHYS J, V85, P1450, DOI 10.1016/S0006-3495(03)74577-9; Rutkowska-Wlodarczyk I, 2008, BIOCHEMISTRY-US, V47, P2710, DOI 10.1021/bi701168z; Savioli L, 2004, PARASITOL INT, V53, P103, DOI 10.1016/j.parint.2004.01.001; Scheper GC, 2002, J BIOL CHEM, V277, P3303, DOI 10.1074/jbc.M103607200; SCHNEIDER RJ, 2007, TRANSLATIONAL CONTRO, P401; Seol Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158103; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Spivak-Kroizman T, 2002, FEBS LETT, V516, P9, DOI 10.1016/S0014-5793(02)02445-6; STEPINSKI J, 1995, NUCLEOS NUCLEOT, V14, P717; Tomoo K, 2005, BBA-PROTEINS PROTEOM, V1753, P191, DOI 10.1016/j.bbapap.2005.07.023; Tomoo K, 2003, J MOL BIOL, V328, P365, DOI 10.1016/S0022-2836(03)00314-0; Tomoo K, 2002, BIOCHEM J, V362, P539, DOI 10.1042/0264-6021:3620539; Verjovski-Almeida S, 2003, NAT GENET, V35, P148, DOI 10.1038/ng1237; Volpon L, 2006, EMBO J, V25, P5138, DOI 10.1038/sj.emboj.7601380; von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779; von der Haar T, 2006, J MOL BIOL, V356, P982, DOI 10.1016/j.jmb.2005.12.034; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Yoffe Y, 2006, EUKARYOT CELL, V5, P1969, DOI 10.1128/EC.00230-06; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140; Zuberek J, 2004, BIOCHEMISTRY-US, V43, P5370, DOI 10.1021/bi030266t; Zuberek J, 2003, RNA, V9, P52, DOI 10.1261/rna.2133403	69	27	27	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31336	31349		10.1074/jbc.M109.049858	http://dx.doi.org/10.1074/jbc.M109.049858			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19710013	hybrid, Green Published			2022-12-25	WOS:000271378400060
J	Fan, JJ; Rone, MB; Papadopoulos, V				Fan, Jinjiang; Rone, Malena B.; Papadopoulos, Vassilios			Translocator Protein 2 Is Involved in Cholesterol Redistribution during Erythropoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTOR; TRANSCRIPTION FACTOR GATA-1; HUMAN BREAST-CANCER; BINDING-SITES; STEROID-BIOSYNTHESIS; CELL-PROLIFERATION; MOUSE; TRANSPORT; EXPRESSION; ERYTHROBLASTS	Translocator protein (TSPO) is an 18-kDa cholesterol- and drug-binding protein conserved from bacteria to humans. While surveying for Tspo-like genes, we identified its paralogous gene, Tspo2, encoding an evolutionarily conserved family of proteins that arose by gene duplications before the divergence of avians and mammals. Comparative analysis of Tspo1 and Tspo2 functions suggested that Tspo2 has become subfunctionalized, typical of duplicated genes, characterized by the loss of diagnostic drug ligand-binding but retention of cholesterol-binding properties, hematopoietic tissue- and erythroid cell-specific distribution, and subcellular endoplasmic reticulum and nuclear membrane localization. Expression of Tspo2 in erythroblasts is strongly correlated with the down-regulation of the enzymes involved in cholesterol biosynthesis. Overexpression of TSPO2 in erythroid cells resulted in the redistribution of intracellular free cholesterol, an essential step in nucleus expulsion during erythrocyte maturation. Taken together, these data identify the TSPO2 family of proteins as mediators of cholesterol redistribution-dependent erythroblast maturation during mammalian erythropoiesis.	[Papadopoulos, Vassilios] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ H3H 2R9, Canada; McGill Univ, Dept Med, Montreal, PQ H3A 1A4, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3A 1A4, Canada; McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3A 1A4, Canada	McGill University; McGill University; McGill University; McGill University	Papadopoulos, V (corresponding author), McGill Univ, Res Inst, Ctr Hlth, 2155 Guy St,5th Floor, Montreal, PQ H3H 2R9, Canada.	vassilios.papadopoulos@mcgill.ca	Fan, Jinjiang/C-2010-2009; Papadopoulos, Vassilios/AAI-2613-2019	Fan, Jinjiang/0000-0003-3102-4833; Papadopoulos, Vassilios/0000-0002-1183-8568	National Institutes of Health [HD37031, ES07747]; Canada Research Chair in Biochemical Pharmacology; Le Fonds de la Recherche en Sante du Quebec; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chair in Biochemical Pharmacology; Le Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants HD37031 and ES07747. This work was also supported by a Canada Research Chair in Biochemical Pharmacology ( to V. P.). The Research Institute of the McGill University Health Center was supported by a center grant from Le Fonds de la Recherche en Sante du Quebec.	ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; [Anonymous], 2005, PHYLIP PHYLOGENY INF; Azarashvili T, 2007, CELL CALCIUM, V42, P27, DOI 10.1016/j.ceca.2006.11.004; BOLGER GT, 1985, BRAIN RES, V338, P366, DOI 10.1016/0006-8993(85)90170-2; BRODSKY I, 1966, CANCER RES, V26, P198; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Delavoie F, 2003, BIOCHEMISTRY-US, V42, P4506, DOI 10.1021/bi0267487; Donohue TJ, 1997, P NATL ACAD SCI USA, V94, P4821, DOI 10.1073/pnas.94.10.4821; Gavish M, 1999, PHARMACOL REV, V51, P629; Hardwick M, 1999, CANCER RES, V59, P831; Hauet T, 2005, MOL ENDOCRINOL, V19, P540, DOI 10.1210/me.2004-0307; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holm TM, 2002, BLOOD, V99, P1817, DOI 10.1182/blood.V99.5.1817; Hui C, 2006, CELL SIGNAL, V18, P1844, DOI 10.1016/j.cellsig.2006.04.006; Infante RE, 2008, J BIOL CHEM, V283, P1064, DOI 10.1074/jbc.M707944200; ITO E, 1993, NATURE, V362, P466, DOI 10.1038/362466a0; JosephLiauzun E, 1997, J BIOL CHEM, V272, P28102, DOI 10.1074/jbc.272.44.28102; Keller MA, 2006, PHYSIOL GENOMICS, V28, P114, DOI 10.1152/physiolgenomics.00055.2006; Komor M, 2005, STEM CELLS, V23, P1154, DOI 10.1634/stemcells.2004-0171; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lacapere JJ, 2001, BIOCHEM BIOPH RES CO, V284, P536, DOI 10.1006/bbrc.2001.4975; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; Li W, 2007, BIOCHEM PHARMACOL, V73, P491, DOI 10.1016/j.bcp.2006.10.025; Lindemann P, 2004, PLANT CELL PHYSIOL, V45, P723, DOI 10.1093/pcp/pch088; Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200; Meurs I, 2005, EXP HEMATOL, V33, P1309, DOI 10.1016/j.exphem.2005.07.004; Molineux G, 2006, ERYTHROPOIETINS ERYT; MONTFOORT A, 1978, LIPIDS, V13, P580, DOI 10.1007/BF02535819; Moritz KM, 1997, AM J PHYSIOL-REG I, V273, pR1829, DOI 10.1152/ajpregu.1997.273.6.R1829; MURPHY DB, 1986, J CELL BIOL, V102, P628, DOI 10.1083/jcb.102.2.628; Nakazawa F, 2009, GENE EXPR PATTERNS, V9, P114, DOI 10.1016/j.gep.2008.09.005; OLSON JMM, 1988, EUR J PHARMACOL, V152, P47, DOI 10.1016/0014-2999(88)90834-5; PAPADOPOULOS V, 1990, J BIOL CHEM, V265, P3772; Papadopoulos V, 2006, NEUROSCIENCE, V138, P749, DOI 10.1016/j.neuroscience.2005.05.063; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Reiner S, 2005, BIOCHEM SOC T, V33, P1186, DOI 10.1042/BST0331186; Rone MB, 2009, BIOCHEMISTRY-US, V48, P6909, DOI 10.1021/bi900854z; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; SASAKI K, 1982, ARCH HISTOL JAPON, V45, P247, DOI 10.1679/aohc.45.247; Shalev H, 2007, AM J HEMATOL, V82, P199, DOI 10.1002/ajh.20804; Simos G, 1996, J BIOL CHEM, V271, P12617, DOI 10.1074/jbc.271.21.12617; Snyder MJ, 1998, CELL TISSUE RES, V294, P161, DOI 10.1007/s004410051166; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; TAKETANI S, 1994, J BIOL CHEM, V269, P7527; VERMA A, 1987, P NATL ACAD SCI USA, V84, P2256, DOI 10.1073/pnas.84.8.2256; Wakabayashi J, 2003, GENES CELLS, V8, P619, DOI 10.1046/j.1365-2443.2003.00658.x; WHITELAW E, 1990, MOL CELL BIOL, V10, P6596, DOI 10.1128/MCB.10.12.6596; Woods MJ, 1996, BIOCHEM PHARMACOL, V52, P1805, DOI 10.1016/S0006-2952(96)00558-8; Yeliseev AA, 1997, P NATL ACAD SCI USA, V94, P5101, DOI 10.1073/pnas.94.10.5101; YELISEEV AA, 1995, J BIOL CHEM, V270, P21167, DOI 10.1074/jbc.270.36.21167; ZAVALA F, 1991, BIOCHEM BIOPH RES CO, V176, P1577, DOI 10.1016/0006-291X(91)90468-M	53	68	70	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30484	30497		10.1074/jbc.M109.029876	http://dx.doi.org/10.1074/jbc.M109.029876			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19729679	Green Published, hybrid			2022-12-25	WOS:000271090000051
J	Mosessian, S; Avliyakulov, NK; Mulholland, DJ; Boontheung, P; Loo, JA; Wu, H				Mosessian, Sherly; Avliyakulov, Nuraly K.; Mulholland, David J.; Boontheung, Pinmanee; Loo, Joseph A.; Wu, Hong			Analysis of PTEN Complex Assembly and Identification of Heterogeneous Nuclear Ribonucleoprotein C as a Component of the PTEN-associated Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID PHOSPHATASE-ACTIVITY; TUMOR-SUPPRESSOR PTEN; GEL-ELECTROPHORESIS; PROTEIN STABILITY; CELL-MIGRATION; MESSENGER-RNA; PDZ DOMAIN; PHOSPHORYLATION; LOCALIZATION; MULTIPLE	PTEN (phosphatase and tensin homolog deleted on chromosome 10) is well characterized for its role in antagonizing the phosphoinositide 3-kinase pathway. Previous studies using size-exclusion chromatography demonstrated PTEN recruitment into high molecular mass complexes and hypothesized that PTEN phosphorylation status and PDZ binding domain may be required for such complex formation. In this study, we set out to test the structural requirements for PTEN complex assembly and identify the component(s) of the PTEN complex(es). Our results demonstrated that the PTEN catalytic function and PDZ binding domain are not absolutely required for its complex formation. On the other hand, PTEN phosphorylation status has a significant impact on its complex assembly. Our results further demonstrate enrichment of the PTEN complex in nuclear lysates, suggesting a mechanism through which PTEN phosphorylation may regulate its complex assembly. These results prompted further characterization of other protein components within the PTEN complex(es). Using size-exclusion chromatography and two-dimensional difference gel electrophoresis followed by mass spectrometry analysis, we identified heterogeneous nuclear ribonucleoprotein C (hnRNP C) as a novel protein recruited to higher molecular mass fractions in the presence of PTEN. Further analysis indicates that endogenous hnRNP C and PTEN interact and co-localize within the nucleus, suggesting a potential role for PTEN, alongside hnRNP C, in RNA regulation.	[Mosessian, Sherly; Mulholland, David J.; Wu, Hong] Univ Calif Los Angeles, Inst Mol Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Avliyakulov, Nuraly K.; Loo, Joseph A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Boontheung, Pinmanee; Loo, Joseph A.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Wu, H (corresponding author), Univ Calif Los Angeles, Inst Mol Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	hwu@mednet.ucla.edu		Mosessian, Sherly/0000-0002-8665-5053	National Institutes of Health [P50 CA092131, R01 CA107166]; National Cancer Institute/National Institutes of Health [U01 CA84128-06]; Prostate Cancer Foundation; Department of Defense [PC031130]; W. M. Keck Foundation; Jonsson Comprehensive Cancer Center; dean's office at the David Geffen School of Medicine; Chancellor's Bioscience Facility grant; UCLA; NATIONAL CANCER INSTITUTE [F32CA112988, P50CA092131, R01CA107166, U01CA084128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate Cancer Foundation; Department of Defense(United States Department of Defense); W. M. Keck Foundation(W.M. Keck Foundation); Jonsson Comprehensive Cancer Center; dean's office at the David Geffen School of Medicine; Chancellor's Bioscience Facility grant; UCLA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported, in whole or in part, by National Institutes of Health Grants P50 CA092131 and R01 CA107166 (to H. W.), National Cancer Institute/National Institutes of Health Grant U01 CA84128-06, the Prostate Cancer Foundation, and Department of Defense Grant PC031130 (to H. W.). The UCLA Mass Spectrometry and Proteomics Technology Center was established with a grant from the W. M. Keck Foundation. The functional proteomics laboratory (DIGE Shared Resource) was supported by the Jonsson Comprehensive Cancer Center, the dean's office at the David Geffen School of Medicine, and a Chancellor's Bioscience Facility grant, UCLA.	Adey NB, 2000, CANCER RES, V60, P35; Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; Carracedo A, 2008, CELL, V133, P550, DOI 10.1016/j.cell.2008.04.023; Chang CJ, 2008, MOL CELL BIOL, V28, P3281, DOI 10.1128/MCB.00310-08; CHOI YD, 1986, SCIENCE, V231, P1534, DOI 10.1126/science.3952495; Crockett DK, 2005, PROTEOMICS, V5, P1250, DOI 10.1002/pmic.200401046; Ford LP, 2000, MOL CELL BIOL, V20, P9084, DOI 10.1128/MCB.20.23.9084-9091.2000; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Gil A, 2006, MOL BIOL CELL, V17, P4002, DOI 10.1091/mbc.E06-05-0380; GORLACH M, 1992, EMBO J, V11, P3289, DOI 10.1002/j.1460-2075.1992.tb05407.x; Holcik M, 2003, MOL CELL BIOL, V23, P280, DOI 10.1128/MCB.23.1.280-288.2003; Hossain MN, 2007, MOL CELL BIOCHEM, V296, P151, DOI 10.1007/s11010-006-9308-2; Kotelevets L, 2004, FASEB J, V18, P115, DOI 10.1096/fj.04-1942fje; Li DM, 1997, CANCER RES, V57, P2124; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Miller SJ, 2002, FEBS LETT, V528, P145, DOI 10.1016/S0014-5793(02)03274-X; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Odriozola L, 2007, J BIOL CHEM, V282, P23306, DOI 10.1074/jbc.M611240200; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stone JR, 2002, J BIOL CHEM, V277, P15621, DOI 10.1074/jbc.M112153200; Sumitomo M, 2004, CANCER CELL, V5, P67, DOI 10.1016/S1535-6108(03)00331-3; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; SWANSON MS, 1987, MOL CELL BIOL, V7, P1731, DOI 10.1128/MCB.7.5.1731; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tonge R, 2001, PROTEOMICS, V1, P377; Torres J, 2003, J BIOL CHEM, V278, P30652, DOI 10.1074/jbc.M212610200; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Weng LP, 2001, HUM MOL GENET, V10, P599, DOI 10.1093/hmg/10.6.599; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199; Yu ZB, 2002, J BIOL CHEM, V277, P40247, DOI 10.1074/jbc.M207608200	43	16	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30159	30166		10.1074/jbc.M109.027995	http://dx.doi.org/10.1074/jbc.M109.027995			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19740742	Green Published, hybrid			2022-12-25	WOS:000271090000019
J	Pick, H; Etter, S; Baud, O; Schmauder, R; Bordoli, L; Schwede, T; Vogel, H				Pick, Horst; Etter, Sylvain; Baud, Olivia; Schmauder, Ralf; Bordoli, Lorenza; Schwede, Torsten; Vogel, Horst			Dual Activities of Odorants on Olfactory and Nuclear Hormone Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ESTROGEN-RECEPTOR; FUNCTIONAL EXPRESSION; MOLECULAR-BASIS; PROGESTERONE-RECEPTORS; CRYSTAL-STRUCTURE; BINDING AFFINITY; STRUCTURAL BASIS; ER-ALPHA; LIGAND; PREDICTION	We have screened an odorant compound library and discovered molecules acting as chemical signals that specifically activate both G-protein-coupled olfactory receptors (ORs) on the cell surface of olfactory sensory neurons and the human nuclear estrogen receptor alpha (ER) involved in transcriptional regulation of cellular differentiation and proliferation in a wide variety of tissues. Hence, these apparent dual active odorants induce distinct signal transduction pathways at different subcellular localizations, which affect both neuronal signaling, resulting in odor perception, and the ER-dependent transcriptional control of specific genes. We demonstrate these effects using fluorescence-based in vitro and cellular assays. Among these odorants, we have identified synthetic sandalwood compounds, an important class of molecules used in the fragrance industry. For one estrogenic odorant we have also identified the cognate OR. This prompted us to compare basic molecular recognition principles of odorants on the two structurally and apparent functionally non-related receptors using computational modeling in combination with functional assays. Faced with the increasing evidence that ORs may perform chemosensory functions in a number of tissues outside of the nasal olfactory epithelium, the unraveling of these molecular ligand-receptor interaction principles is of critical importance. In addition the evidence that certain olfactory sensory neurons naturally co-express ORs and ERs may provide a direct functional link between the olfactory and hormonal systems in humans. Our results are therefore useful for defining the structural and functional characteristics of ER-specific odorants and the role of odorant molecules in cellular processes other than olfaction.	[Pick, Horst; Etter, Sylvain; Baud, Olivia; Schmauder, Ralf; Vogel, Horst] Ecole Polytech Fed Lausanne, Inst Sci & Ingenierie Chim, CH-1015 Lausanne, Switzerland; [Bordoli, Lorenza; Schwede, Torsten] Univ Basel, Swiss Inst Bioinformat, Biozentrum, CH-4056 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; University of Basel	Vogel, H (corresponding author), Ecole Polytech Fed Lausanne, Inst Sci & Ingenierie Chim, CH-1015 Lausanne, Switzerland.	Horst.Vogel@epfl.ch	Schwede, Torsten/A-4650-2008; Vogel, Horst/AAJ-5490-2021	Schwede, Torsten/0000-0003-2715-335X; Schmauder, Ralf/0000-0002-8441-4264	SystemsX program of the Swiss National Science Foundation; Ecole Polytechnique Fe de rale de Lausaunne	SystemsX program of the Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); Ecole Polytechnique Fe de rale de Lausaunne	This work was supported by the SystemsX program of the Swiss National Science Foundation and by internal grants of the Ecole Polytechnique Fe de rale de Lausaunne.	Abaffy T, 2007, J BIOL CHEM, V282, P1216, DOI 10.1074/jbc.M609355200; Abdelrahim M, 2006, CANCER RES, V66, P2459, DOI 10.1158/0008-5472.CAN-05-3132; Anstead GM, 1997, STEROIDS, V62, P268, DOI 10.1016/S0039-128X(96)00242-5; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Barni T, 1999, J CLIN ENDOCR METAB, V84, P4266, DOI 10.1210/jc.84.11.4266; Bieri S, 2004, CHEM SENSES, V29, P483, DOI 10.1093/chemse/bjh050; Bissantz C, 2004, J CHEM INF COMP SCI, V44, P1162, DOI 10.1021/ci034181a; Blair RM, 2000, TOXICOL SCI, V54, P138, DOI 10.1093/toxsci/54.1.138; Brown MB, 2006, DRUG DELIV, V13, P175, DOI 10.1080/10717540500455975; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CRAMER CJ, 1992, J COMPUT AID MOL DES, V6, P629, DOI 10.1007/BF00126219; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Doszczak L, 2007, ANGEW CHEM INT EDIT, V46, P3367, DOI 10.1002/anie.200605002; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Fang H, 2000, ENVIRON HEALTH PERSP, V108, P723, DOI 10.1289/ehp.00108723; Feige JN, 2005, J BIOL CHEM, V280, P17880, DOI 10.1074/jbc.M500786200; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Floriano WB, 2004, CHEM SENSES, V29, P269, DOI 10.1093/chemse/bjh030; Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Howes MJR, 2002, J PHARM PHARMACOL, V54, P1521, DOI 10.1211/002235702216; Htun H, 1999, MOL BIOL CELL, V10, P471, DOI 10.1091/mbc.10.2.471; Jacquier V, 2006, P NATL ACAD SCI USA, V103, P14325, DOI 10.1073/pnas.0603942103; Jacquier V, 2006, J NEUROCHEM, V97, P537, DOI 10.1111/j.1471-4159.2006.03771.x; Jankevics H, 2005, BIOCHEMISTRY-US, V44, P11676, DOI 10.1021/bi050744v; Kaminski RM, 2006, J PHARMACOL EXP THER, V317, P694, DOI 10.1124/jpet.105.098319; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Kraft P, 2000, ANGEW CHEM INT EDIT, V39, P2981; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Likhite VS, 2006, MOL ENDOCRINOL, V20, P3120, DOI 10.1210/me.2006-0068; Lill MA, 2006, CHEMMEDCHEM, V1, P73, DOI 10.1002/cmdc.200500024; Man O, 2004, PROTEIN SCI, V13, P240, DOI 10.1110/ps.03296404; Matsuda K, 2008, J CELL BIOCHEM, V103, P136, DOI 10.1002/jcb.21393; Meegan MJ, 2007, J ENZYM INHIB MED CH, V22, P655, DOI 10.1080/14756360701503232; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mueller SO, 2004, ANAL BIOANAL CHEM, V378, P582, DOI 10.1007/s00216-003-2238-x; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pick H, 2007, J MOL BIOL, V374, P1213, DOI 10.1016/j.jmb.2007.10.007; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; REESE JC, 1992, J BIOL CHEM, V267, P9868; Rimkus GG, 1996, CHEMOSPHERE, V33, P2033, DOI 10.1016/0045-6535(96)00321-9; Romanelli RG, 2004, J BIOL CHEM, V279, P117, DOI 10.1074/jbc.M307955200; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schiniedeberg K, 2007, J STRUCT BIOL, V159, P400, DOI 10.1016/j.jsb.2007.04.013; Schreurs RHMM, 2002, TOXICOL APPL PHARM, V183, P1, DOI 10.1006/taap.2002.9458; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shepherd GM, 2006, NATURE, V444, P316, DOI 10.1038/nature05405; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shiau AK, 2002, NAT STRUCT BIOL, V9, P359, DOI 10.1038/nsb787; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Stenoien DL, 2001, MOL CELL BIOL, V21, P4404, DOI 10.1128/MCB.21.13.4404-4412.2001; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Terasaki M, 2009, ENVIRON TOXICOL CHEM, V28, P204, DOI 10.1897/08-225.1; Touhara K, 2007, NEUROCHEM INT, V51, P132, DOI 10.1016/j.neuint.2007.05.020; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; van Lipzig MMH, 2004, J MED CHEM, V47, P1018, DOI 10.1021/jm0309607; Vedani A, 2005, J MED CHEM, V48, P3700, DOI 10.1021/jm050185q; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Yamasaki K, 2003, TOXICOL LETT, V142, P119, DOI 10.1016/S0378-4274(03)00019-5; Zozulya S, 2001, GENOME BIOL, V2	74	15	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30547	30555		10.1074/jbc.M109.040964	http://dx.doi.org/10.1074/jbc.M109.040964			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19723634	hybrid, Green Published			2022-12-25	WOS:000271090000057
J	Lim, SK; Ju, JH; Zazopoulos, E; Jiang, H; Seo, JW; Chen, YH; Feng, ZY; Rajski, SR; Farnet, CM; Shen, B				Lim, Si-Kyu; Ju, Jianhua; Zazopoulos, Emmanuel; Jiang, Hui; Seo, Jeong-Woo; Chen, Yihua; Feng, Zhiyang; Rajski, Scott R.; Farnet, Chris M.; Shen, Ben			iso-Migrastatin, Migrastatin, and Dorrigocin Production in Streptomyces platensis NRRL 18993 Is Governed by a Single Biosynthetic Machinery Featuring an Acyltransferase-less Type I Polyketide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION INHIBITORS; GENE-CLUSTER; MOLECULAR CHARACTERIZATION; LACTIMIDOMYCIN; SYNTHETASE; CONGENERS; PROTEIN; KETOREDUCTASE; DISCOVERY; DISCRETE	iso-Migrastatin and related glutarimide-containing polyketides are potent inhibitors of tumor cell migration and their implied potential as antimetastatic agents for human cancers has garnered significant attention. Genome scanning of Streptomyces platensis NRRL 18993 unveiled two candidate gene clusters (088D and mgs); each encodes acyltransferase-less type I polyketide synthases commensurate with iso-migrastatin biosynthesis. Both clusters were inactivated by lambda-RED-mediated PCR-targeting mutagenesis in S. platensis; iso-migrastatin production was completely abolished in the Delta mgsF mutant SB11012 strain, whereas inactivation of 088D-orf7 yielded the SB11006 strain that exhibited no discernible change in iso-migrastatin biosynthesis. These data indicate that iso-migrastatin production is governed by the mgs cluster. Systematic gene inactivation allowed determination of the precise boundaries of the mgs cluster and the essentiality of the genes within the mgs cluster in iso-migrastatin production. The mgs cluster consists of 11 open reading frames that encode three acyltransferase-less type I polyketide synthases (MgsEFG), one discrete acyltransferase (MgsH), a type II thioesterase (MgsB), three post-PKS tailoring enzymes (MgsIJK), two glutarimide biosynthesis enzymes (MgsCD), and one regulatory protein (MgsA). A model for iso-migrastatin biosynthesis is proposed based on functional assignments derived from bioinformatics and is further supported by the results of in vivo gene inactivation experiments.	[Shen, Ben] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Natl Cooperat Drug Discovery Grp, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA; [Zazopoulos, Emmanuel; Farnet, Chris M.] Thall Pharmaceut Inc, Montreal, PQ H4S 2C8, Canada	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shen, B (corresponding author), Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, 777 Highland Ave, Madison, WI 53705 USA.	bshen@pharmacy.wisc.edu	Farnet, Chris/ABE-5463-2021; Seo, Jung-Hun/G-2659-2012	Seo, Jung-Hun/0000-0002-5039-2503; Farnet, Chris/0000-0003-4927-198X	National Institutes of Health [CA106150, CA113297]; NATIONAL CANCER INSTITUTE [R01CA106150, U19CA113297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA106150 and CA113297.	Anton N, 2004, J BACTERIOL, V186, P2567, DOI 10.1128/JB.186.9.2567-2575.2004; Aparicio JF, 1996, GENE, V169, P9, DOI 10.1016/0378-1119(95)00800-4; Boissier F, 2006, J BIOL CHEM, V281, P4434, DOI 10.1074/jbc.M510250200; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Bruntner C, 1999, MOL GEN GENET, V262, P102; Butler AR, 1999, CHEM BIOL, V6, P287, DOI 10.1016/S1074-5521(99)80074-X; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; Chater KF, 2006, PHILOS T R SOC B, V361, P761, DOI 10.1098/rstb.2005.1758; Chen XH, 2006, J BACTERIOL, V188, P4024, DOI 10.1128/JB.00052-06; Chen Y, 2008, J BACTERIOL, V190, P5587, DOI 10.1128/JB.00592-08; Cheng YQ, 2009, METHOD ENZYMOL, V459, P165, DOI 10.1016/S0076-6879(09)04608-4; Cheng YQ, 2003, P NATL ACAD SCI USA, V100, P3149, DOI 10.1073/pnas.0537286100; Christiansen G, 2008, MOL BIOL EVOL, V25, P1695, DOI 10.1093/molbev/msn120; Doi-Katayama Y, 2000, J ANTIBIOT, V53, P484, DOI 10.7164/antibiotics.53.484; FERNANDEZMORENO MA, 1991, CELL, V66, P769, DOI 10.1016/0092-8674(91)90120-N; Gaul C, 2004, J AM CHEM SOC, V126, P11326, DOI 10.1021/ja048779q; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Heathcole ML, 2001, CHEM BIOL, V8, P207, DOI 10.1016/S1074-5521(01)00002-3; Ju JH, 2005, J AM CHEM SOC, V127, P11930, DOI 10.1021/ja053118u; Ju JH, 2005, J AM CHEM SOC, V127, P1622, DOI 10.1021/ja043808i; Ju JH, 2008, BIOORG MED CHEM LETT, V18, P5951, DOI 10.1016/j.bmcl.2008.07.072; Ju J, 2007, ORG LETT, V9, P5183, DOI 10.1021/ol702249g; Ju JH, 2006, ORG LETT, V8, P5865, DOI 10.1021/ol062470p; Ju JH, 2009, J AM CHEM SOC, V131, P1370, DOI 10.1021/ja808462p; KARWOWSKI JP, 1994, J ANTIBIOT, V47, P862, DOI 10.7164/antibiotics.47.862; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Korman TP, 2004, BIOCHEMISTRY-US, V43, P14529, DOI 10.1021/bi048133a; Larsen TM, 1999, BIOCHEMISTRY-US, V38, P16146, DOI 10.1021/bi9915768; Mao YQ, 1999, CHEM BIOL, V6, P251, DOI 10.1016/S1074-5521(99)80040-4; Miller MT, 2002, P NATL ACAD SCI USA, V99, P14752, DOI 10.1073/pnas.232361199; Miller MT, 2001, NAT STRUCT BIOL, V8, P684, DOI 10.1038/90394; Nakae K, 2000, J ANTIBIOT, V53, P1130, DOI 10.7164/antibiotics.53.1130; Nguyen T, 2008, NAT BIOTECHNOL, V26, P225, DOI 10.1038/nbt1379; Njardarson JT, 2004, J AM CHEM SOC, V126, P1038, DOI 10.1021/ja039714a; Partida-Martinez LP, 2007, CHEMBIOCHEM, V8, P41, DOI 10.1002/cbic.200600393; Piel J, 2004, ENVIRON MICROBIOL, V6, P921, DOI 10.1111/j.1462-2920.2004.00531.x; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; Sambrook J, 2001, MOL CLONING LAB MANU; Sanchez C, 2001, CHEM BIOL, V8, P725, DOI 10.1016/S1074-5521(01)00047-3; Shan DD, 2005, P NATL ACAD SCI USA, V102, P3772, DOI 10.1073/pnas.0500658102; Shen B, 2007, ACS SYM SER, V955, P154; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; SUGAWARA K, 1992, J ANTIBIOT, V45, P1433, DOI 10.7164/antibiotics.45.1433; Tang GL, 2004, CHEM BIOL, V11, P33, DOI 10.1016/j.chembiol.2003.12.014; Tang GL, 2007, J BIOL CHEM, V282, P20273, DOI 10.1074/jbc.M702814200; Tang L, 1996, MOL MICROBIOL, V22, P801, DOI 10.1046/j.1365-2958.1996.01528.x; White J, 1997, J BACTERIOL, V179, P627, DOI 10.1128/jb.179.3.627-633.1997; Wietzorrek A, 1997, MOL MICROBIOL, V25, P1181, DOI 10.1046/j.1365-2958.1997.5421903.x; Woo EJ, 2002, J ANTIBIOT, V55, P141, DOI 10.7164/antibiotics.55.141; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; Xue YQ, 1998, P NATL ACAD SCI USA, V95, P12111, DOI 10.1073/pnas.95.21.12111; Zazopoulos E, 2003, NAT BIOTECHNOL, V21, P187, DOI 10.1038/nbt784	52	42	48	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29746	29756		10.1074/jbc.M109.046805	http://dx.doi.org/10.1074/jbc.M109.046805			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19726666	Green Published, hybrid			2022-12-25	WOS:000270896800056
J	Pradeepa, MM; Nikhil, G; Kishore, AH; Bharath, GN; Kundu, TK; Rao, MRS				Pradeepa, Madapura M.; Nikhil, Gupta; Kishore, Annavarapu Hari; Bharath, Giriyapura N.; Kundu, Tapas K.; Rao, Manchanahalli R. Satyanarayana			Acetylation of Transition Protein 2 (TP2) by KAT3B (p300) Alters Its DNA Condensation Property and Interaction with Putative Histone Chaperone NPM3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE SPERMATOGENESIS; NUCLEIC-ACIDS; KINASE-A; TRANSCRIPTION; SPERMIOGENESIS; IDENTIFICATION; INVOLVEMENT; SPERM; MICE; HYPERACETYLATION	The hallmark of mammalian spermiogenesis is the dramatic chromatin remodeling process wherein the nucleosomal histones are replaced by the transition proteins TP1, TP2, and TP4. Subsequently these transition proteins are replaced by the protamines P1 and P2. Hyperacetylation of histone H4 is linked to their replacement by transition proteins. Here we report that TP2 is acetylated in vivo as detected by anti-acetylated lysine antibody and mass spectrometric analysis. Further, recombinant TP2 is acetylated in vitro by acetyltransferase KAT3B (p300) more efficiently than by KAT2B (PCAF). In vivo p300 was demonstrated to acetylate TP2. p300 acetylates TP2 in its C-terminal domain, which is highly basic in nature and possesses chromatin-condensing properties. Mass spectrometric analysis showed that p300 acetylates four lysine residues in the C-terminal domain of TP2. Acetylation of TP2 by p300 leads to significant reduction in its DNA condensation property as studied by circular dichroism and atomic force microscopy analysis. TP2 also interacts with a putative histone chaperone, NPM3, wherein expression is elevated in haploid spermatids. Interestingly, acetylation of TP2 impedes its interaction with NPM3. Thus, acetylation of TP2 adds a new dimension to its role in the dynamic reorganization of chromatin during mammalian spermiogenesis.	[Pradeepa, Madapura M.; Nikhil, Gupta; Kishore, Annavarapu Hari; Bharath, Giriyapura N.; Kundu, Tapas K.; Rao, Manchanahalli R. Satyanarayana] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India; [Rao, Manchanahalli R. Satyanarayana] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Rao, MRS (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Jakkur PO, Bangalore 560064, Karnataka, India.	mrsrao@jncasr.ac.in	madapura, Pradeepa/AAS-1288-2020; , Proteomics Core UNC/AFQ-7201-2022	madapura, Pradeepa/0000-0001-9095-9247; Kundu, Tapas/0000-0001-7790-214X	Department of Biotechnology, Ministry of Science and Technology, New Delhi, India; Council of Scientific and Industrial Research, New Delhi, India	Department of Biotechnology, Ministry of Science and Technology, New Delhi, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Department of Biotechnology, Ministry of Science and Technology, New Delhi, India.; Supported by a fellowship from the Council of Scientific and Industrial Research, New Delhi, India.; Supported by the J. C. Bose Fellowship from the Department of Science and Technology, Ministry of Science and Technology.	Allen MJ, 1997, NUCLEIC ACIDS RES, V25, P2221, DOI 10.1093/nar/25.11.2221; BASKARAN R, 1990, J BIOL CHEM, V265, P21039; BASKARAN R, 1991, BIOCHEM BIOPH RES CO, V179, P1491, DOI 10.1016/0006-291X(91)91741-T; Brewer L, 2002, J BIOL CHEM, V277, P38895, DOI 10.1074/jbc.M204755200; CHRISTENSEN ME, 1984, NUCLEIC ACIDS RES, V12, P4575, DOI 10.1093/nar/12.11.4575; Frehlick LJ, 2007, BIOESSAYS, V29, P49, DOI 10.1002/bies.20512; Govin J, 2006, J BIOL CHEM, V281, P37888, DOI 10.1074/jbc.M608147200; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; Huang N, 2005, J BIOL CHEM, V280, P5496, DOI 10.1074/jbc.M407856200; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; KUNDU TK, 1995, BIOCHEMISTRY-US, V34, P5143, DOI 10.1021/bi00015a027; Kundu TK, 1996, BIOCHEMISTRY-US, V35, P15626, DOI 10.1021/bi961271i; Kundu TK, 1999, MOL CELL BIOL, V19, P1605; LEUBA SH, 1994, P NATL ACAD SCI USA, V91, P11621, DOI 10.1073/pnas.91.24.11621; MacArthur CA, 1997, GENOMICS, V42, P137, DOI 10.1006/geno.1997.4353; Marcon L, 2004, BIOL REPROD, V70, P910, DOI 10.1095/biolreprod.103.022541; Meetei AR, 2000, J BIOL CHEM, V275, P38500, DOI 10.1074/jbc.M002734200; Meetei AR, 2002, BIOCHEMISTRY-US, V41, P185, DOI 10.1021/bi0117652; Meistrich M., 1989, HISTONES OTHER BASIC, P165; Motoi N, 2008, DEV GROWTH DIFFER, V50, P307, DOI [10.1111/j.1440-169x.2008.01034.x, 10.1111/j.1440-169X.2008.01034.x]; Pradeepa MM, 2008, MOL CELL BIOL, V28, P4331, DOI 10.1128/MCB.00519-07; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Shirley CR, 2004, BIOL REPROD, V71, P1220, DOI 10.1095/biolreprod.104.029363; SINGH J, 1987, J BIOL CHEM, V262, P734; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Steen Hanno, 2002, Sci STKE, V2002, ppl16, DOI 10.1126/stke.2002.154.pl16; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Swaminathan V, 2005, MOL CELL BIOL, V25, P7534, DOI 10.1128/MCB.25.17.7534-7545.2005; Ullas KS, 2003, J BIOL CHEM, V278, P52673, DOI 10.1074/jbc.M308365200; ULLAS KS, 2009, J HISTOCHEM CYTOCHEM, V57, P951; Wouters-Tyrou D, 1998, BIOCHIMIE, V80, P117, DOI 10.1016/S0300-9084(98)80018-7; YANG X, 1996, NATURE, V382, P331; Yu YE, 2000, P NATL ACAD SCI USA, V97, P4683, DOI 10.1073/pnas.97.9.4683; Zhao M, 2004, BIOL REPROD, V71, P1016, DOI 10.1095/biolreprod.104.028191; Zhao M, 2001, MOL CELL BIOL, V21, P7243, DOI 10.1128/MCB.21.21.7243-7255.2001; Zirwes RF, 1997, P NATL ACAD SCI USA, V94, P11387, DOI 10.1073/pnas.94.21.11387	37	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29956	29967		10.1074/jbc.M109.052043	http://dx.doi.org/10.1074/jbc.M109.052043			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19710011	hybrid, Green Published			2022-12-25	WOS:000270896800074
J	Ishikawa, S; Taira, T; Niki, T; Takahashi-Niki, K; Maita, C; Maita, H; Ariga, H; Iguchi-Ariga, SMM				Ishikawa, Shizuma; Taira, Takahiro; Niki, Takeshi; Takahashi-Niki, Kazuko; Maita, Chinatsu; Maita, Hiroshi; Ariga, Hiroyoshi; Iguchi-Ariga, Sanae M. M.			Oxidative Status of DJ-1-dependent Activation of Dopamine Synthesis through Interaction of Tyrosine Hydroxylase and 4-Dihydroxy-L-phenylalanine (L-DOPA) Decarboxylase with DJ-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; ANDROGEN RECEPTOR; ANTIOXIDATIVE STRESS; ALPHA-SYNUCLEIN; CELL-DEATH; PROTEIN; MUTATIONS; GENE; PARK7; LOCALIZATION	Parkinson disease (PD) is caused by loss of dopamine, which is synthesized from tyrosine by two enzymes, tyrosine hydroxylase (TH) and 4-dihydroxy-L-phenylalanine decarboxylase (DDC). DJ-1 is a causative gene for the familial form of PD, but little is known about the roles of DJ-1 in dopamine synthesis. In this study, we found that DJ-1 directly bound to TH and DDC and positively regulated their activities in human dopaminergic cells. Mutants of DJ-1 found in PD patients, including heterozygous mutants, lost their activity and worked as dominant-negative forms toward wild-type DJ-1. When cells were treated with H2O2, 6-hydroxydopamine, or 1-methyl-4-phenylpyridinium, changes in activities of TH and DDC accompanied by oxidation of cysteine 106 of DJ-1 occurred. It was found that DJ-1 possessing Cys-106 with SH and SOH forms was active and that DJ-1 possessing Cys-106 with SO2H and SO3H forms was inactive in terms of stimulation of TH and DDC activities. These findings indicate an essential role of DJ-1 in dopamine synthesis and contribution of DJ-1 to the sporadic form of PD.	[Niki, Takeshi; Takahashi-Niki, Kazuko; Maita, Hiroshi; Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Ishikawa, Shizuma; Maita, Chinatsu; Iguchi-Ariga, Sanae M. M.] Hokkaido Univ, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Taira, Takahiro] Yamanashi Univ, Interdisciplinary Grad Sch Med & Engn, Chuoh 4093898, Japan	Hokkaido University; Hokkaido University; University of Yamanashi	Ariga, H (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan.	hiro@pharm.hokudai.ac.jp	Maita, Hiroshi/D-5495-2012; Ariga, Sanae/H-9647-2013; Ariga, Hiroyoshi/B-5895-2013	Ariga, Hiroyoshi/0000-0001-7384-2143	Ministry of Education, Science, Culture, and Sports; National Institute of Biomedical Innovation in Japan; Grants-in-Aid for Scientific Research [21390014] Funding Source: KAKEN	Ministry of Education, Science, Culture, and Sports(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation in Japan(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Science, Culture, and Sports and by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation in Japan.	Abou-Sleiman PM, 2003, ANN NEUROL, V54, P283, DOI 10.1002/ana.10675; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Annesi G, 2005, ANN NEUROL, V58, P803, DOI 10.1002/ana.20666; Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663; Hedrich K, 2004, NEUROLOGY, V62, P389, DOI 10.1212/01.WNL.0000113022.51739.88; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; Itagaki C, 1999, BIOCHEMISTRY-US, V38, P15673, DOI 10.1021/bi9914255; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Miyazaki S, 2008, J NEUROCHEM, V105, P2418, DOI 10.1111/j.1471-4159.2008.05327.x; Mori K, 1998, J BIOL CHEM, V273, P29794, DOI 10.1074/jbc.273.45.29794; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Niki T, 2003, MOL CANCER RES, V1, P247; Shinbo YM, 2005, INT J ONCOL, V26, P641; SUTHERLAND C, 1993, EUR J BIOCHEM, V217, P715, DOI 10.1111/j.1432-1033.1993.tb18297.x; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Tehranian R, 2006, J NEUROCHEM, V99, P1188, DOI 10.1111/j.1471-4159.2006.04146.x; Tillman JE, 2007, CANCER RES, V67, P4630, DOI 10.1158/0008-5472.CAN-06-4556; Toska K, 2002, J NEUROCHEM, V83, P775, DOI 10.1046/j.1471-4159.2002.01172.x; Wang J, 2009, J BIOL CHEM, V284, P14011, DOI 10.1074/jbc.M901310200; Yanagida T, 2009, OXID MED CELL LONGEV, V2, P36, DOI 10.4161/oxim.2.1.7985; Yoshida T, 2008, EXP CELL RES, V314, P1217, DOI 10.1016/j.yexcr.2008.01.002; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030	36	67	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28832	28844		10.1074/jbc.M109.019950	http://dx.doi.org/10.1074/jbc.M109.019950			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19703902	hybrid, Green Published			2022-12-25	WOS:000270678900040
J	Risteli, M; Ruotsalainen, H; Salo, AM; Sormunen, R; Sipila, L; Baker, NL; Lamande, SR; Vimpari-Kauppinen, L; Myllyla, R				Risteli, Maija; Ruotsalainen, Heli; Salo, Antti M.; Sormunen, Raija; Sipila, Laura; Baker, Naomi L.; Lamande, Shireen R.; Vimpari-Kauppinen, Leena; Myllyla, Raili			Reduction of Lysyl Hydroxylase 3 Causes Deleterious Changes in the Deposition and Organization of Extracellular Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; TISSUE DISTRIBUTION; COLLAGEN; VI; FIBRONECTIN; GLUCOSYLTRANSFERASE; DEFICIENCY; EXPRESSION; CLONING; ENZYME	Lysyl hydroxylase 3 (LH3) is a multifunctional enzyme possessing lysyl hydroxylase, collagen galactosyltransferase, and glucosyltransferase (GGT) activities. We report here an important role for LH3 in the organization of the extracellular matrix (ECM) and cytoskeleton. Deposition of ECM was affected in heterozygous LH3 knock-out mouse embryonic fibroblasts (MEF+/-) and in skin fibroblasts collected from a member of a Finnish epidermolysis bullosa simplex (EBS) family known to be deficient in GGT activity. We show the GGT deficiency to be due to a transcriptional defect in one LH3 allele. The ECM abnormalities also lead to defects in the arrangement of the cytoskeleton in both cell lines. Ultrastructural abnormalities were observed in the skin of heterozygous LH3 knock-out mice indicating that even a moderate decrease in LH3 has deleterious consequences in vivo. The LH3 null allele in the EBS family member and the resulting abnormalities in the organization of the extracellular matrix, similar to those found in MEF+/-, may explain the correlation between the severity of the phenotype and the decrease in GGT activity reported in this family.	[Risteli, Maija; Ruotsalainen, Heli; Salo, Antti M.; Sipila, Laura; Myllyla, Raili] Univ Oulu, Dept Biochem, FI-90014 Oulu, Finland; [Sormunen, Raija] Univ Oulu, Dept Pathol, Bioctr Oulu, FI-90014 Oulu, Finland; [Baker, Naomi L.; Lamande, Shireen R.] Univ Melbourne, Royal Childrens Hosp, Dept Pediat, Parkville, Vic 3052, Australia; [Baker, Naomi L.; Lamande, Shireen R.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Vimpari-Kauppinen, Leena] Kainuu Cent Hosp, Dermatol Clin, Kajaani 87140, Finland	Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Myllyla, R (corresponding author), Univ Oulu, Dept Biochem, POB 3000, FI-90014 Oulu, Finland.	raili.myllyla@oulu.fi		Lamande, Shireen/0000-0003-2938-2711; Ruotsalainen, Heli/0000-0003-4923-5196	Research Council for Biosciences and Environment within the Academy of Finland; Sigrid Juselius Foundation; Biocenter Oulu; Glycoscience Graduate School; Research and Science Foundation of Farmos; Societas Scientiarum Fermica; Maud Kuistila Memorial Foundation	Research Council for Biosciences and Environment within the Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocenter Oulu; Glycoscience Graduate School; Research and Science Foundation of Farmos; Societas Scientiarum Fermica; Maud Kuistila Memorial Foundation	This work was supported by grants from the Research Council for Biosciences and Environment within the Academy of Finland, the Sigrid Juselius Foundation, Biocenter Oulu, Glycoscience Graduate School, Research and Science Foundation of Farmos, Societas Scientiarum Fermica, and the Maud Kuistila Memorial Foundation.	Aszodi A, 2006, ANNU REV CELL DEV BI, V22, P591, DOI 10.1146/annurev.cellbio.22.010305.104258; CHU ML, 1988, J BIOL CHEM, V263, P18601; ENGVALL E, 1986, J CELL BIOL, V102, P703, DOI 10.1083/jcb.102.3.703; Eyre D, 2002, MOL GENET METAB, V76, P211, DOI 10.1016/S1096-7192(02)00036-7; GEIGERB, 2001, NAT REV MOL CELL BIO, V2, P793; Ha-Vinh R, 2004, AM J MED GENET A, V131A, P115, DOI 10.1002/ajmg.a.30231; HAUTALA T, 1992, GENOMICS, V13, P62, DOI 10.1016/0888-7543(92)90202-4; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; Hocking DC, 2000, J BIOL CHEM, V275, P10673, DOI 10.1074/jbc.275.14.10673; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; KIVIRIKKO KI, 1992, POSTTRANSLATIONAL MO; Lamande SR, 2006, J BIOL CHEM, V281, P16607, DOI 10.1074/jbc.M510192200; Li SH, 2003, AM J PATHOL, V163, P1045, DOI 10.1016/S0002-9440(10)63464-5; MCDONALD JA, 1982, J CELL BIOL, V92, P485, DOI 10.1083/jcb.92.2.485; Mercer DK, 2003, BIOCHEM BIOPH RES CO, V307, P803, DOI 10.1016/S0006-291X(03)01262-2; Minamitani T, 2004, EXP CELL RES, V298, P305, DOI 10.1016/j.yexcr.2004.04.030; MYLLYLA R, 1975, EUR J BIOCHEM, V52, P401, DOI 10.1111/j.1432-1033.1975.tb04008.x; Myllyla R, 2007, J CELL PHYSIOL, V212, P323, DOI 10.1002/jcp.21036; Passoja K, 1998, P NATL ACAD SCI USA, V95, P10482, DOI 10.1073/pnas.95.18.10482; Putnam AJ, 2001, AM J PHYSIOL-CELL PH, V280, pC556, DOI 10.1152/ajpcell.2001.280.3.C556; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Rautavuoma K, 2000, MATRIX BIOL, V19, P73, DOI 10.1016/S0945-053X(99)00058-X; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Ruotsalainen H, 1999, MATRIX BIOL, V18, P325, DOI 10.1016/S0945-053X(99)00016-5; Sabatelli P, 2001, MATRIX BIOL, V20, P475, DOI 10.1016/S0945-053X(01)00160-3; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; Sambrook J, 2001, MOL CLONING LAB MANU; SAVOLAINEN ER, 1981, NEW ENGL J MED, V304, P197, DOI 10.1056/NEJM198101223040403; Schneider VA, 2007, MATRIX BIOL, V26, P12, DOI 10.1016/j.matbio.2006.09.007; Schneider VA, 2006, NEURON, V50, P683, DOI 10.1016/j.neuron.2006.04.024; Sipila L, 2007, J BIOL CHEM, V282, P33381, DOI 10.1074/jbc.M704198200; Squarzoni S, 2006, J CELL PHYSIOL, V206, P160, DOI 10.1002/jcp.20443; Steinmann B., 2002, CONNECTIVE TISSUE IT, P431, DOI DOI 10.1002/0471221929.CH9; Timpl R, 1994, EXTRACELLULAR MATRIX, P207, DOI 10.1016/B978-0-12-775170-2.50012-3; Uzawa K, 2003, BIOCHEM BIOPH RES CO, V305, P484, DOI 10.1016/S0006-291X(03)00799-X; Valtavaara M, 1997, J BIOL CHEM, V272, P6831, DOI 10.1074/jbc.272.11.6831; Valtavaara M, 1998, J BIOL CHEM, V273, P12881, DOI 10.1074/jbc.273.21.12881; van der Slot AJ, 2004, MATRIX BIOL, V23, P251, DOI 10.1016/j.matbio.2004.06.001; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Wang CG, 2009, J CELL MOL MED, V13, P508, DOI 10.1111/j.1582-4934.2008.00286.x; Yeowell HN, 1999, MATRIX BIOL, V18, P179, DOI 10.1016/S0945-053X(99)00013-X; Yeowell HN, 2000, MOL GENET METAB, V71, P212, DOI 10.1006/mgme.2000.3076	46	34	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28204	28211		10.1074/jbc.M109.038190	http://dx.doi.org/10.1074/jbc.M109.038190			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19696018	Green Published, hybrid			2022-12-25	WOS:000270676300048
J	Maier, N; Morris, G; Johenning, FW; Schmitz, D				Maier, Nikolaus; Morris, Genela; Johenning, Friedrich W.; Schmitz, Dietmar			An Approach for Reliably Investigating Hippocampal Sharp Wave-Ripples In Vitro	PLOS ONE			English	Article								Background: Among the various hippocampal network patterns, sharp wave-ripples (SPW-R) are currently the mechanistically least understood. Although accurate information on synaptic interactions between the participating neurons is essential for comprehensive understanding of the network function during complex activities like SPW-R, such knowledge is currently notably scarce. Methodology/Principal Findings: We demonstrate an in vitro approach to SPW-R that offers a simple experimental tool allowing detailed analysis of mechanisms governing the sharp wave-state of the hippocampus. We combine interface storage of slices with modifications of a conventional submerged recording system and established in vitro SPW-R comparable to their in vivo counterpart. We show that slice storage in the interface chamber close to physiological temperature is the required condition to preserve network integrity that is necessary for the generation of SPW-R. Moreover, we demonstrate the utility of our method for studying synaptic and network properties of SPW-R, using electrophysiological and imaging methods that can only be applied in the submerged system. Conclusions/Significance: The approach presented here demonstrates a reliable and experimentally simple strategy for studying hippocampal sharp wave-ripples. Given its utility and easy application we expect our model to foster the generation of new insight into the network physiology underlying SPW-R.			Maier, N (corresponding author), Charite, Neurosci Res Ctr, D-13353 Berlin, Germany.	dietmar.schmitz@charite.de	Maier, Nikolaus/CAF-2990-2022; Maier, Nikolaus/CAH-9008-2022	Maier, Nikolaus/0000-0001-5203-0736; Morris, Genela/0000-0002-5417-8977; Schmitz, Dietmar/0000-0003-2741-5241				Behrens CJ, 2005, NAT NEUROSCI, V8, P1560, DOI 10.1038/nn1571; Both M, 2008, HIPPOCAMPUS, V18, P899, DOI 10.1002/hipo.20446; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Colgin LL, 2005, NEUROSCI LETT, V385, P46, DOI 10.1016/j.neulet.2005.05.005; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Foffani G, 2007, NEURON, V55, P930, DOI 10.1016/j.neuron.2007.07.040; HAAS HL, 1979, J NEUROSCI METH, V1, P323, DOI 10.1016/0165-0270(79)90021-9; Hajos N, 2009, EUR J NEUROSCI, V29, P319, DOI 10.1111/j.1460-9568.2008.06577.x; Ikegaya Y, 2005, NEUROSCI RES, V52, P132, DOI 10.1016/j.neures.2005.02.004; Johenning FW, 2007, CELL CALCIUM, V41, P271, DOI 10.1016/j.ceca.2006.07.005; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Klausberger T, 2004, NAT NEUROSCI, V7, P41, DOI 10.1038/nn1159; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kubota D, 2003, J NEUROPHYSIOL, V89, P81, DOI 10.1152/jn.00542.2002; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; Maier N, 2002, J PHYSIOL-LONDON, V541, P521, DOI 10.1113/jphysiol.2002.017624; Meyer AH, 2002, J NEUROSCI, V22, P7055; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Papatheodoropoulos C, 2002, BRAIN RES BULL, V57, P187, DOI 10.1016/S0361-9230(01)00738-9; Papatheodoropoulos C, 2002, NEUROSCI LETT, V319, P17, DOI 10.1016/S0304-3940(01)02505-8; Schuchmann S, 2002, J NEUROPHYSIOL, V87, P2929, DOI 10.1152/jn.2002.87.6.2929; STALEY KJ, 1992, J NEUROPHYSIOL, V67, P1346, DOI 10.1152/jn.1992.67.5.1346; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; SUZUKI SS, 1988, ELECTROEN CLIN NEURO, V69, P532, DOI 10.1016/0013-4694(88)90165-4; Wong T, 2005, NEUROSCIENCE, V134, P107, DOI 10.1016/j.neuroscience.2005.04.019; Wu CP, 2006, J PHYSIOL-LONDON, V576, P457, DOI 10.1113/jphysiol.2006.114918; Wu CP, 2009, HIPPOCAMPUS, V19, P205, DOI 10.1002/hipo.20497; Wu CP, 2005, J NEUROPHYSIOL, V94, P741, DOI 10.1152/jn.00086.2005; Wu CP, 2005, J NEUROPHYSIOL, V93, P2302, DOI 10.1152/jn.00806.2004; Wu CP, 2002, J PHYSIOL-LONDON, V540, P509, DOI 10.1113/jphysiol.2001.013441; YLINEN A, 1995, J NEUROSCI, V15, P30; Zhang L, 2008, HIPPOCAMPUS, V18, P294, DOI 10.1002/hipo.20389	39	48	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2009	4	9							e6925	10.1371/journal.pone.0006925	http://dx.doi.org/10.1371/journal.pone.0006925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZH	19738897	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000269622300010
J	Carnoy, C; Roten, CA				Carnoy, Christophe; Roten, Claude-Alain			The dif/Xer Recombination Systems in Proteobacteria	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; CHROMOSOME DIMER RESOLUTION; ESCHERICHIA-COLI; FILAMENTOUS PHAGE; TERMINUS REGION; DIF SITE; DNA; GENOME; XERC; INTEGRATION	In E. coli, 10 to 15% of growing bacteria produce dimeric chromosomes during DNA replication. These dimers are resolved by XerC and XerD, two tyrosine recombinases that target the 28-nucleotide motif (dif) associated with the chromosome's replication terminus. In streptococci and lactococci, an alternative system is composed of a unique, Xer-like recombinase (XerS) genetically linked to a dif-like motif (dif(SL)) located at the replication terminus. Preliminary observations have suggested that the dif/Xer system is commonly found in bacteria with circular chromosomes but that assumption has not been confirmed in an exhaustive analysis. The aim of the present study was to extensively characterize the dif/Xer system in the proteobacteria, since this taxon accounts for the majority of genomes sequenced to date. To that end, we analyzed 234 chromosomes from 156 proteobacterial species and showed that most species (87.8%) harbor XerC and XerD-like recombinases and a dif-related sequence which (i) is located in non-coding sequences, (ii) is close to the replication terminus (as defined by the cumulative GC skew) (iii) has a palindromic structure, (iv) is encoded by a low G+C content and (v) contains a highly conserved XerD binding site. However, not all proteobacteria display this dif/XerCD system. Indeed, a sub-group of pathogenic epsilon-proteobacteria (including Helicobacter sp and Campylobacter sp) harbors a different recombination system, composed of a single recombinase (XerH) which is phylogenetically distinct from the other Xer recombinases and a motif (dif(H)) sharing homologies with dif(SL). Furthermore, no homologs to dif or Xer recombinases could be detected in small endosymbiont genomes or in certain bacteria with larger chromosomes like the Legionellales. This raises the question of the presence of other chromosomal deconcatenation systems in these species. Our study highlights the complexity of dif/Xer recombinase systems in proteobacteria and paves the way for systematic detection of these components in prokaryotes.			Carnoy, C (corresponding author), INSERM, U801, F-59045 Lille, France.	christophe.carnoy@univ-lille2.fr		CARNOY, Christophe/0000-0003-2047-5153				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson SGE, 2006, SCIENCE, V314, P259, DOI 10.1126/science.1133739; Aussel L, 2002, CELL, V108, P195, DOI 10.1016/S0092-8674(02)00624-4; Bigot S, 2007, MOL MICROBIOL, V64, P1434, DOI 10.1111/j.1365-2958.2007.05755.x; Blakely G, 1996, GENE DEV, V10, P762, DOI 10.1101/gad.10.6.762; BLAKELY G, 1991, NEW BIOL, V3, P789; BLAKELY G, 1993, CELL, V75, P351, DOI 10.1016/0092-8674(93)80076-Q; Blakely GW, 1997, J MOL BIOL, V265, P30, DOI 10.1006/jmbi.1996.0709; Bloor AE, 2006, APPL ENVIRON MICROB, V72, P2520, DOI 10.1128/AEM.72.4.2520-2525.2006; BRENNER DJ, 1984, BERGEYS MANUAL SYSTE, V1, P279; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Campos J, 2003, J BACTERIOL, V185, P5685, DOI 10.1128/JB.185.19.5685-5696.2003; Carnoy C, 2002, J BACTERIOL, V184, P4489, DOI 10.1128/JB.184.16.4489-4499.2002; Chalker AF, 2000, J MOL MICROB BIOTECH, V2, P225; CLERGET M, 1991, NEW BIOL, V3, P780; Cooke GD, 2003, J BIOTECHNOL, V101, P229, DOI 10.1016/S0168-1656(02)00339-5; Cornet F, 1996, GENE DEV, V10, P1152, DOI 10.1101/gad.10.9.1152; Cui TL, 2007, EMBO REP, V8, P181, DOI 10.1038/sj.embor.7400880; DAI H, 1988, VIROLOGY, V167, P613, DOI 10.1016/0042-6822(88)90124-9; Derbise A, 2007, MOL MICROBIOL, V63, P1145, DOI 10.1111/j.1365-2958.2006.05570.x; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Gonzalez MD, 2002, J BACTERIOL, V184, P6050, DOI 10.1128/JB.184.21.6050-6055.2002; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hayes F, 1997, J MOL BIOL, V266, P525, DOI 10.1006/jmbi.1996.0828; Hayes F, 1997, GENE, V198, P105, DOI 10.1016/S0378-1119(97)00299-0; Hendrickson H, 2007, MOL MICROBIOL, V64, P42, DOI 10.1111/j.1365-2958.2007.05596.x; Huber KE, 2002, NATURE, V417, P656, DOI 10.1038/nature00782; Iida T, 2002, J BACTERIOL, V184, P4933, DOI 10.1128/JB.184.17.4933-4935.2002; Jensen RB, 2006, J BACTERIOL, V188, P6016, DOI 10.1128/JB.00330-06; KERSULYTE D, 2009, PLOS ONE IN PRESS; Krause A, 2006, NAT BIOTECHNOL, V24, P1385, DOI 10.1038/nbt1243; Kuempel P, 1996, GENE DEV, V10, P1162, DOI 10.1101/gad.10.9.1162; KUEMPEL PL, 1991, NEW BIOL, V3, P799; Le Bourgeois P, 2007, PLOS GENET, V3, P1190, DOI 10.1371/journal.pgen.0030117; LESLIE NR, 1995, EMBO J, V14, P1561, DOI 10.1002/j.1460-2075.1995.tb07142.x; Lin NT, 2001, MOL GENET GENOMICS, V266, P425, DOI 10.1007/s004380100532; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; McLeod SM, 2004, MOL MICROBIOL, V54, P935, DOI 10.1111/j.1365-2958.2004.04309.x; Neilson L, 1999, MOL MICROBIOL, V31, P915, DOI 10.1046/j.1365-2958.1999.01231.x; Noe L, 2005, NUCLEIC ACIDS RES, V33, pW540, DOI 10.1093/nar/gki478; OLSEN GJ, 1994, J BACTERIOL, V176, P1, DOI 10.1128/JB.176.1.1-6.1994; Perals K, 2000, MOL MICROBIOL, V36, P33, DOI 10.1046/j.1365-2958.2000.01847.x; Recchia GD, 1999, MOL MICROBIOL, V34, P1146, DOI 10.1046/j.1365-2958.1999.01668.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sciochetti SA, 2001, J BACTERIOL, V183, P1058, DOI 10.1128/JB.183.3.1058-1068.2001; SIROIS S, 1995, J BACTERIOL, V177, P4183, DOI 10.1128/jb.177.14.4183-4186.1995; Slater SC, 2009, J BACTERIOL, V191, P2501, DOI 10.1128/JB.01779-08; Snyder LAS, 2005, MICROBIOL-SGM, V151, P4005, DOI 10.1099/mic.0.27925-0; Steiner W, 1999, MOL MICROBIOL, V31, P579, DOI 10.1046/j.1365-2958.1999.01198.x; Steiner WW, 1998, J BACTERIOL, V180, P6269; STIRLING CJ, 1989, EMBO J, V8, P1623, DOI 10.1002/j.1460-2075.1989.tb03547.x; STIRLING CJ, 1988, EMBO J, V7, P4389, DOI 10.1002/j.1460-2075.1988.tb03338.x; STIRLING CJ, 1988, MOL GEN GENET, V214, P80, DOI 10.1007/BF00340183; Subramanya HS, 1997, EMBO J, V16, P5178, DOI 10.1093/emboj/16.17.5178; SUMMERS DK, 1988, EMBO J, V7, P851, DOI 10.1002/j.1460-2075.1988.tb02884.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Val ME, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000201; Val ME, 2005, MOL CELL, V19, P559, DOI 10.1016/j.molcel.2005.07.002; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804; Yen MR, 2002, APPL ENVIRON MICROB, V68, P2924, DOI 10.1128/AEM.68.6.2924-2933.2002	61	76	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6531	10.1371/journal.pone.0006531	http://dx.doi.org/10.1371/journal.pone.0006531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19727445	Green Published, Green Submitted, gold			2022-12-25	WOS:000269522900001
J	Cesselin, F; Bourgoin, S; Mauborgne, A; Hamon, M; Le Bars, D				Cesselin, Francois; Bourgoin, Sylvie; Mauborgne, Annie; Hamon, Michel; Le Bars, Daniel			Freezing of Enkephalinergic Functions by Multiple Noxious Foci: A Source of Pain Sensitization?	PLOS ONE			English	Article								Background: The functional significance of proenkephalin systems in processing pain remains an open question and indeed is puzzling. For example, a noxious mechanical stimulus does not alter the release of Met-enkephalin-like material (MELM) from segments of the spinal cord related to the stimulated area of the body, but does increase its release from other segments. Methodology/Principal Findings: Here we show that, in the rat, a noxious mechanical stimulus applied to either the right or the left hind paw elicits a marked increase of MELM release during perifusion of either the whole spinal cord or the cervico-trigeminal area. However, these stimulatory effects were not additive and indeed, disappeared completely when the right and left paws were stimulated simultaneously. Conclusion/Significance: We have concluded that in addition to the concept of a diffuse control of the transmission of nociceptive signals through the dorsal horn, there is a diffuse control of the modulation of this transmission. The "freezing'' of Met-enkephalinergic functions represents a potential source of central sensitization in the spinal cord, notably in clinical situations involving multiple painful foci, e. g. cancer with metastases, poly-traumatism or rheumatoid arthritis.			Cesselin, F (corresponding author), CNRS, INSERM, UMRS 975, Team Pain,UMR 7225, Paris, France.	francois.cesselin@upmc.fr						BASBAUM AI, 1979, J COMP NEUROL, V187, P513, DOI 10.1002/cne.901870304; BERNARD JF, 1995, J COMP NEUROL, V353, P480, DOI 10.1002/cne.903530403; BING Z, 1990, NEUROSCIENCE, V37, P809, DOI 10.1016/0306-4522(90)90110-P; BING Z, 1991, NEUROSCIENCE, V44, P693, DOI 10.1016/0306-4522(91)90088-6; BING Z, 1991, PAIN, V47, P71, DOI 10.1016/0304-3959(91)90013-N; BOUHASSIRA D, 1992, BRAIN RES, V595, P353, DOI 10.1016/0006-8993(92)91071-L; BOURGOIN S, 1986, J PHARMACOL EXP THER, V238, P360; BOURGOIN S, 1988, PAIN, V32, P107, DOI 10.1016/0304-3959(88)90029-2; BRENNAN TJ, 1989, J NEUROPHYSIOL, V61, P573, DOI 10.1152/jn.1989.61.3.573; CADDEN SW, 1993, BRAIN RES, V628, P65, DOI 10.1016/0006-8993(93)90938-J; CADDEN SW, 1991, BRAIN RES, V558, P63, DOI 10.1016/0006-8993(91)90714-7; CESSELIN F, 1980, BRAIN RES, V191, P289, DOI 10.1016/0006-8993(80)90335-2; CESSELIN F, 1985, BRAIN RES, V339, P305, DOI 10.1016/0006-8993(85)90096-4; CESSELIN F, 1982, BRAIN RES, V237, P325, DOI 10.1016/0006-8993(82)90445-0; CESSELIN F, 1999, OPIOIDS PAIN CONTROL, P70; COLLIN E, 1992, SYNAPSE, V11, P76, DOI 10.1002/syn.890110110; Fields HL, 2006, WALL MELZACKS TXB PA, P125; FLEISCHMANN A, 1989, PHYSIOL BEHAV, V46, P151, DOI 10.1016/0031-9384(89)90248-5; FREMINET A, 1972, PFLUG ARCH EUR J PHY, V334, P293, DOI 10.1007/BF00592164; GERHART KD, 1981, J NEUROPHYSIOL, V46, P1309, DOI 10.1152/jn.1981.46.6.1309; Heinricher M.M., 2008, SENSES COMPREHENSIVE, V5, P593; HYLDEN JLK, 1989, NEUROSCIENCE, V28, P27, DOI 10.1016/0306-4522(89)90229-7; LEBARS D, 1987, BRAIN RES, V412, P190, DOI 10.1016/0006-8993(87)91460-0; LEBARS D, 1981, BRAIN RES, V204, P387, DOI 10.1016/0006-8993(81)90597-7; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; McGaraughty S, 1997, BRAIN RES BULL, V43, P263, DOI 10.1016/S0361-9230(97)00002-6; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; MORGAN MM, 1994, J NEUROPHYSIOL, V72, P1152, DOI 10.1152/jn.1994.72.3.1152; MORTON CR, 1988, PAIN, V34, P75, DOI 10.1016/0304-3959(88)90184-4; MORTON CR, 1987, BRAIN RES, V410, P347, DOI 10.1016/0006-8993(87)90336-2; NESS TJ, 1991, J NEUROPHYSIOL, V66, P29, DOI 10.1152/jn.1991.66.1.29; NESS TJ, 1991, J NEUROPHYSIOL, V66, P20, DOI 10.1152/jn.1991.66.1.20; Neugebauer V, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-8; SATO A, 2002, INT C SERIES, V1238; SCHOUENBORG J, 1985, BRAIN RES, V328, P23, DOI 10.1016/0006-8993(85)91318-6; TOMLINSON RWW, 1983, BRAIN RES, V279, P291, DOI 10.1016/0006-8993(83)90195-6; VILLANUEVA L, 1986, J NEUROPHYSIOL, V56, P1185, DOI 10.1152/jn.1986.56.4.1185; VILLANUEVA L, 1994, J PHYSIOL-LONDON, V475, P255, DOI 10.1113/jphysiol.1994.sp020066; Villanueva L, 1996, PAIN, V67, P231, DOI 10.1016/0304-3959(96)03121-1; WEILFUGAZZA J, 1984, BRAIN RES, V297, P247, DOI 10.1016/0006-8993(84)90566-3; Whitehouse MW, 2007, INFLAMM RES, V56, P133, DOI 10.1007/s00011-006-6117-8; WILLER JC, 1990, EUR J PHARMACOL, V182, P347, DOI 10.1016/0014-2999(90)90293-F; YAKSH TL, 1980, BRAIN RES, V192, P133, DOI 10.1016/0006-8993(80)91014-8	43	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6874	10.1371/journal.pone.0006874	http://dx.doi.org/10.1371/journal.pone.0006874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19727441	gold, Green Submitted, Green Published			2022-12-25	WOS:000269522900010
J	Sabot, OJ; Mwita, A; Cohen, JM; Ipuge, Y; Gordon, M; Bishop, D; Odhiambo, M; Ward, L; Goodman, C				Sabot, Oliver J.; Mwita, Alex; Cohen, Justin M.; Ipuge, Yahya; Gordon, Megumi; Bishop, David; Odhiambo, Moses; Ward, Lorrayne; Goodman, Catherine			Piloting the Global Subsidy: The Impact of Subsidized Artemisinin-Based Combination Therapies Distributed through Private Drug Shops in Rural Tanzania	PLOS ONE			English	Article								Background: WHO estimates that only 3% of fever patients use recommended artemisinin-based combination therapies (ACTs), partly reflecting their high prices in the retail sector from where many patients seek treatment. To overcome this challenge, a global ACT subsidy has been proposed. We tested this proposal through a pilot program in rural Tanzania. Methods/Principal Findings: Three districts were assigned to serve either as a control or to receive the subsidy plus a package of supporting interventions. From October 2007, ACTs were sold at a 90% subsidy through the normal private supply chain to intervention district drug shops. Data were collected at baseline and during intervention using interviews with drug shop customers, retail audits, mystery shoppers, and audits of public and NGO facilities. The proportion of consumers in the intervention districts purchasing ACTs rose from 1% at baseline to 44.2% one year later (p<0.001), and was significantly higher among consumers purchasing for children under 5 than for adults (p=0.005). No change in ACT usage was observed in the control district. Consumers paid a mean price of $0.58 for ACTs, which did not differ significantly from the price paid for sulphadoxine-pyrimethamine, the most common alternative. Drug shops in population centers were significantly more likely to stock ACTs than those in more remote areas (p<0.001). Conclusions: A subsidy introduced at the top of the private sector supply chain can significantly increase usage of ACTs and reduce their retail price to the level of common monotherapies. Additional interventions may be needed to ensure access to ACTs in remote areas and for poorer individuals who appear to seek treatment at drug shops less frequently.			Sabot, OJ (corresponding author), Clinton Fdn HIV AIDS Initiat, Malaria Control Team, Boston, MA USA.	osabot@clintonfoundation.org		Cohen, Justin/0000-0003-4481-6784; Goodman, Catherine/0000-0002-2241-3485	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 2008, WORLD MAL REP 2008; *AUSTR GOV, 2006, ARR OP COMM SERV OBL; CHEN A, 2008, REV PRIVATE SECTOR A; Cohen JM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-200; Goodman C, 2004, TROP MED INT HEALTH, V9, P655, DOI 10.1111/j.1365-3156.2004.01245.x; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING; Kachur SP, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-25; Laxminarayan R, 2006, HEALTH AFFAIR, V25, P325, DOI 10.1377/hlthaff.25.2.325; McCombie SC, 1996, SOC SCI MED, V43, P933, DOI 10.1016/0277-9536(95)00446-7; *MED MAL VENT, 2008, UND ANT MARK UG 2007; Oxfam, 2009, BLIND OPT CHALL MYTH; Rehwagen Christiane, 2006, BMJ, V332, P1176, DOI 10.1136/bmj.332.7551.1176-b; ROBINSON JC, 1987, JAMA-J AM MED ASSOC, V257, P3241, DOI 10.1001/jama.257.23.3241; *ROLL BACK MAL PAR, 2007, TECHN DIG AFF MED FA; *TACAIDS, 2006, TANZ HIV AIDS IND SU; *TANZ FOOD DRUG AU, 2007, REG DUK DAW BAR TANZ; *TANZ NAT BUR STAT, 2004, 2002 POP HOUS CENS G; Tanzania Ministry of Health and Social Welfare, 2006, NAT GUID MAL DIAGN T; *UNICEF ROLL BACK, 2007, MAL CHILDR PROGR INT; WHO, 2006, GUID TREATM MAL; Wolf K., 2005, COSTING ARTEMISININ; Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x	22	68	68	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2009	4	9							e6857	10.1371/journal.pone.0006857	http://dx.doi.org/10.1371/journal.pone.0006857			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RW	19724644	Green Published, Green Accepted, gold			2022-12-25	WOS:000269522800004
J	Zhang, H; Yang, JH; Zheng, YS; Zhang, P; Chen, X; Wu, J; Xu, L; Luo, XQ; Ke, ZY; Zhou, H; Qu, LH; Chen, YQ				Zhang, Hua; Yang, Jian-Hua; Zheng, Yu-Sheng; Zhang, Peng; Chen, Xiao; Wu, Jun; Xu, Ling; Luo, Xue-Qun; Ke, Zhi-Yong; Zhou, Hui; Qu, Liang-Hu; Chen, Yue-Qin			Genome-Wide Analysis of Small RNA and Novel MicroRNA Discovery in Human Acute Lymphoblastic Leukemia Based on Extensive Sequencing Approach	PLOS ONE			English	Article							EXPRESSION PROFILES; MIRNA EXPRESSION; GENES; INTENSIFICATION; CANDIDATES; PREDICTION; MANAGEMENT; ONCOGENES; CHILDREN; IMPROVES	Background: MicroRNAs ( miRNAs) have been proved to play an important role in various cellular processes and function as tumor suppressors or oncogenes in cancers including leukemia. The identification of a large number of novel miRNAs and other small regulatory RNAs will provide valuable insights into the roles they play in tumorgenesis. Methodology/Principal Findings: To gain further understanding of the role of miRNAs relevant to acute lymphoblastic leukemia ( ALL), we employed the sequencing-by-synthesis (SBS) strategy to sequence small RNA libraries prepared from ALL patients and normal donors. In total we identified 159 novel miRNAs and 116 novel miRNA*s from both libraries. Among the 159 novel miRNAs, 42 were identified with high stringency in our data set. Furthermore, we demonstrated the different expression patterns of 20 newly identified and several known miRNAs between ALL patients and normal donors, suggesting these miRNAs may be associated with ALL and could constitute an ALL-specific miRNA signature. Interestingly, GO "biological process'' classifications revealed that a set of significantly abnormally expressed miRNAs are associated with disease relapse, which implies that these dysregulated miRNAs might promote the progression of ALL by regulating genes involved in the pathway of the disease development. Conclusion/Significance: The study presents a comprehensive picture of the expression of small RNAs in human acute lymphoblastic leukemia and highlights novel and known miRNAs differentially expressed between ALL patients and normal donors. To our knowledge, this is the first study to look at genome-wide known and novel miRNA expression patterns in in human acute lymphoblastic leukemia. Our data revealed that these deregulated miRNAs may be associated with ALL or the onset of relapse.			Zhang, H (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Key Lab Gene Engn, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China.	lsscyq@mail.sysu.edu.cn	Yang, JianHua/A-5330-2011; Zhang, Hua/AAF-3999-2020; Zhang, Hua/AAA-2164-2022	Zhang, Hua/0000-0001-9731-2737; Qu, Liang-Hu/0000-0003-3657-2863; Zhou, Hui/0000-0001-9157-3792; Yang, Jian-Hua/0000-0003-3863-2786				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Bostrom BC, 2003, BLOOD, V101, P3809, DOI 10.1182/blood-2002-08-2454; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Clote P, 2005, RNA, V11, P578, DOI 10.1261/rna.7220505; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Faderl S, 2003, CANCER-AM CANCER SOC, V98, P1337, DOI 10.1002/cncr.11664; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hutchinson RJ, 2003, J CLIN ONCOL, V21, P1790, DOI 10.1200/JCO.2003.03.009; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lange BJ, 2002, BLOOD, V99, P825, DOI 10.1182/blood.V99.3.825; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Marton S, 2008, LEUKEMIA, V22, P330, DOI 10.1038/sj.leu.2405022; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Moore VD, 2008, BLOOD, V111, P2300, DOI 10.1182/blood-2007-06-098012; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Narayan S, 2007, HEMATOLOGY, V12, P39, DOI 10.1080/10245330600938125; O'Toole AS, 2006, NUCLEIC ACIDS RES, V34, P3338, DOI 10.1093/nar/gkl428; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Pui CH, 2003, J CLIN ONCOL, V21, P179, DOI 10.1200/JCO.2003.10.032; Pui CH, 2008, LANCET ONCOL, V9, P257, DOI 10.1016/S1470-2045(08)70070-6; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schotte D, 2009, LEUKEMIA, V23, P313, DOI 10.1038/leu.2008.286; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Steffen P, 2006, BIOINFORMATICS, V22, P500, DOI 10.1093/bioinformatics/btk010; Takada S, 2008, LEUKEMIA, V22, P1274, DOI 10.1038/sj.leu.2405031; Wang X, 2008, BRIT J HAEMATOL, V143, P248, DOI 10.1111/j.1365-2141.2008.07329.x; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wojcik I, 2005, NEOPLASMA, V52, P318; Zanette DL, 2007, BRAZ J MED BIOL RES, V40, P1435, DOI 10.1590/S0100-879X2007001100003; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028	54	33	36	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2009	4	9							e6849	10.1371/journal.pone.0006849	http://dx.doi.org/10.1371/journal.pone.0006849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RW	19724645	gold, Green Submitted, Green Published			2022-12-25	WOS:000269522800002
J	Ni, M; Zhou, H; Wey, SA; Baumeister, P; Lee, AS				Ni, Min; Zhou, Hui; Wey, Shiuan; Baumeister, Peter; Lee, Amy S.			Regulation of PERK Signaling and Leukemic Cell Survival by a Novel Cytosolic Isoform of the UPR Regulator GRP78/BiP	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; PRE-MESSENGER-RNA; VIRUS PRECORE PROTEIN; ER CHAPERONE; ATPASE ACTIVITY; BINDING-SITE; CANCER CELLS; IN-VITRO; BIP	The unfolded protein response (UPR) is an evolutionarily conserved mechanism to allow cells to adapt to stress targeting the endoplasmic reticulum (ER). Induction of ER chaperone GRP78/BiP increases protein folding capacity; as such it represents a major survival arm of UPR. Considering the central importance of the UPR in regulating cell survival and death, evidence is emerging that cells evolve feedback regulatory pathways to modulate the key UPR executors, however, the precise mechanisms remain to be elucidated. Here, we report the fortuitous discovery of GRP78va, a novel isoform of GRP78 generated by alternative splicing (retention of intron 1) and alternative translation initiation. Bioinformatic and biochemical analyses revealed that expression of GRP78va is enhanced by ER stress and is notably elevated in human leukemic cells and leukemia patients. In contrast to the canonical GRP78 which is primarily an ER lumenal protein, GRP78va is devoid of the ER signaling peptide and is cytosolic. Through specific knockdown of endogenous GRP78va by siRNA without affecting canonical GRP78, we showed that GRP78va promotes cell survival under ER stress. We further demonstrated that GRP78va has the ability to regulate PERK signaling and that GRP78va is able to interact with and antagonize PERK inhibitor P58 IPK. Our study describes the discovery of GRP78va, a novel cytosolic isoform of GRP78/BiP, and the first characterization of the modulation of UPR signaling via alternative splicing of nuclear pre-mRNA. Our study further reveals a novel survival mechanism in leukemic cells and other cell types where GRP78va is expressed.			Ni, M (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA.	amylee@ccnt.usc.edu		Lee, Amy/0000-0002-0378-5443	NATIONAL CANCER INSTITUTE [R01CA111700, R01CA027607] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA027607, R01 CA111700] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; BAUMEISTER P, 2009, MOL CANC TH IN PRESS; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; Cunnea PM, 2003, J BIOL CHEM, V278, P1059, DOI 10.1074/jbc.M206995200; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Duriez M, 2008, J BIOL CHEM, V283, P32352, DOI 10.1074/jbc.M807178200; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; GARCIA PD, 1988, J CELL BIOL, V106, P1093, DOI 10.1083/jcb.106.4.1093; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; GAUT JR, 1993, J BIOL CHEM, V268, P7248; Goodman AG, 2007, J VIROL, V81, P2221, DOI 10.1128/JVI.02151-06; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Khan MM, 2004, J BIOL CHEM, V279, P11814, DOI 10.1074/jbc.M312121200; Kurisu J, 2003, GENES CELLS, V8, P189, DOI 10.1046/j.1365-2443.2003.00625.x; Ladiges WC, 2005, DIABETES, V54, P1074, DOI 10.2337/diabetes.54.4.1074; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; LEE TG, 1990, P NATL ACAD SCI USA, V87, P6208, DOI 10.1073/pnas.87.16.6208; Levine CG, 2005, MOL BIOL CELL, V16, P279, DOI 10.1091/mbc.E04-06-0508; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu C, 2003, AM J PATHOL, V163, P1859, DOI 10.1016/S0002-9440(10)63545-6; Liu Y, 2007, MOL PHARMACEUT, V4, P435, DOI 10.1021/mp060122j; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Ota J, 2003, ONCOGENE, V22, P5720, DOI 10.1038/sj.onc.1206855; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; Parker R, 2001, MOL CELL BIOL, V21, P3220, DOI 10.1128/MCB.21.9.3220-3233.2001; Pattacini L, 2004, LEUKEMIA RES, V28, P191, DOI 10.1016/S0145-2126(03)00218-2; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Rao RV, 2002, FEBS LETT, V514, P122, DOI 10.1016/S0014-5793(02)02289-5; Rauschert N, 2008, LAB INVEST, V88, P375, DOI 10.1038/labinvest.2008.2; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2007, MOL BIOL CELL, V18, P3681, DOI 10.1091/mbc.e07-03-0272; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sakabe NJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-59; Salesse S, 2004, LEUKEMIA, V18, P727, DOI 10.1038/sj.leu.2403310; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shani G, 2008, MOL CELL BIOL, V28, P666, DOI 10.1128/MCB.01716-07; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; Theoleyre O, 2004, ONCOGENE, V23, P920, DOI 10.1038/sj.onc.1207206; TING J, 1988, DNA-J MOLEC CELL BIO, V7, P275, DOI 10.1089/dna.1988.7.275; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; WANG M, 2009, ANTIOXID RE IN PRESS; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Yu DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003951; Zhang YC, 2006, MOL PHARMACOL, V70, P1424, DOI 10.1124/mol.106.024323; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	70	114	116	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6868	10.1371/journal.pone.0006868	http://dx.doi.org/10.1371/journal.pone.0006868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718440	Green Published, Green Submitted, gold			2022-12-25	WOS:000269415900029
J	Ocbina, PJR; Tuson, M; Anderson, KV				Ocbina, Polloneal Jymmiel R.; Tuson, Miquel; Anderson, Kathryn V.			Primary Cilia Are Not Required for Normal Canonical Wnt Signaling in the Mouse Embryo	PLOS ONE			English	Article								Background: Sonic hedgehog (Shh) signaling in the mouse requires the microtubule-based organelle, the primary cilium. The primary cilium is assembled and maintained through the process of intraflagellar transport (IFT) and the response to Shh is blocked in mouse mutants that lack proteins required for IFT. Although the phenotypes of mouse IFT mutants do not overlap with phenotypes of known Wnt pathway mutants, recent studies report data suggesting that the primary cilium modulates responses to Wnt signals. Methodology/Principal Findings: We therefore carried out a systematic analysis of canonical Wnt signaling in mutant embryos and cells that lack primary cilia because of loss of the anterograde IFT kinesin-II motor (Kif3a) or IFT complex B proteins (Ift172 or Ift88). We also analyzed mutant embryos with abnormal primary cilia due to defects in retrograde IFT (Dync2h1). The mouse IFT mutants express the canonical Wnt target Axin2 and activate a transgenic canonical Wnt reporter, BAT-gal, in the normal spatial pattern and to the same quantitative level as wild type littermates. Similarly, mouse embryonic fibroblasts (MEFs) derived from IFT mutants respond normally to added Wnt3a. The switch from canonical to non-canonical Wnt also appears normal in IFT mutant MEFs, as both wild-type and mutant cells do not activate the canonical Wnt reporter in the presence of both Wnt3a and Wnt5a. Conclusions: We conclude that loss of primary cilia or defects in retrograde IFT do not affect the response of the midgestation embryo or embryo-derived fibroblasts to Wnt ligands.			Ocbina, PJR (corresponding author), Sloan Kettering Inst, Dev Biol Program, New York, NY USA.	k-anderson@sloankettering.edu		Tuson, Miquel/0000-0003-2239-0532; Anderson, Kathryn/0000-0003-1657-2161	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK074038] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK074038] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AANSTAD P, 2009, CURR BIOL; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Chazaud C, 2006, DEVELOPMENT, V133, P3379, DOI 10.1242/dev.02523; Cho A, 2008, DEV BIOL, V321, P27, DOI 10.1016/j.ydbio.2008.05.558; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Dunty WC, 2008, DEVELOPMENT, V135, P85, DOI 10.1242/dev.009266; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Eggenschwiler JT, 2000, DEV BIOL, V227, P648, DOI 10.1006/dbio.2000.9918; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gerdes JM, 2008, CURR TOP DEV BIOL, V85, P175, DOI 10.1016/S0070-2153(08)00807-7; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gorivodsky M, 2009, DEV BIOL, V325, P24, DOI 10.1016/j.ydbio.2008.09.019; Greene NDE, 1998, MECH DEVELOP, V73, P59, DOI 10.1016/S0925-4773(98)00029-X; Haraguchi K, 2006, J BIOL CHEM, V281, P4094, DOI 10.1074/jbc.M507028200; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; He X, 2008, NAT CELL BIOL, V10, P11, DOI 10.1038/ncb0108-11; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Ishikawa T, 2003, DEV BIOL, V253, P230, DOI 10.1016/S0012-1606(02)00020-9; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kishimoto N, 2008, DEV CELL, V14, P954, DOI 10.1016/j.devcel.2008.03.010; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Nurnberger J, 2002, MOL BIOL CELL, V13, P3096, DOI 10.1091/mbc.E02-04-0195; Ocbina PJR, 2008, DEV DYNAM, V237, P2030, DOI 10.1002/dvdy.21551; Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892; PERRY WL, 1995, GENETICS, V141, P321; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Serluca FC, 2009, DEVELOPMENT, V136, P1621, DOI 10.1242/dev.020735; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tobin JL, 2008, P NATL ACAD SCI USA, V105, P6714, DOI 10.1073/pnas.0707057105; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	58	101	103	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6839	10.1371/journal.pone.0006839	http://dx.doi.org/10.1371/journal.pone.0006839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718259	Green Published, Green Submitted, gold			2022-12-25	WOS:000269415900012
J	Honig, G; Jongsma, ME; van der Hart, MCG; Tecott, LH				Honig, Gerard; Jongsma, Minke E.; van der Hart, Marieke C. G.; Tecott, Laurence H.			Chronic Citalopram Administration Causes a Sustained Suppression of Serotonin Synthesis in the Mouse Forebrain	PLOS ONE			English	Article							ACUTE TRYPTOPHAN DEPLETION; OF-FUNCTION MUTATION; SELECTIVE SEROTONIN; REUPTAKE INHIBITOR; ANTIDEPRESSANT ACTION; RAT-BRAIN; EXTRACELLULAR SEROTONIN; IN-VIVO; FLUOXETINE TREATMENT; MONOAMINE SYNTHESIS	Background: Serotonin (5-HT) is a neurotransmitter with important roles in the regulation of neurobehavioral processes, particularly those regulating affect in humans. Drugs that potentiate serotonergic neurotransmission by selectively inhibiting the reuptake of serotonin (SSRIs) are widely used for the treatment of psychiatric disorders. Although the regulation of serotonin synthesis may be an factor in SSRI efficacy, the effect of chronic SSRI administration on 5-HT synthesis is not well understood. Here, we describe effects of chronic administration of the SSRI citalopram (CIT) on 5-HT synthesis and content in the mouse forebrain. Methodology/Principal Findings: Citalopram was administered continuously to adult male C57BL/6J mice via osmotic minipump for 2 days, 14 days or 28 days. Plasma citalopram levels were found to be within the clinical range. 5-HT synthesis was assessed using the decarboxylase inhibition method. Citalopram administration caused a suppression of 5-HT synthesis at all time points. CIT treatment also caused a reduction in forebrain 5-HIAA content. Following chronic CIT treatment, forebrain 5-HT stores were more sensitive to the depleting effects of acute decarboxylase inhibition. Conclusions/Significance: Taken together, these results demonstrate that chronic citalopram administration causes a sustained suppression of serotonin synthesis in the mouse forebrain. Furthermore, our results indicate that chronic 5-HT reuptake inhibition renders 5-HT brain stores more sensitive to alterations in serotonin synthesis. These results suggest that the regulation of 5-HT synthesis warrants consideration in efforts to develop novel antidepressant strategies.			Honig, G (corresponding author), Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA.	ghonig@gmail.com	Honig, Gerard/ABB-5333-2020	Honig, Gerard/0000-0001-9147-7450	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Agazzi A, 2003, DIGEST LIVER DIS, V35, P590, DOI 10.1016/S1590-8658(03)00277-9; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Anthony JP, 2000, J NEUROSCI RES, V61, P82, DOI 10.1002/1097-4547(20000701)61:1<82::AID-JNR10>3.0.CO;2-E; Arborelius L, 1996, N-S ARCH PHARMACOL, V353, P630, DOI 10.1007/BF00167182; Artigas F, 2006, CURR DRUG TARGETS, V7, P139, DOI 10.2174/138945006775515446; Artigas F, 2001, TRENDS PHARMACOL SCI, V22, P224, DOI 10.1016/S0165-6147(00)01682-5; AZMITIA EC, 1969, SCIENCE, V166, P1274, DOI 10.1126/science.166.3910.1274; BADAWY AAB, 1991, BRIT J PHARMACOL, V102, P429, DOI 10.1111/j.1476-5381.1991.tb12190.x; BADAWY AAB, 1981, BIOCHEM PHARMACOL, V30, P1211, DOI 10.1016/0006-2952(81)90299-9; BADAWY AAB, 1982, BRIT J PHARMACOL, V77, P59, DOI 10.1111/j.1476-5381.1982.tb09269.x; Bano S, 1999, Pak J Pharm Sci, V12, P11; Barton CL, 1999, SYNAPSE, V31, P13, DOI 10.1002/(SICI)1098-2396(199901)31:1<13::AID-SYN3>3.0.CO;2-Y; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; BENKELFAT C, 1994, ARCH GEN PSYCHIAT, V51, P687; Benkelfat C, 1999, NEUROPSYCHOPHARMACOL, V21, P153; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Blakely RD, 2005, NEURON, V48, P701, DOI 10.1016/j.neuron.2005.11.029; BLIER P, 1988, N-S ARCH PHARMACOL, V337, P246, DOI 10.1007/BF00168834; BOADLEBIBER MC, 1978, BIOCHEM PHARMACOL, V27, P1069, DOI 10.1016/0006-2952(78)90160-0; BOHMAKER K, 1992, NEUROPHARMACOLOGY, V31, P451, DOI 10.1016/0028-3908(92)90083-2; Booij L, 2002, NEUROPSYCHOPHARMACOL, V27, P852, DOI 10.1016/S0893-133X(02)00361-5; BOSKER FJ, 1995, NEUROPHARMACOLOGY, V34, P501, DOI 10.1016/0028-3908(95)00023-Y; BOSKER FJ, 2009, J NEUROCHEM; Brosen K, 2001, EUR NEUROPSYCHOPHARM, V11, P275, DOI 10.1016/S0924-977X(01)00101-8; CACCIA S, 1993, BRIT J PHARMACOL, V110, P355, DOI 10.1111/j.1476-5381.1993.tb13817.x; CACCIA S, 1992, NEUROPHARMACOLOGY, V31, P343, DOI 10.1016/0028-3908(92)90066-X; CACCIA S, 1992, J PHARM PHARMACOL, V44, P250, DOI 10.1111/j.2042-7158.1992.tb03592.x; Calcagno E, 2007, J NEUROCHEM, V103, P1111, DOI 10.1111/j.1471-4159.2007.04806.x; CARLSSON A, 1972, J NEURAL TRANSM, V33, P23, DOI 10.1007/BF01244726; CARLSSON A, 1970, J PHARM PHARMACOL, V22, P726, DOI 10.1111/j.2042-7158.1970.tb12769.x; CARLSSON A, 1976, J NEURAL TRANSM, V39, P1, DOI 10.1007/BF01248762; CARLSSON A, 1973, J NEURAL TRANSM, V34, P79, DOI 10.1007/BF01244661; Carlsson A, 1972, Biochem Soc Symp, P17; CARLSSON A, 1978, J NEURAL TRANSM, V43, P73, DOI 10.1007/BF01579067; CARLSSON A, 1978, N-S ARCH PHARMACOL, V303, P157, DOI 10.1007/BF00508062; Castren E, 2005, NAT REV NEUROSCI, V6, P241, DOI 10.1038/nrn1629; Cervo L, 2005, J NEUROSCI, V25, P8165, DOI 10.1523/JNEUROSCI.1816-05.2005; CHAPUT Y, 1986, N-S ARCH PHARMACOL, V333, P342, DOI 10.1007/BF00500007; Costa E, 1972, Adv Biochem Psychopharmacol, V4, P171; CREMERS T, 2008, J NEUROSCI METHODS; Cremers TIFH, 2000, EUR J PHARMACOL, V397, P63, DOI 10.1016/S0014-2999(00)00247-8; Daugherty WP, 2001, BRAIN RES, V923, P103, DOI 10.1016/S0006-8993(01)03198-5; Dawson LA, 2000, BRIT J PHARMACOL, V130, P797, DOI 10.1038/sj.bjp.0703378; DELGADO PL, 1990, ARCH GEN PSYCHIAT, V47, P411; DELGADO PL, 1994, ARCH GEN PSYCHIAT, V51, P865; DELGADO PL, 1991, PSYCHOPHARMACOL BULL, V27, P321; DELIA G, 1978, ACTA PSYCHIAT SCAND, V57, P239, DOI 10.1111/j.1600-0447.1978.tb06890.x; DEMONTIGNY C, 1990, J CLIN PSYCHIAT, V51, P4; DUFOUR H, 1987, INT CLIN PSYCHOPHARM, V2, P225, DOI 10.1097/00004850-198707000-00005; Dygalo NN, 2006, PHARMACOL BIOCHEM BE, V85, P220, DOI 10.1016/j.pbb.2006.08.004; Esteban S, 1999, N-S ARCH PHARMACOL, V360, P135, DOI 10.1007/s002109900045; Evans AK, 2009, NEUROSCI LETT, V455, P36, DOI 10.1016/j.neulet.2009.03.025; Felton TM, 2003, N-S ARCH PHARMACOL, V367, P297, DOI 10.1007/s00210-002-0688-x; FERNSTROM JD, 1971, SCIENCE, V173, P149, DOI 10.1126/science.173.3992.149; Fox M, 2008, PSYCHOPHARMACOLOGY, V201, P203, DOI 10.1007/s00213-008-1268-7; Gardier AM, 2003, J NEUROCHEM, V86, P13, DOI 10.1046/j.1471-4159.2003.01827.x; Glatt C.E., 2005, NEURON, V45, P11; Glatt CE, 2005, NEURON, V48, P704, DOI 10.1016/j.neuron.2005.11.019; Hervas I, 2001, NEUROPSYCHOPHARMACOL, V24, P11, DOI 10.1016/S0893-133X(00)00175-5; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; HJORTH S, 1994, NEUROPHARMACOLOGY, V33, P331, DOI 10.1016/0028-3908(94)90062-0; Holt A, 1996, N-S ARCH PHARMACOL, V354, P17; Homberg JR, 2007, NEUROSCIENCE, V146, P1662, DOI 10.1016/j.neuroscience.2007.03.030; HWANG EC, 1980, RES COMMUN CHEM PATH, V29, P79; INVERNIZZI R, 1992, BRAIN RES, V584, P322, DOI 10.1016/0006-8993(92)90914-U; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Jans LAW, 2007, MOL PSYCHIATR, V12, P522, DOI 10.1038/sj.mp.4001920; Johnson DA, 2007, BIOL PSYCHIAT, V62, P1228, DOI 10.1016/j.biopsych.2007.05.003; Jongsma ME, 2005, PROG NEURO-PSYCHOPH, V29, P738, DOI 10.1016/j.pnpbp.2005.04.026; JONGSMA ME, 2006, SEROTONERGIC AUGMENT; KABUTO H, 1994, ACTA MED OKAYAMA, V48, P311; KABUTO H, 1994, NEUROCHEM RES, V19, P463, DOI 10.1007/BF00967325; Kam K, 2007, J NEUROSCI, V27, P9192, DOI 10.1523/JNEUROSCI.1198-07.2007; Kanemaru K, 2009, NEUROCHEM INT, V54, P363, DOI 10.1016/j.neuint.2009.01.005; KATZUNG BG, 2004, BASIC CLIN PHARM, pR14; Kawahara Y, 2007, PSYCHOPHARMACOLOGY, V194, P73, DOI 10.1007/s00213-007-0826-8; Kim DK, 2005, NEUROPHARMACOLOGY, V49, P798, DOI 10.1016/j.neuropharm.2005.08.010; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; KRAGHSORENSEN P, 1981, ACTA PHARMACOL TOX, V48, P53; KRAMER PD, 1997, LISTENING PROZAC, pR19; Lakhan SE, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-2; LASSEN J B, 1978, European Journal of Pharmacology, V47, P351; Leyton M, 2000, J PSYCHOPHARMACOL, V14, P284, DOI 10.1177/026988110001400317; Leyton M, 1997, NEUROPSYCHOPHARMACOL, V16, P294, DOI 10.1016/S0893-133X(96)00262-X; Lira A, 2003, BIOL PSYCHIAT, V54, P960, DOI 10.1016/S0006-3223(03)00696-6; Maciag D, 2006, EUR J PHARMACOL, V532, P265, DOI 10.1016/j.ejphar.2005.12.081; Marsteller DA, 2007, SYNAPSE, V61, P877, DOI 10.1002/syn.20428; Mathews TA, 2004, J NEUROSCI METH, V140, P169, DOI 10.1016/j.jneumeth.2004.05.017; Michaud CM, 2001, JAMA-J AM MED ASSOC, V285, P535, DOI 10.1001/jama.285.5.535; Mockus SM, 1998, J MOL NEUROSCI, V10, P163, DOI 10.1007/BF02761772; Moller S E, 1990, Eur Neuropsychopharmacol, V1, P41, DOI 10.1016/0924-977X(90)90009-Y; Moore P, 1998, ARCH GEN PSYCHIAT, V55, P534, DOI 10.1001/archpsyc.55.6.534; MORET C, 1992, NEUROPHARMACOLOGY, V31, P679, DOI 10.1016/0028-3908(92)90146-G; Moret C, 1997, J NEURAL TRANSM, V104, P147, DOI 10.1007/BF01273177; MUCKSELER D, 1995, NEUROPSYCHOPHARMACOL, V12, P251; MuckSeler D, 1996, J NEUROCHEM, V67, P2434; NURIA B, 1996, J NEUROCHEM, V67, P669; O'Leary OF, 2007, PSYCHOPHARMACOLOGY, V192, P357, DOI 10.1007/s00213-007-0728-9; Olivier JDA, 2008, PSYCHOPHARMACOLOGY, V200, P243, DOI 10.1007/s00213-008-1201-0; Olivier JDA, 2008, NEUROSCIENCE, V152, P573, DOI 10.1016/j.neuroscience.2007.12.032; OSIPOVA DV, 2008, J NEUROSCI RES; OVERO KF, 1982, PROG NEURO-PSYCHOPH, V6, P311, DOI 10.1016/S0278-5846(82)80181-4; Parker G, 2009, BRIT J PSYCHIAT, V194, P1, DOI 10.1192/bjp.bp.108.054767; PEDERSEN OL, 1982, PSYCHOPHARMACOLOGY, V77, P199, DOI 10.1007/BF00464566; PERRY KW, 1992, LIFE SCI, V50, P1683, DOI 10.1016/0024-3205(92)90423-M; Peters EJ, 2009, PHARMACOGENET GENOM, V19, P1, DOI 10.1097/FPC.0b013e3283163ecd; Graziano P, 2006, PSYCHOPHARMACOLOGY, V186, P362, DOI 10.1007/s00213-005-0213-2; Pothos EN, 2000, J NEUROSCI, V20, P7297; Rasmussen BB, 2000, THER DRUG MONIT, V22, P143, DOI 10.1097/00007691-200004000-00001; RUTTER JJ, 1993, J PHARMACOL EXP THER, V265, P1319; Shoaf SE, 1998, NEUROPSYCHOPHARMACOL, V19, P345, DOI 10.1016/S0893-133X(98)00032-3; Shoaf SE, 2000, J CEREBR BLOOD F MET, V20, P244, DOI 10.1097/00004647-200002000-00004; SHOPSIN B, 1975, PSYCHOPHARMACOL COMM, V1, P239; Smith KA, 1999, BRIT J PSYCHIAT, V174, P525, DOI 10.1192/bjp.174.6.525; Stenfors C, 2002, LIFE SCI, V71, P2867, DOI 10.1016/S0024-3205(02)02138-0; Stenfors C, 2001, N-S ARCH PHARMACOL, V363, P222, DOI 10.1007/s002100000347; Tao R, 2000, J PHARMACOL EXP THER, V294, P571; Taylor TN, 2009, J NEUROSCI, V29, P8103, DOI 10.1523/JNEUROSCI.1495-09.2009; Tenner K, 2008, NEUROSCI LETT, V431, P21, DOI 10.1016/j.neulet.2007.11.012; Thase Michael E, 2008, Curr Psychiatry Rep, V10, P487; TROUVIN JH, 1993, LIFE SCI, V52, pPL187, DOI 10.1016/0024-3205(93)90116-K; TROUVIN JH, 1992, APPETITE, V19, P222, DOI 10.1016/0195-6663(92)90150-5; Van den Bogaert A, 2005, NEURON, V48, P704, DOI 10.1016/j.neuron.2005.11.017; WALINDER J, 1981, ACTA PSYCHIAT SCAND, V63, P179, DOI 10.1111/j.1600-0447.1981.tb00719.x; WALINDER J, 1975, LANCET, V1, P984; WALINDER J, 1976, ARCH GEN PSYCHIAT, V33, P1384; *WHO, 2008, MENT HLTH DIS DEPR; Yamane F, 2001, BIOCHEM PHARMACOL, V62, P1481, DOI 10.1016/S0006-2952(01)00798-5; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540; Zhang XD, 2005, NEURON, V45, P11, DOI 10.1016/j.neuron.2004.12.014; Zhou Z., 2005, NEURON, V48, P702; Zhou ZF, 2005, NEURON, V48, P702, DOI 10.1016/j.neuron.2005.11.018	132	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2009	4	8							e6797	10.1371/journal.pone.0006797	http://dx.doi.org/10.1371/journal.pone.0006797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JE	19710918	Green Published, gold, Green Submitted			2022-12-25	WOS:000269415600011
J	Fischer, K; Pendu, R; van Schooten, CJ; van Dijk, K; Denis, CV; van den Berg, HM; Lenting, PJ				Fischer, Kathelijn; Pendu, Ronan; van Schooten, Carina J.; van Dijk, Karin; Denis, Cecile V.; van den Berg, H. Marijke; Lenting, Peter J.			Models for Prediction of Factor VIII Half-Life in Severe Haemophiliacs: Distinct Approaches for Blood Group O and Non-O Patients	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; COAGULATION-FACTOR-VIII; RECOMBINANT FACTOR-VIII; 1-DEAMINO-8-D-ARGININE VASOPRESSIN; FACTOR PROPEPTIDE; INTERLEUKIN-11; DISEASE; PHARMACOKINETICS; DESMOPRESSIN; CLEARANCE	Background: Von Willebrand factor (VWF) is critical for the in vivo survival of factor VIII (FVIII). Since FVIII half-life correlates with VWF-antigen pre-infusion levels, we hypothesized that VWF levels are useful to predict FVIII half-life. Methodology: Standardized half-life studies and analysis of pre-infusion VWF and VWF-propeptide levels were performed in a cohort of 38 patients with severe haemophilia A (FVIII < 1 IU/ml), aged 15-44 years. Nineteen patients had blood-group O. Using multivariate linear regression-analysis (MVLR-analysis), the association of VWF-antigen, VWF-propeptide, age and body-weight with FVIII half-life was evaluated. Principal Findings: FVIII half-life was shorter in blood-group O-patients compared to non-O-patients (11.5 +/- 2.6 h versus 14.3 +/- 3.0 h; p = 0.004). VWF-antigen levels correlated with FVIII half-life considerably better in patients with blood-group non-O than O (Pearson-rank = 0.70 and 0.47, respectively). Separate prediction models evolved from MVLR-analysis for blood-group O and non-O patients, based on VWF-antigen and VWF/propeptide ratio. Predicted half-lives deviated less than 3 h of observed half-life in 34/38 patients (89%) or less than 20% in 31/38 patients (82%). Conclusion: Our approach may identify patients with shorter FVIII half-lives, and adapt treatment protocols when half-life studies are unavailable. In addition, our data indicate that survival of FVIII is determined by survival of endogenous VWF rather than VWF levels per se.			Fischer, K (corresponding author), Univ Med Ctr Utrecht, Dept Haematol, Van Creveldkliniek, Utrecht, Netherlands.	peter.lenting@inserm.fr	Denis, Cecile/A-7649-2011; Fischer, Kathelijn/M-2395-2017; Lenting, Peter/F-8269-2013; Lenting, Peter/AAH-5663-2019	Denis, Cecile/0000-0001-5152-9156; Lenting, Peter/0000-0002-7937-3429; Lenting, Peter/0000-0002-7937-3429; Fischer, Kathelijn/0000-0001-7126-6613; van Dijk, Karin/0000-0002-2054-2857				Berntorp E, 2003, HAEMOPHILIA, V9, P1, DOI 10.1046/j.1365-2516.9.s1.17.x; Borchiellini A, 1996, BLOOD, V88, P2951, DOI 10.1182/blood.V88.8.2951.bloodjournal8882951; Collins PW, 2009, J THROMB HAEMOST, V7, P413, DOI 10.1111/j.1538-7836.2008.03270.x; Deitcher SR, 1999, HAEMOPHILIA, V5, P88, DOI 10.1046/j.1365-2516.1999.t01-1-00282.x; Denis CV, 2001, BLOOD, V97, P465, DOI 10.1182/blood.V97.2.465; Federici AB, 2004, BLOOD, V103, P2032, DOI 10.1182/blood-2003-06-2072; FIJNVANDRAAT CJ, 1998, THESIS U AMSTERDAM; FIJNVANDRAAT K, 1995, BRIT J HAEMATOL, V91, P474, DOI 10.1111/j.1365-2141.1995.tb05325.x; Fischer K, 2001, HAEMOPHILIA, V7, P446, DOI 10.1046/j.1365-2516.2001.00545.x; Graw J, 2005, NAT REV GENET, V6, P488, DOI 10.1038/nrg1617; Jenkins PV, 2006, TRANSFUSION, V46, P1836, DOI 10.1111/j.1537-2995.2006.00975.x; Lenting PJ, 2007, J THROMB HAEMOST, V5, P1353, DOI 10.1111/j.1538-7836.2007.02572.x; Lenting PJ, 2004, J BIOL CHEM, V279, P12102, DOI 10.1074/jbc.M310436200; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; MANNUCCI PM, 1977, LANCET, V1, P869; MCLELLAN DS, 1985, THROMB RES, V40, P113, DOI 10.1016/0049-3848(85)90355-X; MORFINI M, 1991, THROMB HAEMOSTASIS, V66, P384; MORFINI M, 1993, THROMB HAEMOSTASIS, V70, P270; Noe DA, 1996, HAEMOSTASIS, V26, P289; Nossent AY, 2006, J THROMB HAEMOST, V4, P2556, DOI 10.1111/j.1538-7836.2006.02273.x; Olsen EHN, 2003, BLOOD, V102, P436, DOI 10.1182/blood-2003-01-0290; Ragni MV, 2008, HAEMOPHILIA, V14, P968, DOI 10.1111/j.1365-2516.2008.01827.x; Romijn RA, 2003, J BIOL CHEM, V278, P15035, DOI 10.1074/jbc.M208977200; Schambeck CM, 2004, THROMB HAEMOSTASIS, V92, P42, DOI 10.1160/th04-02-0063; Schooten CJ, 2005, J THROMB HAEMOST, V3, P2228, DOI 10.1111/j.1538-7836.2005.01571.x; van Dijk K, 2005, HAEMATOLOGICA, V90, P494; van Mourik JA, 1999, BLOOD, V94, P179, DOI 10.1182/blood.V94.1.179.413k18_179_185; van Schooten CJ, 2008, BLOOD, V112, P1704, DOI 10.1182/blood-2008-01-133181; Vlot AJ, 2000, THROMB HAEMOSTASIS, V83, P65; Yarnell JWG, 2000, ARTERIOSCL THROM VAS, V20, P271, DOI 10.1161/01.ATV.20.1.271	30	46	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6745	10.1371/journal.pone.0006745	http://dx.doi.org/10.1371/journal.pone.0006745			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707594	Green Submitted, Green Published, gold			2022-12-25	WOS:000269278400012
J	Belsham, DD; Fick, LJ; Dalvi, PS; Centeno, ML; Chalmers, JA; Lee, PKP; Wang, YY; Drucker, DJ; Koletar, MM				Belsham, Denise D.; Fick, Laura J.; Dalvi, Prasad S.; Centeno, Maria-Luisa; Chalmers, Jennifer A.; Lee, Paul K. P.; Wang, Yangyang; Drucker, Daniel J.; Koletar, Margaret M.			Ciliary neurotrophic factor recruitment of glucagon-like peptide-1 mediates neurogenesis, allowing immortalization of adult murine hypothalamic neurons	FASEB JOURNAL			English	Article						adult neuronal cell lines; neuroendocrinology; proglucagon; signal transduction	TRANSGENIC MICE; CELL-LINES; NESTIN EXPRESSION; PROGENITOR CELLS; GENE-EXPRESSION; NERVOUS-SYSTEM; RAT; BRAIN; PROLIFERATION; RECEPTOR	The distinct lack of cell lines derived from the adult brain is evident. Ciliary neurotrophic factor (CNTF) triggers neurogenesis in primary culture from adult mouse hypothalamus, as detected by bromodeoxyuridine and Ki67 immunostaining. Using SV-40 T-antigen, we immortalized dividing neurons and generated clonal cell lines expressing neuropeptides and receptors involved in neuroendocrine function. We hypothesized that proglucagon-derived peptides may be the mechanistic downstream effectors of CNTF due to documented neuroprotective and proliferative effects. Indeed, proglucagon gene expression was induced by CNTF, and exposure of primary cells to glucagon-like peptide-1 receptor (GLP-1) agonist, exendin-4, induced cell proliferation. Intracerebroventricular injection of CNTF into adult mice caused increased expression of proglucagon peptide in the hypothalamus. Using a specific GLP-1-receptor antagonist, we found that neurogenesis was significantly attenuated and primary culture from GLP-1-receptor-knockout mice lacked CNTF-mediated neuronal proliferation, thus linking the induction of neurogenesis in the hypothalamus to GLP-1-receptor signaling.-Belsham, D. D., Fick, L. J., Dalvi, P. S., Centeno, M.-L., Chalmers, J. A., Lee, P. K. P., Wang, Y., Drucker, D. J., Koletar, M. M. Ciliary neurotrophic factor recruitment of glucagon-like peptide-1 mediates neurogenesis allowing immortalization of adult murine hypothalamic neurons. FASEB J. 23, 4256-4265 (2009). www.fasebj.org	[Belsham, Denise D.; Fick, Laura J.; Dalvi, Prasad S.; Centeno, Maria-Luisa; Chalmers, Jennifer A.; Lee, Paul K. P.; Wang, Yangyang; Koletar, Margaret M.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Belsham, Denise D.] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON M5S 1A8, Canada; [Belsham, Denise D.; Drucker, Daniel J.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Koletar, Margaret M.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A8, Canada; [Belsham, Denise D.] Toronto Gen Hosp, Res Inst, Univ Hlth Network, Div Cellular & Mol Biol, Toronto, ON, Canada; [Drucker, Daniel J.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Belsham, DD (corresponding author), Univ Toronto, Dept Physiol, Med Sci Bldg 3247A,1 Kings Coll Cir, Toronto, ON M5S 1A8, Canada.	d.belsham@utoronto.ca	Drucker, Daniel J/A-4092-2010; Dalvi, Prasad/F-1866-2015; Wang, Yangyang/GXH-5679-2022		Canadian Institutes for Health Research; Natural Sciences and Engineering Research Council; Canada Foundation for Innovation; Canada Research Chairs Program; Ontario Graduate Studentship; Banting and Best Diabetes Centre Studentships	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs Program(Canada Research Chairs); Ontario Graduate Studentship; Banting and Best Diabetes Centre Studentships	We thank Dr. Bernardo Yusta and members of the Belsham Lab for critical reading of the manuscript. We acknowledge funding from Canadian Institutes for Health Research, Natural Sciences and Engineering Research Council, Canada Foundation for Innovation, and the Canada Research Chairs Program to D. D. B. L. J. F. was supported by an Ontario Graduate Studentship. L. J. F. and P. S. D. both held Banting and Best Diabetes Centre Studentships.	Alvarez E, 1996, J NEUROCHEM, V66, P920; BELL GI, 1983, NATURE, V302, P716, DOI 10.1038/302716a0; Belsham DD, 2004, ENDOCRINOLOGY, V145, P393, DOI 10.1210/en.2003-0946; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; CEPKO CL, 1989, ANNU REV NEUROSCI, V12, P47, DOI 10.1146/annurev.ne.12.030189.000403; Cheng H, 2008, ENDOCRINOLOGY, V149, P703, DOI 10.1210/en.2007-0772; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Cui H, 2006, FASEB J, V20, P2654, DOI 10.1096/fj.06-5989fje; DEVITRY F, 1974, P NATL ACAD SCI USA, V71, P3575; DRUCKER DJ, 1988, J BIOL CHEM, V263, P13475; Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306; Drucker DJ, 1996, P NATL ACAD SCI USA, V93, P7911, DOI 10.1073/pnas.93.15.7911; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Everitt B J, 1990, Acta Neurochir Suppl (Wien), V47, P1; Fain JN, 2006, VITAM HORM, V74, P443, DOI 10.1016/S0083-6729(06)74018-3; Farilla L, 2003, ENDOCRINOLOGY, V144, P5149, DOI 10.1210/en.2003-0323; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; HANAHAN D, 1989, SCIENCE, V246, P1265, DOI 10.1126/science.2686032; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; HEINRICH G, 1984, J BIOL CHEM, V259, P4082; HOFFMAN PN, 1975, J CELL BIOL, V66, P351, DOI 10.1083/jcb.66.2.351; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Kokoeva MV, 2007, J COMP NEUROL, V505, P209, DOI 10.1002/cne.21492; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; LEE YC, 1990, ENDOCRINOLOGY, V127, P2217, DOI 10.1210/endo-127-5-2217; Li Y, 1999, BRAIN RES, V838, P1, DOI 10.1016/S0006-8993(99)01502-4; Lotz B, 1996, NEUROLOGY, V46, P1244; LUI EY, 1990, ENDOCRINOLOGY, V126, P110, DOI 10.1210/endo-126-1-110; Luque RM, 2007, ENDOCRINOLOGY, V148, P4601, DOI 10.1210/en.2007-0500; Markakis EA, 2004, J NEUROSCI, V24, P2886, DOI 10.1523/JNEUROSCI.4161-03.2004; MCKAY RDG, 1989, CELL, V58, P815, DOI 10.1016/0092-8674(89)90934-3; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Ning K, 2006, EMBO J, V25, P2377, DOI 10.1038/sj.emboj.7601118; ORNITZ DM, 1987, SCIENCE, V238, P188, DOI 10.1126/science.2821617; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Perry T, 2003, J NEUROSCI RES, V72, P603, DOI 10.1002/jnr.10611; Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481; Piessevaux J, 2006, J BIOL CHEM, V281, P32953, DOI 10.1074/jbc.M600776200; ROSENFELD MG, 1988, ANNU REV NEUROSCI, V11, P353, DOI 10.1146/annurev.neuro.11.1.353; SCHMECHEL DE, 1980, BRAIN RES, V190, P195, DOI 10.1016/0006-8993(80)91169-5; Scrocchi LA, 1998, DIABETES, V47, P632, DOI 10.2337/diabetes.47.4.632; SENDTNER M, 1991, J CELL SCI, P103; Sleeman M W, 2000, Pharm Acta Helv, V74, P265, DOI 10.1016/S0031-6865(99)00050-3; Velazquez E, 2003, EUR J BIOCHEM, V270, P3001, DOI 10.1046/j.1432-1033.2003.03677.x; Wauman J, 2008, MOL ENDOCRINOL, V22, P965, DOI 10.1210/me.2007-0414; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; WINDLE JJ, 1990, MOL ENDOCRINOL, V4, P597, DOI 10.1210/mend-4-4-597	49	80	81	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2009	23	12					4256	4265		10.1096/fj.09-133454	http://dx.doi.org/10.1096/fj.09-133454			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19703933				2022-12-25	WOS:000272193700020
J	Huang, CC; Chiribau, CB; Majumder, M; Chiang, CM; Wek, RC; Kelm, RJ; Khalili, K; Snider, MD; Hatzoglou, M				Huang, Charlie C.; Chiribau, Calin-Bogdan; Majumder, Mithu; Chiang, Cheng-Ming; Wek, Ronald C.; Kelm, Robert J., Jr.; Khalili, Kamel; Snider, Martin D.; Hatzoglou, Maria			A Bifunctional Intronic Element Regulates the Expression of the Arginine/Lysine Transporter Cat-1 via Mechanisms Involving the Purine-rich Element Binding Protein A (Pur alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME ENTRY SITE; GENE-EXPRESSION; MESSENGER-RNA; MEDIATED TRANSLATION; RESPONSE ELEMENT; TRANSCRIPTION; ACTIVATION; DIFFERENTIATION; IDENTIFICATION; PROLIFERATION	Expression of the arginine/lysine transporter Cat-1 is highly induced in proliferating and stressed cells via mechanisms that include transcriptional activation. A bifunctional INE (intronic element) within the first intron of the Cat-1 gene was identified and characterized in this study. The INE had high sequence homology to an amino acid response element and was shown to act as a transcriptional enhancer in unstressed cells by binding the transcription factor, purine-rich element binding protein A (Pur alpha). During endoplasmic reticulum stress, binding of Pur alpha to the INE decreased; the element acted as a positive regulator in early stress by binding of the transcription factor ATF4 and as a negative regulator in prolonged stress by binding the stress-induced C/EBP family member, CHOP. We conclude that transcriptional control of the Cat-1 gene is tightly controlled by multiple cis-DNA elements, contributing to regulation of cationic amino acid transport for cell growth and proliferation. In addition, we propose that genes may use stress-response elements such as the INE to support basal expression in the absence of stress.	[Huang, Charlie C.; Chiribau, Calin-Bogdan; Majumder, Mithu; Hatzoglou, Maria] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Snider, Martin D.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Kelm, Robert J., Jr.] Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA; [Khalili, Kamel] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA; [Khalili, Kamel] Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA 19122 USA	Case Western Reserve University; Case Western Reserve University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Indiana University System; Indiana University-Purdue University Indianapolis; University of Vermont; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Hatzoglou, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, 10900 Euclid Ave, Cleveland, OH 44106 USA.	mxh8@case.edu			National Institutes of Health [R01DK060596, R01DK053307, R01CA103867, R01CA124760]; NATIONAL CANCER INSTITUTE [R01CA124760, R01CA103867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060596, R01DK053307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK060596 and R01DK053307 (to M.H.) and R01CA103867 and R01CA124760 (to C.-M.C.).	Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Edinger AL, 2003, DEV CELL, V5, P571, DOI 10.1016/S1534-5807(03)00291-0; Fernandez J, 2005, MOL CELL, V17, P405, DOI 10.1016/j.molcel.2004.12.024; Fernandez J, 2003, J BIOL CHEM, V278, P50000, DOI 10.1074/jbc.M305903200; Fernandez J, 2002, J BIOL CHEM, V277, P11780, DOI 10.1074/jbc.M110778200; Fernandez J, 2001, J BIOL CHEM, V276, P12285, DOI 10.1074/jbc.M009714200; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hatzoglou M, 2004, ANNU REV NUTR, V24, P377, DOI 10.1146/annurev.nutr.23.011702.073120; Inoue T, 2009, PROSTATE, V69, P861, DOI 10.1002/pros.20936; Ji J, 2007, MOL CELL BIOL, V27, P1531, DOI 10.1128/MCB.00629-06; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Johnson EM, 2003, ANTICANCER RES, V23, P2093; Kaye DM, 2000, CIRCULATION, V102, P2707, DOI 10.1161/01.CIR.102.22.2707; Kelm RJ, 1999, J BIOL CHEM, V274, P14238, DOI 10.1074/jbc.274.20.14238; Khalili K, 2003, MOL CELL BIOL, V23, P6857, DOI 10.1128/MCB.23.19.6857-6875.2003; Kilberg M, 2002, J NUTR, V132, P1801, DOI 10.1093/jn/132.7.1801; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Lopez AB, 2007, BIOCHEM J, V402, P163, DOI 10.1042/BJ20060941; MEISTERERNST M, 1991, CELL, V66, P981, DOI 10.1016/0092-8674(91)90443-3; Palii SS, 2006, BIOCHEM J, V395, P517, DOI 10.1042/BJ20051867; Pan YX, 2007, BIOCHEM J, V401, P299, DOI 10.1042/BJ20061261; PECK LJ, 1985, CELL, V40, P129, DOI 10.1016/0092-8674(85)90316-2; Perkins CP, 1997, GENE DEV, V11, P914, DOI 10.1101/gad.11.7.914; Sadakata T, 2000, MOL BRAIN RES, V77, P47, DOI 10.1016/S0169-328X(00)00039-5; Sharma VK, 2007, PHYSIOL GENOMICS, V31, P96, DOI 10.1152/physiolgenomics.00183.2006; Shima Y, 2006, BLOOD, V107, P1352, DOI 10.1182/blood-2005-08-3166; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Subramanian SV, 2004, MOL BIOL CELL, V15, P4532, DOI 10.1091/mbc.E04-04-0348; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3; Yaman I, 2002, J BIOL CHEM, V277, P41539, DOI 10.1074/jbc.M204850200; Yang ZY, 2007, CIRCULATION, V115, P1269, DOI 10.1161/CIRCULATIONAHA.106.665836	35	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32312	32320		10.1074/jbc.M109.024471	http://dx.doi.org/10.1074/jbc.M109.024471			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19720825	Green Published, hybrid			2022-12-25	WOS:000272028400013
J	Bai, SM; Nasser, MW; Wang, B; Hsu, SH; Datta, J; Kutay, H; Yadav, A; Nuovo, G; Kumar, P; Ghoshal, K				Bai, Shoumei; Nasser, Mohd W.; Wang, Bo; Hsu, Shu-Hao; Datta, Jharna; Kutay, Huban; Yadav, Arti; Nuovo, Gerard; Kumar, Pawan; Ghoshal, Kalpana			MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; SERUM RESPONSE FACTOR; TUMOR-SUPPRESSOR; DOWN-REGULATION; LUNG-CANCER; IN-VIVO; EXPRESSION; MIR-122; LIVER; DEGRADATION	MicroRNAs are negative regulators of protein coding genes. The liver-specific microRNA-122 (miR-122) is frequently suppressed in primary hepatocellular carcinomas (HCCs). In situ hybridization demonstrated that miR-122 is abundantly expressed in hepatocytes but barely detectable in primary human HCCs. Ectopic expression of miR-122 in nonexpressing HepG2, Hep3B, and SK-Hep-1 cells reversed their tumorigenic properties such as growth, replication potential, clonogenic survival, anchorage-independent growth, migration, invasion, and tumor formation in nude mice. Further, miR-122-expressing HCC cells retained an epithelial phenotype that correlated with reduced Vimentin expression. ADAM10 (a distintegrin and metalloprotease family 10), serum response factor (SRF), and insulin-like growth factor 1 receptor (Igf1R) that promote tumorigenesis were validated as targets of miR-122 and were repressed by the microRNA. Conversely, depletion of the endogenous miR-122 in Huh-7 cells facilitated their tumorigenic properties with concomitant up-regulation of these targets. Expression of SRF or Igf1R partially reversed tumor suppressor function of miR-122. Further, miR-122 impeded angiogenic properties of endothelial cells in vitro. Notably, ADAM10, SRF, and Igf1R were up-regulated in primary human HCCs compared with the matching liver tissue. Co-labeling studies demonstrated exclusive localization of miR-122 in the benign livers, whereas SRF predominantly expressed in HCC. More importantly, growth and clonogenic survival of miR-122-expressing HCC cells were significantly reduced upon treatment with sorafenib, a multi-kinase inhibitor clinically effective against HCC. Collectively, these results suggest that the loss of multifunctional miR-122 contributes to the malignant phenotype of HCC cells, and miR-122 mimetic alone or in combination with anticancer drugs can be a promising therapeutic regimen against liver cancer.	[Bai, Shoumei; Nasser, Mohd W.; Wang, Bo; Hsu, Shu-Hao; Datta, Jharna; Kutay, Huban; Ghoshal, Kalpana] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Yadav, Arti; Kumar, Pawan] Ohio State Univ, Dept Otolaryngol Head & Neck Surg, Columbus, OH 43210 USA; [Ghoshal, Kalpana] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Nuovo, Gerard] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ghoshal, K (corresponding author), 420 W 12th Ave, Columbus, OH 43210 USA.	Kalpana.Ghoshal@osumc.edu	Nasser, Mohd/Y-3355-2019; Wang, Bo/F-6519-2011; Kumar, Pawan/H-7777-2013	HSU, SHU-HAO/0000-0002-9444-4192; Wang, Bo/0000-0001-9234-035X	National Institutes of Health [CA122694, CA086978]; NATIONAL CANCER INSTITUTE [R01CA086978, R21CA122694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA122694 and CA086978.	Bai S, 2007, J BIOL CHEM, V282, P27171, DOI 10.1074/jbc.M700691200; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Braconi C, 2008, HEPATOLOGY, V47, P1807, DOI 10.1002/hep.22326; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chai JY, 2004, FASEB J, V18, P1264, DOI 10.1096/fj.03-1232fje; Chang JH, 2008, J VIROL, V82, P8215, DOI 10.1128/JVI.02575-07; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; COULOUARN C, 2009, ONCOGENE IN PRESS; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; Datta J, 2007, CANCER RES, V67, P2736, DOI 10.1158/0008-5472.CAN-06-4433; Duffy MJ, 2009, CLIN CANCER RES, V15, P1140, DOI 10.1158/1078-0432.CCR-08-1585; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Finn RS, 2009, EXPERT REV ANTICANC, V9, P503, DOI 10.1586/ERA.09.6; Fornari F, 2009, CANCER RES, V69, P5761, DOI 10.1158/0008-5472.CAN-08-4797; FRANCO CA, 2009, CELL ADH MI IN PRESS, V3; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Hopfner M, 2006, BIOCHEM PHARMACOL, V71, P1435, DOI 10.1016/j.bcp.2006.02.006; Jopling CL, 2008, BIOCHEM SOC T, V36, P1220, DOI 10.1042/BST0361220; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Kumar P, 2008, MOL CANCER THER, V7, P2060, DOI 10.1158/1535-7163.MCT-08-0287; Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Motiwala T, 2004, P NATL ACAD SCI USA, V101, P13844, DOI 10.1073/pnas.0405451101; Motiwala T, 2009, J BIOL CHEM, V284, P455, DOI 10.1074/jbc.M802840200; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Nuovo GJ, 2009, NAT PROTOC, V4, P107, DOI 10.1038/nprot.2008.215; Park MY, 2007, INT J ONCOL, V31, P1309; Tanaka S, 2009, CANCER SCI, V100, P1, DOI 10.1111/j.1349-7006.2008.01006.x; Tarnawski A, 2005, BIOCHEM BIOPH RES CO, V334, P207, DOI 10.1016/j.bbrc.2005.05.204; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Visone R, 2008, GASTROENTEROLOGY, V135, P1866, DOI 10.1053/j.gastro.2008.10.074; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106	46	405	447	3	62	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32015	32027		10.1074/jbc.M109.016774	http://dx.doi.org/10.1074/jbc.M109.016774			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19726678	hybrid, Green Published			2022-12-25	WOS:000271572700057
J	Song, GS; Zhang, YX; Wang, L				Song, Guisheng; Zhang, Yuxia; Wang, Li			MicroRNA-206 Targets notch3, Activates Apoptosis, and Inhibits Tumor Cell Migration and Focus Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIR-206 EXPRESSION; BREAST-CANCER; MECHANISM; BIOGENESIS; RECEPTORS; ALPHA; SHP	MicroRNAs contribute to cancer development by acting as oncogenes or tumor suppressor genes. However, only a few microRNA target genes were determined. We identified a nearly perfect complementarity between miR-206 and the 3'-untranslated regions of both mouse and human notch3. Expression of miR-206 decreased the luciferase activity dose-dependently when cotransfected with the mouse or human notch3 3'-untranslated region-luciferase reporter containing the miR-206 target site in HeLa cells. This suppression was relieved by deletion and mutation of the miR-206-binding site and was partially recovered by expression of notch3 or by a specific inhibitor of miR-206. Interestingly, overexpression of miR-206 decreased the levels of both Notch3 protein and mRNA. Expression of miR-206 markedly induced apoptotic cell death and blocked the anti-apoptotic activity of Notch3. In addition, ectopic expression of miR-206 inhibited HeLa cell migration and focus formation. Therefore, we identified miR-206 as a pro-apoptotic activator of cell death, which was associated with its inhibition of notch3 signaling and tumor formation. The inhibition of cancer cell migration and focus formation by miR-206 strongly suggests that miR-206 may function as a novel tumor suppressor.	[Wang, Li] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Med, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84132 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Wang, L (corresponding author), Univ Utah, Sch Med, Huntsman Canc Inst, Dept Med, 30 North 1900 East,SOM 3C310, Salt Lake City, UT 84132 USA.	l.wang@hsc.utah.edu	Vickers, Michael M/E-4095-2010; song, guisheng/E-4913-2011		National Institutes of Health [P30 CA042014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work performed by the Flow Cytometry Core was supported by National Institutes of Health Grant P30 CA042014 awarded to the Huntsman Cancer Institute.	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gupta A, 2006, NATURE, V442, P82, DOI 10.1038/nature04836; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; He N, 2008, GASTROENTEROLOGY, V134, P793, DOI 10.1053/j.gastro.2008.01.006; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Negrini M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1867; Park SM, 2008, CYTOKINE GROWTH F R, V19, P303, DOI 10.1016/j.cytogfr.2008.04.011; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Roccaro AM, 2009, BLOOD, V113, P4391, DOI 10.1182/blood-2008-09-178228; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; Song GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006880; Tang YH, 2009, INT HEART J, V50, P377, DOI 10.1536/ihj.50.377; Vermeulen A, 2007, RNA, V13, P723, DOI 10.1261/rna.448107; Walden TB, 2009, J CELL PHYSIOL, V218, P444, DOI 10.1002/jcp.21621; Wang WL, 2002, J BIOL CHEM, V277, P21723, DOI 10.1074/jbc.M202224200; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070	26	180	188	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31921	31927		10.1074/jbc.M109.046862	http://dx.doi.org/10.1074/jbc.M109.046862			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19723635	Green Published, hybrid			2022-12-25	WOS:000271572700047
J	Monette, A; Ajamian, L; Lopez-Lastra, M; Mouland, AJ				Monette, Anne; Ajamian, Lara; Lopez-Lastra, Marcelo; Mouland, Andrew J.			Human Immunodeficiency Virus Type 1 (HIV-1) Induces the Cytoplasmic Retention of Heterogeneous Nuclear Ribonucleoprotein A1 by Disrupting Nuclear Import IMPLICATIONS FOR HIV-1 GENE EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING-PROTEIN; VIROLOGICAL SYNAPSE FORMATION; PORE COMPLEX COMPOSITION; MAJOR CAPSID PROTEIN; TRANS-ACTING FACTOR; HNRNP A/B PROTEINS; MESSENGER-RNA; GENOMIC RNA; CELL-CYCLE; TRANSLATION INITIATION	Human immunodeficiency virus type 1 (HIV-1) co-opts host proteins and cellular machineries to its advantage at every step of the replication cycle. Here we show that HIV-1 enhances heterogeneous nuclear ribonucleoprotein (hnRNP) A1 expression and promotes the relocalization of hnRNP A1 to the cytoplasm. The latter was dependent on the nuclear export of the unspliced viral genomic RNA (vRNA) and to alterations in the abundance and localization of the FG-repeat nuclear pore glycoprotein p62. hnRNP A1 and vRNA remain colocalized in the cytoplasm supporting a post-nuclear function during the late stages of HIV-1 replication. Consistently, we show that hnRNP A1 acts as an internal ribosomal entry site trans-acting factor up-regulating internal ribosome entry site-mediated translation initiation of the HIV-1 vRNA. The up-regulation and cytoplasmic retention of hnRNP A1 by HIV-1 would ensure abundant expression of viral structural proteins in cells infected with HIV-1.	Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, HIV RNA Trafficking Lab 1, Montreal, PQ H3T 1E2, Canada; [Monette, Anne; Ajamian, Lara; Mouland, Andrew J.] McGill Univ, Div Expt Med, Dept Med, Montreal, PQ H3A 2B4, Canada; [Lopez-Lastra, Marcelo] Pontificia Univ Catolica Chile, Mol Virol Lab, Ctr Invest Med, Inst Milenio Inmunol & Inmunoterapia,Fac Med, Santiago 8330024, Chile; [Mouland, Andrew J.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University; Pontificia Universidad Catolica de Chile; McGill University	Mouland, AJ (corresponding author), McGill Univ, Lady Davis Inst Med Res, Sir Mortimer B Davis Jewish Gen Hosp, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.	andrew.mouland@mcgill.ca	Lopez-Lastra, Marcelo/HHM-9832-2022	Lopez-Lastra, Marcelo/0000-0002-7936-8478	Chilean Fondo Nacional de Ciencia y Techologia [1090318, 7070200]; Canadian Foundation for Innovation [6848]; Canadian Institutes of Health Research (CIHR) [MOP-38111, MOP-56974]	Chilean Fondo Nacional de Ciencia y Techologia; Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Chilean Fondo Nacional de Ciencia y Techologia Grants 1090318 and 7070200 (to M. L. L.) and by the Canadian Foundation for Innovation (project # 6848) and Canadian Institutes of Health Research (CIHR) Grants MOP-38111 and MOP-56974 (to A. J. M.).	Ajamian L, 2008, RNA, V14, P914, DOI 10.1261/rna.829208; Bardina MV, 2009, J VIROL, V83, P3150, DOI 10.1128/JVI.01456-08; Barth W, 1999, BIOCHEM CELL BIOL, V77, P355, DOI 10.1139/bcb-77-4-355; Beriault V, 2004, J BIOL CHEM, V279, P44141, DOI 10.1074/jbc.M404691200; BIAMONTI G, 1993, J MOL BIOL, V230, P77, DOI 10.1006/jmbi.1993.1127; Bilodeau PS, 2001, J VIROL, V75, P8487, DOI 10.1128/JVI.75.18.8487-8497.2001; Black AC, 1996, VIRUS GENES, V12, P275, DOI 10.1007/BF00284648; Bonifaci N, 1997, P NATL ACAD SCI USA, V94, P5055, DOI 10.1073/pnas.94.10.5055; Bonnal S, 2005, J BIOL CHEM, V280, P4144, DOI 10.1074/jbc.M411492200; Bour S, 1996, J VIROL, V70, P8285, DOI 10.1128/JVI.70.12.8285-8300.1996; Brasey A, 2003, J VIROL, V77, P3939, DOI 10.1128/JVI.77.7.3939-3949.2003; Brooks S A, 2000, Nucleic Acids Res, V28, pE49, DOI 10.1093/nar/28.10.e49; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Cammas A, 2007, MOL BIOL CELL, V18, P5048, DOI 10.1091/mbc.E07-06-0603; Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Chatel-Chaix L, 2004, MOL CELL BIOL, V24, P2637, DOI 10.1128/MCB.24.7.2637-2648.2004; Cheunim T, 2008, VIRUS RES, V131, P189, DOI 10.1016/j.virusres.2007.09.006; Cochrane AW, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-18; Damgaard CK, 2002, RNA, V8, P1401, DOI 10.1017/S1355838202023075; Darshan MS, 2004, J VIROL, V78, P12179, DOI 10.1128/JVI.78.22.12179-12188.2004; Dowling D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-18; Enokizono Yoshiaki, 2003, Nucleic Acids Res Suppl, P231; Fridell RA, 1997, J CELL SCI, V110, P1325; Friend LR, 2008, BBA-MOL CELL RES, V1783, P1972, DOI 10.1016/j.bbamcr.2008.05.021; Gordon-Alonso M, 2006, J IMMUNOL, V177, P5129, DOI 10.4049/jimmunol.177.8.5129; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Gustin KE, 2002, J VIROL, V76, P8787, DOI 10.1128/JVI.76.17.8787-8796.2002; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; HAMILTON BJ, 1993, J BIOL CHEM, V268, P8881; Hamilton BJN, 1997, J BIOL CHEM, V272, P28732, DOI 10.1074/jbc.272.45.28732; Henriet S, 2009, MICROBIOL MOL BIOL R, V73, P211, DOI 10.1128/MMBR.00040-08; Hofmann W, 2001, J CELL BIOL, V152, P895, DOI 10.1083/jcb.152.5.895; Hubert T, 2009, TRAFFIC, V10, P1257, DOI 10.1111/j.1600-0854.2009.00940.x; Iervolino A, 2002, MOL CELL BIOL, V22, P2255, DOI 10.1128/MCB.22.7.2255-2266.2002; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Jolly C, 2005, J VIROL, V79, P12088, DOI 10.1128/JVI.79.18.12088-12094.2005; Karlsson K, 1998, J BIOL CHEM, V273, P18966, DOI 10.1074/jbc.273.30.18966; Kim S, 1997, BIOCHEMISTRY-US, V36, P5185, DOI 10.1021/bi9625509; Kneller ELP, 2009, J VIROL, V83, P770, DOI 10.1128/JVI.01279-08; Kodiha M, 2004, CELL DEATH DIFFER, V11, P862, DOI 10.1038/sj.cdd.4401432; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kotsopoulou E, 2000, J VIROL, V74, P4839, DOI 10.1128/JVI.74.10.4839-4852.2000; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Lehmann M, 2009, J BIOL CHEM, V284, P14572, DOI 10.1074/jbc.M808531200; Levesque K, 2006, TRAFFIC, V7, P1177, DOI 10.1111/j.1600-0854.2006.00461.x; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; Li TW, 2004, P NATL ACAD SCI USA, V101, P8551, DOI 10.1073/pnas.0402889101; Lichtenstein M, 2001, TRAFFIC, V2, P261, DOI 10.1034/j.1600-0854.2001.1o002.x; MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254; Mclaren M, 2004, RNA, V10, P1119, DOI 10.1261/rna.5263904; MICHAEL WM, 1995, CELL, V83, P415; Mouland AJ, 2001, MOL CELL BIOL, V21, P2133, DOI 10.1128/MCB.21.6.2133-2143.2001; MUNICIO MM, 1995, J BIOL CHEM, V270, P15884, DOI 10.1074/jbc.270.26.15884; Najera I, 1999, J MOL BIOL, V285, P1951, DOI 10.1006/jmbi.1998.2473; Nelson LM, 2003, VIROLOGY, V306, P162, DOI 10.1016/S0042-6822(02)00025-9; Nelson LM, 2002, J BIOL CHEM, V277, P23958, DOI 10.1074/jbc.M200724200; Nguyen DG, 2006, J VIROL, V80, P130, DOI 10.1128/JVI.80.1.130-137.2006; Patry C, 2004, MOL CANCER THER, V3, P1193; Patry C, 2003, CANCER RES, V63, P7679; Percipalle P, 1997, J MOL BIOL, V266, P722, DOI 10.1006/jmbi.1996.0801; PINOLROMA S, 1992, NATURE, V355, P730, DOI 10.1038/355730a0; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Poon DTK, 2002, VIROLOGY, V293, P368, DOI 10.1006/viro.2001.1283; Porter FW, 2009, J VIROL, V83, P1941, DOI 10.1128/JVI.01752-08; SADAIE MR, 1988, SCIENCE, V239, P910, DOI 10.1126/science.3277284; Sakai K, 2006, P NATL ACAD SCI USA, V103, P3369, DOI 10.1073/pnas.0509417103; Sol-Foulon N, 2007, EMBO J, V26, P516, DOI 10.1038/sj.emboj.7601509; Svitkin YV, 1996, EMBO J, V15, P7147, DOI 10.1002/j.1460-2075.1996.tb01106.x; Swanson CM, 2006, TRAFFIC, V7, P1440, DOI 10.1111/j.1600-0854.2006.00488.x; Tange TO, 2001, EMBO J, V20, P5748; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Visa N, 1996, CELL, V84, P253, DOI 10.1016/S0092-8674(00)80980-0; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; YANG XM, 1994, P NATL ACAD SCI USA, V91, P6924, DOI 10.1073/pnas.91.15.6924; Zhang H, 2000, J VIROL, V74, P8252, DOI 10.1128/JVI.74.18.8252-8261.2000; Zhang Y, 2008, BIOCHEM BIOPH RES CO, V367, P54, DOI 10.1016/j.bbrc.2007.12.118; ZOLOTUKHIN AS, 1994, J VIROL, V68, P7944, DOI 10.1128/JVI.68.12.7944-7952.1994; Zolotukhin AS, 2003, MOL CELL BIOL, V23, P6618, DOI 10.1128/MCB.23.18.6618-6630.2003	80	70	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31350	31362		10.1074/jbc.M109.048736	http://dx.doi.org/10.1074/jbc.M109.048736			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19737937	Green Published, hybrid			2022-12-25	WOS:000271378400061
J	Clarke, BR; Greenfield, LK; Bouwman, C; Whitfield, C				Clarke, Bradley R.; Greenfield, Laura K.; Bouwman, Catrien; Whitfield, Chris			Coordination of Polymerization, Chain Termination, and Export in Assembly of the Escherichia coli Lipopolysaccharide O9a Antigen in an ATP-binding Cassette Transporter-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; GRAM-NEGATIVE BACTERIA; GENE-CLUSTER; CAPSULAR POLYSACCHARIDES; POLYACRYLAMIDE GELS; ABC TRANSPORTER; O-ANTIGENS; BIOSYNTHESIS; EXPRESSION; SYSTEM	The Escherichia coli O9a O-polysaccharide (O-PS) is a prototype for O-PS synthesis and export by the ATP-binding cassette transporter-dependent pathway. Comparable systems are widespread in Gram-negative bacteria. The polymannose O9a O-PS is assembled on a polyisoprenoid lipid intermediate by mannosyltransferases located at the cytoplasmic membrane, and the final polysaccharide chain length is determined by the chain terminating dual kinase/methyltransferase, WbdD. The WbdD protein is tethered to the membrane via a C-terminal region containing amphipathic helices located between residues 601 and 669. Here, we establish that the C-terminal domain of WbdD plays an additional pivotal role in assembly of the O-PS by forming a complex with the chain-extending mannosyltransferase, WbdA. Membrane preparations from a Delta wbdD mutant had severely diminished mannosyltransferase activity in vitro, and no significant amounts of the WbdA protein are targeted to the membrane fraction. Expression of a polypeptide comprising the WbdD C-terminal region was sufficient to restore both proper localization of WbdA and mannosyltransferase activity. In contrast to WbdA, the other required mannosyltransferases (WbdBC) are targeted to the membrane independent of WbdD. A bacterial two-hybrid system confirmed the interaction of WbdD and WbdA and identified two regions in the C terminus of WbdD that contributed to the interaction. Therefore, in the O9a assembly export system, the WbdD protein orchestrates the critical localization and coordination of activities involved in O-PS chain extension and termination at the cytoplasmic membrane.	[Clarke, Bradley R.; Greenfield, Laura K.; Bouwman, Catrien; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, New Sci Complex, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca			Natural Sciences and Engineering Research Council	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part the Natural Sciences and Engineering Research Council ( to C. W.).	ALEXANDER DC, 1994, J BACTERIOL, V176, P7079, DOI 10.1128/JB.176.22.7079-7084.1994; BRONNER D, 1993, J BACTERIOL, V175, P5984, DOI 10.1128/JB.175.18.5984-5992.1993; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cieslewicz M, 1996, J BACTERIOL, V178, P3212, DOI 10.1128/jb.178.11.3212-3220.1996; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Feng L, 2004, J BACTERIOL, V186, P4510, DOI 10.1128/JB.186.14.4510-4519.2004; Fraenkel D., 1996, ESCHERICHIA COLI SAL, P189; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heinrichs DE, 1998, J BIOL CHEM, V273, P29497, DOI 10.1074/jbc.273.45.29497; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hudson T, 2009, J BACTERIOL, V191, P1716, DOI 10.1128/JB.01371-08; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kido N, 1998, MOL MICROBIOL, V27, P1213, DOI 10.1046/j.1365-2958.1998.00765.x; KIDO N, 1995, J BACTERIOL, V177, P2178, DOI 10.1128/jb.177.8.2178-2187.1995; Kos V, 2009, J BIOL CHEM, V284, P2947, DOI 10.1074/jbc.M807213200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehrer J, 2007, J BACTERIOL, V189, P2618, DOI 10.1128/JB.01905-06; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McNulty C, 2006, MOL MICROBIOL, V59, P907, DOI 10.1111/j.1365-2958.2005.05010.x; Miller J. H., 1972, EXPT MOL GENETICS, P432; Miller JH., 1972, EXPT MOL GENETICS; Moutevelis E, 2009, J MOL BIOL, V385, P726, DOI 10.1016/j.jmb.2008.11.028; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Preston A, 2006, J BIOL CHEM, V281, P18135, DOI 10.1074/jbc.M513904200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rahn A, 2003, MOL MICROBIOL, V47, P1045, DOI 10.1046/j.1365-2958.2003.03354.x; Rick P, 1996, ESCHERICHIA COLI SAL, P104; Rigg GP, 1998, MICROBIOL-SGM, V144, P2905, DOI 10.1099/00221287-144-10-2905; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sambrook J., 1989, MOL CLONING LAB MANU; SCHWEIZER HP, 1993, BIOTECHNIQUES, V15, P831; Sperandeo P, 2009, BBA-MOL CELL BIOL L, V1791, P594, DOI 10.1016/j.bbalip.2009.01.011; STEENBERGEN SM, 1992, J BACTERIOL, V174, P1099, DOI 10.1128/jb.174.4.1099-1108.1992; Steenbergen SM, 2008, MOL MICROBIOL, V68, P1252, DOI 10.1111/j.1365-2958.2008.06231.x; Steiner K, 2008, J BIOL CHEM, V283, P21120, DOI 10.1074/jbc.M801833200; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; WHITFIELD C, 1989, J GEN MICROBIOL, V135, P2589; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Zhou GP, 2005, GLYCOBIOLOGY, V15, P347, DOI 10.1093/glycob/cwi016	47	37	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30662	30672		10.1074/jbc.M109.052878	http://dx.doi.org/10.1074/jbc.M109.052878			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19734145	hybrid, Green Published			2022-12-25	WOS:000271090000068
J	Collins, RF; Touret, N; Kuwata, H; Tandon, NN; Grinstein, S; Trimble, WS				Collins, Richard F.; Touret, Nicolas; Kuwata, Hirotaka; Tandon, Narendra N.; Grinstein, Sergio; Trimble, William S.			Uptake of Oxidized Low Density Lipoprotein by CD36 Occurs by an Actin-dependent Pathway Distinct from Macropinocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOAM CELL-FORMATION; CLASS-B; M-CSF; MACROPHAGES; RECEPTOR; PHAGOCYTOSIS; ENDOCYTOSIS; ERYTHROCYTES; PLATELETS	The class B scavenger receptor CD36 has numerous ligands that include modified forms of low density lipoprotein, fibrillar amyloid, apoptotic cells, and Plasmodium falciparum-infected red blood cells, linking this molecule to atherosclerosis, Alzheimer disease, malaria, and other diseases. We studied the signaling events that follow receptor engagement and lead to CD36 and ligand internalization. We show that oxidized low density lipoprotein or antibody-induced clustering of CD36 triggers macropinocytosis and internalization of the receptor-ligand complex. Remarkably, however, CD36 internalization is independent of macropinocytosis and occurs by a novel endocytic mechanism that depends on actin, but not dynamin. This actin-driven endocytosis requires the activation Src family kinases, JNK, and Rho family GTPases, but, unlike macropinocytosis, it is not affected by inhibitors of phosphatidylinositol 3-kinase or Na/H exchange. Manipulation of this unique mode of internalization may prove helpful in the prevention and management of the wide range of diseases in which CD36 is implicated.	[Collins, Richard F.; Kuwata, Hirotaka; Grinstein, Sergio; Trimble, William S.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Touret, Nicolas] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Tandon, Narendra N.] Otsuka Maryland Med Labs, Thrombosis Res Lab, Rockville, MD 20850 USA; [Grinstein, Sergio; Trimble, William S.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta; University of Toronto	Trimble, WS (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	wtrimble@sickkids.ca	Kuwata, Hiro/N-2023-2019	Kuwata, Hiro/0000-0002-5023-1777	Canadian Institutes of Health [FRN68956]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant FRN68956.	Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Zhao B, 2006, J BIOL CHEM, V281, P15757, DOI 10.1074/jbc.M510714200; COUNILLON L, 1993, P NATL ACAD SCI USA, V90, P4508, DOI 10.1073/pnas.90.10.4508; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Graf GA, 1999, J BIOL CHEM, V274, P12043, DOI 10.1074/jbc.274.17.12043; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Jones NL, 1999, ANAT REC, V255, P57; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Kruth HS, 2005, J BIOL CHEM, V280, P2352, DOI 10.1074/jbc.M407167200; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; Miao WM, 2001, BLOOD, V97, P1689, DOI 10.1182/blood.V97.6.1689; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; Patel SN, 2004, J INFECT DIS, V189, P204, DOI 10.1086/380764; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; RACOOSIN EL, 1992, J CELL SCI, V102, P867; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Sun B, 2007, J LIPID RES, V48, P2560, DOI 10.1194/jlr.M700163-JLR200; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Thorne RF, 2007, FEBS LETT, V581, P1227, DOI 10.1016/j.febslet.2007.02.043; Zeng YC, 2003, J BIOL CHEM, V278, P45931, DOI 10.1074/jbc.M307722200	23	39	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30288	30297		10.1074/jbc.M109.045104	http://dx.doi.org/10.1074/jbc.M109.045104			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19740737	Green Published, hybrid			2022-12-25	WOS:000271090000032
J	Ghosh, S; Marintcheva, B; Takahashi, M; Richardson, CC				Ghosh, Sharmistha; Marintcheva, Boriana; Takahashi, Masateru; Richardson, Charles C.			C-terminal Phenylalanine of Bacteriophage T7 Single-stranded DNA-binding Protein Is Essential for Strand Displacement Synthesis by T7 DNA Polymerase at a Nick in DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE 32 PROTEIN; ESCHERICHIA-COLI THIOREDOXIN; REPLICATION FORK; DEOXYRIBONUCLEIC-ACID; NUCLEIC-ACIDS; LIMITED PROTEOLYSIS; T7-DNA POLYMERASE; CRYSTAL-STRUCTURE; HELICASE-PRIMASE; COOH TERMINUS	Single-stranded DNA-binding protein (gp2.5), encoded by gene 2.5 of bacteriophage T7, plays an essential role in DNA replication. Not only does it remove impediments of secondary structure in the DNA, it also modulates the activities of the other replication proteins. The acidic C-terminal tail of gp2.5, bearing a C-terminal phenylalanine, physically and functionally interacts with the helicase and DNA polymerase. Deletion of the phenylalanine or substitution with a nonaromatic amino acid gives rise to a dominant lethal phenotype, and the altered gp2.5 has reduced affinity for T7 DNA polymerase. Suppressors of the dominant lethal phenotype have led to the identification of mutations in gene 5 that encodes the T7 DNA polymerase. The altered residues in the polymerase are solvent-exposed and lie in regions that are adjacent to the bound DNA. gp2.5 lacking the C-terminal phenylalanine has a lower affinity for gp5-thioredoxin relative to the wild-type gp2.5, and this affinity is partially restored by the suppressor mutations in DNA polymerase. gp2.5 enables T7 DNA polymerase to catalyze strand displacement DNA synthesis at a nick in DNA. The resulting 5'-single-stranded DNA tail provides a loading site for T7 DNA helicase. gp2.5 lacking the C-terminal phenylalanine does not support this event with wild-type DNA polymerase but does to a limited extent with T7 DNA polymerase harboring the suppressor mutations.	[Ghosh, Sharmistha; Marintcheva, Boriana; Takahashi, Masateru; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	ccr@hms.harvard.edu			National Institutes of Health [GM 54937]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397, R25GM054937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 54937 (to C. C. R.).	Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; BURKE RL, 1980, J BIOL CHEM, V255, P1484; CHASE JW, 1986, ANNU REV BIOCHEM, V55, P103, DOI 10.1146/annurev.biochem.55.1.103; Delagoutte E, 2001, BIOCHEMISTRY-US, V40, P4459, DOI 10.1021/bi001306l; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; ENGLER MJ, 1983, J BIOL CHEM, V258, P1165; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; He ZG, 2003, J BIOL CHEM, V278, P29538, DOI 10.1074/jbc.M304318200; Hollis T, 2001, P NATL ACAD SCI USA, V98, P9557, DOI 10.1073/pnas.171317698; HOSODA J, 1978, J BIOL CHEM, V253, P7547; Johnson DE, 2007, P NATL ACAD SCI USA, V104, P5312, DOI 10.1073/pnas.0701062104; KIM YT, 1994, J BIOL CHEM, V269, P5270; KIM YT, 1992, J BIOL CHEM, V267, P15032; KIM YT, 1993, P NATL ACAD SCI USA, V90, P10173, DOI 10.1073/pnas.90.21.10173; Kong DC, 1998, J BIOL CHEM, V273, P6556, DOI 10.1074/jbc.273.11.6556; KOWALCZYKOWSKI SC, 1981, J MOL BIOL, V145, P75, DOI 10.1016/0022-2836(81)90335-1; KRASSA KB, 1991, P NATL ACAD SCI USA, V88, P4010, DOI 10.1073/pnas.88.9.4010; Kumar JK, 2001, J BIOL CHEM, V276, P34905, DOI 10.1074/jbc.M104151200; LECHNER RL, 1983, J BIOL CHEM, V258, P1174; LECHNER RL, 1983, J BIOL CHEM, V258, P1185; Lee J, 2002, J MOL BIOL, V316, P19, DOI 10.1006/jmbi.2001.5325; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Lee SJ, 2006, J BIOL CHEM, V281, P25841, DOI 10.1074/jbc.M604602200; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; LONBERG N, 1981, J MOL BIOL, V145, P123, DOI 10.1016/0022-2836(81)90337-5; Lu D, 2008, P NATL ACAD SCI USA, V105, P9169, DOI 10.1073/pnas.0800741105; Lu D, 2009, BIOCHEMISTRY-US, V48, P6764, DOI 10.1021/bi900361r; Marintcheva B, 2008, P NATL ACAD SCI USA, V105, P1855, DOI 10.1073/pnas.0711919105; Marintcheva B, 2006, J BIOL CHEM, V281, P25831, DOI 10.1074/jbc.M604601200; Marintcheva B, 2009, MOL MICROBIOL, V72, P869, DOI 10.1111/j.1365-2958.2009.06682.x; MARK DF, 1976, P NATL ACAD SCI USA, V73, P780, DOI 10.1073/pnas.73.3.780; NAKAI H, 1988, J BIOL CHEM, V263, P9831; Nelson SW, 2008, J BIOL CHEM, V283, P22838, DOI 10.1074/jbc.M802762200; NEWPORT JW, 1981, J MOL BIOL, V145, P105, DOI 10.1016/0022-2836(81)90336-3; Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; Rezende LF, 2002, J BIOL CHEM, V277, P50643, DOI 10.1074/jbc.M207359200; Savvides SN, 2004, PROTEIN SCI, V13, P1942, DOI 10.1110/ps.04661904; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; Shereda RD, 2009, J MOL BIOL, V386, P612, DOI 10.1016/j.jmb.2008.12.065; Shokri L, 2008, NUCLEIC ACIDS RES, V36, P5668, DOI 10.1093/nar/gkn551; TABOR S, 1990, J BIOL CHEM, V265, P8322; TABOR S, 1987, J BIOL CHEM, V262, P16212; TABOR S, 1989, J BIOL CHEM, V264, P6447; WILLIAMS KR, 1978, J BIOL CHEM, V253, P2463; WILLIAMS KR, 1983, J BIOL CHEM, V258, P3346; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614	50	25	25	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30339	30349		10.1074/jbc.M109.024059	http://dx.doi.org/10.1074/jbc.M109.024059			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726688	Green Published, hybrid			2022-12-25	WOS:000271090000037
J	Xu, J; Song, PH; Nakamura, S; Miller, M; Barone, S; Alper, SL; Riederer, B; Bonhagen, J; Arend, LJ; Amlal, H; Seidler, U; Soleimani, M				Xu, Jie; Song, Penghong; Nakamura, Suguru; Miller, Marian; Barone, Sharon; Alper, Seth L.; Riederer, Brigitte; Bonhagen, Janina; Arend, Lois J.; Amlal, Hassane; Seidler, Ursula; Soleimani, Manoocher			Deletion of the Chloride Transporter Slc26a7 Causes Distal Renal Tubular Acidosis and Impairs Gastric Acid Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDULLARY COLLECTING DUCT; CL-/HCO3-EXCHANGER; INTERCALATED CELLS; PARIETAL-CELLS; SULFATE TRANSPORTER; ANION-EXCHANGER; FUNCTIONAL-CHARACTERIZATION; BASOLATERAL MEMBRANE; INTRACELLULAR PH; MICE LACKING	SLC26A7 (human)/Slc26a7 (mouse) is a recently identified chloride-base exchanger and/or chloride transporter that is expressed on the basolateral membrane of acid-secreting cells in the renal outer medullary collecting duct(OMCD) and in gastric parietal cells. Here, we show that mice with genetic deletion of Slc26a7 expression develop distal renal tubular acidosis, as manifested by metabolic acidosis and alkaline urine pH. In the kidney, basolateral Cl-/HCO3- exchange activity in acid-secreting intercalated cells in the OMCD was significantly decreased in hypertonic medium (a normal milieu for the medulla) but was reduced only mildly in isotonic medium. Changing from a hypertonic to isotonic medium (relative hypotonicity) decreased the membrane abundance of Slc26a7 in kidney cells in vivo and in vitro. In the stomach, stimulated acid secretion was significantly impaired in isolated gastric mucosa and in the intact organ. We propose that SLC26A7 dysfunction should be investigated as a potential cause of unexplained distal renal tubular acidosis or decreased gastric acid secretion in humans.	[Amlal, Hassane; Soleimani, Manoocher] Univ Cincinnati, Ctr Genet Transport & Epithelial Biol, Cincinnati, OH 45267 USA; [Arend, Lois J.] Univ Cincinnati, Dept Pathol, Cincinnati, OH 45267 USA; [Miller, Marian] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Alper, Seth L.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Alper, Seth L.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Renal, Boston, MA 02115 USA; [Soleimani, Manoocher] Vet Affairs Med Ctr, Res Serv, Cincinnati, OH 45220 USA; [Xu, Jie; Barone, Sharon; Amlal, Hassane; Soleimani, Manoocher] Univ Cincinnati, Dept Med, Cincinnati, OH 45267 USA; [Song, Penghong; Riederer, Brigitte; Bonhagen, Janina; Seidler, Ursula] Leibniz Univ Hannover, Dept Gastroenterol, D-30625 Hannover, Germany; [Nakamura, Suguru] Murray State Univ, Dept Biol Sci, Murray, KY 42071 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati; Leibniz University Hannover; Murray State University	Soleimani, M (corresponding author), Univ Cincinnati, Ctr Genet Transport & Epithelial Biol, 231 Albert Sabin Way,MSB G259, Cincinnati, OH 45267 USA.	Manoocher.Soleimani@uc.edu	Arend, Lois/ABE-2002-2020; soleimani, m/U-6889-2017; Seidler, Ursula/HII-8049-2022	Arend, Lois/0000-0001-5434-7630; soleimani, m/0000-0002-3446-8870; Seidler, Ursula/0000-0002-9600-2769	Department of Veterans Affairs; National Institutes of Health [DK62809, DK 43495]; Deutsche Forschungsgemeinschaft Sachbeihilfe [Se 460/9-5, 9-6]; Ministry of Science in Lower Saxony; DCA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062809, R01DK043495, R56DK062809, R37DK043495] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft Sachbeihilfe(German Research Foundation (DFG)); Ministry of Science in Lower Saxony; DCA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by a Merit Review award from the Department of Veterans Affairs (to M. S.) and National Institutes of Health Grants DK62809 (to M. S.) and DK 43495 (to S. L. A.). This work was also supported by the Deutsche Forschungsgemeinschaft Sachbeihilfe Se 460/9-5 and 9-6 and Ministry of Science in Lower Saxony (to U. S.), and by grants from the DCA dialysis care group (to M. S.).	ALPER SL, 1989, P NATL ACAD SCI USA, V86, P5429, DOI 10.1073/pnas.86.14.5429; Barone S, 2004, J AM SOC NEPHROL, V15, P2002, DOI 10.1097/01.ASN.0000135060.83250.07; BERGLINDH T, 1977, GASTROENTEROLOGY, V73, P874; BISSIG M, 1994, J BIOL CHEM, V269, P3017; CAMPBELL VW, 1989, J BIOL CHEM, V264, P11381; Dorwart MR, 2007, J PHYSIOL-LONDON, V584, P333, DOI 10.1113/jphysiol.2007.135855; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; FORTE JG, 1975, J PHYSIOL-LONDON, V244, P33, DOI 10.1113/jphysiol.1975.sp010783; Gawenis LR, 2004, J BIOL CHEM, V279, P30531, DOI 10.1074/jbc.M403779200; Hassoun H, 1998, BLOOD, V92, P1785, DOI 10.1182/blood.V92.5.1785.417k17_1785_1792; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Karet FE, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000023433.08833.88; Kim KH, 2005, J BIOL CHEM, V280, P6463, DOI 10.1074/jbc.M409162200; Lohi H, 2002, J BIOL CHEM, V277, P14246, DOI 10.1074/jbc.M111802200; Lohi H, 2000, GENOMICS, V70, P102, DOI 10.1006/geno.2000.6355; McDaniel N, 2005, AM J PHYSIOL-GASTR L, V289, pG550, DOI 10.1152/ajpgi.00095.2005; Melvin JE, 1999, J BIOL CHEM, V274, P22855, DOI 10.1074/jbc.274.32.22855; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; MUALLEM S, 1985, J BIOL CHEM, V260, P6641; Petrovic S, 2004, AM J PHYSIOL-RENAL, V286, pF161, DOI 10.1152/ajprenal.00219.2003; Petrovic S, 2003, AM J PHYSIOL-GASTR L, V284, pG1093, DOI 10.1152/ajpgi.00454.2002; Petrovic S, 2003, AM J PHYSIOL-RENAL, V284, pF103, DOI 10.1152/ajprenal.00205.2002; RABON E, 1983, J EXP BIOL, V106, P119; Recalde S, 2006, AM J PATHOL, V169, P165, DOI 10.2353/ajpath.2006.051096; Romero Michael F, 2006, Novartis Found Symp, V273, P126; SCHUSTER VL, 1991, AM J PHYSIOL, V260, pF506, DOI 10.1152/ajprenal.1991.260.4.F506; SCHUSTER VL, 1993, ANNU REV PHYSIOL, V55, P267, DOI 10.1146/annurev.ph.55.030193.001411; SCHWARTZ GJ, 1988, AM J PHYSIOL, V255, pF1003, DOI 10.1152/ajprenal.1988.255.5.F1003; Schweinfest CW, 2006, J BIOL CHEM, V281, P37962, DOI 10.1074/jbc.M607527200; SCHWEINFEST CW, 1993, P NATL ACAD SCI USA, V90, P4166, DOI 10.1073/pnas.90.9.4166; Silver RB, 1999, AM J PHYSIOL-RENAL, V276, pF799, DOI 10.1152/ajprenal.1999.276.6.F799; Soleimani M, 2001, AM J PHYSIOL-RENAL, V280, pF356, DOI 10.1152/ajprenal.2001.280.2.F356; Soleimani Manoocher, 2006, Novartis Found Symp, V273, P91; Stehberger PA, 2007, J AM SOC NEPHROL, V18, P1408, DOI 10.1681/ASN.2006101072; STUARTTILLEY A, 1994, AM J PHYSIOL, V266, pC559, DOI 10.1152/ajpcell.1994.266.2.C559; Vincourt JB, 2003, FASEB J, V17, P890, DOI 10.1096/fj.02-0787fje; Wang ZH, 2002, AM J PHYSIOL-GASTR L, V282, pG573, DOI 10.1152/ajpgi.00338.2001; WEINER ID, 1993, AM J PHYSIOL, V265, pF406, DOI 10.1152/ajprenal.1993.265.3.F406; Xu J, 2005, AM J PHYSIOL-CELL PH, V289, pC493, DOI 10.1152/ajpcell.00030.2005; Xu J, 2006, J AM SOC NEPHROL, V17, P956, DOI 10.1681/ASN.2005111174; Xu J, 2008, P NATL ACAD SCI USA, V105, P17955, DOI 10.1073/pnas.0800616105; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	42	66	68	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29470	29479		10.1074/jbc.M109.044396	http://dx.doi.org/10.1074/jbc.M109.044396			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19723628	Green Published, hybrid			2022-12-25	WOS:000270896800029
J	Yue, JB; Wei, WJ; Lam, CMC; Zhao, YJ; Dong, M; Zhang, LR; Zhang, LH; Lee, HC				Yue, Jianbo; Wei, Wenjie; Lam, Connie M. C.; Zhao, Yong-Juan; Dong, Min; Zhang, Liang-Ren; Zhang, Li-He; Lee, Hon-Cheung			CD38/cADPR/Ca2+ Pathway Promotes Cell Proliferation and Delays Nerve Growth Factor-induced Differentiation in PC12 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-ADP-RIBOSE; EMBRYONAL CARCINOMA-CELLS; MEDIATED NEURONAL DIFFERENTIATION; ADENOSINE-DIPHOSPHORIBOSE CADPR; MUSCARINIC RECEPTOR ACTIVATION; ADENINE-DINUCLEOTIDE PHOSPHATE; CDK INHIBITOR P21(WAF1/CIP1); ARTERIAL SMOOTH-MUSCLE; INDUCED CA2+ RELEASE; NEURITE OUTGROWTH	Intracellular Ca2+ mobilization plays an important role in a wide variety of cellular processes, and multiple second messengers are responsible for mediating intracellular Ca2+ changes. Here we explored the role of one endogenous Ca2+-mobilizing nucleotide, cyclic adenosine diphosphoribose (cADPR), in the proliferation and differentiation of neurosecretory PC12 cells. We found that cADPR induced Ca2+ release in PC12 cells and that CD38 is the main ADP-ribosyl cyclase responsible for the acetylcholine (ACh)-induced cADPR production in PC12 cells. In addition, the CD38/cADPR signaling pathway is shown to be required for the ACh-induced Ca2+ increase and cell proliferation. Inhibition of the pathway, on the other hand, accelerated nerve growth factor (NGF)-induced neuronal differentiation in PC12 cells. Conversely, overexpression of CD38 increased cell proliferation but delayed NGF-induced differentiation. Our data indicate that cADPR plays a dichotomic role in regulating proliferation and neuronal differentiation of PC12 cells.	[Yue, Jianbo; Wei, Wenjie; Lam, Connie M. C.; Zhao, Yong-Juan; Lee, Hon-Cheung] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; [Dong, Min; Zhang, Liang-Ren; Zhang, Li-He] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 10019, Peoples R China	University of Hong Kong; Peking University	Yue, JB (corresponding author), Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China.	jyue@hku.hk; leehc@hku.hk	Dong, Min/D-5367-2016; Zhang, Liang/GWM-6088-2022; Zhao, Yongjuan/AAS-9919-2021; Yue, Jianbo/C-4463-2009; Yue, Jianbo/AAC-4588-2019; Lee, Hon Cheung/C-4329-2009; Yue, Jianbo/K-8002-2015	Dong, Min/0000-0001-6655-2818; Yue, Jianbo/0000-0001-6384-5447; Zhao, Yong Juan/0000-0003-4564-1912	Research Grant Council (RGC) grants from Hong Kong; National Natural Science Foundation of China (NSFC)/RGC [N_HKU 722/08, 20831160506, 90713005]; Leukemia and Lymphoma Society of America	Research Grant Council (RGC) grants from Hong Kong(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)/RGC(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society)	This work was supported by Research Grant Council (RGC) grants from Hong Kong (to H. C. L. and J. Y.), National Natural Science Foundation of China (NSFC)/RGC Grant N_HKU 722/08 (to H. C. L.), NSFC grants from China (20831160506, to L. H. Z. and 90713005, to L. R. Z.), and a Special Fellow Award from the Leukemia and Lymphoma Society of America (to J. Y.).	BARRY VA, 1994, BIOCHEM J, V300, P589, DOI 10.1042/bj3000589; BARRY VA, 1994, J CELL SCI, V107, P451; Bennett DL, 1998, BIOCHEM J, V329, P349; Berkeley JL, 2000, J NEUROCHEM, V75, P487, DOI 10.1046/j.1471-4159.2000.0750487.x; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; Billon N, 1999, ONCOGENE, V18, P2872, DOI 10.1038/sj.onc.1202712; Billon N, 1996, ONCOGENE, V13, P2047; Brailoiu E, 2005, J BIOL CHEM, V280, P5646, DOI 10.1074/jbc.M408746200; Brailoiu E, 2006, J BIOL CHEM, V281, P15923, DOI 10.1074/jbc.M602249200; Bruzzone S, 2003, BIOCHEM J, V375, P395, DOI 10.1042/BJ20030556; Burry RW, 2001, J NEUROSCI RES, V63, P45, DOI 10.1002/1097-4547(20010101)63:1<45::AID-JNR6>3.0.CO;2-Y; Churaman D, 2008, CELL SIGNAL, V20, P2347, DOI 10.1016/j.cellsig.2008.09.005; Churamani D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000797; Clementi E, 1996, J BIOL CHEM, V271, P17739, DOI 10.1074/jbc.271.30.17739; Costa LG, 2001, GROWTH FACTORS, V18, P227, DOI 10.3109/08977190109029112; Diamandis P, 2007, NAT CHEM BIOL, V3, P268, DOI 10.1038/nchembio873; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Erhardt JA, 1998, ONCOGENE, V16, P443, DOI 10.1038/sj.onc.1201577; Erhardt JA, 1998, J BIOL CHEM, V273, P23517, DOI 10.1074/jbc.273.36.23517; Galderisi U, 2003, ONCOGENE, V22, P5208, DOI 10.1038/sj.onc.1206558; Galione A, 2000, Sci STKE, V2000, ppe1; Galione A, 2002, CELL CALCIUM, V32, P343, DOI 10.1016/S0143416002001902; Ge ZD, 2003, J VASC RES, V40, P28, DOI 10.1159/000068936; GIZANGGINSBERG E, 1994, MOL ENDOCRINOL, V8, P249, DOI 10.1210/me.8.2.249; Graeff RM, 1997, METHOD ENZYMOL, V280, P230; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gu XF, 2004, J MED CHEM, V47, P5674, DOI 10.1021/jm040092t; Guse AH, 2005, FEBS J, V272, P4590, DOI 10.1111/j.1742-4658.2005.04863.x; Guse AH, 2004, CURR MED CHEM, V11, P847, DOI 10.2174/0929867043455602; Guse AH, 1999, NATURE, V398, P70, DOI 10.1038/18024; Higashida H, 1997, J BIOL CHEM, V272, P31272, DOI 10.1074/jbc.272.50.31272; Higashida H, 2001, BIOL CHEM, V382, P23, DOI 10.1515/BC.2001.004; Higashida H, 2007, NEUROSCI RES, V57, P339, DOI 10.1016/j.neures.2006.11.008; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim SY, 2008, AM J PHYSIOL-RENAL, V294, pF982, DOI 10.1152/ajprenal.00483.2007; Koizumi S, 1999, NEURON, V22, P125, DOI 10.1016/S0896-6273(00)80684-4; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; LEE HC, 1994, NATURE, V370, P307, DOI 10.1038/370307a0; LEVI A, 1988, MOL NEUROBIOL, V2, P201, DOI 10.1007/BF02935346; Ma W, 2000, EUR J NEUROSCI, V12, P1227, DOI 10.1046/j.1460-9568.2000.00010.x; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Marampon F, 2008, MOL BIOL CELL, V19, P2566, DOI 10.1091/mbc.E06-12-1110; Martins AHB, 2005, J BIOL CHEM, V280, P19576, DOI 10.1074/jbc.M502513200; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morgan AJ, 2008, METHODS, V46, P194, DOI 10.1016/j.ymeth.2008.09.013; Morita K, 2006, J PHARMACOL SCI, V101, P40, DOI 10.1254/jphs.FP0050991; Munshi CB, 2002, J BIOL CHEM, V277, P49453, DOI 10.1074/jbc.M209313200; Noguchi N, 1997, J BIOL CHEM, V272, P3133, DOI 10.1074/jbc.272.6.3133; Park DS, 1997, J NEUROSCI, V17, P8975; Podesta M, 2000, FASEB J, V14, P680, DOI 10.1096/fasebj.14.5.680; Poluha W, 1997, J BIOL CHEM, V272, P24002, DOI 10.1074/jbc.272.38.24002; Resende RR, 2008, EXP CELL RES, V314, P1429, DOI 10.1016/j.yexcr.2008.01.003; Resende RR, 2008, CELL CALCIUM, V43, P107, DOI 10.1016/j.ceca.2007.04.007; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Scarfi S, 2008, STEM CELLS, V26, P2855, DOI 10.1634/stemcells.2008-0488; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; STEINER B, 1990, EMBO J, V9, P3539, DOI 10.1002/j.1460-2075.1990.tb07563.x; Tang WX, 2002, AM J PHYSIOL-HEART C, V282, pH1304, DOI 10.1152/ajpheart.00843.2001; Thomas JM, 2002, CURR BIOL, V12, P2018, DOI 10.1016/S0960-9822(02)01335-0; Thomas JM, 2001, BIOCHEM J, V359, P451, DOI 10.1042/0264-6021:3590451; TROY CM, 1992, J CELL BIOL, V117, P1085, DOI 10.1083/jcb.117.5.1085; vanGrunsven LA, 1996, ONCOGENE, V12, P855; WALSETH TF, 1993, BIOCHIM BIOPHYS ACTA, V1178, P235, DOI 10.1016/0167-4889(93)90199-Y; Wang YX, 2004, AM J PHYSIOL-CELL PH, V286, pC538, DOI 10.1152/ajpcell.00106.2003; Yamasaki M, 2005, CURR BIOL, V15, P874, DOI 10.1016/j.cub.2005.04.033; Yan GZ, 1997, J NEUROSCI, V17, P6122; YAN GZ, 1995, J NEUROSCI, V15, P6200; Zhang JS, 2005, BIOCHEM BIOPH RES CO, V335, P920, DOI 10.1016/j.bbrc.2005.07.163; Zocchi E, 1998, J BIOL CHEM, V273, P8017, DOI 10.1074/jbc.273.14.8017	71	41	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29335	29342		10.1074/jbc.M109.049767	http://dx.doi.org/10.1074/jbc.M109.049767			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19696022	Green Published, hybrid			2022-12-25	WOS:000270896800013
J	Hirao, A; Tahara, Y; Kimura, I; Shibata, S				Hirao, Akiko; Tahara, Yu; Kimura, Ichiro; Shibata, Shigenobu			A Balanced Diet Is Necessary for Proper Entrainment Signals of the Mouse Liver Clock	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; GENE-EXPRESSION; GLYCEMIC INDEX; MESSENGER-RNA; PHASE; FOOD; PACEMAKER; GLUCOSE; TISSUES; PER1	Background: The peripheral circadian clock in mice is entrained not only by light-dark cycles but also by daily restricted feeding schedules. Behavioral and cell culture experiments suggest an increase in glucose level as a factor in such feeding-induced entrainment. For application of feeding-induced entrainment in humans, nutrient content and dietary variations should be considered. Principal Finding: To elucidate the food composition necessary for dietary entrainment, we examined whether complete or partial substitution of dietary nutrients affected phase shifts in liver clocks of mice. Compared with fasting mice or ad libitum fed mice, the liver bioluminescence rhythm advanced by 3-4 h on the middle day in Per2::luciferase knock-in mice that were administered a standard mouse diet, i.e. AIN-93M formula [0.6-0.85 g/10 g mouse BW] (composition: 14% casein, 47% cornstarch, 15% gelatinized cornstarch, 10% sugar, 4% soybean oil, and 10% other [fiber, vitamins, minerals, etc.]), for 2 days. When each nutrient was tested alone (100% nutrient), an insignificant weak phase advance was found to be induced by cornstarch and soybean oil, but almost no phase advance was induced by gelatinized cornstarch, high-amylose cornstarch, glucose, sucrose, or casein. A combination of glucose and casein without oil, vitamin, or fiber caused a significant phase advance. When cornstarch in AIN-93M was substituted with glucose, sucrose, fructose, polydextrose, high-amylose cornstarch, or gelatinized cornstarch, the amplitude of phase advance paralleled the increase in blood glucose concentration. Conclusions: Our results strongly suggest the following: (1) balanced diets containing carbohydrates/sugars and proteins are good for restricted feeding-induced entrainment of the peripheral circadian clock and (2) a balanced diet that increases blood glucose, but not by sugar alone, is suitable for entrainment. These findings may assist in the development of dietary recommendations for on-board meals served to air travelers and shift workers to reduce jet lag-like symptoms.			Shibata, S (corresponding author), Waseda Univ, Sch Adv Sci & Engn, Lab Physiol & Pharmacol, Shinjuku Ku, Tokyo, Japan.	shibatas@waseda.jp	Tahara, Yu/Q-4324-2018	Tahara, Yu/0000-0002-3015-8883				Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Arora S, 2006, NEUROPEPTIDES, V40, P375, DOI 10.1016/j.npep.2006.07.001; Bechtold D, 2008, J GENET, V87, P447, DOI 10.1007/s12041-008-0067-6; BOULOS Z, 1980, NEUROSCI BIOBEHAV R, V4, P119, DOI 10.1016/0149-7634(80)90010-X; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Davidson AJ, 2003, GENES BRAIN BEHAV, V2, P32, DOI 10.1034/j.1601-183X.2003.00005.x; DOCKRAY GJ, 2009, REGUL PEPT IN PRESS; ENGLYST HN, 1987, AM J CLIN NUTR, V46, P873, DOI 10.1093/ajcn/46.6.873; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; Frost G, 2000, DIABETIC MED, V17, P336, DOI 10.1046/j.1464-5491.2000.00266.x; GREEN GM, 1989, AM J PHYSIOL, V256, pG1016, DOI 10.1152/ajpgi.1989.256.6.G1016; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Hayasaka N, 2007, ENDOCRINOLOGY, V148, P3316, DOI 10.1210/en.2007-0010; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; KATO H, 1984, LIFE SCI, V34, P331, DOI 10.1016/0024-3205(84)90620-9; Kawamoto T, 2006, J BIOCHEM, V140, P401, DOI 10.1093/jb/mvj165; KING DP, 2000, ANN REV NEU IN PRESS, V3, P713; Kobayashi H, 2004, GENES CELLS, V9, P857, DOI 10.1111/j.1365-2443.2004.00769.x; KRIEGER DT, 1972, SCIENCE, V178, P1205, DOI 10.1126/science.178.4066.1205; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; LIU X, 2009, J NUTR BIOCH; Lundberg K, 2007, NEUROPEPTIDES, V41, P59, DOI 10.1016/j.npep.2006.09.049; Meerlo P, 1997, J BIOL RHYTHM, V12, P80, DOI 10.1177/074873049701200109; MILLER JB, 1992, AM J CLIN NUTR, V56, P1034, DOI 10.1093/ajcn/56.6.1034; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; MORIYA T, 2009, EUR J NEURO IN PRESS; Ohta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002601; SAITO M, 1981, EXPERIENTIA, V37, P754, DOI 10.1007/BF01967962; Shimazoe T, 2008, FASEB J, V22, P1479, DOI 10.1096/fj.07-9372com; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Stephan FK, 1998, PHYSIOL BEHAV, V65, P277, DOI 10.1016/S0031-9384(98)00166-8; Stephan FK, 1997, PHYSIOL BEHAV, V62, P995, DOI 10.1016/S0031-9384(97)00204-7; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshikawa T, 2005, J BIOL RHYTHM, V20, P500, DOI 10.1177/0748730405280775; Young ME, 2002, J MOL CELL CARDIOL, V34, P223, DOI 10.1006/jmcc.2001.1504	39	61	63	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2009	4	9							e6909	10.1371/journal.pone.0006909	http://dx.doi.org/10.1371/journal.pone.0006909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZH	19738906	Green Published, gold, Green Submitted			2022-12-25	WOS:000269622300006
J	Song, C; Yao, HS				Song, Chen; Yao, Haishan			Duality in Binocular Rivalry: Distinct Sensitivity of Percept Sequence and Percept Duration to Imbalance between Monocular Stimuli	PLOS ONE			English	Article							CONTINUOUS FLASH SUPPRESSION; VISUAL AWARENESS; FUSION; CONSCIOUSNESS; COMPETITION; DOMINANCE; VISION; MODEL	Background: Visual perception is usually stable and accurate. However, when the two eyes are simultaneously presented with conflicting stimuli, perception falls into a sequence of spontaneous alternations, switching between one stimulus and the other every few seconds. Known as binocular rivalry, this visual illusion decouples subjective experience from physical stimulation and provides a unique opportunity to study the neural correlates of consciousness. The temporal properties of this alternating perception have been intensively investigated for decades, yet the relationship between two fundamental properties-the sequence of percepts and the duration of each percept-remains largely unexplored. Methodology/Principal Findings: Here we examine the relationship between the percept sequence and the percept duration by quantifying their sensitivity to the strength imbalance between two monocular stimuli. We found that the percept sequence is far more susceptible to the stimulus imbalance than does the percept duration. The percept sequence always begins with the stronger stimulus, even when the stimulus imbalance is too weak to cause a significant bias in the percept duration. Therefore, introducing a small stimulus imbalance affects the percept sequence, whereas increasing the imbalance affects the percept duration, but not vice versa. To investigate why the percept sequence is so vulnerable to the stimulus imbalance, we further measured the interval between the stimulus onset and the first percept, during which subjects experienced the fusion of two monocular stimuli. We found that this interval is dramatically shortened with increased stimulus imbalance. Conclusions/Significance: Our study shows that in binocular rivalry, the strength imblanace between monocular stimuli has a much greater impact on the percept sequence than on the percept duration, and increasing this imbalance can accelerate the process responsible for the percept sequence.			Song, C (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai, Peoples R China.	chen.song@ieee.org	Song, Chen/B-3269-2008; Song, Chen/ABC-2033-2021	Song, Chen/0000-0002-5418-5747; Yao, Haishan/0000-0003-4974-9197				Andrews TJ, 2004, CURR BIOL, V14, P418, DOI 10.1016/j.cub.2004.02.030; Arnold DH, 2008, VISION RES, V48, P994, DOI 10.1016/j.visres.2008.01.020; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; BLAKE R, 1990, PERCEPT PSYCHOPHYS, V48, P593, DOI 10.3758/BF03211605; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; BLAKE R, 1991, INVEST OPHTH VIS SCI, V32, P2821; Blake R, 2003, NEURON, V39, P869, DOI 10.1016/S0896-6273(03)00495-1; BLAKE R, 1985, PERCEPT PSYCHOPHYS, V37, P114, DOI 10.3758/BF03202845; Blake R., 2001, BRAIN MIND, V2, P5, DOI [https://doi.org/10.1023/A:1017925416289, DOI 10.1023/A:1017925416289, 10.1023/A:1017925416289]; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carter O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000343; Chen XC, 2004, CURR BIOL, V14, P1013, DOI 10.1016/j.cub.2004.05.042; Chong SC, 2006, VISION RES, V46, P1794, DOI 10.1016/j.visres.2005.10.031; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; Ehrenstein WH, 2005, GRAEF ARCH CLIN EXP, V243, P926, DOI 10.1007/s00417-005-1128-7; Freeman AW, 2005, J NEUROPHYSIOL, V94, P4412, DOI 10.1152/jn.00557.2005; Hohwy J, 2008, COGNITION, V108, P687, DOI 10.1016/j.cognition.2008.05.010; Kim CY, 2005, TRENDS COGN SCI, V9, P381, DOI 10.1016/j.tics.2005.06.012; LEAT SJ, 1984, PERCEPTION, V13, P351, DOI 10.1068/p130351; Leopold DA, 2002, NAT NEUROSCI, V5, P605, DOI 10.1038/nn0602-851; LEVELT WJM, 1966, BRIT J PSYCHOL, V57, P225, DOI 10.1111/j.2044-8295.1966.tb01023.x; LIU L, 1992, VISION RES, V32, P1471, DOI 10.1016/0042-6989(92)90203-U; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Maloney LT, 2005, P NATL ACAD SCI USA, V102, P3164, DOI 10.1073/pnas.0407157102; MUELLER TJ, 1990, VISUAL NEUROSCI, V4, P63, DOI 10.1017/S0952523800002777; Ning QA, 1997, NEURON, V18, P359, DOI 10.1016/S0896-6273(00)81238-6; Noest AJ, 2007, J VISION, V7, DOI 10.1167/7.8.10; Pearson J, 2004, J VISION, V4, P196, DOI 10.1167/4.3.6; Pearson J, 2008, TRENDS COGN SCI, V12, P334, DOI 10.1016/j.tics.2008.05.006; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Tononi G, 2008, ANN NY ACAD SCI, V1124, P239, DOI 10.1196/annals.1440.004; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Tsuchiya N, 2006, J VISION, V6, P1068, DOI 10.1167/6.10.6; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100; WOLFE JM, 1983, PERCEPTION, V12, P447, DOI 10.1068/p120447	38	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2009	4	9							e6912	10.1371/journal.pone.0006912	http://dx.doi.org/10.1371/journal.pone.0006912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	491ZH	19738903	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000269622300008
J	Ruderfer, DM; Roberts, DC; Schreiber, SL; Perlstein, EO; Kruglyak, L				Ruderfer, Douglas M.; Roberts, David C.; Schreiber, Stuart L.; Perlstein, Ethan O.; Kruglyak, Leonid			Using Expression and Genotype to Predict Drug Response in Yeast	PLOS ONE			English	Article							ANTICANCER DRUGS; PROTEIN EXPRESSION; CANCER; PHARMACOGENOMICS; CHEMOSENSITIVITY; SENSITIVITY; RESISTANCE; PROFILES; TRAITS	Personalized, or genomic, medicine entails tailoring pharmacological therapies according to individual genetic variation at genomic loci encoding proteins in drug-response pathways. It has been previously shown that steady-state mRNA expression can be used to predict the drug response (i.e., sensitivity or resistance) of non-genotyped mammalian cancer cell lines to chemotherapeutic agents. In a real-world setting, clinicians would have access to both steady-state expression levels of patient tissue(s) and a patient's genotypic profile, and yet the predictive power of transcripts versus markers is not well understood. We have previously shown that a collection of genotyped and expression-profiled yeast strains can provide a model for personalized medicine. Here we compare the predictive power of 6,229 steady-state mRNA transcript levels and 2,894 genotyped markers using a pattern recognition algorithm. We were able to predict with over 70% accuracy the drug sensitivity of 104 individual genotyped yeast strains derived from a cross between a laboratory strain and a wild isolate. We observe that, independently of drug mechanism of action, both transcripts and markers can accurately predict drug response. Marker-based prediction is usually more accurate than transcript-based prediction, likely reflecting the genetic determination of gene expression in this cross.			Ruderfer, DM (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	eperlste@princeton.edu; leonid@genomics.princeton.edu	Ruderfer, Douglas M/M-5795-2016	Ruderfer, Douglas M/0000-0002-2365-386X; Perlstein, Ethan/0000-0002-4734-4391	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [P50 GM071508, 50GM071508] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baudhuin LM, 2007, CLIN PHARMACOL THER, V82, P373, DOI 10.1038/sj.clpt.6100350; BENZ R, 1983, BIOPHYS J, V41, P381, DOI 10.1016/S0006-3495(83)84449-X; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Chinn LW, 2007, CLIN PHARMACOL THER, V81, P265, DOI 10.1038/sj.clpt.6100052; Christians Uwe, 2005, Expert Opin Drug Metab Toxicol, V1, P641, DOI 10.1517/17425255.1.4.641; Court MH, 2007, J CLIN PHARMACOL, V47, P1087, DOI 10.1177/0091270007303768; Dan S, 2002, CANCER RES, V62, P1139; Fujita K, 2007, CURR DRUG METAB, V8, P554; Grant SFA, 2007, EXPERT REV MOL DIAGN, V7, P371, DOI 10.1586/14737159.7.4.371; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; HARFORD CM, 2007, PHARMACOGENOMICS, V8, P1159; Hastie T, 1998, CLASSIFICATION PAIRW; Huang RS, 2007, P NATL ACAD SCI USA, V104, P9758, DOI 10.1073/pnas.0703736104; Huang Y, 2007, CANCER METAST REV, V26, P183, DOI 10.1007/s10555-007-9050-6; Ifergan I, 2003, CANCER-AM CANCER SOC, V98, P1958, DOI 10.1002/cncr.11741; Kang HC, 2007, CANCER LETT, V247, P40, DOI 10.1016/j.canlet.2006.03.017; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Kim HS, 2007, P NATL ACAD SCI USA, V104, P19387, DOI 10.1073/pnas.0708194104; Lo HW, 2007, CURR OPIN PHARMACOL, V7, P367, DOI 10.1016/j.coph.2007.06.009; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Lynch T, 2007, AM FAM PHYSICIAN, V76, P391; Ma Y, 2006, CLIN CANCER RES, V12, P4583, DOI 10.1158/1078-0432.CCR-06-0290; Marrer E, 2007, CHEM BIOL DRUG DES, V69, P381, DOI 10.1111/j.1747-0285.2007.00522.x; O'Shaughnessy KM, 2006, BRIT J CLIN PHARMACO, V61, P783, DOI 10.1111/j.1365-2125.2006.02683.x; Ooyama A, 2007, CANCER SCI, V98, P577, DOI 10.1111/j.1349-7006.2007.00424.x; Perlstein EO, 2006, CHEM BIOL, V13, P319, DOI 10.1016/j.chembiol.2006.01.010; Perlstein EO, 2007, NAT GENET, V39, P496, DOI 10.1038/ng1991; Platt  J., 1998, FAST TRAINING SUPPOR; Quintieri L, 2007, ADV EXP MED BIOL, V593, P95; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Swen JJ, 2007, PLOS MED, V4, P1317, DOI 10.1371/journal.pmed.0040209; Weber WA, 2005, J NUCL MED, V46, P983; Witten I. H., 2005, DATA MINING PRACTICA	35	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2009	4	9							e6907	10.1371/journal.pone.0006907	http://dx.doi.org/10.1371/journal.pone.0006907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZF	19730698	Green Published, gold, Green Submitted			2022-12-25	WOS:000269622100012
J	Sainz, N; Rodriguez, A; Catalan, V; Becerril, S; Ramirez, B; Gomez-Ambrosi, J; Fruhbeck, G				Sainz, Neira; Rodriguez, Amaia; Catalan, Victoria; Becerril, Sara; Ramirez, Beatriz; Gomez-Ambrosi, Javier; Fruhbeck, Gema			Leptin Administration Favors Muscle Mass Accretion by Decreasing FoxO3a and Increasing PGC-1 alpha in ob/ob Mice	PLOS ONE			English	Article							GENETICALLY-OBESE MICE; FATTY-ACID OXIDATION; SKELETAL-MUSCLE; UBIQUITIN LIGASES; ADIPOSE-TISSUE; MITOCHONDRIAL BIOGENESIS; TRANSCRIPTION FACTORS; PROTEIN-DEGRADATION; CALORIC RESTRICTION; CELL-PROLIFERATION	Absence of leptin has been associated with reduced skeletal muscle mass in leptin-deficient ob/ob mice. The aim of our study was to examine the effect of leptin on the catabolic and anabolic pathways regulating muscle mass. Gastrocnemius, extensor digitorum longus and soleus muscle mass as well as fiber size were significantly lower in ob/ob mice compared to wild type littermates, being significantly increased by leptin administration (P<0.001). This effect was associated with an inactivation of the muscle atrophy-related transcription factor forkhead box class O3 (FoxO3a) (P<0.05), and with a decrease in the protein expression levels of the E3 ubiquitin-ligases muscle atrophy F-box (MAFbx) (P<0.05) and muscle RING finger 1 (MuRF1) (P<0.05). Moreover, leptin increased (P<0.01) protein expression levels of peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha), a regulator of muscle fiber type, and decreased (P<0.05) myostatin protein, a negative regulator of muscle growth. Leptin administration also activated (P<0.01) the regulators of cell cycle progression proliferating cell nuclear antigen (PCNA) and cyclin D1, and increased (P<0.01) myofibrillar protein troponin T. The present study provides evidence that leptin treatment may increase muscle mass of ob/ob mice by inhibiting myofibrillar protein degradation as well as enhancing muscle cell proliferation.			Sainz, N (corresponding author), Univ Navarra, Metab Res Lab, E-31080 Pamplona, Spain.	gfruhbeck@unav.es	Catalan, Victoria/H-3566-2017; Gómez-Ambrosi, Javier/D-2984-2017; Ramírez, Beatriz/I-1922-2017; Sáinz, Neira/AAA-4624-2019; Rodriguez, Amaia/D-3044-2019	Catalan, Victoria/0000-0002-7513-7509; Gómez-Ambrosi, Javier/0000-0001-5601-1604; Ramírez, Beatriz/0000-0003-3381-7220; Sainz, Neira/0000-0003-0298-3031; Becerril, Sara/0000-0002-3441-1970; Rodriguez, Amaia/0000-0002-2180-461X				Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Adams GR, 2006, APPL PHYSIOL NUTR ME, V31, P782, DOI 10.1139/h06-053; Allen DL, 2008, AM J PHYSIOL-ENDOC M, V294, pE918, DOI 10.1152/ajpendo.00798.2007; Allen DL, 2007, AM J PHYSIOL-CELL PH, V292, pC188, DOI 10.1152/ajpcell.00542.2005; Alt JR, 2000, GENE DEV, V14, P3102, DOI 10.1101/gad.854900; Amirouche A, 2009, ENDOCRINOLOGY, V150, P286, DOI 10.1210/en.2008-0959; Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Barazzoni R, 2005, ENDOCRINOLOGY, V146, P2098, DOI 10.1210/en.2004-1396; BERGEN WG, 1975, AM J CLIN NUTR, V28, P157, DOI 10.1093/ajcn/28.2.157; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; BOOTH FW, 1992, AM J PHYSIOL, V262, pR329, DOI 10.1152/ajpregu.1992.262.3.R329; Borriello A, 2007, CELL CYCLE, V6, P1053, DOI 10.4161/cc.6.9.4142; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruusgaard JC, 2003, J PHYSIOL-LONDON, V551, P467, DOI 10.1113/jphysiol.2003.045328; Carbo N, 2000, J NUTR BIOCHEM, V11, P431, DOI 10.1016/S0955-2863(00)00101-7; Catalan V, 2007, HORM METAB RES, V39, P495, DOI 10.1055/s-2007-982502; Ceddia RB, 2001, FRONT BIOSCI-LANDMRK, V6, pD90, DOI 10.2741/ceddia; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Della-Fera MA, 2005, OBES RES, V13, P1540, DOI 10.1038/oby.2005.189; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dube JJ, 2007, AM J PHYSIOL-REG I, V293, pR642, DOI 10.1152/ajpregu.00133.2007; Durieux AC, 2007, ENDOCRINOLOGY, V148, P3140, DOI 10.1210/en.2006-1500; Eley HL, 2007, J BIOL CHEM, V282, P7087, DOI 10.1074/jbc.M610378200; Feldman BJ, 2006, P NATL ACAD SCI USA, V103, P15675, DOI 10.1073/pnas.0607501103; Fruhbeck G, 1998, NATURE, V391, P843, DOI 10.1038/35993; Fruhbeck G, 2001, P NUTR SOC, V60, P301, DOI 10.1079/PNS200196; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Guerra B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003466; Harris RBS, 1999, ENDOCRINOLOGY, V140, P138, DOI 10.1210/en.140.1.138; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hittel DS, 2009, DIABETES, V58, P30, DOI 10.2337/db08-0943; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Ji M, 2008, CELL SIGNAL, V20, P1452, DOI 10.1016/j.cellsig.2008.03.013; JOHNSON SE, 1993, J CELL PHYSIOL, V154, P39, DOI 10.1002/jcp.1041540106; Joulia D, 2003, EXP CELL RES, V286, P263, DOI 10.1016/S0014-4827(03)00074-0; Kakuma T, 2000, ENDOCRINOLOGY, V141, P4576, DOI 10.1210/en.141.12.4576; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Koncarevic A, 2007, FASEB J, V21, P427, DOI 10.1096/fj.06-6665com; Krawiec BJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1555, DOI 10.1152/ajpendo.00622.2006; Lambert AJ, 2004, EXP GERONTOL, V39, P289, DOI 10.1016/j.exger.2003.12.009; Lang T, 2004, BIOCHEM BIOPH RES CO, V323, P1091, DOI 10.1016/j.bbrc.2004.08.192; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Li MY, 2008, J CELL PHYSIOL, V217, P377, DOI 10.1002/jcp.21507; Liu CM, 2007, CANCER GENE THER, V14, P945, DOI 10.1038/sj.cgt.7701091; Madiehe AM, 2002, ENDOCRINOLOGY, V143, P3875, DOI 10.1210/en.2002-220362; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Moylan JS, 2008, AM J PHYSIOL-CELL PH, V295, pC986, DOI 10.1152/ajpcell.00041.2008; Muzzin P, 1996, P NATL ACAD SCI USA, V93, P14804, DOI 10.1073/pnas.93.25.14804; Nakashima K, 2007, BIOSCI BIOTECH BIOCH, V71, P1650, DOI 10.1271/bbb.70057; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; O'Connor RS, 2007, J APPL PHYSIOL, V103, P1099, DOI 10.1152/japplphysiol.00101.2007; Oda Akihiko, 2001, Kobe Journal of Medical Sciences, V47, P141; Ojuka EO, 2003, FASEB J, V17, P675, DOI 10.1096/fj.02-0951com; Park HY, 2001, EXP MOL MED, V33, P95, DOI 10.1038/emm.2001.17; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Ramsay TG, 2003, J ANIM SCI, V81, P3046; Rathbone CR, 2008, MUSCLE NERVE, V37, P84, DOI 10.1002/mus.20897; Reilly ME, 2000, J MUSCLE RES CELL M, V21, P763, DOI 10.1023/A:1010336624154; Reisz-Porszasz S, 2003, AM J PHYSIOL-ENDOC M, V285, pE876, DOI 10.1152/ajpendo.00107.2003; Rodriguez A, 2007, ENDOCRINOLOGY, V148, P324, DOI 10.1210/en.2006-0940; ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sahu A, 2004, ENDOCRINOLOGY, V145, P2613, DOI 10.1210/en.2004-0032; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; Southgate RJ, 2007, J BIOL CHEM, V282, P21176, DOI 10.1074/jbc.M702039200; Sriwijitkamol A, 2006, AM J PHYSIOL-ENDOC M, V290, pE925, DOI 10.1152/ajpendo.00429.2005; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tajmir P, 2004, ENDOCRINOLOGY, V145, P1550, DOI 10.1210/en.2003-1128; Tajmir P, 2003, J CELL PHYSIOL, V197, P122, DOI 10.1002/jcp.10351; Taylor WE, 2001, AM J PHYSIOL-ENDOC M, V280, pE221, DOI 10.1152/ajpendo.2001.280.2.E221; Terada S, 2004, AM J PHYSIOL-ENDOC M, V286, pE208, DOI 10.1152/ajpendo.00051.2003; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; TROSTLER N, 1982, INT J OBESITY, V6, P557; TROSTLER N, 1979, METABOLISM, V28, P928, DOI 10.1016/0026-0495(79)90093-3; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Warmington SA, 2000, INT J OBESITY, V24, P1040, DOI 10.1038/sj.ijo.0801357; WIELAND O, 1957, BIOCHEM Z, V329, P313; Wu AL, 2008, ENDOCRINOLOGY, V149, P1407, DOI 10.1210/en.2007-1470; Yang W, 2007, J BIOL CHEM, V282, P3799, DOI 10.1074/jbc.M610185200; Yu TY, 2008, BIOSCI BIOTECH BIOCH, V72, P13, DOI 10.1271/bbb.70244; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	92	107	110	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2009	4	9							e6808	10.1371/journal.pone.0006808	http://dx.doi.org/10.1371/journal.pone.0006808			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZF	19730740	Green Published, gold			2022-12-25	WOS:000269622100001
J	Wadlow, RC; Wittner, BS; Finley, SA; Bergquist, H; Upadhyay, R; Finn, S; Loda, M; Mahmood, U; Ramaswamy, S				Wadlow, Raymond C.; Wittner, Ben S.; Finley, S. Aidan; Bergquist, Henry; Upadhyay, Rabi; Finn, Stephen; Loda, Massimo; Mahmood, Umar; Ramaswamy, Sridhar			Systems-Level Modeling of Cancer-Fibroblast Interaction	PLOS ONE			English	Article								Cancer cells interact with surrounding stromal fibroblasts during tumorigenesis, but the complex molecular rules that govern these interactions remain poorly understood thus hindering the development of therapeutic strategies to target cancer stroma. We have taken a mathematical approach to begin defining these rules by performing the first large-scale quantitative analysis of fibroblast effects on cancer cell proliferation across more than four hundred heterotypic cell line pairings. Systems-level modeling of this complex dataset using singular value decomposition revealed that normal tissue fibroblasts variably express at least two functionally distinct activities, one which reflects transcriptional programs associated with activated mesenchymal cells, that act either coordinately or at cross-purposes to modulate cancer cell proliferation. These findings suggest that quantitative approaches may prove useful for identifying organizational principles that govern complex heterotypic cell-cell interactions in cancer and other contexts.			Wadlow, RC (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.	sridhar@mgh.harvard.edu	Finn, Stephen/V-3236-2019	Finn, Stephen/0000-0002-8628-5814; Wadlow, Raymond/0000-0003-1959-5406; Mahmood, Umar/0000-0001-7414-6123; Upadhyay, Rabi/0000-0002-2154-0132	NCI NIH HHS [K08 CA100339-06, K08 CA100339] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA100339] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Affara Nesrine I., 2009, V539, P1, DOI 10.1007/978-1-60327-003-8_1; Beppu H, 2008, ONCOGENE, V27, P1063, DOI 10.1038/sj.onc.1210720; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Clark CJ, 2008, J CELL BIOCHEM, V104, P721, DOI 10.1002/jcb.21688; CORNIL I, 1991, P NATL ACAD SCI USA, V88, P6028, DOI 10.1073/pnas.88.14.6028; De Wever O, 2004, J CELL SCI, V117, P4691, DOI 10.1242/jcs.01322; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Efron B., 1994, INTRO BOOTSTRAP; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; LITTLE RJA, 2002, STAT ANAL WITH MISSI; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Louwerse DJ, 1999, J CHEMOMETR, V13, P491, DOI 10.1002/(SICI)1099-128X(199909/10)13:5<491::AID-CEM537>3.0.CO;2-2; MADSEN MW, 1990, EUR J CANCER, V26, P793, DOI 10.1016/0277-5379(90)90154-L; MANTONI TS, 2008, CANC BIOL THER, V7; Mullen P, 1996, INT J CANCER, V67, P816, DOI 10.1002/(SICI)1097-0215(19960917)67:6<816::AID-IJC10>3.0.CO;2-#; Murase Kenya, 2004, Magn Reson Med Sci, V3, P165, DOI 10.2463/mrms.3.165; Nilsson J, 1997, J CHEMOMETR, V11, P511; Olumi AF, 1999, CANCER RES, V59, P5002; Orend G, 2005, INT J BIOCHEM CELL B, V37, P1066, DOI 10.1016/j.biocel.2004.12.002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ostman A, 2004, CYTOKINE GROWTH F R, V15, P275, DOI 10.1016/j.cytogfr.2004.03.002; Preffer FI, 2002, STEM CELLS, V20, P417, DOI 10.1634/stemcells.20-5-417; Rowe RG, 2009, J CELL BIOL, V184, P399, DOI 10.1083/jcb.200810113; Sakaie KE, 2007, NEUROIMAGE, V34, P169, DOI 10.1016/j.neuroimage.2006.08.034; Sasser AK, 2007, CANCER LETT, V254, P255, DOI 10.1016/j.canlet.2007.03.012; Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thiery JP, 1999, CANCER METAST REV, V18, P31, DOI 10.1023/A:1006256219004; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639; Yashiro M, 2005, BREAST CANCER RES TR, V90, P307, DOI 10.1007/s10549-004-5364-z	37	20	21	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6888	10.1371/journal.pone.0006888	http://dx.doi.org/10.1371/journal.pone.0006888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19727395	Green Submitted, gold, Green Published			2022-12-25	WOS:000269522900017
J	Salas, A; Lovo-Gomez, J; Alvarez-Iglesias, V; Cerezo, M; Lareu, MV; Macaulay, V; Richards, MB; Carracedo, A				Salas, Antonio; Lovo-Gomez, Jose; Alvarez-Iglesias, Vanesa; Cerezo, Maria; Victoria Lareu, Maria; Macaulay, Vincent; Richards, Martin B.; Carracedo, Angel			Mitochondrial Echoes of First Settlement and Genetic Continuity in El Salvador	PLOS ONE			English	Article							MTDNA HAPLOGROUP X; DNA DIVERSITY; ANCIENT DNA; POPULATION; LINEAGES; AFFINITIES; AMERINDS; SEQUENCES; DIFFERENTIATION; EVOLUTIONARY	Background: From Paleo-Indian times to recent historical episodes, the Mesoamerican isthmus played an important role in the distribution and patterns of variability all around the double American continent. However, the amount of genetic information currently available on Central American continental populations is very scarce. In order to shed light on the role of Mesoamerica in the peopling of the New World, the present study focuses on the analysis of the mtDNA variation in a population sample from El Salvador. Methodology/Principal Findings: We have carried out DNA sequencing of the entire control region of the mitochondrial DNA (mtDNA) genome in 90 individuals from El Salvador. We have also compiled more than 3,985 control region profiles from the public domain and the literature in order to carry out inter-population comparisons. The results reveal a predominant Native American component in this region: by far, the most prevalent mtDNA haplogroup in this country (at similar to 90%) is A2, in contrast with other North, Meso- and South American populations. Haplogroup A2 shows a star-like phylogeny and is very diverse with a substantial proportion of mtDNAs (45%; sequence range 16090-16365) still unobserved in other American populations. Two different Bayesian approaches used to estimate admixture proportions in El Salvador shows that the majority of the mtDNAs observed come from North America. A preliminary founder analysis indicates that the settlement of El Salvador occurred about 13,400 +/- 65,200 Y.B.P.. The founder age of A2 in El Salvador is close to the overall age of A2 in America, which suggests that the colonization of this region occurred within a few thousand years of the initial expansion into the Americas. Conclusions/Significance: As a whole, the results are compatible with the hypothesis that today's A2 variability in El Salvador represents to a large extent the indigenous component of the region. Concordant with this hypothesis is also the observation of a very limited contribution from European and African women (similar to 5%). This implies that the Atlantic slave trade had a very small demographic impact in El Salvador in contrast to its transformation of the gene pool in neighbouring populations from the Caribbean facade.			Salas, A (corresponding author), Univ Santiago de Compostela, Fac Med, Unidade Xenet, Dept Anat Patol & Ciencias Forenses, Galicia, Spain.	antonio.salas@usc.es	Lareu, Maviky/E-4909-2013; Salas, Antonio/E-3977-2012; Carracedo, Angel/D-4257-2012; Salas, Antonio/U-2029-2019	Lareu, Maviky/0000-0002-6165-9795; Salas, Antonio/0000-0002-2336-702X; Carracedo, Angel/0000-0003-1085-8986; Salas, Antonio/0000-0002-2336-702X; RICHARDS, MARTIN/0000-0003-3118-0967; Cerezo Fernandez, Maria/0000-0003-3073-1130				Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Alvarez-Iglesias V, 2007, FORENSIC SCI INT-GEN, V1, P44, DOI 10.1016/j.fsigen.2006.09.001; Alvarez-Iglesias V, 2006, INT C SERIES, V11, P4; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-113; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 2004, SCIENCE, V305, P1402; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; BATISTA O, 1995, HUM MOL GENET, V4, P921, DOI 10.1093/hmg/4.5.921; Beleza S, 2005, HUM GENET, V117, P366, DOI 10.1007/s00439-005-1290-3; Bert F, 2004, ANN HUM BIOL, V31, P9, DOI 10.1080/03014460310001616464; BOLES TC, 1995, J FORENSIC SCI, V40, P349; Bolnick DA, 2003, AM J PHYS ANTHROPOL, V122, P336, DOI 10.1002/ajpa.10284; Bonilla C, 2004, AM J HUM BIOL, V16, P289, DOI 10.1002/ajhb.20025; Brehm A, 2003, HUM GENET, V114, P77, DOI 10.1007/s00439-003-1024-3; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Budowle B, 2002, INT J LEGAL MED, V116, P212, DOI 10.1007/s00414-001-0283-6; Burckhardt F, 1999, NUCLEIC ACIDS RES, V27, P138, DOI 10.1093/nar/27.1.138; *CONCULTURA, 2000, BIBL HIST SALV EL SA; Dipierri JE, 1998, HUM BIOL, V70, P1001; Dornelles CL, 2005, AM J PHYS ANTHROPOL, V127, P439, DOI 10.1002/ajpa.20103; Dornelles CL, 2004, AM J HUM BIOL, V16, P479, DOI 10.1002/ajhb.20038; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Forster P, 1996, AM J HUM GENET, V59, P935; Garcia-Bour J, 2004, AM J PHYS ANTHROPOL, V123, P361, DOI 10.1002/ajpa.10337; GINTHER C, 1993, EXS, V67, P211; Gonzalez AM, 2003, AM J PHYS ANTHROPOL, V120, P391, DOI 10.1002/ajpa.10168; Green LD, 2000, AM J HUM GENET, V66, P989, DOI 10.1086/302801; HORAI S, 1993, MOL BIOL EVOL, V10, P23; Kittles RA, 1999, AM J PHYS ANTHROPOL, V108, P381, DOI 10.1002/(SICI)1096-8644(199904)108:4<381::AID-AJPA1>3.0.CO;2-5; KOLMAN CJ, 1995, GENETICS, V140, P275; Kolman CJ, 1997, GENETICS, V147, P1289; Lalueza-Fox C, 2003, AM J PHYS ANTHROPOL, V121, P97, DOI 10.1002/ajpa.10236; Lalueza-Fox C, 2001, ANN HUM GENET, V65, P137, DOI 10.1017/S0003480001008533; LARIN JLY, 2000, EL SALVADOR DESCUBRI; LORENZ JC, 1994, SPE FORMATION EVAL, V9, P66, DOI 10.2118/21877-PA; Lovo-Gomez J, 2007, FORENSIC SCI INT, V171, P198, DOI 10.1016/j.forsciint.2006.07.005; Malhi RS, 2001, HUM BIOL, V73, P17, DOI 10.1353/hub.2001.0008; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; Mendizabal I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-213; MERRIWETHER DA, 2002, GENE FLOW GENETIC VA, P89; MERRIWETHER DA, 2000, AM PAST AM PRESENT G, P89; *MIN ED ES, 1994, HIST EL SALV; Monsalve MV, 2002, AM J PHYS ANTHROPOL, V119, P288, DOI 10.1002/ajpa.10116; Monson K.L., 2002, FORENSIC SCI COMMUN, V4, P2; Moraga M, 2005, AM J PHYS ANTHROPOL, V127, P170, DOI 10.1002/ajpa.10438; Moraga ML, 2000, AM J PHYS ANTHROPOL, V113, P19, DOI 10.1002/1096-8644(200009)113:1<19::AID-AJPA3>3.0.CO;2-X; Nei N, 1987, MOL EVOLUTIONARY GEN; Pagano S, 2005, J FORENSIC SCI, V50, P1239; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pereira L, 2000, ANN HUM GENET, V64, P491, DOI 10.1046/j.1469-1809.2000.6460491.x; RIBEIRODOSSANTO.AK, 2006, FORENSIC SCI INT; RibeirodosSantos AKC, 1996, AM J PHYS ANTHROPOL, V101, P29, DOI 10.1002/(SICI)1096-8644(199609)101:1<29::AID-AJPA3>3.0.CO;2-8; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rickards O, 1999, AM J HUM GENET, V65, P519, DOI 10.1086/302513; Rubicz R, 2003, HUM BIOL, V75, P809, DOI 10.1353/hub.2004.0009; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Salas A, 2008, J HUM GENET, V53, P662, DOI 10.1007/s10038-008-0297-8; Salas A, 2007, FORENSIC SCI INT, V168, P1, DOI 10.1016/j.forsciint.2006.05.037; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Salas A, 2005, AM J HUM GENET, V77, P676, DOI 10.1086/491675; Salas A, 2005, AM J PHYS ANTHROPOL, V128, P855, DOI 10.1002/ajpa.20117; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; SANTOS M, 1994, HUM BIOL, V66, P963; Santos SEB, 1996, ANN HUM GENET, V60, P305, DOI 10.1111/j.1469-1809.1996.tb01194.x; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; Smith DG, 1999, AM J PHYS ANTHROPOL, V110, P271, DOI 10.1002/(SICI)1096-8644(199911)110:3<271::AID-AJPA2>3.0.CO;2-C; SOARES P, 2009, AM J HUM GE IN PRESS; Starikovskaya YB, 1998, AM J HUM GENET, V63, P1473, DOI 10.1086/302087; STONE AC, 1993, AM J PHYS ANTHROPOL, V92, P463, DOI 10.1002/ajpa.1330920405; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Torres MM, 2006, AM J HUM BIOL, V18, P59, DOI 10.1002/ajhb.20461; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1993, AM J HUM GENET, V53, P563; Trovoada MJ, 2004, ANN HUM GENET, V68, P40, DOI 10.1046/j.1529-8817.2003.00070.x; Vernesi C, 2002, HUM BIOL, V74, P725, DOI 10.1353/hub.2002.0060; Vona G, 2005, AM J PHYS ANTHROPOL, V127, P361, DOI 10.1002/ajpa.20070; Ward RH, 1996, AM J HUM BIOL, V8, P317, DOI 10.1002/(SICI)1520-6300(1996)8:3<317::AID-AJHB2>3.0.CO;2-X; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; Williams SR, 2002, AM J PHYS ANTHROPOL, V117, P246, DOI 10.1002/ajpa.10035; Yao YG, 2006, HUM GENET, V119, P505, DOI 10.1007/s00439-006-0154-9	86	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2009	4	9							e6882	10.1371/journal.pone.0006882	http://dx.doi.org/10.1371/journal.pone.0006882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	490RW	19724647	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000269522800007
J	Stralberg, D; Jongsomjit, D; Howell, CA; Snyder, MA; Alexander, JD; Wiens, JA; Root, TL				Stralberg, Diana; Jongsomjit, Dennis; Howell, Christine A.; Snyder, Mark A.; Alexander, John D.; Wiens, John A.; Root, Terry L.			Re-Shuffling of Species with Climate Disruption: A No-Analog Future for California Birds?	PLOS ONE			English	Article							POLLEN SPECTRA; DISTRIBUTIONS; MODELS; VEGETATION; SELECTION; CONSEQUENCES; PALEOECOLOGY; CONSERVATION; COMMUNITIES; PREDICTION	By facilitating independent shifts in species' distributions, climate disruption may result in the rapid development of novel species assemblages that challenge the capacity of species to co-exist and adapt. We used a multivariate approach borrowed from paleoecology to quantify the potential change in California terrestrial breeding bird communities based on current and future species-distribution models for 60 focal species. Projections of future no-analog communities based on two climate models and two species-distribution-model algorithms indicate that by 2070 over half of California could be occupied by novel assemblages of bird species, implying the potential for dramatic community reshuffling and altered patterns of species interactions. The expected percentage of no-analog bird communities was dependent on the community scale examined, but consistent geographic patterns indicated several locations that are particularly likely to host novel bird communities in the future. These no-analog areas did not always coincide with areas of greatest projected species turnover. Efforts to conserve and manage biodiversity could be substantially improved by considering not just future changes in the distribution of individual species, but including the potential for unprecedented changes in community composition and unanticipated consequences of novel species assemblages.			Stralberg, D (corresponding author), PRBO Conservat Sci, Petaluma, CA USA.	dstralberg@prbo.org	Snyder, Mark/B-6835-2008; Alexander, John/GVS-7271-2022; Stralberg, Diana/W-9267-2019	Snyder, Mark/0000-0001-8242-7697; Stralberg, Diana/0000-0003-4900-024X				Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Bakkenes M, 2002, GLOBAL CHANGE BIOL, V8, P390, DOI 10.1046/j.1354-1013.2001.00467.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown JH, 2000, AM NAT, V156, P314, DOI 10.1086/303385; Brown JH, 1997, P NATL ACAD SCI USA, V94, P9729, DOI 10.1073/pnas.94.18.9729; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; CHASE M, 2005, BIRD CONSERVATION IM, P130; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Davis F., 1998, CALIFORNIA GAP ANAL; deGroot RS, 1995, J BIOGEOGR, V22, P935, DOI 10.2307/2845994; Diffenbaugh NS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035075; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Everitt B., 1974, CLUSTER ANAL; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Flower RJ, 1997, HYDROBIOLOGIA, V344, P27, DOI 10.1023/A:1002941908602; Gavin DG, 2003, QUATERNARY RES, V60, P356, DOI 10.1016/S0033-5894(03)00088-7; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; Graham RW, 1996, SCIENCE, V272, P1601; Hastie T.J., 2017, STAT SCI; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; HUNTLEY B, 1991, ANN BOT-LONDON, V67, P15, DOI 10.1093/oxfordjournals.aob.a088205; HUNTLEY B, 1990, QUATERNARY RES, V33, P360, DOI 10.1016/0033-5894(90)90062-P; Huntley B, 2004, ECOL LETT, V7, P417, DOI 10.1111/j.1461-0248.2004.00598.x; Huntley B., 2007, CLIMATIC ATLAS EUROP; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Jackson ST, 2004, ANNU REV EARTH PL SC, V32, P495, DOI 10.1146/annurev.earth.32.101802.120435; JACKSON ST, 1991, ECOLOGY, V72, P641, DOI 10.2307/2937204; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Lenihan JM, 2008, CLIMATIC CHANGE, V87, pS215, DOI 10.1007/s10584-007-9362-0; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Maurer EP, 2008, HYDROL EARTH SYST SC, V12, P551; MAYER KE, 1988, GUIDE WILDLIFE HABIT, P166; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Nix H. A., 1986, ATLAS ELAPID SNAKES, V7, P4; OVERPECK JT, 1985, QUATERNARY RES, V23, P87, DOI 10.1016/0033-5894(85)90074-2; OVERPECK JT, 1992, GEOLOGY, V20, P1071, DOI 10.1130/0091-7613(1992)020<1071:MENAVC>2.3.CO;2; Pal JS, 2007, B AM METEOROL SOC, V88, P1395, DOI 10.1175/BAMS-88-9-1395; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; R Development Core Team, 2007, R LANG ENV STAT COMP; Ralph C.J., 1993, GEN TECHNICAL REPORT; Ricklefs RE, 2008, AM NAT, V172, P741, DOI 10.1086/593002; ROOT TL, 1993, CONSERV BIOL, V7, P256, DOI 10.1046/j.1523-1739.1993.07020256.x; ROTENBERRY JT, 1985, OECOLOGIA, V67, P213, DOI 10.1007/BF00384286; Sauer J. R., 2005, N AM BREEDING BIRD S; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Seastedt TR, 2008, FRONT ECOL ENVIRON, V6, P547, DOI 10.1890/070046; Seoane J, 2004, ECOL MODEL, V171, P209, DOI 10.1016/j.ecolmodel.2003.08.006; SHUFORD WD, 2008, STUDIES W BIRDS W FI, V1; Simpson GL, 2007, J STAT SOFTW, V22, P1; Snyder MA, 2005, EARTH INTERACT, V9; Solomon S., 2007, 4 IPCC; TEMPLE S A, 1989, American Birds, V43, P260; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; WIENS JA, P NATL ACAD SCI US; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104	66	132	135	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2009	4	9							e6825	10.1371/journal.pone.0006825	http://dx.doi.org/10.1371/journal.pone.0006825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RW	19724641	Green Published, gold, Green Submitted			2022-12-25	WOS:000269522800001
J	Ichiyama, R; Potuzak, M; Balak, M; Kalderon, N; Edgerton, VR				Ichiyama, Ronaldo; Potuzak, Melissa; Balak, Marissa; Kalderon, Nurit; Edgerton, V. Reggie			Enhanced Motor Function by Training in Spinal Cord Contused Rats Following Radiation Therapy	PLOS ONE			English	Article								Weight-bearing stepping, without supraspinal re-connectivity, can be attained by treadmill training in an animal whose spinal cord has been completely transected at the lower thoracic level. Repair of damaged tissue and of supraspinal connectivity/circuitry following spinal cord injury in rat can be achieved by specific cell elimination with radiation therapy of the lesion site delivered within a critical time window, 2-3 weeks postinjury. Here we examined the effects of training in the repaired spinal cord following clinical radiation therapy. Studies were performed in a severe rat spinal cord contusion injury model, one similar to fracture/crush injuries in humans; the injury was at the lower thoracic level and the training was a combined hindlimb standing and stepping protocol. Radiotherapy, in a similar manner to that reported previously, resulted in a significant level of tissue repair/preservation at the lesion site. Training in the irradiated group, as determined by limb kinematics tests, resulted in functional improvements that were significant for standing and stepping capacity, and yielded a significant direct correlation between standing and stepping performance. In contrast, the training in the unirradiated group resulted in no apparent beneficial effects, and yielded an inverse correlation between standing and stepping performance, e. g., subject with good standing showed poor stepping capacity. Further, without any training, a differential functional change was observed in the irradiated group; standing capacity was significantly inhibited while stepping showed a slight trend of improvement compared with the unirradiated group. These data suggest that following repair by radiation therapy the spinal circuitries which control posture and locomotor were modified, and that the beneficial functional modulation of these circuitries is use dependent. Further, for restoring beneficial motor function following radiotherapy, training seems to be crucial.			Ichiyama, R (corresponding author), Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds, W Yorkshire, England.	kalderon@spinalcordcure.org; vre@ucla.edu	Ichiyama, Ronaldo/B-7856-2009; 慧, 胡/C-5968-2009	Ichiyama, Ronaldo/0000-0002-7640-8032	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039375, P01NS016333] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS016333, NS16333, R01 NS039375, NS39375] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARBEAU H, 1987, BRAIN RES, V412, P84, DOI 10.1016/0006-8993(87)91442-9; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Belanger M, 1996, J NEUROPHYSIOL, V76, P471, DOI 10.1152/jn.1996.76.1.471; CAJAL SRY, 1928, DEGENERATION REGENER, V2, P482; Conta AC, 2004, J COMP NEUROL, V479, P347, DOI 10.1002/cne.20319; de Leon RD, 1998, J NEUROPHYSIOL, V79, P1329, DOI 10.1152/jn.1998.79.3.1329; de Leon RD, 2002, PROG BRAIN RES, V137, P141; de Leon RD, 1999, J NEUROPHYSIOL, V81, P85, DOI 10.1152/jn.1999.81.1.85; de Leon RD, 1998, J NEUROPHYSIOL, V80, P83; de Leon RD, 1999, PROG BRAIN RES, V123, P341, DOI 10.1016/S0079-6123(08)62869-1; Edgerton V R, 1997, Adv Neurol, V72, P233; Edgerton VR, 2004, ANNU REV NEUROSCI, V27, P145, DOI 10.1146/annurev.neuro.27.070203.144308; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797, DOI 10.1152/jn.1997.77.2.797; Heng C, 2009, EXP NEUROL, V216, P139, DOI 10.1016/j.expneurol.2008.11.023; HODGSON JA, 1994, MED SCI SPORT EXER, V26, P1491; Hutchinson KJ, 2004, BRAIN, V127, P1403, DOI 10.1093/brain/awh160; KAKULAS BA, 1987, PARAPLEGIA, V25, P212, DOI 10.1038/sc.1987.37; Kalderon N, 1996, P NATL ACAD SCI USA, V93, P11185, DOI 10.1073/pnas.93.20.11185; Kalderon N, 2005, CURR PHARM DESIGN, V11, P1237, DOI 10.2174/1381612053507477; Kalderon N, 2001, BRAIN RES, V904, P199, DOI 10.1016/S0006-8993(01)02402-7; KALDERON N, 1996, P NATL ACAD SCI USA, V93, P10079; Kalderon N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000565; LOVELY RG, 1990, BRAIN RES, V514, P206, DOI 10.1016/0006-8993(90)91417-F; LOVELY RG, 1986, EXP NEUROL, V92, P421, DOI 10.1016/0014-4886(86)90094-4; PRATT CA, 1994, J NEUROPHYSIOL, V71, P1981, DOI 10.1152/jn.1994.71.5.1981; Qi HX, 2004, SOMATOSENS MOT RES, V21, P229, DOI 10.1080/08990220400012588; Stokes BT, 2002, SPINAL CORD, V40, P101, DOI 10.1038/sj.sc.3101254; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; Timoszyk WK, 2002, J NEUROPHYSIOL, V88, P3108, DOI 10.1152/jn.01050.2001; WERNIG A, 1992, PARAPLEGIA, V30, P229, DOI 10.1038/sc.1992.61; Wu CWH, 2000, NEURON, V28, P967, DOI 10.1016/S0896-6273(00)00167-7	33	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6862	10.1371/journal.pone.0006862	http://dx.doi.org/10.1371/journal.pone.0006862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718437	Green Published, Green Submitted, gold			2022-12-25	WOS:000269415900025
J	Nardinocchi, L; Puca, R; Sacchi, A; Rechavi, G; Givol, D; D'Orazi, G				Nardinocchi, Lavinia; Puca, Rosa; Sacchi, Ada; Rechavi, Gideon; Givol, David; D'Orazi, Gabriella			Targeting Hypoxia in Cancer Cells by Restoring Homeodomain Interacting Protein-Kinase 2 and p53 Activity and Suppressing HIF-1 alpha	PLOS ONE			English	Article								Background: The tumor suppressor homeodomain-interacting protein kinase-2 (HIPK2) by phosphorylating serine 46 (Ser46) is a crucial regulator of p53 apoptotic function. HIPK2 is also a transcriptional co-repressor of hypoxia-inducible factor-1 alpha (HIF-1 alpha) restraining tumor angiogenesis and chemoresistance. HIPK2 can be deregulated in tumors by several mechanisms including hypoxia. Here, we sought to target hypoxia by restoring HIPK2 function and suppressing HIF-1 alpha, in order to provide evidence for the involvement of both HIPK2 and p53 in counteracting hypoxia-induced chemoresistance. Methodology/Principal Findings: Upon exposure of colon and lung cancer cells to hypoxia, by either low oxygen or cobalt, HIPK2 function was impaired allowing for increased HIF-1 alpha expression and inhibiting the p53-apoptotic response to drug. Cobalt suppressed HIPK2 recruitment onto HIF-1 alpha promoter. Hypoxia induced expression of the p53 target MDM2 that downregulates HIPK2, thus MDM2 inhibition by siRNA restored the HIPK2/p53Ser46 response to drug. Zinc supplementation to hypoxia-treated cells increased HIPK2 protein stability and nuclear accumulation, leading to restoration of HIPK2 binding to HIF-1 alpha promoter, repression of MDR1, Bcl2, and VEGF genes, and activation of the p53 apoptotic response to drug. Combination of zinc and ADR strongly suppressed tumor growth in vivo by inhibiting HIF-1 pathway and upregulating p53 apoptotic target genes. Conclusions/Significance: We show here for the first time that hypoxia-induced HIPK2 deregulation was counteracted by zinc that restored HIPK2 suppression of HIF-1 pathway and reactivated p53 apoptotic response to drug, underscoring the potential use of zinc supplementation in combination with chemotherapy to address hypoxia and improve tumor treatment.			Nardinocchi, L (corresponding author), Natl Canc Inst Regina Elena, Dept Expt Oncol, Mol Oncogenesis Lab, Rome, Italy.	gdorazi@unich.it	D'Orazi, Gabriella/T-2792-2019	D'Orazi, Gabriella/0000-0001-6876-9105	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Achison M, 2003, ONCOGENE, V22, P3431, DOI 10.1038/sj.onc.1206434; Beyersmann D, 2001, BIOMETALS, V14, P331, DOI 10.1023/A:1012905406548; Calzado MA, 2007, CELL CYCLE, V6, P139, DOI 10.4161/cc.6.2.3788; Calzado MA, 2009, NAT CELL BIOL, V11, P85, DOI 10.1038/ncb1816; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Choi CY, 1999, J BIOL CHEM, V274, P33194, DOI 10.1074/jbc.274.47.33194; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; D'Orazi G, 2006, CLIN CANCER RES, V12, P735, DOI 10.1158/1078-0432.CCR-05-1557; Dauth I, 2007, CANCER RES, V67, P2274, DOI 10.1158/0008-5472.CAN-06-2884; Di Stefano V, 2005, ONCOGENE, V24, P5431, DOI 10.1038/sj.onc.1208717; Di Stefano V, 2004, ONCOGENE, V23, P5185, DOI 10.1038/sj.onc.1207656; Di Stefano V, 2004, EXP CELL RES, V293, P311, DOI 10.1016/j.yexcr.2003.09.032; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Eby GA, 2005, MED HYPOTHESES, V64, P1124, DOI 10.1016/j.mehy.2004.12.019; Gresko E, 2005, BIOCHEM BIOPH RES CO, V329, P1293, DOI 10.1016/j.bbrc.2005.02.113; Gresko E, 2006, EMBO J, V25, P1883, DOI 10.1038/sj.emboj.7601077; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Ho E, 2004, J NUTR BIOCHEM, V15, P572, DOI 10.1016/j.jnutbio.2004.07.005; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Hollstein M, 1999, MUTAT RES-FUND MOL M, V431, P199, DOI 10.1016/S0027-5107(99)00162-1; Iwakuma T, 2003, MOL CANCER RES, V1, P993; JOENGER AC, 2007, ONCOGENE, V26, P2226; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lai A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004758; Li XL, 2007, ONCOGENE, V26, P7231, DOI 10.1038/sj.onc.1210523; Li XQ, 2008, MOL CANCER THER, V7, P1207, DOI 10.1158/1535-7163.MCT-07-2187; Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007; Mayo LD, 2005, J BIOL CHEM, V280, P25953, DOI 10.1074/jbc.M503026200; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Nardinocchi L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-1; Nardinocchi L, 2009, BBA-MOL CELL RES, V1793, P368, DOI 10.1016/j.bbamcr.2008.10.013; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pierantoni GM, 2007, J CLIN INVEST, V117, P693, DOI 10.1172/JCI29852; Pierantoni GM, 2002, BIOCHEM BIOPH RES CO, V290, P942, DOI 10.1006/bbrc.2001.6310; Pistritto G, 2007, CELL DEATH DIFFER, V14, P1837, DOI 10.1038/sj.cdd.4402186; Puca R, 2008, GYNECOL ONCOL, V109, P403, DOI 10.1016/j.ygyno.2008.02.018; Puca R, 2008, CANCER RES, V68, P3707, DOI 10.1158/0008-5472.CAN-07-6776; Puca R, 2009, EXP CELL RES, V315, P67, DOI 10.1016/j.yexcr.2008.10.018; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Roscic A, 2006, MOL CELL, V24, P77, DOI 10.1016/j.molcel.2006.08.004; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shah MR, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-84; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Wesierska-Gadek J, 2007, J CELL BIOCHEM, V100, P865, DOI 10.1002/jcb.21211	49	42	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2009	4	8							e6819	10.1371/journal.pone.0006819	http://dx.doi.org/10.1371/journal.pone.0006819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JG	19714248	Green Published, gold, Green Submitted			2022-12-25	WOS:000269415800008
J	Uhrig, M; Ittrich, C; Wiedmann, V; Knyazev, Y; Weninger, A; Riemenschneider, M; Hartmann, T				Uhrig, Markus; Ittrich, Carina; Wiedmann, Verena; Knyazev, Yuri; Weninger, Annette; Riemenschneider, Matthias; Hartmann, Tobias			New Alzheimer Amyloid beta Responsive Genes Identified in Human Neuroblastoma Cells by Hierarchical Clustering	PLOS ONE			English	Article								Alzheimer's disease (AD) is characterized by neuronal degeneration and cell loss. A beta(42), in contrast to A beta(40), is thought to be the pathogenic form triggering the pathological cascade in AD. In order to unravel overall gene regulation we monitored the transcriptomic responses to increased or decreased A beta(40) and A beta(42) levels, generated and derived from its precursor C99 (C-terminal fragment of APP comprising 99 amino acids) in human neuroblastoma cells. We identified fourteen differentially expressed transcripts by hierarchical clustering and discussed their involvement in AD. These fourteen transcripts were grouped into two main clusters each showing distinct differential expression patterns depending on Ab40 and Ab42 levels. Among these transcripts we discovered an unexpected inverse and strong differential expression of neurogenin 2 (NEUROG2) and KIAA0125 in all examined cell clones. C99-overexpression had a similar effect on NEUROG2 and KIAA0125 expression as a decreased A beta(42)/A beta(40) ratio. Importantly however, an increased A beta(42)/A beta(40) ratio, which is typical of AD, had an inverse expression pattern of NEUROG2 and KIAA0125: An increased A beta(42)/A beta(40) ratio up-regulated NEUROG2, but down-regulated KIAA0125, whereas the opposite regulation pattern was observed for a decreased A beta(42)/A beta(40) ratio. We discuss the possibilities that the so far uncharacterized KIAA0125 might be a counter player of NEUROG2 and that KIAA0125 could be involved in neurogenesis, due to the involvement of NEUROG2 in developmental neural processes.			Uhrig, M (corresponding author), Univ Heidelberg, Ctr Mol Biol, ZMBH, D-6900 Heidelberg, Germany.	Tobias.Hartmann@Uniklinikum-Saarland.de	Hartmann, Tobias/AAB-8297-2022	Hartmann, Tobias/0000-0001-7481-6430				Altug-Teber O, 2007, CYTOGENET GENOME RES, V119, P171, DOI 10.1159/000112058; BIEDLER JL, 1978, CANCER RES, V38, P3751; DELAMONTE SM, 1995, AM J PATHOL, V147, P934; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Galichet C, 2008, DEVELOPMENT, V135, P2031, DOI 10.1242/dev.015115; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grimm HS, 2003, J BIOL CHEM, V278, P13077, DOI 10.1074/jbc.M210380200; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kempermann G, 2006, P NATL ACAD SCI USA, V103, P780, DOI 10.1073/pnas.0510291103; Koo BH, 2006, J BIOL CHEM, V281, P12485, DOI 10.1074/jbc.M511083200; Koo BH, 2007, J BIOL CHEM, V282, P16146, DOI 10.1074/jbc.M610161200; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Nagase T, 1995, DNA Res, V2, P167, DOI 10.1093/dnares/2.4.167; Nagase T., 1995, DNA RES, V2, P199; Pappachan J, 2008, ARCH DIS CHILD, V93, P890, DOI 10.1136/adc.2008.142836; ROSS RA, 1983, J NATL CANCER I, V71, P741; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SAWTELL NM, 1989, J CELL BIOL, V109, P2929, DOI 10.1083/jcb.109.6.2929; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Verret L, 2007, J NEUROSCI, V27, P6771, DOI 10.1523/JNEUROSCI.5564-06.2007; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wang CS, 2000, BRAIN RES, V865, P157, DOI 10.1016/S0006-8993(00)02183-1; Yamada H, 1999, HYPERTENSION, V33, P1414, DOI 10.1161/01.HYP.33.6.1414; Yan RT, 2001, P NATL ACAD SCI USA, V98, P15014, DOI 10.1073/pnas.261455698; YOUNKIN SG, 1995, ANN NEUROL, V37, P287, DOI 10.1002/ana.410370303; Zhang C, 2007, EXP NEUROL, V204, P77, DOI 10.1016/j.expneurol.2006.09.018	37	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6779	10.1371/journal.pone.0006779	http://dx.doi.org/10.1371/journal.pone.0006779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707560	Green Published, Green Submitted, gold			2022-12-25	WOS:000269335000022
J	Wada, T; Honda, M; Minami, I; Tooi, N; Amagai, Y; Nakatsuji, N; Aiba, K				Wada, Tamaki; Honda, Makoto; Minami, Itsunari; Tooi, Norie; Amagai, Yuji; Nakatsuji, Norio; Aiba, Kazuhiro			Highly Efficient Differentiation and Enrichment of Spinal Motor Neurons Derived from Human and Monkey Embryonic Stem Cells	PLOS ONE			English	Article								Background: There are no cures or efficacious treatments for severe motor neuron diseases. It is extremely difficult to obtain naive spinal motor neurons (sMNs) from human tissues for research due to both technical and ethical reasons. Human embryonic stem cells (hESCs) are alternative sources. Several methods for MN differentiation have been reported. However, efficient production of naive sMNs and culture cost were not taken into consideration in most of the methods. Methods/Principal Findings: We aimed to establish protocols for efficient production and enrichment of sMNs derived from pluripotent stem cells. Nestin+neural stem cell (NSC) clusters were induced by Noggin or a small molecule inhibitor of BMP signaling. After dissociation of NSC clusters, neurospheres were formed in a floating culture containing FGF2. The number of NSCs in neurospheres could be expanded more than 30-fold via several passages. More than 33% of HB9+ sMN progenitor cells were observed after differentiation of dissociated neurospheres by all-trans retinoic acid (ATRA) and a Shh agonist for another week on monolayer culture. HB9+ sMN progenitor cells were enriched by gradient centrifugation up to 80% purity. These HB9+ cells differentiated into electrophysiologically functional cells and formed synapses with myotubes during a few weeks after ATRA/SAG treatment. Conclusions and Significance: The series of procedures we established here, namely neural induction, NSC expansion, sMN differentiation and sMN purification, can provide large quantities of naive sMNs derived from human and monkey pluripotent stem cells. Using small molecule reagents, reduction of culture cost could be achieved.			Wada, T (corresponding author), Stem Cell & Drug Discovery Inst SCDI, Shimogyo Ku, Kyoto, Japan.	wada@scdi.or.jp; aiba@scdi.or.jp						Arce V, 1999, J NEUROSCI RES, V55, P119, DOI 10.1002/(SICI)1097-4547(19990101)55:1<119::AID-JNR13>3.3.CO;2-Y; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; BERG DK, 1978, J CELL BIOL, V77, P83, DOI 10.1083/jcb.77.1.83; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; CAMU W, 1994, J NEUROL SCI, V124, P73, DOI 10.1016/0022-510X(94)90185-6; CAMU W, 1992, J NEUROSCI METH, V44, P59, DOI 10.1016/0165-0270(92)90114-S; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chiba S, 2005, EXP BRAIN RES, V163, P86, DOI 10.1007/s00221-004-2148-y; Christou YA, 2007, NEUROPATH APPL NEURO, V33, P485, DOI 10.1111/j.1365-2990.2007.00883.x; Davidson KC, 2007, MOL CELL NEUROSCI, V36, P408, DOI 10.1016/j.mcn.2007.07.013; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; DIMOS JT, 2008, SCIENCE; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Erceg S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002122; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Gingras M, 2007, J NEUROSCI METH, V163, P111, DOI 10.1016/j.jneumeth.2007.02.024; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; Karumbayaram S, 2009, DIS MODEL MECH, V2, P189, DOI 10.1242/dmm.002113; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; Kuhn TB, 2003, METHOD CELL BIOL, V71, P67, DOI 10.1016/S0091-679X(03)01005-7; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; LI XJ, 2008, STEM CELLS; Marchant F, 2008, AM POETRY REV, V37, P3; MARTI E, 1995, DEVELOPMENT, V121, P2537; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Naka H, 2008, NAT NEUROSCI, V11, P1014, DOI 10.1038/nn.2168; Okada Y, 2008, STEM CELLS, V26, P3086, DOI 10.1634/stemcells.2008-0293; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Robertson MJ, 2008, FRONT BIOSCI-LANDMRK, V13, P21, DOI 10.2741/2558; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Roy NS, 2005, EXP NEUROL, V196, P224, DOI 10.1016/j.expneurol.2005.06.021; SCHNAAR RL, 1981, J NEUROSCI, V1, P204; Shan JF, 2005, BIOCHEMISTRY-US, V44, P15495, DOI 10.1021/bi0512602; Soundararajan P, 2007, STEM CELLS, V25, P1697, DOI 10.1634/stemcells.2006-0654; STRONG MJ, 1989, IN VITRO CELL DEV B, V25, P939; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; TANABE Y, 1995, CURR BIOL, V5, P651, DOI 10.1016/S0960-9822(95)00130-8; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Tropepe V, 1997, J NEUROSCI, V17, P7850; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang SC, 2008, PHILOS T R SOC B, V363, P87, DOI 10.1098/rstb.2006.2014	53	84	96	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2009	4	8							e6722	10.1371/journal.pone.0006722	http://dx.doi.org/10.1371/journal.pone.0006722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JF	19701462	Green Published, gold, Green Submitted			2022-12-25	WOS:000269268300006
J	Myette, JR; Soundararajan, V; Behr, J; Shriver, Z; Raman, R; Sasisekharan, R				Myette, James R.; Soundararajan, Venkataramanan; Behr, Jonathan; Shriver, Zachary; Raman, Rahul; Sasisekharan, Ram			Heparin/Heparan Sulfate N-Sulfamidase from Flavobacterium heparinum STRUCTURAL AND BIOCHEMICAL INVESTIGATION OF CATALYTIC NITROGEN-SULFUR BOND CLEAVAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; RECOMBINANT EXPRESSION; SUBSTRATE-SPECIFICITY; MOLECULAR-CLONING; ESCHERICHIA-COLI; BINDING SITES; PURIFICATION; GLYCOSAMINOGLYCANS; ARYLSULFATASE; PROTEOGLYCANS	Sulfated polysaccharides such as heparin and heparan sulfate glycosaminoglycans (HSGAGs) are chemically and structurally heterogeneous biopolymers that that function as key regulators of numerous biological functions. The elucidation of HSGAG fine structure is fundamental to understanding their functional diversity, and this is facilitated by the use of select degrading enzymes of defined substrate specificity. Our previous studies have reported the cloning, characterization, recombinant expression, and structure-function analysis in Escherichia coli of the Flavobacterium heparinum 2-O-sulfatase and 6-O-sulfatase enzymes that cleave O-sulfate groups from specific locations of the HSGAG polymer. Building on these preceding studies, we report here the molecular cloning and recombinant expression in Escherichia coli of an N-sulfamidase, specific for HSGAGs. In addition, we examine the basic enzymology of this enzyme through molecular modeling studies and structure-function analysis of substrate specificity and basic biochemistry. We use the results from these studies to propose a novel mechanism for nitrogen-sulfur bond cleavage by the N-sulfamidase. Taken together, our structural and biochemical studies indicate that N-sulfamidase is a predominantly exolytic enzyme that specifically acts on N-sulfated and 6-O-desulfated glucosamines present as monosaccharides or at the nonreducing end of odd-numbered oligosaccharide substrates. In conjunction with the previously reported specificities for the F. heparinum 2-O-sulfatase, 6-O-sulfatase, and unsaturated glucuronyl hydrolase, we are able to now reconstruct in vitro the defined exolytic sequence for the heparin and heparan sulfate degradation pathway of F. heparinum and apply these enzymes in tandem toward the exo-sequencing of heparin-derived oligosaccharides.	MIT, Harvard Mit Div Hlth Sci & Technol, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sasisekharan, R (corresponding author), 77 Massachusetts Ave,Rm 16-561, Cambridge, MA 02139 USA.	rams@mit.edu			National Institutes of Health [GM57073]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057073, R01GM057073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM57073.	Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BEIL S, 1995, EUR J BIOCHEM, V229, P385, DOI 10.1111/j.1432-1033.1995.0385k.x; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Boltes I, 2001, STRUCTURE, V9, P483, DOI 10.1016/S0969-2126(01)00609-8; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; BRUCE JS, 1985, EUR J BIOCHEM, V148, P359, DOI 10.1111/j.1432-1033.1985.tb08847.x; CHEN FTA, 1995, ANAL BIOCHEM, V230, P273, DOI 10.1006/abio.1995.1474; Dierks T, 1998, J BIOL CHEM, V273, P25560, DOI 10.1074/jbc.273.40.25560; DIETRICH CP, 1973, J BIOL CHEM, V248, P6408; Ernst S, 1996, BIOCHEM J, V315, P589, DOI 10.1042/bj3150589; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW100, DOI 10.1093/nar/gkh464; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Hankin DM, 1996, J CHEM SOC DALTON, P4063, DOI 10.1039/dt9960004063; Hanson SR, 2004, ANGEW CHEM INT EDIT, V43, P5736, DOI 10.1002/anie.200300632; Kertesz MA, 2000, FEMS MICROBIOL REV, V24, P135, DOI 10.1016/S0168-6445(99)00033-9; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; LINDAHL U, 1980, P NATL ACAD SCI-BIOL, V77, P6551, DOI 10.1073/pnas.77.11.6551; Liu J, 2002, J BIOL CHEM, V277, P33456, DOI 10.1074/jbc.M202034200; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Myette JR, 2009, J BIOL CHEM, V284, P35177, DOI 10.1074/jbc.M109.053801; Myette JR, 2003, J BIOL CHEM, V278, P12157, DOI 10.1074/jbc.M211420200; Myette JR, 2002, BIOCHEMISTRY-US, V41, P7424, DOI 10.1021/bi012147o; NAKAMURA T, 1988, J CLIN MICROBIOL, V26, P1070, DOI 10.1128/JCM.26.5.1070-1071.1988; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Prince JM, 2002, DEV DYNAM, V223, P497, DOI 10.1002/dvdy.10070; Raman R, 2003, J BIOL CHEM, V278, P12167, DOI 10.1074/jbc.M211425200; Rhomberg AJ, 1998, P NATL ACAD SCI USA, V95, P4176, DOI 10.1073/pnas.95.8.4176; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Sasisekharan R, 1996, J BIOL CHEM, V271, P3124, DOI 10.1074/jbc.271.6.3124; SASISEKHARAN R, 1995, BIOCHEMISTRY-US, V34, P14441, DOI 10.1021/bi00044a022; Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745; Shriver Z, 1999, J BIOL CHEM, V274, P4082, DOI 10.1074/jbc.274.7.4082; Venkataraman G, 1999, SCIENCE, V286, P537, DOI 10.1126/science.286.5439.537; Vives RR, 2006, CURR GENE THER, V6, P35, DOI 10.2174/156652306775515565	37	17	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35189	35200		10.1074/jbc.M109.053835	http://dx.doi.org/10.1074/jbc.M109.053835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19726673	Green Published, hybrid			2022-12-25	WOS:000272439600072
J	Romano, SA; Cordeiro, Y; Lima, LMTR; Lopes, MH; Silva, JL; Foguel, D; Linden, R				Romano, Sebastian A.; Cordeiro, Yraima; Lima, Luis Mauricio T. R.; Lopes, Marilene H.; Silva, Jerson L.; Foguel, Debora; Linden, Rafael			Reciprocal remodeling upon binding of the prion protein to its signaling partner hop/STI1	FASEB JOURNAL			English	Article						GPI-anchored proteins; multiprotein complexes; structural modifications; trophic signals; SAXS	STRESS-INDUCIBLE PROTEIN-1; SMALL-ANGLE SCATTERING; CO-CHAPERONE HOP; CELLULAR PRION; TETRATRICOPEPTIDE REPEAT; MOLECULAR CHAPERONE; X-RAY; DOMAIN; COMPLEXES; HSP90	The glycosylphosphatidylinositol (GPI)anchored prion protein (PrPC), usually associated with neurodegenerative diseases, modulates various cellular responses and may scaffold multiprotein cell surface signaling complexes. Engagement of PrPC with the secret-able cochaperone hop/STI1 induces neurotrophic transmembrane signals through unknown molecular mechanisms. We addressed whether interaction of PrPC and hop/STI1 entails structural rearrangements relevant for signaling. Using recombinant wild-type and mutant mouse proteins and binding peptides, we measured circular dichroism (CD), fluorescence spectroscopy, and small angle X-ray scattering (SAXS). PrPC: hop/STI1 interaction triggers loss of PrP helical structures, involving at least a perturbation of the PrP143-153 alpha-helix, but no secondary structural modification of hop/STI1 was detected. Novel SAXS models revealed a significant C-terminal compaction of hop/STI1 when bound to PrP. Differing from a recent dimeric model of human hop/STI1, both size-exclusion chromatography and SAXS data support a monomeric form of free murine hop/STI1. Changes in the PrP143-153 alpha-helix may engage the transmembrane signaling proteins laminin receptor precursor and neural cell adhesion molecule, both of which bind that domain of PrPC, and further ligands may be engaged by the tertiary structural changes of hop/STI1. These reciprocal structural modifications indicate a versatile mechanism for signaling mediated by PrPC: hop/STI1 interaction, consistent with the hypothesis of PrPC-dependent multiprotein signaling complexes.-Romano, S. A., Cordeiro, Y., Lima, L. M. T. R., Lopes, M. H., Silva, J. L., Foguel, D., Linden, R. Reciprocal remodeling upon binding of the prion protein to its signaling partner hop/STI1. FASEB J. 23, 4308-4316 (2009). www.fasebj.org	[Romano, Sebastian A.; Linden, Rafael] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Cordeiro, Yraima; Lima, Luis Mauricio T. R.] Univ Fed Rio de Janeiro, Fac Farm, BR-21941 Rio De Janeiro, Brazil; [Silva, Jerson L.; Foguel, Debora] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941 Rio De Janeiro, Brazil; [Lopes, Marilene H.] Ludwig Inst Canc Res, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Ludwig Institute for Cancer Research	Linden, R (corresponding author), UFRJ, CCS, Inst Biofis, Bloco G,Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil.	rlinden@biof.ufrj.br	Silva, Jerson/J-8984-2014; Lopes, Marilene/GLV-4734-2022; Lima, Luis Mauricio/AAL-2098-2021; Linden, Rafael/F-2275-2011; Neurociencia, Inct/I-1011-2013; Cordeiro, Yraima/J-7619-2012; SILVA, JERSON Lima/GRF-1442-2022	Silva, Jerson/0000-0001-9523-9441; Lopes, Marilene/0000-0003-2496-0674; Linden, Rafael/0000-0003-3287-336X; Cordeiro, Yraima/0000-0003-4278-212X; SILVA, JERSON Lima/0000-0001-9523-9441; Foguel, Debora/0000-0001-7312-7115; TR Lima, Luis Mauricio/0000-0001-6020-0504; Romano, Sebastian/0000-0002-1430-4633	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [472741/2007-1, 486489/2006-0, 420036/2005-9, 410554/2006-5, 151567/2004-2, 480986/2004-5, 420015/2005-1, 472174/2007-0, IMBEBB 42.0120/2005-0]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ) [APQ1-E-26/170.406/2006]; Brazilian Synchrotron Light Laboratory [D11A-SAS1 7690/08]; FAPESP [03/13189-2]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian Synchrotron Light Laboratory; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	We thank Dr. Tomas S. Plivelic, Dr. Fernando Q. Reis, and Dr. Lucas Sanfelici for excellent technical assistance with the LNLS beamline and Talita M. Oliveira for assistance on purification of STI1. This research was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq 472741/2007-1, 486489/2006-0, 420036/2005-9, 410554/2006-5, 151567/2004-2, 480986/2004-5, 420015/2005-1, 472174/2007-0; IMBEBB 42.0120/2005-0); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ APQ1-E-26/170.406/2006, PRONEX and CNE Programs); Brazilian Synchrotron Light Laboratory (LNLS; D11A-SAS1 7690/08); and FAPESP 03/13189-2.	Americo TA, 2007, BIOCHEM BIOPH RES CO, V358, P620, DOI 10.1016/j.bbrc.2007.04.202; ARRUDACARVALHO M, 2007, BIOCHEM BIOPH RES CO, V358, P620; Baumann F, 2007, EMBO J, V26, P538, DOI 10.1038/sj.emboj.7601510; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bray D, 2004, ANNU REV BIOPH BIOM, V33, P53, DOI 10.1146/annurev.biophys.33.110502.132703; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; Carrigan PE, 2004, J BIOL CHEM, V279, P16185, DOI 10.1074/jbc.M314130200; Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324; Christen B, 2009, J MOL BIOL, V389, P833, DOI 10.1016/j.jmb.2009.04.040; Collins SJ, 2004, LANCET, V363, P51, DOI 10.1016/S0140-6736(03)15171-9; Cordeiro Y, 2004, J BIOL CHEM, V279, P5346, DOI 10.1074/jbc.M312262200; Erlich RB, 2007, GLIA, V55, P1690, DOI 10.1002/glia.20579; Eustace BK, 2004, CELL CYCLE, V3, P1098; Flom G, 2007, BIOCHEM J, V404, P159, DOI 10.1042/BJ20070084; Glatter O., 1982, SMALL ANGLE XRAY SCA, P119; Golbik R, 1998, J MOL BIOL, V276, P505, DOI 10.1006/jmbi.1997.1538; Gomes AMO, 2003, BIOCHEMISTRY-US, V42, P5540, DOI 10.1021/bi027207k; Hernandez MP, 2002, J BIOL CHEM, V277, P38294, DOI 10.1074/jbc.M206566200; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; Lee KS, 2003, REV MED VIROL, V13, P399, DOI 10.1002/rmv.408; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Lima LMTR, 2004, J BIOL CHEM, V279, P47968, DOI 10.1074/jbc.M407696200; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Lu BY, 2001, EUR J BIOCHEM, V268, P3767, DOI 10.1046/j.1432-1327.2001.02283.x; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Matozo HC, 2007, BIOPHYS J, V92, P4424, DOI 10.1529/biophysj.106.094961; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; Odunuga OO, 2004, BIOESSAYS, V26, P1058, DOI 10.1002/bies.20107; Onuoha SC, 2008, J MOL BIOL, V379, P732, DOI 10.1016/j.jmb.2008.02.013; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; ROSEN CG, 1969, BIOCHEMISTRY-US, V8, P3915, DOI 10.1021/bi00838a006; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Lima LMTR, 2006, BIOCHEMISTRY-US, V45, P9180, DOI 10.1021/bi060532d; van der Spuy J, 2001, PROTEIN EXPRES PURIF, V21, P462, DOI 10.1006/prep.2001.1399; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Whitty A, 2008, NAT CHEM BIOL, V4, P435, DOI 10.1038/nchembio0808-435; WU S, 2007, NUCLEIC ACIDS RES, V35, P3357; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325	52	19	19	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4308	4316		10.1096/fj.09-138974	http://dx.doi.org/10.1096/fj.09-138974			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19703931				2022-12-25	WOS:000272193700025
J	Baum, N; Schiene-Fischer, C; Frost, M; Schumann, M; Sabapathy, K; Ohlenschlager, O; Grosse, F; Schlott, B				Baum, N.; Schiene-Fischer, C.; Frost, M.; Schumann, M.; Sabapathy, K.; Ohlenschlaeger, O.; Grosse, F.; Schlott, B.			The prolyl cis/trans isomerase cyclophilin 18 interacts with the tumor suppressor p53 and modifies its functions in cell cycle regulation and apoptosis	ONCOGENE			English	Article						apoptosis; cell cycle; cyclosporin; genetic polymorphism; peptidyl-prolyl cis/trans isomerization	CIS-TRANS ISOMERASE; DEPENDENT PROLINE ISOMERIZATION; CYCLOSPORINE-A; LUNG-CANCER; POLYMORPHIC VARIANTS; DNA-DAMAGE; WILD-TYPE; PIN1; PROTEIN; CATALYSIS	The functional diversity of the tumor suppressor protein p53 is mainly regulated by protein interactions. In this study, we describe a new interaction with the peptidylprolyl cis/trans isomerase cyclophilin 18 (Cyp18). The interaction reduced the sequence-specific DNA binding of p53 in vitro, whereas the inhibition of the interaction increased p53-reporter gene activity in vivo. The active site of the folding helper enzyme Cyp18 was directly involved in binding. The proline-rich region (amino acids 64-91) of p53 was most likely responsible for the observed binding because a synthetic peptide comprising amino acids 68-81 of p53 inhibited this interaction, and a p53 variant containing a proline residue at position 72 (p53(P72)) interacted with Cyp18 more effectively than the corresponding p53(R72) variant. Impairment of the Cyp18-p53 interaction induced an accumulation of cells in the G2/M phase of the cell cycle, which was more pronounced when p53(P72) was expressed compared with p53(R72) in an otherwise isogenic cellular background. Moreover, p53-dependent apoptosis was elevated in Cyp18 knockout cells, suggesting an antiapoptotic potential of Cyp18-p53 complexes. Functional in vivo data hint to a possible clinical relevance of the p53-Cyp18 interaction observed. Oncogene (2009) 28, 3915-3925; doi:10.1038/onc.2009.248; published online 31 August 2009	[Schlott, B.] Leibniz Inst Age Res, Fritz Lipmann Inst, Biochem Grp, Dept Biochem, D-07745 Jena, Thuringia, Germany; [Schiene-Fischer, C.; Frost, M.; Schumann, M.] Max Planck Res Unit Prot Folding, Halle, Saale, Germany; [Sabapathy, K.] Natl Canc Ctr, Div Cellular & Mol Res, Mol Carcinogenesis Lab, Singapore, Singapore; [Ohlenschlaeger, O.] Leibniz Inst Age Res, Dept NMR, D-07745 Jena, Thuringia, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Max Planck Society; National Cancer Centre Singapore (NCCS); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Schlott, B (corresponding author), Leibniz Inst Age Res, Fritz Lipmann Inst, Biochem Grp, Dept Biochem, Beutenbergstr 11, D-07745 Jena, Thuringia, Germany.	bschlott@fli-leibniz.de		Ohlenschlaeger, Oliver/0000-0002-6428-4423	Deutsche Forschungsgemeinschaft [GK1026, SFB604]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft grant GK1026 (to CS-F) and SFB604 (to Gunter Fischer, Halle, and FG). The technical assistance of Mrs Anita Willitzer is acknowledged. Jurkat cells were kindly provided by J Luban (Columbia University, New York).	Akakura S, 2001, J BIOL CHEM, V276, P14649, DOI 10.1074/jbc.M100200200; Albrechtsen N, 1999, ONCOGENE, V18, P7706, DOI 10.1038/sj.onc.1202952; Arevalo-Rodriguez M, 2000, EMBO J, V19, P3739, DOI 10.1093/emboj/19.14.3739; Bauerschmidt C, 2007, GENES CELLS, V12, P745, DOI 10.1111/j.1365-2443.2007.01090.x; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Braaten D, 2001, EMBO J, V20, P1300, DOI 10.1093/emboj/20.6.1300; Choi KJ, 2007, CANCER RES, V67, P3654, DOI 10.1158/0008-5472.CAN-06-1759; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Fanghanel J, 2003, ANGEW CHEM INT EDIT, V42, P490, DOI 10.1002/anie.200390149; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; HARDING MW, 1986, J BIOL CHEM, V261, P8547; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P1684, DOI 10.1021/bi00459a003; Herman M, 2001, J LAB CLIN MED, V137, P14, DOI 10.1067/mlc.2001.111469; Howard BA, 2005, CANCER RES, V65, P8853, DOI 10.1158/0008-5472.CAN-05-1219; Howard BA, 2004, LUNG CANCER, V46, P313, DOI 10.1016/j.lungcan.2004.05.013; Hsu T, 2001, NAT CELL BIOL, V3, P538, DOI 10.1038/35078508; Jensen P, 1999, J AM ACAD DERMATOL, V40, P177, DOI 10.1016/S0190-9622(99)70185-4; Johnson MD, 1999, J NEUROSCI, V19, P2996; King FW, 2001, EMBO J, V20, P6297, DOI 10.1093/emboj/20.22.6297; LAMB P, 1986, MOL CELL BIOL, V6, P1379, DOI 10.1128/MCB.6.5.1379; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; LARSSON R, 1991, ANTICANCER RES, V11, P455; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Liu WF, 2001, FEBS LETT, V496, P105, DOI 10.1016/S0014-5793(01)02411-5; Ma L, 2005, P NATL ACAD SCI USA, V102, P14266, DOI 10.1073/pnas.0501352102; MARKS WH, 1991, TRANSPLANTATION, V52, P340, DOI 10.1097/00007890-199108000-00030; MATLASHEWSKI GJ, 1987, MOL CELL BIOL, V7, P961, DOI 10.1128/MCB.7.2.961; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; PRICE ER, 1994, P NATL ACAD SCI USA, V91, P3931, DOI 10.1073/pnas.91.9.3931; Pyrzynska B, 2002, J BIOL CHEM, V277, P14102, DOI 10.1074/jbc.M104443200; Rey O, 1999, ONCOGENE, V18, P827, DOI 10.1038/sj.onc.1202328; Rippmann JF, 2000, CELL GROWTH DIFFER, V11, P409; Ross HJ, 1997, LUNG CANCER-J IASLC, V18, P189, DOI 10.1016/S0169-5002(97)00061-5; Scheibel T, 1998, BIOCHEM PHARMACOL, V56, P675, DOI 10.1016/S0006-2952(98)00120-8; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siddique M, 2006, ONCOGENE, V25, P3489, DOI 10.1038/sj.onc.1209405; Soe K, 2002, ONCOGENE, V21, P6614, DOI 10.1038/sj.onc.1205912; Taylor WR, 1999, MOL BIOL CELL, V10, P3607, DOI 10.1091/mbc.10.11.3607; Thomas M, 1999, MOL CELL BIOL, V19, P1092; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Whitesell L, 1998, MOL CELL BIOL, V18, P1517, DOI 10.1128/MCB.18.3.1517; Wulf G, 2003, BREAST CANCER RES, V5, P76, DOI 10.1186/bcr572; Wulf GM, 2002, J BIOL CHEM, V277, P47976, DOI 10.1074/jbc.C200538200; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; YANG WM, 1995, J BIOL CHEM, V270, P15187, DOI 10.1074/jbc.270.25.15187; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116; Zylicz M, 2001, EMBO J, V20, P4634, DOI 10.1093/emboj/20.17.4634	52	29	29	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2009	28	44					3915	3925		10.1038/onc.2009.248	http://dx.doi.org/10.1038/onc.2009.248			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	515LJ	19718045				2022-12-25	WOS:000271471900006
J	Giannakis, M; Backhed, HK; Chen, SL; Faith, JJ; Wu, M; Guruge, JL; Engstrand, L; Gordon, JI				Giannakis, Marios; Backhed, Helene Kling; Chen, Swaine L.; Faith, Jeremiah J.; Wu, Meng; Guruge, Janaki L.; Engstrand, Lars; Gordon, Jeffrey I.			Response of Gastric Epithelial Progenitors to Helicobacter pylori Isolates Obtained from Swedish Patients with Chronic Atrophic Gastritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEINS; GENE-EXPRESSION; POSITIVE SELECTION; ESCHERICHIA-COLI; COMPARATIVE GENOMICS; PHASE VARIATION; STEM-CELLS; CANCER; INFECTION; COLONIZATION	Helicobacter pylori infection is associated with gastric adenocarcinoma in some humans, especially those that develop an antecedent condition, chronic atrophic gastritis (ChAG). Gastric epithelial progenitors (GEPs) in transgenic gnotobiotic mice with a ChAG-like phenotype harbor intracellular collections of H. pylori. To characterize H. pylori adaptations to ChAG, we sequenced the genomes of 24 isolates obtained from 6 individuals, each sampled over a 4-year interval, as they did or did not progress from normal gastric histology to ChAG and/or adenocarcinoma. H. pylori populations within study participants were largely clonal and remarkably stable regardless of disease state. GeneChip studies of the responses of a cultured mouse gastric stem cell-like line (mGEPs) to infection with sequenced strains yielded a 695-member dataset of transcripts that are (i) differentially expressed after infection with ChAG-associated isolates, but not with a "normal" or a heat-killed ChAG isolate, and (ii) enriched in genes and gene functions associated with tumorigenesis in general and gastric carcinogenesis in specific cases. Transcriptional profiling of a ChAG strain during mGEP infection disclosed a set of responses, including up-regulation of hopZ, an adhesin belonging to a family of outer membrane proteins. Expression profiles of wild-type and Delta hopZ strains revealed a number of pH-regulated genes modulated by HopZ, including hopP, which binds sialylated glycans produced by GEPs in vivo. Genetic inactivation of hopZ produced a fitness defect in the stomachs of gnotobiotic transgenic mice but not in wild-type littermates. This study illustrates an approach for identifying GEP responses specific to ChAG-associated H. Pylori strains and bacterial genes important for survival in a model of the ChAG gastric ecosystem.	[Giannakis, Marios; Backhed, Helene Kling; Chen, Swaine L.; Faith, Jeremiah J.; Wu, Meng; Guruge, Janaki L.; Gordon, Jeffrey I.] Washington Univ, Ctr Genome Sci, St Louis, MO 63108 USA; [Chen, Swaine L.] Washington Univ, Dept Mol Microbiol, St Louis, MO 63108 USA; [Backhed, Helene Kling; Engstrand, Lars] Smittskyddsinst, Swedish Inst Infect Dis Control, S-17182 Solna, Sweden; [Backhed, Helene Kling; Engstrand, Lars] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden	Washington University (WUSTL); Washington University (WUSTL); Swedish Institute for Infectious Disease Control; Karolinska Institutet	Gordon, JI (corresponding author), 4444 Forest Pk Blvd,Campus Box 8510, St Louis, MO 63108 USA.	jgordon@wustl.edu	Wu, Meng/P-9657-2019; Giannakis, Marios/Z-4908-2019	Chen, Swaine/0000-0002-0107-2861	National Institutes of Health [DK58529, DK52574, DK081620, DK64540]; Swedish Cancer Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058529, P50DK064540, K01DK081620, P30DK052574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Cancer Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK58529, DK52574, DK081620, and DK64540 and the Swedish Cancer Foundation.	Aanensen DM, 2005, NUCLEIC ACIDS RES, V33, pW728, DOI 10.1093/nar/gki415; Ang S, 2001, INFECT IMMUN, V69, P1679, DOI 10.1128/IAI.69.3.1679-1686.2001; Appelmelk BJ, 2000, INFECT IMMUN, V68, P5928, DOI 10.1128/IAI.68.10.5928-5932.2000; Appelmelk BJ, 1999, INFECT IMMUN, V67, P5361, DOI 10.1128/IAI.67.10.5361-5366.1999; Aras RA, 2002, NUCLEIC ACIDS RES, V30, P5391, DOI 10.1093/nar/gkf686; Aro P, 2004, SCAND J GASTROENTERO, V39, P1280, DOI 10.1080/00365520410008141; Backstrom A, 2004, P NATL ACAD SCI USA, V101, P16923, DOI 10.1073/pnas.0404817101; Baudin E, 1998, BRIT J CANCER, V78, P1102, DOI 10.1038/bjc.1998.635; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder BR, 2008, IMMUNOL LETT, V118, P116, DOI 10.1016/j.imlet.2008.03.017; Blaser MJ, 2007, NATURE, V449, P843, DOI 10.1038/nature06198; Blaser MJ, 1999, P NATL ACAD SCI USA, V96, P8359, DOI 10.1073/pnas.96.15.8359; BLASER MJ, 1994, J CLIN INVEST, V94, P4, DOI 10.1172/JCI117336; Bury-Mone S, 2004, MOL MICROBIOL, V53, P623, DOI 10.1111/j.1365-2958.2004.04137.x; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Chen Y, 2007, ARCH INTERN MED, V167, P821, DOI 10.1001/archinte.167.8.821; Cosgrove EJ, 2008, BIOINFORMATICS, V24, P2482, DOI 10.1093/bioinformatics/btn476; Davids W, 2002, J MOL EVOL, V54, P458, DOI 10.1007/s00239-001-0029-6; de Jonge R, 2004, J MED MICROBIOL, V53, P375, DOI 10.1099/jmm.0.45551-0; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Enroth H, 2000, CANCER EPIDEM BIOMAR, V9, P981; FERRERO RL, 1992, J BACTERIOL, V174, P4212, DOI 10.1128/JB.174.13.4212-4217.1992; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Giannakis M, 2008, P NATL ACAD SCI USA, V105, P4358, DOI 10.1073/pnas.0800668105; Hamajima N, 2006, CANCER SCI, V97, P1129, DOI 10.1111/j.1349-7006.2006.00290.x; Holtmann G, 2004, J GASTROENTEROL, V39, P1027, DOI 10.1007/s00535-004-1440-8; Hooper LV, 2002, METHOD MICROBIOL, V31, P559, DOI 10.1016/S0580-9517(02)31030-4; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Keates AC, 2008, INFECT IMMUN, V76, P3992, DOI 10.1128/IAI.00584-08; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Lee HS, 2003, J PATHOL, V200, P39, DOI 10.1002/path.1288; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lundin A, 2005, INFECT IMMUN, V73, P4818, DOI 10.1128/IAI.73.8.4818-4822.2005; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Merrell DS, 2003, INFECT IMMUN, V71, P3529, DOI 10.1128/IAI.71.6.3529-3539.2003; Miao XP, 2007, WORLD J GASTROENTERO, V13, P2867, DOI 10.3748/wjg.v13.i20.2867; Necchi V, 2007, GASTROENTEROLOGY, V132, P1009, DOI 10.1053/j.gastro.2007.01.049; Oh JD, 2005, P NATL ACAD SCI USA, V102, P5186, DOI 10.1073/pnas.0407657102; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; Owen RJ, 2003, J MED MICROBIOL, V52, P515, DOI 10.1099/jmm.0.04988-0; Peck B, 1999, NUCLEIC ACIDS RES, V27, P3325, DOI 10.1093/nar/27.16.3325; Petersen L, 2007, GENOME RES, V17, P1336, DOI 10.1101/gr.6254707; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rokkas T, 2007, CLIN GASTROENTEROL H, V5, P1413, DOI 10.1016/j.cgh.2007.08.010; Roth C, 2005, NUCLEIC ACIDS RES, V33, pD495, DOI 10.1093/nar/gki090; Salama N, 2000, P NATL ACAD SCI USA, V97, P14668, DOI 10.1073/pnas.97.26.14668; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Skoglund A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005885; Storskrubb T, 2005, SCAND J GASTROENTERO, V40, P302, DOI 10.1080/00365520410010625; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Syder AJ, 1999, MOL CELL, V3, P263, DOI 10.1016/S1097-2765(00)80454-2; Takeno A, 2008, BRIT J CANCER, V99, P1307, DOI 10.1038/sj.bjc.6604682; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turner KME, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-30; Wang G, 1999, MOL MICROBIOL, V31, P1265, DOI 10.1046/j.1365-2958.1999.01268.x; Xu Q, 2000, P NATL ACAD SCI USA, V97, P9671, DOI 10.1073/pnas.97.17.9671; Yamaoka Y, 2002, GASTROENTEROLOGY, V123, P1992, DOI 10.1053/gast.2002.37074; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Ye WM, 2004, JNCI-J NATL CANCER I, V96, P388, DOI 10.1093/jnci/djh057; Yoshida M, 2004, J BIOL CHEM, V279, P46008, DOI 10.1074/jbc.M404393200; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	65	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30383	30394		10.1074/jbc.M109.052738	http://dx.doi.org/10.1074/jbc.M109.052738			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19723631	Green Published, hybrid			2022-12-25	WOS:000271090000041
J	Licht, A; Brantl, S				Licht, Andreas; Brantl, Sabine			The Transcriptional Repressor CcpN from Bacillus subtilis Uses Different Repression Mechanisms at Different Promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI RNA-POLYMERASE; ESCHERICHIA-COLI; ALPHA-SUBUNIT; GLUCONEOGENIC GENES; SIGMA-FACTOR; PROTEIN P4; BINDING; ACTIVATION; INHIBITION; INITIATION	CcpN, a transcriptional repressor from Bacillus subtilis that is responsible for the carbon catabolite repression of three genes, has been characterized in detail in the past 4 years. However, nothing is known about the actual repression mechanism as yet. Here, we present a detailed study on how CcpN exerts its repression effect at its three known target promoters of the genes sr1, pckA, and gapB. Using gel shift assays under non-repressive and repressive conditions, we showed that CcpN and RNA polymerase can bind simultaneously and that CcpN does not prevent RNA polymerase (RNAP) binding to the promoter. Furthermore, we investigated the effect of CcpN on open complex formation and demonstrate that CcpN also does not act at this step of transcription initiation at the sr1 and pckA and presumably at the gapB promoter. Investigation of abortive transcript synthesis revealed that CcpN acts differently at the three promoters: At the sr1 and pckA promoter, promoter clearance is impeded by CcpN, whereas synthesis of abortive transcripts is repressed at the gapB promoter. Eventually, we demonstrated with Far Western blots and co-elution experiments that CcpN is able to interact with the RNAP alpha-subunit, which completes the picture of the requirements for the repressive action of CcpN. On the basis of the presented results, we propose a new working model for CcpN action.	[Licht, Andreas; Brantl, Sabine] Univ Jena, Arbeitsgrp Bakteriengenet, D-07743 Jena, Germany	Friedrich Schiller University of Jena	Licht, A (corresponding author), Philosophenweg 12, D-07743 Jena, Germany.	andreas.licht@uni-jena.de			Deutsche Forschungsgemeinschaft [BR1552/6-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grant BR1552/6-3 from the Deutsche Forschungsgemeinschaft (to S. B.).	Barragan MJL, 2005, J BIOL CHEM, V280, P10683, DOI 10.1074/jbc.M412259200; Campbell EA, 2008, CURR OPIN MICROBIOL, V11, P121, DOI 10.1016/j.mib.2008.02.016; CHOY HE, 1995, EMBO J, V14, P4523, DOI 10.1002/j.1460-2075.1995.tb00131.x; COLLADOVIDES J, 1991, MICROBIOL REV, V55, P371, DOI 10.1128/MMBR.55.3.371-394.1991; ELLINGER T, 1994, J MOL BIOL, V239, P466, DOI 10.1006/jmbi.1994.1389; Escolar L, 1998, J BACTERIOL, V180, P2579, DOI 10.1128/JB.180.9.2579-2582.1998; Fillinger S, 2000, J BIOL CHEM, V275, P14031, DOI 10.1074/jbc.275.19.14031; Fujita M, 1998, J BIOCHEM, V124, P89, DOI 10.1093/oxfordjournals.jbchem.a022102; Fujita M, 1998, GENE, V221, P185, DOI 10.1016/S0378-1119(98)00452-1; Gourse RL, 2000, MOL MICROBIOL, V37, P687, DOI 10.1046/j.1365-2958.2000.01972.x; Greene EA, 1996, J BIOL CHEM, V271, P11455, DOI 10.1074/jbc.271.19.11455; HELTZEL A, 1990, BIOCHEMISTRY-US, V29, P9572, DOI 10.1021/bi00493a011; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; Ilag LL, 2004, STRUCTURE, V12, P269, DOI 10.1016/j.str.2004.01.007; KAWAMURA F, 1984, J BACTERIOL, V160, P442, DOI 10.1128/JB.160.1.442-444.1984; Kim JH, 2005, MOL MICROBIOL, V56, P155, DOI 10.1111/j.1365-2958.2005.04496.x; Licht A, 2005, MOL MICROBIOL, V58, P189, DOI 10.1111/j.1365-2958.2005.04810.x; Licht A, 2006, J MOL BIOL, V364, P434, DOI 10.1016/j.jmb.2006.09.021; Lopez PJ, 1998, J MOL BIOL, V276, P861, DOI 10.1006/jmbi.1997.1576; Lucht A, 2008, J MOL BIOL, V380, P17, DOI 10.1016/j.jmb.2008.05.002; Meijer WJJ, 2004, NUCLEIC ACIDS RES, V32, P1166, DOI 10.1093/nar/gkh290; Monsalve M, 1996, EMBO J, V15, P383, DOI 10.1002/j.1460-2075.1996.tb00368.x; Monsalve M, 1996, P NATL ACAD SCI USA, V93, P8913, DOI 10.1073/pnas.93.17.8913; RECORD MT, 1996, ESCHERICHIA COLI SAL; Rojo F, 2001, CURR OPIN MICROBIOL, V4, P145, DOI 10.1016/S1369-5274(00)00180-6; Schneider R, 1999, MOL MICROBIOL, V34, P953, DOI 10.1046/j.1365-2958.1999.01656.x; SCHOLTEN PM, 1986, NUCLEIC ACIDS RES, V14, P3981, DOI 10.1093/nar/14.10.3981; Schroder O, 2000, J MOL BIOL, V298, P737, DOI 10.1006/jmbi.2000.3708; Servant P, 2005, MOL MICROBIOL, V55, P1435, DOI 10.1111/j.1365-2958.2005.04473.x; Severinova E, 1998, J MOL BIOL, V279, P9, DOI 10.1006/jmbi.1998.1742; Shah IM, 2004, J MOL BIOL, V343, P513, DOI 10.1016/j.jmb.2004.08.057; SUMMERS AO, 1992, J BACTERIOL, V174, P3097, DOI 10.1128/jb.174.10.3097-3101.1992; Tannler S, 2008, J BACTERIOL, V190, P6178, DOI 10.1128/JB.00552-08; Tannler S, 2008, METAB ENG, V10, P216, DOI 10.1016/j.ymben.2008.06.002; Turinsky AJ, 1998, J BACTERIOL, V180, P5961, DOI 10.1128/JB.180.22.5961-5967.1998; Ujiie H, 2009, J BIOCHEM, V145, P59, DOI 10.1093/jb/mvn143; WAGNER R, 2000, TRANSCRIPTIONAL REGU; WILLIAMS DR, 1993, NUCLEIC ACIDS RES, V21, P1141, DOI 10.1093/nar/21.5.1141; Yoshida K, 2001, NUCLEIC ACIDS RES, V29, P683, DOI 10.1093/nar/29.3.683; Zhang Y, 2006, J BACTERIOL, V188, P4300, DOI 10.1128/JB.00220-06; Zorrilla S, 2008, BIOPHYS J, V95, P4403, DOI 10.1529/biophysj.108.135863	41	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30032	30038		10.1074/jbc.M109.033076	http://dx.doi.org/10.1074/jbc.M109.033076			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726675	hybrid, Green Published			2022-12-25	WOS:000271090000005
J	Peng, GD; Han, M; Du, YM; Lin, AN; Yu, L; Zhang, YQ; Jing, NH				Peng, Guangdun; Han, Mei; Du, Yimin; Lin, Anning; Yu, Lei; Zhang, Yuqiu; Jing, Naihe			SIP30 Is Regulated by ERK in Peripheral Nerve Injury-induced Neuropathic Pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC CONSTRICTION INJURY; PRIMARY SENSORY NEURONS; TRANSCRIPTION FACTOR CREB; PROTEIN-KINASE CASCADE; DORSAL-HORN NEURONS; SPINAL-CORD-INJURY; SCIATIC-NERVE; MECHANICAL ALLODYNIA; INFLAMMATORY PAIN; GROWTH-FACTOR	ERK plays an important role in chronic neuropathic pain. However, the underlying mechanism is largely unknown. Here we show that in chronic constriction injury-treated rat spinal cords, up-regulation of SIP30 (SNAP25-interacting protein 30), which is involved in the development and maintenance of chronic constriction injury-induced neuropathic pain, correlates with ERK activation and that the up-regulation of SIP30 is suppressed by intrathecal delivery of the MEK inhibitor U0126. In PC12 cells, up-regulation of SIP30 by nerve growth factor is also dependent on ERK activation. We found that there is an ERK-responsive region in the rat sip30 promoter. Activation of ERK promotes the recruitment of the transcription factor cyclic AMP-response element-binding protein to the sip30 gene promoter. Taken together, our results provide a potential downstream target of ERK activation-mediated neuropathic pain.	[Han, Mei; Zhang, Yuqiu] Fudan Univ, Inst Brain Sci, Inst Neurobiol, Shanghai 200032, Peoples R China; [Han, Mei; Zhang, Yuqiu] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China; [Peng, Guangdun; Jing, Naihe] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Mol Cell Biol Lab, Shanghai 200031, Peoples R China; [Du, Yimin] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Lin, Anning] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Yu, Lei] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Yu, Lei] Rutgers State Univ, Ctr Alcohol Studies, Piscataway, NJ 08854 USA	Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; University of Chicago; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Zhang, YQ (corresponding author), Fudan Univ, Inst Brain Sci, Inst Neurobiol, Shanghai 200032, Peoples R China.	yuqiuzhang@fudan.edu.cn; njing@sibs.ac.cn	Peng, Guangdun/AAH-9044-2019; Zhang, Yu-Qiu/CAF-6295-2022; Zhang, Yu-Qiu/AAS-2516-2020	Peng, Guangdun/0000-0002-8586-0637	National Natural Science Foundation of China [30623003, 30721065, 30821002, 30830034, 30870835]; National Key Basic Research and Development Program of China [005CB522704, 2006CB943902, 2007CB512303, 2007CB512502, 2007CB947101, 2008KR0695, 2009CB941100]; Shanghai Key Project of Basic Science Research [06DJ14001, 06DZ22032, 08DJ1400501]; Council of Shanghai Municipal Government for Science and Technology [088014199];  [National High- Tech Research and Development Program of China 2006AA02Z186]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program of China(National Basic Research Program of China); Shanghai Key Project of Basic Science Research; Council of Shanghai Municipal Government for Science and Technology; 	This work was supported in part by the National Natural Science Foundation of China Grants 30623003, 30721065, 30821002, 30830034, and 30870835, National Key Basic Research and Development Program of China Grants 005CB522704, 2006CB943902, 2007CB512303, 2007CB512502, 2007CB947101, 2008KR0695, and 2009CB941100, National High- Tech Research and Development Program of China Grant 2006AA02Z186, Shanghai Key Project of Basic Science Research Grants 06DJ14001, 06DZ22032, and 08DJ1400501, and the Council of Shanghai Municipal Government for Science and Technology Grant 088014199.	Bark C, 2004, J NEUROSCI, V24, P8796, DOI 10.1523/JNEUROSCI.1940-04.2004; Basbaum AI, 1999, CURR BIOL, V9, pR429, DOI 10.1016/S0960-9822(99)80273-5; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Ciruela A, 2003, BRIT J PHARMACOL, V138, P751, DOI 10.1038/sj.bjp.0705103; Crown ED, 2006, EXP NEUROL, V199, P397, DOI 10.1016/j.expneurol.2006.01.003; Dai Y, 2002, J NEUROSCI, V22, P7737; Euskirchen G, 2004, MOL CELL BIOL, V24, P3804, DOI 10.1128/MCB.24.9.3804-3814.2004; Frassoni C, 2005, NEUROSCIENCE, V131, P813, DOI 10.1016/j.neuroscience.2004.11.042; Galan A, 2003, MOL BRAIN RES, V116, P126, DOI 10.1016/S0169-328X(03)00284-5; Galan A, 2002, NEUROSCI LETT, V322, P37, DOI 10.1016/S0304-3940(02)00078-2; Gao X, 2001, BIOCHEM BIOPH RES CO, V284, P1098, DOI 10.1006/bbrc.2001.5089; Garry EM, 2005, MOL CELL NEUROSCI, V30, P523, DOI 10.1016/j.mcn.2005.08.016; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hefti FF, 2006, TRENDS PHARMACOL SCI, V27, P85, DOI 10.1016/j.tips.2005.12.001; Herzberg U, 1997, NEUROREPORT, V8, P1613, DOI 10.1097/00001756-199705060-00012; Hoeger-Bement MK, 2003, J NEUROSCI, V23, P5437; Hou QL, 2006, BIOCHEM BIOPH RES CO, V347, P955, DOI 10.1016/j.bbrc.2006.06.184; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Ji R R, 2007, Handb Exp Pharmacol, P359; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Ji RR, 1997, J NEUROSCI, V17, P1776; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Ji RR, 2006, NEURON GLIA BIOL, V2, P259, DOI 10.1017/S1740925X07000403; Ji Ru-Rong, 2004, Curr Opin Investig Drugs, V5, P71; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Josiah DT, 2006, PSYCHOPHARMACOLOGY, V188, P152, DOI 10.1007/s00213-006-0481-5; Karim F, 2001, J NEUROSCI, V21, P3771, DOI 10.1523/JNEUROSCI.21-11-03771.2001; Kawasaki Y, 2004, J NEUROSCI, V24, P8310, DOI 10.1523/JNEUROSCI.2396-04.2004; Lee HK, 2002, J NEUROCHEM, V81, P1338, DOI 10.1046/j.1471-4159.2002.00937.x; Lim G, 2003, PAIN, V105, P275, DOI 10.1016/S0304-3959(03)00242-2; Ma WY, 2003, BRAIN RES, V988, P97, DOI 10.1016/S0006-8993(03)03348-1; Ma WY, 2001, PAIN, V93, P295, DOI 10.1016/S0304-3959(01)00335-9; Malik-Hall M, 2005, EUR J NEUROSCI, V21, P3387, DOI 10.1111/j.1460-9568.2005.04173.x; Marie-Claire C, 2007, NEUROPHARMACOLOGY, V52, P430, DOI 10.1016/j.neuropharm.2006.08.012; McMahon SB, 1996, PHILOS T R SOC B, V351, P431, DOI 10.1098/rstb.1996.0039; Moalem G, 2004, NEUROSCIENCE, V129, P767, DOI 10.1016/j.neuroscience.2004.08.035; MOLANDER C, 1984, J COMP NEUROL, V230, P133, DOI 10.1002/cne.902300112; Obata K, 2004, EUR J NEUROSCI, V20, P2881, DOI 10.1111/j.1460-9568.2004.03754.x; Obata K, 2004, LIFE SCI, V74, P2643, DOI 10.1016/j.lfs.2004.01.007; Obata K, 2007, J NEUROCHEM, V102, P1569, DOI 10.1111/j.1471-4159.2007.04656.x; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Ro LS, 1999, PAIN, V79, P265, DOI 10.1016/S0304-3959(98)00164-X; Sah DWY, 2003, NAT REV DRUG DISCOV, V2, P460, DOI 10.1038/nrd1107; Sandkuhler J, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-9; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shen CY, 2008, J BIOL CHEM, V283, P17721, DOI 10.1074/jbc.M800013200; Song XS, 2005, ACTA PHARMACOL SIN, V26, P789, DOI 10.1111/j.1745-7254.2005.00123.x; Sweatt JD, 1999, LEARN MEMORY, V6, P399, DOI 10.1101/lm.6.5.399; Takaishi K, 1996, PAIN, V66, P297, DOI 10.1016/0304-3959(96)03023-0; Tseng TJ, 2007, EXP NEUROL, V206, P17, DOI 10.1016/j.expneurol.2007.04.006; Verderio C, 2004, NEURON, V41, P599, DOI 10.1016/S0896-6273(04)00077-7; Wang XD, 2005, EUR J NEUROSCI, V22, P1090, DOI 10.1111/j.1460-9568.2005.04282.x; Xin WJ, 2006, J NEUROSCI RES, V84, P934, DOI 10.1002/jnr.21013; Xu NJ, 2004, J BIOL CHEM, V279, P40601, DOI 10.1074/jbc.M406896200; Yu CG, 2005, MOL BRAIN RES, V138, P244, DOI 10.1016/j.molbrainres.2005.04.013; ZHANG YQ, 2009, PAIN; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022; Zhuang ZY, 2006, J NEUROSCI, V26, P3551, DOI 10.1523/JNEUROSCI.5290-05.2006	65	26	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30138	30147		10.1074/jbc.M109.036756	http://dx.doi.org/10.1074/jbc.M109.036756			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19723624	Green Published, hybrid			2022-12-25	WOS:000271090000017
J	Spindler, V; Heupel, WM; Efthymiadis, A; Schmidt, E; Eming, R; Rankl, C; Hinterdorfer, P; Muller, T; Drenckhahn, D; Waschke, J				Spindler, Volker; Heupel, Wolfgang-Moritz; Efthymiadis, Athina; Schmidt, Enno; Eming, Ruediger; Rankl, Christian; Hinterdorfer, Peter; Mueller, Thomas; Drenckhahn, Detlev; Waschke, Jens			Desmocollin 3-mediated Binding Is Crucial for Keratinocyte Cohesion and Is Impaired in Pemphigus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; ADHESIVE INTERFACE; TRANS-INTERACTION; DESMOGLEIN 3; N-CADHERIN; VULGARIS; SKIN; IGG; DESMOSOME; AUTOANTIBODIES	Desmocollin (Dsc) 1-3 and desmoglein (Dsg) 1-4, transmembrane proteins of the cadherin family, form the adhesive core of desmosomes. Here we provide evidence that Dsc3 homo- and heterophilic trans-interaction is crucial for epidermal integrity. Single molecule atomic force microscopy (AFM) revealed homophilic trans-interaction of Dsc3. Dsc3 displayed heterophilic interaction with Dsg1 but not with Dsg3. A monoclonal antibody targeted against the extracellular domain reduced homophilic and heterophilic binding as measured by AFM, caused intraepidermal blistering in a model of human skin, and a loss of intercellular adhesion in cultured keratinocytes. Because autoantibodies against Dsg1 are associated with skin blistering in pemphigus, we characterized the role of Dsc3 binding for pemphigus pathogenesis. In contrast to AFM experiments, laser tweezer trapping revealed that pemphigus autoantibodies reduced binding of Dsc3-coated beads to the keratinocyte cell surface. These data indicate that loss of heterophilic Dsc3/Dsg1 binding may contribute to pemphigus skin blistering.	[Spindler, Volker; Heupel, Wolfgang-Moritz; Efthymiadis, Athina; Drenckhahn, Detlev; Waschke, Jens] Univ Wurzburg, Inst Anat & Cell Biol, D-97070 Wurzburg, Germany; [Schmidt, Enno] Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Eming, Ruediger] Univ Marburg, Dept Dermatol, D-35037 Marburg, Germany; [Rankl, Christian; Hinterdorfer, Peter] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Mueller, Thomas] Univ Wurzburg, Dept Mol Plant Physiol & Biophys, D-97082 Wurzburg, Germany	University of Wurzburg; University of Lubeck; Philipps University Marburg; Johannes Kepler University Linz; University of Wurzburg	Waschke, J (corresponding author), Univ Wurzburg, Inst Anat & Cell Biol, Koellikerstr 6, D-97070 Wurzburg, Germany.	jens.waschke@mail.uni-wuerzburg.de	Heupel, Wolfgang-Moritz/B-7788-2009; Schmidt, Enno/C-4008-2009; Spindler, Volker/G-1704-2019; Hinterdorfer, Peter/C-4235-2013	Schmidt, Enno/0000-0002-1206-8913; Spindler, Volker/0000-0002-1302-5421; Hinterdorfer, Peter/0000-0003-2583-1305; Mueller, Thomas/0000-0003-1862-7357; Rankl, Christian/0000-0002-7354-7651	Deutsche Forschungsgemeinschaft [SFB487, TP B5, B2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB487 (TP B5 and B2).	AMAGAI, 1994, J INVEST DERMATOL, V103, P608, DOI 10.1111/1523-1747.ep12397292; Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697; Baumgartner W, 2003, J NEUROSCI, V23, P11008; Baumgartner W, 2008, J MOL BIOL, V378, P44, DOI 10.1016/j.jmb.2008.02.023; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Berkowitz P, 2008, J INVEST DERMATOL, V128, P738, DOI 10.1038/sj.jid.5701080; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Berkowitz P, 2008, AM J PATHOL, V173, P1628, DOI 10.2353/ajpath.2008.080391; Bolling MC, 2007, BRIT J DERMATOL, V157, P168, DOI 10.1111/j.1365-2133.2007.07920.x; Chen JL, 2008, J CELL SCI, V121, P2844, DOI 10.1242/jcs.031518; Ebner A, 2007, BIOCONJUGATE CHEM, V18, P1176, DOI 10.1021/bc070030s; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; Gotsch U, 1997, J CELL SCI, V110, P583; Heupel WM, 2008, MOL CELL NEUROSCI, V37, P548, DOI 10.1016/j.mcn.2007.12.003; Heupel WM, 2008, J IMMUNOL, V181, P1825, DOI 10.4049/jimmunol.181.3.1825; Heupel WM, 2009, J BIOL CHEM, V284, P8589, DOI 10.1074/jbc.M808813200; Hisamatsu Y, 2004, BRIT J DERMATOL, V151, P73, DOI 10.1111/j.1365-2133.2004.05995.x; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; Kottke MD, 2006, J CELL SCI, V119, P797, DOI 10.1242/jcs.02888; Mahoney MG, 2006, EXP DERMATOL, V15, P101, DOI 10.1111/j.1600-0625.2006.00391.x; Marcozzi C, 1998, J CELL SCI, V111, P495; MULLER R, 2009, CLIN EXP DE IN PRESS; Nuber UA, 1996, EUR J CELL BIOL, V71, P1; Perret E, 2002, EMBO J, V21, P2537, DOI 10.1093/emboj/21.11.2537; Posy S, 2008, J MOL BIOL, V378, P954, DOI 10.1016/j.jmb.2008.02.063; Schmidt E, 2009, AM J PHYSIOL-CELL PH, V296, pC162, DOI 10.1152/ajpcell.00161.2008; Sharma PM, 2009, J INVEST DERMATOL, V129, P2309, DOI 10.1038/jid.2009.41; Spindler V, 2007, AM J PATHOL, V171, P906, DOI 10.2353/ajpath.2007.070028; Stanley JR, 2006, NEW ENGL J MED, V355, P1800, DOI 10.1056/NEJMra061111; Syed SEH, 2002, BIOCHEM J, V362, P317, DOI 10.1042/0264-6021:3620317; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Waschke J, 2005, J CLIN INVEST, V115, P3157, DOI 10.1172/JCI23475; Waschke J, 2008, HISTOCHEM CELL BIOL, V130, P21, DOI 10.1007/s00418-008-0420-0; Waschke J, 2007, J MEMBRANE BIOL, V216, P83, DOI 10.1007/s00232-007-9037-9; Waschke J, 2006, J CELL BIOL, V175, P721, DOI 10.1083/jcb.200605125; Wendeler MW, 2007, J MOL BIOL, V370, P220, DOI 10.1016/j.jmb.2007.04.062; Yokouchi M, 2009, J INVEST DERMATOL, V129, P2156, DOI 10.1038/jid.2009.61	39	84	84	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30556	30564		10.1074/jbc.M109.024810	http://dx.doi.org/10.1074/jbc.M109.024810			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19717567	hybrid, Green Published			2022-12-25	WOS:000271090000058
J	Toth, AM; Li, ZQ; Cattaneo, R; Samuel, CE				Toth, Ann M.; Li, Zhiqun; Cattaneo, Roberto; Samuel, Charles E.			RNA-specific Adenosine Deaminase ADAR1 Suppresses Measles Virus-induced Apoptosis and Activation of Protein Kinase PKR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICE-SITE VARIANTS; EDITING ENZYME ADAR1; DNA BINDING DOMAIN; PRE-MESSENGER-RNA; C-PROTEIN; HUMAN-CELLS; INTERFERON ACTION; EXPRESSION; BRAIN; RECEPTORS	ADAR1 (adenosine deaminase acting on RNA) catalyzes the conversion of adenosine to inosine, a process known as A-to-I editing. Extensive A-to-I editing has been described in viral RNAs isolated from the brains of patients persistently infected with measles virus, although the precise role of ADAR during measles virus infection remains unknown. We generated human HeLa cells stably deficient in ADAR1 ("ADAR1(kd) cells") through short hairpin RNA-mediated knockdown, and using these cells, we tested the effect of ADAR1 deficiency on measles virus (MVvac strain) growth and virus-induced cell death. We found that the growth of mutant viruses lacking expression of the viral accessory proteins V and C (V-ko and C-ko, respectively) was decreased in ADAR1-deficient cells compared with ADAR1-sufficient cells. In addition, apoptosis was enhanced in ADAR1-deficient cells following infection with wild type and V-ko virus but not following infection with C-ko virus or treatment with tumor necrosis factor-alpha or staurosporine. Furthermore, in C-ko-infected ADAR1-sufficient cells when ADAR1 did not protect against apoptosis, caspase cleavage of the ADAR1 p150 protein was detected. Finally, enhanced apoptosis in ADAR1(kd) cells following infection with wild type and V-ko virus correlated with enhanced activation of PKR kinase and interferon regulatory factor IRF-3. Taken together, these results demonstrate that ADAR1 is a proviral, antiapoptotic host factor in the context of measles virus infection and suggest that the antiapoptotic activity of ADAR1 is achieved through suppression of activation of proapoptotic and double-stranded RNA-dependent activities, as exemplified by PKR and IRF-3.	[Toth, Ann M.; Samuel, Charles E.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Li, Zhiqun; Samuel, Charles E.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA; [Cattaneo, Roberto] Mayo Clin, Coll Med, Dept Mol Med & Virol, Rochester, MN 55905 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Mayo Clinic	Samuel, CE (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	samuel@lifesci.ucsb.edu			National Institutes of Health, NIAID [AI-12520, AI-20611, AI-63476]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020611, R01AI063476, R01AI012520, R37AI012520] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grants AI-12520 and AI-20611 (to C. E. S.) and AI-63476 (to R. C.).	Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BACZKO K, 1993, VIROLOGY, V197, P188, DOI 10.1006/viro.1993.1579; Bankamp B, 2005, VIROLOGY, V336, P120, DOI 10.1016/j.virol.2005.03.009; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; BASS BL, 1987, CELL, V48, P607, DOI 10.1016/0092-8674(87)90239-X; CATTANEO R, 1994, CURR OPIN GENET DEV, V4, P895, DOI 10.1016/0959-437X(94)90076-0; CATTANEO R, 1989, VIROLOGY, V173, P415, DOI 10.1016/0042-6822(89)90554-0; CATTANEO R, 1988, CELL, V55, P255, DOI 10.1016/0092-8674(88)90048-7; Clerzius G, 2009, J VIROL, V83, P10119, DOI 10.1128/JVI.02457-08; Devaux P, 2004, J VIROL, V78, P11632, DOI 10.1128/JVI.78.21.11632-11640.2004; Devaux P, 2007, VIROLOGY, V360, P72, DOI 10.1016/j.virol.2006.09.049; DORIA M, 2009, NUCL ACIDS IN PRESS; Garg RK, 2002, POSTGRAD MED J, V78, P63, DOI 10.1136/pmj.78.916.63; George CX, 1999, P NATL ACAD SCI USA, V96, P4621, DOI 10.1073/pnas.96.8.4621; Griffin DE., 2007, FIELDS VIROLOGY, P1551; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Herbert A, 1997, P NATL ACAD SCI USA, V94, P8421, DOI 10.1073/pnas.94.16.8421; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Iizasa H, 2009, NAT IMMUNOL, V10, P16, DOI 10.1038/ni0109-16; Jayan GC, 2002, J VIROL, V76, P12399, DOI 10.1128/JVI.76.23.12399-12404.2002; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; KIM U, 1994, P NATL ACAD SCI USA, V91, P11457, DOI 10.1073/pnas.91.24.11457; Kumar M, 1997, P NATL ACAD SCI USA, V94, P3542, DOI 10.1073/pnas.94.8.3542; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Liu Y, 1999, J BIOL CHEM, V274, P5070, DOI 10.1074/jbc.274.8.5070; Liu Y, 1999, J BIOL CHEM, V274, P18351, DOI 10.1074/jbc.274.26.18351; Liu Y, 1997, J BIOL CHEM, V272, P4419, DOI 10.1074/jbc.272.7.4419; LUO GX, 1990, J VIROL, V64, P1021, DOI 10.1128/JVI.64.3.1021-1027.1990; Navaratnarajah CK, 2009, CURR TOP MICROBIOL, V329, P59; Nie YZ, 2007, J VIROL, V81, P917, DOI 10.1128/JVI.01527-06; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; PATTERSON JB, 1995, VIROLOGY, V210, P508, DOI 10.1006/viro.1995.1370; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Phuphuakrat A, 2008, J VIROL, V82, P10864, DOI 10.1128/JVI.00238-08; Poulsen H, 2001, MOL CELL BIOL, V21, P7862, DOI 10.1128/MCB.21.22.7862-7871.2001; REBAGLIATI MR, 1987, CELL, V48, P599, DOI 10.1016/0092-8674(87)90238-8; Reutter GL, 2001, VIROLOGY, V285, P100, DOI 10.1006/viro.2001.0962; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Taylor DR, 2005, J VIROL, V79, P6291, DOI 10.1128/JVI.79.10.6291-6298.2005; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Toth AM, 2006, PROG NUCLEIC ACID RE, V81, P369, DOI 10.1016/S0079-6603(06)81010-X; Toth AM, 2009, J VIROL, V83, P961, DOI 10.1128/JVI.01669-08; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; WEIER HUG, 1995, GENOMICS, V30, P372, DOI 10.1006/geno.1995.0034; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zahn RC, 2007, J VIROL, V81, P457, DOI 10.1128/JVI.00067-06; Zhang P, 2008, J VIROL, V82, P840, DOI 10.1128/JVI.01891-07; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	56	113	119	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29350	29356		10.1074/jbc.M109.045146	http://dx.doi.org/10.1074/jbc.M109.045146			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19710021	Green Published, hybrid			2022-12-25	WOS:000270896800015
J	Marquez, L; Suarez, J; Iglesias, M; Bermudez-Silva, FJ; de Fonseca, FR; Andreu, M				Marquez, Lucia; Suarez, Juan; Iglesias, Mar; Javier Bermudez-Silva, Francisco; Rodriguez de Fonseca, Fernando; Andreu, Montserrat			Ulcerative Colitis Induces Changes on the Expression of the Endocannabinoid System in the Human Colonic Tissue	PLOS ONE			English	Article								Background: Recent studies suggest potential roles of the endocannabinoid system in gastrointestinal inflammation. Although cannabinoid CB(2) receptor expression is increased in inflammatory disorders, the presence and function of the remaining proteins of the endocannabinoid system in the colonic tissue is not well characterized. Methodology: Cannabinoid CB(1) and CB(2) receptors, the enzymes for endocannabinoid biosynthesis DAGL alpha, DAGL beta and NAPE-PLD, and the endocannabinoid-degradating enzymes FAAH and MAGL were analysed in both acute untreated active ulcerative pancolitis and treated quiescent patients in comparison with healthy human colonic tissue by immunocytochemistry. Analyses were carried out according to clinical criteria, taking into account the severity at onset and treatment received. Principal Findings: Western blot and immunocytochemistry indicated that the endocannabinoid system is present in the colonic tissue, but it shows a differential distribution in epithelium, lamina propria, smooth muscle and enteric plexi. Quantification of epithelial immunoreactivity showed an increase of CB(2) receptor, DAGL alpha and MAGL expression, mainly in mild and moderate pancolitis patients. In contrast, NAPE-PLD expression decreased in moderate and severe pancolitis patients. During quiescent pancolitis, CB(1), CB(2) and DAGL alpha expression dropped, while NAPE-PLD expression rose, mainly in patients treated with 5-ASA or 5-ASA+corticosteroids. The number of immune cells containing MAGL and FAAH in the lamina propria increased in acute pancolitis patients, but dropped after treatment. Conclusions: Endocannabinoids signaling pathway, through CB(2) receptor, may reduce colitis-associated inflammation suggesting a potential drugable target for the treatment of inflammatory bowel diseases.			Marquez, L (corresponding author), Univ Autonoma Barcelona, Hosp Mar, Dept Gastroenterol, E-08193 Barcelona, Spain.	fernando.rodriguez@fundacionimabis.org	Bermudez-Silva, Francisco-Javier/Q-6920-2016; Andreu, Montserrat/D-9911-2015; DE FONSECA, FERNANDO RODRIGUEZ/E-9767-2012; Suarez, Juan/I-5188-2015; Marquez, Lucia/AAI-8215-2021	Bermudez-Silva, Francisco-Javier/0000-0003-3133-9691; Andreu, Montserrat/0000-0003-4286-1098; Suarez, Juan/0000-0001-5254-9802; MARQUEZ MOSQUERA, LUCIA/0000-0002-3182-9570				Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bermudez-Silva FJ, 2008, DIABETOLOGIA, V51, P476, DOI 10.1007/s00125-007-0890-y; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Calignano A, 2000, Prog Brain Res, V129, P471; Capasso R, 2005, GASTROENTEROLOGY, V129, P941, DOI 10.1053/j.gastro.2005.06.018; Casu MA, 2003, EUR J PHARMACOL, V459, P97, DOI 10.1016/S0014-2999(02)02830-3; D'Argenio G, 2006, FASEB J, V20, P568, DOI 10.1096/fj.05-4943fje; De Hertogh G, 2008, WORLD J GASTROENTERO, V14, P845, DOI 10.3748/wjg.14.845; Di Marzo V, 2006, GUT, V55, P1373, DOI 10.1136/gut.2005.090472; DICARLO G, 2003, EXPERT OPIN INV DRUG, V3, P771; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Duncan M, 2005, ALIMENT PHARM THER, V22, P667, DOI 10.1111/j.1365-2036.2005.02648.x; Duncan M, 2008, AM J PHYSIOL-GASTR L, V295, pG1255, DOI 10.1152/ajpgi.90500.2008; Fowler CJ, 2005, PHARMACOL BIOCHEM BE, V81, P248, DOI 10.1016/j.pbb.2005.01.023; Geboes K, 1998, NEUROGASTROENT MOTIL, V10, P189, DOI 10.1046/j.1365-2982.1998.00102.x; Giang DK, 1997, P NATL ACAD SCI USA, V94, P2238, DOI 10.1073/pnas.94.6.2238; Griffin G, 1997, EUR J PHARMACOL, V339, P53, DOI 10.1016/S0014-2999(97)01336-8; Ihenetu K, 2003, EUR J PHARMACOL, V464, P207, DOI 10.1016/S0014-2999(03)01379-7; Izzo AA, 2001, BRIT J PHARMACOL, V134, P563, DOI 10.1038/sj.bjp.0704293; Izzo Angelo A., 2001, Current Opinion in Pharmacology, V1, P597, DOI 10.1016/S1471-4892(01)00102-3; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; Liu J, 2008, NEUROPHARMACOLOGY, V54, P1, DOI 10.1016/j.neuropharm.2007.05.020; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Massa F, 2005, J MOL MED, V83, P944, DOI 10.1007/s00109-005-0698-5; Mathison R, 2004, BRIT J PHARMACOL, V142, P1247, DOI 10.1038/sj.bjp.0705889; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Okamoto Y, 2007, CHEM BIODIVERS, V4, P1842, DOI 10.1002/cbdv.200790155; Pertwee RG, 2001, GUT, V48, P859, DOI 10.1136/gut.48.6.859; Pinto L, 2002, GASTROENTEROLOGY, V123, P227, DOI 10.1053/gast.2002.34242; Pinto L, 2002, PROSTAG LEUKOTR ESS, V66, P333, DOI 10.1054/plef.2001.0345; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; Richardson JD, 1998, PAIN, V75, P111, DOI 10.1016/S0304-3959(97)00213-3; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; Storr M, 2002, CAN J PHYSIOL PHARM, V80, P67, DOI 10.1139/Y02-005; Storr MA, 2008, J MOL MED, V86, P925, DOI 10.1007/s00109-008-0359-6; Suarez J, 2008, J COMP NEUROL, V509, P400, DOI 10.1002/cne.21774; Sugiura T, 2000, CHEM PHYS LIPIDS, V108, P89, DOI 10.1016/S0009-3084(00)00189-4; TRUELOVE SC, 1955, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.4947.1041; Wright K, 2005, GASTROENTEROLOGY, V129, P437, DOI 10.1053/j.gastro.2005.05.026; Wright KL, 2008, BRIT J PHARMACOL, V153, P263, DOI 10.1038/sj.bjp.0707486	44	83	83	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2009	4	9							e6893	10.1371/journal.pone.0006893	http://dx.doi.org/10.1371/journal.pone.0006893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZF	19730730	gold, Green Published, Green Submitted			2022-12-25	WOS:000269622100002
J	Rodrigue, S; Malmstrom, RR; Berlin, AM; Birren, BW; Henn, MR; Chisholm, SW				Rodrigue, Sebastien; Malmstrom, Rex R.; Berlin, Aaron M.; Birren, Bruce W.; Henn, Matthew R.; Chisholm, Sallie W.			Whole Genome Amplification and De novo Assembly of Single Bacterial Cells	PLOS ONE			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; PROCHLOROCOCCUS; POLYMERASE; EVOLUTION	Background: Single-cell genome sequencing has the potential to allow the in-depth exploration of the vast genetic diversity found in uncultured microbes. We used the marine cyanobacterium Prochlorococcus as a model system for addressing important challenges facing high-throughput whole genome amplification (WGA) and complete genome sequencing of individual cells. Methodology/Principal Findings: We describe a pipeline that enables single-cell WGA on hundreds of cells at a time while virtually eliminating non-target DNA from the reactions. We further developed a post-amplification normalization procedure that mitigates extreme variations in sequencing coverage associated with multiple displacement amplification (MDA), and demonstrated that the procedure increased sequencing efficiency and facilitated genome assembly. We report genome recovery as high as 99.6% with reference-guided assembly, and 95% with de novo assembly starting from a single cell. We also analyzed the impact of chimera formation during MDA on de novo assembly, and discuss strategies to minimize the presence of incorrectly joined regions in contigs. Conclusions/Significance: The methods describe in this paper will be useful for sequencing genomes of individual cells from a variety of samples.			Rodrigue, S (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	chisholm@mit.edu	Malmstrom, Rex/K-7339-2012; Berlin, Aaron M/AFY-6549-2022	Berlin, Aaron M/0000-0002-0714-2808; Malmstrom, Rex/0000-0002-4758-7369; Chisholm, Sallie/0000-0003-1480-2445	NIAID NIH HHS [HHSN266200400001C] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Binga EK, 2008, ISME J, V2, P233, DOI 10.1038/ismej.2008.10; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Ibrahim SF, 2003, CURR OPIN BIOTECH, V14, P5, DOI 10.1016/S0958-1669(02)00009-5; Ibrahim SF, 2007, ADV BIOCHEM ENG BIOT, V106, P19, DOI 10.1007/10_2007_073; KARL DM, 2002, BIOGEOCHEMISTRY MARI, P315; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kvist T, 2007, APPL MICROBIOL BIOT, V74, P926, DOI 10.1007/s00253-006-0725-7; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McCutcheon JP, 2007, P NATL ACAD SCI USA, V104, P19392, DOI 10.1073/pnas.0708855104; Pan XH, 2008, P NATL ACAD SCI USA, V105, P15499, DOI 10.1073/pnas.0808028105; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	32	182	224	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2009	4	9							e6864	10.1371/journal.pone.0006864	http://dx.doi.org/10.1371/journal.pone.0006864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RW	19724646	Green Submitted, Green Published, gold			2022-12-25	WOS:000269522800006
J	Schippers, MB; Gazzola, V; Goebel, R; Keysers, C				Schippers, Marleen B.; Gazzola, Valeria; Goebel, Rainer; Keysers, Christian			Playing Charades in the fMRI: Are Mirror and/or Mentalizing Areas Involved in Gestural Communication?	PLOS ONE			English	Article							TEMPORO-PARIETAL JUNCTION; GRASP REPRESENTATIONS; ACTION RECOGNITION; SOCIAL-INTERACTION; NEURON SYSTEM; BROCAS AREA; MIND; BRAIN; PREMOTOR; MECHANISMS	Communication is an important aspect of human life, allowing us to powerfully coordinate our behaviour with that of others. Boiled down to its mere essentials, communication entails transferring a mental content from one brain to another. Spoken language obviously plays an important role in communication between human individuals. Manual gestures however often aid the semantic interpretation of the spoken message, and gestures may have played a central role in the earlier evolution of communication. Here we used the social game of charades to investigate the neural basis of gestural communication by having participants produce and interpret meaningful gestures while their brain activity was measured using functional magnetic resonance imaging. While participants decoded observed gestures, the putative mirror neuron system (pMNS: premotor, parietal and posterior mid-temporal cortex), associated with motor simulation, and the temporoparietal junction (TPJ), associated with mentalizing and agency attribution, were significantly recruited. Of these areas only the pMNS was recruited during the production of gestures. This suggests that gestural communication relies on a combination of simulation and, during decoding, mentalizing/agency attribution brain areas. Comparing the decoding of gestures with a condition in which participants viewed the same gestures with an instruction not to interpret the gestures showed that although parts of the pMNS responded more strongly during active decoding, most of the pMNS and the TPJ did not show such significant task effects. This suggests that the mere observation of gestures recruits most of the system involved in voluntary interpretation.			Schippers, MB (corresponding author), Univ Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands.	m.b.schippers@med.umcg.nl	Keysers, Christian/H-6251-2013	Keysers, Christian/0000-0002-2845-5467; Gazzola, Valeria/0000-0003-0324-0619; Goebel, Rainer/0000-0003-1780-2467				Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Arbib MA, 2008, J PHYSIOL-PARIS, V102, P4, DOI 10.1016/j.jphysparis.2008.03.001; BLAKEMORE SJ, 2001, NATURE REV NEUROSCIE; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brett M, 2002, NEUROIMAGE; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buxbaum LJ, 2005, COGNITIVE BRAIN RES, V25, P226, DOI 10.1016/j.cogbrainres.2005.05.014; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Choi SH, 2001, EXP BRAIN RES, V139, P311, DOI 10.1007/s002210100777; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; Ciaramidaro A, 2007, NEUROPSYCHOLOGIA, V45, P3105, DOI 10.1016/j.neuropsychologia.2007.05.011; Cubelli R, 2006, NEUROSCI LETT, V407, P118, DOI 10.1016/j.neulet.2006.08.019; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Ferrari PF, 2003, EUR J NEUROSCI, V17, P1703, DOI 10.1046/j.1460-9568.2003.02601.x; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Fridman EA, 2006, NEUROIMAGE, V29, P417, DOI 10.1016/j.neuroimage.2005.07.026; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Fujii N, 2008, SOC NEUROSCI-UK, V3, P250, DOI 10.1080/17470910701434610; Gallagher HL, 2004, NEUROPSYCHOLOGIA, V42, P1725, DOI 10.1016/j.neuropsychologia.2004.05.006; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; GAZZOLA V, 2008, CEREB CORTEX; Gazzola V, 2007, CURR BIOL, V17, P1235, DOI 10.1016/j.cub.2007.06.045; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Hampton AN, 2008, P NATL ACAD SCI USA, V105, P6741, DOI 10.1073/pnas.0711099105; Hamzei F, 2003, NEUROIMAGE, V19, P637, DOI 10.1016/S1053-8119(03)00087-9; Heiser M, 2003, EUR J NEUROSCI, V17, P1123, DOI 10.1046/j.1460-9568.2003.02530.x; Hermsdorfer J, 2001, NEUROIMAGE, V14, P149, DOI 10.1006/nimg.2001.0796; Hickok G, 2009, J COGNITIVE NEUROSCI, V21, P1229, DOI 10.1162/jocn.2009.21189; Higuchi S, 2007, CORTEX, V43, P350, DOI 10.1016/S0010-9452(08)70460-X; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Iacoboni M, 2004, NEUROIMAGE, V21, P1167, DOI 10.1016/j.neuroimage.2003.11.013; Iverson JM, 1998, NATURE, V396, P228, DOI 10.1038/24300; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Kampe KKW, 2003, J NEUROSCI, V23, P5258; Kendon A., 1994, RES LANG SOC INTERAC, V27, P175, DOI [10.1207/s15327973rlsi2703_2, DOI 10.1207/S15327973RLSI2703_2]; Keysers C, 2003, EXP BRAIN RES, V153, P628, DOI 10.1007/s00221-003-1603-5; Keysers C, 2006, PROG BRAIN RES, V156, P379, DOI 10.1016/S0079-6123(06)56021-2; Keysers C, 2007, TRENDS COGN SCI, V11, P194, DOI 10.1016/j.tics.2007.02.002; KILNER J, 2007, SOCIAL NEUROSCIENCE, P158; KILNER JM, 2007, COGNITIVE PROCESSES; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Lotze M, 2006, NEUROPSYCHOLOGIA, V44, P1787, DOI 10.1016/j.neuropsychologia.2006.03.016; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; McNeill D., 1992, HAND MIND WHAT GESTU; MELINGER A, 2004, GESTURE COMMUNICATIV; Mitchell JP, 2008, CEREB CORTEX, V18, P262, DOI 10.1093/cercor/bhm051; Moll J, 2000, NEUROLOGY, V54, P1331, DOI 10.1212/WNL.54.6.1331; Montgomery KJ, 2007, SOC COGN AFFECT NEUR, V2, P114, DOI 10.1093/scan/nsm004; Mozaz M, 2002, J INT NEUROPSYCH SOC, V8, P958, DOI 10.1017/S1355617702870114; Nair DG, 2003, COGNITIVE BRAIN RES, V15, P250, DOI 10.1016/S0926-6410(02)00197-0; Nelissen K, 2005, SCIENCE, V310, P332, DOI 10.1126/science.1115593; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; OCHIPA C, 1989, ANN NEUROL, V25, P190, DOI 10.1002/ana.410250214; Ohgami Y, 2004, NEUROREPORT, V15, P1903, DOI 10.1097/00001756-200408260-00014; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pazzaglia M, 2008, CURR BIOL, V18, P1766, DOI 10.1016/j.cub.2008.09.061; Pelphrey KA, 2004, J COGNITIVE NEUROSCI, V16, P1706, DOI 10.1162/0898929042947900; Petrides M, 2005, NATURE, V435, P1235, DOI 10.1038/nature03628; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; ROTHI LJG, 1985, J NEUROL NEUROSUR PS, V48, P207, DOI 10.1136/jnnp.48.3.207; Saxe R, 2004, NEUROPSYCHOLOGIA, V42, P1435, DOI 10.1016/j.neuropsychologia.2004.04.015; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Scholz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004869; Siegal M, 2002, NAT REV NEUROSCI, V3, P463, DOI 10.1038/nrn844; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Sommer M, 2007, NEUROIMAGE, V35, P1378, DOI 10.1016/j.neuroimage.2007.01.042; Thioux M, 2008, CURR BIOL, V18, pR431, DOI 10.1016/j.cub.2008.03.018; Thompson JC, 2007, NEUROIMAGE, V37, P966, DOI 10.1016/j.neuroimage.2007.05.058; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; van der Gaag C, 2007, SOC NEUROSCI-UK, V2, P179, DOI 10.1080/17470910701376878; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Walter H, 2004, J COGNITIVE NEUROSCI, V16, P1854, DOI 10.1162/0898929042947838; Wheaton KJ, 2004, NEUROIMAGE, V22, P277, DOI 10.1016/j.neuroimage.2003.12.043; Willems RM, 2007, CEREB CORTEX, V17, P2322, DOI 10.1093/cercor/bhl141	95	53	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2009	4	8							e6801	10.1371/journal.pone.0006801	http://dx.doi.org/10.1371/journal.pone.0006801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JE	19710923	Green Published, gold			2022-12-25	WOS:000269415600015
J	Rabeling, C; Lino-Neto, J; Cappellari, SC; Dos-Santos, IA; Mueller, UG; Bacci, M				Rabeling, Christian; Lino-Neto, Jose; Cappellari, Simone C.; Dos-Santos, Iracenir A.; Mueller, Ulrich G.; Bacci, Mauricio, Jr.			Thelytokous Parthenogenesis in the Fungus-Gardening Ant Mycocepurus smithii (Hymenoptera: Formicidae)	PLOS ONE			English	Article							APIS-MELLIFERA-CAPENSIS; BIROI FOREL FORMICIDAE; JAPANESE QUEENLESS ANT; CLONAL REPRODUCTION; NEST ARCHITECTURE; GROWING ANTS; SEXUAL REPRODUCTION; PRISTOMYRMEX-PUNGENS; WORKER REPRODUCTION; COLONY STRUCTURE	The general prevalence of sexual reproduction over asexual reproduction among organisms testifies to the evolutionary benefits of recombination, such as accelerated adaptation to changing environments and elimination of deleterious mutations. Documented instances of asexual reproduction in groups otherwise dominated by sexual reproduction challenge evolutionary biologists to understand the special circumstances that might confer an advantage to asexual reproductive strategies. Here we report one such instance of asexual reproduction in the ants. We present evidence for obligate thelytoky in the asexual fungus-gardening ant, Mycocepurus smithii, in which queens produce female offspring from unfertilized eggs, workers are sterile, and males appear to be completely absent. Obligate thelytoky is implicated by reproductive physiology of queens, lack of males, absence of mating behavior, and natural history observations. An obligate thelytoky hypothesis is further supported by the absence of evidence indicating sexual reproduction or genetic recombination across the species' extensive distribution range (Mexico-Argentina). Potential conflicting evidence for sexual reproduction in this species derives from three Mycocepurus males reported in the literature, previously regarded as possible males of M. smithii. However, we show here that these specimens represent males of the congeneric species M. obsoletus, and not males of M. smithii. Mycocepurus smithii is unique among ants and among eusocial Hymenoptera, in that males seem to be completely absent and only queens (and not workers) produce diploid offspring via thelytoky. Because colonies consisting only of females can be propagated consecutively in the laboratory, M. smithii could be an adequate study organism a) to test hypotheses of the population-genetic advantages and disadvantages of asexual reproduction in a social organism and b) inform kin conflict theory. For a Portuguese translation of the abstract, please see Abstract S1.			Rabeling, C (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	rabeling@mail.utexas.edu	; Bacci, Mauricio/C-4960-2013	Cappellari-Rabeling, Simone/0000-0001-5277-6407; Bacci, Mauricio/0000-0002-5619-1411				Agrawal AF, 2006, CURR BIOL, V16, pR696, DOI 10.1016/j.cub.2006.07.063; Baer B, 2006, J MORPHOL, V267, P1165, DOI 10.1002/jmor.10467; Barton N, 1998, NATURE, V395, P751, DOI 10.1038/27338; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Baudry E, 2004, GENETICS, V167, P243, DOI 10.1534/genetics.167.1.243; Bell G., 1982, MASTERPIECE NATURE E; Birky CW, 2004, P NATL ACAD SCI USA, V101, P2651, DOI 10.1073/pnas.0308453101; Bolton B., 1975, Handbook Ident Br Insects, V6, P1; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; BOURKE AFG, 1988, Q REV BIOL, V63, P291, DOI 10.1086/415930; CAGNIANT H, 1979, INSECT SOC, V26, P51, DOI 10.1007/BF02283912; CAGNIANT H, 1973, CR ACAD SCI D NAT, V277, P2197; CARSON HL, 1982, SCIENCE, V218, P68, DOI 10.1126/science.218.4567.68; COOK JM, 1993, HEREDITY, V71, P421, DOI 10.1038/hdy.1993.157; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; CROZIER RH, 1977, ANNU REV ENTOMOL, V22, P263, DOI 10.1146/annurev.en.22.010177.001403; Dobata S, 2009, P ROY SOC B-BIOL SCI, V276, P567, DOI 10.1098/rspb.2008.1215; EIDMANN H., 1936, Arb. physiol. angew. Ent. Berl., V3, P81; EIDMANN H., 1936, Arb. physiol. angew. Ent. Berl., V3, P26; Fernandez-Marin H, 2005, J NAT HIST, V39, P1735, DOI 10.1080/00222930400027462; Fernandez-Marin H, 2004, BIOL J LINN SOC, V81, P39, DOI 10.1111/j.1095-8312.2004.00268.x; Forel A., 1908, Verhandlungen der Zoologisch-Botanischen Gesellschaft in Wien, V58; Forel A, 1893, T ENTOMOLOGICAL SOC, P333; Foucaud J, 2007, MOL BIOL EVOL, V24, P2465, DOI 10.1093/molbev/msm180; Foucaud J, 2006, EVOLUTION, V60, P1646, DOI 10.1111/j.0014-3820.2006.tb00509.x; Fournier D, 2005, NATURE, V435, P1230, DOI 10.1038/nature03705; Grafen A., 1985, Oxford Surveys in Evolutionary Biology, V2, P28; Grasso DA, 2000, ETHOL ECOL EVOL, V12, P309; Haag CR, 2004, ANN ZOOL FENN, V41, P539; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hartmann A, 2005, INSECT SOC, V52, P155, DOI 10.1007/s00040-004-0786-5; Hasegawa Eisuke, 2001, Entomological Science, V4, P399; HEINZE J, 1995, NATURWISSENSCHAFTEN, V82, P40, DOI 10.1007/s001140050139; HIMLER AG, 2009, P ROYAL SOC LONDON B; ITOW T, 1984, INSECT SOC, V31, P87, DOI 10.1007/BF02223694; Keller L, 2007, AM NAT, V169, P1, DOI 10.1086/509938; Kempf W. W., 1963, Studia Entomologica Petropolis (NS), V6, P417; KERR W. E., 1961, REV BRASIL BIOL, V21, P45; Kobayashi K, 2008, ENTOMOL SCI, V11, P167, DOI 10.1111/j.1479-8298.2008.00272.x; KONDRASHOV AS, 1982, GENET RES, V40, P325, DOI 10.1017/S0016672300019194; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; Mackay WP, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.27; Maynard S.J, 1978, EVOLUTION SEX; Meselson M, 2007, SCIENCE, V318, P202, DOI 10.1126/science.1150197; Mikheyev AS, 2008, MOL ECOL, V17, P4480, DOI 10.1111/j.1365-294X.2008.03940.x; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Normark BB, 2003, BIOL J LINN SOC, V79, P69, DOI 10.1046/j.1095-8312.2003.00182.x; Ohkawara K, 2006, BIOL LETTERS, V2, P359, DOI 10.1098/rsbl.2006.0491; Pearcy M, 2006, HEREDITY, V96, P377, DOI 10.1038/sj.hdy.6800813; Pearcy M, 2004, SCIENCE, V306, P1780, DOI 10.1126/science.1105453; Plantard O, 1998, P ROY SOC B-BIOL SCI, V265, P1075, DOI 10.1098/rspb.1998.0401; QUELLER DC, 1984, BIOL J LINN SOC, V23, P133, DOI 10.1111/j.1095-8312.1984.tb00133.x; Rabeling C, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.4001; Rabeling C, 2004, THESIS U TUBINGEN GE; Ravary F, 2004, INSECT SOC, V51, P67, DOI 10.1007/s00040-003-0724-y; Ravary F, 2002, INSECT SOC, V49, P114, DOI 10.1007/s00040-002-8288-9; Sasaki T, 2003, J ETHOL, V21, P145, DOI 10.1007/s10164-002-0085-4; Schilder K, 1999, MOL ECOL, V8, P1497, DOI 10.1046/j.1365-294x.1999.00727.x; Schilder K, 1999, INSECT SOC, V46, P150, DOI 10.1007/s000400050126; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Schultz TR, 2002, INSECT SOC, V49, P331, DOI 10.1007/PL00012657; Silvestre Rogerio, 2001, Biotemas, V14, P37; STOUTHAMER R, 1994, HEREDITY, V73, P317, DOI 10.1038/hdy.1994.139; Stouthamer R, 1997, INFLUENTIAL PASSENGERS, P102; Suomalainen E, 1987, CYTOLOGY EVOLUTION P; Tschinkel WR, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.21; Tschinkel WR, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.9; Tschinkel WR, 2003, PALAEOGEOGR PALAEOCL, V192, P321, DOI 10.1016/S0031-0182(02)00690-9; TSUJI K, 1995, INSECT SOC, V42, P333, DOI 10.1007/BF01240430; TSUJI K, 1990, ANIM BEHAV, V39, P843, DOI 10.1016/S0003-3472(05)80948-0; TSUJI K, 1995, AM NAT, V146, P586, DOI 10.1086/285816; TSUJI K, 1988, BEHAV ECOL SOCIOBIOL, V23, P247, DOI 10.1007/BF00302947; TUCKER KW, 1958, GENETICS, V43, P299; VANDEL A., 1928, BULL BIOL FRANCE ET BELGIQUE, V62, P164; VERMA S, 1983, APIDOLOGIE, V14, P41, DOI 10.1051/apido:19830104; Vo TL, 2009, MYCOLOGIA, V101, P206, DOI 10.3852/07-055; Weber N. A., 1972, GARDENING ANTS ATTIN; Wenseleers T, 2000, J EVOLUTION BIOL, V13, P277, DOI 10.1046/j.1420-9101.2000.00168.x; West SA, 1999, J EVOLUTION BIOL, V12, P1003; Williams D.F., 1988, P433; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi	85	42	43	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6781	10.1371/journal.pone.0006781	http://dx.doi.org/10.1371/journal.pone.0006781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707513	Green Published, gold			2022-12-25	WOS:000269335000024
J	Skilton, A; Ho, JCY; Mercer, B; Outwin, E; Watts, FZ				Skilton, Andrew; Ho, Jenny C. Y.; Mercer, Brenda; Outwin, Emily; Watts, Felicity Z.			SUMO Chain Formation Is Required for Response to Replication Arrest in S. pombe	PLOS ONE			English	Article								SUMO is a ubiquitin-like protein that is post-translationally attached to one or more lysine residues on target proteins. Despite having only 18% sequence identity with ubiquitin, SUMO contains the conserved beta beta alpha beta beta alpha beta fold present in ubiquitin. However, SUMO differs from ubiquitin in having an extended N-terminus. In S. pombe the N-terminus of SUMO/Pmt3 is significantly longer than those of SUMO in S. cerevisiae, human and Drosophila. Here we investigate the role of this N-terminal region. We have used two dimensional gel electrophoresis to demonstrate that S. pombe SUMO/Pmt3 is phosphorylated, and that this occurs on serine residues at the extreme N-terminus of the protein. Mutation of these residues (in pmt3-1) results in a dramatic reduction in both the levels of high Mr SUMO-containing species and of total SUMO/Pmt3, indicating that phosphorylation of SUMO/Pmt3 is required for its stability. Despite the significant reduction in high Mr SUMO-containing species, pmt3-1 cells do not display an aberrant cell morphology or sensitivity to genotoxins or stress. Additionally, we demonstrate that two lysine residues in the N-terminus of S. pombe SUMO/Pmt3 (K14 and K30) can act as acceptor sites for SUMO chain formation in vitro. Inability to form SUMO chains results in aberrant cell and nuclear morphologies, including stretched and fragmented chromatin. SUMO chain mutants are sensitive to the DNA synthesis inhibitor, hydroxyurea (HU), but not to other genotoxins, such as UV, MMS or CPT. This implies a role for SUMO chains in the response to replication arrest in S. pombe.			Skilton, A (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England.	f.z.watts@sussex.ac.uk	Skilton, Andi/AAS-5885-2021	Skilton, Andi/0000-0002-9573-372X	Biotechnology and Biological Sciences Research Council [85/C15586, BD/D526861/1, G/07462] Funding Source: Medline; Medical Research Council [G122/18, G0500308] Funding Source: Medline; Medical Research Council [G0300662B] Funding Source: researchfish; MRC [G0500308] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALKHODAIRY F, 1995, J CELL SCI, V108, P475; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bayer P, 1998, J MOL BIOL, V280, P275, DOI 10.1006/jmbi.1998.1839; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Caspari T, 2000, MOL CELL BIOL, V20, P1254, DOI 10.1128/MCB.20.4.1254-1262.2000; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Harlow E., 1988, ANTIBODIES LAB MANUA; Hay RT, 2001, TRENDS BIOCHEM SCI, V26, P332, DOI 10.1016/S0968-0004(01)01849-7; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Ho JCY, 2003, BIOCHEM J, V372, P97, DOI 10.1042/BJ20021645; Ho JCY, 2001, NUCLEIC ACIDS RES, V29, P4179, DOI 10.1093/nar/29.20.4179; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Klein HL, 2006, CELL, V127, P455, DOI 10.1016/j.cell.2006.10.019; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Matic I, 2008, J PROTEOME RES, V7, P4050, DOI 10.1021/pr800368m; Mullen JR, 2008, J BIOL CHEM, V283, P19912, DOI 10.1074/jbc.M802690200; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; RECHSTEINER M, 1987, ANNU REV CELL BIOL, V3, P1, DOI 10.1146/annurev.cb.03.110187.000245; Shayeghi M, 1997, NUCLEIC ACIDS RES, V25, P1162, DOI 10.1093/nar/25.6.1162; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Takahashi Y, 2003, J BIOCHEM, V133, P415, DOI 10.1093/jb/mvg054; Tanaka K, 1999, MOL CELL BIOL, V19, P8660; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Watts FZ, 2007, CHROMOSOMA, V116, P15, DOI 10.1007/s00412-006-0079-z; Xhemalce B, 2004, EMBO J, V23, P3844, DOI 10.1038/sj.emboj.7600394	36	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6750	10.1371/journal.pone.0006750	http://dx.doi.org/10.1371/journal.pone.0006750			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707600	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000269278400015
J	Szikra, T; Barabas, P; Bartoletti, TM; Huang, W; Akopian, A; Thoreson, WB; Krizaj, D				Szikra, Tamas; Barabas, Peter; Bartoletti, Theodore M.; Huang, Wei; Akopian, Abram; Thoreson, Wallace B.; Krizaj, David			Calcium Homeostasis and Cone Signaling Are Regulated by Interactions between Calcium Stores and Plasma Membrane Ion Channels	PLOS ONE			English	Article								Calcium is a messenger ion that controls all aspects of cone photoreceptor function, including synaptic release. The dynamic range of the cone output extends beyond the activation threshold for voltage-operated calcium entry, suggesting another calcium influx mechanism operates in cones hyperpolarized by light. We have used optical imaging and whole-cell voltage clamp to measure the contribution of store-operated Ca2+ entry (SOCE) to Ca2+ homeostasis and its role in regulation of neurotransmission at cone synapses. Mn2+ quenching of Fura-2 revealed sustained divalent cation entry in hyperpolarized cones. Ca2+ influx into cone inner segments was potentiated by hyperpolarization, facilitated by depletion of intracellular Ca2+ stores, unaffected by pharmacological manipulation of voltage-operated or cyclic nucleotide-gated Ca2+ channels and suppressed by lanthanides, 2-APB, MRS 1845 and SKF 96365. However, cation influx through store-operated channels crossed the threshold for activation of voltage-operated Ca2+ entry in a subset of cones, indicating that the operating range of inner segment signals is set by interactions between store-and voltage-operated Ca2+ channels. Exposure to MRS 1845 resulted in similar to 40% reduction of light-evoked postsynaptic currents in photopic horizontal cells without affecting the light responses or voltage-operated Ca2+ currents in simultaneously recorded cones. The spatial pattern of store-operated calcium entry in cones matched immunolocalization of the store-operated sensor STIM1. These findings show that store-operated channels regulate spatial and temporal properties of Ca2+ homeostasis in vertebrate cones and demonstrate their role in generation of sustained excitatory signals across the first retinal synapse.			Szikra, T (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	david.krizaj@hsc.utah.edu	Krrr, Daa/ABG-2688-2020; Thoreson, Wallace B./F-6172-2010	Krrr, Daa/0000-0003-4468-3029; Thoreson, Wallace B./0000-0001-7104-042X	NEI NIH HHS [R01 EY013870-07, EY13870, R01 EY010542-15, R29 EY010542, EY10542, R01 EY013870, R01 EY010542, R01 EY013870-08] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013870, R01EY010542, R55EY010542, R29EY010542] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Albert AP, 2007, J PHYSIOL-LONDON, V583, P25, DOI 10.1113/jphysiol.2007.137802; BARNES S, 1989, J GEN PHYSIOL, V94, P719, DOI 10.1085/jgp.94.4.719; Baumann L, 2004, INVEST OPHTH VIS SCI, V45, P708, DOI 10.1167/iovs.03-0937; Bautista DM, 2004, J PHYSIOL-LONDON, V556, P805, DOI 10.1113/jphysiol.2003.060004; BAYLOR DA, 1971, J PHYSIOL-LONDON, V214, P265, DOI 10.1113/jphysiol.1971.sp009432; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Bobanovic LK, 1999, BIOCHEM J, V340, P593, DOI 10.1042/0264-6021:3400593; Borges S, 2008, J PHYSIOL-LONDON, V586, P605, DOI 10.1113/jphysiol.2007.143339; Brechard S, 2008, CELL CALCIUM, V44, P492, DOI 10.1016/j.ceca.2008.03.002; Cadetti L, 2005, J PHYSIOL-LONDON, V569, P773, DOI 10.1113/jphysiol.2005.096545; Cadetti L, 2006, EUR J NEUROSCI, V23, P2983, DOI 10.1111/j.1460-9568.2006.04845.x; Carafoli E, 1999, BIOCHEM BIOPH RES CO, V266, P624, DOI 10.1006/bbrc.1999.1879; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; Chiarini LB, 2003, J NEUROSCI RES, V74, P875, DOI 10.1002/jnr.10739; Chol SY, 2008, VISUAL NEUROSCI, V25, P693, DOI 10.1017/S0952523808080814; Da Silva N, 2008, INVEST OPHTH VIS SCI, V49, P3065, DOI 10.1167/iovs.07-1118; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Di Capite J, 2009, CURR BIOL, V19, P853, DOI 10.1016/j.cub.2009.03.063; Doonan F, 2005, INVEST OPHTH VIS SCI, V46, P3530, DOI 10.1167/iovs.05-0248; DRAPEAU P, 1984, J PHYSIOL-LONDON, V348, P493, DOI 10.1113/jphysiol.1984.sp015121; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Fain GL, 2006, BIOESSAYS, V28, P344, DOI 10.1002/bies.20382; Fomina AF, 1999, J NEUROSCI, V19, P3711; Fox DA, 1999, ANN NY ACAD SCI, V893, P282, DOI 10.1111/j.1749-6632.1999.tb07837.x; FUORTES MGF, 1973, J PHYSIOL-LONDON, V234, P199, DOI 10.1113/jphysiol.1973.sp010341; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Hara MR, 2007, ANNU REV PHARMACOL, V47, P117, DOI 10.1146/annurev.pharmtox.47.120505.105311; Harper JL, 2003, BIOCHEM PHARMACOL, V65, P329, DOI 10.1016/S0006-2952(02)01488-0; Heidelberger R, 2005, PROG RETIN EYE RES, V24, P682, DOI 10.1016/j.preteyeres.2005.04.002; Babak AK, 2006, J NEUROPHYSIOL, V96, P2688, DOI 10.1152/jn.00118.2006; Klejman ME, 2009, NEUROCHEM INT, V54, P49, DOI 10.1016/j.neuint.2008.10.005; KOCH KW, 1985, J BIOL CHEM, V260, P6788; Kreft M, 2003, J NEUROPHYSIOL, V90, P218, DOI 10.1152/jn.01025.2002; Krizaj D, 2003, J PHYSIOL-LONDON, V547, P761, DOI 10.1113/jphysiol.2002.035683; Krizaj D, 2002, J COMP NEUROL, V451, P1, DOI 10.1002/cne.10281; Krizaj D, 2002, FRONT BIOSCI-LANDMRK, V7, pD2023, DOI 10.2741/krizaj; Krizaj D, 1998, NEURON, V21, P249, DOI 10.1016/S0896-6273(00)80531-0; KRIZAJ D, 2007, P KEYST C BRECK CO; Lefkimmiatis K, 2009, NAT CELL BIOL, V11, P433, DOI 10.1038/ncb1850; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Litjens T, 2004, J PHYSIOL-LONDON, V558, P85, DOI 10.1113/jphysiol.2004.065870; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Maple BR, 1999, NEUROREPORT, V10, P3605, DOI 10.1097/00001756-199911260-00026; MARIANI AP, 1986, PROC R SOC SER B-BIO, V227, P483, DOI 10.1098/rspb.1986.0035; MARICQ AV, 1988, NEURON, V1, P503, DOI 10.1016/0896-6273(88)90181-X; MERCURIO AM, 1982, J NEUROCYTOL, V11, P263, DOI 10.1007/BF01258247; Montalvo GB, 2006, J BIOL CHEM, V281, P35616, DOI 10.1074/jbc.M603518200; Moran J, 1999, J NEUROCHEM, V73, P568, DOI 10.1046/j.1471-4159.1999.0730568.x; NORMANN RA, 1979, J PHYSIOL-LONDON, V286, P509, DOI 10.1113/jphysiol.1979.sp012634; Parekh AB, 2006, PFLUG ARCH EUR J PHY, V453, P303, DOI 10.1007/s00424-006-0089-y; Paschen W, 2005, CELL CALCIUM, V38, P409, DOI 10.1016/j.ceca.2005.06.019; Rabl K, 2005, J NEUROSCI, V25, P4633, DOI 10.1523/JNEUROSCI.4298-04.2005; RIEKE F, 1994, NEURON, V13, P863, DOI 10.1016/0896-6273(94)90252-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Savchenko A, 1997, NATURE, V390, P694, DOI 10.1038/37803; SHIBUYA I, 1992, ENDOCRINOLOGY, V131, P1936, DOI 10.1210/en.131.4.1936; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Szikra T, 2006, NEUROSCIENCE, V141, P143, DOI 10.1016/j.neuroscience.2006.03.054; Szikra T, 2008, J PHYSIOL-LONDON, V586, P4859, DOI 10.1113/jphysiol.2008.160051; Szikra T, 2007, VISUAL NEUROSCI, V24, P733, DOI 10.1017/S0952523807070587; Thoreson WB, 1997, J NEUROPHYSIOL, V77, P2175, DOI 10.1152/jn.1997.77.4.2175; Thoreson WB, 2003, NEUROSCIENCE, V122, P785, DOI 10.1016/j.neuroscience.2003.08.012; Trebak M, 2003, CELL CALCIUM, V33, P451, DOI 10.1016/S0143-4160(03)00056-3; Usachev YM, 1999, J PHYSIOL-LONDON, V519, P115, DOI 10.1111/j.1469-7793.1999.0115o.x; Vessey JP, 2005, J NEUROSCI, V25, P4108, DOI 10.1523/JNEUROSCI.5253-04.2005; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004; Zerbes M, 2001, CELL CALCIUM, V29, P49, DOI 10.1054/ceca.2000.0160	71	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6723	10.1371/journal.pone.0006723	http://dx.doi.org/10.1371/journal.pone.0006723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696927	Green Submitted, gold, Green Published			2022-12-25	WOS:000269267600011
J	Fuchsova, B; Fernandez, ME; Alfonso, J; Frasch, AC				Fuchsova, Beata; Fernandez, Maria E.; Alfonso, Julieta; Frasch, Alberto C.			Cysteine Residues in the Large Extracellular Loop (EC2) Are Essential for the Function of the Stress-regulated Glycoprotein M6a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL CA3C NEURONS; TETRASPANIN PROTEINS; NEURITE EXTENSION; APICAL DENDRITES; RAT HIPPOCAMPUS; INDUCED ATROPHY; CROSS-LINKING; GROWTH-FACTOR; GENE FAMILY; EXPRESSION	Gpm6a was identified as a stress-responsive gene in the hippocampal formation. This gene is down-regulated in the hippocampus of both socially and physically stressed animals, and this effect can be reversed by antidepressant treatment. Previously we showed that the stress-regulated protein M6a is a key modulator for neurite outgrowth and filopodium/spine formation. In the present work, mutational analysis was used to characterize the action of M6a at the molecular level. We show that four cysteines 162, 174, 192, and 202 within EC2 are functionally crucial sites. The presence of cysteines 162 and 202 is essential for the efficient cell surface expression of the M6a protein. In contrast, cysteines 174 and 192, which form a disulfide bridge as shown by biochemical analysis, are not required for the efficient surface expression of M6a. Their mutation to alanine does not interfere with the localization of M6a to filopodial protrusions in primary hippocampal neurons. The neurons expressing C174A and/or C192A mutants display decreased filopodia number. In non-permeabilized cells, these mutant proteins are not recognized by a function-blocking monoclonal antibody directed to M6a. Moreover, neurons in contact with axons expressing C174A/C192A mutant display significantly lower density of presynaptic clusters over their dendrites. Taken together, this study demonstrates that cysteines in the EC2 domain are critical for the role of M6a in filopodium outgrowth and synaptogenesis.	[Frasch, Alberto C.] Consejo Nacl Invest Cient & Tecn, Natl Res Council, RA-1033 Buenos Aires, DF, Argentina; [Fuchsova, Beata; Fernandez, Maria E.; Alfonso, Julieta; Frasch, Alberto C.] Univ Nacl San Martin, Consejo Nacl Invest Cient & Tecn, Inst Invest Biotecnol INTECH, RA-1650 San Martin, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Fuchsova, B (corresponding author), Univ Nacl San Martin, INTI, Inst Invest Biotecnol, Edificio 24,Av Gen Paz 5445, RA-1650 San Martin, Buenos Aires, Argentina.	beata@iib.unsam.edu.ar		Frasch, Alberto Carlos/0000-0001-7532-653X	Howard Hughes Medical Institute; Agencia Nacional de Promocion Cientifica y Tecnologica	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported in part by an international Research Scholars grant from the Howard Hughes Medical Institute (to A. C. F.) and the Agencia Nacional de Promocion Cientifica y Tecnologica.	Alfonso J, 2006, BIOL PSYCHIAT, V59, P244, DOI 10.1016/j.biopsych.2005.06.036; Alfonso J, 2005, P NATL ACAD SCI USA, V102, P17196, DOI 10.1073/pnas.0504262102; Alfonso J, 2004, EUR J NEUROSCI, V19, P659, DOI 10.1111/j.1460-9568.2004.03178.x; Berditchevski F, 2001, J CELL SCI, V114, P4143; Boks MPM, 2008, AM J MED GENET B, V147B, P707, DOI 10.1002/ajmg.b.30667; Brocco M, 2003, J NEUROSCI RES, V74, P744, DOI 10.1002/jnr.10781; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Cooper B, 2008, BRAIN RES, V1197, P1, DOI 10.1016/j.brainres.2007.11.066; DAVIDSON FF, 1994, P NATL ACAD SCI USA, V91, P4029, DOI 10.1073/pnas.91.9.4029; Donohue HS, 2006, NEUROSCIENCE, V140, P597, DOI 10.1016/j.neuroscience.2006.02.072; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Gudz TI, 2002, J NEUROSCI, V22, P7398; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; IWAMOTO R, 1994, EMBO J, V13, P2322, DOI 10.1002/j.1460-2075.1994.tb06516.x; Kazarov AR, 2002, J CELL BIOL, V158, P1299, DOI 10.1083/jcb.200204056; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Kohl S, 1998, ACTA ANAT, V162, P75; Kovalenko OV, 2007, MOL CELL PROTEOMICS, V6, P1855, DOI 10.1074/mcp.M700183-MCP200; Kovalenko OV, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-11; Kovalenko OV, 2004, BIOCHEM J, V377, P407, DOI 10.1042/BJ20031037; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; Latysheva N, 2006, MOL CELL BIOL, V26, P7707, DOI 10.1128/MCB.00849-06; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; Masciopinto F, 2001, VIRUS RES, V80, P1, DOI 10.1016/S0168-1702(01)00245-3; Michibata H, 2008, STEM CELLS DEV, V17, P641, DOI 10.1089/scd.2008.0088; Mukobata S, 2002, BIOCHEM BIOPH RES CO, V297, P722, DOI 10.1016/S0006-291X(02)02284-2; Nishiuchi R, 2005, P NATL ACAD SCI USA, V102, P1939, DOI 10.1073/pnas.0409493102; Roussel G, 1998, J NEUROCYTOL, V27, P695, DOI 10.1023/A:1006924400768; Sandi C, 2003, EUR J NEUROSCI, V17, P2447, DOI 10.1046/j.1460-9568.2003.02675.x; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Sousa N, 2000, NEUROSCIENCE, V97, P253, DOI 10.1016/S0306-4522(00)00050-6; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Stipp CS, 2001, J BIOL CHEM, V276, P40545, DOI 10.1074/jbc.M107338200; Stipp CS, 2001, J BIOL CHEM, V276, P4853, DOI 10.1074/jbc.M009859200; Tarone G, 2000, INT J DEV BIOL, V44, P725; Tarrant JM, 2003, TRENDS IMMUNOL, V24, P610, DOI 10.1016/j.it.2003.09.011; WEIMBS T, 1992, BIOCHEMISTRY-US, V31, P12289, DOI 10.1021/bi00164a002; Werner H, 2001, MOL CELL NEUROSCI, V18, P593, DOI 10.1006/mcne.2001.1044; Wu DF, 2007, J BIOL CHEM, V282, P22239, DOI 10.1074/jbc.M700941200; YAN YM, 1993, NEURON, V11, P423, DOI 10.1016/0896-6273(93)90147-J; Yan YM, 1996, J COMP NEUROL, V370, P465, DOI 10.1002/(SICI)1096-9861(19960708)370:4<465::AID-CNE4>3.0.CO;2-2; Yauch RL, 2000, BIOCHEM J, V351, P629, DOI 10.1042/0264-6021:3510629; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200; Zhao J, 2008, MOL VIS, V14, P1623	51	24	26	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					32075	32088		10.1074/jbc.M109.012377	http://dx.doi.org/10.1074/jbc.M109.012377			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19737934	Green Published, hybrid			2022-12-25	WOS:000271572700062
J	Heyno, E; Gross, CM; Laureau, C; Culcasi, M; Pietri, S; Krieger-Liszkay, A				Heyno, Eiri; Gross, Christine M.; Laureau, Constance; Culcasi, Marcel; Pietri, Sylvia; Krieger-Liszkay, Anja			Plastid Alternative Oxidase (PTOX) Promotes Oxidative Stress When Overexpressed in Tobacco	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; TERMINAL OXIDASE; PHOTOSYSTEM-II; IN-VITRO; SUPEROXIDE-DISMUTASE; PROTEIN-DEGRADATION; PLASTOQUINONE-POOL; ARABIDOPSIS; IMMUTANS; LIGHT	Photoinhibition and production of reactive oxygen species were studied in tobacco plants overexpressing the plastid terminal oxidase (PTOX). In high light, these plants was more susceptible to photoinhibition than wild-type plants. Also oxygen-evolving activity of isolated thylakoid membranes from the PTOX-overexpressing plants was more strongly inhibited in high light than in thylakoids from wild-type plants. In contrast in low light, in the PTOX overexpressor, the thylakoids were protected against photoinhibition while in wild type they were significantly damaged. The production of superoxide and hydroxyl radicals was shown by EPR spin-trapping techniques in the different samples. Superoxide and hydroxyl radical production was stimulated in the overexpressor. Two-thirds of the superoxide production was maintained in the presence of DNPINT, an inhibitor of the cytochrome b(6)f complex. No increase of the SOD content was observed in the overexpressor compared with the wild type. We propose that superoxide is produced by PTOX in a side reaction and that PTOX can only act as a safety valve under stress conditions when the generated superoxide is detoxified by an efficient antioxidant system.	CEA, iBiTecS, Serv Bioenerget Biol Struct & Mecanisme, CNRS,URA 2096, F-91191 Gif Sur Yvette, France; [Laureau, Constance] Univ Paris 11, Lab Ecol Systemat & Evolut, CNRS, UMR 8079,IFR 87, F-91405 Orsay, France; [Culcasi, Marcel; Pietri, Sylvia] CNRS, Sondes Mol Biol Lab Chim Prov, UMR 6264, F-13397 Marseille 20, France	CEA; Centre National de la Recherche Scientifique (CNRS); AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Krieger-Liszkay, A (corresponding author), CEA Saclay, iBiTec S, Bat 532, F-91191 Gif Sur Yvette, France.	anja.krieger-liszkay@cea.fr		Krieger-Liszkay, Anja/0000-0001-7141-4129; PIETRI, SYLVIA/0000-0002-9207-0780; Heyno, Eiri/0000-0003-2172-0341				Affourtit C, 2002, FEBS LETT, V510, P121, DOI 10.1016/S0014-5793(01)03261-6; Aluru MR, 2004, PHYSIOL PLANTARUM, V120, P4, DOI 10.1111/j.0031-9317.2004.0217.x; ANANYEV G, 1994, PHOTOSYNTH RES, V41, P327, DOI 10.1007/BF00019410; Andersson ME, 1999, FEBS LETT, V449, P17, DOI 10.1016/S0014-5793(99)00376-2; Arato A, 2004, BBA-BIOENERGETICS, V1608, P171, DOI 10.1016/j.bbabio.2003.12.003; Berliner LJ, 2001, FREE RADICAL BIO MED, V30, P489, DOI 10.1016/S0891-5849(00)00491-3; Berthold DA, 2000, BBA-BIOENERGETICS, V1460, P241, DOI 10.1016/S0005-2728(00)00149-3; Berthold DA, 2003, ANNU REV PLANT BIOL, V54, P497, DOI 10.1146/annurev.arplant.54.031902.134915; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; Carol P, 1999, PLANT CELL, V11, P57, DOI 10.1105/tpc.11.1.57; Carol P, 2001, TRENDS PLANT SCI, V6, P31, DOI 10.1016/S1360-1385(00)01811-2; Cournac L, 2000, PHILOS T ROY SOC B, V355, P1447, DOI 10.1098/rstb.2000.0705; Culcasi M, 2006, FREE RADICAL BIO MED, V40, P1524, DOI 10.1016/j.freeradbiomed.2005.12.029; Diaz M, 2007, PLANT CELL ENVIRON, V30, P1578, DOI 10.1111/j.1365-3040.2007.01735.x; Dutilleul C, 2003, PLANT CELL, V15, P1212, DOI 10.1105/tpc.009464; FREJAVILLE C, 1995, J MED CHEM, V38, P258, DOI 10.1021/jm00002a007; Fu AG, 2005, J BIOL CHEM, V280, P42489, DOI 10.1074/jbc.M508940200; Ivanov B, 2007, FEBS LETT, V581, P1342, DOI 10.1016/j.febslet.2007.02.044; Joet T, 2002, J BIOL CHEM, V277, P31623, DOI 10.1074/jbc.M203538200; Josse EM, 2003, EUR J BIOCHEM, V270, P3787, DOI 10.1046/j.1432-1033.2003.03766.x; Karoui H, 2002, CHEM COMMUN, P3030, DOI 10.1039/b209787g; Keren N, 1997, P NATL ACAD SCI USA, V94, P1579, DOI 10.1073/pnas.94.4.1579; KEREN N, 1995, J BIOL CHEM, V270, P806, DOI 10.1074/jbc.270.2.806; Kliebenstein DJ, 1998, PLANT PHYSIOL, V118, P637, DOI 10.1104/pp.118.2.637; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; Kruk J, 2001, J BIOL CHEM, V276, P86, DOI 10.1074/jbc.M003602200; Kruk J, 1999, PHOTOSYNTH RES, V62, P273, DOI 10.1023/A:1006374319191; Kuntz M, 2004, PLANTA, V218, P896, DOI 10.1007/s00425-004-1217-6; LAASCH H, 1987, PLANTA, V171, P220, DOI 10.1007/BF00391097; Lennon AM, 2003, PLANTA, V218, P254, DOI 10.1007/s00425-003-1111-7; Nixon Peter J., 2006, V23, P237; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Pospisil P, 2004, BIOCHEMISTRY-US, V43, P6783, DOI 10.1021/bi036219i; Quiles MJ, 2006, PLANT CELL ENVIRON, V29, P1463, DOI 10.1111/j.1365-3040.2006.01510.x; RAMOS CL, 1992, J BIOL CHEM, V267, P8307; Rosso D, 2006, PLANT PHYSIOL, V142, P574, DOI 10.1104/pp.106.085886; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Shahbazi M, 2007, PLANT PHYSIOL, V145, P691, DOI 10.1104/pp.107.106336; Stepien P, 2009, PLANT PHYSIOL, V149, P1154, DOI 10.1104/pp.108.132407; Streb P, 2005, PLANT CELL ENVIRON, V28, P1123, DOI 10.1111/j.1365-3040.2005.01350.x; TREBST A, 1978, Z NATURFORSCH C, V33, P919; WETZEL CM, 1994, PLANT J, V6, P161, DOI 10.1046/j.1365-313X.1994.6020161.x; Wu DY, 1999, PLANT CELL, V11, P43, DOI 10.1105/tpc.11.1.43	44	61	62	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31174	31180		10.1074/jbc.M109.021667	http://dx.doi.org/10.1074/jbc.M109.021667			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740740	Green Published, hybrid			2022-12-25	WOS:000271378400045
J	Ingaramo, M; Beckett, D				Ingaramo, Maria; Beckett, Dorothy			Distinct Amino Termini of Two Human HCS Isoforms Influence Biotin Acceptor Substrate Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLOCARBOXYLASE SYNTHETASE DEFICIENCY; MULTIPLE CARBOXYLASE DEFICIENCY; ESCHERICHIA-COLI; COA CARBOXYLASE; BIOTINYLATION; EXPRESSION; SEQUENCE; PROTEIN; GENE; IDENTIFICATION	The human holocarboxylase synthetase (HCS) catalyzes transfer of biotin to biotin-dependent carboxylases, and the enzyme is therefore of fundamental importance for many physiological processes, including fatty acid synthesis, gluconeogenesis, and amino acid catabolism. In addition, the enzyme functions in regulating transcription initiation at several genes that code for proteins involved in biotin metabolism. Two major forms of HCS exist in humans, which differ at the amino terminus by 57 amino acids. In this work, the two proteins were expressed in Escherichia coli, purified, and subjected to biochemical characterization. Equilibrium sedimentation indicates that the two proteins are monomers both in their apo-forms and when bound to the enzymatic intermediate biotinyl 5'-AMP. Steady state kinetic analyses as a function of biotin, ATP, or a minimal biotin-accepting substrate concentration indicate similar behaviors for both isoforms. However, pre-steady state analysis of biotin transfer reveals that the full-length HCS associates with the minimal biotin acceptor substrate with a rate twice as fast as that of the truncated isoform. These results are consistent with a role for the HCS amino terminus in biotin acceptor substrate recognition.	[Ingaramo, Maria; Beckett, Dorothy] Univ Maryland, Dept Chem & Biochem, Ctr Biol Struct & Org, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Beckett, D (corresponding author), Univ Maryland, Dept Chem & Biochem, Ctr Biol Struct & Org, College Pk, MD 20742 USA.	dbeckett@umd.edu			National Institutes of Health [R01-GM46511, S10-RR15899]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM46511 and S10-RR15899.	ABBOTT J, 1993, BIOCHEMISTRY-US, V32, P9649, DOI 10.1021/bi00088a017; Aoki Y, 1997, PEDIATR RES, V42, P849, DOI 10.1203/00006450-199712000-00021; BAKER H, 1962, ANAL BIOCHEM, V3, P31, DOI 10.1016/0003-2697(62)90041-6; BURRI BJ, 1985, AM J HUM GENET, V37, P326; BURRI BJ, 1981, J CLIN INVEST, V68, P1491, DOI 10.1172/JCI110402; Campeau E, 2001, J BIOL CHEM, V276, P12310, DOI 10.1074/jbc.M009717200; CHAUHAN J, 1991, J BIOL CHEM, V266, P10035; DAKSHINAMURTI K, 1968, ARCH BIOCHEM BIOPHYS, V127, P17, DOI 10.1016/0003-9861(68)90195-1; Eisenstein E, 1999, BIOCHEMISTRY-US, V38, P13077, DOI 10.1021/bi991241q; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Healy S, 2009, PROTEIN SCI, V18, P314, DOI 10.1002/pro.37; Hiratsuka M, 1998, BBA-PROTEIN STRUCT M, V1385, P165, DOI 10.1016/S0167-4838(98)00032-6; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; LANE MD, 1964, J BIOL CHEM, V239, P2865; LEONDELRIO A, 1995, P NATL ACAD SCI USA, V92, P4626, DOI 10.1073/pnas.92.10.4626; LEONDELRIO A, 1994, J BIOL CHEM, V269, P22964; Marblestone JG, 2006, PROTEIN SCI, V15, P182, DOI 10.1110/ps.051812706; MOCK DM, 1981, NEW ENGL J MED, V304, P820, DOI 10.1056/NEJM198104023041405; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Narang MA, 2004, HUM MOL GENET, V13, P15, DOI 10.1093/hmg/ddh006; Nenortas E, 1996, J BIOL CHEM, V271, P7559, DOI 10.1074/jbc.271.13.7559; ROARK DE, 1976, BIOPHYS CHEM, V5, P185, DOI 10.1016/0301-4622(76)80034-8; Sakamoto O, 1999, PEDIATR RES, V46, P671, DOI 10.1203/00006450-199912000-00006; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; SHERWOOD WG, 1982, J PEDIATR-US, V101, P546, DOI 10.1016/S0022-3476(82)80697-5; Solorzano-Vargas RS, 2002, P NATL ACAD SCI USA, V99, P5325, DOI 10.1073/pnas.082097699; SUZUKI Y, 1994, NAT GENET, V8, P122, DOI 10.1038/ng1094-122; SWEETMAN L, 1985, ANN NY ACAD SCI, V447, P288, DOI 10.1111/j.1749-6632.1985.tb18446.x; Tissot G, 1998, EUR J BIOCHEM, V258, P586, DOI 10.1046/j.1432-1327.1998.2580586.x; Yang X, 2001, HUM GENET, V109, P526, DOI 10.1007/s004390100603; Zempleni J, 2005, ANNU REV NUTR, V25, P175, DOI 10.1146/annurev.nutr.25.121304.131724	31	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30862	30870		10.1074/jbc.M109.046201	http://dx.doi.org/10.1074/jbc.M109.046201			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19740736	hybrid, Green Published			2022-12-25	WOS:000271378400014
J	Dettori, R; Sonzogni, S; Meyer, L; Lopez-Garcia, LA; Morrice, NA; Zeuzem, S; Engel, M; Piiper, A; Neimanis, S; Frodin, M; Biondi, RM				Dettori, Rosalia; Sonzogni, Silvina; Meyer, Lucas; Lopez-Garcia, Laura A.; Morrice, Nick A.; Zeuzem, Stefan; Engel, Matthias; Piiper, Albrecht; Neimanis, Sonja; Frodin, Morten; Biondi, Ricardo M.			Regulation of the Interaction between Protein Kinase C-related Protein Kinase 2 (PRK2) and Its Upstream Kinase, 3-Phosphoinositide-dependent Protein Kinase 1 (PDK1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROPHOBIC MOTIF PHOSPHORYLATION; DOCKING-SITE; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; RAT-LIVER; RNA POLYMERASE; BINDING POCKET; AGC KINASES; ACTIVATION; MECHANISM	The members of the AGC kinase family frequently exhibit three conserved phosphorylation sites: the activation loop, the hydrophobic motif (HM), and the zipper (Z)/turn-motif (TM) phosphorylation site. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates the activation loop of numerous AGC kinases, including the protein kinase C-related protein kinases (PRKs). Here we studied the docking interaction between PDK1 and PRK2 and analyzed the mechanisms that regulate this interaction. In vivo labeling of recombinant PRK2 by P-32(i) revealed phosphorylation at two sites, the activation loop and the Z/TM in the C-terminal extension. We provide evidence that phosphorylation of the Z/TM site of PRK2 inhibits its interaction with PDK1. Our studies further provide a mechanistic model to explain different steps in the docking interaction and regulation. Interestingly, we found that the mechanism that negatively regulates the docking interaction of PRK2 to the upstream kinase PDK1 is directly linked to the activation mechanism of PRK2 itself. Finally, our results indicate that the mechanisms underlying the regulation of the interaction between PRK2 and PDK1 are specific for PRK2 and do not apply for other AGC kinases.	[Dettori, Rosalia; Sonzogni, Silvina; Meyer, Lucas; Lopez-Garcia, Laura A.; Zeuzem, Stefan; Piiper, Albrecht; Neimanis, Sonja; Biondi, Ricardo M.] Johann Wolfgang Goethe Univ Hosp, Dept Internal Med 1, Res Grp PhosphoSites, D-60590 Frankfurt, Germany; [Engel, Matthias] Univ Saarland, Dept Pharmaceut & Med Chem, D-66041 Saarbrucken, Germany; [Morrice, Nick A.] Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland; [Frodin, Morten] BRIC, DK-2200 Copenhagen N, Denmark	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Saarland University; University of Dundee	Biondi, RM (corresponding author), Goethe Univ Frankfurt, Dept Internal Med 1, Res Grp PhosphoSites, D-60590 Frankfurt, Germany.	biondi@med.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019	Biondi, Ricardo/0000-0002-8873-7167; Frodin, Morten/0000-0003-3691-9820	Europrofession Foundation; BMBF Go-Bio; DFG [BI 1044/5-1]	Europrofession Foundation; BMBF Go-Bio(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	This work was supported by the Europrofession Foundation (Saarbrucken, Germany), BMBF Go-Bio, and DFG (BI 1044/5-1).	Balendran A, 2000, FEBS LETT, V484, P217, DOI 10.1016/S0014-5793(00)02162-1; Balendran A, 2000, J BIOL CHEM, V275, P20806, DOI 10.1074/jbc.M000421200; Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Campbell David G, 2002, J Biomol Tech, V13, P119; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Engel M, 2006, EMBO J, V25, P5469, DOI 10.1038/sj.emboj.7601416; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; GABRIELLI B, 1984, FEBS LETT, V175, P219, DOI 10.1016/0014-5793(84)80740-1; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Hindie V, 2009, NAT CHEM BIOL, V5, P758, DOI 10.1038/nchembio.208; Huang X, 2003, STRUCTURE, V11, P21, DOI 10.1016/S0969-2126(02)00937-1; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Kim SJ, 2009, J VIRAL HEPATITIS, V16, P697, DOI 10.1111/j.1365-2893.2009.01108.x; Kim SJ, 2004, J BIOL CHEM, V279, P50031, DOI 10.1074/jbc.M408617200; Kitagawa M, 1996, BIOCHEM BIOPH RES CO, V220, P963, DOI 10.1006/bbrc.1996.0515; Lim WG, 2008, ARCH BIOCHEM BIOPHYS, V479, P170, DOI 10.1016/j.abb.2008.09.008; Lim WG, 2006, CELL SIGNAL, V18, P1473, DOI 10.1016/j.cellsig.2005.11.009; Lim WG, 2005, CELL SIGNAL, V17, P1084, DOI 10.1016/j.cellsig.2004.12.003; Mayor F, 2007, CELL CYCLE, V6, P528, DOI 10.4161/cc.6.5.3920; MORRICE NA, 1994, J BIOL CHEM, V269, P20040; MUKAI H, 1994, BIOCHEM BIOPH RES CO, V199, P897, DOI 10.1006/bbrc.1994.1313; Mukai H, 2003, J BIOCHEM, V133, P17, DOI 10.1093/jb/mvg019; PALMER RH, 1995, EUR J BIOCHEM, V227, P344, DOI 10.1111/j.1432-1033.1995.tb20395.x; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Romano RA, 2009, PROTEIN SCI, V18, P1486, DOI 10.1002/pro.146; Schmidt A, 2007, EMBO J, V26, P1624, DOI 10.1038/sj.emboj.7601637; Smith KJ, 2004, STRUCTURE, V12, P1067, DOI 10.1016/j.str.2004.02.040; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yu WP, 1997, J BIOL CHEM, V272, P10030; Zhao B, 2007, PROTEIN SCI, V16, P2761, DOI 10.1110/ps.073161707	39	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30318	30327		10.1074/jbc.M109.051151	http://dx.doi.org/10.1074/jbc.M109.051151			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19723632	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000271090000035
J	Fritsch, A; Spassov, S; Elfert, S; Schlosser, A; Gache, Y; Meneguzzi, G; Bruckner-Tuderman, L				Fritsch, Anja; Spassov, Sashko; Elfert, Susanne; Schlosser, Andreas; Gache, Yannick; Meneguzzi, Guerrino; Bruckner-Tuderman, Leena			Dominant-negative Effects of COL7A1 Mutations Can be Rescued by Controlled Overexpression of Normal Collagen VII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROPHIC EPIDERMOLYSIS-BULLOSA; GENE-THERAPY; PROCOLLAGEN-VII; OSTEOGENESIS IMPERFECTA; ANCHORING FIBRILS; TRIPLE-HELIX; MOUSE MODEL; HUMAN SKIN; MECHANISMS; EXPRESSION	Dominant-negative interference by glycine substitution mutations in the COL7A1 gene causes dominant dystrophic epidermolysis bullosa (DDEB), a skin fragility disorder with mechanically induced blistering. Although qualitative and quantitative alterations of the COL7A1 gene product, collagen VII, underlie DDEB, the lack of direct correlation between mutations and the clinical phenotype has rendered DDEB less amenable to therapeutic targeting. To delineate the molecular mechanisms of DDEB, we used recombinant expression of wildtype (WT) and mutant collagen VII, which contained a naturally occurring COL7A1 mutation, G1776R, G2006D, or G2015E, for characterization of the triple helical molecules. The mutants were co-expressed with WT in equal amounts and could form heterotrimeric hybrid triple helices, as demonstrated by affinity purification and mass spectrometry. The thermal stability of the mutant molecules was strongly decreased, as evident in their sensitivity to trypsin digestion. The helix-to-coil transition, T-m, of the mutant molecules was 31-34 degrees C, and of WT collagen VII 41 degrees C. Co-expression of WT with G1776R- or G2006D-collagen VII resulted in partial intracellular retention of the collagen, and mutant collagen VII had reduced ability to support cell adhesion. Intriguingly, controlled overexpression of WT collagen VII gradually improved the thermal stability of the collective of collagen VII molecules. Co-expression in a ratio of 90% WT:10% mutant increased the T-m to 41 degrees C for G1776R- collagen VII and to 39 degrees C for G2006D- and G2015E-collagen VII. Therefore, increasing the expression of WT collagen VII in the skin of patients with DDEB can be considered a valid therapeutic approach.	[Fritsch, Anja; Spassov, Sashko; Elfert, Susanne; Bruckner-Tuderman, Leena] Univ Med Ctr Freiburg, Dept Dermatol, D-79104 Freiburg, Germany; [Elfert, Susanne] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Bruckner-Tuderman, Leena] Univ Freiburg, LIFENET, Sch Life Sci, FRIAS, D-79104 Freiburg, Germany; [Schlosser, Andreas] Univ Freiburg, Ctr Syst Biol ZBSA, Core Facil Prote, D-79104 Freiburg, Germany; [Gache, Yannick; Meneguzzi, Guerrino] Univ Nice Sophia Antipolis, INSERM U634, F-06103 Nice 2, France	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Bruckner-Tuderman, L (corresponding author), Univ Med Ctr Freiburg, Dept Dermatol, Hauptstr 7, D-79104 Freiburg, Germany.	bruckner-tuderman@uniklinik-freiburg.de	Spassov, Sashko/C-2105-2013	Spassov, Sashko/0000-0002-3585-3682; Meneguzzi, Guerrino/0000-0002-1609-6540; Gache, Yannick/0000-0002-5638-4854	Federal Ministry for Education and Research; BMBF; Debra International; German Research Foundation	Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF)); Debra International; German Research Foundation(German Research Foundation (DFG))	This work was supported in part by grants from the Federal Ministry for Education and Research, BMBF (EB-Network, Project 9), Debra International, and the German Research Foundation (Bioss and FRIAS Lifenet programs).	BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; BRUCKNERTUDERMAN L, 1995, J CELL BIOL, V131, P551, DOI 10.1083/jcb.131.2.551; BURGESON RE, 1993, J INVEST DERMATOL, V101, P252, DOI 10.1111/1523-1747.ep12365129; Cao TY, 2001, J CELL BIOL, V152, P651, DOI 10.1083/jcb.152.3.651; Chen M, 1997, J BIOL CHEM, V272, P14516, DOI 10.1074/jbc.272.23.14516; Conese M, 2004, GENE THER, V11, P1735, DOI 10.1038/sj.gt.3302362; Dharma B, 2001, CLIN EXP DERMATOL, V26, P93, DOI 10.1046/j.1365-2230.2001.0801.x; Fine JD, 2008, J AM ACAD DERMATOL, V58, P931, DOI 10.1016/j.jaad.2008.02.004; Fritsch A, 2008, J CLIN INVEST, V118, P1669, DOI 10.1172/JCI34292; Gache Y, 2004, HUM GENE THER, V15, P921, DOI 10.1089/hum.2004.15.921; Goto M, 2006, J INVEST DERMATOL, V126, P2614, DOI 10.1038/sj.jid.5700435; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Hammami-Hauasli N, 1998, J BIOL CHEM, V273, P19228, DOI 10.1074/jbc.273.30.19228; Has C, 2008, EXPERT REV DERMATOL, V3, P721; Hengge UR, 2008, J INVEST DERMATOL, V128, P499, DOI 10.1038/sj.jid.5701241; Hyde TJ, 2006, J BIOL CHEM, V281, P36937, DOI 10.1074/jbc.M605135200; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Kern JS, 2009, MOL THER, V17, P1605, DOI 10.1038/mt.2009.144; Kern JS, 2006, J INVEST DERMATOL, V126, P1006, DOI 10.1038/sj.jid.5700219; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; Marini S, 2000, J BIOL CHEM, V275, P18657, DOI 10.1074/jbc.M000283200; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Mecklenbeck S, 2002, HUM GENE THER, V13, P1655, DOI 10.1089/10430340260201743; Mecklenbeck S, 1999, J INVEST DERMATOL, V112, P398, DOI 10.1046/j.1523-1747.1999.00518.x; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Ortiz-Urda S, 2002, NAT MED, V8, P1166, DOI 10.1038/nm766; Pace RA, 2008, ANN NEUROL, V64, P294, DOI 10.1002/ana.21439; Persikov AV, 2004, HUM MUTAT, V24, P330, DOI 10.1002/humu.20091; Rattenholl A, 2002, J BIOL CHEM, V277, P26372, DOI 10.1074/jbc.M203247200; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Villone D, 2008, J BIOL CHEM, V283, P24506, DOI 10.1074/jbc.M802415200; Vindevoghel L, 1997, J BIOL CHEM, V272, P10196; Woodley DT, 2008, J BIOL CHEM, V283, P17838, DOI 10.1074/jbc.M709452200; Xu K, 2008, J BIOL CHEM, V283, P34337, DOI 10.1074/jbc.M805485200	34	35	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30248	30256		10.1074/jbc.M109.045294	http://dx.doi.org/10.1074/jbc.M109.045294			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726672	Green Published, hybrid			2022-12-25	WOS:000271090000028
J	Gray, CH; McGarry, LC; Spence, HJ; Riboldi-Tunnicliffe, A; Ozanne, BW				Gray, Christopher H.; McGarry, Lynn C.; Spence, Heather J.; Riboldi-Tunnicliffe, Alan; Ozanne, Bradford W.			Novel beta-Propeller of the BTB-Kelch Protein Krp1 Provides a Binding Site for Lasp-1 That Is Necessary for Pseudopodial Extension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPEAT SUPERFAMILY; SUBSTRATE ADAPTER; CRYSTAL-STRUCTURE; KEAP1; UBIQUITINATION; PATHWAY; TARGETS; DOMAIN; PROTHYMOSIN; EXPRESSION	Kelch-related protein 1 (Krp1) is up-regulated in oncogene-transformed fibroblasts. The Kelch repeats interact directly with the actin-binding protein Lasp-1 in membrane ruffles at the tips of pseudopodia, where both proteins are necessary for pseudopodial elongation. Herein, we investigate the molecular basis for this interaction. Probing an array of overlapping decapeptides of Rattus norvegicus ( Rat) Krp1 with recombinant Lasp-1 revealed two binding sites; one ((YDPMENECYLT327)-Y-317) precedes the first of five Kelch repeats, and the other ((TEVNDIWKYEDD574)-T-563) is in the last of the five Kelch repeats. Mutational analysis established that both binding sites are necessary for Krp1-Lasp-1 interaction in vitro and function in vivo. The crystal structure of the C-terminal domain of rat Krp1 (amino acids 289-606) reveals that both binding sites are brought into close proximity by the formation of a novel six-bladed beta-propeller, where the first blade is not formed by a Kelch repeat.	[Gray, Christopher H.; McGarry, Lynn C.; Spence, Heather J.; Ozanne, Bradford W.] Beatson Inst Canc Res, Invas & Metastasis Lab, Glasgow G61 1BD, Lanark, Scotland; [Riboldi-Tunnicliffe, Alan] Univ Glasgow, Dept Chem, Fac Biol Life Sci, Glasgow G12 8QQ, Lanark, Scotland	Beatson Institute; University of Glasgow	Gray, CH (corresponding author), Beatson Inst Canc Res, Invas & Metastasis Lab, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	c.gray@beatson.gla.ac.uk		Riboldi-Tunnicliffe, Alan/0000-0003-2244-2486	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK ( to B. W. O.).	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beamer LJ, 2005, ACTA CRYSTALLOGR D, V61, P1335, DOI [10.1107/S0907444905022626, 10.1107/S090744905022626]; BORK P, 1994, J MOL BIOL, V236, P1277, DOI 10.1016/0022-2836(94)90056-6; Chew CS, 1998, AM J PHYSIOL-CELL PH, V275, pC56, DOI 10.1152/ajpcell.1998.275.1.C56; Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Greenberg CC, 2008, EXP CELL RES, V314, P1177, DOI 10.1016/j.yexcr.2007.12.009; Grunewald TGP, 2007, BRIT J CANCER, V96, P296, DOI 10.1038/sj.bjc.6603545; Grunewald TGP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-31; HENNIGAN RF, 1994, ONCOGENE, V9, P3591; ITO N, 1994, J MOL BIOL, V238, P794, DOI 10.1006/jmbi.1994.1335; Karapetian RN, 2005, MOL CELL BIOL, V25, P1089, DOI 10.1128/MCB.25.3.1089-1099.2005; Li XC, 2004, J BIOL CHEM, V279, P54750, DOI 10.1074/jbc.M410073200; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Lu SJ, 2003, J CELL SCI, V116, P2169, DOI 10.1242/jcs.00425; Padmanabhan B, 2008, ACTA CRYSTALLOGR F, V64, P233, DOI 10.1107/S1744309108004995; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Rondou P, 2008, J BIOL CHEM, V283, P11083, DOI 10.1074/jbc.M708473200; Salinas GD, 2006, J BIOL CHEM, V281, P40164, DOI 10.1074/jbc.M608194200; Spence HJ, 2006, MOL CELL BIOL, V26, P1480, DOI 10.1128/MCB.26.4.1480-1495.2006; Spence HJ, 2000, ONCOGENE, V19, P1266, DOI 10.1038/sj.onc.1203433; Taylor A, 1998, MOL CELL BIOCHEM, V183, P105, DOI 10.1023/A:1006824331819; TOMASETTO C, 1995, FEBS LETT, V373, P245, DOI 10.1016/0014-5793(95)01040-L; VARKEY JP, 1995, GENE DEV, V9, P1074, DOI 10.1101/gad.9.9.1074; Williams SK, 2005, J NEUROSCI RES, V81, P622, DOI 10.1002/jnr.20588; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200	31	26	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30498	30507		10.1074/jbc.M109.023259	http://dx.doi.org/10.1074/jbc.M109.023259			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726686	Green Published, hybrid			2022-12-25	WOS:000271090000052
J	Khan, MA; Walden, WE; Goss, DJ; Theil, EC				Khan, Mateen A.; Walden, William E.; Goss, Dixie J.; Theil, Elizabeth C.			Direct Fe2+ Sensing by Iron-responsive Messenger RNA.Repressor Complexes Weakens Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FERRITIN IRE-RNA; REGULATORY PROTEINS; TRANSLATIONAL CONTROL; HAIRPIN LOOP; MITOCHONDRIAL ACONITASE; INTERNAL LOOP/BULGE; MOLECULAR CONTROL; NMR-SPECTROSCOPY; RIBOSOMAL-RNA; METAL-ION	Fe2+ is now shown to weaken binding between ferritin and mitochondrial aconitase messenger RNA noncoding regulatory structures ((iron-responsive element) (IRE)-RNAs) and the regulatory proteins (IRPs), which adds a direct role of iron to regulation that can complement the well known regulatory protein modification and degradative pathways related to iron-induced mRNA translation. We observe that the K-d value increases 17-fold in 5'-untranslated region IRE-RNA.repressor complexes; Fe2+, is studied in the absence of O-2. Other metal ions, Mn2+ and Mg2+ have similar effects to Fe2+ but the required Mg2+ concentration is 100 times greater than for Fe2+ or Mn2+. Metal ions also weaken ethidium bromide binding to IRE-RNA with no effect on IRP fluorescence, using Mn2+ as an O-2-resistant surrogate for Fe2+, indicating that metal ions bound IRERNA but not IRP. Fe2+ decreases IRP repressor complex stability of ferritin IRE-RNA 5-10 times compared with 2-5 times for mitochondrial aconitase IRE-RNA, over the same concentration range, suggesting that differences among IRE-RNA structures contribute to the differences in the iron responses observed in vivo. The results show the IRE-RNA.repressor complex literally responds to Fe2+, selectively for each IRE-mRNA.	[Khan, Mateen A.; Goss, Dixie J.] CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA; [Walden, William E.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Theil, Elizabeth C.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Theil, Elizabeth C.] Univ Calif Berkeley, Dept Nutr Sci & Toxicolol, Berkeley, CA 94720 USA	City University of New York (CUNY) System; Hunter College (CUNY); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California Berkeley	Goss, DJ (corresponding author), 695 Pk Ave, New York, NY 10065 USA.	dgoss@hunter.cuny.edu; etheil@chori.org		Khan, Mateen A./0000-0002-2300-4595	National Institutes of Health [DK20251, DK47281]; National Science Foundation [MCB0814051]; Professional Staff Congress-City University of New York Faculty Award; Children's Hospital Oakland Research Institute Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047281, R37DK020251, R01DK020251, R56DK020251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Professional Staff Congress-City University of New York Faculty Award; Children's Hospital Oakland Research Institute Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK20251 (to E. C. T.) and DK47281 (to W. E. W.). This work was also supported by National Science Foundation Grant MCB0814051 (to D. J. G. and M. K.), a Professional Staff Congress-City University of New York Faculty Award (to D. J. G.), and the Children's Hospital Oakland Research Institute Foundation (to E. C. T.).	Addess KJ, 1997, J MOL BIOL, V274, P72, DOI 10.1006/jmbi.1997.1377; Butt J, 1996, P NATL ACAD SCI USA, V93, P4345, DOI 10.1073/pnas.93.9.4345; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; Coppins RL, 2007, CURR OPIN MICROBIOL, V10, P176, DOI 10.1016/j.mib.2007.03.006; Deck KM, 2009, J BIOL CHEM, V284, P12701, DOI 10.1074/jbc.M807717200; DICKEY LF, 1988, J BIOL CHEM, V263, P3071; DIX DJ, 1993, J MOL BIOL, V231, P230, DOI 10.1006/jmbi.1993.1278; Erlitzki R, 2002, J BIOL CHEM, V277, P42579, DOI 10.1074/jbc.M207918200; Firpo MA, 1996, J BIOL CHEM, V271, P4693; Gdaniec Z, 1998, BIOCHEMISTRY-US, V37, P1505, DOI 10.1021/bi9719814; Gunshin H, 2001, FEBS LETT, V509, P309, DOI 10.1016/S0014-5793(01)03189-1; GUO B, 1994, J BIOL CHEM, V269, P24252; HARRELL CM, 1991, P NATL ACAD SCI USA, V88, P4166, DOI 10.1073/pnas.88.10.4166; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hintze KJ, 2005, P NATL ACAD SCI USA, V102, P15048, DOI 10.1073/pnas.0505148102; Hintze KJ, 2007, J BIOL CHEM, V282, P34365, DOI 10.1074/jbc.M700254200; Ke YH, 1998, J BIOL CHEM, V273, P23637, DOI 10.1074/jbc.273.37.23637; Ke YH, 2000, BIOCHEMISTRY-US, V39, P6235, DOI 10.1021/bi9924765; Khan MA, 2008, J BIOL CHEM, V283, P1340, DOI 10.1074/jbc.M703356200; Kim HY, 1996, J BIOL CHEM, V271, P24226, DOI 10.1074/jbc.271.39.24226; Laing LG, 1996, BIOCHEMISTRY-US, V35, P13586, DOI 10.1021/bi961310q; Leipuviene R, 2007, CELL MOL LIFE SCI, V64, P2945, DOI 10.1007/s00018-007-7198-4; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lipfert J, 2007, J MOL BIOL, V365, P1393, DOI 10.1016/j.jmb.2006.10.022; Martick M, 2008, NATURE, V454, P899, DOI 10.1038/nature07117; MELEFORS O, 1993, J BIOL CHEM, V268, P5974; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Nelson JA, 2008, RNA, V14, P605, DOI 10.1261/rna.912608; Oshikane H, 2006, SCIENCE, V312, P1950, DOI 10.1126/science.1128470; Phillips JD, 1996, BIOCHEMISTRY-US, V35, P15704, DOI 10.1021/bi960653l; Piccinelli P, 2007, RNA, V13, P952, DOI 10.1261/rna.464807; Rangan P, 2004, J MOL BIOL, V339, P41, DOI 10.1016/j.jmb.2004.03.059; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Selezneva AI, 2006, ACTA CRYSTALLOGR F, V62, P249, DOI 10.1107/S1744309106004192; Shenvi CL, 2005, RNA, V11, P1898, DOI 10.1261/rna.2192805; SIERZPUTOWSKAGRACZ H, 1995, NUCLEIC ACIDS RES, V23, P146, DOI 10.1093/nar/23.1.146; Theil EC, 2000, J BIOL CHEM, V275, P40659, DOI 10.1074/jbc.R000019200; Thorp HH, 1996, INORG CHEM, V35, P2773, DOI 10.1021/ic951094u; Vicens Q, 2008, RNA, V14, P2013, DOI 10.1261/rna.1027208; Vogt M, 2006, J AM CHEM SOC, V128, P16764, DOI 10.1021/ja057035p; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang B, 2008, BIOCHEMISTRY-US, V47, P3454, DOI 10.1021/bi702372x; WANG YH, 1990, NUCLEIC ACIDS RES, V18, P4463, DOI 10.1093/nar/18.15.4463; ZAHRINGER J, 1976, P NATL ACAD SCI USA, V73, P857, DOI 10.1073/pnas.73.3.857	46	30	30	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30122	30128		10.1074/jbc.M109.041061	http://dx.doi.org/10.1074/jbc.M109.041061			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19720833	hybrid, Green Published			2022-12-25	WOS:000271090000015
J	Kienesberger, PC; Lee, D; Pulinilkunnil, T; Brenner, DS; Cai, LZ; Magnes, C; Koefeler, HC; Streith, IE; Rechberger, GN; Haemmerle, G; Flier, JS; Zechner, R; Kim, YB; Kershaw, EE				Kienesberger, Petra C.; Lee, Daeho; Pulinilkunnil, Thomas; Brenner, Daniel S.; Cai, Lingzhi; Magnes, Christoph; Koefeler, Harald C.; Streith, Ingo E.; Rechberger, Gerald N.; Haemmerle, Guenter; Flier, Jeffrey S.; Zechner, Rudolf; Kim, Young-Bum; Kershaw, Erin E.			Adipose Triglyceride Lipase Deficiency Causes Tissue-specific Changes in Insulin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; TRIACYLGLYCEROL LIPASE; GLUCOSE-HOMEOSTASIS; LIPID-ACCUMULATION; ENERGY-METABOLISM; KNOCKOUT MICE; RESISTANCE; LIPOTOXICITY; SENSITIVITY; PROTEIN	Triacylglycerol accumulation in insulin target tissues is associated with insulin resistance. Paradoxically, mice with global targeted deletion of adipose triglyceride lipase (ATGL), the rate-limiting enzyme in triacylglycerol hydrolysis, display improved glucose tolerance and insulin sensitivity despite triacylglycerol accumulation in multiple tissues. To determine the molecular mechanisms for this phenotype, ATGL-deficient (ATGL(-/-)) and wild-type mice were injected with saline or insulin (10 units/kg, intraperitoneally), and then phosphorylation and activities of key insulin-signaling proteins were determined in insulin target tissues (liver, adipose tissue, and muscle). Insulin signaling and/or glucose transport was also evaluated in isolated adipocytes and skeletal muscle ex vivo. In ATGL(-/-) mice, insulin-stimulated phosphatidylinositol 3-kinase and Akt activities as well as phosphorylation of critical residues of IRS1 (Tyr(P)-612) and Akt (Ser(P)-473) were increased in skeletal muscle in vivo. Insulin-stimulated phosphatidylinositol 3-kinase activity and total insulin receptor and insulin receptor substrate 1, but not other parameters, were also increased in white adipose tissue in vivo. In contrast, in vivo measures of insulin signaling were decreased in brown adipose tissue and liver. Interestingly, the enhanced components of insulin signaling identified in skeletal muscle and white adipose tissue in vivo and their expected downstream effects on glucose transport were not present ex vivo. ATGL deficiency altered intramyocellular lipids as well as serum factors known to influence insulin sensitivity. Thus, skeletal muscle, rather than other tissues, primarily contributes to enhanced insulin sensitivity in ATGL(-/-) mice in vivo despite triacylglycerol accumulation, and both local and systemic factors contribute to tissue-specific effects of global ATGL deficiency on insulin action.	[Kienesberger, Petra C.; Streith, Ingo E.; Rechberger, Gerald N.; Haemmerle, Guenter; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Kienesberger, Petra C.; Lee, Daeho; Brenner, Daniel S.; Flier, Jeffrey S.; Kim, Young-Bum; Kershaw, Erin E.] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol & Metab, Boston, MA 02215 USA; [Kienesberger, Petra C.; Lee, Daeho; Brenner, Daniel S.; Flier, Jeffrey S.; Kim, Young-Bum] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Lee, Daeho] Cheju Natl Univ, Coll Med, Dept Internal Med, Cheju 690756, South Korea; [Pulinilkunnil, Thomas] Univ Alberta, Fac Med & Dent, Dept Pediat, Cardiovasc Res Ctr, Edmonton, AB T6G 2S2, Canada; [Cai, Lingzhi; Kershaw, Erin E.] Univ Pittsburgh, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA 15261 USA; [Magnes, Christoph] Inst Med Technol & Hlth Management, A-8036 Graz, Austria; [Koefeler, Harald C.] Med Univ Graz, Med Res Ctr, Core Facil Mass Spectrometry Lipid, A-8010 Graz, Austria	University of Graz; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Jeju National University; University of Alberta; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical University of Graz	Kim, YB (corresponding author), 330 Brookline Ave,CLS-736, Boston, MA 02215 USA.	ykim2@bidmc.harvard.edu; kershawe@pitt.edu	Pulinilkunnil, Thomas C/L-5511-2016; Pulinilkunnil, Thomas/H-4387-2019; Kershaw, Erin E/G-9587-2013; Flier, jeffrey/AAG-6223-2019	Pulinilkunnil, Thomas C/0000-0003-1228-893X; Pulinilkunnil, Thomas/0000-0003-1228-893X; Kershaw, Erin E/0000-0002-3887-4868; Zechner, Rudolf/0000-0001-5483-1182; Kofeler, Harald/0000-0002-2725-9616; Haemmerle, Guenter/0000-0001-9900-5896; Magnes, Christoph/0000-0002-5153-7444; Rechberger, Gerald N./0000-0002-0071-317X; Kienesberger, Petra/0000-0001-9643-8338	National Institutes of Health [K08-DK065833, R03-DK077697, R37-DK028082, DK043051, P30-DK57521]; Austrian Ministry of Science and Research [F30]; Wittgenstein Award [Z136]; Austrian Science Foundation [W901]; American Diabetes Association [1-09-RA-87]; Austrian Science Fund (FWF) [Z 136, W 901, F 3002] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043051, K08DK065833, R37DK028082, P30DK057521, R37DK043051, R03DK077697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Ministry of Science and Research; Wittgenstein Award(Austrian Science Fund (FWF)); Austrian Science Foundation(Austrian Science Fund (FWF)); American Diabetes Association(American Diabetes Association); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K08-DK065833 and R03-DK077697 (to E. E. K.), R37-DK028082 (to J. S. F.), DK043051 (to Y. B. K.), and P30-DK57521 (to the Beth Israel Deaconess Medical Center Metabolic Physiology Core Facility). This work was also supported by Austrian Ministry of Science and Research GEN-AU Grant GOLD-Genomics of Lipid-associated Disorders (to R. Z.), F30 (SFB LIPOTOX) (to R. Z.), Wittgenstein Award Z136 (to R. Z.), Austrian Science Foundation Grant W901 DK (to R. Z. and P. C. K.), and American Diabetes Association Grant 1-09-RA-87 (to Y. B. K.).	Adamo KB, 1998, J APPL PHYSIOL, V84, P908, DOI 10.1152/jappl.1998.84.3.908; CUSHMAN SW, 1978, J LIPID RES, V19, P269; CZECH MP, 1976, J CLIN INVEST, V57, P1523, DOI 10.1172/JCI108422; FOLCH J, 1957, J BIOL CHEM, V226, P497; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Guan XL, 2006, YEAST, V23, P465, DOI 10.1002/yea.1362; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kahn CR, 2000, J PEDIATR ENDOCR MET, V13, P1377; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim YB, 1999, J CLIN INVEST, V104, P733, DOI 10.1172/JCI6928; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; KOOPMANS SJ, 1995, METABOLISM, V44, P291, DOI 10.1016/0026-0495(95)90157-4; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Levin MC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1772, DOI 10.1152/ajpendo.00158.2007; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Machann J, 2004, DIABETES OBES METAB, V6, P239, DOI 10.1111/j.1462-8902.2004.00339.x; Magnes C, 2008, ANAL CHEM, V80, P5736, DOI 10.1021/ac800031u; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Minokoshi Y, 2003, J BIOL CHEM, V278, P33609, DOI 10.1074/jbc.R300019200; Park SY, 2005, AM J PHYSIOL-ENDOC M, V289, pE30, DOI 10.1152/ajpendo.00251.2004; Peyot ML, 2009, J BIOL CHEM, V284, P16848, DOI 10.1074/jbc.M109.006650; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Timmers S, 2008, PHYSIOL BEHAV, V94, P242, DOI 10.1016/j.physbeh.2007.12.002; Tozzo E, 1997, ENDOCRINOLOGY, V138, P1604, DOI 10.1210/en.138.4.1604; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Voshol PJ, 2003, ENDOCRINOLOGY, V144, P3456, DOI 10.1210/en.2002-0036; Wolf G, 2007, NUTR REV, V65, P251, DOI 10.1111/j.1753-4887.2007.tb00302.x; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	41	95	99	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30218	30229		10.1074/jbc.M109.047787	http://dx.doi.org/10.1074/jbc.M109.047787			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19723629	hybrid, Green Published			2022-12-25	WOS:000271090000025
J	Wen, KK; Rubenstein, PA; DeMali, KA				Wen, Kuo-Kuang; Rubenstein, Peter A.; DeMali, Kris A.			Vinculin Nucleates Actin Polymerization and Modifies Actin Filament Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE THIN-FILAMENTS; COUPLING MEMBRANE PROTRUSION; F-ACTIN; ALPHA-ACTININ; ARP2/3 COMPLEX; 3-DIMENSIONAL RECONSTRUCTION; INTRAMOLECULAR ASSOCIATION; CYTOSKELETAL PROTEIN; MYOSIN SUBFRAGMENT-1; SKELETAL-MUSCLE	Vinculin links integrins to the actin cytoskeleton by binding F-actin. Little is known with respect to how this interaction occurs or affects actin dynamics. Here we assess the consequence of the vinculin tail (VT) on actin dynamics by examining its binding to monomeric and filamentous yeast actins. VT causes pyrene-labeled G-actin to polymerize in low ionic strength buffer (G-buffer), conditions that normally do not promote actin polymerization. Analysis by electron microscopy shows that, under these conditions, the filaments form small bundles at low VT concentrations, which gradually increase in size until saturation occurs at a ratio of 2 VT:1 actin. Addition of VT to pyrene-labeled mutant yeast G-actin (S265C) produced a fluorescence excimer band, which requires a relatively normal filament geometry. In higher ionic strength polymerization-promoting F-buffer, substoichiometric amounts of VT accelerate the polymerization of pyrene-labeled WT actin. However, the amplitude of the pyrene fluorescence caused by actin polymerization is quenched as the VT concentration increases without an effect on net actin polymerization as determined by centrifugation assays. Finally, addition of VT to preformed pyrene-labeled S265C F-actin causes a concentration-dependent decrease in the maximum amplitude of the pyrene fluorescence band demonstrating the ability of VT to remodel the conformation of the actin filament. These observations support the idea that vinculin can link adhesion plaques to the cytoskeleton by initiating the formation of bundled actin filaments or by remodeling existing filaments.	[Wen, Kuo-Kuang; Rubenstein, Peter A.; DeMali, Kris A.] Univ Iowa, Dept Biochem, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	DeMali, KA (corresponding author), Univ Iowa, Dept Biochem, Roy J & Lucille A Carver Coll Med, 51 Newton Rd,4-470 BSB, Iowa City, IA 52242 USA.	kris-demali@uiowa.edu		DeMali, Kris/0000-0003-0906-1371; Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health [1K01CA111818, GM33689]; American Cancer Society [115274]; NATIONAL CANCER INSTITUTE [K01CA111818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1K01CA111818 (to K. A. D.) and GM33689 (to P. A. R.). This work was also supported by American Cancer Society Research Scholar Grant 115274 (to K. A. D.).	Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bamburg JR, 1999, TRENDS CELL BIOL, V9, P364, DOI 10.1016/S0962-8924(99)01619-0; Bobkov AA, 2004, J MOL BIOL, V337, P93, DOI 10.1016/j.jmb.2004.01.014; BRETSCHER A, 1981, P NATL ACAD SCI-BIOL, V78, P6849, DOI 10.1073/pnas.78.11.6849; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; COOK RK, 1993, J BIOL CHEM, V268, P2410; DeMali KA, 2003, J CELL SCI, V116, P2389, DOI 10.1242/jcs.00605; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; DETMERS P, 1981, J BIOL CHEM, V256, P99; Esue O, 2008, J MOL BIOL, V384, P324, DOI 10.1016/j.jmb.2008.09.043; Feng L, 1997, J BIOL CHEM, V272, P16829, DOI 10.1074/jbc.272.27.16829; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Goldmann WH, 1998, EUR J BIOCHEM, V254, P413, DOI 10.1046/j.1432-1327.1998.2540413.x; GRAZI E, 1980, FEBS LETT, V112, P67, DOI 10.1016/0014-5793(80)80129-3; Hodgkinson JL, 1997, J MOL BIOL, V273, P150, DOI 10.1006/jmbi.1997.1307; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Huttelmaier S, 1997, EUR J BIOCHEM, V247, P1136, DOI 10.1111/j.1432-1033.1997.01136.x; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; JOCKUSCH BM, 1981, P NATL ACAD SCI-BIOL, V78, P3005, DOI 10.1073/pnas.78.5.3005; Johnson RP, 2000, J BIOL CHEM, V275, P95, DOI 10.1074/jbc.275.1.95; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; LEHMAN W, 1994, NATURE, V368, P65, DOI 10.1038/368065a0; LEHMAN W, 1995, J MOL BIOL, V251, P191, DOI 10.1006/jmbi.1995.0425; MCGOUGH A, 1994, J CELL BIOL, V126, P433, DOI 10.1083/jcb.126.2.433; MENKEL AR, 1994, J CELL BIOL, V126, P1231, DOI 10.1083/jcb.126.5.1231; MILLER L, 1988, J BIOL CHEM, V263, P1996; Moese S, 2007, CELL MICROBIOL, V9, P1148, DOI 10.1111/j.1462-5822.2006.00856.x; Mullins RD, 1997, J CELL BIOL, V136, P331, DOI 10.1083/jcb.136.2.331; Nolz JC, 2007, MOL CELL BIOL, V27, P5986, DOI 10.1128/MCB.00136-07; ORIOLAUDIT C, 1978, EUR J BIOCHEM, V87, P371, DOI 10.1111/j.1432-1033.1978.tb12386.x; OTTO JJ, 1986, CELL MOTIL CYTOSKEL, V6, P48, DOI 10.1002/cm.970060107; PARDO JV, 1983, P NATL ACAD SCI-BIOL, V80, P1008, DOI 10.1073/pnas.80.4.1008; PARDO JV, 1983, J CELL BIOL, V97, P1081, DOI 10.1083/jcb.97.4.1081; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; ROSENFELD GC, 1985, J CELL BIOL, V100, P669, DOI 10.1083/jcb.100.3.669; Schindeler A, 2005, EXP CELL RES, V307, P367, DOI 10.1016/j.yexcr.2005.04.006; SCHRODER RR, 1993, NATURE, V364, P171, DOI 10.1038/364171a0; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Sowa GZ, 2006, J PHYS CHEM B, V110, P22279, DOI 10.1021/jp063371w; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Steimle PA, 1999, J BIOL CHEM, V274, P18414, DOI 10.1074/jbc.274.26.18414; Tseng Y, 2004, J BIOL CHEM, V279, P1819, DOI 10.1074/jbc.M306090200; Tseng Y, 2001, J MOL BIOL, V310, P351, DOI 10.1006/jmbi.2001.4716; VIBERT P, 1993, J CELL BIOL, V123, P313, DOI 10.1083/jcb.123.2.313; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Weekes J, 1996, BIOCHEM J, V314, P827, DOI 10.1042/bj3140827; Wen KK, 2008, J BIOL CHEM, V283, P9444, DOI 10.1074/jbc.M709806200; Wen KK, 2009, J BIOL CHEM, V284, P16776, DOI 10.1074/jbc.M109.006981; WILKINS JA, 1982, CELL, V28, P83, DOI 10.1016/0092-8674(82)90377-4; WILKINS JA, 1986, J CELL BIOL, V102, P1085, DOI 10.1083/jcb.102.3.1085; Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200; Zimerman B, 2004, CELL MOTIL CYTOSKEL, V58, P143, DOI 10.1002/cm.20005	55	56	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30463	30473		10.1074/jbc.M109.021295	http://dx.doi.org/10.1074/jbc.M109.021295			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19736312	Green Published, hybrid			2022-12-25	WOS:000271090000049
J	Qi, Q; August, A				Qi, Qian; August, Avery			The Tec Family Kinase Itk Exists as a Folded Monomer in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL RECEPTOR; BRUTONS TYROSINE KINASE; CYCLOPHILIN-A; REGULATORY DOMAINS; STRUCTURAL BASIS; HOMOLOGY DOMAIN; ACTIVE ITK; ACTIVATION; SRC; BTK	Tec family tyrosine kinases transduce signals from antigen and other receptors. In particular, Itk plays an important role in T-cell development and activation. Itk has an N-terminal pleckstrin homology domain, a Tec Homology domain with a proline-rich region, SH3 and SH2 domains and a kinase domain, the structure each of which has been determined. However, the full structure of Itk and other Tec kinases remain elusive. Models of Itk suggest either a head to tail dimer, with the SH2 domain interacting with the SH3 domain, or a folded monomer with the SH3 domain interacting with the proline-rich region. We show here that in vivo Itk exists as a monomer, with the pleckstrin homology domain less than 80 angstrom from the C terminus. Zn2+ coordinating residues in the Tec Homology domain, not the proline-rich region, are critical for this intramolecular interaction. These data have implications for our understanding of Tec family kinase structure.	[August, Avery] Penn State Univ, Ctr Mol Immunol & Infect Dis, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Qi, Qian] Penn State Univ, Immunol & Infect Dis Grad Program, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	August, A (corresponding author), Penn State Univ, Ctr Mol Immunol & Infect Dis, Dept Vet & Biomed Sci, 115 Henning Bldg, University Pk, PA 16802 USA.	axa45@psu.edu	Qi, Qian/E-7454-2012		National Institutes of Health [AI51626, AI065566]; Pennsylvania Dept. of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051626, R01AI065566, R56AI065566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Dept. of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI51626 and AI065566 (to A. A.). The Center for Molecular Immunology and Infectious Disease at Penn State was supported in part by a grant from the Pennsylvania Dept. of Health.	Andreotti AH, 1997, NATURE, V385, P93, DOI 10.1038/385093a0; Au-Yeung BB, 2007, J IMMUNOL, V179, P111, DOI 10.4049/jimmunol.179.1.111; Au-Yeung BB, 2006, J IMMUNOL, V176, P3895, DOI 10.4049/jimmunol.176.7.3895; August A, 2002, INT J BIOCHEM CELL B, V34, P1184, DOI 10.1016/S1357-2725(02)00068-7; AUGUST A, 1994, P NATL ACAD SCI USA, V91, P9347, DOI 10.1073/pnas.91.20.9347; August A, 1997, P NATL ACAD SCI USA, V94, P11227, DOI 10.1073/pnas.94.21.11227; Bence K, 1997, NATURE, V389, P296, DOI 10.1038/38520; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Braaten D, 2001, EMBO J, V20, P1300, DOI 10.1093/emboj/20.6.1300; Brazin KN, 2000, J MOL BIOL, V302, P607, DOI 10.1006/jmbi.2000.4091; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Broussard C, 2006, IMMUNITY, V25, P93, DOI 10.1016/j.immuni.2006.05.011; Bunnell SC, 1996, J BIOL CHEM, V271, P25646, DOI 10.1074/jbc.271.41.25646; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Ching KA, 2000, J IMMUNOL, V165, P256, DOI 10.4049/jimmunol.165.1.256; Colgan J, 2004, IMMUNITY, V21, P189, DOI 10.1016/j.immuni.2004.07.005; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Gibson S, 1996, J BIOL CHEM, V271, P7079, DOI 10.1074/jbc.271.12.7079; Gonfloni S, 2000, NAT STRUCT BIOL, V7, P281; Hao SL, 2006, FEBS LETT, V580, P2691, DOI 10.1016/j.febslet.2006.04.023; Hao SL, 2002, FEBS LETT, V525, P53, DOI 10.1016/S0014-5793(02)03066-1; Hu JF, 2008, J IMMUNOL, V180, P6544, DOI 10.4049/jimmunol.180.10.6544; Hu J, 2007, EUR J IMMUNOL, V37, P2892, DOI 10.1002/eji.200737311; Hyvonen M, 1997, EMBO J, V16, P3396, DOI 10.1093/emboj/16.12.3396; Jiang Y, 1998, NATURE, V395, P808, DOI 10.1038/27454; King PD, 1996, INT IMMUNOL, V8, P1707, DOI 10.1093/intimm/8.11.1707; Liu KQ, 1998, J EXP MED, V187, P1721, DOI 10.1084/jem.187.10.1721; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Ma YC, 1998, P NATL ACAD SCI USA, V95, P12197, DOI 10.1073/pnas.95.21.12197; Marquez JA, 2003, EMBO J, V22, P4616, DOI 10.1093/emboj/cdg448; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; O Atherly L, 2006, IMMUNITY, V25, P79, DOI 10.1016/j.immuni.2006.05.012; Oda A, 2000, BLOOD, V95, P1663; Okoh MP, 1999, BIOCHEM BIOPH RES CO, V265, P151, DOI 10.1006/bbrc.1999.1407; Parrini MC, 1999, CHEM BIOL, V6, P679, DOI 10.1016/S1074-5521(00)80015-0; Qi Q, 2006, J BIOL CHEM, V281, P38529, DOI 10.1074/jbc.M609180200; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Schaeffer EM, 2001, NAT IMMUNOL, V2, P1183, DOI 10.1038/ni734; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Smith CIE, 2001, BIOESSAYS, V23, P436, DOI 10.1002/bies.1062; Takemoto K, 2003, J CELL BIOL, V160, P235, DOI 10.1083/jcb.200207111; Tomlinson MG, 1999, J BIOL CHEM, V274, P13577, DOI 10.1074/jbc.274.19.13577; Woods ML, 2001, EMBO J, V20, P1232, DOI 10.1093/emboj/20.6.1232; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamashita Y, 1998, BLOOD, V91, P1496, DOI 10.1182/blood.V91.5.1496.1496_1496_1507	46	13	13	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29882	29892		10.1074/jbc.M109.003129	http://dx.doi.org/10.1074/jbc.M109.003129			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19717557	hybrid, Green Published			2022-12-25	WOS:000270896800068
J	Sin, WC; Tse, M; Planque, N; Perbal, B; Lampe, PD; Naus, CC				Sin, Wun-Chey; Tse, Mimi; Planque, Nathalie; Perbal, Bernard; Lampe, Paul D.; Naus, Christian C.			Matricellular Protein CCN3 (NOV) Regulates Actin Cytoskeleton Reorganization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEIN; C6 GLIOMA-CELLS; INTERCELLULAR COMMUNICATION; CONNEXIN43 INTERACTS; RETROVIRAL DELIVERY; POSSIBLE MECHANISM; DOWN-REGULATION; TUMOR-CELLS; N-CADHERIN; ADHESION	CCN3 (NOV), a putative ligand for integrin receptors, is tightly associated with the extracellular matrix and mediates diverse cellular functions, including cell adhesion and proliferation. CCN3 has been shown to negatively regulate growth although it promotes migration in a cell type-specific manner. In this study, overexpression of CCN3 reduces growth and increases intercellular adhesion of breast cancer cells. Interestingly, CCN3 overexpression also led to the formation of multiple pseudopodia that are enriched in actin, CCN3, and vinculin. Breast cancer cells preincubated with exogenous CCN3 protein also induced the same phenotype, indicating that secreted CCN3 is sufficient to induce changes in cell morphology. Surprisingly, extracellular CCN3 is internalized to the early endosomes but not to the membrane protrusions, suggesting pseudopodia- enriched CCN3 may derive from a different source. The presence of an intracellular variant of CCN3 will be consistent with our finding that the cytoplasmic tail of the gap junction protein connexin43 (Cx43) associates with CCN3. Cx43 is a channel protein permitting intercellular communication to occur. However, neither the channel properties nor the protein levels of Cx43 are affected by the CCN3 protein. In contrast, CCN3 proteins are down-regulated in the absence of Cx43. Finally, we showed that overexpression of CCN3 increases the activity of the small GTPase Rac1, thereby revealing a pathway that links Cx43 directly to actin reorganization.	[Sin, Wun-Chey] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Planque, Nathalie; Perbal, Bernard] Univ Paris 07, F-75005 Paris, France; [Lampe, Paul D.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	University of British Columbia; UDICE-French Research Universities; Universite Paris Cite; Fred Hutchinson Cancer Center	Sin, WC (corresponding author), Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	wcsin@interchange.ubc.ca; cnaus@interchange.ubc.ca			Canadian Institutes of Health Research [MOP 81202]; European PROTHETS (Prognosis and Therapeutic Targets of Ewing Family of Tumors) FP6 [503036]; French Ministry of Education; National Institutes of Health [GM55632]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055632] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); European PROTHETS (Prognosis and Therapeutic Targets of Ewing Family of Tumors) FP6(European Commission); French Ministry of Education; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Operating Grant MOP 81202 (to C. C. N. and W. C. S.) from the Canadian Institutes of Health Research and European PROTHETS (Prognosis and Therapeutic Targets of Ewing Family of Tumors) FP6 Contract 503036 and the French Ministry of Education (to B. P.). This work was also supported in part by National Institutes of Health Grant GM55632 (to P. D. L.).	Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Bates DC, 2007, GLIA, V55, P1554, DOI 10.1002/glia.20569; Benini S, 2005, ONCOGENE, V24, P4349, DOI 10.1038/sj.onc.1208620; Bleau AM, 2007, J CELL BIOCHEM, V101, P1475, DOI 10.1002/jcb.21262; Bleau AM, 2005, FRONT BIOSCI-LANDMRK, V10, P998, DOI 10.2741/1594; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Butkevich E, 2004, CURR BIOL, V14, P650, DOI 10.1016/j.cub.2004.03.063; Chen Y., 2005, MOL IMAGING FRET MIC, P126; Cotrina ML, 2008, GLIA, V56, P1791, DOI 10.1002/glia.20728; D'Souza-Schorey C, 1998, MOL CELL BIOL, V18, P3936, DOI 10.1128/MCB.18.7.3936; DeMali KA, 2002, J CELL BIOL, V159, P881, DOI 10.1083/jcb.200206043; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Fu CT, 2004, J BIOL CHEM, V279, P36943, DOI 10.1074/jbc.M403952200; Fukunaga-Kalabis M, 2008, ONCOGENE, V27, P2552, DOI 10.1038/sj.onc.1210896; Fukunaga-Kalabis M, 2006, J CELL BIOL, V175, P563, DOI 10.1083/jcb.200602132; Gellhaus A, 2004, J BIOL CHEM, V279, P36931, DOI 10.1074/jbc.M404073200; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Girish V, 2004, Indian J Cancer, V41, P47; GOLDBERG GS, 1995, BIOTECHNIQUES, V18, P490; Gupta N, 2001, J CLIN PATHOL-MOL PA, V54, P293, DOI 10.1136/mp.54.5.293; Hedlund TE, 1999, PROSTATE, V41, P154; Herve JC, 2004, BBA-BIOMEMBRANES, V1662, P22, DOI 10.1016/j.bbamem.2003.10.022; Hirschi KK, 1996, CELL GROWTH DIFFER, V7, P861; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Iacobas DA, 2005, PHYSIOL GENOMICS, V20, P211, DOI 10.1152/physiolgenomics.00229.2003; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Lafont J, 2005, CELL COMMUN ADHES, V12, P41, DOI 10.1080/15419060500383069; Laurent M, 2003, FASEB J, V17, P1919, DOI 10.1096/fj.02-1023fje; Lazar N, 2007, J CELL COMMUN SIGNAL, V1, P91, DOI 10.1007/s12079-007-0009-8; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Li CL, 2002, J CLIN PATHOL-MOL PA, V55, P250, DOI 10.1136/mp.55.4.250; Lin CG, 2005, J BIOL CHEM, V280, P8229, DOI 10.1074/jbc.M404903200; Lin CG, 2003, J BIOL CHEM, V278, P24200, DOI 10.1074/jbc.M302028200; Matsuda T, 2006, J MOL CELL CARDIOL, V40, P495, DOI 10.1016/j.yjmcc.2005.12.010; McLachlan E, 2006, CANCER RES, V66, P9886, DOI 10.1158/0008-5472.CAN-05-4302; McLeod TL, 2001, CELL COMMUN ADHES, V8, P441, DOI 10.3109/15419060109080767; Mesnil M, 2005, BBA-BIOMEMBRANES, V1719, P125, DOI 10.1016/j.bbamem.2005.11.004; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; NAUS CCG, 1992, CELL MOL NEUROBIOL, V12, P163, DOI 10.1007/BF00713370; Naus CCG, 2002, CAN J PHYSIOL PHARM, V80, P136, DOI 10.1139/Y02-009; Perbal B, 1999, P NATL ACAD SCI USA, V96, P869, DOI 10.1073/pnas.96.3.869; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Perbal Bernard, 2006, Cell Commun Signal, V4, P6, DOI 10.1186/1478-811X-4-6; Planque N, 2006, J CELL BIOCHEM, V99, P105, DOI 10.1002/jcb.20887; Planque N, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-15; Powers MJ, 1998, MICROSC RES TECHNIQ, V43, P379, DOI 10.1002/(SICI)1097-0029(19981201)43:5<379::AID-JEMT4>3.0.CO;2-0; Qin H, 2002, J BIOL CHEM, V277, P29132, DOI 10.1074/jbc.M200797200; Sakamoto K, 2002, J BIOL CHEM, V277, P29399, DOI 10.1074/jbc.M203727200; Scemes E, 2007, NEURON GLIA BIOL, V3, P199, DOI 10.1017/S1740925X08000069; Shao Q, 2005, CANCER RES, V65, P2705, DOI 10.1158/0008-5472.CAN-04-2367; Simon AM, 1998, TRENDS CELL BIOL, V8, P477, DOI 10.1016/S0962-8924(98)01372-5; Sin WC, 2008, J CELL BIOCHEM, V103, P1772, DOI 10.1002/jcb.21571; Stout C, 2004, CURR OPIN CELL BIOL, V16, P507, DOI 10.1016/j.ceb.2004.07.014; Stuart HC, 2008, J BIOL CHEM, V283, P34785, DOI 10.1074/jbc.M804014200; Vallacchi V, 2008, CANCER RES, V68, P715, DOI 10.1158/0008-5472.CAN-07-2103; VAN AL, 1997, GENE DEV, V11, P2295; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wahab NA, 2001, BIOCHEM J, V359, P89, DOI 10.1042/0264-6021:3590089; Wong NC, 1998, CLIN EXP METASTAS, V16, P50; Xu X, 2001, CELL COMMUN ADHES, V8, P321, DOI 10.3109/15419060109080746; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049	67	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29935	29944		10.1074/jbc.M109.042630	http://dx.doi.org/10.1074/jbc.M109.042630			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19706598	Green Published, hybrid			2022-12-25	WOS:000270896800072
J	Woloszynek, JC; Kovacs, A; Ohlemiller, KK; Roberts, M; Sands, MS				Woloszynek, Josh C.; Kovacs, Atilla; Ohlemiller, Kevin K.; Roberts, Marie; Sands, Mark S.			Metabolic Adaptations to Interrupted Glycosaminoglycan Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUCOLIPIDOSIS TYPE-IV; LYSOSOMAL STORAGE DISORDERS; MURINE MODEL; MARROW TRANSPLANTATION; AUTOPHAGY; DISEASE; MICE; DYSFUNCTION; THERAPY; FAT	Lysosomal storage diseases (LSD) are metabolic disorders characterized by accumulation of undegraded material. The mucopolysaccharidoses (MPS) are LSDs defined by the storage of glycosaminoglycans. Previously, we hypothesized that cells affected with LSD have increased energy expenditure for biosynthesis because of deficiencies of raw materials sequestered within the lysosome. Thus, LSDs can be characterized as diseases of deficiency as well as overabundance (lysosomal storage). In this study, metabolite analysis identified deficiencies in simple sugars, nucleotides, and lipids in the livers of MPSI mice. In contrast, most amino acids, amino acid derivatives, dipeptides, and urea were elevated. These data suggest that protein catabolism, perhaps because of increased autophagy, is at least partially fulfilling intermediary metabolism. Thus, maintaining glycosaminoglycan synthesis in the absence of recycled precursors results in major shifts in the energy utilization of the cells. A high fat diet increased simple sugars and some fats and lowered the apparent protein catabolism. Interestingly, autophagy, which is increased in several LSDs, is responsive to dietary intervention and is reduced in MPSVII and MPSI mice fed a high fat diet. Although long term dietary treatment improved body weight in MPSVII mice, it failed to improve life span or retinal function. In addition, the ventricular hypertrophy and proximal aorta dilation observed in MPSVII mice were unchanged by a high fat, simple sugar diet. As the mechanism of this energy imbalance is better understood, a more targeted nutrient approach may yet prove beneficial as an adjunct therapy to traditional approaches.	[Woloszynek, Josh C.; Kovacs, Atilla; Roberts, Marie; Sands, Mark S.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Woloszynek, Josh C.; Sands, Mark S.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Ohlemiller, Kevin K.] Washington Univ, Sch Med, Dept Otolaryngol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Sands, MS (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid, St Louis, MO 63110 USA.	msands@dom.wustl.edu		Sands, Mark/0000-0002-5559-0832	National Institutes of Health [HD-0055461, NS-43205, DC-004665, NS-057105, DC-08321]; Mucopolysaccharidosis Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD055461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043205, R56NS043205, P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008321, R55DC008321, P30DC004665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mucopolysaccharidosis Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants HD-0055461 and NS-43205 (to M. S. S.) and DC-004665, NS-057105, and DC-08321 (to K. K. O.). This work was also supported by a grant from the Mucopolysaccharidosis Society (to J. C. W. and M. S. S.).	BEAMER WG, 1982, MOUSE NEWSLETT, V67, P21; Du H, 2001, J LIPID RES, V42, P489; FRATANTONI JC, 1968, SCIENCE, V162, P570, DOI 10.1126/science.162.3853.570; Fukuda T, 2006, ANN NEUROL, V59, P700, DOI 10.1002/ana.20807; Galvin N, 2008, PEDIATR DEVEL PATHOL, V11, P185, DOI 10.2350/07-03-0242.1; Heldermon CD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000772; HORIUCHI M, 1993, FEBS LETT, V326, P267, DOI 10.1016/0014-5793(93)81805-A; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Kumagai AK, 1999, DIABETES-METAB RES, V15, P261, DOI 10.1002/(SICI)1520-7560(199907/08)15:4<261::AID-DMRR43>3.0.CO;2-Z; Ohlemiller KK, 2000, EXP EYE RES, V71, P469, DOI 10.1006/exer.2000.0897; Pacheco CD, 2009, HUM MOL GENET, V18, P956, DOI 10.1093/hmg/ddn423; Roe CR, 2006, J INHERIT METAB DIS, V29, P332, DOI 10.1007/s10545-006-0290-3; Roe CR, 2002, J CLIN INVEST, V110, P259, DOI [10.1172/JCI200215311, 10.1172/JCI0215311]; ROME LH, 1986, BIOCHEM J, V235, P707, DOI 10.1042/bj2350707; Schaheen L, 2006, DEV BIOL, V293, P382, DOI 10.1016/j.ydbio.2006.02.008; Schuldt AJT, 2004, P NATL ACAD SCI USA, V101, P603, DOI 10.1073/pnas.0305284101; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Takamura A, 2008, BIOCHEM BIOPH RES CO, V367, P616, DOI 10.1016/j.bbrc.2007.12.187; VANDERVUSSE GJ, 1992, PHYSIOL REV, V72, P881, DOI 10.1152/physrev.1992.72.4.881; Vellodi A, 2005, BRIT J HAEMATOL, V128, P413, DOI 10.1111/j.1365-2141.2004.05293.x; Venkatachalam K, 2008, CELL, V135, P838, DOI 10.1016/j.cell.2008.09.041; Venugopal B, 2007, AM J HUM GENET, V81, P1070, DOI 10.1086/521954; Venugopal B, 2009, J CELL PHYSIOL, V219, P344, DOI 10.1002/jcp.21676; Vergarajauregui S, 2008, HUM MOL GENET, V17, P2723, DOI 10.1093/hmg/ddn174; Walkley SU, 2009, J INHERIT METAB DIS, V32, P181, DOI 10.1007/s10545-008-1040-5; Wang Wei, 2007, Expert Rev Cardiovasc Ther, V5, P1123, DOI 10.1586/14779072.5.6.1123; Woloszynek JC, 2004, BIOCHEM J, V379, P461, DOI 10.1042/BJ20031048; Woloszynek JC, 2007, J BIOL CHEM, V282, P35765, DOI 10.1074/jbc.M705124200	29	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29684	29691		10.1074/jbc.M109.020818	http://dx.doi.org/10.1074/jbc.M109.020818			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19700765	hybrid, Green Published			2022-12-25	WOS:000270896800050
J	Haerteis, S; Krueger, B; Korbmacher, C; Rauh, R				Haerteis, Silke; Krueger, Bettina; Korbmacher, Christoph; Rauh, Robert			The delta-Subunit of the Epithelial Sodium Channel (ENaC) Enhances Channel Activity and Alters Proteolytic ENaC Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE NA+ CHANNEL; GAMMA-SUBUNIT; FUNCTIONAL EXPRESSION; ELASTASE ACTIVATION; LIDDLE-SYNDROME; ALPHA-SUBUNIT; CLONING; CLEAVAGE; INHIBITION; PROTEINS	The epithelial sodium channel (ENaC) is probably a heterotrimer with three well characterized subunits (alpha beta gamma). In humans an additional delta-subunit (delta-hENaC) exists but little is known about its function. Using the Xenopus laevis oocyte expression system, we compared the functional properties of alpha beta gamma- and delta beta gamma-hENaC and investigated whether delta beta gamma-hENaC can be proteolytically activated. The amiloride-sensitive ENaC whole-cell current (Delta I-ami) was about 11-fold larger in oocytes expressing delta beta gamma-hENaC than in oocytes expressing alpha beta gamma-hENaC. The 2-fold larger single-channel Na+ conductance of delta beta gamma-hENaC cannot explain this difference. Using a chemiluminescence assay, we demonstrated that an increased channel surface expression is also not the cause. Thus, overall channel activity of delta beta gamma-hENaC must be higher than that of alpha beta gamma-hENaC. Experiments exploiting the properties of the known beta S520C mutant ENaC confirmed this conclusion. Moreover, chymotrypsin had a reduced stimulatory effect on delta beta gamma-hENaC whole-cell currents compared with its effect on alpha beta gamma-hENaC whole-cell currents (2-fold versus 5-fold). This suggests that the cell surface pool of so-called near-silent channels that can be proteolytically activated is smaller for delta beta gamma-hENaC than for alpha beta gamma-hENaC. Proteolytic activation of delta beta gamma-hENaC was associated with the appearance of a delta-hENaC cleavage product at the cell surface. Finally, we demonstrated that a short inhibitory 13-mer peptide corresponding to a region of the extracellular loop of human alpha-ENaC inhibited Delta I-ami in oocytes expressing alpha beta gamma-hENaC but not in those expressing delta beta gamma-hENaC. We conclude that the delta-subunit of ENaC alters proteolytic channel activation and enhances base-line channel activity.	[Haerteis, Silke; Krueger, Bettina; Korbmacher, Christoph; Rauh, Robert] Univ Erlangen Nurnberg, Inst Zellulare & Mol Physiol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Korbmacher, C (corresponding author), Univ Erlangen Nurnberg, Inst Zellulare & Mol Physiol, Waldstr 6, D-91054 Erlangen, Germany.	christoph.korbmacher@physiologie2.med.uni-erlangen.de	Rauh, Robert/F-4129-2014; Haerteis, Silke/AGS-5314-2022	Rauh, Robert/0000-0002-9406-3939; Haerteis, Silke/0000-0002-9440-3307	Deutsche Forschungsgemeinschaft [SFB423]; Johannes and Frieda Marohn Stiftung; BioMedTec International Graduate School "Lead Structures of Cell Function" of the Elitenetwork Bavaria	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Johannes and Frieda Marohn Stiftung; BioMedTec International Graduate School "Lead Structures of Cell Function" of the Elitenetwork Bavaria	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB423 (Kidney Injury, Pathogenesis and Regenerative Mechanisms, Project A12 (to C. K.)), by the Johannes and Frieda Marohn Stiftung (to C. K.), an Elitenetwork Bavaria fellowship (to S. H.), and the BioMedTec International Graduate School "Lead Structures of Cell Function" of the Elitenetwork Bavaria (to S. H.).	Abriel H, 1999, J PHYSIOL-LONDON, V516, P31, DOI 10.1111/j.1469-7793.1999.031aa.x; Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; Anantharam A, 2006, J PHYSIOL-LONDON, V574, P333, DOI 10.1113/jphysiol.2006.109173; Babini E, 2003, J BIOL CHEM, V278, P28418, DOI 10.1074/jbc.M301315200; Biasio W, 2004, J BIOL CHEM, V279, P5429, DOI 10.1074/jbc.M311155200; Brockway LM, 2002, AM J PHYSIOL-CELL PH, V283, pC126, DOI 10.1152/ajpcell.00457.2001; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Canessa CM, 2007, NATURE, V449, P293, DOI 10.1038/449293a; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2008, AM J PHYSIOL-RENAL, V294, pF47, DOI 10.1152/ajprenal.00399.2007; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Charles RP, 2008, J BIOL CHEM, V283, P2622, DOI 10.1074/jbc.M708829200; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Diakov A, 2004, J BIOL CHEM, V279, P38134, DOI 10.1074/jbc.M403260200; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Drummond HA, 2006, AM J PHYSIOL-CELL PH, V290, pC404, DOI 10.1152/ajpcell.00210.2005; Drummond HA, 2008, HYPERTENSION, V51, P1265, DOI 10.1161/HYPERTENSIONAHA.107.093401; DURIEUX ME, 1994, FEBS LETT, V337, P235, DOI 10.1016/0014-5793(94)80198-3; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Giraldez T, 2007, J NEUROCHEM, V102, P1304, DOI 10.1111/j.1471-4159.2007.04622.x; Golestaneh N, 2001, BIOCHEM BIOPH RES CO, V280, P1300, DOI 10.1006/bbrc.2001.4275; Harris M, 2008, J BIOL CHEM, V283, P7455, DOI 10.1074/jbc.M707399200; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; Hughey RP, 2007, CURR OPIN NEPHROL HY, V16, P444, DOI 10.1097/MNH.0b013e32821f6072; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Ji HL, 2006, J BIOL CHEM, V281, P8233, DOI 10.1074/jbc.M512293200; Ji HL, 2004, J BIOL CHEM, V279, P26939, DOI 10.1074/jbc.M401143200; Ji HL, 2004, J BIOL CHEM, V279, P8428, DOI 10.1074/jbc.M312012200; Kellenberger S, 2002, J PHYSIOL-LONDON, V543, P413, DOI 10.1113/jphysiol.2002.022020; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Knight KK, 2008, J BIOL CHEM, V283, P27477, DOI 10.1074/jbc.M804176200; Konstas AA, 2002, J BIOL CHEM, V277, P29406, DOI 10.1074/jbc.M203018200; Konstas AA, 2001, PFLUG ARCH EUR J PHY, V442, P752, DOI 10.1007/s004240100597; Konstas AA, 2000, PFLUG ARCH EUR J PHY, V441, P341, DOI 10.1007/s004240000430; Kusche-Vihrog K, 2008, PFLUG ARCH EUR J PHY, V455, P849, DOI 10.1007/s00424-007-0341-0; Lu M, 2008, J BIOL CHEM, V283, P11981, DOI 10.1074/jbc.M708001200; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; Nesterov V, 2008, AM J PHYSIOL-RENAL, V295, pF1052, DOI 10.1152/ajprenal.00031.2008; Nie HG, 2009, AM J RESP CELL MOL, V40, P543, DOI 10.1165/rcmb.2008-0166OC; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Planes C, 2007, CURR TOP DEV BIOL, V78, P23, DOI 10.1016/S0070-2153(06)78002-4; Rauh R, 2006, PFLUG ARCH EUR J PHY, V452, P290, DOI 10.1007/s00424-005-0026-5; Rossier BC, 2002, J GEN PHYSIOL, V120, P67, DOI 10.1085/jgp.20028638; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Ruffieux-Daidie D, 2008, J AM SOC NEPHROL, V19, P2170, DOI 10.1681/ASN.2007101130; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; VOILLEY N, 1995, GENOMICS, V28, P560, DOI 10.1006/geno.1995.1188; VOILLEY N, 1994, P NATL ACAD SCI USA, V91, P247, DOI 10.1073/pnas.91.1.247; Volk T, 2004, PFLUG ARCH EUR J PHY, V447, P884, DOI 10.1007/s00424-003-1193-x; Waldmann R, 1996, GENOMICS, V34, P262, DOI 10.1006/geno.1996.0282; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; Wielputz MO, 2007, J BIOL CHEM, V282, P28264, DOI 10.1074/jbc.M702168200; Yamamura H, 2005, J PHARMACOL EXP THER, V315, P965, DOI 10.1124/jpet.105.092775; Yamamura H, 2005, MOL PHARMACOL, V68, P1142, DOI 10.1124/mol.104.010850; Yamamura H, 2004, J BIOL CHEM, V279, P44483, DOI 10.1074/jbc.M408929200; Yamamura H, 2004, J BIOL CHEM, V279, P12529, DOI 10.1074/jbc.M400274200; Yamamura H, 2008, BIOCHEM BIOPH RES CO, V373, P155, DOI 10.1016/j.bbrc.2008.06.008; Yamamura H, 2006, BIOCHEM BIOPH RES CO, V349, P317, DOI 10.1016/j.bbrc.2006.08.043; Yamamura H, 2008, EUR J PHARMACOL, V600, P32, DOI 10.1016/j.ejphar.2008.10.022; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	75	49	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29024	29040		10.1074/jbc.M109.018945	http://dx.doi.org/10.1074/jbc.M109.018945			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19717556	Green Published, hybrid			2022-12-25	WOS:000270678900060
J	Switzer, CH; Ridnour, LA; Cheng, RYS; Sparatore, A; Del Soldato, P; Moody, TW; Vitek, MP; Roberts, DD; Wink, DA				Switzer, C. H.; Ridnour, L. A.; Cheng, R. Y. S.; Sparatore, A.; Del Soldato, P.; Moody, T. W.; Vitek, M. P.; Roberts, D. D.; Wink, D. A.			Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity	ONCOGENE			English	Article						dithiolethione; PP2A; Akt; cancer; breast; lung	PROTEIN PHOSPHATASE 2A; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TUMOR-SUPPRESSOR; HEME OXYGENASE-1; KINASE-B; TYROSINE PHOSPHORYLATION; REGULATORY SUBUNITS; 3T3-L1 ADIPOCYTES; C-MYC; PATHWAY	The chemopreventative effects of dithiolethione compounds are attributed to their activation of antioxidant response elements (AREs) by reacting with the Nrf2/Keap1 protein complex. In this study, we show anti-proliferative effects of the dithiolethione compound ACS1 in human cancer cell lines (A549 and MDA-MB-231) by increasing the activity of the tumor suppressor protein phoshatase 2A (PP2A). ACS-1 inhibited epidermal growth factor (EGF)-induced cellular proliferation in a concentration-and time-dependent manner. Akt activation, as determined by serine-473 phosphorylation, was inhibited by ACS-1 in cells stimulated with either EGF or fibronectin. Furthermore, ACS-1 inhibited mammalian target of rapamycin signaling and decreased c-myc protein levels. ACS-1 did not proximally alter EGF receptor or integrin signaling, but caused a concentration-dependent increase in PP2A activity. The effect of ACS-1 on Akt activation was not observed in the presence of the PP2A inhibitor okadaic acid. ACS-1 effects on PP2A activity were independent of ARE activation and cAMP formation. In addition to ACS-1, other dithiolethione compounds showed similar effects in reducing Akt activation, suggesting that this class of compounds may have other effects beyond chemoprevention. Oncogene (2009) 28, 3837-3846; doi:10.1038/onc.2009.244; published online 24 August 2009	[Switzer, C. H.; Ridnour, L. A.; Cheng, R. Y. S.; Wink, D. A.] NCI, Radiat Biol Branch, NIH, Bethesda, MD 20892 USA; [Sparatore, A.] Univ Milan, Dipartimento Sci Farmaceut Pietro Pratesi, Milan, Italy; [Del Soldato, P.] Sulfidris, Milan, Italy; [Vitek, M. P.] Duke Univ, Med Ctr, Div Neurol, Durham, NC 27710 USA; [Roberts, D. D.] NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Milan; Duke University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wink, DA (corresponding author), NCI, Radiat Biol Branch, NIH, Bldg 10,Room B3-B35, Bethesda, MD 20892 USA.	wink@mail.nih.gov	Switzer, Christopher/D-9203-2013; Roberts, David D./A-9699-2008; Sparatore, Anna/J-8634-2015; Cheng, Robert/E-9799-2013	Roberts, David D./0000-0002-2481-2981; Sparatore, Anna/0000-0003-2135-2649; Azad, Mahan/0000-0002-8633-3513; Cheng, Robert/0000-0003-0287-6439; Wink, David/0000-0002-5652-7480; Vitek, Michael/0000-0001-8140-8048; Ridnour, Lisa A./0000-0001-9446-8349	NATIONAL CANCER INSTITUTE [ZIASC009174, Z01BC010899] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 BC010899-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Arnold HK, 2008, CANCER METAST REV, V27, P147, DOI 10.1007/s10555-008-9128-9; Bae EJ, 2007, HEPATOLOGY, V46, P730, DOI 10.1002/hep.21769; Bass SE, 2009, CLIN CANCER RES, V15, P1964, DOI 10.1158/1078-0432.CCR-08-1870; Busserolles J, 2006, INT J BIOCHEM CELL B, V38, P1510, DOI 10.1016/j.biocel.2006.03.013; Cai WJ, 2007, CARDIOVASC RES, V76, P29, DOI 10.1016/j.cardiores.2007.05.026; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Danen EHJ, 2001, J CELL PHYSIOL, V189, P1, DOI 10.1002/jcp.1137; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Dulak J, 2008, CIRCULATION, V117, P231, DOI 10.1161/CIRCULATIONAHA.107.698316; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Feschenko MS, 2002, J PHARMACOL EXP THER, V302, P111, DOI 10.1124/jpet.302.1.111; Guadagni F, 2007, ANTICANCER RES, V27, P3147; Hamada T, 1999, AM J MED SCI, V318, P146, DOI 10.1097/00000441-199909000-00009; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Isenberg JS, 2007, BRIT J PHARMACOL, V151, P142, DOI 10.1038/sj.bjp.0707198; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kim SG, 1998, BIOCHEM PHARMACOL, V55, P1585, DOI 10.1016/S0006-2952(97)00669-2; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Kwak MK, 2001, MUTAT RES-FUND MOL M, V480, P305, DOI 10.1016/S0027-5107(01)00190-7; Lam S, 2002, JNCI-J NATL CANCER I, V94, P1001; Lee JS, 2005, CANCER LETT, V224, P171, DOI 10.1016/j.canlet.2004.09.042; Li L, 2007, FREE RADICAL BIO MED, V42, P706, DOI 10.1016/j.freeradbiomed.2006.12.011; LI M, 1995, BIOCHEMISTRY-US, V34, P1988, DOI 10.1021/bi00006a020; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Longin S, 2007, J BIOL CHEM, V282, P26971, DOI 10.1074/jbc.M704059200; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; Matsuoka Y, 2003, BRIT J PHARMACOL, V138, P1303, DOI 10.1038/sj.bjp.0705182; Moody TW, 2010, LUNG CANCER, V68, P154, DOI 10.1016/j.lungcan.2009.06.012; Paugh SW, 2006, MOL PHARMACOL, V70, P41, DOI 10.1124/mol.105.020552; Perrotti D, 2008, CANCER METAST REV, V27, P159, DOI 10.1007/s10555-008-9119-x; Persad S, 2003, CANCER METAST REV, V22, P375, DOI 10.1023/A:1023777013659; Prickett TD, 2006, J BIOL CHEM, V281, P30503, DOI 10.1074/jbc.M601054200; Qiao M, 2008, CELL CYCLE, V7, P2991, DOI 10.4161/cc.7.19.6784; Resjo S, 2002, CELL SIGNAL, V14, P231, DOI 10.1016/S0898-6568(01)00238-8; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Sarnataro D, 2006, MOL PHARMACOL, V70, P1298, DOI 10.1124/mol.106.025601; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Sawai H, 2006, ONCOGENE, V25, P3237, DOI 10.1038/sj.onc.1209356; Schmidt A, 2006, MICROVASC RES, V71, P152, DOI 10.1016/j.mvr.2006.01.001; Trotta R, 2007, J EXP MED, V204, P2397, DOI 10.1084/jem.20070419; Ugi S, 2004, MOL CELL BIOL, V24, P8778, DOI 10.1128/MCB.24.19.8778-8789.2004; Ugi S, 2002, MOL CELL BIOL, V22, P2375, DOI 10.1128/MCB.22.7.2375-2387.2002; Xing YN, 2008, CELL, V133, P154, DOI 10.1016/j.cell.2008.02.041; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang YS, 2008, MOL CANCER THER, V7, P3470, DOI 10.1158/1535-7163.MCT-08-0625	49	39	39	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2009	28	43					3837	3846		10.1038/onc.2009.244	http://dx.doi.org/10.1038/onc.2009.244			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	512KT	19701246	Green Accepted			2022-12-25	WOS:000271248400007
J	Metzgar, D; Baynes, D; Hansen, CJ; McDonough, EA; Cabrera, DR; Ellorin, MM; Blair, PJ; Russell, KL; Faix, DJ				Metzgar, David; Baynes, Darcie; Hansen, Christian J.; McDonough, Erin A.; Cabrera, Daisy R.; Ellorin, Melody M.; Blair, Patrick J.; Russell, Kevin L.; Faix, Dennis J.			Inference of Antibiotic Resistance and Virulence among Diverse Group A Streptococcus Strains Using emm Sequencing and Multilocus Genotyping Methods	PLOS ONE			English	Article								Background: Group A Streptococcus pyogenes ( GAS) exhibits a high degree of clinically relevant phenotypic diversity. Strains vary widely in terms of antibiotic resistance (AbR), clinical severity, and transmission rate. Currently, strain identification is achieved by emm typing ( direct sequencing of the genomic segment coding for the antigenic portion of the M protein) or by multilocus genotyping methods. Phenotype analysis, including critical AbR typing, is generally achieved by much slower and more laborious direct culture-based methods. Methodology/Principal Findings: We compare genotype identification ( by emm typing and PCR/ESI-MS) with directly measured phenotypes ( AbR and outbreak associations) for 802 clinical isolates of GAS collected from symptomatic patients over a period of 6 years at 10 military facilities in the United States. All independent strain characterization methods are highly correlated. This shows that recombination, horizontal transfer, and other forms of reassortment are rare in GAS insofar as housekeeping genes, primary virulence and antibiotic resistance determinants, and the emm gene are concerned. Therefore, genotyping methods offer an efficient way to predict emm type and the associated AbR and virulence phenotypes. Conclusions/Significance: The data presented here, combined with much historical data, suggest that emm typing assays and faster molecular methods that infer emm type from genomic signatures could be used to efficiently infer critical phenotypic characteristics based on robust genotype: phenotype correlations. This, in turn, would enable faster and better-targeted responses during identified outbreaks of constitutively resistant or particularly virulent emm types.			Metzgar, D (corresponding author), Naval Hlth Res Ctr, Dept Resp Dis Res, San Diego, CA USA.	david.metzgar@med.navy.mil						BLACK CM, 1993, MOL CELL PROBE, V7, P255, DOI 10.1006/mcpr.1993.1038; Bronze MS, 1996, AM J MED SCI, V311, P41, DOI 10.1097/00000441-199601000-00008; Brundage JF, 1996, PEDIATRICS, V97, P964; CLEARY PP, 1992, LANCET, V339, P518, DOI 10.1016/0140-6736(92)90339-5; Crum NF, 2005, CLIN INFECT DIS, V40, P511, DOI 10.1086/427502; Descheemaeker P, 2000, J ANTIMICROB CHEMOTH, V45, P167, DOI 10.1093/jac/45.2.167; Ecker DJ, 2005, P NATL ACAD SCI USA, V102, P8012, DOI 10.1073/pnas.0409920102; Enright MC, 2001, INFECT IMMUN, V69, P2416, DOI 10.1128/IAI.69.4.2416-2427.2001; Facklam R, 1999, EMERG INFECT DIS, V5, P247, DOI 10.3201/eid0502.990209; Grivea IN, 2006, ANTIMICROB AGENTS CH, V50, P256, DOI 10.1128/AAC.50.1.256-261.2006; GUNZENHAUSER JD, 1995, J INFECT DIS, V172, P124, DOI 10.1093/infdis/172.1.124; Horn DL, 1998, CLIN INFECT DIS, V26, P1341, DOI 10.1086/516375; Kaplan EL, 1999, PEDIATR INFECT DIS J, V18, P1069, DOI 10.1097/00006454-199912000-00008; KAPLAN EL, 1994, J INFECT DIS, V170, P1346, DOI 10.1093/infdis/170.5.1346; Lamagni TL, 2008, EMERG INFECT DIS, V14, P202, DOI 10.3201/eid1402.070888; Macris MH, 1998, PEDIATR INFECT DIS J, V17, P377, DOI 10.1097/00006454-199805000-00006; Martin JM, 2002, NEW ENGL J MED, V346, P1200, DOI 10.1056/NEJMoa013169; MARTIN PR, 1990, SCAND J INFECT DIS, V22, P421, DOI 10.3109/00365549009027073; Perez-Trallero E, 1999, EMERG INFECT DIS, V5, P235, DOI 10.3201/eid0502.990207; RUSSELL KL, 2006, TXB MILITARY MED REC, P227; SCHWARTZ B, 1990, LANCET, V336, P1167, DOI 10.1016/0140-6736(90)92777-F; WALLACE MR, 1989, JAMA-J AM MED ASSOC, V262, P2557, DOI 10.1001/jama.262.18.2557; WANNAMAKER LW, 1953, NEW ENGL J MED, V249, P1, DOI 10.1056/NEJM195307022490101	23	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2009	4	9							e6897	10.1371/journal.pone.0006897	http://dx.doi.org/10.1371/journal.pone.0006897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZF	19730733	Green Published, gold, Green Submitted			2022-12-25	WOS:000269622100003
J	Birjmohun, RS; Vergeer, M; Stroes, ESG; Sandhu, MS; Ricketts, SL; Tanck, MW; Wareham, NJ; Jukema, JW; Kastelein, JJP; Khaw, KT; Boekholdt, SM				Birjmohun, Rakesh S.; Vergeer, Menno; Stroes, Erik S. G.; Sandhu, Manjinder S.; Ricketts, Sally L.; Tanck, Michael W.; Wareham, Nicholas J.; Jukema, J. Wouter; Kastelein, John J. P.; Khaw, Kay-Tee; Boekholdt, S. Matthijs			Both Paraoxonase-1 Genotype and Activity Do Not Predict the Risk of Future Coronary Artery Disease; the EPIC-Norfolk Prospective Population Study	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; HEART-DISEASE; GENE POLYMORPHISMS; MYOCARDIAL-INFARCTION; VITAMIN-E; ASSOCIATION ANALYSIS; SERUM PARAOXONASE; PON1; OXIDATION; THICKNESS	Paraoxonase-1 (PON1) is an antioxidant enzyme, that resides on high-density lipoprotein (HDL). PON1-activity, is heavily influenced by the PON1-Q192R polymorphism. PON1 is considered to protect against atherosclerosis, but it is unclear whether this relation is independent of its carrier, HDL. In order to evaluate the atheroprotective potential of PON1, we assessed the relationships among PON1-genotype, PON1-activity and risk of future coronary artery disease (CAD), in a large prospective case-control study. Methodology/Principal Findings: Cases (n = 1138) were apparently healthy men and women aged 45-79 years who developed fatal or nonfatal CAD during a mean follow-up of 6 years. Controls (n = 2237) were matched by age, sex and enrollment time. PON1-activity was similar in cases and controls (60.7 +/- 645.3 versus 62.6 +/- 645.8 U/L, p = 0.3) and correlated with HDL-cholesterol levels (r = 0.16, p < 0.0001). The PON1-Q192R polymorphism had a profound impact on PON1-activity, but did not predict CAD risk (Odds Ratio [OR] per R allele 0.98[0.84-1.15], p = 0.8). Using conditional logistic regression, quartiles of PON1-activity showed a modest inverse relation with CAD risk (OR for the highest versus the lowest quartile 0.77[0.63-0.95], p = 0.01; p-trend = 0.06). PON1-activity adjusted for Q192R polymorphism correlated better with HDL-cholesterol (r = 0.26, p < 0.0001) and more linearly predicted CAD risk (0.79[0.64-0.98], p = 0.03; p-trend = 0.008). However, these relationships were abolished after adjustment for HDL (particles-cholesterol-size) and apolipoprotein A-l (0.94[0.74-1.18], p-trend = 0.3). Conclusions/Significance: This study, shows that PON1-activity inversely relates to CAD risk, but not independent of HDL, due to its close association with the HDL-particle. These data strongly suggest that a low PON1-activity is not a causal factor in atherogenesis.			Birjmohun, RS (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.s.birjmohun@amc.uva.nl	Jukema, J. Wouter/ABD-6503-2021; Boekholdt, Matthijs S.M./G-7562-2014; Kastelein, John/AAF-7950-2020; Khaw, Kay-Tee/AAZ-3209-2021	Jukema, J. Wouter/0000-0002-3246-8359; Tanck, Michael/0000-0001-9828-4459; Ricketts, Sally/0000-0002-5644-7958; Boekholdt, Matthijs/0000-0002-0861-0765	British Heart Foundation [PG/08/094/26019] Funding Source: Medline; Cancer Research UK Funding Source: Medline; Medical Research Council [G0801566, G0401527] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Department of Health Funding Source: Medline; MRC [G0801566] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALBERS JJ, 1992, CLIN CHEM, V38, P658; Ascherio A, 1999, ANN INTERN MED, V130, P963, DOI 10.7326/0003-4819-130-12-199906150-00003; Aviram M, 1998, J CLIN INVEST, V101, P1581, DOI 10.1172/JCI1649; Barter P, 2004, ATHEROSCLEROSIS SUPP, V5, P25, DOI 10.1016/j.atherosclerosissup.2004.03.003; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Boekholdt MS, 2004, AM J MED, V117, P390, DOI 10.1016/j.amjmed.2004.04.010; Bruins P, 1997, CIRCULATION, V96, P3542; Cascorbi I, 1999, PHARMACOGENETICS, V9, P755, DOI 10.1097/00008571-199912000-00010; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Diaz MN, 1997, NEW ENGL J MED, V337, P408, DOI 10.1056/NEJM199708073370607; Fortunato G, 2003, ATHEROSCLEROSIS, V167, P141, DOI 10.1016/S0021-9150(02)00423-9; Frei B, 1996, VITAM HORM, V52, P1, DOI 10.1016/S0083-6729(08)60405-7; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gardemann A, 2000, ATHEROSCLEROSIS, V152, P421, DOI 10.1016/S0021-9150(99)00489-X; GARIN MCB, 1994, BIOCHEM J, V304, P549, DOI 10.1042/bj3040549; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; GRANE RM, 2006, J AM COLL CARDIOL, V20, P2429; Herrmann SM, 1996, ATHEROSCLEROSIS, V126, P299, DOI 10.1016/0021-9150(96)05917-5; Jarvik GP, 2000, ARTERIOSCL THROM VAS, V20, P2441, DOI 10.1161/01.ATV.20.11.2441; Jarvik GP, 2002, ARTERIOSCL THROM VAS, V22, P1329, DOI 10.1161/01.ATV.0000027101.40323.3A; Jeyarajah EJ, 2006, CLIN LAB MED, V26, P847, DOI 10.1016/j.cll.2006.07.006; Leus FR, 2000, ATHEROSCLEROSIS, V149, P371, DOI 10.1016/S0021-9150(99)00324-X; Li D, 1996, J LIPID RES, V37, P1978; Lonn E, 2006, NEW ENGL J MED, V355, P209; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; Mackness B, 1998, ATHEROSCLEROSIS, V139, P341, DOI 10.1016/S0021-9150(98)00095-1; Mackness B, 2003, CIRCULATION, V107, P2775, DOI 10.1161/01.CIR.0000070954.00271.13; MACKNESS MI, 1991, FEBS LETT, V286, P152, DOI 10.1016/0014-5793(91)80962-3; Odawara M, 1997, J CLIN ENDOCR METAB, V82, P2257, DOI 10.1210/jc.82.7.2257; Oliveira SA, 2004, INT J CARDIOL, V94, P73, DOI 10.1016/j.ijcard.2003.05.011; Ombres D, 1998, ARTERIOSCL THROM VAS, V18, P1611, DOI 10.1161/01.ATV.18.10.1611; Rosenzweig A, 2007, NEW ENGL J MED, V357, P497, DOI 10.1056/NEJMe078121; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Smith GD, 2008, INT J EPIDEMIOL, V37, P416, DOI 10.1093/ije/dym187; Thomson MJ, 2007, CARDIOVASC DRUG THER, V21, P195, DOI 10.1007/s10557-007-6027-1; Thyagarajan B, 2008, CLIN CHEM, V54, P738, DOI 10.1373/clinchem.2007.099044; Troughton JA, 2008, ATHEROSCLEROSIS, V197, P556, DOI 10.1016/j.atherosclerosis.2007.08.019; Tsimikas S, 2005, NEW ENGL J MED, V353, P46, DOI 10.1056/NEJMoa043175; van Himbergen TM, 2008, ATHEROSCLEROSIS, V199, P408, DOI 10.1016/j.atherosclerosis.2007.11.018; Wang XL, 2003, ARTERIOSCL THROM VAS, V23, P328, DOI 10.1161/01.ATV.0000051702.38086.C1; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; Watzinger N, 2002, CARDIOLOGY, V98, P116, DOI 10.1159/000066321; Wheeler JG, 2004, LANCET, V363, P689, DOI 10.1016/S0140-6736(04)15642-0; WITZTUM JL, 1994, LANCET, V344, P793, DOI 10.1016/S0140-6736(94)92346-9	45	40	41	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2009	4	8							e6809	10.1371/journal.pone.0006809	http://dx.doi.org/10.1371/journal.pone.0006809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JE	19710913	gold, Green Submitted, Green Published			2022-12-25	WOS:000269415600020
J	Friman, VP; Lindstedt, C; Hiltunen, T; Laakso, J; Mappes, J				Friman, Ville-Petri; Lindstedt, Carita; Hiltunen, Teppo; Laakso, Jouni; Mappes, Johanna			Predation on Multiple Trophic Levels Shapes the Evolution of Pathogen Virulence	PLOS ONE			English	Article								The pathogen virulence is traditionally thought to co-evolve as a result of reciprocal selection with its host organism. In natural communities, pathogens and hosts are typically embedded within a web of interactions with other species, which could affect indirectly the pathogen virulence and host immunity through trade-offs. Here we show that selection by predation can affect both pathogen virulence and host immune defence. Exposing opportunistic bacterial pathogen Serratia marcescens to predation by protozoan Tetrahymena thermophila decreased its virulence when measured as host moth Parasemia plantaginis survival. This was probably because the bacterial anti-predatory traits were traded off with bacterial virulence factors, such as motility or resource use efficiency. However, the host survival depended also on its allocation to warning signal that is used against avian predation. When infected with most virulent ancestral bacterial strain, host larvae with a small warning signal survived better than those with an effective large signal. This suggests that larval immune defence could be traded off with effective defence against bird predators. However, the signal size had no effect on larval survival when less virulent control or evolved strains were used for infection suggesting that anti-predatory defence against avian predators, might be less constrained when the invading pathogen is rather low in virulence. Our results demonstrate that predation can be important indirect driver of the evolution of both pathogen virulence and host immunity in communities with multiple species interactions. Thus, the pathogen virulence should be viewed as a result of both past evolutionary history, and current ecological interactions.			Friman, VP (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Evolutionary Res, Jyvaskyla, Finland.	vifriman@jyu.fi	Hiltunen, Teppo/A-4308-2015; Mappes, Johanna/AAZ-3627-2021; Laakso, Jouni/I-7794-2013	Hiltunen, Teppo/0000-0001-7206-2399; Laakso, Jouni/0000-0001-8245-9912; Friman, Ville-Petri/0000-0002-1592-157X; Mappes, Johanna/0000-0002-1117-5629				Armitage SAO, 2005, HEREDITY, V94, P650, DOI 10.1038/sj.hdy.6800675; Borer ET, 2009, P NATL ACAD SCI USA, V106, P503, DOI 10.1073/pnas.0808778106; Brown MRW, 1999, TRENDS MICROBIOL, V7, P46, DOI 10.1016/S0966-842X(98)01425-5; BROWN RC, 1975, NATURE, V254, P434, DOI 10.1038/254434a0; Brussow H, 2007, MOL MICROBIOL, V65, P583, DOI 10.1111/j.1365-2958.2007.05826.x; Buckling A, 2008, HEREDITY, V100, P484, DOI 10.1038/sj.hdy.6801093; Cotter SC, 2004, J EVOLUTION BIOL, V17, P421, DOI 10.1046/j.1420-9101.2003.00655.x; Cotter SC, 2004, J ANIM ECOL, V73, P283, DOI 10.1111/j.0021-8790.2004.00806.x; DAVIES B, 1991, J GEN MICROBIOL, V137, P705, DOI 10.1099/00221287-137-3-705; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; Edeline E, 2008, P NATL ACAD SCI USA, V105, P19792, DOI 10.1073/pnas.0808011105; Fordyce JA, 2008, EVOLUTION, V62, P1610, DOI 10.1111/j.1558-5646.2008.00388.x; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Friman VP, 2008, P ROY SOC B-BIOL SCI, V275, P1625, DOI 10.1098/rspb.2008.0174; GONZALEZ JM, 1993, MAR ECOL PROG SER, V102, P257, DOI 10.3354/meps102257; Grill CP, 1998, OECOLOGIA, V114, P274, DOI 10.1007/s004420050446; GRIMONT PAD, 1978, ANNU REV MICROBIOL, V32, P221, DOI 10.1146/annurev.mi.32.100178.001253; Harb OS, 2000, ENVIRON MICROBIOL, V2, P251, DOI 10.1046/j.1462-2920.2000.00112.x; Holt RD, 2007, AM NAT, V169, P690, DOI 10.1086/513188; Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Lindstedt C, 2008, ANIM BEHAV, V75, P1703, DOI 10.1016/j.anbehav.2007.10.024; Lindstedt C, 2009, EVOLUTION, V63, P469, DOI 10.1111/j.1558-5646.2008.00561.x; Losey JE, 1997, NATURE, V388, P269, DOI 10.1038/40849; Malik-Kale P, 2007, APPL ENVIRON MICROB, V73, P3123, DOI 10.1128/AEM.01399-06; Matz C, 2005, P NATL ACAD SCI USA, V102, P16819, DOI 10.1073/pnas.0505350102; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Monger Bruce C., 1992, Advances in Limnology, V37, P173; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Ojala K, 2007, FUNCT ECOL, V21, P1162, DOI 10.1111/j.1365-2435.2007.01322.x; Ojala K, 2005, EVOL ECOL RES, V7, P1153; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; PARUCHURI DK, 1987, J BACTERIOL, V169, P61, DOI 10.1128/jb.169.1.61-65.1987; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Rantala MJ, 2005, FUNCT ECOL, V19, P323, DOI 10.1111/j.1365-2435.2005.00979.x; Rigby MC, 2000, P ROY SOC B-BIOL SCI, V267, P171, DOI 10.1098/rspb.2000.0983; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Schmid-Hempel P, 2003, P ROY SOC B-BIOL SCI, V270, P357, DOI 10.1098/rspb.2002.2265; SCHULENBURG H, 2008, P ROY SOC LOND B BIO, V364, P3; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Vodovar N, 2004, TRENDS MICROBIOL, V12, P235, DOI 10.1016/j.tim.2004.03.007; Wei JR, 2006, INT J MED MICROBIOL, V296, P117, DOI 10.1016/j.ijmm.2006.01.033; West SA, 2003, P ROY SOC B-BIOL SCI, V270, P37, DOI 10.1098/rspb.2002.2209	47	59	61	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6761	10.1371/journal.pone.0006761	http://dx.doi.org/10.1371/journal.pone.0006761			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707586	Green Published, gold, Green Submitted			2022-12-25	WOS:000269278400024
J	Lopman, B; Armstrong, B; Atchison, C; Gray, JJ				Lopman, Ben; Armstrong, Ben; Atchison, Christina; Gray, Jim J.			Host, Weather and Virological Factors Drive Norovirus Epidemiology: Time-Series Analysis of Laboratory Surveillance Data in England and Wales	PLOS ONE			English	Article								Norovirus, the most commonly identified cause of both sporadic cases and outbreaks of infectious diarrhoea in developed countries, exhibits a complex epidemiology and has a strong wintertime seasonality. Viral populations are dynamic and evolve under positive selection pressure. Methods: Time series-adapted Poisson regression models were fitted to daily counts of laboratory reports of norovirus in England and Wales from 1993 to 2006. Findings: Inverse linear associations with daily temperature over the previous seven weeks (rate ratio (RR) = 0.85; 95% CI: 0.83 to 0.86 for every 1 degrees C increase) and relative humidity over the previous five weeks (RR = 0.980; 95% CI: 0.973 to 0.987 for every 1% increase) were found, with temperature having a greater overall effect. The emergence of new norovirus variants (RR = 1.16; 95% CI: 1.10 to 1.22) and low population immunity were also associated with heightened norovirus activity. Temperature and humidity, which may be localised, had highly consistent effects in each region of England and Wales. Conclusions: These results point to a complex interplay between host, viral and climatic factors driving norovirus epidemic patterns. Increases in norovirus are associated with cold, dry temperature, low population immunity and the emergence of novel genogroup 2 type 4 antigenic variants.			Lopman, B (corresponding author), Hlth Protect Agcy, Ctr Infect, Gastrointestinal Emerging & Zoonot Infect Dept, London, England.	ben.lopman@hpa.org.uk		Atchison, Christina/0000-0001-8304-7389; armstrong, benedict/0000-0003-4407-0409				ADLER JL, 1969, J INFECT DIS, V119, P668, DOI 10.1093/infdis/119.6.668; Allen DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001485; Allwood Paul B, 2005, Int J Environ Res Public Health, V2, P442, DOI 10.3390/ijerph2005030008; Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; BLACKLOW NR, 1987, CIBA F SYMP, V128, P144; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Buckow R, 2008, APPL ENVIRON MICROB, V74, P1030, DOI 10.1128/AEM.01784-07; Cannon JL, 2006, J FOOD PROTECT, V69, P2761, DOI 10.4315/0362-028X-69.11.2761; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; D'Souza RM, 2008, EPIDEMIOL INFECT, V136, P56, DOI 10.1017/S0950268807008229; D'Souza RM, 2004, EPIDEMIOLOGY, V15, P86, DOI 10.1097/01.ede.0000101021.03453.3e; de Wit MAS, 2001, AM J EPIDEMIOL, V154, P666, DOI 10.1093/aje/154.7.666; Duizer E., 2008, Eurosurveillance, V13, P18867; Duizer E, 2004, J GEN VIROL, V85, P79, DOI 10.1099/vir.0.19478-0; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; FERNANDEZ MAL, 2008, T R SOC TROP MED HYG; Gallimore CI, 2007, ARCH VIROL, V152, P1295, DOI 10.1007/s00705-007-0954-9; Glass RI, 2000, J INFECT DIS, V181, pS254, DOI 10.1086/315588; HARRIS JP, 2008, EMERG INFECT DIS; Hashizume M, 2008, EPIDEMIOL INFECT, V136, P1281, DOI 10.1017/S0950268807009776; Hedlund KO, 2000, J INFECT DIS, V181, pS275, DOI 10.1086/315585; HEMMES JH, 1960, NATURE, V188, P430, DOI 10.1038/188430a0; Kovats RS, 2004, EPIDEMIOL INFECT, V132, P443, DOI 10.1017/S0950268804001992; LEVY K, 2008, INT J EPIDEMIOL; LINDESMITH L, 2007, PLOS MED; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Lopman BA, 2004, EMERG INFECT DIS, V10, P1827, DOI 10.3201/eid1010.030941; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Marks PJ, 2000, EPIDEMIOL INFECT, V124, P481, DOI 10.1017/S0950268899003805; Matsui SM, 2000, J INFECT DIS, V181, pS331, DOI 10.1086/315587; McCullagh P., 1989, GEN LINEAR MODELS, V(2nd), DOI [10.1007/978-1-4899-3242-6, https://doi.org/10.1007/978-1-4899-3242-6, DOI 10.1007/978-1-4899-3242-6]; Mounts AW, 2000, J INFECT DIS, V181, pS284, DOI 10.1086/315586; O'Neill PD, 2005, STAT MED, V24, P2011, DOI 10.1002/sim.2090; PARKER DE, 1992, INT J CLIMATOL, V12, P317, DOI 10.1002/joc.3370120402; PARRINO TA, 1977, NEW ENGL J MED, V297, P86, DOI 10.1056/NEJM197707142970204; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; SIEBENGA J, 2008, ANAL AMINO ACID VARI; Tam CC, 2006, EPIDEMIOL INFECT, V134, P119, DOI 10.1017/S0950268805004899; Wall P G, 1996, Commun Dis Rep CDR Rev, V6, pR93; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046; Widdowson MA, 2004, J INFECT DIS, V190, P27, DOI 10.1086/420888; WYATT RG, 1974, J INFECT DIS, V129, P709, DOI 10.1093/infdis/129.6.709; Yusuf S, 2007, EPIDEMIOL INFECT, V135, P1077, DOI 10.1017/S095026880600776X	44	96	105	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2009	4	8							e6671	10.1371/journal.pone.0006671	http://dx.doi.org/10.1371/journal.pone.0006671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JF	19701458	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000269268300002
J	Huby, AC; Rastaldi, MP; Caron, K; Smithies, O; Dussaule, JC; Chatziantoniou, C				Huby, Anne-Cecile; Rastaldi, Maria-Pia; Caron, Kathleen; Smithies, Oliver; Dussaule, Jean-Claude; Chatziantoniou, Christos			Restoration of Podocyte Structure and Improvement of Chronic Renal Disease in Transgenic Mice Overexpressing Renin	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHESIS; TISSUE GROWTH-FACTOR; MATRIX METALLOPROTEINASES; MESENCHYMAL TRANSITION; GLOMERULAR FIBROSIS; BMP ANTAGONIST; I GENE; REVERSAL; KIDNEY; COLLAGEN	Background: Proteinuria is a major marker of the decline of renal function and an important risk factor of coronary heart disease. Elevated proteinuria is associated to the disruption of slit-diaphragm and loss of podocyte foot processes, structural alterations that are considered irreversible. The objective of the present study was to investigate whether proteinuria can be reversed and to identify the structural modifications and the gene/protein regulation associated to this reversal. Methodology/Principal Findings: We used a novel transgenic strain of mouse (RenTg) that overexpresses renin at a constant high level. At the age of 12-month, RenTg mice showed established lesions typical of chronic renal disease such as perivascular and periglomerular inflammation, glomerular ischemia, glomerulosclerosis, mesangial expansion and tubular dilation. Ultrastructural analysis indicated abnormal heterogeneity of basement membrane thickness and disappearance of podocyte foot processes. These structural alterations were accompanied by decreased expressions of proteins specific of podocyte (nephrin, podocin), or tubular epithelial cell (E-cadherin and megalin) integrity. In addition, since TGF beta is considered the major pro-fibrotic agent in renal disease and since exogenous administration of BMP7 is reported to antagonize the TGF beta-induced phenotype changes in kidney, we have screened the expressions of several genes belonging in the TGF beta/BMP superfamily. We found that the endogenous inhibitors of BMPs such as noggin and Usag-1 were several-fold activated inhibiting the action of BMPs and thus reinforcing the deleterious action of TGF beta. Treatment with an AT1 receptor antagonist, at dose that did not decrease arterial pressure, gradually reduced albuminuria. This decrease was accompanied by re-expression of podocin, nephrin, E-cadherin and megalin, and reappearance of podocyte foot processes. In addition, expressions of noggin and Usag-1 were markedly decreased, permitting thus activation of the beneficial action of BMPs. Conclusions/Significance: These findings show that proteinuria and alterations in the expression of proteins involved in the integrity and function of glomerular and renal epithelial phenotype are reversible events when the local action of angiotensin II is blocked, and provide hope that chronic renal disease can be efficiently treated.			Huby, AC (corresponding author), INSERM, UMR 702, Paris, France.	christos.chatziantoniou@chusa.jussieu.fr	Chatziantoniou, Christos/L-2501-2016	Caron, Kathleen/0000-0002-7033-9232	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049277] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL049277-16, R01 HL049277-17, HL049277, R01 HL049277] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adamczak M, 2003, J AM SOC NEPHROL, V14, P2833, DOI 10.1097/01.ASN.0000095248.91994.D3; Anjaneyulu M, 2004, AM J NEPHROL, V24, P488, DOI 10.1159/000080722; Benigni A, 2001, J AM SOC NEPHROL, V12, P941, DOI 10.1681/ASN.V125941; Boffa JJ, 1999, CIRCULATION, V100, P1901, DOI 10.1161/01.CIR.100.18.1901; Boffa JJ, 2003, J AM SOC NEPHROL, V14, P1132, DOI 10.1097/01.ASN.0000060574.38107.3B; Caron KMI, 2004, P NATL ACAD SCI USA, V101, P3106, DOI 10.1073/pnas.0307333101; Caron KMI, 2002, P NATL ACAD SCI USA, V99, P8248, DOI 10.1073/pnas.112222199; Carvajal G, 2008, KIDNEY INT, V74, P585, DOI 10.1038/ki.2008.213; DIAMOND JR, 1990, AM J PATHOL, V137, P1323; Eliahou H, 2001, AM J NEPHROL, V21, P78, DOI 10.1159/000046225; Fakhouri F, 2001, J AM SOC NEPHROL, V12, P2701, DOI 10.1681/ASN.V12122701; Flamant M, 2007, HYPERTENSION, V50, P212, DOI 10.1161/HYPERTENSIONAHA.107.089631; Flamant M, 2006, J AM SOC NEPHROL, V17, P3374, DOI 10.1681/ASN.2006060677; Francois H, 2004, FASEB J, V18, P926, DOI 10.1096/fj.03-0702fje; Guha M, 2007, FASEB J, V21, P3355, DOI 10.1096/fj.06-6713com; Herfs M, 2008, AM J PATHOL, V172, P1391, DOI 10.2353/ajpath.2008.071004; Hosojima M, 2009, ENDOCRINOLOGY, V150, P871, DOI 10.1210/en.2008-0886; Ivanova L, 2008, AM J PHYSIOL-RENAL, V294, pF1238, DOI 10.1152/ajprenal.00326.2007; Kim HS, 2002, P NATL ACAD SCI USA, V99, P4602, DOI 10.1073/pnas.072083799; Li XC, 2008, AM J PHYSIOL-CELL PH, V294, pC1034, DOI 10.1152/ajpcell.00432.2007; Liu BC, 2007, ACTA PHARMACOL SIN, V28, P1810, DOI 10.1111/j.1745-7254.2007.00649.x; Macconi D, 2006, AM J PATHOL, V168, P1073, DOI 10.2353/ajpath.2006.050701; MACCONI D, 2009, AM J PATHOL; NavarroCid J, 1996, AM J HYPERTENS, V9, P1077, DOI 10.1016/0895-7061(96)00195-1; OHMURA T, 2007, ACTA DIABETOL; Okada H, 1997, AM J PHYSIOL-RENAL, V273, pF563, DOI 10.1152/ajprenal.1997.273.4.F563; Perkovic V, 2008, PLOS MED, V5, P1486, DOI 10.1371/journal.pmed.0050207; Piecha G, 2008, AM J PHYSIOL-RENAL, V295, pF137, DOI 10.1152/ajprenal.00065.2008; Placier S, 2006, NEPHROL DIAL TRANSPL, V21, P881, DOI 10.1093/ndt/gfk004; Ronco P, 2008, KIDNEY INT, V74, P873, DOI 10.1038/ki.2008.349; Ruperez M, 2003, AM J PATHOL, V163, P1937, DOI 10.1016/S0002-9440(10)63552-3; Shweke N, 2008, AM J PATHOL, V173, P631, DOI 10.2353/ajpath.2008.080025; Tanaka M, 2008, KIDNEY INT, V73, P181, DOI 10.1038/sj.ki.5002626; Weigert C, 2002, DIABETOLOGIA, V45, P890, DOI 10.1007/s00125-002-0843-4; Yanagita M, 2006, J CLIN INVEST, V116, P70, DOI 10.1172/JCI25445; Ying L, 2003, HYPERTENSION, V42, P937, DOI 10.1161/01.HYP.0000099240.89890.94; Zeisberg M, 2005, J BIOL CHEM, V280, P8094, DOI 10.1074/jbc.M413102200; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeisberg M, 2008, PEDIATR NEPHROL, V23, P1395, DOI 10.1007/s00467-008-0818-x; Zhou Y, 2009, AM J PATHOL, V174, P21, DOI 10.2353/ajpath.2009.080620; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	41	51	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6721	10.1371/journal.pone.0006721	http://dx.doi.org/10.1371/journal.pone.0006721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696925	Green Published, gold, Green Submitted			2022-12-25	WOS:000269267600010
J	Yassin, ER; Sarma, NJ; Abdul-Nabi, AM; Dombrowski, J; Han, Y; Takeda, A; Yaseen, NR				Yassin, Enas R.; Sarma, Nayan J.; Abdul-Nabi, Anmaar M.; Dombrowski, James; Han, Ye; Takeda, Akiko; Yaseen, Nabeel R.			Dissection of the Transformation of Primary Human Hematopoietic Cells by the Oncogene NUP98-HOXA9	PLOS ONE			English	Article								NUP98-HOXA9 is the prototype of a group of oncoproteins associated with acute myeloid leukemia. It consists of an N-terminal portion of NUP98 fused to the homeodomain of HOXA9 and is believed to act as an aberrant transcription factor that binds DNA through the homeodomain. Here we show that NUP98-HOXA9 can regulate transcription without binding to DNA. In order to determine the relative contributions of the NUP98 and HOXA9 portions to the transforming ability of NUP98-HOXA9, the effects of NUP98-HOXA9 on primary human CD34+ cells were dissected and compared to those of wildtype HOXA9. In contrast to previous findings in mouse cells, HOXA9 had only mild effects on the differentiation and proliferation of primary human hematopoietic cells. The ability of NUP98-HOXA9 to disrupt the differentiation of primary human CD34+ cells was found to depend primarily on the NUP98 portion, whereas induction of long-term proliferation required both the NUP98 moiety and an intact homeodomain. Using oligonucleotide microarrays in primary human CD34+ cells, a group of genes was identified whose dysregulation by NUP98-HOXA9 is attributable primarily to the NUP98 portion. These include RAP1A, HEY1, and PTGS2 (COX-2). Their functions may reflect the contribution of the NUP98 moiety of NUP98-HOXA9 to leukemic transformation. Taken together, these results suggest that the effects of NUP98-HOXA9 on gene transcription and cell transformation are mediated by at least two distinct mechanisms: one that involves promoter binding through the homeodomain with direct transcriptional activation, and another that depends predominantly on the NUP98 moiety and does not involve direct DNA binding.			Yassin, ER (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	nyaseen@path.wustl.edu	Han, Ye/A-2173-2010	Yaseen, Nabeel/0000-0001-6902-5116	NCI NIH HHS [T32 CA009547, P30 CA91842, P30 CA091842] Funding Source: Medline; NHLBI NIH HHS [K02 HL084179, R01 HL082549] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA091842, T32CA009547] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL084179, R01HL082549] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADACHI M, 1992, ONCOGENE, V7, P323; Arai A, 2001, J BIOL CHEM, V276, P10453, DOI 10.1074/jbc.M004627200; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Bai XT, 2006, CANCER RES, V66, P4584, DOI 10.1158/0008-5472.CAN-05-3101; Balduini A, 2004, EXP CELL RES, V300, P84, DOI 10.1016/j.yexcr.2004.07.011; Bei L, 2005, J BIOL CHEM, V280, P12359, DOI 10.1074/jbc.M408138200; Bernard MP, 2008, CURR PHARM DESIGN, V14, P2051, DOI 10.2174/138161208785294654; Borrow J, 1996, NAT GENET, V12, P159, DOI 10.1038/ng0296-159; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Calvo KR, 2002, ONCOGENE, V21, P4247, DOI 10.1038/sj.onc.1205516; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; CAVARD C, 2009, J PATHOL; Chung KY, 2006, CANCER RES, V66, P11781, DOI 10.1158/0008-5472.CAN-06-0706; Delehanty LL, 2003, BLOOD, V101, P1744, DOI 10.1182/blood-2002-04-1278; Denning DP, 2007, MOL CELL PROTEOMICS, V6, P272, DOI 10.1074/mcp.M600309-MCP200; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Elagib KE, 2004, MOL CELL BIOL, V24, P7779, DOI 10.1128/MCB.24.17.7779-7794.2004; ENGIN F, 2009, HUM MOL GENET; Fontoura BMA, 2000, J BIOL CHEM, V275, P31289, DOI 10.1074/jbc.M004651200; Garcia J, 2001, MOL CELL BIOL, V21, P2659, DOI 10.1128/MCB.21.8.2659-2670.2001; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Ghannam G, 2004, J BIOL CHEM, V279, P866, DOI 10.1074/jbc.M307280200; Gurevich RM, 2004, BLOOD, V104, P1127, DOI 10.1182/blood-2003-10-3550; Harris Randall E, 2007, Subcell Biochem, V42, P93; Henning K, 2007, EXP HEMATOL, V35, P1321, DOI 10.1016/j.exphem.2007.05.014; Hirose K, 2008, ONCOGENE, V27, P6056, DOI 10.1038/onc.2008.210; Hulleman E, 2009, J CELL MOL MED, V13, P136, DOI 10.1111/j.1582-4934.2008.00307.x; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jankovic D, 2008, BLOOD, V111, P5672, DOI 10.1182/blood-2007-09-108175; Kang SJ, 2008, BIOCHEM BIOPH RES CO, V372, P629, DOI 10.1016/j.bbrc.2008.05.079; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kawagoe H, 1999, LEUKEMIA, V13, P687, DOI 10.1038/sj.leu.2401410; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Konishi J, 2007, CANCER RES, V67, P8051, DOI 10.1158/0008-5472.CAN-07-1022; Kroon E, 2001, EMBO J, V20, P350, DOI 10.1093/emboj/20.3.350; Lawrence HJ, 1999, LEUKEMIA, V13, P1993, DOI 10.1038/sj.leu.2401578; Lucas B, 2005, ONCOGENE, V24, P6418, DOI 10.1038/sj.onc.1208794; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Moore MAS, 2005, EXP HEMATOL, V33, P719, DOI 10.1016/j.exphem.2005.04.011; Nakamura T, 1999, BLOOD, V94, P741, DOI 10.1182/blood.V94.2.741.414k04_741_747; Nakamura T, 1996, NAT GENET, V12, P154, DOI 10.1038/ng0296-154; Nefedova Y, 2008, DRUG RESIST UPDATE, V11, P210, DOI 10.1016/j.drup.2008.09.002; Palmqvist L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000768; Pineault N, 2003, BLOOD, V101, P4529, DOI 10.1182/blood-2002-08-2484; Pogoda JM, 2005, INT J CANCER, V114, P634, DOI 10.1002/ijc.20788; Pritchard CEJ, 1999, J CELL BIOL, V145, P237, DOI 10.1083/jcb.145.2.237; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; Robak P, 2008, LEUKEMIA LYMPHOMA, V49, P1452, DOI 10.1080/10428190802108854; Romana SP, 2006, LEUKEMIA, V20, P696, DOI 10.1038/sj.leu.2404130; Shanmugam K, 1999, MOL CELL BIOL, V19, P7577; Shen WF, 1997, J BIOL CHEM, V272, P8198, DOI 10.1074/jbc.272.13.8198; Stork PJS, 2005, BLOOD, V106, P2952, DOI 10.1182/blood-2005-03-1062; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; SUTHERLAND HJ, 1990, P NATL ACAD SCI USA, V87, P3584, DOI 10.1073/pnas.87.9.3584; Takeda A, 2006, CANCER RES, V66, P6628, DOI 10.1158/0008-5472.CAN-06-0458; Ulrich CM, 2006, NAT REV CANCER, V6, P130, DOI 10.1038/nrc1801; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Yaseen NR, 1997, P NATL ACAD SCI USA, V94, P4451, DOI 10.1073/pnas.94.9.4451; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	61	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6719	10.1371/journal.pone.0006719	http://dx.doi.org/10.1371/journal.pone.0006719			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696924	gold, Green Submitted, Green Published			2022-12-25	WOS:000269267600009
J	Addo, J; Smeeth, L; Leon, DA				Addo, Juliet; Smeeth, Liam; Leon, David A.			Hypertensive Target Organ Damage in Ghanaian Civil Servants with Hypertension	PLOS ONE			English	Article							ELECTROCARDIOGRAPHIC STRAIN PATTERN; LEFT-VENTRICULAR HYPERTROPHY; PRESSURE-RELATED DISEASE; STAGE RENAL-DISEASE; ETHNIC-DIFFERENCES; BLOOD-PRESSURE; STROKE MORTALITY; PREVALENCE; PREDICTION; MANAGEMENT	Background: Low levels of detection, treatment and control of hypertension have repeatedly been reported from sub Saharan Africa, potentially increasing the likelihood of target organ damage. Methods: A cross-sectional study was conducted on 1015 urban civil servants aged >= 25 years from seven central government ministries in Accra, Ghana. Participants diagnosed to have hypertension were examined for target organ involvement. Hypertensive target organ damage was defined as the detection of any of the following: left ventricular hypertrophy diagnosed by electrocardiogram, reduction in glomerular filtration rate, the presence of hypertensive retinopathy or a history of a stroke. Results: Of the 219 hypertensive participants examined, 104 (47.5%) had evidence of target organ damage. The presence of target organ damage was associated with higher systolic and diastolic blood pressure levels. The odds of developing hypertensive target organ damage was five to six times higher in participants with blood pressure (BP)>= 180/110 mmHg compared to those with BP<140/90 mmHg, and there was a trend to higher odds of target organ damage with increasing BP (p = 0.001). Women had about lower odds of developing target organ damage compared to men. Conclusions: The high prevalence of target organ damage in this working population associated with increasing blood pressure, emphasises the need for hypertension control programs aimed at improving the detection of hypertension, and importantly addressing the issues inhibiting the effective treatment and control of people with hypertension in the population.			Addo, J (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	Juliet.addo@lshtm.ac.uk	Leon, David A/G-2195-2010; Smeeth, Liam/X-5862-2018	Leon, David A/0000-0001-9747-1762; Smeeth, Liam/0000-0002-9168-6022				Addo J, 2008, ETHNIC DIS, V18, P505; Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Addo J, 2009, INT J ENV RES PUB HE, V6, P200, DOI 10.3390/ijerph6010200; Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Agyemang C, 2006, J HUM HYPERTENS, V20, P67, DOI 10.1038/sj.jhh.1001923; Amoah AGB, 2003, ETHNIC DIS, V13, P310; Ayodele O E, 2005, Cardiovasc J S Afr, V16, P89; Bovet P, 2002, INT J EPIDEMIOL, V31, P240, DOI 10.1093/ije/31.1.240; Bryson CL, 2006, AM J KIDNEY DIS, V48, P720, DOI 10.1053/j.ajkd.2006.07.023; Cappuccio FP, 2004, HYPERTENSION, V43, P1017, DOI 10.1161/01.HYP.0000126176.03319.d8; Chaturvedi N, 2004, J HYPERTENS, V22, P1731, DOI 10.1097/00004872-200409000-00017; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cuspidi C, 2001, Ital Heart J, V2, P702; Edwards R, 2000, J HYPERTENS, V18, P145, DOI 10.1097/00004872-200018020-00003; Ferdinand Keith C, 2006, J Clin Hypertens (Greenwich), V8, P21, DOI 10.1111/j.1524-6175.2006.05295.x; Gavin JR, 1997, DIABETES CARE, V20, P1183; Hsieh BP, 2005, AM HEART J, V150, P161, DOI 10.1016/j.ahj.2004.08.041; KAUFMAN J, 1993, ETHNICITY & DISEASE, VOL 3, SUPPLEMENT, pS83; Komolafe MA, 2007, TROP DOCT, V37, P186, DOI 10.1258/004947507781524557; Larsen CT, 2002, EUR HEART J, V23, P315, DOI 10.1053/euhj.2001.2774; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lemogoum D, 2005, AM J PREV MED, V29, P95, DOI 10.1016/j.amepre.2005.07.025; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LEVY D, 1994, CIRCULATION, V90, P1786, DOI 10.1161/01.CIR.90.4.1786; LOPES AAS, 1994, AM J KIDNEY DIS, V24, P554, DOI 10.1016/S0272-6386(12)80211-3; MENSAH GA, 1994, J HUM HYPERTENS, V8, P799; Mensah George A., 2002, Cardiology Clinics, V20, P225, DOI 10.1016/S0733-8651(02)00004-8; Messerli FH, 2007, LANCET, V370, P591, DOI 10.1016/S0140-6736(07)61299-9; Noblat Antonio Carlos Beisl, 2004, Arq Bras Cardiol, V83, P314; Noblat Antonio Carlos Beisl, 2004, Arq. Bras. Cardiol., V82, P111, DOI 10.1590/S0066-782X2004000200002; Noblat Antonio Carlos Beisl, 2004, Arq. Bras. Cardiol., V83, P308; Noblat Antonio Carlos Beisl, 2004, Arq Bras Cardiol, V82, P116; Okin PM, 2006, CIRCULATION, V113, P67, DOI 10.1161/CIRCULATIONAHA.105.569491; Okin PM, 2004, HYPERTENSION, V44, P48, DOI 10.1161/01.HYP.0000132556.91792.6a; Okin PM, 2002, AM J HYPERTENS, V15, P663, DOI 10.1016/S0895-7061(02)02945-X; Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569; Perkovic V, 2007, HYPERTENSION, V50, P991, DOI 10.1161/HYPERTENSIONAHA.107.095497; *POOL PROJ RES GRO, 1978, J CHRON DIS, V31, P201, DOI DOI 10.1016/0021-9681(78)90073-5; RAUTAHARJU PM, 1994, J ELECTROCARDIOL, V27, P20, DOI 10.1016/S0022-0736(94)80040-5; Rose G, 1982, CARDIOVASCULAR SURVE; Salako B L, 2007, Cardiovasc J Afr, V18, P77; Seedat Y K, 2006, Cardiovasc J S Afr, V17, P47; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; Walker RW, 2000, LANCET, V355, P1684, DOI 10.1016/S0140-6736(00)02240-6; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634; WONG TY, 2005, BR MED B, P73; Xue JL, 2007, J AM SOC NEPHROL, V18, P1299, DOI 10.1681/ASN.2006050524	48	27	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2009	4	8							e6672	10.1371/journal.pone.0006672	http://dx.doi.org/10.1371/journal.pone.0006672			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484VF	19701488	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000269075800008
J	Delanote, V; Vanloo, B; Catillon, M; Friederich, E; Vandekerckhove, J; Gettemans, J				Delanote, Veerle; Vanloo, Berlinda; Catillon, Marie; Friederich, Evelyne; Vandekerckhove, Joel; Gettemans, Jan			An alpaca single-domain antibody blocks filopodia formation by obstructing L-plastin-mediated F-actin bundling	FASEB JOURNAL			English	Article						immunomodulation; cytoskeleton; fimbrin; cancer cell; invasion	CANCER-CELL MIGRATION; COLON-CANCER; T-PLASTIN; PROTEIN; INVASION; EXPRESSION; COMPLEX; FASCIN; GENE; FIMBRIN	L-plastin, a conserved modular F-actin bundling protein, is ectopically expressed in tumor cells and contributes to cell malignancy and invasion. The underlying molecular mechanisms involved remain unclear, in part, because specific inhibitors of L-plastin are lacking. We used recombinant alpaca-derived L-plastin single-domain antibodies (nanobodies) as effector of L-plastin function in cells. Key findings were compared with L-plastin down-regulation by RNAi. We show that nanobodies strongly interact with L-plastin by targeting discrete conformational epitopes with nanomolar affinity. A nanobody that selectively interacts with the tandem ABDs in L-plastin completely inhibits F-actin bundling at equimolar ratios, in contrast to a control green fluorescent protein (GFP) nanobody. This "knockout" nanobody inhibits filopodia formation, motility, and invasion when expressed in PC-3 cells. L-plastin RNA interference showed no significant effect on filopodial integrity and only marginally restrained the motile properties of cells. L-plastin nanobodies uniquely expose a fundamental role for this protein in filopodia formation and cell migration. Therefore, these molecules represent a potent instrument to ablate functions of structural proteins without manipulating gene expression. In addition, we show that they can be instrumental in uncovering new functions of proteins that remain obscured by RNAi.-Delanote, V., Vanloo, B., Catillon, M., Friederich, E., Vandekerckhove, J., Gettemans, J. An alpaca singledomain antibody blocks filopodia formation by obstructing L-plastin-mediated F-actin bundling. FASEB J. 24, 105-118(2010). www.fasebj.org	[Delanote, Veerle; Vanloo, Berlinda; Vandekerckhove, Joel; Gettemans, Jan] Univ Ghent, Dept Biochem, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Catillon, Marie; Friederich, Evelyne] Univ Luxembourg, Fac Sci Technol & Commun, Life Sci Res Unit, Luxembourg, Luxembourg; [Delanote, Veerle; Vanloo, Berlinda; Vandekerckhove, Joel; Gettemans, Jan] VIB, Dept Med Prot Res, Ghent, Belgium	Ghent University; University of Luxembourg; Flanders Institute for Biotechnology (VIB)	Gettemans, J (corresponding author), Univ Ghent, Dept Biochem, Fac Med & Hlth Sci, Albert Baertsoenkaai 3, B-9000 Ghent, Belgium.	jan.gettemans@ugent.be			Fund for Scientific Research-Flanders (FWO-Vlaanderen); Stichting tegen Kanker; Vlaamse Liga tegen Kanker; Ghent University (GOA); Human Frontier Science Program (HFSP); Interuniversity Attraction Poles [IUAP06]; Stichting Emmanuel van der Schueren	Fund for Scientific Research-Flanders (FWO-Vlaanderen)(FWO); Stichting tegen Kanker; Vlaamse Liga tegen Kanker; Ghent University (GOA)(Ghent University); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Interuniversity Attraction Poles(Belgian Federal Science Policy Office); Stichting Emmanuel van der Schueren	This work was supported by the Fund for Scientific Research-Flanders (FWO-Vlaanderen), the Stichting tegen Kanker, the Vlaamse Liga tegen Kanker, the Concerted Actions Programme of Ghent University (GOA), the Human Frontier Science Program (HFSP) and the Interuniversity Attraction Poles (IUAP06). V. D. is supported by the Vlaamse Liga tegen Kanker through a grant of the Stichting Emmanuel van der Schueren. The authors thank Dr. A. Lambrechts for help with microscopy. The authors also thank Dr. Ariane De Ganck and Dr. Katrien Van Impe for their contributions to this work.	Adams JC, 2000, J CELL BIOL, V150, P807, DOI 10.1083/jcb.150.4.807; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brieher WM, 2004, J CELL BIOL, V165, P233, DOI 10.1083/jcb.200311040; Cao T, 2005, ANN CLIN LAB SCI, V35, P227; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Correia I, 1999, J CELL BIOL, V146, P831, DOI 10.1083/jcb.146.4.831; DEARRUDA MV, 1990, J CELL BIOL, V111, P1069, DOI 10.1083/jcb.111.3.1069; Delanote V, 2005, TRAFFIC, V6, P335, DOI 10.1111/j.1600-0854.2005.00276.x; Delanote V, 2005, ACTA PHARMACOL SIN, V26, P769, DOI 10.1111/j.1745-7254.2005.00145.x; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Evans JG, 2003, J CELL BIOL, V161, P697, DOI 10.1083/jcb.200212037; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; Faix J, 2009, INT J BIOCHEM CELL B, V41, P1656, DOI 10.1016/j.biocel.2009.02.012; Foran E, 2006, INT J CANCER, V118, P2098, DOI 10.1002/ijc.21593; Galkin VE, 2008, P NATL ACAD SCI USA, V105, P1494, DOI 10.1073/pnas.0708667105; Giganti A, 2005, J CELL SCI, V118, P1255, DOI 10.1242/jcs.01698; GLENNEY JR, 1981, J BIOL CHEM, V256, P9283; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hara T, 2007, MOL CELL PROTEOMICS, V6, P479, DOI 10.1074/mcp.M600129-MCP200; Howl J, 2007, BIOCHEM SOC T, V35, P767, DOI 10.1042/BST0350767; Janji B, 2006, J CELL SCI, V119, P1947, DOI 10.1242/jcs.02874; Kaufmann U, 2000, J CELL SCI, V113, P4121; Klemke M, 2007, INT J CANCER, V120, P2590, DOI 10.1002/ijc.22589; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; LICHTLEN P, 2002, TARGETS, V1, P37; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; MCBRIDE HM, 1992, J CELL BIOL, V119, P1451, DOI 10.1083/jcb.119.6.1451; NAMBA Y, 1992, J BIOCHEM-TOKYO, V112, P503, DOI 10.1093/oxfordjournals.jbchem.a123929; Otsuka M, 2001, BIOCHEM BIOPH RES CO, V289, P876, DOI 10.1006/bbrc.2001.6047; PACAUD M, 1993, BIOCHEMISTRY-US, V32, P3448, DOI 10.1021/bi00064a031; PARK TS, 1994, CANCER RES, V54, P1775; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Rutka JT, 2008, NEOPLASIA, V10, P149, DOI 10.1593/neo.07909; Shinomiya H, 2007, BIOPHYS CHEM, V131, P36, DOI 10.1016/j.bpc.2007.09.001; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Thompson CC, 2007, GUT, V56, P95, DOI 10.1136/gut.2005.083691; Towbin H, 1992, Biotechnology, V24, P145; van den Abbeele A, 2007, CANCER LETT, V255, P57, DOI 10.1016/j.canlet.2007.03.023; Vignjevic D, 2008, SEMIN CANCER BIOL, V18, P12, DOI 10.1016/j.semcancer.2007.08.001; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Visintin M, 2008, J BIOTECHNOL, V135, P1, DOI 10.1016/j.jbiotec.2008.02.012; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Zheng JP, 1999, AM J PATHOL, V155, P115, DOI 10.1016/S0002-9440(10)65106-1; Zheng JP, 1997, AM J PATHOL, V150, P2009	47	44	48	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					105	118		10.1096/fj.09-134304	http://dx.doi.org/10.1096/fj.09-134304			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19726756				2022-12-25	WOS:000273233600013
J	Hayer, S; Pundt, N; Peters, MA; Wunrau, C; Kuhnel, I; Neugebauer, K; Strietholt, S; Zwerina, J; Korb, A; Penninger, J; Joosten, LAB; Gay, S; Ruckle, T; Schett, G; Pap, T				Hayer, Silvia; Pundt, Noreen; Peters, Marvin A.; Wunrau, Christina; Kuehnel, Inga; Neugebauer, Katja; Strietholt, Simon; Zwerina, Jochen; Korb, Adelheid; Penninger, Josef; Joosten, Leo A. B.; Gay, Steffen; Rueckle, Thomas; Schett, Georg; Pap, Thomas			PI3K gamma regulates cartilage damage in chronic inflammatory arthritis	FASEB JOURNAL			English	Article						inflammation; rheumatoid arthritis; synovial fibroblast; chondrocytes; signaling	PHOSPHOINOSITIDE 3-KINASE GAMMA; FIBROBLAST-LIKE SYNOVIOCYTES; MATRIX METALLOPROTEINASES; RHEUMATOID-ARTHRITIS; EMBRYONIC LETHALITY; NEUTRAL PROTEASES; MODEL; DEGRADATION; INHIBITION; EXPRESSION	The gamma isoform of phosphoinositide 3-kinase (PI3K gamma) has been viewed as restricted to leukocytes mediating the regulation of chemokine-induced migration and recruitment of neutrophils, monocytes, and macrophages. In line with the observation that PI3K gamma-deficient mice display defects in adaptive immunity, inhibition of PI3K gamma reduces synovial inflammation in the collagen-induced arthritis mouse model of inflammatory arthritis [rheumatoid arthritis (RA)], which has been attributed to reduced influx of inflammatory cells. Challenging the concept of leukocyte-restricted PI3K gamma function, we report here a novel, nonredundant function of PI3K gamma as an important regulator of fibroblast-induced cartilage destruction during chronic destructive arthritis. We show that in human tumor necrosis factor transgenic mice, the loss of PI3K gamma leads to a milder inflammatory arthritis. Interestingly, PI3K gamma deficiency does not alter the recruitment of inflammatory cells, but significantly reduces cartilage damage through reduced expression of matrix metalloproteinases in fibroblasts and chondrocytes. In vitro analyses demonstrate that the decreased invasiveness of fibroblasts is mediated by reduced phosphorylation of Akt and extracellular signal-regulated kinase. Using a PI3K gamma specific inhibitor, these data are confirmed in human synovial fibroblasts from patients with RA who exhibit a disease-specific up-regulation of PI3K gamma. Our data indicate that in addition to mediating the recruitment of inflammatory cells, PI3K gamma is an important regulator of fibroblast-mediated joint destruction in RA and suggest that specific inhibitors of PI3K gamma will interfere with the activation of RA synovial fibroblasts and reduce cartilage destruction in RA.-Hayer, S., Pundt, N., Peters, M. A., Wunrau, C., Kuhnel, I., Neugebauer, K., Strietholt, S., Zwerina, J., Korb, A., Penninger, J., Joosten, L. A. B., Gay, S., Ruckle, T., Schett, G., Pap, T. Phosphatidylinositol 3-kinase-gamma regulates cartilage damage in chronic inflammatory arthritis. FASEB J. 23, 4288-4298 (2009). www.fasebj.org	[Zwerina, Jochen; Schett, Georg] Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany; [Hayer, Silvia] Med Univ Vienna, Dept Internal Med 3, Div Rheumatol, Vienna, Austria; [Pundt, Noreen; Peters, Marvin A.; Wunrau, Christina; Kuehnel, Inga; Neugebauer, Katja; Strietholt, Simon; Pap, Thomas] Univ Hosp Muenster, Div Mol Med Musculoskeletal Tissue, Munster, Germany; [Korb, Adelheid] Univ Hosp Muenster, Dept Internal Med Nephrol & Rheumatol, Munster, Germany; [Penninger, Josef] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria; [Joosten, Leo A. B.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Gay, Steffen] Univ Zurich Hosp, Ctr Expt Rheumatol, CH-8091 Zurich, Switzerland; [Rueckle, Thomas] Merck Serono Int, Operat Excellence, Geneva, Switzerland	University of Erlangen Nuremberg; Medical University of Vienna; University of Munster; University of Munster; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Radboud University Nijmegen; University of Zurich; University Zurich Hospital; Merck KGaA; EMD Serono Inc.	Schett, G (corresponding author), Univ Erlangen Nurnberg, Dept Internal Med 3, Krankenhausstr 12, D-91054 Erlangen, Germany.	georg.schett@uk-erlangen.de	Penninger, Josef M/I-6860-2013; Joosten, Leo AB/H-3138-2015	Penninger, Josef M/0000-0002-8194-3777; Joosten, Leo AB/0000-0001-6166-9830	Austrian Science Fund START prize; Deutsche Forschungegemeinschaft [SFB492, SFB 643]; Forschergruppe [661]; Interdisciplinary Center for Clinical Research Erlangen; European Union	Austrian Science Fund START prize(Austrian Science Fund (FWF)); Deutsche Forschungegemeinschaft(German Research Foundation (DFG)); Forschergruppe; Interdisciplinary Center for Clinical Research Erlangen; European Union(European Commission)	We thank Birgit Niederreiter, Carl-Walter Steiner, Karolina v. Dalwigk, Love Amoyo, Margareta Tryniecki, Borna Truckenbrod, and Vera Eckervogt for excellent technical assistance. We further thank George Kollias (Alexander Fleming Biomedical Sciences Research Centre, Vari, Greece), who originally generated the Tg197 hTNFtg mice, for kindly providing these mice. We also thank Montserrat Camps and Christian Rommel (Merck Serono, Geneva, Switzerland) for the scientific discussions, Tzventanka Bondeva and Reinhard Wetzker (Institute of Molecular Cell Biology, University of Jena, Jena, Germany) for kindly providing an antibody against PI3K gamma, and Jennifer Gerding for carefully reading the manuscript. This work was supported by an Austrian Science Fund START prize (G. S.), the Deutsche Forschungegemeinschaft through its SFB492 (T. P.), SFB 643 (G. S.), Forschergruppe 661 (G. S.), the Interdisciplinary Center for Clinical Research Erlangen (G. S.), and the European Union projects MASTERSWITCH (S. H., G. S.), ADIPOA (G. S.), and KINACEPT (G. S.).	Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cawson T, 1998, MOL MED TODAY, V4, P130, DOI 10.1016/S1357-4310(97)01192-1; Del Prete A, 2004, EMBO J, V23, P3505, DOI 10.1038/sj.emboj.7600361; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Endo D, 2009, INT ARCH ALLERGY IMM, V149, P66, DOI 10.1159/000211375; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; HARRIS ED, 1990, NEW ENGL J MED, V322, P1277, DOI 10.1056/nejm199005033221805; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hayer S, 2007, ARTHRITIS RHEUM-US, V56, P79, DOI 10.1002/art.22313; Heller R, 2008, CARDIOVASC RES, V80, P96, DOI 10.1093/cvr/cvn159; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kong D, 2008, CANCER SCI, V99, P1734, DOI 10.1111/j.1349-7006.2008.00891.x; Lehmann K, 2009, BIOCHEM J, V419, P603, DOI 10.1042/BJ20081268; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Ludwig T, 2002, AM J PHYSIOL-RENAL, V283, pF319, DOI 10.1152/ajprenal.00327.2001; Muller-Ladner U, 1997, Curr Opin Rheumatol, V9, P213; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; ORONSKY AL, 1976, ARCH BIOCHEM BIOPHYS, V176, P539, DOI 10.1016/0003-9861(76)90197-1; Otero M, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2292; Pap T, 2000, ARTHRITIS RHEUM, V43, P1226, DOI 10.1002/1529-0131(200006)43:6<1226::AID-ANR5>3.0.CO;2-4; Pap T, 2000, ARTHRITIS RES, V2, P361, DOI 10.1186/ar113; Pomel V, 2006, J MED CHEM, V49, P3857, DOI 10.1021/jm0601598; Puri KD, 2005, BLOOD, V106, P150, DOI 10.1182/blood-2005-01-0023; Randis TM, 2008, EUR J IMMUNOL, V38, P1215, DOI 10.1002/eji.200838266; Rannou FO, 2006, JOINT BONE SPINE, V73, P29, DOI 10.1016/j.jbspin.2004.12.013; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Schett G, 2009, J BONE MINER RES, V24, P1142, DOI 10.1359/jbmr.090533; Sweeney SE, 2004, INT J BIOCHEM CELL B, V36, P372, DOI 10.1016/S1357-2725(03)00259-0; Szekanecz Z, 2006, CURR DRUG TARGETS, V7, P91, DOI 10.2174/138945006775270231; Tolboom TCA, 2002, ANN RHEUM DIS, V61, P975, DOI 10.1136/ard.61.11.975; UITTO VJ, 1980, EUR J BIOCHEM, V105, P409, DOI 10.1111/j.1432-1033.1980.tb04515.x; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Wang ZL, 2009, BIOCHEM BIOPH RES CO, V386, P569, DOI 10.1016/j.bbrc.2009.06.060	41	53	70	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4288	4298		10.1096/fj.09-135160	http://dx.doi.org/10.1096/fj.09-135160			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19734303				2022-12-25	WOS:000272193700023
J	Kim, HW; Haider, HK; Jiang, SJ; Ashraf, M				Kim, Ha Won; Haider, Husnain K.; Jiang, Shujia; Ashraf, Muhammad			Ischemic Preconditioning Augments Survival of Stem Cells via miR-210 Expression by Targeting Caspase-8-associated Protein 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFARCTED HEART; INTERMITTENT HYPOXIA; OXIDATIVE STRESS; NUCLEAR-BODIES; ACTIVATION; MICRORNAS; APOPTOSIS; FLASH; TRANSPLANTATION; TRANSCRIPTION	MicroRNAs (miRs) participate in most cellular functions by posttranscriptional regulation of gene expression albeit with little information regarding their role in ischemic preconditioning (IP) of stem cells. We report that IP of bone marrow-derived mesenchymal stem cells (MSCs) with two cycles of 30-min ischemia/reoxygenation (I/R) supported their survival under subsequent longer exposure to anoxia and following engraftment in the infarcted heart. IP significantly reduced apoptosis in MSCs through activation of Akt (Ser(473)) and ERK1/2 (Thr(202)/Tyr(204)) and nuclear translocation of hypoxia-inducible factor-1 alpha (HIF-1 alpha). We observed concomitant induction of miR-210 in the preconditioned MSCs ((MSCs)-M-PC). Inhibition of HIF-1 alpha or of miR-210 abrogated the cytoprotective effects of preconditioning. Extrapolation of these data to in vivo studies in a rat model of acute myocardial infarction predominantly improved stem cell survival after engraftment with a role for miR-210. Notably, multiple I/R cycles more effectively regulated the miR-210 and hence promoted MSC survival compared with single-cycle hypoxia of an equal duration. Real time PCR array for rat apoptotic genes, computational target gene analyses, and luciferase reporter assay identified FLICE-associated huge protein (FLASH)/caspase-8-associated protein-2 (Casp8ap2) in (MSCs)-M-PC as the target gene of miR-210. Induction of FLASH/CASP8AP2 in miR-210 knocked-down (MSCs)-M-PC resulted in increased cell apoptosis. Taken together, these data demonstrated that cytoprotection afforded by IP was regulated by miR210 induction via FLASH/Casp8ap2 suppression. These results highlighted that IP by multiple short episodes of I/R is a novel strategy to promote stem cell survival.	[Kim, Ha Won; Haider, Husnain K.; Jiang, Shujia; Ashraf, Muhammad] Univ Cincinnati, Dept Pathol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Ashraf, M (corresponding author), Univ Cincinnati, Dept Pathol, Cincinnati, OH 45267 USA.	ashrafm@ucmail.uc.edu	Haider, Khawaja/AAI-6819-2020; Ashraf, Muhammad/ABB-3463-2021	Haider, Khawaja/0000-0002-7907-4808; Kim, Ha Won/0000-0001-6272-4248	National Institutes of Health [R37-HL074272, HL-080686, HL087246, HL087288, HL089535]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089535, R37HL074272, R01HL087288, R01HL087246, R01HL080686] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R37-HL074272, HL-080686, and HL087246 ( to M. A.) and HL087288 and HL089535 ( to H. K. H).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14808, DOI 10.1073/pnas.0604227103; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Dai Y, 2007, J MOL CELL CARDIOL, V42, P1036, DOI 10.1016/j.yjmcc.2007.04.001; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Foshay Kara M, 2007, Curr Stem Cell Res Ther, V2, P264, DOI 10.2174/157488807782793781; Gross Eric R, 2007, Drug Discov Today Dis Mech, V4, P165, DOI 10.1016/j.ddmec.2007.10.005; Haider HK, 2008, J MOL CELL CARDIOL, V45, P554, DOI 10.1016/j.yjmcc.2008.05.004; Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Imai Y, 1999, NATURE, V398, P777, DOI 10.1038/19709; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krieghoff-Henning E, 2008, BBA-MOL CELL RES, V1783, P2185, DOI 10.1016/j.bbamcr.2008.07.002; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lu G, 2009, CIRCULATION, V119, P2587, DOI 10.1161/CIRCULATIONAHA.108.827691; Milovic-Holm K, 2007, EMBO J, V26, P391, DOI 10.1038/sj.emboj.7601504; Nanduri J, 2008, RESP PHYSIOL NEUROBI, V164, P277, DOI 10.1016/j.resp.2008.07.006; Niagara MI, 2007, CIRC RES, V100, P545, DOI 10.1161/01.RES.0000258460.41160.ef; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Shujia J, 2008, CARDIOVASC RES, V77, P525, DOI 10.1093/cvr/cvm077; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Yuan GX, 2004, J PHYSIOL-LONDON, V557, P773, DOI 10.1113/jphysiol.2003.058503	25	267	282	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33161	33168		10.1074/jbc.M109.020925	http://dx.doi.org/10.1074/jbc.M109.020925			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19721136	hybrid, Green Published			2022-12-25	WOS:000272028500020
J	Cheng, XL; Shen, Z; Yin, LT; Lu, SH; Cui, YP				Cheng, Xiaolong; Shen, Zheng; Yin, Litian; Lu, Shih-Hsin; Cui, Yongping			ECRG2 Regulates Cell Migration/Invasion through Urokinase-type Plasmin Activator Receptor (uPAR)/beta 1 Integrin Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION; TUMOR-GROWTH; CANCER; INVASION; CARCINOMA; BINDING; GENE; UPAR; INVASIVENESS; SUPPRESSION	ECRG2 is a novel gene that shows sequence similarity to KAZAL-type serine protease inhibitor. We have previously demonstrated that ECRG2 inhibits migration/invasion of lung cancer PG cells. However, the mechanism by which ECRG2 performs these activities is a compelling question. Urokinase-type plasmin activator (uPA) binding to uPAR induces migration/invasion through multiple interactors including integrins. In this study, we found that ECRG2 binds specifically to the kringle domain of uPA. Moreover, we demonstrated that ECRG2 forms a complex with uPA.uPAR, that such a complex modifies the dynamical association of uPAR with beta 1 integrins, and that disruption inhibits Src/MAP (mitogen-activated protein) kinase pathway, resulting in suppression of cell migration/invasion in an in vitro Matrigel migration/invasion assay. Conversely, depletion of ECRG2 markedly enhanced the association of uPAR with beta 1 integrins, elevated basal Src/MAP kinase activation, and stimulated HT1080, MDA-MB-231, and MCF-7 cell migration/invasion. Together, our results provide evidence that ECRG2 is involved in the regulation of migration/invasion through uPA/uPAR/beta 1 integrins/Src/MAP kinase pathway and may represent a novel therapeutic target for cancer.	[Cui, Yongping] Shanxi Med Univ, Dept Cell Biol & Genet, Taiyuan 030001, Shanxi, Peoples R China; [Cheng, Xiaolong] Shanxi Med Univ, Dept Anat, Taiyuan 030001, Shanxi, Peoples R China; [Shen, Zheng] Univ S Florida, Hlth Sci Ctr, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA; [Yin, Litian] Shanxi Univ, Key Lab Chem Biol & Mol Engn, Minist Educ, Inst Biotechnol, Taiyuan 030006, Shanxi, Peoples R China; [Lu, Shih-Hsin] Peking Union Med Coll, Dept Etiol & Carcinogenesis, Inst Canc, Beijing 100021, Peoples R China; [Lu, Shih-Hsin] Chinese Acad Med Sci, Beijing 100021, Peoples R China; [Cui, Yongping] Shanxi Med Univ, Key Lab Cellular Physiol, Minist Educ, Taiyuan 030001, Shanxi, Peoples R China	Shanxi Medical University; Shanxi Medical University; State University System of Florida; University of South Florida; Shanxi University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Shanxi Medical University	Cui, YP (corresponding author), Shanxi Med Univ, Dept Cell Biol & Genet, Taiyuan 030001, Shanxi, Peoples R China.	cuiy0922@yahoo.com			National Nature Science Foundation of China [30971518, 30500588]; Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi	This work was supported by National Nature Science Foundation of China Grants 30971518 and 30500588 and by the Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi (to Y.C.).	Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684; Ahmed N, 2003, BRIT J CANCER, V89, P374, DOI 10.1038/sj.bjc.6601098; Bass R, 2002, J BIOL CHEM, V277, P46845, DOI 10.1074/jbc.C200532200; Bauer TW, 2005, CANCER RES, V65, P7775, DOI 10.1158/0008-5472.CAN-05-0946; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Chapman HA, 2001, THROMB HAEMOSTASIS, V86, P124; Cheng XL, 2008, J BIOL CHEM, V283, P5888, DOI 10.1074/jbc.M708145200; Cui YP, 2003, BIOCHEM BIOPH RES CO, V302, P904, DOI 10.1016/S0006-291X(03)00122-0; Czekay RP, 2003, J CELL BIOL, V160, P781, DOI 10.1083/jcb.200208117; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Franco P, 2006, J CELL SCI, V119, P3424, DOI 10.1242/jcs.03067; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Geng Y, 2008, ARCH BIOCHEM BIOPHYS, V479, P153, DOI 10.1016/j.abb.2008.08.023; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Gond CS, 2007, INT J ONCOL, V31, P19; Huang G, 2005, HYBRIDOMA, V24, P86, DOI 10.1089/hyb.2005.24.86; Huang G, 2007, CARCINOGENESIS, V28, P2274, DOI 10.1093/carcin/bgm140; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Sidenius N, 2003, CANCER METAST REV, V22, P205, DOI 10.1023/A:1023099415940; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Sitrin RG, 2004, AM J RESP CELL MOL, V30, P233, DOI 10.1165/rcmb.2003-0079OC; Smith SL, 2003, ONCOGENE, V22, P8677, DOI 10.1038/sj.onc.1207127; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; Sturge J, 2003, J CELL BIOL, V162, P789, DOI 10.1083/jcb.200302124; Su Tao, 1998, Zhonghua Zhongliu Zazhi, V20, P254; Suzuki M, 2004, J BIOL CHEM, V279, P14899, DOI 10.1074/jbc.M313130200; Tang CH, 2008, CELL MOL LIFE SCI, V65, P1916, DOI 10.1007/s00018-008-7573-9; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; Wei Y, 2001, MOL BIOL CELL, V12, P2975, DOI 10.1091/mbc.12.10.2975; Wei Y, 1999, J CELL BIOL, V144, P1285, DOI 10.1083/jcb.144.6.1285	31	20	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					30897	30906		10.1074/jbc.M109.011213	http://dx.doi.org/10.1074/jbc.M109.011213			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19717562	Green Published, hybrid			2022-12-25	WOS:000271378400018
J	Shah, KM; Stewart, SE; Wei, W; Woodman, CBJ; O'Neil, JD; Dawson, CW; Young, LS				Shah, K. M.; Stewart, S. E.; Wei, W.; Woodman, C. B. J.; O'Neil, J. D.; Dawson, C. W.; Young, L. S.			The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation	ONCOGENE			English	Article						EBV; NPC; interferon; endosomes; lysosomes	EPSTEIN-BARR-VIRUS; DOWN-REGULATION; CELL-RECEPTOR; 2A; ACTIVATION; CARCINOMA; SUSCEPTIBILITY; PATHOGENESIS; TRAFFICKING; ASSOCIATION	Although frequently expressed in Epstein-Barr virus (EBV)-positive malignancies, the role that latent membrane protein 2A and 2B (LMP2A and LMP2B) have in the oncogenic process remains obscure. Here we show a novel function for these proteins in epithelial cells, namely, their ability to modulate signalling from type I/II interferon receptors (IFNRs). We show that LMP2A- and LMP2B-expressing epithelial cells show decreased responsiveness to interferon (IFN)alpha and IFN gamma, as assessed by STAT1 phosphorylation, ISGF3 and GAF-mediated binding to IFN-stimulated response element and IFN gamma-activated factor sequence elements and luciferase reporter activation. Transcriptional pro. ling highlighted the extent of this modulation, with both viral proteins impacting 'globally' on IFN-stimulated gene expression. Although not affecting the levels of cell-surface IFNRs, LMP2A and LMP2B accelerated the turnover of IFNRs through processes requiring endosome acidification. This function may form part of EBV's strategy to limit anti-viral responses and de. ne a novel function for LMP2A and LMP2B in modulating signalling from receptors that participate in innate immune responses. Oncogene (2009) 28, 3903-3914; doi:10.1038/onc.2009.249; published online 31 August 2009	[Shah, K. M.; Wei, W.; Woodman, C. B. J.; O'Neil, J. D.; Dawson, C. W.; Young, L. S.] Univ Birmingham, Canc Res UK Inst Canc Studies, Sch Med, Birmingham B15 2TT, W Midlands, England; [Stewart, S. E.] Univ Edinburgh, Sch Med, Div Pathway Med, Edinburgh, Midlothian, Scotland	Cancer Research UK; University of Birmingham; University of Edinburgh	Young, LS (corresponding author), Univ Birmingham, Canc Res UK Inst Canc Studies, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England.	L.S.Young@bham.ac.uk	Young, Lawrence S/B-7213-2009	Young, Lawrence S/0000-0003-3919-4298; Wei, Wenbin/0000-0003-1288-6999	Cancer Research UK; European Commission's FP6 Life Sciences Health Programme [LSHC-CT-.2005-018704]	Cancer Research UK(Cancer Research UK); European Commission's FP6 Life Sciences Health Programme	This work was supported by programme funding from Cancer Research UK and the European Commission's FP6 Life Sciences Health Programme (INCA project LSHC-CT-.2005-018704).	Adachi K, 2007, ARCH VIROL, V152, P2217, DOI 10.1007/s00705-007-1061-7; Allen MD, 2005, J VIROL, V79, P1789, DOI 10.1128/JVI.79.3.1789-1802.2005; Anderson LJ, 2008, VIROLOGY, V371, P257, DOI 10.1016/j.virol.2007.10.009; Beadling C, 1996, EMBO J, V15, P1902, DOI 10.1002/j.1460-2075.1996.tb00541.x; Cassady KA, 2002, J VIROL, V76, P2029, DOI 10.1128/jvi.76.5.2029-2035.2002; Cho NH, 2006, J VIROL, V80, P108, DOI 10.1128/JVI.80.1.108-118.2006; Claudinon J, 2007, BIOCHIMIE, V89, P735, DOI 10.1016/j.biochi.2007.03.014; CONRAD M, 1993, J VIROL, V67, P6170, DOI 10.1128/JVI.67.10.6170-6178.1993; Dawson CW, 2000, VIROLOGY, V272, P204, DOI 10.1006/viro.2000.0344; Dawson CW, 2001, VIROLOGY, V289, P192, DOI 10.1006/viro.2001.1142; Dykstra ML, 2001, IMMUNITY, V14, P57, DOI 10.1016/S1074-7613(01)00089-9; Feys HB, 2008, BLOOD, V112, P102; Ikeda M, 2007, VIROLOGY, V360, P461, DOI 10.1016/j.virol.2006.10.046; Katze MG, 2002, J INTERF CYTOK RES, V22, P283, DOI 10.1089/107999002753675695; Li QL, 2007, J VIROL, V81, P2117, DOI 10.1128/JVI.01961-06; Liu J, 2008, BIOCHEM BIOPH RES CO, V367, P388, DOI 10.1016/j.bbrc.2007.12.137; Longan L, 2000, J GEN VIROL, V81, P2245, DOI 10.1099/0022-1317-81-9-2245; Longnecker R, 2000, ADV CANCER RES, V79, P175, DOI 10.1016/S0065-230X(00)79006-3; Mancao C, 2007, BLOOD, V110, P3715, DOI 10.1182/blood-2007-05-090142; Morrison JA, 2003, J VIROL, V77, P12276, DOI 10.1128/JVI.77.22.12276-12284.2003; Morrison TE, 2001, IMMUNITY, V15, P787, DOI 10.1016/S1074-7613(01)00226-6; Nanbo A, 2002, REV MED VIROL, V12, P321, DOI 10.1002/rmv.363; Offermann MK, 2007, CURR TOP MICROBIOL, V312, P185; Ogino T, 2007, INT J CANCER, V120, P2401, DOI 10.1002/ijc.22334; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rechsteiner MP, 2008, J VIROL, V82, P1739, DOI 10.1128/JVI.01723-07; Rechsteiner MP, 2007, J GEN VIROL, V88, P1454, DOI 10.1099/vir.0.82790-0; Rezaee SAR, 2006, J GEN VIROL, V87, P1781, DOI 10.1099/vir.0.81919-0; Rovedo M, 2007, J VIROL, V81, P84, DOI 10.1128/JVI.01302-06; Scholle F, 2000, J VIROL, V74, P10681, DOI 10.1128/JVI.74.22.10681-10689.2000; Stewart S, 2004, P NATL ACAD SCI USA, V101, P15730, DOI 10.1073/pnas.0402135101; Tao Qian, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000312; Uozaki H, 2008, INT J CLIN EXP PATHO, V1, P198; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	36	70	72	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2009	28	44					3903	3914		10.1038/onc.2009.249	http://dx.doi.org/10.1038/onc.2009.249			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	515LJ	19718044	Green Accepted			2022-12-25	WOS:000271471900005
J	Lee, EF; Czabotar, PE; Yang, H; Sleebs, BE; Lessene, G; Colman, PM; Smith, BJ; Fairlie, WD				Lee, Erinna F.; Czabotar, Peter E.; Yang, Hong; Sleebs, Brad E.; Lessene, Guillaume; Colman, Peter M.; Smith, Brian J.; Fairlie, W. Douglas			Conformational Changes in Bcl-2 Pro-survival Proteins Determine Their Capacity to Bind Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; BH3 MIMETIC ABT-737; CELL-DEATH; BH3-ONLY PROTEINS; PEPTIDE COMPLEX; X-L; MEMBRANE PERMEABILIZATION; MAXIMUM-LIKELIHOOD; CRYSTAL-STRUCTURE; MULTIPLE-MYELOMA	Antagonists of anti-apoptotic Bcl-2 family members hold promise as cancer therapeutics. Apoptosis is triggered when a peptide containing a BH3 motif or a small molecule BH3 peptidomimetic, such as ABT 737, binds to the relevant Bcl-2 family members. ABT-737 is an antagonist of Bcl-2, Bcl-x(L), and Bcl-w but not of Mcl-1. Here we describe new structures of mutant BH3 peptides bound to Bcl-x(L) and Mcl-1. These structures suggested a rationale for the failure of ABT-737 to bind Mcl-1, but a designed variant of ABT-737 failed to acquire binding affinity for Mcl-1. Rather, it was selective for Bcl-x(L), a result attributable in part to significant backbone refolding and movements of helical segments in its ligand binding site. To date there are few reported crystal structures of organic ligands in complex with their pro-survival protein targets. Our structure of this new organic ligand provided insights into the structural transitions that occur within the BH3 binding groove, highlighting significant differences in the structural properties of members of the Bcl-2 pro-survival protein family. Such differences are likely to influence and be important in the quest for compounds capable of selectively antagonizing the different family members.	[Lee, Erinna F.; Czabotar, Peter E.; Yang, Hong; Sleebs, Brad E.; Lessene, Guillaume; Colman, Peter M.; Smith, Brian J.; Fairlie, W. Douglas] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute	Smith, BJ (corresponding author), Walter & Eliza Hall Inst Med Res, Struct Biol Div, 1G Royal Pde, Parkville, Vic 3052, Australia.	bsmith@wehi.edu.au; fairlie@wehi.edu.au	Smith, Brian J/F-8282-2011; Fairlie, Walter/M-8401-2015; Lee, Erinna/N-1523-2015; Sleebs, Brad/J-9639-2014	Smith, Brian J/0000-0003-0498-1910; Fairlie, Walter/0000-0002-2498-1160; Lee, Erinna/0000-0003-1255-9808; Sleebs, Brad/0000-0001-9117-1048; Czabotar, Peter/0000-0002-2594-496X	Australian National Health and Medical Research Council Program fellowships [461221, 575561]; Leukemia and Lymphoma Society [SCOR 7015-02]; Cancer Council of Victoria Grant-in-aid [461239]; Leukemia Foundation of Australia Phillip Desbrow post doctoral fellowship; Australian Cancer Research Foundation	Australian National Health and Medical Research Council Program fellowships(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Cancer Council of Victoria Grant-in-aid(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Leukemia Foundation of Australia Phillip Desbrow post doctoral fellowship; Australian Cancer Research Foundation	This work was supported by Australian National Health and Medical Research Council Program fellowships ( to W. D. F. and P. M. C.) and Grant 461221 ( to P. M. C.) and Project Grant 575561 ( to P. E. C.), Leukemia and Lymphoma Society Grant SCOR 7015-02, Cancer Council of Victoria Grant-in-aid 461239 ( to W. D. F.) and a fellowship ( to E. F. L.), Leukemia Foundation of Australia Phillip Desbrow post doctoral fellowship ( to E. F. L.), and by the Australian Cancer Research Foundation ( to P. M. C.).	Ackler S, 2008, MOL CANCER THER, V7, P3265, DOI 10.1158/1535-7163.MCT-08-0268; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bruncko M, 2007, J MED CHEM, V50, P641, DOI 10.1021/jm061152t; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; Degterev A, 2001, NAT CELL BIOL, V3, P173, DOI 10.1038/35055085; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enyedy IJ, 2001, J MED CHEM, V44, P4313, DOI 10.1021/jm010016f; Feng W, 2007, J MOL BIOL, V372, P223, DOI 10.1016/j.jmb.2007.06.069; Feng WY, 2003, BRIT J HAEMATOL, V121, P332, DOI 10.1046/j.1365-2141.2003.04268.x; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Fletcher JI, 2008, CELL CYCLE, V7, P39, DOI 10.4161/cc.7.1.5178; Fu XR, 2007, J MOL BIOL, V371, P1099, DOI 10.1016/j.jmb.2007.04.069; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Lee EF, 2008, CELL DEATH DIFFER, V15, P1609, DOI 10.1038/cdd.2008.86; Lee EF, 2007, CELL DEATH DIFFER, V14, P1711, DOI 10.1038/sj.cdd.4402178; Lee EF, 2008, J CELL BIOL, V180, P341, DOI 10.1083/jcb.200708096; Lee EF, 2009, ANGEW CHEM INT EDIT, V48, P4318, DOI 10.1002/anie.200805761; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Liu XQ, 2006, J EXP MED, V203, P2953, DOI 10.1084/jem.20061151; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Mohammad RM, 2007, CLIN CANCER RES, V13, P2226, DOI 10.1158/1078-0432.CCR-06-1574; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Prakesch M, 2008, BIOORGAN MED CHEM, V16, P7443, DOI 10.1016/j.bmc.2008.06.023; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Shoemaker AR, 2008, CLIN CANCER RES, V14, P3268, DOI 10.1158/1078-0432.CCR-07-4622; Shoemaker AR, 2006, CANCER RES, V66, P8731, DOI 10.1158/0008-5472.CAN-06-0367; Smits C, 2008, STRUCTURE, V16, P818, DOI 10.1016/j.str.2008.02.009; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Tzung SP, 2001, NAT CELL BIOL, V3, P183, DOI 10.1038/35055095; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784; Yin H, 2005, J AM CHEM SOC, V127, P10191, DOI 10.1021/ja050122x; Yin H, 2005, J AM CHEM SOC, V127, P5463, DOI 10.1021/ja0446404; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang B, 2002, BLOOD, V99, P1885, DOI 10.1182/blood.V99.6.1885; Zobel K, 2006, ACS CHEM BIOL, V1, P525, DOI 10.1021/cb600276q	60	77	79	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30508	30517		10.1074/jbc.M109.040725	http://dx.doi.org/10.1074/jbc.M109.040725			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726685	Green Published, hybrid			2022-12-25	WOS:000271090000053
J	Hu, YL; Guimond, SE; Travers, P; Cadman, S; Hohenester, E; Turnbull, JE; Kim, SH; Bouloux, PM				Hu, Youli; Guimond, Scott E.; Travers, Paul; Cadman, Steven; Hohenester, Erhard; Turnbull, Jeremy E.; Kim, Soo-Hyun; Bouloux, Pierre-Marc			Novel Mechanisms of Fibroblast Growth Factor Receptor 1 Regulation by Extracellular Matrix Protein Anosmin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; LINKED KALLMANNS-SYNDROME; FIBRONECTIN TYPE-III; FACTOR FGF RECEPTOR; HEPARAN-SULFATE; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; HORMONE NEURONS; AXONAL GROWTH; ACTIVATION	Activation of fibroblast growth factor (FGF) signaling is initiated by a multiprotein complex formation between FGF, FGF receptor (FGFR), and heparan sulfate proteoglycan on the cell membrane. Cross-talk with other factors could affect this complex assembly and modulate the biological response of cells to FGF. We have previously demonstrated that anosmin-1, a glycosylated extracellular matrix protein, interacts with the FGFR1 signaling complex and enhances its activity in an IIIc isoform-specific and HS-dependent manner. The molecular mechanism of anosmin-1 action on FGFR1 signaling, however, remains unknown. Here, we show that anosmin-1 directly binds to FGFR1 with high affinity. This interaction involves domains in the N terminus of anosmin-1 (cysteine-rich region, whey acidic protein-like domain and the first fibronectin type III domain) and the D2-D3 extracellular domains of FGFR1. In contrast, anosmin-1 binds to FGFR2IIIc with much lower affinity and displays negligible binding to FGFR3IIIc. We also show that FGFR1-bound anosmin-1, although capable of binding to FGF2 alone, cannot bind to a FGF2.heparin complex, thus preventing FGFR1.FGF2.heparin complex formation. By contrast, heparin-bound anosmin-1 binds to pre-formed FGF2.FGFR1 complex, generating an anosmin-1.FGFR1.FGF2.heparin complex. Furthermore, a functional interaction between anosmin-1 and the FGFR1 signaling complex is demonstrated by immunofluorescence co-localization and Transwell migration assays where anosmin-1 was shown to induce opposing effects during chemotaxis of human neuronal cells. Our study provides molecular and cellular evidence for a modulatory action of anosmin-1 on FGFR1 signaling, whereby binding of anosmin-1 to FGFR1 and heparin can play a dual role in assembly and activity of the ternary FGFR1.FGF2.heparin complex.	[Hu, Youli; Kim, Soo-Hyun; Bouloux, Pierre-Marc] UCL, Ctr Neuroendocrinol, Sch Med, London NW3 2PF, England; [Guimond, Scott E.; Turnbull, Jeremy E.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Travers, Paul] Univ Edinburgh, Scottish Ctr Regenerat Med, Edinburgh EH16 4SB, Midlothian, Scotland; [Hohenester, Erhard] Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England	University of London; University College London; UCL Medical School; University of Liverpool; University of Edinburgh; Imperial College London	Hu, YL (corresponding author), UCL, Ctr Neuroendocrinol, Sch Med, Royal Free Campus, London NW3 2PF, England.	y.hu@medsch.ucl.ac.uk; skim@sgul.ac.uk	Kim, Soo Hyun/ABG-8773-2020	Kim, Soo Hyun/0000-0002-9394-1437; Guimond, Scott/0000-0002-5903-418X	Biotechnology and Biological Sciences Research Council [BB/F007167/1]; BBSRC [BB/F007167/1, BB/F006616/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F006616/1] Funding Source: researchfish; Medical Research Council [G0700711B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/F007167/1.	Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Andrenacci D, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-47; Bottcher RT, 2004, NAT CELL BIOL, V6, P38, DOI 10.1038/ncb1082; Bribian A, 2006, MOL CELL NEUROSCI, V33, P2, DOI 10.1016/j.mcn.2006.05.009; Bulow HE, 2002, P NATL ACAD SCI USA, V99, P6346, DOI 10.1073/pnas.092128099; Carafoli F, 2008, J MOL BIOL, V377, P524, DOI 10.1016/j.jmb.2008.01.030; Cariboni A, 2004, HUM MOL GENET, V13, P2781, DOI 10.1093/hmg/ddh309; Christensen C, 2006, FEBS LETT, V580, P3386, DOI 10.1016/j.febslet.2006.05.008; Chung WCJ, 2008, ENDOCRINOLOGY, V149, P4997, DOI 10.1210/en.2007-1634; Detillieux KA, 2003, CARDIOVASC RES, V57, P8, DOI 10.1016/S0008-6363(02)00708-3; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Doherty P, 2000, MOL CELL NEUROSCI, V16, P283, DOI 10.1006/mcne.2000.0907; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; Freeman KW, 2003, CANCER RES, V63, P6237; Gill JC, 2004, ENDOCRINOLOGY, V145, P3830, DOI 10.1210/en.2004-0214; Gonzalez-Martinez D, 2004, J NEUROSCI, V24, P10384, DOI 10.1523/JNEUROSCI.3400-04.2004; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; Guimond SE, 1999, CURR BIOL, V9, P1343, DOI 10.1016/S0960-9822(00)80060-3; Hardelin JP, 2008, SEX DEV, V2, P181, DOI 10.1159/000152034; Harmer NJ, 2004, J MOL BIOL, V339, P821, DOI 10.1016/j.jmb.2004.04.031; Hu YL, 2005, J MOL BIOL, V350, P553, DOI 10.1016/j.jmb.2005.04.031; Hu YL, 2004, BIOCHEM J, V384, P495, DOI 10.1042/BJ20041078; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; Kim SH, 2008, J NEUROENDOCRINOL, V20, P141, DOI 10.1111/j.1365-2826.2007.01627.x; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; Kulahin N, 2008, MOL CELL NEUROSCI, V37, P528, DOI 10.1016/j.mcn.2007.12.001; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; Olsen SK, 2004, P NATL ACAD SCI USA, V101, P935, DOI 10.1073/pnas.0307287101; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; Ostrovsky O, 2002, J BIOL CHEM, V277, P2444, DOI 10.1074/jbc.M108540200; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Pitteloud N, 2007, J CLIN INVEST, V117, P457, DOI 10.1172/JCI29884; Pitteloud N, 2006, MOL CELL ENDOCRINOL, V254, P60, DOI 10.1016/j.mce.2006.04.021; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Robertson A, 2001, BIOCHEM J, V357, P647, DOI 10.1042/0264-6021:3570647; Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0; Sanchez-Heras E, 2006, J BIOL CHEM, V281, P35208, DOI 10.1074/jbc.M608655200; Sandilands E, 2007, EMBO REP, V8, P1162, DOI 10.1038/sj.embor.7401097; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Tsai PS, 2005, MOL ENDOCRINOL, V19, P225, DOI 10.1210/me.2004-0330; Tsang M, 2002, NAT CELL BIOL, V4, P165, DOI 10.1038/ncb749; VANNELLI GB, 1995, J NEUROSCI, V15, P4382; Zhang WQ, 2006, J BIOL CHEM, V281, P37302, DOI 10.1074/jbc.M604905200	48	56	61	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29905	29920		10.1074/jbc.M109.049155	http://dx.doi.org/10.1074/jbc.M109.049155			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19696444	Green Published, hybrid			2022-12-25	WOS:000270896800070
J	Nudds, RL; Codd, JR; Sellers, WI				Nudds, Robert L.; Codd, Jonathan R.; Sellers, William I.			Evidence for a Mass Dependent Step-Change in the Scaling of Efficiency in Terrestrial Locomotion	PLOS ONE			English	Article								A reanalysis of existing data suggests that the established tenet of increasing efficiency of transport with body size in terrestrial locomotion requires re-evaluation. Here, the statistical model that described the data best indicated a dichotomy between the data for small (<1 kg) and large animals (>1 kg). Within and between these two size groups there was no detectable difference in the scaling exponents (slopes) relating metabolic (E(met)) and mechanical costs (E(mech, CM)) of locomotion to body mass (M(b)). Therefore, no scaling of efficiency (E(mech, CM)/E(met)) with M(b) was evident within each size group. Small animals, however, appeared to be generally less efficient than larger animals (7% and 26% respectively). Consequently, it is possible that the relationship between efficiency and M(b) is not continuous, but, rather, involves a step-change. This step-change in the efficiency of locomotion mirrors previous findings suggesting a postural cause for an apparent size dichotomy in the relationship between E(met) and M(b). Currently data for E(mech, CM) is lacking, but the relationship between efficiency in terrestrial locomotion and M(b) is likely to be determined by posture and kinematics rather than body size alone. Hence, scaling of efficiency is likely to be more complex than a simple linear relationship across body sizes. A homogenous study of the mechanical cost of terrestrial locomotion across a broad range of species, body sizes, and importantly locomotor postures is a priority for future research.			Nudds, RL (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	Robert.Nudds@manchester.ac.uk	Sellers, William Irvin/Q-3843-2019	Sellers, William Irvin/0000-0002-2913-5406; Codd, Jonathan/0000-0003-0211-1786				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alexander RM, 2005, J EXP BIOL, V208, P1645, DOI 10.1242/jeb.01484; Arampatzis A, 2000, J BIOMECH, V33, P457, DOI 10.1016/S0021-9290(99)00187-6; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; CAVAGNA GA, 1976, J PHYSIOL-LONDON, V262, P639, DOI 10.1113/jphysiol.1976.sp011613; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; DAWSON TJ, 1973, NATURE, V246, P313, DOI 10.1038/246313a0; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Full R.J., 1989, ENERGY TRANSFORMATIO, P175; HEGLUND NC, 1982, J EXP BIOL, V97, P41; HOYT DF, 1981, NATURE, V292, P239, DOI 10.1038/292239a0; Kramer PA, 2008, GAIT POSTURE, V27, P209, DOI 10.1016/j.gaitpost.2007.03.009; Minetti AE, 1999, J EXP BIOL, V202, P2329; Pfau T, 2006, J EXP BIOL, V209, P3742, DOI 10.1242/jeb.02439; RAYNER JMV, 1995, ISRAEL J ZOOL, V41, P321; Reilly SM, 2007, ZOOLOGY, V110, P271, DOI 10.1016/j.zool.2007.01.003; Reilly SM, 2006, P ROY SOC B-BIOL SCI, V273, P1563, DOI 10.1098/rspb.2006.3489; Saini M, 1998, J BIOMECH ENG-T ASME, V120, P133, DOI 10.1115/1.2834293; TAYLOR CR, 1982, J EXP BIOL, V97, P1; Thirunarayan M.A., 1996, GAIT POSTURE, P306, DOI 10.1016/0966-6362(95)01058-0	20	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2009	4	9							e6927	10.1371/journal.pone.0006927	http://dx.doi.org/10.1371/journal.pone.0006927			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZH	19738898	Green Published, Green Submitted, gold			2022-12-25	WOS:000269622300011
J	Herbeck, JT; Gottlieb, GS; Wong, K; Detels, R; Phair, JP; Rinaldo, CR; Jacobson, LP; Margolick, JB; Mullins, JI				Herbeck, Joshua T.; Gottlieb, Geoffrey S.; Wong, Kim; Detels, Roger; Phair, John P.; Rinaldo, Charles R.; Jacobson, Lisa P.; Margolick, Joseph B.; Mullins, James I.			Fidelity of SNP Array Genotyping Using Epstein Barr Virus-Transformed B-Lymphocyte Cell Lines: Implications for Genome-Wide Association Studies	PLOS ONE			English	Article								Background: As availability of primary cells can be limited for genetic studies of human disease, lymphoblastoid cell lines (LCL) are common sources of genomic DNA. LCL are created in a transformation process that entails in vitro infection of human B-lymphocytes with the Epstein-Barr Virus (EBV). Methodology/Principal Findings: To test for genotypic errors potentially induced by the Epstein-Barr Virus transformation process, we compared single nucleotide polymorphism (SNP) genotype calls in peripheral blood mononuclear cells (PBMC) and LCL from the same individuals. The average mismatch rate across 19 comparisons was 0.12% for SNPs with a population call rate of at least 95%, and 0.03% at SNPs with a call rate of at least 99%. Mismatch rates were not correlated across genotype subarrays run on all sample pairs. Conclusions/Significance: Genotypic discrepancies found in PBMC and LCL pairs were not significantly different than control pairs, and were not correlated across subarrays. These results suggest that mismatch rates are minimal with stringent quality control, and that most genotypic discrepancies are due to technical artifacts rather than the EBV transformation process. Thus, LCL likely constitute a reliable DNA source for host genotype analysis.			Herbeck, JT (corresponding author), Univ Washington, Sch Med, Seattle, WA 98195 USA.	herbeck@u.washington.edu		Gottlieb, Geoffrey/0000-0002-5749-481X; Jacobson, Lisa P./0000-0003-1722-6826	NCRR NIH HHS [5MO1 RR00722, M01 RR000722] Funding Source: Medline; NIAID NIH HHS [T32 AI007140, U01 AI035041, U01 AI035039, U01 AI037613, R37 AI047734, U01 AI035040, R37 AI47734, P30AI27757, T32 AI07140, UO1 AI35042, UO1 AI37984, U01 AI035043, P30 AI027757, UO1 AI37613, UO1 AI35043, U01 AI035042, UO1 AI35040, U01 AI037984, UO1 AI35041, UO1 AI35039] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035041, U01AI035040, P30AI027757, R37AI047734, U01AI035043, U01AI037613, U01AI035039, U01AI035042, U01AI037984, T32AI007140] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*AFF, 2007, BRLMM IMPR GEN CALL; CAPUTO JL, 1991, J TISSUE CULTURE MET, V13, P39; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Jeon JP, 2007, CANCER GENET CYTOGEN, V173, P122, DOI 10.1016/j.cancergencyto.2006.10.010; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; LOUIE LG, 1991, AM J HUM GENET, V48, P637; McElroy JP, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-15; PELLOQUIN F, 1986, IN VITRO CELL DEV B, V22, P689; Plagnol V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002966; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436	13	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2009	4	9							e6915	10.1371/journal.pone.0006915	http://dx.doi.org/10.1371/journal.pone.0006915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZF	19730697	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000269622100015
J	Wallach, AD; Ritchie, EG; Read, J; O'Neill, AJ				Wallach, Arian D.; Ritchie, Euan G.; Read, John; O'Neill, Adam J.			More than Mere Numbers: The Impact of Lethal Control on the Social Stability of a Top-Order Predator	PLOS ONE			English	Article							NORTH-WESTERN AUSTRALIA; BIALOWIEZA PRIMEVAL FOREST; FECAL MARKING BEHAVIOR; SCENT-MARKING; CANIS-LUPUS; WOLF; WOLVES; DINGOES; ECOLOGY; MITOCHONDRIAL	Population control of socially complex species may have profound ecological implications that remain largely invisible if only their abundance is considered. Here we discuss the effects of control on a socially complex top-order predator, the dingo ( Canis lupus dingo). Since European occupation of Australia, dingoes have been controlled over much of the continent. Our aim was to investigate the effects of control on their abundance and social stability. We hypothesized that dingo abundance and social stability are not linearly related, and proposed a theoretical model in which dingo populations may fluctuate between three main states: ( A) below carrying capacity and socially fractured, ( B) above carrying capacity and socially fractured, or ( C) at carrying capacity and socially stable. We predicted that lethal control would drive dingoes into the unstable states A or B, and that relaxation of control would allow recovery towards C. We tested our predictions by surveying relative abundance ( track density) and indicators of social stability (scent-marking and howling) at seven sites in the arid zone subject to differing degrees of control. We also monitored changes in dingo abundance and social stability following relaxation and intensification of control. Sites where dingoes had been controlled within the previous two years were characterized by low scent-marking activity, but abundance was similar at sites with and without control. Signs of social stability steadily increased the longer an area was allowed to recover from control, but change in abundance did not follow a consistent path. Comparison of abundance and stability among all sites and years demonstrated that control severely fractures social groups, but that the effect of control on abundance was neither consistent nor predictable. Management decisions involving large social predators must therefore consider social stability to ensure their conservation and ecological functioning.			Wallach, AD (corresponding author), Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia.	arian.wallach@adelaide.edu.au	Wallach, Arian D./ABC-9215-2020; Ritchie, Euan/N-1088-2014	Wallach, Arian D./0000-0002-6640-3887; Ritchie, Euan/0000-0003-4410-8868; Read, John/0000-0003-0605-5259; Wallach, Arian/0000-0001-9689-0092				ALLEN L, 1998, AUSTR VERTEBRATE PES, V11, P421; Allen L., 2000, PACK SIZE PREY BEHAV; Allen LR, 2001, J APPL ECOL, V38, P76, DOI 10.1046/j.1365-2664.2001.00569.x; Andersone Z, 2002, MAMM BIOL, V67, P79, DOI 10.1078/1616-5047-00012; ANDERSSON M, 1984, ANNU REV ECOL SYST, V15, P165, DOI 10.1146/annurev.es.15.110184.001121; Barja I, 2005, FOLIA ZOOL, V54, P21; Barja I, 2004, NATURWISSENSCHAFTEN, V91, P489, DOI 10.1007/s00114-004-0557-1; Barja I, 2009, ANIM BEHAV, V77, P489, DOI 10.1016/j.anbehav.2008.11.004; Berger KM, 2006, CONSERV BIOL, V20, P751, DOI 10.1111/j.1523-1739.2006.00336.x; Brainerd SM, 2008, J WILDLIFE MANAGE, V72, P89, DOI 10.2193/2006-305; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CATLING PC, 1992, WILDLIFE RES, V19, P195, DOI 10.1071/WR9920195; Chapron G, 2008, SCIENCE, V320, P47, DOI 10.1126/science.320.5872.47a; Conner MM, 1998, J WILDLIFE MANAGE, V62, P690, DOI 10.2307/3802345; Corbett L. K., 1995, DINGO AUSTR ASIA; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Gehring TM, 2003, CAN FIELD NAT, V117, P419, DOI 10.22621/cfn.v117i3.744; Gese EM, 1998, CAN J ZOOL, V76, P1037, DOI 10.1139/cjz-76-6-1037; Glen AS, 2007, AUSTRAL ECOL, V32, P492, DOI 10.1111/j.1442-9993.2007.01721.x; Haber GC, 1996, CONSERV BIOL, V10, P1068, DOI 10.1046/j.1523-1739.1996.10041068.x; HARRINGTON FH, 1986, ANIM BEHAV, V34, P1575, DOI 10.1016/S0003-3472(86)80231-7; HARRINGTON FH, 1987, ANIM BEHAV, V35, P7, DOI 10.1016/S0003-3472(87)80204-X; JOHNSON C, 2006, AUSTR MAMMAL EXTINCT; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; Knowlton FF, 1999, J RANGE MANAGE, V52, P398, DOI 10.2307/4003765; LEHMAN N, 1992, BEHAV ECOL SOCIOBIOL, V30, P83; Link WA, 2006, ECOLOGY, V87, P2626, DOI 10.1890/0012-9658(2006)87[2626:MWATFO]2.0.CO;2; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; MCILROY JC, 1991, WILDLIFE RES, V18, P315, DOI 10.1071/WR9910315; Nowak S, 2007, J ETHOL, V25, P231, DOI 10.1007/s10164-006-0015-y; O'Neill A., 2002, LIVING DINGO; Post E, 1999, NATURE, V401, P905, DOI 10.1038/44814; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reddiex B, 2006, WILDLIFE RES, V33, P691, DOI 10.1071/WR05102; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; ROTHMAN RJ, 1979, ANIM BEHAV, V27, P750, DOI 10.1016/0003-3472(79)90010-1; Sand H, 2006, ANIM BEHAV, V72, P781, DOI 10.1016/j.anbehav.2005.11.030; Sapolsky RM, 2006, SOC FORCES, V85, P217, DOI 10.1353/sof.2006.0142; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Sillero-Zubiri C, 1998, J ZOOL, V245, P351, DOI 10.1111/j.1469-7998.1998.tb00110.x; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; Stahler DR, 2002, CAN J ZOOL, V80, P360, DOI 10.1139/Z01-223; THOMSON PC, 1992, WILDLIFE RES, V19, P531, DOI 10.1071/WR9920531; THOMSON PC, 1992, WILDLIFE RES, V19, P543, DOI 10.1071/WR9920543; THOMSON PC, 1992, WILDLIFE RES, V19, P519, DOI 10.1071/WR9920519; Van Meter PE, 2009, HORM BEHAV, V55, P329, DOI 10.1016/j.yhbeh.2008.11.001; VANDYCK S, 2008, MAMMALS AUSTR, P750; Vucetich JA, 2004, ANIM BEHAV, V67, P1117, DOI 10.1016/j.anbehav.2003.06.018; Vucetich JA, 1997, CONSERV BIOL, V11, P957, DOI 10.1046/j.1523-1739.1997.95366.x; Wallach AD, 2009, BIOL CONSERV, V142, P1253, DOI 10.1016/j.biocon.2009.01.011; Wallach AD, 2009, BIOL CONSERV, V142, P43, DOI 10.1016/j.biocon.2008.09.021; Zub K, 2003, BEHAVIOUR, V140, P635, DOI 10.1163/156853903322149478	52	72	82	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2009	4	9							e6861	10.1371/journal.pone.0006861	http://dx.doi.org/10.1371/journal.pone.0006861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RW	19724642	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000269522800005
J	Bon, JM; Leader, JK; Weissfeld, JL; Coxson, HO; Zheng, B; Branch, RA; Kondragunta, V; Lee, JS; Zhang, YZ; Choi, AMK; Lokshin, AE; Kaminski, N; Gur, D; Sciurba, FC				Bon, Jessica M.; Leader, Joseph K.; Weissfeld, Joel L.; Coxson, Harvey O.; Zheng, Bin; Branch, Robert A.; Kondragunta, Venkateswarlu; Lee, Janet S.; Zhang, Yingze; Choi, Augustine M. K.; Lokshin, Anna E.; Kaminski, Naftali; Gur, David; Sciurba, Frank C.			The Influence of Radiographic Phenotype and Smoking Status on Peripheral Blood Biomarker Patterns in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; QUANTITATIVE ASSESSMENT; INFLAMMATORY MARKERS; AIRWAY-OBSTRUCTION; CIGARETTE-SMOKE; EMPHYSEMA; SERUM; COPD; ASSOCIATIONS; DIMENSIONS	Background: Chronic obstructive pulmonary disease (COPD) is characterized by both airway remodeling and parenchymal destruction. The identification of unique biomarker patterns associated with airway dominant versus parenchymal dominant patterns would support the existence of unique phenotypes representing independent biologic processes. A cross-sectional study was performed to examine the association of serum biomarkers with radiographic airway and parenchymal phenotypes of COPD. Methodology/Principal Findings: Serum from 234 subjects enrolled in a CT screening cohort was analyzed for 33 cytokines and growth factors using a multiplex protein array. The association of serum markers with forced expiratory volume in one second percent predicted (FEV1%) and quantitative CT measurements of airway thickening and emphysema was assessed with and without stratification for current smoking status. Significant associations were found with several serum inflammatory proteins and measurements of FEV1%, airway thickening, and parenchymal emphysema independent of smoking status. The association of select analytes with airway thickening and emphysema was independent of FEV1%. Furthermore, the relationship between other inflammatory markers and measurements of physiologic obstruction or airway thickening was dependent on current smoking status. Conclusions/Significance: Airway and parenchymal phenotypes of COPD are associated with unique systemic serum biomarker profiles. Serum biomarker patterns may provide a more precise classification of the COPD syndrome, provide insights into disease pathogenesis and identify targets for novel patient-specific biological therapies.			Bon, JM (corresponding author), Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.	bonjm@upmc.edu	Coxson, Harvey O/A-9861-2017; Sciurba, Frank/AAZ-9339-2021; Bon, Jessica/AAK-6714-2021; Zheng, Bin/HGU-5316-2022	Coxson, Harvey O/0000-0001-5750-9711; Kaminski, Naftali/0000-0001-5917-4601; sciurba, frank/0000-0001-7468-2225; Lee, Janet/0000-0002-6812-6043; Zheng, Bin/0000-0002-7682-6648	NATIONAL CANCER INSTITUTE [P50CA090440] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084948] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA090440] Funding Source: Medline; NHLBI NIH HHS [P50 HL084948] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agusti AGN, 2003, EUR RESPIR J, V21, P347, DOI 10.1183/09031936.03.00405703; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Drannik AG, 2004, AM J RESP CRIT CARE, V170, P1164, DOI 10.1164/rccm.200311-1521OC; Eid AA, 2001, AM J RESP CRIT CARE, V164, P1414, DOI 10.1164/ajrccm.164.8.2008109; Feghali-Bostwick CA, 2008, AM J RESP CRIT CARE, V177, P156, DOI 10.1164/rccm.200701-014OC; GELB AF, 1993, AM REV RESPIR DIS, V147, P1157, DOI 10.1164/ajrccm/147.5.1157; Gorelik E, 2005, CANCER EPIDEM BIOMAR, V14, P981, DOI 10.1158/1055-9965.EPI-04-0404; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; He JQ, 2006, HUM GENET, V119, P365, DOI 10.1007/s00439-006-0143-z; HERSH CP, 2006, AM J RESP CRIT CARE; HOGG JC, 1968, NEW ENGL J MED, V278, P1355, DOI 10.1056/NEJM196806202782501; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hoshino T, 2007, AM J RESP CRIT CARE, V176, P49, DOI 10.1164/rccm.200603-316OC; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kraan TCTMV, 2002, GENES IMMUN, V3, P436, DOI 10.1038/sj.gene.6363896; LEADER J, 2007, P SPIE, V6511; Leader JK, 2003, ACAD RADIOL, V10, P1224, DOI 10.1016/S1076-6332(03)00380-5; Lee JS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-64; Lemos-Gonzalez Y, 2007, BRIT J CANCER, V96, P1569, DOI 10.1038/sj.bjc.6603770; MacNee William, 2005, Proc Am Thorac Soc, V2, P258, DOI 10.1513/pats.200504-045SR; McNittGray MF, 1997, J COMPUT ASSIST TOMO, V21, P939, DOI 10.1097/00004728-199711000-00017; Mouawad R, 2006, MELANOMA RES, V16, P335; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; Muller V, 2006, ANTICANCER RES, V26, P1479; Nakano Y, 2000, AM J RESP CRIT CARE, V162, P1102, DOI 10.1164/ajrccm.162.3.9907120; Nakano Y, 2005, AM J RESP CRIT CARE, V171, P142, DOI 10.1164/rccm.200407-874OC; Nakano Y, 2002, CHEST, V122, p271S, DOI 10.1378/chest.122.6_suppl.271S-a; PATEL BD, 2008, AM J RESP CRIT CARE; Pinto-Plata V, 2007, THORAX, V62, P595, DOI 10.1136/thx.2006.064428; Sadeghnejad A, 2007, AM J RESP CRIT CARE, V176, P748, DOI 10.1164/rccm.200704-543OC; Schols AMWJ, 1996, THORAX, V51, P819, DOI 10.1136/thx.51.8.819; Sethi S, 2008, AM J RESP CRIT CARE, V177, P491, DOI 10.1164/rccm.200708-1234OC; Shapiro SD, 2001, AM J RESP CRIT CARE, V164, P339, DOI 10.1164/ajrccm.164.3.2105072c; Thakore AH, 2007, AM J CARDIOL, V99, P1598, DOI 10.1016/j.amjcard.2007.01.036; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Wannamethee SG, 2005, EUR HEART J, V26, P1765, DOI 10.1093/eurheartj/ehi183; Zhang J, 2002, EXP BIOL MED, V227, P823, DOI 10.1177/153537020222700916; Zheng B, 2007, MED PHYS, V34, P2844, DOI 10.1118/1.2742777; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	42	34	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6865	10.1371/journal.pone.0006865	http://dx.doi.org/10.1371/journal.pone.0006865			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718453	Green Published, gold, Green Accepted			2022-12-25	WOS:000269415900026
J	Shahrestani, P; Leung, HT; Le, PK; Pak, WL; Tse, S; Ocorr, K; Huang, TS				Shahrestani, Parvin; Leung, Hung-Tat; Le, Phung Khanh; Pak, William L.; Tse, Stephanie; Ocorr, Karen; Huang, Taosheng			Heterozygous Mutation of Drosophila Opa1 Causes the Development of Multiple Organ Abnormalities in an Age-Dependent and Organ-Specific Manner	PLOS ONE			English	Article								Optic Atrophy 1 (OPA1) is a ubiquitously expressed dynamin-like GTPase in the inner mitochondrial membrane. It plays important roles in mitochondrial fusion, apoptosis, reactive oxygen species (ROS) and ATP production. Mutations of OPA1 result in autosomal dominant optic atrophy (DOA). The molecular mechanisms by which link OPA1 mutations and DOA are not fully understood. Recently, we created a Drosophila model to study the pathogenesis of optic atrophy. Heterozygous mutation of Drosophila OPA1 (dOpa1) by P-element insertion results in no obvious morphological abnormalities, whereas homozygous mutation is embryonic lethal. In eye-specific somatic clones, homozygous mutation of dOpa1 causes rough (mispatterning) and glossy (decreased lens deposition) eye phenotypes in adult Drosophila. In humans, heterozygous mutations in OPA1 have been associated with mitochondrial dysfunction, which is predicted to affect multiple organs. In this study, we demonstrated that heterozygous dOpa1 mutation perturbs the visual function and an ERG profile of the Drosophila compound eye. We independently showed that antioxidants delayed the onset of mutant phenotypes in ERG and improved larval vision function in phototaxis assay. Furthermore, heterozygous dOpa1 mutation also caused decreased heart rate, increased heart arrhythmia, and poor tolerance to stress induced by electrical pacing. However, antioxidants had no effects on the dysfunctional heart of heterozygous dOpa1 mutants. Under stress, heterozygous dOpa1 mutations caused reduced escape response, suggesting abnormal function of the skeletal muscles. Our results suggest that heterozygous mutation of dOpa1 shows organ-specific pathogenesis and is associated with multiple organ abnormalities in an age-dependent and organ-specific manner.			Shahrestani, P (corresponding author), Univ Calif Irvine, Irvine, CA 92717 USA.	huangts@uci.edu		Huang, Taosheng/0000-0001-6601-6687	NATIONAL EYE INSTITUTE [R01EY000033, R01EY018876, R37EY000033, R56EY000033] Funding Source: NIH RePORTER; NEI NIH HHS [R56 EY000033, 1R01EY018876-01, R01 EY000033, R37 EY000033, EY00033, R01 EY018876] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681; Amati-Bonneau P, 2003, AM J OPHTHALMOL, V136, P1170, DOI 10.1016/S0002-9394(03)00665-2; Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Bette S, 2005, ACTA NEUROPATHOL, V109, P393, DOI 10.1007/s00401-004-0970-8; BUCHNER E, 1991, J NEUROGENET, V7, P153, DOI 10.3109/01677069109167432; Cammarato A, 2008, MOL BIOL CELL, V19, P553, DOI 10.1091/mbc.E07-09-0890; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Chen SQ, 2007, AM J OPHTHALMOL, V143, P186, DOI 10.1016/j.ajo.2006.06.049; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Delettre C, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-8; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Eiberg H, 2006, J MED GENET, V43, P435, DOI 10.1136/jmg.2005.034892; EIBERG H, 1994, HUM MOL GENET, V3, P977, DOI 10.1093/hmg/3.6.977; GORGONE G, 1986, OPHTHALMOLOGICA, V192, P28, DOI 10.1159/000309608; Ke Tie, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P481; LARRIVEE DC, 1981, J GEN PHYSIOL, V78, P521, DOI 10.1085/jgp.78.5.521; LILLY M, 1990, GENETICS, V124, P293; Lodi R, 2004, ANN NEUROL, V56, P719, DOI 10.1002/ana.20278; Misaka T, 2002, J BIOL CHEM, V277, P15834, DOI 10.1074/jbc.M109260200; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; PAK WL, 1995, INVEST OPHTH VIS SCI, V36, P2340; Payne M, 2004, AM J OPHTHALMOL, V138, P749, DOI 10.1016/j.ajo.2004.06.011; Pedram A, 2006, MOL BIOL CELL, V17, P2125, DOI 10.1091/mbc.E05-11-1013; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Tang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004492; Tong JJY, 2007, NAT GENET, V39, P476, DOI 10.1038/ng2004; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Votruba M, 1998, J MED GENET, V35, P793, DOI 10.1136/jmg.35.10.793; Votruba M, 2003, J INHERIT METAB DIS, V26, P209, DOI 10.1023/A:1024441302074; Yarosh W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040006; AM J HUM GENET, V65, P1428	34	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6867	10.1371/journal.pone.0006867	http://dx.doi.org/10.1371/journal.pone.0006867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718456	Green Published, gold			2022-12-25	WOS:000269415900028
J	Demougeot, L; Normand, H; Denise, P; Papaxanthis, C				Demougeot, Laurent; Normand, Herve; Denise, Pierre; Papaxanthis, Charalambos			Discrete and Effortful Imagined Movements Do Not Specifically Activate the Autonomic Nervous System	PLOS ONE			English	Article							SIMULATED MOVEMENT; MENTAL SIMULATION; IMAGERY; PERFORMANCE; VOLUNTARY; RESPONSES; STRENGTH; REFLEX; ARM	Background: The autonomic nervous system (ANS) is activated in parallel with the motor system during cyclical and effortful imagined actions. However, it is not clear whether the ANS is activated during motor imagery of discrete movements and whether this activation is specific to the movement being imagined. Here, we explored these topics by studying the baroreflex control of the cardiovascular system. Methodology/Principal Findings: Arterial pressure and heart rate were recorded in ten subjects who executed or imagined trunk or leg movements against gravity. Trunk and leg movements result in different physiological reactions (orthostatic hypotension phenomenon) when they are executed. Interestingly, ANS activation significantly, but similarly, increased during imagined trunk and leg movements. Furthermore, we did not observe any physiological modulation during a control mental-arithmetic task or during motor imagery of effortless movements (horizontal wrist displacements). Conclusions/Significance: We concluded that ANS activation during motor imagery is general and not specific and physiologically prepares the organism for the upcoming effortful action.			Demougeot, L (corresponding author), Univ Bourgogne, UFR STAPS, BP 278877, Dijon, France.	charalambos.papaxanthis@u-bourgogne.fr	Denise, Pierre/E-2174-2011; NORMAND, Hervé/N-8787-2015	Denise, Pierre/0000-0002-9049-7692; 				Alam M, 1937, J PHYSIOL-LONDON, V89, P372, DOI 10.1113/jphysiol.1937.sp003485; BEYER L, 1990, INT J PSYCHOPHYSIOL, V9, P75, DOI 10.1016/0167-8760(90)90008-2; Courtine G, 2004, COGNITIVE BRAIN RES, V22, P67, DOI 10.1016/j.cogbrainres.2004.07.008; DECETY J, 1991, BEHAV BRAIN RES, V42, P1, DOI 10.1016/S0166-4328(05)80033-6; DECETY J, 1993, J PHYSIOL-LONDON, V461, P549, DOI 10.1113/jphysiol.1993.sp019528; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; Fadiga L, 2004, J CLIN NEUROPHYSIOL, V21, P157, DOI 10.1097/00004691-200405000-00004; Gentili R, 2006, NEUROSCIENCE, V137, P761, DOI 10.1016/j.neuroscience.2005.10.013; Gentili R, 2004, BEHAV BRAIN RES, V155, P231, DOI 10.1016/j.bbr.2004.04.027; Guillot A, 2005, BRAIN RES REV, V50, P387, DOI 10.1016/j.brainresrev.2005.09.004; Guillot A, 2005, J MOTOR BEHAV, V37, P10, DOI 10.3200/JMBR.37.1.10-20; Hall C. R., 1997, J MENTAL IMAG, V21, P143, DOI DOI 10.1037/T07979-000; HOBBS SF, 1985, NEUROSCI LETT, V57, P85, DOI 10.1016/0304-3940(85)90044-8; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Krogh A, 1913, J PHYSIOL-LONDON, V47, P112; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; MITCHELL JH, 1985, AM J CARDIOL, V55, pD34, DOI 10.1016/0002-9149(85)91053-7; Naito E, 2002, J NEUROSCI, V22, P3683; Paccalin C, 2000, BRAIN RES, V862, P194, DOI 10.1016/S0006-8993(00)02145-4; Papadelis C, 2007, BRAIN COGNITION, V64, P74, DOI 10.1016/j.bandc.2007.01.001; Papaxanthis C, 2003, NEUROSCI LETT, V339, P41, DOI 10.1016/S0304-3940(02)01472-6; Petersen CM, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-9; PRESSMAN GL, 1963, IEEE T BIO-MED ENG, VBM10, P73, DOI 10.1109/TBMEL.1963.4322794; Ranganathan VK, 2004, NEUROPSYCHOLOGIA, V42, P944, DOI 10.1016/j.neuropsychologia.2003.11.018; SCHLINDWEIN P, 2008, AUTON NEUROSCI; Vieilledent S, 2003, COGNITIVE BRAIN RES, V16, P238, DOI 10.1016/S0926-6410(02)00279-3; WANG YD, 1992, BEHAV BRAIN RES, V52, P167, DOI 10.1016/S0166-4328(05)80227-X; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Yaguez L, 1998, BEHAV BRAIN RES, V90, P95, DOI 10.1016/S0166-4328(97)00087-9; YUE G, 1992, J NEUROPHYSIOL, V67, P1114, DOI 10.1152/jn.1992.67.5.1114	30	21	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6769	10.1371/journal.pone.0006769	http://dx.doi.org/10.1371/journal.pone.0006769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707571	gold, Green Published			2022-12-25	WOS:000269335000015
J	Kim, S; Mangin, P; Dangelmaier, C; Lillian, R; Jackson, SP; Daniel, JL; Kunapuli, SP				Kim, Soochong; Mangin, Pierre; Dangelmaier, Carol; Lillian, Rivka; Jackson, Shaun P.; Daniel, James L.; Kunapuli, Satya P.			Role of Phosphoinositide 3-Kinase beta in Glycoprotein VI-mediated Akt Activation in Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-GAMMA-CHAIN; PROTEIN-KINASE-B; COLLAGEN RECEPTOR; TYROSINE PHOSPHORYLATION; FACTOR-I; ANTITHROMBOTIC THERAPY; ADENOSINE-DIPHOSPHATE; SIGNAL-TRANSDUCTION; T-CELLS; C-SRC	Glycoprotein (GP) VI is a critical platelet collagen receptor. Phosphoinositide 3-kinase (PI3K) plays an important role in GPVI-mediated platelet activation, yet the major PI3K isoforms involved in this process have not been identified. In addition, stimulation of GPVI results in the activation of Akt, a downstream effector of PI3K. Thus, we investigated the contribution of PI3K isoforms to GPVI-mediated platelet activation and Akt activation. A protein kinase C inhibitor GF 109203X or a P2Y(12) receptor antagonist AR-C69931MX partly reduced GPVI-induced Akt phosphorylation. Platelets from mice dosed with clopidogrel also showed partial Akt phosphorylation, indicating that GPVI-mediated Akt phosphorylation is regulated by both secretion-dependent and -independent pathways. In addition, GPVI-induced Akt phosphorylation in the presence of ADP antagonists was completely inhibited by PI3K inhibitor LY294002 and PI3K beta inhibitor TGX-221 indicating an essential role of PI3K beta in Akt activation directly downstream of GPVI. Moreover, GPVI-mediated platelet aggregation, secretion, and intracellular Ca2+ mobilization were significantly inhibited by TGX-221, and less strongly inhibited by PI3K alpha inhibitor PIK75, but were not affected by PI3K gamma inhibitor AS252424 and PI3K delta inhibitor IC87114. Consistently, GPVI-induced integrin alpha(IIb)beta(3) activation of PI3K gamma(-/-) and PI3K delta(-/-) platelets also showed no significant difference compared with wild-type platelets. These results demonstrate that GPVI-induced Akt activation in platelets is dependent in part on G(1) stimulation through P2Y12 receptor activation by secreted ADP. In addition, a significant portion of GPVI-dependent, ADP-independent Akt activation also exists, and PI3K beta plays an essential role in GPVI-mediated platelet aggregation and Akt activation.	[Kunapuli, Satya P.] Temple Univ, Dept Physiol, Sch Med, Philadelphia, PA 19140 USA; [Kim, Soochong; Kunapuli, Satya P.] Temple Univ, Sol Sherry Thrombosis Res Ctr, Sch Med, Philadelphia, PA 19140 USA; [Dangelmaier, Carol; Daniel, James L.; Kunapuli, Satya P.] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19140 USA; [Mangin, Pierre; Lillian, Rivka; Jackson, Shaun P.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Monash University	Kunapuli, SP (corresponding author), Temple Univ, Dept Physiol, Sch Med, 3420 N Broad St, Philadelphia, PA 19140 USA.	spk@temple.edu	Mangin, Pierre/H-9354-2016	Jackson, Shaun/0000-0002-4750-1991	National Institutes of Health [HL60683, HL80444]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060683, R01HL080444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL60683 and HL80444 ( to S. P. K.).	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Asazuma N, 2000, J BIOL CHEM, V275, P33427, DOI 10.1074/jbc.M001439200; Barry FA, 2002, J BIOL CHEM, V277, P12874, DOI 10.1074/jbc.M200482200; Baurand A, 2001, EUR J PHARMACOL, V412, P213, DOI 10.1016/S0014-2999(01)00733-6; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; CANOBBIO I, 2009, BLOOD IN PRESS; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Cho MJ, 2002, BLOOD, V99, P2442, DOI 10.1182/blood.V99.7.2442; CLAPHAM DE, 1997, ANN REV PHARM TOXICO, V167, P203; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; DANIEL JL, 1994, BIOCHEM J, V302, P617, DOI 10.1042/bj3020617; Ezumi Y, 1998, J EXP MED, V188, P267, DOI 10.1084/jem.188.2.267; Geiger J, 1999, ARTERIOSCL THROM VAS, V19, P2007, DOI 10.1161/01.ATV.19.8.2007; Gibbins J, 1996, J BIOL CHEM, V271, P18095, DOI 10.1074/jbc.271.30.18095; Gibbins JM, 1998, J BIOL CHEM, V273, P34437, DOI 10.1074/jbc.273.51.34437; Gibbins JM, 1997, FEBS LETT, V413, P255, DOI 10.1016/S0014-5793(97)00926-5; Gilio K, 2009, J BIOL CHEM, V284, P33750, DOI 10.1074/jbc.M109.048439; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hayakawa M, 2006, BIOORGAN MED CHEM, V14, P6847, DOI 10.1016/j.bmc.2006.06.046; Hers I, 2007, BLOOD, V110, P4243, DOI 10.1182/blood-2006-10-050633; Hirsch E, 2001, FASEB J, V15, P2019, DOI 10.1096/fj.00-0810fje; Hu YH, 2000, J MED CHEM, V43, P3045, DOI 10.1021/jm000117y; Ichinohe T, 1997, J BIOL CHEM, V272, P63; ICHINOHE T, 1995, J BIOL CHEM, V270, P28029; Ingall AH, 1999, J MED CHEM, V42, P213, DOI 10.1021/jm981072s; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Kauffenstein G, 2001, FEBS LETT, V505, P281, DOI 10.1016/S0014-5793(01)02824-1; Kim S, 2006, BLOOD, V107, P947, DOI 10.1182/blood-2005-07-3040; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Kim S, 2007, BLOOD, V110, P4206, DOI 10.1182/blood-2007-03-080804; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kowalska MA, 2000, BLOOD, V96, P50, DOI 10.1182/blood.V96.1.50.013k40_50_57; Kroner C, 2000, J BIOL CHEM, V275, P27790, DOI 10.1074/jbc.M000540200; Lagrue AH, 1999, FEBS LETT, V448, P95, DOI 10.1016/S0014-5793(99)00340-3; Lova P, 2003, J BIOL CHEM, V278, P131, DOI 10.1074/jbc.M204821200; Maxwell MJ, 2004, J BIOL CHEM, V279, P32196, DOI 10.1074/jbc.M400746200; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Nieswandt B, 2000, J BIOL CHEM, V275, P23998, DOI 10.1074/jbc.M003803200; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Quek LS, 1998, CURR BIOL, V8, P1137, DOI 10.1016/S0960-9822(98)70471-3; Quek LS, 2000, BLOOD, V96, P4246; Quinter PG, 2007, J THROMB HAEMOST, V5, P362, DOI 10.1111/j.1538-7836.2007.02309.x; Quinton TM, 2002, BIOCHEM J, V368, P535, DOI 10.1042/BJ20020226; Quinton TM, 2002, BLOOD, V99, P3228, DOI 10.1182/blood.V99.9.3228; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Senis YA, 2005, PLATELETS, V16, P191, DOI 10.1080/09537100400016711; Smith U, 2000, BIOCHEM BIOPH RES CO, V268, P315, DOI 10.1006/bbrc.2000.2145; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Trumel C, 1999, BLOOD, V94, P4156, DOI 10.1182/blood.V94.12.4156.424k29_4156_4165; Tsuji M, 1997, J BIOL CHEM, V272, P23528, DOI 10.1074/jbc.272.38.23528; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Watson SP, 1998, IMMUNOL TODAY, V19, P260, DOI 10.1016/S0167-5699(98)01267-5; Watson SP, 2001, THROMB HAEMOSTASIS, V86, P276; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; Yang J, 2000, P NATL ACAD SCI USA, V97, P9984, DOI 10.1073/pnas.180194597	61	98	101	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33763	33772		10.1074/jbc.M109.048553	http://dx.doi.org/10.1074/jbc.M109.048553			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19700402	hybrid, Green Published			2022-12-25	WOS:000272165200006
J	Everitt, AB; Seymour, VAL; Curmi, J; Laver, DR; Gage, PW; Tierney, ML				Everitt, Andrea B.; Seymour, Victoria A. L.; Curmi, John; Laver, Derek R.; Gage, Peter W.; Tierney, M. Louise			Protein interactions involving the gamma 2 large cytoplasmic loop of GABA(A) receptors modulate conductance	FASEB JOURNAL			English	Article						single-channel conductance; diazepam; MA helix; competitor peptide	CULTURED HIPPOCAMPAL-NEURONS; SINGLE-CHANNEL CONDUCTANCE; NICOTINIC ACETYLCHOLINE-RECEPTORS; ACID TYPE-A; AMINOBUTYRIC-ACID; CHLORIDE CHANNELS; CROSS-TALK; GATED CHANNELS; SUBUNIT; GABARAP	Native GABA(A) channels display a single-channel conductance ranging between similar to 10 and 90 pS. Diazepam increases the conductance of some of these native channels but never those of recombinant receptors, unless they are coexpressed with GABARAP. This trafficking protein clusters recombinant receptors in the membrane, suggesting that high-conductance channels arise from receptors that are at locally high concentrations. The amphipathic (MA) helix that is present in the large cytoplasmic loop of every subunit of all ligand-gated ion channels mediates protein-protein interactions. Here we report that when applied to inside-out patches, a peptide mimicking the MA helix of the gamma 2 subunit (gamma(381-403)) of the GABA(A) receptor abrogates the potentiating effect of diazepam on both endogenous receptors and recombinant GABA(A) receptors coexpressed with GABARAP, by substantially reducing their conductance. The protein interaction disrupted by the peptide did not involve GABARAP, because a shorter peptide (gamma(386-403)) known to compete with the gamma 2-GABARAP interaction did not affect the conductance of recombinant alpha beta gamma receptors coexpressed with GABARAP. The requirement for receptor clustering and the fact that the gamma 2 MA helix is able to self-associate support a mechanism whereby adjacent GABA(A) receptors interact via their gamma 2-subunit MA helices, altering ion permeation through each channel. Alteration of ion-channel function arising from dynamic interactions between ion channels of the same family has not been reported previously and highlights a novel way in which inhibitory neurotransmission in the brain may be differentially modulated.-Everitt, A. B., Seymour, V. A. L., Curmi, J., Laver, D. R., Gage, P. W., Tierney, M. L. Protein interactions involving the gamma 2 large cytoplasmic loop of GABAA receptors modulate conductance. FASEB J. 23, 4361-4369 (2009). www.fasebj.org	[Tierney, M. Louise] Australian Natl Univ, Div Mol Biosci, John Curtin Sch Med Res, Struct Biol Programme, Canberra, ACT 0200, Australia; [Laver, Derek R.] Univ Newcastle, Sch Biomed Sci, Newcastle, NSW 2308, Australia; [Laver, Derek R.] Hunter Med Res Inst, Newcastle, NSW, Australia	Australian National University; John Curtin School of Medical Research; University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Tierney, ML (corresponding author), Australian Natl Univ, Div Mol Biosci, John Curtin Sch Med Res, Struct Biol Programme, Bldg 54,Garran Rd, Canberra, ACT 0200, Australia.	louise.tierney@anu.edu.au			National Health and Medical Research Council [418027]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The authors acknowledge the foresight and contribution made by the late Peter W. Gage. We thank P.J. Milburn and S. M. Howitt for comments on the manuscript. This work was supported by a National Health and Medical Research Council grant to M. L. T. and D. R. L. (418027).	ANGELOTTI TP, 1993, J NEUROSCI, V13, P1429; Boue-Grabot E, 2004, J BIOL CHEM, V279, P52517, DOI 10.1074/jbc.M410223200; Boue-Grabot E, 2004, J BIOL CHEM, V279, P6967, DOI 10.1074/jbc.M307772200; Boue-Grabot E, 2003, J NEUROSCI, V23, P1246, DOI 10.1523/JNEUROSCI.23-04-01246.2003; Carland JE, 2009, J BIOL CHEM, V284, P2023, DOI 10.1074/jbc.M806618200; Castillo M, 2005, J BIOL CHEM, V280, P27062, DOI 10.1074/jbc.M503746200; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chen L, 2000, P NATL ACAD SCI USA, V97, P11557, DOI 10.1073/pnas.190133497; Christie SB, 2006, MOL CELL NEUROSCI, V31, P1, DOI 10.1016/j.mcn.2005.08.014; Christie SB, 2002, J NEUROSCI, V22, P684, DOI 10.1523/JNEUROSCI.22-03-00684.2002; CURMI JP, 1993, J MEMBRANE BIOL, V136, P273; Eghbali M, 2000, MOL PHARMACOL, V58, P463, DOI 10.1124/mol.58.3.463; Eghbali M, 2003, EUR J PHARMACOL, V468, P75, DOI 10.1016/S0014-2999(03)01641-8; Eghbali M, 1997, NATURE, V388, P71, DOI 10.1038/40404; Everitt AB, 2004, J BIOL CHEM, V279, P21701, DOI 10.1074/jbc.M312806200; FATIMASHAD K, 1992, P ROY SOC B-BIOL SCI, V250, P99, DOI 10.1098/rspb.1992.0136; GAGE PW, 1994, P ROY SOC B-BIOL SCI, V255, P167, DOI 10.1098/rspb.1994.0024; Gaul S, 2007, J STEROID BIOCHEM, V104, P35, DOI 10.1016/j.jsbmb.2006.09.042; Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008; GRAY R, 1985, J NEUROPHYSIOL, V54, P134, DOI 10.1152/jn.1985.54.1.134; Guyon A, 1999, J PHYSIOL-LONDON, V516, P719, DOI 10.1111/j.1469-7793.1999.0719u.x; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Higgins MK, 2002, EMBO J, V21, P2087, DOI 10.1093/emboj/21.9.2087; HORN R, 1987, BIOPHYS J, V51, P255, DOI 10.1016/S0006-3495(87)83331-3; Kawaguchi SY, 2007, J NEUROSCI, V27, P6788, DOI 10.1523/JNEUROSCI.1981-07.2007; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Khakh BS, 2000, NATURE, V406, P405, DOI 10.1038/35019066; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Luu T, 2005, J MEMBRANE BIOL, V205, P17, DOI 10.1007/s00232-005-0759-2; Luu T, 2006, J BIOL CHEM, V281, P35699, DOI 10.1074/jbc.M605590200; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Marsden KC, 2007, J NEUROSCI, V27, P14326, DOI 10.1523/JNEUROSCI.4433-07.2007; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nymann-Andersen J, 2002, J NEUROCHEM, V80, P815, DOI 10.1046/j.0022-3042.2002.00762.x; Nymann-Andersen J, 2002, J NEUROCHEM, V83, P1164, DOI 10.1046/j.1471-4159.2002.01222.x; ROGERS CJ, 1994, J PHYSIOL-LONDON, V475, P69, DOI 10.1113/jphysiol.1994.sp020050; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; Seymour VAL, 2009, J MEMBRANE BIOL, V227, P111, DOI 10.1007/s00232-008-9150-4; SIGEL E, 1988, J NEUROSCI, V8, P289; Sokolova O, 2001, STRUCTURE, V9, P215, DOI 10.1016/S0969-2126(01)00578-0; Tierney ML, 2008, INT J BIOCHEM CELL B, V40, P968, DOI 10.1016/j.biocel.2007.10.029; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264	44	16	16	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	DEC	2009	23	12					4361	4369		10.1096/fj.09-137042	http://dx.doi.org/10.1096/fj.09-137042			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19703932	Green Published			2022-12-25	WOS:000272193700031
J	Ascenzi, P; di Masi, A; Coletta, M; Ciaccio, C; Fanali, G; Nicoletti, FP; Smulevich, G; Fasano, M				Ascenzi, Paolo; di Masi, Alessandra; Coletta, Massimo; Ciaccio, Chiara; Fanali, Gabriella; Nicoletti, Francesco P.; Smulevich, Giulietta; Fasano, Mauro			Ibuprofen Impairs Allosterically Peroxynitrite Isomerization by Ferric Human Serum Heme-Albumin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID-BINDING; ANTI-HIV DRUGS; CRYSTAL-STRUCTURE; LIGAND-BINDING; NITRIC-OXIDE; CRYSTALLOGRAPHIC ANALYSIS; ENZYMATIC-PROPERTIES; MEDIATED OXIDATION; WARFARIN-BINDING; HUMAN HEMALBUMIN	Human serum albumin (HSA) participates in heme scavenging; in turn, heme endows HSA with myoglobin-like reactivity and spectroscopic properties. Here, the allosteric effect of ibuprofen on peroxynitrite isomerization to NO3- catalyzed by ferric human serum heme-albumin (HSA-heme-Fe(III)) is reported. Data were obtained at 22.0 C. HSA-heme-Fe(III) catalyzes peroxynitrite isomerization in the absence and presence of CO2; the values of the second order catalytic rate constant (k(on)) are 4.1 x 10(5) and 4.5 x 10(5) M-1 s(-1), respectively. Moreover, HSA-heme-Fe( III) prevents peroxynitrite-mediated nitration of free added L-tyrosine. The pH dependence of k(on) (p(Ka) = 6.9) suggests that peroxynitrous acid reacts preferentially with the heme-Fe(III) atom, in the absence and presence of CO2. The HSA-heme-Fe(III)-catalyzed isomerization of peroxynitrite has been ascribed to the reactive pentacoordinated heme-Fe(III) atom. In the absence and presence of CO2, ibuprofen impairs dose-dependently peroxynitrite isomerization by HSA-heme-Fe(III) and facilitates the nitration of free added L-tyrosine; the value of the dissociation equilibrium constant for ibuprofen binding to HSA-heme-Fe(III) (L) ranges between 7.7 x 10(-4) and 9.7 x 10(-4)M. Underconditionswhere[ibuprofen] is >> L, the kinetics of HSA-heme-Fe(III)-catalyzed isomerization of peroxynitrite is superimposable to that obtained in the absence of HSA-heme-Fe(III) or in the presence of non-catalytic HSA-heme-Fe(III)-cyanide complex and HSA. Ibuprofen binding impairs allosterically peroxynitrite isomerization by HSA-heme-Fe(III), inducing the hexacoordination of the heme-Fe(III) atom. These results represent the first evidence for peroxynitrite isomerization by HSA-heme-Fe(III), highlighting the allosteric modulation of HSA-heme-Fe(III) reactivity by heterotropic interaction(s), and outlining the role of drugs in modulating HSA functions. The present results could be relevant for the drug-dependent protective role of HSA-heme-Fe(III) in vivo.	[Ascenzi, Paolo] Univ Roma Tre, Dept Biol, I-00146 Rome, Italy; Univ Roma Tre, Interdepartmental Lab Electron Microscopy, I-00146 Rome, Italy; [Ascenzi, Paolo] IRCCS Lazzaro Spallanzani, Natl Inst Infect Dis, I-00149 Rome, Italy; [Coletta, Massimo; Ciaccio, Chiara] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy; [Coletta, Massimo; Smulevich, Giulietta] Interuniv Consortium Res Chem Met Biol Syst, I-70126 Bari, Italy; [Fanali, Gabriella; Fasano, Mauro] Univ Insubria, Dept Struct & Funct Biol, I-21052 Busto Arsizio, VA, Italy; [Fanali, Gabriella; Fasano, Mauro] Univ Insubria, Ctr Neurosci, I-21052 Busto Arsizio, VA, Italy; [Nicoletti, Francesco P.; Smulevich, Giulietta] Univ Florence, Dept Chem, I-50019 Sesto Fiorentino, FI, Italy	Roma Tre University; Roma Tre University; IRCCS Lazzaro Spallanzani; University of Rome Tor Vergata; University of Insubria; University of Insubria; University of Florence	Ascenzi, P (corresponding author), Univ Roma Tre, Dept Biol, Viale Guglielmo Marconi 446, I-00146 Rome, Italy.	ascenzi@uniroma3.it	smulevich, giulietta/A-6510-2008; Fasano, Mauro/A-7100-2008; di Masi, Alessandra/K-2300-2018; Coletta, Massimo/N-9049-2015; Coletta, Massimiliano/GSN-5927-2022	Fasano, Mauro/0000-0003-0628-5871; COLETTA, Massimiliano/0000-0002-5489-9467; Smulevich, Giulietta/0000-0003-3021-8919	Ministry for Health of Italy; Italian Ministry of University and Research [COFIN 2007SFZXZ7002]	Ministry for Health of Italy(Ministry of Health, Italy); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by grants from the Ministry for Health of Italy (National Institute for Infectious Diseases I. R. C. C. S. "Lazzaro Spallanzani," Roma, Italy, Ricerca Corrente 2008) (to P. A.) and the Italian Ministry of University and Research (COFIN 2007SFZXZ7002) (to M. C.).	Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Ascenzi P, 2006, MINI-REV MED CHEM, V6, P483, DOI 10.2174/138955706776361448; Ascenzi P, 2005, IUBMB LIFE, V57, P749, DOI 10.1080/15216540500380871; Ascenzi P, 2006, BIOCHEM BIOPH RES CO, V339, P450, DOI 10.1016/j.bbrc.2005.11.031; Ascenzi P, 2005, BIOCHEM MOL BIOL EDU, V33, P169, DOI 10.1002/bmb.2005.494033032470; Ascenzi P, 2005, BIOCHEM BIOPH RES CO, V334, P481, DOI 10.1016/j.bbrc.2005.06.127; Ascenzi P, 2008, BIOCHEM BIOPH RES CO, V369, P686, DOI 10.1016/j.bbrc.2008.02.077; Ascenzi P, 2008, METHOD ENZYMOL, V436, P317, DOI 10.1016/S0076-6879(08)36018-2; Ascenzi P, 2007, BIOCHEM BIOPH RES CO, V353, P469, DOI 10.1016/j.bbrc.2006.12.041; Ascenzi P, 2006, IUBMB LIFE, V58, P611, DOI 10.1080/15216540600746344; Ascenzi P, 2009, BIOCHEM BIOPH RES CO, V387, P83, DOI 10.1016/j.bbrc.2009.06.117; Baroni S, 2001, EUR J BIOCHEM, V268, P6214, DOI 10.1046/j.0014-2956.2001.02569.x; Baroni S, 2009, BIOCHEM BIOPH RES CO, V385, P385, DOI 10.1016/j.bbrc.2009.05.075; Bertucci C, 2002, CURR MED CHEM, V9, P1463, DOI 10.2174/0929867023369673; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; Bocedi A, 2005, FEBS J, V272, P6287, DOI 10.1111/j.1742-4658.2005.05015.x; Bocedi A, 2004, IUBMB LIFE, V56, P609, DOI 10.1080/15216540400016286; Boffi A, 1999, BIOPHYS J, V77, P1143, DOI 10.1016/S0006-3495(99)76965-1; Bohle DS, 1996, METHOD ENZYMOL, V269, P302; BROWN RD, 1992, J CLIN PHARMACOL, V32, P231, DOI 10.1002/j.1552-4604.1992.tb03831.x; Cabrera-Crespo J, 2000, BIOTECHNOL APPL BIOC, V31, P101, DOI 10.1042/BA19990095; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; CARTER DC, 1999, Patent No. 5948609; Chuang VTG, 2002, PHARMACEUT RES, V19, P1458, DOI 10.1023/A:1020496314081; Curry S, 2002, VOX SANG, V83, P315, DOI 10.1111/j.1423-0410.2002.tb05326.x; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; DIANA FJ, 1989, J PHARM SCI-US, V78, P195, DOI 10.1002/jps.2600780304; DILL KA, 1989, BIOCHEMISTRY-US, V28, P5439, DOI 10.1021/bi00439a019; Dockal M, 2000, PROTEIN SCI, V9, P1455, DOI 10.1110/ps.9.8.1455; Fanali G, 2005, FEBS J, V272, P4672, DOI 10.1111/j.1742-4658.2005.04883.x; Fanali G, 2007, FEBS J, V274, P4491, DOI 10.1111/j.1742-4658.2007.05978.x; Fanali G, 2009, FEBS J, V276, P2241, DOI 10.1111/j.1742-4658.2009.06952.x; Fanali G, 2009, J BIOL INORG CHEM, V14, P209, DOI 10.1007/s00775-008-0439-7; Fasano M, 2005, IUBMB LIFE, V57, P787, DOI 10.1080/15216540500404093; Fasano M, 2004, J BIOL INORG CHEM, V9, P800, DOI 10.1007/s00775-004-0598-0; Fasano M, 2002, J INORG BIOCHEM, V91, P487, DOI 10.1016/S0162-0134(02)00473-7; Fasano M, 2001, J BIOL INORG CHEM, V6, P650, DOI 10.1007/s007750100242; FASANO M, 2008, HUMAN SERUM HAEME AL, P121; Fasano M, 2007, IUBMB LIFE, V59, P436, DOI 10.1080/15216540701474523; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Goldstein S, 2005, CHEM REV, V105, P2457, DOI 10.1021/cr0307087; Goldstein S, 2008, METHOD ENZYMOL, V436, P49, DOI 10.1016/S0076-6879(08)36004-2; Groves JT, 1999, CURR OPIN CHEM BIOL, V3, P226, DOI 10.1016/S1367-5931(99)80036-2; HAMILTON JA, 1984, P NATL ACAD SCI-BIOL, V81, P3718, DOI 10.1073/pnas.81.12.3718; Hamilton JA, 2004, PROG LIPID RES, V43, P177, DOI 10.1016/j.plipres.2003.09.002; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Herold S, 2005, COMP BIOCHEM PHYS A, V142, P124, DOI 10.1016/j.cbpb.2005.06.009; Herold S, 2004, J AM CHEM SOC, V126, P6945, DOI 10.1021/ja0493300; Herold S, 2003, BIOCHEMISTRY-US, V42, P14036, DOI 10.1021/bi0350349; Herold S, 2003, CHEM RES TOXICOL, V16, P390, DOI 10.1021/tx025595l; Herold S, 2001, J AM CHEM SOC, V123, P4085, DOI 10.1021/ja010111d; Kamal JKA, 2002, J BIOL INORG CHEM, V7, P273, DOI 10.1007/s007750100294; Kharitonov VG, 1997, BIOCHEMISTRY-US, V36, P6814, DOI 10.1021/bi970201o; Kissner R, 2002, J AM CHEM SOC, V124, P234, DOI 10.1021/ja010497s; Komatsu T, 2005, J AM CHEM SOC, V127, P15933, DOI 10.1021/ja054819u; Komatsu T, 2004, J AM CHEM SOC, V126, P14304, DOI 10.1021/ja046022t; Komatsu T, 2000, BIOCONJUGATE CHEM, V11, P772, DOI 10.1021/bc000016e; Koppenol WH, 1996, METHOD ENZYMOL, V269, P296; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; Kragh-Hansen U, 2006, J MOL BIOL, V363, P702, DOI 10.1016/j.jmb.2006.08.056; Ma XL, 2000, J PHARMACOL EXP THER, V292, P912; MARTIN W, 1990, BIOPHARM DRUG DISPOS, V11, P265, DOI 10.1002/bdd.2510110311; Mattu M, 2001, J INORG BIOCHEM, V84, P293, DOI 10.1016/S0162-0134(01)00185-4; Miller YI, 1999, BBA-MOL BASIS DIS, V1454, P153, DOI 10.1016/S0925-4439(99)00027-7; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Monzani E, 2002, BIOPHYS J, V83, P2248, DOI 10.1016/S0006-3495(02)73985-4; Monzani E, 2001, BBA-PROTEIN STRUCT M, V1547, P302, DOI 10.1016/S0167-4838(01)00192-3; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Nicoletti FP, 2008, J AM CHEM SOC, V130, P11677, DOI 10.1021/ja800966t; Peters T., 1996, ALL ALBUMIN BIOCH GE; Petitpas I, 2003, P NATL ACAD SCI USA, V100, P6440, DOI 10.1073/pnas.1137188100; Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200; Pfeiffer S, 1997, J BIOL CHEM, V272, P3465, DOI 10.1074/jbc.272.6.3465; REGAZZI BM, 1986, INT J CLIN PHARM RES, V6, P469; Sakurai Y, 2004, PHARM RES-DORDR, V21, P285, DOI 10.1023/B:PHAM.0000016241.84630.06; Schulz R, 1997, AM J PHYSIOL-HEART C, V272, pH1212, DOI 10.1152/ajpheart.1997.272.3.H1212; Shimanovich R, 2001, ARCH BIOCHEM BIOPHYS, V387, P307, DOI 10.1006/abbi.2000.2247; Simard JR, 2006, J MOL BIOL, V361, P336, DOI 10.1016/j.jmb.2006.06.028; Simard JR, 2005, P NATL ACAD SCI USA, V102, P17958, DOI 10.1073/pnas.0506440102; SPECTOR AA, 1975, J LIPID RES, V16, P165; Squadrito GL, 2002, CHEM RES TOXICOL, V15, P885, DOI 10.1021/tx020004c; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Sulkowska A, 2004, BIOPOLYMERS, V74, P256, DOI 10.1002/bip.20031; Wardell M, 2002, BIOCHEM BIOPH RES CO, V291, P813, DOI 10.1006/bbrc.2002.6540; Yamasaki K, 1999, BBA-PROTEIN STRUCT M, V1432, P313, DOI 10.1016/S0167-4838(99)00098-9; Zunszain PA, 2008, J MOL BIOL, V381, P394, DOI 10.1016/j.jmb.2008.06.016; Zunszain Patricia A, 2003, BMC Struct Biol, V3, P6, DOI 10.1186/1472-6807-3-6	91	41	41	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31006	31017		10.1074/jbc.M109.010736	http://dx.doi.org/10.1074/jbc.M109.010736			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19734142	Green Published, hybrid			2022-12-25	WOS:000271378400030
J	Lian, N; Wang, WG; Li, LZ; Elefteriou, F; Yang, XL				Lian, Na; Wang, Weiguang; Li, Lingzhen; Elefteriou, Florent; Yang, Xiangli			Vimentin Inhibits ATF4-mediated Osteocalcin Transcription and Osteoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING VIMENTIN; INTERMEDIATE-FILAMENT; TRANSGENIC MICE; BONE-FORMATION; CELLS; EXPRESSION; PROTEINS; GENE; BINDING; ATF4	Activating transcription factor 4 (ATF4) is an osteoblast-enriched transcription factor that regulates osteocalcin transcription and osteoblast terminal differentiation. To identify functional partners of ATF4, we applied ROS17/2.8 osteoblast nuclear extracts and purified recombinant His-ATF4 onto a Ni+ affinity matrix chromatography column. Vimentin was identified by liquid chromatography-mass spectrometry. Coimmunoprecipitation and pulldown assays revealed that vimentin interacted with ATF4 with its first leucine zipper domain. DNA cotransfection and gel retardation demonstrated that vimentin inhibited the transactivation activity of ATF4 on osteocalcin by preventing it to bind OSE1, the ATF4 binding site on the osteocalcin promoter. Northern hybridization revealed that vimentin was expressed at a high level in immature osteoblasts and a low level in fully differentiated osteoblasts. Down-regulation of vimentin by small interfering RNA induced endogenous osteocalcin transcription in immature osteoblasts. Conversely, ectopic overexpression of vimentin in osteoblasts inhibited osteoblast differentiation as shown by lower alkaline phosphatase activity, delayed mineralization, and decreased expression of osteoblast marker genes such as bone sialoprotein and osteocalcin. Together, our data uncover a novel mechanism whereby a cytoskeletal protein, vimentin, acts as a break on differentiation in immature osteoblasts by interacting with ATF4.	[Li, Lingzhen; Elefteriou, Florent; Yang, Xiangli] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Lian, Na; Wang, Weiguang; Li, Lingzhen; Elefteriou, Florent; Yang, Xiangli] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Lian, Na; Wang, Weiguang; Li, Lingzhen; Elefteriou, Florent; Yang, Xiangli] Vanderbilt Univ, Med Ctr, Ctr Bone Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Yang, XL (corresponding author), 2215B Garland Ave,1225F MRB 4, Nashville, TN 37232 USA.	xiangli.yang@vanderbilt.edu	Elefteriou, Florent/P-2586-2017; Elefteriou, Florent/GMW-8429-2022	Elefteriou, Florent/0000-0002-2972-5633; Elefteriou, Florent/0000-0002-2972-5633; Elefteriou, Xiangli/0000-0002-2333-8747	Vanderbilt University career developmental; University of Texas Health Science Center at San Antonio; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE017111] Funding Source: NIH RePORTER	Vanderbilt University career developmental; University of Texas Health Science Center at San Antonio; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Vanderbilt University career developmental funds and new investigator award from University of Texas Health Science Center at San Antonio (to X.Y.).	Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064; AUBIN JE, 1995, BONE, V17, P77; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; CAPETANAKI Y, 1990, ONCOGENE, V5, P645; CAPETANAKI Y, 1989, J CELL BIOL, V109, P1653, DOI 10.1083/jcb.109.4.1653; CAPETANAKI YG, 1984, P NATL ACAD SCI-BIOL, V81, P6909, DOI 10.1073/pnas.81.22.6909; Colucci-Guyon E, 1999, GLIA, V25, P33, DOI 10.1002/(SICI)1098-1136(19990101)25:1<33::AID-GLIA4>3.0.CO;2-J; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eckes B, 2000, J CELL SCI, V113, P2455; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hartig R, 1998, J CELL SCI, V111, P3573; Henrion D, 1997, J CLIN INVEST, V100, P2909, DOI 10.1172/JCI119840; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; LOMRI A, 1990, BONE, V11, P445, DOI 10.1016/8756-3282(90)90141-K; LOMRI A, 1988, BIOCHIM BIOPHYS ACTA, V970, P333, DOI 10.1016/0167-4889(88)90133-4; MONTEIRO MJ, 1994, J CELL BIOL, V127, P1327, DOI 10.1083/jcb.127.5.1327; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; OLSON EN, 1989, ONCOGENE, V4, P907; ROGERS KR, 1995, EUR J CELL BIOL, V66, P136; Schinke T, 1999, NAT GENET, V21, P150, DOI 10.1038/5928; Schinke T, 1999, J BIOL CHEM, V274, P30182, DOI 10.1074/jbc.274.42.30182; SINGH B, 1989, VIROLOGY, V173, P144, DOI 10.1016/0042-6822(89)90230-4; STEINERT PM, 1990, CELL, V60, P521, DOI 10.1016/0092-8674(90)90651-T; TAPSCOTT SJ, 1981, DEV BIOL, V86, P40, DOI 10.1016/0012-1606(81)90313-4; Terzi F, 1997, J CLIN INVEST, V100, P1520, DOI 10.1172/JCI119675; VINSON CR, 1993, GENE DEV, V7, P1047, DOI 10.1101/gad.7.6.1047; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yang XL, 2000, J BIOL CHEM, V275, P1065, DOI 10.1074/jbc.275.2.1065; Yu VWC, 2009, GENE EXPR PATTERNS, V9, P335, DOI 10.1016/j.gep.2009.02.002; Yu VWC, 2005, J CELL BIOL, V169, P591, DOI 10.1083/jcb.200412139	37	48	49	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30518	30525		10.1074/jbc.M109.052373	http://dx.doi.org/10.1074/jbc.M109.052373			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726676	hybrid, Green Published			2022-12-25	WOS:000271090000054
J	Peck, GR; Chavez, JA; Roach, WG; Budnik, BA; Lane, WS; Karlsson, HKR; Zierath, JR; Lienhard, GE				Peck, Grantley R.; Chavez, Jose A.; Roach, William G.; Budnik, Bogdan A.; Lane, William S.; Karlsson, Hakan K. R.; Zierath, Juleen R.; Lienhard, Gustav E.			Insulin-stimulated Phosphorylation of the Rab GTPase-activating Protein TBC1D1 Regulates GLUT4 Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; GLUCOSE-TRANSPORT; 3T3-L1 ADIPOCYTES; KINASE; CONTRACTION; INHIBITION; OBESITY; AS160	Insulin stimulates the translocation of the glucose transporter GLUT4 from intracellular locations to the plasma membrane in adipose and muscle cells. Prior studies have shown that Akt phosphorylation of the Rab GTPase-activating protein, AS160 (160-kDa Akt substrate; also known as TBC1D4), triggers GLUT4 translocation, most likely by suppressing its Rab GTPase-activating protein activity. However, the regulation of a very similar protein, TBC1D1 (TBC domain family, member 1), which is mainly found in muscle, in insulin-stimulated GLUT4 translocation has been unclear. In the present study, we have identified likely Akt sites of insulin-stimulated phosphorylation of TBC1D1 in C2C12 myotubes. We show that a mutant of TBC1D1, in which several Akt sites have been converted to alanine, is considerably more inhibitory to insulin-stimulated GLUT4 translocation than wild-type TBC1D1. This result thus indicates that similar to AS160, Akt phosphorylation of TBC1D1 enables GLUT4 translocation. We also show that in addition to Akt activation, activation of the AMP-dependent protein kinase partially relieves the inhibition of GLUT4 translocation by TBC1D1. Finally, we show that the R125W variant of TBC1D1, which has been genetically associated with obesity, is equally inhibitory to insulin-stimulated GLUT4 translocation, as is wild-type TBC1D1, and that healthy and type 2 diabetic individuals express approximately the same level of TBC1D1 in biopsies of vastus lateralis muscle. In conclusion, phosphorylation of TBC1D1 is required for GLUT4 translocation. Thus, the regulation of TBC1D1 resembles that of its paralog, AS160.	[Peck, Grantley R.; Chavez, Jose A.; Roach, William G.; Lienhard, Gustav E.] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA; [Budnik, Bogdan A.; Lane, William S.] Harvard Univ, Ctr Syst Biol, Mass Spectrometry & Prote Resource Lab, Cambridge, MA 02318 USA; [Karlsson, Hakan K. R.; Zierath, Juleen R.] Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden	Dartmouth College; Harvard University; Karolinska Institutet	Lienhard, GE (corresponding author), Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA.	gustav.e.lienhard@dartmouth.edu	Budnik, Bogdan/AGG-8824-2022; Budnik, Bogdan/AAH-9987-2019; Peck, Grantley/H-2318-2013	Budnik, Bogdan/0000-0003-3622-2003; Zierath, Juleen/0000-0001-6891-7497; Karlsson, Hakan/0000-0003-0818-5460	National Institutes of Health [DK25336, DK42816]; European Research Council; Swedish Research Council; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK042816, R01DK042816, R56DK025336, R01DK025336, R55DK025336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK25336 and DK42816 (to G. E. L.). This work was also supported by grants from the European Research Council and the Swedish Research Council (to J. R. Z.).	Ariga M, 2008, J BIOL CHEM, V283, P10208, DOI 10.1074/jbc.M710604200; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Chavez JA, 2008, J BIOL CHEM, V283, P9187, DOI 10.1074/jbc.M708934200; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; FROST SC, 1985, J BIOL CHEM, V260, P2646; Fujii N, 2006, AM J PHYSIOL-ENDOC M, V291, pE867, DOI 10.1152/ajpendo.00207.2006; Funai K, 2009, DIABETES, V58, P1096, DOI 10.2337/db08-1477; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Karlsson HKR, 2009, DIABETES, V58, P847, DOI 10.2337/db08-1539; Lyons PD, 2009, BIOSCIENCE REP, V29, P229, DOI 10.1042/BSR20080162; Meyre D, 2008, HUM MOL GENET, V17, P1798, DOI 10.1093/hmg/ddn070; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Nickerson JG, 2007, APPL PHYSIOL NUTR ME, V32, P865, DOI 10.1139/H07-084; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Roach WG, 2007, BIOCHEM J, V403, P353, DOI 10.1042/BJ20061798; Ryder JW, 2000, DIABETES, V49, P647, DOI 10.2337/diabetes.49.4.647; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; TANNER LI, 1987, J BIOL CHEM, V262, P8975; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333	26	67	70	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30016	30023		10.1074/jbc.M109.035568	http://dx.doi.org/10.1074/jbc.M109.035568			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19740738	hybrid, Green Published			2022-12-25	WOS:000271090000003
J	Lin, DH; Yue, P; Pan, CY; Sun, P; Zhang, X; Han, ZG; Roos, M; Caplan, M; Giebisch, G; Wang, WH				Lin, Dao-Hong; Yue, Peng; Pan, Chu-Yang; Sun, Peng; Zhang, Xin; Han, Zeguang; Roos, Marcel; Caplan, Michael; Giebisch, Gerhard; Wang, Wen-Hui			POSH Stimulates the Ubiquitination and the Clathrin-independent Endocytosis of ROMK1 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICAL COLLECTING DUCT; PROTEIN-TYROSINE KINASE; EPITHELIAL NA+ CHANNEL; K+ CHANNEL; POTASSIUM CHANNEL; SODIUM-CHANNEL; SURFACE EXPRESSION; DISTAL NEPHRON; JNK ACTIVATION; LIGASE POSH	POSH (plenty of SH3) is a scaffold protein that has been shown to act as an E3 ubiquitin ligase. Here we report that POSH stimulates the ubiquitination of Kir1.1 (ROMK) and enhances the internalization of this potassium channel. Immunostaining reveals the expression of POSH in the renal cortical collecting duct. Immunoprecipitation of renal tissue lysate with ROMK antibody and glutathione S-transferase pulldown experiments demonstrated the association between ROMK and POSH. Moreover, immunoprecipitation of lysates of HEK293T cells transfected with ROMK1 or with constructs encoding the ROMK-N terminus or ROMK1-C-Terminus demonstrated that POSH binds to ROMK1 on its N terminus. To study the effect of POSH on ROMK1 channels, we measured potassium currents with electrophysiological methods in HEK293T cells and in oocytes transfected or injected with ROMK1 and POSH. POSH decreased potassium currents, and the inhibitory effect of POSH on ROMK channels was dose-dependent. Biotinylation assay further showed that POSH decreased surface expression of ROMK channels in HEK293T cells transfected with ROMK1 and POSH. The effect of POSH on ROMK1 channels was specific because POSH did not inhibit sodium current in oocytes injected with ENaC-alpha, beta, and gamma subunits. Moreover, POSH still decreased the potassium current in oocytes injected with a ROMK1 mutant (R1 Delta 373-378), in which a clathrin-dependent tyrosine-based internalization signal residing between amino acid residues 373 and 378 is deleted. However, the inhibitory effect of POSH on ROMK channels was absent in cells expressing with dominant negative dynamin and POSH Delta RING, in which the RING domain was deleted. Expression of POSH also increased the ubiquitination of ROMK1, whereas expression of POSH Delta RING diminished its ubiquitination in HEK293T cells. The notion that POSH may serve as an E3 ubiquitin ligase is also supported by in vitro ubiquitination assays in which adding POSH increased the ROMK ubiquitination. We conclude that POSH inhibits ROMK channels by enhancing dynamin-dependent and clathrin-independent endocytosis and by stimulating ubiquitination of ROMK channels.	[Wang, Wen-Hui] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA; [Roos, Marcel; Caplan, Michael; Giebisch, Gerhard] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Zhang, Xin; Han, Zeguang] Chinese Natl Human Genome Ctr, Shanghai Minist Key Lab Dis & Hlth Genom, Shanghai 210203, Peoples R China	New York Medical College; Yale University	Wang, WH (corresponding author), New York Med Coll, Dept Pharmacol, 15 Dana Rd, Valhalla, NY 10595 USA.	wenhui_wang@nymc.edu		Caplan, Michael/0000-0001-5768-4405; Han, Ze-Guang/0000-0002-1018-1752	National Institutes of Health [DK54983, DK17433, DK072614]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054983, P01DK017433, R01DK072614, R56DK072614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54983, DK17433, and DK072614.	Alroy I, 2005, P NATL ACAD SCI USA, V102, P1478, DOI 10.1073/pnas.0408717102; Babilonia E, 2005, J BIOL CHEM, V280, P10790, DOI 10.1074/jbc.M414610200; BOIM MA, 1995, AM J PHYSIOL-RENAL, V268, pF1132, DOI 10.1152/ajprenal.1995.268.6.F1132; Chu PY, 2003, AM J PHYSIOL-RENAL, V285, pF1179, DOI 10.1152/ajprenal.00150.2003; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; He GC, 2007, J CLIN INVEST, V117, P1078, DOI 10.1172/JCI30087; Hebert SC, 2005, PHYSIOL REV, V85, P319, DOI 10.1152/physrev.00051.2003; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; Hryciw DH, 2004, J BIOL CHEM, V279, P54996, DOI 10.1074/jbc.M411491200; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Kim GH, 2006, CELL SIGNAL, V18, P553, DOI 10.1016/j.cellsig.2005.05.026; Kohda Y, 1998, KIDNEY INT, V54, P1214, DOI 10.1046/j.1523-1755.1998.00120.x; Konstas AA, 2002, J BIOL CHEM, V277, P29406, DOI 10.1074/jbc.M203018200; Lazrak A, 2006, P NATL ACAD SCI USA, V103, P1615, DOI 10.1073/pnas.0510609103; Lin DH, 2008, J BIOL CHEM, V283, P7674, DOI 10.1074/jbc.M705574200; Lin DH, 2004, AM J PHYSIOL-RENAL, V286, pF881, DOI 10.1152/ajprenal.00301.2003; Lin DH, 2005, P NATL ACAD SCI USA, V102, P4306, DOI 10.1073/pnas.0409767102; Lin DH, 2002, J BIOL CHEM, V277, P44278, DOI 10.1074/jbc.M203702200; Lu M, 2002, J BIOL CHEM, V277, P37881, DOI 10.1074/jbc.M206644200; Macica CM, 1996, AM J PHYSIOL-RENAL, V271, pF588, DOI 10.1152/ajprenal.1996.271.3.F588; Mennitt PA, 1997, J AM SOC NEPHROL, V8, P1823; Moral Z, 2001, J BIOL CHEM, V276, P7156, DOI 10.1074/jbc.M008671200; O'Connell AD, 2005, P NATL ACAD SCI USA, V102, P9954, DOI 10.1073/pnas.0504332102; PALMER LG, 1994, J GEN PHYSIOL, V104, P693, DOI 10.1085/jgp.104.4.693; Palmer LG, 1999, AM J PHYSIOL-RENAL, V277, pF821, DOI 10.1152/ajprenal.1999.277.6.F821; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Ring AM, 2007, P NATL ACAD SCI USA, V104, P4025, DOI 10.1073/pnas.0611728104; Rougier JS, 2005, AM J PHYSIOL-CELL PH, V288, pC692, DOI 10.1152/ajpcell.00460.2004; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; Staub O, 1997, AM J PHYSIOL-CELL PH, V272, pC1871, DOI 10.1152/ajpcell.1997.272.6.C1871; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Sterling H, 2002, J BIOL CHEM, V277, P4317, DOI 10.1074/jbc.M109739200; Tuvia S, 2007, J CELL BIOL, V177, P51, DOI 10.1083/jcb.200611036; Wang WH, 1997, ANNU REV PHYSIOL, V59, P413, DOI 10.1146/annurev.physiol.59.1.413; Wei Y, 2001, AM J PHYSIOL-RENAL, V281, pF206, DOI 10.1152/ajprenal.2001.281.2.F206; Xu ZH, 2006, J BIOL CHEM, V281, P303, DOI 10.1074/jbc.M509060200; Xu ZH, 2003, EMBO J, V22, P252, DOI 10.1093/emboj/cdg021; Yoo D, 2003, J BIOL CHEM, V278, P23066, DOI 10.1074/jbc.M212301200; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V283, pF630, DOI 10.1152/ajprenal.00378.2001	45	19	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29614	29624		10.1074/jbc.M109.041582	http://dx.doi.org/10.1074/jbc.M109.041582			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19710010	Green Published, hybrid			2022-12-25	WOS:000270896800043
J	Shu, RZ; Zhang, F; Liu, XS; Li, CL; Wang, L; Tai, YL; Wu, XL; Yang, X; Liao, XD; Jin, Y; Gu, MM; Huang, L; Pang, XF; Wang, ZG				Shu, Run-Zhe; Zhang, Feng; Liu, Xue-Song; Li, Chun-Liang; Wang, Long; Tai, Yi-Lin; Wu, Xiao-Lin; Yang, Xue; Liao, Xiao-Dong; Jin, Ying; Gu, Ming-Min; Huang, Lei; Pang, Xiao-Fen; Wang, Zhu-Gang			Target Deletion of the Cytoskeleton-Associated Protein Palladin Does Not Impair Neurite Outgrowth in Mice	PLOS ONE			English	Article								Palladin is an actin cytoskeleton-associated protein which is crucial for cell morphogenesis and motility. Previous studies have shown that palladin is localized to the axonal growth cone in neurons and may play an important role in axonal extension. Previously, we have generated palladin knockout mice which display cranial neural tube closure defect and embryonic lethality before embryonic day 15.5 (E15.5). To further study the role of palladin in the developing nervous system, we examined the innervation of palladin-deficient mouse embryos since the 200 kd, 140 kd, 90-92 kd and 50 kd palladin isoforms were undetectable in the mutant mouse embryo brain. Contrary to the results of previous studies, we found no inhibition of the axonal extension in palladin-deficient mouse embryos. The cortical neurons derived from palladin-deficient mice also showed no significant difference in neurite outgrowth as compared with those from wild-type mice. Moreover, no difference was found in neurite outgrowth of neural stem cell derived-neurons between palladin-deficient mice and wild-type mice. In conclusion, these results suggest that palladin is dispensable for normal neurite outgrowth in mice.			Shu, RZ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China.	xiaofenpang@126.com; zhugangw@shsmu.edu.cn	Yang, xue/G-3626-2016; Liu, Xue-Song/ADF-2183-2022; Li, Chunliang/P-4373-2018	Liu, Xue-Song/0000-0002-7736-0077; Huang, Lei/0000-0002-4851-4807; Li, Chunliang/0000-0002-5938-5510				Bentley CA, 2000, J NEUROSCI, V20, P7706; Boukhelifa M, 2006, FEBS J, V273, P26, DOI 10.1111/j.1742-4658.2005.05036.x; Boukhelifa M, 2004, CELL MOTIL CYTOSKEL, V58, P17, DOI 10.1002/cm.10173; Boukhelifa M, 2001, MOL BIOL CELL, V12, P2721, DOI 10.1091/mbc.12.9.2721; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dixon RDS, 2008, J BIOL CHEM, V283, P6222, DOI 10.1074/jbc.M707694200; Goicoechea SM, 2008, EUR J CELL BIOL, V87, P517, DOI 10.1016/j.ejcb.2008.01.010; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HOGAN B, 1994, MANIPULATING MOUSE E, P340; Liu XS, 2007, BLOOD, V110, P870, DOI 10.1182/blood-2007-01-068528; Liu XS, 2007, J CELL BIOCHEM, V100, P1288, DOI 10.1002/jcb.21126; Luo HJ, 2005, MOL CELL NEUROSCI, V29, P507, DOI 10.1016/j.mcn.2004.12.002; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; Mykkanen OM, 2001, MOL BIOL CELL, V12, P3060, DOI 10.1091/mbc.12.10.3060; Otey CA, 2005, INT REV CYTOL, V246, P31, DOI 10.1016/S0074-7696(05)46002-7; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Wang HV, 2008, DEV DYNAM, V237, P3342, DOI 10.1002/dvdy.21755; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9	20	5	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2009	4	9							e6916	10.1371/journal.pone.0006916	http://dx.doi.org/10.1371/journal.pone.0006916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZF	19730728	Green Published, gold, Green Submitted			2022-12-25	WOS:000269622100016
J	Chauhan, SC; Madhubala, R				Chauhan, Swati C.; Madhubala, Rentala			Glyoxalase I Gene Deletion Mutants of Leishmania donovani Exhibit Reduced Methylglyoxal Detoxification	PLOS ONE			English	Article								Background: Glyoxalase I is a metalloenzyme of the glyoxalase pathway that plays a central role in eliminating the toxic metabolite methyglyoxal. The protozoan parasite Leishmania donovani possesses a unique trypanothione dependent glyoxalase system. Principal Findings: Analysis of the L. donovani GLOI sequence predicted a mitochondrial targeting sequence, suggesting that the enzyme is likely to be targeted to the mitochondria. In order to determine definitively the intracellular localization of GLOI in L. donovani, a full-length GLOI gene was fused to green fluorescent protein (GFP) gene to generate a chimeric construct. Confocal microscopy of L. donovani promastigotes carrying this chimeric construct and immunofluorescence microscopy using anti-GLOI antibodies demonstrated that GLOI is localized in the kinetoplast of the parasite apart from the cytosol. To study the physiological role of GLOI in Leishmania, we first created promastigote mutants heterozygous for GLOI by targeted gene replacement using either hygromycin or neomycin phosphotransferases as selectable markers. Heterozygous mutants of L. donovani display a slower growth rate, have lower glyoxalase I activity and have reduced ability to detoxify methylglyoxal in comparison to the wild-type parasites. Complementation of the heterozygous mutant with an episomal GLOI construct showed the restoration of heterozygous mutant phenotype nearly fully to that of the wild-type. Null mutants were obtained only after GLOI was expressed from an episome in heterozygous mutants. Conclusions: We for the first time report localization of GLOI in L. donovani in the kinetoplast. To study the physiological role of GLOI in Leishmania, we have generated GLOI attenuated strains by targeted gene replacement and report that GLOI is likely to be an important gene since GLOI mutants in L. donovani showed altered phenotype. The present data supports that the GLOI plays an essential role in the survival of this pathogenic organism and that inhibition of the enzyme potentiates the toxicity of methylglyoxal.			Chauhan, SC (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	madhubala@mail.jnu.ac.in	madhubala, Rentala/C-3445-2015	madhubala, rentala/0000-0002-0034-399X				ALEXANDER NM, 1971, CANCER RES, V31, P1875; Amicarelli F, 2003, FREE RADICAL BIO MED, V35, P856, DOI 10.1016/S0891-5849(03)00438-6; ARONSSON AC, 1978, BIOCHEM BIOPH RES CO, V81, P1235, DOI 10.1016/0006-291X(78)91268-8; AYOUB FM, 1993, LEUKEMIA RES, V17, P397, DOI 10.1016/0145-2126(93)90094-2; BELLO AR, 1994, P NATL ACAD SCI USA, V91, P11442, DOI 10.1073/pnas.91.24.11442; BRANDAU S, 1995, BIOCHEM J, V310, P225, DOI 10.1042/bj3100225; Cameron AD, 1999, BIOCHEMISTRY-US, V38, P13480, DOI 10.1021/bi990696c; CARRINGTON SJ, 1986, IRCS MED SCI-BIOCHEM, V14, P763; Chen M, 2001, ANTIMICROB AGENTS CH, V45, P2023, DOI 10.1128/AAC.45.7.2023-2029.2001; CLAPPER ML, 1991, BIOCHIM BIOPHYS ACTA, V1096, P209, DOI 10.1016/0925-4439(91)90007-V; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Clugston SL, 1998, BIOCHEMISTRY-US, V37, P8754, DOI 10.1021/bi972791w; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; D'Silva C, 2000, J MED CHEM, V43, P2072, DOI 10.1021/jm990259w; Dakin HD, 1913, J BIOL CHEM, V14, P155; DUDANI AK, 1984, BIOCHEM BIOPH RES CO, V119, P962, DOI 10.1016/0006-291X(84)90867-2; Dumas C, 1997, EMBO J, V16, P2590, DOI 10.1093/emboj/16.10.2590; EGYUD LG, 1968, SCIENCE, V160, P1140, DOI 10.1126/science.160.3832.1140; EGYUD LG, 1966, P NATL ACAD SCI USA, V56, P203, DOI 10.1073/pnas.56.1.203; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; GILLESPIE E, 1981, BIOCHEM BIOPH RES CO, V98, P463, DOI 10.1016/0006-291X(81)90862-7; Goswami S, 2006, J BIOL CHEM, V281, P18914, DOI 10.1074/jbc.C600089200; Greig N, 2006, BIOCHEM J, V400, P217, DOI 10.1042/BJ20060882; He MM, 2000, BIOCHEMISTRY-US, V39, P8719, DOI 10.1021/bi000856g; Irsch T, 2004, J BIOL CHEM, V279, P22209, DOI 10.1074/jbc.M401240200; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; MacLean MJ, 1998, MOL MICROBIOL, V27, P563, DOI 10.1046/j.1365-2958.1998.00701.x; MARINARI UM, 1984, CELL BIOCHEM FUNCT, V2, P243, DOI 10.1002/cbf.290020411; Mottram JC, 1996, P NATL ACAD SCI USA, V93, P6008, DOI 10.1073/pnas.93.12.6008; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neuberg C, 1913, BIOCHEM Z, V49, P502; NYANDIEKA HS, 1978, CLIN BIOCHEM, V11, P150, DOI 10.1016/S0009-9120(78)90349-1; Padmanabhan PK, 2006, BIOCHEM J, V393, P227, DOI 10.1042/BJ20050948; Padmanabhan PK, 2005, BIOCHEM BIOPH RES CO, V337, P1237, DOI 10.1016/j.bbrc.2005.09.179; Papadopoulou B, 1996, BIOCHEM BIOPH RES CO, V224, P772, DOI 10.1006/bbrc.1996.1098; PAPADOPOULOU B, 1994, J BIOL CHEM, V269, P7310; RACKER E, 1951, J BIOL CHEM, V190, P685; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3; THORNALLEY PJ, 1994, BIOCHEM PHARMACOL, V47, P418, DOI 10.1016/0006-2952(94)90035-3; VANDERJAGT DL, 1972, BIOCHEMISTRY-US, V11, P3735, DOI 10.1021/bi00770a011; VANDERJAGT DL, 1975, BIOCHEMISTRY-US, V14, P3669, DOI 10.1021/bi00687a024; Verma NK, 2004, ANTIMICROB AGENTS CH, V48, P3010, DOI 10.1128/AAC.48.8.3010-3015.2004; Vickers TJ, 2004, P NATL ACAD SCI USA, V101, P13186, DOI 10.1073/pnas.0402918101	43	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2009	4	8							e6805	10.1371/journal.pone.0006805	http://dx.doi.org/10.1371/journal.pone.0006805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JE	19710909	gold, Green Published, Green Submitted			2022-12-25	WOS:000269415600017
J	Destoumieux-Garzon, D; Brehelin, M; Bulet, P; Boublik, Y; Girard, PA; Baghdiguian, S; Zumbihl, R; Escoubas, JM				Destoumieux-Garzon, Delphine; Brehelin, Michel; Bulet, Philippe; Boublik, Yvan; Girard, Pierre-Alain; Baghdiguian, Stephen; Zumbihl, Robert; Escoubas, Jean-Michel			Spodoptera frugiperda X-Tox Protein, an Immune Related Defensin Rosary, Has Lost the Function Ancestral Defensins	PLOS ONE			English	Article								Background: X-tox proteins are a family of immune-related proteins only found in Lepidoptera and characterized by imperfectly conserved tandem repeats of several defensin-like motifs. Previous phylogenetic analysis of X-tox genes supported the hypothesis that X-tox have evolved from defensins in a lineage-specific gene evolution restricted to Lepidoptera. In this paper, we performed a protein study in which we asked whether X-tox proteins have conserved the antimicrobial functions of their ancestral defensins and have evolved as defensin reservoirs. Methodology/Principal Findings: We followed the outcome of Spod-11-tox, an X-tox protein characterized in Spodoptera frugiperda, in bacteria-challenged larvae using both immunochemistry and antimicrobial assays. Three hours post infection, the Spod-11-tox protein was expressed in 80% of the two main classes of circulating hemocytes (granulocytes and plasmatocytes). Located in secretory granules of hemocytes, Spod-11-tox was never observed in contact with microorganisms entrapped within phagolyzosomes showing that Spod-11-tox is not involved in intracellular pathogen killing. In fact, the Spod-11-tox protein was found to be secreted into the hemolymph of experimentally challenged larvae. In order to determine antimicrobial properties of the Spod-11-tox protein, it was consequently fractionated according to a protocol frequently used for antimicrobial peptide purification. Over the course of purification, the anti-Spod-11-tox immunoreactivity was found to be dissociated from the antimicrobial activity. This indicates that Spod-11-tox is not processed into bioactive defensins in response to a microbial challenge. Conclusions/Significance: Altogether, our results show that X-tox proteins have not evolved as defensin reservoirs and have lost the antimicrobial properties of the ancestral insect defensins. The lepidopteran X-tox protein family will provide a valuable and tractable model to improve our knowledge on the molecular evolution of defensins, a class of innate immune effectors largely distributed over the three eukaryotic kingdoms.	[Destoumieux-Garzon, Delphine] CNRS, UMR5119, Lab Ecosyst Lagunaires, CC80, Montpellier, France; [Destoumieux-Garzon, Delphine] IFREMER, UMR 5119, Lab Ecosyst Lagunaires, CC80, Montpellier, France; [Destoumieux-Garzon, Delphine] Univ Montpellier 2, UMR5119, Lab Ecosyst Lagunaires, CC80, Montpellier, France; [Brehelin, Michel; Girard, Pierre-Alain; Zumbihl, Robert; Escoubas, Jean-Michel] INRA, UMR 1133, Lab Ecol Microbienne Insect & Interact Hote Pathog, CC54, Montpellier, France; [Brehelin, Michel; Girard, Pierre-Alain; Zumbihl, Robert; Escoubas, Jean-Michel] Univ Montpellier 2, UMR1133, Lab EMIP, CC54, Montpellier, France; [Bulet, Philippe] Univ Grenoble 1, CNRS, UMR5525, TIMC IMAG, Archamps, France; [Boublik, Yvan] CNRS, Plateforme Prot Recombinantes UMR5237, Montpellier, France; [Baghdiguian, Stephen] Univ Montpellier 2, CNRS, Inst Sci Evolut, UMR5554,CC63, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Ifremer; Universite de Montpellier; Universite de Montpellier; INRAE; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Escoubas, JM (corresponding author), INRA, UMR 1133, Lab Ecol Microbienne Insect & Interact Hote Pathog, CC54, Montpellier, France.	Jean-Michel.Escoubas@univ-montp2.fr	BUELT, PHILIPPE/C-8451-2014; Destoumieux-Garzón, Delphine/O-3328-2014; BULET, Philippe/C-8557-2014; ESCOUBAS, Jean-Michel/G-4027-2010	Destoumieux-Garzón, Delphine/0000-0002-8793-9138; BULET, Philippe/0000-0001-9016-265X; ESCOUBAS, Jean-Michel/0000-0002-6138-1148; Baghdiguian, Stephen/0000-0002-2992-9708				BEVINS CL, 1990, ANNU REV BIOCHEM, V59, P395, DOI 10.1146/annurev.bi.59.070190.002143; Brehelin M., 1986, P36; CASTEELSJOSSON K, 1993, EMBO J, V12, P1569, DOI 10.1002/j.1460-2075.1993.tb05801.x; CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0; Cytrynska M, 2007, PEPTIDES, V28, P533, DOI 10.1016/j.peptides.2006.11.010; Destoumieux D, 2000, J CELL SCI, V113, P461; Eleftherianos I, 2007, CELL MICROBIOL, V9, P1137, DOI 10.1111/j.1462-5822.2006.00855.x; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Girard PA, 2008, DEV COMP IMMUNOL, V32, P575, DOI 10.1016/j.dci.2007.09.004; Hetru C, 1997, Methods Mol Biol, V78, P35; Hoffmann J., 2007, ANN REV IMMUNOL; Lamberty M, 1999, J BIOL CHEM, V274, P9320, DOI 10.1074/jbc.274.14.9320; Lamberty M, 2001, J BIOL CHEM, V276, P4085, DOI 10.1074/jbc.M002998200; Lee YS, 2004, INSECT MOL BIOL, V13, P65, DOI 10.1111/j.1365-2583.2004.00462.x; Mitta G, 1999, J CELL SCI, V112, P4233; Nardi JB, 2003, DEV GENES EVOL, V213, P477, DOI 10.1007/s00427-003-0352-6; Ribeiro C, 2003, J BIOL CHEM, V278, P3030, DOI 10.1074/jbc.M210353200; Ribeiro C, 2006, J INSECT PHYSIOL, V52, P417, DOI 10.1016/j.jinsphys.2006.01.005; Seitz V, 2003, DEV COMP IMMUNOL, V27, P207, DOI 10.1016/S0145-305X(02)00097-6; Shelby KS, 2009, J INVERTEBR PATHOL, V101, P86, DOI 10.1016/j.jip.2009.05.002; SHIGENAGA T, 1990, J BIOL CHEM, V265, P21350; Sicard M, 2004, APPL ENVIRON MICROB, V70, P6473, DOI 10.1128/AEM.70.11.6473-6480.2004; SUN SC, 1990, SCIENCE, V250, P1729, DOI 10.1126/science.2270488; TANAKA H, 2008, INSECT BIOCH MOL BIO; Taniai K, 2006, INSECT MOL BIOL, V15, P269, DOI 10.1111/j.1365-2583.2006.00639.x; Volkoff AN, 2003, GENE, V319, P43, DOI 10.1016/S0378-1119(03)00789-3; Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862; Yu XQ, 2002, EUR J BIOCHEM, V269, P1827, DOI 10.1046/j.1432-1033.2002.02830.x; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	31	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2009	4	8							e6795	10.1371/journal.pone.0006795	http://dx.doi.org/10.1371/journal.pone.0006795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JE	19710910	Green Published, Green Submitted, gold			2022-12-25	WOS:000269415600009
J	Dominguez, JF; Guo, LX; Molnar, MAC; Escobedo, AB; Dunphy, T; Lund, TD; Turman, JE				Dominguez, Jesus F.; Guo, Lixin; Carrasco Molnar, Marco A.; Ballester Escobedo, Antonio; Dunphy, Taylor; Lund, Trent D.; Turman, Jack E., Jr.			Novel Indirect Calorimetry Technology to Analyze Metabolism in Individual Neonatal Rodent Pups	PLOS ONE			English	Article								Background: The ability to characterize the development of metabolic function in neonatal rodents has been limited due to technological constraints. Low respiratory volumes and flows at rest pose unique problems, making it difficult to reliably measure O-2 consumption, CO2 production, respiratory quotient (RQ), and energy expenditure (EE). Our aim was to develop and validate a commercial-grade indirect calorimetry system capable of characterizing the metabolic phenotype of individual neonatal rodents. Methodology/Principal Findings: To address this research need, we developed a novel, highly sensitive open-circuit indirect calorimetry system capable of analyzing respiratory gas exchange in a single neonatal rodent pup. Additionally, we derived an equation from known metabolic relationships to estimate inlet flow rates, improving the efficiency of data collection. To validate the neonatal rodent indirect calorimetry system and evaluate the applicability of the derived equation for predicting appropriate flow rates, we conducted a series of experiments evaluating the impact of sex, litter size, time of day (during the light phase), and ambient temperature on neonatal rat metabolic parameters. Data revealed that the only metabolic parameter influenced by litter size is a neonatal rat's RQ, with rat pups reared in a small litter (5 pups) having lower RQ's than rat pups reared in either medium (8 pups) or large (11 pups) litters. Furthermore, data showed that ambient temperature affected all metabolic parameters measured, with colder temperatures being associated with higher CO2 production, higher O-2 consumption, and higher energy expenditure. Conclusion/Significance: The results of this study demonstrate that the modified Panlab Oxylet system reliably assesses early postnatal metabolism in individual neonatal rodents. This system will be of paramount importance to further our understanding of processes associated with the developmental origins of adult metabolic disease.			Dominguez, JF (corresponding author), Univ So Calif, Keck Sch Med, Ctr Premature Infant Hlth & Dev, Los Angeles, CA 90033 USA.	jdomingu@usc.edu	Linong, Ji/AAB-6543-2020					ALBERTS JR, 1978, J COMP PHYSIOL PSYCH, V92, P231, DOI 10.1037/h0077459; De Boo HA, 2006, AUST NZ J OBSTET GYN, V46, P4, DOI 10.1111/j.1479-828X.2006.00506.x; EVEN PC, 1994, NEUROSCI BIOBEHAV R, V18, P435, DOI 10.1016/0149-7634(94)90056-6; FIOROTTO ML, 1991, AM J PHYSIOL, V260, pR1104, DOI 10.1152/ajpregu.1991.260.6.R1104; Garrett-Cox RG, 2003, J PEDIATR SURG, V38, P37, DOI 10.1053/jpsu.2003.50006; KEEN CL, 1981, J NUTR, V111, P226, DOI 10.1093/jn/111.2.226; Kuhn CM, 1998, INT J DEV NEUROSCI, V16, P261, DOI 10.1016/S0736-5748(98)00034-3; Luketich JD, 1998, NUTRITION, V14, P672, DOI 10.1016/S0899-9007(98)00066-5; Lusk G, 1924, J BIOL CHEM, V59, P41; Plagemann A, 2006, HORM RES, V65, P83, DOI 10.1159/000091511; PLANCHE E, 1983, AM J PHYSIOL, V245, pE107, DOI 10.1152/ajpendo.1983.245.2.E107; Saiki C, 1996, J PHYSIOL-LONDON, V491, P261, DOI 10.1113/jphysiol.1996.sp021213; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363	13	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2009	4	8							e6790	10.1371/journal.pone.0006790	http://dx.doi.org/10.1371/journal.pone.0006790			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JE	19710924	Green Submitted, Green Published, gold			2022-12-25	WOS:000269415600005
J	Menteyne, A; Levavasseur, F; Audinat, E; Avignone, E				Menteyne, Alexis; Levavasseur, Francoise; Audinat, Etienne; Avignone, Elena			Predominant Functional Expression of Kv1.3 by Activated Microglia of the Hippocampus after Status epilepticus	PLOS ONE			English	Article								Background: Growing evidence indicates that the functional state of microglial cells differs according to the pathological conditions that trigger their activation. In particular, activated microglial cells can express sets of Kv subunits which sustain delayed rectifying potassium currents (Kdr) and modulate differently microglia proliferation and ability to release mediators. We recently reported that hippocampal microglia is in a particular activation state after a status epilepticus (SE) and the present study aimed at identifying which of the Kv channels are functionally expressed by microglia in this model. Methodology/Principal Findings: SE was induced by systemic injection of kainate in CX3CR1(eGFP/+) mice and whole cell recordings of fluorescent microglia were performed in acute hippocampal slices prepared 48 h after SE. Microglia expressed Kdr currents which were characterized by a potential of half-maximal activation near 225 mV, prominent steady-state and cumulative inactivations. Kdr currents were almost abolished by the broad spectrum antagonist 4-Aminopyridine (1 mM). In contrast, tetraethylammonium (TEA) at a concentration of 1 mM, known to block Kv3.1, Kv1.1 and 1.2 subunits, only weakly reduced Kdr currents. However, at a concentration of 5 mM which should also affect Kv1.3 and 1.6, TEA inhibited about 30% of the Kdr conductance. Alpha-dendrotoxin, which selectively inhibits Kv1.1, 1.2 and 1.6, reduced only weakly Kdr currents, indicating that channels formed by homomeric assemblies of these subunits are not important contributors of Kdr currents. Finally, agitoxin-2 and margatoxin strongly inhibited the current. Conclusions/Significance: These results indicate that Kv1.3 containing channels predominantly determined Kdr currents in activated microglia after SE.			Menteyne, A (corresponding author), INSERM, Unite 603, Paris, France.	etienne.audinat@parisdescartes.fr	Audinat, Etienne/F-4789-2019	Audinat, Etienne/0000-0002-6389-422X				Ahn HS, 2005, NEUROSCIENCE, V133, P1007, DOI 10.1016/j.neuroscience.2005.03.041; Avignone E, 2008, J NEUROSCI, V28, P9133, DOI 10.1523/JNEUROSCI.1820-08.2008; Benkovic SA, 2004, BRAIN RES, V1024, P59, DOI 10.1016/j.brainres.2004.07.021; BERTOLI A, 1994, EUR BIOPHYS J, V23, P379; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Bordey A, 2003, EUR J NEUROSCI, V18, P2893, DOI 10.1111/j.1460-9568.2003.03021.x; Boucsein C, 2000, EUR J NEUROSCI, V12, P2049, DOI 10.1046/j.1460-9568.2000.00100.x; CHANDY KG, 1993, TRENDS PHARMACOL SCI, V14, P434, DOI 10.1016/0165-6147(93)90181-I; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Draheim HJ, 1999, NEUROSCIENCE, V89, P1379, DOI 10.1016/S0306-4522(98)00407-2; Farber K, 2005, BRAIN RES REV, V48, P133, DOI 10.1016/j.brainresrev.2004.12.003; FERRONI S, 1992, EUR BIOPHYS J BIOPHY, V21, P185; Fordyce CB, 2005, J NEUROSCI, V25, P7139, DOI 10.1523/JNEUROSCI.1251-05.2005; Franciosi S, 2006, J NEUROSCI, V26, P11652, DOI 10.1523/JNEUROSCI.2490-06.2006; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; GARCIACALVO M, 1993, J BIOL CHEM, V268, P18866; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; GRUPE A, 1990, EMBO J, V9, P1749, DOI 10.1002/j.1460-2075.1990.tb08299.x; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kaushal V, 2007, J NEUROSCI, V27, P234, DOI 10.1523/JNEUROSCI.3593-06.2007; KETTENMANN H, 1990, J NEUROSCI RES, V26, P278, DOI 10.1002/jnr.490260303; KIRSCH GE, 1991, FEBS LETT, V278, P55, DOI 10.1016/0014-5793(91)80082-E; Kotecha SA, 1999, J NEUROSCI, V19, P10680, DOI 10.1523/JNEUROSCI.19-24-10680.1999; Lagrutta A, 2006, J PHARMACOL EXP THER, V317, P1054, DOI 10.1124/jpet.106.101162; Li F, 2008, J NEUROCHEM, V106, P2093, DOI 10.1111/j.1471-4159.2008.05559.x; Macica CM, 2001, J NEUROSCI, V21, P1160; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Mathie A, 1998, GEN PHARMACOL-VASC S, V30, P13, DOI 10.1016/S0306-3623(97)00034-7; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; NORENBERG W, 1992, NEUROSCI LETT, V147, P171, DOI 10.1016/0304-3940(92)90587-W; Pannasch U, 2006, MOL CELL NEUROSCI, V33, P401, DOI 10.1016/j.mcn.2006.08.009; PHILIPSON LH, 1993, BIOCHIM BIOPHYS ACTA, V1153, P111, DOI 10.1016/0005-2736(93)90282-5; Schilling T, 2007, BRAIN RES, V1186, P21, DOI 10.1016/j.brainres.2007.10.027; Spencer RH, 1997, J BIOL CHEM, V272, P2389; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; Uebele VN, 1998, AM J PHYSIOL-CELL PH, V274, pC1485, DOI 10.1152/ajpcell.1998.274.6.C1485; Vicente R, 2006, J BIOL CHEM, V281, P37675, DOI 10.1074/jbc.M605617200; Villalonga N, 2007, BIOCHEM BIOPH RES CO, V352, P913, DOI 10.1016/j.bbrc.2006.11.120; VISENTIN S, 1995, J NEUROSCI RES, V42, P439, DOI 10.1002/jnr.490420402; WU CY, 2008, NEUROSCIENCE	41	40	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6770	10.1371/journal.pone.0006770	http://dx.doi.org/10.1371/journal.pone.0006770			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707551	Green Published, gold, Green Submitted			2022-12-25	WOS:000269335000016
J	van Zijl, F; Mair, M; Csiszar, A; Schneller, D; Zulehner, G; Huber, H; Eferl, R; Beug, H; Dolznig, H; Mikulits, W				van Zijl, F.; Mair, M.; Csiszar, A.; Schneller, D.; Zulehner, G.; Huber, H.; Eferl, R.; Beug, H.; Dolznig, H.; Mikulits, W.			Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge	ONCOGENE			English	Article						TGF-beta; PDGF; tumor-stroma interaction; epithelial to mesenchymal transition; spheroid	GROWTH-FACTOR; TGF-BETA; STELLATE CELLS; LIVER FIBROSIS; HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL EXPRESSION; RAT-LIVER; PROGRESSION; HEPATOCYTES; MYOFIBROBLASTS	The tumor-stroma crosstalk is a dynamic process fundamental in tumor development. In hepatocellular carcinoma (HCC), the progression of malignant hepatocytes frequently depends on transforming growth factor (TGF)-beta provided by stromal cells. TGF-beta induces an epithelial to mesenchymal transition (EMT) of oncogenic Ras-transformed hepatocytes and an upregulation of platelet-derived growth factor (PDGF) signaling. To analyse the influence of the hepatic tumor-stroma crosstalk onto tumor growth and progression, we co-injected malignant hepatocytes and myofibroblasts (MFBs). For this, we either used in vitro-activated p19(ARF) MFBs or in vivo-activated MFBs derived from physiologically inflamed livers of Mdr2/p19(ARF) double-null mice. We show that co-transplantation of MFBs with Ras-transformed hepatocytes strongly enhances tumor growth. Genetic interference with the PDGF signaling decreases tumor cell growth and maintains plasma membrane-located E-cadherin and beta-catenin at the tumor-host border, indicating a blockade of hepatocellular EMT. We further generated a collagen gel-based three dimensional HCC model in vitro to monitor the MFB-induced invasion of micro-organoid HCC spheroids. This invasion was diminished after inhibition of TGF-beta or PDGF signaling. These data suggest that the TGF-beta/PDGF axis is crucial during hepatic tumor-stroma crosstalk, regulating both tumor growth and cancer progression. Oncogene (2009) 28, 4022-4033; doi:10.1038/onc.2009.253; published online 31 August 2009	[van Zijl, F.; Schneller, D.; Zulehner, G.; Huber, H.; Mikulits, W.] Med Univ Vienna, Div Inst Canc Res, Dept Med 1, A-1090 Vienna, Austria; [Mair, M.; Eferl, R.] Ludwig Boltzmann Inst Canc Res, Vienna, Austria; [Csiszar, A.; Beug, H.] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Dolznig, H.] Med Univ Vienna, Inst Clin Pathol, A-1090 Vienna, Austria	Medical University of Vienna; Ludwig Boltzmann Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Medical University of Vienna	Mikulits, W (corresponding author), Med Univ Vienna, Div Inst Canc Res, Dept Med 1, Borschke Gasse 8A, A-1090 Vienna, Austria.	wolfgang.mikulits@meduniwien.ac.at	Mikulits, Wolfgang/AAH-4043-2021; Dolznig, Helmut/L-7005-2015; Csiszar, Agnes/I-2747-2019	Dolznig, Helmut/0000-0002-6063-3585; Csiszar, Agnes/0000-0001-7911-3427; Eferl, Robert/0000-0002-6074-7144; Mikulits, Wolfgang/0000-0003-4612-7106	FWF [P19598-B13, SFB F28]; 'Hochschuljubilaumsstiftung der Stadt Wien'; Herzfelder Family Foundation; European Union [HEALTH-F4-2008-202047]	FWF(Austrian Science Fund (FWF)); 'Hochschuljubilaumsstiftung der Stadt Wien'; Herzfelder Family Foundation; European Union(European Commission)	Mdr2 null mice were kindly provided by Dr Ilan Stein. We thank Dr Takako Sasaki for the fibulin-2 antibody. This work was supported by the Austrian Science Fund, FWF, grant numbers P19598-B13 (to WM) and SFB F28 (to RE, HB and WM), the 'Hochschuljubilaumsstiftung der Stadt Wien' (to WM), the Herzfelder Family Foundation (to WM), and the European Union, FP7 Health Research, project number HEALTH-F4-2008-202047 (to WM).	Amann T, 2009, CANCER SCI, V100, P646, DOI 10.1111/j.1349-7006.2009.01087.x; Benckert C, 2003, CANCER RES, V63, P1083; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; Campbell JS, 2007, DIFFERENTIATION, V75, P843, DOI 10.1111/j.1432-0436.2007.00235.x; Campbell JS, 2005, P NATL ACAD SCI USA, V102, P3389, DOI 10.1073/pnas.0409722102; de Visser KE, 2006, CONTRIB MICROBIOL, V13, P118, DOI 10.1159/000092969; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009; Fischer ANM, 2007, ONCOGENE, V26, P3395, DOI 10.1038/sj.onc.1210121; Fischer ANM, 2005, CARCINOGENESIS, V26, P931, DOI 10.1093/carcin/bgi043; Forbes SJ, 2004, GASTROENTEROLOGY, V126, P955, DOI 10.1053/j.gastro.2004.02.025; Friedman SL, 2004, NAT CLIN PRACT GASTR, V1, P98, DOI 10.1038/ncpgasthep0055; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550; Giannelli G, 2005, GASTROENTEROLOGY, V129, P1375, DOI 10.1053/j.gastro.2005.09.055; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Gotzmann J, 2006, ONCOGENE, V25, P3170, DOI 10.1038/sj.onc.1209083; Gotzmann J, 2002, J CELL SCI, V115, P1189; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Herzig M, 2007, ONCOGENE, V26, P2290, DOI 10.1038/sj.onc.1210029; Ikegami T, 2007, CELLS TISSUES ORGANS, V185, P213, DOI 10.1159/000101322; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Kensler TW, 2003, NAT REV CANCER, V3, P321, DOI 10.1038/nrc1076; Kisseleva T, 2006, J HEPATOL, V45, P429, DOI 10.1016/j.jhep.2006.04.014; Knittel T, 1999, GASTROENTEROLOGY, V117, P1205, DOI 10.1016/S0016-5085(99)70407-5; KNITTEL T, 1992, GASTROENTEROLOGY, V102, P1724, DOI 10.1016/0016-5085(92)91736-N; Lahsnig C, 2009, ONCOGENE, V28, P638, DOI 10.1038/onc.2008.418; Lee HC, 2006, FRONT BIOSCI-LANDMRK, V11, P1901, DOI 10.2741/1933; Lee JS, 2005, SEMIN LIVER DIS, V25, P125, DOI 10.1055/s-2005-871192; Lee TK, 2006, CANCER RES, V66, P9948, DOI 10.1158/0008-5472.CAN-06-1092; Magness ST, 2004, HEPATOLOGY, V40, P1151, DOI 10.1002/hep.20427; Marra F, 2002, FRONT BIOSCI, V7, pD1899, DOI 10.2741/marra; Mikula M, 2006, J CELL PHYSIOL, V209, P560, DOI 10.1002/jcp.20772; Morini Sergio, 2005, Italian Journal of Anatomy and Embryology, V110, P193; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nitta T, 2008, HEPATOLOGY, V48, P909, DOI 10.1002/hep.22397; Ostman A, 2001, ADV CANCER RES, V80, P1, DOI 10.1016/S0065-230X(01)80010-5; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pinzani M, 1996, AM J PATHOL, V148, P785; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Proell V, 2005, BBA-MOL CELL RES, V1744, P76, DOI 10.1016/j.bbamcr.2004.12.009; RAMADORI G, 1990, VIRCHOWS ARCH B, V59, P349, DOI 10.1007/BF02899424; Roderfeld M, 2006, FASEB J, V20, P444, DOI 10.1096/fj.05-4828com; Rossmanith W, 2001, MICROSC RES TECHNIQ, V52, P430, DOI 10.1002/1097-0029(20010215)52:4<430::AID-JEMT1028>3.0.CO;2-3; Russo FP, 2006, GASTROENTEROLOGY, V130, P1807, DOI 10.1053/j.gastro.2006.01.036; Sasaki T, 1996, J CELL SCI, V109, P2895; Sherman M, 2005, SEMIN LIVER DIS, V25, P143, DOI 10.1055/s-2005-871194; Sprenger H, 1999, J HEPATOL, V30, P88, DOI 10.1016/S0168-8278(99)80011-7; Stock P, 2007, MOL CANCER THER, V6, P1932, DOI 10.1158/1535-7163.MCT-06-0720; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tsuboi Y, 2004, LIVER INT, V24, P432, DOI 10.1111/j.1478-3231.2004.0940.x; Witz IP, 2008, CANCER RES, V68, P9, DOI 10.1158/0008-5472.CAN-07-2917; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200	59	130	131	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 12	2009	28	45					4022	4033		10.1038/onc.2009.253	http://dx.doi.org/10.1038/onc.2009.253			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	530AC	19718050	Green Accepted, Bronze			2022-12-25	WOS:000272560300007
J	Bu, SY; Mashek, MT; Mashek, DG				Bu, So Young; Mashek, Mara T.; Mashek, Douglas G.			Suppression of Long Chain Acyl-CoA Synthetase 3 Decreases Hepatic de Novo Fatty Acid Synthesis through Decreased Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; INSULIN-RESISTANCE; GENE-EXPRESSION; LIPID DROPLETS; PPAR-ALPHA; LIVER; RECEPTOR; SREBP-1C; LIPOGENESIS; INHIBITION	Long chain acyl-CoA synthetases (ACSL) and fatty acid transport proteins (FATP) activate fatty acids to acyl-CoAs in the initial step of fatty acid metabolism. Numerous isoforms of ACSL and FATP exist with different tissue distribution patterns, intracellular locations, and substrate preferences, suggesting that each isoform has distinct functions in channeling fatty acids into different metabolic pathways. Because fatty acids, acyl-CoAs, and downstream lipid metabolites regulate various transcription factors that control hepatic energy metabolism, we hypothesized that ACSL or FATP isoforms differentially regulate hepatic gene expression. Using small interference RNA (siRNA), we knocked down each liver-specific ACSL and FATP isoform in rat primary hepatocyte cultures and subsequently analyzed reporter gene activity of numerous transcription factors and performed quantitative mRNA analysis of their target genes. Compared with control cells, which were transfected with control siRNA, knockdown of acyl-CoA synthetase 3 (ACSL3) significantly decreased reporter gene activity of several lipogenic transcription factors such as peroxisome proliferator activation receptor-gamma, carbohydrate-responsive element-binding protein, sterol regulatory element-binding protein-1c, and liver X receptor-alpha and the expression of their target genes. These findings were further supported by metabolic labeling studies that showed [1-C-14] acetate incorporation into lipid extracts was decreased in cells treated with ACSL3 siRNAs and that ACSL3 expression is up-regulated in ob/ob mice and mice fed a high sucrose diet. ACSL3 knockdown decreased total acyl-CoA synthetase activity without substantially altering the expression of other ACSL isoforms. In summary, these results identify a novel role for ACSL3 in mediating transcriptional control of hepatic lipogenesis.	[Bu, So Young; Mashek, Mara T.; Mashek, Douglas G.] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Mashek, DG (corresponding author), Univ Minnesota, Dept Food Sci & Nutr, 1334 Eckles Ave, St Paul, MN 55108 USA.	dmashek@umn.edu	Mashek, Douglas/ABD-6844-2021	Mashek, Douglas/0000-0001-7033-3386	American Diabetes Association [07-07-JF-43]; Minnesota Obesity Center	American Diabetes Association(American Diabetes Association); Minnesota Obesity Center	This work was supported by American Diabetes Association Grant 07-07-JF-43 (to D. G. M.) and the Minnesota Obesity Center.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Dentin R, 2005, J CLIN INVEST, V115, P2843, DOI 10.1172/JCI25256; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Diraison F, 2002, AM J PHYSIOL-ENDOC M, V282, pE46, DOI 10.1152/ajpendo.2002.282.1.E46; Doege H, 2006, GASTROENTEROLOGY, V130, P1245, DOI 10.1053/j.gastro.2006.02.006; Forsythe CE, 2008, LIPIDS, V43, P65, DOI 10.1007/s11745-007-3132-7; Fujimoto Y, 2007, J LIPID RES, V48, P1280, DOI 10.1194/jlr.M700050-JLR200; Fujino T, 1996, J BIOL CHEM, V271, P16748, DOI 10.1074/jbc.271.28.16748; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; GIBBONS GF, 1992, BIOCHEM J, V287, P749, DOI 10.1042/bj2870749; He ZB, 2004, AM J PHYSIOL-ENDOC M, V287, pE424, DOI 10.1152/ajpendo.00568.2003; Hernandez C, 2009, CELL METAB, V9, P215, DOI 10.1016/j.cmet.2009.02.001; Higuchi N, 2008, HEPATOL RES, V38, P1122, DOI 10.1111/j.1872-034X.2008.00382.x; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Innis SM, 2003, J PEDIATR-US, V143, pS1, DOI 10.1067/S0022-3476(03)00396-2; Jump DB, 2005, J NUTR, V135, P2503, DOI 10.1093/jn/135.11.2503; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Li LO, 2006, J BIOL CHEM, V281, P37246, DOI 10.1074/jbc.M604427200; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lorente-Cebrian S, 2006, J PHYSIOL BIOCHEM, V62, P61, DOI 10.1007/BF03174067; Mashek DG, 2006, J BIOL CHEM, V281, P945, DOI 10.1074/jbc.M507646200; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; Mashek DG, 2006, J LIPID RES, V47, P2004, DOI 10.1194/jlr.M600150-JLR200; Mashek DG, 2006, CURR OPIN LIPIDOL, V17, P274, DOI 10.1097/01.mol.0000226119.20307.2b; MCGARRY JD, 1978, J BIOL CHEM, V253, P4128; Muoio DM, 2000, AM J PHYSIOL-ENDOC M, V279, pE1366, DOI 10.1152/ajpendo.2000.279.6.E1366; Nakamura MT, 2004, LIPIDS, V39, P1077, DOI 10.1007/s11745-004-1333-0; Pawar A, 2003, J BIOL CHEM, V278, P35931, DOI 10.1074/jbc.M306238200; Pawar A, 2002, J BIOL CHEM, V277, P39243, DOI 10.1074/jbc.M206170200; Pinent M, 2008, GENOMICS, V92, P26, DOI 10.1016/j.ygeno.2008.03.010; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Sapiro JM, 2009, J LIPID RES, V50, P1621, DOI 10.1194/jlr.M800614-JLR200; Schadinger SE, 2005, AM J PHYSIOL-ENDOC M, V288, pE1195, DOI 10.1152/ajpendo.00513.2004; Schroeder F, 2008, LIPIDS, V43, P1, DOI 10.1007/s11745-007-3111-z; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Stoeckman AK, 2002, J BIOL CHEM, V277, P27029, DOI 10.1074/jbc.M202638200; Tobe K, 2001, J BIOL CHEM, V276, P38337, DOI 10.1074/jbc.C100160200; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Van Horn CG, 2005, BIOCHEMISTRY-US, V44, P1635, DOI 10.1021/bi047721l; Vedala A, 2006, J LIPID RES, V47, P2562, DOI 10.1194/jlr.M600200-JLR200; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; Westerbacka J, 2007, DIABETES, V56, P2759, DOI 10.2337/db07-0156; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; Xu J, 2001, J BIOL CHEM, V276, P9800, DOI 10.1074/jbc.M008973200; Yao HB, 2008, J BIOL CHEM, V283, P849, DOI 10.1074/jbc.M706160200; Zhang YL, 2006, J BIOL CHEM, V281, P37603, DOI 10.1074/jbc.M604709200	52	72	76	1	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30474	30483		10.1074/jbc.M109.036665	http://dx.doi.org/10.1074/jbc.M109.036665			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19737935	Green Published, hybrid			2022-12-25	WOS:000271090000050
J	Masuoka, HC; Mott, J; Bronk, SF; Werneburg, NW; Akazawa, Y; Kaufmann, SH; Gores, GJ				Masuoka, Howard C.; Mott, Justin; Bronk, Steven F.; Werneburg, Nathan W.; Akazawa, Yuko; Kaufmann, Scott H.; Gores, Gregory J.			Mcl-1 Degradation during Hepatocyte Lipoapoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY LIVER-DISEASE; PROTEIN-KINASE-C; HUMAN NONALCOHOLIC STEATOHEPATITIS; ENDOPLASMIC-RETICULUM STRESS; INDUCED INSULIN-RESISTANCE; HEPATIC STEATOSIS; BCL-2 FAMILY; APOPTOSIS; ACIDS; THETA	The mechanisms of free fatty acid-induced lipoapoptosis are incompletely understood. Here we demonstrate that Mcl-1, an anti-apoptotic member of the Bcl-2 family, was rapidly degraded in hepatocytes in response to palmitate and stearate by a proteasome-dependent pathway. Overexpression of a ubiquitin-resistant Mcl-1 mutant in Huh-7 cells attenuated palmitate-mediated Mcl-1 loss and lipoapoptosis; conversely, short hairpin RNA-targeted knockdown of Mcl-1 sensitized these cells to lipoapoptosis. Palmitate-induced Mcl-1 degradation was attenuated by the novel protein kinase C (PKC) inhibitor rottlerin. Of the two human novel PKC isozymes, PKC delta and PKC theta, only activation of PKC theta was observed by phospho-immunoblot analysis. As compared with Jurkat cells, a smaller PKC theta polypeptide and mRNA were expressed in hepatocytes consistent with an alternative splice variant. Short hairpin RNA-mediated knockdown of PKC theta reduced Mcl-1 degradation and lipoapoptosis. Likewise, genetic deletion of Pkc theta also attenuated Mcl-1 degradation and cytotoxicity by palmitate in primary hepatocytes. During treatment with palmitate, rottlerin inhibited phosphorylation of Mcl-1 at Ser(159), a phosphorylation site previously implicated in Mcl-1 turnover. Consistent with these results, an Mcl-1 S159A mutant was resistant to degradation and improved cell survival during palmitate treatment. Collectively, these results implicate PKC theta-dependent destabilization of Mcl-1 as a mechanism contributing to hepatocyte lipoapoptosis.	[Masuoka, Howard C.; Mott, Justin; Bronk, Steven F.; Werneburg, Nathan W.; Akazawa, Yuko; Gores, Gregory J.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Kaufmann, Scott H.] Mayo Clin, Coll Med, Div Oncol Res, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Gores, GJ (corresponding author), Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, 200 1st St SW, Rochester, MN 55905 USA.	gores.gregory@mayo.edu		Mott, Justin/0000-0002-2927-6962; Kaufmann, Scott/0000-0002-4900-7145	National Institutes of Health [R01 DK41876, T32 07198, K01 DK79875, R01 CA69008]; Mayo Foundation;  [P309K 84567]; NATIONAL CANCER INSTITUTE [R01CA069008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK079875, P30DK084567, R01DK041876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK41876 (to G. J. G.), T32 07198 (to H. C. M.), K01 DK79875 (to J. L. M.), R01 CA69008 (to S. H. K.), and the optical microscopy core of P309K 84567. This work was also supported by the Mayo Foundation.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Araya J, 2004, CLIN SCI, V106, P635, DOI 10.1042/CS20030326; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Chavez-Tapia NC, 2006, ANN INTERN MED, V144, P379, DOI 10.7326/0003-4819-144-5-200603070-00021; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Datta R, 1997, J BIOL CHEM, V272, P20317, DOI 10.1074/jbc.272.33.20317; De Almeida IT, 2002, CLIN NUTR, V21, P219, DOI 10.1054/clnu.2001.0529; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Doege H, 2008, J BIOL CHEM, V283, P22186, DOI 10.1074/jbc.M803510200; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gentile CL, 2008, J NUTR BIOCHEM, V19, P567, DOI 10.1016/j.jnutbio.2007.10.001; Hamasaki A, 1998, J EXP MED, V188, P1985, DOI 10.1084/jem.188.11.1985; Han J, 2004, J BIOL CHEM, V279, P22020, DOI 10.1074/jbc.M313234200; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Kahraman A, 2009, DIGEST DIS SCI, V54, P1908, DOI 10.1007/s10620-008-0583-5; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kobayashi S, 2007, J BIOL CHEM, V282, P18407, DOI 10.1074/jbc.M610010200; Kodama Y, 2009, GASTROENTEROLOGY, V136, P1423, DOI 10.1053/j.gastro.2008.12.064; Larter CZ, 2008, J HEPATOL, V48, P638, DOI 10.1016/j.jhep.2007.12.011; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu Y, 2002, BIOCHEM J, V361, P255, DOI 10.1042/bj3610255; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Nehra V, 2001, DIGEST DIS SCI, V46, P2347, DOI 10.1023/A:1012338828418; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Print CG, 1998, P NATL ACAD SCI USA, V95, P12424, DOI 10.1073/pnas.95.21.12424; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Ratziu V, 2006, HEPATOLOGY, V44, P802, DOI 10.1002/hep.21391; RICHIERI GV, 1995, J LIPID RES, V36, P229; Ross AJ, 1998, NAT GENET, V18, P251, DOI 10.1038/ng0398-251; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schultz A, 2003, CELL DEATH DIFFER, V10, P662, DOI 10.1038/sj.cdd.4401235; Schulze-Bergkamen H, 2004, HEPATOLOGY, V39, P645, DOI 10.1002/hep.20138; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Timmers S, 2008, PHYSIOL BEHAV, V94, P242, DOI 10.1016/j.physbeh.2007.12.002; Tzung SP, 1997, AM J PATHOL, V150, P1985; Vick B, 2009, HEPATOLOGY, V49, P627, DOI 10.1002/hep.22664; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570; Warr MR, 2008, CURR MOL MED, V8, P138; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	62	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30039	30048		10.1074/jbc.M109.039545	http://dx.doi.org/10.1074/jbc.M109.039545			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19734538	Green Published, hybrid			2022-12-25	WOS:000271090000006
J	Dong, SM; Cheng, YH; Yang, J; Li, JY; Liu, XJ; Wang, XB; Wang, D; Krall, TJ; Delphin, ES; Zhang, CX				Dong, Shimin; Cheng, Yunhui; Yang, Jian; Li, Jingyuan; Liu, Xiaojun; Wang, Xiaobin; Wang, Dong; Krall, Thomas J.; Delphin, Ellise S.; Zhang, Chunxiang			MicroRNA Expression Signature and the Role of MicroRNA-21 in the Early Phase of Acute Myocardial Infarction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ELEGANS; GROWTH; IDENTIFICATION; GENES; MICE; CARCINOMA; APOPTOSIS; LIN-14; RATS; AP-1	Several recent reports have suggested that microRNAs (miRNAs) might play critical roles in acute myocardial infarction (AMI). However, the miRNA expression signature in the early phase of AMI has not been identified. In this study, the miRNA expression signature was investigated in rat hearts 6 h after AMI. Compared with the expression signature in the non-infarcted areas, 38 miRNAs were differentially expressed in infarcted areas and 33 miRNAs were aberrantly expressed in the border areas. Remarkably, miR-21 expression was significantly down-regulated in infarcted areas, but was up-regulated in border areas. The down-regulation of miR-21 in the infarcted areas was inhibited by ischemic preconditioning, a known cardiac protective method. Overexpression of miR-21 via adenovirus expressing miR-21 (Ad-miR-21) decreased myocardial infarct size by 29% at 24 h and decreased the dimension of left ventricles at 2 weeks after AMI. Using both gain-of-function and loss-of-function approaches in cultured cardiac myocytes, we identified that miR-21 had a protective effect on ischemia-induced cell apoptosis that was associated with its target gene programmed cell death 4 and activator protein 1 pathway. The protective effect of miR-21 against ischemia-induced cardiac myocyte damage was further confirmed in vivo by decreased cell apoptosis in the border and infarcted areas of the infarcted rat hearts after treatment with Ad-miR-21. The results suggest that miRNAs such as miR-21 may play critical roles in the early phase of AMI.	[Dong, Shimin; Cheng, Yunhui; Yang, Jian; Li, Jingyuan; Liu, Xiaojun; Wang, Xiaobin; Wang, Dong; Krall, Thomas J.; Delphin, Ellise S.; Zhang, Chunxiang] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Anesthesiol, RNA & Cardiovasc Res Lab, Newark, NJ 07101 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Zhang, CX (corresponding author), 185 S Orange Ave,MSB E548, Newark, NJ 07101 USA.	zhangc3@umdnj.edu	Vickers, Michael M/E-4095-2010; Cheng, Yunhui/D-3922-2012; zhang, xiang chun/HCH-7063-2022; Li, Jingyuan/G-2723-2012; Liu, Xiaojun/C-1650-2009; Cheng, Yunhui/A-4683-2011	zhang, xiang chun/0000-0001-8303-6495; Liu, Xiaojun/0000-0003-4758-7040; 	National Institutes of Health [HL080133]; American Heart Association [09GRNT2250567]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080133, R01HL095707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL080133 and American Heart Association Grant 09GRNT2250567.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Burke AP, 2007, MED CLIN N AM, V91, P553, DOI 10.1016/j.mcna.2007.03.005; Chen HH, 2009, BRIT J ORAL MAX SURG, V47, P14, DOI 10.1016/j.bjoms.2008.06.008; Cho MA, 2007, J ENDOCRINOL, V195, P255, DOI 10.1677/JOE-06-0193; Eckle T, 2006, AM J PHYSIOL-HEART C, V291, pH2533, DOI 10.1152/ajpheart.00472.2006; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Hajjar RJ, 1998, P NATL ACAD SCI USA, V95, P5251, DOI 10.1073/pnas.95.9.5251; Hwang SK, 2007, GENE THER, V14, P1353, DOI 10.1038/sj.gt.3302983; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kolakowski S, 2006, J CARDIAC SURG, V21, P559, DOI 10.1111/j.1540-8191.2006.00296.x; Kong Yong, 2005, GeoActa, V3, P62; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Pasquinelli AE, 2005, CURR OPIN GENET DEV, V15, P200, DOI 10.1016/j.gde.2005.01.002; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Tang XL, 2006, AM J PHYSIOL-HEART C, V291, pH2308, DOI 10.1152/ajpheart.00479.2006; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yin C, 2008, FEBS LETT, V582, P4137, DOI 10.1016/j.febslet.2008.11.014; ZAUG AJ, 1986, SCIENCE, V231, P470, DOI 10.1126/science.3941911; Zheng B, 2004, BASIC RES CARDIOL, V99, P264, DOI 10.1007/s00395-004-0470-y	30	387	436	0	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29514	29525		10.1074/jbc.M109.027896	http://dx.doi.org/10.1074/jbc.M109.027896			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19706597	Green Published, hybrid			2022-12-25	WOS:000270896800034
J	Liang, J; Lei, TH; Song, YT; Yanes, N; Qi, YF; Fu, MG				Liang, Jian; Lei, Tianhua; Song, Yuting; Yanes, Natalie; Qi, Yongfen; Fu, Mingui			RNA-destabilizing Factor Tristetraprolin Negatively Regulates NF-kappa B Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; MESSENGER-RNA; MACROPHAGE ACTIVATION; INFLAMMATORY DISEASES; GENE-EXPRESSION; TNF-ALPHA; FAMILY; PATHWAY; LOCALIZATION; TRANSDUCTION	Tristetraprolin (TTP) is a CCCH zinc finger-containing protein that destabilizes mRNA by binding to an AU-rich element. Mice deficient in TTP develop a severe inflammatory syndrome mainly because of overproduction of tumor necrosis factor alpha. We report here that TTP also negatively regulates NF-kappa B signaling at the transcriptional corepressor level, by which it may repress inflammatory gene transcription. TTP expression inhibited NF-kappa B-dependent transcription. However, overexpression of TTP did not affect reporter mRNA stability. Instead, TTP functioned as a corepressor of p65/NF-kappa B. In support of this concept, we found that TTP physically interacted with the p65 subunit of NF-kappa B and was also associated with HDAC1, -3, and -7 in vivo. Treatment with histone deacetylase inhibitors or small interfering RNA induced HDAC1 or HDAC3 knockdown completely or partly abolished the inhibitory activity of TTP on NF-kappa B reporter activation. Consistently, chromatin immuno-precipitation showed decreased recruitment of HDAC1 and increased recruitment of CREB-binding protein on the Mcp-1 promoter in TTP-/- cells compared with wild-type cells. Moreover, overexpression of TTP blocked CREB-binding protein-induced acetylation of p65/NF-kappa B. Taken together, these data suggest that TTP may also function in vivo as a modulator in suppressing the transcriptional activity of NF-kappa B.	[Liang, Jian; Lei, Tianhua; Song, Yuting; Yanes, Natalie; Qi, Yongfen; Fu, Mingui] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Fu, MG (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, 4000 Cent Florida Blvd, Orlando, FL 32816 USA.	mfu@mail.ucf.edu			James and Esther King New Investigator research grant; American Heart Association	James and Esther King New Investigator research grant; American Heart Association(American Heart Association)	This work was supported by a James and Esther King New Investigator research grant and an American Heart Association beginning grant-in-aid (to M. F.).	Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Batchelder C, 1999, GENE DEV, V13, P202, DOI 10.1101/gad.13.2.202; Cao HP, 2004, J BIOL CHEM, V279, P21489, DOI 10.1074/jbc.M400900200; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Fairhurst AM, 2003, ARTHRITIS RES THER, V5, pR214, DOI 10.1186/ar778; Goler-Baron V, 2008, GENE DEV, V22, P2022, DOI 10.1101/gad.473608; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Ishmael FT, 2008, J IMMUNOL, V180, P8342, DOI 10.4049/jimmunol.180.12.8342; Johnson BA, 2000, ONCOGENE, V19, P1657, DOI 10.1038/sj.onc.1203474; Johnson BA, 2002, J BIOL CHEM, V277, P18029, DOI 10.1074/jbc.M110465200; Johnson BA, 2002, ONCOGENE, V21, P4237, DOI 10.1038/sj.onc.1205526; KANOH J, 1995, MOL BIOL CELL, V6, P1185, DOI 10.1091/mbc.6.9.1185; Kuprash DV, 1999, J IMMUNOL, V162, P4045; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002880; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; O'Neill LAJ, 2006, NAT REV DRUG DISCOV, V5, P549, DOI 10.1038/nrd2070; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Pfitzner E, 2004, CURR PHARM DESIGN, V10, P2839; Phillips RS, 2002, J BIOL CHEM, V277, P11606, DOI 10.1074/jbc.M111457200; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Thompson MJ, 1996, GENE, V174, P225, DOI 10.1016/0378-1119(96)00084-4; Twizere JC, 2003, J NATL CANCER I, V95, P1846, DOI 10.1093/jnci/djg118; WARBRICK E, 1994, GENE, V151, P243, DOI 10.1016/0378-1119(94)90664-5; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Zhu W, 2001, AM J PHYSIOL-LUNG C, V281, pL499, DOI 10.1152/ajplung.2001.281.2.L499	32	72	72	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29383	29390		10.1074/jbc.M109.024745	http://dx.doi.org/10.1074/jbc.M109.024745			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19738286	Green Published, hybrid			2022-12-25	WOS:000270896800019
J	Goebel, EM; Zhang, XQ; Harvill, ET				Goebel, Elizabeth M.; Zhang, Xuqing; Harvill, Eric T.			Bordetella pertussis Infection or Vaccination Substantially Protects Mice against B. bronchiseptica Infection	PLOS ONE			English	Article								Although B. bronchiseptica efficiently infects a wide range of mammalian hosts and efficiently spreads among them, it is rarely observed in humans. In contrast to the many other hosts of B. bronchiseptica, humans are host to the apparently specialized pathogen B. pertussis, the great majority having immunity due to vaccination, infection or both. Here we explore whether immunity to B. pertussis protects against B. bronchiseptica infection. In a murine model, either infection or vaccination with B. pertussis induced antibodies that recognized antigens of B. bronchiseptica and protected the lower respiratory tract of mice against three phylogenetically disparate strains of B. bronchiseptica that efficiently infect naive animals. Furthermore, vaccination with purified B. pertussis-derived pertactin, filamentous hemagglutinin or the human acellular vaccine, Adacel, conferred similar protection against B. bronchiseptica challenge. These data indicate that individual immunity to B. pertussis affects B. bronchiseptica infection, and suggest that the high levels of herd immunity against B. pertussis in humans could explain the lack of observed B. bronchiseptica transmission. This could also explain the apparent association of B. bronchiseptica infections with an immunocompromised state.			Goebel, EM (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	eth10@psu.edu		Harvill, Eric/0000-0001-8893-2133	NIAID NIH HHS [R01 AI053075, R01 AI053075-04, R01 AI053075-02, R01 AI053075-03, R01 AI053075-05] Funding Source: Medline; NIGMS NIH HHS [GM083113, R01 GM083113] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083113] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMADOR C, 1991, REV INFECT DIS, V13, P771; Baumler AJ, 1998, INFECT IMMUN, V66, P4579; Belen O, 2003, PEDIATR INFECT DIS J, V22, P380; Bjornstad ON, 2005, TRENDS MICROBIOL, V13, P355, DOI 10.1016/j.tim.2005.06.007; Bonhoeffer J, 2005, INFECTION, V33, P13, DOI 10.1007/s15010-005-4004-9; Buboltz AM, 2008, J BACTERIOL, V190, P5502, DOI 10.1128/JB.00226-08; Casadevall A, 2000, INFECT IMMUN, V68, P6511, DOI 10.1128/IAI.68.12.6511-6518.2000; Circolo A, 1999, IMMUNOPHARMACOLOGY, V42, P135, DOI 10.1016/S0162-3109(99)00021-1; Cotter PA, 1998, INFECT IMMUN, V66, P5921, DOI 10.1128/IAI.66.12.5921-5929.1998; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; David S, 2004, VACCINE, V22, P1892, DOI 10.1016/j.vaccine.2003.11.005; De Jesus-Berrios Yohana, 2005, P R Health Sci J, V24, P197; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Gerlach G, 2001, MICROBES INFECT, V3, P61, DOI 10.1016/S1286-4579(00)01353-8; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; Gopinathan L, 2007, MICROBES INFECT, V9, P442, DOI 10.1016/j.micinf.2007.01.001; Greger M, 2007, CRIT REV MICROBIOL, V33, P243, DOI 10.1080/10408410701647594; GUEIRARD P, 1995, J CLIN MICROBIOL, V33, P2002, DOI 10.1128/JCM.33.8.2002-2006.1995; Hallander HO, 1999, SCAND J INFECT DIS, V31, P281, DOI 10.1080/00365549950163581; Harvill ET, 1999, INFECT IMMUN, V67, P6109, DOI 10.1128/IAI.67.11.6109-6118.1999; He QS, 1998, JAMA-J AM MED ASSOC, V280, P635, DOI 10.1001/jama.280.7.635; Heininger U, 1999, CLIN INFECT DIS, V28, P602, DOI 10.1086/515154; HIJNEN M, 2006, BORDETELLA PERTUSSIS; IMAIZUMI A, 1983, J CLIN MICROBIOL, V17, P781, DOI 10.1128/JCM.17.5.781-786.1983; Kirimanjeswara GS, 2003, INFECT IMMUN, V71, P1719, DOI 10.1128/IAI.71.4.1719-1724.2003; Kirimanjeswara GS, 2005, J IMMUNOL, V175, P7504, DOI 10.4049/jimmunol.175.11.7504; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Liese JG, 2003, ARCH DIS CHILD, V88, P684, DOI 10.1136/adc.88.8.684; Llombart M, 2006, ARCH BRONCONEUMOL, V42, P255, DOI 10.1016/S1579-2129(06)60457-6; Lorenzo-Pajuelo B, 2002, J CLIN MICROBIOL, V40, P3146, DOI 10.1128/JCM.40.9.3146-3154.2002; Lysenko ES, 2005, PLOS PATHOG, V1, P3, DOI 10.1371/journal.ppat.0010001; Maixnerova M, 2003, Cent Eur J Public Health, V11 Suppl, pS17; Mastrantonio P, 1998, J CLIN MICROBIOL, V36, P999, DOI 10.1128/JCM.36.4.999-1002.1998; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08; Pishko EJ, 2004, EUR J IMMUNOL, V34, P184, DOI 10.1002/eji.200324234; Poolman JT, 2007, EXPERT REV VACCINES, V6, P47, DOI 10.1586/14760584.6.1.47; Restif O, 2006, P ROY SOC B-BIOL SCI, V273, P409, DOI 10.1098/rspb.2005.3335; SCHLAPFER G, 1995, PEDIATR INFECT DIS J, V14, P209, DOI 10.1097/00006454-199503000-00008; Shapiro S, 2002, INFECT IMMUN, V70, P2598, DOI 10.1128/IAI.70.5.2598-2604.2002; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Stehr K, 1998, PEDIATRICS, V101, P1, DOI 10.1542/peds.101.1.1; STIBITZ S, 1991, J BACTERIOL, V173, P4288, DOI 10.1128/JB.173.14.4288-4296.1991; Tan MW, 2002, ANNU REV MICROBIOL, V56, P539, DOI 10.1146/annurev.micro.56.012302.161110; van den Berg BM, 2000, VACCINE, V19, P1118, DOI 10.1016/S0264-410X(00)00329-7; VONKOENIG CHW, 1988, J CLIN MICROBIOL, V26, P2558, DOI 10.1128/JCM.26.12.2558-2560.1988; Watanabe Mineo, 2004, Expert Rev Anti Infect Ther, V2, P447, DOI 10.1586/14787210.2.3.447; Willems RJL, 1998, VACCINE, V16, P410, DOI 10.1016/S0264-410X(97)80919-X; Wolfe DN, 2007, INFECT IMMUN, V75, P4972, DOI 10.1128/IAI.00763-07; Wolfe DN, 2007, INFECT IMMUN, V75, P4416, DOI 10.1128/IAI.00412-07; Wolfe DN, 2005, INFECT IMMUN, V73, P6508, DOI 10.1128/IAI.73.10.6508-6513.2005; WOODARD DR, 1995, CLIN INFECT DIS, V20, P193, DOI 10.1093/clinids/20.1.193; WOOLFREY BF, 1991, CLIN MICROBIOL REV, V4, P243, DOI 10.1128/CMR.4.3.243-255.1991; Yih WK, 1999, EMERG INFECT DIS, V5, P441, DOI 10.3201/eid0503.990317; Zhang YX, 2002, IMMUNOLOGY, V105, P286, DOI 10.1046/j.0019-2805.2001.01368.x	55	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6778	10.1371/journal.pone.0006778	http://dx.doi.org/10.1371/journal.pone.0006778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707559	Green Published, gold			2022-12-25	WOS:000269335000021
J	Tennant, DA; Frezza, C; MacKenzie, ED; Nguyen, QD; Zheng, L; Selak, MA; Roberts, DL; Dive, C; Watson, DG; Aboagye, EO; Gottlieb, E				Tennant, D. A.; Frezza, C.; MacKenzie, E. D.; Nguyen, Q. D.; Zheng, L.; Selak, M. A.; Roberts, D. L.; Dive, C.; Watson, D. G.; Aboagye, E. O.; Gottlieb, E.			Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death	ONCOGENE			English	Article						cancer; metabolism; prolyl hydroxylase; hypoxia; alpha-ketoglutarate; HIF	INDUCIBLE FACTORS HIF-1-ALPHA; TUMOR-SUPPRESSOR; CANCER; EXPRESSION; FACTOR-1-ALPHA; INHIBITION; DISEASE; FAMILY; PHD1; OVEREXPRESSION	Cells exposed to low-oxygen conditions (hypoxia) alter their metabolism to survive. This response, although vital during development and high-altitude survival, is now known to be a major factor in the selection of cells with a transformed metabolic phenotype during tumorigenesis. It is thought that hypoxia-selected cells have increased invasive capacity and resistance to both chemo-and radiotherapies, and therefore represent an attractive target for antitumor therapy. Hypoxia inducible factors (HIFs) are responsible for the majority of gene expression changes under hypoxia, and are themselves controlled by the oxygen-sensing HIF prolyl hydroxylases (PHDs). It was previously shown that mutations in succinate dehydrogenase lead to the inactivation PHDs under normoxic conditions, which can be overcome by treatment with alpha-ketoglutarate derivatives. Given that solid tumors contain large regions of hypoxia, the reactivation of PHDs in these conditions could induce metabolic catastrophe and therefore prove an effective antitumor therapy. In this report we demonstrate that derivatized alpha-ketoglutarate can be used as a strategy for maintaining PHD activity under hypoxia. By increasing intracellular alpha-ketoglutarate and activating PHDs we trigger PHD-dependent reversal of HIF1 activation, and PHD-dependent hypoxic cell death. We also show that derivatized alpha-ketoglutarate can permeate multiple layers of cells, reducing HIF1 alpha levels and its target genes in vivo. Oncogene (2009) 28, 4009-4021; doi:10.1038/onc.2009.250; published online 31 August 2009	[Tennant, D. A.; Frezza, C.; MacKenzie, E. D.; Selak, M. A.; Gottlieb, E.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Nguyen, Q. D.; Aboagye, E. O.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Comprehens Canc Imaging Ctr, London, England; [Zheng, L.; Watson, D. G.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Roberts, D. L.; Dive, C.] Univ Manchester, Paterson Inst Canc Res, Manchester, Lancs, England	Beatson Institute; Imperial College London; University of Strathclyde; Paterson Institute for Cancer Research; University of Manchester	Gottlieb, E (corresponding author), Beatson Inst Canc Res, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	e.gottlieb@beatson.gla.ac.uk	Frezza, Christian/G-2174-2010; Gottlieb, Eyal/G-6450-2010; Tennant, Daniel/ABE-8145-2021	Frezza, Christian/0000-0002-3293-7397; Gottlieb, Eyal/0000-0002-9770-0956; Tennant, Daniel/0000-0003-0499-2732; ABOAGYE, Eric/0000-0003-2276-6771; Dive, Caroline/0000-0002-1726-8850; Zheng, Liang/0000-0002-5346-4111; Roberts, Darren/0000-0001-7175-7754	Cancer Research UK; Association for International Cancer Research; Cancer Research UK [10337] Funding Source: researchfish; Medical Research Council [MC_U120081322] Funding Source: researchfish; MRC [MC_U120081322] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Association for International Cancer Research; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Cancer Research UK and the Association for International Cancer Research. We thank Tom Hamilton and Derek Miller for their invaluable assistance with the in vivo work, Colin Nixon and Mairi Macdonald for helping with the histology, Margaret O'Prey for help with the microscopy, Celeste Simon for generously providing us with the HIF1 alpha-expressing plasmid and Ayala King for her excellent editorial work.	Aebersold DM, 2001, CANCER RES, V61, P2911; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Berra E, 2001, EMBO REP, V2, P615, DOI 10.1093/embo-reports/kve130; Birner P, 2001, CLIN CANCER RES, V7, P1661; Bishop T, 2008, MOL CELL BIOL, V28, P3386, DOI 10.1128/MCB.02041-07; Bracken CP, 2003, CELL MOL LIFE SCI, V60, P1376, DOI 10.1007/s00018-003-2370-y; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chandel NS, 2008, CELL DEATH DIFFER, V15, P619, DOI 10.1038/cdd.2008.11; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Erler JT, 2004, MOL CELL BIOL, V24, P2875, DOI 10.1128/MCB.24.7.2875-2889.2004; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; GOLDBERG MA, 1991, BLOOD, V77, P271; Hewitson KS, 2007, J BIOL CHEM, V282, P3293, DOI 10.1074/jbc.M608337200; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Ikeda E, 2005, PATHOL INT, V55, P603, DOI 10.1111/j.1440-1827.2005.01877.x; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Khatua S, 2003, CANCER RES, V63, P1865; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Knowles HJ, 2003, CANCER RES, V63, P1764; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Rofstad EK, 2000, INT J RADIAT BIOL, V76, P589, DOI 10.1080/095530000138259; Schlisio S, 2008, GENE DEV, V22, P884, DOI 10.1101/gad.1648608; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Taylor MS, 2001, GENE, V275, P125, DOI 10.1016/S0378-1119(01)00633-3; To KKW, 2005, CELL CYCLE, V4, P881, DOI 10.4161/cc.4.7.1839; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Williamson J R, 1979, Methods Enzymol, V55, P200; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200	50	87	88	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 12	2009	28	45					4009	4021		10.1038/onc.2009.250	http://dx.doi.org/10.1038/onc.2009.250			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	530AC	19718054				2022-12-25	WOS:000272560300006
J	Potula, HSK; Wang, D; Van Quyen, D; Singh, NK; Kundumani-Sridharan, V; Karpurapu, M; Park, EA; Glasgow, WC; Rao, GN				Potula, Harihara S. K.; Wang, Dong; Van Quyen, Dong; Singh, Nikhlesh K.; Kundumani-Sridharan, Venkatesh; Karpurapu, Manjula; Park, Edwards A.; Glasgow, Wayne C.; Rao, Gadiparthi N.			Src-dependent STAT-3-mediated Expression of Monocyte Chemoattractant Protein-1 Is Required for 15(S)-Hydroxyeicosatetraenoic Acid-induced Vascular Smooth Muscle Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED NEOINTIMA FORMATION; LOW-DENSITY-LIPOPROTEIN; E-KNOCKOUT MICE; ARACHIDONIC-ACID; ARTERIAL INJURY; BALLOON INJURY; VESSEL WALL; HUMAN 15-LIPOXYGENASE; INTIMAL HYPERPLASIA; DEFICIENT MICE	To understand the role of human 15-lipoxygenase 1 (15-LOX1) in vascular wall remodeling, we have studied the effect of the major 15-LOX1 metabolite of arachidonic acid, 15(S)-hydroxyeicosatetraenoic acid (15(S)-HETE), on vascular smooth muscle cell (VSMC) migration both in vitro and in vivo. Among 5(S)-HETE, 12(S)-HETE, and 15(S)-HETE, 15(S)-HETE potentially stimulated more vascular smooth muscle cell ( VSMC) migration. In addition, 15(S)-HETE-induced VSMC migration was dependent on Src-mediated activation of signal transducer and activator of transcription-3 (STAT-3). 15(S)-HETE also induced monocyte chemoattractant protein-1 (MCP-1) expression via Src-STAT-3 signaling, and neutralizing anti-MCP-1 antibodies completely negated 15(S)-HETE-induced VSMC migration. Cloning and characterization of a 2.6-kb MCP-1 promoter revealed the presence of four putative STAT-binding sites, and the site that is proximal to the transcription start site was found to be essential for 15(S)-HETE-induced Src-STAT-3-mediated MCP-1 expression. Rat carotid arteries that were subjected to balloon injury and transduced with Ad-15-LOX1 upon exposure to [H-3] arachidonic acid ex vivo produced 15-HETE as a major eicosanoid and enhanced balloon injury-induced expression of MCP-1 in smooth muscle cells in Src and STAT-3-dependent manner in vivo. Adenovirus-mediated delivery of 15-LOX1 into rat carotid artery also led to recruitment and homing of macrophages to medial region in response to injury. In addition, transduction of Ad-15-LOX1 into arteries enhanced balloon injury-induced smooth muscle cell migration from media to intima and neointima formation. These results show for the first time that 15-LOX1-15(S)-HETE axis plays a major role in vascular wall remodeling after balloon angioplasty.	[Potula, Harihara S. K.; Wang, Dong; Van Quyen, Dong; Singh, Nikhlesh K.; Kundumani-Sridharan, Venkatesh; Karpurapu, Manjula; Rao, Gadiparthi N.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Park, Edwards A.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Memphis, TN 38163 USA; [Glasgow, Wayne C.] Mercer Univ, Sch Med, Div Basic Med Sci, Macon, GA 31207 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Mercer University	Rao, GN (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	grao@physio1.utmem.edu	Kundumani-Sridharan, Venkatesh/I-4799-2016; Kundumani-Sridharan, Venkatesh/ABD-9613-2021; Singh, Nikhlesh/AAA-4253-2020; Kundumani-Sridharan, Venkatesh/AAB-4535-2020	Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Singh, Nikhlesh/0000-0002-3665-6023; Quyen, Dong Van/0000-0003-1002-7517	National Institutes of Health [HL064165]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL064165 (NHLBI; to G.N.R.).	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Bajpai AK, 2007, INVEST OPHTH VIS SCI, V48, P4930, DOI 10.1167/iovs.07-0617; BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; BERKNER KL, 1988, BIOTECHNIQUES, V6, P616; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; BRYANT RW, 1982, J BIOL CHEM, V257, P6050; Burysek L, 2002, J BIOL CHEM, V277, P33509, DOI 10.1074/jbc.M201941200; Cao HQ, 2006, CIRC RES, V98, P913, DOI 10.1161/01.RES.0000216954.55724.a2; Chang MS, 2005, INVEST OPHTH VIS SCI, V46, P849, DOI 10.1167/iovs.04-1166; Chava KR, 2009, ARTERIOSCL THROM VAS, V29, P809, DOI 10.1161/ATVBAHA.109.185777; Cheranov SY, 2008, BLOOD, V111, P5581, DOI 10.1182/blood-2007-11-126680; Cheranov SY, 2009, BLOOD, V113, P6023, DOI 10.1182/blood-2008-10-183210; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dronadula N, 2006, J LIPID RES, V47, P767, DOI 10.1194/jlr.M500369-JLR200; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Gu JL, 2001, CIRCULATION, V103, P1446, DOI 10.1161/01.CIR.103.10.1446; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Harats D, 2000, ARTERIOSCL THROM VAS, V20, P2100, DOI 10.1161/01.ATV.20.9.2100; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; HENRIKSSON P, 1985, BIOCHIM BIOPHYS ACTA, V834, P272, DOI 10.1016/0005-2760(85)90166-3; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; HUGOU I, 1995, ATHEROSCLEROSIS, V113, P189, DOI 10.1016/0021-9150(94)05446-P; Inoue S, 2002, CIRCULATION, V106, P2700, DOI 10.1161/01.CIR.0000038140.80105.AD; Kelavkar UP, 2001, CARCINOGENESIS, V22, P1765, DOI 10.1093/carcin/22.11.1765; Kilty I, 1999, EUR J BIOCHEM, V266, P83, DOI 10.1046/j.1432-1327.1999.00818.x; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; Krymskaya VP, 2004, FASEB J, V18, P428, DOI 10.1096/fj.04-2869fje; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kuhn H, 2007, J CARDIOVASC PHARM, V50, P609, DOI 10.1097/FJC.0b013e318159f177; Kuhn Hartmut, 2005, Expert Rev Cardiovasc Ther, V3, P1099, DOI 10.1586/14779072.3.6.1099; Kundumani-Sridharan V, 2007, AM J PATHOL, V171, P1381, DOI 10.2353/ajpath.2007.061258; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; LIN L, 1994, CIRC RES, V74, P197, DOI 10.1161/01.RES.74.2.197; Liu ZM, 2005, J BIOL CHEM, V280, P14700, DOI 10.1074/jbc.M500322200; Natarajan R, 1999, CARDIOVASC RES, V41, P489, DOI 10.1016/S0008-6363(98)00312-5; Neeli I, 2004, J BIOL CHEM, V279, P46122, DOI 10.1074/jbc.M406922200; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Ni WH, 2001, CIRCULATION, V103, P2096; Nony PA, 2005, J BIOL CHEM, V280, P31413, DOI 10.1074/jbc.M500418200; Raines EW, 2005, J LIPID RES, V46, P1081, DOI 10.1194/jlr.R500004-JLR200; RAO GN, 1994, J BIOL CHEM, V269, P32586; Reape TJ, 1999, ATHEROSCLEROSIS, V147, P213, DOI 10.1016/S0021-9150(99)00346-9; Sampath P, 2003, MOL CELL BIOL, V23, P1509, DOI 10.1128/MCB.23.5.1509-1519.2003; Schepers A, 2006, ARTERIOSCL THROM VAS, V26, P2063, DOI 10.1161/01.ATV.0000235694.69719.e2; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schober A, 2004, CIRC RES, V95, P1125, DOI 10.1161/01.RES.0000149518.86865.3e; Schober A, 2008, ARTERIOSCL THROM VAS, V28, P1950, DOI 10.1161/ATVBAHA.107.161224; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; SIGAL E, 1988, BIOCHEM BIOPH RES CO, V157, P457, DOI 10.1016/S0006-291X(88)80271-7; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; SIMON TC, 1989, ATHEROSCLEROSIS, V75, P31, DOI 10.1016/0021-9150(89)90204-9; Srivastava K, 2007, CANCER RES, V67, P4328, DOI 10.1158/0008-5472.CAN-06-3594; Sun P, 2009, ONCOGENE, V28, P1339, DOI 10.1038/onc.2008.480; Tang X, 2006, ARTERIOSCL THROM VAS, V26, P78, DOI 10.1161/01.ATV.0000191640.73313.ad; Verma S, 2002, CIRCULATION, V105, P1890, DOI 10.1161/01.CIR.0000015126.83143.B4; Wang D, 2007, CIRC RES, V100, P807, DOI 10.1161/01.RES.0000261350.61711.9e; YLAHERTTUALA S, 1990, P NATL ACAD SCI USA, V87, P6959, DOI 10.1073/pnas.87.18.6959; Zhao L, 2004, TRENDS CARDIOVAS MED, V14, P191, DOI 10.1016/j.tcm.2004.04.003; Zhu DL, 2003, CIRC RES, V92, P992, DOI 10.1161/01.RES.0000070881.65194.8F; Zhu H, 2003, J BIOL CHEM, V278, P13350, DOI 10.1074/jbc.M212104200	62	52	56	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31142	31155		10.1074/jbc.M109.012526	http://dx.doi.org/10.1074/jbc.M109.012526			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19736311	hybrid, Green Published			2022-12-25	WOS:000271378400042
J	Beigneux, AP; Gin, P; Davies, BSJ; Weinstein, MM; Bensadoun, A; Fong, LG; Young, SG				Beigneux, Anne P.; Gin, Peter; Davies, Brandon S. J.; Weinstein, Michael M.; Bensadoun, Andre; Fong, Loren G.; Young, Stephen G.			Highly Conserved Cysteines within the Ly6 Domain of GPIHBP1 Are Crucial for the Binding of Lipoprotein Lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT REGULATORY PROTEIN; SITE-DIRECTED MUTAGENESIS; PLASMINOGEN-ACTIVATOR; CRYSTAL-STRUCTURE; HEPARIN-BINDING; LIGAND-BINDING; CELL-SURFACE; IDENTIFICATION; CHYLOMICRONS; RECEPTOR	GPIHBP1, a glycosylphosphatidylinositol-anchored endothelial cell protein of the lymphocyte antigen 6 (Ly6) family, binds lipoprotein lipase (LPL) avidly and is required for the lipolytic processing of triglyceride-rich lipoproteins. GPIHBP1 contains two key structural motifs, an acidic domain and an Ly6 motif (a three-fingered domain specified by 10 cysteines). The acidic domain is required for LPL binding, but the importance of the Ly6 domain is less clear. To explore that issue, we transfected cells with a wild-type GPIHBP1 expression vector or mutant GPIHBP1 vectors in which specific cysteines in the Ly6 domain were changed to alanine. The mutant GPIHBP1 proteins reached the cell surface, as judged by antibody binding studies and by the ability of a phosphatidylinositol-specific phospholipase C to release these proteins from the cell surface. However, cells expressing the cysteine mutants could not bind LPL. The acidic domain of the cysteine mutants appeared to remain accessible, as judged by binding studies with an antibody against the acidic domain. We also developed a cell-free assay of LPL binding. We created a rat monoclonal antibody against the carboxyl terminus of mouse GPIHBP1 and used that antibody to coat agarose beads. We then tested the ability of soluble forms of GPIHBP1 that had been immobilized on monoclonal antibody-coated beads to bind LPL. In this assay, wild-type soluble GPIHBP1 bound LPL avidly, but the cysteine mutants did not. Thus, our studies suggest that a structurally intact Ly6 domain (in addition to the acidic domain) is essential for LPL binding.	[Beigneux, Anne P.; Gin, Peter; Davies, Brandon S. J.; Weinstein, Michael M.; Fong, Loren G.; Young, Stephen G.] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Weinstein, Michael M.; Young, Stephen G.] Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Bensadoun, Andre] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University	Beigneux, AP (corresponding author), 675 Charles E Young Dr S, Los Angeles, CA 90095 USA.	abeigneux@mednet.ucla.edu		Young, Stephen/0000-0001-7270-3176; Davies, Brandon/0000-0002-7168-8522	National Institutes of Health [R01 HL094732, P01 HL090553, R01 HL087228]; American Heart Association National Office; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094732, P01HL090553, R01HL087228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association National Office(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL094732 (to A. P. B.), P01 HL090553 (to S. G. Y.), and R01 HL087228 (to S. G. Y.). This work was also supported by Scientist Development Award from the American Heart Association National Office (to A. P. B.).	Beigneux AP, 2008, J LIPID RES, V49, P1312, DOI 10.1194/jlr.M700593-JLR200; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Beigneux AP, 2009, CURR OPIN LIPIDOL, V20, P211, DOI 10.1097/MOL.0b013e32832ac026; Beigneux AP, 2009, ARTERIOSCL THROM VAS, V29, P956, DOI 10.1161/ATVBAHA.109.186577; Dallinga-Thie GM, 2009, ARTERIOSCL THROM VAS, V29, pE10; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Favre B, 2007, J INVEST DERMATOL, V127, P301, DOI 10.1038/sj.jid.5700551; Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2; Gardsvoll H, 1999, J BIOL CHEM, V274, P37995, DOI 10.1074/jbc.274.53.37995; Gin P, 2008, J BIOL CHEM, V283, P29554, DOI 10.1074/jbc.M802579200; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; HATA A, 1993, J BIOL CHEM, V268, P8447; Huang YX, 2007, ACTA CRYSTALLOGR D, V63, P714, DOI 10.1107/S0907444907015557; Ioka RX, 2003, J BIOL CHEM, V278, P7344, DOI 10.1074/jbc.M211932200; KIEFFER B, 1994, BIOCHEMISTRY-US, V33, P4471, DOI 10.1021/bi00181a006; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; MA YH, 1994, J LIPID RES, V35, P2049; Mallya M, 2006, PROTEIN SCI, V15, P2244, DOI 10.1110/ps.062242606; Petranka J, 1996, BLOOD CELL MOL DIS, V22, P281, DOI 10.1006/bcmd.1996.0111; Ploug M, 1998, BIOCHEMISTRY-US, V37, P16494, DOI 10.1021/bi981203r; Sendak RA, 1998, J LIPID RES, V39, P1310; Young SG, 2007, CURR OPIN LIPIDOL, V18, P389, DOI 10.1097/MOL.0b013e3281527914	22	57	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30240	30247		10.1074/jbc.M109.046391	http://dx.doi.org/10.1074/jbc.M109.046391			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19726683	Green Published, hybrid			2022-12-25	WOS:000271090000027
J	Morita, I; Kakuda, S; Takeuchi, Y; Itoh, S; Kawasaki, N; Kizuka, Y; Kawasaki, T; Oka, S				Morita, Ippei; Kakuda, Shinako; Takeuchi, Yusuke; Itoh, Satsuki; Kawasaki, Nana; Kizuka, Yasuhiko; Kawasaki, Toshisuke; Oka, Shogo			HNK-1 Glyco-epitope Regulates the Stability of the Glutamate Receptor Subunit GluR2 on the Neuronal Cell Surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; AMPA RECEPTORS; CARBOHYDRATE EPITOPE; SYNAPTIC PLASTICITY; N-CADHERIN; FUNCTIONAL EXPRESSION; L2/HNK-1 CARBOHYDRATE; MEMORY CONSOLIDATION; ADHESION MOLECULES; PERINEURONAL NETS	HNK-1 (human natural killer-1) glyco-epitope, a sulfated glucuronic acid attached to N-acetyllactosamine on the nonreducing termini of glycans, is highly expressed in the nervous system. Our previous report showed that mice lacking a glucuronyltransferase (GlcAT-P), a key enzyme for biosynthesis of the HNK-1 epitope, showed reduced long term potentiation at hippocampal CA1 synapses. In this study, we identified an alpha-amino-3-hydroxy-5-methylisoxazole propionate (AMPA)-type glutamate receptor subunit, GluR2, which directly contributes to excitatory synaptic transmission and synaptic plasticity, as a novel HNK-1 carrier molecule. We demonstrated that the HNK-1 epitope is specifically expressed on the N-linked glycan(s) on GluR2 among the glutamate receptors tested, and the glycan structure, including HNK-1 on GluR2, was determined using liquid chromatography-tandem mass spectrometry. As for the function of HNK-1 on GluR2, we found that the GluR2 not carrying HNK-1 was dramatically endocytosed and expressed less on the cell surface compared with GluR2 carrying HNK-1 in both cultured hippocampal neurons and heterologous cells. These results suggest that HNK-1 stabilizes GluR2 on neuronal surface membranes and regulates the number of surface AMPA receptors. Moreover, we showed that the expression of the HNK-1 epitope enhanced the interaction between GluR2 and N-cadherin, which has important roles in AMPA receptor trafficking. Our findings suggest that the HNK-1 epitope on GluR2 regulates cell surface stability of GluR2 by modulating the interaction with N-cadherin.	[Morita, Ippei; Kizuka, Yasuhiko] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto 6068507, Japan; [Kakuda, Shinako; Takeuchi, Yusuke; Oka, Shogo] Kyoto Univ, Grad Sch Med, Dept Biol Chem, Kyoto 6068507, Japan; [Itoh, Satsuki; Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biol, Tokyo 1588501, Japan; [Kawasaki, Toshisuke] Ritsumeikan Univ, Res Ctr Glycobiotechnol, Shiga 5258577, Japan	Kyoto University; Kyoto University; National Institute of Health Sciences - Japan; Ritsumeikan University	Oka, S (corresponding author), Kawahara Cho 53,Sakyo Ku, Kyoto 6068507, Japan.	shogo@hs.med.kyoto-u.ac.jp		Kizuka, Yasuhiko/0000-0002-3181-9743	Ministry of Education, Culture, Sports, Science and Technology [21370053]; Mizutani Foundation for Glycoscience	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mizutani Foundation for Glycoscience	This work was supported in part by Grant-in-aid for Scientific Research (B) 21370053 (to S. O.) from the Ministry of Education, Culture, Sports, Science and Technology and by the Mizutani Foundation for Glycoscience (to S. O.).	Bakker H, 1997, J BIOL CHEM, V272, P29942, DOI 10.1074/jbc.272.47.29942; Bassani S, 2009, NEUROSCIENCE, V158, P55, DOI 10.1016/j.neuroscience.2008.10.007; BRONNERFRASER M, 1987, DEV BIOL, V123, P321, DOI 10.1016/0012-1606(87)90390-3; Bruckner G, 2000, J COMP NEUROL, V428, P616, DOI 10.1002/1096-9861(20001225)428:4<616::AID-CNE3>3.0.CO;2-K; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dityatev A, 2003, NAT REV NEUROSCI, V4, P456, DOI 10.1038/nrn1115; Everts I, 1997, MOL PHARMACOL, V52, P861, DOI 10.1124/mol.52.5.861; Hall RA, 1997, J NEUROCHEM, V68, P625; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Kastning K, 2007, P NATL ACAD SCI USA, V104, P2991, DOI 10.1073/pnas.0611170104; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Kizuka Y, 2006, J BIOL CHEM, V281, P13644, DOI 10.1074/jbc.M601453200; Kizuka Y, 2008, GLYCOBIOLOGY, V18, P331, DOI 10.1093/glycob/cwn012; KUNEMUND V, 1988, J CELL BIOL, V106, P213, DOI 10.1083/jcb.106.1.213; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Liedtke S, 2001, GLYCOBIOLOGY, V11, P373, DOI 10.1093/glycob/11.5.373; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; MARTINI R, 1992, EUR J NEUROSCI, V4, P628, DOI 10.1111/j.1460-9568.1992.tb00171.x; Maruo K, 2003, BRAIN RES, V977, P294, DOI 10.1016/S0006-8993(03)02838-5; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; Morita I, 2008, J BIOCHEM, V143, P719, DOI 10.1093/jb/mvm221; Nakamura M, 2004, EUR J NEUROSCI, V20, P2929, DOI 10.1111/j.1460-9568.2004.03768.x; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Pasternack A, 2003, J NEUROCHEM, V84, P1184, DOI 10.1046/j.1471-4159.2003.01611.x; Pradel G, 1999, J NEUROBIOL, V39, P197, DOI 10.1002/(SICI)1097-4695(199905)39:2<197::AID-NEU4>3.0.CO;2-9; RABOUILLE C, 1995, J CELL SCI, V108, P1617; Saghatelyan AK, 2000, EUR J NEUROSCI, V12, P3331, DOI 10.1046/j.1460-9568.2000.00216.x; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; SAKIMURA K, 1990, FEBS LETT, V272, P73, DOI 10.1016/0014-5793(90)80452-O; Santos SD, 2009, NEUROSCIENCE, V158, P105, DOI 10.1016/j.neuroscience.2008.02.037; Seiki T, 1999, BIOCHEM BIOPH RES CO, V255, P182, DOI 10.1006/bbrc.1999.0151; Standley S, 1998, J NEUROCHEM, V70, P2434; Strekalova T, 2001, MOL CELL NEUROSCI, V17, P1102, DOI 10.1006/mcne.2001.0991; Terayama K, 1997, P NATL ACAD SCI USA, V94, P6093, DOI 10.1073/pnas.94.12.6093; Uemura K, 2006, NEUROSCI LETT, V402, P278, DOI 10.1016/j.neulet.2006.04.018; Wintergerst ES, 1996, NEUROSCI LETT, V209, P173, DOI 10.1016/0304-3940(96)12643-4; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200; Yoshihara T, 2009, J BIOL CHEM, V284, P12550, DOI 10.1074/jbc.M809188200	45	40	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30209	30217		10.1074/jbc.M109.024208	http://dx.doi.org/10.1074/jbc.M109.024208			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19729452	hybrid, Green Published			2022-12-25	WOS:000271090000024
J	Ahn, YH; Kurie, JM				Ahn, Young-Ho; Kurie, Jonathan M.			MKK4/SEK1 Is Negatively Regulated through a Feedback Loop Involving the E3 Ubiquitin Ligase Itch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; MEDIATES UBIQUITINATION; DIFFERENTIAL REGULATION; PROTEIN LIGASE; KINASE 1; DEGRADATION; PHOSPHORYLATION; ACTIVATION; ACTS; SCAFFOLD	Cells exposed to environmental stress rapidly activate the MAPK cascade (MKKK/MKK/MAPK). The transient nature of stress signaling is a consequence of negative feedback signals that lead to kinase dephosphorylation, degradation, and sequestration, which have not been fully elucidated for MKK family members. Here, we investigated the signals that negatively regulate MKK4/SEK1, an upstream activator of the MAPKs JNK and p38/HOG1. Following exposure of cells to sorbitol, MKK4 underwent ubiquitination and degradation in a proteasome-dependent manner. MKK4 ubiquitination required JNK kinase activity. The JNK substrate Itch (a HECT domain-containing Nedd4-like ubiquitin protein ligase) bound to MKK4, ubiquitinated lysines 140 and 143, and promoted MKK4 degradation. Other E3 ligases within the MAPK modular complex did not ubiquitinate MKK4. These data suggest that MKK4 is negatively regulated through a feedback loop involving the E3 ubiquitin ligase Itch, which has a fundamental role in the mechanism that controls MKK4 protein levels.	[Kurie, Jonathan M.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Unit 432, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Kurie, JM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Unit 432, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jkurie@mdanderson.org			National Institutes of Health, NCI [R01 CA105155]; NATIONAL CANCER INSTITUTE [R01CA105155, P50CA070907] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA105155 from NCI.	Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen W, 2002, J BIOL CHEM, V277, P49105, DOI 10.1074/jbc.M204934200; Deacon K, 1997, J BIOL CHEM, V272, P14489, DOI 10.1074/jbc.272.22.14489; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Johnson GL, 2005, CURR OPIN CHEM BIOL, V9, P325, DOI 10.1016/j.cbpa.2005.04.004; Kuo WL, 2004, J BIOL CHEM, V279, P23073, DOI 10.1074/jbc.M313696200; Laine Aaron, 2005, Sci STKE, V2005, pre5, DOI 10.1126/stke.2812005re5; Liu WH, 2005, MOL CELL BIOL, V25, P1367, DOI 10.1128/MCB.25.4.1367-1378.2005; Lu ZM, 2009, ANNU REV BIOCHEM, V78, P435, DOI 10.1146/annurev.biochem.013008.092711; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Meza R, 1996, FEMS MICROBIOL LETT, V145, P333, DOI 10.1111/j.1574-6968.1996.tb08597.x; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Sobko A, 2002, DEV CELL, V2, P745, DOI 10.1016/S1534-5807(02)00186-7; Sundvall M, 2008, P NATL ACAD SCI USA, V105, P4162, DOI 10.1073/pnas.0708333105; Wang YQ, 2003, J BIOL CHEM, V278, P22284, DOI 10.1074/jbc.M301272200; Xia Y, 1998, GENE DEV, V12, P3369, DOI 10.1101/gad.12.21.3369; Xia Y, 2007, MOL CELL BIOL, V27, P510, DOI 10.1128/MCB.01355-06; Xu ZH, 2003, EMBO J, V22, P252, DOI 10.1093/emboj/cdg021; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966	35	14	15	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29399	29404		10.1074/jbc.M109.044958	http://dx.doi.org/10.1074/jbc.M109.044958			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19737936	Green Published, hybrid			2022-12-25	WOS:000270896800021
J	Fan, YH; Mao, RF; Zhao, YL; Yu, Y; Sun, WJ; Song, P; Shi, ZC; Zhang, DK; Yvon, E; Zhang, H; Fu, SB; Yang, JH				Fan, Yihui; Mao, Renfang; Zhao, Yanling; Yu, Yang; Sun, Wenjing; Song, Ping; Shi, Zhongcheng; Zhang, Dekai; Yvon, Eric; Zhang, Hong; Fu, Songbin; Yang, Jianhua			Tumor Necrosis Factor-alpha Induces RelA Degradation via Ubiquitination at Lysine 195 to Prevent Excessive Nuclear Factor-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; INTERLEUKIN-6 GENE; TERMINATION; LIGASE; PROTEINS; INSIGHTS; P65/RELA; P65	Ubiquitination-mediated degradation of the RelA subunit of nuclear factor-kappa B (NF-kappa B) is critical for the termination of NF-kappa B activation. However, the precise mechanism for the ubiquitination of RelA is still not fully understood. Here we report that tumor necrosis factor-alpha (TNF alpha) induces RelA polyubiquitination at the lysine 195 residue, and this ubiquitination event is critical for the degradation of RelA and termination of TNF alpha-mediated NF-kappa B activation. Overexpression of a RelA mutant with an arginine substitution for the lysine 195 residue dramatically inhibits RelA polyubiquitination and induces a stronger NF-kappa B activation compared with the wild type. Reconstitution of RelA-deficient mouse embryo fibroblast cells with wild-type RelA or RelA containing a K195R mutation revealed the importance of this site in TNF alpha-mediated RelA polyubiquitination, degradation, and attenuation of NF-kappa B activation. Our finding is the first report that substitution of a key RelA lysine residue with arginine inhibits TNF alpha-induced RelA ubiquitination and enhances TNF alpha-induced NF-kappa B activation.	[Fan, Yihui; Yu, Yang; Sun, Wenjing; Yang, Jianhua] Baylor Coll Med, Texas Childrens Canc Ctr, Dan L Duncan Canc Ctr, Dept Pediat, Houston, TX 77030 USA; [Mao, Renfang; Zhang, Hong] Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Song, Ping; Yvon, Eric] Baylor Coll Med, Texas Childrens Canc Ctr, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Shi, Zhongcheng; Zhang, Dekai] Texas A&M Univ, Inst Biosci & Technol, Ctr Extracellular Matrix Biol, Houston, TX 77030 USA; [Yvon, Eric] Univ Paris 04, Ecole Prat Hautes Etud, F-75007 Paris, France; [Fan, Yihui; Zhao, Yanling; Fu, Songbin] Harbin Med Coll, Med Genet Lab, Harbin 150081, Peoples R China	Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Texas Children's Cancer Center; Texas A&M University System; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Harbin Medical University	Yang, JH (corresponding author), Baylor Coll Med, Texas Childrens Canc Ctr, Dan L Duncan Canc Ctr, Dept Pediat, 1 Baylor Plaza,BCM320,6621 Fannin St,MC3-3320, Houston, TX 77030 USA.	jianhuay@bcm.edu			National Institutes of Health [1R21CA106513-01A2]; American Cancer Society [RSG-06-070-01-TBE]; Virginia and L. E. Simmons Family Foundation; Fleming and Davenport Award; NATIONAL CANCER INSTITUTE [R21CA106513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Virginia and L. E. Simmons Family Foundation; Fleming and Davenport Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R21CA106513-01A2. This work was also supported by American Cancer Society Grant RSG-06-070-01-TBE (to J. Y.), the Virginia and L. E. Simmons Family Foundation (to J. Y.), and the Fleming and Davenport Award (to H. Z.).	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Mao XC, 2009, GENE DEV, V23, P849, DOI 10.1101/gad.1748409; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; Rodrigues L, 2009, EMBO J, V28, P1283, DOI 10.1038/emboj.2009.74; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; SHIMIZU H, 1990, MOL CELL BIOL, V10, P561, DOI 10.1128/MCB.10.2.561; Sun SC, 2008, TRENDS IMMUNOL, V29, P469, DOI 10.1016/j.it.2008.07.003; Sun WJ, 2009, CELL SIGNAL, V21, P95, DOI 10.1016/j.cellsig.2008.09.012; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Yu Y, 2008, J BIOL CHEM, V283, P24497, DOI 10.1074/jbc.M802825200; ZHANG Y, 1990, MOL CELL BIOL, V10, P3818, DOI 10.1128/MCB.10.7.3818	23	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29290	29297		10.1074/jbc.M109.018994	http://dx.doi.org/10.1074/jbc.M109.018994			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19706600	Green Published, hybrid			2022-12-25	WOS:000270896800008
J	Farrell, KB; Tusnady, GE; Eiden, MV				Farrell, Karen B.; Tusnady, Gabor E.; Eiden, Maribeth V.			New Structural Arrangement of the Extracellular Regions of the Phosphate Transporter SLC20A1, the Receptor for Gibbon Ape Leukemia Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE PROTEIN TOPOLOGY; CELL-SURFACE RECEPTORS; RETROVIRUS RECEPTOR; PREDICTION; INFECTION; FAMILY; DOMAIN; ENTRY; IDENTIFICATION; REVEALS	Infection of a host cell by a retrovirus requires an initial interaction with a cellular receptor. For numerous gammaretroviruses, such as the gibbon ape leukemia virus, woolly monkey virus, feline leukemia virus subgroup B, feline leukemia virus subgroup T, and 10A1 murine leukemia virus, this receptor is the human type III sodium-dependent inorganic phosphate transporter, SLC20A1, formerly known as PiT1. Understanding the critical receptor functionalities and interactions with the virus that lead to successful infection requires that we first know the surface structure of the cellular receptor. Previous molecular modeling from the protein sequence, and limited empirical data, predicted a protein with 10 transmembrane helices. Here we undertake the biochemical approach of substituted cysteine accessibility mutagenesis to resolve the topology of this receptor in live cells. We discover that there are segments of the protein that are unexpectedly exposed to the outside milieu. By using information determined by substituted cysteine accessibility mutagenesis to set constraints in HMMTOP, a hidden Markov model-based transmembrane topology prediction method, we now propose a comprehensive topological model for SLC20A1, a transmembrane protein with 12 transmembrane helices and 7 extracellular regions, that varies from previous models and should permit approaches that define both virus interaction and transport function.	[Farrell, Karen B.; Eiden, Maribeth V.] NIH, Sect Mol Virol, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA; [Tusnady, Gabor E.] Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, H-1113 Budapest, Hungary	National Institutes of Health (NIH) - USA; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences	Eiden, MV (corresponding author), 49 Convent Dr,MSC 4483,Bldg 49,Rm 5A60, Bethesda, MD 20892 USA.	eidenm@mail.nih.gov	Tusnády, Gábor E./AAI-1136-2021; Tusnády, Gábor E/A-3207-2009	Tusnády, Gábor E./0000-0001-8105-0285; Tusnády, Gábor E/0000-0001-8105-0285	National Institutes of Health; Bolyai Janos scholarship; Hungarian Research and Development Funds [OTKA K75460]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002592, Z01MH002592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bolyai Janos scholarship(Hungarian Academy of Sciences); Hungarian Research and Development Funds; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported by a Bolyai Janos scholarship and Hungarian Research and Development Funds OTKA K75460 ( to G. E. T.).	Bernsel A, 2005, PROTEIN SCI, V14, P1723, DOI 10.1110/ps.051395305; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Chaudry GJ, 1997, J VIROL, V71, P8078, DOI 10.1128/JVI.71.10.8078-8081.1997; Eiden MV, 1996, J VIROL, V70, P1080, DOI 10.1128/JVI.70.2.1080-1085.1996; Farrell KB, 2002, J VIROL, V76, P7683, DOI 10.1128/JVI.76.15.7683-7693.2002; Feldman SA, 2004, J VIROL, V78, P595, DOI 10.1128/JVI.78.2.595-602.2004; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Hein S, 2003, J VIROL, V77, P5926, DOI 10.1128/JVI.77.10.5926-5932.2003; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; JOHANN SV, 1993, J VIROL, V67, P6733, DOI 10.1128/JVI.67.11.6733-6736.1993; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kavanaugh MP, 1996, KIDNEY INT, V49, P959, DOI 10.1038/ki.1996.135; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LANDER MR, 1984, J VIROL, V52, P695, DOI 10.1128/JVI.52.2.695-698.1984; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Malhotra S, 1996, J VIROL, V70, P321, DOI 10.1128/JVI.70.1.321-326.1996; MILLER DG, 1994, J VIROL, V68, P8270, DOI 10.1128/JVI.68.12.8270-8276.1994; OHARA B, 1990, CELL GROWTH DIFFER, V1, P119; OLAH Z, 1994, J BIOL CHEM, V269, P25426; Pedersen L, 1997, J VIROL, V71, P7619, DOI 10.1128/JVI.71.10.7619-7622.1997; Rost B, 2001, J STRUCT BIOL, V134, P204, DOI 10.1006/jsbi.2001.4336; Salaun C, 2001, J VIROL, V75, P5584, DOI 10.1128/JVI.75.12.5584-5592.2001; Tusnady GE, 2008, NUCLEIC ACIDS RES, V36, pD234, DOI 10.1093/nar/gkm751; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; VANZEIJL M, 1994, P NATL ACAD SCI USA, V91, P1168, DOI 10.1073/pnas.91.3.1168; Virkki LV, 2007, AM J PHYSIOL-RENAL, V293, pF643, DOI 10.1152/ajprenal.00228.2007; WILSON CA, 1995, J VIROL, V69, P534, DOI 10.1128/JVI.69.1.534-537.1995; Zhu QS, 2007, METHODS, V41, P439, DOI 10.1016/j.ymeth.2006.08.004	30	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29979	29987		10.1074/jbc.M109.022566	http://dx.doi.org/10.1074/jbc.M109.022566			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19717569	Green Published, hybrid			2022-12-25	WOS:000270896800076
J	Greenstein, AE; Hammel, M; Cavazos, A; Alber, T				Greenstein, Andrew E.; Hammel, Michal; Cavazos, Alexandra; Alber, Tom			Interdomain Communication in the Mycobacterium tuberculosis Environmental Phosphatase Rv1364c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-SIGMA-FACTOR; PROTEIN-PROTEIN INTERACTIONS; X-RAY SOLUTION; BACILLUS-SUBTILIS; TRANSCRIPTION FACTOR; FACTOR ANTAGONISTS; SIGNALING PATHWAY; SCATTERING SAXS; ENERGY STRESS; EXPRESSION	An "environmental phosphatase" controls bacterial transcriptional responses through alternative sigma factor subunits of RNA polymerase and a partner switching mechanism has been proposed to mediate phosphatase regulation. In many bacteria, the environmental phosphatase and multiple regulators are encoded in separate genes whose products form transient complexes. In contrast, in the Mycobacterium tuberculosis homolog, Rv1364c, the phosphatase is fused to two characteristic regulatory modules with sequence similarities to anti-sigma factor kinases and anti-anti-sigma factor proteins. Here we exploit this fusion to explore interactions between the phosphatase and the regulatory domains. We show quantitatively that the anti-sigma factor kinase domain activates the phosphatase domain, the kinase-phosphatase fusion protein autophosphorylates in Escherichia coli, and phosphorylation is antagonized by the phosphatase activity. Small angle x-ray scattering defines solution structures consistent with the interdomain communication observed biochemically. Taken together, these data indicate that Rv1364c provides a single chain framework to understand the structure, function, and regulation of environmental phosphatases throughout the bacterial kingdom.	[Alber, Tom] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Hammel, Michal] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Alber, T (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 374B Stanley Hall 3220, Berkeley, CA 94720 USA.	tom@ucxray.berkeley.edu		Greenstein, Andrew/0000-0002-1470-1970; Hammel, Michal/0000-0002-5610-9289	National Institutes of Health TB Structural Genomics Consortium [P01 AI68135]; National Science Foundation graduate research fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068135] Funding Source: NIH RePORTER	National Institutes of Health TB Structural Genomics Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation graduate research fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health TB Structural Genomics Consortium Grant P01 AI68135 (to T. A.) and a National Science Foundation graduate research fellowship (to A. G.). 1 Current address: Gilead Sciences, 333 Lakeside Dr., Foster City, CA 94404.	Bashyam MD, 2004, INFECT GENET EVOL, V4, P301, DOI 10.1016/j.meegid.2004.04.003; Beaucher J, 2002, MOL MICROBIOL, V45, P1527, DOI 10.1046/j.1365-2958.2002.03135.x; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Campbell EA, 2008, CURR OPIN MICROBIOL, V11, P121, DOI 10.1016/j.mib.2008.02.016; Chen CC, 2004, J BACTERIOL, V186, P6830, DOI 10.1128/JB.186.20.6830-6836.2004; Chen CC, 2003, MOL MICROBIOL, V49, P1657, DOI 10.1046/j.1365-2958.2003.03663.x; Clarkson J, 2004, J MOL BIOL, V342, P1187, DOI 10.1016/j.jmb.2004.07.090; Delumeau O, 2002, J BACTERIOL, V184, P5583, DOI 10.1128/JB.184.20.5583-5589.2002; Fjeld CC, 1999, J BIOL CHEM, V274, P20336, DOI 10.1074/jbc.274.29.20336; Geiman DE, 2004, INFECT IMMUN, V72, P1733, DOI 10.1128/IAI.72.3.1733-1745.2004; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Guinier A., 1955, SMALL ANGLE SCATTERI; Hampshire T, 2004, TUBERCULOSIS, V84, P228, DOI 10.1016/j.tube.2003.12.010; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Kim TJ, 2004, J BACTERIOL, V186, P6124, DOI 10.1128/jb.186.18.6124-6132.2004; Kim TJ, 2004, J MOL BIOL, V341, P135, DOI 10.1016/j.jmb.2004.05.043; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Pane-Farre J, 2005, J MOL MICROB BIOTECH, V9, P65, DOI 10.1159/000088837; Parida BK, 2005, TUBERCULOSIS, V85, P347, DOI 10.1016/j.tube.2005.08.001; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rodrigue S, 2006, FEMS MICROBIOL REV, V30, P926, DOI 10.1111/j.1574-6976.2006.00040.x; Sachdeva P, 2008, FEBS J, V275, P6295, DOI 10.1111/j.1742-4658.2008.06753.x; Said-Salim B, 2006, MOL MICROBIOL, V62, P1251, DOI 10.1111/j.1365-2958.2006.05455.x; Song TS, 2003, MOL MICROBIOL, V50, P949, DOI 10.1046/j.1365-2958.2003.03739.x; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Urbauer JL, 2002, P NATL ACAD SCI USA, V99, P1831, DOI 10.1073/pnas.032464699; Vijay K, 2000, MOL MICROBIOL, V35, P180, DOI 10.1046/j.1365-2958.2000.01697.x; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WOOLFSON DN, 1995, PROTEIN SCI, V4, P1596, DOI 10.1002/pro.5560040818; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Yang XF, 1996, GENE DEV, V10, P2265, DOI 10.1101/gad.10.18.2265; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291	37	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29828	29835		10.1074/jbc.M109.056168	http://dx.doi.org/10.1074/jbc.M109.056168			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19700407	Green Published, hybrid			2022-12-25	WOS:000270896800063
J	Chanda, D; Li, TG; Song, KH; Kim, YH; Sim, JG; Lee, CH; Chiang, JYL; Choi, HS				Chanda, Dipanjan; Li, Tiangang; Song, Kwang-Hoon; Kim, Yong-Hoon; Sim, Jeonggu; Lee, Chul Ho; Chiang, John Y. L.; Choi, Hueng-Sik			Hepatocyte Growth Factor Family Negatively Regulates Hepatic Gluconeogenesis via Induction of Orphan Nuclear Receptor Small Heterodimer Partner in Primary Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HEPG2 LIVER-CELLS; SIGNALING PATHWAY; GENE-EXPRESSION; DIABETIC-NEPHROPATHY; MICE; UPSTREAM; INSULIN; HYPERGLYCEMIA; PROMOTER	Hepatic gluconeogenesis is tightly balanced by opposing stimulatory (glucagon) and inhibitory (insulin) signaling pathways. Hepatocyte growth factor (HGF) is a pleiotropic growth factor that mediates diverse biological processes. In this study, we investigated the effect of HGF and its family member, macrophage-stimulating factor (MSP), on hepatic gluconeogenesis in primary hepatocytes. HGF and MSP significantly repressed expression of the key hepatic gluconeogenic enzyme genes, phosphoenolpyruvate carboxykinase (PEPCK), and glucose-6-phosphatase (Glc-6-Pase) and reduced glucose production. HGF and MSP activated small heterodimer partner (SHP) gene promoter and induced SHP mRNA and protein levels, and the effect of HGF and MSP on SHP gene expression was demonstrated to be mediated via activation of the AMP-activated protein kinase (AMPK) signaling pathway. We demonstrated that upstream stimulatory factor-1 (USF-1) specifically mediated HGF effect on SHP gene expression, and inhibition of USF-1 by dominant negative USF-1 significantly abrogated HGF-mediated activation of the SHP promoter. Elucidation of the mechanism showed that USF-1 bound to E-box-1 in the SHP promoter, and HGF increased USF-1 DNA binding on the SHP promoter via AMPK and DNA-dependent protein kinase-mediated pathways. Adenoviral overexpression of USF-1 significantly repressed PEPCK and Glc-6-Pase gene expression and reduced glucose production. Knockdown of endogenous SHP expression significantly reversed this effect. Finally, knockdown of SHP or inhibition of AMPK signaling reversed the ability of HGF to suppress hepatocyte nuclear factor 4 alpha-mediated up-regulation of PEPCK and Glc-6-Pase gene expression along with the HGF- and MSP-mediated suppression of gluconeogenesis. Overall, our results suggest a novel signaling pathway through HGF/AMPK/USF-1/SHP to inhibit hepatic gluconeogenesis.	[Chanda, Dipanjan; Sim, Jeonggu; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea; [Li, Tiangang; Song, Kwang-Hoon; Chiang, John Y. L.] Northeastern Ohio Univ Coll Med & Pharm, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Kim, Yong-Hoon; Lee, Chul Ho] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea	Chonnam National University; Northeast Ohio Medical University (NEOMED); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Choi, HS (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr	Chanda, Dipanjan/AAU-3996-2021; Chiang, John Y. L./G-2658-2011	Chanda, Dipanjan/0000-0003-0685-187X; Chiang, John Y. L./0000-0001-9360-7650	National Institutes of Health [DK44442, DK58379]; Korea Science and Engineering Foundation [NRL-ROA-2005-000-10047-0]; Korea Research Foundation [2006-005-J03003]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK044442, R01DK044442, R37DK058379, R01DK058379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korea Research Foundation(National Research Foundation of Korea); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK44442 and DK58379 (to J. Y. L. C.). This work was also supported by Korea Science and Engineering Foundation through the National Research Laboratory Program Grant NRL-ROA-2005-000-10047-0 and by Korea Research Foundation Grant 2006-005-J03003) (to H. S. C.).	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Chanda D, 2008, AM J PHYSIOL-ENDOC M, V295, pE368, DOI 10.1152/ajpendo.00800.2007; Chanda D, 2008, ENDOCR J, V55, P253, DOI 10.1507/endocrj.K07E-103; Chen QY, 1997, HEPATOLOGY, V26, P59; Cruzado JM, 2004, DIABETES, V53, P1119, DOI 10.2337/diabetes.53.4.1119; Dai CS, 2004, J AM SOC NEPHROL, V15, P2637, DOI 10.1097/01.ASN.0000139479.09658.EE; Dai CS, 2003, J BIOL CHEM, V278, P27080, DOI 10.1074/jbc.M211947200; Danilkovitch A, 1999, J LEUKOCYTE BIOL, V65, P345, DOI 10.1002/jlb.65.3.345; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Garcia-Ocana A, 2000, J BIOL CHEM, V275, P1226, DOI 10.1074/jbc.275.2.1226; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hiratsuka A, 2005, J CLIN ENDOCR METAB, V90, P2927, DOI 10.1210/jc.2004-1588; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Imagawa S, 2006, ARTERIOSCL THROM VAS, V26, P2407, DOI 10.1161/01.ATV.0000240318.61359.e3; Iynedjian PB, 1998, BIOCHEM J, V333, P705, DOI 10.1042/bj3330705; Kato N, 2005, DIABETES, V54, P846, DOI 10.2337/diabetes.54.3.846; Kim HJ, 2003, NUCLEIC ACIDS RES, V31, P6860, DOI 10.1093/nar/gkg906; Kim JH, 2008, J MOL BIOL, V383, P502, DOI 10.1016/j.jmb.2008.08.036; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; KODAMA H, 1994, DIABETOLOGIA, V37, P739, DOI 10.1007/s001250050173; Lee YS, 2007, INT REV CYTOL, V261, P117, DOI 10.1016/S0074-7696(07)61003-1; Liu HY, 2008, J BIOL CHEM, V283, P30642, DOI 10.1074/jbc.M803698200; McElwee KJ, 2004, J INVEST DERMATOL, V123, P34, DOI 10.1111/j.0022-202X.2004.22712.x; Nakamura S, 1998, J HYPERTENS, V16, P2019, DOI 10.1097/00004872-199816121-00025; Park MK, 2003, EXP MOL MED, V35, P494, DOI 10.1038/emm.2003.64; Rehman J, 2003, J AM COLL CARDIOL, V41, P1408, DOI 10.1016/S0735-1097(03)00231-6; Roccisana J, 2005, DIABETES, V54, P2090, DOI 10.2337/diabetes.54.7.2090; Satani K, 2006, DIABETIC MED, V23, P617, DOI 10.1111/j.1464-5491.2006.01849.x; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Shiota G, 1995, J MED, V26, P295; Song KH, 2007, HEPATOLOGY, V46, P1993, DOI 10.1002/hep.21878; TOMIYA T, 1992, HEPATOLOGY, V15, P1, DOI 10.1002/hep.1840150102; van Deursen D, 2008, DIABETOLOGIA, V51, P2078, DOI 10.1007/s00125-008-1125-6; Vazquez-Chantada M, 2009, HEPATOLOGY, V49, P608, DOI 10.1002/hep.22660; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Xie YB, 2009, NUCLEIC ACIDS RES, V37, P4100, DOI 10.1093/nar/gkp333; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yanai K, 1997, J BIOL CHEM, V272, P30558, DOI 10.1074/jbc.272.48.30558; You WK, 2008, BMB REP, V41, P833, DOI 10.5483/BMBRep.2008.41.12.833	40	45	49	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28510	28521		10.1074/jbc.M109.022244	http://dx.doi.org/10.1074/jbc.M109.022244			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19720831	Green Published, hybrid			2022-12-25	WOS:000270678900005
J	Oh, M; Kim, H; Yang, IW; Park, JH; Cong, WT; Baek, MC; Bareiss, S; Ki, H; Lu, Q; No, J; Kwon, I; Choi, JK; Kim, K				Oh, Minsoo; Kim, Hangun; Yang, Ilhwan; Park, Ja-Hye; Cong, Wei-Tao; Baek, Moon-Chang; Bareiss, Sonja; Ki, Hyunkyoung; Lu, Qun; No, Jinhyung; Kwon, Inho; Choi, Jung-Kap; Kim, Kwonseop			GSK-3 Phosphorylates delta-Catenin and Negatively Regulates Its Stability via Ubiquitination/Proteosome-mediated Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; NEURODEGENERATIVE DISEASE; ALZHEIMERS-DISEASE; ADHERENS JUNCTION; ARMADILLO PROTEIN; E-CADHERIN; PRESENILIN-1; EXPRESSION; MECHANISM	delta-Catenin was first identified because of its interaction with presenilin-1, and its aberrant expression has been reported in various human tumors and in patients with Cri-du-Chat syndrome, a form of mental retardation. However, the mechanism whereby delta-catenin is regulated in cells has not been fully elucidated. We investigated the possibility that glycogen-synthase kinase-3 (GSK-3) phosphorylates delta-catenin and thus affects its stability. Initially, we found that the level of delta-catenin was greater and the half-life of delta-catenin was longer in GSK-3 beta(-/-) fibroblasts than those in GSK-3 beta(+/+)fibroblasts. Furthermore, four different approaches designed to specifically inhibit GSK-3 activity, i.e. GSK-3-specific chemical inhibitors, Wnt-3a conditioned media, small interfering RNAs, and GSK-3 alpha and -3 beta kinase dead constructs, consistently showed that the levels of endogenous delta-catenin in CWR22Rv-1 prostate carcinoma cells and primary cortical neurons were increased by inhibiting GSK-3 activity. In addition, it was found that both GSK-3 alpha and -3 beta interact with and phosphorylate delta-catenin. The phosphorylation of Delta C207-delta-catenin (lacking 207 C-terminal residues) and T1078A delta-catenin by GSK-3 was noticeably reduced compared with that of wild type delta-catenin, and the data from liquid chromatography-tandem mass spectrometry analyses suggest that the Thr(1078) residue of delta-catenin is one of the GSK-3 phosphorylation sites. Treatment with MG132 or ALLN, specific inhibitors of proteosome-dependent proteolysis, increased delta-catenin levels and caused an accumulation of ubiquitinated delta-catenin. It was also found that GSK-3 triggers the ubiquitination of delta-catenin. These results suggest that GSK-3 interacts with and phosphorylates delta-catenin and thereby negatively affects its stability by enabling its ubiquitination/proteosome-mediated proteolysis.	[Ki, Hyunkyoung; No, Jinhyung; Kwon, Inho; Choi, Jung-Kap; Kim, Kwonseop] Chonnam Natl Univ, Coll Pharm, Kwangju 500757, South Korea; [Ki, Hyunkyoung; No, Jinhyung; Kwon, Inho; Choi, Jung-Kap; Kim, Kwonseop] Chonnam Natl Univ, Res Inst Drug Dev, Kwangju 500757, South Korea; [Park, Ja-Hye; Baek, Moon-Chang] Kyungpook Natl Univ, Sch Med, Dept Mol Med, Taegu 700422, South Korea; [Cong, Wei-Tao] Wenzhou Med Coll, Sch Pharm, Wenzhou 325000, Peoples R China; [Bareiss, Sonja; Lu, Qun; Kim, Kwonseop] E Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27834 USA	Chonnam National University; Chonnam National University; Kyungpook National University; Wenzhou Medical University; University of North Carolina; East Carolina University	Kim, K (corresponding author), Chonnam Natl Univ, Coll Pharm, Bldg 1-211,300 Yongbong Dong, Kwangju 500757, South Korea.	koskim@chonnam.ac.kr			National Institutes of Health [AG026630, CA111891]; Korea Healthcare Technology R D Project [A084462]; Korean Ministry for Health, Welfare Family Affairs; New Technology R D Project; NATIONAL CANCER INSTITUTE [R01CA111891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG026630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Healthcare Technology R D Project; Korean Ministry for Health, Welfare Family Affairs; New Technology R D Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG026630 (to Q. L.) and CA111891 (to Q. L.). This work was also supported by Korea Healthcare Technology R & D Project Grant A084462, funds from the Korean Ministry for Health, Welfare& Family Affairs (to K. K.), and a grant from the New Technology R & D Project (Gwang-Ju Technopark, Korea).	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Abu-Elneel K, 2008, J BIOL CHEM, V283, P32781, DOI 10.1074/jbc.M804688200; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Ho C, 2000, J COMP NEUROL, V420, P261; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Ide N, 1999, BIOCHEM BIOPH RES CO, V256, P456, DOI 10.1006/bbrc.1999.0364; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Jones SB, 2002, NEUROSCIENCE, V115, P1009, DOI 10.1016/S0306-4522(02)00532-8; Kaytor MD, 2002, CURR OPIN NEUROBIOL, V12, P275, DOI 10.1016/S0959-4388(02)00320-3; Kim H, 2005, J BIOL CHEM, V280, P22462, DOI 10.1074/jbc.M502769200; Kim JS, 2006, BIOCHEM BIOPH RES CO, V351, P903, DOI 10.1016/j.bbrc.2006.10.135; Kim K, 2002, EXP CELL RES, V275, P171, DOI 10.1006/excr.2002.5503; Kosik KS, 2005, TRENDS CELL BIOL, V15, P172, DOI 10.1016/j.tcb.2005.01.004; Lau KF, 1999, J PEPT RES, V54, P85, DOI 10.1034/j.1399-3011.1999.00083.x; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lu Q, 2005, HUM PATHOL, V36, P1037, DOI 10.1016/j.humpath.2005.07.012; Lu Q, 2002, J NEUROSCI RES, V67, P618, DOI 10.1002/jnr.10151; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Maccioni RB, 2001, ARCH MED RES, V32, P367, DOI 10.1016/S0188-4409(01)00316-2; Mackie S, 2005, FEBS J, V272, P4202, DOI 10.1111/j.1742-4658.2005.04832.x; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Megy S, 2006, FEBS LETT, V580, P5411, DOI 10.1016/j.febslet.2006.08.084; Paffenholz R, 1997, DIFFERENTIATION, V61, P293, DOI 10.1046/j.1432-0436.1997.6150293.x; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Rodova M, 2004, MOL CELL BIOL, V24, P7188, DOI 10.1128/MCB.24.16.7188-7196.2004; Russell WK, 2001, ANAL CHEM, V73, P2682, DOI 10.1021/ac001332p; Setoyama D, 2007, P NATL ACAD SCI USA, V104, P18001, DOI 10.1073/pnas.0706952104; Silverman JB, 2007, J NEUROSCI, V27, P8505, DOI 10.1523/JNEUROSCI.1395-07.2007; Soond SM, 2008, J BIOL CHEM, V283, P16077, DOI 10.1074/jbc.M800384200; Tanahashi H, 1999, NEUROREPORT, V10, P563, DOI 10.1097/00001756-199902250-00022; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Tesco G, 2000, ANN NY ACAD SCI, V920, P227; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Wei S, 2008, J BIOL CHEM, V283, P26759, DOI 10.1074/jbc.M802160200; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Xia XB, 2003, BIOCHEMISTRY-US, V42, P9195, DOI 10.1021/bi034597h; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208; Zhou JH, 1997, NEUROREPORT, V8, P2085, DOI 10.1097/00001756-199705260-00054	39	36	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28579	28589		10.1074/jbc.M109.002659	http://dx.doi.org/10.1074/jbc.M109.002659			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706605	Green Published, hybrid			2022-12-25	WOS:000270678900012
J	Carpenter, J; Hutter, S; Baines, JF; Roller, J; Saminadin-Peter, SS; Parsch, J; Jiggins, FM				Carpenter, Jennifer; Hutter, Stephan; Baines, John F.; Roller, Julia; Saminadin-Peter, Sarah S.; Parsch, John; Jiggins, Francis M.			The Transcriptional Response of Drosophila melanogaster to Infection with the Sigma Virus (Rhabdoviridae)	PLOS ONE			English	Article							HOST-PARASITE INTERACTIONS; IMMUNE-RESPONSE; RNA VIRUSES; ANTIVIRAL RESPONSE; VIRAL-INFECTION; IN-VIVO; TOLL; GENES; TRANSMISSION; TRANSLATION	Background: Bacterial and fungal infections induce a potent immune response in Drosophila melanogaster, but it is unclear whether viral infections induce an antiviral immune response. Using microarrays, we examined the changes in gene expression in Drosophila that occur in response to infection with the sigma virus, a negative-stranded RNA virus (Rhabdoviridae) that occurs in wild populations of D. melanogaster. Principal Findings: We detected many changes in gene expression in infected flies, but found no evidence for the activation of the Toll, IMD or Jak-STAT pathways, which control immune responses against bacteria and fungi. We identified a number of functional categories of genes, including serine proteases, ribosomal proteins and chorion proteins that were overrepresented among the differentially expressed genes. We also found that the sigma virus alters the expression of many more genes in males than in females. Conclusions: These data suggest that either Drosophila do not mount an immune response against the sigma virus, or that the immune response is not controlled by known immune pathways. If the latter is true, the genes that we identified as differentially expressed after infection are promising candidates for controlling the host's response to the sigma virus.			Carpenter, J (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	jenny@jennycarpenter.com	Hutter, Stephan/K-3677-2014; Baines, John F/B-3580-2010	Baines, John F/0000-0002-8132-4909; Jiggins, Francis Michael/0000-0001-7470-8157; Hutter, Stephan/0000-0003-2432-8898	Wellcome Trust [WT081279] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ammar ED, 2009, ANNU REV ENTOMOL, V54, P447, DOI 10.1146/annurev.ento.54.110807.090454; Avila A, 2002, MOL CELL BIOL, V22, P8787, DOI 10.1128/MCB.22.24.8787-8795.2002; Baker DA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-454; Bangham J, 2008, MOL ECOL, V17, P3800, DOI 10.1111/j.1365-294X.2008.03873.x; Bangham J, 2008, GENETICS, V178, P2191, DOI 10.1534/genetics.107.085449; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Bourtzis K, 2000, INSECT MOL BIOL, V9, P635, DOI 10.1046/j.1365-2583.2000.00224.x; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Brun G, 1980, GENET BIOL DROSOPHIL, P625; Carpenter JA, 2007, MOL ECOL, V16, P3947, DOI 10.1111/j.1365-294X.2007.03460.x; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019; CONTAMINE D, 1989, GENETICS, V123, P525; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; FLEURIET A, 1988, EVOL BIOL, V23, P1; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Gnad F, 2006, BIOINFORMATICS, V22, P2577, DOI 10.1093/bioinformatics/btl422; Hurst GDD, 2003, INSECT MOL BIOL, V12, P93, DOI 10.1046/j.1365-2583.2003.00380.x; Hutter S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r12; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lewis E.B., 1960, DROS INFORM SERV, V34, P117, DOI DOI 10.1101/PDB.REC081414; McKean KA, 2005, EVOLUTION, V59, P1510; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Roxstrom-Lindquist K, 2004, EMBO REP, V5, P207, DOI 10.1038/sj.embor.7400073; Sanchez-Martinez JG, 2007, AQUAC RES, V38, P1339, DOI 10.1111/j.1365-2109.2007.01827.x; SPRADLING AC, 1980, P NATL ACAD SCI-BIOL, V77, P1096, DOI 10.1073/pnas.77.2.1096; Townsend JP, 2002, GENOME BIOL, V3; Townsend JP, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-54; Tsai CW, 2008, APPL ENVIRON MICROB, V74, P3251, DOI 10.1128/AEM.02248-07; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Whitlow ZW, 2006, J VIROL, V80, P11733, DOI 10.1128/JVI.00971-06; WYERS F, 1995, J VIROL, V69, P4463, DOI 10.1128/JVI.69.7.4463-4470.1995; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102	42	56	58	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6838	10.1371/journal.pone.0006838	http://dx.doi.org/10.1371/journal.pone.0006838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718442	Green Published, Green Submitted, gold			2022-12-25	WOS:000269415900011
J	Kanerva, K; Lappalainen, J; Makitie, LT; Virolainen, S; Kovanen, PT; Andersson, LC				Kanerva, Kristiina; Lappalainen, Jani; Makitie, Laura T.; Virolainen, Susanna; Kovanen, Petri T.; Andersson, Leif C.			Expression of Antizyme Inhibitor 2 in Mast Cells and Role of Polyamines as Selective Regulators of Serotonin Secretion	PLOS ONE			English	Article								Background: Upon IgE-mediated activation, mast cells (MC) exocytose their cytoplasmic secretory granules and release a variety of bioactive substances that trigger inflammatory responses. Polyamines mediate numerous cellular and physiological functions. We report here that MCs express antizyme inhibitor 2 (AZIN2), an activator of polyamine biosynthesis, previously reported to be exclusively expressed in the brain and testis. We have investigated the intracellular localization of AZIN2 both in resting and activated MCs. In addition, we have examined the functional role of polyamines, downstream effectors of AZIN2, as potential regulators of MC activity. Methodology/Principal Findings: Immunostainings show that AZIN2 is expressed in primary and neoplastic human and rodent MCs. We demonstrate that AZIN2 localizes in the Vamp-8 positive, serotonin-containing subset of MC granules, but not in tryptase-containing granules, as revealed by double immunofluorescence stainings. Furthermore, activation of MCs induces rapid upregulation of AZIN2 expression and its redistribution, suggesting a role for AZIN2 in secretory granule exocytosis. We also demonstrate that release of serotonin from activated MCs is polyamine-dependent whereas release of histamine and beta-hexosaminidase is not, indicating a granule subtype-specific function for polyamines. Conclusions/Significance: The study reports for the first time the expression of AZIN2 outside the brain and testis, and demonstrates the intracellular localization of endogenous AZIN2 in MCs. The granule subtype-specific expression and its induction after MC activation suggest a role for AZIN2 as a local, in situ regulator of polyamine biosynthesis in association with serotonin-containing granules of MCs. Furthermore, our data indicates a novel function for polyamines as selective regulators of serotonin release from MCs.			Kanerva, K (corresponding author), Univ Helsinki, Dept Pathol, Haartman Inst, Helsinki, Finland.	leif.andersson@helsinki.fi		Kanerva, Kristiina/0000-0003-1680-9448				Bercovich Z, 2004, J BIOL CHEM, V279, P54097, DOI 10.1074/jbc.M410234200; BUEB JL, 1992, BIOCHEM J, V282, P545, DOI 10.1042/bj2820545; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Choi KS, 2005, BIOCHEM BIOPH RES CO, V328, P206, DOI 10.1016/j.bbrc.2004.11.172; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Ivanov IP, 2000, P NATL ACAD SCI USA, V97, P4808, DOI 10.1073/pnas.070055897; Ivanov IP, 1998, GENOMICS, V52, P119, DOI 10.1006/geno.1998.5434; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kanerva K, 2008, BIOCHEM J, V409, P187, DOI 10.1042/BJ20071004; Keren-Paz A, 2006, ONCOGENE, V25, P5163, DOI 10.1038/sj.onc.1209521; Kirshenbaum AS, 1999, BLOOD, V94, P2333, DOI 10.1182/blood.V94.7.2333.419k30_2333_2342; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; KITAMURA Y, 1989, ANNU REV IMMUNOL, V7, P59, DOI 10.1146/annurev.iy.07.040189.000423; KOENIG H, 1983, NATURE, V305, P530, DOI 10.1038/305530a0; KULCZYCKI A, 1974, J EXP MED, V139, P600, DOI 10.1084/jem.139.3.600; Lappalainen J, 2007, CLIN EXP ALLERGY, V37, P1404, DOI 10.1111/j.1365-2222.2007.02778.x; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lopez-Contreras AJ, 2008, J BIOL CHEM, V283, P20761, DOI 10.1074/jbc.M801024200; Makitie LT, 2009, EXP CELL RES, V315, P1008, DOI 10.1016/j.yexcr.2009.01.029; Mangold U, 2008, ONCOGENE, V27, P604, DOI 10.1038/sj.onc.1210685; MCCORMACK JG, 1989, BIOCHEM J, V264, P167, DOI 10.1042/bj2640167; Mekori YA, 2000, IMMUNOL REV, V173, P131, DOI 10.1034/j.1600-065X.2000.917305.x; Metcalfe DD, 2008, BLOOD, V112, P946, DOI 10.1182/blood-2007-11-078097; MITCHELL JLA, 1994, BIOCHEM J, V299, P19, DOI 10.1042/bj2990019; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Murakami Y, 1996, J BIOL CHEM, V271, P3340, DOI 10.1074/jbc.271.7.3340; Nilsson J, 2000, BIOCHEM J, V346, P699, DOI 10.1042/0264-6021:3460699; Pitkanen LT, 2001, BIOCHEM BIOPH RES CO, V287, P1051, DOI 10.1006/bbrc.2001.5703; PRICE LS, 1995, CURR BIOL, V5, P68, DOI 10.1016/S0960-9822(95)00018-2; Puri N, 2008, P NATL ACAD SCI USA, V105, P2580, DOI 10.1073/pnas.0707854105; Schipper RG, 2004, J HISTOCHEM CYTOCHEM, V52, P1259, DOI 10.1369/jhc.4C6389.2004; Shantz LM, 2007, AMINO ACIDS, V33, P213, DOI 10.1007/s00726-007-0531-2; Shin M, 2008, HISTOCHEM CELL BIOL, V129, P659, DOI 10.1007/s00418-008-0400-4; Snapir Z, 2008, BIOCHEM J, V410, P613, DOI 10.1042/BJ20071423; TAUB D, 1995, J IMMUNOL, V154, P2393; THEOHARIDES TC, 1982, NATURE, V297, P229, DOI 10.1038/297229a0; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289	39	38	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6858	10.1371/journal.pone.0006858	http://dx.doi.org/10.1371/journal.pone.0006858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718454	gold, Green Submitted, Green Published			2022-12-25	WOS:000269415900023
J	Bronner, IF; Bochdanovits, Z; Rizzu, P; Kamphorst, W; Ravid, R; van Swieten, JC; Heutink, P				Bronner, Iraad F.; Bochdanovits, Zoltan; Rizzu, Patrizia; Kamphorst, Wouter; Ravid, Rivka; van Swieten, John C.; Heutink, Peter			Comprehensive mRNA Expression Profiling Distinguishes Tauopathies and Identifies Shared Molecular Pathways	PLOS ONE			English	Article								Background: Understanding the aetiologies of neurodegenerative diseases such as Alzheimer's disease (AD), Pick's disease (PiD), Progressive Supranuclear Palsy (PSP) and Frontotemporal dementia (FTD) is often hampered by the considerable clinical and molecular overlap between these diseases and normal ageing. The development of high throughput genomic technologies such as microarrays provide a new molecular tool to gain insight in the complexity and relationships between diseases, as they provide data on the simultaneous activity of multiple genes, gene networks and cellular pathways. Methodology/Principal Findings: We have constructed genome wide expression profiles from snap frozen post-mortem tissue from the medial temporal lobe of patients with four neurodegenerative disorders (5 AD, 5 PSP, 5 PiD and 5 FTD patients) and 5 control subjects. All patients were matched for age, gender, ApoE-e and MAPT (tau) haplotype. From all groups a total of 790 probes were shown to be differently expressed when compared to control individuals. The results from these experiments were then used to investigate the correlations between clinical, pathological and molecular findings. From the 790 identified probes we extracted a gene set of 166 probes whose expression could discriminate between these disorders and normal ageing. Conclusions/Significance: From genome wide expression profiles we extracted a gene set of 166 probes whose expression could discriminate between neurological disorders and normal ageing. This gene set can be further developed into an accurate microarray-based classification test. Furthermore, from this dataset we extracted a disease specific set of genes and identified two aging related transcription factors (FOXO1A and FOXO3A) as possible drug targets related to neurodegenerative disease.			Bronner, IF (corresponding author), Vrije Univ Amsterdam Med Ctr, Sect Med Genom, Dept Clin Genet, Amsterdam, Netherlands.	p.heutink@vumc.nl		Heutink, Peter/0000-0001-5218-1737; van Swieten, John/0000-0001-6278-6844				Bakker WJ, 2004, J CELL BIOL, V164, P175, DOI 10.1083/jcb.200307056; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Bochdanovits Z, 2003, EVOLUTION, V57, P1829; Bochdanovits Z, 2003, MOL BIOL EVOL, V20, P1760, DOI 10.1093/molbev/msg179; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRONNER IF, 2005, BRAIN; Bronner IF, 2007, EUR J HUM GENET, V15, P369, DOI 10.1038/sj.ejhg.5201772; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; CONSTANTINIDIS J, 1985, PICK DEMENTIA ANATOM, P72; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Fitzpatrick R, 2002, BBA-GENE STRUCT EXPR, V1574, P10, DOI 10.1016/S0167-4781(01)00322-0; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Harrison PJ, 1995, NEUROSCI LETT, V200, P151, DOI 10.1016/0304-3940(95)12102-A; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Hribal ML, 2003, J CELL BIOL, V162, P535, DOI 10.1083/jcb.200212107; Huang TT, 2006, NAT CELL BIOL, V8, P1043, DOI 10.1038/ncb1006-1043; Hynd MR, 2003, J NEUROCHEM, V85, P543, DOI 10.1046/j.1471-4159.2003.01747.x; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lukiw WJ, 1997, J NEUROSCI RES, V50, P937, DOI 10.1002/(SICI)1097-4547(19971215)50:6<937::AID-JNR4>3.0.CO;2-E; Mandel S, 2005, ANN NY ACAD SCI, V1053, P356, DOI 10.1196/annals.1344.031; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neary D, 2005, LANCET NEUROL, V4, P771, DOI 10.1016/S1474-4422(05)70223-4; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Park JW, 2006, J MED GENET, V43, P598, DOI 10.1136/jmg.2005.040162; Preece P, 2003, MOL BRAIN RES, V116, P7, DOI 10.1016/S0169-328X(03)00208-0; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Rizzu P, 2006, AM J MED GENET B, V141B, P944, DOI 10.1002/ajmg.b.30410; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Scaravilli T, 2005, MOVEMENT DISORD, V20, pS21, DOI 10.1002/mds.20536; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Shelton JG, 2004, CELL CYCLE, V3, P372; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Spillantini MG, 1997, P NATL ACAD SCI USA, V94, P4113, DOI 10.1073/pnas.94.8.4113; Stuart CA, 1999, METABOLISM, V48, P876, DOI 10.1016/S0026-0495(99)90222-6; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Yasojima K, 2001, BRAIN RES PROTOC, V8, P212, DOI 10.1016/S1385-299X(01)00119-2	49	32	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2009	4	8							e6826	10.1371/journal.pone.0006826	http://dx.doi.org/10.1371/journal.pone.0006826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JG	19714246	Green Published, gold, Green Submitted			2022-12-25	WOS:000269415800010
J	Nandy, A				Nandy, Ashesh			Empirical Relationship between Intra-Purine and Intra-Pyrimidine Differences in Conserved Gene Sequences	PLOS ONE			English	Article							GRAPHICAL REPRESENTATION; DNA-SEQUENCES; TOPOLOGICAL INDEXES; NUCLEOTIDE; EVOLUTION	DNA sequences seen in the normal character-based representation appear to have a formidable mixing of the four nucleotides without any apparent order. Nucleotide frequencies and distributions in the sequences have been studied extensively, since the simple rule given by Chargaff almost a century ago that equates the total number of purines to the pyrimidines in a duplex DNA sequence. While it is difficult to trace any relationship between the bases from studies in the character representation of a DNA sequence, graphical representations may provide a clue. These novel representations of DNA sequences have been useful in providing an overview of base distribution and composition of the sequences and providing insights into many hidden structures. We report here our observation based on a graphical representation that the intra-purine and intra-pyrimidine differences in sequences of conserved genes generally follow a quadratic distribution relationship and show that this may have arisen from mutations in the sequences over evolutionary time scales. From this hitherto undescribed relationship for the gene sequences considered in this report we hypothesize that such relationships may be characteristic of these sequences and therefore could become a barrier to large scale sequence alterations that override such characteristics, perhaps through some monitoring process inbuilt in the DNA sequences. Such relationship also raises the possibility of intron sequences playing an important role in maintaining the characteristics and could be indicative of possible intron-late phenomena.			Nandy, A (corresponding author), Jadavpur Univ, Sch Environm Studies, Kolkata, W Bengal, India.	anandy43@yahoo.com						Aguero-Chapin G, 2009, J PROTEOME RES, V8, P2122, DOI 10.1021/pr800867y; ARNOLD J, 1988, NUCLEIC ACIDS RES, V16, P7145, DOI 10.1093/nar/16.14.7145; Cruz-Monteagudo M, 2008, CHEM RES TOXICOL, V21, P619, DOI 10.1021/tx700296t; Estrada E, 2001, CURR MED CHEM, V8, P1573, DOI 10.2174/0929867013371923; Freeman JM., 1998, SCIENCE, V279, P1827, DOI [10.1126/science.279.5358.1827a, DOI 10.1126/science.279.5358.1827a, DOI 10.1126/SCIENCE.279.5358.1827A]; Garcia JA, 2005, REV MEX FIS, V51, P122; GATES MA, 1986, J THEOR BIOL, V119, P319, DOI 10.1016/S0022-5193(86)80144-8; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gonzalez-Diaz H, 2008, PROTEOMICS, V8, P750, DOI 10.1002/pmic.200700638; Gonzalez-Diaz H, 2007, CURR TOP MED CHEM, V7, P1015, DOI 10.2174/156802607780906771; Gonzalez-Diaz H, 2008, CURR TOP MED CHEM, V8, P1676, DOI 10.2174/156802608786786543; Greco C, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S15; HAMORI E, 1983, J BIOL CHEM, V258, P1318; JEFFREY HJ, 1990, NUCLEIC ACIDS RES, V18, P2163, DOI 10.1093/nar/18.8.2163; Larionov S, 2008, CHAOS, V18, DOI 10.1063/1.2826631; LEONG PM, 1995, COMPUT APPL BIOSCI, V11, P503; LEWIN B, GENES, V9, P18; Liao B, 2006, CHEM PHYS LETT, V421, P313, DOI 10.1016/j.cplett.2006.01.030; Liebovitch LS, 1996, BIOPHYS J, V71, P1539, DOI 10.1016/S0006-3495(96)79356-6; Lo NW, 2007, J INF SCI ENG, V23, P1723; Lolle SJ, 2005, NATURE, V434, P505, DOI 10.1038/nature03380; NANDY A, 1995, CURR SCI INDIA, V68, P75; NANDY A, 1994, CURR SCI INDIA, V66, P309; Nandy A, 2006, ARKIVOC, P211, DOI 10.3998/ark.5550190.0007.907; Nandy Ashesh, 2009, In Silico Biology, V9, P77, DOI 10.3233/ISB-2009-0389; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; Prusak B, 2004, ACTA BIOCHIM POL, V51, P897; QIDAI, 2007, J COMPUT CHEM, V28, P1434; Randic M, 2000, J CHEM INF COMP SCI, V40, P1235, DOI 10.1021/ci000034q; Raychaudhury C, 1999, J CHEM INF COMP SCI, V39, P243, DOI 10.1021/ci980077v; Roy A, 1998, J BIOSCIENCES, V23, P55, DOI 10.1007/BF02728525; STREHLER EE, 1986, J MOL BIOL, V190, P291, DOI 10.1016/0022-2836(86)90003-3; SUEOKA N, 1962, P NATL ACAD SCI USA, V48, P483; Wang WP, 2006, INT J QUANTUM CHEM, V106, P1998, DOI 10.1002/qua.21001	34	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2009	4	8							e6829	10.1371/journal.pone.0006829	http://dx.doi.org/10.1371/journal.pone.0006829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JG	19714250	Green Submitted, Green Published, gold			2022-12-25	WOS:000269415800013
J	Oakley, MS; Majam, V; Mahajan, B; Gerald, N; Anantharaman, V; Ward, JM; Faucette, LJ; McCutchan, TF; Zheng, H; Terabe, M; Berzofsky, JA; Aravind, L; Kumar, S				Oakley, Miranda S.; Majam, Victoria; Mahajan, Babita; Gerald, Noel; Anantharaman, Vivek; Ward, Jerrold M.; Faucette, Lawrence J.; McCutchan, Thomas F.; Zheng, Hong; Terabe, Masaki; Berzofsky, Jay A.; Aravind, L.; Kumar, Sanjai			Pathogenic Roles of CD14, Galectin-3, and OX40 during Experimental Cerebral Malaria in Mice	PLOS ONE			English	Article								An in-depth knowledge of the host molecules and biological pathways that contribute towards the pathogenesis of cerebral malaria would help guide the development of novel prognostics and therapeutics. Genome-wide transcriptional profiling of the brain tissue during experimental cerebral malaria (ECM) caused by Plasmodium berghei ANKA parasites in mice, a well established surrogate of human cerebral malaria, has been useful in predicting the functional classes of genes involved and pathways altered during the course of disease. To further understand the contribution of individual genes to the pathogenesis of ECM, we examined the biological relevance of three molecules -CD14, galectin-3, and OX40 that were previously shown to be overexpressed during ECM. We find that CD14 plays a predominant role in the induction of ECM and regulation of parasite density; deletion of the CD14 gene not only prevented the onset of disease in a majority of susceptible mice (only 21% of CD14-deficient compared to 80% of wildtype mice developed ECM, p < 0.0004) but also had an ameliorating effect on parasitemia (a 2 fold reduction during the cerebral phase). Furthermore, deletion of the galectin-3 gene in susceptible C57BL/6 mice resulted in partial protection from ECM (47% of galectin-3-deficient versus 93% of wildtype mice developed ECM, p < 0.0073). Subsequent adherence assays suggest that galectin-3 induced pathogenesis of ECM is not mediated by the recognition and binding of galectin-3 to P. berghei ANKA parasites. A previous study of ECM has demonstrated that brain infiltrating T cells are strongly activated and are CD44(+) CD62L(-) differentiated memory T cells [1]. We find that OX40, a marker of both T cell activation and memory, is selectively upregulated in the brain during ECM and its distribution among CD4(+) and CD8(+) T cells accumulated in the brain vasculature is approximately equal.			Oakley, MS (corresponding author), US FDA, Ctr Biol Evaluat & Res, Div Bacterial Parasit & Allergen Prod, Bethesda, MD 20014 USA.	sanjai.kumar@fda.hhs.gov	Anantharaman, Vivek/ABB-9991-2021	Anantharaman, Vivek/0000-0001-8395-0009; Aravind, L/0000-0003-0771-253X	NATIONAL CANCER INSTITUTE [ZIASC004020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000208, ZIGAI001047, Z01AI001047, ZIAAI000208] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM594244] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Almkvist J, 2002, GLYCOCONJUGATE J, V19, P575, DOI 10.1023/B:GLYC.0000014088.21242.e0; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; BAUM PR, 1994, EMBO J, V13, P3992, DOI 10.1002/j.1460-2075.1994.tb06715.x; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; BERENDT AR, 1994, PARASITOL TODAY, V10, P412, DOI 10.1016/0169-4758(94)90238-0; Bernardes ES, 2006, AM J PATHOL, V168, P1910, DOI 10.2353/ajpath.2006.050636; Carboni S, 2003, J NEUROIMMUNOL, V145, P1, DOI 10.1016/j.jneuroim.2003.07.001; CELADA A, 1984, INT ARCH ALLER A IMM, V73, P363, DOI 10.1159/000233499; CLARK IA, 1994, PARASITOL TODAY, V10, P410, DOI 10.1016/0169-4758(94)90237-2; Coban C, 2007, INT IMMUNOL, V19, P67, DOI 10.1093/intimm/dxl123; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; FINLEY RW, 1982, J IMMUNOL, V129, P2213; Giacomelli R, 2001, CLIN EXP RHEUMATOL, V19, P317; GRAU GE, 1986, J IMMUNOL, V137, P2348; Griffith JW, 2007, J INFECT DIS, V196, P1553, DOI 10.1086/522865; HAZIOT A, 1995, J IMMUNOL, V154, P6529; Haziot A, 2001, J IMMUNOL, V166, P1075, DOI 10.4049/jimmunol.166.2.1075; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Higgins LM, 1999, J IMMUNOL, V162, P486; Hori T, 2006, INT J HEMATOL, V83, P17, DOI 10.1532/IJH97.05151; HSU DK, 1992, J BIOL CHEM, V267, P14167; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Hughes RC, 2001, BIOCHIMIE, V83, P667; KHARAZMI A, 1984, SCAND J IMMUNOL, V20, P93, DOI 10.1111/j.1365-3083.1984.tb00981.x; Kleshchenko YY, 2004, INFECT IMMUN, V72, P6717, DOI 10.1128/IAI.72.11.6717-6721.2004; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; KUMAR S, 1989, J IMMUNOL, V143, P2017; Lepenies B, 2008, MED MICROBIOL IMMUN, V197, P39, DOI 10.1007/s00430-007-0057-y; Liu FT, 2005, INT ARCH ALLERGY IMM, V136, P385, DOI 10.1159/000084545; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Maegraith B, 1972, Adv Parasitol, V10, P49, DOI 10.1016/S0065-308X(08)60172-4; MALLETT S, 1990, EMBO J, V9, P1063, DOI 10.1002/j.1460-2075.1990.tb08211.x; Miu J, 2008, J IMMUNOL, V180, P1217, DOI 10.4049/jimmunol.180.2.1217; Miyake K, 2006, J ENDOTOXIN RES, V12, P195, DOI 10.1179/096805106X118807; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; MOUTSATSOS IK, 1987, P NATL ACAD SCI USA, V84, P6452, DOI 10.1073/pnas.84.18.6452; Nakahara S, 2005, APOPTOSIS, V10, P267, DOI 10.1007/s10495-005-0801-y; Nangia-Makker P, 2007, J BIOENERG BIOMEMBR, V39, P79, DOI 10.1007/s10863-006-9063-9; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; Oakley MS, 2008, INFECT IMMUN, V76, P4518, DOI 10.1128/IAI.00525-08; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Pelletier I, 2002, J BIOL CHEM, V277, P17663, DOI 10.1074/jbc.M201562200; Potter S, 2006, INT J PARASITOL, V36, P485, DOI 10.1016/j.ijpara.2005.12.005; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Salek-Ardakani S, 2006, VACCINE, V24, P872, DOI 10.1016/j.vaccine.2005.07.108; Sato S, 2002, GLYCOCONJUGATE J, V19, P583, DOI 10.1023/B:GLYC.0000014089.17121.cc; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Takasawa N, 2001, JPN J CANCER RES, V92, P377, DOI 10.1111/j.1349-7006.2001.tb01105.x; TAYLOR TE, 2009, T R SOC TROP MED HYG; Togbe D, 2007, AM J PATHOL, V170, P1640, DOI 10.2353/ajpath.2007.060889; TRUBOWITZ S, 1968, SCIENCE, V162, P273, DOI 10.1126/science.162.3850.273; van den Berg TK, 2004, J IMMUNOL, V173, P1902, DOI 10.4049/jimmunol.173.3.1902; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; Weinberg AD, 1999, J IMMUNOL, V162, P1818; Weinberg AD, 2004, J LEUKOCYTE BIOL, V75, P962, DOI 10.1189/jlb.1103586; Wenisch C, 1996, CLIN EXP IMMUNOL, V105, P74, DOI 10.1046/j.1365-2249.1996.d01-723.x; Wiese L, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-3; Wiese L, 2006, EXP NEUROL, V200, P216, DOI 10.1016/j.expneurol.2006.02.011; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yanez DM, 1996, J IMMUNOL, V157, P1620; Yoshioka T, 2000, EUR J IMMUNOL, V30, P2815, DOI 10.1002/1521-4141(200010)30:10<2815::AID-IMMU2815>3.0.CO;2-#	62	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2009	4	8							e6793	10.1371/journal.pone.0006793	http://dx.doi.org/10.1371/journal.pone.0006793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JE	19710907	Green Published, Green Submitted, gold			2022-12-25	WOS:000269415600007
J	Barr, FD; Krohmer, LJ; Hamilton, JW; Sheldon, LA				Barr, Fiona D.; Krohmer, Lori J.; Hamilton, Joshua W.; Sheldon, Lynn A.			Disruption of Histone Modification and CARM1 Recruitment by Arsenic Represses Transcription at Glucocorticoid Receptor-Regulated Promoters	PLOS ONE			English	Article								Chronic exposure to inorganic arsenic (iAs) found in the environment is one of the most significant and widespread environmental health risks in the U. S. and throughout the world. It is associated with a broad range of health effects from cancer to diabetes as well as reproductive and developmental anomalies. This diversity of diseases can also result from disruption of metabolic and other cellular processes regulated by steroid hormone receptors via aberrant transcriptional regulation. Significantly, exposure to iAs inhibits steroid hormone-mediated gene activation. iAs exposure is associated with disease, but is also used therapeutically to treat specific cancers complicating an understanding of iAs action. Transcriptional activation by steroid hormone receptors is accompanied by changes in histone and non-histone protein post-translational modification (PTM) that result from the enzymatic activity of coactivator and corepressor proteins such as GRIP1 and CARM1. This study addresses how iAs represses steroid receptor-regulated gene transcription. PTMs on histones H3 and H4 at the glucocorticoid receptor (GR)-activated mouse mammary tumor virus (MMTV) promoter were identified by chromatin immunoprecipitation analysis following exposure to steroid hormone +/- iAs. Histone H3K18 and H3R17 amino acid residues had significantly different patterns of PTMs after treatment with iAs. Promoter interaction of the coactivator CARM1 was disrupted, but the interaction of GRIP1, a p160 coactivator through which CARM1 interacts with a promoter, was intact. Over-expression of CARM1 was able to fully restore and GRIP1 partially restored iAs-repressed transcription indicating that these coactivators are functionally associated with iAs-mediated transcriptional repression. Both are essential for robust transcription at steroid hormone regulated genes and both are associated with disease when inappropriately expressed. We postulate that iAs effects on CARM1 and GRIP1 may underlie some of its therapeutic effects and as well be associated with its toxic effects.			Barr, FD (corresponding author), Dartmouth Med Sch, Dept Physiol, Lebanon, NH USA.	Lynn.A.Sheldon@Dartmouth.edu			NIEHS NIH HHS [P42 ES007373, ES007373, ES013168, R01 ES013168] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013168, P42ES007373] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Aoyagi S, 2008, MOL CELL ENDOCRINOL, V280, P1, DOI 10.1016/j.mce.2007.08.016; Aoyagi S, 2007, MOL ENDOCRINOL, V21, P843, DOI 10.1210/me.2006-0244; Balk Steven P, 2008, Nucl Recept Signal, V6, pe001, DOI 10.1621/nrs.06001; Baumann CT, 2001, MOL ENDOCRINOL, V15, P485, DOI 10.1210/me.15.4.485; Bode AM, 2005, PROG NUCLEIC ACID RE, V79, P237, DOI 10.1016/S0079-6603(04)79005-4; Bodwell JE, 2004, CHEM RES TOXICOL, V17, P1064, DOI 10.1021/tx0499113; BODWELL JE, 1984, BIOCHEMISTRY-US, V23, P4237, DOI 10.1021/bi00313a034; CHARRON J, 1989, MOL CELL BIOL, V9, P3127, DOI 10.1128/MCB.9.7.3127; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen DG, 2000, J BIOL CHEM, V275, P40810, DOI 10.1074/jbc.M005459200; Chen HB, 2006, MOL CELL BIOL, V26, P3728, DOI 10.1128/MCB.26.10.3728-3737.2006; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; DACWAG CS, 2009, MOL CELL BIOL; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Davey JC, 2008, ENVIRON HEALTH PERSP, V116, P165, DOI 10.1289/ehp.10131; Davey JC, 2007, TOXICOL SCI, V98, P75, DOI 10.1093/toxsci/kfm013; DiRenzo J, 2000, MOL CELL BIOL, V20, P7541, DOI 10.1128/MCB.20.20.7541-7549.2000; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Feng Q, 2006, MOL CELL BIOL, V26, P7846, DOI 10.1128/MCB.00568-06; Fletcher TM, 2000, MOL CELL BIOL, V20, P6466, DOI 10.1128/MCB.20.17.6466-6475.2000; Fletcher TM, 2002, MOL CELL BIOL, V22, P3255, DOI 10.1128/MCB.22.10.3255-3263.2002; Fragoso G, 1998, MOL CELL BIOL, V18, P3633, DOI 10.1128/MCB.18.6.3633; Frigo DE, 2006, MOL ENDOCRINOL, V20, P971, DOI 10.1210/me.2004-0075; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Georgel PT, 2003, GENE DEV, V17, P1617, DOI 10.1101/gad.1097603; Golebiowski F, 2005, MOL CELL BIOCHEM, V279, P133, DOI 10.1007/s11010-005-8285-1; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Higashimoto K, 2007, P NATL ACAD SCI USA, V104, P12318, DOI 10.1073/pnas.0610792104; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Hong SH, 2001, MOL CELL BIOL, V21, P7172, DOI 10.1128/MCB.21.21.7172-7182.2001; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Jacobsen BM, 2005, MOL ENDOCRINOL, V19, P574, DOI 10.1210/me.2004-0287; Johnson TA, 2008, MOL BIOL CELL, V19, P3308, DOI 10.1091/mbc.E08-02-0123; Kaltreider Ronald C., 2001, Environmental Health Perspectives, V109, P245, DOI 10.2307/3434692; Kannan-Thulasiraman P, 2006, J BIOL CHEM, V281, P22446, DOI 10.1074/jbc.M603111200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lambert JR, 2003, MOL ENDOCRINOL, V17, P1085, DOI 10.1210/me.2001-0183; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Li C, 2007, MOL CELL BIOL, V27, P1296, DOI 10.1128/MCB.00336-06; Li J, 2003, J BIOL CHEM, V278, P13183, DOI 10.1074/jbc.M300269200; Li SS, 2007, CELL SIGNAL, V19, P1101, DOI 10.1016/j.cellsig.2007.02.002; Li XT, 2003, MOL CELL BIOL, V23, P3763, DOI 10.1128/MCB.23.11.3763-3773.2003; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Naeem H, 2007, MOL CELL BIOL, V27, P120, DOI 10.1128/MCB.00815-06; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; National Research Council (NRC), 2001, ARS DRINK WAT 2001 U; Oh AS, 2008, MOL CELL BIOL, V28, P6580, DOI 10.1128/MCB.00118-08; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; ROSENBLATT AE, 2009, MOL ENDOCRINOL; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; SCHNEKENBURGER M, 2007, MOL CELL BIOL; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Sheldon LA, 2001, J BIOL CHEM, V276, P32423, DOI 10.1074/jbc.C100315200; SIMONS SS, 1990, J BIOL CHEM, V265, P1938; Smith AH, 2002, SCIENCE, V296, P2145, DOI 10.1126/science.1072896; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Teyssier C, 2002, J BIOL CHEM, V277, P46066, DOI 10.1074/jbc.M207623200; Teyssier C, 2006, MOL ENDOCRINOL, V20, P1276, DOI 10.1210/me.2005-0393; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; Verma A, 2002, J BIOL CHEM, V277, P44988, DOI 10.1074/jbc.M207176200; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Xu W, 2004, GENE DEV, V18, P144, DOI 10.1101/gad.1141704; Yi P, 2008, MOL CELL, V29, P465, DOI 10.1016/j.molcel.2007.12.030; Zhou X., 2008, CARCINOGENESIS	74	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6766	10.1371/journal.pone.0006766	http://dx.doi.org/10.1371/journal.pone.0006766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707557	Green Submitted, Green Published, gold			2022-12-25	WOS:000269335000012
J	Chen, MH; Huang, JD; Hu, L; Zheng, BJ; Chen, LL; Tsang, SL; Guan, XY				Chen, Muhan; Huang, Jian-dong; Hu, Liang; Zheng, Bo-jian; Chen, Leilei; Tsang, Sze Lan; Guan, Xin-yuan			Transgenic CHD1L Expression in Mouse Induces Spontaneous Tumors	PLOS ONE			English	Article								Background: Amplification of 1q21 is the most frequent genetic alteration in hepatocellular carcinoma (HCC), which was detected in 58-78% of primary HCC cases by comparative genomic hybridization (CGH). Using chromosome microdissection/hybrid selection approach we recently isolated a candidate oncogene CHD1L from 1q21 region. Our previous study has demonstrated that CHD1L had strong oncogenic ability, which could be effectively suppressed by siRNA against CHD1L. The molecular mechanism of CHD1L in tumorigenesis has been associated with its role in promoting cell proliferation. Methodology/Principal Findings: To further investigate the in vivo oncogenic role of CHD1L, CHD1L ubiquitous-expression transgenic mouse model was generated. Spontaneous tumor formations were found in 10/41 (24.4%) transgenic mice, including 4 HCCs, but not in their 39 wild-type littermates. In addition, alcohol intoxication was used to induce hepatocyte pathological lesions and results found that overexpression of CHD1L in hepatocytes could promote tumor susceptibility in CHD1L-transgenic mice. To address the mechanism of CHD1L in promoting cell proliferation, DNA content between CHD1L-transgenic and wildtype mouse embryo fibroblasts (MEFs) was compared by flow cytometry. Flow cytometry results found that CHD1L could facilitate DNA synthesis and G1/S transition through the up-regulation of Cyclin A, Cyclin D1, Cyclin E, CDK2, and CDK4, and down-regulation of Rb, p27 Kip1, and p53. Conclusion/ Significance: Taken together, our data strongly support that CHD1L is a novel oncogene and plays an important role in HCC pathogenesis			Chen, MH (corresponding author), Univ Hong Kong, Dept Clin Oncol, Pokfulam, Hong Kong, Peoples R China.	xyguan@hkucc.hku.hk	Chen, Leilei/F-7668-2011; Guan, Xin-Yuan/A-3639-2009; /C-4277-2009	Chen, Polly Leilei/0000-0002-1987-3878; Guan, Xin-Yuan/0000-0002-4485-6017; /0000-0001-7531-2816				El-Serag HB, 2001, HEPATOLOGY, V33, P62, DOI 10.1053/jhep.2001.21041; Guan XY, 2000, GENE CHROMOSOME CANC, V29, P110; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; He QJ, 2003, CANCER GENET CYTOGEN, V144, P112, DOI 10.1016/S0165-4608(02)00959-7; HOGAN B, 1983, NATURE, V306, P313, DOI 10.1038/306313a0; Kiuru-Kuhlefelt S, 1998, MODERN PATHOL, V11, P227; Kusano N, 1999, HEPATOLOGY, V29, P1858, DOI 10.1002/hep.510290636; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Ma NF, 2008, HEPATOLOGY, V47, P503, DOI 10.1002/hep.22072; Marchio A, 1997, GENE CHROMOSOME CANC, V18, P59, DOI 10.1002/(SICI)1098-2264(199701)18:1<59::AID-GCC7>3.0.CO;2-0; Montalto G, 2002, ANN NY ACAD SCI, V963, P13, DOI 10.1111/j.1749-6632.2002.tb04090.x; Pani G, 2004, BIOCHEM BIOPH RES CO, V325, P97, DOI 10.1016/j.bbrc.2004.09.213; Qin LX, 1999, CANCER RES, V59, P5662; Schulten HJ, 2004, AM J CLIN PATHOL, V122, P546, DOI 10.1309/MBQ1ECRYU8CRD2WH; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang Y, 2002, CANCER-AM CANCER SOC, V95, P2346, DOI 10.1002/cncr.10963; Wong N, 1999, AM J PATHOL, V154, P37, DOI 10.1016/S0002-9440(10)65248-0	18	37	37	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2009	4	8							e6727	10.1371/journal.pone.0006727	http://dx.doi.org/10.1371/journal.pone.0006727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JF	19701453	gold, Green Published, Green Submitted			2022-12-25	WOS:000269268300007
J	Ibos, G; Duhamel, JR; Ben Hamed, S				Ibos, Guilhem; Duhamel, Jean-Rene; Ben Hamed, Suliann			The Spatial and Temporal Deployment of Voluntary Attention across the Visual Field	PLOS ONE			English	Article							DYNAMICS; SEARCH; CONNECTIONS; MECHANISMS; RESOLUTION; ACUITY; TIME	Several studies have addressed the question of the time it takes for attention to shift from one position in space to another. Here we present a behavioural paradigm which offers a direct access to an estimate of voluntary shift time by comparing, in the same task, a situation in which subjects are required to re-engage their attention at the same spatial location with a situation in which they need to shift their attention to another location, all other sensory, cognitive and motor parameters being equal. We show that spatial attention takes on average 55 ms to voluntarily shift from one hemifield to the other and 38 ms to shift within the same hemifield. In addition, we show that across and within hemifields attentional processes are different. In particular, attentional spotlight division appears to be more difficult to operate within than across hemifields.			Ibos, G (corresponding author), Univ Lyon 1, Ctr Neurosci Cognit, CNRS, Bron, France.	benhamed@isc.cnrs.fr	Ben Hamed, Suliann/O-6070-2014; Duhamel, Jean-René/M-4723-2017	Ben Hamed, Suliann/0000-0003-1510-7284; Duhamel, Jean-René/0000-0003-0210-1027; Ibos, Guilhem/0000-0002-9280-1280				Awh E, 2000, J EXP PSYCHOL HUMAN, V26, P834, DOI 10.1037/0096-1523.26.2.834; Beirne RO, 2005, VISUAL NEUROSCI, V22, P79, DOI 10.1017/S0952523805221119; Castet E, 2006, J VISION, V6, P196, DOI 10.1167/6.3.2; Christmann C, 2004, Q J EXP PSYCHOL-A, V57, P357, DOI 10.1080/02724980343000350; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; Hazlett CJ, 2004, J COGNITIVE NEUROSCI, V16, P742, DOI 10.1162/089892904970735; Horowitz TS, 2004, J VISION, V4, P585, DOI 10.1167/4.7.6; Jonides J., 1981, VOLUNTARY VERSUS AUT; KINCHLA RA, 1992, ANNU REV PSYCHOL, V43, P711, DOI 10.1146/annurev.ps.43.020192.003431; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Kraft A, 2005, COGNITIVE BRAIN RES, V24, P19, DOI 10.1016/j.cogbrainres.2004.12.004; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; McKeefry DJ, 2003, INVEST OPHTH VIS SCI, V44, P2267, DOI 10.1167/iovs.02-0772; McMains SA, 2004, NEURON, V42, P677, DOI 10.1016/S0896-6273(04)00263-6; MILLODOT M, 1974, VISION RES, V14, P1497, DOI 10.1016/0042-6989(74)90031-5; Montagnini A, 2007, J VISION, V7, DOI 10.1167/7.14.8; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; Muller MM, 2003, NATURE, V424, P309, DOI 10.1038/nature01812; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; ROCKLAND KS, 1983, J COMP NEUROL, V216, P303, DOI 10.1002/cne.902160307; ROVAMO J, 1982, INVEST OPHTH VIS SCI, V23, P666; SPERLING G, 1995, PSYCHOL REV, V102, P503, DOI 10.1037/0033-295X.102.3.503; SPERLING G, 1980, ATTETNION PERFORMANC, V8; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; VanRullen R, 2001, PERCEPTION, V30, P655, DOI 10.1068/p3029; VanRullen R, 2007, P NATL ACAD SCI USA, V104, P19204, DOI 10.1073/pnas.0707316104; Vassilev A, 2009, VISION RES, V49, P524, DOI 10.1016/j.visres.2008.12.010; WEICHSELGARTNER E, 1987, SCIENCE, V238, P778, DOI 10.1126/science.3672124; Wolfe JM, 2000, NATURE, V406, P691, DOI 10.1038/35021132; WOLFE JM, 1995, ACAD RADIOL, V2, P74, DOI 10.1016/S1076-6332(05)80252-1; Wolfs GGMC, 1998, EUR UROL, V33, P1, DOI 10.1159/000019527; YANTIS S, 1988, PERCEPT PSYCHOPHYS, V43, P203, DOI 10.3758/BF03214200; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P121, DOI 10.1037/0096-1523.16.1.121; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921	38	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6716	10.1371/journal.pone.0006716	http://dx.doi.org/10.1371/journal.pone.0006716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487JB	19696923	Green Published, Green Submitted, gold			2022-12-25	WOS:000269267600007
J	Kaler, P; Augenlicht, L; Klampfer, L				Kaler, P.; Augenlicht, L.; Klampfer, L.			Macrophage-derived IL-1 beta stimulates Wnt signaling and growth of colon cancer cells: a crosstalk interrupted by vitamin D-3	ONCOGENE			English	Article						Wnt; IL-1; colon cancer; STAT1; macrophages; vitamin D	TUMOR-ASSOCIATED MACROPHAGES; NF-KAPPA-B; BETA-CATENIN; COLORECTAL-CANCER; ACTIVATED MACROPHAGES; D-RECEPTOR; INHIBITION; EXPRESSION; MICROENVIRONMENT; TRANSCRIPTION	Tumor-associated macrophages mediate the link between inflammation and cancer progression. Here, we showed that macrophage-derived soluble factors induce canonical Wnt signaling in colon cancer cells and promote their growth. Tumor cells induced the release of interleukin (IL)-1 beta from macrophages, which induced phosphorylation of GSK3 beta, stabilized beta-catenin, enhanced T-cell factor (TCF)-dependent gene activation and induced the expression of Wnt target genes in tumor cells. Neutralization experiments using anti-IL-1 beta-specific antibodies, or silencing of IL-1 beta in THP1 macrophages, showed that IL-1 beta was required for macrophages to induce Wnt signaling and to support the growth of tumor cells. Constitutive activation of signal transducer and activator of transcription (STAT) 1 in THP1 macrophages was essential for the induction of IL-1 beta and thus for the activation of beta-catenin signaling in tumor cells. Vitamin D-3, an effective chemopreventive agent, interrupted this crosstalk by blocking the constitutive activation of STAT1 and the production of IL-1 beta in macrophages, and therefore-in a vitamin D receptor-dependent manner-inhibited the ability of macrophages to activate Wnt signaling in colon carcinoma cells. Our data therefore established that vitamin D-3 exerts its chemopreventive activity by interrupting a crosstalk between tumor epithelial cells and the tumor microenvironment. Oncogene (2009) 28, 3892-3902; doi:10.1038/onc.2009.247; published online 24 August 2009	[Kaler, P.; Augenlicht, L.; Klampfer, L.] Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Oncol, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Klampfer, L (corresponding author), Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Med, 111 E 210th St,Room 316, Bronx, NY 10467 USA.	lklampf@aecom.yu.edu			NCI [CA 111361, U54 CA 100926, P30-13330]; NATIONAL CANCER INSTITUTE [U54CA100926, R01CA111361] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Paolo Norio for reading the paper. This work was supported by CA 111361 (to LK), U54 CA 100926 (to LA) and P30-13330 from NCI.	Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Brabletz T, 1998, PATHOL RES PRACT, V194, P701, DOI 10.1016/S0344-0338(98)80129-5; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Etoh T, 2000, CLIN CANCER RES, V6, P3545; Fichera A, 2007, J SURG RES, V142, P239, DOI 10.1016/j.jss.2007.02.038; Forssell J, 2007, CLIN CANCER RES, V13, P1472, DOI 10.1158/1078-0432.CCR-06-2073; GARLAND CF, 1989, LANCET, V2, P1176, DOI 10.1016/s0140-6736(89)91789-3; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; Gunter MJ, 2006, CANCER EPIDEM BIOMAR, V15, P1126, DOI 10.1158/1055-9965.EPI-06-0042; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Kampman E, 2000, CANCER CAUSE CONTROL, V11, P459, DOI 10.1023/A:1008914108739; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; Klampfer L, 2005, ONCOGENE, V24, P3932, DOI 10.1038/sj.onc.1208552; Klampfer L, 2004, J BIOL CHEM, V279, P36680, DOI 10.1074/jbc.M405197200; Klampfer L, 2003, MOL CANCER RES, V1, P855; Klampfer L, 2007, CANCER RES, V67, P8477, DOI 10.1158/0008-5472.CAN-07-0210; Kumagai T, 2003, J NATL CANCER I, V95, P896, DOI 10.1093/jnci/95.12.896; Kusmartsev S, 2005, J IMMUNOL, V174, P4880, DOI 10.4049/jimmunol.174.8.4880; Lamprecht SA, 2003, NAT REV CANCER, V3, P601, DOI 10.1038/nrc1144; Lee C, 2006, MOL PHARMACOL, V69, P1041, DOI 10.1124/mol.105.018481; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lipkin M, 2006, J MED FOOD, V9, P135, DOI 10.1089/jmf.2006.9.135; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; NEWMARK HL, 1992, CANCER RES, V52, pS2067; Oguma K, 2008, EMBO J, V27, P1671, DOI 10.1038/emboj.2008.105; Oosterling SJ, 2005, J PATHOL, V207, P147, DOI 10.1002/path.1830; Oyama T, 2008, CARCINOGENESIS, V29, P666, DOI 10.1093/carcin/bgn001; Pai R, 2008, CANCER RES, V68, P5086, DOI 10.1158/0008-5472.CAN-07-2325; Palmer HG, 2004, NAT MED, V10, P917, DOI 10.1038/nm1095; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Pendas-Franco N, 2008, ANTICANCER RES, V28, P2613; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Rasola A, 2007, ONCOGENE, V26, P1078, DOI 10.1038/sj.onc.1209859; Robsahm TE, 2004, CANCER CAUSE CONTROL, V15, P149, DOI 10.1023/B:CACO.0000019494.34403.09; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; Shah S, 2003, J BIOL CHEM, V278, P48137, DOI 10.1074/jbc.M307154200; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; SIZIOPIKOU KP, 1991, CANCER, V68, P1035, DOI 10.1002/1097-0142(19910901)68:5<1035::AID-CNCR2820680522>3.0.CO;2-D; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Taketo MM, 2004, NAT GENET, V36, P320, DOI 10.1038/ng0404-320; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Tsukada J, 1996, MOL CELL BIOL, V16, P2183; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036	51	189	196	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2009	28	44					3892	3902		10.1038/onc.2009.247	http://dx.doi.org/10.1038/onc.2009.247			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	515LJ	19701245	Green Accepted			2022-12-25	WOS:000271471900004
J	Kabat, JL; Barberan-Soler, S; Zahler, AM				Kabat, Jennifer L.; Barberan-Soler, Sergio; Zahler, Alan M.			HRP-2, the Caenorhabditis elegans Homolog of Mammalian Heterogeneous Nuclear Ribonucleoproteins Q and R, Is an Alternative Splicing Factor That Binds to UCUAUC Splicing Regulatory Elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNC-52 TRANSCRIPTS; RNA RECOGNITION; HNRNP; PROTEIN; MOTIFS; GENE; CELLS; EXONS; INTERFERENCE; CONSERVATION	Alternative splicing is regulated by cis sequences in the pre-mRNA that serve as binding sites for trans-acting alternative splicing factors. In a previous study, we used bioinformatics and molecular biology to identify and confirm that the intronic hexamer sequence UCUAUC is a nematode alternative splicing regulatory element. In this study, we used RNA affinity chromatography to identify trans factors that bind to this sequence. HRP-2, the Caenorhabditis elegans homolog of human heterogeneous nuclear ribonucleoproteins Q and R, binds to UCUAUC in the context of unc-52 intronic regulatory sequences as well as to RNAs containing tandem repeats of this sequence. The three Us in the hexamer are the most important determinants of this binding specificity. We demonstrate, using RNA interference, that HRP-2 regulates the alternative splicing of two genes, unc-52 and lin-10, both of which have cassette exons flanked by an intronic UCUAUC motif. We propose that HRP-2 is a protein responsible for regulating alternative splicing through binding interactions with the UCUAUC sequence.	[Zahler, Alan M.] Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Zahler, AM (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	zahler@biology.ucsc.edu		Zahler, Alan/0000-0003-0027-1647; Barberan-Soler, Sergio/0000-0002-5243-6813	National Institutes of Health [R01-GM061646]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM061646 (to A. M. Z.).	Caputi M, 1999, EMBO J, V18, P4060, DOI 10.1093/emboj/18.14.4060; Caputi M, 2001, J BIOL CHEM, V276, P43850, DOI 10.1074/jbc.M102861200; Chasin LA, 2007, ADV EXP MED BIOL, V623, P85, DOI 10.1007/978-0-387-77374-2_6; Chen HH, 2008, MOL CELL BIOL, V28, P6929, DOI 10.1128/MCB.01332-08; Dominguez C, 2006, NUCLEIC ACIDS RES, V34, P3634, DOI 10.1093/nar/gkl488; Fairbrother WG, 2004, NUCLEIC ACIDS RES, V32, pW187, DOI 10.1093/nar/gkh393; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kabat JL, 2006, PLOS COMPUT BIOL, V2, P734, DOI 10.1371/journal.pcbi.0020086; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kinnaird JH, 2004, EXP CELL RES, V298, P418, DOI 10.1016/j.yexcr.2004.04.043; Kuroyanagi H, 2006, NAT METHODS, V3, P909, DOI 10.1038/NMETH944; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Longman D, 2000, EMBO J, V19, P1625, DOI 10.1093/emboj/19.7.1625; Lundquist EA, 1996, DEVELOPMENT, V122, P1601; MAINS PE, 1999, C ELEGANS PRACTICAL, P227; Mourelatos Z, 2001, EMBO J, V20, P5443, DOI 10.1093/emboj/20.19.5443; Ponthier JL, 2006, J BIOL CHEM, V281, P12468, DOI 10.1074/jbc.M511556200; ROGALSKI TM, 1995, GENETICS, V139, P159; Roller AB, 2000, GENETICS, V154, P1169; Rossoll W, 2002, HUM MOL GENET, V11, P93, DOI 10.1093/hmg/11.1.93; Rukov JL, 2007, MOL BIOL EVOL, V24, P909, DOI 10.1093/molbev/msm023; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Spike CA, 2002, DEVELOPMENT, V129, P4999; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Venables JP, 2008, MOL CELL BIOL, V28, P6033, DOI 10.1128/MCB.00726-08; Voelker RB, 2007, GENOME RES, V17, P1023, DOI 10.1101/gr.6017807; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	40	19	20	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28490	28497		10.1074/jbc.M109.023101	http://dx.doi.org/10.1074/jbc.M109.023101			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706616	hybrid, Green Published			2022-12-25	WOS:000270678900003
J	Ban, R; Matsuzaki, H; Akashi, T; Sakashita, G; Taniguchi, H; Park, SY; Tanaka, H; Furukawa, K; Urano, T				Ban, Reiko; Matsuzaki, Hideki; Akashi, Tomohiro; Sakashita, Gyosuke; Taniguchi, Hisaaki; Park, Sam-Yong; Tanaka, Hirofumi; Furukawa, Koichi; Urano, Takeshi			Mitotic Regulation of the Stability of Microtubule Plus-end Tracking Protein EB3 by Ubiquitin Ligase SIAH-1 and Aurora Mitotic Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITS CELL-GROWTH; NEGATIVE REGULATORS; BINDING-PROTEINS; SPINDLE; ACTIVATION; DYNAMICS; MITOSIS; PHOSPHORYLATION; DEGRADATION; APC	Microtubule plus-end tracking proteins (+TIPs) control microtubule dynamics in fundamental processes such as cell cycle, intracellular transport, and cell motility, but how +TIPs are regulated during mitosis remains largely unclear. Here we show that the endogenous end-binding protein family EB3 is stable during mitosis, facilitates cell cycle progression at prometaphase, and then is down-regulated during the transition to G, phase. The ubiquitin-protein isopeptide ligase SIAH-1 facilitates EB3 polyubiquitination and subsequent proteasome-mediated degradation, whereas SIAH-1 knockdown increases EB3 stability and steady-state levels. Two mitotic kinases, Aurora-A and Aurora-B, phosphorylate endogenous EB3 at Ser-176, and the phosphorylation triggers disruption of the EB3-SIAH-1 complex, resulting in EB3 stabilization during mitosis. Our results provide new insight into a regulatory mechanism of +TIPs in cell cycle transition.	[Ban, Reiko; Sakashita, Gyosuke; Urano, Takeshi] Shimane Univ, Dept Biochem, Sch Med, Izumo, Shimane 6938501, Japan; [Ban, Reiko; Sakashita, Gyosuke; Furukawa, Koichi; Urano, Takeshi] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4668550, Japan; [Akashi, Tomohiro] Nagoya Univ, Grad Sch Med, Div Mol Mycol & Med, Nagoya, Aichi 4668550, Japan; [Matsuzaki, Hideki; Taniguchi, Hisaaki] Univ Tokushima, Inst Enzyme Res, Tokushima 7708503, Japan; [Park, Sam-Yong] Yokohama City Univ, Prot Design Lab, Yokohama, Kanagawa 2300045, Japan; [Tanaka, Hirofumi] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Tokyo 1920392, Japan	Shimane University; Nagoya University; Nagoya University; Tokushima University; Yokohama City University; Tokyo University of Pharmacy & Life Sciences	Ban, R (corresponding author), Shimane Univ, Dept Biochem, Sch Med, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	banrei@med.shimane-u.ac.jp; turano@med.shimane-u.ac.jp	Akashi, Tomohiro/I-7245-2014	Urano, Takeshi/0000-0003-3383-3554	grant-in-aid for scientific research	grant-in-aid for scientific research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for scientific research (to G. S., K. F., and T. U.).	Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Andrews PD, 2003, CURR OPIN CELL BIOL, V15, P672, DOI 10.1016/j.ceb.2003.10.013; Ban R, 2004, J BIOL CHEM, V279, P16394, DOI 10.1074/jbc.M313257200; Berrueta L, 1998, P NATL ACAD SCI USA, V95, P10596, DOI 10.1073/pnas.95.18.10596; Bruzzoni-Giovanelli H, 1999, ONCOGENE, V18, P7101, DOI 10.1038/sj.onc.1203187; Bu W, 2001, ONCOGENE, V20, P3185, DOI 10.1038/sj.onc.1204429; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Cassimeris L, 1999, CURR OPIN CELL BIOL, V11, P134, DOI 10.1016/S0955-0674(99)80017-9; Engelender S, 2008, AUTOPHAGY, V4, P372, DOI 10.4161/auto.5604; Ferrari S, 2006, CELL MOL LIFE SCI, V63, P781, DOI 10.1007/s00018-005-5515-3; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; Fiucci G, 2004, P NATL ACAD SCI USA, V101, P3510, DOI 10.1073/pnas.0400177101; Frew IJ, 2002, MOL CELL BIOL, V22, P8155, DOI 10.1128/MCB.22.23.8155-8164.2002; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gadea BB, 2006, P NATL ACAD SCI USA, V103, P4493, DOI 10.1073/pnas.0600702103; Geraldo S, 2008, NAT CELL BIOL, V10, P1181, DOI 10.1038/ncb1778; Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Gutierrez GJ, 2006, TRENDS BIOCHEM SCI, V31, P324, DOI 10.1016/j.tibs.2006.04.001; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Honda K, 2000, ONCOGENE, V19, P2812, DOI 10.1038/sj.onc.1203609; House CM, 2006, STRUCTURE, V14, P695, DOI 10.1016/j.str.2005.12.013; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; James P, 1996, GENETICS, V144, P1425; Juwana JP, 1999, INT J CANCER, V81, P275, DOI 10.1002/(SICI)1097-0215(19990412)81:2<275::AID-IJC18>3.0.CO;2-Z; Kinoshita K, 2006, J MUSCLE RES CELL M, V27, P107, DOI 10.1007/s10974-005-9045-2; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Li XY, 2004, J BIOL CHEM, V279, P47201, DOI 10.1074/jbc.M403029200; MARTINEAU SN, 1995, J CELL BIOL, V131, P191, DOI 10.1083/jcb.131.1.191; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; Moore A, 2004, TRENDS CELL BIOL, V14, P537, DOI 10.1016/j.tcb.2004.09.001; MORGAN DO, 2007, CELL CYCLE PRINCIPLE, P46; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Morrison EE, 2007, CELL MOL LIFE SCI, V64, P307, DOI 10.1007/s00018-007-6360-3; Nakagawa H, 2000, ONCOGENE, V19, P210, DOI 10.1038/sj.onc.1203308; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Ohashi S, 2006, ONCOGENE, V25, P7691, DOI 10.1038/sj.onc.1209754; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peth A, 2007, J MOL BIOL, V368, P550, DOI 10.1016/j.jmb.2007.02.052; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Santelli E, 2005, J BIOL CHEM, V280, P34278, DOI 10.1074/jbc.M506707200; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Steinmetz MO, 2007, J STRUCT BIOL, V158, P137, DOI 10.1016/j.jsb.2006.07.018; Straube A, 2007, CURR BIOL, V17, P1318, DOI 10.1016/j.cub.2007.06.058; SU LK, 1995, CANCER RES, V55, P2972; Sugiyama K, 2002, ONCOGENE, V21, P3103, DOI 10.1038/sj.onc.1205432; Sumara I, 2008, TRENDS CELL BIOL, V18, P84, DOI 10.1016/j.tcb.2007.12.001; Sun L, 2008, P NATL ACAD SCI USA, V105, P7153, DOI 10.1073/pnas.0710018105; Taguchi S, 2002, FEBS LETT, V519, P59, DOI 10.1016/S0014-5793(02)02711-4; TIMAUER JS, 2002, MOL BIOL CELL, V13, P3614; Vaughan KT, 2005, J CELL BIOL, V171, P197, DOI 10.1083/jcb.200509150; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Xu ZH, 2006, J BIOL CHEM, V281, P303, DOI 10.1074/jbc.M509060200; Yun S, 2008, J BIOL CHEM, V283, P1034, DOI 10.1074/jbc.M705874200	63	45	45	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28367	28381		10.1074/jbc.M109.000273	http://dx.doi.org/10.1074/jbc.M109.000273			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19696028	hybrid, Green Published			2022-12-25	WOS:000270676300062
J	Cao, Y; Zhang, DM; Pan, WQ				Cao, Yi; Zhang, Dongmei; Pan, Weiqing			Construction of Transgenic Plasmodium berghei as a Model for Evaluation of Blood-Stage Vaccine Candidate of Plasmodium falciparum Chimeric Protein 2.9	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; APICAL MEMBRANE ANTIGEN-1; RODENT MALARIA PARASITE; GROWTH IN-VITRO; FLUORESCENT PROTEIN; TERMINAL FRAGMENT; AOTUS MONKEYS; IMMUNOGENICITY; ANTIBODIES; YOELII	Background: The function of the 19 kDa C-terminal region of the merozoite surface protein 1 (MSP1-19) expressed by Plasmodium has been demonstrated to be conserved across distantly related Plasmodium species. The green fluorescent protein (GFP) is a reporter protein that has been widely used because it can be easily detected in living organisms by fluorescence microscopy and flow cytometry. Methodology and Results: In this study, we used gene targeting to generate transgenic P. berghei (Pb) parasites (designated as PfMSP1-19Pb) that express the MSP1-19 of P. falciparum (Pf) and the GFP reporter protein simultaneously. The replacement of the PbMSP1-19 locus by PfMSP1-19 was verified by PCR and Southern analysis. The expression of the chimeric PbfMSP-1 and the GFP was verified by Western blot and fluorescence microscopy, respectively. Moreover, GFP-expressing transgenic parasites in blood stages can be readily differentiated from other blood cells using flow cytometry. A comparion of growth rates between wild-type and the PfMSP1-19Pb transgenic parasite indicated that the replacement of the MSP1-19 region and the expression of the GFP protein were not deleterious to the transgenic parasites. We used this transgenic mouse parasite as a murine model to evaluate the protective efficacy in vivo of specific IgG elicited by a PfCP-2.9 malaria vaccine that contains the PfMSP1-19. The BALB/c mice passively transferred with purified rabbit IgG to the PfCP-2.9 survived a lethal challenge of the PfMSP1-19Pb transgenic murine parasites, but not the wild-type P. berghei whereas the control mice passively transferred with purified IgG obtained from adjuvant only-immunized rabbits were vulnerable to both transgenic and wild-type infections. Conclusions: We generated a transgenic P. berghei line that expresses PfMSP1-19 and the GFP reporter gene simultaneously. The availability of this parasite line provides a murine model to evaluate the protective efficacy in vivo of anti-MSP1-19 antibodies, including, potentially, those elicited by the PfCP-2.9 malaria vaccine in human volunteers.			Cao, Y (corresponding author), Second Mil Med Univ, Dept Pathogen Biol, Shanghai, Peoples R China.	wqpan0912@yahoo.com.cn						BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P29, DOI 10.1016/0166-6851(91)90127-R; Cao Yi, 2008, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V26, P327; Corran PH, 2004, INFECT IMMUN, V72, P6185, DOI 10.1128/IAI.72.10.6185-6189.2004; de Koning-Ward TF, 2003, J EXP MED, V198, P869, DOI 10.1084/jem.20030085; Egan AF, 1999, PARASITE IMMUNOL, V21, P133, DOI 10.1046/j.1365-3024.1999.00209.x; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Girard MP, 2007, VACCINE, V25, P1567, DOI 10.1016/j.vaccine.2006.09.074; Good MF, 2001, NAT REV IMMUNOL, V1, P117, DOI 10.1038/35100540; Herrera S, 2002, INT J PARASITOL, V32, P1625, DOI 10.1016/S0020-7519(02)00191-1; Hirunpetcharat C, 1997, J IMMUNOL, V159, P3400; HOLDER AA, 1984, PHILOS T ROY SOC B, V307, P171, DOI 10.1098/rstb.1984.0117; Hu JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001952; Hu J, 2006, AM J TROP MED HYG, V75, P317; Janse CJ, 2006, NAT PROTOC, V1, P614, DOI 10.1038/nprot.2006.88; Kumar S, 2000, INFECT IMMUN, V68, P2215, DOI 10.1128/IAI.68.4.2215-2223.2000; Langermans JAM, 2006, HUM VACCINES, V2, P222, DOI 10.4161/hv.2.5.3276; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Mambo G, 2008, INFECT IMMUN, V76, P2018, DOI 10.1128/IAI.01409-07; Menard R, 1997, METHODS, V13, P148, DOI 10.1006/meth.1997.0507; Mota MM, 2001, MOL BIOCHEM PARASIT, V113, P271, DOI 10.1016/S0166-6851(01)00228-6; Nair M, 2002, J MOL BIOL, V322, P741, DOI 10.1016/S0022-2836(02)00806-9; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; O'Donnell RA, 2000, NAT MED, V6, P91, DOI 10.1038/71595; Pan WQ, 2004, J IMMUNOL, V172, P6167, DOI 10.4049/jimmunol.172.10.6167; Ramjanee S, 2007, VACCINE, V25, P886, DOI 10.1016/j.vaccine.2006.09.035; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Sachdeva S, 2006, VACCINE, V24, P2007, DOI 10.1016/j.vaccine.2005.11.041; Sambrook J, 2001, MOL CLONING LAB MANU; Saul A, 2001, J EXP MED, V193, pF51, DOI 10.1084/jem.193.12.F51; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Sultan AA, 1999, INFECT IMMUN, V67, P2602, DOI 10.1128/IAI.67.5.2602-2606.1999; vanderWel AM, 1997, J EXP MED, V185, P1499, DOI 10.1084/jem.185.8.1499; VANDIJK MR, 1995, SCIENCE, V268, P1358, DOI 10.1126/science.7761856; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130; 2004, MALVAC M 2004 EV MAL	37	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6894	10.1371/journal.pone.0006894	http://dx.doi.org/10.1371/journal.pone.0006894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19727400	gold, Green Submitted, Green Published			2022-12-25	WOS:000269522900022
J	Hu, JC; Cui, GF; Li, CM; Liu, C; Shang, EC; Lai, LH; Jin, CW; Wang, JW; Xia, B				Hu, Jicheng; Cui, Gaofeng; Li, Congmin; Liu, Cong; Shang, Erchang; Lai, Luhua; Jin, Changwen; Wang, Jiwu; Xia, Bin			Structure and Novel Functional Mechanism of Drosophila SNF in Sex-Lethal Splicing	PLOS ONE			English	Article								Sans-fille (SNF) is the Drosophila homologue of mammalian general splicing factors U1A and U2B '', and it is essential in Drosophila sex determination. We found that, besides its ability to bind U1 snRNA, SNF can also bind polyuridine RNA tracts flanking the male-specific exon of the master switch gene Sex-lethal (Sxl) pre-mRNA specifically, similar to Sex-lethal protein (SXL). The polyuridine RNA binding enables SNF directly inhibit Sxl exon 3 splicing, as the dominant negative mutant SNF(1621) binds U1 snRNA but not polyuridine RNA. Unlike U1A, both RNA recognition motifs (RRMs) of SNF can recognize polyuridine RNA tracts independently, even though SNF and U1A share very high sequence identity and overall structure similarity. As SNF RRM1 tends to self-associate on the opposite side of the RNA binding surface, it is possible for SNF to bridge the formation of super-complexes between two introns flanking Sxl exon 3 or between a intron and U1 snRNP, which serves the molecular basis for SNF to directly regulate Sxl splicing. Taken together, a new functional model for SNF in Drosophila sex determination is proposed. The key of the new model is that SXL and SNF function similarly in promoting Sxl male-specific exon skipping with SNF being an auxiliary or backup to SXL, and it is the combined dose of SXL and SNF governs Drosophila sex determination.			Hu, JC (corresponding author), Beijing Nucl Magnet Resonance Ctr, Beijing, Peoples R China.	jiwuwang@allelebiotech.com; binxia@pku.edu.cn	Xia, Bin/O-1160-2016; liu, cong/H-1103-2011; Cui, Gaofeng/A-1107-2013	Xia, Bin/0000-0002-2197-6403; Cui, Gaofeng/0000-0001-5267-9033				ALBRECHT EB, 1993, GENETICS, V134, P801; Allain FHT, 1997, EMBO J, V16, P5764, DOI 10.1093/emboj/16.18.5764; Auweter SD, 2008, CELL MOL LIFE SCI, V65, P516, DOI 10.1007/s00018-007-7378-2; Avila FW, 2007, CURR BIOL, V17, P643, DOI 10.1016/j.cub.2007.02.038; BELL LR, 1991, CELL, V65, P229, DOI 10.1016/0092-8674(91)90157-T; BERNSTEIN M, 1995, GENETICS, V139, P631; BOPP D, 1991, GENE DEV, V5, P403, DOI 10.1101/gad.5.3.403; Chou MY, 2000, MOL CELL, V5, P949, DOI 10.1016/S1097-2765(00)80260-9; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Cline TW, 1999, P NATL ACAD SCI USA, V96, P14451, DOI 10.1073/pnas.96.25.14451; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deshpande G, 1996, MOL CELL BIOL, V16, P5036; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; Erickson JW, 2007, PLOS BIOL, V5, P2821, DOI 10.1371/journal.pbio.0050332; FLICKINGER TW, 1994, GENE DEV, V8, P914, DOI 10.1101/gad.8.8.914; GANS M, 1975, GENETICS, V81, P683; Gebauer F, 1998, RNA, V4, P142; GOLLIN SM, 1981, DEV GENET, V2, P203, DOI 10.1002/dvg.1020020206; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; HARPER DS, 1992, NUCLEIC ACIDS RES, V20, P3645, DOI 10.1093/nar/20.14.3645; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HORABIN JI, 1993, MOL CELL BIOL, V13, P1408, DOI 10.1128/MCB.13.3.1408; HORABIN JI, 1993, MOL CELL BIOL, V13, P7734, DOI 10.1128/MCB.13.12.7734; HOWE PWA, 1994, EMBO J, V13, P3873, DOI 10.1002/j.1460-2075.1994.tb06698.x; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KANAAR R, 1995, EMBO J, V14, P4530, DOI 10.1002/j.1460-2075.1995.tb00132.x; Katsamba PS, 2002, J BIOL CHEM, V277, P33267, DOI 10.1074/jbc.M200304200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Kramer SG, 1999, DEVELOPMENT, V126, P191; Labourier E, 2001, RNA, V7, P457, DOI 10.1017/S1355838201001327; Lallena MJ, 2002, CELL, V109, P285, DOI 10.1016/S0092-8674(02)00730-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Law MJ, 2006, RNA, V12, P1168, DOI 10.1261/rna.75206; LEE AL, 1994, BIOCHEMISTRY-US, V33, P13775, DOI 10.1021/bi00250a031; Lu JR, 1997, BIOCHEMISTRY-US, V36, P10393, DOI 10.1021/bi9709811; Markley JL, 1998, EUR J BIOCHEM, V256, P1, DOI 10.1046/j.1432-1327.1998.2560001.x; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; Nagengast AA, 2003, DEVELOPMENT, V130, P463, DOI 10.1242/dev.00274; OLIVER B, 1988, GENETICS, V120, P159; OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Penalva LOF, 2003, MICROBIOL MOL BIOL R, V67, P343, DOI 10.1128/MMBR.67.3.343-359.2003; PolycarpouSchwarz M, 1996, RNA, V2, P11; SAKAMOTO H, 1992, NUCLEIC ACIDS RES, V20, P5533, DOI 10.1093/nar/20.21.5533; SALZ HK, 1992, GENETICS, V130, P547; Salz HK, 1996, GENETICS, V144, P95; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schutt C, 2000, DEVELOPMENT, V127, P667; Sefton L, 2000, NATURE, V405, P970, DOI 10.1038/35016119; Stark H, 2001, NATURE, V409, P539, DOI 10.1038/35054102; STEINMANNZWICKY M, 1988, EMBO J, V7, P3889, DOI 10.1002/j.1460-2075.1988.tb03275.x; Tronchere H, 1997, NATURE, V388, P397, DOI 10.1038/41137; Vaynberg J, 2006, TRENDS BIOTECHNOL, V24, P22, DOI 10.1016/j.tibtech.2005.09.006; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Wang JW, 1997, J BIOL CHEM, V272, P22227, DOI 10.1074/jbc.272.35.22227; WANG JW, 1994, GENE DEV, V8, P2072, DOI 10.1101/gad.8.17.2072; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; WITTEKIND M, 1992, BIOCHEMISTRY-US, V31, P6254, DOI 10.1021/bi00142a013; Yang D, 2001, MOL CELL BIOL, V21, P1581, DOI 10.1128/MCB.21.5.1581-1592.2001	62	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6890	10.1371/journal.pone.0006890	http://dx.doi.org/10.1371/journal.pone.0006890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19727396	Green Submitted, Green Published, gold			2022-12-25	WOS:000269522900019
J	Oppegard, SC; Nam, KH; Carr, JR; Skaalure, SC; Eddington, DT				Oppegard, Shawn C.; Nam, Ki-Hwan; Carr, Janai R.; Skaalure, Stacey C.; Eddington, David T.			Modulating Temporal and Spatial Oxygenation over Adherent Cellular Cultures	PLOS ONE			English	Article								Oxygen is a key modulator of many cellular pathways, but current devices permitting in vitro oxygen modulation fail to meet the needs of biomedical research. A microfabricated insert for multiwell plates has been developed to more effectively control the temporal and spatial oxygen concentration to better model physiological phenomena found in vivo. The platform consists of a polydimethylsiloxane insert that nests into a standard multiwell plate and serves as a passive microfluidic gas network with a gas-permeable membrane aimed to modulate oxygen delivery to adherent cells. Equilibration time is on the order of minutes and a wide variety of oxygen profiles can be attained based on the device design, such as the cyclic profile achieved in this study, and even oxygen gradients to mimic those found in vivo. The proper biological consequences of the device's oxygen delivery were confirmed in cellular models via a proliferation assay and western analysis of the upregulation of hypoxia inducible transcription factor-1 alpha. These experiments serve as a demonstration for the platform as a viable tool to increase experimental throughput and permit novel experimental possibilities in any biomedical research lab.			Oppegard, SC (corresponding author), Univ Illinois, Dept Bioengn, Chicago, IL 60680 USA.	dte@uic.edu		Skaalure, Stacey/0000-0001-5746-0575; Nam, Ki-Hwan/0000-0001-9943-6792; Carr-Ascher, Janai/0000-0002-2074-4643				Allen CB, 2001, AM J PHYSIOL-LUNG C, V281, pL1021, DOI 10.1152/ajplung.2001.281.4.L1021; Allen JW, 2003, HEPATOLOGY, V38, p270A; Allen JW, 2003, BIOTECHNOL BIOENG, V82, P253, DOI 10.1002/bit.10569; Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Baumgardner JE, 2003, RESP PHYSIOL NEUROBI, V136, P131, DOI 10.1016/S1569-9048(03)00077-6; Cairns RA, 2001, CANCER RES, V61, P8903; CARRAWAY ER, 1991, ANAL CHEM, V63, P337, DOI 10.1021/ac00004a007; Drew MC, 1997, ANNU REV PLANT PHYS, V48, P223, DOI 10.1146/annurev.arplant.48.1.223; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; FALANGA V, 2005, J CELLULAR PHYSL, V154, P506; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Harvey AJ, 2007, ANIM REPROD SCI, V98, P113, DOI 10.1016/j.anireprosci.2006.10.008; Heo YS, 2007, ANAL CHEM, V79, P1126, DOI 10.1021/ac061990v; HOLZER C, 1987, J CELL PHYSIOL, V133, P297, DOI 10.1002/jcp.1041330213; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Lee HLT, 2006, LAB CHIP, V6, P1229, DOI 10.1039/b608014f; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Lin JH, 1998, CLIN PHARMACOKINET, V35, P361, DOI 10.2165/00003088-199835050-00003; Mehta G, 2007, BIOMED MICRODEVICES, V9, P123, DOI 10.1007/s10544-006-9005-7; Mukhopadhyay R, 2007, ANAL CHEM, V79, P7249, DOI 10.1021/ac071972t; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Prabhakar NR, 2002, AM J RESP CRIT CARE, V165, P859, DOI 10.1164/ajrccm.165.7.2202030c; Randall GC, 2005, P NATL ACAD SCI USA, V102, P10813, DOI 10.1073/pnas.0503287102; Roman GT, 2005, ANAL CHEM, V77, P1414, DOI 10.1021/ac048811z; ROSEN P, 1991, EXP EYE RES, V53, P597, DOI 10.1016/0014-4835(91)90218-4; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Tilles AW, 2001, BIOTECHNOL BIOENG, V73, P379, DOI 10.1002/bit.1071; Uno K, 2007, DEV DYNAM, V236, P981, DOI 10.1002/dvdy.21122; Vollmer AP, 2005, LAB CHIP, V5, P1059, DOI 10.1039/b508097e; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yuan GX, 2005, J BIOL CHEM, V280, P4321, DOI 10.1074/jbc.M407706200; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W; ZHONG H, 1999, CANCER RES, V60, P4693	33	63	64	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6891	10.1371/journal.pone.0006891	http://dx.doi.org/10.1371/journal.pone.0006891			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19727397	Green Published, gold			2022-12-25	WOS:000269522900020
J	Pitkaniemi, J; Varvio, SL; Corander, J; Lehti, N; Partanen, J; Tuomilehto-Wolf, E; Tuomilehto, J; Thomas, A; Arjas, E				Pitkaniemi, Janne; Varvio, Sirkka-Liisa; Corander, Jukka; Lehti, Nella; Partanen, Jukka; Tuomilehto-Wolf, Eva; Tuomilehto, Jaakko; Thomas, Andrew; Arjas, Elja			Full Likelihood Analysis of Genetic Risk with Variable Age at Onset Disease-Combining Population-Based Registry Data and Demographic Information	PLOS ONE			English	Article							HLA-ASSOCIATED RISKS; FINNISH POPULATION; DIABETES-MELLITUS; HAPLOTYPE; ASCERTAINMENT; SUSCEPTIBILITY; EPIDEMIOLOGY; MODELS	Background: In genetic studies of rare complex diseases it is common to ascertain familial data from population based registries through all incident cases diagnosed during a pre-defined enrollment period. Such an ascertainment procedure is typically taken into account in the statistical analysis of the familial data by constructing either a retrospective or prospective likelihood expression, which conditions on the ascertainment event. Both of these approaches lead to a substantial loss of valuable data. Methodology and Findings: Here we consider instead the possibilities provided by a Bayesian approach to risk analysis, which also incorporates the ascertainment procedure and reference information concerning the genetic composition of the target population to the considered statistical model. Furthermore, the proposed Bayesian hierarchical survival model does not require the considered genotype or haplotype effects be expressed as functions of corresponding allelic effects. Our modeling strategy is illustrated by a risk analysis of type 1 diabetes mellitus (T1D) in the Finnish population-based on the HLA-A, HLA-B and DRB1 human leucocyte antigen (HLA) information available for both ascertained sibships and a large number of unrelated individuals from the Finnish bone marrow donor registry. The heterozygous genotype DR3/DR4 at the DRB1 locus was associated with the lowest predictive probability of T1D free survival to the age of 15, the estimate being 0.936 (0.926; 0.945 95% credible interval) compared to the average population T1D free survival probability of 0.995. Significance: The proposed statistical method can be modified to other population-based family data ascertained from a disease registry provided that the ascertainment process is well documented, and that external information concerning the sizes of birth cohorts and a suitable reference sample are available. We confirm the earlier findings from the same data concerning the HLA-DR3/4 related risks for T1D, and also provide here estimated predictive probabilities of disease free survival as a function of age.			Pitkaniemi, J (corresponding author), Univ Helsinki, Dept Publ Hlth, Helsinki, Finland.	janne.pitkaniemi@helsinki.fi	Partanen, Jukka/B-7207-2014	Partanen, Jukka/0000-0001-6681-4734				[Anonymous], 2001, BAYESIAN SURVIVAL AN; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Burton PR, 2003, GENET EPIDEMIOL, V24, P24, DOI 10.1002/gepi.10206; Clayton D, 2003, BIOMETRIKA, V90, P976, DOI 10.1093/biomet/90.4.976; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; GAUDERMAN WJ, 1994, GENET EPIDEMIOL, V11, P171, DOI 10.1002/gepi.1370110207; Gelman A., 2004, BAYESIAN DATA ANAL; Glickman ME, 2002, LIFETIME DATA ANAL, V8, P211, DOI 10.1023/A:1015880003274; Harkanen T, 2000, SCAND J STAT, V27, P577, DOI 10.1111/1467-9469.00209; Kraft P, 2000, AM J HUM GENET, V66, P1119, DOI 10.1086/302808; Lambert AP, 2004, J CLIN ENDOCR METAB, V89, P4037, DOI 10.1210/jc.2003-032084; LANGHOLZ B, 1995, GENET EPIDEMIOL, V12, P441, DOI 10.1002/gepi.1370120502; Marsh Steven G E, 2004, Tissue Antigens, V63, P505, DOI 10.1111/j.1399-0039.2004.00213.x; Mensah FK, 2007, GENET EPIDEMIOL, V31, P348, DOI 10.1002/gepi.20215; Pitkaniemi J, 2004, HUM HERED, V57, P69, DOI 10.1159/000077544; Seaman SR, 2002, GENET EPIDEMIOL, V22, P356, DOI 10.1002/gepi.0197; Siegmund KD, 1998, EPIDEMIOLOGY, V9, P557, DOI 10.1097/00001648-199809000-00015; Siegmund KD, 2000, HUM HERED, V50, P205, DOI 10.1159/000022916; Sobel E, 1996, AM J HUM GENET, V58, P1323; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sun WL, 2004, LIFETIME DATA ANAL, V10, P229, DOI 10.1023/B:LIDA.0000036390.15378.5e; THOMAS D, 1995, GENET EPIDEMIOL, V12, P455, DOI 10.1002/gepi.1370120503; TIENARI PJ, 1992, DIABETOLOGIA, V35, P254, DOI 10.1007/BF00400926; TUOMILEHTO J, 1992, DIABETOLOGIA, V35, P70, DOI 10.1007/BF00400854; TUOMILEHTOWOLF E, 1989, LANCET, V2, P299; *U HELS DEP MATH, OPENBUGS	26	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6836	10.1371/journal.pone.0006836	http://dx.doi.org/10.1371/journal.pone.0006836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718441	Green Published, gold, Green Submitted			2022-12-25	WOS:000269415900009
J	Roberson, EDO; Pevsner, J				Roberson, Elisha D. O.; Pevsner, Jonathan			Visualization of Shared Genomic Regions and Meiotic Recombination in High-Density SNP Data	PLOS ONE			English	Article							WIDE ASSOCIATION; RISK LOCUS; SUSCEPTIBILITY; POLYMORPHISM; IDENTITY; ALLELES	Background: A fundamental goal of single nucleotide polymorphism (SNP) genotyping is to determine the sharing of alleles between individuals across genomic loci. Such analyses have diverse applications in defining the relatedness of individuals (including unexpected relationships in nominally unrelated individuals, or consanguinity within pedigrees), analyzing meiotic crossovers, and identifying a broad range of chromosomal anomalies such as hemizygous deletions and uniparental disomy, and analyzing population structure. Principal Findings: We present SNPduo, a command-line and web accessible tool for analyzing and visualizing the relatedness of any two individuals using identity by state. Using identity by state does not require prior knowledge of allele frequencies or pedigree information, and is more computationally tractable and is less affected by population stratification than calculating identity by descent probabilities. The web implementation visualizes shared genomic regions, and generates UCSC viewable tracks. The command-line version requires pedigree information for compatibility with existing software and determining specified relationships even though pedigrees are not required for IBS calculation, generates no visual output, is written in portable C++, and is well-suited to analyzing large datasets. We demonstrate how the SNPduo web tool identifies meiotic crossover positions in siblings, and confirm our findings by visualizing meiotic recombination in synthetic three-generation pedigrees. We applied SNPduo to 210 nominally unrelated Phase I / II HapMap samples and, consistent with previous findings, identified six undeclared pairs of related individuals. We further analyzed identity by state in 2,883 individuals from multiplex families with autism and identified a series of anomalies including related parents, an individual with mosaic loss of chromosome 18, an individual with maternal heterodisomy of chromosome 16, and unexplained replicate samples. Conclusions: SNPduo provides the ability to explore and visualize SNP data to characterize the relatedness between individuals. It is compatible with, but distinct from, other established analysis software such as PLINK, and performs favorably in benchmarking studies for the analyses of genetic relatedness.			Roberson, EDO (corresponding author), Johns Hopkins Sch Med, Program Human Genet, Baltimore, MD 21218 USA.	Pevsner@kennedykrieger.org	Roberson, Elisha D.O./J-1747-2012; Roberson, Elisha/ABC-1810-2020	Roberson, Elisha D.O./0000-0001-5921-2399; Roberson, Elisha/0000-0001-5921-2399	NICHD NIH HHS [HD24061, P30 HD024061] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BISHOP DT, 1990, AM J HUM GENET, V46, P254; CHAKRABORTY R, 1993, UNIFIED APPROACH STU, P153; Cheung VG, 2007, AM J HUM GENET, V80, P526, DOI 10.1086/512131; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lisi EC, 2008, AM J MED GENET A, V146A, P601, DOI 10.1002/ajmg.a.32190; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; MILLER N, 2009, AM J MED A IN PRESS; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; R Development Core Team, 2007, R LANG ENV STAT COMP; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; THOMSON G, 1994, GENET EPIDEMIOL, V11, P353, DOI 10.1002/gepi.1370110405; Ting JC, 2007, HUM MUTAT, V28, P1225, DOI 10.1002/humu.20583; Wirtenberger M, 2005, HUM GENET, V117, P389, DOI 10.1007/s00439-005-1323-y	28	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2009	4	8							e6711	10.1371/journal.pone.0006711	http://dx.doi.org/10.1371/journal.pone.0006711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JB	19696932	Green Submitted, gold, Green Published			2022-12-25	WOS:000269267600003
J	Blackburn, JS; Liu, I; Coon, CI; Brinckerhoff, CE				Blackburn, J. S.; Liu, I.; Coon, C. I.; Brinckerhoff, C. E.			A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis	ONCOGENE			English	Article						MMP-1; PAR-1; angiogenesis; superarray; xenograft	THROMBIN RECEPTOR; CELLS; EXPRESSION; PAR-1; GROWTH; PROGRESSION; INHIBITION; MECHANISMS; PROGNOSIS; SYSTEM	Hallmarks of malignant melanoma are its propensity to metastasize and its resistance to treatment, giving patients with advanced disease a poor prognosis. The transition of melanoma from non-invasive radial growth phase (RGP) to invasive and metastatically competent vertical growth phase (VGP) is a major step in tumor progression, yet the mechanisms governing this transformation are unknown. Matrix metalloproteinase-1 (MMP-1) is highly expressed by VGP melanomas, and is thought to contribute to melanoma progression by degrading type I collagen within the skin to facilitate melanoma invasion. Protease activated receptor-1 (PAR-1) is activated by MMP-1, and is also expressed by VGP melanomas. However, the effects of MMP-1 signaling through PAR-1 have not been examined in melanoma. Here, we demonstrate that an MMP-1/PAR-1 signaling axis exists in VGP melanoma, and is necessary for melanoma invasion. Introduction of MMP-1 into RGP melanoma cells induced gene expression associated with tumor progression and promoted invasion in vitro, and enhanced tumor growth and conferred metastatic capability in vivo. This study demonstrates that both the type I collagenase and PAR-1 activating functions of MMP-1 are required for melanoma progression, and suggests that MMP-1 may be a major contributor to the transformation of melanoma from non-invasive to malignant disease. Oncogene (2009) 28, 4237-4248; doi: 10.1038/onc.2009.272; published online 7 September 2009	[Blackburn, J. S.; Coon, C. I.; Brinckerhoff, C. E.] Dartmouth Med Sch, Dept Biochem, Lebanon, NH 03756 USA; [Liu, I.; Brinckerhoff, C. E.] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Dept Med, Lebanon, NH 03766 USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Brinckerhoff, CE (corresponding author), Dartmouth Med Sch, Dept Med, 1 Med Ctr Dr,Rubin Bldg,HB 7936, Lebanon, NH 03756 USA.	brinckerhoff@dartmouth.edu		Blackburn, Jessica/0000-0001-9464-3784	NIH [CA-77267, AR-26599, T32-AI07363]; Friends of the Norris Cotton Cancer Center; NATIONAL CANCER INSTITUTE [P30CA023108, R01CA077267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR026599, R01AR026599] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friends of the Norris Cotton Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Shaun Coughlin (University of California, San Francisco, CA, USA) for his generous gift of the AP-PAR-1 construct. This work was supported by NIH grants CA-77267 and AR-26599 (to CEB), NIH grant T32-AI07363 (to JSB) and the Prouty Pilot Grant by the Friends of the Norris Cotton Cancer Center (to CEB).	Agarwal A, 2008, MOL CANCER THER, V7, P2746, DOI 10.1158/1535-7163.MCT-08-0177; Airola K, 1999, BRIT J CANCER, V80, P733, DOI 10.1038/sj.bjc.6690417; Arora P, 2007, J CELL SCI, V120, P921, DOI 10.1242/jcs.03409; Balch CM, 2004, CA-CANCER J CLIN, V54, P131, DOI 10.3322/canjclin.54.3.131; Berwick M, 2009, DERMATOL CLIN, V27, P205, DOI 10.1016/j.det.2008.12.002; Blackburn JS, 2007, CANCER RES, V67, P10849, DOI 10.1158/0008-5472.CAN-07-1791; Blackburn JS, 2008, AM J PATHOL, V173, P1736, DOI 10.2353/ajpath.2008.080512; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; BRESLOW A, 1970, ANN SURG, V172, P902, DOI 10.1097/00000658-197011000-00017; Clark W H Jr, 1975, Semin Oncol, V2, P83; Curran S, 2000, EUR J CANCER, V36, P1621, DOI 10.1016/S0959-8049(00)00156-8; Depasquale I, 2008, HISTOPATHOLOGY, V52, P500, DOI 10.1111/j.1365-2559.2008.02978.x; DURKO M, 1998, BIOCHIM BIOPHYS ACTA, V1356, P271; Even-Ram SC, 2001, J BIOL CHEM, V276, P10952, DOI 10.1074/jbc.M007027200; Fingleton B, 2006, FRONT BIOSCI-LANDMRK, V11, P479, DOI 10.2741/1811; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Haluska Frank G, 2006, Curr Oncol Rep, V8, P400, DOI 10.1007/s11912-006-0065-x; Hofmann UB, 2005, BIOCHIMIE, V87, P307, DOI 10.1016/j.biochi.2005.01.013; Hofmann UB, 2000, J INVEST DERMATOL, V115, P337, DOI 10.1046/j.1523-1747.2000.00068.x; Huntington JT, 2004, J BIOL CHEM, V279, P33168, DOI 10.1074/jbc.M405102200; Iida J, 2004, J INVEST DERMATOL, V122, P167, DOI 10.1046/j.0022-202X.2003.22114.x; Ishii Y, 2003, INT J CANCER, V103, P161, DOI 10.1002/ijc.10808; Leiter U, 2004, J SURG ONCOL, V86, P172, DOI 10.1002/jso.20079; Loffek S, 2005, J INVEST DERMATOL, V124, P638, DOI 10.1111/j.0022-202X.2005.23629.x; Ludeman MJ, 2005, J BIOL CHEM, V280, P13122, DOI 10.1074/jbc.M410381200; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; Massi D, 2005, HUM PATHOL, V36, P676, DOI 10.1016/j.humpath.2005.04.008; Nierodzik ML, 1998, BLOOD, V92, P3694, DOI 10.1182/blood.V92.10.3694.422k40_3694_3700; Nikkola J, 2005, CLIN CANCER RES, V11, P5158, DOI 10.1158/1078-0432.CCR-04-2478; Ntayi C, 2001, EXP CELL RES, V270, P110, DOI 10.1006/excr.2001.5306; Ornstein DL, 2001, INT J HEMATOL, V73, P157, DOI 10.1007/BF02981932; Petrella BL, 2005, ONCOGENE, V24, P1043, DOI 10.1038/sj.onc.1208305; Rothhammer T, 2008, EUR J CANCER, V44, P2526, DOI 10.1016/j.ejca.2008.07.029; Salah Z, 2007, MOL CANCER RES, V5, P229, DOI 10.1158/1541-7786.MCR-06-0261; SUZUKI K, 1990, BIOCHEMISTRY-US, V29, P10261, DOI 10.1021/bi00496a016; Tellez C, 2003, ONCOGENE, V22, P3130, DOI 10.1038/sj.onc.1206453; Tellez CS, 2007, J INVEST DERMATOL, V127, P387, DOI 10.1038/sj.jid.5700539; Ueda Y, 2006, PIGM CELL RES, V19, P112, DOI 10.1111/j.1600-0749.2006.00304.x; Villares GJ, 2008, CANCER RES, V68, P9078, DOI 10.1158/0008-5472.CAN-08-2397; Wyatt CA, 2005, CANCER RES, V65, P11101, DOI 10.1158/0008-5472.CAN-05-2446	41	72	73	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 3	2009	28	48					4237	4248		10.1038/onc.2009.272	http://dx.doi.org/10.1038/onc.2009.272			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DS	19734937	Green Accepted			2022-12-25	WOS:000272876300002
J	Soeda, A; Park, M; Lee, D; Mintz, A; Androutsellis-Theotokis, A; McKay, RD; Engh, J; Iwama, T; Kunisada, T; Kassam, AB; Pollack, IF; Park, DM				Soeda, A.; Park, M.; Lee, D.; Mintz, A.; Androutsellis-Theotokis, A.; McKay, R. D.; Engh, J.; Iwama, T.; Kunisada, T.; Kassam, A. B.; Pollack, I. F.; Park, D. M.			Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1 alpha	ONCOGENE			English	Article						glioma; cancer stem cell; HIF-1 alpha; hypoxia; CD133	INDUCIBLE FACTOR 1-ALPHA; TUMOR ANGIOGENESIS; FACTOR-I; EXPRESSION; CANCER; GROWTH; PRECURSORS; PROLIFERATION; PATHWAY; FACTOR-1-ALPHA	Hypoxia contributes to the progression of a variety of cancers by activating adaptive transcriptional programs that promote cell survival, motility and tumor angiogenesis. Although the importance of hypoxia and subsequent hypoxia-inducible factor-1 alpha (HIF-1 alpha) activation in tumor angiogenesis is well known, their role in the regulation of glioma-derived stem cells is unclear. In this study, we show that hypoxia (1% oxygen) promotes the self-renewal capacity of CD133-positive human glioma-derived cancer stem cells (CSCs). Propagation of the glioma-derived CSCs in a hypoxic environment also led to the expansion of cells bearing CXCR4 (CD184), CD44(low) and A2B5 surface markers. The enhanced self-renewal activity of the CD133-positive CSCs in hypoxia was preceded by upregulation of HIF-1 alpha. Knockdown of HIF-1 alpha abrogated the hypoxia-mediated CD133-positive CSC expansion. Inhibition of the phosphatidylinositol 3-kinase (PI3K)-Akt or ERK1/2 pathway reduced the hypoxia-driven CD133 expansion, suggesting that these signaling cascades may modulate the hypoxic response. Finally, CSCs propagated at hypoxia robustly retained the undifferentiated phenotype, whereas CSCs cultured at normoxia did not. These results suggest that response to hypoxia by CSCs involves the activation of HIF-1a to enhance the self-renewal activity of CD133-positive cells and to inhibit the induction of CSC differentiation. This study illustrates the importance of the tumor microenvironment in determining cellular behavior. Oncogene (2009) 28, 3949-3959; doi:10.1038/onc.2009.252; published online 31 August 2009	[Park, D. M.] Univ Pittsburgh, Inst Canc, UPMC Canc Pavil, Brain Tumor Program, Pittsburgh, PA 15232 USA; [Mintz, A.; Engh, J.; Kassam, A. B.; Pollack, I. F.; Park, D. M.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15232 USA; [Androutsellis-Theotokis, A.; McKay, R. D.] NIH, Mol Biol Lab, Bethesda, MD 20892 USA; [Iwama, T.] Gifu Univ, Sch Med, Dept Neurosurg, Gifu 500, Japan; [Kunisada, T.] Gifu Univ, Sch Med, Dept Tissue & Organ Dev Regenerat & Adv Med Sci, Gifu 500, Japan; [Park, D. M.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; Gifu University; Gifu University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Park, DM (corresponding author), Univ Pittsburgh, Inst Canc, UPMC Canc Pavil, Brain Tumor Program, 5th Floor,5150 Ctr Ave, Pittsburgh, PA 15232 USA.	parkdm@upmc.edu	Park, Deric/C-5675-2013	Androutsellis-Theotokis, Andreas/0000-0002-1985-4589; Kunisada, Takahiro/0000-0003-1651-2716; Iwama, Toru/0000-0002-9426-284X	Uehara Memorial Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002981] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Akio Soeda is in part supported by the Uehara Memorial Foundation.	Aebersold DM, 2001, CANCER RES, V61, P2911; Alvarez-Tejado M, 2001, J BIOL CHEM, V276, P22368, DOI 10.1074/jbc.M011688200; Arsham AM, 2002, J BIOL CHEM, V277, P15162, DOI 10.1074/jbc.M111162200; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Birner P, 2000, CANCER RES, V60, P4693; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chen HL, 2007, STEM CELLS, V25, P2291, DOI 10.1634/stemcells.2006-0609; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Ehtesham M, 2004, NEOPLASIA, V6, P287, DOI 10.1593/neo.03427; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Li J, 2004, J BIOL CHEM, V279, P41275, DOI 10.1074/jbc.C400297200; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Nieoullon V, 2005, MOL CELL NEUROSCI, V28, P462, DOI 10.1016/j.mcn.2004.10.007; Ogden AT, 2008, NEUROSURGERY, V62, P505, DOI 10.1227/01.neu.0000316019.28421.95; Oka N, 2007, BIOCHEM BIOPH RES CO, V360, P553, DOI 10.1016/j.bbrc.2007.06.094; Oka N, 2009, NEUROL MED-CHIR, V49, P146, DOI 10.2176/nmc.49.146; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Park DM, 2007, CELL CYCLE, V6, P467, DOI 10.4161/cc.6.4.3856; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shimogai R, 2008, INT J GYNECOL CANCER, V18, P499, DOI 10.1111/j.1525-1438.2007.01055.x; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soeda A, 2008, J BIOL CHEM, V283, P10958, DOI 10.1074/jbc.M704205200; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wurmser AE, 2004, SCIENCE, V304, P1253, DOI 10.1126/science.1099344; Xu L, 2004, CLIN CANCER RES, V10, P701, DOI 10.1158/1078-0432.CCR-0953-03; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W; Zhong H, 2000, CANCER RES, V60, P1541	49	495	520	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 12	2009	28	45					3949	3959		10.1038/onc.2009.252	http://dx.doi.org/10.1038/onc.2009.252			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	530AC	19718046				2022-12-25	WOS:000272560300001
J	Chen, YJ; Dominguez-Brauer, C; Wang, ZB; Asara, JM; Costa, RH; Tyner, AL; Lau, LF; Raychaudhuri, P				Chen, Yi-Ju; Dominguez-Brauer, Carmen; Wang, Zebin; Asara, John M.; Costa, Robert H.; Tyner, Angela L.; Lau, Lester F.; Raychaudhuri, Pradip			A Conserved Phosphorylation Site within the Forkhead Domain of FoxM1B Is Required for Its Activation by Cyclin-CDK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M1 TRANSCRIPTION FACTOR; GENE-EXPRESSION PROFILES; CELL-CYCLE PROGRESSION; PROTEIN-KINASE CK2; MITOTIC PROGRESSION; BINDING DOMAIN; SOMATIC WEE1; CANCER; MITOSIS; PHASE	The Forkhead box M1 (FoxM1) transcription factor is critical for expression of the genes essential for G1/S transition and mitotic progression. To explore the cell cycle regulation of FoxM1, we examined the phosphorylation profile of FoxM1. Here, we show that the phosphorylated status and the activity of FoxM1 increase as cells progress from S to G2/M phases. Moreover, dephosphorylation of FoxM1 coincides with exit from mitosis. Using mass spectrometry, we have identified a new conserved phosphorylation site (Ser-251) within the forkhead domain of FoxM1. Disruption of Ser-251 inhibits phosphorylation of FoxM1 and dramatically decreases its transcriptional activity. Wedemonstrate that the Ser-251 residue is required for CDK1-dependent phosphorylation of FoxM1 as well as its interaction with the coactivator CREB-binding protein (CBP). Interestingly, the transcriptional activity of the S251A mutant protein remains responsive to activation by overexpressed Polo-like kinase 1 (PLK1). Cells expressing the S251A mutant exhibit reduced expression of the G2/M phase genes and impaired mitotic progression. Our results demonstrate that the transcriptional activity of FoxM1 is controlled in a cell cycle-dependent fashion by temporally regulated phosphorylation and dephosphorylation events, and that the phosphorylation at Ser-251 is critical for the activation of FoxM1.	[Chen, Yi-Ju; Dominguez-Brauer, Carmen; Wang, Zebin; Costa, Robert H.; Tyner, Angela L.; Lau, Lester F.; Raychaudhuri, Pradip] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Dept Pathol, Sch Med, Boston, MA 02115 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Raychaudhuri, P (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, M-C 669,900 S Ashland Ave,MBRB Rm 2302, Chicago, IL 60607 USA.	pradip@uic.edu		Lau, Lester/0000-0002-4364-2914; Tyner, Angela/0000-0001-7448-8625	National Institutes of Health [CA 124488, CA 77637, AG021842, DK44525, DK068503]; United States Public Health Service; NATIONAL CANCER INSTITUTE [R01CA077637, R01CA124488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK044525, R01DK044525, R01DK068503, R01DK054687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021842] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA 124488 and CA 77637 ( to P. R.) from the United States Public Health Service, and NIH Grants AG021842 ( to L. F. L.), DK44525, and DK068503 ( to A. L. T.).	ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Barz T, 2003, J CELL SCI, V116, P1563, DOI 10.1242/jcs.00352; Bektas N, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-42; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Dai B, 2007, ONCOGENE, V26, P6212, DOI 10.1038/sj.onc.1210443; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Kaestner KH, 2000, GENE DEV, V14, P142; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Korver W, 1997, GENOMICS, V46, P435, DOI 10.1006/geno.1997.5065; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2008, CELL CYCLE, V7, P2720, DOI 10.4161/cc.7.17.6580; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Li Q, 2009, CANCER RES, V69, P3501, DOI 10.1158/0008-5472.CAN-08-3045; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Luscher-Firzlaff JM, 2006, FEBS LETT, V580, P1716, DOI 10.1016/j.febslet.2006.02.021; Luscher-Firzlaff JM, 1999, ONCOGENE, V18, P5620, DOI 10.1038/sj.onc.1202967; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Park HJ, 2008, ONCOGENE, V27, P1696, DOI 10.1038/sj.onc.1210814; Park HJ, 2008, MOL CELL BIOL, V28, P5162, DOI 10.1128/MCB.00387-08; Petrovic V, 2008, J BIOL CHEM, V283, P453, DOI 10.1074/jbc.M705792200; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Poole A, 2005, MOL CELL BIOCHEM, V274, P163, DOI 10.1007/s11010-005-2945-z; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Wang IC, 2008, ONCOGENE, V27, P4137, DOI 10.1038/onc.2008.60; Wang IC, 2008, J BIOL CHEM, V283, P20770, DOI 10.1074/jbc.M709892200; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; Whitmarsh AJ, 2000, CELL MOL LIFE SCI, V57, P1172, DOI 10.1007/PL00000757; Wierstra I, 2006, BIOL CHEM, V387, P963, DOI 10.1515/BC.2006.120; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827; Yde CW, 2008, ONCOGENE, V27, P4986, DOI 10.1038/onc.2008.146; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036	55	66	67	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30695	30707		10.1074/jbc.M109.007997	http://dx.doi.org/10.1074/jbc.M109.007997			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19737929	hybrid, Green Published			2022-12-25	WOS:000271090000071
J	Plumlee, CR; Lee, C; Beg, AA; Decker, T; Shuman, HA; Schindler, C				Plumlee, Courtney R.; Lee, Carolyn; Beg, Amer A.; Decker, Thomas; Shuman, Howard A.; Schindler, Christian			Interferons Direct an Effective Innate Response to Legionella pneumophila Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTRACELLULAR MULTIPLICATION; TRANSCRIPTION FACTORS; TARGETED DISRUPTION; MACROPHAGE IMMUNITY; MOUSE MACROPHAGES; GAMMA-INTERFERON; CYTOPLASMIC DNA; VIRAL-INFECTION; DENDRITIC CELLS	Legionella pneumophila remains an important opportunistic pathogen of human macrophages. Its more limited ability to replicate in murine macrophages has been attributed to redundant innate sensor systems that detect and effectively respond to this infection. The current studies evaluate the role of one of these innate response systems, the type I interferon (IFN-I) autocrine loop. The ability of L. pneumophila to induce IFN-I expression was found to be dependent on IRF-3, but not NF-kappa B. Secreted IFN-Is then in turn suppress the intracellular replication of L. pneumophila. Surprisingly, this suppression is mediated by a pathway that is independent of Stat1, Stat2, Stat3, but correlates with the polarization of macrophages toward the M1 or classically activated phenotype.	[Lee, Carolyn; Shuman, Howard A.; Schindler, Christian] Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA; [Plumlee, Courtney R.] Columbia Univ, Dept Biol Sci, New York, NY 10032 USA; [Schindler, Christian] Columbia Univ, Dept Med, New York, NY 10032 USA; [Beg, Amer A.] Univ S Florida, Moffitt Canc Ctr, Tampa, FL 33612 USA; [Decker, Thomas] Univ Vienna, A-1030 Vienna, Austria	Columbia University; Columbia University; Columbia University; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Vienna	Schindler, C (corresponding author), Columbia Univ, Dept Microbiol & Immunol, HHSC 908,701 W 168th St, New York, NY 10032 USA.	cws4@columbia.edu			National Institutes of Health [AI 058211, HL 55413, 5T32 AI07525, 5T32 DK007328, AI 059715, AI23549]; Austrian Science Foundation [P20522-B05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007525, R01AI059715, R01AI023549, R01AI058211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007328] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [F 2803] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Foundation(Austrian Science Fund (FWF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported, in whole or in part, by National Institutes of Health Grants AI 058211 (to C. S.), HL 55413 (to C. S.), 5T32 AI07525 (to C. R. P.), 5T32 DK007328 (to C. R. P.), AI 059715 (to A. A. B.), and AI23549 (to H. A. S.). This research was also supported by the Austrian Science Foundation (FWF) Grant P20522-B05 (to T. D.).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Abu-Zant A, 2007, CELL MICROBIOL, V9, P246, DOI 10.1111/j.1462-5822.2006.00785.x; Akamine M, 2007, MICROBIOL IMMUNOL, V51, P279, DOI 10.1111/j.1348-0421.2007.tb03909.x; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Archer KA, 2006, INFECT IMMUN, V74, P3325, DOI 10.1128/IAI.02049-05; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Coers J, 2007, CELL MICROBIOL, V9, P2344, DOI 10.1111/j.1462-5822.2007.00963.x; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Deng JC, 2001, INFECT IMMUN, V69, P6382, DOI 10.1128/IAI.69.10.6382-6390.2001; Escalante CR, 2002, STRUCTURE, V10, P383, DOI 10.1016/S0969-2126(02)00723-2; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; Fong CHY, 2008, J EXP MED, V205, P1269, DOI 10.1084/jem.20080124; Fortier A, 2005, TRENDS MICROBIOL, V13, P328, DOI 10.1016/j.tim.2005.05.007; GEBRAN SJ, 1994, INFECT IMMUN, V62, P3197, DOI 10.1128/IAI.62.8.3197-3205.1994; Gimeno R, 2005, MOL CELL BIOL, V25, P5456, DOI 10.1128/MCB.25.13.5456-5465.2005; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hawn TR, 2007, J IMMUNOL, V179, P6981, DOI 10.4049/jimmunol.179.10.6981; Hawn TR, 2006, J INFECT DIS, V193, P1693, DOI 10.1086/504525; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Hilbi H, 2001, MOL MICROBIOL, V42, P603, DOI 10.1046/j.1365-2958.2001.02645.x; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hovel-Miner G, 2009, J BACTERIOL, V191, P2461, DOI 10.1128/JB.01578-08; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Losick VP, 2006, J EXP MED, V203, P2177, DOI 10.1084/jem.20060766; Losick VP, 2009, INFECT IMMUN, V77, P196, DOI 10.1128/IAI.01011-08; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; NASH TW, 1988, J IMMUNOL, V140, P3978; Neild AL, 2004, CELL MICROBIOL, V6, P1011, DOI 10.1111/j.1462-5822.2004.00450.x; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; Opitz B, 2006, J BIOL CHEM, V281, P36173, DOI 10.1074/jbc.M604638200; Park C, 1999, NUCLEIC ACIDS RES, V27, P4191, DOI 10.1093/nar/27.21.4191; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Sabria Miguel, 2003, Am J Respir Med, V2, P235; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schiavoni G, 2004, J IMMUNOL, V173, P1266, DOI 10.4049/jimmunol.173.2.1266; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schindler C, 2008, SEMIN CELL DEV BIOL, V19, P311, DOI 10.1016/j.semcdb.2008.08.010; Schneider K, 2008, CELL HOST MICROBE, V3, P67, DOI 10.1016/j.chom.2007.12.008; Segal G, 2005, FEMS MICROBIOL REV, V29, P65, DOI 10.1016/j.femsre.2004.07.001; Song L, 2006, BLOOD, V108, P3237, DOI 10.1182/blood-2006-04-020271; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Sutterwala FS, 2006, J ENDOTOXIN RES, V12, P251, DOI 10.1179/096805106X118771; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tam MA, 2008, CELL MICROBIOL, V10, P1517, DOI 10.1111/j.1462-5822.2008.01144.x; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Timmer AM, 2008, J EXP MED, V205, P1255, DOI 10.1084/jem.20081056; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Wang JM, 2007, J IMMUNOL, V178, P6777, DOI 10.4049/jimmunol.178.11.6777; Wang XY, 2007, J IMMUNOL, V178, P6770, DOI 10.4049/jimmunol.178.11.6770; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zhao WL, 2008, J IMMUNOL, V180, P5483, DOI 10.4049/jimmunol.180.8.5483; Zhao WL, 2007, J IMMUNOL, V179, P463, DOI 10.4049/jimmunol.179.1.463	71	60	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30058	30066		10.1074/jbc.M109.018283	http://dx.doi.org/10.1074/jbc.M109.018283			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19720834	Green Published, hybrid			2022-12-25	WOS:000271090000008
J	Taylor, WA; Hatch, GM				Taylor, William A.; Hatch, Grant M.			Identification of the Human Mitochondrial Linoleoyl-coenzyme A Monolysocardiolipin Acyltransferase (MLCL AT-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; BARTH-SYNDROME PATIENTS; CARDIOLIPIN METABOLISM; ENDOTHELIAL LINEAGES; RESPIRATORY-CHAIN; DE-NOVO; BIOSYNTHESIS; HEART; MEMBRANE; MOUSE	Here we report the identification of a previously uncharacterized human protein as the human monolysocardiolipin acyltransferase-1 (MLCL AT-1). Pig liver mitochondria were treated with n-butyl alcohol followed by Q-Sepharose chromatography, preparative gel electrophoresis, cytidine diphosphate-1,2-diacyl-sn-glycerol-Sepharose chromatography, and finally monolysocardiolipin-adriamycin-agarose affinity chromatography. Elution with either monolysocardiolipin or linoleoyl coenzyme A revealed a major band at 74 kDa with high specific activity (2,300 pmol/min/mg) for the acylation of monolysocardiolipin to cardiolipin using [1-C-14]linoleoyl coenzyme A as substrate. Matrix-assisted laser desorption ionization time-of-flight-mass spectrometry analysis followed by search of the Mascot protein data base revealed peptide matches consistent with a 59-kDa protein identified as unknown human protein (GenBank (TM) protein accession number AAX93141; nucleotide accession number AC011742.3). The purified human recombinant MLCL AT-1 protein utilized linoleoyl coenzyme A> oleoyl coenzyme A> palmitoyl coenzyme A for the specific acylation of monolysocardiolipin to cardiolipin. Expression of MLCL AT-1 in HeLa cells increased mitochondrial monolysocardiolipin acyltransferase activity and [1-C-14]linoleic acid incorporated into cardiolipin, whereas RNA interference knockdown of MLCL AT-1 in HeLa cells resulted in reduction in enzyme activity and [1-C-14]linoleic acid incorporated into cardiolipin. In contrast, expression of MLCL AT-1 in HeLa cells did not alter [1-C-14]oleic or [1-C-14]palmitate incorporation into cardiolipin indicating in vivo specificity for the remodeling of cardiolipin with linoleate. Finally, expression of MLCL AT-1 in Barth syndrome lymphoblasts, which exhibit cardiolipin levels 20% that of normal lymphoblasts, increased mitochondrial monolysocardiolipin acyltransferase activity, [1-C-14]linoleic acid incorporation into cardiolipin, cardiolipin mass, and succinate dehydrogenase (mitochondrial complex II) activity compared with mock-transfected Barth syndrome lymphoblasts. The results identify MLCL AT-1 as a human mitochondrial monolysocardiolipin acyltransferase involved in the remodeling of cardiolipin.	[Hatch, Grant M.] Univ Manitoba, Dept Pharmacol & Therapeut, Fac Med, Winnipeg, MB R3E 0W3, Canada; [Hatch, Grant M.] Univ Manitoba, Dept Biochem, Winnipeg, MB R3E 0W3, Canada; [Hatch, Grant M.] Univ Manitoba, Dept Med Genet, Winnipeg, MB R3E 0W3, Canada; [Hatch, Grant M.] Univ Manitoba, Dept Internal Med, Winnipeg, MB R3E 0W3, Canada; [Hatch, Grant M.] Univ Manitoba, Ctr Res & Treatment Atherosclerosis, Winnipeg, MB R3E 0W3, Canada	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba	Hatch, GM (corresponding author), Univ Manitoba, Dept Pharmacol & Therapeut, Fac Med, 753 McDermot Ave, Winnipeg, MB R3E 0W3, Canada.	hatchgm@ms.umanitoba.ca			Canadian Institutes of Health Research; Manitoba Health Research Council; Barth Syndrome Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council; Barth Syndrome Foundation of Canada	This work was supported by grants from the Canadian Institutes of Health Research, the Manitoba Health Research Council, and the Barth Syndrome Foundation of Canada.	Athea Y, 2007, DIABETES, V56, P786, DOI 10.2337/db06-0187; Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Cao JS, 2009, AM J PHYSIOL-ENDOC M, V296, pE647, DOI 10.1152/ajpendo.90761.2008; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Colby TD, 1999, P NATL ACAD SCI USA, V96, P3531, DOI 10.1073/pnas.96.7.3531; Danos M, 2008, BIOCHEM CELL BIOL, V86, P11, DOI [10.1139/O07-156, 10.1139/o07-156]; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; EICHBERG J, 1974, J BIOL CHEM, V249, P3423; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; Hatch GM, 1998, INT J MOL MED, V1, P33; Hatch GM, 1996, J BIOL CHEM, V271, P25810, DOI 10.1074/jbc.271.42.25810; Hatch GM, 2004, BIOCHEM CELL BIOL, V82, P99, DOI 10.1139/o03-074; Hauff KD, 2006, PROG LIPID RES, V45, P91, DOI 10.1016/j.plipres.2005.12.001; Hauff K, 2009, BIOCHEM J, V417, P573, DOI 10.1042/BJ20080650; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; Hostetler K. Y., 1982, PHOSPHOLIPIDS, V4, P215; HOSTETLER KY, 1975, BIOCHIM BIOPHYS ACTA, V380, P382, DOI 10.1016/0005-2760(75)90106-X; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; KELLEY M, 1992, BIOCHEM J, V288, P315, DOI 10.1042/bj2880315; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma BJ, 1999, J LIPID RES, V40, P1837; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; MORTON RK, 1955, METHOD ENZYMOL, V1, P26; Ott M, 2007, CELL DEATH DIFFER, V14, P1243, DOI 10.1038/sj.cdd.4402135; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; RUSTOW B, 1989, BIOCHIM BIOPHYS ACTA, V1002, P261, DOI 10.1016/0005-2760(89)90296-8; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; SCHLAME M, 1990, BIOCHEM J, V272, P589, DOI 10.1042/bj2720589; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Singer T P, 1974, Methods Biochem Anal, V22, P123, DOI 10.1002/9780470110423.ch3; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Taylor WA, 2003, J BIOL CHEM, V278, P12716, DOI 10.1074/jbc.M210329200; Valianpour F, 2002, CLIN CHEM, V48, P1390; Van QY, 2007, BIOCHEM J, V401, P103, DOI 10.1042/BJ20060373; Volchenboum SL, 2000, J BIOL CHEM, V275, P7958, DOI 10.1074/jbc.275.11.7958; Wang CY, 2007, BLOOD, V110, P3601, DOI 10.1182/blood-2007-04-086827; Xiong JW, 2008, CIRC RES, V102, P1057, DOI 10.1161/CIRCRESAHA.107.163907; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; YANG SY, 1995, BIOCHEMISTRY-US, V34, P6441, DOI 10.1021/bi00019a025; Yao KW, 1996, J BIOL CHEM, V271, P17816, DOI 10.1074/jbc.271.30.17816; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zhao Y, 2009, J LIPID RES, V50, P945, DOI 10.1194/jlr.M800567-JLR200	46	76	77	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30360	30371		10.1074/jbc.M109.048322	http://dx.doi.org/10.1074/jbc.M109.048322			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19737925	hybrid, Green Published			2022-12-25	WOS:000271090000039
J	Guo, XJ; Nie, L; Esmailzadeh, L; Zhang, JS; Bender, JR; Sadeghi, MM				Guo, Xiaojia; Nie, Lei; Esmailzadeh, Leila; Zhang, Jiasheng; Bender, Jeffrey R.; Sadeghi, Mehran M.			Endothelial and Smooth Muscle-derived Neuropilin-like Protein Regulates Platelet-derived Growth Factor Signaling in Human Vascular Smooth Muscle Cells by Modulating Receptor Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BETA-RECEPTOR; TYROSINE PHOSPHORYLATION; NEGATIVE REGULATION; PROLIFERATION; MIGRATION; KINASE; ACTIVATION; BINDING; CBL; SITE	Endothelial and smooth muscle cell-derived neuropilin-like protein (ESDN) is up-regulated in the neointima of remodeling arteries and modulates vascular smooth muscle cell (VSMC) growth. Platelet-derived growth factor (PDGF) is the prototypic growth factor for VSMCs and plays a key role in vascular remodeling. Here, we sought to further define ESDN function in primary human VSMCs. ESDN down-regulation by RNA interference significantly enhanced PDGF-induced VSMC DNA synthesis and migration. This was associated with increased ERK1/2, Src, and PDGF receptor (PDGFR)beta phosphorylation, without altering total PDGFR beta expression levels. In binding assays, ESDN down-regulation significantly increased I-125-PDGF maximum binding (B-max) to PDGF receptors on VSMCs without altering the binding constant (K-d), raising the possibility that ESDN regulates PDGFR processing. ESDN down-regulation significantly reduced ligand-induced PDGFR beta ubiquitination. This was associated with a significant reduction in the expression level of c-Cbl, an E3 ubiquitin ligase that ubiquitinylates PDGFR beta. Thus, ESDN modulates PDGF signaling in VSMCs via regulation of PDGFR surface levels. The ESDN effect is mediated, at least in part, through effects on PDGFR beta ubiquitination. ESDN may serve as a target for regulating PDGFR beta signaling in VSMCs.	[Guo, Xiaojia; Nie, Lei; Esmailzadeh, Leila; Zhang, Jiasheng; Sadeghi, Mehran M.] Vet Affairs Connecticut Healthcare Syst, West Haven, CT 06516 USA; [Guo, Xiaojia; Nie, Lei; Esmailzadeh, Leila; Zhang, Jiasheng; Sadeghi, Mehran M.] Yale Univ, Sch Med, Cardiovasc Mol Imaging Lab, New Haven, CT 06520 USA; [Bender, Jeffrey R.] Yale Univ, Sch Med, Sect Cardiovasc Med, Raymond & Beverly Sackler Fdn Cardiovasc Lab, New Haven, CT 06520 USA; [Guo, Xiaojia; Nie, Lei; Esmailzadeh, Leila; Zhang, Jiasheng; Bender, Jeffrey R.; Sadeghi, Mehran M.] Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, New Haven, CT 06520 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Yale University; Yale University	Sadeghi, MM (corresponding author), Vet Affairs Connecticut Healthcare Syst, 950 Campbell Ave,111B, West Haven, CT 06516 USA.	mehran.sadeghi@yale.edu			National Institutes of Health [HL70295, RO1 HL085093]; Department of Veterans Affairs merit award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070295, R01HL085093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs merit award(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Program Project HL70295 and RO1 HL085093. This work was also supported by a Department of Veterans Affairs merit award (to M. M. S.).	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; ERPEL T, 1995, CURR OPIN CELL BIOL, V7, P176, DOI 10.1016/0955-0674(95)80025-5; Huang M, 2007, ARTERIOSCL THROM VAS, V27, P2597, DOI 10.1161/ATVBAHA.107.154211; JACKSON CL, 1993, ARTERIOSCLER THROMB, V13, P1218, DOI 10.1161/01.ATV.13.8.1218; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Juliano RL, 2004, BIOCHEM SOC T, V32, P443, DOI 10.1042/BST0320443; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Kim M, 2008, MOL CANCER RES, V6, P222, DOI 10.1158/1541-7786.MCR-07-0142; Kobuke K, 2001, J BIOL CHEM, V276, P34105, DOI 10.1074/jbc.M105293200; Koshikawa K, 2002, ONCOGENE, V21, P2822, DOI 10.1038/sj.onc.1205405; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; Lewis CD, 2001, PLATELETS, V12, P352; Miyake S, 1999, J BIOL CHEM, V274, P16619, DOI 10.1074/jbc.274.23.16619; MORI S, 1992, J BIOL CHEM, V267, P6429; MORI S, 1995, J BIOL CHEM, V270, P29447, DOI 10.1074/jbc.270.49.29447; MORI S, 1993, J BIOL CHEM, V268, P577; Mureebe L, 1997, SURGERY, V122, P138, DOI 10.1016/S0039-6060(97)90002-7; Nakata S, 2007, J BIOL CHEM, V282, P37815, DOI 10.1074/jbc.M707461200; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Persson C, 2004, MOL CELL BIOL, V24, P2190, DOI 10.1128/MCB.24.5.2190-2201.2004; Reddi AL, 2007, J BIOL CHEM, V282, P29336, DOI 10.1074/jbc.M701797200; Sadeghi MM, 2007, AM J TRANSPLANT, V7, P2098, DOI 10.1111/j.1600-6143.2007.01919.x; Sambi BS, 2006, CELL SIGNAL, V18, P971, DOI 10.1016/j.cellsig.2005.08.003; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; Spencer JA, 2005, P NATL ACAD SCI USA, V102, P2946, DOI 10.1073/pnas.0500058102; Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Weber DS, 2004, CIRC RES, V94, P1219, DOI 10.1161/01.RES.0000126848.54740.4A; Welser JV, 2007, CIRC RES, V101, P672, DOI 10.1161/CIRCRESAHA.107.151415; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2	31	18	19	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29376	29382		10.1074/jbc.M109.049684	http://dx.doi.org/10.1074/jbc.M109.049684			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19696027	hybrid, Green Published			2022-12-25	WOS:000270896800018
J	Jin, Y; Watt, RM; Danchin, A; Huang, JD				Jin, Ye; Watt, Rory M.; Danchin, Antoine; Huang, Jian-dong			Use of a Riboswitch-controlled Conditional Hypomorphic Mutation to Uncover a Role for the Essential csrA Gene in Bacterial Autoaggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA SECONDARY STRUCTURE; OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI; BIOFILM FORMATION; ANTIGEN 43; EXPRESSION; BINDING; AGGREGATION; TRANSLATION; PREDICTION	Essential genes encode biological functions critical for cell survival. Correspondingly, their null mutants are often difficult to obtain, which impedes subsequent genetic and functional analysis. Here, we describe the development and utility of a theophylline-responsive riboswitch that enables target gene expression to be specifically "tuned" from low to high levels, which may be used to generate conditional hypomorphic mutants. Low levels of gene activity in the absence of the ligand (theophylline) permit cell survival, enabling gene activities to be investigated. Normal gene expression levels and wild-type phenotypes can be restored by the addition of the ligand. We demonstrate the utility of this approach with csrA, an essential gene in Escherichia coli that encodes the global regulatory protein CsrA. We placed the theophylline-responsive riboswitch immediately upstream of the csrA ribosome binding site, with the resulting mutant named switch-csrA. Hypomorphism of switch-csrA and its specific responsiveness to theophylline were verified by phenotypic examination and translation analysis. The utility of switch-csrA revealed a previously unidentified function for CsrA, namely its role as a repressor of cellular autoaggregation. Specifically, switch-csrA in the non-ligand-bound form produced low levels of CsrA, and its cells autoaggregated. Theophylline binding induced conformational changes in the riboswitch and permitted efficient csrA translation; consequently, autoaggregation did not occur. Our results indicate that CsrA modulates autoaggregation via the polysaccharide adhesin poly-beta-1,6-N-acetyl-D-glucosamine. In summary, the use of ligand-responsive riboswitches to construct conditional hypomorphic mutants represents a novel approach for investigating the activities of essential genes, which effectively complements traditional genetic approaches.	[Jin, Ye; Huang, Jian-dong] Univ Hong Kong, Li Ka Shing Fac Med, Dept Biochem, Pok Fu Lam, Hong Kong, Peoples R China; [Watt, Rory M.] Univ Hong Kong, Fac Dent, Pok Fu Lam, Hong Kong, Peoples R China; [Danchin, Antoine] Inst Pasteur, CNRS, URA2171, F-75724 Paris 15, France	University of Hong Kong; University of Hong Kong; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Huang, JD (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Biochem, Pok Fu Lam, Hong Kong, Peoples R China.	jdhuang@hkucc.hku.hk	Watt, Rory M./B-2177-2009; /C-4277-2009	Watt, Rory M./0000-0002-8718-1988; Danchin, Antoine/0000-0002-6350-5001; /0000-0001-7531-2816	University of Hong Kong Committee on Research and Conference; Research Grants Council of Hong Kong [HKU 7485/06M]	University of Hong Kong Committee on Research and Conference(University of Hong Kong); Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by the University of Hong Kong Committee on Research and Conference Grants Seed Funding Program for Basic Research and by Research Grants Council of Hong Kong Grant HKU 7485/06M (to J. D. H.).	Baker CS, 2007, J BACTERIOL, V189, P5472, DOI 10.1128/JB.00529-07; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; BRUNEL C, 1995, J MOL BIOL, V253, P277, DOI 10.1006/jmbi.1995.0552; Danese PN, 2000, MOL MICROBIOL, V37, P424, DOI 10.1046/j.1365-2958.2000.02008.x; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Dubey AK, 2003, J BACTERIOL, V185, P4450, DOI 10.1128/JB.185.15.4450-4460.2003; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Henderson IR, 1997, FEMS MICROBIOL LETT, V149, P115, DOI 10.1016/S0378-1097(97)00065-7; Herring CD, 2004, J BACTERIOL, V186, P2673, DOI 10.1128/JB.186.9.2673-2681.2004; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Jin Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-165; Jonas K, 2008, MOL MICROBIOL, V70, P236, DOI 10.1111/j.1365-2958.2008.06411.x; Judson N, 2000, NAT BIOTECHNOL, V18, P740, DOI 10.1038/77305; Liu MY, 1997, J BIOL CHEM, V272, P17502, DOI 10.1074/jbc.272.28.17502; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Mushegian A, 1999, CURR OPIN GENET DEV, V9, P709, DOI 10.1016/S0959-437X(99)00023-4; OCHIAI K, 1993, J MED MICROBIOL, V39, P183, DOI 10.1099/00222615-39-3-183; Sherlock O, 2005, INFECT IMMUN, V73, P1954, DOI 10.1128/IAI.73.4.1954-1963.2005; Sherlock O, 2004, J BACTERIOL, V186, P8058, DOI 10.1128/JB.186.23.8058-8065.2004; Suess B, 2004, NUCLEIC ACIDS RES, V32, P1610, DOI 10.1093/nar/gkh321; Timmermans J, 2009, J BACTERIOL, V191, P1722, DOI 10.1128/JB.01573-08; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zimmermann GR, 2000, RNA, V6, P659, DOI 10.1017/S1355838200000169	28	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28738	28745		10.1074/jbc.M109.028076	http://dx.doi.org/10.1074/jbc.M109.028076			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19706608	Green Published, hybrid			2022-12-25	WOS:000270678900030
J	Melnikova, VO; Balasubramanian, K; Villares, GJ; Dobroff, AS; Zigler, M; Wang, H; Petersson, F; Price, JE; Schroit, A; Prieto, VG; Hung, MC; Bar-Eli, M				Melnikova, Vladislava O.; Balasubramanian, Krishnakumar; Villares, Gabriel J.; Dobroff, Andrey S.; Zigler, Maya; Wang, Hua; Petersson, Frederik; Price, Janet E.; Schroit, Alan; Prieto, Victor G.; Hung, Mien-Chie; Bar-Eli, Menashe			Crosstalk between Protease-activated Receptor 1 and Platelet-activating Factor Receptor Regulates Melanoma Cell Adhesion Molecule (MCAM/MUC18) Expression and Melanoma Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ENDOTHELIAL-CELLS; BREAST-CANCER CELLS; KAPPA-B ACTIVATION; TUMOR-GROWTH; THROMBIN RECEPTOR; MALIGNANT-MELANOMA; SIGNALING PATHWAYS; INVASION; PHOSPHORYLATION; OVEREXPRESSION	The cellular and molecular pathways that regulate platelet activation, blood coagulation, and inflammation are emerging as critical players in cancer progression and metastasis. Here, we demonstrate a novel signaling mechanism whereby protease-activated receptor 1 (PAR1) mediates expression of melanoma cell adhesion molecule MCAM/MUC18 (MUC18), a critical marker of melanoma metastasis, via activation of platelet-activating factor receptor (PAFR) and cAMP-responsive element-binding protein (CREB). We found that PAR1 silencing with small hairpin RNA inhibits MUC18 expression in metastatic melanoma cells by inhibiting CREB phosphorylation, activity, and binding to the MUC18 promoter. We further demonstrate that the PAF/PAFR pathway mediates MUC18 expression downstream of PAR1. Indeed, PAR1 silencing down-regulates PAFR expression and PAF production, PAFR silencing blocks MUC18 expression, and re-expression of PAFR in PAR1-silenced cells rescues MUC18 expression. We further demonstrate that the PAR1-PAFR-MUC18 pathway mediates melanoma cell adhesion to microvascular endothelial cells, transendothelial migration, and metastatic retention in the lungs. Rescuing PAFR expression in PAR1-silenced cells fully restores metastatic phenotype of melanoma, indicating that PAFR plays critical role in the molecular mechanism of PAR1 action. Our results link the two pro-inflammatory G-protein-coupled receptors, PAR1 and PAFR, with the metastatic dissemination of melanoma and suggest that PAR1, PAFR, and MUC18 are attractive therapeutic targets for preventing melanoma metastasis.	[Melnikova, Vladislava O.; Balasubramanian, Krishnakumar; Villares, Gabriel J.; Dobroff, Andrey S.; Zigler, Maya; Wang, Hua; Price, Janet E.; Schroit, Alan; Bar-Eli, Menashe] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Prieto, Victor G.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Petersson, Frederik] Karolinska Univ Hosp, Karolinska Inst, Dept Pathol & Oncol, SE-17176 Stockholm, Sweden	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Karolinska Institutet; Karolinska University Hospital	Bar-Eli, M (corresponding author), 1515 Holcombe Blvd,Unit 173, Houston, TX 77030 USA.	mbareli@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021; Dobroff, Andrey/A-9814-2016	Hung, Mien-Chie/0000-0003-4317-4740; Dobroff, Andrey/0000-0003-2162-9951	National Institutes of Health [RO1CA760980]; Career Development Award, NIH SPORE in Skin Cancer [P50CA093459]; Melanoma Research Foundation; NATIONAL CANCER INSTITUTE [P50CA093459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award, NIH SPORE in Skin Cancer; Melanoma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1CA760980 (to M.B.-E.). This work was also supported by Career Development Award P50CA093459 from NIH SPORE in Skin Cancer and from Melanoma Research Foundation (to V. M.).	Anfosso F, 1998, J BIOL CHEM, V273, P26852, DOI 10.1074/jbc.273.41.26852; Auguste P, 2007, AM J PATHOL, V170, P1781, DOI 10.2353/ajpath.2007.060886; Biancone L, 2003, CLIN CANCER RES, V9, P4214; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; BROMBERG ME, 1995, P NATL ACAD SCI USA, V92, P8205, DOI 10.1073/pnas.92.18.8205; Bussolati B, 2000, AM J PATHOL, V157, P1713, DOI 10.1016/S0002-9440(10)64808-0; Chay CH, 2002, UROLOGY, V60, P760, DOI 10.1016/S0090-4295(02)01969-6; Chen DX, 2008, J EXP MED, V205, P1739, DOI 10.1084/jem.20071427; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Countryman NB, 2000, J INVEST DERMATOL, V115, P267, DOI 10.1046/j.1523-1747.2000.00058.x; Dardik R, 1998, BRIT J CANCER, V77, P2069, DOI 10.1038/bjc.1998.349; DeNardo DG, 2008, CANCER METAST REV, V27, P11, DOI 10.1007/s10555-007-9100-0; Deo DD, 2004, J BIOL CHEM, V279, P3497, DOI 10.1074/jbc.M304497200; Dobroff AS, 2009, J BIOL CHEM, V284, P26194, DOI 10.1074/jbc.M109.019836; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Even-Ram SC, 2001, J BIOL CHEM, V276, P10952, DOI 10.1074/jbc.M007027200; FISCHER EG, 1995, CANCER RES, V55, P1629; GASIC GJ, 1968, P NATL ACAD SCI USA, V61, P46, DOI 10.1073/pnas.61.1.46; Glinskii OV, 2005, NEOPLASIA, V7, P522, DOI 10.1593/neo.04646; Johnson JP, 1999, CANCER METAST REV, V18, P345, DOI 10.1023/A:1006304806799; Keese CR, 2002, BIOTECHNIQUES, V33, P842, DOI 10.2144/02334rr01; Kim MP, 2009, CELL TISSUE RES, V335, P249, DOI 10.1007/s00441-008-0682-9; KLEPFISH A, 1993, INT J CANCER, V53, P978; KRAVCHENKO VV, 1995, J BIOL CHEM, V270, P14928, DOI 10.1074/jbc.270.25.14928; LAURI D, 1991, LAB INVEST, V65, P525; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Melnikova VO, 2006, J BIOL CHEM, V281, P2911, DOI 10.1074/jbc.M508683200; Mercer PF, 2007, ANN NY ACAD SCI, V1096, P86, DOI 10.1196/annals.1397.073; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Mills L, 2002, CANCER RES, V62, P5106; Mintz-Weber CS, 2000, J BIOL CHEM, V275, P34672, DOI 10.1074/jbc.M003812200; Mourad-Zeidan AA, 2008, AM J PATHOL, V173, P1839, DOI 10.2353/ajpath.2008.080380; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Nierodzik ML, 1998, BLOOD, V92, P3694, DOI 10.1182/blood.V92.10.3694.422k40_3694_3700; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pei Y, 1998, J IMMUNOL, V161, P1954; Robert EG, 2001, CURR PHARM DESIGN, V7, P1615, DOI 10.2174/1381612013397203; Ruf W, 2006, SEMIN THROMB HEMOST, V32, P61, DOI 10.1055/s-2006-939555; Rummel MM, 1996, CANCER RES, V56, P2218; Satyamoorthy K, 2001, ONCOGENE, V20, P4676, DOI 10.1038/sj.onc.1204616; Seo KH, 2004, CANCER RES, V64, P6482, DOI 10.1158/0008-5472.CAN-03-2774; Shi IM, 1999, J PATHOL, V189, P4, DOI 10.1002/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P; Shih IM, 1997, CANCER RES, V57, P3835; SHIH IM, 1994, CANCER RES, V54, P2514; Sreevidya CS, 2008, CANCER RES, V68, P3978, DOI 10.1158/0008-5472.CAN-07-6132; Tellez C, 2003, J BIOL CHEM, V278, P46632, DOI 10.1074/jbc.M309159200; Tellez CS, 2007, J INVEST DERMATOL, V127, P387, DOI 10.1038/sj.jid.5700539; Timar J, 2005, ONCOLOGY-BASEL, V69, P185, DOI 10.1159/000088069; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Villares GJ, 2008, CANCER RES, V68, P9078, DOI 10.1158/0008-5472.CAN-08-2397; Villares GJ, 2009, CANCER RES, V69, P6730, DOI 10.1158/0008-5472.CAN-09-0300; Walterscheid JP, 2002, J EXP MED, V195, P171, DOI 10.1084/jem.20011450; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; WOJTUKIEWICZ MZ, 1992, THROMB RES, V68, P233, DOI 10.1016/0049-3848(92)90081-K; Xie SH, 1997, CANCER RES, V57, P2295; Xie SH, 1997, ONCOGENE, V15, P2069, DOI 10.1038/sj.onc.1201358	61	62	69	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28845	28855		10.1074/jbc.M109.042150	http://dx.doi.org/10.1074/jbc.M109.042150			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19703903	hybrid, Green Published			2022-12-25	WOS:000270678900041
J	Cheng, RCK; Tikhonov, DB; Zhorov, BS				Cheng, Ricky C. K.; Tikhonov, Denis B.; Zhorov, Boris S.			Structural Model for Phenylalkylamine Binding to L-type Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTED MOLECULAR FLEXIBILITY; CA2+ CHANNEL; OPTICAL ISOMERS; BENZOTHIAZEPINE BINDING; POTASSIUM CHANNEL; ALPHA-1 SUBUNIT; K+ CHANNEL; PHARMACOLOGICAL EVALUATION; DIHYDROPYRIDINE-BINDING; VERAPAMIL ANALOGS	Phenylalkylamines (PAAs), a major class of L-type calcium channel (LTCC) blockers, have two aromatic rings connected by a flexible chain with a nitrile substituent. Structural aspects of ligand-channel interactions remain unclear. We have built a KvAP-based model of LTCC and used Monte Carlo energy minimizations to dock devapamil, verapamil, gallopamil, and other PAAs. The PAA-LTCC models have the following common features: (i) the meta-methoxy group in ringA, which is proximal to the nitrile group, accepts an H-bond from a PAA-sensing Tyr_IIIS6; (ii) the meta-methoxy group in ring B accepts an H-bond from a PAA-sensing Tyr_IVS6; (iii) the ammonium group is stabilized at the focus of P-helices; and (iv) the nitrile group binds to a Ca2+ ion coordinated by the selectivity filter glutamates in repeats III and IV. The latter feature can explain Ca2+ potentiation of PAA action and the presence of an electronegative atom at a similar position of potent PAA analogs. Tyr substitution of a Thr in IIIS5 is known to enhance action of devapamil and verapamil. Our models predict that the para-methoxy group in ring A of devapamil and verapamil accepts an H-bond from this engineered Tyr. The model explains structure-activity relationships of PAAs, effects of LTCC mutations on PAA potency, data on PAA access to LTCC, and Ca2+ potentiation of PAA action. Common and class-specific aspects of action of PAAs, dihydropyridines, and benzothiazepines are discussed in view of the repeat interface concept.	[Cheng, Ricky C. K.; Tikhonov, Denis B.; Zhorov, Boris S.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Tikhonov, Denis B.] Russian Acad Sci, IM Sechenov Evolutionary Physiol & Biochem Inst, St Petersburg 194223, Russia	McMaster University; North-Western State Medical University named after I.I. Mechnikov; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Zhorov, BS (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.	zhorov@mcmaster.ca	Tikhonov, Denis/AAK-9148-2020; Zhorov, Boris/T-9892-2019; Zhorov, Boris S./V-8072-2019	Zhorov, Boris/0000-0002-3630-7114; Tikhonov, Denis/0000-0001-8523-4305	Canadian Institutes of Health Research [MOP-53229]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-53229 (to B. S. Z.). Computations were performed using the facilities of the Shared Hierarchical Academic Research Computing Network (SHARCNET).	ALMERS W, 1984, J PHYSIOL-LONDON, V353, P585, DOI 10.1113/jphysiol.1984.sp015352; BAYER R, 1975, N-S ARCH PHARMACOL, V290, P69, DOI 10.1007/BF00499990; Berjukov S, 1996, BRIT J PHARMACOL, V119, P1197, DOI 10.1111/j.1476-5381.1996.tb16022.x; Beyl S, 2007, J BIOL CHEM, V282, P3864, DOI 10.1074/jbc.M609153200; Bruhova I, 2008, MOL PHARMACOL, V74, P1033, DOI 10.1124/mol.108.049759; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; CATTERALL WA, 1992, TRENDS PHARMACOL SCI, V13, P256, DOI 10.1016/0165-6147(92)90079-L; Cleary L., 2004, Autonomic & Autacoid Pharmacology, V24, P63, DOI 10.1111/j.1474-8673.2004.00317.x; DEI S, 1993, J MED CHEM, V36, P439, DOI 10.1021/jm00056a003; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Dilmac N, 2004, MOL PHARMACOL, V66, P1236, DOI 10.1124/mol.104.000893; Doring F, 1996, J BIOL CHEM, V271, P11745, DOI 10.1074/jbc.271.20.11745; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dudley SC, 2000, J GEN PHYSIOL, V116, P679, DOI 10.1085/jgp.116.5.679; Faraldo-Gomez JD, 2007, J MOL BIOL, V365, P649, DOI 10.1016/j.jmb.2006.09.069; FERRY DR, 1985, BRIT J PHARMACOL, V84, P811, DOI 10.1111/j.1476-5381.1985.tb17375.x; Freeze BS, 2006, MOL PHARMACOL, V70, P718, DOI 10.1124/mol.106.023473; GLOSSMANN H, 1990, REV PHYSL BIOCH PHAR, V114, P1; GOLL A, 1986, N-S ARCH PHARMACOL, V334, P303, DOI 10.1007/BF00508786; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; HERING S, 1993, MOL PHARMACOL, V43, P820; HESCHELER J, 1982, PFLUG ARCH EUR J PHY, V393, P287, DOI 10.1007/BF00581411; HOCKERMAN GH, 1995, J BIOL CHEM, V270, P22119, DOI 10.1074/jbc.270.38.22119; Hockerman GH, 1997, J BIOL CHEM, V272, P18759, DOI 10.1074/jbc.272.30.18759; Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361; Huber I, 2000, BIOCHEM J, V347, P829, DOI 10.1042/0264-6021:3470829; Huber IG, 2004, J BIOL CHEM, V279, P55211, DOI 10.1074/jbc.M409008200; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Johnson BD, 1996, MOL PHARMACOL, V50, P1388; KAUMANN AJ, 1976, N-S ARCH PHARMACOL, V292, P21, DOI 10.1007/BF00506485; Lacinova L, 2005, GEN PHYSIOL BIOPHYS, V24, P3; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; LEE KS, 1983, NATURE, V302, P790, DOI 10.1038/302790a0; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; Lipkind GM, 2003, MOL PHARMACOL, V63, P499, DOI 10.1124/mol.63.3.499; Lipkind GM, 2001, BIOCHEMISTRY-US, V40, P6786, DOI 10.1021/bi010269a; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; LUDWIG C, 1977, BRIT J PHARMACOL, V59, P411, DOI 10.1111/j.1476-5381.1977.tb08394.x; MANNHOLD R, 1986, ARCH PHARM, V319, P990, DOI 10.1002/ardp.19863191107; MANNHOLD R, 1978, N-S ARCH PHARMACOL, V302, P217, DOI 10.1007/BF00517988; NAKAYAMA H, 1991, P NATL ACAD SCI USA, V88, P9203, DOI 10.1073/pnas.88.20.9203; Nawrath H, 1997, N-S ARCH PHARMACOL, V355, P79; Pagel PS, 1998, EUR J PHARMACOL, V348, P213, DOI 10.1016/S0014-2999(98)00145-9; SATOH K, 1980, J CARDIOVASC PHARM, V2, P309, DOI 10.1097/00005344-198005000-00008; Schuster A, 1996, EMBO J, V15, P2365, DOI 10.1002/j.1460-2075.1996.tb00592.x; SEYDL K, 1993, PFLUG ARCH EUR J PHY, V424, P552, DOI 10.1007/BF00374922; Sokolov S, 2001, CIRC RES, V89, P700, DOI 10.1161/hh2001.098983; STRIESSNIG J, 1991, P NATL ACAD SCI USA, V88, P10769, DOI 10.1073/pnas.88.23.10769; STRIESSNIG J, 1990, P NATL ACAD SCI USA, V87, P9108, DOI 10.1073/pnas.87.23.9108; TEODORI E, 1994, EUR J MED CHEM, V29, P139, DOI 10.1016/0223-5234(94)90211-9; Tikhonov DB, 2005, BIOPHYS J, V88, P184, DOI 10.1529/biophysj.104.048173; Tikhonov DB, 2008, J BIOL CHEM, V283, P17594, DOI 10.1074/jbc.M800141200; Tikhonov DB, 2007, BIOPHYS J, V93, P1557, DOI 10.1529/biophysj.106.100248; Tikhonov DB, 2009, J BIOL CHEM, V284, P19006, DOI 10.1074/jbc.M109.011296; Triggle DJ, 2003, CELL MOL NEUROBIOL, V23, P293, DOI 10.1023/A:1023632419813; TRIGGLE DJ, 1991, J CARDIOVASC PHARM, V18, pS1; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Zhorov BS, 2004, J NEUROCHEM, V88, P782, DOI 10.1111/j.1471-4159.2004.02261.x; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	62	39	40	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28332	28342		10.1074/jbc.M109.027326	http://dx.doi.org/10.1074/jbc.M109.027326			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19700404	hybrid, Green Published			2022-12-25	WOS:000270676300059
J	Evertsen, J; Alemzadeh, R; Wang, XJ				Evertsen, Jennifer; Alemzadeh, Ramin; Wang, Xujing			Increasing Incidence of Pediatric Type 1 Diabetes Mellitus in Southeastern Wisconsin: Relationship with Body Weight at Diagnosis	PLOS ONE			English	Article								Introduction: Several studies have confirmed the increasing rate of type 1 diabetes mellitus (T1DM) in children and the link with increasing BMI at diagnosis termed the 'accelerator hypothesis'. Our objective was to assess whether changing incidence of type 1 diabetes in a group of children and adolescent from the Midwest United States was associated with changes in BMI. Methods: Data from 1618 (52.1% M/47.9% F) newly-diagnosed children and adolescents (<19 years) with T1DM, admitted to Children's Hospital of Wisconsin (CHW) between January 1995 and December 2004, was analyzed in relationship to body mass index (BMI) standard deviation score (SDS). Results: An overall, 10-year cumulative incidence of 27.92 per 100,000 (19.12 to 41.72/100,000) was observed, with an average yearly cumulative incidence of 2.39%. The increase was largest in the younger age groups, 0-4, 5-9, and 10-14 having an average yearly increase of 2.4, 2.3, and 3.0%, respectively, corresponding to a relative 10-year increase of 25.3, 33.8, and 38.0%, respectively. Age at diagnosis was inversely correlated with BMI SDS (p<0.001) and remained significant for both males and females. Conclusions: Annual incidence of T1DM increased two-fold at CHW over the 10-year study period. The majority of the increase was observed in the youngest age groups, which also appeared to be the heaviest. This research adds to the growing literature supporting the hypothesis that excess weight gain during childhood may be a risk factor for early manifestation of T1DM.			Evertsen, J (corresponding author), Med Coll Wisconsin, Dept Epidemiol, Milwaukee, WI 53226 USA.	Jennifer.evertsen@aurora.org						ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Barker JM, 2004, J CLIN ENDOCR METAB, V89, P3896, DOI 10.1210/jc.2003-031887; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; BJORK E, 1992, J CLIN ENDOCR METAB, V75, P1574, DOI 10.1210/jc.75.6.1574; *CDCP, EP INF SOFTW; Charkaluk ML, 2002, PEDIATR RES, V52, P859, DOI 10.1203/01.PDR.0000034261.44203.26; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cotellessa M, 2003, DIABETES CARE, V26, P1786, DOI 10.2337/diacare.26.6.1786; Dabelea D, 2006, DIABETES CARE, V29, P290, DOI 10.2337/diacare.29.02.06.dc05-1339; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; DAWSON B, 2001, BASIC  CLIN BIOSTATI; Ehehalt S, 2008, DIABETIC MED, V25, P755, DOI 10.1111/j.1464-5491.2008.02450.x; Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353; Gardner SG, 1997, BRIT MED J, V315, P713, DOI 10.1136/bmj.315.7110.713; GIMENEZ M, DIABETES CARE, V30, P1593; Green A, 2001, DIABETOLOGIA, V44, pB3, DOI 10.1007/PL00002950; Harjutsalo V, 2008, LANCET, V371, P1777, DOI 10.1016/S0140-6736(08)60765-5; Karvonen M, 1999, DIABETES CARE, V22, P1066, DOI 10.2337/diacare.22.7.1066; KAVONEN M, 2000, DIABETES CARE, V23, P1516; Kibirige M, 2003, DIABETES CARE, V26, P2865, DOI 10.2337/diacare.26.10.2865; Knerr I, 2005, DIABETOLOGIA, V48, P2501, DOI 10.1007/s00125-005-0033-2; Kordonouri O, 2005, DIABETIC MED, V22, P1783, DOI 10.1111/j.1464-5491.2005.01792.x; KOSTRABA JN, 1992, EPIDEMIOLOGY, V3, P232, DOI 10.1097/00001648-199205000-00008; LAPORTE R, 1995, DIABETES AM, pCH3; Libman IM, 2003, DIABETES CARE, V26, P2871, DOI 10.2337/diacare.26.10.2871; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; Rangasami JJ, 1997, ARCH DIS CHILD, V77, P210, DOI 10.1136/adc.77.3.210; Sabbah E, 2000, DIABETES CARE, V23, P1326, DOI 10.2337/diacare.23.9.1326; Schober E, 2008, EUR J PEDIATR, V167, P293, DOI 10.1007/s00431-007-0480-5; Schoenle EJ, 2001, DIABETOLOGIA, V44, P286, DOI 10.1007/s001250051615; *US CENS BUR, COUNT CENS DAT; Weets I, 2007, DIABETES-METAB RES, V23, P637, DOI 10.1002/dmrr.758; Wilkin TJ, 2006, ARCH DIS CHILD, V91, P456, DOI 10.1136/adc.2006.094037; Wilkin TJ, 2006, DIABETES CARE, V29, P1462, DOI 10.2337/dc06-0345; Wilkin TJ, 2001, DIABETOLOGIA, V44, P914, DOI 10.1007/s001250100548; *WISC DEP HLTH FAM, SERV GEOGR REG; *WISC DEP HLTH FAM, OB EP WISC STUD; *WISC HOSP ASS, HOSP UT REP; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460	39	35	37	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6873	10.1371/journal.pone.0006873	http://dx.doi.org/10.1371/journal.pone.0006873			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19727402	Green Published, Green Submitted, gold			2022-12-25	WOS:000269522900009
J	Sacrey, LAR; Clark, CAM; Whishaw, IQ				Sacrey, Lori-Ann R.; Clark, Callie A. M.; Whishaw, Ian Q.			Music Attenuates Excessive Visual Guidance of Skilled Reaching in Advanced but Not Mild Parkinson's Disease	PLOS ONE			English	Article								Parkinson's disease (PD) results in movement and sensory impairments that can be reduced by familiar music. At present, it is unclear whether the beneficial effects of music are limited to lessening the bradykinesia of whole body movement or whether beneficial effects also extend to skilled movements of PD subjects. This question was addressed in the present study in which control and PD subjects were given a skilled reaching task that was performed with and without accompanying preferred musical pieces. Eye movements and limb use were monitored with biomechanical measures and limb movements were additionally assessed using a previously described movement element scoring system. Preferred musical pieces did not lessen limb and hand movement impairments as assessed with either the biomechanical measures or movement element scoring. Nevertheless, the PD patients with more severe motor symptoms as assessed by Hoehn and Yahr (HY) scores displayed enhanced visual engagement of the target and this impairment was reduced during trials performed in association with accompanying preferred musical pieces. The results are discussed in relation to the idea that preferred musical pieces, although not generally beneficial in lessening skilled reaching impairments, may normalize the balance between visual and proprioceptive guidance of skilled reaching.			Sacrey, LAR (corresponding author), Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada.	lori.sacrey@uleth.ca	Sacrey, Lori/AAB-6412-2020	Sacrey, Lori/0000-0002-4229-6933				Adamovich SV, 2001, NEUROSCIENCE, V104, P1027, DOI 10.1016/S0306-4522(01)00099-9; BAGLEY S, 1991, PHYSIOTHERAPY, V77, P415, DOI DOI 10.1016/S0031-9406(10)62035-4; BARONI A, 1984, NEUROLOGY, V34, P868, DOI 10.1212/WNL.34.7.868; Berardelli A, 2001, BRAIN, V124, P2131, DOI 10.1093/brain/124.11.2131; BurleighJacobs A, 1997, MOVEMENT DISORD, V12, P206, DOI 10.1002/mds.870120211; CAIRD FI, 1991, REHABILITATION PARKI; Castiello U, 2000, NEUROPSYCHOLOGIA, V38, P46, DOI 10.1016/S0028-3932(99)00049-4; Chomiak T, 2008, J NEUROPHYSIOL, V100, P327, DOI 10.1152/jn.90392.2008; Chuma T, 2007, J NEUROL, V254, P58, DOI 10.1007/s00415-007-4010-1; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; de Bruin N, 2008, J MOTOR BEHAV, V40, P337, DOI 10.3200/JMBR.40.4.337-346; Deijen JB, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-43; Dibble LE, 2004, GAIT POSTURE, V19, P215, DOI 10.1016/S0966-6362(03)00065-1; Doan J, 2006, J MOTOR BEHAV, V38, P45, DOI 10.3200/JMBR.38.1.45-59; Doan JB, 2008, BEHAV BRAIN RES, V194, P207, DOI 10.1016/j.bbr.2008.07.015; Dunnewold RJW, 1997, J NEUROSCI METH, V74, P107, DOI 10.1016/S0165-0270(97)02254-1; Eshkol N, 1958, MOVEMENT NOTATION; FLOWERS KA, 1976, BRAIN, V99, P269, DOI 10.1093/brain/99.2.269; GEORGIOU N, 1994, J NEUROL NEUROSUR PS, V57, P368, DOI 10.1136/jnnp.57.3.368; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Howe TE, 2003, CLIN REHABIL, V17, P363, DOI 10.1191/0269215503cr621oa; Hu B, 2003, EXP BRAIN RES, V153, P543, DOI 10.1007/s00221-003-1611-5; Keijsers NLW, 2005, EUR J NEUROSCI, V21, P239, DOI 10.1111/j.1460-9568.2004.03840.x; KLOCKGETHER T, 1994, MOVEMENT DISORD, V9, P48, DOI 10.1002/mds.870090108; Lehman David A, 2005, J Neurol Phys Ther, V29, P2; Ma HI, 2004, AM J PHYS MED REHAB, V83, P530, DOI 10.1097/01.PHM.0000130032.97113.E0; MARTINEZ AJ, 1973, NEUROLOGY, V23, P421; Melvin KG, 2005, BEHAV BRAIN RES, V160, P188, DOI 10.1016/j.bbr.2004.12.001; Mooney DM, 2004, P NATL ACAD SCI USA, V101, P320, DOI 10.1073/pnas.0304445101; Pacchetti C, 2000, PSYCHOSOM MED, V62, P386, DOI 10.1097/00006842-200005000-00012; Ponsen MM, 2008, PARKINSONISM RELAT D, V14, P199, DOI 10.1016/j.parkreldis.2007.07.019; Posner M. I., 1994, IMAGES MIND; Sacks O., 1982, AWAKENINGS; Siegert RJ, 2002, J CLIN EXP NEUROPSYC, V24, P146, DOI 10.1076/jcen.24.2.146.991; Slavutskaya M, 2007, SPAN J PSYCHOL, V10, P277, DOI 10.1017/S1138741600006545; Stern G M, 1980, J Neural Transm Suppl, P137; SWALLOW M, 1990, THERAPY PARKINSONS D, P109; Thaut MH, 2002, NEUROPSYCHOLOGIA, V40, P1073, DOI 10.1016/S0028-3932(01)00141-5; Thaut MH, 1996, MOVEMENT DISORD, V11, P193, DOI 10.1002/mds.870110213; Tresilian JR, 1997, BRAIN, V120, P2093, DOI 10.1093/brain/120.11.2093; Whishaw IQ, 2002, BEHAV BRAIN RES, V133, P165, DOI 10.1016/S0166-4328(01)00479-X	41	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6841	10.1371/journal.pone.0006841	http://dx.doi.org/10.1371/journal.pone.0006841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718260	gold, Green Submitted, Green Published			2022-12-25	WOS:000269415900014
J	Villar, J; Perez-Mendez, L; Espinosa, E; Flores, C; Blanco, J; Muriel, A; Basaldua, S; Muros, M; Blanch, L; Artigas, A; Kacmarek, RM				Villar, Jesus; Perez-Mendez, Lina; Espinosa, Elena; Flores, Carlos; Blanco, Jesus; Muriel, Arturo; Basaldua, Santiago; Muros, Mercedes; Blanch, Lluis; Artigas, Antonio; Kacmarek, Robert M.		GRECIA Grp; GEN-SEP Grp	Serum Lipopolysaccharide Binding Protein Levels Predict Severity of Lung Injury and Mortality in Patients with Severe Sepsis	PLOS ONE			English	Article								Background: There is a need for biomarkers insuring identification of septic patients at high-risk for death. We performed a prospective, multicenter, observational study to investigate the time-course of lipopolysaccharide binding protein (LBP) serum levels in patients with severe sepsis and examined whether serial serum levels of LBP could be used as a marker of outcome. Methodology/Principal Findings: LBP serum levels at study entry, at 48 hours and at day-7 were measured in 180 patients with severe sepsis. Data regarding the nature of infections, disease severity, development of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), and intensive care unit (ICU) outcome were recorded. LBP serum levels were similar in survivors and non-survivors at study entry (117.4 +/- 75.7 mu g/mL vs. 129.8 +/- 71.3 mu g/mL, P = 0.249) but there were significant differences at 48 hours (77.2 +/- 57.0 vs. 121.2 +/- 73.4 mu g/mL, P < 0.0001) and at day-7 (64.7 +/- 45.8 vs. 89.7 +/- 61.1 mu g/ml, p = 0.017). At 48 hours, LBP levels were significantly higher in ARDS patients than in ALI patients (112.5 +/- 71.8 mu g/ml vs. 76.6 +/- 55.9 mu g/ml, P = 0.0001). An increase of LBP levels at 48 hours was associated with higher mortality (odds ratio 3.97; 95%CI: 1.84-8.56; P < 0.001). Conclusions/Significance: Serial LBP serum measurements may offer a clinically useful biomarker for identification of patients with severe sepsis having the worst outcomes and the highest probability of developing sepsis-induced ARDS.			Villar, J (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain.	jesus.villar54@gmail.com	Villar, Jesús/R-4526-2019; Flores, Carlos/R-1159-2019	Villar, Jesús/0000-0001-5687-3562; Perez-Mendez, Lina/0000-0001-8246-333X; antonio, artigas/0000-0002-8029-1017; Tejera, Paula/0000-0002-0317-890X; Flores, Carlos/0000-0001-5352-069X				BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Blairon L, 2003, J INFECT DIS, V187, P287, DOI 10.1086/346046; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; Bregeon F, 2005, ANESTHESIOLOGY, V102, P331; Brun-Buisson C, 2004, INTENS CARE MED, V30, P580, DOI 10.1007/s00134-003-2121-4; Chien JW, 2008, BLOOD, V111, P2462, DOI 10.1182/blood-2007-09-101709; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Cunningham Steven C, 2006, Surg Infect (Larchmt), V7, P251, DOI 10.1089/sur.2006.7.251; Dentener MA, 2000, AM J RESP CELL MOL, V23, P146, DOI 10.1165/ajrcmb.23.2.3855; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; Ferrer R, 2008, JAMA-J AM MED ASSOC, V299, P2294, DOI 10.1001/jama.299.19.2294; FISHER CJ, 1994, JAMA-J AM MED ASSOC, V271, P1836, DOI 10.1001/jama.271.23.1836; Flores C, 2008, CRIT CARE, V12, DOI 10.1186/cc7098; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; Gaini S, 2008, CLIN EXP IMMUNOL, V151, P423, DOI 10.1111/j.1365-2249.2007.03586.x; Gaini S, 2007, CRIT CARE, V11, DOI 10.1186/cc5967; Gaini S, 2006, CRIT CARE, V10, DOI 10.1186/cc4866; GALLAY P, 1994, J INFECT DIS, V170, P1319, DOI 10.1093/infdis/170.5.1319; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gharib SA, 2006, AM J RESP CRIT CARE, V173, P653, DOI 10.1164/rccm.200509-1473OC; Grunwald U, 1996, J IMMUNOL, V157, P4119; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Herrera MT, 2003, INTENS CARE MED, V29, P1345, DOI 10.1007/s00134-003-1756-5; Hubacek JA, 2001, CRIT CARE MED, V29, P557, DOI 10.1097/00003246-200103000-00015; Kalil AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002291; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lee PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003712; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Martin GS, 2005, CRIT CARE, V9, pR74, DOI 10.1186/cc3025; Martin TR, 1997, AM J RESP CRIT CARE, V155, P937, DOI 10.1164/ajrccm.155.3.9117029; McClintock D, 2008, CRIT CARE, V12, DOI 10.1186/cc6846; Minter RM, 2009, AM J PHYSIOL-GASTR L, V296, pG45, DOI 10.1152/ajpgi.00041.2008; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Padkin A, 2003, CRIT CARE MED, V31, P2332, DOI 10.1097/01.CCM.0000085141.75513.2B; Polderman KH, 1999, LANCET, V353, P380, DOI 10.1016/S0140-6736(05)74953-9; Prucha M, 2003, CRIT CARE, V7, pR154, DOI 10.1186/cc2386; Sablotzki A, 2001, THORAC CARDIOV SURG, V49, P273, DOI 10.1055/s-2001-17803; Sakr Y, 2008, CRIT CARE MED, V36, P2014, DOI 10.1097/CCM.0b013e31817b86e3; Salluh JIF, 2008, CRIT CARE MED, V36, P2192, DOI 10.1097/CCM.0b013e31817c0cd8; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Shapiro NI, 2009, CRIT CARE MED, V37, P96, DOI 10.1097/CCM.0b013e318192fd9d; Suistomaa M, 2000, INTENS CARE MED, V26, P1773, DOI 10.1007/s001340000677; Tunnell RD, 1998, ANAESTHESIA, V53, P1045, DOI 10.1046/j.1365-2044.1998.00566.x; Villar J, 2004, CRIT CARE, V8, P180, DOI 10.1186/cc2863; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vreugdenhil ACE, 1999, J IMMUNOL, V163, P2792; Wang ZX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004380; Wurfel Mark M, 2007, Proc Am Thorac Soc, V4, P77, DOI 10.1513/pats.200608-149JG; Zweigner J, 2001, BLOOD, V98, P3800, DOI 10.1182/blood.V98.13.3800	50	50	55	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6818	10.1371/journal.pone.0006818	http://dx.doi.org/10.1371/journal.pone.0006818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718443	Green Published, Green Submitted, gold			2022-12-25	WOS:000269415900002
J	Chen, F; He, YQ				Chen, Fang; He, Yongqun			Caspase-2 Mediated Apoptotic and Necrotic Murine Macrophage Cell Death Induced by Rough Brucella abortus	PLOS ONE			English	Article								Brucella species are Gram-negative, facultative intracellular bacteria that cause zoonotic brucellosis. Survival and replication inside macrophages is critical for establishment of chronic Brucella infection. Virulent smooth B. abortus strain 2308 inhibits programmed macrophage cell death and replicates inside macrophages. Cattle B. abortus vaccine strain RB51 is an attenuated rough, lipopolysaccharide O antigen-deficient mutant derived from smooth strain 2308. B. abortus rough mutant RA1 contains a single wboA gene mutation in strain 2308. Our studies demonstrated that live RB51 and RA1, but not strain 2308 or heat-killed Brucella, induced both apoptotic and necrotic cell death in murine RAW264.7 macrophages and bone marrow derived macrophages. The same phenomenon was also observed in primary mouse peritoneal macrophages from mice immunized intraperitoneally with vaccine strain RB51 using the same dose as regularly performed in protection studies. Programmed macrophage cell death induced by RB51 and RA1 was inhibited by a caspase-2 inhibitor (Z-VDVADFMK). Caspase-2 enzyme activation and cleavage were observed at the early infection stage in macrophages infected with RB51 and RA1 but not strain 2308. The inhibition of macrophage cell death promoted the survival of rough Brucella cells inside macrophages. The critical role of caspase-2 in mediating rough B. abortus induced macrophage cell death was confirmed using caspase-2 specific shRNA. The mitochondrial apoptosis pathway was activated in macrophages infected with rough B. abortus as demonstrated by increase in mitochondrial membrane permeability and the release of cytochrome c to cytoplasm in macrophages infected with rough Brucella. These results demonstrate that rough B. abortus strains RB51 and RA1 induce apoptotic and necrotic murine macrophage cell death that is mediated by caspase-2. The biological relevance of Brucella O antigen and caspase-2-mediated macrophage cell death in Brucella pathogenesis and protective Brucella immunity is discussed.			Chen, F (corresponding author), Univ Michigan, Sch Med, Unit Lab Anim Med, Ann Arbor, MI 48109 USA.	yongqunh@umich.edu		He, Yongqun/0000-0001-9189-9661	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R21AI057875] Funding Source: NIH RePORTER; NIAID NIH HHS [U54 AI057153, 1R21AI057875-01, 1-U54-AI-057153, R21 AI057875, R21 AI057875-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; Baumann S, 2006, CURR OPIN IMMUNOL, V18, P438, DOI 10.1016/j.coi.2006.05.016; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bras M, 2005, BIOCHEMISTRY-MOSCOW+, V70, P231, DOI 10.1007/s10541-005-0105-4; Bricker BJ, 2002, VET MICROBIOL, V90, P435, DOI 10.1016/S0378-1135(02)00228-6; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; Chen Y, 2008, PHARM RES-DORDR, V25, P72, DOI 10.1007/s11095-007-9504-0; Ciaramella A, 2002, J INFECT DIS, V186, P1277, DOI 10.1086/344645; Cloeckaert A, 2002, VACCINE, V20, P1820, DOI 10.1016/S0264-410X(02)00035-X; Colussi PA, 1999, IMMUNOL CELL BIOL, V77, P58, DOI 10.1046/j.1440-1711.1999.00788.x; Dahmer MK, 2005, J NEUROSCI RES, V80, P576, DOI 10.1002/jnr.20471; de Bagues MPJ, 2004, INFECT IMMUN, V72, P2429, DOI 10.1128/IAI.72.4.2429-2433.2004; DETILLEUX PG, 1990, VET PATHOL, V27, P317, DOI 10.1177/030098589002700503; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Enoksson M, 2004, J BIOL CHEM, V279, P49575, DOI 10.1074/jbc.C400374200; Faderl S, 1999, CLIN CANCER RES, V5, P4041; Fernandez-Prada CM, 2003, INFECT IMMUN, V71, P2110, DOI 10.1128/IAI.71.4.2110-2119.2003; Fewell GD, 2006, DRUG DISCOV TODAY, V11, P975, DOI 10.1016/j.drudis.2006.09.008; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; FREEMAN BA, 1961, J INFECT DIS, V108, P333, DOI 10.1093/infdis/108.3.333; FREEMAN BA, 1964, J INFECT DIS, V114, P441, DOI 10.1093/infdis/114.5.441; Galdiero E, 2000, MICROBIOLOGICA, V23, P271; Gonzalez D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002760; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Gross A, 2000, INFECT IMMUN, V68, P342, DOI 10.1128/IAI.68.1.342-351.2000; He YQ, 2006, INFECT IMMUN, V74, P5035, DOI 10.1128/IAI.01998-05; He YQ, 2001, INFECT IMMUN, V69, P5502, DOI 10.1128/IAI.69.9.5502-5508.2001; Hetz CA, 2005, BIOCHEM CELL BIOL, V83, P579, DOI 10.1139/o05-065; Jesenberger V, 2000, J EXP MED, V192, P1035, DOI 10.1084/jem.192.7.1035; Kroemer G, 2003, BIOCHEM BIOPH RES CO, V304, P433, DOI 10.1016/S0006-291X(03)00614-4; Krumschnabel G, 2009, CELL DEATH DIFFER, V16, P195, DOI 10.1038/cdd.2008.170; Lapaque N, 2005, CURR OPIN MICROBIOL, V8, P60, DOI 10.1016/j.mib.2004.12.003; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lee IK, 1999, CAN J VET RES, V63, P284; Li HL, 1997, J BIOL CHEM, V272, P21010, DOI 10.1074/jbc.272.34.21010; MAJNO G, 1995, AM J PATHOL, V146, P3; Marianelli C, 2004, J CLIN MICROBIOL, V42, P5439, DOI 10.1128/JCM.42.12.5439-5443.2004; Martin-Martin AI, 2008, MICROBES INFECT, V10, P706, DOI 10.1016/j.micinf.2008.02.013; McQuiston JR, 1999, INFECT IMMUN, V67, P3830, DOI 10.1128/IAI.67.8.3830-3835.1999; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pei JW, 2006, INFECT IMMUN, V74, P2667, DOI 10.1128/IAI.74.5.2667-2675.2006; Pei JW, 2004, INFECT IMMUN, V72, P440, DOI 10.1128/IAI.72.1.440-450.2004; Porte F, 2003, INFECT IMMUN, V71, P1481, DOI 10.1128/IAI.71.3.1481-1490.2003; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Reed WP, 2004, SURG ENDOSC, V18, P11, DOI 10.1007/s00464-003-8913-3; Rittig MG, 2003, J LEUKOCYTE BIOL, V74, P1045, DOI 10.1189/jlb.0103015; Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009; Roop RM, 2003, ANNU REV MICROBIOL, V57, P57, DOI 10.1146/annurev.micro.57.030502.090803; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Santos RL, 2001, INFECT IMMUN, V69, P2293, DOI 10.1128/IAI.69.4.2293-2301.2001; Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9; SCHURIG GG, 1991, VET MICROBIOL, V28, P171, DOI 10.1016/0378-1135(91)90091-S; Seleem MN, 2004, BIOTECHNIQUES, V37, P740, DOI 10.2144/04375BM05; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; STEVENS MG, 1995, INFECT IMMUN, V63, P3199, DOI 10.1128/IAI.63.8.3199-3205.1995; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; TIMONEY JF, 1988, GENUS BRUCELLA HAGAN, P135; Tolomeo M, 2003, CLIN INFECT DIS, V36, P1533, DOI 10.1086/375223; Troy CM, 2003, CELL DEATH DIFFER, V10, P101, DOI 10.1038/sj.cdd.4401175; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; Vemulapalli R, 1999, CLIN DIAGN LAB IMMUN, V6, P760, DOI 10.1128/CDLI.6.5.760-764.1999; Yoo NJ, 2004, APMIS, V112, P330; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zhang XN, 2005, INT J CANCER, V113, P397, DOI 10.1002/ijc.20553; Zhang YP, 2007, MECH AGEING DEV, V128, P213, DOI 10.1016/j.mad.2006.11.030; Zhivotovsky B, 2005, BIOCHEM BIOPH RES CO, V331, P859, DOI 10.1016/j.bbrc.2005.03.191	73	58	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2009	4	8							e6830	10.1371/journal.pone.0006830	http://dx.doi.org/10.1371/journal.pone.0006830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JG	19714247	Green Published, gold, Green Submitted			2022-12-25	WOS:000269415800014
J	Gacsi, M; Gyori, B; Viranyi, Z; Kubinyi, E; Range, F; Belenyi, B; Miklosi, A				Gacsi, Marta; Gyori, Borbala; Viranyi, Zsofia; Kubinyi, Eniko; Range, Friederike; Belenyi, Beatrix; Miklosi, Adam			Explaining Dog Wolf Differences in Utilizing Human Pointing Gestures: Selection for Synergistic Shifts in the Development of Some Social Skills	PLOS ONE			English	Article							REARED WOLVES; COGNITION; ANIMALS	Background: The comparison of human related communication skills of socialized canids may help to understand the evolution and the epigenesis of gesture comprehension in humans. To reconcile previously contradicting views on the origin of dogs' outstanding performance in utilizing human gestures, we suggest that dog-wolf differences should be studied in a more complex way. Methodology/Principal Findings: We present data both on the performance and the behaviour of dogs and wolves of different ages in a two-way object choice test. Characteristic behavioural differences showed that for wolves it took longer to establish eye contact with the pointing experimenter, they struggled more with the handler, and pups also bit her more before focusing on the human's signal. The performance of similarly hand-reared 8-week-old dogs and wolves did not differ in utilizing the simpler proximal momentary pointing. However, when tested with the distal momentary pointing, 4-month-old pet dogs outperformed the same aged hand reared wolves. Thus early and intensive socialisation does not diminish differences between young dogs and wolves in behaviour and performance. Socialised adult wolves performed similarly well as dogs in this task without pretraining. The success of adult wolves was accompanied with increased willingness to cooperate. Conclusion/Significance: Thus, we provide evidence for the first time that socialised adult wolves are as successful in relying on distal momentary pointing as adult pet dogs. However, the delayed emergence of utilising human distal momentary pointing in wolves shows that these wild canines react to a lesser degree to intensive socialisation in contrast to dogs, which are able to control agonistic behaviours and inhibition of actions in a food related task early in development. We suggest a "synergistic'' hypothesis, claiming that positive feedback processes (both evolutionary and epigenetic) have increased the readiness of dogs to attend to humans, providing the basis for dog-human communication.			Gacsi, M (corresponding author), Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary.	gm.art@t-online.hu	Kubinyi, Eniko/B-5824-2013; Miklosi, Adam/N-5147-2017	Kubinyi, Eniko/0000-0002-4468-9845; Gacsi, Marta/0000-0003-3080-7545; Range, Friederike/0000-0003-3127-5536; Miklosi, Adam/0000-0003-4831-8985	Austrian Science Fund FWF [P 21244] Funding Source: Medline; Austrian Science Fund (FWF) [P 21244] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Coppinger R., 2001, DOGS NEW UNDERSTANDI; Gacsi M, 2005, DEV PSYCHOBIOL, V47, P111, DOI 10.1002/dev.20082; GACSI M, 2009, BRAIN BEHAV IN PRESS; Gacsi M, 2009, ANIM COGN, V12, P471, DOI 10.1007/s10071-008-0208-6; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 2005, CURR BIOL, V15, P226, DOI 10.1016/j.cub.2005.01.040; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Kubinyi E, 2007, COMP COGN BEHAV REV, V2, P26; Lakatos G, 2009, ANIM COGN, V12, P621, DOI 10.1007/s10071-009-0221-4; Miklosi A, 2004, ANIM BEHAV, V67, P995, DOI 10.1016/j.anbehav.2003.10.008; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Miklosi A., 2007, DOG BEHAV EVOLUTION; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; Packard Jane M., 2003, P35; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; RIEDEL J, 2007, ANIM BEHAV, DOI DOI 10.1016/J.ANBE-HAV.2007.08.010; Soproni K, 2002, J COMP PSYCHOL, V116, P27, DOI 10.1037//0735-7036.116.1.27; Szetei V, 2003, APPL ANIM BEHAV SCI, V83, P141, DOI 10.1016/S0168-1591(03)00114-X; Topal J, 2005, ANIM BEHAV, V70, P1367, DOI 10.1016/j.anbehav.2005.03.025; Udell MAR, 2008, ANIM BEHAV, V76, P1767, DOI 10.1016/j.anbehav.2008.07.028; Viranyi Z, 2008, ANIM COGN, V11, P373, DOI 10.1007/s10071-007-0127-y	21	140	141	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2009	4	8							e6584	10.1371/journal.pone.0006584	http://dx.doi.org/10.1371/journal.pone.0006584			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JG	19714197	Green Published, gold, Green Submitted			2022-12-25	WOS:000269415800001
J	Gordon, WR; Vardar-Ulu, D; L'Heureux, S; Ashworth, T; Malecki, MJ; Sanchez-Irizarry, C; McArthur, DG; Histen, G; Mitchell, JL; Aster, JC; Blacklow, SC				Gordon, Wendy R.; Vardar-Ulu, Didem; L'Heureux, Sarah; Ashworth, Todd; Malecki, Michael J.; Sanchez-Irizarry, Cheryll; McArthur, Debbie G.; Histen, Gavin; Mitchell, Jennifer L.; Aster, Jon C.; Blacklow, Stephen C.			Effects of S1 Cleavage on the Structure, Surface Export, and Signaling Activity of Human Notch1 and Notch2	PLOS ONE			English	Article								Background: Notch receptors are normally cleaved during maturation by a furin-like protease at an extracellular site termed S1, creating a heterodimer of non-covalently associated subunits. The S1 site lies within a key negative regulatory region (NRR) of the receptor, which contains three highly conserved Lin12/Notch repeats and a heterodimerization domain (HD) that interact to prevent premature signaling in the absence of ligands. Because the role of S1 cleavage in Notch signaling remains unresolved, we investigated the effect of S1 cleavage on the structure, surface trafficking and ligand-mediated activation of human Notch1 and Notch2, as well as on ligand-independent activation of Notch1 by mutations found in human leukemia. Principal Findings: The X-ray structure of the Notch1 NRR after furin cleavage shows little change when compared with that of an engineered Notch1 NRR lacking the S1-cleavage loop. Likewise, NMR studies of the Notch2 HD domain show that the loop containing the S1 site can be removed or cleaved without causing a substantial change in its structure. However, Notch1 and Notch2 receptors engineered to resist S1 cleavage exhibit unexpected differences in surface delivery and signaling competence: S1-resistant Notch1 receptors exhibit decreased, but detectable, surface expression and ligand-mediated receptor activation, whereas S1-resistant Notch2 receptors are fully competent for cell surface delivery and for activation by ligands. Variable dependence on S1 cleavage also extends to T-ALL-associated NRR mutations, as common class 1 mutations display variable decrements in ligand-independent activation when introduced into furin-resistant receptors, whereas a class 2 mutation exhibits increased signaling activity. Conclusions/Significance: S1 cleavage has distinct effects on the surface expression of Notch1 and Notch2, but is not generally required for physiologic or pathophysiologic activation of Notch proteins. These findings are consistent with models for receptor activation in which ligand-binding or T-ALL-associated mutations lead to conformational changes of the NRR that permit metalloprotease cleavage.			Gordon, WR (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	sblacklow@rics.bwh.harvard.edu		Vardar-Ulu, Didem/0000-0003-3793-0124; Malecki, Michael/0000-0002-5996-8054; Gordon, Wendy/0000-0001-7696-5560	NATIONAL CANCER INSTITUTE [P01CA119070, R01CA092433] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA119070-029001, P01 CA119070-020003, R01 CA092433-05, P01 CA119070-039001, P01 CA119070-01A19001, R01 CA092433-06A2, R01 CA092433-04, P01 CA119070, R01 CA092433, P01 CA119070-01A10003, R01 CA092433-05S1, P01 CA119070-030003] Funding Source: Medline; PHS HHS [P01 119070] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aster JC, 1997, J BIOL CHEM, V272, P11336; Aster JC, 2008, ANNU REV PATHOL-MECH, V3, P587, DOI 10.1146/annurev.pathmechdis.3.121806.154300; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Bush G, 2001, DEV BIOL, V229, P494, DOI 10.1006/dbio.2000.9992; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Gordon WR, 2009, BLOOD, V113, P4381, DOI 10.1182/blood-2008-08-174748; GREENWALD I, 1990, NATURE, V346, P197, DOI 10.1038/346197a0; Harrison SC, 2005, ADV VIRUS RES, V64, P231, DOI 10.1016/S0065-3527(05)64007-9; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kidd S, 2002, MECH DEVELOP, V115, P41, DOI 10.1016/S0925-4773(02)00120-X; Ko KWS, 1998, J BIOL CHEM, V273, P27779, DOI 10.1074/jbc.273.43.27779; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Lawrence N, 2000, DEVELOPMENT, V127, P3185; Li K, 2008, J BIOL CHEM, V283, P8046, DOI 10.1074/jbc.M800170200; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Peterson FC, 2001, BIOCHEMISTRY-US, V40, P6275, DOI 10.1021/bi0100992; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Sanchez-Irizarry C, 2004, MOL CELL BIOL, V24, P9265, DOI 10.1128/MCB.24.21.9265-9273.2004; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Willnow TE, 1996, BIOCHEM J, V313, P71, DOI 10.1042/bj3130071; Xu AG, 2005, J BIOL CHEM, V280, P30158, DOI 10.1074/jbc.M505569200; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096	34	75	78	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2009	4	8							e6613	10.1371/journal.pone.0006613	http://dx.doi.org/10.1371/journal.pone.0006613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JF	19701457	gold, Green Submitted, Green Published			2022-12-25	WOS:000269268300001
J	Dosch, DD; Ballmer-Hofer, K				Dosch, Debora Dell'Era; Ballmer-Hofer, Kurt			Transmembrane domain-mediated orientation of receptor monomers in active VEGFR-2 dimers	FASEB JOURNAL			English	Article						angiogenesis; receptor tyrosine kinase	GROWTH-FACTOR RECEPTOR; TYROSINE KINASE DOMAIN; PAPILLOMAVIRUS E5 PROTEIN; STEM-CELL FACTOR; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; EGF RECEPTOR; ACTIVATION; ANGIOGENESIS; COMPLEX	Vascular endothelial growth factors (VEGFs) activate cellular receptor tyrosine kinases (RTKs) such as VEGFR-1, -2, and -3. These receptors are activated upon ligand binding to the extracellular receptor domain (ECD), resulting in receptor dimerization and activation of the intracellular kinase domain. Here we investigated the molecular mechanism of activation of the human VEGFR-2 expressed in human HEK293, monkey COS-1, and porcine aortic endothelial cells. To study the role of dimerization in receptor activation we created a series of dimerization- promoting transmembrane domain (TMD) mutants lacking the extracellular domain. The TMDs consisted of 23 valine and 2 glutamic acid residues spaced 7 aa apart in different positions of the transmembrane helix. All TMDs dimerized VEGFR-2, each in a specific orientation, giving rise to a series of either active or inactive receptor dimers. One particular TMD, V6/13E, gave rise to highly active kinase dimers, while all the other dimerizing TMD mutant receptors had 6- to 10-fold lower activity. When the V6/13E TMD was introduced into the full-length receptor in place of the native TMD, it promoted ligand-independent activation. Nonactivating TMDs, on the other hand, gave rise to inactive receptor mutants, both in the absence and in the presence of VEGF. These data demonstrate that dimerization is necessary, but not sufficient, for receptor activation, and that ligand-mediated receptor activation requires specific orientation of receptor monomers. Our study also shows that dimerization is mimicked by distinct dimerization- promoting TMDs that position the intracellular kinase domain either in an active or inactive conformation.-Dell'Era Dosch, D., Ballmer-Hofer, K. Transmembrane domain-mediated orientation of receptor monomers in active VEGFR-2 dimers. FASEB J. 24, 32-38 (2010). www.fasebj.org	[Dosch, Debora Dell'Era; Ballmer-Hofer, Kurt] Paul Scherrer Inst, CH-5232 Villigen, AG, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Ballmer-Hofer, K (corresponding author), Paul Scherrer Inst, OFLC 102, CH-5232 Villigen, AG, Switzerland.	kurt.ballmer@psi.ch		Ballmer-Hofer, Kurt/0000-0002-3800-9129	Swiss National Science Foundation [3100B-103545]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank Dr. R. Jaussi for his technical support in plasmid construction and Dr. P. Berger and A. Giese for critically reading this manuscript. This project was supported in part by Swiss National Science Foundation grant 3100B-103545 issued to K.B.-H.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Barton WA, 2006, NAT STRUCT MOL BIOL, V13, P524, DOI 10.1038/nsmb1101; Bell CA, 2000, MOL BIOL CELL, V11, P3589, DOI 10.1091/mbc.11.10.3589; Bennasroune A, 2004, MOL BIOL CELL, V15, P3464, DOI 10.1091/mbc.E03-10-0753; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Cebe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3; Chen LI, 1997, J CELL BIOL, V137, P619, DOI 10.1083/jcb.137.3.619; Crooks D, 2000, MOL BIOL CELL, V11, P3559, DOI 10.1091/mbc.11.10.3559; DiMaio D, 2000, CYTOKINE GROWTH F R, V11, P283, DOI 10.1016/S1359-6101(00)00012-5; Drevs J, 2000, CANCER RES, V60, P4819; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; GULLICK WJ, 1992, EMBO J, V11, P43, DOI 10.1002/j.1460-2075.1992.tb05025.x; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Lemmon MA, 2007, CELL, V130, P213, DOI 10.1016/j.cell.2007.07.006; Liu HL, 2007, EMBO J, V26, P891, DOI 10.1038/sj.emboj.7601545; LOFTS FJ, 1993, ONCOGENE, V8, P2813; Mattoon D, 2001, ONCOGENE, V20, P3824, DOI 10.1038/sj.onc.1204523; McTigue MA, 1999, STRUCT FOLD DES, V7, P319, DOI 10.1016/S0969-2126(99)80042-2; MEYER AN, 1994, P NATL ACAD SCI USA, V91, P4634, DOI 10.1073/pnas.91.11.4634; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Ruch C, 2007, NAT STRUCT MOL BIOL, V14, P249, DOI 10.1038/nsmb1202; Schlessinger J, 2003, SCIENCE, V300, P750, DOI 10.1126/science.1082024; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schubert C, 2007, J BIOL CHEM, V282, P4094, DOI 10.1074/jbc.M608183200; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Smith BC, 1996, REAL-TIME IMAGING, V2, P3, DOI 10.1006/rtim.1996.0002; Stauber DJ, 2000, P NATL ACAD SCI USA, V97, P49, DOI 10.1073/pnas.97.1.49; Tao Q, 2001, J BIOL CHEM, V276, P21916, DOI 10.1074/jbc.M100763200; TESSLER S, 1994, J BIOL CHEM, V269, P12456; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; Walter M, 2007, J MOL BIOL, V367, P839, DOI 10.1016/j.jmb.2007.01.036; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Yang Y, 2008, P NATL ACAD SCI USA, V105, P7681, DOI 10.1073/pnas.0802896105; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	40	41	42	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					32	38		10.1096/fj.09-132670	http://dx.doi.org/10.1096/fj.09-132670			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19726758				2022-12-25	WOS:000273233600006
J	Evangelisti, C; Florian, MC; Massimi, I; Dominici, C; Giannini, G; Galardi, S; Bue, MC; Massalini, S; McDowell, HP; Messi, E; Gulino, A; Farace, MG; Ciafre, SA				Evangelisti, Cristina; Florian, Maria Carolina; Massimi, Isabella; Dominici, Carlo; Giannini, Giuseppe; Galardi, Silvia; Bue, Maria Cristina; Massalini, Simone; McDowell, Heather P.; Messi, Elio; Gulino, Alberto; Farace, Maria Giulia; Ciafre, Silvia Anna			MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness	FASEB JOURNAL			English	Article						MicroRNA; tumor; neuronal; retinoic acid	MICRORNA EXPRESSION; RETINOIC ACID; DOUBLECORTIN; GENE; MIGRATION; DIFFERENTIATION; SPECIFICITY; DIAGNOSIS; SUGGESTS; CRITERIA	MicroRNAs are a class of sophisticated regulators of gene expression, acting as post-transcriptional inhibitors that recognize their target mRNAs through base pairing with short regions along the 3'UTRs. Several microRNAs are tissue specific, suggesting a specialized role in tissue differentiation or maintenance, and quite a few are critically involved in tumorigenesis. We studied miR-128, a brain-enriched microRNA, in retinoic acid-differentiated neuroblastoma cells, and we found that this microRNA is up-regulated in treated cells, where it down-modulates the expression of two proteins involved in the migratory potential of neural cells: Reelin and DCX. Consistently, miR-128 ectopic overexpression suppressed Reelin and DCX, whereas the LNA antisense-mediated miR-128 knockdown caused the two proteins to increase. Ectopic miR-128 overexpression reduced neuroblastoma cell motility and invasiveness, and impaired cell growth. Finally, the analysis of a small series of primary human neuroblastomas showed an association between high levels of miR-128 expression and favorable features, such as favorable Shimada category or very young age at diagnosis. Thus, we provide evidence for a role for miR-128 in the molecular events modulating neuroblastoma progression and aggressiveness.-Evangelisti, C., Florian, M. C., Massimi, I., Dominici, C., Giannini, G., Galardi, S., Bue, M. C., Massalini, S., McDowell, H. P., Messi, E., Gulino, A., Farace, M. G., Ciafre, S. A. MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness. FASEB J. 23, 4276-4287 (2009). www.fasebj.org	[Evangelisti, Cristina; Galardi, Silvia; Bue, Maria Cristina; Massalini, Simone; Farace, Maria Giulia; Ciafre, Silvia Anna] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy; [Florian, Maria Carolina; Messi, Elio] Univ Milan, Fac Farm, Dipartimento Endocrinol Fisiopatol & Biol Applica, Milan, Italy; [Massimi, Isabella; Giannini, Giuseppe; Gulino, Alberto] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Dominici, Carlo; McDowell, Heather P.] Univ Roma La Sapienza, Dept Pediat, I-00185 Rome, Italy; [Dominici, Carlo] Bambino Gesu Pediat Hosp, Lab Oncol, Rome, Italy; [Dominici, Carlo] Univ Liverpool, Div Child Hlth, Sch Reprod & Dev Med, Liverpool L69 3BX, Merseyside, England; [McDowell, Heather P.] Royal Liverpool Childrens Natl Hlth Serv Trust Al, Div Oncol, Liverpool, Merseyside, England; [Gulino, Alberto] Neuromed Inst, Pozzilli, Italy	University of Rome Tor Vergata; University of Milan; Sapienza University Rome; Sapienza University Rome; IRCCS Bambino Gesu; University of Liverpool; IRCCS Neuromed	Ciafre, SA (corresponding author), Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, Via Montpellier 1, I-00133 Rome, Italy.	ciafre@uniroma2.it	ciafrè, silvia anna/G-1783-2012; Giannini, Giuseppe/B-5672-2013; Florian, M. Carolina/AAH-5309-2019	ciafrè, silvia anna/0000-0001-6467-8396; Giannini, Giuseppe/0000-0003-0299-4056; Florian, M. Carolina/0000-0002-5791-1310; Messi, Elio/0000-0002-9515-1463; GALARDI, SILVIA/0000-0002-3646-4064	Italian Ministry of Instruction; University and Scientific Research; FIRB [RBNE01H3K5, RBNE01MBEC]; Italy-USA Collaborative Programme; Ministry of Health; Associazione Italiana per la Ricerca sul Cancro; National Research Council; Ministry of University and Research; Telethon [GGP07118]	Italian Ministry of Instruction(Ministry of Education, Universities and Research (MIUR)); University and Scientific Research; FIRB; Italy-USA Collaborative Programme; Ministry of Health; Associazione Italiana per la Ricerca sul Cancro; National Research Council; Ministry of University and Research; Telethon	The authors are grateful to Dr. Pierluigi Altavista (Section of Toxicology and Biomedical Sciences, ENEA Research Center Casaccia, Rome) for performing the statistical analysis. This study was funded in part by grants from the Italian Ministry of Instruction, University and Scientific Research, FIRB RBNE01H3K5 to S. A. C., FIRB RBNE01MBEC and Italy-USA Collaborative Programme, Ministry of Health to MGF, and from Associazione Italiana per la Ricerca sul Cancro, Ministry of Health, the National Research Council, the Ministry of University and Research, Telethon grant GGP07118 to G. G.	Baetge E E, 1992, Perspect Dev Neurobiol, V1, P21; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernreuther C, 2006, ACTA NEUROPATHOL, V111, P247, DOI 10.1007/s00401-006-0038-z; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Castel V, 2007, CLIN TRANSL ONCOL, V9, P478, DOI 10.1007/s12094-007-0091-7; Chen Y, 2007, J NEUROCHEM, V103, P650, DOI 10.1111/j.1471-4159.2007.04797.x; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Daou MC, 2005, ACTA NEUROPATHOL, V110, P472, DOI 10.1007/s00401-005-1070-0; De Bernardi B, 2003, J CLIN ONCOL, V21, P1592, DOI 10.1200/JCO.2003.05.191; des Portes V, 1998, CELL, V92, P51; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Encinas M, 1999, J NEUROCHEM, V73, P1409, DOI 10.1046/j.1471-4159.1999.0731409.x; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gao FB, 2008, TRENDS NEUROSCI, V31, P20, DOI 10.1016/j.tins.2007.10.004; Hoebeeck J, 2007, INT J CANCER, V120, P533, DOI 10.1002/ijc.22326; Kato M, 2008, BIOL CELL, V100, P71, DOI 10.1042/BC20070078; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Masui K, 2008, BRAIN TUMOR PATHOL, V25, P1, DOI 10.1007/s10014-007-0225-1; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Messi E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-30; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Mizuguchi M, 1999, AM J PATHOL, V155, P1713, DOI 10.1016/S0002-9440(10)65486-7; Mosse YP, 2007, GENE CHROMOSOME CANC, V46, P936, DOI 10.1002/gcc.20477; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Oltra S, 2005, DIAGN MOL PATHOL, V14, P53, DOI 10.1097/01.pas.0000149876.32376.c0; Perrone G, 2007, MODERN PATHOL, V20, P344, DOI 10.1038/modpathol.3800743; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sato N, 2006, GASTROENTEROLOGY, V130, P548, DOI 10.1053/j.gastro.2005.11.008; Seigel GM, 2007, MOL VIS, V13, P823; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shimada H, 1999, CANCER, V86, P349, DOI 10.1002/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.3.CO;2-P; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Voigt A, 2003, MED PEDIATR ONCOL, V40, P205, DOI 10.1002/mpo.10250; Wang Q, 2002, CANCER LETT, V179, P71, DOI 10.1016/S0304-3835(01)00846-1; Watanabe Y, 2007, METHOD ENZYMOL, V427, P65, DOI 10.1016/S0076-6879(07)27004-1; Yang HKC, 2004, J NEUROSCI RES, V76, P282, DOI 10.1002/jnr.20071; Yarrow JC, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-21; Zhang Y, 2009, J MOL MED, V87, P43, DOI 10.1007/s00109-008-0403-6	45	124	127	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4276	4287		10.1096/fj.09-134965	http://dx.doi.org/10.1096/fj.09-134965			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19713529	Green Submitted			2022-12-25	WOS:000272193700022
J	Tang, FM; Kokontis, J; Lin, YT; Liao, ST; Lin, AN; Xiang, JL				Tang, Fangming; Kokontis, John; Lin, Yuting; Liao, Shutsung; Lin, Anning; Xiang, Jialing			Androgen via p21 Inhibits Tumor Necrosis Factor alpha-induced JNK Activation and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; NF-KAPPA-B; C-JUN KINASE; PROTEIN-KINASE; IKK-BETA; RECEPTOR; IDENTIFICATION; PHOSPHORYLATION; PROGRESSION; REPRESSION	The male hormone androgen is a growth/survival factor for its target tissues or organs. Yet, the underlying mechanism is incompletely understood. Here, we report that androgen via p21 inhibits tumor necrosis factor alpha-induced JNK activation and apoptosis. Inhibition by androgen requires the transcription activity of androgen receptor (AR) and de novo protein synthesis. Androgen center dot AR induces expression of p21 that in turn inhibits tumor necrosis factor alpha-induced JNK and apoptosis. Furthermore, genetic interruption of p21 alleles abolishes the inhibition by androgen. Our results reveal a novel cross-talk between androgen center dot AR and JNK, thereby providing a molecular mechanism underlying the survival function of androgen.	[Tang, Fangming; Kokontis, John; Liao, Shutsung; Lin, Anning] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Lin, Yuting; Xiang, Jialing] IIT, Dept Biol Chem & Phys Sci, Chicago, IL 60616 USA	University of Chicago; Illinois Institute of Technology	Lin, AN (corresponding author), Univ Chicago, Ben May Dept Canc Res, 929 E 57th St, Chicago, IL 60637 USA.	anninglin@bsd.uchcicago.edu; xiang@iit.edu			National Institutes of Health [CA090516, CA128114, GM71409, ES015868]; NATIONAL CANCER INSTITUTE [R01CA058073, K01CA090516, R01CA128114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA090516 and CA128114 (to J.X.) and GM71409 and ES015868 (to A.L.).	ANDERSON KM, 1968, NATURE, V219, P277, DOI 10.1038/219277a0; BRUCHOVSKY N, 1968, J BIOL CHEM, V243, P2012; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chuu CP, 2005, CANCER RES, V65, P2082, DOI 10.1158/0008-5472.CAN-04-3992; DAI TN, 1995, ONCOGENE, V10, P849; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dawson N A, 2000, Curr Oncol Rep, V2, P409; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng HB, 2008, J BIOL CHEM, V283, P20754, DOI 10.1074/jbc.M800024200; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Huang S, 2003, MOL CELL, V11, P1491, DOI 10.1016/S1097-2765(03)00180-1; Huggins C, 1941, ARCH SURG-CHICAGO, V43, P209, DOI 10.1001/archsurg.1941.01210140043004; Isaacs JT, 2000, JNCI-J NATL CANCER I, V92, P1367, DOI 10.1093/jnci/92.17.1367; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KOKONTIS J, 1994, CANCER RES, V54, P1566; Kokontis JM, 2005, PROSTATE, V65, P287, DOI 10.1002/pros.20285; Kokontis JM, 1998, MOL ENDOCRINOL, V12, P941, DOI 10.1210/me.12.7.941; Kokontis JM, 1999, VITAM HORM, V55, P219; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Lin YT, 2006, MOL CELL BIOL, V26, P1908, DOI 10.1128/MCB.26.5.1908-1916.2006; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Lorenzo PI, 2008, NEOPLASIA, V10, P418, DOI 10.1593/neo.07985; Lu S, 1999, MOL ENDOCRINOL, V13, P376, DOI 10.1210/me.13.3.376; Lu XH, 1997, J BIOL CHEM, V272, P24751, DOI 10.1074/jbc.272.40.24751; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Roy AK, 2001, ANN NY ACAD SCI, V949, P44; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Shim J, 1996, NATURE, V381, P804, DOI 10.1038/381804a0; Singh SV, 2007, CANCER RES, V67, P7439, DOI 10.1158/0008-5472.CAN-07-0120; Tang FM, 2002, MOL CELL BIOL, V22, P8571, DOI 10.1128/MCB.22.24.8571-8579.2002; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tang GL, 2001, MOL CELL, V8, P1005, DOI 10.1016/S1097-2765(01)00380-X; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Waller AS, 2000, J MOL ENDOCRINOL, V24, P339, DOI 10.1677/jme.0.0240339; Wolff JM, 2000, EUR UROL, V38, P365, DOI 10.1159/000020310; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966	46	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2009	284	47					32353	32358		10.1074/jbc.M109.042994	http://dx.doi.org/10.1074/jbc.M109.042994			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VR	19723627	hybrid, Green Published			2022-12-25	WOS:000272028400018
J	Szwagierczak, A; Antonenka, U; Popowicz, GM; Sitar, T; Holak, TA; Rakin, A				Szwagierczak, Aleksandra; Antonenka, Uladzimir; Popowicz, Grzegorz M.; Sitar, Tomasz; Holak, Tad A.; Rakin, Alexander			Structures of the Arm-type Binding Domains of HPI and HAI7 Integrases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAMBDA-INTEGRASE; NMR STRUCTURE; TRANSFER-RNA; DNA; PROTEIN; RECOMBINATION; RECOGNITION; REFINEMENT; ISLANDS; COMPLEX	The structures of the N-terminal domains of two integrases of closely related but not identical asn tDNA-associated genomic islands, Yersinia HPI (high pathogenicity island; encoding siderophore yersiniabactin biosynthesis and transport) and an Erwinia carotovora genomic island with yet unknown function, HAI7, have been resolved. Both integrases utilize a novel four-stranded beta-sheet DNA-binding motif, in contrast to the known proteins that bind their DNA targets by means of three-stranded beta-sheets. Moreover, the beta-sheets in Int(HPI) and Int(HAI7) are longer than those in other integrases, and the structured helical N terminus is positioned perpendicularly to the large C-terminal helix. These differences strongly support the proposal that the integrases of the genomic islands make up a distinct evolutionary branch of the site-specific recombinases that utilize a unique DNA-binding mechanism.	[Antonenka, Uladzimir; Rakin, Alexander] Univ Munich, Max Von Pettenkofer Inst, D-80336 Munich, Germany; Max Planck Inst Biochem, D-82152 Martinsried, Germany	University of Munich; Max Planck Society	Rakin, A (corresponding author), Univ Munich, Max Von Pettenkofer Inst, Pettenkoferstr 9A, D-80336 Munich, Germany.	rakin@mvp.uni-muenchen.de	Popowicz, Grzegorz/G-4769-2017	Popowicz, Grzegorz/0000-0003-2818-7498	Deutsche Forschungsgemeinschaft [RA 991/1-2, RA 991/1-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by Deutsche Forschungsgemeinschaft Grants RA 991/1-2 and RA 991/1-3.	Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Antonenka U, 2006, INT J MED MICROBIOL, V296, P341, DOI 10.1016/j.ijmm.2006.02.021; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balding C, 2005, ENVIRON MICROBIOL, V7, P1558, DOI 10.1111/j.1462-2920.2005.00845.x; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; Biswas T, 2005, NATURE, V435, P1059, DOI 10.1038/nature03657; Boyd EF, 2009, TRENDS MICROBIOL, V17, P47, DOI 10.1016/j.tim.2008.11.003; Connolly KM, 1998, NAT STRUCT BIOL, V5, P546, DOI 10.1038/799; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Fadeev EA, 2009, J MOL BIOL, V388, P682, DOI 10.1016/j.jmb.2009.03.041; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rakin A, 2001, MOL MICROBIOL, V39, P407, DOI 10.1046/j.1365-2958.2001.02227.x; RAKIN A, 1999, HIGH PATHOGENICITY I; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Williams KP, 2002, NUCLEIC ACIDS RES, V30, P866, DOI 10.1093/nar/30.4.866; Wojciak JM, 1999, NAT STRUCT BIOL, V6, P366; Wojciak JM, 2002, P NATL ACAD SCI USA, V99, P3434, DOI 10.1073/pnas.052017999	23	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31664	31671		10.1074/jbc.M109.059261	http://dx.doi.org/10.1074/jbc.M109.059261			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19737930	hybrid, Green Published			2022-12-25	WOS:000271572700021
J	Harris, CR; DeWan, A; Zupnick, A; Normart, R; Gabriel, A; Prives, C; Levine, AJ; Hoh, J				Harris, C. R.; DeWan, A.; Zupnick, A.; Normart, R.; Gabriel, A.; Prives, C.; Levine, A. J.; Hoh, J.			p53 responsive elements in human retrotransposons	ONCOGENE			English	Article						p53; LINE-1; genome stability	SUPPRESSOR PROTEIN P53; DNA-BINDING; GENE-EXPRESSION; L1 RETROTRANSPOSITION; ACTIVATION; CELLS; APOPTOSIS; LINE-1; IDENTIFICATION; METHYLATION	Long interspersed nuclear elements-1 (L1s) are highly repetitive DNA elements that are capable of altering the human genome through retrotransposition. To protect against L1 retroposition, the cell downregulates the expression of L1 proteins by various mechanisms, including high-density cytosine methylation of L1 promoters and DICER-dependent destruction of L1 mRNAs. In this report, a large number of p53 responsive elements, or p53 DNA binding sites, were detected in L1 elements within the human genome. At least some of these p53 responsive elements are functional and can act to increase the levels of L1 mRNA expression. The p53 protein can directly bind to a short 15-nucleotide sequence within the L1 promoter. This p53 responsive element within L1 is a recent addition to evolution, appearing B20 million years ago. This suggests an interplay between L1 elements, which have a rich history of causing changes in the genome, and the p53 protein, the function of which is to protect against genomic changes. To understand these observations, a model is proposed in which the increased expression of L1 mRNAs by p53 actually increases, rather than decreases, the genomic stability through amplification of p53-dependent processes for genomic protection. Oncogene (2009) 28, 3857 -3865; doi:10.1038/onc.2009.246; published online 31 August 2009	[Harris, C. R.; Normart, R.] Raymond & Beverly Sackler Fdn, New Brunswick, NJ USA; [Harris, C. R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, New Brunswick, NJ USA; [Harris, C. R.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08903 USA; [DeWan, A.; Hoh, J.] Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; [Zupnick, A.; Prives, C.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Gabriel, A.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA; [Levine, A. J.] Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Yale University; Columbia University; Rutgers State University New Brunswick; Institute for Advanced Study - USA	Levine, AJ (corresponding author), Inst Adv Study, Sch Nat Sci, Einstein Dr, Princeton, NJ 08540 USA.	alevine@ias.edu		DeWan, Andrew/0000-0002-7679-8704	Verto Institute; NIH [K25HG00060, R01EY015771, R01MH44292, P01CA87497]; NATIONAL CANCER INSTITUTE [P01CA087497] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015771] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K25HG000060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH044292] Funding Source: NIH RePORTER	Verto Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was primarily supported by the Verto Institute, with additional support provided by NIH Grant nos K25HG00060, R01EY015771, R01MH44292 and P01CA87497.	Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Bensaad K, 2005, NAT MED, V11, P1278, DOI 10.1038/nm1205-1278; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Budhram-Mahadeo V, 1999, J BIOL CHEM, V274, P15237, DOI 10.1074/jbc.274.21.15237; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Donehower LA, 2005, EXP GERONTOL, V40, P7, DOI 10.1016/j.exger.2004.10.007; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Esteve PO, 2005, P NATL ACAD SCI USA, V102, P1000, DOI 10.1073/pnas.0407729102; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Haoudi A, 2004, J BIOMED BIOTECHNOL, P185, DOI 10.1155/S1110724304403131; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; HOLLANDER MC, 1993, J BIOL CHEM, V268, P24385; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Jin SK, 2001, J CELL SCI, V114, P4139; Jordan JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000104; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kannan K, 2001, ONCOGENE, V20, P3449, DOI 10.1038/sj.onc.1204446; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Kwon HS, 2006, BBA-GENE STRUCT EXPR, V1759, P141, DOI 10.1016/j.bbaexp.2006.04.005; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LANE DP, 1992, NATURE, V358, P16; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lee KC, 1999, MOL CELL BIOL, V19, P1279; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; Ori A, 1998, EMBO J, V17, P544, DOI 10.1093/emboj/17.2.544; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; Pochampally R, 1999, J BIOL CHEM, V274, P15271, DOI 10.1074/jbc.274.21.15271; Resnick-Silverman L, 1998, GENE DEV, V12, P2102, DOI 10.1101/gad.12.14.2102; Tchenio T, 2000, NUCLEIC ACIDS RES, V28, P411, DOI 10.1093/nar/28.2.411; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Woodcock DM, 1997, J BIOL CHEM, V272, P7810, DOI 10.1074/jbc.272.12.7810; Zhao RB, 2000, GENE DEV, V14, P981	39	67	68	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2009	28	44					3857	3865		10.1038/onc.2009.246	http://dx.doi.org/10.1038/onc.2009.246			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	515LJ	19718052	Green Accepted			2022-12-25	WOS:000271471900001
J	Passarini, F; Wientjes, E; Hienerwadel, R; Croce, R				Passarini, Francesca; Wientjes, Emilie; Hienerwadel, Rainer; Croce, Roberta			Molecular Basis of Light Harvesting and Photoprotection in CP24 UNIQUE FEATURES OF THE MOST RECENT ANTENNA COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-II ANTENNA; TIME-RESOLVED FLUORESCENCE; HIGHER-PLANT ANTENNA; GREEN PLANTS; CHLAMYDOMONAS-REINHARDTII; CHLOROPHYLL FLUORESCENCE; ZEAXANTHIN FORMATION; CHROMOPHORE-BINDING; THERMAL DISSIPATION; ENERGY-DISSIPATION	CP24 is a minor antenna complex of Photosystem II, which is specific for land plants. It has been proposed that this complex is involved in the process of excess energy dissipation, which protects plants from photodamage in high light conditions. Here, we have investigated the functional architecture of the complex, integrating mutation analysis with time-resolved spectroscopy. A comprehensive picture is obtained about the nature, the spectroscopic properties, and the role in the quenching in solution of the pigments in the individual binding sites. The lowest energy absorption band in the chlorophyll a region corresponds to chlorophylls 611/612, and it is not the site of quenching in CP24. Chlorophylls 613 and 614, which are present in the major light-harvesting complex of Photosystem appear to be absent in CP24. In contrast to all other light-harvesting complexes, CP24 is stable when the L1 carotenoid binding site is empty and upon mutations in the third helix, whereas mutations in the first helix strongly affect the folding/stability of the pigment-protein complex. The absence of lutein in L1 site does not have any effect on the quenching, whereas substitution of violaxanthin in the L2 site with lutein or zeaxanthin results in a complex with enhanced quenched fluorescence. Triplet-minus-singlet measurements indicate that zeaxanthin and lutein in site L2 are located closer to chlorophylls than violaxanthin, thus suggesting that they can act as direct quenchers via a strong interaction with a neighboring chlorophyll. The results provide the molecular basis for the zeaxanthin-dependent quenching in isolated CP24.	[Passarini, Francesca; Wientjes, Emilie; Croce, Roberta] Univ Groningen, Dept Biophys Chem, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Hienerwadel, Rainer] Univ Aix Marseille 2, Fac Sci Luminy, Dept Biol, Lab Genet & Biophys Plantes, F-13288 Marseille, France	University of Groningen; CEA; UDICE-French Research Universities; Aix-Marseille Universite	Croce, R (corresponding author), Univ Groningen, Dept Biophys Chem, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	R.Croce@rug.nl	Croce, Roberta/N-4067-2014; Wientjes, Emilie/AAC-8491-2019; Croce, Roberta/ABG-3595-2021; Croce, Roberta/F-1174-2014; Croce, Roberta/HGU-9554-2022; Wientjes, Emilie/M-6387-2014	Croce, Roberta/0000-0003-3469-834X; Wientjes, Emilie/0000-0003-2625-8045; Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X; Wientjes, Emilie/0000-0003-2625-8045	Netherlands Organization for Scientific Research Earth and Life Science, VIDI; Frans/Nederlandse Academie via a Van Gogh	Netherlands Organization for Scientific Research Earth and Life Science, VIDI(Netherlands Organization for Scientific Research (NWO)); Frans/Nederlandse Academie via a Van Gogh	This work was supported by The Netherlands Organization for Scientific Research Earth and Life Science through a VIDI grant and by the Frans/Nederlandse Academie via a Van Gogh grant.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Ballottari M, 2009, J BIOL CHEM, V284, P8103, DOI 10.1074/jbc.M808326200; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Barzda V, 1998, BIOCHEMISTRY-US, V37, P546, DOI 10.1021/bi972123a; Bassi R, 1999, P NATL ACAD SCI USA, V96, P10056, DOI 10.1073/pnas.96.18.10056; Bassi R, 2000, PHOTOSYNTH RES, V64, P243, DOI 10.1023/A:1006409506272; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Bode S, 2009, P NATL ACAD SCI USA, V106, P12311, DOI 10.1073/pnas.0903536106; BOEKEMA EJ, 1995, P NATL ACAD SCI USA, V92, P175, DOI 10.1073/pnas.92.1.175; Bonente G, 2008, PHOTOCHEM PHOTOBIOL, V84, P1359, DOI 10.1111/j.1751-1097.2008.00456.x; BRIANTAIS JM, 1994, PHOTOSYNTH RES, V40, P287, DOI 10.1007/BF00034778; Caffarri S, 2004, BIOCHEMISTRY-US, V43, P9467, DOI 10.1021/bi036265i; Caffarri S, 2007, FEBS LETT, V581, P4704, DOI 10.1016/j.febslet.2007.08.066; Cinque G, 2000, PHOTOSYNTH RES, V64, P233, DOI 10.1023/A:1006467617697; Crimi M, 2001, EUR J BIOCHEM, V268, P260, DOI 10.1046/j.1432-1033.2001.01874.x; Croce R, 1999, J BIOL CHEM, V274, P29613, DOI 10.1074/jbc.274.42.29613; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Croce R, 2007, BIOCHEMISTRY-US, V46, P3846, DOI 10.1021/bi602531k; DAINESE P, 1991, J BIOL CHEM, V266, P8136; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; DEMMIGADAMS B, 1990, PLANT PHYSIOL, V92, P293, DOI 10.1104/pp.92.2.293; DEXTER DL, 1953, J CHEM PHYS, V21, P836, DOI 10.1063/1.1699044; Digris AV, 1999, EUR BIOPHYS J BIOPHY, V28, P526, DOI 10.1007/s002490050235; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; Finazzi G, 2006, BIOCHEMISTRY-US, V45, P1490, DOI 10.1021/bi0521588; Frank HA, 2001, BIOCHEMISTRY-US, V40, P1220, DOI 10.1021/bi001160q; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Ihalainen JA, 2005, J PHYS CHEM B, V109, P21150, DOI 10.1021/jp0519316; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Johnson MP, 2009, PLANT PHYSIOL, V149, P1061, DOI 10.1104/pp.108.129957; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Koziol AG, 2007, PLANT PHYSIOL, V143, P1802, DOI 10.1104/pp.092536; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Lampoura SS, 2002, BIOCHEMISTRY-US, V41, P9139, DOI 10.1021/bi025724x; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Miloslavina Y, 2008, FEBS LETT, V582, P3625, DOI 10.1016/j.febslet.2008.09.044; Morosinotto T, 2002, J BIOL CHEM, V277, P36913, DOI 10.1074/jbc.M205339200; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Mozzo M, 2008, BBA-BIOENERGETICS, V1777, P1263, DOI 10.1016/j.bbabio.2008.04.036; Mozzo M, 2008, J BIOL CHEM, V283, P6184, DOI 10.1074/jbc.M708961200; Mozzo M, 2006, BBA-BIOENERGETICS, V1757, P1607, DOI 10.1016/j.bbabio.2006.06.018; Pagano A, 1998, J BIOL CHEM, V273, P17154, DOI 10.1074/jbc.273.27.17154; Palacios MA, 2002, J PHYS CHEM B, V106, P5782, DOI 10.1021/jp014078t; PETER GF, 1991, J BIOL CHEM, V266, P16745; PLUMLEY FG, 1987, P NATL ACAD SCI USA, V84, P146, DOI 10.1073/pnas.84.1.146; Remelli R, 1999, J BIOL CHEM, V274, P33510, DOI 10.1074/jbc.274.47.33510; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; RUBAN AV, 1994, PLANT PHYSIOL, V104, P227, DOI 10.1104/pp.104.1.227; SIEFERMANNHARMS D, 1987, PHYSIOL PLANTARUM, V69, P561, DOI 10.1111/j.1399-3054.1987.tb09240.x; Somsen OJG, 2005, CHEMPHYSCHEM, V6, P1622, DOI 10.1002/cphc.200400648; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Teramoto H, 2001, PLANT CELL PHYSIOL, V42, P849, DOI 10.1093/pcp/pce115; van Amerongen H, 2001, J PHYS CHEM B, V105, P604, DOI 10.1021/jp0028406; van Oort B, 2008, BIOPHYS J, V95, P5851, DOI 10.1529/biophysj.108.140467; Wehner A, 2006, J BIOL CHEM, V281, P21924, DOI 10.1074/jbc.M602915200; Young A. J, 1993, CAROTENOIDS PHOTOSYN	64	48	48	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29536	29546		10.1074/jbc.M109.036376	http://dx.doi.org/10.1074/jbc.M109.036376			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19700403	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000270896800036
J	Beamish, H; de Boer, L; Giles, N; Stevens, F; Oakes, V; Gabrielli, B				Beamish, Heather; de Boer, Leonore; Giles, Nichole; Stevens, Frankie; Oakes, Vanessa; Gabrielli, Brian			Cyclin A/cdk2 Regulates Adenomatous Polyposis Coli-dependent Mitotic Spindle Anchoring	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACTS; CELL-CYCLE; CHROMOSOME ALIGNMENT; S-PHASE; APC; MITOSIS; INSTABILITY; PROTEIN; CANCER; EB1	Mutations in adenomatous polyposis coli (APC) protein is a major contributor to tumor initiation and progression in several tumor types. These mutations affect APC function in the Wnt-beta-catenin signaling and influence mitotic spindle anchoring to the cell cortex and orientation. Here we report that the mitotic anchoring and orientation function of APC is regulated by cyclin A/cdk2. Knockdown of cyclin A and inhibition of cdk2 resulted in cells arrested in mitosis with activation of the spindle assembly checkpoint. The mitotic spindle was unable to form stable attachments to the cell cortex, and this resulted in the spindles failing to locate to the central position in the cells and undergo dramatic rotation. We have demonstrated that cyclin A/cdk2 specifically associates with APC in late G2 phase and phosphorylates it at Ser-1360, located in the mutation cluster region of APC. Mutation of APC Ser-1360 to Ala results in identical off-centered mitotic spindles. Thus, this cyclin A/cdk2-dependent phosphorylation of APC affects astral microtubule attachment to the cortical surface in mitosis.	[Beamish, Heather; de Boer, Leonore; Giles, Nichole; Stevens, Frankie; Oakes, Vanessa; Gabrielli, Brian] Univ Queensland, Diamantina Inst Canc Immunol & Metab Med, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia	University of Queensland	Gabrielli, B (corresponding author), Univ Queensland, Diamantina Inst Canc Immunol & Metab Med, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia.	brianG@uq.edu.au	Gabrielli, Brian G/B-3655-2011	Gabrielli, Brian G/0000-0003-3933-1651; Stevens, Frankie/0000-0002-2556-473X	National Health and Medical Research Council of Australia; Cancer Council of Queensland	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Queensland(Cancer Council Queensland)	This work was supported in part by the National Health and Medical Research Council of Australia and the Cancer Council of Queensland.	Aaltonen K, 2006, BRIT J CANCER, V94, P1697, DOI 10.1038/sj.bjc.6603147; Aoki K, 2007, ONCOGENE, V26, P3511, DOI 10.1038/sj.onc.1210141; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Askham JM, 2000, ONCOGENE, V19, P1950, DOI 10.1038/sj.onc.1203498; BUENDIA B, 1992, J CELL BIOL, V116, P1431, DOI 10.1083/jcb.116.6.1431; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; De Boer L, 2008, ONCOGENE, V27, P4261, DOI 10.1038/onc.2008.74; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Dikovskaya D, 2007, J CELL BIOL, V176, P183, DOI 10.1083/jcb.200610099; Draviam VM, 2006, EMBO J, V25, P2814, DOI 10.1038/sj.emboj.7601168; Fung TK, 2007, MOL BIOL CELL, V18, P1861, DOI 10.1091/mbc.E06-12-1092; Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; Gabrielli BG, 1996, J CELL SCI, V109, P1081; Goldstone S, 2001, ONCOGENE, V20, P921, DOI 10.1038/sj.onc.1204177; Gong DQ, 2007, CURR BIOL, V17, P85, DOI 10.1016/j.cub.2006.11.066; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Hadjihannas MV, 2006, P NATL ACAD SCI USA, V103, P10747, DOI 10.1073/pnas.0604206103; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; KNOBLICH JA, 1993, EMBO J, V12, P65, DOI 10.1002/j.1460-2075.1993.tb05632.x; McCartney BM, 2001, NAT CELL BIOL, V3, P933, DOI 10.1038/ncb1001-933; Mitra J, 2004, ONCOGENE, V23, P3361, DOI 10.1038/sj.onc.1207446; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Nathke I, 2006, NAT REV CANCER, V6, P967, DOI 10.1038/nrc2010; O'Connell MJ, 2000, TRENDS CELL BIOL, V10, P296, DOI 10.1016/S0962-8924(00)01773-6; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; ROSENBLATT J, 1992, P NATL ACAD SCI USA, V89, P2824, DOI 10.1073/pnas.89.7.2824; Rusan NM, 2008, J CELL BIOL, V181, P719, DOI 10.1083/jcb.200802107; Skoufias DA, 2001, P NATL ACAD SCI USA, V98, P4492, DOI 10.1073/pnas.081076898; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Stevens FE, 2008, ONCOGENE, V27, P1345, DOI 10.1038/sj.onc.1210779; Strausfeld UP, 1996, J CELL SCI, V109, P1555; Tournier S, 2004, MOL BIOL CELL, V15, P3345, DOI 10.1091/mbc.E04-03-0256; Trzepacz C, 1997, J BIOL CHEM, V272, P21681, DOI 10.1074/jbc.272.35.21681; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Warrener R, 2003, FASEB J, V17, P1550, DOI 10.1096/fj.02-1003fje; Zhang JY, 2007, J CELL BIOL, V178, P773, DOI 10.1083/jcb.200702138	39	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					29015	29023		10.1074/jbc.M109.042820	http://dx.doi.org/10.1074/jbc.M109.042820			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19703905	Green Published, hybrid			2022-12-25	WOS:000270678900059
J	Rujiviphat, J; Meglei, G; Rubinstein, JL; McQuibban, GA				Rujiviphat, Jarungjit; Meglei, Gabriela; Rubinstein, John L.; McQuibban, G. Angus			Phospholipid Association Is Essential for Dynamin-related Protein Mgm1 to Function in Mitochondrial Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHOLOGY; YEAST	Mgm1, the yeast ortholog of mammalian OPA1, is a key component in mitochondrial membrane fusion and is required for maintaining mitochondrial dynamics and morphology. We showed recently that the purified short isoform of Mgm1 (s-Mgm1) possesses GTPase activity, self- assembles into low order oligomers, and interacts specifically with negatively charged phospholipids (Meglei, G., and McQuibban, G. A. (2009) Biochemistry 48, 1774-1784). Here, we demonstrate that s-Mgm1 binds to a mixture of phospholipids characteristic of the mitochondrial inner membrane. Binding to physiologically representative lipids results in similar to 50-fold stimulation of s-Mgm1 GTPase activity. s-Mgm1 point mutants that are defective in oligomerization and lipid binding do not exhibit such stimulation and do not function in vivo. Electron microscopy and lipid turbidity assays demonstrate that s-Mgm1 promotes liposome interaction. Furthermore, s-Mgm1 assembles onto liposomes as oligomeric rings with 3-fold symmetry. The projection map of negatively stained s-Mgm1 shows six monomers, consistent with two stacked trimers. Taken together, our data identify a lipid-binding domain in Mgm1, and the structural analysis suggests a model of how Mgm1 promotes the fusion of opposing mitochondrial inner membranes.	[Rujiviphat, Jarungjit; Meglei, Gabriela; Rubinstein, John L.; McQuibban, G. Angus] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Rubinstein, John L.] Univ Toronto, Mol Struct & Funct Program, Hosp Sick Children, Inst Res, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	McQuibban, GA (corresponding author), Univ Toronto, Dept Biochem, 1 Kings Coll Circle,Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	angus.mcquibban@utoronto.ca		Rubinstein, John/0000-0003-0566-2209	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by an operating grant from the Canadian Institutes of Health Research (to G. A. M.).	Connell E, 2008, ANAL BIOCHEM, V377, P83, DOI 10.1016/j.ab.2008.02.016; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Mears JA, 2008, METHOD CELL BIOL, V88, P237, DOI 10.1016/S0091-679X(08)00413-5; Meglei G, 2009, BIOCHEMISTRY-US, V48, P1774, DOI 10.1021/bi801723d; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Park J, 2009, DIS MODEL MECH, V2, P336, DOI 10.1242/dmm.003178; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Schlame M, 1997, BBA-LIPID LIPID MET, V1348, P207, DOI 10.1016/S0005-2760(97)00119-7; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Whitworth AJ, 2008, DIS MODEL MECH, V1, P168, DOI 10.1242/dmm.000109; Zick M, 2009, FEBS LETT, V583, P2237, DOI 10.1016/j.febslet.2009.05.053	15	55	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2009	284	42					28682	28686		10.1074/jbc.M109.044933	http://dx.doi.org/10.1074/jbc.M109.044933			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505GD	19703904	Green Published, hybrid			2022-12-25	WOS:000270678900023
J	Leung, G; Eisen, MB				Leung, Garmay; Eisen, Michael B.			Identifying Cis-Regulatory Sequences by Word Profile Similarity	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; MODULES; GENOME; ELEMENTS; REGIONS; CONSERVATION; PREDICTION; CLUSTERS	Background: Recognizing regulatory sequences in genomes is a continuing challenge, despite a wealth of available genomic data and a growing number of experimentally validated examples. Methodology/Principal Findings: We discuss here a simple approach to search for regulatory sequences based on the compositional similarity of genomic regions and known cis-regulatory sequences. This method, which is not limited to searching for predefined motifs, recovers sequences known to be under similar regulatory control. The words shared by the recovered sequences often correspond to known binding sites. Furthermore, we show that although local word profile clustering is predictive for the regulatory sequences involved in blastoderm segmentation, local dissimilarity is a more universal feature of known regulatory sequences in Drosophila. Conclusions/Significance: Our method leverages sequence motifs within a known regulatory sequence to identify coregulated sequences without explicitly defining binding sites. We also show that regulatory sequences can be distinguished from surrounding sequences by local sequence dissimilarity, a novel feature in identifying regulatory sequences across a genome. Source code for WPH-finder is available for download at http://rana.lbl.gov/downloads/wph.tar.gz.			Leung, G (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.	garmay@berkeley.edu		Eisen, Michael/0000-0002-7528-738X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002779] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [R01 HG002779, HG002779] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abnizova I, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-109; Bachtrog D, 1999, MOL BIOL EVOL, V16, P602, DOI 10.1093/oxfordjournals.molbev.a026142; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Chan BY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-262; DAVIDSON EH, 2001, GENOME REGULATORY SY; Emberly E, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-57; Glazov EA, 2005, GENOME RES, V15, P800, DOI 10.1101/gr.3545105; Grad YH, 2004, BIOINFORMATICS, V20, P2738, DOI 10.1093/bioinformatics/bth320; Halfon MS, 2006, NAT GENET, V38, P1102, DOI 10.1038/ng1006-1102; Halligan DL, 2006, GENOME RES, V16, P875, DOI 10.1101/gr.5022906; Hare EE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000106; Ivan A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r22; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kantorovitz MR, 2007, BIOINFORMATICS, V23, pI249, DOI 10.1093/bioinformatics/btm211; Klingler M, 1996, DEV BIOL, V177, P73, DOI 10.1006/dbio.1996.0146; Li L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r101; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Lifanov AP, 2003, GENOME RES, V13, P579, DOI 10.1101/gr.668403; Nasiadka A., 2002, AD DEV BIOL, V12, P155; Nazina AG, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-65; Pierstorff N, 2006, BIOINFORMATICS, V22, P2858, DOI 10.1093/bioinformatics/btl499; Poulin F, 2005, GENOMICS, V85, P774, DOI 10.1016/j.ygeno.2005.03.003; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; Rajewsky N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-30; Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-129; Sosinsky A, 2007, P NATL ACAD SCI USA, V104, P6305, DOI 10.1073/pnas.0701614104; Zhang CL, 2006, NUCLEIC ACIDS RES, V34, P2238, DOI 10.1093/nar/gkl248	29	18	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2009	4	9							e6901	10.1371/journal.pone.0006901	http://dx.doi.org/10.1371/journal.pone.0006901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZF	19730735	Green Published, gold, Green Submitted			2022-12-25	WOS:000269622100006
J	Kersulyte, D; Lee, W; Subramaniam, D; Anant, S; Herrera, P; Cabrera, L; Balqui, J; Barabas, O; Kalia, A; Gilman, RH; Berg, DE				Kersulyte, Dangeruta; Lee, WooKon; Subramaniam, Dharmalingam; Anant, Shrikant; Herrera, Phabiola; Cabrera, Lilia; Balqui, Jacqueline; Barabas, Orsolya; Kalia, Awdhesh; Gilman, Robert H.; Berg, Douglas E.			Helicobacter Pylori's Plasticity Zones Are Novel Transposable Elements	PLOS ONE			English	Article								Background: Genes present in only certain strains of a bacterial species can strongly affect cellular phenotypes and evolutionary potentials. One segment that seemed particularly rich in strain-specific genes was found by comparing the first two sequenced Helicobacter pylori genomes (strains 26695 and J99) and was named a "plasticity zone''. Principal Findings: We studied the nature and evolution of plasticity zones by sequencing them in five more Helicobacter strains, determining their locations in additional strains, and identifying them in recently released genome sequences. They occurred as discrete units, inserted at numerous chromosomal sites, and were usually flanked by direct repeats of 5'AAGAATG, a sequence generally also present in one copy at unoccupied sites in other strains. This showed that plasticity zones are transposable elements, to be called TnPZs. Each full length TnPZ contained a cluster of type IV protein secretion genes (tfs3), a tyrosine recombinase family gene ("xerT''), and a large (>= 2800 codon) orf encoding a protein with helicase and DNA methylase domains, plus additional orfs with no homology to genes of known function. Several TnPZ types were found that differed in gene arrangement or DNA sequence. Our analysis also indicated that the first-identified plasticity zones (in strains 26695 and J99) are complex mosaics of TnPZ remnants, formed by multiple TnPZ insertions, and spontaneous and transposable element mediated deletions. Tests using laboratory-generated deletions showed that TnPZs are not essential for viability, but identified one TnPZ that contributed quantitatively to bacterial growth during mouse infection and another that affected synthesis of proinflammatory cytokines in cell culture. Conclusions: We propose that plasticity zone genes are contained in conjugative transposons (TnPZs) or remnants of them, that TnPZ insertion is mediated by XerT recombinase, and that some TnPZ genes affect bacterial phenotypes and fitness.			Kersulyte, D (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	berg@borcim.wustl.edu	Barabas, Orsolya/F-3961-2012; Herrera, Phabiola/AAL-7992-2021; Anant, Shrikant/AAF-8020-2020	Barabas, Orsolya/0000-0002-2873-5872; Kalia, Awdhesh/0000-0001-5365-1702	FIC NIH HHS [D43 TW006581, D43TW006581] Funding Source: Medline; NIDDK NIH HHS [R01 DK063041, R01 DK63041] Funding Source: Medline; PHS HHS [T35 1007646] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW006581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063041] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akada JK, 2003, MICROBIOL-SGM, V149, P1901, DOI 10.1099/mic.0.26129-0; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Alm RA, 1999, J MOL MED, V77, P834, DOI 10.1007/s001099900067; Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; Atmakuri K, 2007, EMBO J, V26, P2540, DOI 10.1038/sj.emboj.7601696; AUSUBEL FM, 1994, CURRENT PROTOCOLS S, V27; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Baltrus DA, 2009, J BACTERIOL, V191, P447, DOI 10.1128/JB.01416-08; Barabas O, 2008, CELL, V132, P208, DOI 10.1016/j.cell.2007.12.029; Barre F.-X., 2002, MOBILE DNA, P149; Becker EC, 2000, J MOL BIOL, V300, P1067, DOI 10.1006/jmbi.2000.3902; Berg DE, 1989, MOBILE DNA; Bjorkholm B, 2001, P NATL ACAD SCI USA, V98, P14607, DOI 10.1073/pnas.241517298; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; BONNE L, 2009, NUCL ACIDS IN PRESS; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Burrus V, 2006, PLASMID, V55, P173, DOI 10.1016/j.plasmid.2006.01.001; CARNOY C, 2009, PLOS ONE IN PRESS; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; CHURCHWARD G, 2002, MOBILE DNA, V2, P177; CRAIG NL, 2002, MOBILE DNA, V2; Dillehay TD, 2009, P NATL ACAD SCI USA, V106, P971, DOI 10.1073/pnas.0808424106; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Forterre P, 2007, BIOCHIMIE, V89, P427, DOI 10.1016/j.biochi.2006.12.009; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Harper CG, 2002, J CLIN MICROBIOL, V40, P4536, DOI 10.1128/JCM.40.12.4536-4543.2002; HARTL DL, 1983, CELL, V35, P503, DOI 10.1016/0092-8674(83)90184-8; Israel DA, 2006, CURR OPIN GASTROEN, V22, P3, DOI 10.1097/01.mog.0000194790.51714.f0; JILK RA, 1993, J BACTERIOL, V175, P1264, DOI 10.1128/JB.175.5.1264-1271.1993; Karnholz A, 2006, J BACTERIOL, V188, P882, DOI 10.1128/JB.188.3.882-893.2006; Kersulyte D, 2004, J BACTERIOL, V186, P7521, DOI 10.1128/JB.186.22.7521-7528.2004; Kersulyte D, 2003, J BACTERIOL, V185, P3764, DOI 10.1128/JB.185.13.3764-3772.2003; Kersulyte D, 2002, J BACTERIOL, V184, P992, DOI 10.1128/jb.184.4.992-1002.2002; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; McNulty SL, 2004, J CLIN MICROBIOL, V42, P5658, DOI 10.1128/JCM.42.12.5658-5663.2004; Narra HP, 2006, CURR BIOL, V16, pR705, DOI 10.1016/j.cub.2006.08.024; NEVERS P, 1977, NATURE, V268, P109, DOI 10.1038/268109a0; Occhialini A, 2000, INFECT IMMUN, V68, P6240, DOI 10.1128/IAI.68.11.6240-6249.2000; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; Oleastro M, 2008, J INFECT DIS, V198, P1379, DOI 10.1086/592166; Reznikoff WS, 2008, ANNU REV GENET, V42, P269, DOI 10.1146/annurev.genet.42.110807.091656; Rizwan M, 2008, J BACTERIOL, V190, P1146, DOI 10.1128/JB.01309-07; Romo-Gonzalez C, 2009, INFECT IMMUN, V77, P2201, DOI 10.1128/IAI.01284-08; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; Subramanya HS, 1997, EMBO J, V16, P5178, DOI 10.1093/emboj/16.17.5178; Surtees JA, 2003, CURR TOP DEV BIOL, V56, P145, DOI 10.1016/S0070-2153(03)01010-X; Tabassam FH, 2008, CELL MICROBIOL, V10, P1008, DOI 10.1111/j.1462-5822.2007.01104.x; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Val ME, 2005, MOL CELL, V19, P559, DOI 10.1016/j.molcel.2005.07.002; van Passel MWJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000059; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; WANG G, 1993, J BACTERIOL, V175, P1264; Wirth T, 2005, MOL ECOL, V14, P3289, DOI 10.1111/j.1365-294X.2005.02687.x; Yamaoka Y, 2008, J MED MICROBIOL, V57, P545, DOI 10.1099/jmm.0.2008/000570-0; Ziemienowicz A, 1999, P NATL ACAD SCI USA, V96, P3729, DOI 10.1073/pnas.96.7.3729	59	74	78	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2009	4	9							e6859	10.1371/journal.pone.0006859	http://dx.doi.org/10.1371/journal.pone.0006859			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RX	19727398	gold, Green Published			2022-12-25	WOS:000269522900007
J	McKellar, AE; Hendry, AP				McKellar, Ann E.; Hendry, Andrew P.			How Humans Differ from Other Animals in Their Levels of Morphological Variation	PLOS ONE			English	Article							REPRODUCTIVE SUCCESS; BODY-MASS; SOCIOECONOMIC-STATUS; FACE RECOGNITION; SOCIAL-CLASSES; HEIGHT; POPULATION; WEIGHT; EVOLUTION; SELECTION	Animal species come in many shapes and sizes, as do the individuals and populations that make up each species. To us, humans might seem to show particularly high levels of morphological variation, but perhaps this perception is simply based on enhanced recognition of individual conspecifics relative to individual heterospecifics. We here more objectively ask how humans compare to other animals in terms of body size variation. We quantitatively compare levels of variation in body length (height) and mass within and among 99 human populations and 848 animal populations (210 species). We find that humans show low levels of within-population body height variation in comparison to body length variation in other animals. Humans do not, however, show distinctive levels of within-population body mass variation, nor of among-population body height or mass variation. These results are consistent with the idea that natural and sexual selection have reduced human height variation within populations, while maintaining it among populations. We therefore hypothesize that humans have evolved on a rugged adaptive landscape with strong selection for body height optima that differ among locations.			McKellar, AE (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	ann.mckellar@queensu.ca	Hendry, Andrew/C-5765-2008	Hendry, Andrew/0000-0002-4807-6667; McKellar, Ann/0000-0002-7032-3759				Arnold SJ, 2001, GENETICA, V112, P9, DOI 10.1023/A:1013373907708; Ball K, 2005, SOC SCI MED, V60, P1987, DOI 10.1016/j.socscimed.2004.08.056; BIELICKI T, 1992, ANN HUM BIOL, V19, P589, DOI 10.1080/03014469200002402; Blackburn Tim M., 1999, Diversity and Distributions, V5, P165, DOI 10.1046/j.1472-4642.1999.00046.x; CARMICHAEL CM, 1995, J GERONTOL A-BIOL, V50, pB237, DOI 10.1093/gerona/50A.4.B237; Darwin C., 1859, ORIGIN SPECIES NATUR; Dasgupta I, 1997, AM J HUM BIOL, V9, P7, DOI 10.1002/(SICI)1520-6300(1997)9:1<7::AID-AJHB2>3.0.CO;2-#; Donohue K, 2005, NEW PHYTOL, V166, P83, DOI 10.1111/j.1469-8137.2005.01357.x; ENDLER JA, 1973, SCIENCE, V179, P243, DOI 10.1126/science.179.4070.243; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fisher R.A., 1930, GENETICAL THEORY NAT; HOULE D, 1992, GENETICS, V130, P195; Katzmarzyk PT, 1998, AM J PHYS ANTHROPOL, V106, P483, DOI 10.1002/(SICI)1096-8644(199808)106:4<483::AID-AJPA4>3.0.CO;2-K; Kingsolver JG, 2004, EVOLUTION, V58, P1608; LANDE R, 1977, SYST ZOOL, V26, P214, DOI 10.2307/2412845; Lange H, 2004, BEHAV ECOL, V15, P549, DOI 10.1093/beheco/arh044; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; MASCIETAYLOR CGN, 1987, ANN HUM BIOL, V14, P59, DOI 10.1080/03014468700008841; Migliano AB, 2007, P NATL ACAD SCI USA, V104, P20216, DOI 10.1073/pnas.0708024105; Nettle D, 2002, HUM NATURE-INT BIOS, V13, P473, DOI 10.1007/s12110-002-1004-7; Nettle D, 2002, P ROY SOC B-BIOL SCI, V269, P1919, DOI 10.1098/rspb.2002.2111; Nettle D, 2008, AM NAT, V172, P658, DOI 10.1086/591690; Pascalis O, 1998, BEHAV PROCESS, V43, P87, DOI 10.1016/S0376-6357(97)00090-9; Pawlowski B, 2000, NATURE, V403, P156, DOI 10.1038/35003107; Peirce JW, 2001, BEHAV PROCESS, V55, P13, DOI 10.1016/S0376-6357(01)00158-9; Perry GH, 2009, TRENDS ECOL EVOL, V24, P218, DOI 10.1016/j.tree.2008.11.008; Polivy J, 2002, ANNU REV PSYCHOL, V53, P187, DOI 10.1146/annurev.psych.53.100901.135103; Polo V, 2002, BEHAV ECOL, V13, P696, DOI 10.1093/beheco/13.5.696; Pusey AE, 2005, INT J PRIMATOL, V26, P3, DOI 10.1007/s10764-005-0721-2; Raychaudhuri Arun, 2003, International Journal of Human Genetics, V3, P151; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Ruff Christopher B., 1994, Yearbook of Physical Anthropology, V37, P65; SCHUMACHER A, 1979, J HUM EVOL, V8, P809, DOI 10.1016/0047-2484(79)90013-7; Sear R, 2006, HUM NATURE-INT BIOS, V17, P405, DOI 10.1007/s12110-006-1003-1; Shriver Mark D, 2004, Hum Genomics, V1, P274; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; SPUHLER JN, 1982, SOC BIOL, V29, P53; Stephan CN, 2001, MED HYPOTHESES, V57, P633, DOI 10.1054/mehy.2001.1431; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Templeton AR, 2002, NATURE, V416, P45, DOI 10.1038/416045a	40	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2009	4	9							e6876	10.1371/journal.pone.0006876	http://dx.doi.org/10.1371/journal.pone.0006876			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	489XX	19721716	gold, Green Submitted, Green Published			2022-12-25	WOS:000269461100005
J	Bosgraaf, L; Van Haastert, PJM				Bosgraaf, Leonard; Van Haastert, Peter J. M.			Navigation of Chemotactic Cells by Parallel Signaling to Pseudopod Persistence and Orientation	PLOS ONE			English	Article								The mechanism of chemotaxis is one of the most interesting issues in modern cell biology. Recent work shows that shallow chemoattractant gradients do not induce the generation of pseudopods, as has been predicted in many models. This poses the question of how else cells can steer towards chemoattractants. Here we use a new computational algorithm to analyze the extension of pseudopods by Dictyostelium cells. We show that a shallow gradient of cAMP induces a small bias in the direction of pseudopod extension, without significantly affecting parameters such as pseudopod frequency or size. Persistent movement, caused by alternating left/right splitting of existing pseudopodia, amplifies the effects of this bias by up to 5-fold. Known players in chemotactic pathways play contrasting parts in this mechanism; PLA2 and cGMP signal to the cytoskeleton to regulate the splitting process, while PI 3-kinase and soluble guanylyl cyclase mediate the directional bias. The coordinated regulation of pseudopod generation, orientation and persistence by multiple signaling pathways allows eukaryotic cells to detect extremely shallow gradients.			Van Haastert, PJM (corresponding author), Univ Groningen, Dept Cell Biochem, Haren, Netherlands.	P.J.M.van.haastert@rug.nl						ALCANTARA F, 1974, J GEN MICROBIOL, V85, P321, DOI 10.1099/00221287-85-2-321; Ambrosi D, 2004, B MATH BIOL, V66, P1851, DOI 10.1016/j.bulm.2004.04.004; Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; BOSGRAAF L, 2009, QUIMP3 AUTOMAT UNPUB; Bosgraaf L, 2008, J CELL SCI, V121, P3589, DOI 10.1242/jcs.031781; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005253; Bourne HR, 2002, NATURE, V419, P21, DOI 10.1038/419021a; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Chen LF, 2003, MOL BIOL CELL, V14, P5028, DOI 10.1091/mbc.E03-05-0339; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; CODLING EA, 2008, J R SOC INTERFACE, V15, P15; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; DEVREOTES PN, 1983, DEV BIOL, V96, P405, DOI 10.1016/0012-1606(83)90178-1; Dormann D, 2006, CURR OPIN GENET DEV, V16, P367, DOI 10.1016/j.gde.2006.06.003; Franca-Koh J, 2006, CURR OPIN GENET DEV, V16, P333, DOI 10.1016/j.gde.2006.06.001; GAIL MH, 1970, BIOPHYS J, V10, P980, DOI 10.1016/S0006-3495(70)86347-0; HALL RL, 1977, J MATH BIOL, V4, P327, DOI 10.1007/BF00275081; Janetopoulos C, 2004, P NATL ACAD SCI USA, V101, P8951, DOI 10.1073/pnas.0402152101; Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; Niggli V, 2000, FEBS LETT, V473, P217, DOI 10.1016/S0014-5793(00)01534-9; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; PATLAK CLIFFORD S., 1953, BULL MATH BIOPHYS, V15, P311, DOI 10.1007/BF02476407; POTEL MJ, 1979, J CELL SCI, V36, P281; Roelofs J, 2002, J BIOL CHEM, V277, P9167, DOI 10.1074/jbc.M111437200; SWANSON JA, 1982, CELL, V28, P225, DOI 10.1016/0092-8674(82)90340-3; TOMCHIK KJ, 1981, SCIENCE, V212, P443, DOI 10.1126/science.6259734; van Haastert PJM, 2007, BIOPHYS J, V93, P1787, DOI 10.1529/biophysj.107.104356; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Veltman DM, 2008, J CELL BIOL, V180, P747, DOI 10.1083/jcb.200709180; Veltman DM, 2006, MOL BIOL CELL, V17, P3921, DOI 10.1091/mbc.E06-05-0381; Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	37	73	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2009	4	8							e6842	10.1371/journal.pone.0006842	http://dx.doi.org/10.1371/journal.pone.0006842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JH	19718261	Green Submitted, Green Published, gold			2022-12-25	WOS:000269415900015
J	Goren, A; Dahan, N; Goren, E; Baruch, L; Machluf, M				Goren, Amit; Dahan, Nitsan; Goren, Efrat; Baruch, Limor; Machluf, Marcelle			Encapsulated human mesenchymal stem cells: a unique hypoimmunogenic platform for long-term cellular therapy	FASEB JOURNAL			English	Article						bone marrow-derived stem cells; cell-based therapy; cell immunogenicity; tumor angiogenesis; cell encapsulation	ENDOGENOUS INHIBITORS; DIFFERENTIATION; ANGIOGENESIS; BIOCOMPATIBILITY; IMMUNOGENICITY; ENDOSTATIN; CHALLENGES; FRAGMENT; DELIVERY; RELEASE	Cell encapsulation is a promising approach for long-term delivery of therapeutic agents. Nonetheless, this system has failed to reach clinical settings, as the entrapped cells provoke a host immune reaction. Mesenchymal stem cells (MSCs), however, potentially may overcome this impediment and serve as a promising platform for cell-based microencapsulation. They are known to be hypoimmunogenic and can be genetically modified to express a variety of therapeutic factors. We have designed alginate-PLL microcapsules that can encapsulate human MSCs (hMSCs) for extended periods, as demonstrated by fluorescence and H-3-thymidine assays. The encapsulated hMSCs maintained their mesenchymal surface markers and differentiated to all the typical mesoderm lineages. In vitro and in vivo immunogenicity studies revealed that encapsulated hMSCs were significantly hypoimmunogenic, leading to a 3-fold decrease in cytokine expression compared to entrapped cell lines. The efficacy of such systems was demonstrated by genetically modifying the cells to express the hemopexin-like protein (PEX), an inhibitor of angiogenesis. Live imaging and tumor measurements showed that encapsulated hMSC-PEX injected adjacent to glioblastoma tumors in nude mice led to a significant reduction in tumor volume (87%) and weight (83%). We clearly demonstrate that hMSCs are the cell of choice for microencapsulation cell based-therapy, thus bringing this technology closer to clinical application.-Goren, A., Dahan, N., Goren, E., Baruch, L., Machluf, M. Encapsulated human mesenchymal stem cells: a unique hypoimmunogenic platform for long-term cellular therapy. FASEB J. 24, 22-31 (2010). www.fasebj.org	[Machluf, Marcelle] Technion Israel Inst Technol, Fac Biotechnol & Food Engn, Lab Canc Drug Delivery & Mammalian Cell Technol, Haifa, Israel	Technion Israel Institute of Technology	Machluf, M (corresponding author), Technion Israel Inst Technol, Fac Biotechnol & Food Engn, Lab Canc Drug Delivery & Mammalian Cell Technol, Haifa, Israel.	machlufm@tx.technion.ac.il	Baruch, Limor/AAC-7019-2022		Edward Satell Fellowship	Edward Satell Fellowship	We thank Prof. Rona S. Carroll ( Harvard Medical School, Boston, MA, USA) for the lentiviral vectors and Dr. Tendler Mark for his assistance with the animal studies. This work was financially supported by a grant from the Edward Satell Fellowship.	Alhadlaq A, 2004, STEM CELLS DEV, V13, P436, DOI 10.1089/1547328041797552; Aslan H, 2006, STEM CELLS, V24, P1728, DOI 10.1634/stemcells.2005-0546; Barry FP, 2005, STEM CELLS DEV, V14, P252, DOI 10.1089/scd.2005.14.252; Baruch L, 2006, BIOPOLYMERS, V82, P570, DOI 10.1002/bip.20509; Bello L, 2002, CLIN CANCER RES, V8, P3539; Bello L, 2001, CANCER RES, V61, P8730; Benny O, 2005, CLIN CANCER RES, V11, P768; Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269; Benoit DSW, 2007, ADV FUNCT MATER, V17, P2085, DOI 10.1002/adfm.200700012; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Brooks PC, 1998, CELL, V92, P391, DOI 10.1016/S0092-8674(00)80931-9; Bunger CM, 2005, BIOMATERIALS, V26, P2353, DOI 10.1016/j.biomaterials.2004.07.017; Compte M, 2009, STEM CELLS, V27, P753, DOI 10.1634/stemcells.2008-0831; de Groot M, 2004, J SURG RES, V121, P141, DOI 10.1016/j.jss.2004.02.018; de Vos P, 2002, DIABETOLOGIA, V45, P159, DOI 10.1007/s00125-001-0729-x; Ding HF, 2007, BIOCHEM BIOPH RES CO, V362, P923, DOI 10.1016/j.bbrc.2007.08.094; Duvshani-Eshet M, 2007, MOL CANCER THER, V6, P2371, DOI 10.1158/1535-7163.MCT-07-0019; Figliuzzi M, 2006, ACTA BIOMATER, V2, P221, DOI 10.1016/j.actbio.2005.12.002; Ghidoni I, 2008, CYTOTECHNOLOGY, V58, P49, DOI 10.1007/s10616-008-9161-0; Gohlke U, 1996, FEBS LETT, V378, P126, DOI 10.1016/0014-5793(95)01435-7; Hoelters J, 2005, J GENE MED, V7, P718, DOI 10.1002/jgm.731; Jackson L, 2007, J POSTGRAD MED, V53, P121; JARVIS AP, 1986, IN VITRO CELL DEV B, V22, P589, DOI 10.1007/BF02623518; Joki T, 2001, NAT BIOTECHNOL, V19, P35, DOI 10.1038/83481; Kim SK, 2005, CLIN CANCER RES, V11, P5965, DOI 10.1158/1078-0432.CCR-05-0371; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; Le Blanc K, 2007, J INTERN MED, V262, P509, DOI 10.1111/j.1365-2796.2007.01844.x; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; Liu Y, 2009, J MICROENCAPSUL, V26, P130, DOI [10.1080/02652040802193014, 10.1080/02652040802193014 ]; McMahon JM, 2006, STEM CELLS DEV, V15, P87, DOI 10.1089/scd.2006.15.87; Mosca JD, 2000, CLIN ORTHOP RELAT R, pS71; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Orive G, 2006, BIOMATERIALS, V27, P3691, DOI 10.1016/j.biomaterials.2006.02.048; Orive G, 2004, TRENDS BIOTECHNOL, V22, P87, DOI 10.1016/j.tibtech.2003.11.004; Perrot P, 2007, ANN PLAS SURG, V59, P201, DOI 10.1097/SAP.0b013e31802c1ff2; Read TA, 2001, NAT BIOTECHNOL, V19, P29, DOI 10.1038/83471; Rege TA, 2005, NEURO-ONCOLOGY, V7, P106, DOI 10.1215/S115285170400119X; Ren C, 2008, GENE THER, V15, P1446, DOI 10.1038/gt.2008.101; Ren CC, 2008, STEM CELLS, V26, P2332, DOI 10.1634/stemcells.2008-0084; SOONSHIONG P, 1994, LANCET, V343, P950, DOI 10.1016/S0140-6736(94)90067-1; Steinert A, 2003, J ORTHOP RES, V21, P1090, DOI 10.1016/S0736-0266(03)00100-1; Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527; Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030; Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001; Uccelli A, 2006, EUR J IMMUNOL, V36, P2566, DOI 10.1002/eji.200636416; Van Damme A, 2006, STEM CELLS, V24, P896, DOI 10.1634/stemcells.2003-0106; Visted T, 2003, EXPERT OPIN BIOL TH, V3, P551; Weber M, 2002, BIOMATERIALS, V23, P2003, DOI 10.1016/S0142-9612(01)00329-5; Weir C, 2008, HEART LUNG CIRC, V17, P395, DOI 10.1016/j.hlc.2008.01.006; Zilberman Y, 2002, POLYM ADVAN TECHNOL, V13, P863, DOI 10.1002/pat.231	50	110	118	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2010	24	1					22	31		10.1096/fj.09-131888	http://dx.doi.org/10.1096/fj.09-131888			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	539DL	19726759				2022-12-25	WOS:000273233600005
J	Kuzmenkin, A; Liang, HM; Xu, GX; Pfannkuche, K; Eichhorn, H; Fatima, A; Luo, HY; Saric, T; Wernig, M; Jaenisch, R; Hescheler, J				Kuzmenkin, Alexey; Liang, Huamin; Xu, Guoxing; Pfannkuche, Kurt; Eichhorn, Hardy; Fatima, Azra; Luo, Hongyan; Saric, Tomo; Wernig, Marius; Jaenisch, Rudolf; Hescheler, Juergen			Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro	FASEB JOURNAL			English	Article						iPS cells; cardiac differentiation; electrophysiology; patch-clamp; reprogramming	RECTIFIER K+-CURRENT; ION-CHANNEL EXPRESSION; CARDIAC MYOCYTES; SODIUM-CHANNELS; SOMATIC-CELLS; CALCIUM-CHANNEL; 2 COMPONENTS; GENERATION; MOUSE; FIBROBLASTS	Several types of terminally differentiated somatic cells can be reprogrammed into a pluripotent state by ectopic expression of Klf4, Oct3/4, Sox2, and c-Myc. Such induced pluripotent stem (iPS) cells have great potential to serve as an autologous source of cells for tissue repair. In the process of developing iPS-cell-based therapies, the major goal is to determine whether differentiated cells derived from iPS cells, such as cardiomyocytes (CMs), have the same functional properties as their physiological in vivo counterparts. Therefore, we differentiated murine iPS cells to CMs in vitro and characterized them by RTPCR, immunocytochemistry, and electrophysiology. As key markers of cardiac lineages, transcripts for Nkx2.5, alpha MHC, Mlc2v, and cTnT could be identified. Immunocytochemical stainings revealed the presence of organized sarcomeric actinin but the absence of mature atrial natriuretic factor. We examined characteristics and developmental changes of action potentials, as well as functional hormonal regulation and sensitivity to channel blockers. In addition, we determined expression patterns and functionality of cardiac-specific voltage-gated Na+, Ca2+, and K+ channels at early and late differentiation stages and compared them with CMs derived from murine embryonic stem cells (ESCs) as well as with fetal CMs. We conclude that iPS cells give rise to functional CMs in vitro, with established hormonal regulation pathways and functionally expressed cardiac ion channels; CMs generated from iPS cells have a ventricular phenotype; and cardiac development of iPS cells is delayed compared with maturation of native fetal CMs and of ESC-derived CMs. This difference may reflect the incomplete reprogramming of iPS cells and should be critically considered in further studies to clarify the suitability of the iPS model for regenerative medicine of heart disorders.-Kuzmenkin, A., Liang, H., Xu, G., Pfannkuche, K., Eichhorn, H., Fatima, A., Luo, H., S. aric, T., Wernig, M., Jaenisch, R., Hescheler, J. Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro. FASEB J. 23, 4168-4180 (2009). www.fasebj.org	[Kuzmenkin, Alexey; Liang, Huamin; Xu, Guoxing; Pfannkuche, Kurt; Eichhorn, Hardy; Fatima, Azra; Luo, Hongyan; Saric, Tomo; Hescheler, Juergen] Univ Cologne, Inst Neurophysiol, Med Ctr, D-50931 Cologne, Germany; [Saric, Tomo; Hescheler, Juergen] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Liang, Huamin; Xu, Guoxing; Luo, Hongyan] Huazhong Univ Sci & Technol, Dept Physiol, Wuhan 430074, Peoples R China; [Liang, Huamin; Xu, Guoxing; Luo, Hongyan] Huazhong Univ Sci & Technol, Tongji Med Coll, Chinese German Stem Cell Ctr, Wuhan 430074, Peoples R China; [Wernig, Marius; Jaenisch, Rudolf] MIT, Whitehead Inst Biomed Res, Cambridge, MA USA; [Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA USA	University of Cologne; University of Cologne; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Hescheler, J (corresponding author), Univ Cologne, Inst Neurophysiol, Med Ctr, Robert Koch Str 39, D-50931 Cologne, Germany.	j.hescheler@uni-koeln.de	Saric, Tomo/B-3415-2015	Saric, Tomo/0000-0001-8344-1095; Pfannkuche, Kurt Paul/0000-0002-4284-774X	Koln Fortune [102/2007]; German Federal Ministry for Education and Research [01 GN 0541]	Koln Fortune; German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	We thank Cornelia Bottinger and Rebecca Dieterich for technical assistance and Matthias Matzkies for fruitful discussion. This work was supported by a Koln Fortune grant to A. K. (102/2007) and by a German Federal Ministry for Education and Research grant to J. H. and T. S.. ( BMBF, grant 01 GN 0541).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Banach K, 2003, AM J PHYSIOL-HEART C, V284, pH2114, DOI 10.1152/ajpheart.01106.2001; Bony C, 2001, J CELL BIOL, V152, P717, DOI 10.1083/jcb.152.4.717; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Davies MP, 1996, CIRC RES, V78, P15, DOI 10.1161/01.RES.78.1.15; Doevendans PA, 2000, J MOL CELL CARDIOL, V32, P839, DOI 10.1006/jmcc.2000.1128; Ehrlich JR, 2003, J PHYSIOL-LONDON, V551, P801, DOI 10.1113/jphysiol.2003.046417; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Feron O, 1999, LIFE SCI, V64, P471, DOI 10.1016/S0024-3205(98)00590-6; Fiset C, 1997, J PHYSIOL-LONDON, V504, P557, DOI 10.1111/j.1469-7793.1997.557bd.x; Fleischmann BK, 2004, J CLIN INVEST, V114, P994, DOI 10.1172/JCI200415925; Fleischmann M, 1998, FEBS LETT, V440, P370, DOI 10.1016/S0014-5793(98)01476-8; GRANT AO, 1989, CIRC RES, V65, P1247, DOI 10.1161/01.RES.65.5.1247; Gryshchenko O, 2000, PFLUG ARCH EUR J PHY, V439, P798, DOI 10.1007/s004240051007; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hescheler J, 1997, CARDIOVASC RES, V36, P149, DOI 10.1016/S0008-6363(97)00193-4; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; INSEL PA, 1983, NEW ENGL J MED, V308, P1361; Jaenisch R, 2004, NEW ENGL J MED, V351, P2787, DOI 10.1056/NEJMp048304; Ji GJ, 1999, FASEB J, V13, P313, DOI 10.1096/fasebj.13.2.313; JURKIEWICZ NK, 1993, CIRC RES, V72, P75, DOI 10.1161/01.RES.72.1.75; Kamiya K, 2001, MOL PHARMACOL, V60, P244, DOI 10.1124/mol.60.2.244; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kodama I, 1999, AM J PHYSIOL-HEART C, V276, pH793, DOI 10.1152/ajpheart.1999.276.3.H793; Kolossov E, 2005, FASEB J, V19, P577, DOI 10.1096/fj.03-1451fje; Kolossov E, 1998, J CELL BIOL, V143, P2045, DOI 10.1083/jcb.143.7.2045; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; LEFKOWITZ RJ, 1976, LIFE SCI, V18, P461, DOI 10.1016/0024-3205(76)90323-4; Lei M, 2004, J PHYSIOL-LONDON, V559, P835, DOI 10.1113/jphysiol.2004.068643; Lei M, 1996, EXP PHYSIOL, V81, P725, DOI 10.1113/expphysiol.1996.sp003972; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Maingret F, 2002, BIOCHEM BIOPH RES CO, V292, P339, DOI 10.1006/bbrc.2002.6674; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; MALTSEV VA, 1993, MECH DEVELOP, V44, P41, DOI 10.1016/0925-4773(93)90015-P; Marionneau C, 2005, J PHYSIOL-LONDON, V562, P223, DOI 10.1113/jphysiol.2004.074047; Matsumura H, 2007, NAT METHODS, V4, P23, DOI 10.1038/NMETH973; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; MCDONALD TV, 1989, BIOPHYS J, V55, P1261, DOI 10.1016/S0006-3495(89)82921-2; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; NAYLER WG, 1983, MED J AUSTRALIA, V2, P506, DOI 10.5694/j.1326-5377.1983.tb122621.x; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; ONO K, 1995, AM J PHYSIOL-HEART C, V269, pH453, DOI 10.1152/ajpheart.1995.269.2.H453; Oyamada Y, 1996, EXP CELL RES, V229, P318, DOI 10.1006/excr.1996.0377; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pfannkuche K, 2009, CELL PHYSIOL BIOCHEM, V24, P73, DOI 10.1159/000227815; Pond AL, 2000, J BIOL CHEM, V275, P5997, DOI 10.1074/jbc.275.8.5997; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; SANGUINETTI MC, 1992, HYPERTENSION, V19, P228, DOI 10.1161/01.HYP.19.3.228; Schenke-Layland K, 2008, STEM CELLS, V26, P1537, DOI 10.1634/stemcells.2008-0033; SCHOUTEN VJA, 1984, EUR HEART J, V5, P984, DOI 10.1093/oxfordjournals.eurheartj.a061618; Schram G, 2002, CIRC RES, V90, P939, DOI 10.1161/01.RES.0000018627.89528.6F; Sensch O, 2000, BRIT J PHARMACOL, V131, P1089, DOI 10.1038/sj.bjp.0703673; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; SPEDDING M, 1992, BIOCHEM SOC T, V20, P147, DOI 10.1042/bst0200147; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; VERHEIJCK EE, 1995, CIRC RES, V76, P607, DOI 10.1161/01.RES.76.4.607; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhang Z, 2002, CIRC RES, V90, P981, DOI 10.1161/01.RES.0000018003.14304.E2	72	99	113	0	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4168	4180		10.1096/fj.08-128546	http://dx.doi.org/10.1096/fj.08-128546			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19703934				2022-12-25	WOS:000272193700013
J	Shein, NA; Grigoriadis, N; Alexandrovich, AG; Simeonidou, C; Lourbopoulos, A; Polyzoidou, E; Trembovler, V; Mascagni, P; Dinarello, CA; Shohami, E				Shein, Na'ama A.; Grigoriadis, Nikolaos; Alexandrovich, Alexander G.; Simeonidou, Constantina; Lourbopoulos, Athanasios; Polyzoidou, Eleni; Trembovler, Victoria; Mascagni, Paolo; Dinarello, Charles A.; Shohami, Esther			Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury	FASEB JOURNAL			English	Article						epigenetic; closed head injury; regeneration	FOCAL CEREBRAL-ISCHEMIA; CLOSED-HEAD INJURY; SUBEROYLANILIDE HYDROXAMIC ACID; AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSGENIC MOUSE MODEL; BINDING-PROTEIN CBP; HUNTINGTONS-DISEASE; ANTILEUKEMIC ACTIVITY; NERVOUS-SYSTEM; VALPROIC ACID	Despite efforts aimed at developing novel therapeutics for traumatic brain injury (TBI), no specific pharmacological agent is currently clinically available. Here, we show that the pan-histone deacetylase (HDAC) inhibitor ITF2357, a compound shown to be safe and effective in humans, improves functional recovery and attenuates tissue damage when administered as late as 24 h postinjury. Using a well-characterized, clinically relevant mouse model of closed head injury (CHI), we demonstrate that a single dose of ITF2357 administered 24 h postinjury improves neurobehavioral recovery from d 6 up to 14 d postinjury (improved neurological score vs. vehicle; P <= 0.05), and that this functional benefit is accompanied by decreased neuronal degeneration, reduced lesion volume (22% reduction vs. vehicle; P <= 0.01), and is preceded by increased acetylated histone H3 levels and attenuation of injury-induced decreases in cytoprotective heat-shock protein 70 kDa and phosphorylated Akt. Moreover, reduced glial accumulation and activation were observed 3 d postinjury, and total p53 levels at the area of injury and caspase-3 immunoreactivity within microglia/macrophages at the trauma area were elevated, suggesting enhanced clearance of these cells via apoptosis following treatment. Hence, our findings underscore the relevance of HDAC inhibitors for ameliorating trauma-induced functional deficits and warrant consideration of applying ITF2357 for this indication.-Shein, N. A., Grigoriadis, N., Alexandrovich, A. G., Simeonidou, C., Lourbopoulos, A., Polyzoidou, E., Trembovler, V., Mascagni, P., Dinarello, C. A., Shohami, E. Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury. FASEB J. 23, 4266-4275 (2009). www.fasebj.org	[Shein, Na'ama A.; Alexandrovich, Alexander G.; Trembovler, Victoria; Shohami, Esther] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel; [Grigoriadis, Nikolaos; Lourbopoulos, Athanasios; Polyzoidou, Eleni] AHEPA Univ Hosp, Dept Neurol, Thessaloniki, Greece; [Simeonidou, Constantina] Aristotle Univ Thessaloniki, Dept Physiol, GR-54006 Thessaloniki, Greece; [Mascagni, Paolo] Res Ctr, Balsamo, Italy; [Dinarello, Charles A.] Univ Colorado Denver, Dept Med, Aurora, CO USA	Hebrew University of Jerusalem; Aristotle University of Thessaloniki; Ahepa University Hospital; Aristotle University of Thessaloniki; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Shohami, E (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel.	esty@cc.huji.ac.il	Dinarello, Charles/C-8524-2013		U. S. National Institutes of Health [AI-15614]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015614, R01AI015614] Funding Source: NIH RePORTER	U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	E. S. is the incumbent of the Dr. Leon and Mina Deutch Chair in psychopharmacology at the Hebrew University. This work was supported by U. S. National Institutes of Health grant AI-15614 (to C. A. D.). P. M. is an employee of Italfarmaco, S. p. A., Italy. The authors thank Prof. A. Rubinstein (Hebrew University) for his assistance in obtaining antibodies used in this series of experiments.	Albert MS, 2007, NEW ENGL J MED, V357, P502, DOI 10.1056/NEJMcibr073273; Armeanu S, 2005, J HEPATOL, V42, P210, DOI 10.1016/j.jhep.2004.10.020; Atweh GF, 1999, BLOOD, V93, P1790; Barbetti V, 2008, ONCOGENE, V27, P1767, DOI 10.1038/sj.onc.1210820; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Brown IR, 2007, ANN NY ACAD SCI, V1113, P147, DOI 10.1196/annals.1391.032; Camelo S, 2005, J NEUROIMMUNOL, V164, P10, DOI 10.1016/j.jneuroim.2005.02.022; Carlisi D, 2008, INT J ONCOL, V32, P177; Carta S, 2006, BLOOD, V108, P1618, DOI 10.1182/blood-2006-03-014126; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Delgado-Esteban M, 2007, J NEUROCHEM, V102, P194, DOI 10.1111/j.1471-4159.2007.04450.x; Dutcher SA, 1998, J NEUROTRAUM, V15, P411, DOI 10.1089/neu.1998.15.411; Faraco G, 2006, MOL PHARMACOL, V70, P1876, DOI 10.1124/mol.106.027912; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Gerstner T, 2008, EXPERT OPIN PHARMACO, V9, P285, DOI 10.1517/14656566.9.2.285 ; Glauben R, 2008, GUT, V57, P613, DOI 10.1136/gut.2007.134650; Glauben R, 2006, J IMMUNOL, V176, P5015, DOI 10.4049/jimmunol.176.8.5015; Golay J, 2007, LEUKEMIA, V21, P1892, DOI 10.1038/sj.leu.2404860; Grosjean MB, 2007, HISTOL HISTOPATHOL, V22, P235, DOI 10.14670/HH-22.235; Hahnen E, 2008, EXPERT OPIN INV DRUG, V17, P169, DOI 10.1517/13543784.17.2.169; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jin KL, 2001, J MOL NEUROSCI, V16, P49, DOI 10.1385/JMN:16:1:49; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Khan O, 2008, NAT CLIN PRACT ONCOL, V5, P714, DOI 10.1038/ncponc1238; Kilic E, 2006, FASEB J, V20, P1185, DOI 10.1096/fj.05-4829fje; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Langley B, 2005, CNS NEUROL DISORD-DR, V4, P41, DOI 10.2174/1568007053005091; Leoni F, 2005, MOL MED, V11, P1, DOI 10.2119/2006-00005.Dinarello; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Moussaieff A, 2008, J CEREBR BLOOD F MET, V28, P1341, DOI 10.1038/jcbfm.2008.28; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; OSBORNE KA, 1987, J NEUROL NEUROSUR PS, V50, P402, DOI 10.1136/jnnp.50.4.402; Perrine SP, 2005, ANN NY ACAD SCI, V1054, P257, DOI 10.1196/annals.1345.033; Petri S, 2006, NEUROBIOL DIS, V22, P40, DOI 10.1016/j.nbd.2005.09.013; Qi X, 2004, MOL PHARMACOL, V66, P899, DOI 10.1124/mol.104.001339; Rouaux C, 2004, BIOCHEM PHARMACOL, V68, P1157, DOI 10.1016/j.bcp.2004.05.035; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Ryu H, 2003, P NATL ACAD SCI USA, V100, P4281, DOI 10.1073/pnas.0737363100; Saha RN, 2006, CELL DEATH DIFFER, V13, P539, DOI 10.1038/sj.cdd.4401769; Shein NA, 2007, J NEUROCHEM, V103, P1523, DOI 10.1111/j.1471-4159.2007.04862.x; Sinn DI, 2007, NEUROBIOL DIS, V26, P464, DOI 10.1016/j.nbd.2007.02.006; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Vojinovic J, 2008, ARTHRITIS RHEUM-US, V58, pS943; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Ying MY, 2006, J BIOL CHEM, V281, P12580, DOI 10.1074/jbc.M511677200; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085	51	81	82	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2009	23	12					4266	4275		10.1096/fj.09-134700	http://dx.doi.org/10.1096/fj.09-134700			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	525DL	19723705	Green Published			2022-12-25	WOS:000272193700021
J	Perez-Oliva, AB; Olivares, C; Jimenez-Cervantes, C; Garcia-Borron, JC				Perez-Oliva, Ana B.; Olivares, Concepcion; Jimenez-Cervantes, Celia; Garcia-Borron, Jose C.			Mahogunin Ring Finger-1 (MGRN1) E3 Ubiquitin Ligase Inhibits Signaling from Melanocortin Receptor by Competition with G alpha(s)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ARRESTIN; MUTANT MICE; PROTEIN; MUTATIONS; SYSTEM; EXPRESSION; NEURODEGENERATION; PIGMENTATION; TRAFFICKING; ATTRACTIN	Mahogunin ring finger-1 (MGRN1) is a RING domain-containing ubiquitin ligase mutated in mahoganoid, a mouse mutation causing coat color darkening, congenital heart defects, high embryonic lethality, and spongiform neurodegeneration. The melanocortin hormones regulate pigmentation, cortisol production, food intake, and body weight by signaling through five G protein-coupled receptors positively coupled to the cAMP pathway (MC1R-MC5R). Genetic analysis has shown that mouse Mgrn1 is an accessory protein for melanocortin signaling that may inhibit MC1R and MC4R by unknown mechanisms. These melanocortin receptors (MCRs) regulate pigmentation and body weight, respectively. We show that human melanoma cells express 4 MGRN1 isoforms differing in the C-terminal exon 17 and in usage of exon 12. This exon contains nuclear localization signals. MGRN1 isoforms decreased MC1R and MC4R signaling to cAMP, without effect on beta(2)-adrenergic receptor. Inhibition was independent on receptor plasma membrane expression, ubiquitylation, internalization, or stability and occurred upstream of G alpha(s) binding to/activation of adenylyl cyclase. MGRN1 co-immunoprecipitated with MCRs, suggesting a physical interaction of the proteins. Significantly, overexpression of G alpha(s) abolished the inhibitory effect of MGRN1 and decreased co-immunoprecipitation with MCRs, suggesting competition between MGRN1 and G alpha(s) for binding to MCRs. Although all MGRN1s were located in the cytosol in the absence of MCRs, exon 12-containing isoforms accumulated in the nuclei upon co-expression with the receptors. Therefore, MGRN1 inhibits MCR signaling by a new mechanism involving displacement of G alpha(s), thus accounting for key features of the mahoganoid phenotype. Moreover, MGRN1 might provide a novel pathway for melanocortin signaling from the cell surface to the nucleus.	[Perez-Oliva, Ana B.; Olivares, Concepcion; Jimenez-Cervantes, Celia; Garcia-Borron, Jose C.] Univ Murcia, Dept Biochem & Mol Biol, Sch Med, E-30100 Murcia, Spain	University of Murcia	Garcia-Borron, JC (corresponding author), Univ Murcia, Espinardo 30100, Spain.	gborron@um.es	Olivares, Conchi/H-2794-2015; Perez-Oliva, Ana Belen/GNW-3708-2022; Jimenez-Cervantes, Celia/H-1953-2015; Perez-Oliva, Ana B/K-2674-2017; Garcia-Borron, Jose Carlos/H-2247-2015	Olivares, Conchi/0000-0001-7518-3858; Jimenez-Cervantes, Celia/0000-0002-5821-9510; Perez-Oliva, Ana B/0000-0002-2596-0871; Garcia-Borron, Jose Carlos/0000-0002-9192-588X	Comision Interministerial de Ciencia y Tecnolog a (CICYT), Spain [SAF2006-11206]; Fondo Europeo de Desarrollo Regional funds ( European Community); Comunidad Autonoma Region de Murcia [464/2008]; Plan de Ciencia y Tecnologia [2007/10]; Ministerio de Educacion y Ciencia	Comision Interministerial de Ciencia y Tecnolog a (CICYT), Spain(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Fondo Europeo de Desarrollo Regional funds ( European Community)(European Commission); Comunidad Autonoma Region de Murcia; Plan de Ciencia y Tecnologia; Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported in part by Comision Interministerial de Ciencia y Tecnolog a (CICYT), Spain, Grant SAF2006-11206, Fondo Europeo de Desarrollo Regional funds ( European Community), Comunidad Autonoma Region de Murcia Grant 464/2008, and the Plan de Ciencia y Tecnologia 2007/10.; The nucleotide sequence(s) reported in this paper has been submitted to the GenBank (TM)/EBI Data Bank with accession number( s) ABO69623 and ABO69624. 1 Fellow of the Formacion de Personal Investigador program of the Ministerio de Educacion y Ciencia.	Adan RAH, 2003, TRENDS PHARMACOL SCI, V24, P315, DOI 10.1016/S0165-6147(03)00130-5; Bagher P, 2006, PIGM CELL RES, V19, P635, DOI 10.1111/j.1600-0749.2006.00340.x; Barsh GS, 2002, J RECEPT SIGNAL TR R, V22, P63, DOI 10.1081/RRS-120014588; Barsh GS, 2006, PIGMENTARY SYSTEM, P395, DOI DOI 10.1002/9780470987100.CH19; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Cota CD, 2006, DEV DYNAM, V235, P3438, DOI 10.1002/dvdy.20992; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gantz I, 2003, AM J PHYSIOL-ENDOC M, V284, pE468, DOI 10.1152/ajpendo.00434.2002; Garcia-Borron JC, 2005, PIGM CELL RES, V18, P393, DOI 10.1111/j.1600-0749.2005.00278.x; GESCHWIND II, 1966, ENDOCRINOLOGY, V79, P1165, DOI 10.1210/endo-79-6-1165; He L, 2003, ANN NY ACAD SCI, V994, P288, DOI 10.1111/j.1749-6632.2003.tb03192.x; He L, 2003, SCIENCE, V299, P710, DOI 10.1126/science.1079694; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jiao J, 2009, GENESIS, V47, P524, DOI 10.1002/dvg.20529; Jimenez-Cervantes C, 2001, FEBS LETT, V508, P44, DOI 10.1016/S0014-5793(01)03025-3; Kim BY, 2007, MOL BIOL CELL, V18, P1129, DOI 10.1091/mbc.E06-09-0787; Kraehn GM, 2001, BRIT J CANCER, V84, P72, DOI 10.1054/bjoc.2000.1535; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Luttrell LM, 2002, J CELL SCI, V115, P455; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Mas JS, 2003, PIGM CELL RES, V16, P540, DOI 10.1034/j.1600-0749.2003.00073.x; Miller KA, 1997, GENETICS, V146, P1407; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; Miyamura Y, 2007, PIGM CELL RES, V20, P2, DOI 10.1111/j.1600-0749.2006.00358.x; Mountjoy KG, 2003, ENDOCRINOLOGY, V144, P5488, DOI 10.1210/en.2003-0570; MUCA C, 1994, ONCOGENE, V9, P3647; Murakami H, 2005, PIGM CELL RES, V18, P265, DOI 10.1111/j.1600-0749.2005.00234.x; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Oliva ABP, 2009, HUM MUTAT, V30, P811, DOI 10.1002/humu.20971; Phan LK, 2002, J CLIN INVEST, V110, P1449, DOI 10.1172/JC1200216131; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Sanchez-Laorden BL, 2007, J BIOL CHEM, V282, P3241, DOI 10.1074/jbc.M606865200; Sanchez-Laorden BL, 2006, J INVEST DERMATOL, V126, P172, DOI 10.1038/sj.jid.5700036; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, J BIOL CHEM, V282, P29549, DOI 10.1074/jbc.M700852200; Starowicz K, 2003, LIFE SCI, V73, P823, DOI 10.1016/S0024-3205(03)00349-7; Sun K, 2007, NEUROBIOL AGING, V28, P1840, DOI 10.1016/j.neurobiolaging.2007.07.012; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wojcikiewicz RJH, 2004, TRENDS PHARMACOL SCI, V25, P35, DOI 10.1016/j.tips.2003.11.008	44	40	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2009	284	46					31714	31725		10.1074/jbc.M109.028100	http://dx.doi.org/10.1074/jbc.M109.028100			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	516VZ	19737927	hybrid, Green Published			2022-12-25	WOS:000271572700026
J	Ghosh, A; Rossi, ML; Aulds, J; Croteau, D; Bohr, VA				Ghosh, Avik; Rossi, Marie L.; Aulds, Jason; Croteau, Deborah; Bohr, Vilhelm A.			Telomeric D-loops Containing 8-Oxo-2 '-deoxyguanosine Are Preferred Substrates for Werner and Bloom Syndrome Helicases and Are Bound by POT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; RECQ HELICASES; OXIDATIVE STRESS; SYNDROME PROTEIN; WRN PROTEIN; BINDING; SITE; END; TELOMESTATIN; 8-OXOGUANINE	8-Oxo-2'-deoxyguanosine (8-oxodG) is one of the most important oxidative DNA lesions, and G-rich telomeric DNA is especially susceptible to oxidative DNA damage. RecQ helicases WRN and BLM and telomere- binding protein POT1 are thought to play roles in telomere maintenance. This study examines the ability of WRN, BLM, and RecQ5 to unwind and POT1 to bind telomeric D-loops containing 8-oxodG. The results demonstrate that WRN and BLM preferentially unwind telomeric D-loops containing 8-oxodG and that POT1 binds with higher affinity to telomeric D-loops with 8-oxodG but shows no preference for telomeric single-stranded DNA with 8-oxodG. We speculate that telomeric D-loops with 8-oxodG may have a greater tendency to form G-quadruplex DNA structures than telomeric DNA lacking 8-oxodG.	[Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Bohr, VA (corresponding author), NIA, Lab Mol Gerontol, NIH, Biomed Res Ctr, 251 Bayview Blvd, Baltimore, MD 21224 USA.	BohrV@.nih.gov	Croteau, Deb/AAP-5933-2020; Bohr, Vilhelm/AAP-5931-2020	Croteau, Deborah/0000-0002-6094-4084	National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000727, ZIAAG000726, ZIAAG000721] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Program of the National Institute on Aging.	Aldaye FA, 2006, ANGEW CHEM INT EDIT, V45, P2204, DOI 10.1002/anie.200502481; Bianchi A, 1999, EMBO J, V18, P5735, DOI 10.1093/emboj/18.20.5735; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; Brosh RM, 2000, NUCLEIC ACIDS RES, V28, P2420, DOI 10.1093/nar/28.12.2420; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Castro L, 2001, NUTRITION, V17, P161, DOI 10.1016/S0899-9007(00)00570-0; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Du XB, 2004, MOL CELL BIOL, V24, P8437, DOI 10.1128/MCB.24.19.8437-8446.2004; Gomez D, 2006, CANCER RES, V66, P6908, DOI 10.1158/0008-5472.CAN-06-1581; Greider CW, 1996, SCI AM, V274, P92, DOI 10.1038/scientificamerican0296-92; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Gros J, 2007, NUCLEIC ACIDS RES, V35, P3064, DOI 10.1093/nar/gkm111; Han HY, 2001, J AM CHEM SOC, V123, P8902, DOI 10.1021/ja002179j; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Henle ES, 1999, J BIOL CHEM, V274, P962, DOI 10.1074/jbc.274.2.962; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Izumikawa K, 2008, BIOCHEM J, V413, P505, DOI 10.1042/BJ20071392; Kanvah S, 2005, NUCLEIC ACIDS RES, V33, P5133, DOI 10.1093/nar/gki801; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; Kawanishi S, 1999, BIOCHEMISTRY-US, V38, P16733, DOI 10.1021/bi990890z; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lei M, 2003, NATURE, V426, P198, DOI 10.1038/nature02092; Li JL, 2001, BIOCHEMISTRY-US, V40, P15194, DOI 10.1021/bi011067h; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LIPSCOMB LA, 1995, P NATL ACAD SCI USA, V92, P719, DOI 10.1073/pnas.92.3.719; Machwe A, 2000, NUCLEIC ACIDS RES, V28, P2762, DOI 10.1093/nar/28.14.2762; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Oikawa S, 1999, FEBS LETT, V453, P365, DOI 10.1016/S0014-5793(99)00748-6; Opresko PL, 2008, MECH AGEING DEV, V129, P79, DOI 10.1016/j.mad.2007.10.007; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Orren DK, 1999, NUCLEIC ACIDS RES, V27, P3557, DOI 10.1093/nar/27.17.3557; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Peakman LJ, 2003, J MOL BIOL, V333, P321, DOI 10.1016/j.jmb.2003.08.042; Shen JC, 2000, TRENDS GENET, V16, P213, DOI 10.1016/S0168-9525(99)01970-8; Shin-ya K, 2001, J AM CHEM SOC, V123, P1262, DOI 10.1021/ja005780q; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Sowd G, 2008, NUCLEIC ACIDS RES, V36, P4242, DOI 10.1093/nar/gkn385; Szalai VA, 2002, J AM CHEM SOC, V124, P1625, DOI 10.1021/ja0119651; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Walpita D, 1999, P NATL ACAD SCI USA, V96, P5622, DOI 10.1073/pnas.96.10.5622; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102	51	42	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2009	284	45					31074	31084		10.1074/jbc.M109.027532	http://dx.doi.org/10.1074/jbc.M109.027532			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	514EZ	19734539	Green Published, hybrid			2022-12-25	WOS:000271378400036
J	Ohneda, K; Ohmori, S; Ishijima, Y; Nakano, M; Yamamoto, M				Ohneda, Kinuko; Ohmori, Shin'ya; Ishijima, Yasushi; Nakano, Mayu; Yamamoto, Masayuki			Characterization of a Functional ZBP-89 Binding Site That Mediates Gata1 Gene Expression during Hematopoietic Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; IN-VIVO; SELF-ASSOCIATION; CELL-DEVELOPMENT; SP1; ENHANCER; ELEMENT; FAMILY; IDENTIFICATION; REQUIREMENTS	GATA-1 is a lineage-restricted transcription factor that plays essential roles in hematopoietic development. The Gata1 gene hematopoietic enhancer allowed Gata1 reporter expression in erythroid cells and megakaryocytes of transgenic mice. The Gata1 hematopoietic enhancer activity is strictly dependent on a GATA site located in the 5' region of the enhancer. However, the importance of the GC-rich region adjacent to the 3'-end of this GATA site has been also suggested. In this study, we show that this GC-rich region contains five contiguous deoxyguanosine residues (G(5) string) that are bound by multiple nuclear proteins. Interestingly, deletion of one deoxyguanosine residue from the G(5) string (G(4) mutant) specifically eliminates binding to ZBP-89, a Kruppel-like transcription factor, but not to Sp3 and other binding factors. We demonstrate that GATA-1 and ZBP-89 occupy chromatin regions of the Gata1 enhancer and physically associate in vitro through zinc finger domains. Gel mobility shift assays and DNA affinity precipitation assays suggest that binding of ZBP-89 to this region is reduced in the absence of GATA-1 binding to the G1HE. Luciferase reporter assays demonstrate that ZBP-89 activates the Gata1 enhancer depending on the G(5) string sequence. Finally, transgenic mouse studies reveal that the G4 mutation significantly reduced the reporter activity of the Gata1 hematopoietic regulatory domain encompassing an 8.5-kbp region of the Gata1 gene. These data provide compelling evidence that the G(5) string is necessary for Gata1 gene expression in vivo and ZBP-89 is the functional trans-acting factor for this cis-acting region.	[Ohneda, Kinuko; Ohmori, Shin'ya; Ishijima, Yasushi] Takasaki Univ Hlth & Welf, Fac Pharm, Dept Pharm, Takasaki, Gunma 3700033, Japan; [Nakano, Mayu] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan; [Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 9808575, Japan	University of Tsukuba; Tohoku University	Ohneda, K (corresponding author), 60 Nakaorui Machi, Takasaki, Gunma 3700033, Japan.	kohneda@takasaki-u.ac.jp	Ohneda, Kinuko/AAC-8822-2019; Yamamoto, Masayuki/A-4873-2010	Yamamoto, Masayuki/0000-0002-9073-9436	Naito Foundation; Japan Science and Technology Corporation; Ministry of Education, Science, Sports and Culture	Naito Foundation(Naito Memorial Foundation); Japan Science and Technology Corporation(Japan Science & Technology Agency (JST)); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Naito Foundation (to K. O.), Japan Science and Technology Corporation-ERATO Environmental Response Project (to M. Y.), and the Ministry of Education, Science, Sports and Culture (to M. Y. and K. O.).	Antona V, 1998, CYTOGENET CELL GENET, V83, P90, DOI 10.1159/000015138; Bai LC, 2000, J BIOL CHEM, V275, P30725, DOI 10.1074/jbc.M004249200; Billon N, 1999, ONCOGENE, V18, P2872, DOI 10.1038/sj.onc.1202712; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Ferreira R, 2007, BLOOD, V109, P5481, DOI 10.1182/blood-2006-11-060491; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Gregory RC, 1996, BLOOD, V87, P1793, DOI 10.1182/blood.V87.5.1793.bloodjournal8751793; Gutierrez L, 2007, BLOOD, V110, P1933, DOI 10.1182/blood-2006-09-048322; Guyot B, 2006, J BIOL CHEM, V281, P13733, DOI 10.1074/jbc.M602052200; Hasegawa T, 1999, BIOCHEM BIOPH RES CO, V256, P249, DOI 10.1006/bbrc.1999.0275; Hasegawa T, 1997, J BIOL CHEM, V272, P4915, DOI 10.1074/jbc.272.8.4915; Hogan B, 1994, MANIPULATING MOUSE E; Jacquelin B, 2001, J BIOL CHEM, V276, P23518, DOI 10.1074/jbc.M102019200; Jin Y, 1998, BLOOD, V92, P2777, DOI 10.1182/blood.V92.8.2777.420k27_2777_2790; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Law GL, 1998, J BIOL CHEM, V273, P19955, DOI 10.1074/jbc.273.32.19955; Lepage A, 1999, BLOOD, V94, P3366, DOI 10.1182/blood.V94.10.3366.422k35_3366_3380; Li XG, 2006, DEVELOPMENT, V133, P3641, DOI 10.1242/dev.02540; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lyons SE, 2002, P NATL ACAD SCI USA, V99, P5454, DOI 10.1073/pnas.082695299; Merchant JL, 1996, MOL CELL BIOL, V16, P6644; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Motohashi H, 2000, CELL, V103, P865, DOI 10.1016/S0092-8674(00)00190-2; NICOLIS S, 1991, NUCLEIC ACIDS RES, V19, P5285, DOI 10.1093/nar/19.19.5285; Nishikawa K, 2003, MOL CELL BIOL, V23, P8295, DOI 10.1128/MCB.23.22.8295-8305.2003; Nishimura S, 2000, MOL CELL BIOL, V20, P713, DOI 10.1128/MCB.20.2.713-723.2000; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Ohneda K, 2002, GENES CELLS, V7, P1243, DOI 10.1046/j.1365-2443.2002.00595.x; Onodera K, 1997, P NATL ACAD SCI USA, V94, P4487, DOI 10.1073/pnas.94.9.4487; Shimizu R, 2001, EMBO J, V20, P5250, DOI 10.1093/emboj/20.18.5250; Shimizu R, 2007, J BIOL CHEM, V282, P15862, DOI 10.1074/jbc.M701936200; Suzuki M, 2006, BLOOD, V108, P726, DOI 10.1182/blood-2005-10-4064; Suzuki M, 2009, MOL CELL BIOL, V29, P1163, DOI 10.1128/MCB.01572-08; Suzuki N, 2003, BLOOD, V102, P3575, DOI 10.1182/blood-2003-04-1154; Suzuki T, 2005, ARTERIOSCL THROM VAS, V25, P1135, DOI 10.1161/01.ATV.0000165656.65359.23; Takahashi S, 2000, BLOOD, V96, P910, DOI 10.1182/blood.V96.3.910.015k29_910_916; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Vyas P, 1999, DEVELOPMENT, V126, P2799; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wang ZY, 1999, BLOOD, V93, P4208, DOI 10.1182/blood.V93.12.4208.412k17_4208_4221; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Whyatt D, 2000, NATURE, V406, P519, DOI 10.1038/35020086; Whyatt David J., 1997, Genes and Function, V1, P11; Wieczorek E, 2000, J BIOL CHEM, V275, P12879, DOI 10.1074/jbc.275.17.12879; Woo AJ, 2008, MOL CELL BIOL, V28, P2675, DOI 10.1128/MCB.01945-07	48	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2009	284	44					30187	30199		10.1074/jbc.M109.026948	http://dx.doi.org/10.1074/jbc.M109.026948			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	510LM	19723625	Green Published, hybrid			2022-12-25	WOS:000271090000022
J	Hao, MM; Bogan, JS				Hao, Mingming; Bogan, Jonathan S.			Cholesterol Regulates Glucose-stimulated Insulin Secretion through Phosphatidylinositol 4,5-Bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE K+ CHANNELS; MEMBRANE DOMAINS; PHOSPHOLIPASE-C; PLASMA-MEMBRANE; DETERGENT RESISTANCE; ACTIN DYNAMICS; CELL-MEMBRANES; LIPID DOMAINS; LIVING CELLS; ATP CHANNELS	Membrane cholesterol modulates the ability of glucose to stimulate insulin secretion from pancreatic beta-cells. The molecular mechanism by which this occurs is not understood. Here, we show that in cultured beta-cells, cholesterol acts through phosphatidylinositol 4,5-bisphosphate (PIP(2)) to regulate actin dynamics, plasma membrane potential, and glucose-stimulated insulin secretion. Cholesterol-overloaded beta-cells exhibited decreased PIP(2) hydrolysis, with diminished glucose-induced actin reorganization, membrane depolarization, and insulin secretion. The converse findings were observed in cholesterol-depleted cells. These results support a model in which cholesterol depletion is coupled through PIP(2) to enhance both plasma membrane Ca(2+) influx from the extracellular space, as well as inositol 1,4,5-triphosphate-stimulated Ca(2+) efflux from intracellular stores. The inability to increase cytosolic Ca(2+) may be the main underlying factor to account for impaired glucose-stimulated insulin secretion in cholesterol-overloaded beta-cells.	[Hao, Mingming] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, New Haven, CT 06520 USA; [Bogan, Jonathan S.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University	Hao, MM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, POB 208020, New Haven, CT 06520 USA.	mingming.hao@yale.edu	Bogan, Jonathan S/A-1575-2010	Bogan, Jonathan S/0000-0001-6463-8466	National Institutes of Health [K01DK078625, R01DK075772]; W. M. Keck Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075772, K01DK078625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K01DK078625 (to M. H.) and R01DK075772 (to J. S. B.). This work was also supported by a grant from the W. M. Keck Foundation (to J. S. B.).	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Alekseev AE, 1998, J GEN PHYSIOL, V111, P381, DOI 10.1085/jgp.111.2.381; Arbuzova A, 2000, BBA-BIOMEMBRANES, V1464, P35, DOI 10.1016/S0005-2736(99)00243-6; Ashcroft FM, 1999, DIABETOLOGIA, V42, P903, DOI 10.1007/s001250051247; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; BEHNKE O, 1984, EUR J CELL BIOL, V35, P200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brunham LR, 2008, J CLIN INVEST, V118, P403, DOI 10.1172/JCI33296; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Chevallier J, 2008, J BIOL CHEM, V283, P27871, DOI 10.1074/jbc.M801463200; Cremesti AE, 2002, FEBS LETT, V531, P47, DOI 10.1016/S0014-5793(02)03489-0; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Epand RM, 2008, BBA-BIOMEMBRANES, V1778, P1576, DOI 10.1016/j.bbamem.2008.03.016; Epand RM, 2004, BIOCHEM J, V379, P527, DOI 10.1042/BJ20040204; EPPS DE, 1994, CHEM PHYS LIPIDS, V69, P137, DOI 10.1016/0009-3084(94)90035-3; Frey D, 2000, J CELL BIOL, V149, P1443, DOI 10.1083/jcb.149.7.1443; Fryirs M, 2009, CURR OPIN LIPIDOL, V20, P159, DOI 10.1097/MOL.0b013e32832ac180; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; Hao M, 2007, DIABETES, V56, P2328, DOI 10.2337/db07-0056; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; Haugh JM, 2002, J CELL SCI, V115, P303; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; HITCHCOCK SE, 1980, J BIOL CHEM, V255, P5668; Hope HR, 1996, MOL BIOL CELL, V7, P843, DOI 10.1091/mbc.7.6.843; HOWELL S L, 1986, Diabetes Metabolism Reviews, V2, P107; HUANG ZJ, 1992, ANAL BIOCHEM, V200, P199, DOI 10.1016/0003-2697(92)90299-M; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Johnson CM, 2008, J BIOL CHEM, V283, P29920, DOI 10.1074/jbc.M805921200; Kiyokawa E, 2005, J BIOL CHEM, V280, P24072, DOI 10.1074/jbc.M502244200; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; LAYCHOCK SG, 1983, BIOCHEM J, V216, P101, DOI 10.1042/bj2160101; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lin CW, 2005, DIABETES, V54, P2852, DOI 10.2337/diabetes.54.10.2852; Linder MD, 2007, MOL BIOL CELL, V18, P47, DOI 10.1091/mbc.E06-07-0575; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337/diabetes.54.1.166; Musse AA, 2009, NEUROSCI LETT, V450, P32, DOI 10.1016/j.neulet.2008.11.022; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Nevins AK, 2003, AM J PHYSIOL-CELL PH, V285, pC698, DOI 10.1152/ajpcell.00093.2003; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Patra SK, 1999, J LIPOSOME RES, V9, P247, DOI 10.3109/08982109909024788; Petersen NH, 2008, J LIPID RES, V49, P2023, DOI 10.1194/jlr.M800145-JLR200; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; RIDLEY AJ, 1994, BIOESSAYS, V16, P321, DOI 10.1002/bies.950160506; Rodi PM, 2008, BIOPHYS CHEM, V135, P14, DOI 10.1016/j.bpc.2008.02.015; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Shaw JE, 2006, J STRUCT BIOL, V155, P458, DOI 10.1016/j.jsb.2006.04.015; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Sun Y, 2003, J BIOL CHEM, V278, P5813, DOI 10.1074/jbc.M208687200; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Tamarina NA, 2005, DIABETES, V54, P3073, DOI 10.2337/diabetes.54.11.3073; Thore S, 2005, J CELL SCI, V118, P4463, DOI 10.1242/jcs.02577; Thore S, 2004, J BIOL CHEM, V279, P19396, DOI 10.1074/jbc.C400088200; Thore S, 2007, DIABETES, V56, P818, DOI 10.2337/db06-0843; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Tong J, 2008, BIOPHYS J, V94, P125, DOI 10.1529/biophysj.107.110536; Trapp S, 1998, J GEN PHYSIOL, V112, P333, DOI 10.1085/jgp.112.3.333; van Meer G, 2004, CURR OPIN CELL BIOL, V16, P373, DOI 10.1016/j.ceb.2004.06.004; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; van Rheenen J, 2002, MOL BIOL CELL, V13, P3257, DOI 10.1091/mbc.E02-04-0231; Wang JY, 2002, J BIOL CHEM, V277, P34401, DOI 10.1074/jbc.M203954200; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Wassall SR, 2004, CHEM PHYS LIPIDS, V132, P79, DOI 10.1016/j.chemphyslip.2004.09.007; Wilson JR, 2001, FEBS LETT, V492, P101, DOI 10.1016/S0014-5793(01)02241-4; Wustner D, 2002, J BIOL CHEM, V277, P30325, DOI 10.1074/jbc.M202626200; Xu C, 2003, J CELL BIOL, V161, P779, DOI 10.1083/jcb.200301070	75	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29489	29498		10.1074/jbc.M109.038034	http://dx.doi.org/10.1074/jbc.M109.038034			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19729450	Green Published, hybrid			2022-12-25	WOS:000270896800031
J	Pelish, TM; McClain, MS				Pelish, Teal M.; McClain, Mark S.			Dominant-negative Inhibitors of the Clostridium perfringens epsilon-Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYLORI VACUOLATING TOXIN; STAPHYLOCOCCAL ALPHA-HEMOLYSIN; PROTEIN-PROTEIN INTERACTIONS; ANTHRAX PROTECTIVE ANTIGEN; ESCHERICHIA-COLI; MDCK CELLS; IN-VIVO; CRYSTAL-STRUCTURE; MEMBRANE; MUTANT	The Clostridium perfringens epsilon-toxin is responsible for a severe, often lethal intoxication. In this study, we characterized dominant-negative inhibitors of the epsilon-toxin. Site-specific mutations were introduced into the gene encoding epsilon-toxin, and recombinant proteins were expressed in Escherichia coli. Paired cysteine substitutions were introduced at locations predicted to form a disulfide bond. One cysteine in each mutant was introduced into the membrane insertion domain of the toxin; the second cysteine was introduced into the protein backbone. Mutant proteins with cysteine substitutions at amino acid positions I51/A114 and at V56/F118 lacked detectable cytotoxic activity in a MDCK cell assay. Cytotoxic activity could be reconstituted in both mutant proteins by incubation with dithiothreitol, indicating that the lack of cytotoxic activity was attributable to the formation of a disulfide bond. Fluorescent labeling of the cysteines also indicated that the introduced cysteines participated in a disulfide bond. When equimolar mixtures of wildtype epsilon-toxin and mutant proteins were added to MDCK cells, the I51C/A114C and V56C/F118C mutant proteins each inhibited the activity of wild-type epsilon-toxin. Further analysis of the inhibitory activity of the I51C/A114C and V56C/F118C mutant proteins indicated that these proteins inhibit the ability of the active toxin to form stable oligomeric complexes in the context of MDCK cells. These results provide further insight into the properties of dominant-negative inhibitors of oligomeric pore-forming toxins and provide the basis for developing new therapeutics for treating intoxication by epsilon-toxin.	[McClain, Mark S.] Vanderbilt Univ, Sch Med, Div Infect Dis, Dept Med, Nashville, TN 37232 USA	Vanderbilt University	McClain, MS (corresponding author), Vanderbilt Univ, Sch Med, Div Infect Dis, Dept Med, A2200 Med Ctr N, Nashville, TN 37232 USA.	mark.mcclain@vanderbilt.edu	McClain, Mark S/A-6942-2009	McClain, Mark S/0000-0002-9857-4883	National Institutes of Health, NIAID [R21 AI065435, R01 AI079123]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065435, R01AI079123] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 AI065435 and R01 AI079123 (to M. S. M.) from NIAID.	Adamson RH, 2005, INFECT IMMUN, V73, P4879, DOI 10.1128/IAI.73.8.4879-4887.2005; Ahuja N, 2003, BIOCHEM BIOPH RES CO, V307, P446, DOI 10.1016/S0006-291X(03)01227-0; Aulinger BA, 2005, INFECT IMMUN, V73, P3408, DOI 10.1128/IAI.73.6.3408-3414.2005; Beers M.H., 2005, MERCK MANUAL DIAGNOS; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; CAMERON CM, 1980, ONDERSTEPOORT J VET, V47, P287; Cheley S, 1997, PROTEIN ENG, V10, P1433, DOI 10.1093/protein/10.12.1433; Cole AR, 2004, NAT STRUCT MOL BIOL, V11, P797, DOI 10.1038/nsmb804; delaRosa C, 1997, J ANIM SCI, V75, P2328; Dorca-Arevalo J, 2008, VET MICROBIOL, V131, P14, DOI 10.1016/j.vetmic.2008.02.015; EVANS SV, 1990, J MOL BIOL, V213, P885, DOI 10.1016/S0022-2836(05)80270-0; Gardner D E, 1972, N Z Vet J, V20, P167, DOI 10.1080/00480169.1972.34041; Genisset C, 2006, INFECT IMMUN, V74, P1786, DOI 10.1128/IAI.74.3.1786-1794.2006; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; GLEESONWHITE MH, 1955, LANCET, V1, P384; Hauer P J, 1999, Dev Biol Stand, V101, P85; Hotze EM, 2001, J BIOL CHEM, V276, P8261, DOI 10.1074/jbc.M009865200; Ivie SE, 2008, INFECT IMMUN, V76, P2843, DOI 10.1128/IAI.01664-07; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; KOHN J, 1955, LANCET, V1, P385; KOIDE T, 1973, EUR J BIOCHEM, V32, P417, DOI 10.1111/j.1432-1033.1973.tb02624.x; MacKenzie CR, 1999, J BIOL CHEM, V274, P22604, DOI 10.1074/jbc.274.32.22604; McClain MS, 2007, INFECT IMMUN, V75, P1785, DOI 10.1128/IAI.01643-06; McClain MS, 2003, INFECT IMMUN, V71, P2266, DOI 10.1128/IAI.71.4.2266-2271.2003; McClain MS, 2001, J BACTERIOL, V183, P6499, DOI 10.1128/JB.183.22.6499-6508.2001; Minami J, 1997, MICROBIOL IMMUNOL, V41, P527, DOI 10.1111/j.1348-0421.1997.tb01888.x; Minard KI, 2007, FREE RADICAL BIO MED, V42, P106, DOI 10.1016/j.freeradbiomed.2006.09.024; Miyata S, 2002, J BIOL CHEM, V277, P39463, DOI 10.1074/jbc.M206731200; Miyata S, 2001, J BIOL CHEM, V276, P13778, DOI 10.1074/jbc.M011527200; Mourez M, 2003, P NATL ACAD SCI USA, V100, P13803, DOI 10.1073/pnas.2436299100; NAGAHAMA M, 1991, TOXICON, V29, P211, DOI 10.1016/0041-0101(91)90105-Z; Nagahama M, 1998, J NAT TOXINS, V7, P291; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Oyston PCF, 1998, MICROBIOL-SGM, V144, P333, DOI 10.1099/00221287-144-2-333; PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0; PAYNE DW, 1994, FEMS MICROBIOL LETT, V116, P161, DOI 10.1016/0378-1097(94)90068-X; Petit L, 1997, J BACTERIOL, V179, P6480, DOI 10.1128/jb.179.20.6480-6487.1997; Petit L, 2003, CELL MICROBIOL, V5, P155, DOI 10.1046/j.1462-5822.2003.00262.x; Petit L, 2001, J BIOL CHEM, V276, P15736, DOI 10.1074/jbc.M010412200; Rodriguez-Almazan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005545; Rossjohn J, 1998, J STRUCT BIOL, V121, P92, DOI 10.1006/jsbi.1997.3947; Rossjohn J, 1998, BIOCHEMISTRY-US, V37, P741, DOI 10.1021/bi9721039; SAKURAI J, 1987, FEMS MICROBIOL LETT, V41, P317; SAKURAI J, 1987, TOXICON, V25, P279, DOI 10.1016/0041-0101(87)90256-X; SAKURAI J, 1985, BIOCHEM BIOPH RES CO, V128, P760, DOI 10.1016/0006-291X(85)90112-3; SAKURAI J, 1987, MICROB PATHOGENESIS, V3, P469, DOI 10.1016/0882-4010(87)90017-9; SAKURAI J, 1986, MICROB PATHOGENESIS, V1, P417, DOI 10.1016/0882-4010(86)90003-3; Sellman BR, 2001, SCIENCE, V292, P695, DOI 10.1126/science.109563; Singh Y, 2001, J BIOL CHEM, V276, P22090, DOI 10.1074/jbc.M010222200; Smith LDS, 1984, PATHOGENIC ANAEROBIC, V3rd; Soler-Jover A, 2004, J HISTOCHEM CYTOCHEM, V52, P931, DOI 10.1369/jhc.4A6254.2004; Soler-Jover A, 2007, TOXICON, V50, P530, DOI 10.1016/j.toxicon.2007.04.025; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; Spyres LM, 2003, INFECT IMMUN, V71, P3294, DOI 10.1128/IAI.71.6.3294-3301.2003; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Torres VJ, 2006, INFECT IMMUN, V74, P2093, DOI 10.1128/IAI.74.4.2093-2101.2006; Uzal FA, 1998, VET REC, V143, P472, DOI 10.1136/vr.143.17.472; Uzal FA, 1998, VET REC, V142, P722, DOI 10.1136/vr.142.26.722; Vinion-Dubiel AD, 1999, J BIOL CHEM, V274, P37736, DOI 10.1074/jbc.274.53.37736; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wai SN, 2003, J BACTERIOL, V185, P5491, DOI 10.1128/JB.185.18.5491-5499.2003; Weng YP, 2004, J BIOL CHEM, V279, P6805, DOI 10.1074/jbc.M308675200; Willhite DC, 2002, INFECT IMMUN, V70, P3824, DOI 10.1128/IAI.70.7.3824-3832.2002; WORTHINGTON R W, 1975, Onderstepoort Journal of Veterinary Research, V42, P25; Yan M, 2003, MOL MED, V9, P46, DOI 10.1007/BF03402106; Yano H, 2003, ANAL CHEM, V75, P4682, DOI 10.1021/ac0343329	67	29	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29446	29453		10.1074/jbc.M109.021782	http://dx.doi.org/10.1074/jbc.M109.021782			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19720828	Green Published, hybrid			2022-12-25	WOS:000270896800026
J	Silva, G; Jeney, V; Chora, A; Larsen, R; Balla, J; Soares, MP				Silva, Gabriela; Jeney, Viktoria; Chora, Angelo; Larsen, Rasmus; Balla, Jozsef; Soares, Miguel P.			Oxidized Hemoglobin Is an Endogenous Proinflammatory Agonist That Targets Vascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ADENOVIRUS-MEDIATED EXPRESSION; HEME OXYGENASE 1; RED-BLOOD-CELLS; HYDROGEN-PEROXIDE; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; BACTERIAL-ENDOTOXIN; NALP3 INFLAMMASOME; CROSS-LINKING	Several pathologic conditions are associated with hemolysis, i.e. release of ferrous (Fe(II)) hemoglobin from red blood cells. Oxidation of cell-free hemoglobin produces (Fe(III)) methemoglobin. More extensive oxidation produces (Fe(III)/Fe(IV)=O) ferryl hemoglobin. Both cell-free methemoglobin and ferryl hemoglobin are thought to contribute to the pathogenesis of hemolytic disorders. We show hereby that ferryl hemoglobin, but not hemoglobin or methemoglobin, acts as a potent proinflammatory agonist that induces vascular endothelial cells in vitro to rearrange the actin cytoskeleton, forming intercellular gaps and disrupting the integrity of the endothelial cell monolayer. Furthermore, ferryl hemoglobin induces the expression of proinflammatory genes in endothelial cells in vitro, e.g. E-selectin, Icam-1, and Vcam-1, through the activation of the nuclear factor kappa B family of transcription factors. This proinflammatory effect, which requires actin polymerization, involves the activation of the c-Jun N-terminal kinase and the p38 mitogen-activated protein kinase signal transduction pathways. When administered to naive mice, ferryl hemoglobin induces the recruitment of polymorphonuclear cells, demonstrating that it acts as a proinflammatory agonist in vivo. In conclusion, oxidized hemoglobin, i.e. ferryl hemoglobin, acts as a proinflammatory agonist that targets vascular endothelial cells.	[Soares, Miguel P.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Jeney, Viktoria; Balla, Jozsef] Univ Debrecen, Dept Med, Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary	Instituto Gulbenkian de Ciencia; University of Debrecen	Soares, MP (corresponding author), Inst Gulbenkian Ciencias, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal.	mpsoares@igc.gulbenkian.pt	Larsen, Rasmus/I-9204-2012; Ferreira Chora, Angelo/AAZ-6503-2021; Soares, Miguel P/G-4188-2011; Jeney, Viktória/AAF-5355-2019; Jeney, Viktoria/A-6779-2011	Ferreira Chora, Angelo/0000-0002-7941-7196; Balla, Jozsef/0000-0001-7923-2645; Silva, Gabriela/0000-0002-4004-9904; Soares, Miguel/0000-0002-9314-4833	Fundacao para a Ciencia e a Tecnologia, Portugal [POCTI/BIA-BCM/56829/2004, POCTI/SAU-MNO/56066/2004, POCTI/SAU/56066/2007]; European Commission's Sixth Framework Program, XENOME [LSHB-CT-2006-037377]; GEMI fund (Linde Healthcare)	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); European Commission's Sixth Framework Program, XENOME; GEMI fund (Linde Healthcare)	This work was supported by Grants POCTI/BIA-BCM/56829/2004, POCTI/SAU-MNO/56066/2004, and POCTI/SAU/56066/2007 from Fundacao para a Ciencia e a Tecnologia, Portugal, European Commission's Sixth Framework Program, XENOME (LSHB-CT-2006-037377), and the GEMI fund (Linde Healthcare) (to M. P. S.).	Anrather J, 2005, J BIOL CHEM, V280, P244, DOI 10.1074/jbc.M409344200; APPELMELK BJ, 1992, ANAL BIOCHEM, V207, P311, DOI 10.1016/0003-2697(92)90017-2; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; BUBB MR, 1994, J BIOL CHEM, V269, P14869; BULLARD DC, 1995, J CLIN INVEST, V95, P1782, DOI 10.1172/JCI117856; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; COLUCCI M, 1983, J CLIN INVEST, V71, P1893, DOI 10.1172/JCI110945; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Ferreira A, 2008, J MOL MED, V86, P1097, DOI 10.1007/s00109-008-0368-5; Giulivi C, 2001, J BIOL CHEM, V276, P24129, DOI 10.1074/jbc.M010697200; GIULIVI C, 1994, METHOD ENZYMOL, V231, P490; Giulivi C, 1998, FREE RADICAL BIO MED, V24, P269, DOI 10.1016/S0891-5849(97)00226-8; Goldman DW, 1998, AM J PHYSIOL-HEART C, V275, pH1046, DOI 10.1152/ajpheart.1998.275.3.H1046; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Jia YP, 2007, J BIOL CHEM, V282, P4894, DOI 10.1074/jbc.M609955200; Kaneko M, 1996, ARTERIOSCL THROM VAS, V16, P1047, DOI 10.1161/01.ATV.16.8.1047; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kawashima A, 2002, HUM PATHOL, V33, P125, DOI 10.1053/hupa.2002.30217; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Liu XY, 2003, AM J PHYSIOL-CELL PH, V285, pC1036, DOI 10.1152/ajpcell.00164.2003; MAPLES KR, 1990, ARCH BIOCHEM BIOPHYS, V277, P402, DOI 10.1016/0003-9861(90)90596-Q; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masuoka N, 2006, J BIOL CHEM, V281, P21728, DOI 10.1074/jbc.M513818200; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Melamed-Frank M, 2001, BLOOD, V98, P3693, DOI 10.1182/blood.V98.13.3693; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; OWEN JA, 1958, NATURE, V182, P1373, DOI 10.1038/1821373a0; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Reeder BJ, 2002, BIOCHEM SOC T, V30, P745, DOI 10.1042/bst0300745; Reeder BJ, 2008, J BIOL CHEM, V283, P30780, DOI 10.1074/jbc.M804709200; ROTH RI, 1994, BLOOD, V83, P2860, DOI 10.1182/blood.V83.10.2860.2860; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; Seldon MP, 2007, J IMMUNOL, V179, P7840, DOI 10.4049/jimmunol.179.11.7840; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Silva G, 2006, J IMMUNOL, V177, P1894, DOI 10.4049/jimmunol.177.3.1894; Soares MP, 2009, TRENDS MOL MED, V15, P50, DOI 10.1016/j.molmed.2008.12.004; Soares MP, 2004, J IMMUNOL, V172, P3553, DOI 10.4049/jimmunol.172.6.3553; Soares MP, 1998, J IMMUNOL, V161, P4572; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Su DH, 1997, INFECT IMMUN, V65, P1258, DOI 10.1128/IAI.65.4.1258-1266.1997; Svistunenko DA, 1997, J BIOL CHEM, V272, P7114, DOI 10.1074/jbc.272.11.7114; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; Vallelian F, 2008, FREE RADICAL BIO MED, V45, P1150, DOI 10.1016/j.freeradbiomed.2008.07.013; Vollaard NBJ, 2005, FREE RADICAL BIO MED, V39, P1216, DOI 10.1016/j.freeradbiomed.2005.06.012; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; WEISS SJ, 1982, J BIOL CHEM, V257, P2947; WINTERBOURN C, 1985, REACTIONS SUPEROXIDE; Wrighton CJ, 1996, J EXP MED, V183, P1013, DOI 10.1084/jem.183.3.1013; Wu KK, 1996, ANNU REV MED, V47, P315; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Ziouzenkova O, 1999, J BIOL CHEM, V274, P18916, DOI 10.1074/jbc.274.27.18916	67	99	102	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2009	284	43					29582	29595		10.1074/jbc.M109.045344	http://dx.doi.org/10.1074/jbc.M109.045344			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	507ZW	19700768	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000270896800040
J	Parnas, A; Nadler, M; Nisemblat, S; Horovitz, A; Mandel, H; Azem, A				Parnas, Avital; Nadler, Michal; Nisemblat, Shahar; Horovitz, Amnon; Mandel, Hanna; Azem, Abdussalam			The MitCHAP-60 Disease Is Due to Entropic Destabilization of the Human Mitochondrial Hsp60 Oligomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY SPASTIC PARAPLEGIA; ESCHERICHIA-COLI; MOLECULAR CHAPERONE; YEAST MITOCHONDRIA; IN-VITRO; GROEL; PROTEIN; MUTATION; PURIFICATION; HEAT-SHOCK-PROTEIN-60	The 60-kDa heat shock protein (mHsp60) is a vital cellular complex that mediates the folding of many of the mitochondrial proteins. Its function is executed in cooperation with the co-chaperonin, mHsp 10, and requires ATP. Recently, the discovery of a new mHsp60-associated neurodegenerative disorder, MitCHAP-60 disease, has been reported. The disease is caused by a point mutation at position 3 (D3G) of the mature mitochondrial Hsp60 protein, which renders it unable to complement the deletion of the homologous bacterial protein in Escherichia coli (Magen, D., Georgopoulos, C., Bross, P., Ang, D., Segev, Y., Goldsher, D., Nemirovski, A., Shahar, E., Ravid, S., Luder, A., Heno, B., Gershoni-Baruch, R., Skorecki, K., and Mandel, H. (2008) Am. J. Hum. Genet. 83, 30 - 42). The molecular basis of the MitCHAP-60 disease is still unknown. In this study, we present an in vitro structural and functional analysis of the purified wild-type human mHsp60 and the MitCHAP-60 mutant. We show that the D3G mutation leads to destabilization of the mHsp60 oligomer and causes its disassembly at low protein concentrations. We also show that the mutant protein has impaired protein folding and ATPase activities. An additional mutant that lacks the first three amino, acids (N-del), including Asp-3, is similarly impaired in refolding activity. Surprisingly, however, this mutant exhibits profound stabilization of its oligomeric structure. These results suggest that the D3G mutation leads to entropic destabilization of the mHsp60 oligomer, which severely impairs its chaperone function, thereby causing the disease.	[Parnas, Avital; Nisemblat, Shahar; Azem, Abdussalam] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69778 Tel Aviv, Israel; [Nadler, Michal; Horovitz, Amnon] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Mandel, Hanna] Technion Israel Inst Technol, Rappaport Fac Med, IL-31096 Haifa, Israel; [Mandel, Hanna] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel; [Mandel, Hanna] Metab Dis Unit, IL-31096 Haifa, Israel	Tel Aviv University; Weizmann Institute of Science; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Horovitz, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69778 Tel Aviv, Israel.	amnon.horovitz@weizmann.ac.il; azema@tauex.tau.ac.il			Israel Science Foundation [1902/08]; Eshkol Fellowship from the Ministry of Science	Israel Science Foundation(Israel Science Foundation); Eshkol Fellowship from the Ministry of Science	This work was supported by a grant from the Morasha program of the Israel Science Foundation (Grant 1902/08) (to A. A. and H. M.) and by an Eshkol Fellowship from the Ministry of Science (to A. P.).	Altamirano MM, 1997, P NATL ACAD SCI USA, V94, P3576, DOI 10.1073/pnas.94.8.3576; Bonshtien AL, 2007, J BIOL CHEM, V282, P4463, DOI 10.1074/jbc.M606433200; Bonshtien AL, 2009, CELL STRESS CHAPERON, V14, P509, DOI 10.1007/s12192-009-0104-2; Bross P, 2008, J BIOL CHEM, V283, P15694, DOI 10.1074/jbc.M800548200; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Buckle AM, 1997, P NATL ACAD SCI USA, V94, P3571, DOI 10.1073/pnas.94.8.3571; Cappello F, 2007, CANCER BIOL THER, V6, P487, DOI 10.4161/cbt.6.4.4087; CHANDRASEKHAR GN, 1986, J BIOL CHEM, V261, P2414; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; Deocaris CC, 2006, CELL STRESS CHAPERON, V11, P116, DOI 10.1379/CSC-144R.1; DICKSON R, 1994, J BIOL CHEM, V269, P26858; Hansen J, 2007, J NEUROL, V254, P897, DOI 10.1007/s00415-006-0470-y; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; Hard F. U., 1996, NATURE, V381, P571; HOROVITZ A, 1993, J BIOL CHEM, V268, P9957; HOROVITZ A, 1993, J MOL BIOL, V231, P58, DOI 10.1006/jmbi.1993.1256; Horovitz A, 2005, CURR OPIN STRUC BIOL, V15, P646, DOI 10.1016/j.sbi.2005.10.001; Horovitz A, 1998, CURR OPIN STRUC BIOL, V8, P93, DOI 10.1016/S0959-440X(98)80015-8; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Iosefson O, 2007, PROTEIN SCI, V16, P316, DOI 10.1110/ps.062459607; Knowlton A A, 2003, Cardiovasc Toxicol, V3, P263, DOI 10.1385/CT:3:3:263; LANDRY SJ, 1993, NATURE, V364, P255, DOI 10.1038/364255a0; Landry SJ, 1996, P NATL ACAD SCI USA, V93, P11622, DOI 10.1073/pnas.93.21.11622; Levy-Rimler G, 2002, FEBS LETT, V529, P1, DOI 10.1016/S0014-5793(02)03178-2; Levy-Rimler G, 2001, EUR J BIOCHEM, V268, P3465, DOI 10.1046/j.1432-1327.2001.02243.x; Lin Z, 2006, CRIT REV BIOCHEM MOL, V41, P211, DOI 10.1080/10409230600760382; Magen D, 2008, AM J HUM GENET, V83, P30, DOI 10.1016/j.ajhg.2008.05.016; Nielsen KL, 1998, MOL CELL, V2, P93, DOI 10.1016/S1097-2765(00)80117-3; Osterloh A, 2004, J BIOL CHEM, V279, P47906, DOI 10.1074/jbc.M408440200; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; PICKETTS DJ, 1989, J BIOL CHEM, V264, P12001; Richardson A, 2001, J BIOL CHEM, V276, P4981, DOI 10.1074/jbc.M008628200; ROSPERT S, 1993, P NATL ACAD SCI USA, V90, P10967, DOI 10.1073/pnas.90.23.10967; Viitanen PV, 1998, METHOD ENZYMOL, V290, P203, DOI 10.1016/S0076-6879(98)90020-9; WHITE ZW, 1995, J BIOL CHEM, V270, P20404, DOI 10.1074/jbc.270.35.20404; Xanthoudakis S, 1999, EMBO J, V18, P2049, DOI 10.1093/emboj/18.8.2049; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001	39	42	43	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2009	284	41					28198	28203		10.1074/jbc.M109.031997	http://dx.doi.org/10.1074/jbc.M109.031997			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	505FP	19706612	Green Published, hybrid			2022-12-25	WOS:000270676300047
J	Haraguchi, S; Nakagawara, A				Haraguchi, Seiki; Nakagawara, Akira			A Simple PCR Method for Rapid Genotype Analysis of the TH-MYCN Transgenic Mouse	PLOS ONE			English	Article								Background: The TH-MYCN transgenic mouse is the most widely used murine model of human neuroblastoma, in which a human MYCN oncogene is targeted to neuroectodermal cells of developing mice under the influence of the rat tyrosine hydroxylase promoter. So far, homozygous transgenic mice have been identified by either Southern blot or quantitative real-time PCR. Principal Findings: To establish a simple and reliable genotyping method by conventional PCR, we confirmed the integration of the transgene in the TH-MYCN transgenic mouse by Southern blot and inverse PCR analyses. Our results showed that either five or six copies were found to be inserted in a head-to-tail tandem configuration at a single locus. The MYCN transgene/host DNA junction was sequenced and the integration site was identified at chromosome 18qE4. Finally, we succeeded in designing rapid, simple and reliable genotyping method by common PCR using primers flanking the integrated TH-MYCN transgene. Conclusion: We established a simple and reliable genotyping PCR method for determining the integration site of the TH-MYCN transgene that enables all possible genotypes to be distinguished within several hours. TH-MYCN mice are excellent model for human neuroblastoma study, thus our results will largely be useful for facilitating the pace of neuroblastoma study, including in the study of the tumourigenic process, and in the development of therapies to treat patients suffering from neuroblastoma.			Haraguchi, S (corresponding author), Chiba Canc Ctr, Res Inst, Lab Embryon & Dev Genet, Chuo Ku, 666-2 Nitonacho, Chiba 2608717, Japan.	akiranak@chiba-cc.jp			Grants-in-Aid for Scientific Research [21390317] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Burkhart CA, 2002, J BIOCHEM BIOPH METH, V52, P145, DOI 10.1016/S0165-022X(02)00052-0; Cheng AJ, 2007, EUR J CANCER, V43, P1467, DOI 10.1016/j.ejca.2007.03.008; Hackett CS, 2003, CANCER RES, V63, P5266; HOGAN B, 1994, MANIPULATING MOUSE E, P219; Moore HC, 2008, J CLIN PATHOL, V61, P1098, DOI 10.1136/jcp.2007.054627; OCHMAN H, 1988, GENETICS, V120, P621; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985	9	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2009	4	9							e6902	10.1371/journal.pone.0006902	http://dx.doi.org/10.1371/journal.pone.0006902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZF	19730731	Green Published, gold, Green Submitted			2022-12-25	WOS:000269622100007
J	Ji, Q; Hao, XB; Zhang, M; Tang, WH; Meng, Y; Li, L; Xiang, DB; DeSano, JT; Bommer, GT; Fan, DM; Fearon, ER; Lawrence, TS; Xu, L				Ji, Qing; Hao, Xinbao; Zhang, Min; Tang, Wenhua; Meng, Yang; Li, Ling; Xiang, Debing; DeSano, Jeffrey T.; Bommer, Guido T.; Fan, Daiming; Fearon, Eric R.; Lawrence, Theodore S.; Xu, Liang			MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; STEM-CELLS; P53; SUPPRESSOR; IDENTIFICATION; EXPRESSION; APOPTOSIS; GROWTH; CONTRIBUTES; ACTIVATION	Background: MicroRNAs (miRNAs) have been implicated in cancer initiation and progression via their ability to affect expression of genes and proteins that regulate cell proliferation and/or cell death. Transcription of the three miRNA miR-34 family members was recently found to be directly regulated by p53. Among the target proteins regulated by miR-34 are Notch pathway proteins and Bcl-2, suggesting the possibility of a role for miR-34 in the maintenance and survival of cancer stem cells. Methodology/Principal Findings: We examined the roles of miR-34 in p53-mutant human pancreatic cancer cell lines MiaPaCa2 and BxPC3, and the potential link to pancreatic cancer stem cells. Restoration of miR-34 expression in the pancreatic cancer cells by either transfection of miR-34 mimics or infection with lentiviral miR-34-MIF downregulated Bcl-2 and Notch1/2. miR-34 restoration significantly inhibited clonogenic cell growth and invasion, induced apoptosis and G1 and G2/M arrest in cell cycle, and sensitized the cells to chemotherapy and radiation. We identified that CD44+/CD133+ MiaPaCa2 cells are enriched with tumorsphere-forming and tumor-initiating cells or cancer stem/progenitor cells with high levels of Notch/Bcl-2 and loss of miR-34. More significantly, miR-34 restoration led to an 87% reduction of the tumor-initiating cell population, accompanied by significant inhibition of tumorsphere growth in vitro and tumor formation in vivo. Conclusions/Significance: Our results demonstrate that miR-34 may restore, at least in part, the tumor suppressing function of the p53 in p53-deficient human pancreatic cancer cells. Our data support the view that miR-34 may be involved in pancreatic cancer stem cell self-renewal, potentially via the direct modulation of downstream targets Bcl-2 and Notch, implying that miR-34 may play an important role in pancreatic cancer stem cell self-renewal and/or cell fate determination. Restoration of miR-34 may hold significant promise as a novel molecular therapy for human pancreatic cancer with loss of p53-miR34, potentially via inhibiting pancreatic cancer stem cells.			Ji, Q (corresponding author), Third Mil Med Univ, Inst Gastroenterol, Southwest Hosp, Chongqing, Peoples R China.	liangxu@umich.edu	Xin, Xiaofei/N-4518-2018; Xiang, Debing/AAZ-7727-2020; Bommer, Guido/A-8425-2011	Xin, Xiaofei/0000-0002-7618-0808; Bommer, Guido/0000-0001-6898-4884; Hao, Xinbao/0000-0002-5398-8564	NATIONAL CANCER INSTITUTE [R01CA121830, R21CA128220, P30CA046592, R01CA134655] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA121830-03, P30 CA046592, R21 CA128220-02, CA128220-01, P30 CA46592, R01 CA121830, R01 CA134655-01A1, R21 CA128220, R01 CA134655, CA121830-01, R01 CA121830-04S1] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Bui M, 1998, CANCER METAST REV, V17, P391, DOI 10.1023/A:1006197923640; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dai Y, 2009, AM J TRANSL RES, V1, P1; Dai Y, 2008, CLIN CANCER RES, V14, P7701, DOI 10.1158/1078-0432.CCR-08-0188; Dai Y, 2009, INT J RADIAT ONCOL, V74, P1217, DOI 10.1016/j.ijrobp.2009.03.057; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Han Z, 2007, J EXP CLIN CANC RES, V26, P261; Hatfield S, 2008, CELL TISSUE RES, V331, P57, DOI 10.1007/s00441-007-0530-3; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Immervoll H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-48; Ji Q, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-266; Korkaya H, 2007, BIODRUGS, V21, P299, DOI 10.2165/00063030-200721050-00002; Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Meng Y, 2008, MOL CANCER THER, V7, P2192, DOI 10.1158/1535-7163.MCT-08-0333; Nicolis SK, 2007, NEUROBIOL DIS, V25, P217, DOI 10.1016/j.nbd.2006.08.022; Papagiannakopoulos T, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-15; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; Simeone DM, 2008, CLIN CANCER RES, V14, P5646, DOI 10.1158/1078-0432.CCR-08-0584; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Wang ZW, 2006, MOL CANCER THER, V5, P483, DOI 10.1158/1535-7163.MCT-05-0299; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wicha MS, 2006, CLIN CANCER RES, V12, P5606, DOI 10.1158/1078-0432.CCR-06-1537; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Xu L, 2005, MOL CANCER THER, V4, P197; Xu L, 2002, HUM GENE THER, V13, P469, DOI 10.1089/10430340252792594; Xu L, 2002, MOL CANCER THER, V1, P337; Xu L, 1999, TUMOR TARGET, V4, P92; Xu LN, 1997, HUM GENE THER, V8, P467, DOI 10.1089/hum.1997.8.4-467; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; ZENZ T, 2008, BLOOD; Zhang WY, 2007, AM J PATHOL, V171, P728, DOI 10.2353/ajpath.2007.070070	48	539	591	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2009	4	8							e6816	10.1371/journal.pone.0006816	http://dx.doi.org/10.1371/journal.pone.0006816			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JG	19714243	Green Submitted, gold, Green Published			2022-12-25	WOS:000269415800006
J	Caillaud, MC; Paganelli, L; Lecomte, P; Deslandes, L; Quentin, M; Pecrix, Y; Le Bris, M; Marfaing, N; Abad, P; Favery, B				Caillaud, Marie-Cecile; Paganelli, Laetitia; Lecomte, Philippe; Deslandes, Laurent; Quentin, Michael; Pecrix, Yann; Le Bris, Manuel; Marfaing, Nicolas; Abad, Pierre; Favery, Bruno			Spindle Assembly Checkpoint Protein Dynamics Reveal Conserved and Unsuspected Roles in Plant Cell Division	PLOS ONE			English	Article								Background: In eukaryotes, the spindle assembly checkpoint ( SAC) ensures that chromosomes undergoing mitosis do not segregate until they are properly attached to the microtubules of the spindle. Methodology/Principal Findings: We investigated the mechanism underlying this surveillance mechanism in plants, by characterising the orthogolous SAC proteins BUBR1, BUB3 and MAD2 from Arabidopsis. We showed that the cell cycle-regulated BUBR1, BUB3.1 and MAD2 proteins interacted physically with each other. Furthermore, BUBR1 and MAD2 interacted specifically at chromocenters. Following SAC activation by global defects in spindle assembly, these three interacting partners localised to unattached kinetochores. In addition, in cases of 'wait anaphase', plant SAC proteins were associated with both kinetochores and kinetochore microtubules. Unexpectedly, BUB3.1 was also found in the phragmoplast midline during the final step of cell division in plants. Conclusions/Significance: We conclude that plant BUBR1, BUB3.1 and MAD2 proteins may have the SAC protein functions conserved from yeast to humans. The association of BUB3.1 with both unattached kinetochore and phragmoplast suggests that in plant, BUB3.1 may have other roles beyond the spindle assembly checkpoint itself. Finally, this study of the SAC dynamics pinpoints uncharacterised roles of this surveillance mechanism in plant cell division.	[Caillaud, Marie-Cecile; Paganelli, Laetitia; Lecomte, Philippe; Quentin, Michael; Marfaing, Nicolas; Abad, Pierre; Favery, Bruno] INRA, Unite Mixte Rech 1301, Sophia Antipolis, France; [Caillaud, Marie-Cecile; Paganelli, Laetitia; Lecomte, Philippe; Quentin, Michael; Marfaing, Nicolas; Abad, Pierre; Favery, Bruno] CNRS, Unite Mixte Rech 6243, Sophia Antipolis, France; [Caillaud, Marie-Cecile; Paganelli, Laetitia; Lecomte, Philippe; Quentin, Michael; Marfaing, Nicolas; Abad, Pierre; Favery, Bruno] Univ Nice Sophia Antipolis, Unite Mixte Rech 1301, Sophia Antipolis, France; [Deslandes, Laurent] CNRS, INRA, Unite Mixte Rech 2594, Castanet Tolosan, France; [Pecrix, Yann; Le Bris, Manuel] Univ Paul Cezanne, IMEP, Unite Mixte Rech, CNRS,Inst Rech Dev 6116, Marseille, France	INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Caillaud, MC (corresponding author), INRA, Unite Mixte Rech 1301, Sophia Antipolis, France.	favery@sophia.inra.fr	Quentin, Michaël/AFN-9766-2022; Caillaud, Marie-Cecile/G-9320-2018; Favery, Bruno/B-9062-2008; Deslandes, Laurent/N-5752-2017	Quentin, Michaël/0000-0002-8030-1203; Caillaud, Marie-Cecile/0000-0002-0348-7024; Favery, Bruno/0000-0003-3323-1852; LECOMTE, Philippe/0000-0003-1186-6283; Pecrix, Yann/0000-0002-6537-3145				Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Austin JR, 2005, J CELL SCI, V118, P3895, DOI 10.1242/jcs.02512; Basu J, 1998, CHROMOSOMA, V107, P376, DOI 10.1007/s004120050321; Caillaud MC, 2008, PLANT CELL, V20, P423, DOI 10.1105/tpc.107.057422; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chen RH, 2002, J CELL BIOL, V158, P487, DOI 10.1083/jcb.200204048; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Criqui MC, 2000, PLANT J, V24, P763, DOI 10.1111/j.1365-313X.2000.t01-1-.x; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Fang YD, 2005, MOL BIOL CELL, V16, P5710, DOI 10.1091/mbc.E05-08-0706; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; Genschik P, 1998, PLANT CELL, V10, P2063; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Houben A, 2003, CURR OPIN PLANT BIOL, V6, P554, DOI 10.1016/j.pbi.2003.09.007; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kimbara J, 2004, CHROMOSOME RES, V12, P703, DOI 10.1023/B:CHRO.0000045760.42880.8c; Lee YRJ, 2001, PLANT CELL, V13, P2427, DOI 10.1105/tpc.13.11.2427; Lermontova I, 2008, FRONT BIOSCI-LANDMRK, V13, P5202, DOI 10.2741/3076; Lermontova I, 2006, PLANT CELL, V18, P2443, DOI 10.1105/tpc.106.043174; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Martinez-Exposito MJ, 1999, P NATL ACAD SCI USA, V96, P8493, DOI 10.1073/pnas.96.15.8493; Menges M, 2005, PLANT J, V41, P546, DOI 10.1111/j.1365-313X.2004.02319.x; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Perez-Perez JM, 2008, PLANT J, V53, P78, DOI 10.1111/j.1365-313X.2007.03312.x; Pfleger CM, 2000, GENE DEV, V14, P655; Ritzenthaler C, 2002, PLANT CELL, V14, P237, DOI 10.1105/tpc.010237; Sczaniecka M, 2008, J BIOL CHEM, V283, P23039, DOI 10.1074/jbc.M803594200; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Talbert PB, 2002, PLANT CELL, V14, P1053, DOI 10.1105/tpc.010425; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; van Damme D, 2004, PLANT J, V40, P386, DOI 10.1111/j.1365-313X.2004.02222.x; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Vos JW, 2008, PLANT CELL, V20, P2783, DOI 10.1105/tpc.107.056796; Yu HG, 1999, J CELL BIOL, V145, P425, DOI 10.1083/jcb.145.3.425	43	52	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2009	4	8							e6757	10.1371/journal.pone.0006757	http://dx.doi.org/10.1371/journal.pone.0006757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489JE	19710914	Green Submitted, Green Published, gold			2022-12-25	WOS:000269415600002
J	Bheda, A; Shackelford, J; Pagano, JS				Bheda, Anjali; Shackelford, Julia; Pagano, Joseph S.			Expression and Functional Studies of Ubiquitin C-Terminal Hydrolase L1 Regulated Genes	PLOS ONE			English	Article								Deubiquitinating enzymes (DUBs) have been increasingly implicated in regulation of cellular processes, but a functional role for Ubiquitin C-terminal Hydrolases (UCHs), which has been largely relegated to processing of small ubiquitinated peptides, remains unexplored. One member of the UCH family, UCH L1, is expressed in a number of malignancies suggesting that this DUB might be involved in oncogenic processes, and increased expression and activity of UCH L1 have been detected in EBV-immortalized cell lines. Here we present an analysis of genes regulated by UCH L1 shown by microarray profiles obtained from cells in which expression of the gene was inhibited by RNAi. Microarray data were verified with subsequent real-time PCR analysis. We found that inhibition of UCH L1 activates genes that control apoptosis, cell cycle arrest and at the same time suppresses expression of genes involved in proliferation and migration pathways. These findings are complemented by biological assays for apoptosis, cell cycle progression and migration that support the data obtained from microarray analysis, and suggest that the multi-functional molecule UCH L1 plays a role in regulating principal pathways involved in oncogenesis.			Bheda, A (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	jspagano@med.unc.edu			NATIONAL CANCER INSTITUTE [P01CA019014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI085545] Funding Source: NIH RePORTER; NCI NIH HHS [2-P01-CA19014-26, P01 CA019014] Funding Source: Medline; NIAID NIH HHS [R03 AI085545] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bheda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005955; Bonin M, 2004, MOL BRAIN RES, V126, P88, DOI 10.1016/j.molbrainres.2004.03.025; Caballero OL, 2002, ONCOGENE, V21, P3003, DOI 10.1038/sj.onc.1205390; Cairns RA, 2003, CURR MOL MED, V3, P659, DOI 10.2174/1566524033479447; Campbell LK, 2003, MODERN PATHOL, V16, P963, DOI 10.1097/01.MP.0000087088.88280.B0; DORAN JF, 1983, J NEUROCHEM, V40, P1542, DOI 10.1111/j.1471-4159.1983.tb08124.x; Fuchs SY, 2002, CANCER BIOL THER, V1, P337; Hibi K, 2004, ANTICANCER RES, V24, P3731; HSIEH S, 2009, J PROTEOME RES; Kim HJ, 2009, ONCOGENE, V28, P117, DOI 10.1038/onc.2008.364; KOZBOR D, 1982, P NATL ACAD SCI-BIOL, V79, P6651, DOI 10.1073/pnas.79.21.6651; Labat-Robert J, 2002, SEMIN CANCER BIOL, V12, P187, DOI 10.1016/S1044-579X(02)00022-6; Leiblich A, 2007, PROSTATE, V67, P1761, DOI 10.1002/pros.20654; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Long EM, 2003, LUNG CANCER-J IASLC, V42, P9, DOI 10.1016/S0169-5002(03)00279-4; Maddika S, 2007, DRUG RESIST UPDATE, V10, P13, DOI 10.1016/j.drup.2007.01.003; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; Meng XB, 2004, CELL CYCLE, V3, P343; Miyoshi Y, 2006, CANCER SCI, V97, P523, DOI 10.1111/j.1349-7006.2006.00202.x; Mizukami H, 2008, ANTICANCER RES, V28, P2697; Mohammad RM, 1996, ENZYME PROTEIN, V49, P262, DOI 10.1159/000468636; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Rolen U, 2006, MOL CARCINOGEN, V45, P260, DOI 10.1002/mc.20177; ROLEN U, 2008, J CELL MOL MED; Sasaki H, 2001, JPN J CLIN ONCOL, V31, P532, DOI 10.1093/jjco/hye113; Sattler M, 2000, CRIT REV ONCOGENESIS, V11, P63; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Seliger B, 2007, CLIN CANCER RES, V13, P27, DOI 10.1158/1078-0432.CCR-06-0824; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Shen H, 2006, APOPTOSIS, V11, P1049, DOI 10.1007/s10495-006-6303-8; Spender LC, 1999, J VIROL, V73, P4678, DOI 10.1128/JVI.73.6.4678-4688.1999; Sun A, 2007, J CELL BIOCHEM, V102, P1400, DOI 10.1002/jcb.21609; Takano T, 2004, EUR J CANCER, V40, P614, DOI 10.1016/j.ejca.2003.11.016; Takase T, 2003, HEPATO-GASTROENTEROL, V50, P1278; Tan YY, 2008, MOL CELL BIOCHEM, V318, P109, DOI 10.1007/s11010-008-9862-x; Tezel E, 2000, CLIN CANCER RES, V6, P4764; Wan F, 2008, INT J CANCER, V123, P32, DOI 10.1002/ijc.23463; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Yan B, 2006, NEUROSCI LETT, V407, P124, DOI 10.1016/j.neulet.2006.08.032	41	49	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2009	4	8							e6764	10.1371/journal.pone.0006764	http://dx.doi.org/10.1371/journal.pone.0006764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488FQ	19707515	Green Published, gold, Green Submitted			2022-12-25	WOS:000269335000010
J	Verhoeven, GS; Alexeeva, S; Dogterom, M; den Blaauwen, T				Verhoeven, Gertjan S.; Alexeeva, Svetlana; Dogterom, Marileen; den Blaauwen, Tanneke			Differential Bacterial Surface Display of Peptides by the Transmembrane Domain of OmpA	PLOS ONE			English	Article								Peptide libraries or antigenic determinants can be displayed on the surface of bacteria through insertion in a suitable outer membrane scaffold protein. Here, we inserted the well-known antibody epitopes 3xFLAG and 2xmyc in exterior loops of the transmembrane (TM) domain of OmpA. Although these highly charged epitopes were successfully displayed on the cell surface, their levels were 10-fold reduced due to degradation. We verified that the degradation was not caused by the absence of the C-terminal domain of OmpA. In contrast, a peptide that was only moderately charged (SA-1) appeared to be stably incorporated in the outer membrane at normal protein levels. Together, these results suggest that the display efficiency is sensitive to the charge of the inserted epitopes. In addition, the high-level expression of OmpA variants with surface-displayed epitopes adversely affected growth in a strain dependent, transient manner. In a MC4100 derived strain growth was affected, whereas in MC1061 derived strains growth was unaffected. Finally, results obtained using a gel-shift assay to monitor beta-barrel folding in vivo show that the insertion of small epitopes can change the heat modifiability of the OmpA TM domain from 'aberrant' to normal, and predict that some beta-barrels will not display any significant heat-modifiability at all.			Verhoeven, GS (corresponding author), Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	t.denblaauwen@uva.nl	Alexeeva, Svetlana/J-3181-2016	Alexeeva, Svetlana/0000-0002-2863-9434; den Blaauwen, Tanneke/0000-0002-5403-5597				Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; AGTERBERG M, 1987, GENE, V59, P145, DOI 10.1016/0378-1119(87)90275-7; AGTERBERG M, 1990, VACCINE, V8, P85, DOI 10.1016/0264-410X(90)90184-N; AGTERBERG M, 1990, GENE, V88, P37, DOI 10.1016/0378-1119(90)90057-X; ARJARA G, 2007, REFOLDING BETA BARRE; Bessette PH, 2007, ANAL CHEM, V79, P2174, DOI 10.1021/ac0616916; Bessette PH, 2004, PROTEIN ENG DES SEL, V17, P731, DOI 10.1093/protein/gzh084; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Camaj P, 2001, BIOL CHEM, V382, P1669, DOI 10.1515/BC.2001.202; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHEN R, 1980, P NATL ACAD SCI-BIOL, V77, P4592, DOI 10.1073/pnas.77.8.4592; COLE ST, 1983, J BACTERIOL, V153, P581, DOI 10.1128/JB.153.2.581-587.1983; Costanzo A, 2006, J BACTERIOL, V188, P4627, DOI 10.1128/JB.01981-05; Daugherty PS, 2007, CURR OPIN STRUC BIOL, V17, P474, DOI 10.1016/j.sbi.2007.07.004; den Blaauwen T, 2003, MOL MICROBIOL, V47, P539, DOI 10.1046/j.1365-2958.2003.03316.x; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Eisner G, 2003, J CELL BIOL, V163, P35, DOI 10.1083/jcb.200306069; FREUDL R, 1986, J MOL BIOL, V188, P491, DOI 10.1016/0022-2836(86)90171-3; FREUDL R, 1989, GENE, V82, P229, DOI 10.1016/0378-1119(89)90048-6; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hasselblatt H, 2007, GENE DEV, V21, P2659, DOI 10.1101/gad.445307; Kleinschmidt JH, 2006, CHEM PHYS LIPIDS, V141, P30, DOI 10.1016/j.chemphyslip.2006.02.004; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Koebnik R, 1999, J BACTERIOL, V181, P3688, DOI 10.1128/JB.181.12.3688-3694.1999; Koppelman CM, 2004, MOL MICROBIOL, V51, P645, DOI 10.1046/j.1365-2958.2003.03876.x; Lee SY, 2003, TRENDS BIOTECHNOL, V21, P45, DOI 10.1016/S0167-7799(02)00006-9; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mejare M, 1998, PROTEIN ENG, V11, P489, DOI 10.1093/protein/11.6.489; Mitra K, 2006, NAT STRUCT MOL BIOL, V13, P957, DOI 10.1038/nsmb1166; Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983; Peters JE, 2003, J BACTERIOL, V185, P2017, DOI 10.1128/JB.185.6.2017-2021.2003; REITHMEIER RA, 1974, FEBS LETT, V41, P195, DOI 10.1016/0014-5793(74)81210-X; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; RIED G, 1994, MOL GEN GENET, V243, P127, DOI 10.1007/BF00280309; Roosild TP, 2006, ACTA CRYSTALLOGR F, V62, P835, DOI 10.1107/S1744309106029125; RUPPERT A, 1994, VACCINE, V12, P492, DOI 10.1016/0264-410X(94)90305-0; Slootstra JW, 1997, MOL DIVERS, V2, P156, DOI 10.1007/BF01682203; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; SURREY T, 1992, P NATL ACAD SCI USA, V89, P7457, DOI 10.1073/pnas.89.16.7457; TASCHNER PEM, 1988, J BACTERIOL, V170, P1533, DOI 10.1128/jb.170.4.1533-1540.1988; Vandeputte-Rutten L, 2003, J BIOL CHEM, V278, P24825, DOI 10.1074/jbc.M302803200	41	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2009	4	8							e6739	10.1371/journal.pone.0006739	http://dx.doi.org/10.1371/journal.pone.0006739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487MJ	19707582	gold, Green Published, Green Submitted			2022-12-25	WOS:000269278400007
J	Ishikawa, T; Rompikuntal, PK; Lindmark, B; Milton, DL; Wai, SN				Ishikawa, Takahiko; Rompikuntal, Pramod Kumar; Lindmark, Barbro; Milton, Debra L.; Wai, Sun Nyunt			Quorum Sensing Regulation of the Two hcp Alleles in Vibrio cholerae O1 Strains	PLOS ONE			English	Article							VI-SECRETION-SYSTEM; ESCHERICHIA-COLI; PROTEIN SECRETION; VIRULENCE DETERMINANTS; GENES; IDENTIFICATION; COLONIZATION; CONSTRUCTION; EXPRESSION; INFECTION	Background: The type VI secretion system (T6SS) has emerged as a protein secretion system important to several Gram-negative bacterial species. One of the common components of the system is Hcp, initially described as a hemolysin coregulated protein in a serotype O17 strain of Vibrio cholerae. Homologs to V. cholerae hcp genes have been found in all characterized type VI secretion systems and they are present also in the serotype O1 strains of V. cholerae that are the cause of cholera diseases but seemed to have non-functional T6SS. Methodology/Principal Findings: The serotype O1 V. cholerae strain A1552 was shown to express detectable levels of Hcp as determined by immunoblot analyses using polyclonal anti-Hcp antiserum. We found that the expression of Hcp was growth phase dependent. The levels of Hcp in quorum sensing deficient mutants of V. cholerae were compared with the levels in wild type V. cholerae O1 strain A1552. The expression of Hcp was positively and negatively regulated by the quorum sensing regulators HapR and LuxO, respectively. In addition, we observed that expression of Hcp was dependent on the cAMP-CRP global transcriptional regulatory complex and required the RpoN sigma factor. Conclusion/Significance: Our results show that serotype O1 strains of V. cholerae do express Hcp which is regarded as one of the important T6SS components and is one of the secreted substrates in non-O1 non-O139 V. cholerae isolates. We found that expression of Hcp was strictly regulated by the quorum sensing system in the V. cholerae O1 strain. In addition, the expression of Hcp required the alternative sigma factor RpoN and the cAMP- CRP global regulatory complex. Interestingly, the environmental isolates of V. cholerae O1 strains that showed higher levels of the HapR quorum sensing regulator in comparison with our laboratory standard serotype O1 strain A1552 where also expressing higher levels of Hcp.			Ishikawa, T (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	sun.nyunt.wai@molbiol.umu.se	rompikuntal, pramod/C-6917-2015	rompikuntal, pramod/0000-0002-4754-4676; Wai, Sun Nyunt/0000-0003-4793-4671				AIBA H, 1982, NUCLEIC ACIDS RES, V10, P1345, DOI 10.1093/nar/10.4.1345; Aubert DF, 2008, INFECT IMMUN, V76, P1979, DOI 10.1128/IAI.01338-07; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bladergroen MR, 2003, MOL PLANT MICROBE IN, V16, P53, DOI 10.1094/MPMI.2003.16.1.53; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Das S, 2000, FEMS MICROBIOL LETT, V190, P87, DOI 10.1111/j.1574-6968.2000.tb09267.x; Das S, 2002, BIOCHEM BIOPH RES CO, V295, P922, DOI 10.1016/S0006-291X(02)00782-9; Das Soumita, 2003, In Silico Biology, V3, P287; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; GEUSKENS V, 1992, EMBO J, V11, P5121, DOI 10.1002/j.1460-2075.1992.tb05619.x; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Joelsson A, 2007, APPL ENVIRON MICROB, V73, P3742, DOI 10.1128/AEM.02804-06; Johansson J, 2000, CELL, V102, P475, DOI 10.1016/S0092-8674(00)00052-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenz DH, 2007, MOL MICROBIOL, V63, P859, DOI 10.1111/j.1365-2958.2006.05545.x; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Liang W, 2007, MICROBIOL-SGM, V153, P2964, DOI 10.1099/mic.0.2007/006668-0; Liu H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000093; Mattinen L, 2008, MICROBIOL-SGM, V154, P2387, DOI 10.1099/mic.0.2008/017582-0; Mattinen L, 2007, PROTEOMICS, V7, P3527, DOI 10.1002/pmic.200600759; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Mukhopadhyay S, 1999, J BACTERIOL, V181, P6615, DOI 10.1128/JB.181.21.6615-6622.1999; Pilatz S, 2006, INFECT IMMUN, V74, P3576, DOI 10.1128/IAI.01262-05; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Skorupski K, 1996, GENE, V169, P47, DOI 10.1016/0378-1119(95)00793-8; Song T, 2008, MOL MICROBIOL, V70, P100, DOI 10.1111/j.1365-2958.2008.06392.x; Suarez G, 2008, MICROB PATHOGENESIS, V44, P344, DOI 10.1016/j.micpath.2007.10.005; Tam VC, 2007, CELL HOST MICROBE, V1, P95, DOI 10.1016/j.chom.2007.03.005; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Valeru SP, 2009, INFECT IMMUN, V77, P935, DOI 10.1128/IAI.00929-08; Williams SG, 1996, INFECT IMMUN, V64, P283, DOI 10.1128/IAI.64.1.283-289.1996; Yildiz FH, 1998, J BACTERIOL, V180, P773, DOI 10.1128/JB.180.4.773-784.1998; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	43	90	97	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2009	4	8							e6734	10.1371/journal.pone.0006734	http://dx.doi.org/10.1371/journal.pone.0006734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JF	19701456	Green Published, gold, Green Submitted			2022-12-25	WOS:000269268300011
J	Lake, RJ; Grimm, LM; Veraksa, A; Banos, A; Artavanis-Tsakonas, S				Lake, Robert J.; Grimm, Lisa M.; Veraksa, Alexey; Banos, Andrew; Artavanis-Tsakonas, Spyros			In Vivo Analysis of the Notch Receptor S1 Cleavage	PLOS ONE			English	Article							PROTEOLYTIC RELEASE; DROSOPHILA; DELTA; EXPRESSION	A ligand-independent cleavage (S1) in the extracellular domain of the mammalian Notch receptor results in what is considered to be the canonical heterodimeric form of Notch on the cell surface. The in vivo consequences and significance of this cleavage on Drosophila Notch signaling remain unclear and contradictory. We determined the cleavage site in Drosophila and examined its in vivo function by a transgenic analysis of receptors that cannot be cleaved. Our results demonstrate a correlation between loss of cleavage and loss of in vivo function of the Notch receptor, supporting the notion that S1 cleavage is an in vivo mechanism of Notch signal control.			Lake, RJ (corresponding author), Fox Chase Canc Ctr, Epigenet & Progenitor Cell Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	artavanis@hms.harvard.edu		Veraksa, Alexey/0000-0003-2920-080X	Intramural NIH HHS [Z01 NS002608] Funding Source: Medline; NCI NIH HHS [CA098402, R01 CA098402] Funding Source: Medline; NIGMS NIH HHS [GM62931, R01 GM062931] Funding Source: Medline; NINDS NIH HHS [F32 NS010735, NS10735] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010735, Z01NS002608] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baron M, 2002, MOL MEMBR BIOL, V19, P27, DOI 10.1080/09687680110112929; Benjannet S, 1997, J BIOL CHEM, V272, P26210, DOI 10.1074/jbc.272.42.26210; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Bush G, 2001, DEV BIOL, V229, P494, DOI 10.1006/dbio.2000.9992; DE SB, 1999, NATURE, V398, P518; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; GRIMWADE BG, 1985, DEV BIOL, V107, P503, DOI 10.1016/0012-1606(85)90331-8; Hu Y, 2002, DEV CELL, V2, P69, DOI 10.1016/S1534-5807(01)00105-8; Ikeuchi T, 2003, J BIOL CHEM, V278, P7751, DOI 10.1074/jbc.C200711200; Kidd S, 2002, MECH DEVELOP, V115, P41, DOI 10.1016/S0925-4773(02)00120-X; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Mishra-Gorur K, 2002, J CELL BIOL, V159, P313, DOI 10.1083/jcb.200203117; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; STIFANI S, 1992, NAT GENET, V2, P119, DOI 10.1038/ng1092-119; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Veraksa A, 2005, DEV DYNAM, V232, P827, DOI 10.1002/dvdy.20272; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096	31	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2009	4	8							e6728	10.1371/journal.pone.0006728	http://dx.doi.org/10.1371/journal.pone.0006728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487JF	19701455	Green Submitted, Green Published, gold			2022-12-25	WOS:000269268300008
J	Doesburg, SM; Green, JJ; McDonald, JJ; Ward, LM				Doesburg, Sam M.; Green, Jessica J.; McDonald, John J.; Ward, Lawrence M.			Rhythms of Consciousness: Binocular Rivalry Reveals Large-Scale Oscillatory Network Dynamics Mediating Visual Perception	PLOS ONE			English	Article							GAMMA-BAND RESPONSES; PHASE SYNCHRONIZATION; NEURONAL RESPONSES; NEURAL ACTIVITY; CORTICAL AREAS; EEG; FREQUENCY; THETA; TASK; INTEGRATION	Consciousness has been proposed to emerge from functionally integrated large-scale ensembles of gamma-synchronous neural populations that form and dissolve at a frequency in the theta band. We propose that discrete moments of perceptual experience are implemented by transient gamma-band synchronization of relevant cortical regions, and that disintegration and reintegration of these assemblies is time-locked to ongoing theta oscillations. In support of this hypothesis we provide evidence that (1) perceptual switching during binocular rivalry is time-locked to gamma-band synchronizations which recur at a theta rate, indicating that the onset of new conscious percepts coincides with the emergence of a new gamma-synchronous assembly that is locked to an ongoing theta rhythm; (2) localization of the generators of these gamma rhythms reveals recurrent prefrontal and parietal sources; (3) theta modulation of gamma-band synchronization is observed between and within the activated brain regions. These results suggest that ongoing theta-modulated-gamma mechanisms periodically reintegrate a large-scale prefrontal-parietal network critical for perceptual experience. Moreover, activation and network inclusion of inferior temporal cortex and motor cortex uniquely occurs on the cycle immediately preceding responses signaling perceptual switching. This suggests that the essential prefrontal-parietal oscillatory network is expanded to include additional cortical regions relevant to tasks and perceptions furnishing consciousness at that moment, in this case image processing and response initiation, and that these activations occur within a time frame consistent with the notion that conscious processes directly affect behaviour.			Doesburg, SM (corresponding author), Univ British Columbia, Dept Psychol, Psychophys & Cognit Neurosci Lab, Vancouver, BC, Canada.	sdoesburg@cw.bc.ca	McDonald, John/P-6966-2015; Green, Jessica/G-1039-2011	Green, Jessica/0000-0003-3570-529X; McDonald, Robert/0000-0002-7273-6549; Ward, Lawrence/0000-0003-4431-5015; Miller, William/0000-0003-0750-6314				Alkire MT, 2005, PROG BRAIN RES, V150, P229, DOI 10.1016/S0079-6123(05)50017-7; Andrews TJ, 2001, TRENDS COGN SCI, V5, P407, DOI 10.1016/S1364-6613(00)01756-3; BARRS BJ, 1997, J CONSC STUDIES, V44, P521; Basar E, 2006, INT J PSYCHOPHYSIOL, V60, P133, DOI 10.1016/j.ijpsycho.2005.12.007; Beck DM, 2001, NAT NEUROSCI, V4, P645, DOI 10.1038/88477; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; BLAKE RR, 1971, J EXP PSYCHOL, V88, P327, DOI 10.1037/h0030877; Bodovitz S, 2004, MED HYPOTHESES, V62, P1003, DOI 10.1016/j.mehy.2004.01.009; Bodovitz S, 2008, MED HYPOTHESES, V70, P8, DOI 10.1016/j.mehy.2007.05.022; Burgess AP, 2002, INT J PSYCHOPHYSIOL, V46, P91, DOI 10.1016/S0167-8760(02)00108-3; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cosmelli D, 2004, NEUROIMAGE, V23, P128, DOI 10.1016/j.neuroimage.2004.05.008; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; DENNETT DC, 1992, BEHAV BRAIN SCI, V15, P183, DOI 10.1017/S0140525X00068229; Doesburg SM, 2008, CEREB CORTEX, V18, P386, DOI 10.1093/cercor/bhm073; Doesburg SM, 2005, NEUROREPORT, V16, P1139, DOI 10.1097/00001756-200508010-00001; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P6048, DOI 10.1073/pnas.88.14.6048; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; ENGEL AK, 1991, P NATL ACAD SCI USA, V88, P9136, DOI 10.1073/pnas.88.20.9136; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fell J, 2002, CONSCIOUS COGN, V11, P114, DOI 10.1006/ccog.2001.0536; Ford JM, 2007, SCHIZOPHRENIA BULL, V33, P848, DOI 10.1093/schbul/sbm062; FRIEN A, 1994, NEUROREPORT, V5, P2273, DOI 10.1097/00001756-199411000-00017; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Fries P, 2002, J NEUROSCI, V22, P3739; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Goffaux V, 2004, NEUROSCI LETT, V354, P14, DOI 10.1016/j.neulet.2003.09.029; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Green JJ, 2008, PLOS BIOL, V6, P730, DOI 10.1371/journal.pbio.0060081; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Gruber T, 2008, BRAIN RES, V1196, P74, DOI 10.1016/j.brainres.2007.12.037; Gruber T, 2002, J COGNITIVE NEUROSCI, V14, P732, DOI 10.1162/08989290260138636; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hoechstetter K, 2004, BRAIN TOPOGR, V16, P233; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; John ER, 2002, BRAIN RES REV, V39, P1, DOI 10.1016/S0165-0173(02)00142-X; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; LIBET B, 1985, BEHAV BRAIN SCI, V8, P529, DOI 10.1017/S0140525X00044903; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Llinas R, 1998, PHILOS T ROY SOC B, V353, P1841, DOI 10.1098/rstb.1998.0336; LLINAS R, 1993, P NATL ACAD SCI USA, V90, P2078, DOI 10.1073/pnas.90.5.2078; LLINAS RR, 1991, NEUROSCIENCE, V44, P521, DOI 10.1016/0306-4522(91)90075-Y; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Mima T, 2000, CLIN NEUROPHYSIOL, V111, P326, DOI 10.1016/S1388-2457(99)00229-1; Nakatani C, 2005, J COGNITIVE NEUROSCI, V17, P1969, DOI 10.1162/089892905775008706; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rose M, 2005, J NEUROSCI, V25, P10101, DOI 10.1523/JNEUROSCI.2998-05.2005; Rose M, 2006, CEREB CORTEX, V16, P1522, DOI 10.1093/cercor/bhj089; Sarnthein J, 1998, P NATL ACAD SCI USA, V95, P7092, DOI 10.1073/pnas.95.12.7092; Sauseng P, 2008, NEUROIMAGE, V40, P308, DOI 10.1016/j.neuroimage.2007.11.032; Schack B, 2002, INT J PSYCHOPHYSIOL, V44, P143, DOI 10.1016/S0167-8760(01)00199-4; Scherg M, 2002, J CLIN NEUROPHYSIOL, V19, P91, DOI 10.1097/00004691-200203000-00001; SEARLE JR, 1992, REDISCOVERY MIND, P287; Shapiro KL, 1997, TRENDS COGN SCI, V1, P291, DOI 10.1016/S1364-6613(97)01094-2; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Srinivasan R, 1999, J NEUROSCI, V19, P5435; Supp GG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000684; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Tononi G, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-31; Tononi G, 1998, P NATL ACAD SCI USA, V95, P3198, DOI 10.1073/pnas.95.6.3198; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Ward L. M., 1992, PSYCHOPHYSICAL APPRO, P187; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]	81	252	255	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 3	2009	4	7							e6142	10.1371/journal.pone.0006142	http://dx.doi.org/10.1371/journal.pone.0006142			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	468GY	19582165	Green Published, gold, Green Submitted			2022-12-25	WOS:000267806300011
